data_5ms9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5ms9 _Structure_validation_residue.Date_analyzed 2017-08-04 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.527 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 44.6 m-85 . . . . . 0 N--CA 1.449 -0.514 0 CA-C-O 120.51 0.195 . . . . 0.0 110.572 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 20.4 pt -134.96 177.46 6.8 Favored 'Isoleucine or valine' 0 C--O 1.246 0.876 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.498 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.13 174.03 30.22 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.936 -175.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.7 p -70.79 -48.22 55.41 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 120.753 0.311 . . . . 0.0 110.948 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -96.54 5.87 49.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.949 176.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 61.8 m 63.86 42.1 6.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.903 172.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.72 9.18 56.85 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.792 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.13 113.63 43.71 Favored Pre-proline 0 C--O 1.222 -0.384 0 CA-C-N 117.645 0.723 . . . . 0.0 110.125 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.75 143.82 13.51 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.639 2.226 . . . . 0.0 112.612 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 12.7 p -71.08 112.84 6.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.655 -176.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.8 m -81.44 74.63 8.43 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.177 175.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -51.58 -64.33 0.85 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -173.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.6 m -91.9 13.33 18.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.47 0.652 . . . . 0.0 110.717 -169.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 74.13 131.96 0.23 Allowed Glycine 0 N--CA 1.436 -1.347 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.661 -177.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . 0.57 ' O ' HD23 ' A' ' 155' ' ' LEU . 1.7 m -61.49 156.9 18.3 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 113.942 -1.129 . . . . 0.0 109.858 171.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 154' ' ' CYS . 41.2 mt -137.93 178.1 7.37 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -174.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.479 HD22 ' C ' ' A' ' 155' ' ' LEU . 0.1 OUTLIER 35.43 31.25 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.979 1.312 . . . . 0.0 114.446 -178.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 63.31 35.54 92.2 Favored Glycine 0 N--CA 1.454 -0.132 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.593 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -79.24 -147.66 4.1 Favored Glycine 0 C--N 1.328 0.104 0 C-N-CA 121.286 -0.483 . . . . 0.0 113.442 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -157.93 126.44 5.53 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.251 -0.558 . . . . 0.0 110.624 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . 0.408 ' SG ' ' SG ' ' A' ' 154' ' ' CYS . 4.9 m -64.18 124.56 21.98 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 122.241 0.216 . . . . 0.0 110.942 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.64 HG22 ' HG2' ' A' ' 165' ' ' ARG . 1.3 m -116.31 -35.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.913 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' A' ' 165' ' ' ARG . . . -139.28 169.62 11.93 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.527 ' HD3' ' CE1' ' A' ' 140' ' ' TYR . 78.4 Cg_exo -51.16 107.14 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.316 2.01 . . . . 0.0 112.604 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 75.28 -11.35 1.1 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.471 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.64 ' HG2' HG22 ' A' ' 161' ' ' VAL . 18.3 ttp180 -83.45 90.74 7.24 Favored 'General case' 0 CA--C 1.488 -1.425 0 CA-C-O 121.652 0.739 . . . . 0.0 109.312 175.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.61 145.04 28.23 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.648 167.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -92.38 129.23 38.37 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 35.7 m -106.6 132.53 52.49 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.267 0.979 . . . . 0.0 111.925 -167.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 52.6 m -57.07 -55.5 33.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 113.331 -1.759 . . . . 0.0 114.501 -167.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 17.1 t80 177.75 125.89 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.692 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 79.98 28.95 48.45 Favored Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.42 169.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 172' ' ' PHE . 1.4 m-85 -118.34 121.25 39.92 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 118.797 -1.161 . . . . 0.0 110.502 166.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.417 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 4.3 t -89.23 140.11 29.81 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 96.45 128.59 5.81 Favored Glycine 0 N--CA 1.425 -2.038 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -171.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.18 9.76 0.81 Allowed 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.413 1.409 . . . . 0.0 113.229 -168.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.497 ' O ' HD12 ' A' ' 155' ' ' LEU . 41.3 tt0 -117.79 19.79 13.64 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.378 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.432 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.6 OUTLIER 24.31 59.54 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 117.228 2.307 . . . . 0.0 117.228 178.077 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -115.47 21.0 14.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.395 1.093 . . . . 0.0 109.028 168.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 20.6 mmt180 -113.3 81.53 1.52 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.658 -1.61 . . . . 0.0 107.603 175.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.509 ' HA ' ' CE2' ' A' ' 172' ' ' PHE . 2.3 m-20 -80.5 49.6 1.18 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.52 -167.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.496 ' CG ' ' O ' ' A' ' 181' ' ' TYR . 20.4 p90 -86.32 98.64 11.08 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -87.27 155.14 20.19 Favored 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 118.296 -2.753 . . . . 0.0 106.763 175.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 19.8 p -86.06 135.45 33.62 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.049 -1.06 . . . . 0.0 109.618 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -153.64 155.09 25.94 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -73.77 129.25 13.29 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.16 1.907 . . . . 0.0 110.809 173.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 10.6 t -82.43 114.21 20.72 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . 0.426 ' O ' ' HB2' ' A' ' 215' ' ' ARG . 59.3 m-85 -94.29 138.93 31.71 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.773 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' THR . . . . . 0.464 ' O ' ' HD2' ' A' ' 215' ' ' ARG . 89.2 m -107.8 -19.76 13.43 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -163.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 25.4 t -150.47 115.62 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 121.467 -0.771 . . . . 0.0 109.613 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.613 ' CG1' ' HA ' ' A' ' 195' ' ' CYS . 16.5 mt -130.88 120.16 46.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 10.7 p -117.08 -166.5 1.18 Allowed 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 155.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -66.75 -5.29 11.48 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.841 0.829 . . . . 0.0 109.764 172.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -83.76 -73.79 0.4 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.224 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 60.7 mtt -128.38 161.18 30.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.443 0.163 . . . . 0.0 110.966 -175.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.613 ' HA ' ' CG1' ' A' ' 190' ' ' ILE . 84.5 m -92.03 -25.55 18.76 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.572 173.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -161.27 -58.7 0.05 Allowed 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 169.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 125.78 -26.05 5.46 Favored Glycine 0 C--N 1.317 -0.48 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.619 170.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -118.13 -0.11 11.66 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 117.159 0.48 . . . . 0.0 111.294 176.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 62.75 175.48 0.15 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.83 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 22.8 t 176.14 130.3 0.04 OUTLIER 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.543 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -84.23 36.32 2.92 Favored Glycine 0 CA--C 1.509 -0.343 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 174.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.97 104.3 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 122.331 1.062 . . . . 0.0 109.412 175.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 37.9 t -93.05 124.1 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 CA-C-N 113.841 -1.527 . . . . 0.0 109.631 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 20.2 t -154.64 -177.3 6.39 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 104.292 -2.484 . . . . 0.0 104.292 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 14.3 p -99.36 157.28 16.52 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 120.317 1.417 . . . . 0.0 109.014 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.597 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 36.5 tttm -56.61 -44.37 81.06 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 120.201 -0.599 . . . . 0.0 109.788 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.2 m -43.58 -54.87 4.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.892 174.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.14 -53.07 60.62 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 124.05 0.844 . . . . 0.0 111.322 177.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 94.6 m -63.69 -26.62 68.75 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -176.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 226' ' ' ALA . 60.9 m -85.79 -47.49 9.68 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 118.481 0.582 . . . . 0.0 110.008 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -67.23 -54.44 21.0 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -173.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.56 HG22 ' HA2' ' A' ' 234' ' ' GLY . 16.2 p -102.8 152.86 20.76 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.851 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER 66.12 -40.5 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.336 0.654 . . . . 0.0 112.14 -176.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 61.01 59.06 10.75 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 119.134 0.879 . . . . 0.0 114.785 169.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.464 ' HD2' ' O ' ' A' ' 188' ' ' THR . 8.6 mmt85 -128.64 -90.12 0.5 Allowed 'General case' 0 C--O 1.245 0.827 0 CA-C-N 117.845 0.822 . . . . 0.0 111.847 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.472 ' CB ' HD12 ' A' ' 190' ' ' ILE . . . -165.93 168.46 15.74 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . 0.597 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 11.2 t90 -164.96 150.15 9.53 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 95.84 -174.06 31.29 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.305 -0.95 . . . . 0.0 114.245 168.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -137.09 133.55 18.57 Favored Pre-proline 0 N--CA 1.444 -0.729 0 CA-C-O 121.248 0.547 . . . . 0.0 111.163 -175.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -86.11 117.05 4.09 Favored 'Cis proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.408 -1.913 . . . . 0.0 112.233 -5.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 70.3 m 33.23 94.57 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.768 1.227 . . . . 0.0 113.781 177.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 36.3 mt-10 -101.17 113.63 26.84 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.76 139.5 35.34 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.779 0.323 . . . . 0.0 111.253 -170.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 5.9 p -145.62 155.98 52.74 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.926 -175.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.64 166.89 14.53 Favored 'Trans proline' 0 CA--C 1.504 -1.025 0 C-N-CA 122.27 1.98 . . . . 0.0 111.339 167.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 210' ' ' CYS . . . -63.75 -122.98 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 O-C-N 123.969 0.793 . . . . 0.0 111.794 171.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.68 108.97 1.22 Allowed Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.533 -173.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -80.58 -57.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.71 2.273 . . . . 0.0 113.168 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -84.15 153.56 63.01 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.12 64.75 8.39 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.415 2.077 . . . . 0.0 112.543 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 80.6 m -119.48 -103.85 0.4 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 172.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.529 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 59.5 mtt180 -145.45 134.43 22.57 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 172.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -39.85 -41.97 1.23 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.56 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -73.45 9.7 7.44 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.417 -0.897 . . . . 0.0 113.882 -176.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . 0.529 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 6.1 m-85 -124.05 146.97 48.22 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 122.099 0.952 . . . . 0.0 112.595 -171.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -122.6 129.02 25.2 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 114.009 -1.451 . . . . 0.0 108.432 171.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -62.04 113.39 1.85 Allowed 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.097 1.865 . . . . 0.0 111.202 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -48.48 128.67 15.16 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.512 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 26.9 pt -75.75 4.18 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.587 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -110.97 -56.73 2.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.008 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 36.0 p -94.42 -37.53 11.39 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.01 -176.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 100.93 0.17 55.06 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.175 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -81.62 129.94 34.87 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.784 0.802 . . . . 0.0 110.578 -176.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 2.2 m -61.44 115.05 3.58 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 113.816 -1.538 . . . . 0.0 109.371 173.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 45.4 tt0 -119.57 139.74 51.66 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.187 -177.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.577 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 20.0 t70 -77.24 145.43 37.55 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -177.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.543 HG23 ' HG3' ' A' ' 249' ' ' GLU . 15.1 m -100.15 145.26 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.411 ' OD2' ' HB2' ' A' ' 250' ' ' CYS . 10.4 t70 -73.63 80.51 1.51 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 165.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.543 ' HG3' HG23 ' A' ' 247' ' ' VAL . 36.8 mp0 -51.63 -34.85 39.56 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.175 0.512 . . . . 0.0 110.334 -174.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.411 ' HB2' ' OD2' ' A' ' 248' ' ' ASP . 62.8 m -52.58 -44.22 65.78 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.501 173.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -90.16 -32.09 16.78 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.68 0.752 . . . . 0.0 110.401 -173.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.1 -17.43 31.04 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.942 -170.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.599 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.1 mp -125.55 79.93 66.71 Favored Pre-proline 0 C--O 1.239 0.551 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -39.41 114.23 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 124.446 3.431 . . . . 0.0 115.48 -172.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 57.74 34.37 70.43 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 113.637 -1.619 . . . . 0.0 114.174 174.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.599 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.9 OUTLIER -73.54 -24.51 60.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 118.16 0.98 . . . . 0.0 110.905 177.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 50.5 t -90.49 114.69 26.93 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -103.77 83.36 2.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.267 0.556 . . . . 0.0 110.609 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -158.9 -105.49 0.21 Allowed Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.185 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -124.29 -88.33 0.8 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.525 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' ASN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 272' ' ' LYS . 10.2 m120 -94.84 157.65 15.83 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 11.8 t -137.85 126.12 23.14 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 173.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 41.0 mt -132.13 169.78 21.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -171.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.43 ' ND2' ' HB3' ' A' ' 269' ' ' PHE . 0.9 OUTLIER -134.96 130.28 35.55 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 117.248 -1.781 . . . . 0.0 113.835 -174.249 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 1.7 t -113.61 163.96 14.29 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.532 163.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.577 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 4.1 m -73.12 130.0 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 C-N-CA 119.312 -0.955 . . . . 0.0 108.719 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.429 ' N ' ' CE2' ' A' ' 235' ' ' PHE . . . 98.2 -17.52 58.49 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.959 -175.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 41.9 t -179.69 150.74 0.42 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.532 1.166 . . . . 0.0 110.524 -173.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . 0.43 ' HB3' ' ND2' ' A' ' 264' ' ' ASN . 30.2 p90 -96.43 160.28 14.49 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.61 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -116.77 117.59 30.19 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -177.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 68.8 m -102.61 132.39 48.74 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.237 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 261' ' ' ASN . 22.7 ttpp -101.18 122.52 43.78 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.131 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 56.6 m -107.1 145.1 30.46 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.114 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . 0.428 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 38.9 Cg_exo -57.97 156.34 29.27 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.636 2.224 . . . . 0.0 110.842 169.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -54.41 146.37 16.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.073 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.15 -29.67 3.44 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.803 -177.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' HIS . . . . . 0.572 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 29.8 m-70 -81.25 162.66 23.44 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 120.986 0.422 . . . . 0.0 110.728 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -146.63 116.83 7.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.044 -171.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 45.2 tp -63.13 127.75 32.68 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.977 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -114.8 101.57 9.19 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -70.17 -8.02 46.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.724 0.297 . . . . 0.0 111.339 -173.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 51.5 t -67.68 -31.77 53.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.514 0.674 . . . . 0.0 110.18 172.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 30.7 p -139.68 28.93 2.15 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.015 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 29.46 44.87 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.166 0.986 . . . . 0.0 113.292 -172.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -112.36 127.24 55.95 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.906 -172.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 98.0 m -88.03 107.62 18.83 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 171.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 8.9 tp10 . . . . . 0 C--O 1.244 0.792 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.582 ' CE2' ' HD3' ' A' ' 163' ' ' PRO . 51.6 m-85 . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 120.932 0.396 . . . . 0.0 110.001 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 23.9 pt -137.21 -173.15 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.179 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.75 176.5 46.84 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.649 -174.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.8 p -75.08 -32.75 61.54 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.596 -0.355 . . . . 0.0 111.726 -176.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -109.72 16.01 22.38 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.981 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 60.7 m 61.71 30.19 18.36 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.634 175.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.05 2.86 61.8 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.733 -1.223 . . . . 0.0 113.112 -174.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.72 103.93 54.27 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 117.434 0.617 . . . . 0.0 110.192 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.89 149.82 26.39 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.468 2.112 . . . . 0.0 112.553 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.07 105.14 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 122.118 0.961 . . . . 0.0 112.179 -174.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.8 m -80.69 82.41 6.7 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.958 173.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -51.04 -64.91 0.66 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -175.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 31.2 m -97.07 9.55 41.77 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.083 0.468 . . . . 0.0 110.862 -166.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 80.23 131.67 0.99 Allowed Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.333 -174.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . 0.44 ' O ' HD23 ' A' ' 155' ' ' LEU . 85.7 m -72.21 159.43 34.11 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.323 -0.939 . . . . 0.0 108.881 172.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.539 HD12 ' O ' ' A' ' 176' ' ' GLN . 76.6 mt -141.79 164.35 30.43 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.719 0.295 . . . . 0.0 110.517 -167.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 10.5 t30 52.0 24.43 2.63 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.413 1.07 . . . . 0.0 111.364 -166.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.05 38.41 95.96 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.39 -173.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.14 -151.6 0.45 Allowed Glycine 0 CA--C 1.524 0.596 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.42 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -151.51 119.29 6.14 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 122.0 -0.706 . . . . 0.0 111.894 -175.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.27 125.76 22.06 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 176.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 165' ' ' ARG . 20.0 m -118.06 -39.36 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 120.615 0.245 . . . . 0.0 110.966 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.477 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -140.63 171.19 8.05 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.582 ' HD3' ' CE2' ' A' ' 140' ' ' TYR . 87.3 Cg_exo -52.02 110.69 0.47 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 121.872 1.714 . . . . 0.0 111.988 175.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 77.11 -14.35 0.85 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.97 0.908 . . . . 0.0 110.793 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.477 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 1.7 mtm-85 -86.65 88.51 7.68 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 121.19 0.519 . . . . 0.0 110.151 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 73.8 m -82.31 145.98 29.67 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.965 166.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -89.75 119.32 30.05 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 175.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 73.6 m -98.12 130.1 44.91 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.97 0.794 . . . . 0.0 111.249 -171.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 16.4 m -53.8 -56.86 13.73 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -167.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -158.19 -86.51 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.131 -1.027 . . . . 0.0 112.332 -169.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -90.76 44.64 2.88 Favored Glycine 0 CA--C 1.498 -1.028 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.378 -166.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.498 ' CD1' ' N ' ' A' ' 172' ' ' PHE . 3.1 m-85 -118.69 129.49 55.31 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.401 173.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.57 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 7.4 t -103.4 141.44 35.95 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 94.59 124.65 4.16 Favored Glycine 0 C--N 1.298 -1.542 0 N-CA-C 107.916 -2.074 . . . . 0.0 107.916 -168.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -72.21 19.55 0.3 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.934 1.756 . . . . 0.0 113.175 -166.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.539 ' O ' HD12 ' A' ' 155' ' ' LEU . 45.2 tt0 -122.58 15.21 10.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 176.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.438 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.6 OUTLIER 28.68 56.37 0.11 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 117.314 2.339 . . . . 0.0 117.314 177.549 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -111.46 22.05 15.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 122.34 1.066 . . . . 0.0 108.873 167.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.479 ' HD2' ' O ' ' A' ' 173' ' ' THR . 92.3 mtt180 -116.07 86.88 2.56 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.222 -1.353 . . . . 0.0 109.007 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -85.63 48.63 1.62 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.547 -168.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.57 ' HE2' ' N ' ' A' ' 173' ' ' THR . 25.0 p90 -85.6 95.67 9.41 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -78.28 162.63 26.38 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 118.781 -2.449 . . . . 0.0 108.681 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 75.3 p -96.26 138.64 33.56 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.227 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -159.19 162.12 32.51 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.095 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -83.13 143.86 11.58 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.842 2.361 . . . . 0.0 111.889 173.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 4.9 t -96.71 115.82 28.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.959 0.409 . . . . 0.0 110.252 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -95.73 149.09 21.87 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.982 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 6.6 m -117.13 -15.08 10.53 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -167.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 26.2 t -145.66 114.35 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 O-C-N 121.176 -0.953 . . . . 0.0 110.709 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.449 HD11 ' CB ' ' A' ' 216' ' ' ALA . 3.5 mt -134.87 118.95 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -173.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.3 m -115.56 -166.84 1.17 Allowed 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 155.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -68.49 -5.06 17.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.761 0.791 . . . . 0.0 109.991 172.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -73.3 -74.01 0.19 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.353 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 62.3 mtt -149.67 160.68 43.32 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 196' ' ' GLN . 55.5 m -89.52 -19.48 24.98 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.652 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.507 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 36.6 tt0 166.06 -85.9 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.204 171.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 126.43 -27.24 5.04 Favored Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 171.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -82.25 69.16 8.93 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 167.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.73 142.44 58.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.36 0.6 . . . . 0.0 111.023 -175.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 29.7 t -113.84 143.52 44.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.471 -175.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.95 22.28 8.38 Favored Glycine 0 CA--C 1.501 -0.783 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.179 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.593 HD12 ' HA ' ' A' ' 253' ' ' ILE . 1.5 tt -60.09 99.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 171.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 25.2 t -86.91 95.11 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.533 0 CA-C-O 123.918 1.818 . . . . 0.0 108.36 171.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.9 m -133.45 -179.03 5.26 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 111.123 -2.762 . . . . 0.0 106.072 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 27.5 p -103.29 166.74 10.25 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.131 -1.028 . . . . 0.0 112.323 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.562 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 21.9 tttp -61.13 -41.79 97.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.345 173.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 30.3 m -45.05 -52.04 9.4 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 114.515 -1.22 . . . . 0.0 109.409 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.417 HD11 HG11 ' A' ' 247' ' ' VAL . 8.6 tp -63.09 -49.27 75.15 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 112.53 -2.123 . . . . 0.0 110.606 -174.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 88.0 m -68.51 -22.4 64.53 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.543 -177.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 20.9 m -81.18 -45.2 16.72 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 123.681 0.613 . . . . 0.0 110.672 173.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.17 -52.35 35.55 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -172.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.501 ' CG2' ' HA2' ' A' ' 234' ' ' GLY . 17.7 p -105.56 152.78 22.65 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.198 177.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 1.4 t 67.55 -45.05 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 123.584 0.754 . . . . 0.0 112.218 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.56 ' O ' ' HD2' ' A' ' 215' ' ' ARG . . . 55.35 59.43 10.48 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 118.559 0.618 . . . . 0.0 114.499 173.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.56 ' HD2' ' O ' ' A' ' 214' ' ' GLY . 17.4 mmm180 -125.64 -75.98 0.59 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.226 0.513 . . . . 0.0 111.048 177.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.449 ' CB ' HD11 ' A' ' 190' ' ' ILE . . . -171.1 163.39 7.29 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 118.642 0.656 . . . . 0.0 109.88 174.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . 0.587 ' O ' ' HB2' ' A' ' 222' ' ' GLU . 19.1 t90 -158.81 142.77 15.37 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 106.15 179.03 23.41 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.144 -1.027 . . . . 0.0 113.954 170.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -135.52 133.44 20.33 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -89.6 118.36 3.64 Favored 'Cis proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.496 -1.46 . . . . 0.0 111.733 -4.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 68.7 m 45.17 88.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.587 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 12.3 mt-10 -107.27 107.23 18.06 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -75.21 144.06 42.85 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.746 -166.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -123.53 120.95 26.85 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -174.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -62.14 167.04 11.47 Favored 'Trans proline' 0 CA--C 1.499 -1.239 0 C-N-CA 122.089 1.859 . . . . 0.0 110.563 159.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.35 -142.24 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 122.289 1.042 . . . . 0.0 110.397 163.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.37 106.37 0.65 Allowed Pre-proline 0 C--N 1.298 -1.668 0 CA-C-N 113.82 -1.536 . . . . 0.0 112.168 -169.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.1 -57.57 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.234 2.623 . . . . 0.0 112.87 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -95.99 162.8 22.73 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -64.31 83.27 0.15 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.135 1.89 . . . . 0.0 112.271 174.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 34.1 t -157.91 152.67 25.12 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.196 -1.365 . . . . 0.0 107.504 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.465 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 24.0 mtt180 -64.04 131.68 48.29 Favored 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.101 -176.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -38.56 -45.95 1.13 Allowed 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -175.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.501 ' HA2' ' CG2' ' A' ' 212' ' ' THR . . . -72.99 7.22 10.05 Favored Glycine 0 C--N 1.319 -0.385 0 C-N-CA 120.718 -0.753 . . . . 0.0 114.256 -173.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 232' ' ' ARG . 3.5 m-85 -122.28 150.66 42.02 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.942 0.877 . . . . 0.0 112.61 -171.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.62 121.34 25.78 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 114.309 -1.314 . . . . 0.0 107.819 169.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.49 115.27 2.33 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.093 2.529 . . . . 0.0 112.26 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -50.62 137.9 18.89 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.853 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 41.8 mt -71.17 -16.34 19.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.207 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 -100.9 -62.46 1.24 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.617 0.722 . . . . 0.0 109.973 -174.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 32.2 p -80.18 -40.1 27.95 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.382 -176.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 98.05 8.26 55.52 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -90.81 127.03 36.2 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 121.852 0.834 . . . . 0.0 110.615 -177.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 95.8 m -50.49 121.0 5.12 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 113.227 -1.806 . . . . 0.0 110.85 172.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -120.36 133.32 55.46 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 7.2 t70 -77.18 149.68 35.54 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -173.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.549 HG23 ' HG3' ' A' ' 249' ' ' GLU . 11.0 m -100.15 145.26 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -177.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -72.54 75.89 1.07 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 167.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.549 ' HG3' HG23 ' A' ' 247' ' ' VAL . 17.1 mp0 -53.24 -37.59 62.21 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.271 0.628 . . . . 0.0 110.654 -169.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 56.4 m -51.13 -35.83 37.56 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.096 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -100.43 -37.63 8.76 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.865 0.84 . . . . 0.0 110.246 -176.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -71.13 -17.72 62.55 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.374 -176.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.627 HG22 ' HB3' ' A' ' 256' ' ' LEU . 5.3 mp -135.31 73.24 64.25 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 173.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.453 ' HD2' HG13 ' A' ' 202' ' ' ILE . 36.0 Cg_endo -62.65 124.28 13.85 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.509 2.139 . . . . 0.0 112.902 -170.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 95.18 -4.95 67.9 Favored Glycine 0 C--N 1.308 -0.995 0 CA-C-N 114.429 -1.259 . . . . 0.0 113.437 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.627 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.5 OUTLIER -68.03 -39.73 83.04 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 118.392 1.096 . . . . 0.0 110.0 -176.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 46.6 t -122.95 69.47 0.99 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.493 0.663 . . . . 0.0 109.281 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -107.46 16.04 24.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.964 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -87.55 -4.73 79.69 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.796 178.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -169.08 -137.61 2.29 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' ASN . . . . . 0.423 ' OD1' ' HE2' ' A' ' 272' ' ' LYS . 2.9 t-20 -88.66 156.82 18.8 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 9.1 t -145.79 125.12 13.04 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 7.6 mt -130.05 165.74 29.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 -174.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.477 ' ND2' ' HB3' ' A' ' 269' ' ' PHE . 0.8 OUTLIER -132.2 121.49 23.76 Favored 'General case' 0 CA--C 1.494 -1.177 0 C-N-CA 117.461 -1.695 . . . . 0.0 114.627 -177.051 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.1 t -105.83 159.83 15.71 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.777 167.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.443 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 35.7 m -72.28 121.4 22.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 114.42 -30.77 6.78 Favored Glycine 0 C--N 1.316 -0.547 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.423 -169.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.0 m -179.22 163.97 1.34 Allowed 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 118.383 1.091 . . . . 0.0 110.164 -169.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . 0.477 ' HB3' ' ND2' ' A' ' 264' ' ' ASN . 34.9 p90 -104.7 153.24 21.52 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.803 174.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -108.27 118.2 36.13 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.454 -175.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 99.5 m -105.71 160.52 15.15 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.415 0.626 . . . . 0.0 110.372 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.423 ' HE2' ' OD1' ' A' ' 261' ' ' ASN . 46.2 mtmt -138.69 123.27 18.52 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.194 176.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 68.0 m -99.45 137.28 20.28 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.091 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -48.94 152.71 4.41 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.913 2.409 . . . . 0.0 111.055 170.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -48.96 134.27 17.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.054 0.454 . . . . 0.0 111.811 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 88.63 -36.21 3.48 Favored Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.53 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' HIS . . . . . 0.438 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 24.4 m-70 -71.1 156.99 38.95 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.565 0.698 . . . . 0.0 111.329 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -140.94 129.26 22.37 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.924 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 42.4 tp -62.18 125.24 23.21 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.423 0.63 . . . . 0.0 111.016 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.49 ' OD1' ' HB ' ' A' ' 282' ' ' VAL . 22.0 t-20 -111.52 97.16 6.54 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -64.6 -15.73 61.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.455 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.49 ' HB ' ' OD1' ' A' ' 280' ' ' ASN . 48.1 t -57.58 -29.39 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 120.83 0.348 . . . . 0.0 110.416 173.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.502 ' O ' ' HG3' ' A' ' 285' ' ' LYS . 19.5 p -142.47 25.75 1.83 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.543 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 256' ' ' LEU . 79.0 mm-40 28.57 41.93 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -167.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 283' ' ' SER . 90.7 mttt -115.65 135.72 53.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.306 0.575 . . . . 0.0 111.836 -173.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 94.1 m -87.61 112.45 22.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.825 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 10.8 tp10 . . . . . 0 N--CA 1.433 -1.289 0 CA-C-O 118.12 -0.943 . . . . 0.0 108.499 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.578 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 91.3 m-85 . . . . . 0 C--O 1.234 0.242 0 CA-C-O 121.14 0.495 . . . . 0.0 111.764 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 34.7 pt -132.71 -174.43 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.41 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.67 -170.81 34.04 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.904 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.1 p -77.83 -44.11 28.37 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.918 0.389 . . . . 0.0 111.7 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -111.35 21.12 16.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.084 -176.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 27.2 m 66.51 27.24 9.77 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 124.009 0.818 . . . . 0.0 110.551 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.2 -4.13 88.4 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.859 -172.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.57 110.11 41.03 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 118.292 1.046 . . . . 0.0 110.976 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.78 149.89 18.37 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.978 2.452 . . . . 0.0 112.385 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 149' ' ' VAL . 14.3 p -83.12 103.74 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-O 121.702 0.763 . . . . 0.0 111.089 -172.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.22 88.13 5.5 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.636 171.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -57.94 -53.85 53.62 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -169.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 34.7 m -95.82 16.87 16.41 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.199 0.524 . . . . 0.0 111.112 -169.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 77.26 129.5 0.41 Allowed Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.3 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 35.5 m -76.1 150.85 37.18 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.421 -1.389 . . . . 0.0 110.129 172.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.564 HD12 ' O ' ' A' ' 176' ' ' GLN . 76.7 mt -147.72 167.34 24.89 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.019 -168.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.601 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 2.3 t-20 48.87 27.02 1.46 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.03 -164.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 66.39 37.22 92.57 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.756 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -68.66 -150.87 0.33 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.64 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -157.35 126.76 6.0 Favored 'General case' 0 C--N 1.318 -0.761 0 O-C-N 122.191 -0.594 . . . . 0.0 111.214 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -67.28 120.19 13.4 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 175.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.623 HG22 ' HG2' ' A' ' 165' ' ' ARG . 1.0 OUTLIER -109.16 -43.77 6.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.211 179.232 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' A' ' 165' ' ' ARG . . . -134.28 170.77 10.42 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 173.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.578 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 75.7 Cg_exo -54.34 111.36 0.69 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.282 1.988 . . . . 0.0 112.681 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 69.91 -1.82 2.23 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.928 0.891 . . . . 0.0 110.736 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.623 ' HG2' HG22 ' A' ' 161' ' ' VAL . 5.7 ttp180 -93.45 89.24 6.23 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 121.5 0.667 . . . . 0.0 109.216 169.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 49.3 t -92.41 139.83 30.2 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.375 171.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -90.52 106.91 18.82 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 80.3 m -84.68 134.79 34.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.617 -171.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 28.6 m -55.21 -55.53 30.23 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -168.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -175.7 117.89 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.016 0.436 . . . . 0.0 111.328 -178.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 76.94 42.41 20.24 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.433 -0.803 . . . . 0.0 114.28 165.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.601 ' CE2' ' HB2' ' A' ' 156' ' ' ASN . 62.3 m-85 -120.93 140.31 52.02 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 117.59 0.695 . . . . 0.0 112.146 163.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.731 HG23 ' CE2' ' A' ' 181' ' ' TYR . 39.6 p -87.1 119.24 27.12 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.724 0.774 . . . . 0.0 110.617 -177.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 101.84 144.69 15.2 Favored Glycine 0 N--CA 1.425 -2.048 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.18 20.62 0.4 Allowed 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.162 1.241 . . . . 0.0 112.306 -172.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.564 ' O ' HD12 ' A' ' 155' ' ' LEU . 35.7 tt0 -113.73 1.04 14.73 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.789 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.585 ' HA ' ' CB ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 36.32 62.3 0.72 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 118.018 2.599 . . . . 0.0 118.018 178.044 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -120.63 1.04 10.55 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 119.869 -0.732 . . . . 0.0 111.835 174.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 32.7 mmt180 -106.62 100.35 9.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.335 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.558 ' HA ' ' CE1' ' A' ' 172' ' ' PHE . 1.3 m-20 -74.63 100.63 4.0 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.291 -170.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.731 ' CE2' HG23 ' A' ' 173' ' ' THR . 19.7 p90 -140.05 77.97 1.64 Allowed 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 172.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 63.5 mtt85 -73.3 127.43 32.63 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 118.597 -2.564 . . . . 0.0 108.503 175.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 3.9 p -78.13 164.52 24.91 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.978 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.532 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . 157.29 142.31 3.37 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.651 -162.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.53 132.47 6.8 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.821 2.347 . . . . 0.0 112.096 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . 0.622 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 76.8 m -90.86 112.05 23.72 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.408 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -89.0 154.81 19.91 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.17 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 35.1 p -105.27 -18.86 13.99 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -165.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 p -167.95 118.28 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-N 118.889 0.768 . . . . 0.0 110.474 -174.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.1 mt -130.35 123.11 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -169.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.1 m -126.44 -166.48 1.58 Allowed 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 162.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -61.08 -8.2 3.19 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.321 0.964 . . . . 0.0 110.251 174.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -75.66 -76.05 0.16 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.114 -175.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 70.7 mtm -144.42 168.58 19.76 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 67.6 m -86.67 -36.54 18.68 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 122.335 1.064 . . . . 0.0 109.292 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -148.14 -67.44 0.24 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.731 173.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 123.69 -0.26 9.28 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.508 171.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -119.0 -19.8 8.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.343 -0.428 . . . . 0.0 111.076 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 63.24 97.11 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.222 0.534 . . . . 0.0 111.077 -176.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 42.4 t -113.68 140.18 48.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.709 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -94.08 25.68 20.79 Favored Glycine 0 CA--C 1.505 -0.533 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.986 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.455 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -61.72 107.0 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 121.989 0.9 . . . . 0.0 109.388 174.62 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.0 t -98.27 120.98 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 CA-C-O 122.734 1.254 . . . . 0.0 110.193 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 14.3 t -152.91 -178.76 7.11 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 103.137 -2.912 . . . . 0.0 103.137 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.535 HG21 ' HA ' ' A' ' 181' ' ' TYR . 8.0 p -102.38 161.44 13.7 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 121.197 1.817 . . . . 0.0 108.763 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.53 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 53.6 tttm -57.24 -43.22 82.73 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.997 177.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.5 m -47.9 -54.96 11.0 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.925 175.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.412 ' CD1' HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -58.37 -55.07 39.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.716 179.574 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 65.8 m -74.45 -20.95 59.83 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -170.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 80.0 m -90.22 -38.81 13.19 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 121.878 -0.514 . . . . 0.0 110.595 176.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -67.74 -57.73 5.84 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.52 HG22 ' HA2' ' A' ' 234' ' ' GLY . 3.4 p -92.53 160.81 14.87 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.385 -1.279 . . . . 0.0 107.765 175.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 27.3 m 58.01 -35.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 125.196 1.398 . . . . 0.0 114.668 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 58.11 60.45 8.93 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 119.548 1.067 . . . . 0.0 114.8 167.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.85 -95.02 0.49 Allowed 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.356 175.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -164.02 163.17 23.41 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 174.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . 0.622 ' HD1' ' SG ' ' A' ' 186' ' ' CYS . 17.7 t90 -151.45 146.33 25.85 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 121.56 -0.712 . . . . 0.0 109.794 -174.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 86.75 -179.93 48.97 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.167 -0.539 . . . . 0.0 113.774 171.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.572 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 8.9 p80 -141.28 131.1 12.89 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 175.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . 0.572 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 10.5 Cg_endo -53.63 149.51 16.15 Favored 'Cis proline' 0 C--N 1.352 0.763 0 C-N-CA 123.772 -1.345 . . . . 0.0 111.856 -5.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 22.2 m -63.43 83.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.775 0.672 . . . . 0.0 112.52 -170.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -58.55 123.0 14.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.63 0.252 . . . . 0.0 110.619 173.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.36 147.32 30.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.259 -175.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 18.8 m -142.0 148.51 49.02 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -173.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -65.2 166.1 20.04 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.059 1.839 . . . . 0.0 109.151 156.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.27 -107.32 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.314 0.578 . . . . 0.0 111.564 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.07 113.05 5.69 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.325 -172.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -89.9 -61.75 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.111 2.54 . . . . 0.0 112.526 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -78.73 163.36 61.3 Favored Pre-proline 0 CA--C 1.514 -0.44 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.79 52.69 2.18 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.753 1.636 . . . . 0.0 112.865 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 50.9 m -123.67 -178.0 3.9 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 171.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.518 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 26.0 mmt180 -76.72 142.18 40.58 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.169 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 32.5 ptt-85 -38.5 -40.37 0.56 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 176.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.52 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -75.15 5.56 33.29 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.626 -176.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . 0.518 ' CD1' ' HB2' ' A' ' 232' ' ' ARG . 2.0 m-85 -120.88 154.85 35.29 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.971 0.891 . . . . 0.0 112.493 -171.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.39 130.5 23.54 Favored Pre-proline 0 N--CA 1.441 -0.877 0 CA-C-N 113.982 -1.463 . . . . 0.0 108.152 170.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -61.15 112.86 1.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.001 1.8 . . . . 0.0 111.126 175.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -48.02 135.06 13.17 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.719 0.771 . . . . 0.0 110.678 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 23.6 mt -71.21 -12.52 16.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.496 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -107.96 -59.45 1.84 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.395 0.617 . . . . 0.0 110.677 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 33.7 p -81.68 -39.81 23.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.187 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 100.32 4.18 55.18 Favored Glycine 0 N--CA 1.435 -1.367 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -84.5 126.96 33.76 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 121.853 0.835 . . . . 0.0 110.634 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 7.4 m -55.61 120.16 6.81 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.716 172.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -126.85 132.89 50.85 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 7.3 t70 -77.8 147.42 35.25 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 121.447 0.641 . . . . 0.0 109.632 -175.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.616 HG23 ' HG3' ' A' ' 249' ' ' GLU . 10.4 m -97.83 145.09 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.281 -177.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -74.28 76.86 1.84 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 168.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.616 ' HG3' HG23 ' A' ' 247' ' ' VAL . 28.2 mp0 -52.11 -37.8 55.3 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 124.021 0.826 . . . . 0.0 109.946 -171.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 42.6 m -47.7 -36.4 11.2 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.824 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -102.4 -42.88 5.84 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.685 0.755 . . . . 0.0 110.319 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -63.84 -23.07 67.21 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.8 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.629 ' O ' ' HB2' ' A' ' 256' ' ' LEU . 3.9 mp -124.05 88.2 52.74 Favored Pre-proline 0 N--CA 1.45 -0.434 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 174.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -73.1 142.46 34.35 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 121.301 1.334 . . . . 0.0 112.35 -175.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 77.43 5.7 85.96 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.506 -170.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.629 ' HB2' ' O ' ' A' ' 253' ' ' ILE . 10.4 tp -53.24 -92.31 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 122.827 0.451 . . . . 0.0 111.285 175.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 22.9 t -96.08 61.52 2.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.502 0.668 . . . . 0.0 109.51 -175.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -86.6 51.9 2.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.628 0.728 . . . . 0.0 109.643 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . 0.423 ' O ' ' HD3' ' A' ' 274' ' ' PRO . . . -137.6 28.35 2.76 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 148.43 -133.24 4.5 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -177.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -103.28 158.02 16.61 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 42.7 t -142.76 124.44 14.98 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 50.6 mt -130.21 116.33 36.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.918 -167.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -76.23 120.4 21.45 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.85 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.7 t -107.21 158.77 16.85 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 158.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 31.3 m -75.11 123.15 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 C-N-CA 118.612 -1.235 . . . . 0.0 108.498 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.489 ' N ' ' HE1' ' A' ' 235' ' ' PHE . . . 113.04 -24.22 13.07 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.669 -171.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.7 t 174.01 162.08 0.18 Allowed 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 117.471 0.636 . . . . 0.0 109.852 -172.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -102.8 158.45 16.25 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 121.002 -1.061 . . . . 0.0 109.178 174.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -115.51 127.96 55.65 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 56.7 m -100.43 152.01 20.86 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.529 0.68 . . . . 0.0 111.751 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -121.59 100.42 7.0 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.08 171.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 18.2 m -88.8 156.99 49.59 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.395 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 43.6 Cg_exo -58.07 156.03 31.2 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 121.831 1.687 . . . . 0.0 110.359 171.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -56.55 144.53 31.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.655 0.264 . . . . 0.0 110.842 -177.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.13 -32.69 3.48 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.237 -0.983 . . . . 0.0 111.968 -176.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' HIS . . . . . 0.458 ' HB2' ' O ' ' A' ' 274' ' ' PRO . 14.6 m-70 -72.42 154.69 40.75 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.06 0.457 . . . . 0.0 111.283 -175.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -137.68 121.27 17.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.862 -174.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 35.2 tp -69.52 136.95 52.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.114 0.483 . . . . 0.0 111.672 -175.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -124.11 100.51 6.75 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 171.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -65.16 -14.19 59.98 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.951 0.782 . . . . 0.0 112.533 -172.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 73.5 t -58.43 -36.93 61.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.629 0.728 . . . . 0.0 109.874 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 31.3 m -134.08 30.49 3.63 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.398 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 23.51 50.52 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 114.135 -1.393 . . . . 0.0 113.164 -172.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -102.36 130.79 49.2 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.439 -174.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 33.3 m -94.87 97.8 10.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.652 173.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.668 -0.682 . . . . 0.0 109.305 -179.553 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.443 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 90.6 m-85 . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 33.3 pt -141.41 -171.21 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 123.531 0.519 . . . . 0.0 110.376 -173.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 86.97 -174.08 45.51 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.254 -0.884 . . . . 0.0 112.369 -174.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.5 p -75.82 -34.36 60.13 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -110.78 12.44 22.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.034 -176.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 33.6 m 62.66 29.46 16.86 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 123.668 0.605 . . . . 0.0 110.258 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.17 -17.92 60.13 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.618 -172.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.69 120.91 56.23 Favored Pre-proline 0 C--N 1.326 -0.428 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.315 -174.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -88.7 140.63 4.31 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.933 2.422 . . . . 0.0 112.605 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.1 p -66.52 105.29 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 122.25 1.024 . . . . 0.0 111.731 -173.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 76.84 6.8 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.989 175.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -52.41 -65.82 0.49 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -176.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 37.7 m -85.6 23.37 1.39 Allowed 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 120.728 0.299 . . . . 0.0 111.63 -171.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 106.43 -101.6 1.79 Allowed Glycine 0 N--CA 1.436 -1.301 0 CA-C-O 122.21 0.895 . . . . 0.0 113.049 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 148.43 131.43 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 111.368 -2.416 . . . . 0.0 105.004 -175.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 21.4 mt -117.49 171.58 7.9 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -168.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 172' ' ' PHE . 0.2 OUTLIER 42.43 30.11 0.19 Allowed 'General case' 0 N--CA 1.478 0.944 0 O-C-N 124.426 1.079 . . . . 0.0 113.157 -172.374 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.8 39.37 91.35 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 119.951 -1.118 . . . . 0.0 111.955 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -74.63 -144.54 0.98 Allowed Glycine 0 CA--C 1.511 -0.21 0 CA-C-N 115.426 -0.387 . . . . 0.0 113.685 -173.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.28 130.52 10.41 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.8 m -67.41 115.57 7.18 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 122.312 -0.242 . . . . 0.0 110.891 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 165' ' ' ARG . 3.7 m -101.43 -37.02 5.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.974 176.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -139.78 172.67 6.03 Favored Pre-proline 0 C--O 1.233 0.235 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.443 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 76.4 Cg_exo -54.09 107.1 0.19 Allowed 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.421 2.081 . . . . 0.0 112.869 176.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 70.52 8.68 6.69 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.044 0.938 . . . . 0.0 110.238 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.497 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 1.4 mmt180 -103.06 81.66 1.99 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.822 176.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 12.6 t -81.34 146.17 30.49 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 173.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -98.68 147.86 24.42 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 14.4 m -111.41 124.66 52.71 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 124.775 1.297 . . . . 0.0 112.66 -160.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.476 ' H ' ' ND2' ' A' ' 156' ' ' ASN . 64.5 m -51.99 -54.46 29.57 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -154.84 -86.37 0.05 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 118.516 -1.274 . . . . 0.0 113.746 -165.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -92.11 39.6 3.0 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 119.651 -1.262 . . . . 0.0 112.826 -167.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.56 ' CZ ' ' HB3' ' A' ' 156' ' ' ASN . 9.1 m-85 -120.7 126.23 49.67 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 119.522 -0.871 . . . . 0.0 113.036 176.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.48 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 4.7 t -93.37 164.81 13.07 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 164.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.28 132.63 5.51 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.54 2.9 4.69 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 121.198 1.265 . . . . 0.0 112.962 -167.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -118.68 4.34 11.63 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.325 0.584 . . . . 0.0 110.661 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 39.32 50.6 2.0 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -106.03 -12.37 15.81 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.476 0.655 . . . . 0.0 110.321 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -60.85 -67.41 0.4 Allowed 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.802 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.8 t70 79.59 81.96 0.06 Allowed 'General case' 0 CA--C 1.509 -0.603 0 O-C-N 123.775 0.672 . . . . 0.0 109.445 163.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.48 ' HE2' ' N ' ' A' ' 173' ' ' THR . 37.0 p90 -102.42 66.06 0.96 Allowed 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 172.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -46.97 119.52 2.58 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 113.479 -1.691 . . . . 0.0 109.869 172.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 64.6 p -84.39 136.91 33.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.809 -172.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.419 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -158.27 145.79 12.27 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.86 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -59.92 139.87 90.17 Favored 'Trans proline' 0 CA--C 1.529 0.232 0 C-N-CA 122.268 1.979 . . . . 0.0 111.47 171.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 5.8 t -96.44 133.94 40.23 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.123 -174.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -110.32 130.81 55.48 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.481 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' A' ' 215' ' ' ARG . 48.9 p -112.52 -4.34 14.2 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -168.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 p -168.58 116.85 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 118.991 0.814 . . . . 0.0 111.504 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.592 HD11 ' CB ' ' A' ' 216' ' ' ALA . 3.7 mt -117.07 119.32 61.61 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -169.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 45.7 t -104.54 156.45 17.95 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 145.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -50.43 -31.26 14.58 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 119.988 1.267 . . . . 0.0 109.702 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -56.17 -59.22 5.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 113.526 -1.67 . . . . 0.0 111.591 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 5.7 mmt -136.87 126.12 24.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.559 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 79.9 m -76.79 -19.24 57.81 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.87 0.843 . . . . 0.0 110.716 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -146.97 -68.6 0.25 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 171.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 125.06 -18.42 7.0 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -96.72 -41.87 8.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.705 -0.747 . . . . 0.0 110.068 177.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 67.62 84.85 0.15 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.477 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 48.0 t -99.44 148.15 24.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.109 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -92.59 22.29 34.05 Favored Glycine 0 CA--C 1.504 -0.626 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.771 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.422 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -60.61 110.99 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 167.727 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.02 97.22 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-O 124.081 1.896 . . . . 0.0 109.482 -173.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 13.7 t -119.38 -175.69 2.99 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 112.232 -2.258 . . . . 0.0 106.986 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 7.6 p -100.97 164.04 12.0 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 119.281 -0.968 . . . . 0.0 108.872 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -61.94 -45.95 91.47 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.994 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.9 m -45.24 -55.05 6.24 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.537 173.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.51 -54.5 46.28 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.988 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 19.1 m -68.95 -22.08 64.15 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 84.6 m -94.42 -33.83 12.98 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.1 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -73.69 -58.49 3.27 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.543 HG21 ' CG2' ' A' ' 247' ' ' VAL . 20.0 p -99.62 157.59 16.35 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.944 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.2 t 66.86 -46.69 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 122.855 0.462 . . . . 0.0 112.022 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 215' ' ' ARG . . . 80.6 178.96 52.56 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 114.68 0.632 . . . . 0.0 114.68 171.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 188' ' ' THR . 8.0 mpt_? 92.08 -73.94 0.01 OUTLIER 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.647 1.179 . . . . 0.0 112.844 170.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.592 ' CB ' HD11 ' A' ' 190' ' ' ILE . . . -172.8 165.86 5.27 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.069 1.304 . . . . 0.0 111.855 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . 0.419 ' CZ2' ' HA3' ' A' ' 184' ' ' GLY . 22.0 t90 -150.9 149.2 29.36 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.869 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 77.74 166.32 27.32 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 115.674 1.03 . . . . 0.0 115.674 167.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.417 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 77.7 m-70 -122.32 134.62 24.92 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 114.706 -0.747 . . . . 0.0 109.755 175.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . 0.417 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 22.7 Cg_exo -65.37 155.85 77.79 Favored 'Cis proline' 0 C--N 1.347 0.46 0 C-N-CA 123.287 -1.547 . . . . 0.0 111.225 -2.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 33.7 t -52.14 115.61 1.8 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.322 -171.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -107.66 115.01 29.39 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 13.3 ttp -89.03 138.85 31.04 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.43 -172.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 84.0 m -128.08 122.8 22.34 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -54.03 166.26 1.63 Allowed 'Trans proline' 0 CA--C 1.515 -0.462 0 C-N-CA 123.609 2.873 . . . . 0.0 113.622 165.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -39.09 106.7 0.06 Allowed 'General case' 0 CA--C 1.504 -0.801 0 O-C-N 123.962 0.789 . . . . 0.0 111.214 163.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 31.4 85.75 0.14 Allowed Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 111.633 -2.531 . . . . 0.0 111.99 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -39.57 -58.61 0.81 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.874 3.049 . . . . 0.0 115.182 -170.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -78.58 156.09 78.25 Favored Pre-proline 0 CA--C 1.515 -0.385 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -68.61 91.57 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.773 1.648 . . . . 0.0 112.474 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 42.7 t -163.85 179.21 7.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.787 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.627 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 22.6 mmm-85 -92.75 140.22 29.74 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 22.1 ptt85 -41.31 -57.14 2.23 Favored 'General case' 0 C--O 1.218 -0.574 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -175.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.475 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -67.52 6.79 2.33 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 115.123 0.809 . . . . 0.0 115.123 -174.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . 0.627 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 2.1 m-85 -131.07 173.47 10.98 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 118.238 1.019 . . . . 0.0 111.828 -174.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.43 HD13 ' O ' ' A' ' 235' ' ' PHE . 0.2 OUTLIER -135.48 130.56 19.04 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 113.562 -1.654 . . . . 0.0 107.504 172.021 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.01 113.82 1.9 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 121.95 1.766 . . . . 0.0 111.641 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -50.71 132.21 26.02 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.669 0.747 . . . . 0.0 110.964 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 19.6 mt -76.48 -2.01 3.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.024 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 43.1 mtm180 -104.43 -57.59 2.01 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.301 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 31.5 p -95.2 -45.36 7.22 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.366 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 104.11 12.64 28.99 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -95.45 131.35 41.7 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 122.009 0.909 . . . . 0.0 110.352 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 77.8 m -49.08 112.25 0.6 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 113.261 -1.791 . . . . 0.0 110.495 167.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -116.84 134.49 54.71 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.508 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 10.9 t70 -75.84 145.36 40.66 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 121.635 0.731 . . . . 0.0 111.122 -170.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.579 HG23 ' HG3' ' A' ' 249' ' ' GLU . 4.5 m -98.23 145.19 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.87 177.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -75.85 78.13 2.76 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 169.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.579 ' HG3' HG23 ' A' ' 247' ' ' VAL . 22.7 mp0 -53.03 -36.06 60.14 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 123.747 0.654 . . . . 0.0 110.017 -172.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 24.6 m -48.36 -39.15 21.2 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.432 173.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -96.45 -39.73 9.43 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.83 0.824 . . . . 0.0 110.313 -177.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -73.68 -20.25 60.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.202 -1.363 . . . . 0.0 111.757 -172.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 202' ' ' ILE . 4.1 mp -121.83 81.5 41.82 Favored Pre-proline 0 N--CA 1.446 -0.672 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -24.02 -49.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.889 1 C-N-CA 127.169 5.246 . . . . 0.0 117.764 -170.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -124.93 28.99 5.03 Favored Glycine 0 CA--C 1.502 -0.745 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.906 -165.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.6 143.07 26.65 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.673 -0.764 . . . . 0.0 110.385 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 7.5 t 72.29 -72.27 0.12 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -169.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 60.02 -75.01 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.056 0.942 . . . . 0.0 113.202 175.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -75.48 71.18 1.85 Allowed Glycine 0 CA--C 1.508 -0.38 0 N-CA-C 111.694 -0.562 . . . . 0.0 111.694 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 154.54 -175.86 32.53 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -106.15 113.19 26.57 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 117.476 0.638 . . . . 0.0 109.774 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 48.7 t -89.3 133.15 34.59 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 46.5 mt -132.87 106.77 10.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.335 -174.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.643 ' ND2' ' HB3' ' A' ' 269' ' ' PHE . 0.9 OUTLIER -83.83 129.39 34.94 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -167.255 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.8 t -111.13 163.86 13.45 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.908 163.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.508 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 2.4 p -70.07 120.39 17.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.415 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.549 ' HA2' ' CE2' ' A' ' 235' ' ' PHE . . . 114.42 -33.38 5.43 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.61 -172.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 7.5 p -179.81 161.51 0.98 Allowed 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 117.822 0.811 . . . . 0.0 109.765 -172.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . 0.643 ' HB3' ' ND2' ' A' ' 264' ' ' ASN . 43.1 p90 -101.38 157.94 16.43 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.823 175.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -120.67 122.0 39.52 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 52.8 m -101.21 143.18 31.6 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.725 0.774 . . . . 0.0 111.682 -176.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -103.04 104.71 14.91 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.436 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 56.8 m -86.3 138.42 34.3 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.552 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . 0.419 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 52.5 Cg_exo -56.28 162.52 7.62 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.548 2.165 . . . . 0.0 111.308 172.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -54.35 136.83 43.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.179 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.15 -26.78 4.22 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.74 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' HIS . . . . . 0.5 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 16.1 m-70 -78.34 157.85 28.99 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.28 0.562 . . . . 0.0 111.613 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -145.99 140.87 27.18 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.417 -175.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 51.0 tp -74.78 126.53 31.11 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.19 0.519 . . . . 0.0 109.681 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 284' ' ' GLN . 52.7 t30 -120.29 112.13 18.64 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -78.99 -6.75 57.08 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.721 0.638 . . . . 0.0 112.263 -173.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 39.0 t -58.07 -21.21 16.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.116 0.484 . . . . 0.0 110.564 168.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 24.8 t -146.93 -15.16 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.183 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 280' ' ' ASN . 16.9 mp0 73.74 52.62 0.11 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.369 1.067 . . . . 0.0 109.481 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -130.99 149.9 52.39 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.289 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 86.8 m -101.35 94.71 6.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.294 176.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.5 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 76.4 mm-40 . . . . . 0 C--O 1.253 1.238 0 CA-C-O 118.755 -0.64 . . . . 0.0 109.483 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.472 ' HB2' ' SG ' ' A' ' 145' ' ' CYS . 89.7 m-85 . . . . . 0 CA--C 1.515 -0.387 0 CA-C-O 120.582 0.23 . . . . 0.0 110.993 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 30.6 pt -129.29 169.11 21.13 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.86 172.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.97 169.61 20.75 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.651 -176.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.2 p -77.62 -47.12 20.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.625 0.213 . . . . 0.0 110.528 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -88.04 2.81 50.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.236 0.541 . . . . 0.0 109.937 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.472 ' SG ' ' HB2' ' A' ' 140' ' ' TYR . 0.6 OUTLIER 61.93 44.69 8.09 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.667 171.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.22 8.65 55.64 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 119.641 -1.266 . . . . 0.0 112.493 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.62 118.75 44.65 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.222 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -89.09 131.92 2.23 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.959 2.44 . . . . 0.0 113.725 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.5 p -66.47 116.03 5.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.954 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.516 ' HB3' ' SG ' ' A' ' 154' ' ' CYS . 0.0 OUTLIER -81.87 75.87 8.79 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.275 0.56 . . . . 0.0 109.844 171.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.98 -64.79 0.79 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.306 -0.861 . . . . 0.0 113.133 -171.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 55.8 m -91.88 19.03 6.98 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.158 0.504 . . . . 0.0 111.941 -168.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 80.73 120.29 0.44 Allowed Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.898 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . 0.516 ' SG ' ' HB3' ' A' ' 150' ' ' CYS . 89.1 m -74.29 157.75 35.24 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 113.443 -1.378 . . . . 0.0 108.33 172.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.542 HD12 ' O ' ' A' ' 176' ' ' GLN . 76.9 mt -147.15 174.52 11.51 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -165.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 172' ' ' PHE . 0.2 OUTLIER 49.25 19.13 0.29 Allowed 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.274 0.984 . . . . 0.0 112.624 -172.159 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.6 37.29 93.45 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.247 -0.977 . . . . 0.0 111.949 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -80.76 -141.56 2.95 Favored Glycine 0 C--O 1.236 0.25 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.658 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -157.78 126.54 5.66 Favored 'General case' 0 C--O 1.218 -0.597 0 O-C-N 122.317 -0.519 . . . . 0.0 111.526 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.99 124.46 19.98 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 123.139 0.274 . . . . 0.0 111.142 176.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.0 m -116.28 -35.3 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.191 0.519 . . . . 0.0 111.419 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.501 ' HB3' ' CB ' ' A' ' 165' ' ' ARG . . . -137.11 175.86 3.18 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 174.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.441 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 22.9 Cg_exo -60.58 109.24 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 121.316 1.344 . . . . 0.0 111.889 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 71.73 3.23 4.59 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.591 1.156 . . . . 0.0 111.119 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.501 ' CB ' ' HB3' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -96.11 86.74 4.35 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.527 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 70.1 m -79.63 150.64 30.93 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.368 172.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -93.08 121.41 34.39 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 172.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 61.6 m -106.08 132.12 52.54 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.418 -175.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 89.6 m -60.78 -52.03 66.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.963 -1.471 . . . . 0.0 114.114 -164.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -161.76 -93.6 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 118.852 -1.139 . . . . 0.0 113.111 -170.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -85.44 55.19 4.89 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.878 -164.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.56 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 4.5 m-85 -124.48 137.89 54.39 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.832 171.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.547 ' OG1' ' HG3' ' A' ' 179' ' ' ARG . 27.0 p -88.32 121.07 30.29 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.508 176.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 99.82 134.11 8.37 Favored Glycine 0 N--CA 1.426 -1.967 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.91 9.59 1.31 Allowed 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 120.903 1.068 . . . . 0.0 112.431 -172.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.542 ' O ' HD12 ' A' ' 155' ' ' LEU . 39.2 tt0 -110.37 25.01 12.25 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 171.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.8 OUTLIER 18.69 71.76 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 173.345 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.476 ' O ' ' HD3' ' A' ' 179' ' ' ARG . 8.6 pt-20 -124.13 31.64 5.75 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.93 0.871 . . . . 0.0 110.604 172.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 24.0 mmt180 -135.71 93.25 2.92 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 113.729 -1.578 . . . . 0.0 108.582 177.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -87.67 61.32 6.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 122.045 0.926 . . . . 0.0 109.935 -171.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.499 ' CE2' HG23 ' A' ' 173' ' ' THR . 26.0 p90 -83.12 91.39 7.21 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 171.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -89.33 136.5 32.99 Favored 'General case' 0 N--CA 1.437 -1.077 0 O-C-N 119.988 -1.695 . . . . 0.0 107.186 -176.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 77.1 p -86.57 134.69 33.63 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.72 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -158.73 155.29 26.34 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -71.73 160.23 48.63 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.41 2.073 . . . . 0.0 111.904 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 3.6 t -117.73 105.83 12.4 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -177.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . 0.64 ' O ' ' HB3' ' A' ' 215' ' ' ARG . 37.4 m-85 -100.21 135.87 40.97 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.633 -172.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.6 m -97.45 -21.43 17.15 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -167.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 54.6 t -149.47 115.29 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -171.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.1 mt -134.73 119.67 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -164.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.4 p -116.56 -167.36 1.27 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.103 159.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -71.65 -5.61 34.95 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.024 0.916 . . . . 0.0 109.152 171.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -83.58 -67.26 0.8 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.551 -174.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 43.0 ttp -146.53 139.28 25.3 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.666 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.669 ' O ' ' HB2' ' A' ' 196' ' ' GLN . 68.2 m -84.52 -15.43 45.88 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.586 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.669 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 3.9 mm-40 92.94 -158.8 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.568 1.147 . . . . 0.0 112.106 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 64.71 8.24 32.51 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.274 -0.876 . . . . 0.0 113.693 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 55.59 25.94 8.6 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.865 0.332 . . . . 0.0 110.642 -175.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 61.68 27.93 17.2 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.312 -176.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 39.2 t -70.95 137.41 49.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.951 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.36 57.99 3.49 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.342 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.442 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -61.16 109.83 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 170.087 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 5.4 t -89.08 116.11 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 CA-C-O 122.527 1.156 . . . . 0.0 111.348 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 19.7 t -151.68 -179.7 7.65 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 18.5 p -105.66 161.58 14.26 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 120.64 1.564 . . . . 0.0 109.27 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.496 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 46.2 tttm -59.21 -41.51 88.77 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.609 0.718 . . . . 0.0 109.534 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.7 m -46.88 -54.91 8.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.826 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.93 -51.36 69.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.253 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 64.4 m -62.8 -39.53 94.55 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 60.2 m -79.95 -29.86 39.76 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.716 -175.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -71.1 -60.9 1.98 Allowed 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.58 HG22 ' HA2' ' A' ' 234' ' ' GLY . 24.6 p -97.29 144.4 27.11 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.89 -174.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.425 HG21 ' CD1' ' A' ' 256' ' ' LEU . 1.5 t 59.73 -36.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 96.15 -105.7 3.27 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 120.655 1.57 . . . . 0.0 112.498 -177.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.64 ' HB3' ' O ' ' A' ' 187' ' ' PHE . 78.1 mtt180 55.27 -131.84 1.83 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.648 0.737 . . . . 0.0 110.847 177.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.46 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -160.09 169.43 23.37 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 175.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . 0.496 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 24.9 t90 -149.69 145.4 26.68 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.606 -173.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 81.8 -178.33 53.71 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-O 121.527 0.515 . . . . 0.0 114.237 172.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.478 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 86.9 m-70 -131.62 130.29 22.35 Favored Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . 0.478 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 18.8 Cg_endo -57.03 156.1 28.53 Favored 'Cis proline' 0 C--N 1.353 0.774 0 C-N-CA 124.002 -1.249 . . . . 0.0 111.044 -4.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 58.3 m -67.51 78.46 0.17 Allowed 'General case' 0 C--N 1.32 -0.683 0 O-C-N 123.579 0.549 . . . . 0.0 111.923 -173.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -53.94 115.15 1.87 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.034 0.445 . . . . 0.0 110.853 173.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' MET . . . . . 0.46 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 0.0 OUTLIER -91.1 132.66 35.91 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.032 -174.016 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 70.8 m -97.94 124.04 49.18 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -167.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -62.26 152.63 75.26 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 123.968 3.112 . . . . 0.0 113.65 165.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -39.84 103.5 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.125 0 CA-C-O 122.284 1.04 . . . . 0.0 112.043 162.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 18.24 102.46 0.02 OUTLIER Pre-proline 0 C--N 1.311 -1.106 0 CA-C-N 111.335 -2.666 . . . . 0.0 114.42 -175.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -52.93 -49.88 16.04 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.893 2.395 . . . . 0.0 112.196 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -85.5 111.2 35.26 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.19 64.91 7.0 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.071 2.514 . . . . 0.0 114.265 -172.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 81.0 m -96.69 -84.52 0.36 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 168.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.408 ' HB3' ' CD2' ' A' ' 235' ' ' PHE . 14.4 ttm180 -145.98 135.72 23.34 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 168.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -39.16 -39.53 0.61 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -174.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.58 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -80.82 9.34 52.69 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 120.279 -0.963 . . . . 0.0 113.947 -176.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . 0.513 ' HE2' ' N ' ' A' ' 267' ' ' GLY . 1.9 m-85 -121.96 152.38 39.75 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -168.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.444 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.0 OUTLIER -129.89 131.82 23.75 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 114.047 -1.433 . . . . 0.0 107.778 169.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -63.41 111.59 1.51 Allowed 'Trans proline' 0 C--O 1.238 0.496 0 C-N-CA 122.173 1.915 . . . . 0.0 111.238 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -55.42 127.57 30.22 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.057 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 40.4 pt -80.9 12.35 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.14 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -110.46 -39.55 4.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.612 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 78.6 p -111.98 -39.51 4.49 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.95 0.881 . . . . 0.0 110.336 -177.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 102.03 6.07 49.27 Favored Glycine 0 N--CA 1.437 -1.253 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -175.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -97.39 119.7 36.4 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-O 122.079 0.942 . . . . 0.0 110.493 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 3.7 m -55.62 123.54 14.39 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.266 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -123.36 143.51 50.06 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.588 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 8.1 t70 -78.49 145.92 34.69 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.109 0.481 . . . . 0.0 110.32 -178.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.596 HG23 ' HG3' ' A' ' 249' ' ' GLU . 5.3 m -94.97 145.57 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.872 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.35 77.07 1.87 Allowed 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 168.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.596 ' HG3' HG23 ' A' ' 247' ' ' VAL . 35.9 mp0 -53.12 -33.94 54.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 124.375 1.047 . . . . 0.0 110.198 -172.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 7.7 m -46.91 -41.28 15.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.523 173.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -98.79 -42.17 7.32 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.648 0.737 . . . . 0.0 110.302 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.01 -28.62 69.63 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.463 -174.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.519 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.7 mp -123.72 83.13 54.25 Favored Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 173.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.6 122.96 12.67 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.767 2.311 . . . . 0.0 113.919 -166.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 65.41 27.03 72.06 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 113.554 -1.657 . . . . 0.0 113.435 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.519 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.3 OUTLIER -74.46 -28.85 61.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 118.108 0.954 . . . . 0.0 110.407 177.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 51.5 t -85.97 86.76 7.35 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.776 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -74.16 -19.49 60.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.448 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -54.02 -50.3 55.68 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.348 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 175.73 -93.45 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.069 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -110.25 135.76 50.5 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 40.4 t -104.44 134.16 48.1 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 175.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 25.5 mt -131.01 105.78 11.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -70.08 125.4 26.66 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.534 -170.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 268' ' ' SER . 0.1 OUTLIER -110.83 156.23 21.42 Favored 'General case' 0 C--O 1.256 1.398 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.865 155.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.588 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 3.9 m -74.44 127.14 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 C-N-CA 118.155 -1.418 . . . . 0.0 107.876 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.513 ' N ' ' HE2' ' A' ' 235' ' ' PHE . . . 111.28 -25.13 14.37 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.521 -172.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.561 ' O ' HG23 ' A' ' 265' ' ' THR . 27.5 t 173.56 152.61 0.09 Allowed 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.476 0.655 . . . . 0.0 109.613 -174.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -102.78 155.96 17.97 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -110.54 129.75 55.72 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 33.7 m -102.65 134.2 46.4 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.771 177.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -115.81 128.44 55.84 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.404 -177.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 19.3 m -129.57 168.52 16.08 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.724 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.62 155.35 21.87 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.212 1.941 . . . . 0.0 110.904 165.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.56 159.67 21.21 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.889 0.376 . . . . 0.0 110.779 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 89.41 -33.15 4.43 Favored Glycine 0 CA--C 1.504 -0.65 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.325 -174.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -72.15 156.22 39.41 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 120.806 0.336 . . . . 0.0 111.12 -176.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 60.5 mttp -137.06 129.2 29.5 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -174.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.437 HD12 ' O ' ' A' ' 285' ' ' LYS . 32.7 tp -77.35 143.45 38.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 122.035 0.922 . . . . 0.0 112.622 -169.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -124.12 100.45 6.72 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 114.366 -1.288 . . . . 0.0 107.833 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -69.94 -9.72 56.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.118 0.485 . . . . 0.0 111.691 -174.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 62.0 t -64.2 -59.02 4.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-O 121.193 0.521 . . . . 0.0 110.095 174.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 13.8 p -116.41 27.47 9.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.408 -176.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 31.14 51.67 0.14 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.805 -170.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . 0.437 ' O ' HD12 ' A' ' 279' ' ' LEU . 85.2 tttt -106.79 171.36 7.41 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' CYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 25.5 p -160.6 114.79 2.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 118.018 0.372 . . . . 0.0 110.318 177.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 N--CA 1.441 -0.916 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -175.584 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.42 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 88.5 m-85 . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 31.8 pt -139.28 -178.15 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.758 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.697 -173.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.51 153.88 28.51 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.636 -168.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.0 p -64.55 -33.31 75.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.819 0.343 . . . . 0.0 111.788 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -110.87 28.1 9.04 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 79.1 m 56.69 -124.99 1.89 Allowed 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.029 -169.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.65 -39.69 2.55 Favored Glycine 0 C--N 1.292 -1.913 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.402 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.88 118.91 60.91 Favored Pre-proline 0 C--O 1.219 -0.539 0 CA-C-N 117.828 0.814 . . . . 0.0 111.073 -174.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -87.21 139.68 5.28 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.966 2.444 . . . . 0.0 112.411 175.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 149' ' ' VAL . 10.7 p -71.15 103.29 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 122.261 1.029 . . . . 0.0 111.291 -175.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.38 74.39 9.36 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 121.668 -0.645 . . . . 0.0 110.153 175.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -54.3 -48.07 71.71 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -169.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 69.8 m -90.81 18.65 6.27 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.499 0.666 . . . . 0.0 110.546 -168.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 74.97 128.85 0.2 Allowed Glycine 0 N--CA 1.427 -1.926 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.676 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . 0.411 ' SG ' ' SG ' ' A' ' 160' ' ' CYS . 1.7 m -77.34 154.63 32.63 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.186 -1.007 . . . . 0.0 109.316 172.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 50.1 mt -148.93 158.89 44.51 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.663 -166.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.512 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 2.8 t-20 52.58 27.88 5.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.899 -163.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.18 36.4 93.18 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.667 -172.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -64.88 151.77 51.08 Favored Glycine 0 N--CA 1.437 -1.279 0 CA-C-O 122.226 0.904 . . . . 0.0 114.257 -175.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.5 ttt85 -96.31 117.76 31.47 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 113.739 -1.23 . . . . 0.0 112.006 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . 0.411 ' SG ' ' SG ' ' A' ' 154' ' ' CYS . 3.7 m -62.83 126.18 26.48 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 165' ' ' ARG . 19.7 m -114.77 -41.82 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -176.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -138.26 175.49 3.33 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.42 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 17.1 Cg_exo -63.06 108.11 0.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 121.044 1.163 . . . . 0.0 111.721 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 74.4 16.17 3.36 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.703 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.435 ' O ' HG22 ' A' ' 161' ' ' VAL . 1.8 mtm180 -112.83 95.31 5.34 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.545 169.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 9.1 t -87.82 151.98 22.45 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.753 171.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -105.33 120.03 40.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.457 0.646 . . . . 0.0 109.639 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 63.7 m -74.88 124.12 26.31 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.002 -170.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.512 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 77.0 m -60.0 -41.43 92.07 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.455 177.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.48 ' CG ' ' N ' ' A' ' 171' ' ' GLY . 52.5 t80 -140.23 -131.04 0.11 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.296 -176.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.48 ' N ' ' CG ' ' A' ' 170' ' ' TYR . . . -80.82 57.9 4.78 Favored Glycine 0 N--CA 1.435 -1.416 0 CA-C-N 116.157 -0.474 . . . . 0.0 113.148 -165.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.54 ' CD2' ' N ' ' A' ' 172' ' ' PHE . 4.3 m-85 -121.3 125.57 47.38 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 119.714 -0.795 . . . . 0.0 111.527 170.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 3.4 t -90.41 158.57 17.02 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 168.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 87.23 130.84 3.14 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -177.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -75.17 21.29 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 121.498 1.466 . . . . 0.0 114.23 -165.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -120.36 -6.34 9.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.458 0.647 . . . . 0.0 110.029 176.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.44 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.3 OUTLIER 42.81 49.82 5.09 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -175.449 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -106.27 -15.33 14.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.281 0.562 . . . . 0.0 109.664 174.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -57.85 -68.64 0.22 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.183 -1.371 . . . . 0.0 109.062 -175.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 36.5 t70 78.98 73.76 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.395 0.617 . . . . 0.0 110.159 165.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -91.38 67.54 5.7 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.8 1.286 . . . . 0.0 107.704 172.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 21.2 ttp85 -40.1 124.24 1.81 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 112.664 -2.062 . . . . 0.0 110.791 173.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 54.2 p -88.19 139.4 30.54 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.063 -171.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -160.01 146.72 13.09 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.47 129.29 12.7 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.202 1.935 . . . . 0.0 111.609 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . 0.569 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 85.3 m -81.24 117.51 21.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.966 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . 0.447 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 43.8 m-85 -92.99 153.82 18.51 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.098 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' THR . . . . . 0.407 HG23 ' HE ' ' A' ' 215' ' ' ARG . 85.5 m -118.21 -18.79 9.22 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -162.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.2 p -164.9 116.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 O-C-N 121.417 -0.802 . . . . 0.0 110.043 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.429 HD13 ' SG ' ' A' ' 221' ' ' CYS . 2.7 mt -127.01 121.59 58.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -164.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 31.0 p -107.89 177.15 4.9 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 153.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -66.72 -12.4 58.41 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 122.477 1.132 . . . . 0.0 108.597 173.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -78.21 -38.8 42.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.235 -176.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 41.9 ttm -162.31 140.63 8.86 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 -175.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 79.1 m -91.34 -23.91 19.95 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.257 0.551 . . . . 0.0 111.654 -176.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -157.45 -73.69 0.09 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 170.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 127.78 -32.74 3.41 Favored Glycine 0 C--N 1.321 -0.262 0 C-N-CA 120.159 -1.02 . . . . 0.0 111.798 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.404 ' O ' ' HB2' ' A' ' 199' ' ' LEU . 92.1 mt-30 -74.61 -44.92 48.35 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 122.166 0.187 . . . . 0.0 110.701 171.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 198' ' ' GLN . 3.9 mm? 72.04 132.03 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.825 0.703 . . . . 0.0 110.735 -176.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 47.3 t -141.5 152.14 43.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.711 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -108.3 22.12 27.54 Favored Glycine 0 CA--C 1.502 -0.72 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.74 114.22 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 172.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.3 t -102.99 99.73 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 CA-C-O 122.803 1.287 . . . . 0.0 111.093 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 7.4 t -133.3 -178.12 4.84 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 172.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 20.3 p -96.46 163.6 12.98 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.486 -174.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.413 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 72.2 tttt -59.31 -43.61 92.62 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.418 176.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.3 m -47.2 -54.47 10.67 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.391 174.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.478 ' CD1' HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -54.04 -62.29 1.75 Allowed 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.816 177.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 25.6 m -68.64 -22.17 64.42 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.351 -0.539 . . . . 0.0 112.361 -169.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 61.8 m -96.09 -27.8 14.91 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.376 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -66.59 -55.74 13.99 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 172.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.442 ' O ' ' N ' ' A' ' 214' ' ' GLY . 46.3 p -61.77 -154.04 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 112.519 -2.128 . . . . 0.0 112.405 176.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 36.0 m -36.89 -5.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 212' ' ' THR . . . 70.3 -153.77 52.06 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 120.565 1.53 . . . . 0.0 114.556 172.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.407 ' HE ' HG23 ' A' ' 188' ' ' THR . 1.7 mpp_? 99.41 -82.59 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.045 1.338 . . . . 0.0 110.131 169.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.447 ' HB3' ' HB2' ' A' ' 187' ' ' PHE . . . -174.29 168.11 3.99 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 118.026 0.375 . . . . 0.0 110.126 174.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . 0.6 ' O ' ' HB2' ' A' ' 222' ' ' GLU . 13.9 t90 -156.68 146.77 21.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 81.22 156.94 16.26 Favored Glycine 0 C--N 1.333 0.377 0 N-CA-C 114.63 0.612 . . . . 0.0 114.63 170.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.627 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 2.4 p-80 -130.91 136.29 28.67 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 172.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . 0.627 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 73.2 Cg_exo -50.94 143.13 8.05 Favored 'Cis proline' 0 C--N 1.352 0.745 0 C-N-CA 124.64 -0.983 . . . . 0.0 113.297 -0.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . 0.429 ' SG ' HD13 ' A' ' 190' ' ' ILE . 7.9 t -49.71 112.06 0.6 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.029 -171.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.6 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 49.8 mt-10 -103.09 103.71 13.81 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 34.4 mtm -87.81 131.14 34.63 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.846 -172.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 26.6 p -143.65 147.14 37.97 Favored Pre-proline 0 N--CA 1.466 0.354 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -173.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.04 169.33 6.16 Favored 'Trans proline' 0 CA--C 1.5 -1.191 0 C-N-CA 122.896 2.397 . . . . 0.0 112.293 165.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -78.9 -160.64 0.24 Allowed 'General case' 0 N--CA 1.414 -2.254 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 161.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -12.41 86.86 0.03 OUTLIER Pre-proline 0 C--N 1.299 -1.617 0 C-N-CA 126.413 1.885 . . . . 0.0 115.525 -170.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -73.23 -53.49 0.13 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.98 2.454 . . . . 0.0 111.118 174.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 -72.49 141.69 83.19 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.815 177.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -83.08 27.45 0.61 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.26 1.974 . . . . 0.0 113.841 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 68.4 m -83.48 -91.66 0.08 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.669 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 3.8 mpt_? -146.04 147.57 31.76 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 168.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -41.47 -46.83 3.57 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.464 0.477 . . . . 0.0 111.657 170.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 246' ' ' ASP . . . -77.44 7.0 41.65 Favored Glycine 0 C--O 1.224 -0.477 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.817 -176.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . 0.669 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 3.5 m-85 -119.36 142.19 48.38 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.075 0.941 . . . . 0.0 113.357 -170.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.1 125.76 25.72 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 113.918 -1.492 . . . . 0.0 108.975 174.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -67.14 123.3 10.74 Favored 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 122.498 2.132 . . . . 0.0 112.71 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -54.43 139.65 36.59 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.55 0.69 . . . . 0.0 111.033 175.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 31.0 mt -73.08 -16.81 17.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.36 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 47.2 mtm180 -101.34 -66.56 0.91 Allowed 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.682 0.753 . . . . 0.0 110.239 -176.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 28.9 p -76.17 -42.42 46.56 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.688 -175.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 99.26 7.87 53.99 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -85.3 127.27 34.27 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.896 0.855 . . . . 0.0 110.278 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 3.2 m -65.44 121.6 15.26 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.901 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 96.6 mt-30 -119.29 141.34 49.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.645 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.589 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 13.1 t70 -78.02 148.08 34.51 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.07 0.462 . . . . 0.0 110.321 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.487 HG23 ' HG3' ' A' ' 249' ' ' GLU . 5.4 m -100.05 151.28 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.848 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -73.24 77.43 1.31 Allowed 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 166.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.487 ' HG3' HG23 ' A' ' 247' ' ' VAL . 5.6 mp0 -51.26 -40.61 59.26 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.756 -175.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 32.0 m -35.83 -43.59 0.31 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 114.189 -1.369 . . . . 0.0 112.658 171.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -99.72 -31.77 11.38 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.188 0.518 . . . . 0.0 110.694 -174.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.01 -4.21 58.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.905 -170.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.567 ' HB ' ' CD2' ' A' ' 256' ' ' LEU . 54.8 mt -134.4 133.47 21.64 Favored Pre-proline 0 CA--C 1.557 1.243 0 CA-C-N 119.092 0.86 . . . . 0.0 113.193 -174.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -41.14 -73.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.078 1 C-N-CA 125.415 4.076 . . . . 0.0 115.171 -169.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -90.11 31.14 5.5 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.499 -169.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.567 ' CD2' ' HB ' ' A' ' 253' ' ' ILE . 0.6 OUTLIER -66.43 137.96 57.22 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.556 -0.857 . . . . 0.0 109.437 177.422 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . 0.458 ' SG ' ' HB3' ' A' ' 262' ' ' CYS . 7.9 p -55.82 99.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -167.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -92.07 -20.5 21.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.82 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -78.05 70.49 2.55 Favored Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 176.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 130.13 -148.48 18.55 Favored Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -174.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -109.08 146.12 34.53 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 117.033 0.417 . . . . 0.0 109.976 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . 0.458 ' HB3' ' SG ' ' A' ' 257' ' ' CYS . 17.8 p -127.91 147.38 50.46 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 172.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 53.3 mt -138.69 108.8 4.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.375 -167.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -73.36 114.45 11.59 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.747 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 268' ' ' SER . 0.2 OUTLIER -103.32 150.95 23.27 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 161.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.589 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 4.0 m -72.82 133.33 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 C-N-CA 117.553 -1.659 . . . . 0.0 107.503 177.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.545 ' N ' ' HE2' ' A' ' 235' ' ' PHE . . . 97.61 -19.54 54.25 Favored Glycine 0 N--CA 1.434 -1.494 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.607 -174.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.493 ' O ' HG23 ' A' ' 265' ' ' THR . 3.9 p 179.76 142.33 0.14 Allowed 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 117.399 0.599 . . . . 0.0 110.577 -175.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -97.98 156.74 16.49 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . 0.414 ' HG3' ' CG2' ' A' ' 265' ' ' THR . 8.8 mt-10 -117.83 155.69 29.67 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 58.4 m -123.21 154.89 38.13 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.948 0.88 . . . . 0.0 112.311 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -135.5 100.5 4.52 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.763 -1.562 . . . . 0.0 109.386 170.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 38.6 m -104.79 170.28 6.2 Favored Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.539 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.44 157.04 15.74 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 121.801 1.667 . . . . 0.0 111.019 171.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -58.27 154.24 13.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.185 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 87.46 -30.81 4.73 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.934 -176.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' HIS . . . . . 0.496 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 14.2 m-70 -70.66 155.4 40.8 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.176 0.512 . . . . 0.0 112.182 -176.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 99.2 mttt -138.68 133.81 32.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.284 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 15.5 tp -91.28 141.2 29.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.753 0.787 . . . . 0.0 111.44 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -126.76 101.59 6.68 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 174.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.66 -24.45 66.74 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 123.719 0.637 . . . . 0.0 111.387 -175.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 78.8 t -65.2 -43.97 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.488 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 47.3 t -118.92 20.56 12.74 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.276 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 36.13 43.48 0.22 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.737 -173.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 89.7 mttt -91.29 153.07 20.21 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 7.7 t -152.07 86.36 1.3 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.496 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 34.5 tt0 . . . . . 0 C--N 1.312 -1.06 0 CA-C-O 118.259 -0.877 . . . . 0.0 109.822 -173.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.456 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 95.7 m-85 . . . . . 0 CA--C 1.515 -0.375 0 CA-C-O 120.688 0.28 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 33.9 pt -132.2 172.49 16.28 Favored 'Isoleucine or valine' 0 C--O 1.245 0.838 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 174.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.75 158.62 24.6 Favored Glycine 0 N--CA 1.45 -0.368 0 O-C-N 124.014 0.821 . . . . 0.0 112.208 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.7 p -70.76 -25.82 63.08 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.507 -0.407 . . . . 0.0 111.48 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -100.5 -8.29 23.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.932 0.396 . . . . 0.0 109.992 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 86.1 m 69.03 40.52 1.58 Allowed 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.483 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.98 3.97 48.87 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.194 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.31 111.54 61.59 Favored Pre-proline 0 N--CA 1.464 0.255 0 CA-C-N 117.502 0.651 . . . . 0.0 110.819 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -82.8 143.2 11.68 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.173 2.582 . . . . 0.0 112.998 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.3 p -71.75 115.87 12.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.641 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.547 ' HB3' ' O ' ' A' ' 153' ' ' GLY . 0.9 OUTLIER -80.73 78.25 7.51 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 172.343 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -52.27 -60.61 3.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.268 -173.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 17.8 m -94.84 14.52 21.18 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.057 0.456 . . . . 0.0 110.923 -175.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.547 ' O ' ' HB3' ' A' ' 150' ' ' CYS . . . 106.88 -117.32 5.29 Favored Glycine 0 N--CA 1.415 -2.701 0 CA-C-O 122.888 1.271 . . . . 0.0 111.601 -178.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . 0.42 ' O ' HD23 ' A' ' 155' ' ' LEU . 0.6 OUTLIER 162.22 141.24 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 -172.349 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.505 HD12 ' O ' ' A' ' 176' ' ' GLN . 39.1 mt -132.58 170.7 14.81 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 -163.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.661 ' HB3' ' CZ ' ' A' ' 172' ' ' PHE . 9.6 p30 45.5 21.61 0.08 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -174.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 67.37 37.87 90.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.296 -174.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -75.4 -146.76 1.56 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.575 -0.345 . . . . 0.0 112.689 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -157.95 124.87 4.96 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 122.68 -0.306 . . . . 0.0 110.955 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.4 m -61.96 125.39 23.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.62 0.248 . . . . 0.0 111.31 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 165' ' ' ARG . 4.2 m -112.18 -46.91 5.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.859 -0.337 . . . . 0.0 110.453 177.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -128.97 176.1 3.05 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 118.45 -0.786 . . . . 0.0 109.859 170.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.456 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 82.0 Cg_exo -50.67 103.78 0.07 OUTLIER 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 122.524 2.149 . . . . 0.0 113.298 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.1 t30 67.09 5.31 4.05 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.377 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.434 ' O ' HG22 ' A' ' 161' ' ' VAL . 1.7 ttm180 -89.02 82.5 6.65 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 169.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 35.8 t -85.48 137.73 32.71 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -88.9 127.87 35.65 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 35.2 m -109.94 134.03 52.53 Favored 'General case' 0 C--O 1.239 0.502 0 O-C-N 124.231 0.957 . . . . 0.0 112.028 -168.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 91.4 m -56.16 -56.28 22.87 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -165.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -161.9 -87.98 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.06 -1.056 . . . . 0.0 112.901 -166.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -85.81 46.95 3.71 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.564 -165.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.661 ' CZ ' ' HB3' ' A' ' 156' ' ' ASN . 6.9 m-85 -121.28 130.83 53.86 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.922 170.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.54 ' N ' ' HE1' ' A' ' 181' ' ' TYR . 3.5 t -97.37 138.28 35.07 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 173.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 99.12 126.06 5.56 Favored Glycine 0 C--N 1.299 -1.502 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -169.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -67.86 -0.22 5.15 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.55 1.5 . . . . 0.0 113.301 -170.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.505 ' O ' HD12 ' A' ' 155' ' ' LEU . 45.7 tt0 -111.64 24.34 12.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.39 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 1.2 p 23.96 60.92 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 117.506 2.41 . . . . 0.0 117.506 174.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -113.84 26.17 10.57 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.508 1.147 . . . . 0.0 109.441 169.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 17.6 mmt85 -120.9 84.66 2.27 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.597 -1.638 . . . . 0.0 108.592 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -82.72 76.88 9.54 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.828 -172.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.54 ' HE1' ' N ' ' A' ' 173' ' ' THR . 20.4 p90 -111.94 83.29 1.77 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.757 173.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 61.1 mtt85 -84.45 145.7 28.01 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 119.542 -1.974 . . . . 0.0 107.157 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 73.2 p -91.47 135.22 34.0 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.401 -175.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -159.49 162.5 32.92 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.162 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.21 128.56 10.63 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.215 1.943 . . . . 0.0 111.796 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 10.5 t -85.0 115.65 22.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.275 0.56 . . . . 0.0 110.452 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . 0.536 ' O ' ' HB2' ' A' ' 215' ' ' ARG . 42.6 m-85 -101.69 151.51 21.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.435 -175.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' THR . . . . . 0.52 ' HA ' ' CB ' ' A' ' 215' ' ' ARG . 15.4 p -114.42 -23.95 9.1 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -170.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 27.0 t -155.69 116.99 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -171.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 4.0 mt -130.14 118.42 43.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 119.012 -1.075 . . . . 0.0 113.892 -170.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.5 p -112.76 -166.81 1.11 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.566 161.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -67.51 -5.48 15.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.619 0.724 . . . . 0.0 110.388 172.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -92.47 -76.53 0.46 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.43 -173.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 53.1 ttm -136.17 136.31 39.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.826 -172.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 196' ' ' GLN . 29.0 m -84.9 -15.47 44.43 Favored 'General case' 0 C--O 1.247 0.925 0 O-C-N 123.342 0.401 . . . . 0.0 110.823 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 72.3 mm-40 95.09 -165.06 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.211 1.405 . . . . 0.0 112.658 174.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 69.17 -3.57 7.22 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 114.992 -1.003 . . . . 0.0 113.03 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 51.01 39.59 23.43 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.965 0.383 . . . . 0.0 110.263 -172.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 58.0 58.7 3.45 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.579 -177.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 33.5 t -72.85 147.83 45.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.692 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -91.01 26.46 11.13 Favored Glycine 0 CA--C 1.506 -0.511 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.08 106.47 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-O 121.95 0.881 . . . . 0.0 109.356 174.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 12.6 t -94.63 118.9 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.144 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 18.7 t -156.22 179.72 8.96 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 10.7 p -102.37 160.21 14.75 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 120.184 1.356 . . . . 0.0 109.736 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.49 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 37.8 tttm -59.01 -42.26 89.66 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.503 177.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.0 m -44.87 -56.62 4.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.332 174.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.09 -53.74 49.05 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.665 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 91.5 m -67.94 -23.48 65.07 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -174.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 61.4 m -93.84 -34.79 13.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.542 0.61 . . . . 0.0 111.649 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -72.67 -58.12 3.6 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.705 HG22 ' HA2' ' A' ' 234' ' ' GLY . 4.6 p -97.83 159.74 14.74 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.258 177.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.1 t 66.97 -48.42 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 122.565 0.346 . . . . 0.0 111.729 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 60.63 52.03 55.04 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 114.796 0.679 . . . . 0.0 114.796 171.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' A' ' 187' ' ' PHE . 0.0 OUTLIER -123.41 -78.2 0.6 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.813 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.402 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -173.28 167.24 4.81 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . 0.494 ' O ' ' HB2' ' A' ' 222' ' ' GLU . 19.5 t90 -159.61 148.16 17.62 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 92.59 177.48 41.32 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 114.74 0.656 . . . . 0.0 114.74 168.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.523 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 12.2 p80 -143.01 132.14 11.67 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.132 -0.534 . . . . 0.0 109.707 177.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . 0.523 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 52.1 Cg_exo -56.65 148.11 26.29 Favored 'Cis proline' 0 C--N 1.346 0.411 0 C-N-CA 123.694 -1.378 . . . . 0.0 111.444 -4.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 80.0 m -47.22 122.81 4.84 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.795 0.685 . . . . 0.0 111.845 -173.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 33.6 mm-40 -108.35 112.5 24.98 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' MET . . . . . 0.402 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 10.4 ptm -94.38 133.79 37.58 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.269 0.557 . . . . 0.0 110.911 -172.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 74.2 m -94.12 125.16 53.71 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.198 -0.91 . . . . 0.0 113.397 -164.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -64.76 154.21 73.79 Favored 'Trans proline' 0 CA--C 1.512 -0.584 0 C-N-CA 123.092 2.528 . . . . 0.0 113.188 166.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -38.29 104.4 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 122.772 1.272 . . . . 0.0 111.93 163.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 18.52 88.24 0.05 OUTLIER Pre-proline 0 N--CA 1.483 1.189 0 CA-C-N 110.507 -3.042 . . . . 0.0 114.778 174.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -38.04 -55.93 1.08 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 124.387 3.391 . . . . 0.0 113.246 173.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -80.51 106.0 4.59 Favored Pre-proline 0 CA--C 1.518 -0.277 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 170.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.1 35.53 0.3 Allowed 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.112 1.875 . . . . 0.0 114.247 -171.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 33.8 m -69.22 -74.81 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 169.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.458 ' HB3' ' CD2' ' A' ' 235' ' ' PHE . 24.0 tpt180 -149.47 140.4 22.85 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 165.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -36.3 -45.46 0.47 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -177.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.705 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -78.8 9.97 34.55 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.93 -174.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . 0.534 ' HE2' ' N ' ' A' ' 267' ' ' GLY . 2.2 m-85 -116.53 138.39 51.44 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 122.009 0.909 . . . . 0.0 113.426 -169.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.48 137.07 29.61 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.601 173.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.61 124.41 16.01 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.658 2.239 . . . . 0.0 112.92 -177.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -58.27 141.66 50.23 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.652 173.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 26.3 mt -81.45 -13.82 12.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.079 -174.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 65.1 mtt180 -99.57 -59.01 1.8 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.335 0.588 . . . . 0.0 109.823 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 43.8 p -86.63 -33.96 19.97 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.879 -176.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 90.3 5.77 69.5 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -177.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -83.46 134.02 34.88 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 121.591 0.71 . . . . 0.0 110.349 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 4.0 m -59.45 118.73 6.36 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.273 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 83.1 mm-40 -120.38 143.03 48.65 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.602 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 14.9 t70 -79.11 146.16 33.36 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -176.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.615 HG23 ' HG3' ' A' ' 249' ' ' GLU . 5.3 m -98.68 148.22 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.047 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.856 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -75.8 77.28 2.73 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 167.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.615 ' HG3' HG23 ' A' ' 247' ' ' VAL . 40.4 mp0 -53.57 -37.66 63.14 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 123.482 0.489 . . . . 0.0 111.689 -168.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 36.0 t -50.59 -40.47 52.64 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.121 0.486 . . . . 0.0 110.616 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -93.78 -40.32 10.26 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.591 0.71 . . . . 0.0 110.125 -172.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -67.49 -25.01 65.65 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.588 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.1 mp -121.3 83.76 40.11 Favored Pre-proline 0 N--CA 1.449 -0.525 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 173.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -65.34 8.81 0.21 Allowed 'Trans proline' 0 N--CA 1.482 0.813 0 C-N-CA 124.411 3.408 . . . . 0.0 116.379 -168.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -129.81 8.4 6.11 Favored Glycine 0 C--N 1.295 -1.708 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.755 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.65 136.41 42.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.212 0.529 . . . . 0.0 112.189 -174.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 10.7 t 56.78 54.43 7.22 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.681 178.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -94.28 -17.63 22.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.257 177.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -87.8 40.57 3.08 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.434 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 164.03 -160.6 33.52 Favored Glycine 0 N--CA 1.437 -1.234 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -81.41 156.47 25.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.921 0.361 . . . . 0.0 110.425 177.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 15.4 p -138.92 121.14 15.84 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 176.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 16.6 mt -136.16 164.1 32.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -174.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -134.61 132.12 38.65 Favored 'General case' 0 CA--C 1.496 -1.109 0 C-N-CA 117.789 -1.564 . . . . 0.0 114.36 -175.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.89 160.36 20.99 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.867 162.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.602 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 3.0 m -73.1 128.12 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 173.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.534 ' N ' ' HE2' ' A' ' 235' ' ' PHE . . . 112.45 -22.17 17.97 Favored Glycine 0 N--CA 1.419 -2.439 0 C-N-CA 119.977 -1.106 . . . . 0.0 112.147 -173.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 267' ' ' GLY . 8.5 t 166.77 165.04 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.342 0.592 . . . . 0.0 110.18 -177.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -101.15 155.45 18.0 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 119.864 -0.735 . . . . 0.0 109.965 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -109.93 123.86 50.37 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -177.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 66.3 m -114.0 129.07 56.63 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.399 0.618 . . . . 0.0 110.156 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -102.61 114.49 28.76 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.838 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 70.0 m -91.6 148.09 36.59 Favored Pre-proline 0 C--N 1.296 -1.74 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.311 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -52.81 152.67 16.68 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.006 1.804 . . . . 0.0 110.927 173.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -51.61 139.95 19.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.884 0.373 . . . . 0.0 111.115 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 86.92 -34.77 3.5 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.301 -0.952 . . . . 0.0 111.353 -176.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' HIS . . . . . 0.494 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 17.8 m-70 -80.24 163.33 24.08 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 120.968 0.413 . . . . 0.0 110.893 -176.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -146.29 133.71 20.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.561 -173.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.409 HD12 ' O ' ' A' ' 285' ' ' LYS . 46.8 tp -66.56 142.57 57.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.991 0.424 . . . . 0.0 111.063 -176.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -131.23 99.47 4.87 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -61.32 -17.15 52.37 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.861 0.725 . . . . 0.0 112.624 -176.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 215' ' ' ARG . 77.0 t -58.01 -39.48 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.183 0.516 . . . . 0.0 110.597 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 57.7 p -140.89 36.9 1.78 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.951 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 28.25 50.92 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.326 1.051 . . . . 0.0 112.897 -174.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . 0.409 ' O ' HD12 ' A' ' 279' ' ' LEU . 68.9 tttt -104.44 169.59 8.38 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.699 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 53.7 m -141.65 100.21 3.72 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 57.8 mm-40 . . . . . 0 C--O 1.24 0.563 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -173.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' A' ' 147' ' ' GLN . 67.7 m-85 . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 32.6 pt -138.4 -176.33 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.865 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.03 167.61 43.17 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.302 -174.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 34.4 p -77.99 -10.98 59.86 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.778 -0.248 . . . . 0.0 111.516 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 30.7 m80 -109.28 -3.76 16.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.047 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 9.5 t 66.1 26.26 10.71 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.35 0.595 . . . . 0.0 109.623 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -96.09 4.14 64.96 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.615 -0.721 . . . . 0.0 113.076 -173.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 140' ' ' TYR . 0.1 OUTLIER -110.91 108.08 57.74 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.027 -178.297 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -74.06 140.72 28.66 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.119 2.546 . . . . 0.0 112.983 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 149' ' ' VAL . 13.6 p -78.38 103.59 5.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.34 1.067 . . . . 0.0 111.363 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -81.95 82.89 7.42 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.646 174.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -56.33 -69.09 0.16 Allowed 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -173.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 64.9 m -83.05 10.5 7.92 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.78 0.8 . . . . 0.0 110.659 -163.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 71.72 132.31 0.12 Allowed Glycine 0 N--CA 1.424 -2.13 0 CA-C-N 114.374 -1.285 . . . . 0.0 111.491 -170.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 62.4 m -68.06 151.5 46.95 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.23 -0.985 . . . . 0.0 109.503 175.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 38.6 mt -132.36 175.39 9.32 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -172.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.672 ' HB2' ' CZ ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 66.88 11.52 8.36 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 123.791 0.682 . . . . 0.0 112.124 170.615 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.61 32.07 80.06 Favored Glycine 0 CA--C 1.507 -0.458 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -172.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -77.76 -145.55 2.44 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.276 -0.462 . . . . 0.0 114.1 -175.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -149.76 114.13 5.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.63 0.252 . . . . 0.0 110.491 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 35.1 t -58.78 113.77 2.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.891 0.377 . . . . 0.0 110.634 174.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 165' ' ' ARG . 13.0 m -106.96 -46.13 8.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.921 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.438 ' HB1' ' HD2' ' A' ' 163' ' ' PRO . . . -134.11 178.06 1.95 Allowed Pre-proline 0 CA--C 1.541 0.622 0 CA-C-O 118.72 -0.657 . . . . 0.0 109.981 175.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.438 ' HD2' ' HB1' ' A' ' 162' ' ' ALA . 96.2 Cg_exo -49.05 103.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 122.661 2.241 . . . . 0.0 113.589 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 66.31 8.94 6.01 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.238 1.015 . . . . 0.0 109.958 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.497 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -93.08 81.24 4.54 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.613 174.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 63.7 m -85.74 138.75 31.88 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.277 172.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.96 139.16 30.8 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 61.0 m -92.65 110.44 21.87 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 124.182 0.926 . . . . 0.0 111.601 -169.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 24.1 m -65.84 -55.28 17.88 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.44 ' CD2' ' N ' ' A' ' 171' ' ' GLY . 38.0 t80 -121.36 -116.41 0.31 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 118.89 -1.124 . . . . 0.0 112.532 -168.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.44 ' N ' ' CD2' ' A' ' 170' ' ' TYR . . . -91.77 52.13 2.95 Favored Glycine 0 CA--C 1.485 -1.799 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.163 -166.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.672 ' CZ ' ' HB2' ' A' ' 156' ' ' ASN . 6.9 m-85 -119.06 127.8 53.74 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 119.302 -0.959 . . . . 0.0 112.598 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 3.6 t -91.0 162.71 14.6 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 163.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 90.96 131.25 4.92 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.36 -13.2 30.48 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.312 1.341 . . . . 0.0 113.322 -166.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -106.83 14.41 26.71 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.246 0.546 . . . . 0.0 109.601 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 31.33 60.22 0.27 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.735 1.214 . . . . 0.0 113.958 177.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -115.94 -13.92 11.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.925 175.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -56.44 -61.91 2.09 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.907 -1.497 . . . . 0.0 107.967 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 32.8 t70 74.45 69.83 0.1 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.78 0.8 . . . . 0.0 109.524 160.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.474 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 45.3 p90 -94.75 66.22 3.13 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 174.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -57.19 123.74 16.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.136 171.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.429 ' HB ' HG13 ' A' ' 203' ' ' VAL . 41.3 p -73.22 138.02 45.34 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -163.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -140.51 141.61 11.58 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.79 -162.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -72.12 128.66 14.15 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.964 1.776 . . . . 0.0 111.382 172.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 6.4 t -84.53 113.6 21.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.131 0.491 . . . . 0.0 110.09 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -94.6 147.05 23.68 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.766 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' THR . . . . . 0.45 ' HA ' ' CB ' ' A' ' 215' ' ' ARG . 12.9 p -113.5 -2.92 13.77 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.5 t -130.35 159.23 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.639 HD11 ' HB2' ' A' ' 216' ' ' ALA . 40.5 mm -134.55 119.34 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.562 0.696 . . . . 0.0 111.336 174.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 48.2 t -143.17 169.18 18.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.308 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -79.37 -7.5 58.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 122.369 1.081 . . . . 0.0 108.106 167.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -92.44 -71.45 0.64 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.476 -1.693 . . . . 0.0 109.655 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 63.2 mtt -143.83 136.55 27.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.927 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 34.3 m -85.17 -38.79 18.6 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 168.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 157.11 -149.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 113.423 -1.717 . . . . 0.0 106.969 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 94.13 17.21 41.12 Favored Glycine 0 CA--C 1.509 -0.338 0 C-N-CA 119.743 -1.218 . . . . 0.0 112.747 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -90.58 -1.99 57.88 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.227 0.536 . . . . 0.0 110.204 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.412 ' N ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -160.53 8.97 0.09 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.755 -177.392 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 12.6 m -87.97 86.07 7.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.313 0.578 . . . . 0.0 112.248 -169.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -100.25 4.19 57.01 Favored Glycine 0 CA--C 1.506 -0.509 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 170.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.14 114.33 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 114.435 -0.882 . . . . 0.0 109.576 173.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.429 HG13 ' HB ' ' A' ' 183' ' ' THR . 23.0 t -104.68 101.1 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 CA-C-O 122.974 1.369 . . . . 0.0 110.728 176.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 9.6 t -129.27 -176.8 3.99 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 112.529 -2.123 . . . . 0.0 106.204 174.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 26.7 p -107.9 165.6 11.34 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.143 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.751 ' HB3' ' CE3' ' A' ' 217' ' ' TRP . 21.7 ptmt -69.58 -22.02 63.56 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.526 174.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 8.4 m -57.59 -53.07 62.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 172.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.69 -56.43 22.06 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.737 175.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 68.7 m -67.99 -24.15 65.1 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.253 -172.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 78.2 m -101.9 -11.08 19.27 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -82.47 -50.74 8.51 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 164.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 214' ' ' GLY . 40.0 p -78.15 -156.76 0.09 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.886 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.7 t -19.82 -33.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 212' ' ' THR . . . 81.41 -165.33 46.44 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 119.796 -1.192 . . . . 0.0 114.429 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.45 ' CB ' ' HA ' ' A' ' 188' ' ' THR . 72.6 mmt-85 102.72 -80.29 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.837 1.655 . . . . 0.0 109.932 174.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.639 ' HB2' HD11 ' A' ' 190' ' ' ILE . . . -173.53 168.25 4.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 119.101 0.864 . . . . 0.0 110.347 175.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . 0.751 ' CE3' ' HB3' ' A' ' 206' ' ' LYS . 20.7 t90 -164.28 144.44 7.94 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 76.99 -174.27 54.52 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.0 -0.619 . . . . 0.0 113.014 175.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.448 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 31.1 p80 -135.64 131.71 19.36 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . 0.448 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 31.6 Cg_exo -59.94 165.2 26.71 Favored 'Cis proline' 0 N--CA 1.477 0.505 0 C-N-CA 123.733 -1.361 . . . . 0.0 111.821 -5.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 55.9 m -62.63 81.32 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -173.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 216' ' ' ALA . 5.7 mm-40 -50.29 97.93 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.31 0.576 . . . . 0.0 110.438 167.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 19.8 ptt? -99.42 131.89 45.12 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.162 -173.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 18.5 m -142.11 144.17 30.74 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.386 -173.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -59.87 168.17 6.08 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.897 2.398 . . . . 0.0 110.046 160.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.01 -96.3 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.876 0.37 . . . . 0.0 111.213 -176.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.28 113.34 45.67 Favored Pre-proline 0 C--N 1.32 -0.689 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.725 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -83.48 -41.24 0.1 OUTLIER 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.621 2.214 . . . . 0.0 113.698 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -103.89 173.57 3.32 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -174.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -60.19 -18.35 51.28 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.026 1.817 . . . . 0.0 112.011 174.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 14.8 t -64.07 124.69 22.26 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 172.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.481 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 45.3 mtt180 -63.45 135.23 56.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.386 -172.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -30.43 -44.54 0.05 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 246' ' ' ASP . . . -79.78 12.02 31.08 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.895 -1.145 . . . . 0.0 113.952 -173.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . 0.481 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 44.2 m-85 -125.05 158.55 33.47 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 117.994 0.897 . . . . 0.0 112.769 -175.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.28 130.53 21.97 Favored Pre-proline 0 N--CA 1.445 -0.695 0 CA-C-N 113.388 -1.733 . . . . 0.0 107.443 170.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.09 113.03 1.86 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.059 1.839 . . . . 0.0 111.509 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -47.13 130.0 12.52 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.665 0.745 . . . . 0.0 110.959 177.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 29.6 mt -74.49 -3.83 5.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.145 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -104.63 -60.09 1.65 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.913 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 34.9 p -86.41 -44.03 12.35 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.56 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 104.01 6.97 42.05 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.608 -177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -96.55 130.37 43.75 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 122.039 0.923 . . . . 0.0 110.134 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 93.9 m -49.48 120.76 4.39 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 113.066 -1.879 . . . . 0.0 110.465 171.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -120.61 136.07 54.92 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.498 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 19.0 t70 -74.09 141.36 45.67 Favored 'General case' 0 CA--C 1.492 -1.256 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.502 -174.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.515 HG23 ' HG3' ' A' ' 249' ' ' GLU . 4.2 m -93.34 143.94 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.441 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -74.2 76.4 1.8 Allowed 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 166.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.515 ' HG3' HG23 ' A' ' 247' ' ' VAL . 29.7 mp0 -49.04 -38.4 23.78 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.896 0.748 . . . . 0.0 111.18 -171.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 15.5 m -53.19 -32.07 46.05 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.639 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -105.53 -50.29 3.24 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.499 0.72 . . . . 0.0 110.776 -175.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -59.88 -26.93 66.27 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.141 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.591 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.5 mp -118.14 79.88 14.83 Favored Pre-proline 0 N--CA 1.447 -0.575 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 169.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -38.0 103.14 0.04 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.564 0 C-N-CA 124.451 3.434 . . . . 0.0 115.509 -169.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 59.96 38.24 93.87 Favored Glycine 0 C--N 1.312 -0.787 0 CA-C-N 113.667 -1.606 . . . . 0.0 113.77 172.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.591 ' HB3' HG22 ' A' ' 253' ' ' ILE . 1.7 pt? -66.46 -31.31 71.98 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.004 177.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 51.7 t -119.74 81.19 1.69 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.281 0.562 . . . . 0.0 109.669 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -117.41 26.05 10.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.142 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -70.83 -27.32 72.51 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 172.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -149.49 -116.29 0.81 Allowed Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 175.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' ASN . . . . . 0.417 HD22 ' N ' ' A' ' 262' ' ' CYS . 0.2 OUTLIER -112.61 131.17 55.75 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.639 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . 0.417 ' N ' HD22 ' A' ' 261' ' ' ASN . 49.1 t -102.5 140.45 36.76 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 172.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 22.5 mt -130.97 163.31 37.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.7 127.36 38.68 Favored 'General case' 0 CA--C 1.496 -1.131 0 C-N-CA 117.615 -1.634 . . . . 0.0 113.895 -174.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.4 t -113.68 165.56 12.41 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.076 163.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.498 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 30.7 m -70.46 125.36 28.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.83 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.472 ' HA2' ' CE2' ' A' ' 235' ' ' PHE . . . 97.05 -13.07 65.29 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-O 118.962 -0.91 . . . . 0.0 113.935 -177.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.0 t 178.68 157.5 0.49 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.732 1.266 . . . . 0.0 109.874 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -105.97 159.2 16.23 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.872 -0.518 . . . . 0.0 109.876 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -114.84 121.33 42.93 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 68.1 m -111.71 150.75 29.77 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 122.037 0.922 . . . . 0.0 111.917 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.28 109.56 7.83 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 113.503 -1.68 . . . . 0.0 109.694 175.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 10.1 m -84.56 164.4 42.88 Favored Pre-proline 0 C--N 1.314 -0.978 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 51.6 Cg_exo -53.31 156.41 10.69 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 121.921 1.747 . . . . 0.0 111.696 175.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -53.92 140.59 30.34 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.162 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 87.08 -28.55 5.53 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.421 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' HIS . . . . . 0.483 ' HB2' ' O ' ' A' ' 274' ' ' PRO . 21.5 m-70 -81.97 165.82 20.38 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.0 0.429 . . . . 0.0 111.587 -176.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -139.69 137.52 35.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.143 -172.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.404 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 14.9 tp -85.48 139.91 31.11 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.116 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -131.42 98.76 4.62 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.415 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -56.19 -30.53 62.39 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.214 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.41 ' O ' ' HB ' ' A' ' 188' ' ' THR . 42.0 t -56.08 -29.78 27.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.189 -176.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 67.6 m -145.16 33.32 1.09 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.599 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 32.28 45.15 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.914 -1.039 . . . . 0.0 113.474 -174.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 51.1 mttp -88.13 154.84 20.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.006 0.431 . . . . 0.0 111.95 -176.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 5.4 m -139.42 80.81 1.8 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.089 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 N--CA 1.44 -0.964 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -178.892 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.598 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 55.7 m-85 . . . . . 0 CA--C 1.514 -0.413 0 CA-C-O 120.772 0.32 . . . . 0.0 110.412 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 36.0 pt -138.81 -177.81 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.718 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.805 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.38 164.05 22.73 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.363 -175.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 43.5 p -78.16 -39.93 39.39 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.931 0.396 . . . . 0.0 110.905 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -98.67 -10.57 23.07 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.472 176.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 71.4 m 78.99 154.63 0.14 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.054 -1.43 . . . . 0.0 113.476 174.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.41 2.4 4.08 Favored Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 112.913 -1.949 . . . . 0.0 113.808 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.43 ' C ' HE21 ' A' ' 147' ' ' GLN . 0.0 OUTLIER -93.31 104.72 13.04 Favored Pre-proline 0 C--N 1.317 -0.806 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.199 174.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.71 149.96 14.41 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.4 2.066 . . . . 0.0 112.325 -175.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.6 p -78.89 105.93 8.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 122.439 1.114 . . . . 0.0 112.611 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.06 80.15 6.51 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.155 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -56.23 -67.84 0.26 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -172.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 37.6 m -89.18 7.02 37.38 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.166 0.508 . . . . 0.0 111.392 -167.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 73.6 128.06 0.13 Allowed Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.016 -172.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . 0.483 ' O ' HD23 ' A' ' 155' ' ' LEU . 57.1 m -71.22 164.09 26.34 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 113.944 -1.128 . . . . 0.0 109.309 176.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.62 HD12 ' O ' ' A' ' 176' ' ' GLN . 68.7 mt -139.96 162.74 34.46 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.697 -167.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.635 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 2.4 t-20 53.35 26.08 5.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.659 0.743 . . . . 0.0 110.475 -167.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.63 37.24 94.14 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.119 -1.038 . . . . 0.0 112.007 -174.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.46 -147.13 0.51 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.08 134.63 9.63 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 117.591 0.695 . . . . 0.0 110.477 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.43 110.41 9.78 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.246 0.546 . . . . 0.0 110.514 175.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.9 m -95.43 -29.59 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.521 0.677 . . . . 0.0 110.349 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.567 ' HB3' ' CB ' ' A' ' 165' ' ' ARG . . . -139.12 173.71 4.9 Favored Pre-proline 0 N--CA 1.451 -0.417 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.598 ' HD3' ' CE1' ' A' ' 140' ' ' TYR . 78.2 Cg_exo -54.54 105.07 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.199 1.933 . . . . 0.0 112.051 176.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 26.0 t30 66.2 9.83 6.63 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.097 0.959 . . . . 0.0 110.629 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.567 ' CB ' ' HB3' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -98.92 82.69 2.8 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.43 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 74.1 m -82.26 148.17 28.52 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.414 174.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -99.23 131.14 45.47 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 58.2 m -102.65 132.09 48.99 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 123.877 0.736 . . . . 0.0 111.302 -169.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.635 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 19.7 m -47.68 -54.47 11.95 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -168.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.403 ' HD2' ' N ' ' A' ' 171' ' ' GLY . 5.6 t80 -157.65 -83.53 0.05 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 118.716 -1.194 . . . . 0.0 112.51 -170.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.403 ' N ' ' HD2' ' A' ' 170' ' ' TYR . . . -97.69 49.96 1.42 Allowed Glycine 0 CA--C 1.496 -1.151 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.262 -166.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 172' ' ' PHE . 10.2 m-85 -116.79 129.43 56.1 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 118.529 -1.268 . . . . 0.0 113.461 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.49 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 3.3 t -97.29 143.78 27.72 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.438 173.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 93.3 130.75 5.64 Favored Glycine 0 C--N 1.297 -1.628 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 -175.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.21 17.95 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.611 1.54 . . . . 0.0 112.914 -169.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.62 ' O ' HD12 ' A' ' 155' ' ' LEU . 65.8 tt0 -128.15 12.14 6.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.211 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 27.17 59.08 0.09 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 116.885 2.18 . . . . 0.0 116.885 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -109.85 16.18 22.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.24 1.019 . . . . 0.0 109.352 169.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -120.39 91.1 3.46 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.409 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -89.11 86.69 6.95 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.164 0.983 . . . . 0.0 111.853 -170.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.49 ' HE2' ' N ' ' A' ' 173' ' ' THR . 32.4 p90 -116.89 96.2 5.36 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 175.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -74.04 130.73 40.41 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 119.49 -2.006 . . . . 0.0 108.222 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 67.6 p -79.99 168.06 19.68 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.06 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.42 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . 158.16 148.09 5.04 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.316 -164.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -76.25 132.8 14.14 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.15 1.9 . . . . 0.0 111.922 174.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 13.6 t -88.4 116.67 26.79 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . 0.535 ' CD2' ' HB2' ' A' ' 195' ' ' CYS . 16.1 m-85 -102.93 152.56 21.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.362 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' THR . . . . . 0.549 ' HA ' ' HB3' ' A' ' 215' ' ' ARG . 20.0 p -103.28 -54.9 2.51 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.1 p -140.54 120.03 12.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 O-C-N 120.914 -1.116 . . . . 0.0 112.645 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.418 ' CG1' ' SG ' ' A' ' 221' ' ' CYS . 2.1 mp -97.84 116.07 39.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-O 121.907 0.861 . . . . 0.0 111.612 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.0 p -106.86 -167.93 1.34 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 158.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -72.08 -4.83 31.19 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.367 0.604 . . . . 0.0 109.759 172.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -88.89 -69.8 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.482 -173.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.4 ' HG3' ' H ' ' A' ' 196' ' ' GLN . 33.0 tpp -162.99 135.62 5.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.189 -176.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.535 ' HB2' ' CD2' ' A' ' 187' ' ' PHE . 3.2 m -68.31 -19.41 64.67 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.877 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.53 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 44.8 mm-40 93.08 113.85 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.954 1.302 . . . . 0.0 113.34 173.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.04 -9.58 9.63 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.262 174.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 54.18 48.68 20.36 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.762 0.315 . . . . 0.0 110.82 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 6.6 mp 55.57 70.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.815 -175.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 46.3 t -72.2 148.36 45.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.475 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.33 21.55 12.71 Favored Glycine 0 CA--C 1.508 -0.366 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.898 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.3 98.12 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 163.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.39 118.66 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.383 0 CA-C-N 113.819 -1.537 . . . . 0.0 109.072 -175.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 10.1 t -158.11 -178.16 7.09 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 -175.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 26.7 p -108.24 168.44 9.3 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 120.278 1.399 . . . . 0.0 111.33 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.532 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 47.1 tttp -57.71 -44.33 85.84 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.406 174.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.1 m -47.01 -56.04 7.13 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.004 176.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.75 -55.33 36.47 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.206 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 84.7 m -67.36 -23.75 65.63 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -172.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 16.3 m -104.75 -26.69 12.17 Favored 'General case' 0 N--CA 1.429 -1.524 0 O-C-N 121.149 -0.969 . . . . 0.0 111.686 -175.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -71.8 -56.99 4.75 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 170.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.55 HG21 ' CG2' ' A' ' 247' ' ' VAL . 6.0 p -100.23 156.22 17.34 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.592 -1.64 . . . . 0.0 107.16 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.2 t 68.0 -39.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 118.841 -0.599 . . . . 0.0 111.713 -177.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 65.12 49.71 60.79 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 119.061 0.846 . . . . 0.0 113.499 166.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.549 ' HB3' ' HA ' ' A' ' 188' ' ' THR . 31.3 mmt180 -127.7 -90.37 0.52 Allowed 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 120.527 -0.469 . . . . 0.0 112.206 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -165.83 164.96 18.64 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -177.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . 0.718 ' O ' ' HB2' ' A' ' 222' ' ' GLU . 7.0 t90 -168.29 139.55 2.74 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 127.7 167.72 12.34 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 119.634 -1.27 . . . . 0.0 114.53 172.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -132.8 132.18 22.42 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.219 -0.491 . . . . 0.0 109.992 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.46 117.09 4.83 Favored 'Cis proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.011 -1.662 . . . . 0.0 111.61 -3.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . 0.418 ' SG ' ' CG1' ' A' ' 190' ' ' ILE . 34.1 t 39.0 92.89 0.01 OUTLIER 'General case' 0 C--O 1.243 0.751 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 175.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.718 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 34.7 mt-10 -105.48 110.12 22.34 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 2.8 tpt -90.31 138.74 31.29 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -173.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 54.6 m -111.48 129.49 24.05 Favored Pre-proline 0 C--O 1.234 0.277 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -169.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -80.03 151.12 20.97 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.513 2.809 . . . . 0.0 111.641 166.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 37.21 -86.54 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.276 0 O-C-N 124.799 1.312 . . . . 0.0 114.281 174.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.66 166.63 3.26 Favored Pre-proline 0 N--CA 1.44 -0.932 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -168.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -80.08 -85.91 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 121.884 1.722 . . . . 0.0 112.424 177.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -75.48 154.38 85.77 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.083 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -81.7 52.81 4.37 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.821 1.681 . . . . 0.0 113.775 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 71.9 m -104.78 -179.69 4.02 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 171.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.503 ' HB3' ' CD2' ' A' ' 235' ' ' PHE . 73.0 ttt180 -67.53 140.95 57.02 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 170.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -38.67 -50.92 1.66 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -175.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.527 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -70.26 9.27 3.28 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.41 -0.9 . . . . 0.0 114.145 -174.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . 0.503 ' CD2' ' HB3' ' A' ' 232' ' ' ARG . 5.3 m-85 -123.99 153.68 40.93 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 122.31 1.052 . . . . 0.0 113.721 -171.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.441 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.0 OUTLIER -130.19 133.23 24.7 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 113.619 -1.628 . . . . 0.0 108.227 168.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.76 116.39 3.52 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.329 2.019 . . . . 0.0 112.382 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -49.14 132.36 19.38 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.6 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 37.6 pt -73.8 1.2 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.316 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -111.89 -55.49 2.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.422 0.63 . . . . 0.0 110.181 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 66.3 p -92.96 -38.67 11.55 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.417 -175.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 98.33 4.47 57.35 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.394 -175.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -83.75 124.95 31.42 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 121.673 0.749 . . . . 0.0 109.662 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 10.8 m -57.91 114.69 2.44 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 113.446 -1.707 . . . . 0.0 109.401 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -117.1 141.07 48.72 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.505 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 16.3 t70 -76.32 146.27 38.97 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -175.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.55 ' CG2' HG21 ' A' ' 212' ' ' THR . 4.4 m -96.78 151.65 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.983 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.87 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.415 ' OD1' ' HB2' ' A' ' 250' ' ' CYS . 6.3 t0 -78.98 81.07 5.28 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 167.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.504 ' HG3' HG23 ' A' ' 247' ' ' VAL . 2.1 mp0 -52.57 -32.05 39.19 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 123.901 0.751 . . . . 0.0 110.467 -173.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.415 ' HB2' ' OD1' ' A' ' 248' ' ' ASP . 58.0 m -55.04 -42.79 73.09 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.676 172.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -89.96 -33.48 16.38 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 122.29 1.043 . . . . 0.0 109.581 -175.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -79.27 -23.3 43.71 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.087 -174.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.583 ' O ' ' HB3' ' A' ' 256' ' ' LEU . 5.3 mp -132.58 79.21 65.31 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 176.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -55.57 153.93 27.23 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 121.776 1.651 . . . . 0.0 112.289 177.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 78.55 -19.18 5.04 Favored Glycine 0 C--N 1.316 -0.579 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.833 -174.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.583 ' HB3' ' O ' ' A' ' 253' ' ' ILE . 2.1 tt -76.04 115.19 15.51 Favored 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 122.425 -0.456 . . . . 0.0 109.847 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 37.3 t 63.33 19.37 11.64 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.171 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -84.31 56.22 3.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.761 0.791 . . . . 0.0 110.259 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -120.81 7.52 10.99 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 173.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -179.14 -117.47 0.54 Allowed Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -117.4 116.35 27.0 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 17.7 p -108.36 157.86 18.01 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 170.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 21.1 mt -145.49 156.64 13.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -170.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.2 124.81 39.85 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -173.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.6 t -114.54 170.95 7.94 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.191 165.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.505 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 34.6 m -67.59 127.41 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 CA-C-O 121.826 0.822 . . . . 0.0 110.723 -176.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 88.38 -14.75 58.7 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-O 119.007 -0.885 . . . . 0.0 113.554 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 75.3 m -169.9 148.64 3.54 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 118.051 0.925 . . . . 0.0 110.52 -172.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -105.37 152.4 23.0 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.64 -0.662 . . . . 0.0 110.384 174.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.88 126.52 52.03 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 -177.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 18.4 m -106.22 152.06 23.97 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.815 0.817 . . . . 0.0 113.162 -176.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -141.52 96.93 3.06 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.59 171.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 11.7 m -83.55 164.87 43.15 Favored Pre-proline 0 C--N 1.314 -0.952 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -57.32 165.92 5.09 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.939 1.76 . . . . 0.0 111.385 176.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -53.7 137.22 38.07 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.356 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 82.87 -31.07 3.11 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.458 -178.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' HIS . . . . . 0.438 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 15.8 m-70 -74.2 163.18 28.15 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.604 0.24 . . . . 0.0 111.352 -177.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -148.01 148.22 30.47 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 16.3 tp -82.16 141.36 33.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.377 . . . . 0.0 110.817 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -133.14 98.98 4.41 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.001 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -61.45 -23.26 65.74 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.465 0.478 . . . . 0.0 112.164 -174.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.27 -18.06 17.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.327 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 44.4 m -152.4 31.39 0.53 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.791 175.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 25.1 46.3 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.04 1.336 . . . . 0.0 113.808 -173.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 68.3 tttt -98.35 167.53 10.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.361 -171.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 1.8 m -144.43 83.41 1.72 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.438 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 36.4 tt0 . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.779 -0.629 . . . . 0.0 110.092 -171.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.478 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 75.3 m-85 . . . . . 0 C--O 1.235 0.338 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 145' ' ' CYS . 23.2 pt -139.82 178.42 3.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 CA-C-O 121.311 0.577 . . . . 0.0 111.214 -173.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.53 165.95 40.39 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.805 -169.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.9 m -70.73 -31.81 68.77 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.015 0.407 . . . . 0.0 110.785 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -89.84 -8.71 51.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.187 0.518 . . . . 0.0 109.927 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 141' ' ' ILE . 73.3 m 57.22 41.52 26.78 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.909 -175.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.23 2.3 59.42 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.588 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.51 104.39 55.17 Favored Pre-proline 0 C--N 1.329 -0.298 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.809 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.61 142.46 20.61 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.466 2.111 . . . . 0.0 111.661 177.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.8 p -66.64 106.72 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 122.569 1.176 . . . . 0.0 112.137 -173.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 20.8 m -80.23 66.1 5.61 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.831 173.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -52.16 -53.26 45.2 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.593 0.961 . . . . 0.0 113.593 -171.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 36.6 m -93.87 8.92 39.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.435 0.636 . . . . 0.0 110.576 -170.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 77.28 134.29 0.66 Allowed Glycine 0 N--CA 1.427 -1.964 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.266 -172.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.64 154.85 41.41 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 176' ' ' GLN . 42.7 mt -126.78 170.28 12.33 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -173.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 172' ' ' PHE . 0.1 OUTLIER 36.49 35.55 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.731 1.269 . . . . 0.0 113.598 -172.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.36 34.23 67.66 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.003 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -75.52 -151.54 3.17 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-O 121.466 0.481 . . . . 0.0 114.031 -172.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -145.7 122.41 11.18 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.102 0.477 . . . . 0.0 110.567 -179.146 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 19.1 m -68.79 112.12 5.31 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.833 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.8 m -92.39 -33.28 5.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.071 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.451 ' HB3' ' CB ' ' A' ' 165' ' ' ARG . . . -139.88 177.03 2.18 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.478 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 77.7 Cg_exo -53.55 111.64 0.74 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 121.73 1.62 . . . . 0.0 112.496 176.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 61.54 12.7 4.63 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.94 0.896 . . . . 0.0 110.879 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.451 ' CB ' ' HB3' ' A' ' 162' ' ' ALA . 0.4 OUTLIER -103.68 78.25 1.55 Allowed 'General case' 0 CA--C 1.499 -1.003 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.082 178.014 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 59.6 m -71.68 152.93 42.41 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.744 0.783 . . . . 0.0 110.54 171.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -106.28 141.72 37.15 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.629 169.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 29.2 m -97.68 128.68 44.54 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 124.346 1.029 . . . . 0.0 112.072 -163.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 77.9 m -62.96 -55.72 23.38 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 171' ' ' GLY . 40.1 t80 -128.18 -119.73 0.24 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 118.746 -1.181 . . . . 0.0 112.373 -169.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.401 ' N ' ' CD1' ' A' ' 170' ' ' TYR . . . -87.7 54.7 4.39 Favored Glycine 0 N--CA 1.428 -1.853 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.321 -167.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.559 ' CD2' ' N ' ' A' ' 172' ' ' PHE . 5.1 m-85 -119.14 122.24 41.59 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 119.247 -0.981 . . . . 0.0 112.331 173.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.432 ' N ' ' HE1' ' A' ' 181' ' ' TYR . 2.9 t -88.09 157.51 18.84 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 167.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.1 128.48 3.29 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.06 -0.07 7.4 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.498 1.465 . . . . 0.0 113.467 -166.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.466 ' O ' HD12 ' A' ' 155' ' ' LEU . 41.7 tt0 -109.71 8.35 24.71 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 32.87 57.09 0.44 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 177.222 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -114.06 -15.73 12.23 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.877 173.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -57.58 -68.92 0.19 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.157 -1.383 . . . . 0.0 108.645 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.0 t70 78.38 92.64 0.06 Allowed 'General case' 0 CA--C 1.509 -0.626 0 O-C-N 124.132 0.895 . . . . 0.0 110.102 164.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.436 ' CD2' ' O ' ' A' ' 181' ' ' TYR . 32.2 p90 -112.36 64.16 0.63 Allowed 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 173.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 25.7 tpt85 -42.42 121.15 1.85 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.408 171.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 38.9 p -82.28 136.63 35.01 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.347 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.444 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -159.92 155.47 26.59 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.048 -176.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -85.07 167.87 10.72 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.444 2.096 . . . . 0.0 111.847 172.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 69.6 m -116.92 121.06 40.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.155 0.502 . . . . 0.0 111.44 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . 0.65 ' O ' ' HB3' ' A' ' 215' ' ' ARG . 29.6 m-85 -93.36 131.71 38.27 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' THR . . . . . 0.441 ' HA ' ' CG ' ' A' ' 215' ' ' ARG . 19.0 m -89.32 -15.16 34.07 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 113.944 1.091 . . . . 0.0 113.944 -163.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.1 p -165.11 117.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.066 -174.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.404 HD11 ' HB3' ' A' ' 216' ' ' ALA . 6.7 mt -123.7 118.35 53.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -171.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 7.3 p -114.77 -167.11 1.18 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.419 160.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -68.07 -4.08 12.35 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.434 0.635 . . . . 0.0 110.275 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -75.55 -69.97 0.45 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.307 -177.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 22.4 ttt -169.7 152.68 4.68 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 21.8 m -77.24 -24.2 51.2 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 121.099 0.476 . . . . 0.0 111.475 -174.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 176.22 -92.1 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.845 173.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 124.55 11.14 4.66 Favored Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.939 171.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -89.04 -12.7 40.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.204 0.526 . . . . 0.0 109.992 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 65.17 -85.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.996 -177.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 71.1 m 68.93 125.85 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.574 0.702 . . . . 0.0 112.48 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.07 30.25 4.01 Favored Glycine 0 CA--C 1.508 -0.358 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.127 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.75 100.35 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 4.1 t -92.57 98.29 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-O 122.914 1.34 . . . . 0.0 109.751 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.465 ' OG ' HD23 ' A' ' 208' ' ' LEU . 8.4 t -117.69 179.94 3.92 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.659 -2.064 . . . . 0.0 105.976 169.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 19.0 p -107.63 161.93 14.42 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.399 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.413 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 46.3 tttm -61.91 -43.62 98.46 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.13 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 8.4 m -44.76 -55.13 5.59 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 122.22 1.009 . . . . 0.0 109.415 173.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.63 HD11 HG11 ' A' ' 247' ' ' VAL . 6.0 tp -63.7 -52.25 61.41 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.294 -1.775 . . . . 0.0 112.344 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 4.7 t -64.3 -37.29 86.97 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.441 0.638 . . . . 0.0 110.479 -175.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 52.2 m -85.07 -23.82 28.37 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.626 -177.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . 0.438 ' HA ' ' CD ' ' A' ' 228' ' ' PRO . . . -69.88 -52.75 22.12 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 173.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 214' ' ' GLY . 80.8 p -64.77 -156.43 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 113.101 -1.863 . . . . 0.0 111.85 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.414 HG11 HE21 ' A' ' 284' ' ' GLN . 1.6 t -44.25 -1.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.349 0 N-CA-C 116.276 1.954 . . . . 0.0 116.276 -176.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 212' ' ' THR . . . 85.72 -101.97 2.61 Favored Glycine 0 CA--C 1.507 -0.457 0 C-N-CA 119.086 -1.53 . . . . 0.0 113.549 175.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.65 ' HB3' ' O ' ' A' ' 187' ' ' PHE . 0.8 OUTLIER 50.78 -120.33 1.56 Allowed 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.143 0.497 . . . . 0.0 110.34 -169.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.419 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -158.44 159.88 36.19 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 172.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . 0.444 ' CZ2' ' HA3' ' A' ' 184' ' ' GLY . 26.9 t90 -136.07 146.33 46.94 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -174.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 82.25 177.44 51.87 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.735 171.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.524 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 8.0 p80 -143.01 133.4 12.26 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.626 -0.287 . . . . 0.0 110.252 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . 0.524 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 41.4 Cg_exo -57.8 154.03 34.38 Favored 'Cis proline' 0 C--N 1.345 0.366 0 C-N-CA 123.667 -1.389 . . . . 0.0 112.119 -3.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 9.5 m -49.54 123.01 6.97 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.193 -171.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -105.87 102.49 11.92 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' MET . . . . . 0.419 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 17.7 ptm -85.73 137.64 32.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.576 -169.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 99.3 m -135.3 143.17 44.39 Favored Pre-proline 0 C--O 1.235 0.294 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -171.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -64.45 169.17 11.53 Favored 'Trans proline' 0 CA--C 1.512 -0.579 0 C-N-CA 122.788 2.325 . . . . 0.0 110.346 155.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.0 -129.67 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.808 168.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -46.95 102.61 0.32 Allowed Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -166.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . 0.438 ' CD ' ' HA ' ' A' ' 211' ' ' ALA . 63.9 Cg_endo -82.39 -59.68 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.628 2.218 . . . . 0.0 112.389 176.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -70.87 159.6 84.9 Favored Pre-proline 0 CA--C 1.515 -0.368 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.91 58.25 6.81 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 121.706 1.604 . . . . 0.0 113.381 -174.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 43.0 m -135.43 -173.83 3.46 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.563 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 25.7 mmt180 -73.19 144.74 46.7 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.315 174.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -39.29 -42.96 1.08 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 246' ' ' ASP . . . -77.72 7.72 39.74 Favored Glycine 0 C--O 1.222 -0.612 0 C-N-CA 120.342 -0.933 . . . . 0.0 113.187 -176.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . 0.563 ' CD1' ' HB2' ' A' ' 232' ' ' ARG . 3.3 m-85 -120.42 143.0 48.7 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.865 0.84 . . . . 0.0 112.706 -171.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -122.59 131.5 24.37 Favored Pre-proline 0 N--CA 1.439 -0.987 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.082 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -65.66 113.76 2.65 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.051 1.834 . . . . 0.0 111.356 174.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -49.21 135.9 16.08 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 123.492 0.717 . . . . 0.0 111.581 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 29.5 pt -75.63 2.87 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.165 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 49.8 mtm180 -113.29 -56.51 2.4 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.973 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 35.0 p -95.91 -40.56 9.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.749 -174.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 99.44 5.63 55.6 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -175.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -79.01 134.01 36.8 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.806 0.812 . . . . 0.0 110.128 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 4.6 m -68.96 113.99 6.85 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.022 -1.445 . . . . 0.0 109.299 173.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 89.3 mt-30 -116.33 141.26 48.39 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.558 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 12.5 t70 -77.58 144.65 37.38 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.63 HG11 HD11 ' A' ' 208' ' ' LEU . 4.3 m -95.56 146.11 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.082 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -178.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -73.88 75.98 1.64 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 169.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.553 ' HG3' HG23 ' A' ' 247' ' ' VAL . 14.4 mp0 -52.5 -37.12 56.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 123.931 0.77 . . . . 0.0 110.776 -168.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 52.7 m -49.24 -38.71 27.6 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.866 174.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -101.21 -35.78 9.16 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.879 0.847 . . . . 0.0 110.565 -176.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.451 ' HB1' HD21 ' A' ' 208' ' ' LEU . . . -70.38 -20.1 62.97 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.33 -1.305 . . . . 0.0 110.459 -177.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.585 HG22 ' HB3' ' A' ' 256' ' ' LEU . 5.0 mp -137.29 77.63 41.16 Favored Pre-proline 0 N--CA 1.445 -0.703 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 169.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -48.06 113.53 0.83 Allowed 'Trans proline' 0 CA--C 1.514 -0.508 0 C-N-CA 124.018 3.146 . . . . 0.0 114.39 -167.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 61.22 35.97 91.69 Favored Glycine 0 C--N 1.311 -0.824 0 CA-C-N 113.457 -1.702 . . . . 0.0 113.391 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.585 ' HB3' HG22 ' A' ' 253' ' ' ILE . 1.8 pt? -66.96 -23.1 65.92 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 117.367 0.584 . . . . 0.0 110.905 176.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 39.1 t -82.02 121.73 26.91 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -90.26 111.51 22.72 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -171.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 71.49 66.1 2.23 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.749 171.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 174.14 -170.17 43.27 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 119.967 -1.111 . . . . 0.0 112.792 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -88.79 159.08 17.92 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 21.2 t -141.49 125.03 16.71 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 18.2 mt -136.54 109.21 7.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.104 -170.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -72.17 117.17 13.46 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.281 -174.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.3 t -105.38 160.61 14.99 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 157.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.558 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 3.9 m -77.43 128.56 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 C-N-CA 118.344 -1.342 . . . . 0.0 107.924 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.529 ' N ' ' HE1' ' A' ' 235' ' ' PHE . . . 110.5 -30.79 7.88 Favored Glycine 0 C--N 1.311 -0.838 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.669 -170.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 31.7 m -179.11 158.36 0.9 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.079 0.939 . . . . 0.0 109.93 -168.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -104.96 152.36 22.78 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.818 -1.176 . . . . 0.0 108.63 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -107.45 127.89 54.01 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -176.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 92.7 m -106.88 152.43 23.92 Favored 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.342 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -124.07 100.03 6.53 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.033 175.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 4.3 m -81.81 149.32 63.42 Favored Pre-proline 0 C--N 1.31 -1.109 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.869 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.57 162.31 8.48 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.08 1.854 . . . . 0.0 111.25 175.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -53.1 143.08 18.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.519 0.2 . . . . 0.0 111.059 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.49 -31.27 3.57 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.828 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' HIS . . . . . 0.492 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 14.4 m-70 -78.83 169.79 17.67 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 122.708 -0.289 . . . . 0.0 111.372 -177.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -149.5 148.95 30.01 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 39.6 tp -84.94 136.11 33.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.075 0.464 . . . . 0.0 110.534 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -125.71 100.29 6.36 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 174.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.27 -21.11 61.52 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.829 0.705 . . . . 0.0 112.185 -174.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 68.3 t -60.47 -34.07 56.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.177 0.513 . . . . 0.0 110.45 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 20.3 p -132.97 23.49 4.21 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.55 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . 0.414 HE21 HG11 ' A' ' 213' ' ' VAL . 12.5 mp0 29.62 46.63 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.062 -171.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -101.63 165.09 11.41 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.973 -172.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 5.7 m -140.89 88.42 2.18 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.492 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 7.1 tp10 . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.667 -0.682 . . . . 0.0 109.341 -173.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.53 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 98.8 m-85 . . . . . 0 CA--C 1.517 -0.315 0 CA-C-O 120.905 0.383 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 30.0 pt -132.88 174.6 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.967 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.99 174.15 33.23 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.737 -175.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.5 p -75.89 -29.74 58.57 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -111.32 12.61 21.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.34 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 46.2 m 59.67 35.91 22.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.091 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.59 -12.2 72.91 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.613 -0.721 . . . . 0.0 113.347 -174.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.28 110.42 56.05 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 117.336 0.568 . . . . 0.0 110.718 -176.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.37 147.85 18.3 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.931 2.421 . . . . 0.0 112.489 178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 12.4 p -75.14 109.87 8.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.943 0.878 . . . . 0.0 111.035 -176.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.24 77.54 5.75 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.24 173.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -56.54 -59.04 5.57 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -170.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.1 m -90.28 10.77 23.49 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.442 0.639 . . . . 0.0 111.267 -170.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 82.43 126.58 0.98 Allowed Glycine 0 N--CA 1.43 -1.761 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.654 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . 0.415 ' O ' HD23 ' A' ' 155' ' ' LEU . 3.6 m -71.94 153.51 41.79 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 113.854 -1.173 . . . . 0.0 109.559 171.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 154' ' ' CYS . 83.2 mt -141.3 172.7 12.32 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -169.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.635 ' ND2' ' HB2' ' A' ' 177' ' ' CYS . 8.5 p30 43.39 24.62 0.05 Allowed 'General case' 0 N--CA 1.478 0.949 0 O-C-N 124.108 0.88 . . . . 0.0 113.248 -174.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.1 36.8 93.71 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.199 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -73.76 -146.27 0.95 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 121.466 -0.397 . . . . 0.0 113.219 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.8 ttt85 -156.57 123.14 5.08 Favored 'General case' 0 C--O 1.222 -0.35 0 O-C-N 122.204 -0.586 . . . . 0.0 111.345 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 2.4 m -61.38 116.0 4.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.897 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 165' ' ' ARG . 11.2 m -102.1 -50.1 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.803 178.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -127.7 172.9 6.06 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.802 171.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.53 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 74.0 Cg_exo -51.15 107.78 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.128 1.885 . . . . 0.0 112.531 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 76.53 -14.2 0.84 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.816 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.439 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.6 OUTLIER -80.73 85.55 6.07 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.251 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 13.5 t -83.06 143.64 30.45 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.756 173.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -89.19 121.51 31.57 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 176.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 55.8 m -94.38 123.69 37.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.115 -169.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 85.1 m -53.74 -48.83 69.27 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 114.211 -1.359 . . . . 0.0 113.16 -170.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 10.0 t80 177.54 115.95 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.929 -175.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 78.76 43.44 11.61 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 120.356 -0.926 . . . . 0.0 113.522 169.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.565 ' CZ ' ' HB3' ' A' ' 156' ' ' ASN . 25.2 m-85 -124.8 128.25 48.43 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 117.951 0.876 . . . . 0.0 112.39 168.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.774 HG23 ' CE2' ' A' ' 181' ' ' TYR . 43.5 p -88.48 137.33 32.42 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.279 177.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.45 141.66 10.78 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.43 6.27 1.97 Allowed 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.451 1.434 . . . . 0.0 112.473 -170.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.401 ' O ' HD12 ' A' ' 155' ' ' LEU . 11.8 pt20 -129.3 24.64 5.52 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.32 177.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.635 ' HB2' ' ND2' ' A' ' 156' ' ' ASN . 0.0 OUTLIER 32.97 73.83 0.06 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 175.755 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -120.18 16.14 12.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.109 0.481 . . . . 0.0 111.406 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 15.9 mmt85 -123.33 96.26 4.92 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.547 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -80.05 84.36 5.79 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 122.241 1.02 . . . . 0.0 109.891 -173.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.774 ' CE2' HG23 ' A' ' 173' ' ' THR . 28.4 p90 -114.3 84.15 2.0 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 175.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -77.52 127.17 32.06 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 118.766 -2.459 . . . . 0.0 107.825 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 18.0 p -81.93 134.28 35.37 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.877 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -152.88 155.1 25.93 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.872 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.73 136.24 29.97 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.68 2.254 . . . . 0.0 111.012 172.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 5.8 t -108.28 115.65 30.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.92 0.391 . . . . 0.0 111.163 -174.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -95.54 160.4 14.53 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.512 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 24.7 p -111.68 -16.11 13.3 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 -167.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 7.5 p -163.75 123.63 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 119.628 1.104 . . . . 0.0 112.394 -173.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.507 ' CG1' ' HA ' ' A' ' 195' ' ' CYS . 51.7 mt -126.46 115.97 43.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-O 121.645 0.736 . . . . 0.0 112.833 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 25.0 p -115.8 -163.61 0.9 Allowed 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 158.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -61.47 -5.18 1.6 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.601 0.637 . . . . 0.0 110.553 172.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -69.56 -74.39 0.13 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.802 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.459 ' SD ' ' HA2' ' A' ' 197' ' ' GLY . 23.9 ttm -179.16 -171.66 0.21 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 176.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.507 ' HA ' ' CG1' ' A' ' 190' ' ' ILE . 14.0 m -88.08 -24.27 23.48 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 118.185 0.448 . . . . 0.0 111.928 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 12.9 tt0 165.65 -4.24 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 122.015 0.912 . . . . 0.0 109.444 -173.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.459 ' HA2' ' SD ' ' A' ' 194' ' ' MET . . . 103.61 5.13 45.65 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -172.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 61.71 52.66 3.47 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-O 121.466 0.651 . . . . 0.0 109.668 -176.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 63.7 mt -126.13 -179.73 4.86 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.964 -173.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 14.8 t 73.67 120.1 0.04 OUTLIER 'General case' 0 C--O 1.233 0.202 0 O-C-N 124.422 1.076 . . . . 0.0 111.285 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -93.42 33.23 5.25 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.606 177.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.78 97.7 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-O 122.238 1.018 . . . . 0.0 108.921 171.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 1.4 t -90.07 118.62 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.368 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 11.2 t -153.59 -178.63 7.15 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 103.129 -2.915 . . . . 0.0 103.129 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 10.5 p -106.33 163.7 12.62 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 120.538 1.517 . . . . 0.0 110.012 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.48 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 49.6 tttm -63.85 -38.48 91.26 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.486 0.66 . . . . 0.0 109.788 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.0 m -48.63 -56.38 8.62 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.045 171.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.98 -53.73 54.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.905 177.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 54.4 m -67.09 -23.0 65.8 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -175.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 56.3 m -106.56 -11.69 15.81 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 118.979 0.809 . . . . 0.0 113.168 -177.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -83.88 -51.21 7.37 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.961 0.886 . . . . 0.0 108.991 165.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 214' ' ' GLY . 6.7 p -101.66 151.9 21.47 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.275 -178.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 31.5 m 53.01 -37.19 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' A' ' 215' ' ' ARG . . . 78.63 -159.51 46.27 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 120.416 1.462 . . . . 0.0 112.236 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.463 ' HD3' ' O ' ' A' ' 214' ' ' GLY . 0.0 OUTLIER 104.07 -90.6 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.692 1.197 . . . . 0.0 109.497 163.124 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -169.17 160.82 9.96 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.875 0.761 . . . . 0.0 110.125 170.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . 0.48 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 18.8 t90 -152.48 147.83 26.7 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -177.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 78.98 173.18 43.34 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 115.389 0.916 . . . . 0.0 115.389 167.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.502 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 36.0 m-70 -127.79 133.11 24.75 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 114.838 -0.681 . . . . 0.0 109.445 171.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 19.7 Cg_endo -58.6 152.3 39.23 Favored 'Cis proline' 0 C--N 1.347 0.461 0 C-N-CA 123.705 -1.373 . . . . 0.0 111.772 -3.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 43.5 t -55.89 118.43 4.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.254 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -115.28 121.23 42.25 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 19.8 ptm -98.07 146.48 25.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.645 0.26 . . . . 0.0 111.304 -173.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 61.8 m -143.24 148.37 44.27 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.959 -178.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.7 167.65 23.75 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.615 2.21 . . . . 0.0 109.9 163.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.413 ' O ' ' HD3' ' A' ' 228' ' ' PRO . . . -58.62 -94.67 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 120.764 0.316 . . . . 0.0 110.814 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.55 106.75 14.95 Favored Pre-proline 0 C--N 1.315 -0.9 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.072 172.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 226' ' ' ALA . 60.2 Cg_endo -90.63 -43.68 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.491 2.128 . . . . 0.0 113.252 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -100.53 175.55 2.32 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.53 177.53 0.6 Allowed 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 121.656 1.571 . . . . 0.0 112.182 171.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 61.4 m 75.7 146.41 0.09 Allowed 'General case' 0 N--CA 1.47 0.575 0 O-C-N 124.112 0.883 . . . . 0.0 108.844 -166.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -63.13 140.48 58.88 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 118.997 -0.525 . . . . 0.0 109.905 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -32.86 -44.59 0.11 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -75.7 7.95 23.73 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.631 -175.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . 0.585 ' HE1' ' N ' ' A' ' 267' ' ' GLY . 2.5 m-85 -122.49 159.86 26.78 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.947 0.88 . . . . 0.0 112.085 -172.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.63 132.29 23.87 Favored Pre-proline 0 C--N 1.313 -1.018 0 CA-C-N 113.913 -1.494 . . . . 0.0 108.048 172.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -64.2 112.24 1.83 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.51 1.473 . . . . 0.0 110.635 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -51.81 134.44 30.9 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.781 0.8 . . . . 0.0 111.065 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 33.7 pt -78.52 -1.04 3.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 114.656 -1.156 . . . . 0.0 112.026 -174.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -111.27 -56.83 2.33 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.372 0.606 . . . . 0.0 110.057 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 44.3 p -84.52 -46.52 11.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.199 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 104.23 7.81 39.77 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.359 -175.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -92.6 126.61 37.76 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 122.005 0.907 . . . . 0.0 109.919 -177.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 3.8 m -53.89 124.18 14.64 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 113.433 -1.712 . . . . 0.0 110.359 174.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -124.54 135.51 53.22 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.594 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 15.2 t70 -77.49 146.0 36.7 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 121.165 0.507 . . . . 0.0 110.142 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.611 HG23 ' HG3' ' A' ' 249' ' ' GLU . 6.9 m -98.49 146.16 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -74.66 76.76 2.03 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 167.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.611 ' HG3' HG23 ' A' ' 247' ' ' VAL . 32.2 mp0 -52.51 -39.01 60.81 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.388 0.614 . . . . 0.0 110.489 -171.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 53.1 t -55.45 -30.63 60.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.943 176.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -97.42 -40.98 8.43 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 122.064 0.935 . . . . 0.0 109.62 -177.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.76 -16.91 63.94 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.947 -1.478 . . . . 0.0 110.836 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 2.6 mp -120.37 104.97 42.4 Favored Pre-proline 0 N--CA 1.447 -0.611 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 174.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -28.69 -47.88 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.604 1 C-N-CA 126.204 4.603 . . . . 0.0 116.87 -172.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -140.23 43.27 1.14 Allowed Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -174.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 11.1 tp -54.34 125.84 20.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.761 -0.72 . . . . 0.0 110.486 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 98.9 m 60.35 58.37 2.59 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.515 0.674 . . . . 0.0 109.888 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -60.44 120.89 10.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.381 -177.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 101.21 40.57 2.79 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.532 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 172.8 -156.49 25.01 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.787 179.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -111.93 156.82 21.48 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -137.86 132.88 33.19 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 170.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 58.5 mt -130.18 115.18 31.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.527 -170.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -73.61 121.84 21.33 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -172.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 268' ' ' SER . 0.5 OUTLIER -110.01 156.14 20.89 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 153.452 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.594 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 4.1 m -74.97 126.64 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 C-N-CA 117.861 -1.536 . . . . 0.0 107.605 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.585 ' N ' ' HE1' ' A' ' 235' ' ' PHE . . . 113.25 -26.62 10.2 Favored Glycine 0 C--N 1.309 -0.94 0 C-N-CA 119.764 -1.208 . . . . 0.0 111.807 -171.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 265' ' ' THR . 26.5 t 173.67 157.5 0.13 Allowed 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 121.315 0.579 . . . . 0.0 109.502 -174.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -101.81 153.05 20.17 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -109.41 114.05 27.38 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 55.4 m -99.96 160.97 13.91 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.856 -0.737 . . . . 0.0 111.779 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -134.19 112.55 11.19 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.306 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 79.8 m -91.93 158.95 38.94 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.129 177.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 32.0 Cg_exo -61.04 157.07 40.89 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.402 2.068 . . . . 0.0 111.052 171.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -54.8 139.63 39.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.835 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 82.99 -27.1 4.01 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.957 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' HIS . . . . . 0.421 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 13.6 m-70 -77.03 162.94 27.13 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 121.343 0.592 . . . . 0.0 111.286 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -131.9 143.13 49.92 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.379 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 57.0 tp -87.34 133.29 33.72 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.114 0.483 . . . . 0.0 110.532 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -114.48 106.27 14.08 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 172.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -66.8 -19.69 65.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.653 -173.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 47.6 t -62.75 -47.7 91.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.615 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 31.3 t -123.74 31.05 5.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.095 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 29.8 46.59 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.93 -172.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -92.08 120.41 32.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.3 -170.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 7.2 m -102.98 81.1 1.94 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.89 0.376 . . . . 0.0 110.092 173.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 29.9 mm-40 . . . . . 0 C--O 1.242 0.696 0 CA-C-O 118.203 -0.903 . . . . 0.0 109.051 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.473 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 37.7 m-85 . . . . . 0 N--CA 1.448 -0.563 0 CA-C-O 121.188 0.518 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 37.7 pt -140.1 -174.96 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.977 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.192 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.17 157.94 32.61 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.693 -175.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.1 p -61.66 -41.94 98.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.955 0.407 . . . . 0.0 111.685 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -108.15 18.89 20.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.378 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 64.6 28.92 13.23 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.281 173.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.4 9.27 71.14 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 119.77 -1.205 . . . . 0.0 114.548 -175.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.32 120.45 22.21 Favored Pre-proline 0 C--O 1.217 -0.624 0 CA-C-N 118.741 1.27 . . . . 0.0 112.24 -177.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -89.65 153.97 5.2 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.13 2.554 . . . . 0.0 112.973 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 163' ' ' PRO . 10.1 p -97.23 102.89 14.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 122.508 1.147 . . . . 0.0 111.942 -177.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 64.7 m -83.64 96.63 8.73 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 122.097 0.951 . . . . 0.0 110.224 170.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -54.12 -55.41 27.95 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.919 -1.491 . . . . 0.0 114.918 -168.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 47.4 m -94.3 17.05 13.51 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.205 0.526 . . . . 0.0 111.039 -165.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 73.07 131.55 0.16 Allowed Glycine 0 N--CA 1.432 -1.586 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.005 -175.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 69.7 m -69.07 150.95 47.04 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.099 -1.051 . . . . 0.0 110.614 175.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 58.7 mt -133.96 172.96 12.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.566 -170.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.622 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 0.0 OUTLIER 67.08 10.33 7.62 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.389 0.614 . . . . 0.0 111.188 178.05 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.87 36.26 91.72 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.079 -167.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -76.0 -145.23 1.54 Allowed Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.203 -0.498 . . . . 0.0 113.318 -175.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -150.86 118.02 5.95 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.665 -0.315 . . . . 0.0 111.111 -175.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 13.6 t -60.94 125.24 23.0 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.746 0.308 . . . . 0.0 110.34 176.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 165' ' ' ARG . 13.2 m -117.04 -49.28 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.922 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -133.79 173.68 5.56 Favored Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 176.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 149' ' ' VAL . 54.3 Cg_exo -53.91 107.32 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 121.987 1.791 . . . . 0.0 112.465 177.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 73.83 14.58 4.06 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.996 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.45 ' O ' HG22 ' A' ' 161' ' ' VAL . 2.0 mtm180 -113.35 89.45 3.09 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.027 174.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 82.4 m -88.32 141.69 28.34 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.0 169.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -90.32 131.28 36.21 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 60.0 m -104.53 130.96 52.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.901 0.857 . . . . 0.0 112.197 -169.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.622 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 82.2 m -71.02 -57.59 4.4 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 116.204 1.928 . . . . 0.0 116.204 -170.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -136.89 -100.31 0.2 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 118.329 -1.348 . . . . 0.0 113.205 -165.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -90.32 45.39 2.97 Favored Glycine 0 CA--C 1.492 -1.379 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.773 -165.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 172' ' ' PHE . 4.2 m-85 -120.23 127.22 52.22 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 119.502 -0.879 . . . . 0.0 112.186 173.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.402 ' O ' ' HG2' ' A' ' 179' ' ' ARG . 6.5 t -92.15 154.27 18.8 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 166.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 87.97 124.18 2.05 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.31 24.31 0.36 Allowed 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.053 1.836 . . . . 0.0 114.257 -166.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -126.57 5.11 6.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.896 0.855 . . . . 0.0 109.854 176.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 36.99 51.24 0.96 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 113.838 -1.528 . . . . 0.0 114.46 -177.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -109.72 -15.46 14.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.073 0.463 . . . . 0.0 110.656 174.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 173' ' ' THR . 14.4 mmm180 -59.88 -58.49 8.32 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.442 -1.253 . . . . 0.0 107.697 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 34.9 t70 72.71 62.24 0.11 Allowed 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 160.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.459 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 50.5 p90 -91.46 65.47 5.26 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 122.74 1.257 . . . . 0.0 108.478 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -53.76 125.86 19.98 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 168.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 82.1 p -72.25 143.75 48.68 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.345 -160.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -149.69 147.37 17.6 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -167.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -82.27 143.6 12.64 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.177 1.918 . . . . 0.0 111.241 173.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 1.8 m -76.34 116.64 17.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.21 0.529 . . . . 0.0 111.105 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . 0.577 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 21.9 m-30 -84.54 145.18 28.21 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.079 177.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 40.2 p -122.23 -18.35 6.86 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.489 -174.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 66.5 t -139.47 115.05 8.51 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -176.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.534 HD11 ' CB ' ' A' ' 216' ' ' ALA . 20.7 mm -83.71 119.44 32.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -168.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 35.0 t -143.55 138.43 29.12 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.537 -1.665 . . . . 0.0 107.344 170.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -62.73 -33.45 75.15 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 172.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -55.66 -63.02 1.3 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 113.358 -1.746 . . . . 0.0 110.02 171.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 61.3 mtt -154.78 119.26 4.78 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.037 176.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.477 ' HB2' ' CD1' ' A' ' 187' ' ' PHE . 62.9 m -80.65 1.24 30.77 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 110.588 -0.153 . . . . 0.0 110.588 176.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 31.6 mm-40 96.62 -138.49 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.578 1.551 . . . . 0.0 109.452 -172.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 73.56 -37.1 0.84 Allowed Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.131 -0.557 . . . . 0.0 114.468 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -63.71 -14.36 51.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.527 0.664 . . . . 0.0 111.129 -177.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.432 ' N ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -107.43 27.0 9.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.645 -179.952 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 27.0 t -156.6 155.35 31.69 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.214 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -125.88 23.19 5.95 Favored Glycine 0 CA--C 1.504 -0.596 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 175.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.438 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -60.9 112.18 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 175.245 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 46.4 t -104.88 100.02 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-O 122.632 1.206 . . . . 0.0 110.441 175.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 15.6 t -125.17 -175.23 3.25 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 112.575 -2.102 . . . . 0.0 105.862 173.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 12.0 p -101.42 163.17 12.41 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.664 173.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.833 ' HB3' ' CE3' ' A' ' 217' ' ' TRP . 41.4 pttt -68.98 -22.76 64.08 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.337 176.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 9.2 m -59.94 -51.42 69.74 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.13 -48.11 81.25 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.553 175.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.0 -21.98 61.49 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.168 -174.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 86.6 m -101.48 -17.67 16.33 Favored 'General case' 0 C--O 1.212 -0.892 0 O-C-N 121.549 -0.719 . . . . 0.0 112.064 -176.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -81.91 -48.9 10.93 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.915 0.865 . . . . 0.0 109.797 166.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.413 HG22 ' O ' ' A' ' 233' ' ' ARG . 6.4 p -102.4 141.63 34.91 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.675 -176.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 1.3 t 58.51 -38.08 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.455 ' O ' ' HD3' ' A' ' 215' ' ' ARG . . . 81.58 -161.11 42.27 Favored Glycine 0 CA--C 1.505 -0.566 0 CA-C-N 119.812 1.187 . . . . 0.0 112.915 -177.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.455 ' HD3' ' O ' ' A' ' 214' ' ' GLY . 0.0 OUTLIER 102.72 -93.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.487 1.115 . . . . 0.0 108.978 166.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.577 ' HB3' ' HB2' ' A' ' 187' ' ' PHE . . . -172.25 172.71 4.44 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 118.99 0.814 . . . . 0.0 109.24 173.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . 0.833 ' CE3' ' HB3' ' A' ' 206' ' ' LYS . 12.8 t90 -163.12 150.66 13.2 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -177.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 70.7 173.06 12.87 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 114.714 0.646 . . . . 0.0 114.714 170.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -123.97 131.73 24.25 Favored Pre-proline 0 C--N 1.334 -0.105 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.74 167.37 39.57 Favored 'Cis proline' 0 C--N 1.349 0.555 0 C-N-CA 123.806 -1.331 . . . . 0.0 112.616 -1.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 16.2 t -59.4 111.25 1.31 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.653 -176.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -106.12 102.07 11.51 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.02 141.9 35.01 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.381 -169.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 14.8 m -144.05 159.22 53.68 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.429 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.95 167.22 23.97 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.982 2.454 . . . . 0.0 109.769 164.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.458 ' O ' ' HD3' ' A' ' 228' ' ' PRO . . . -56.02 -92.23 0.0 OUTLIER 'General case' 0 C--O 1.211 -0.969 0 CA-C-N 117.957 0.344 . . . . 0.0 110.511 176.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.02 102.59 4.31 Favored Pre-proline 0 C--N 1.316 -0.861 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.057 169.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 226' ' ' ALA . 24.5 Cg_endo -93.52 -44.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.794 2.329 . . . . 0.0 113.858 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -103.15 -179.85 0.85 Allowed Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -173.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.06 174.24 0.99 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 121.849 1.699 . . . . 0.0 112.251 172.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 73.9 m 70.12 128.63 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -168.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -58.96 148.85 29.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -176.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.413 ' O ' HG22 ' A' ' 212' ' ' THR . 17.3 ptp180 -31.71 -47.03 0.12 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 246' ' ' ASP . . . -79.52 11.79 30.45 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.475 -0.869 . . . . 0.0 114.168 -174.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . 0.433 ' O ' HD13 ' A' ' 236' ' ' ILE . 78.5 m-85 -123.08 155.9 35.99 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.867 0.842 . . . . 0.0 113.061 -173.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.433 HD13 ' O ' ' A' ' 235' ' ' PHE . 0.3 OUTLIER -135.41 134.48 21.21 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 114.011 -1.45 . . . . 0.0 107.866 173.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.89 112.47 1.29 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 121.86 1.707 . . . . 0.0 110.932 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -53.48 135.3 40.0 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.832 0.825 . . . . 0.0 110.364 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 30.9 mt -69.69 -13.23 16.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.752 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -103.67 -60.8 1.51 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.388 0.613 . . . . 0.0 110.057 -176.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 44.7 p -84.38 -40.41 17.89 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.873 -175.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 97.6 5.0 57.95 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -83.79 133.3 34.77 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.706 0.765 . . . . 0.0 110.942 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 22.3 m -56.16 108.14 0.44 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.905 170.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -115.19 134.87 54.76 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -178.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.536 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 12.8 t70 -75.62 140.43 42.6 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -176.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.631 HG23 ' HG3' ' A' ' 249' ' ' GLU . 3.7 m -94.38 145.14 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -75.44 77.38 2.5 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 166.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.631 ' HG3' HG23 ' A' ' 247' ' ' VAL . 47.9 mp0 -50.04 -35.32 24.56 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.4 0.619 . . . . 0.0 110.716 -171.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 77.2 m -50.94 -34.83 30.35 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.069 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -103.94 -47.35 4.22 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.428 0.691 . . . . 0.0 110.466 -175.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -63.38 -26.52 68.79 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.935 -177.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.645 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.7 mp -121.38 78.43 35.83 Favored Pre-proline 0 N--CA 1.446 -0.635 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -57.31 112.75 1.22 Allowed 'Trans proline' 0 CA--C 1.514 -0.493 0 C-N-CA 123.358 2.705 . . . . 0.0 114.608 -164.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 74.46 24.51 72.72 Favored Glycine 0 C--N 1.308 -0.976 0 CA-C-N 113.561 -1.654 . . . . 0.0 113.665 175.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.645 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.6 OUTLIER -67.92 -32.94 73.75 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 117.615 0.707 . . . . 0.0 110.537 177.487 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . 0.474 ' HA ' ' HB3' ' A' ' 284' ' ' GLN . 35.3 t -104.05 83.28 2.08 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.488 0.661 . . . . 0.0 109.443 177.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -98.52 -2.79 37.97 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.927 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -60.21 -41.58 98.3 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.46 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -165.31 -109.85 0.23 Allowed Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.953 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' ASN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 272' ' ' LYS . 10.0 m120 -86.68 162.08 18.1 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.162 0.506 . . . . 0.0 111.276 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 4.3 t -148.08 120.46 8.44 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.177 174.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 21.7 mt -128.29 165.2 28.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.58 125.86 33.35 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 117.95 -1.5 . . . . 0.0 113.559 -177.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.2 t -114.25 162.6 16.36 Favored 'General case' 0 C--O 1.259 1.558 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.131 163.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.536 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 27.2 m -72.55 124.84 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 C-N-CA 119.717 -0.793 . . . . 0.0 108.953 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.412 ' HA2' ' CE2' ' A' ' 235' ' ' PHE . . . 105.43 -17.61 43.05 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 119.997 -1.097 . . . . 0.0 112.784 -175.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 41.3 t 175.58 155.2 0.18 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.77 0.785 . . . . 0.0 110.302 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -102.33 155.96 17.9 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -113.18 116.96 30.64 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.057 -173.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 99.2 m -105.07 148.25 27.01 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 261' ' ' ASN . 21.2 ttpp -127.95 132.46 49.24 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -177.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 23.4 m -112.63 157.14 41.19 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.373 -175.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . 0.401 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 51.1 Cg_exo -55.41 156.84 16.19 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.189 1.926 . . . . 0.0 110.944 168.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -56.32 144.15 31.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.676 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.38 -34.31 2.89 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.283 -0.961 . . . . 0.0 112.036 -176.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' HIS . . . . . 0.513 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 16.0 m-70 -75.8 164.16 26.52 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.592 0.234 . . . . 0.0 110.56 -175.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -139.82 142.6 36.63 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -176.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 57.5 tp -73.07 125.01 26.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.112 0.482 . . . . 0.0 111.315 -178.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -102.48 95.6 6.36 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -68.0 -16.05 63.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.085 -172.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 84.7 t -56.33 -49.36 77.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.512 173.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 2.4 p -134.87 40.21 2.94 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.229 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . 0.474 ' HB3' ' HA ' ' A' ' 257' ' ' CYS . 13.5 mp0 25.46 56.54 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.201 -1.363 . . . . 0.0 113.457 -173.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -101.29 176.16 5.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.77 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 38.8 m -147.61 97.64 2.86 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.486 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.513 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 65.7 mm-40 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.358 -0.829 . . . . 0.0 109.54 -174.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.58 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 98.0 m-85 . . . . . 0 C--O 1.227 -0.093 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 30.7 pt -126.9 171.8 14.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 176.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.55 157.71 20.31 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.7 p -65.06 -34.71 79.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.248 0.524 . . . . 0.0 111.174 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -100.22 2.26 42.66 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.051 0.453 . . . . 0.0 110.427 174.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 60.2 m 61.9 43.64 9.1 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.496 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -104.27 3.53 43.89 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 119.953 -1.118 . . . . 0.0 113.646 -176.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.58 110.92 64.09 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 117.54 0.67 . . . . 0.0 109.422 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -80.81 140.3 12.82 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.846 2.364 . . . . 0.0 112.747 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.9 p -67.08 111.36 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.291 1.043 . . . . 0.0 112.364 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -80.21 73.53 7.05 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.541 171.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -50.65 -67.13 0.28 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.699 -1.591 . . . . 0.0 114.239 -171.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 19.4 m -98.22 13.78 30.08 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.394 0.616 . . . . 0.0 111.624 -166.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 79.2 123.35 0.37 Allowed Glycine 0 CA--C 1.5 -0.87 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.668 -175.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 86.4 m -77.0 -17.29 58.96 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -175.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 177' ' ' CYS . 2.2 mp 46.19 -172.37 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -172.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.418 ' ND2' ' SG ' ' A' ' 177' ' ' CYS . 0.8 OUTLIER 51.92 11.06 0.13 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.297 1.439 . . . . 0.0 113.902 171.586 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.31 36.7 84.55 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.799 -174.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -79.24 -145.65 3.31 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.446 -176.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -153.77 118.4 4.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.368 0.584 . . . . 0.0 110.823 -175.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.9 m -62.01 119.75 9.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.746 0.308 . . . . 0.0 111.554 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 165' ' ' ARG . 4.3 m -107.13 -35.85 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 121.134 0.493 . . . . 0.0 110.417 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -140.13 172.21 6.66 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.58 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 79.4 Cg_exo -52.73 106.06 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.175 1.916 . . . . 0.0 112.246 176.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 69.1 -0.04 2.62 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.483 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.504 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -90.41 83.99 5.96 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 172.405 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 40.5 m -84.12 145.33 28.48 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.2 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -92.67 124.66 36.84 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 37.1 m -104.07 135.62 45.23 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 124.142 0.901 . . . . 0.0 112.114 -168.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.4 m -48.73 -53.66 18.04 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -172.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -167.78 -88.16 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.366 -0.934 . . . . 0.0 112.55 -174.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -85.16 57.24 4.98 Favored Glycine 0 N--CA 1.435 -1.385 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.898 -167.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.503 ' CD2' ' N ' ' A' ' 172' ' ' PHE . 8.1 m-85 -122.91 128.49 50.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.223 1.012 . . . . 0.0 111.669 172.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.722 HG23 ' CE1' ' A' ' 181' ' ' TYR . 14.9 p -86.72 119.88 27.42 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.181 177.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 107.4 133.3 7.15 Favored Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -174.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.43 -0.45 8.19 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 120.956 1.104 . . . . 0.0 112.429 -173.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -107.96 19.23 20.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.496 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 155' ' ' LEU . 0.5 OUTLIER 17.66 79.67 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 118.301 2.704 . . . . 0.0 118.301 176.222 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.464 ' HB3' HD13 ' A' ' 155' ' ' LEU . 14.5 pt-20 -126.22 34.53 4.83 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.132 0.968 . . . . 0.0 109.517 167.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 23.0 mmt180 -132.63 88.22 2.5 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.724 -1.58 . . . . 0.0 107.248 176.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -81.0 49.83 1.29 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.808 0.813 . . . . 0.0 111.352 -169.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.722 ' CE1' HG23 ' A' ' 173' ' ' THR . 10.5 p90 -76.59 93.86 3.66 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 176.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -79.15 173.76 12.25 Favored 'General case' 0 N--CA 1.436 -1.15 0 O-C-N 119.733 -1.854 . . . . 0.0 106.162 174.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 81.6 p -98.76 138.87 35.3 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 118.851 -1.14 . . . . 0.0 108.889 169.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -159.75 149.78 19.66 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.727 -173.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.44 132.51 14.94 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.365 2.044 . . . . 0.0 111.041 171.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . 0.566 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 71.5 m -75.2 122.09 23.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.4 0.619 . . . . 0.0 110.236 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -107.55 153.47 22.81 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.793 -175.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' THR . . . . . 0.511 ' O ' ' HB3' ' A' ' 215' ' ' ARG . 29.1 p -100.94 -56.99 2.19 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.002 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 36.9 t -134.06 118.45 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 119.686 -0.805 . . . . 0.0 111.767 -172.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.548 HG13 ' SG ' ' A' ' 195' ' ' CYS . 2.1 mp -102.32 117.21 47.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.465 0.65 . . . . 0.0 111.736 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.3 p -110.98 -168.67 1.33 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 159.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -68.87 -4.84 17.9 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.383 0.611 . . . . 0.0 110.066 171.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -90.81 -76.43 0.44 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.394 -174.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 98.6 mmm -141.68 160.28 40.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.275 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.548 ' SG ' HG13 ' A' ' 190' ' ' ILE . 38.8 m -91.09 -8.15 49.69 Favored 'General case' 0 C--O 1.248 0.99 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.953 175.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 78.22 -140.49 0.02 OUTLIER 'General case' 0 C--N 1.347 0.464 0 CA-C-N 114.2 -1.364 . . . . 0.0 109.863 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 82.56 -7.06 66.31 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.796 172.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 59.1 27.98 17.12 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 122.577 0.351 . . . . 0.0 111.2 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 51.9 44.74 29.17 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.687 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 41.5 t -70.47 155.53 40.59 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.641 -174.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -109.33 20.01 28.58 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.332 177.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.11 113.57 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 173.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 48.9 t -102.46 99.11 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 122.346 1.069 . . . . 0.0 110.502 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 7.9 t -127.77 -175.4 3.46 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 112.479 -2.146 . . . . 0.0 105.436 170.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 30.6 p -101.72 165.29 11.29 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 119.648 1.113 . . . . 0.0 109.923 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.813 ' HB3' ' CE3' ' A' ' 217' ' ' TRP . 0.0 OUTLIER -66.64 -23.85 66.21 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 119.102 -1.039 . . . . 0.0 108.662 175.805 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.8 m -59.51 -55.93 28.4 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.03 -54.96 31.97 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.74 176.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 52.9 m -77.41 -20.51 54.52 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -170.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 226' ' ' ALA . 97.5 m -83.93 -41.73 17.07 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 119.123 0.874 . . . . 0.0 109.914 173.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -64.6 -58.32 6.67 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.494 HG22 ' HA2' ' A' ' 234' ' ' GLY . 5.1 p -91.25 140.69 29.55 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.896 -1.502 . . . . 0.0 108.998 178.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER 58.62 -30.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -177.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 75.82 -162.39 52.92 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 120.209 1.368 . . . . 0.0 114.449 177.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.511 ' HB3' ' O ' ' A' ' 188' ' ' THR . 2.1 mtt180 98.78 -83.3 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.546 1.138 . . . . 0.0 112.371 166.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -174.57 172.02 3.18 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.117 0.417 . . . . 0.0 110.521 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . 0.813 ' CE3' ' HB3' ' A' ' 206' ' ' LYS . 9.6 t90 -165.33 151.38 9.75 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.306 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 221' ' ' CYS . . . 77.23 174.88 41.67 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 115.06 0.784 . . . . 0.0 115.06 171.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.451 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 17.6 m80 -133.3 131.72 21.74 Favored Pre-proline 0 N--CA 1.462 0.172 0 CA-C-N 114.692 -0.754 . . . . 0.0 109.315 174.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 23.0 Cg_endo -61.18 142.93 36.62 Favored 'Cis proline' 0 C--N 1.346 0.409 0 C-N-CA 123.132 -1.612 . . . . 0.0 111.175 -3.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 81.0 m -49.49 121.42 5.06 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.733 0.646 . . . . 0.0 111.784 -172.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -93.44 95.64 9.41 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.22 122.7 33.39 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 -172.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 17.8 p -142.9 150.27 52.57 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.05 -165.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.34 167.11 13.47 Favored 'Trans proline' 0 CA--C 1.515 -0.437 0 C-N-CA 122.867 2.378 . . . . 0.0 110.672 162.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 210' ' ' CYS . . . -62.88 -119.74 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.853 0.835 . . . . 0.0 112.06 174.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -57.13 107.76 1.01 Allowed Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.13 -172.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.6 -55.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.146 2.564 . . . . 0.0 112.366 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -78.22 163.0 64.62 Favored Pre-proline 0 CA--C 1.511 -0.539 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.7 59.05 4.08 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 121.992 1.794 . . . . 0.0 112.031 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 59.3 m -131.23 162.58 29.67 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -66.02 139.8 58.23 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 175.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -36.22 -41.17 0.25 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.494 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -77.25 8.93 29.47 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.629 -175.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . 0.535 ' HE2' ' N ' ' A' ' 267' ' ' GLY . 2.3 m-85 -121.56 149.45 43.11 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.287 1.042 . . . . 0.0 113.067 -171.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.37 124.2 25.14 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 113.736 -1.575 . . . . 0.0 108.818 172.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -63.58 122.1 10.09 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.295 1.997 . . . . 0.0 111.573 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -53.78 131.03 38.81 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.875 177.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 40.9 pt -76.5 7.07 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.555 176.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -113.48 -59.82 1.97 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.547 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 42.1 p -91.31 -44.01 9.44 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.913 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 105.6 7.84 36.05 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -92.77 125.16 37.25 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 121.907 0.861 . . . . 0.0 109.938 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 10.2 m -60.47 122.2 14.01 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 113.296 -1.775 . . . . 0.0 109.938 174.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -119.37 139.21 52.36 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.671 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 17.4 t70 -74.46 143.68 44.54 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.699 HG23 ' HG3' ' A' ' 249' ' ' GLU . 10.0 m -94.52 145.98 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.252 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.89 77.04 1.64 Allowed 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 165.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.699 ' HG3' HG23 ' A' ' 247' ' ' VAL . 6.3 mp0 -52.73 -35.16 55.43 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.478 0.656 . . . . 0.0 109.56 -175.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 6.4 m -53.83 -29.51 41.15 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.211 174.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -103.72 -38.66 6.98 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.719 0.771 . . . . 0.0 109.906 -176.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -72.18 -19.8 61.69 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.869 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.542 HG22 ' HB3' ' A' ' 256' ' ' LEU . 46.7 mt -140.9 74.86 25.56 Favored Pre-proline 0 C--O 1.244 0.77 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -12.51 -80.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.947 1 C-N-CA 126.832 5.021 . . . . 0.0 116.174 -164.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -130.6 64.69 0.61 Allowed Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 119.464 -1.35 . . . . 0.0 111.472 176.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.542 ' HB3' HG22 ' A' ' 253' ' ' ILE . 1.4 pt? -68.63 8.19 0.53 Allowed 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -176.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 56.9 m -114.0 127.43 55.95 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 171.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . 0.405 ' O ' ' HB3' ' A' ' 286' ' ' CYS . 97.8 mt-30 -70.36 91.46 0.75 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.998 0.428 . . . . 0.0 111.962 -175.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 80.45 32.44 34.37 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.912 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -129.74 163.81 22.68 Favored Glycine 0 C--O 1.227 -0.308 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.06 -178.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -102.27 103.2 13.67 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 50.8 t -68.21 123.05 19.63 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.079 0.466 . . . . 0.0 111.072 176.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 47.3 mt -125.56 103.75 12.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.595 ' ND2' ' HB3' ' A' ' 269' ' ' PHE . 1.0 OUTLIER -81.12 128.3 33.59 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -160.798 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 268' ' ' SER . 0.2 OUTLIER -109.21 157.5 18.74 Favored 'General case' 0 C--O 1.257 1.449 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.722 163.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.671 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 3.2 m -72.87 128.68 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 C-N-CA 118.839 -1.144 . . . . 0.0 108.531 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.535 ' N ' ' HE2' ' A' ' 235' ' ' PHE . . . 105.19 -26.81 20.83 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.073 -1.06 . . . . 0.0 110.887 -174.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.481 ' O ' HG23 ' A' ' 265' ' ' THR . 32.6 t 176.09 151.71 0.15 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.124 0.488 . . . . 0.0 110.358 -175.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . 0.595 ' HB3' ' ND2' ' A' ' 264' ' ' ASN . 26.7 p90 -99.4 162.44 13.04 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.968 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -115.32 106.49 14.08 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.808 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 54.4 m -94.6 112.18 23.94 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.346 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -79.19 132.21 36.45 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.106 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 36.2 m -116.26 143.73 31.63 Favored Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.115 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . 0.459 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 36.6 Cg_exo -60.56 167.01 8.82 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.363 2.042 . . . . 0.0 110.89 173.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -59.44 144.35 47.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.711 0.291 . . . . 0.0 110.86 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.6 -27.69 4.66 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.625 -177.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' HIS . . . . . 0.523 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 18.0 m-70 -77.0 160.34 29.21 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.021 0.438 . . . . 0.0 111.317 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -145.97 121.34 10.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.396 -174.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 19.1 tp -77.32 141.47 39.89 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.77 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -133.16 100.09 4.75 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.178 175.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -60.56 -26.05 66.63 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.47 -175.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 58.0 t -58.06 -29.53 36.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.679 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 33.4 t -147.85 34.87 0.84 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.888 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 32.11 38.55 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.448 1.099 . . . . 0.0 113.664 -176.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 96.6 mttt -87.12 149.33 24.75 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.693 -175.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' CYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 258' ' ' GLN . 42.2 t -140.08 83.04 1.9 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.342 0.591 . . . . 0.0 109.507 178.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 3.8 mm-40 . . . . . 0 C--O 1.248 0.988 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.904 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.479 ' CE2' ' HB3' ' A' ' 148' ' ' PRO . 78.9 m-85 . . . . . 0 CA--C 1.512 -0.491 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 147' ' ' GLN . 25.1 pt -135.57 -176.66 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.024 -177.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 96.19 172.98 35.64 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.749 -176.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.0 m -76.51 -29.57 56.84 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 122.759 -0.259 . . . . 0.0 111.12 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -110.61 11.07 22.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.873 0.368 . . . . 0.0 110.425 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 58.1 m 63.5 30.09 15.28 Favored 'General case' 0 C--O 1.228 -0.037 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.129 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -94.26 4.83 70.89 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.873 -174.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.409 ' O ' HG12 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -120.21 97.59 49.1 Favored Pre-proline 0 C--O 1.22 -0.496 0 CA-C-N 117.702 0.751 . . . . 0.0 110.755 -179.458 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.479 ' HB3' ' CE2' ' A' ' 140' ' ' TYR . 52.4 Cg_endo -73.01 148.14 44.53 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.49 2.127 . . . . 0.0 112.19 176.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.17 108.89 3.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.237 -173.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.69 77.24 6.32 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.362 173.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -51.9 -65.97 0.46 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -173.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 60.7 m -86.98 12.43 11.25 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.074 0.464 . . . . 0.0 111.226 -168.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 81.6 127.47 0.91 Allowed Glycine 0 N--CA 1.429 -1.786 0 CA-C-O 122.19 0.883 . . . . 0.0 111.906 -173.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 1.7 m -73.56 152.93 40.45 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 113.989 -1.106 . . . . 0.0 109.307 171.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.631 HD12 ' O ' ' A' ' 176' ' ' GLN . 70.9 mt -135.34 162.89 31.31 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -168.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.65 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 2.6 t-20 48.76 24.88 0.88 Allowed 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.909 0.756 . . . . 0.0 111.605 -168.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 63.22 38.62 96.78 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.212 -176.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -76.28 -140.81 1.04 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.734 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.55 130.99 9.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.075 0.438 . . . . 0.0 111.081 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.26 110.12 5.71 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.265 0.555 . . . . 0.0 110.428 172.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.3 m -98.51 -28.72 3.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.631 -178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.613 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -140.28 173.11 5.33 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 174.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.461 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 49.4 Cg_exo -56.83 104.57 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 121.973 1.782 . . . . 0.0 112.348 178.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 68.06 9.97 7.52 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.216 1.006 . . . . 0.0 110.904 -176.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.613 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.3 OUTLIER -99.69 84.1 2.87 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 8.9 t -86.52 147.72 25.84 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.672 176.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -103.3 131.07 50.65 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.074 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 52.1 m -107.5 136.65 46.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.563 -165.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.65 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 25.4 m -53.12 -56.58 15.21 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -168.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' A' ' 171' ' ' GLY . 35.7 t80 -154.53 -87.61 0.05 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 119.043 -1.063 . . . . 0.0 112.729 -170.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.422 ' N ' ' CD1' ' A' ' 170' ' ' TYR . . . -92.21 52.33 2.81 Favored Glycine 0 CA--C 1.493 -1.305 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.725 -166.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.526 ' CD2' ' N ' ' A' ' 172' ' ' PHE . 3.3 m-85 -124.87 123.91 40.95 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.54 169.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.495 ' O ' ' HG3' ' A' ' 179' ' ' ARG . 2.9 t -91.54 145.39 24.65 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 174.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 87.76 127.86 2.67 Favored Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -173.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.35 24.76 0.35 Allowed 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 121.534 1.489 . . . . 0.0 113.327 -168.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.631 ' O ' HD12 ' A' ' 155' ' ' LEU . 59.4 tt0 -122.31 7.14 9.62 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.437 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.7 OUTLIER 25.65 59.53 0.06 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 -179.393 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -112.42 15.54 20.2 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 122.169 0.985 . . . . 0.0 109.479 171.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' A' ' 173' ' ' THR . 1.4 mmp_? -87.01 -73.33 0.47 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.556 -173.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 21.3 t70 88.38 78.32 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.09 0.948 . . . . 0.0 108.657 167.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.498 ' CG ' ' O ' ' A' ' 181' ' ' TYR . 13.4 p90 -149.46 108.78 3.95 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.678 -176.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -74.49 147.56 41.77 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 119.668 -1.895 . . . . 0.0 109.853 173.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 71.9 p -87.76 137.37 32.4 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.023 0.439 . . . . 0.0 110.337 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -151.25 153.3 24.88 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.435 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.414 ' HG2' ' CE1' ' A' ' 219' ' ' HIS . 5.0 Cg_exo -78.58 132.91 11.3 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.748 2.299 . . . . 0.0 110.696 170.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . 0.514 ' SG ' ' NE ' ' A' ' 215' ' ' ARG . 12.7 t -100.74 117.0 33.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.04 0.447 . . . . 0.0 111.031 -174.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . 0.74 ' O ' ' HB2' ' A' ' 215' ' ' ARG . 20.4 m-85 -98.62 174.67 6.31 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.216 178.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' THR . . . . . 0.489 ' HA ' ' CB ' ' A' ' 215' ' ' ARG . 1.3 p -129.28 -59.52 1.1 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -177.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.2 p -113.88 117.66 56.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.077 0.465 . . . . 0.0 111.151 -170.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.456 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.0 mt -131.17 117.11 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-O 121.781 0.801 . . . . 0.0 113.129 -168.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.9 p -119.13 -164.69 1.07 Allowed 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.038 163.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -60.25 -4.97 0.94 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.878 0.37 . . . . 0.0 111.032 174.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -87.53 -77.45 0.34 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.893 0.377 . . . . 0.0 110.99 -172.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 72.0 mtp -147.38 167.9 23.19 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.456 ' HA ' HG12 ' A' ' 190' ' ' ILE . 35.7 m -90.88 -27.55 18.71 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 121.471 0.653 . . . . 0.0 112.191 -178.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -164.61 5.9 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.904 -0.497 . . . . 0.0 111.638 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 68.36 -52.78 0.45 Allowed Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.976 -0.631 . . . . 0.0 113.221 -172.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -115.83 122.42 45.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.188 0.518 . . . . 0.0 110.501 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.3 tt -71.4 134.74 46.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.129 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 36.3 m -101.22 131.46 47.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.843 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -87.12 14.77 56.59 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.126 177.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.05 121.5 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 167.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 6.8 t -99.03 96.95 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.031 0 CA-C-O 123.026 1.393 . . . . 0.0 109.227 173.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 12.7 p -129.06 -179.29 5.03 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 112.268 -2.242 . . . . 0.0 106.075 176.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 53.4 p -102.02 163.2 12.37 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 119.034 -1.067 . . . . 0.0 111.728 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.697 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 42.4 tttm -56.25 -38.72 71.52 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.689 170.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.4 m -45.86 -55.55 6.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.144 174.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.433 ' CD1' HG11 ' A' ' 247' ' ' VAL . 0.3 OUTLIER -56.44 -53.37 58.19 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 120.229 -0.589 . . . . 0.0 110.133 176.103 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . 0.752 ' HA ' ' CZ ' ' A' ' 215' ' ' ARG . 76.1 m -52.5 -37.29 57.07 Favored 'General case' 0 C--O 1.247 0.922 0 O-C-N 124.088 0.867 . . . . 0.0 113.266 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 61.3 m -94.15 -33.65 13.24 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.47 -45.45 72.36 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 120.721 -1.237 . . . . 0.0 108.93 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 73.6 p -105.65 149.57 26.22 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.34 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.1 t 57.48 -53.46 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 86.06 146.53 9.41 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 119.297 -1.43 . . . . 0.0 111.429 -169.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.752 ' CZ ' ' HA ' ' A' ' 209' ' ' CYS . 0.1 OUTLIER 153.16 -135.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.014 0.526 . . . . 0.0 111.451 -162.491 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.437 ' HB3' HD11 ' A' ' 190' ' ' ILE . . . -160.59 165.95 29.82 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . 0.697 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 17.2 t90 -161.79 145.52 12.44 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 121.891 -0.506 . . . . 0.0 110.26 -173.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 99.01 -175.21 28.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.374 -0.917 . . . . 0.0 114.363 171.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.414 ' CE1' ' HG2' ' A' ' 185' ' ' PRO . 11.2 m170 -132.2 130.84 22.13 Favored Pre-proline 0 C--N 1.327 -0.411 0 O-C-N 122.818 -0.224 . . . . 0.0 110.54 176.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.19 169.31 50.53 Favored 'Cis proline' 0 C--N 1.342 0.22 0 C-N-CA 123.014 -1.661 . . . . 0.0 110.976 -9.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 93.7 m -42.34 113.72 0.48 Allowed 'General case' 0 C--O 1.234 0.239 0 O-C-N 123.354 0.409 . . . . 0.0 111.655 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -102.07 106.26 17.12 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' MET . . . . . 0.408 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 0.6 OUTLIER -99.15 134.19 42.35 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.639 -164.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 32.1 p -141.12 152.25 64.27 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.981 0.42 . . . . 0.0 111.624 -176.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -55.69 171.28 0.72 Allowed 'Trans proline' 0 CA--C 1.514 -0.498 0 C-N-CA 123.154 2.569 . . . . 0.0 111.585 164.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.19 -126.69 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.763 0.792 . . . . 0.0 110.451 169.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.69 109.3 6.32 Favored Pre-proline 0 C--N 1.303 -1.433 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.358 -176.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -82.21 -92.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.254 1.969 . . . . 0.0 111.306 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -125.82 86.94 56.79 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.237 172.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -106.9 -168.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.693 0 C-N-CA 123.182 2.588 . . . . 0.0 111.631 171.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 8.9 p -86.77 -51.49 6.07 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 167.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.562 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 58.6 mtt180 -143.9 133.43 23.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 174.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -45.49 -51.06 12.17 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -173.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 246' ' ' ASP . . . -77.66 11.91 17.78 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.566 -0.826 . . . . 0.0 114.286 -175.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . 0.562 ' CD1' ' HB2' ' A' ' 232' ' ' ARG . 8.1 m-85 -123.32 152.5 41.38 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 122.109 0.957 . . . . 0.0 111.864 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.22 122.92 25.25 Favored Pre-proline 0 N--CA 1.426 -1.641 0 CA-C-N 114.117 -1.401 . . . . 0.0 108.221 171.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -64.41 123.6 12.04 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.59 2.194 . . . . 0.0 112.094 178.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -57.69 126.01 25.5 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.667 174.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 29.1 pt -76.16 7.24 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.981 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 48.0 mtm180 -112.02 -60.92 1.79 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.734 177.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 37.6 p -86.89 -46.16 10.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.862 -176.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 108.71 6.52 30.56 Favored Glycine 0 N--CA 1.436 -1.314 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.487 -176.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -86.96 120.82 28.63 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-O 122.018 0.913 . . . . 0.0 110.505 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 78.1 m -62.82 122.22 15.41 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.397 -1.729 . . . . 0.0 109.884 172.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -114.37 135.73 53.76 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.464 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 4.2 t70 -73.97 147.94 42.56 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.531 HG23 ' HG3' ' A' ' 249' ' ' GLU . 5.3 m -100.19 147.38 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.084 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -177.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -78.06 79.25 4.52 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 167.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.531 ' HG3' HG23 ' A' ' 247' ' ' VAL . 49.8 mp0 -53.2 -36.6 61.14 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.505 -172.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 36.5 m -42.32 -40.16 2.38 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.34 171.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -100.12 -29.05 12.72 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.623 0.725 . . . . 0.0 110.321 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.413 ' C ' HD12 ' A' ' 253' ' ' ILE . . . -87.71 -5.88 58.47 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.2 -172.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.493 HG13 ' NH2' ' A' ' 215' ' ' ARG . 2.8 mp -124.82 125.77 25.4 Favored Pre-proline 0 C--O 1.24 0.573 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -34.14 -81.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 125.277 3.984 . . . . 0.0 114.208 -165.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -116.12 52.28 0.68 Allowed Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 174.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.567 ' HA ' ' OE1' ' A' ' 284' ' ' GLN . 20.0 tp -43.76 -64.92 0.57 Allowed 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.97 0.453 . . . . 0.0 112.172 -175.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 71.7 m -134.05 89.02 2.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -83.06 -59.2 2.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.474 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -79.85 93.79 1.41 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.847 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 124.89 -174.52 17.22 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.672 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -83.63 157.12 22.37 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.78 132.71 18.1 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 5.2 mt -137.71 156.07 31.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -172.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -121.61 117.33 26.45 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.335 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 5.6 t -110.53 166.77 10.73 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.559 164.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.464 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 29.5 m -70.44 130.46 34.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.476 -177.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 83.2 -9.49 60.79 Favored Glycine 0 N--CA 1.433 -1.557 0 C-N-CA 120.263 -0.97 . . . . 0.0 114.315 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 75.1 m -165.42 154.61 12.3 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 118.442 1.121 . . . . 0.0 111.184 -173.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -114.09 149.73 35.11 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.144 -0.972 . . . . 0.0 109.611 171.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -105.46 113.41 26.96 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 59.0 m -121.15 154.93 35.56 Favored 'General case' 0 CA--C 1.5 -0.953 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.504 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.05 106.27 2.61 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.663 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 64.2 m -77.0 172.97 8.3 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.25 152.44 15.12 Favored 'Trans proline' 0 C--O 1.239 0.533 0 C-N-CA 121.243 1.296 . . . . 0.0 110.481 168.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -57.97 156.88 8.53 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.928 -173.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 86.6 -38.01 3.13 Favored Glycine 0 N--CA 1.435 -1.427 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.588 -176.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -81.38 168.51 18.3 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 122.588 -0.36 . . . . 0.0 110.366 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 61.6 mttp -148.8 138.54 22.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.247 -175.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 46.7 tp -93.79 141.65 28.25 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.375 0.422 . . . . 0.0 110.267 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -122.84 106.7 11.12 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -65.15 -13.47 58.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -173.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 76.8 t -59.68 -38.31 75.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.109 0.48 . . . . 0.0 110.807 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 45.1 m -144.63 38.34 1.23 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.955 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . 0.567 ' OE1' ' HA ' ' A' ' 256' ' ' LEU . 23.9 pt20 38.25 32.8 0.05 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.317 1.047 . . . . 0.0 112.81 -175.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -89.82 105.04 17.53 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 122.111 -0.368 . . . . 0.0 111.426 -172.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 45.7 t -108.99 163.9 12.89 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 174.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 C--O 1.248 1.026 0 O-C-N 124.057 0.848 . . . . 0.0 110.249 175.253 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.421 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 88.1 m-85 . . . . . 0 N--CA 1.451 -0.414 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 28.5 pt -135.82 -171.63 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.962 0.41 . . . . 0.0 110.087 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.74 175.15 41.39 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.398 -172.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 37.5 p -71.38 -39.67 71.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.158 0.504 . . . . 0.0 110.738 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 25.9 p-80 -107.59 16.43 23.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.11 -176.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 56.3 m 62.34 28.79 17.1 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.921 174.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.04 -5.18 70.95 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.428 -0.892 . . . . 0.0 113.583 -174.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.407 HE21 ' C ' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -107.92 126.62 29.38 Favored Pre-proline 0 C--O 1.218 -0.565 0 CA-C-N 117.883 0.842 . . . . 0.0 110.562 -176.729 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -87.33 137.86 4.48 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 123.207 2.605 . . . . 0.0 113.078 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.5 p -69.48 122.51 21.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.876 0.846 . . . . 0.0 111.539 -176.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.614 ' HB3' ' SG ' ' A' ' 154' ' ' CYS . 1.4 m -80.08 120.03 23.68 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 168.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -95.33 -63.08 1.2 Allowed 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -172.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 5.4 p -76.75 27.04 0.13 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -172.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 80.27 -19.25 7.0 Favored Glycine 0 CA--C 1.494 -1.234 0 CA-C-O 121.807 0.67 . . . . 0.0 112.966 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . 0.614 ' SG ' ' HB3' ' A' ' 150' ' ' CYS . 68.4 m 62.94 133.81 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 113.201 -1.5 . . . . 0.0 112.208 -175.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 19.7 mt -128.19 167.82 16.3 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 113.484 -1.689 . . . . 0.0 108.69 -173.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.555 ' HB2' ' CZ ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 69.41 12.71 8.34 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.858 0.724 . . . . 0.0 111.526 174.669 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 72.1 33.9 61.91 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -168.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -56.66 130.49 50.38 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 114.966 -0.617 . . . . 0.0 113.428 -175.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -94.27 115.94 28.25 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.781 -0.709 . . . . 0.0 110.893 175.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 14.1 m -66.63 110.68 3.3 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.771 0.319 . . . . 0.0 110.725 -173.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 165' ' ' ARG . 5.7 m -104.27 -38.96 5.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.384 -177.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -140.39 171.9 7.06 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.421 ' HD3' ' CE1' ' A' ' 140' ' ' TYR . 88.5 Cg_exo -47.7 108.1 0.16 Allowed 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 122.137 1.892 . . . . 0.0 112.826 174.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 76.81 -18.33 0.49 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.736 1.215 . . . . 0.0 110.852 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.492 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.2 OUTLIER -78.12 81.68 4.49 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.355 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.35 142.77 29.94 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 169.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -88.36 131.28 34.89 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -175.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.485 ' HA ' ' ND2' ' A' ' 156' ' ' ASN . 27.8 m -87.63 115.03 24.78 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 124.239 0.962 . . . . 0.0 111.307 -175.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 16.8 m -51.71 -54.4 28.68 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -174.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -148.88 -94.4 0.07 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.111 -1.035 . . . . 0.0 112.848 -168.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -89.54 47.81 3.29 Favored Glycine 0 N--CA 1.434 -1.487 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.909 -168.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.555 ' CZ ' ' HB2' ' A' ' 156' ' ' ASN . 16.3 m-85 -122.27 121.91 37.87 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.973 175.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.402 ' O ' ' HG2' ' A' ' 179' ' ' ARG . 4.9 t -90.8 164.56 14.04 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 161.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.37 132.35 5.45 Favored Glycine 0 N--CA 1.438 -1.182 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.27 -24.83 64.88 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.401 1.401 . . . . 0.0 113.501 -167.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -93.18 -0.12 56.99 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.518 0.675 . . . . 0.0 110.697 -178.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.457 ' HB3' ' CB ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 43.11 55.2 4.66 Favored 'General case' 0 N--CA 1.46 0.075 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.676 -174.115 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -106.12 -14.49 15.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.515 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 173' ' ' THR . 14.0 mmt180 -60.03 -64.2 1.03 Allowed 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.263 -177.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 31.1 t0 72.35 64.81 0.12 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.515 0.674 . . . . 0.0 109.853 163.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.433 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 43.2 p90 -87.58 71.06 9.8 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 122.628 1.204 . . . . 0.0 108.026 177.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 -49.99 130.84 22.56 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.073 171.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 44.4 p -79.06 139.31 38.16 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.576 -0.45 . . . . 0.0 109.986 -176.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -157.02 154.8 25.84 Favored Glycine 0 C--N 1.321 -0.261 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -173.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -77.7 133.63 12.94 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.316 2.011 . . . . 0.0 111.889 175.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . 0.572 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 49.1 m -87.58 122.68 31.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.318 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -94.07 137.43 33.27 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.672 179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' THR . . . . . 0.487 ' C ' ' HG2' ' A' ' 215' ' ' ARG . 23.9 m -111.64 -11.44 14.01 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.346 -160.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.7 p -169.72 116.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 O-C-N 121.925 -0.485 . . . . 0.0 110.48 174.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.438 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.4 mt -119.67 118.42 57.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -170.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.3 p -112.21 -171.32 1.83 Allowed 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 156.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -67.89 -4.03 11.6 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.591 0.71 . . . . 0.0 109.877 172.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -89.84 -67.65 0.83 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.631 -176.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 62.7 mtm -136.86 145.47 44.43 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.179 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.438 ' HA ' HG12 ' A' ' 190' ' ' ILE . 74.1 m -85.43 -21.1 28.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.731 0.777 . . . . 0.0 109.676 174.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -162.78 -72.31 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 162.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 126.12 13.7 3.19 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.067 164.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -123.56 1.76 8.92 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 173.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 65.77 -75.03 0.05 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.552 0.741 . . . . 0.0 111.761 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 34.9 t 73.02 139.68 0.06 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.654 0.74 . . . . 0.0 112.362 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -98.93 25.28 28.81 Favored Glycine 0 CA--C 1.505 -0.57 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.593 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 1.7 tt -61.01 104.02 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-O 121.235 0.54 . . . . 0.0 109.849 173.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 10.7 t -96.28 97.43 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-O 122.603 1.192 . . . . 0.0 109.599 171.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.441 ' HB3' ' SG ' ' A' ' 209' ' ' CYS . 9.0 t -123.98 -179.51 4.43 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 172.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 10.4 p -103.17 161.39 13.84 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.659 -177.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.434 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 53.6 tttm -61.71 -44.29 97.21 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.177 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.6 m -46.87 -54.53 9.75 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.944 0.878 . . . . 0.0 110.133 174.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.455 HD21 ' HB1' ' A' ' 252' ' ' ALA . 4.3 tp -64.27 -52.91 56.32 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 113.423 -1.717 . . . . 0.0 112.774 -175.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 204' ' ' SER . 53.2 m -74.32 -18.31 60.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.99 0.424 . . . . 0.0 111.827 -175.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 68.8 m -96.58 -25.69 15.51 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.672 176.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -73.73 -60.51 2.22 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 172.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.664 HG22 ' HA2' ' A' ' 234' ' ' GLY . 15.4 p -92.04 162.77 14.23 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 65.11 -54.04 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 95.05 -122.24 7.13 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 120.248 -0.977 . . . . 0.0 113.849 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.487 ' HG2' ' C ' ' A' ' 188' ' ' THR . 6.4 mpt_? 27.17 -86.84 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -174.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.408 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -167.6 167.46 13.44 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 119.52 1.055 . . . . 0.0 110.985 -171.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . 0.632 ' O ' ' HB2' ' A' ' 222' ' ' GLU . 10.0 t90 -155.02 144.91 21.6 Favored 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 102.3 177.2 27.58 Favored Glycine 0 CA--C 1.505 -0.586 0 C-N-CA 120.159 -1.02 . . . . 0.0 114.147 169.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -129.61 133.97 25.68 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.251 -0.474 . . . . 0.0 110.804 -175.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -89.76 117.0 3.12 Favored 'Cis proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.17 -1.596 . . . . 0.0 111.815 -3.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 98.9 m 40.76 89.18 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 O-C-N 124.113 0.883 . . . . 0.0 112.928 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.632 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 23.8 mt-10 -102.68 111.48 23.82 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 177.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' MET . . . . . 0.408 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 18.9 ptt? -102.35 136.95 41.26 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.112 -166.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 59.4 m -119.24 147.58 43.3 Favored Pre-proline 0 C--O 1.233 0.212 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -167.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -60.27 153.67 57.86 Favored 'Trans proline' 0 CA--C 1.508 -0.812 0 C-N-CA 123.833 3.022 . . . . 0.0 113.495 167.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -42.23 113.27 0.42 Allowed 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.904 0.859 . . . . 0.0 110.508 160.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 23.95 99.66 0.02 OUTLIER Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 111.518 -2.583 . . . . 0.0 113.7 -177.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.65 -62.91 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.835 3.023 . . . . 0.0 113.627 -177.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -69.9 155.14 93.99 Favored Pre-proline 0 CA--C 1.514 -0.411 0 CA-C-O 120.691 0.282 . . . . 0.0 110.348 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.75 58.35 6.97 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 121.739 1.626 . . . . 0.0 113.799 -174.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 64.0 m -132.91 148.11 52.29 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 171.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.519 ' HG3' ' CD1' ' A' ' 235' ' ' PHE . 16.4 ptt180 -55.49 137.16 49.08 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.079 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -31.12 -47.15 0.1 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -166.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.664 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -68.58 5.87 3.93 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 114.981 0.753 . . . . 0.0 114.981 -174.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . 0.519 ' CD1' ' HG3' ' A' ' 232' ' ' ARG . 7.7 m-85 -122.77 150.29 42.99 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 122.089 0.947 . . . . 0.0 112.97 -169.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.425 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.1 OUTLIER -126.52 125.25 24.45 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 114.046 -1.433 . . . . 0.0 108.387 172.382 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -62.69 123.01 11.58 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.339 2.026 . . . . 0.0 111.679 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -54.08 127.25 25.86 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.354 0.597 . . . . 0.0 110.936 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 32.7 pt -65.8 -6.66 4.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.428 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 63.8 mtt85 -106.51 -68.1 0.9 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.491 0.662 . . . . 0.0 110.199 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 24.4 p -79.62 -43.17 23.39 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.351 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 102.72 8.0 43.7 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -176.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -82.28 127.11 32.89 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 122.056 0.932 . . . . 0.0 109.714 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 33.3 m -63.76 114.78 4.24 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 113.458 -1.701 . . . . 0.0 109.829 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -112.94 134.44 54.45 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 6.1 t70 -82.7 144.09 30.48 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.571 HG23 ' HG3' ' A' ' 249' ' ' GLU . 9.2 m -98.61 150.16 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.343 -174.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.67 76.39 2.04 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 169.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.571 ' HG3' HG23 ' A' ' 247' ' ' VAL . 9.7 mp0 -53.55 -39.9 65.1 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.191 0.596 . . . . 0.0 111.443 -167.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 49.2 t -51.54 -33.98 34.51 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.932 0.396 . . . . 0.0 111.284 175.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -98.67 -46.38 5.72 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.738 0.78 . . . . 0.0 110.05 -174.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.455 ' HB1' HD21 ' A' ' 208' ' ' LEU . . . -66.63 -21.55 66.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.813 -177.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.447 ' O ' ' N ' ' A' ' 255' ' ' GLY . 3.7 mp -120.39 79.56 28.64 Favored Pre-proline 0 N--CA 1.445 -0.716 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 175.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -21.61 -29.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 1 C-N-CA 128.256 5.97 . . . . 0.0 120.032 -164.204 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 253' ' ' ILE . . . -172.06 39.03 0.16 Allowed Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 119.265 -1.445 . . . . 0.0 111.915 -175.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.445 ' HB3' HG22 ' A' ' 253' ' ' ILE . 2.2 pt? -70.57 -49.65 45.62 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 119.879 -0.728 . . . . 0.0 111.287 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 47.5 t -124.28 133.49 53.47 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 120.839 0.352 . . . . 0.0 110.086 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -134.77 -89.11 0.35 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.934 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 71.34 -71.49 0.81 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.838 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -152.81 -78.48 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -101.47 147.31 26.51 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 15.0 p -137.56 140.74 41.21 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 6.9 mt -144.62 166.16 12.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -170.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.511 ' ND2' ' HB3' ' A' ' 269' ' ' PHE . 0.8 OUTLIER -131.45 132.91 44.67 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 118.673 -1.211 . . . . 0.0 112.938 177.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.85 161.05 18.75 Favored 'General case' 0 C--O 1.256 1.406 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.905 162.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.419 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 33.5 m -72.17 124.31 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 112.97 -29.5 8.03 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.057 -1.068 . . . . 0.0 112.895 -170.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 39.5 t 173.01 156.62 0.1 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 117.912 0.856 . . . . 0.0 109.465 -170.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . 0.511 ' HB3' ' ND2' ' A' ' 264' ' ' ASN . 40.2 p90 -98.43 161.4 13.7 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 121.832 -0.542 . . . . 0.0 110.029 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -114.93 141.18 48.31 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 95.5 m -124.83 161.53 26.31 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.472 0.653 . . . . 0.0 111.493 175.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -140.39 109.52 6.13 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.592 173.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 3.9 m -91.78 163.34 28.27 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.361 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.91 158.61 8.47 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.564 2.176 . . . . 0.0 111.473 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -57.13 145.06 32.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 86.55 -30.89 4.36 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -173.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' HIS . . . . . 0.513 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 27.3 m-70 -89.08 173.64 8.33 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.001 0.429 . . . . 0.0 110.833 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 95.6 mttt -162.38 153.19 17.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.903 -174.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 65.6 tp -87.57 136.82 32.79 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.45 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -126.6 101.23 6.56 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -63.4 -18.09 63.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.382 -174.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.404 ' HA ' ' NH2' ' A' ' 215' ' ' ARG . 93.9 t -57.08 -33.08 41.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.59 177.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 31.9 m -147.24 35.4 0.89 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.577 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 29.68 49.49 0.06 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.45 1.1 . . . . 0.0 113.368 -175.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -108.16 162.1 14.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.139 0.495 . . . . 0.0 111.768 -173.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' CYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 40.4 m -129.63 102.79 6.51 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 18.1 tt0 . . . . . 0 C--O 1.243 0.756 0 CA-C-O 118.554 -0.736 . . . . 0.0 109.855 -173.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 . . . . . 0 CA--C 1.509 -0.603 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 28.8 pt -133.44 -178.13 2.49 Favored 'Isoleucine or valine' 0 C--O 1.251 1.139 0 O-C-N 124.234 0.958 . . . . 0.0 109.588 172.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.19 163.74 34.77 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.711 -178.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.0 p -76.88 -22.42 53.48 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.883 0.373 . . . . 0.0 111.604 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -97.32 -6.74 33.63 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 13.1 t 67.9 14.48 9.4 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.817 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -89.64 4.78 83.85 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.924 -173.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.7 118.85 54.35 Favored Pre-proline 0 C--O 1.219 -0.533 0 CA-C-N 117.69 0.745 . . . . 0.0 111.126 -176.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -87.22 140.23 5.48 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.695 2.263 . . . . 0.0 112.537 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.3 p -69.92 105.97 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 122.293 1.044 . . . . 0.0 111.934 -176.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.94 78.73 5.37 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.421 175.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -53.24 -70.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.606 -1.179 . . . . 0.0 113.924 -172.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.5 m -90.91 12.46 19.44 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.658 0.742 . . . . 0.0 111.17 -169.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 72.47 127.87 0.1 OUTLIER Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 114.161 -1.381 . . . . 0.0 111.713 -175.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . 0.472 ' O ' HD23 ' A' ' 155' ' ' LEU . 62.0 m -72.98 164.44 26.67 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.197 -1.002 . . . . 0.0 108.96 175.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 154' ' ' CYS . 62.6 mt -143.52 -178.49 5.91 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -166.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 44.44 24.48 0.09 Allowed 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 177.804 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 69.73 28.7 71.78 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.86 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -82.18 -138.7 2.88 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.306 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.25 140.68 4.37 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 117.396 0.598 . . . . 0.0 109.984 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.97 110.98 13.37 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.319 0.581 . . . . 0.0 109.907 171.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.5 m -99.67 -30.33 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.476 -176.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.47 ' HB3' ' CB ' ' A' ' 165' ' ' ARG . . . -140.36 171.73 7.33 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -48.64 96.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.499 2.133 . . . . 0.0 113.229 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 42.0 t30 69.03 15.28 8.82 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.726 0.774 . . . . 0.0 109.997 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.47 ' CB ' ' HB3' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -100.74 86.5 3.12 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.793 172.224 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 60.0 m -82.75 138.37 34.06 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.016 171.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.72 131.81 34.35 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 171.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 72.8 m -115.28 138.27 51.13 Favored 'General case' 0 C--N 1.315 -0.916 0 O-C-N 123.876 0.735 . . . . 0.0 111.474 -170.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 39.6 m -50.37 -55.04 17.38 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.681 -168.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -162.74 -86.29 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 118.578 -1.249 . . . . 0.0 113.516 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -93.83 51.97 2.28 Favored Glycine 0 CA--C 1.489 -1.583 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.003 -164.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.585 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 1.7 m-85 -121.07 134.49 55.27 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 118.563 -1.255 . . . . 0.0 112.841 173.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.771 HG23 ' CE2' ' A' ' 181' ' ' TYR . 8.7 p -87.89 123.61 32.82 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.718 177.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 104.75 133.56 7.79 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 108.991 -1.643 . . . . 0.0 108.991 -175.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.49 12.81 0.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.747 1.631 . . . . 0.0 112.896 -170.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.412 ' O ' HD12 ' A' ' 155' ' ' LEU . 15.7 tt0 -121.95 16.81 10.91 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.246 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.5 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.5 OUTLIER 33.65 69.42 0.14 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 175.578 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -117.41 7.15 12.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.634 0.731 . . . . 0.0 110.509 172.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.585 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 21.4 mmt85 -117.49 89.62 3.16 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.2 -178.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -80.35 54.16 1.95 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.614 -170.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.771 ' CE2' HG23 ' A' ' 173' ' ' THR . 18.7 p90 -84.42 78.38 9.83 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -77.2 140.22 40.08 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 118.976 -2.327 . . . . 0.0 107.682 -178.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 67.0 p -83.73 136.25 34.25 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.168 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -156.16 160.83 30.39 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -80.51 129.52 7.46 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.592 2.195 . . . . 0.0 111.554 175.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . 0.629 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 83.2 m -85.8 118.44 25.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.193 0.52 . . . . 0.0 110.589 177.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . 0.508 ' O ' ' HB2' ' A' ' 215' ' ' ARG . 9.2 m-85 -94.72 150.07 20.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.972 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 21.7 p -108.5 -1.8 19.46 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 28.3 m -141.62 174.37 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.48 HD11 ' HB2' ' A' ' 216' ' ' ALA . 12.8 mm -122.15 114.21 41.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.867 0.842 . . . . 0.0 111.327 176.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.1 t -143.16 127.93 18.23 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.198 175.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -63.87 -20.75 66.06 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 171.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -71.23 -69.36 0.38 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.339 169.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 64.2 mtt -151.39 101.88 2.86 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 176.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.442 ' O ' ' HB3' ' A' ' 187' ' ' PHE . 39.7 m -64.83 -24.76 67.64 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 122.201 0.2 . . . . 0.0 110.737 172.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 142.22 -139.52 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 126.959 2.104 . . . . 0.0 107.561 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 84.02 -50.12 4.35 Favored Glycine 0 C--N 1.332 0.35 0 N-CA-C 115.146 0.818 . . . . 0.0 115.146 170.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -72.36 29.01 0.05 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -171.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.473 ' N ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -156.87 18.22 0.31 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.933 0.397 . . . . 0.0 110.272 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 32.2 t -153.38 135.23 14.59 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.27 0.557 . . . . 0.0 111.115 -175.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -102.37 29.73 11.88 Favored Glycine 0 CA--C 1.502 -0.778 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 173.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.446 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -64.32 104.05 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-O 122.008 0.909 . . . . 0.0 109.425 176.497 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.32 99.05 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-O 122.42 1.105 . . . . 0.0 110.283 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.3 t -123.19 -178.27 3.93 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 113.241 -1.799 . . . . 0.0 106.724 169.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.8 p -100.76 164.4 11.88 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.385 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.519 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 45.5 tttm -60.6 -46.16 91.29 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.44 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.1 m -43.95 -56.23 4.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.88 174.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.451 ' CD1' HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -55.68 -57.47 11.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.53 179.296 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 40.0 m -72.5 -17.4 61.75 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -170.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 66.3 m -92.39 -31.61 15.26 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.021 175.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -70.84 -61.67 1.68 Allowed 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.588 HG22 ' HA2' ' A' ' 234' ' ' GLY . 32.4 p -92.26 152.52 19.78 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.105 174.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.1 t 70.3 -43.8 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.503 ' O ' ' HD2' ' A' ' 215' ' ' ARG . . . 55.97 61.97 6.85 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 115.767 1.067 . . . . 0.0 115.767 170.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 187' ' ' PHE . 14.4 mmm180 -126.43 -82.25 0.62 Allowed 'General case' 0 C--O 1.237 0.44 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.888 176.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.48 ' HB2' HD11 ' A' ' 190' ' ' ILE . . . -169.11 166.74 10.8 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . 0.629 ' HD1' ' SG ' ' A' ' 186' ' ' CYS . 11.6 t90 -159.12 149.42 19.37 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 121.23 -0.919 . . . . 0.0 109.461 -175.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 221' ' ' CYS . . . 87.13 156.68 29.9 Favored Glycine 0 C--O 1.223 -0.542 0 C-N-CA 120.363 -0.922 . . . . 0.0 114.695 168.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.541 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 17.0 p80 -130.57 135.46 27.42 Favored Pre-proline 0 C--O 1.236 0.354 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . 0.541 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 31.6 Cg_exo -59.31 143.37 29.79 Favored 'Cis proline' 0 N--CA 1.477 0.552 0 C-N-CA 124.16 -1.183 . . . . 0.0 111.71 -0.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 43.0 t -41.86 117.77 1.0 Allowed 'General case' 0 N--CA 1.464 0.257 0 O-C-N 124.222 0.951 . . . . 0.0 112.868 -170.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -109.41 120.25 41.95 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -80.29 148.28 30.8 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -176.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 5.8 m -85.4 123.34 73.09 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -172.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.2 167.56 19.89 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.394 2.73 . . . . 0.0 110.847 167.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -39.74 -60.06 1.05 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.12 -172.75 0.33 Allowed Pre-proline 0 N--CA 1.431 -1.418 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 -173.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -84.75 -98.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.801 1.667 . . . . 0.0 110.7 172.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -84.24 166.77 31.33 Favored Pre-proline 0 CA--C 1.513 -0.473 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 169.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.12 65.52 4.25 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.852 1.702 . . . . 0.0 113.162 -176.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 64.2 m -106.2 -173.88 2.4 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 170.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.614 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 86.3 mtt180 -67.75 147.57 52.44 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 119.701 -0.799 . . . . 0.0 108.927 172.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -37.92 -49.98 1.27 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 178.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.588 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -79.33 12.44 26.2 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.605 -0.807 . . . . 0.0 114.833 -174.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . 0.614 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 2.3 m-85 -122.86 146.82 47.22 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 122.093 0.949 . . . . 0.0 113.21 -172.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.87 132.74 24.36 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 114.098 -1.41 . . . . 0.0 107.967 170.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.38 118.85 5.77 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.13 1.887 . . . . 0.0 111.721 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -52.29 136.85 30.01 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 121.727 0.775 . . . . 0.0 110.582 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 33.2 mt -70.93 -16.37 19.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.404 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 42.0 mtm105 -102.52 -63.32 1.17 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.29 0.567 . . . . 0.0 110.248 -176.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 40.5 p -79.34 -38.46 35.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.75 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 94.89 5.41 61.11 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -176.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -86.67 124.36 32.85 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 121.935 0.874 . . . . 0.0 109.121 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 13.0 m -57.92 123.13 14.77 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 113.403 -1.726 . . . . 0.0 110.479 178.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -119.39 142.85 47.82 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.466 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 8.5 t70 -77.85 147.53 35.11 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.602 HG23 ' HG3' ' A' ' 249' ' ' GLU . 15.9 m -94.17 142.88 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.094 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.212 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -70.07 77.5 0.5 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 164.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.602 ' HG3' HG23 ' A' ' 247' ' ' VAL . 20.5 mp0 -52.7 -35.6 55.83 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 123.525 0.515 . . . . 0.0 110.498 -173.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 33.1 m -55.01 -29.33 57.12 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.176 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -103.93 -43.74 5.21 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.923 0.868 . . . . 0.0 109.7 -175.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.34 -22.1 64.71 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.024 -1.444 . . . . 0.0 111.286 -175.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.575 HG22 ' HB3' ' A' ' 256' ' ' LEU . 64.2 mt -131.34 75.61 77.17 Favored Pre-proline 0 N--CA 1.447 -0.603 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -13.04 -91.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.039 1 C-N-CA 126.106 4.537 . . . . 0.0 115.749 -162.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -119.69 59.41 0.53 Allowed Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 119.641 -1.266 . . . . 0.0 111.872 177.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.575 ' HB3' HG22 ' A' ' 253' ' ' ILE . 2.3 pt? -63.97 -38.91 92.79 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.139 177.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 45.8 t -104.86 107.36 18.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.492 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -116.68 35.69 4.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.903 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . 0.577 ' HA3' ' SG ' ' A' ' 286' ' ' CYS . . . -87.96 -9.04 71.58 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.592 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 145.21 -100.11 0.22 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -89.09 158.01 18.12 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.733 0.301 . . . . 0.0 110.778 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.71 132.73 14.29 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 10.7 mt -142.34 165.46 16.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -173.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.93 126.53 43.39 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 118.556 -1.258 . . . . 0.0 113.525 -175.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 4.6 t -115.55 167.78 10.59 Favored 'General case' 0 C--O 1.258 1.52 0 CA-C-O 122.243 1.021 . . . . 0.0 110.322 162.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.432 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 30.4 m -71.11 131.27 34.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.849 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.426 ' CA ' ' HE2' ' A' ' 235' ' ' PHE . . . 88.95 -9.79 75.28 Favored Glycine 0 N--CA 1.423 -2.201 0 CA-C-O 119.264 -0.742 . . . . 0.0 113.527 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 48.3 t -179.51 150.03 0.41 Allowed 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 117.838 0.819 . . . . 0.0 111.255 -172.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -107.31 156.53 18.78 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.89 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -108.27 128.88 55.12 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.961 -176.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 54.9 m -120.56 160.38 23.32 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.313 0.578 . . . . 0.0 111.081 176.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -140.54 124.52 17.37 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.193 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 3.7 m -98.36 170.72 6.64 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 175.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -58.31 156.18 31.7 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.567 1.511 . . . . 0.0 110.611 170.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -59.34 149.39 29.15 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.25 -33.26 3.19 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.113 -174.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -78.69 167.37 21.32 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 120.987 0.422 . . . . 0.0 110.69 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 67.1 mttm -140.22 139.15 35.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.227 -179.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 21.4 tp -81.71 143.98 31.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.041 0.448 . . . . 0.0 110.75 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -124.55 98.46 5.74 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -68.04 -12.83 61.54 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -174.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 42.7 t -66.24 -25.42 35.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.252 0.548 . . . . 0.0 110.266 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 10.3 p -148.05 28.87 0.91 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.618 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 30.06 49.57 0.07 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.709 -1.132 . . . . 0.0 113.16 -171.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -102.65 175.65 5.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.754 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' CYS . . . . . 0.577 ' SG ' ' HA3' ' A' ' 259' ' ' GLY . 92.9 m -141.81 170.41 15.77 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 173.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.561 ' HB2' ' O ' ' A' ' 286' ' ' CYS . 2.4 mp0 . . . . . 0 C--O 1.25 1.099 0 C-N-CA 124.319 1.048 . . . . 0.0 109.408 170.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.568 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 97.9 m-85 . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 121.157 0.504 . . . . 0.0 110.376 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 40.6 pt -131.08 175.03 12.14 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.312 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 101.29 174.18 28.68 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.851 -177.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.3 p -73.54 -31.61 63.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.316 0.579 . . . . 0.0 111.45 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -110.87 7.05 21.7 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.411 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 34.1 m 63.91 37.49 9.48 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 124.204 0.94 . . . . 0.0 111.181 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -93.62 -7.09 61.92 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.906 -176.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.27 112.72 65.9 Favored Pre-proline 0 C--N 1.327 -0.404 0 O-C-N 122.121 -0.635 . . . . 0.0 110.704 -177.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.67 142.45 14.34 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.342 2.695 . . . . 0.0 112.614 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.9 p -73.15 107.73 3.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 122.504 1.145 . . . . 0.0 111.284 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.86 88.03 5.29 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.298 175.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.34 -68.04 0.27 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -175.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 16.7 m -95.71 13.37 26.66 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.824 0.345 . . . . 0.0 111.628 -166.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.23 123.95 0.91 Allowed Glycine 0 N--CA 1.438 -1.221 0 CA-C-O 121.819 0.677 . . . . 0.0 113.066 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 80.4 m -81.14 162.23 23.75 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 172.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 176' ' ' GLN . 79.9 mt -148.22 167.27 25.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 118.04 0.382 . . . . 0.0 110.88 -162.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.523 ' HB2' ' CZ ' ' A' ' 172' ' ' PHE . 10.0 t30 48.31 23.72 0.6 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.327 -164.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 66.0 39.36 94.79 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.256 -0.974 . . . . 0.0 111.774 -177.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.62 -138.16 0.21 Allowed Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.772 -0.727 . . . . 0.0 111.313 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 13.1 ttt180 -159.47 128.99 5.41 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.08 -0.659 . . . . 0.0 111.221 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.4 m -62.91 119.99 10.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.59 0.233 . . . . 0.0 110.691 173.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 16.7 m -105.68 -35.84 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.947 0.403 . . . . 0.0 110.546 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.574 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -139.93 170.55 9.56 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.568 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 76.6 Cg_exo -51.58 109.17 0.29 Allowed 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.208 1.939 . . . . 0.0 112.133 174.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 72.96 -3.07 2.52 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.36 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.574 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.9 OUTLIER -90.92 86.35 6.26 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.516 175.857 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 72.6 m -78.65 141.07 38.27 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.234 171.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -97.79 117.54 32.34 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 172.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 83.0 m -101.18 141.17 34.45 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.036 -170.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 7.0 m -51.11 -53.9 29.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -168.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.42 ' HE2' ' HG1' ' A' ' 183' ' ' THR . 30.8 t80 -167.68 -84.72 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.36 -0.936 . . . . 0.0 113.227 -172.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -90.94 55.91 3.32 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.325 -167.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.564 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 7.0 m-85 -127.11 137.57 53.02 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.509 169.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.603 HG23 ' CE2' ' A' ' 181' ' ' TYR . 64.4 p -87.15 123.79 32.57 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.094 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 102.09 139.84 10.78 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.05 7.82 1.59 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 121.143 1.229 . . . . 0.0 112.449 -172.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.506 ' O ' HD12 ' A' ' 155' ' ' LEU . 18.9 tt0 -119.47 26.1 9.63 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.294 176.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.437 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.7 OUTLIER 23.89 72.72 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 118.693 2.849 . . . . 0.0 118.693 170.614 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -124.96 29.8 6.05 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.103 -0.998 . . . . 0.0 110.929 169.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.564 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 23.9 mmt180 -130.2 93.0 3.38 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.168 175.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.07 53.14 1.16 Allowed 'General case' 0 C--N 1.323 -0.55 0 O-C-N 123.402 0.439 . . . . 0.0 111.189 -169.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.603 ' CE2' HG23 ' A' ' 173' ' ' THR . 16.2 p90 -84.4 80.43 9.22 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -82.75 135.12 35.08 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 119.761 -1.837 . . . . 0.0 108.609 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.42 ' HG1' ' HE2' ' A' ' 170' ' ' TYR . 70.3 p -77.06 171.04 15.44 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 157.18 136.04 2.04 Favored Glycine 0 C--N 1.32 -0.322 0 C-N-CA 119.669 -1.253 . . . . 0.0 112.359 -163.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.62 128.23 15.86 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.133 1.889 . . . . 0.0 111.531 172.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . 0.6 ' SG ' ' HD2' ' A' ' 215' ' ' ARG . 16.5 t -102.18 114.28 28.29 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.474 0.654 . . . . 0.0 110.68 -178.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . 0.568 ' O ' ' HB3' ' A' ' 215' ' ' ARG . 16.8 m-85 -93.62 143.43 26.31 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.262 -177.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 2.4 m -96.23 -27.73 14.87 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -162.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.1 p -163.2 118.79 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.628 -171.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.482 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.4 mt -125.51 118.8 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 122.182 0.992 . . . . 0.0 113.486 -168.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.2 t -116.15 -164.56 0.97 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 113.766 -1.561 . . . . 0.0 106.934 163.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -63.87 -5.71 4.81 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.718 0.77 . . . . 0.0 110.008 170.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -69.84 -75.76 0.11 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.847 -178.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 46.0 ttm -171.2 151.37 3.15 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.957 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.482 ' HA ' HG12 ' A' ' 190' ' ' ILE . 72.8 m -57.43 -46.11 83.92 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 121.73 0.776 . . . . 0.0 110.91 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -151.54 -81.22 0.1 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 166.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.44 -24.33 6.91 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.569 172.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -131.14 45.3 2.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.393 0.616 . . . . 0.0 109.43 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 26.3 tp -169.82 132.76 1.17 Allowed 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.572 -173.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 34.7 t -149.04 -47.46 0.14 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.753 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.84 26.62 10.47 Favored Glycine 0 C--O 1.228 -0.225 0 C-N-CA 120.752 -0.737 . . . . 0.0 114.333 -171.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.29 91.58 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 165.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.49 112.47 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 CA-C-O 122.935 1.35 . . . . 0.0 110.171 -171.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 6.1 t -155.64 -178.74 7.5 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.559 HG21 ' HA ' ' A' ' 181' ' ' TYR . 17.8 p -106.35 171.5 7.32 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 120.883 1.674 . . . . 0.0 110.649 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.693 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 34.0 tttm -59.88 -47.43 85.77 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.777 175.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.9 m -45.21 -55.59 5.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.956 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.73 -48.76 80.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.257 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 97.2 m -61.18 -38.81 87.83 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 56.5 m -83.86 -37.19 22.77 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 121.65 -0.656 . . . . 0.0 111.249 -176.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.14 -57.69 5.66 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.499 HG22 ' HA2' ' A' ' 234' ' ' GLY . 30.5 p -104.05 144.16 31.92 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.152 -175.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.0 t 64.06 -22.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 63.55 51.86 50.85 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 120.435 1.47 . . . . 0.0 114.028 167.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.6 ' HD2' ' SG ' ' A' ' 186' ' ' CYS . 27.1 mtt85 -103.09 -123.03 0.19 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.797 0.808 . . . . 0.0 111.307 -178.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.472 ' CB ' HD11 ' A' ' 190' ' ' ILE . . . -156.8 168.52 27.21 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . 0.693 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 36.6 t90 -161.77 149.74 14.94 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 119.365 0.984 . . . . 0.0 111.188 -170.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 85.09 170.12 46.81 Favored Glycine 0 C--O 1.229 -0.186 0 N-CA-C 115.081 0.792 . . . . 0.0 115.081 170.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.511 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 85.8 m-70 -127.23 133.04 24.63 Favored Pre-proline 0 N--CA 1.457 -0.117 0 C-N-CA 122.949 0.5 . . . . 0.0 109.879 171.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 18.9 Cg_endo -58.73 157.67 36.99 Favored 'Cis proline' 0 C--O 1.236 0.393 0 C-N-CA 123.261 -1.558 . . . . 0.0 112.373 -4.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 33.2 t -53.41 115.56 1.99 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.586 -174.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -105.39 102.76 12.21 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' MET . . . . . 0.483 ' O ' ' HD3' ' A' ' 225' ' ' PRO . 1.3 tpt -79.09 132.42 36.59 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -175.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 92.7 m -83.29 112.58 40.06 Favored Pre-proline 0 C--N 1.332 -0.154 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -172.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 223' ' ' MET . 6.1 Cg_exo -81.41 124.92 4.9 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.598 2.865 . . . . 0.0 111.054 169.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 48.25 -79.16 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.899 0.88 . . . . 0.0 113.228 -174.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 225' ' ' PRO . 0.0 OUTLIER -162.27 -171.54 0.28 Allowed Pre-proline 0 N--CA 1.441 -0.903 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -168.317 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -87.85 -90.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 121.835 1.69 . . . . 0.0 111.478 170.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -87.66 158.12 51.48 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 172.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.02 61.87 7.8 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.19 1.927 . . . . 0.0 114.593 -171.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 92.2 m -110.39 -177.94 3.37 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 169.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.528 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 31.1 mmt180 -62.72 140.63 58.74 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 173.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -37.33 -50.72 1.05 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.499 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -70.1 1.14 19.45 Favored Glycine 0 C--N 1.313 -0.728 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.72 -174.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . 0.528 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 11.3 m-85 -123.17 151.32 42.3 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.159 0.981 . . . . 0.0 113.324 -169.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.32 128.7 24.02 Favored Pre-proline 0 N--CA 1.436 -1.143 0 CA-C-N 114.082 -1.417 . . . . 0.0 108.259 169.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.92 125.17 14.25 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.533 2.156 . . . . 0.0 111.802 178.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -62.61 136.64 57.98 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 35.5 pt -82.78 2.32 3.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.584 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -103.12 -57.37 2.05 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.853 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 52.3 p -89.06 -45.9 9.26 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.5 -178.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 103.06 11.02 35.35 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -96.17 125.23 40.55 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 121.95 0.881 . . . . 0.0 109.992 -177.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 4.3 m -59.06 122.56 14.06 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.832 172.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 75.5 mm-40 -123.37 137.9 54.72 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 6.1 t70 -75.32 147.21 40.33 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-O 121.283 0.563 . . . . 0.0 110.001 -176.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.484 HG23 ' HG3' ' A' ' 249' ' ' GLU . 11.4 m -93.53 144.27 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.426 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -75.03 77.28 2.22 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 168.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.484 ' HG3' HG23 ' A' ' 247' ' ' VAL . 36.2 mp0 -52.42 -35.73 52.7 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.651 0.739 . . . . 0.0 110.515 -171.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 9.5 m -53.39 -33.47 53.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.877 175.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -99.1 -37.42 9.34 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.78 0.8 . . . . 0.0 110.101 -177.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.23 -19.02 63.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.753 -175.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.2 mp -126.66 117.18 22.68 Favored Pre-proline 0 N--CA 1.446 -0.637 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 174.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -35.79 -91.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.483 0.911 1 C-N-CA 125.345 4.03 . . . . 0.0 114.39 -165.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -100.36 56.59 0.8 Allowed Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.406 171.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 22.6 tp -40.3 -65.33 0.42 Allowed 'General case' 0 C--O 1.224 -0.273 0 O-C-N 124.465 0.744 . . . . 0.0 112.894 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 11.3 t -87.62 62.72 7.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.104 0.478 . . . . 0.0 109.857 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -60.4 104.33 0.32 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.55 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 131.92 -17.35 4.92 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.764 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -150.78 -157.85 8.0 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.032 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -108.54 121.55 45.21 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 52.6 t -92.14 133.55 35.68 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 176.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 39.3 mt -132.24 112.51 19.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.442 0.639 . . . . 0.0 110.075 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -74.13 126.44 30.57 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -170.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 6.2 t -113.35 164.91 12.98 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.021 154.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.428 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 30.7 m -69.97 132.2 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 118.705 -1.198 . . . . 0.0 108.899 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 88.53 -10.87 70.11 Favored Glycine 0 C--N 1.314 -0.678 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.571 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.4 p -174.43 143.14 0.82 Allowed 'General case' 0 C--O 1.212 -0.872 0 CA-C-N 118.112 0.956 . . . . 0.0 110.705 -174.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -103.12 151.64 22.33 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -114.7 126.84 55.33 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -175.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 11.1 m -97.05 158.17 15.56 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.867 0.841 . . . . 0.0 111.961 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -134.71 106.26 6.86 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.278 172.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 4.6 m -96.52 156.03 37.21 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 52.2 Cg_exo -55.84 159.9 10.88 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.53 2.154 . . . . 0.0 111.425 172.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -56.17 146.02 24.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.551 0.215 . . . . 0.0 111.07 -177.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.26 -30.0 3.42 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.88 -176.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' HIS . . . . . 0.435 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 17.8 m-70 -78.84 165.01 24.01 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.135 0.493 . . . . 0.0 111.507 -177.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -146.4 135.0 22.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.605 -175.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.516 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 39.0 tp -71.34 140.85 50.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.223 0.535 . . . . 0.0 110.926 177.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -129.56 102.44 6.37 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 170.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -61.01 -24.38 66.12 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 123.521 0.513 . . . . 0.0 111.781 -173.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 16.4 t -62.66 -23.84 33.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.983 0.421 . . . . 0.0 110.826 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 28.1 p -141.63 24.86 2.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.668 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 25.53 48.85 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.142 0.977 . . . . 0.0 112.178 -169.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 81.8 tttt -97.87 159.14 15.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.16 -171.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 4.0 m -137.15 81.25 1.86 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.041 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.435 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 66.5 mm-40 . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.346 -0.835 . . . . 0.0 108.893 -174.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.546 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 94.8 m-85 . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 120.811 0.339 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 26.6 pt -128.31 176.65 7.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.669 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 96.64 167.94 33.77 Favored Glycine 0 C--N 1.318 -0.457 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.761 -176.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.9 p -74.62 -23.61 58.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.176 0.488 . . . . 0.0 111.669 -177.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -109.54 7.3 24.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.534 176.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 30.9 m 64.29 30.05 13.53 Favored 'General case' 0 N--CA 1.462 0.168 0 O-C-N 123.672 0.607 . . . . 0.0 111.013 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.3 -12.22 67.95 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.571 -173.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.77 109.67 63.24 Favored Pre-proline 0 C--O 1.224 -0.259 0 CA-C-N 117.912 0.856 . . . . 0.0 110.745 -174.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.01 139.4 24.2 Favored 'Trans proline' 0 CA--C 1.522 -0.092 0 C-N-CA 123.625 2.884 . . . . 0.0 112.578 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.52 110.53 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.734 0.778 . . . . 0.0 111.479 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.38 77.18 7.17 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.972 176.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -53.86 -68.89 0.14 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -174.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.4 m -88.01 13.55 10.82 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.137 0.494 . . . . 0.0 111.679 -165.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 87.99 122.1 1.75 Allowed Glycine 0 N--CA 1.428 -1.841 0 CA-C-O 122.237 0.909 . . . . 0.0 112.608 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 5.7 m -78.32 155.13 30.3 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 113.185 -1.507 . . . . 0.0 109.034 168.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.556 HD12 ' O ' ' A' ' 176' ' ' GLN . 56.3 mt -149.71 163.22 38.55 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.858 -166.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 172' ' ' PHE . 61.4 t30 47.69 24.13 0.51 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.66 -164.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 67.71 38.3 89.71 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.74 -177.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.22 -152.84 0.59 Allowed Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.723 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -149.07 121.57 8.52 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.223 -0.575 . . . . 0.0 111.808 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.5 m -63.19 114.69 3.92 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.668 177.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 165' ' ' ARG . 8.8 m -104.17 -34.92 3.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.81 0.338 . . . . 0.0 110.935 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.57 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -140.1 171.68 7.47 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.546 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 73.9 Cg_exo -53.3 108.55 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.988 1.792 . . . . 0.0 112.434 177.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 72.81 -7.88 1.37 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.362 1.065 . . . . 0.0 110.423 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.57 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.5 OUTLIER -83.49 82.54 8.25 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 176.295 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 7.1 t -80.88 145.8 31.15 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -96.5 118.68 33.51 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 173.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 84.0 m -90.45 126.97 36.08 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.791 -167.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.0 m -42.62 -51.44 5.19 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 124.633 1.208 . . . . 0.0 112.531 -172.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -165.76 -89.75 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 119.481 -0.888 . . . . 0.0 112.234 -176.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -90.98 54.89 3.32 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.636 -167.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.527 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 7.8 m-85 -129.63 136.5 49.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.608 0.704 . . . . 0.0 111.654 169.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.61 HG23 ' CE2' ' A' ' 181' ' ' TYR . 80.1 p -87.49 132.79 33.9 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.383 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 92.06 146.75 19.14 Favored Glycine 0 N--CA 1.438 -1.167 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.799 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.32 22.89 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.616 1.544 . . . . 0.0 112.407 -174.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.556 ' O ' HD12 ' A' ' 155' ' ' LEU . 50.4 tt0 -120.85 3.28 10.57 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.512 176.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.45 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 32.15 57.59 0.36 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 176.639 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -115.84 17.21 16.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.501 0.667 . . . . 0.0 110.085 175.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 8.8 mmt180 -117.65 90.66 3.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.651 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -78.91 79.46 5.31 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.869 0.843 . . . . 0.0 110.97 -168.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.61 ' CE2' HG23 ' A' ' 173' ' ' THR . 17.4 p90 -112.13 79.97 1.28 Allowed 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 22.9 mtp85 -79.93 144.95 32.91 Favored 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 118.936 -2.352 . . . . 0.0 107.285 -176.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 82.3 p -78.65 138.22 38.21 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.083 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.407 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -151.91 149.78 21.55 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -70.62 128.44 15.25 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.76 1.64 . . . . 0.0 110.787 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 7.8 t -84.17 122.0 28.24 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.113 0.482 . . . . 0.0 109.824 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -107.07 149.03 28.03 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.758 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' THR . . . . . 0.495 ' HA ' ' HB3' ' A' ' 215' ' ' ARG . 17.7 p -102.44 -59.0 1.78 Allowed 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -173.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 p -121.95 117.83 53.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.673 -173.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 4.2 mt -124.28 120.73 60.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -170.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 63.9 p -117.32 -166.29 1.17 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.562 -1.199 . . . . 0.0 107.849 161.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -68.31 -5.59 19.48 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.692 0.678 . . . . 0.0 110.22 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -92.19 -75.83 0.47 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.099 -173.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 72.7 mtm -141.13 143.03 34.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.662 0.268 . . . . 0.0 110.725 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 8.5 m -90.37 -45.61 8.9 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.982 176.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -152.13 3.99 0.39 Allowed 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.253 165.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 92.99 -3.81 74.01 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.132 -175.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 74.31 6.58 4.65 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.277 0.631 . . . . 0.0 112.333 174.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.58 HD13 ' H ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -85.9 19.88 2.41 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.269 0.557 . . . . 0.0 110.957 177.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 15.2 t -102.96 142.83 33.4 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.662 -175.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -126.84 19.61 6.13 Favored Glycine 0 CA--C 1.504 -0.606 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.477 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -67.72 99.27 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 122.093 0.949 . . . . 0.0 109.05 173.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.99 123.1 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.097 174.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 22.9 t -154.33 -178.35 7.08 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.5 p -103.58 161.03 14.23 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 119.752 1.16 . . . . 0.0 108.811 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.435 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 45.4 tttm -59.82 -44.72 93.88 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.067 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.8 m -44.22 -56.2 4.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.931 172.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.443 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -53.77 -53.66 49.22 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.814 177.778 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 99.0 m -68.75 -22.92 64.28 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 45.0 m -96.1 -29.65 13.97 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.056 -178.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -74.08 -60.06 2.44 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 173.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.635 HG22 ' HA2' ' A' ' 234' ' ' GLY . 10.8 p -96.78 160.64 14.26 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.283 178.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 1.4 t 66.32 -41.98 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 118.784 -0.626 . . . . 0.0 111.922 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 62.32 46.75 93.24 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-N 119.155 0.889 . . . . 0.0 113.584 168.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.495 ' HB3' ' HA ' ' A' ' 188' ' ' THR . 0.9 OUTLIER -119.87 -92.47 0.54 Allowed 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.746 -178.22 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.4 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -167.67 166.88 13.69 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . 0.435 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 21.8 t90 -155.18 148.42 24.88 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 122.213 -0.305 . . . . 0.0 110.276 -174.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 221' ' ' CYS . . . 86.09 160.98 34.68 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.756 172.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.579 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 26.2 t60 -135.62 131.88 19.45 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . 0.579 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 51.6 Cg_exo -54.59 142.81 14.39 Favored 'Cis proline' 0 C--N 1.353 0.784 0 C-N-CA 123.896 -1.293 . . . . 0.0 112.282 -2.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 72.2 m -50.64 128.28 20.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.714 -172.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -116.19 121.71 42.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.818 175.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' MET . . . . . 0.4 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 5.1 ppp? -106.62 153.87 21.74 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.287 -171.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 97.8 m -135.07 135.47 22.99 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -173.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -56.99 166.91 3.53 Favored 'Trans proline' 0 CA--C 1.515 -0.447 0 C-N-CA 123.98 3.12 . . . . 0.0 114.111 167.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -39.01 111.59 0.19 Allowed 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.081 162.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 6.42 92.89 0.03 OUTLIER Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 110.137 -3.211 . . . . 0.0 114.162 177.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -58.07 -49.97 11.3 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.747 2.298 . . . . 0.0 113.256 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -49.72 134.58 19.9 Favored Pre-proline 0 CA--C 1.512 -0.488 0 C-N-CA 122.834 0.454 . . . . 0.0 110.521 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.49 45.29 1.93 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.006 1.804 . . . . 0.0 113.301 -172.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 48.8 m -127.7 -176.1 3.67 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.551 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 98.1 mtt180 -61.53 139.21 58.28 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 172.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -38.46 -42.74 0.77 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 177.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.635 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -77.48 9.28 29.18 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.033 -0.604 . . . . 0.0 114.018 -177.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . 0.585 ' HE2' ' N ' ' A' ' 267' ' ' GLY . 2.3 m-85 -121.53 147.5 45.71 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 122.044 0.926 . . . . 0.0 112.776 -172.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -123.23 130.37 24.58 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 113.667 -1.606 . . . . 0.0 108.851 173.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -58.42 112.42 1.17 Allowed 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.333 2.022 . . . . 0.0 111.564 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -51.47 138.88 21.12 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.359 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 23.6 mt -81.91 -6.03 9.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.034 -173.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -109.18 -55.45 2.41 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.452 0.644 . . . . 0.0 110.221 -177.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 47.6 p -90.45 -38.24 13.39 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.907 -176.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 96.79 6.53 58.14 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -176.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -89.11 124.54 34.42 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 122.015 0.912 . . . . 0.0 109.943 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 12.1 m -54.87 121.44 8.64 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.454 176.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -119.81 137.66 53.84 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.559 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 13.4 t70 -76.7 147.29 37.5 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.557 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.621 HG23 ' HG3' ' A' ' 249' ' ' GLU . 6.4 m -99.31 145.27 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.965 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.755 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -72.58 75.94 1.08 Allowed 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 167.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.621 ' HG3' HG23 ' A' ' 247' ' ' VAL . 21.3 mp0 -53.06 -34.62 57.31 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.746 0.784 . . . . 0.0 110.216 -170.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 11.9 m -48.39 -40.3 25.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.836 174.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -103.51 -41.5 5.97 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.856 0.836 . . . . 0.0 110.368 -175.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -66.76 -23.46 66.09 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.546 -1.207 . . . . 0.0 110.624 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.656 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.5 mp -127.54 78.57 74.59 Favored Pre-proline 0 N--CA 1.445 -0.679 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 172.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.32 112.26 0.7 Allowed 'Trans proline' 0 CA--C 1.507 -0.869 0 C-N-CA 124.112 3.208 . . . . 0.0 114.64 -164.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 59.09 35.12 82.61 Favored Glycine 0 C--N 1.307 -1.03 0 CA-C-N 113.233 -1.803 . . . . 0.0 113.811 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.656 ' HB3' HG22 ' A' ' 253' ' ' ILE . 2.2 pt? -63.99 -22.54 66.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 118.06 0.93 . . . . 0.0 110.593 177.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 14.5 t -78.01 4.51 12.03 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.152 0.501 . . . . 0.0 110.688 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 67.34 -86.84 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.809 0.844 . . . . 0.0 113.013 171.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -126.62 11.1 7.11 Favored Glycine 0 CA--C 1.507 -0.417 0 C-N-CA 120.207 -0.997 . . . . 0.0 112.279 -174.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -98.94 -173.92 31.8 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.314 175.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' ASN . . . . . 0.465 ' HB3' ' CG ' ' A' ' 272' ' ' LYS . 2.7 t-20 -107.0 116.99 32.88 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 176.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 269' ' ' PHE . 34.4 t -90.64 134.86 34.09 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 2.7 mp -127.48 112.13 27.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.609 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -74.56 123.52 24.95 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -172.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.4 t -110.74 160.04 17.08 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 155.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.559 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 4.1 m -76.42 128.4 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.886 0 C-N-CA 117.933 -1.507 . . . . 0.0 108.137 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.585 ' N ' ' HE2' ' A' ' 235' ' ' PHE . . . 112.57 -26.83 10.48 Favored Glycine 0 N--CA 1.432 -1.567 0 C-N-CA 119.904 -1.141 . . . . 0.0 111.338 -172.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 37.6 t 173.01 160.02 0.12 Allowed 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 121.112 0.482 . . . . 0.0 110.373 -172.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . 0.516 ' HB2' ' SG ' ' A' ' 262' ' ' CYS . 42.2 p90 -103.69 155.51 18.51 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 121.326 -0.859 . . . . 0.0 109.036 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -116.76 125.52 51.75 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 11.4 m -105.41 154.01 20.9 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.858 0.837 . . . . 0.0 112.203 -176.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.465 ' CG ' ' HB3' ' A' ' 261' ' ' ASN . 10.1 ptmm? -129.63 108.71 10.42 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.342 168.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 32.2 m -85.89 156.14 58.2 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.068 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . 0.491 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 71.8 Cg_exo -50.51 160.64 1.54 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.479 2.12 . . . . 0.0 112.351 173.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -58.25 136.49 57.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.903 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.08 -26.15 5.66 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' HIS . . . . . 0.491 ' HB2' ' O ' ' A' ' 274' ' ' PRO . 14.9 m-70 -79.43 176.78 9.38 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.18 0.514 . . . . 0.0 112.001 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -167.97 144.85 4.15 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.939 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 38.1 tp -91.66 137.99 31.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.033 0.444 . . . . 0.0 110.911 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -125.62 98.43 5.57 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.18 -19.38 61.51 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.629 0.581 . . . . 0.0 112.177 -172.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 79.7 t -58.07 -34.58 49.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.821 177.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 32.2 m -139.49 31.01 2.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.08 177.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . 0.502 ' HB3' ' O ' ' A' ' 256' ' ' LEU . 82.0 mm-40 30.82 44.87 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.299 -0.864 . . . . 0.0 113.111 -173.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -91.43 110.15 21.45 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.49 -175.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 44.8 t -100.3 68.04 1.39 Allowed 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.481 ' HA ' ' ND1' ' A' ' 277' ' ' HIS . 42.3 mt-10 . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.423 -0.798 . . . . 0.0 109.491 -173.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.446 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 46.4 m-85 . . . . . 0 N--CA 1.445 -0.682 0 CA-C-O 120.976 0.417 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 25.7 pt -136.34 -166.01 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.748 -177.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.81 179.92 53.1 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.955 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 30.7 p -74.21 -37.36 63.89 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 122.827 0.451 . . . . 0.0 112.205 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -97.46 6.29 48.41 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 35.3 m 63.23 23.78 14.01 Favored 'General case' 0 C--O 1.22 -0.493 0 O-C-N 123.785 0.678 . . . . 0.0 109.497 -171.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -94.8 1.5 65.78 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.307 -0.473 . . . . 0.0 113.564 -171.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.87 105.7 52.17 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 117.409 0.604 . . . . 0.0 109.402 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -79.69 151.34 22.02 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.756 2.304 . . . . 0.0 112.783 -179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 149' ' ' VAL . 13.3 p -87.95 104.23 14.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 122.325 1.06 . . . . 0.0 111.706 -173.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.53 90.84 5.71 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.548 170.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -52.83 -63.12 1.25 Allowed 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -173.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 4.2 m -84.19 7.34 19.32 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.568 0.699 . . . . 0.0 109.948 -168.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.47 131.71 0.08 OUTLIER Glycine 0 N--CA 1.432 -1.579 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.132 -168.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 72.4 m -66.54 154.6 39.95 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 114.447 -0.877 . . . . 0.0 110.364 176.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 34.5 mt -123.23 162.97 21.55 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.647 -169.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.62 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 2.2 t-20 48.55 38.07 10.4 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.422 -167.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 55.94 38.48 74.98 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.743 -174.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.18 -155.06 0.88 Allowed Glycine 0 C--N 1.32 -0.322 0 CA-C-N 115.216 -0.492 . . . . 0.0 112.086 -176.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -144.95 122.36 11.65 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.746 -0.381 . . . . 0.0 111.232 -171.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.42 111.29 5.86 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.403 173.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 165' ' ' ARG . 14.8 m -101.08 -42.92 10.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 O-C-N 121.94 -0.475 . . . . 0.0 110.092 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -134.17 173.34 5.93 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.446 ' HD3' ' CE1' ' A' ' 140' ' ' TYR . 54.7 Cg_exo -54.29 113.01 1.16 Allowed 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 122.492 2.128 . . . . 0.0 112.033 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 75.2 -10.16 1.27 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.636 0.775 . . . . 0.0 109.642 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.455 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.9 OUTLIER -86.47 82.21 8.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.371 179.007 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 84.4 m -87.48 137.16 32.57 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.684 0.754 . . . . 0.0 110.288 172.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.51 134.74 33.64 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.309 174.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 86.3 m -102.2 124.07 47.15 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.288 0.992 . . . . 0.0 111.655 -169.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.62 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 65.2 m -56.34 -53.92 51.59 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -172.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -151.91 -87.75 0.06 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 118.482 -1.287 . . . . 0.0 114.135 -170.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -93.96 39.09 2.98 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.943 -166.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 172' ' ' PHE . 1.7 m-85 -123.72 125.28 44.46 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 118.188 0.994 . . . . 0.0 111.795 174.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.5 t -87.04 163.73 16.87 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 166.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.91 127.84 2.06 Favored Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -175.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -75.22 15.94 0.74 Allowed 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 121.128 1.219 . . . . 0.0 113.274 -166.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -120.89 2.12 10.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.747 0.784 . . . . 0.0 110.325 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 42.65 48.0 4.66 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 114.299 -1.319 . . . . 0.0 113.854 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -107.66 -18.13 13.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.286 0.565 . . . . 0.0 110.169 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.417 ' O ' ' HB3' ' A' ' 180' ' ' ASP . 6.8 mmt180 -55.95 -73.66 0.06 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.582 -176.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.417 ' HB3' ' O ' ' A' ' 179' ' ' ARG . 27.1 t70 84.96 75.16 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.642 0 O-C-N 124.122 0.889 . . . . 0.0 110.176 168.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.457 ' CD2' ' O ' ' A' ' 181' ' ' TYR . 44.6 p90 -94.72 61.56 2.64 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 169.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 22.1 ptt-85 -51.75 126.36 17.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.439 175.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 42.5 p -79.97 137.73 36.92 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 120.857 0.36 . . . . 0.0 110.188 -173.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.551 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -162.8 159.3 31.66 Favored Glycine 0 C--N 1.323 -0.154 0 CA-C-O 119.365 -0.686 . . . . 0.0 111.505 -175.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.11 141.6 11.79 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.421 2.081 . . . . 0.0 111.977 174.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . 0.615 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 74.7 m -91.03 123.25 34.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.445 0.641 . . . . 0.0 111.294 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . 0.469 ' O ' ' HB2' ' A' ' 215' ' ' ARG . 19.1 m-85 -86.47 144.68 27.16 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.989 176.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 5.0 m -108.39 -18.24 13.8 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -163.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 7.5 p -170.75 118.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 121.614 -0.678 . . . . 0.0 110.272 176.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.4 mt -114.72 120.92 65.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -171.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 11.4 m -110.09 173.57 6.26 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 105.194 -2.151 . . . . 0.0 105.194 152.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -67.45 -6.26 18.58 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.639 1.109 . . . . 0.0 109.902 177.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -77.01 -74.44 0.24 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.284 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 92.7 mmm -132.2 133.46 44.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.789 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 56.0 m -83.15 -31.52 27.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.724 174.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 68.42 117.49 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.425 174.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 118.96 21.25 3.87 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.162 -172.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -75.93 3.94 9.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.474 0.654 . . . . 0.0 110.425 -178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.448 ' N ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -122.53 15.25 10.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.588 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 1.4 t -87.19 128.24 35.14 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.948 -173.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -105.13 14.37 48.3 Favored Glycine 0 CA--C 1.505 -0.534 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.011 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.449 ' CD1' ' HA ' ' A' ' 253' ' ' ILE . 2.1 tt -60.95 103.7 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 171.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.7 t -88.77 95.78 5.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 123.31 1.528 . . . . 0.0 108.09 171.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 19.3 m -137.64 177.33 7.95 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 111.458 -2.61 . . . . 0.0 106.875 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 26.8 p -100.88 161.02 13.89 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.674 -174.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.564 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 44.5 tttm -58.84 -42.83 90.23 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.884 173.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 56.8 m -44.4 -56.39 4.27 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 122.78 1.276 . . . . 0.0 109.594 175.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.608 HD11 HG11 ' A' ' 247' ' ' VAL . 10.8 tp -59.71 -49.68 76.79 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 112.379 -2.191 . . . . 0.0 112.043 -175.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 50.6 m -77.49 -17.62 57.84 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.224 0.535 . . . . 0.0 111.78 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 72.4 m -87.4 -27.21 22.9 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.985 -0.447 . . . . 0.0 110.022 172.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . 0.486 ' HB2' ' CE1' ' A' ' 229' ' ' HIS . . . -73.57 -56.57 4.85 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.816 0.817 . . . . 0.0 109.296 175.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.535 ' CG2' ' HA2' ' A' ' 234' ' ' GLY . 25.5 p -106.02 149.93 26.21 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.488 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.0 t 69.14 -42.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 O-C-N 123.948 0.78 . . . . 0.0 111.628 -174.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 56.75 64.29 4.54 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 119.401 1.0 . . . . 0.0 114.842 171.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 187' ' ' PHE . 21.4 mmt85 -130.41 -80.23 0.54 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 117.707 0.753 . . . . 0.0 110.532 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -169.35 169.73 8.87 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . 0.615 ' HD1' ' SG ' ' A' ' 186' ' ' CYS . 16.0 t90 -157.8 147.4 20.01 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 89.47 169.46 44.12 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 170.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -128.04 131.38 23.76 Favored Pre-proline 0 C--N 1.341 0.237 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.456 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.99 159.94 66.32 Favored 'Cis proline' 0 C--N 1.348 0.524 0 C-N-CA 123.569 -1.429 . . . . 0.0 111.149 -4.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 63.5 m -45.17 121.33 2.82 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 123.563 0.539 . . . . 0.0 111.982 -176.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -107.94 114.51 28.48 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 172.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 47.0 ttp -83.55 129.87 34.98 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.238 0.542 . . . . 0.0 110.244 -170.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 63.9 m -77.27 129.15 78.72 Favored Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -171.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -64.75 173.41 5.69 Favored 'Trans proline' 0 C--N 1.329 -0.458 0 C-N-CA 123.806 3.004 . . . . 0.0 111.208 164.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -43.64 -54.15 5.22 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -169.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -164.22 28.67 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.809 0 CA-C-O 118.765 -0.636 . . . . 0.0 112.266 -176.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -19.63 63.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.237 1 C-N-CA 125.664 4.243 . . . . 0.0 116.77 -155.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . 0.486 ' CE1' ' HB2' ' A' ' 211' ' ' ALA . 28.3 m80 -135.76 155.44 78.05 Favored Pre-proline 0 C--N 1.324 -0.521 0 O-C-N 121.982 -0.449 . . . . 0.0 110.469 -178.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -92.47 35.48 0.24 Allowed 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.35 2.033 . . . . 0.0 110.587 165.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 9.9 t -162.77 -167.36 1.52 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.636 -176.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.513 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 88.9 mtt180 -67.12 149.53 50.41 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -174.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 34.9 mmm-85 -35.11 -64.1 0.29 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.868 0.867 . . . . 0.0 112.921 175.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.535 ' HA2' ' CG2' ' A' ' 212' ' ' THR . . . -82.96 16.04 29.47 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.424 -0.894 . . . . 0.0 114.35 -168.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . 0.513 ' CD1' ' HB2' ' A' ' 232' ' ' ARG . 7.0 m-85 -119.96 137.98 53.73 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 121.847 0.832 . . . . 0.0 112.063 -173.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.79 141.74 34.54 Favored Pre-proline 0 C--N 1.311 -1.107 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 175.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.68 124.0 10.69 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.534 2.156 . . . . 0.0 112.473 -176.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -55.26 139.78 41.33 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.563 171.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 34.2 mt -77.29 -16.53 14.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.089 -173.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -101.13 -61.26 1.39 Allowed 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.775 -175.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 40.7 p -82.09 -38.95 24.09 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.377 -176.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 94.11 5.89 62.05 Favored Glycine 0 N--CA 1.437 -1.296 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.062 -176.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -78.23 139.88 38.91 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 121.79 0.805 . . . . 0.0 110.919 -178.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 63.7 m -62.64 122.41 15.76 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.743 -1.571 . . . . 0.0 110.146 174.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -122.7 133.16 54.51 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 176.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.504 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 1.8 t70 -75.54 151.57 37.9 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.608 HG11 HD11 ' A' ' 208' ' ' LEU . 8.6 m -97.02 145.25 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.451 -177.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -75.75 76.46 2.71 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 169.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.592 ' HG3' HG23 ' A' ' 247' ' ' VAL . 34.1 mp0 -54.11 -33.36 57.54 Favored 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 123.98 0.8 . . . . 0.0 110.359 -169.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 35.1 m -51.1 -42.67 60.79 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.812 174.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -96.58 -34.81 11.3 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.768 0.794 . . . . 0.0 110.268 -177.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -73.13 -20.03 61.01 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.482 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.594 ' O ' ' HG ' ' A' ' 256' ' ' LEU . 5.2 mp -140.54 81.46 17.32 Favored Pre-proline 0 N--CA 1.451 -0.376 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -71.37 31.53 0.24 Allowed 'Trans proline' 0 CA--C 1.515 -0.474 0 C-N-CA 123.373 2.716 . . . . 0.0 113.025 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 253' ' ' ILE . . . -123.39 2.39 9.59 Favored Glycine 0 C--N 1.288 -2.119 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.484 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 253' ' ' ILE . 23.2 mt -65.75 -147.17 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 175.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 284' ' ' GLN . 76.1 m -38.55 128.16 1.46 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.394 0.677 . . . . 0.0 112.698 -174.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -79.73 68.77 5.89 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.998 -174.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 107.24 171.35 22.27 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.914 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 85.66 -154.73 28.56 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.203 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -109.64 138.68 45.65 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 50.2 t -122.48 138.57 54.51 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 173.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 20.9 mt -131.26 164.9 33.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 -174.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.29 125.36 32.61 Favored 'General case' 0 CA--C 1.497 -1.062 0 C-N-CA 117.53 -1.668 . . . . 0.0 114.038 -175.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.0 t -109.26 163.87 12.98 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 122.333 1.063 . . . . 0.0 110.072 166.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.424 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 35.7 m -73.23 127.5 35.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 98.45 -12.63 63.19 Favored Glycine 0 C--N 1.311 -0.848 0 C-N-CA 119.523 -1.322 . . . . 0.0 111.999 -176.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 10.5 t 176.44 162.51 0.39 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.112 1.456 . . . . 0.0 110.858 -177.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . 0.421 ' CZ ' HD13 ' A' ' 256' ' ' LEU . 46.0 p90 -107.26 162.59 13.76 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.233 -0.917 . . . . 0.0 109.56 177.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -116.75 156.55 26.98 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.81 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 56.8 m -136.68 158.54 44.2 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.576 0.703 . . . . 0.0 112.338 172.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -139.68 130.13 25.55 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.141 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 19.6 m -122.12 173.03 4.47 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.992 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.21 155.07 25.77 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.862 1.708 . . . . 0.0 110.141 167.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -58.04 156.94 8.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.139 0.495 . . . . 0.0 111.376 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 86.51 -36.97 3.17 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.255 -176.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' HIS . . . . . 0.572 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 18.1 m-70 -69.63 153.41 43.47 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.08 0.466 . . . . 0.0 111.639 -177.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 54.7 mttp -144.96 139.44 27.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.487 -175.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 45.9 tp -76.07 140.93 42.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.396 0.617 . . . . 0.0 111.85 -175.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -127.07 102.54 7.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.903 173.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -57.8 -27.98 63.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.292 -175.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 66.4 t -56.3 -33.4 37.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.133 0.492 . . . . 0.0 111.513 -175.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 8.3 p -137.83 28.21 2.66 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.015 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 257' ' ' CYS . 0.9 OUTLIER 35.16 43.87 0.13 Allowed 'General case' 0 C--N 1.349 0.584 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.662 -169.602 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -94.64 166.15 12.16 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -172.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' CYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 12.4 t -156.93 106.06 2.21 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.596 -178.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 37.4 tt0 . . . . . 0 C--N 1.315 -0.901 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 . . . . . 0 CA--C 1.517 -0.315 0 CA-C-O 121.016 0.436 . . . . 0.0 111.545 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 34.0 pt -129.87 176.8 7.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.592 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.73 165.73 31.83 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.187 -176.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 40.3 p -64.98 -36.93 85.99 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -106.25 16.1 25.31 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.037 0.446 . . . . 0.0 110.264 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 60.3 m 55.98 36.82 28.04 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.131 173.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -94.25 -2.24 64.13 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.793 -175.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.88 113.67 60.87 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 117.752 0.776 . . . . 0.0 110.804 -176.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.89 143.87 23.72 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.96 2.44 . . . . 0.0 112.507 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.3 p -78.07 110.47 13.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.867 0.842 . . . . 0.0 111.953 -175.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.64 76.73 7.51 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.37 172.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -58.36 -62.61 1.72 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -170.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.3 m -86.36 8.87 19.81 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.586 0.708 . . . . 0.0 109.815 -170.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 74.7 131.78 0.25 Allowed Glycine 0 N--CA 1.428 -1.881 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.149 -172.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 77.3 m -71.86 157.75 37.31 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 175.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 55.6 mt -129.03 165.26 21.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.907 -170.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.699 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 2.3 t-20 49.53 30.97 3.76 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.837 0.711 . . . . 0.0 111.229 -168.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.68 37.25 82.56 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.219 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -73.65 -145.94 0.88 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.414 -0.422 . . . . 0.0 112.958 -175.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 166' ' ' CYS . 21.5 tpt180 -148.37 121.97 9.19 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.881 -174.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -72.96 108.34 5.83 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.41 173.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 165' ' ' ARG . 4.4 m -94.46 -37.25 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.392 -177.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -133.58 177.85 2.05 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 168.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -50.2 107.04 0.14 Allowed 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.383 2.055 . . . . 0.0 113.608 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 64.49 6.61 3.21 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.165 0.986 . . . . 0.0 110.517 -178.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.479 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -92.33 75.53 5.27 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.722 177.106 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 61.4 m -84.34 146.98 27.43 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.188 0.518 . . . . 0.0 110.334 176.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -98.07 144.5 27.5 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 57.7 m -102.96 122.88 45.5 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 124.449 1.093 . . . . 0.0 112.007 -166.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.699 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 93.7 m -61.24 -55.44 31.96 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.423 ' CG ' ' N ' ' A' ' 171' ' ' GLY . 79.6 t80 -132.2 -116.48 0.22 Allowed 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.269 -0.972 . . . . 0.0 112.277 -168.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.423 ' N ' ' CG ' ' A' ' 170' ' ' TYR . . . -87.63 55.51 4.43 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.742 -166.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.573 ' CD1' ' N ' ' A' ' 172' ' ' PHE . 2.1 m-85 -123.99 122.17 37.21 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.273 171.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.412 ' O ' ' HG2' ' A' ' 179' ' ' ARG . 3.1 t -86.36 163.65 17.52 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 166.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 84.75 125.19 1.33 Allowed Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 -176.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.56 19.86 0.53 Allowed 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 121.471 1.447 . . . . 0.0 114.033 -165.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -122.95 3.82 9.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.813 0.816 . . . . 0.0 109.682 175.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 39.06 51.79 1.97 Allowed 'General case' 0 C--N 1.346 0.444 0 CA-C-N 114.141 -1.391 . . . . 0.0 114.537 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -106.82 -16.62 14.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.283 0.563 . . . . 0.0 109.854 174.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 173' ' ' THR . 19.7 mmm180 -56.62 -70.38 0.12 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.809 -174.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 41.1 t0 77.02 69.6 0.06 Allowed 'General case' 0 CA--C 1.502 -0.866 0 CA-C-O 121.907 0.86 . . . . 0.0 109.519 166.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.444 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 38.6 p90 -86.13 65.85 9.29 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-O 122.741 1.258 . . . . 0.0 107.856 173.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -45.89 123.42 4.47 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.657 -1.61 . . . . 0.0 109.26 172.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 80.9 p -76.7 137.39 39.35 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -147.98 143.7 11.46 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -173.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.76 128.64 12.69 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.205 1.936 . . . . 0.0 111.337 174.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . 0.609 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 92.4 m -84.23 119.01 24.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.417 0.627 . . . . 0.0 110.947 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . 0.474 ' HB3' ' O ' ' A' ' 195' ' ' CYS . 69.1 m-85 -95.34 144.75 25.63 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.958 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' THR . . . . . 0.427 ' O ' ' HD2' ' A' ' 215' ' ' ARG . 20.2 p -108.98 -6.04 15.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -167.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.5 p -167.28 116.17 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.502 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.422 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.1 mt -133.86 127.07 51.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -170.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.9 m -128.33 -166.08 1.58 Allowed 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 160.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -63.04 -5.99 3.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 118.943 0.792 . . . . 0.0 110.453 173.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -76.95 -72.75 0.33 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.293 -177.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.418 ' SD ' ' HA2' ' A' ' 197' ' ' GLY . 13.6 ttt -149.96 160.09 43.88 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -173.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 187' ' ' PHE . 61.4 m -90.15 -32.17 16.76 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.167 0.508 . . . . 0.0 111.669 -176.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -148.09 -74.74 0.19 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.463 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.418 ' HA2' ' SD ' ' A' ' 194' ' ' MET . . . 125.78 -29.34 4.71 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -95.68 -24.2 16.65 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 119.845 -0.122 . . . . 0.0 111.206 173.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 58.57 79.81 0.2 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.266 0.555 . . . . 0.0 111.258 177.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 44.2 t -100.27 144.88 28.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.482 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -92.11 29.29 7.69 Favored Glycine 0 CA--C 1.499 -0.951 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 175.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.421 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -60.98 106.64 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 121.783 0.801 . . . . 0.0 108.843 173.107 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.0 t -94.69 123.9 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.816 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 16.7 t -155.24 -178.15 7.05 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.4 p -101.66 159.29 15.44 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 120.434 1.47 . . . . 0.0 109.311 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.436 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 42.2 tttm -56.11 -44.97 79.62 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 120.284 -0.567 . . . . 0.0 109.885 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.5 m -43.87 -56.81 3.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.371 173.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.58 -55.09 36.04 Favored 'General case' 0 CA--C 1.518 -0.261 0 O-C-N 123.755 0.659 . . . . 0.0 112.036 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 53.8 m -75.39 -18.7 59.88 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -171.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 79.9 m -89.67 -39.46 13.18 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 121.74 -0.6 . . . . 0.0 111.28 174.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -67.8 -57.0 7.04 Favored 'General case' 0 C--N 1.345 0.383 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.538 HG22 ' HA2' ' A' ' 234' ' ' GLY . 18.8 p -94.08 157.45 16.08 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.346 174.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.1 t 68.42 -46.73 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 176.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 60.05 59.51 10.3 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 120.737 -0.744 . . . . 0.0 114.638 170.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.427 ' HD2' ' O ' ' A' ' 188' ' ' THR . 30.1 mmt180 -124.85 -84.95 0.64 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 117.525 0.663 . . . . 0.0 110.466 177.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -169.32 165.75 10.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . 0.609 ' HD1' ' SG ' ' A' ' 186' ' ' CYS . 18.5 t90 -153.39 148.4 26.66 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.552 0.215 . . . . 0.0 110.656 -175.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 78.37 163.23 22.47 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 115.086 0.795 . . . . 0.0 115.086 167.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.427 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 6.6 m80 -116.09 132.22 23.36 Favored Pre-proline 0 N--CA 1.453 -0.294 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 168.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . 0.427 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 25.4 Cg_exo -63.3 151.28 69.42 Favored 'Cis proline' 0 C--O 1.232 0.18 0 C-N-CA 123.593 -1.419 . . . . 0.0 111.516 -2.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 84.9 m -54.99 120.19 6.53 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 124.175 0.922 . . . . 0.0 111.15 -175.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -115.85 121.41 42.3 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.89 150.23 23.05 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.604 -172.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 74.1 m -143.35 148.46 44.28 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 120.799 0.333 . . . . 0.0 111.687 -175.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -63.27 168.38 11.13 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.546 2.164 . . . . 0.0 109.94 155.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.8 -118.71 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.997 0.427 . . . . 0.0 110.971 171.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.07 108.52 1.26 Allowed Pre-proline 0 C--N 1.322 -0.623 0 CA-C-O 121.179 0.514 . . . . 0.0 111.91 -174.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.91 -49.53 0.15 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.214 1.943 . . . . 0.0 112.667 -175.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -94.36 178.99 1.32 Allowed Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -63.49 -7.5 12.63 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.0 1.134 . . . . 0.0 112.108 173.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 20.0 t -65.4 144.61 56.96 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.591 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 31.4 mmt180 -75.07 142.77 43.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.361 -174.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.414 ' HG3' ' N ' ' A' ' 234' ' ' GLY . 28.0 ptt-85 -37.78 -53.57 1.27 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.496 1.123 . . . . 0.0 113.06 -177.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.538 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -71.15 0.36 31.62 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.22 -0.514 . . . . 0.0 114.224 -172.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . 0.7 ' CE2' ' HA2' ' A' ' 267' ' ' GLY . 1.8 m-85 -123.1 166.67 14.78 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 118.352 1.076 . . . . 0.0 111.843 -175.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.54 128.0 22.47 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 113.623 -1.626 . . . . 0.0 107.59 169.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -61.03 117.61 4.4 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.321 2.014 . . . . 0.0 112.075 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -55.96 134.69 52.41 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.114 177.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 39.0 mt -73.98 -11.21 14.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.607 175.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -98.04 -58.1 2.06 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.296 -175.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 31.3 p -93.05 -43.8 8.71 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.777 -177.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 102.01 7.36 47.24 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -178.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -94.14 128.73 40.73 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.959 0.885 . . . . 0.0 109.797 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 86.6 m -51.32 117.92 2.93 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.167 -1.833 . . . . 0.0 109.867 169.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -121.24 131.24 54.11 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.482 ' HB3' HG13 ' A' ' 266' ' ' VAL . 4.3 t70 -79.14 150.34 31.77 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 121.297 0.57 . . . . 0.0 110.384 -170.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.583 HG23 ' HG3' ' A' ' 249' ' ' GLU . 8.9 m -100.79 145.39 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.948 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.552 -178.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.24 76.85 1.82 Allowed 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 167.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.583 ' HG3' HG23 ' A' ' 247' ' ' VAL . 55.4 mp0 -52.76 -35.07 55.67 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 123.722 0.639 . . . . 0.0 110.66 -170.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 32.3 m -53.88 -29.16 40.36 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.205 175.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -106.67 -47.44 3.75 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.633 0.73 . . . . 0.0 110.309 -175.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -63.15 -25.57 68.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.612 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.591 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.7 mp -122.65 79.96 47.97 Favored Pre-proline 0 C--O 1.243 0.726 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 173.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.27 118.79 4.65 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.489 2.793 . . . . 0.0 114.649 -165.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 59.11 30.83 67.68 Favored Glycine 0 C--N 1.317 -0.518 0 CA-C-N 113.839 -1.528 . . . . 0.0 114.103 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.591 ' HB3' HG22 ' A' ' 253' ' ' ILE . 1.3 pt? -68.27 -25.79 65.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.565 0.683 . . . . 0.0 111.44 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 48.2 t -102.66 82.39 2.13 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.581 0.705 . . . . 0.0 110.081 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -85.07 116.31 23.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.1 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 165.55 -41.25 0.28 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -170.63 -116.6 0.39 Allowed Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.502 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -98.78 157.56 16.21 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -175.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 32.6 t -140.45 133.61 29.55 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 28.4 mt -138.13 116.72 13.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.022 0.439 . . . . 0.0 110.54 -169.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -77.1 121.29 23.38 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.655 -174.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 8.4 t -106.3 160.9 15.02 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.661 157.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.663 HG12 ' CE1' ' A' ' 235' ' ' PHE . 1.7 t -72.39 119.52 19.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.7 ' HA2' ' CE2' ' A' ' 235' ' ' PHE . . . 113.71 -22.33 14.95 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.376 -174.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 15.6 t 174.21 163.65 0.2 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.566 0.698 . . . . 0.0 111.103 -173.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -111.48 153.53 26.03 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.231 -0.988 . . . . 0.0 108.759 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -111.64 135.85 51.67 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.444 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 64.7 m -109.48 160.33 16.3 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.656 -0.817 . . . . 0.0 111.142 178.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -135.35 95.38 3.27 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.47 176.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 13.7 m -76.05 161.29 75.98 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.161 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -61.66 159.55 32.13 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 121.907 1.738 . . . . 0.0 109.968 170.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -57.76 145.73 33.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.515 0.197 . . . . 0.0 111.059 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.86 -28.9 3.89 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.13 -177.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' HIS . . . . . 0.605 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 17.1 m-70 -78.68 166.37 22.58 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 120.833 0.349 . . . . 0.0 111.228 -177.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -137.82 138.76 39.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.147 -176.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.517 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 51.4 tp -80.01 123.7 28.06 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.819 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -113.85 110.25 19.82 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -64.25 -14.96 58.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.717 -170.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 63.7 t -56.51 -38.84 58.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.908 0.385 . . . . 0.0 110.978 178.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 42.6 m -146.02 36.22 1.03 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.644 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 34.49 48.32 0.28 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.41 0.684 . . . . 0.0 111.853 -170.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 84.8 tttt -82.68 154.9 24.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.583 -172.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 23.2 m -141.02 85.75 2.0 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.605 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 19.0 mm-40 . . . . . 0 C--O 1.239 0.54 0 CA-C-O 118.392 -0.813 . . . . 0.0 108.904 -173.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -149.13 148.89 30.19 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.6 t -150.05 140.79 22.67 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.802 0.334 . . . . 0.0 110.487 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -92.38 -2.94 56.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.448 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.1 m -67.93 138.69 56.18 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.327 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.9 mm -82.32 114.75 23.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.975 0.417 . . . . 0.0 110.0 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -88.14 47.51 1.51 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.572 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -166.47 -153.78 0.17 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 -178.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 28.2 p -76.46 -171.37 1.79 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -121.38 -39.64 2.65 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.924 0.392 . . . . 0.0 110.908 175.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.538 HD12 ' O ' ' A' ' 132' ' ' ASP . 0.3 OUTLIER -69.97 -169.89 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.051 -178.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -120.65 139.57 52.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.041 -176.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 10.2 m -117.17 134.83 54.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.38 0.609 . . . . 0.0 112.033 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 5.1 mpp? -138.41 166.22 24.81 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 173.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' A' ' 137' ' ' GLN . 17.3 m120 64.41 54.93 1.45 Allowed 'General case' 0 N--CA 1.463 0.202 0 O-C-N 123.313 0.383 . . . . 0.0 111.493 173.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 65.81 21.33 69.26 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.341 174.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -89.41 136.0 13.3 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.076 -0.583 . . . . 0.0 113.633 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.9 m -90.25 126.55 35.87 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 173.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 10.6 t -90.67 91.0 8.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.896 -173.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 10.7 t -142.49 151.87 42.12 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.641 -0.662 . . . . 0.0 110.944 -175.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.425 ' O ' ' HB3' ' A' ' 132' ' ' ASP . 35.6 t0 77.66 -44.23 0.42 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 124.642 1.214 . . . . 0.0 112.879 170.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.538 ' O ' HD12 ' A' ' 121' ' ' ILE . 3.2 p30 156.53 -39.63 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 123.814 0.846 . . . . 0.0 110.228 -174.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.95 156.13 19.55 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.163 175.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . 0.447 ' HB3' ' SG ' ' A' ' 145' ' ' CYS . 8.6 t -76.47 137.61 39.78 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.949 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 74.3 mt -89.48 96.61 10.78 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 176.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 61.4 m -62.62 145.91 53.34 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.29 -1.323 . . . . 0.0 113.22 -167.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.441 ' HB2' ' O ' ' A' ' 125' ' ' ASN . 32.7 tt0 -59.43 159.93 7.47 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.284 169.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -63.23 114.49 3.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.009 0.909 . . . . 0.0 111.695 -177.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 95.17 14.32 48.96 Favored Glycine 0 C--N 1.301 -1.381 0 CA-C-N 112.922 -1.945 . . . . 0.0 112.126 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.527 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 44.6 m-85 -115.55 146.97 41.25 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.572 174.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 20.4 pt -134.96 177.46 6.8 Favored 'Isoleucine or valine' 0 C--O 1.246 0.876 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.498 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.13 174.03 30.22 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.936 -175.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.7 p -70.79 -48.22 55.41 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 120.753 0.311 . . . . 0.0 110.948 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -96.54 5.87 49.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.949 176.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 134' ' ' CYS . 61.8 m 63.86 42.1 6.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.903 172.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.72 9.18 56.85 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.792 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.13 113.63 43.71 Favored Pre-proline 0 C--O 1.222 -0.384 0 CA-C-N 117.645 0.723 . . . . 0.0 110.125 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.75 143.82 13.51 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.639 2.226 . . . . 0.0 112.612 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 12.7 p -71.08 112.84 6.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.655 -176.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.8 m -81.44 74.63 8.43 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.177 175.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -51.58 -64.33 0.85 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -173.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.6 m -91.9 13.33 18.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.47 0.652 . . . . 0.0 110.717 -169.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 74.13 131.96 0.23 Allowed Glycine 0 N--CA 1.436 -1.347 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.661 -177.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . 0.57 ' O ' HD23 ' A' ' 155' ' ' LEU . 1.7 m -61.49 156.9 18.3 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 113.942 -1.129 . . . . 0.0 109.858 171.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 154' ' ' CYS . 41.2 mt -137.93 178.1 7.37 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -174.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.479 HD22 ' C ' ' A' ' 155' ' ' LEU . 0.1 OUTLIER 35.43 31.25 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.979 1.312 . . . . 0.0 114.446 -178.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 63.31 35.54 92.2 Favored Glycine 0 N--CA 1.454 -0.132 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.593 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -79.24 -147.66 4.1 Favored Glycine 0 C--N 1.328 0.104 0 C-N-CA 121.286 -0.483 . . . . 0.0 113.442 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -157.93 126.44 5.53 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.251 -0.558 . . . . 0.0 110.624 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . 0.408 ' SG ' ' SG ' ' A' ' 154' ' ' CYS . 4.9 m -64.18 124.56 21.98 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 122.241 0.216 . . . . 0.0 110.942 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.64 HG22 ' HG2' ' A' ' 165' ' ' ARG . 1.3 m -116.31 -35.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.913 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' A' ' 165' ' ' ARG . . . -139.28 169.62 11.93 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.527 ' HD3' ' CE1' ' A' ' 140' ' ' TYR . 78.4 Cg_exo -51.16 107.14 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.316 2.01 . . . . 0.0 112.604 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 75.28 -11.35 1.1 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.471 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.64 ' HG2' HG22 ' A' ' 161' ' ' VAL . 18.3 ttp180 -83.45 90.74 7.24 Favored 'General case' 0 CA--C 1.488 -1.425 0 CA-C-O 121.652 0.739 . . . . 0.0 109.312 175.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.61 145.04 28.23 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.648 167.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -92.38 129.23 38.37 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 35.7 m -106.6 132.53 52.49 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.267 0.979 . . . . 0.0 111.925 -167.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 52.6 m -57.07 -55.5 33.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 113.331 -1.759 . . . . 0.0 114.501 -167.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 17.1 t80 177.75 125.89 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.692 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 79.98 28.95 48.45 Favored Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.42 169.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 172' ' ' PHE . 1.4 m-85 -118.34 121.25 39.92 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 118.797 -1.161 . . . . 0.0 110.502 166.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.417 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 4.3 t -89.23 140.11 29.81 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 96.45 128.59 5.81 Favored Glycine 0 N--CA 1.425 -2.038 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -171.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.18 9.76 0.81 Allowed 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.413 1.409 . . . . 0.0 113.229 -168.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.497 ' O ' HD12 ' A' ' 155' ' ' LEU . 41.3 tt0 -117.79 19.79 13.64 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.378 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.432 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.6 OUTLIER 24.31 59.54 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 117.228 2.307 . . . . 0.0 117.228 178.077 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -115.47 21.0 14.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.395 1.093 . . . . 0.0 109.028 168.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 20.6 mmt180 -113.3 81.53 1.52 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.658 -1.61 . . . . 0.0 107.603 175.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.509 ' HA ' ' CE2' ' A' ' 172' ' ' PHE . 2.3 m-20 -80.5 49.6 1.18 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.52 -167.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.496 ' CG ' ' O ' ' A' ' 181' ' ' TYR . 20.4 p90 -86.32 98.64 11.08 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -87.27 155.14 20.19 Favored 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 118.296 -2.753 . . . . 0.0 106.763 175.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 19.8 p -86.06 135.45 33.62 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.049 -1.06 . . . . 0.0 109.618 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -153.64 155.09 25.94 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -73.77 129.25 13.29 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.16 1.907 . . . . 0.0 110.809 173.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 10.6 t -82.43 114.21 20.72 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . 0.426 ' O ' ' HB2' ' A' ' 215' ' ' ARG . 59.3 m-85 -94.29 138.93 31.71 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.773 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.464 ' O ' ' HD2' ' A' ' 215' ' ' ARG . 89.2 m -107.8 -19.76 13.43 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -163.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 25.4 t -150.47 115.62 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 121.467 -0.771 . . . . 0.0 109.613 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.613 ' CG1' ' HA ' ' A' ' 195' ' ' CYS . 16.5 mt -130.88 120.16 46.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 10.7 p -117.08 -166.5 1.18 Allowed 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 155.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -66.75 -5.29 11.48 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.841 0.829 . . . . 0.0 109.764 172.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -83.76 -73.79 0.4 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.224 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 60.7 mtt -128.38 161.18 30.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.443 0.163 . . . . 0.0 110.966 -175.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.613 ' HA ' ' CG1' ' A' ' 190' ' ' ILE . 84.5 m -92.03 -25.55 18.76 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.572 173.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -161.27 -58.7 0.05 Allowed 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 169.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 125.78 -26.05 5.46 Favored Glycine 0 C--N 1.317 -0.48 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.619 170.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -118.13 -0.11 11.66 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 117.159 0.48 . . . . 0.0 111.294 176.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 62.75 175.48 0.15 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.83 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 22.8 t 176.14 130.3 0.04 OUTLIER 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.543 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -84.23 36.32 2.92 Favored Glycine 0 CA--C 1.509 -0.343 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 174.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.97 104.3 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 122.331 1.062 . . . . 0.0 109.412 175.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 37.9 t -93.05 124.1 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 CA-C-N 113.841 -1.527 . . . . 0.0 109.631 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 20.2 t -154.64 -177.3 6.39 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 104.292 -2.484 . . . . 0.0 104.292 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 14.3 p -99.36 157.28 16.52 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 120.317 1.417 . . . . 0.0 109.014 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.597 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 36.5 tttm -56.61 -44.37 81.06 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 120.201 -0.599 . . . . 0.0 109.788 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.2 m -43.58 -54.87 4.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.892 174.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.14 -53.07 60.62 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 124.05 0.844 . . . . 0.0 111.322 177.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 94.6 m -63.69 -26.62 68.75 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -176.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 226' ' ' ALA . 60.9 m -85.79 -47.49 9.68 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 118.481 0.582 . . . . 0.0 110.008 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -67.23 -54.44 21.0 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -173.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.56 HG22 ' HA2' ' A' ' 234' ' ' GLY . 16.2 p -102.8 152.86 20.76 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.851 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER 66.12 -40.5 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.336 0.654 . . . . 0.0 112.14 -176.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 61.01 59.06 10.75 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 119.134 0.879 . . . . 0.0 114.785 169.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.464 ' HD2' ' O ' ' A' ' 188' ' ' THR . 8.6 mmt85 -128.64 -90.12 0.5 Allowed 'General case' 0 C--O 1.245 0.827 0 CA-C-N 117.845 0.822 . . . . 0.0 111.847 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.472 ' CB ' HD12 ' A' ' 190' ' ' ILE . . . -165.93 168.46 15.74 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . 0.597 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 11.2 t90 -164.96 150.15 9.53 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 95.84 -174.06 31.29 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.305 -0.95 . . . . 0.0 114.245 168.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -137.09 133.55 18.57 Favored Pre-proline 0 N--CA 1.444 -0.729 0 CA-C-O 121.248 0.547 . . . . 0.0 111.163 -175.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -86.11 117.05 4.09 Favored 'Cis proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.408 -1.913 . . . . 0.0 112.233 -5.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 70.3 m 33.23 94.57 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.768 1.227 . . . . 0.0 113.781 177.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 36.3 mt-10 -101.17 113.63 26.84 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.76 139.5 35.34 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.779 0.323 . . . . 0.0 111.253 -170.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 5.9 p -145.62 155.98 52.74 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.926 -175.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.64 166.89 14.53 Favored 'Trans proline' 0 CA--C 1.504 -1.025 0 C-N-CA 122.27 1.98 . . . . 0.0 111.339 167.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 210' ' ' CYS . . . -63.75 -122.98 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 O-C-N 123.969 0.793 . . . . 0.0 111.794 171.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.68 108.97 1.22 Allowed Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.533 -173.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -80.58 -57.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.71 2.273 . . . . 0.0 113.168 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -84.15 153.56 63.01 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.12 64.75 8.39 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.415 2.077 . . . . 0.0 112.543 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 80.6 m -119.48 -103.85 0.4 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 172.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.529 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 59.5 mtt180 -145.45 134.43 22.57 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 172.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -39.85 -41.97 1.23 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.56 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -73.45 9.7 7.44 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.417 -0.897 . . . . 0.0 113.882 -176.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . 0.529 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 6.1 m-85 -124.05 146.97 48.22 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 122.099 0.952 . . . . 0.0 112.595 -171.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -122.6 129.02 25.2 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 114.009 -1.451 . . . . 0.0 108.432 171.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -62.04 113.39 1.85 Allowed 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.097 1.865 . . . . 0.0 111.202 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -48.48 128.67 15.16 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.512 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 26.9 pt -75.75 4.18 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.587 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -110.97 -56.73 2.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.008 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 36.0 p -94.42 -37.53 11.39 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.01 -176.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 100.93 0.17 55.06 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.175 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -81.62 129.94 34.87 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.784 0.802 . . . . 0.0 110.578 -176.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 2.2 m -61.44 115.05 3.58 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 113.816 -1.538 . . . . 0.0 109.371 173.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 45.4 tt0 -119.57 139.74 51.66 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.187 -177.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.577 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 20.0 t70 -77.24 145.43 37.55 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -177.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.543 HG23 ' HG3' ' A' ' 249' ' ' GLU . 15.1 m -100.15 145.26 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.411 ' OD2' ' HB2' ' A' ' 250' ' ' CYS . 10.4 t70 -73.63 80.51 1.51 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 165.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.543 ' HG3' HG23 ' A' ' 247' ' ' VAL . 36.8 mp0 -51.63 -34.85 39.56 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.175 0.512 . . . . 0.0 110.334 -174.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.411 ' HB2' ' OD2' ' A' ' 248' ' ' ASP . 62.8 m -52.58 -44.22 65.78 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.501 173.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -90.16 -32.09 16.78 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.68 0.752 . . . . 0.0 110.401 -173.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.1 -17.43 31.04 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.942 -170.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.599 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.1 mp -125.55 79.93 66.71 Favored Pre-proline 0 C--O 1.239 0.551 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -39.41 114.23 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 124.446 3.431 . . . . 0.0 115.48 -172.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 57.74 34.37 70.43 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 113.637 -1.619 . . . . 0.0 114.174 174.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.599 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.9 OUTLIER -73.54 -24.51 60.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 118.16 0.98 . . . . 0.0 110.905 177.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 50.5 t -90.49 114.69 26.93 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -103.77 83.36 2.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.267 0.556 . . . . 0.0 110.609 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -158.9 -105.49 0.21 Allowed Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.185 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -124.29 -88.33 0.8 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.525 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 272' ' ' LYS . 10.2 m120 -94.84 157.65 15.83 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 11.8 t -137.85 126.12 23.14 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 173.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 41.0 mt -132.13 169.78 21.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -171.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.43 ' ND2' ' HB3' ' A' ' 269' ' ' PHE . 0.9 OUTLIER -134.96 130.28 35.55 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 117.248 -1.781 . . . . 0.0 113.835 -174.249 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 1.7 t -113.61 163.96 14.29 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.532 163.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.577 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 4.1 m -73.12 130.0 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 C-N-CA 119.312 -0.955 . . . . 0.0 108.719 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.429 ' N ' ' CE2' ' A' ' 235' ' ' PHE . . . 98.2 -17.52 58.49 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.959 -175.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 41.9 t -179.69 150.74 0.42 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.532 1.166 . . . . 0.0 110.524 -173.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . 0.43 ' HB3' ' ND2' ' A' ' 264' ' ' ASN . 30.2 p90 -96.43 160.28 14.49 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.61 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -116.77 117.59 30.19 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -177.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 68.8 m -102.61 132.39 48.74 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.237 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 261' ' ' ASN . 22.7 ttpp -101.18 122.52 43.78 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.131 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 56.6 m -107.1 145.1 30.46 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.114 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . 0.428 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 38.9 Cg_exo -57.97 156.34 29.27 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.636 2.224 . . . . 0.0 110.842 169.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -54.41 146.37 16.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.073 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.15 -29.67 3.44 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.803 -177.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' HIS . . . . . 0.572 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 29.8 m-70 -81.25 162.66 23.44 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 120.986 0.422 . . . . 0.0 110.728 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -146.63 116.83 7.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.044 -171.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 45.2 tp -63.13 127.75 32.68 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.977 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -114.8 101.57 9.19 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -70.17 -8.02 46.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.724 0.297 . . . . 0.0 111.339 -173.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 51.5 t -67.68 -31.77 53.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.514 0.674 . . . . 0.0 110.18 172.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 30.7 p -139.68 28.93 2.15 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.015 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 29.46 44.87 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.166 0.986 . . . . 0.0 113.292 -172.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -112.36 127.24 55.95 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.906 -172.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 98.0 m -88.03 107.62 18.83 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 171.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 8.9 tp10 . . . . . 0 C--O 1.244 0.792 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 10.3 p . . . . . 0 N--CA 1.475 0.775 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -131.34 85.66 2.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.953 0.406 . . . . 0.0 110.466 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 26.7 m -67.23 112.52 4.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.968 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -67.11 -44.95 78.64 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.565 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 32.6 t 56.64 86.26 0.07 Allowed 'General case' 0 C--O 1.234 0.26 0 O-C-N 123.703 0.627 . . . . 0.0 111.02 177.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 80.8 mt -61.45 -57.24 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-O 121.317 0.58 . . . . 0.0 109.483 175.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -99.42 92.73 5.54 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.095 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -61.07 131.97 52.29 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 123.646 0.591 . . . . 0.0 110.278 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 21.0 p -75.59 -175.96 3.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.871 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -98.79 -58.11 2.02 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-O 122.192 0.996 . . . . 0.0 110.368 -175.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.431 HD11 ' CA ' ' A' ' 133' ' ' HIS . 25.0 pt -72.13 -177.31 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 113.303 -1.771 . . . . 0.0 114.523 -169.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.27 130.65 44.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.72 -172.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 129' ' ' CYS . 26.5 m -117.9 139.46 51.11 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -173.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.2 mtm -130.18 179.4 5.91 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 171.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.2 m120 66.26 52.93 1.07 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.022 0.439 . . . . 0.0 110.767 171.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 59.6 32.81 74.6 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 115.149 -0.932 . . . . 0.0 113.386 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 135' ' ' LEU . . . -113.12 129.89 9.16 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.015 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.3 m -94.29 146.32 24.11 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.435 ' HB2' ' SG ' ' A' ' 123' ' ' CYS . 50.1 t -96.59 123.1 40.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.9 0.381 . . . . 0.0 110.58 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.6 t -141.65 138.4 32.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.467 177.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.551 ' O ' ' HB2' ' A' ' 132' ' ' ASP . 7.8 t70 63.1 -9.57 0.11 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 172.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 15.5 m-20 108.52 38.65 0.0 OUTLIER 'General case' 0 C--N 1.355 0.832 0 C-N-CA 125.4 1.48 . . . . 0.0 108.119 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.431 ' CA ' HD11 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -157.74 154.17 27.76 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.911 177.071 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 81.2 m -101.02 132.2 46.54 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.311 0.577 . . . . 0.0 112.01 -173.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.403 ' O ' ' HA2' ' A' ' 127' ' ' GLY . 94.0 mt -88.16 92.46 9.16 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.385 174.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 61.8 m -72.96 150.53 42.42 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.262 -171.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -62.01 142.04 57.72 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 167.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -62.45 113.4 2.92 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 122.554 1.169 . . . . 0.0 111.368 -176.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 116.29 5.88 16.37 Favored Glycine 0 N--CA 1.431 -1.644 0 CA-C-N 112.825 -1.989 . . . . 0.0 111.71 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.582 ' CE2' ' HD3' ' A' ' 163' ' ' PRO . 51.6 m-85 -120.46 146.54 46.14 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.932 0.396 . . . . 0.0 110.001 174.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 23.9 pt -137.21 -173.15 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.179 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.75 176.5 46.84 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.649 -174.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.8 p -75.08 -32.75 61.54 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.596 -0.355 . . . . 0.0 111.726 -176.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -109.72 16.01 22.38 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.981 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 60.7 m 61.71 30.19 18.36 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.634 175.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.05 2.86 61.8 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.733 -1.223 . . . . 0.0 113.112 -174.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.72 103.93 54.27 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 117.434 0.617 . . . . 0.0 110.192 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.89 149.82 26.39 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.468 2.112 . . . . 0.0 112.553 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.07 105.14 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 122.118 0.961 . . . . 0.0 112.179 -174.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.8 m -80.69 82.41 6.7 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.958 173.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -51.04 -64.91 0.66 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -175.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 31.2 m -97.07 9.55 41.77 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.083 0.468 . . . . 0.0 110.862 -166.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 80.23 131.67 0.99 Allowed Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.333 -174.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . 0.44 ' O ' HD23 ' A' ' 155' ' ' LEU . 85.7 m -72.21 159.43 34.11 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.323 -0.939 . . . . 0.0 108.881 172.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.539 HD12 ' O ' ' A' ' 176' ' ' GLN . 76.6 mt -141.79 164.35 30.43 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.719 0.295 . . . . 0.0 110.517 -167.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 10.5 t30 52.0 24.43 2.63 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.413 1.07 . . . . 0.0 111.364 -166.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.05 38.41 95.96 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.39 -173.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.14 -151.6 0.45 Allowed Glycine 0 CA--C 1.524 0.596 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.42 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -151.51 119.29 6.14 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 122.0 -0.706 . . . . 0.0 111.894 -175.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.27 125.76 22.06 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 176.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 165' ' ' ARG . 20.0 m -118.06 -39.36 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 120.615 0.245 . . . . 0.0 110.966 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.477 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -140.63 171.19 8.05 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.582 ' HD3' ' CE2' ' A' ' 140' ' ' TYR . 87.3 Cg_exo -52.02 110.69 0.47 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 121.872 1.714 . . . . 0.0 111.988 175.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 77.11 -14.35 0.85 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.97 0.908 . . . . 0.0 110.793 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.477 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 1.7 mtm-85 -86.65 88.51 7.68 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 121.19 0.519 . . . . 0.0 110.151 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 73.8 m -82.31 145.98 29.67 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.965 166.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -89.75 119.32 30.05 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 175.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 73.6 m -98.12 130.1 44.91 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.97 0.794 . . . . 0.0 111.249 -171.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 16.4 m -53.8 -56.86 13.73 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -167.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -158.19 -86.51 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.131 -1.027 . . . . 0.0 112.332 -169.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -90.76 44.64 2.88 Favored Glycine 0 CA--C 1.498 -1.028 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.378 -166.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.498 ' CD1' ' N ' ' A' ' 172' ' ' PHE . 3.1 m-85 -118.69 129.49 55.31 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.401 173.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.57 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 7.4 t -103.4 141.44 35.95 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 94.59 124.65 4.16 Favored Glycine 0 C--N 1.298 -1.542 0 N-CA-C 107.916 -2.074 . . . . 0.0 107.916 -168.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -72.21 19.55 0.3 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.934 1.756 . . . . 0.0 113.175 -166.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.539 ' O ' HD12 ' A' ' 155' ' ' LEU . 45.2 tt0 -122.58 15.21 10.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 176.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.438 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.6 OUTLIER 28.68 56.37 0.11 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 117.314 2.339 . . . . 0.0 117.314 177.549 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -111.46 22.05 15.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 122.34 1.066 . . . . 0.0 108.873 167.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.479 ' HD2' ' O ' ' A' ' 173' ' ' THR . 92.3 mtt180 -116.07 86.88 2.56 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.222 -1.353 . . . . 0.0 109.007 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -85.63 48.63 1.62 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.547 -168.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.57 ' HE2' ' N ' ' A' ' 173' ' ' THR . 25.0 p90 -85.6 95.67 9.41 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -78.28 162.63 26.38 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 118.781 -2.449 . . . . 0.0 108.681 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 75.3 p -96.26 138.64 33.56 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.227 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -159.19 162.12 32.51 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.095 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -83.13 143.86 11.58 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.842 2.361 . . . . 0.0 111.889 173.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 4.9 t -96.71 115.82 28.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.959 0.409 . . . . 0.0 110.252 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -95.73 149.09 21.87 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.982 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 6.6 m -117.13 -15.08 10.53 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -167.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 26.2 t -145.66 114.35 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 O-C-N 121.176 -0.953 . . . . 0.0 110.709 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.449 HD11 ' CB ' ' A' ' 216' ' ' ALA . 3.5 mt -134.87 118.95 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -173.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.3 m -115.56 -166.84 1.17 Allowed 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 155.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -68.49 -5.06 17.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.761 0.791 . . . . 0.0 109.991 172.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -73.3 -74.01 0.19 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.353 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 62.3 mtt -149.67 160.68 43.32 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 196' ' ' GLN . 55.5 m -89.52 -19.48 24.98 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.652 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.507 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 36.6 tt0 166.06 -85.9 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.204 171.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 126.43 -27.24 5.04 Favored Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 171.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -82.25 69.16 8.93 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 167.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.73 142.44 58.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.36 0.6 . . . . 0.0 111.023 -175.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 29.7 t -113.84 143.52 44.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.471 -175.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.95 22.28 8.38 Favored Glycine 0 CA--C 1.501 -0.783 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.179 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.593 HD12 ' HA ' ' A' ' 253' ' ' ILE . 1.5 tt -60.09 99.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 171.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 25.2 t -86.91 95.11 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.533 0 CA-C-O 123.918 1.818 . . . . 0.0 108.36 171.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.9 m -133.45 -179.03 5.26 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 111.123 -2.762 . . . . 0.0 106.072 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 27.5 p -103.29 166.74 10.25 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.131 -1.028 . . . . 0.0 112.323 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.562 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 21.9 tttp -61.13 -41.79 97.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.345 173.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 30.3 m -45.05 -52.04 9.4 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 114.515 -1.22 . . . . 0.0 109.409 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.417 HD11 HG11 ' A' ' 247' ' ' VAL . 8.6 tp -63.09 -49.27 75.15 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 112.53 -2.123 . . . . 0.0 110.606 -174.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 88.0 m -68.51 -22.4 64.53 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.543 -177.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 20.9 m -81.18 -45.2 16.72 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 123.681 0.613 . . . . 0.0 110.672 173.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.17 -52.35 35.55 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -172.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.501 ' CG2' ' HA2' ' A' ' 234' ' ' GLY . 17.7 p -105.56 152.78 22.65 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.198 177.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 1.4 t 67.55 -45.05 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 123.584 0.754 . . . . 0.0 112.218 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.56 ' O ' ' HD2' ' A' ' 215' ' ' ARG . . . 55.35 59.43 10.48 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 118.559 0.618 . . . . 0.0 114.499 173.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.56 ' HD2' ' O ' ' A' ' 214' ' ' GLY . 17.4 mmm180 -125.64 -75.98 0.59 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.226 0.513 . . . . 0.0 111.048 177.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.449 ' CB ' HD11 ' A' ' 190' ' ' ILE . . . -171.1 163.39 7.29 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 118.642 0.656 . . . . 0.0 109.88 174.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . 0.587 ' O ' ' HB2' ' A' ' 222' ' ' GLU . 19.1 t90 -158.81 142.77 15.37 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 106.15 179.03 23.41 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.144 -1.027 . . . . 0.0 113.954 170.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -135.52 133.44 20.33 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -89.6 118.36 3.64 Favored 'Cis proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.496 -1.46 . . . . 0.0 111.733 -4.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 68.7 m 45.17 88.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.587 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 12.3 mt-10 -107.27 107.23 18.06 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -75.21 144.06 42.85 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.746 -166.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -123.53 120.95 26.85 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -174.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -62.14 167.04 11.47 Favored 'Trans proline' 0 CA--C 1.499 -1.239 0 C-N-CA 122.089 1.859 . . . . 0.0 110.563 159.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.35 -142.24 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 122.289 1.042 . . . . 0.0 110.397 163.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.37 106.37 0.65 Allowed Pre-proline 0 C--N 1.298 -1.668 0 CA-C-N 113.82 -1.536 . . . . 0.0 112.168 -169.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.1 -57.57 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.234 2.623 . . . . 0.0 112.87 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -95.99 162.8 22.73 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -64.31 83.27 0.15 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.135 1.89 . . . . 0.0 112.271 174.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 34.1 t -157.91 152.67 25.12 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.196 -1.365 . . . . 0.0 107.504 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.465 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 24.0 mtt180 -64.04 131.68 48.29 Favored 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.101 -176.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -38.56 -45.95 1.13 Allowed 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -175.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.501 ' HA2' ' CG2' ' A' ' 212' ' ' THR . . . -72.99 7.22 10.05 Favored Glycine 0 C--N 1.319 -0.385 0 C-N-CA 120.718 -0.753 . . . . 0.0 114.256 -173.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 232' ' ' ARG . 3.5 m-85 -122.28 150.66 42.02 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.942 0.877 . . . . 0.0 112.61 -171.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.62 121.34 25.78 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 114.309 -1.314 . . . . 0.0 107.819 169.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.49 115.27 2.33 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.093 2.529 . . . . 0.0 112.26 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -50.62 137.9 18.89 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.853 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 41.8 mt -71.17 -16.34 19.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.207 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 -100.9 -62.46 1.24 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.617 0.722 . . . . 0.0 109.973 -174.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 32.2 p -80.18 -40.1 27.95 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.382 -176.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 98.05 8.26 55.52 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -90.81 127.03 36.2 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 121.852 0.834 . . . . 0.0 110.615 -177.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 95.8 m -50.49 121.0 5.12 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 113.227 -1.806 . . . . 0.0 110.85 172.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -120.36 133.32 55.46 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 7.2 t70 -77.18 149.68 35.54 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -173.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.549 HG23 ' HG3' ' A' ' 249' ' ' GLU . 11.0 m -100.15 145.26 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -177.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -72.54 75.89 1.07 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 167.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.549 ' HG3' HG23 ' A' ' 247' ' ' VAL . 17.1 mp0 -53.24 -37.59 62.21 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.271 0.628 . . . . 0.0 110.654 -169.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 56.4 m -51.13 -35.83 37.56 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.096 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -100.43 -37.63 8.76 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.865 0.84 . . . . 0.0 110.246 -176.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -71.13 -17.72 62.55 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.374 -176.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.627 HG22 ' HB3' ' A' ' 256' ' ' LEU . 5.3 mp -135.31 73.24 64.25 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 173.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.453 ' HD2' HG13 ' A' ' 202' ' ' ILE . 36.0 Cg_endo -62.65 124.28 13.85 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.509 2.139 . . . . 0.0 112.902 -170.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 95.18 -4.95 67.9 Favored Glycine 0 C--N 1.308 -0.995 0 CA-C-N 114.429 -1.259 . . . . 0.0 113.437 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.627 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.5 OUTLIER -68.03 -39.73 83.04 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 118.392 1.096 . . . . 0.0 110.0 -176.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 46.6 t -122.95 69.47 0.99 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.493 0.663 . . . . 0.0 109.281 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -107.46 16.04 24.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.964 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -87.55 -4.73 79.69 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.796 178.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -169.08 -137.61 2.29 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . 0.423 ' OD1' ' HE2' ' A' ' 272' ' ' LYS . 2.9 t-20 -88.66 156.82 18.8 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 9.1 t -145.79 125.12 13.04 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 7.6 mt -130.05 165.74 29.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 -174.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.477 ' ND2' ' HB3' ' A' ' 269' ' ' PHE . 0.8 OUTLIER -132.2 121.49 23.76 Favored 'General case' 0 CA--C 1.494 -1.177 0 C-N-CA 117.461 -1.695 . . . . 0.0 114.627 -177.051 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.1 t -105.83 159.83 15.71 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.777 167.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.443 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 35.7 m -72.28 121.4 22.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 114.42 -30.77 6.78 Favored Glycine 0 C--N 1.316 -0.547 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.423 -169.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.0 m -179.22 163.97 1.34 Allowed 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 118.383 1.091 . . . . 0.0 110.164 -169.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . 0.477 ' HB3' ' ND2' ' A' ' 264' ' ' ASN . 34.9 p90 -104.7 153.24 21.52 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.803 174.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -108.27 118.2 36.13 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.454 -175.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 99.5 m -105.71 160.52 15.15 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.415 0.626 . . . . 0.0 110.372 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.423 ' HE2' ' OD1' ' A' ' 261' ' ' ASN . 46.2 mtmt -138.69 123.27 18.52 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.194 176.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 68.0 m -99.45 137.28 20.28 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.091 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -48.94 152.71 4.41 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.913 2.409 . . . . 0.0 111.055 170.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -48.96 134.27 17.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.054 0.454 . . . . 0.0 111.811 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 88.63 -36.21 3.48 Favored Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.53 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' HIS . . . . . 0.438 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 24.4 m-70 -71.1 156.99 38.95 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.565 0.698 . . . . 0.0 111.329 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -140.94 129.26 22.37 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.924 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 42.4 tp -62.18 125.24 23.21 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.423 0.63 . . . . 0.0 111.016 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.49 ' OD1' ' HB ' ' A' ' 282' ' ' VAL . 22.0 t-20 -111.52 97.16 6.54 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -64.6 -15.73 61.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.455 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.49 ' HB ' ' OD1' ' A' ' 280' ' ' ASN . 48.1 t -57.58 -29.39 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 120.83 0.348 . . . . 0.0 110.416 173.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.502 ' O ' ' HG3' ' A' ' 285' ' ' LYS . 19.5 p -142.47 25.75 1.83 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.543 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 256' ' ' LEU . 79.0 mm-40 28.57 41.93 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -167.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 283' ' ' SER . 90.7 mttt -115.65 135.72 53.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.306 0.575 . . . . 0.0 111.836 -173.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 94.1 m -87.61 112.45 22.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.825 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 10.8 tp10 . . . . . 0 N--CA 1.433 -1.289 0 CA-C-O 118.12 -0.943 . . . . 0.0 108.499 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.8 p . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 120.752 0.31 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.27 -34.81 78.2 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.154 0.502 . . . . 0.0 110.26 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 34.0 m -103.14 46.9 0.9 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.962 176.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -59.54 143.11 51.11 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.218 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.1 m -82.74 -22.89 34.23 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.542 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 79.8 mt -95.93 118.59 42.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.558 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -92.02 138.11 31.81 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.428 174.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -89.24 -3.2 58.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.751 -172.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 33.6 t -147.75 149.55 32.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.969 0.414 . . . . 0.0 110.637 176.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -107.08 -50.95 3.0 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.749 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 37.7 pt -86.14 -161.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.409 -173.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.89 136.07 49.93 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.986 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.431 ' SG ' ' HA ' ' A' ' 129' ' ' CYS . 72.0 m -117.69 152.76 34.59 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.803 0.335 . . . . 0.0 111.817 -176.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 76.9 mtp -133.95 167.33 20.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.831 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 61.2 53.18 3.64 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 172.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' A' ' 137' ' ' GLN . . . 64.0 30.0 76.48 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.304 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -99.09 125.86 8.72 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.009 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.7 m -74.16 125.58 28.67 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.819 0.342 . . . . 0.0 110.415 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.431 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 4.4 t -76.39 100.15 5.08 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.34 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.1 m -130.68 122.82 28.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -177.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.6 t70 49.75 -113.32 0.63 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -122.95 39.96 3.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.874 0.845 . . . . 0.0 109.455 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -166.11 167.28 16.48 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.527 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 78.7 m -115.78 124.05 49.77 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.985 -174.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.9 mt -86.49 97.3 10.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.09 0.948 . . . . 0.0 110.014 174.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 56.5 m -76.02 152.47 36.93 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 114.596 -1.184 . . . . 0.0 112.119 -170.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 126' ' ' GLY . 41.9 mt-30 -78.81 158.4 28.19 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 170.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -67.16 111.61 4.01 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 122.73 1.252 . . . . 0.0 112.105 -171.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 125.63 0.44 7.84 Favored Glycine 0 C--N 1.295 -1.745 0 CA-C-N 112.41 -2.177 . . . . 0.0 111.362 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.578 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 91.3 m-85 -118.81 138.88 52.39 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.14 0.495 . . . . 0.0 111.764 174.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 34.7 pt -132.71 -174.43 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.41 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.67 -170.81 34.04 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.904 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.1 p -77.83 -44.11 28.37 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.918 0.389 . . . . 0.0 111.7 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -111.35 21.12 16.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.084 -176.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 27.2 m 66.51 27.24 9.77 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 124.009 0.818 . . . . 0.0 110.551 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.2 -4.13 88.4 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.859 -172.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.57 110.11 41.03 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 118.292 1.046 . . . . 0.0 110.976 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.78 149.89 18.37 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.978 2.452 . . . . 0.0 112.385 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 149' ' ' VAL . 14.3 p -83.12 103.74 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-O 121.702 0.763 . . . . 0.0 111.089 -172.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.22 88.13 5.5 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.636 171.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -57.94 -53.85 53.62 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -169.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 34.7 m -95.82 16.87 16.41 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.199 0.524 . . . . 0.0 111.112 -169.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 77.26 129.5 0.41 Allowed Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.3 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 35.5 m -76.1 150.85 37.18 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.421 -1.389 . . . . 0.0 110.129 172.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.564 HD12 ' O ' ' A' ' 176' ' ' GLN . 76.7 mt -147.72 167.34 24.89 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.019 -168.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.601 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 2.3 t-20 48.87 27.02 1.46 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.03 -164.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 66.39 37.22 92.57 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.756 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -68.66 -150.87 0.33 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.64 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -157.35 126.76 6.0 Favored 'General case' 0 C--N 1.318 -0.761 0 O-C-N 122.191 -0.594 . . . . 0.0 111.214 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -67.28 120.19 13.4 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 175.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.623 HG22 ' HG2' ' A' ' 165' ' ' ARG . 1.0 OUTLIER -109.16 -43.77 6.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.211 179.232 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' A' ' 165' ' ' ARG . . . -134.28 170.77 10.42 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 173.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.578 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 75.7 Cg_exo -54.34 111.36 0.69 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.282 1.988 . . . . 0.0 112.681 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 69.91 -1.82 2.23 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.928 0.891 . . . . 0.0 110.736 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.623 ' HG2' HG22 ' A' ' 161' ' ' VAL . 5.7 ttp180 -93.45 89.24 6.23 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 121.5 0.667 . . . . 0.0 109.216 169.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 49.3 t -92.41 139.83 30.2 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.375 171.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -90.52 106.91 18.82 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 80.3 m -84.68 134.79 34.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.617 -171.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 28.6 m -55.21 -55.53 30.23 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -168.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -175.7 117.89 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.016 0.436 . . . . 0.0 111.328 -178.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 76.94 42.41 20.24 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.433 -0.803 . . . . 0.0 114.28 165.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.601 ' CE2' ' HB2' ' A' ' 156' ' ' ASN . 62.3 m-85 -120.93 140.31 52.02 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 117.59 0.695 . . . . 0.0 112.146 163.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.731 HG23 ' CE2' ' A' ' 181' ' ' TYR . 39.6 p -87.1 119.24 27.12 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.724 0.774 . . . . 0.0 110.617 -177.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 101.84 144.69 15.2 Favored Glycine 0 N--CA 1.425 -2.048 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.18 20.62 0.4 Allowed 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.162 1.241 . . . . 0.0 112.306 -172.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.564 ' O ' HD12 ' A' ' 155' ' ' LEU . 35.7 tt0 -113.73 1.04 14.73 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.789 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.585 ' HA ' ' CB ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 36.32 62.3 0.72 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 118.018 2.599 . . . . 0.0 118.018 178.044 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -120.63 1.04 10.55 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 119.869 -0.732 . . . . 0.0 111.835 174.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 32.7 mmt180 -106.62 100.35 9.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.335 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.558 ' HA ' ' CE1' ' A' ' 172' ' ' PHE . 1.3 m-20 -74.63 100.63 4.0 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.291 -170.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.731 ' CE2' HG23 ' A' ' 173' ' ' THR . 19.7 p90 -140.05 77.97 1.64 Allowed 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 172.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 63.5 mtt85 -73.3 127.43 32.63 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 118.597 -2.564 . . . . 0.0 108.503 175.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 3.9 p -78.13 164.52 24.91 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.978 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.532 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . 157.29 142.31 3.37 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.651 -162.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.53 132.47 6.8 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.821 2.347 . . . . 0.0 112.096 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . 0.622 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 76.8 m -90.86 112.05 23.72 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.408 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -89.0 154.81 19.91 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.17 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 35.1 p -105.27 -18.86 13.99 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -165.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 p -167.95 118.28 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-N 118.889 0.768 . . . . 0.0 110.474 -174.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.1 mt -130.35 123.11 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -169.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.1 m -126.44 -166.48 1.58 Allowed 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 162.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -61.08 -8.2 3.19 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.321 0.964 . . . . 0.0 110.251 174.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -75.66 -76.05 0.16 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.114 -175.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 70.7 mtm -144.42 168.58 19.76 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 67.6 m -86.67 -36.54 18.68 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 122.335 1.064 . . . . 0.0 109.292 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -148.14 -67.44 0.24 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.731 173.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 123.69 -0.26 9.28 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.508 171.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -119.0 -19.8 8.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.343 -0.428 . . . . 0.0 111.076 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 63.24 97.11 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.222 0.534 . . . . 0.0 111.077 -176.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 42.4 t -113.68 140.18 48.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.709 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -94.08 25.68 20.79 Favored Glycine 0 CA--C 1.505 -0.533 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.986 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.455 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -61.72 107.0 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 121.989 0.9 . . . . 0.0 109.388 174.62 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.0 t -98.27 120.98 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 CA-C-O 122.734 1.254 . . . . 0.0 110.193 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 14.3 t -152.91 -178.76 7.11 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 103.137 -2.912 . . . . 0.0 103.137 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.535 HG21 ' HA ' ' A' ' 181' ' ' TYR . 8.0 p -102.38 161.44 13.7 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 121.197 1.817 . . . . 0.0 108.763 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.53 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 53.6 tttm -57.24 -43.22 82.73 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.997 177.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.5 m -47.9 -54.96 11.0 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.925 175.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.412 ' CD1' HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -58.37 -55.07 39.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.716 179.574 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 65.8 m -74.45 -20.95 59.83 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -170.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 80.0 m -90.22 -38.81 13.19 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 121.878 -0.514 . . . . 0.0 110.595 176.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -67.74 -57.73 5.84 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.52 HG22 ' HA2' ' A' ' 234' ' ' GLY . 3.4 p -92.53 160.81 14.87 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.385 -1.279 . . . . 0.0 107.765 175.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 27.3 m 58.01 -35.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 125.196 1.398 . . . . 0.0 114.668 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 58.11 60.45 8.93 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 119.548 1.067 . . . . 0.0 114.8 167.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.85 -95.02 0.49 Allowed 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.356 175.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -164.02 163.17 23.41 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 174.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . 0.622 ' HD1' ' SG ' ' A' ' 186' ' ' CYS . 17.7 t90 -151.45 146.33 25.85 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 121.56 -0.712 . . . . 0.0 109.794 -174.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 86.75 -179.93 48.97 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.167 -0.539 . . . . 0.0 113.774 171.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.572 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 8.9 p80 -141.28 131.1 12.89 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 175.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . 0.572 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 10.5 Cg_endo -53.63 149.51 16.15 Favored 'Cis proline' 0 C--N 1.352 0.763 0 C-N-CA 123.772 -1.345 . . . . 0.0 111.856 -5.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 22.2 m -63.43 83.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.775 0.672 . . . . 0.0 112.52 -170.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -58.55 123.0 14.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.63 0.252 . . . . 0.0 110.619 173.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.36 147.32 30.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.259 -175.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 18.8 m -142.0 148.51 49.02 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -173.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -65.2 166.1 20.04 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.059 1.839 . . . . 0.0 109.151 156.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.27 -107.32 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.314 0.578 . . . . 0.0 111.564 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.07 113.05 5.69 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.325 -172.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -89.9 -61.75 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.111 2.54 . . . . 0.0 112.526 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -78.73 163.36 61.3 Favored Pre-proline 0 CA--C 1.514 -0.44 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.79 52.69 2.18 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.753 1.636 . . . . 0.0 112.865 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 50.9 m -123.67 -178.0 3.9 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 171.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.518 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 26.0 mmt180 -76.72 142.18 40.58 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.169 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 32.5 ptt-85 -38.5 -40.37 0.56 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 176.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.52 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -75.15 5.56 33.29 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.626 -176.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . 0.518 ' CD1' ' HB2' ' A' ' 232' ' ' ARG . 2.0 m-85 -120.88 154.85 35.29 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.971 0.891 . . . . 0.0 112.493 -171.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.39 130.5 23.54 Favored Pre-proline 0 N--CA 1.441 -0.877 0 CA-C-N 113.982 -1.463 . . . . 0.0 108.152 170.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -61.15 112.86 1.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.001 1.8 . . . . 0.0 111.126 175.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -48.02 135.06 13.17 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.719 0.771 . . . . 0.0 110.678 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 23.6 mt -71.21 -12.52 16.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.496 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -107.96 -59.45 1.84 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.395 0.617 . . . . 0.0 110.677 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 33.7 p -81.68 -39.81 23.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.187 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 100.32 4.18 55.18 Favored Glycine 0 N--CA 1.435 -1.367 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -84.5 126.96 33.76 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 121.853 0.835 . . . . 0.0 110.634 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 7.4 m -55.61 120.16 6.81 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.716 172.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -126.85 132.89 50.85 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 7.3 t70 -77.8 147.42 35.25 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 121.447 0.641 . . . . 0.0 109.632 -175.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.616 HG23 ' HG3' ' A' ' 249' ' ' GLU . 10.4 m -97.83 145.09 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.281 -177.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -74.28 76.86 1.84 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 168.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.616 ' HG3' HG23 ' A' ' 247' ' ' VAL . 28.2 mp0 -52.11 -37.8 55.3 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 124.021 0.826 . . . . 0.0 109.946 -171.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 42.6 m -47.7 -36.4 11.2 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.824 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -102.4 -42.88 5.84 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.685 0.755 . . . . 0.0 110.319 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -63.84 -23.07 67.21 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.8 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.629 ' O ' ' HB2' ' A' ' 256' ' ' LEU . 3.9 mp -124.05 88.2 52.74 Favored Pre-proline 0 N--CA 1.45 -0.434 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 174.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -73.1 142.46 34.35 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 121.301 1.334 . . . . 0.0 112.35 -175.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 77.43 5.7 85.96 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.506 -170.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.629 ' HB2' ' O ' ' A' ' 253' ' ' ILE . 10.4 tp -53.24 -92.31 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 122.827 0.451 . . . . 0.0 111.285 175.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 22.9 t -96.08 61.52 2.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.502 0.668 . . . . 0.0 109.51 -175.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -86.6 51.9 2.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.628 0.728 . . . . 0.0 109.643 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.423 ' O ' ' HD3' ' A' ' 274' ' ' PRO . . . -137.6 28.35 2.76 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 148.43 -133.24 4.5 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -177.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -103.28 158.02 16.61 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 42.7 t -142.76 124.44 14.98 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 50.6 mt -130.21 116.33 36.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.918 -167.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -76.23 120.4 21.45 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.85 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.7 t -107.21 158.77 16.85 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 158.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 31.3 m -75.11 123.15 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 C-N-CA 118.612 -1.235 . . . . 0.0 108.498 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.489 ' N ' ' HE1' ' A' ' 235' ' ' PHE . . . 113.04 -24.22 13.07 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.669 -171.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.7 t 174.01 162.08 0.18 Allowed 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 117.471 0.636 . . . . 0.0 109.852 -172.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -102.8 158.45 16.25 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 121.002 -1.061 . . . . 0.0 109.178 174.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -115.51 127.96 55.65 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 56.7 m -100.43 152.01 20.86 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.529 0.68 . . . . 0.0 111.751 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -121.59 100.42 7.0 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.08 171.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 18.2 m -88.8 156.99 49.59 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.395 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 43.6 Cg_exo -58.07 156.03 31.2 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 121.831 1.687 . . . . 0.0 110.359 171.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -56.55 144.53 31.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.655 0.264 . . . . 0.0 110.842 -177.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.13 -32.69 3.48 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.237 -0.983 . . . . 0.0 111.968 -176.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' HIS . . . . . 0.458 ' HB2' ' O ' ' A' ' 274' ' ' PRO . 14.6 m-70 -72.42 154.69 40.75 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.06 0.457 . . . . 0.0 111.283 -175.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -137.68 121.27 17.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.862 -174.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 35.2 tp -69.52 136.95 52.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.114 0.483 . . . . 0.0 111.672 -175.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -124.11 100.51 6.75 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 171.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -65.16 -14.19 59.98 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.951 0.782 . . . . 0.0 112.533 -172.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 73.5 t -58.43 -36.93 61.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.629 0.728 . . . . 0.0 109.874 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 31.3 m -134.08 30.49 3.63 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.398 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 23.51 50.52 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 114.135 -1.393 . . . . 0.0 113.164 -172.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -102.36 130.79 49.2 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.439 -174.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 33.3 m -94.87 97.8 10.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.652 173.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.668 -0.682 . . . . 0.0 109.305 -179.553 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.9 p . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.677 0.275 . . . . 0.0 111.526 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.55 105.97 5.8 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.816 0.341 . . . . 0.0 111.307 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.3 p -160.66 -57.58 0.05 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.207 176.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -172.46 156.4 3.71 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 52.1 m -73.45 71.89 1.33 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.459 0.647 . . . . 0.0 111.075 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.6 tt -155.81 25.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.295 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -92.16 64.27 4.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.144 -174.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -135.03 85.93 2.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.307 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 23.8 p -151.89 -169.62 3.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.577 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -120.73 -56.56 1.94 Allowed 'General case' 0 CA--C 1.498 -1.023 0 CA-C-O 121.598 0.713 . . . . 0.0 109.992 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 33.7 pt -79.24 -168.68 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 114.415 -1.266 . . . . 0.0 113.352 -170.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.528 ' N ' ' HD2' ' A' ' 122' ' ' ARG . 2.0 mpt_? -118.95 122.79 43.05 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.91 -173.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.552 ' SG ' ' HA ' ' A' ' 129' ' ' CYS . 60.2 m -115.09 129.59 56.72 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.697 0.284 . . . . 0.0 110.973 -176.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.0 mtm -126.28 169.8 12.53 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.199 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 65.23 45.85 2.84 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.188 0.518 . . . . 0.0 111.121 174.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.548 ' HA3' ' OE1' ' A' ' 137' ' ' GLN . . . 70.1 27.15 73.34 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.114 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -96.21 126.87 8.96 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 119.608 -1.282 . . . . 0.0 111.1 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.9 t -77.89 130.64 36.85 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 117.222 0.511 . . . . 0.0 109.941 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.552 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 17.0 t -85.97 108.93 18.43 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -176.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.9 m -130.51 127.44 39.14 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.842 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.6 t70 53.98 -109.85 0.51 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.202 0.525 . . . . 0.0 111.359 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -126.15 36.13 4.56 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -157.29 171.18 20.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.525 -177.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 79.6 m -123.19 124.07 42.21 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.103 -174.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.9 mt -85.01 99.42 11.0 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 172.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 56.1 m -80.76 160.48 24.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.152 -170.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.548 ' OE1' ' HA3' ' A' ' 126' ' ' GLY . 53.9 mt-30 -81.0 143.65 32.37 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 167.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.7 tptm -68.34 111.39 4.58 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 122.768 1.27 . . . . 0.0 110.866 -175.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 135.93 -10.58 4.22 Favored Glycine 0 C--N 1.3 -1.429 0 CA-C-N 112.459 -2.155 . . . . 0.0 110.218 -173.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.443 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 90.6 m-85 -125.95 145.92 50.08 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 171.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 33.3 pt -141.41 -171.21 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 123.531 0.519 . . . . 0.0 110.376 -173.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 86.97 -174.08 45.51 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.254 -0.884 . . . . 0.0 112.369 -174.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.5 p -75.82 -34.36 60.13 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -110.78 12.44 22.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.034 -176.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 33.6 m 62.66 29.46 16.86 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 123.668 0.605 . . . . 0.0 110.258 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.17 -17.92 60.13 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.618 -172.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.69 120.91 56.23 Favored Pre-proline 0 C--N 1.326 -0.428 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.315 -174.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -88.7 140.63 4.31 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.933 2.422 . . . . 0.0 112.605 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.1 p -66.52 105.29 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 122.25 1.024 . . . . 0.0 111.731 -173.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 76.84 6.8 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.989 175.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -52.41 -65.82 0.49 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -176.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 37.7 m -85.6 23.37 1.39 Allowed 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 120.728 0.299 . . . . 0.0 111.63 -171.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 106.43 -101.6 1.79 Allowed Glycine 0 N--CA 1.436 -1.301 0 CA-C-O 122.21 0.895 . . . . 0.0 113.049 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 148.43 131.43 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 111.368 -2.416 . . . . 0.0 105.004 -175.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 21.4 mt -117.49 171.58 7.9 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -168.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 172' ' ' PHE . 0.2 OUTLIER 42.43 30.11 0.19 Allowed 'General case' 0 N--CA 1.478 0.944 0 O-C-N 124.426 1.079 . . . . 0.0 113.157 -172.374 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.8 39.37 91.35 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 119.951 -1.118 . . . . 0.0 111.955 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -74.63 -144.54 0.98 Allowed Glycine 0 CA--C 1.511 -0.21 0 CA-C-N 115.426 -0.387 . . . . 0.0 113.685 -173.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.28 130.52 10.41 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.8 m -67.41 115.57 7.18 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 122.312 -0.242 . . . . 0.0 110.891 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 165' ' ' ARG . 3.7 m -101.43 -37.02 5.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.974 176.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -139.78 172.67 6.03 Favored Pre-proline 0 C--O 1.233 0.235 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.443 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 76.4 Cg_exo -54.09 107.1 0.19 Allowed 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.421 2.081 . . . . 0.0 112.869 176.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 70.52 8.68 6.69 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.044 0.938 . . . . 0.0 110.238 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.497 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 1.4 mmt180 -103.06 81.66 1.99 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.822 176.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 12.6 t -81.34 146.17 30.49 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 173.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -98.68 147.86 24.42 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 14.4 m -111.41 124.66 52.71 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 124.775 1.297 . . . . 0.0 112.66 -160.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.476 ' H ' ' ND2' ' A' ' 156' ' ' ASN . 64.5 m -51.99 -54.46 29.57 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -154.84 -86.37 0.05 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 118.516 -1.274 . . . . 0.0 113.746 -165.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -92.11 39.6 3.0 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 119.651 -1.262 . . . . 0.0 112.826 -167.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.56 ' CZ ' ' HB3' ' A' ' 156' ' ' ASN . 9.1 m-85 -120.7 126.23 49.67 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 119.522 -0.871 . . . . 0.0 113.036 176.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.48 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 4.7 t -93.37 164.81 13.07 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 164.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.28 132.63 5.51 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.54 2.9 4.69 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 121.198 1.265 . . . . 0.0 112.962 -167.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -118.68 4.34 11.63 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.325 0.584 . . . . 0.0 110.661 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 39.32 50.6 2.0 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -106.03 -12.37 15.81 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.476 0.655 . . . . 0.0 110.321 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -60.85 -67.41 0.4 Allowed 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.802 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.8 t70 79.59 81.96 0.06 Allowed 'General case' 0 CA--C 1.509 -0.603 0 O-C-N 123.775 0.672 . . . . 0.0 109.445 163.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.48 ' HE2' ' N ' ' A' ' 173' ' ' THR . 37.0 p90 -102.42 66.06 0.96 Allowed 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 172.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -46.97 119.52 2.58 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 113.479 -1.691 . . . . 0.0 109.869 172.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 64.6 p -84.39 136.91 33.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.809 -172.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.419 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -158.27 145.79 12.27 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.86 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -59.92 139.87 90.17 Favored 'Trans proline' 0 CA--C 1.529 0.232 0 C-N-CA 122.268 1.979 . . . . 0.0 111.47 171.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 5.8 t -96.44 133.94 40.23 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.123 -174.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -110.32 130.81 55.48 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.481 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' A' ' 215' ' ' ARG . 48.9 p -112.52 -4.34 14.2 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -168.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 p -168.58 116.85 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 118.991 0.814 . . . . 0.0 111.504 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.592 HD11 ' CB ' ' A' ' 216' ' ' ALA . 3.7 mt -117.07 119.32 61.61 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -169.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 45.7 t -104.54 156.45 17.95 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 145.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -50.43 -31.26 14.58 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 119.988 1.267 . . . . 0.0 109.702 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -56.17 -59.22 5.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 113.526 -1.67 . . . . 0.0 111.591 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 5.7 mmt -136.87 126.12 24.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.559 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 79.9 m -76.79 -19.24 57.81 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.87 0.843 . . . . 0.0 110.716 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -146.97 -68.6 0.25 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 171.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 125.06 -18.42 7.0 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -96.72 -41.87 8.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.705 -0.747 . . . . 0.0 110.068 177.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 67.62 84.85 0.15 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.477 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 48.0 t -99.44 148.15 24.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.109 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -92.59 22.29 34.05 Favored Glycine 0 CA--C 1.504 -0.626 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.771 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.422 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -60.61 110.99 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 167.727 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.02 97.22 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-O 124.081 1.896 . . . . 0.0 109.482 -173.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 13.7 t -119.38 -175.69 2.99 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 112.232 -2.258 . . . . 0.0 106.986 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 7.6 p -100.97 164.04 12.0 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 119.281 -0.968 . . . . 0.0 108.872 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -61.94 -45.95 91.47 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.994 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.9 m -45.24 -55.05 6.24 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.537 173.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.51 -54.5 46.28 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.988 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 19.1 m -68.95 -22.08 64.15 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 84.6 m -94.42 -33.83 12.98 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.1 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -73.69 -58.49 3.27 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.543 HG21 ' CG2' ' A' ' 247' ' ' VAL . 20.0 p -99.62 157.59 16.35 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.944 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.2 t 66.86 -46.69 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 122.855 0.462 . . . . 0.0 112.022 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 215' ' ' ARG . . . 80.6 178.96 52.56 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 114.68 0.632 . . . . 0.0 114.68 171.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 188' ' ' THR . 8.0 mpt_? 92.08 -73.94 0.01 OUTLIER 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.647 1.179 . . . . 0.0 112.844 170.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.592 ' CB ' HD11 ' A' ' 190' ' ' ILE . . . -172.8 165.86 5.27 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.069 1.304 . . . . 0.0 111.855 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . 0.419 ' CZ2' ' HA3' ' A' ' 184' ' ' GLY . 22.0 t90 -150.9 149.2 29.36 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.869 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 77.74 166.32 27.32 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 115.674 1.03 . . . . 0.0 115.674 167.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.417 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 77.7 m-70 -122.32 134.62 24.92 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 114.706 -0.747 . . . . 0.0 109.755 175.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . 0.417 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 22.7 Cg_exo -65.37 155.85 77.79 Favored 'Cis proline' 0 C--N 1.347 0.46 0 C-N-CA 123.287 -1.547 . . . . 0.0 111.225 -2.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 33.7 t -52.14 115.61 1.8 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.322 -171.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -107.66 115.01 29.39 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 13.3 ttp -89.03 138.85 31.04 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.43 -172.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 84.0 m -128.08 122.8 22.34 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -54.03 166.26 1.63 Allowed 'Trans proline' 0 CA--C 1.515 -0.462 0 C-N-CA 123.609 2.873 . . . . 0.0 113.622 165.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -39.09 106.7 0.06 Allowed 'General case' 0 CA--C 1.504 -0.801 0 O-C-N 123.962 0.789 . . . . 0.0 111.214 163.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 31.4 85.75 0.14 Allowed Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 111.633 -2.531 . . . . 0.0 111.99 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -39.57 -58.61 0.81 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.874 3.049 . . . . 0.0 115.182 -170.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -78.58 156.09 78.25 Favored Pre-proline 0 CA--C 1.515 -0.385 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -68.61 91.57 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.773 1.648 . . . . 0.0 112.474 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 42.7 t -163.85 179.21 7.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.787 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.627 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 22.6 mmm-85 -92.75 140.22 29.74 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 22.1 ptt85 -41.31 -57.14 2.23 Favored 'General case' 0 C--O 1.218 -0.574 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -175.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.475 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -67.52 6.79 2.33 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 115.123 0.809 . . . . 0.0 115.123 -174.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . 0.627 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 2.1 m-85 -131.07 173.47 10.98 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 118.238 1.019 . . . . 0.0 111.828 -174.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.43 HD13 ' O ' ' A' ' 235' ' ' PHE . 0.2 OUTLIER -135.48 130.56 19.04 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 113.562 -1.654 . . . . 0.0 107.504 172.021 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.01 113.82 1.9 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 121.95 1.766 . . . . 0.0 111.641 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -50.71 132.21 26.02 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.669 0.747 . . . . 0.0 110.964 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 19.6 mt -76.48 -2.01 3.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.024 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 43.1 mtm180 -104.43 -57.59 2.01 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.301 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 31.5 p -95.2 -45.36 7.22 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.366 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 104.11 12.64 28.99 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -95.45 131.35 41.7 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 122.009 0.909 . . . . 0.0 110.352 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 77.8 m -49.08 112.25 0.6 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 113.261 -1.791 . . . . 0.0 110.495 167.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -116.84 134.49 54.71 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.508 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 10.9 t70 -75.84 145.36 40.66 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 121.635 0.731 . . . . 0.0 111.122 -170.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.579 HG23 ' HG3' ' A' ' 249' ' ' GLU . 4.5 m -98.23 145.19 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.87 177.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -75.85 78.13 2.76 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 169.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.579 ' HG3' HG23 ' A' ' 247' ' ' VAL . 22.7 mp0 -53.03 -36.06 60.14 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 123.747 0.654 . . . . 0.0 110.017 -172.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 24.6 m -48.36 -39.15 21.2 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.432 173.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -96.45 -39.73 9.43 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.83 0.824 . . . . 0.0 110.313 -177.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -73.68 -20.25 60.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.202 -1.363 . . . . 0.0 111.757 -172.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 202' ' ' ILE . 4.1 mp -121.83 81.5 41.82 Favored Pre-proline 0 N--CA 1.446 -0.672 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -24.02 -49.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.889 1 C-N-CA 127.169 5.246 . . . . 0.0 117.764 -170.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -124.93 28.99 5.03 Favored Glycine 0 CA--C 1.502 -0.745 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.906 -165.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.6 143.07 26.65 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.673 -0.764 . . . . 0.0 110.385 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 7.5 t 72.29 -72.27 0.12 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -169.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 60.02 -75.01 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.056 0.942 . . . . 0.0 113.202 175.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -75.48 71.18 1.85 Allowed Glycine 0 CA--C 1.508 -0.38 0 N-CA-C 111.694 -0.562 . . . . 0.0 111.694 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 154.54 -175.86 32.53 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -106.15 113.19 26.57 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 117.476 0.638 . . . . 0.0 109.774 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 48.7 t -89.3 133.15 34.59 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 46.5 mt -132.87 106.77 10.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.335 -174.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.643 ' ND2' ' HB3' ' A' ' 269' ' ' PHE . 0.9 OUTLIER -83.83 129.39 34.94 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -167.255 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.8 t -111.13 163.86 13.45 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.908 163.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.508 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 2.4 p -70.07 120.39 17.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.415 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.549 ' HA2' ' CE2' ' A' ' 235' ' ' PHE . . . 114.42 -33.38 5.43 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.61 -172.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 7.5 p -179.81 161.51 0.98 Allowed 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 117.822 0.811 . . . . 0.0 109.765 -172.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . 0.643 ' HB3' ' ND2' ' A' ' 264' ' ' ASN . 43.1 p90 -101.38 157.94 16.43 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.823 175.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -120.67 122.0 39.52 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 52.8 m -101.21 143.18 31.6 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.725 0.774 . . . . 0.0 111.682 -176.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -103.04 104.71 14.91 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.436 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 56.8 m -86.3 138.42 34.3 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.552 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . 0.419 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 52.5 Cg_exo -56.28 162.52 7.62 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.548 2.165 . . . . 0.0 111.308 172.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -54.35 136.83 43.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.179 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.15 -26.78 4.22 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.74 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' HIS . . . . . 0.5 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 16.1 m-70 -78.34 157.85 28.99 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.28 0.562 . . . . 0.0 111.613 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -145.99 140.87 27.18 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.417 -175.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 51.0 tp -74.78 126.53 31.11 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.19 0.519 . . . . 0.0 109.681 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 284' ' ' GLN . 52.7 t30 -120.29 112.13 18.64 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -78.99 -6.75 57.08 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.721 0.638 . . . . 0.0 112.263 -173.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 39.0 t -58.07 -21.21 16.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.116 0.484 . . . . 0.0 110.564 168.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 24.8 t -146.93 -15.16 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.183 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 280' ' ' ASN . 16.9 mp0 73.74 52.62 0.11 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.369 1.067 . . . . 0.0 109.481 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -130.99 149.9 52.39 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.289 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 86.8 m -101.35 94.71 6.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.294 176.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.5 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 76.4 mm-40 . . . . . 0 C--O 1.253 1.238 0 CA-C-O 118.755 -0.64 . . . . 0.0 109.483 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 54.5 m . . . . . 0 N--CA 1.478 0.95 0 CA-C-O 120.859 0.361 . . . . 0.0 111.279 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.74 -42.47 28.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.161 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.4 p -75.09 115.62 14.92 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.733 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -73.0 -34.14 66.22 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.5 m -78.61 72.23 5.12 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 172.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.1 mt -58.48 115.7 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.346 -173.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -77.52 -25.78 50.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.554 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -92.83 -173.7 3.39 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.427 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 43.3 m -85.03 165.49 17.49 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.866 0.365 . . . . 0.0 110.069 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -123.91 -44.48 2.06 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.859 0.838 . . . . 0.0 110.33 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.556 HG13 ' SG ' ' A' ' 134' ' ' CYS . 0.2 OUTLIER -74.28 178.65 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.716 -178.76 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.437 ' H ' ' HD2' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -107.36 104.54 14.16 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.795 -175.459 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 72.4 m -100.47 117.07 33.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.272 0.558 . . . . 0.0 110.615 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 25.0 mmm -117.57 158.99 23.62 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.36 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 63.22 41.82 7.59 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.118 0.886 . . . . 0.0 110.232 174.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 78.38 7.15 87.99 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.196 -0.911 . . . . 0.0 113.067 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -49.36 124.71 14.83 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.172 -0.537 . . . . 0.0 113.262 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.0 m -79.84 149.26 31.06 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.688 0.28 . . . . 0.0 110.377 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 12.2 t -83.53 101.53 11.5 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.8 m -125.95 134.41 51.54 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.734 -174.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 33.95 -98.12 0.02 OUTLIER 'General case' 0 C--N 1.35 0.609 0 O-C-N 124.87 1.356 . . . . 0.0 112.36 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -134.72 20.25 3.56 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.947 -0.47 . . . . 0.0 110.722 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -149.08 141.42 24.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.338 0.59 . . . . 0.0 110.449 174.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . 0.556 ' SG ' HG13 ' A' ' 121' ' ' ILE . 30.1 m -69.04 160.55 30.77 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.329 0.585 . . . . 0.0 112.342 -173.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 26.9 mt -123.74 129.82 51.68 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 1.5 m -70.81 163.79 26.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 122.205 1.002 . . . . 0.0 113.337 -172.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -95.13 157.23 15.98 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.447 -1.706 . . . . 0.0 107.348 172.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -61.38 109.11 1.06 Allowed 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 123.051 1.405 . . . . 0.0 110.879 -174.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 131.91 -12.36 5.34 Favored Glycine 0 C--N 1.287 -2.186 0 CA-C-N 112.573 -2.103 . . . . 0.0 111.793 173.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.472 ' HB2' ' SG ' ' A' ' 145' ' ' CYS . 89.7 m-85 -123.71 157.54 33.69 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 118.173 0.987 . . . . 0.0 110.993 173.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 30.6 pt -129.29 169.11 21.13 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.86 172.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.97 169.61 20.75 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.651 -176.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 134' ' ' CYS . 14.2 p -77.62 -47.12 20.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.625 0.213 . . . . 0.0 110.528 177.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -88.04 2.81 50.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.236 0.541 . . . . 0.0 109.937 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.472 ' SG ' ' HB2' ' A' ' 140' ' ' TYR . 0.6 OUTLIER 61.93 44.69 8.09 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.667 171.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.22 8.65 55.64 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 119.641 -1.266 . . . . 0.0 112.493 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.62 118.75 44.65 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.222 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -89.09 131.92 2.23 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.959 2.44 . . . . 0.0 113.725 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.5 p -66.47 116.03 5.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.954 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.516 ' HB3' ' SG ' ' A' ' 154' ' ' CYS . 0.0 OUTLIER -81.87 75.87 8.79 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.275 0.56 . . . . 0.0 109.844 171.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.98 -64.79 0.79 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.306 -0.861 . . . . 0.0 113.133 -171.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 55.8 m -91.88 19.03 6.98 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.158 0.504 . . . . 0.0 111.941 -168.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 80.73 120.29 0.44 Allowed Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.898 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . 0.516 ' SG ' ' HB3' ' A' ' 150' ' ' CYS . 89.1 m -74.29 157.75 35.24 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 113.443 -1.378 . . . . 0.0 108.33 172.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.542 HD12 ' O ' ' A' ' 176' ' ' GLN . 76.9 mt -147.15 174.52 11.51 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -165.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 172' ' ' PHE . 0.2 OUTLIER 49.25 19.13 0.29 Allowed 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.274 0.984 . . . . 0.0 112.624 -172.159 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.6 37.29 93.45 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.247 -0.977 . . . . 0.0 111.949 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -80.76 -141.56 2.95 Favored Glycine 0 C--O 1.236 0.25 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.658 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -157.78 126.54 5.66 Favored 'General case' 0 C--O 1.218 -0.597 0 O-C-N 122.317 -0.519 . . . . 0.0 111.526 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.99 124.46 19.98 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 123.139 0.274 . . . . 0.0 111.142 176.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.0 m -116.28 -35.3 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.191 0.519 . . . . 0.0 111.419 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.501 ' HB3' ' CB ' ' A' ' 165' ' ' ARG . . . -137.11 175.86 3.18 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 174.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.441 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 22.9 Cg_exo -60.58 109.24 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 121.316 1.344 . . . . 0.0 111.889 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 71.73 3.23 4.59 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.591 1.156 . . . . 0.0 111.119 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.501 ' CB ' ' HB3' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -96.11 86.74 4.35 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.527 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 70.1 m -79.63 150.64 30.93 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.368 172.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -93.08 121.41 34.39 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 172.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 61.6 m -106.08 132.12 52.54 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.418 -175.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 89.6 m -60.78 -52.03 66.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.963 -1.471 . . . . 0.0 114.114 -164.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -161.76 -93.6 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 118.852 -1.139 . . . . 0.0 113.111 -170.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -85.44 55.19 4.89 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.878 -164.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.56 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 4.5 m-85 -124.48 137.89 54.39 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.832 171.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.547 ' OG1' ' HG3' ' A' ' 179' ' ' ARG . 27.0 p -88.32 121.07 30.29 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.508 176.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 99.82 134.11 8.37 Favored Glycine 0 N--CA 1.426 -1.967 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.91 9.59 1.31 Allowed 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 120.903 1.068 . . . . 0.0 112.431 -172.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.542 ' O ' HD12 ' A' ' 155' ' ' LEU . 39.2 tt0 -110.37 25.01 12.25 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 171.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.8 OUTLIER 18.69 71.76 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 173.345 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.476 ' O ' ' HD3' ' A' ' 179' ' ' ARG . 8.6 pt-20 -124.13 31.64 5.75 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.93 0.871 . . . . 0.0 110.604 172.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 24.0 mmt180 -135.71 93.25 2.92 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 113.729 -1.578 . . . . 0.0 108.582 177.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -87.67 61.32 6.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 122.045 0.926 . . . . 0.0 109.935 -171.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.499 ' CE2' HG23 ' A' ' 173' ' ' THR . 26.0 p90 -83.12 91.39 7.21 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 171.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -89.33 136.5 32.99 Favored 'General case' 0 N--CA 1.437 -1.077 0 O-C-N 119.988 -1.695 . . . . 0.0 107.186 -176.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 77.1 p -86.57 134.69 33.63 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.72 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -158.73 155.29 26.34 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -71.73 160.23 48.63 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.41 2.073 . . . . 0.0 111.904 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 3.6 t -117.73 105.83 12.4 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -177.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . 0.64 ' O ' ' HB3' ' A' ' 215' ' ' ARG . 37.4 m-85 -100.21 135.87 40.97 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.633 -172.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.6 m -97.45 -21.43 17.15 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -167.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 54.6 t -149.47 115.29 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -171.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.1 mt -134.73 119.67 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -164.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.4 p -116.56 -167.36 1.27 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.103 159.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -71.65 -5.61 34.95 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.024 0.916 . . . . 0.0 109.152 171.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -83.58 -67.26 0.8 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.551 -174.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 43.0 ttp -146.53 139.28 25.3 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.666 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.669 ' O ' ' HB2' ' A' ' 196' ' ' GLN . 68.2 m -84.52 -15.43 45.88 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.586 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.669 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 3.9 mm-40 92.94 -158.8 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.568 1.147 . . . . 0.0 112.106 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 64.71 8.24 32.51 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.274 -0.876 . . . . 0.0 113.693 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 55.59 25.94 8.6 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.865 0.332 . . . . 0.0 110.642 -175.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 61.68 27.93 17.2 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.312 -176.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 39.2 t -70.95 137.41 49.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.951 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.36 57.99 3.49 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.342 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.442 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -61.16 109.83 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 170.087 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 5.4 t -89.08 116.11 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 CA-C-O 122.527 1.156 . . . . 0.0 111.348 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 19.7 t -151.68 -179.7 7.65 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 18.5 p -105.66 161.58 14.26 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 120.64 1.564 . . . . 0.0 109.27 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.496 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 46.2 tttm -59.21 -41.51 88.77 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.609 0.718 . . . . 0.0 109.534 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.7 m -46.88 -54.91 8.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.826 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.93 -51.36 69.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.253 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 64.4 m -62.8 -39.53 94.55 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 60.2 m -79.95 -29.86 39.76 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.716 -175.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -71.1 -60.9 1.98 Allowed 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.58 HG22 ' HA2' ' A' ' 234' ' ' GLY . 24.6 p -97.29 144.4 27.11 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.89 -174.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.425 HG21 ' CD1' ' A' ' 256' ' ' LEU . 1.5 t 59.73 -36.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 96.15 -105.7 3.27 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 120.655 1.57 . . . . 0.0 112.498 -177.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.64 ' HB3' ' O ' ' A' ' 187' ' ' PHE . 78.1 mtt180 55.27 -131.84 1.83 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.648 0.737 . . . . 0.0 110.847 177.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.46 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -160.09 169.43 23.37 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 175.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . 0.496 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 24.9 t90 -149.69 145.4 26.68 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.606 -173.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 81.8 -178.33 53.71 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-O 121.527 0.515 . . . . 0.0 114.237 172.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.478 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 86.9 m-70 -131.62 130.29 22.35 Favored Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . 0.478 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 18.8 Cg_endo -57.03 156.1 28.53 Favored 'Cis proline' 0 C--N 1.353 0.774 0 C-N-CA 124.002 -1.249 . . . . 0.0 111.044 -4.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 58.3 m -67.51 78.46 0.17 Allowed 'General case' 0 C--N 1.32 -0.683 0 O-C-N 123.579 0.549 . . . . 0.0 111.923 -173.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -53.94 115.15 1.87 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.034 0.445 . . . . 0.0 110.853 173.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' MET . . . . . 0.46 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 0.0 OUTLIER -91.1 132.66 35.91 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.032 -174.016 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 70.8 m -97.94 124.04 49.18 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -167.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -62.26 152.63 75.26 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 123.968 3.112 . . . . 0.0 113.65 165.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -39.84 103.5 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.125 0 CA-C-O 122.284 1.04 . . . . 0.0 112.043 162.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 18.24 102.46 0.02 OUTLIER Pre-proline 0 C--N 1.311 -1.106 0 CA-C-N 111.335 -2.666 . . . . 0.0 114.42 -175.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -52.93 -49.88 16.04 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.893 2.395 . . . . 0.0 112.196 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -85.5 111.2 35.26 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.19 64.91 7.0 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.071 2.514 . . . . 0.0 114.265 -172.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 81.0 m -96.69 -84.52 0.36 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 168.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.408 ' HB3' ' CD2' ' A' ' 235' ' ' PHE . 14.4 ttm180 -145.98 135.72 23.34 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 168.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -39.16 -39.53 0.61 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -174.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.58 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -80.82 9.34 52.69 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 120.279 -0.963 . . . . 0.0 113.947 -176.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . 0.513 ' HE2' ' N ' ' A' ' 267' ' ' GLY . 1.9 m-85 -121.96 152.38 39.75 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -168.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.444 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.0 OUTLIER -129.89 131.82 23.75 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 114.047 -1.433 . . . . 0.0 107.778 169.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -63.41 111.59 1.51 Allowed 'Trans proline' 0 C--O 1.238 0.496 0 C-N-CA 122.173 1.915 . . . . 0.0 111.238 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -55.42 127.57 30.22 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.057 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 40.4 pt -80.9 12.35 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.14 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -110.46 -39.55 4.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.612 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 78.6 p -111.98 -39.51 4.49 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.95 0.881 . . . . 0.0 110.336 -177.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 102.03 6.07 49.27 Favored Glycine 0 N--CA 1.437 -1.253 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -175.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -97.39 119.7 36.4 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-O 122.079 0.942 . . . . 0.0 110.493 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 3.7 m -55.62 123.54 14.39 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.266 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -123.36 143.51 50.06 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.588 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 8.1 t70 -78.49 145.92 34.69 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.109 0.481 . . . . 0.0 110.32 -178.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.596 HG23 ' HG3' ' A' ' 249' ' ' GLU . 5.3 m -94.97 145.57 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.872 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.35 77.07 1.87 Allowed 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 168.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.596 ' HG3' HG23 ' A' ' 247' ' ' VAL . 35.9 mp0 -53.12 -33.94 54.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 124.375 1.047 . . . . 0.0 110.198 -172.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 7.7 m -46.91 -41.28 15.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.523 173.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -98.79 -42.17 7.32 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.648 0.737 . . . . 0.0 110.302 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.01 -28.62 69.63 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.463 -174.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.519 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.7 mp -123.72 83.13 54.25 Favored Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 173.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.6 122.96 12.67 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.767 2.311 . . . . 0.0 113.919 -166.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 65.41 27.03 72.06 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 113.554 -1.657 . . . . 0.0 113.435 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.519 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.3 OUTLIER -74.46 -28.85 61.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 118.108 0.954 . . . . 0.0 110.407 177.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 51.5 t -85.97 86.76 7.35 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.776 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -74.16 -19.49 60.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.448 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -54.02 -50.3 55.68 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.348 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 175.73 -93.45 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.069 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -110.25 135.76 50.5 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 40.4 t -104.44 134.16 48.1 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 175.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 25.5 mt -131.01 105.78 11.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -70.08 125.4 26.66 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.534 -170.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 268' ' ' SER . 0.1 OUTLIER -110.83 156.23 21.42 Favored 'General case' 0 C--O 1.256 1.398 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.865 155.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.588 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 3.9 m -74.44 127.14 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 C-N-CA 118.155 -1.418 . . . . 0.0 107.876 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.513 ' N ' ' HE2' ' A' ' 235' ' ' PHE . . . 111.28 -25.13 14.37 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.521 -172.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.561 ' O ' HG23 ' A' ' 265' ' ' THR . 27.5 t 173.56 152.61 0.09 Allowed 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.476 0.655 . . . . 0.0 109.613 -174.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -102.78 155.96 17.97 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -110.54 129.75 55.72 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 33.7 m -102.65 134.2 46.4 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.771 177.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -115.81 128.44 55.84 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.404 -177.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 19.3 m -129.57 168.52 16.08 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.724 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.62 155.35 21.87 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.212 1.941 . . . . 0.0 110.904 165.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.56 159.67 21.21 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.889 0.376 . . . . 0.0 110.779 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 89.41 -33.15 4.43 Favored Glycine 0 CA--C 1.504 -0.65 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.325 -174.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -72.15 156.22 39.41 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 120.806 0.336 . . . . 0.0 111.12 -176.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 60.5 mttp -137.06 129.2 29.5 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -174.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.437 HD12 ' O ' ' A' ' 285' ' ' LYS . 32.7 tp -77.35 143.45 38.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 122.035 0.922 . . . . 0.0 112.622 -169.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -124.12 100.45 6.72 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 114.366 -1.288 . . . . 0.0 107.833 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -69.94 -9.72 56.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.118 0.485 . . . . 0.0 111.691 -174.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 62.0 t -64.2 -59.02 4.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-O 121.193 0.521 . . . . 0.0 110.095 174.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 13.8 p -116.41 27.47 9.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.408 -176.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 31.14 51.67 0.14 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.805 -170.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . 0.437 ' O ' HD12 ' A' ' 279' ' ' LEU . 85.2 tttt -106.79 171.36 7.41 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' CYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 25.5 p -160.6 114.79 2.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 118.018 0.372 . . . . 0.0 110.318 177.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 N--CA 1.441 -0.916 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -175.584 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -92.59 11.37 26.78 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.756 0.312 . . . . 0.0 111.468 -177.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.3 m -101.32 26.03 7.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.245 0.545 . . . . 0.0 110.681 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -118.34 158.75 24.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.809 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.0 t -80.35 77.87 7.09 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 174.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.6 mt -85.18 142.79 12.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.157 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 64.71 44.93 3.61 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.42 0.629 . . . . 0.0 110.775 -176.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -78.9 -24.9 43.84 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.097 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 16.9 p -75.15 -179.33 4.33 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.352 176.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -115.86 -55.28 2.44 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.97 -176.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.522 ' N ' ' HD2' ' A' ' 122' ' ' ARG . 0.2 OUTLIER -119.03 156.61 29.34 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.426 -178.156 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 86.7 m -117.35 137.02 52.73 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.785 0.326 . . . . 0.0 111.621 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 63.6 mtm -141.83 140.45 32.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.828 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 70.12 55.91 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.088 0.47 . . . . 0.0 111.898 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.432 ' O ' ' HG3' ' A' ' 137' ' ' GLN . . . 79.12 39.01 20.94 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.787 171.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -112.4 151.98 17.96 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 119.609 -1.281 . . . . 0.0 113.853 176.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.0 m -111.28 126.76 55.23 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 175.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 9.6 t -75.35 122.07 23.19 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 -171.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 69.9 m -139.59 133.91 31.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.05 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.3 t70 44.06 -105.64 0.09 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.625 0.77 . . . . 0.0 112.468 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -130.25 27.96 5.03 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.952 0.882 . . . . 0.0 109.731 177.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -157.95 121.49 4.01 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.646 0.736 . . . . 0.0 109.621 -177.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 44.8 t -85.72 134.93 33.93 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.205 -170.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 49.4 mt -83.07 126.17 32.27 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 72.3 m -102.33 149.17 24.61 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.436 -171.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 126' ' ' GLY . 51.3 mt-30 -69.17 152.55 44.98 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 170.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -59.37 114.63 2.76 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 122.28 1.038 . . . . 0.0 111.353 -176.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 117.23 3.89 16.69 Favored Glycine 0 C--N 1.3 -1.462 0 CA-C-N 112.838 -1.983 . . . . 0.0 111.447 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.42 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 88.5 m-85 -126.38 145.94 50.26 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.442 -0.446 . . . . 0.0 109.995 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 31.8 pt -139.28 -178.15 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.758 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.697 -173.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.51 153.88 28.51 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.636 -168.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.0 p -64.55 -33.31 75.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.819 0.343 . . . . 0.0 111.788 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -110.87 28.1 9.04 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 79.1 m 56.69 -124.99 1.89 Allowed 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.029 -169.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.65 -39.69 2.55 Favored Glycine 0 C--N 1.292 -1.913 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.402 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.88 118.91 60.91 Favored Pre-proline 0 C--O 1.219 -0.539 0 CA-C-N 117.828 0.814 . . . . 0.0 111.073 -174.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -87.21 139.68 5.28 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.966 2.444 . . . . 0.0 112.411 175.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 149' ' ' VAL . 10.7 p -71.15 103.29 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 122.261 1.029 . . . . 0.0 111.291 -175.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.38 74.39 9.36 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 121.668 -0.645 . . . . 0.0 110.153 175.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -54.3 -48.07 71.71 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -169.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 69.8 m -90.81 18.65 6.27 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.499 0.666 . . . . 0.0 110.546 -168.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 74.97 128.85 0.2 Allowed Glycine 0 N--CA 1.427 -1.926 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.676 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . 0.411 ' SG ' ' SG ' ' A' ' 160' ' ' CYS . 1.7 m -77.34 154.63 32.63 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.186 -1.007 . . . . 0.0 109.316 172.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 50.1 mt -148.93 158.89 44.51 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.663 -166.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.512 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 2.8 t-20 52.58 27.88 5.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.899 -163.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.18 36.4 93.18 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.667 -172.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -64.88 151.77 51.08 Favored Glycine 0 N--CA 1.437 -1.279 0 CA-C-O 122.226 0.904 . . . . 0.0 114.257 -175.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.5 ttt85 -96.31 117.76 31.47 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 113.739 -1.23 . . . . 0.0 112.006 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . 0.411 ' SG ' ' SG ' ' A' ' 154' ' ' CYS . 3.7 m -62.83 126.18 26.48 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 165' ' ' ARG . 19.7 m -114.77 -41.82 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -176.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -138.26 175.49 3.33 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.42 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 17.1 Cg_exo -63.06 108.11 0.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 121.044 1.163 . . . . 0.0 111.721 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 74.4 16.17 3.36 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.703 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.435 ' O ' HG22 ' A' ' 161' ' ' VAL . 1.8 mtm180 -112.83 95.31 5.34 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.545 169.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 9.1 t -87.82 151.98 22.45 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.753 171.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -105.33 120.03 40.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.457 0.646 . . . . 0.0 109.639 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 63.7 m -74.88 124.12 26.31 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.002 -170.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.512 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 77.0 m -60.0 -41.43 92.07 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.455 177.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.48 ' CG ' ' N ' ' A' ' 171' ' ' GLY . 52.5 t80 -140.23 -131.04 0.11 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.296 -176.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.48 ' N ' ' CG ' ' A' ' 170' ' ' TYR . . . -80.82 57.9 4.78 Favored Glycine 0 N--CA 1.435 -1.416 0 CA-C-N 116.157 -0.474 . . . . 0.0 113.148 -165.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.54 ' CD2' ' N ' ' A' ' 172' ' ' PHE . 4.3 m-85 -121.3 125.57 47.38 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 119.714 -0.795 . . . . 0.0 111.527 170.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 3.4 t -90.41 158.57 17.02 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 168.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 87.23 130.84 3.14 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -177.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -75.17 21.29 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 121.498 1.466 . . . . 0.0 114.23 -165.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -120.36 -6.34 9.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.458 0.647 . . . . 0.0 110.029 176.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.44 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.3 OUTLIER 42.81 49.82 5.09 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -175.449 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -106.27 -15.33 14.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.281 0.562 . . . . 0.0 109.664 174.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -57.85 -68.64 0.22 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.183 -1.371 . . . . 0.0 109.062 -175.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 36.5 t70 78.98 73.76 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.395 0.617 . . . . 0.0 110.159 165.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -91.38 67.54 5.7 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.8 1.286 . . . . 0.0 107.704 172.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 21.2 ttp85 -40.1 124.24 1.81 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 112.664 -2.062 . . . . 0.0 110.791 173.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 54.2 p -88.19 139.4 30.54 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.063 -171.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -160.01 146.72 13.09 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.47 129.29 12.7 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.202 1.935 . . . . 0.0 111.609 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . 0.569 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 85.3 m -81.24 117.51 21.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.966 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . 0.447 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 43.8 m-85 -92.99 153.82 18.51 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.098 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.407 HG23 ' HE ' ' A' ' 215' ' ' ARG . 85.5 m -118.21 -18.79 9.22 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -162.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.2 p -164.9 116.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 O-C-N 121.417 -0.802 . . . . 0.0 110.043 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.429 HD13 ' SG ' ' A' ' 221' ' ' CYS . 2.7 mt -127.01 121.59 58.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -164.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 31.0 p -107.89 177.15 4.9 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 153.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -66.72 -12.4 58.41 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 122.477 1.132 . . . . 0.0 108.597 173.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -78.21 -38.8 42.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.235 -176.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 41.9 ttm -162.31 140.63 8.86 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 -175.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 79.1 m -91.34 -23.91 19.95 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.257 0.551 . . . . 0.0 111.654 -176.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -157.45 -73.69 0.09 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 170.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 127.78 -32.74 3.41 Favored Glycine 0 C--N 1.321 -0.262 0 C-N-CA 120.159 -1.02 . . . . 0.0 111.798 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.404 ' O ' ' HB2' ' A' ' 199' ' ' LEU . 92.1 mt-30 -74.61 -44.92 48.35 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 122.166 0.187 . . . . 0.0 110.701 171.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 198' ' ' GLN . 3.9 mm? 72.04 132.03 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.825 0.703 . . . . 0.0 110.735 -176.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 47.3 t -141.5 152.14 43.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.711 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -108.3 22.12 27.54 Favored Glycine 0 CA--C 1.502 -0.72 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.74 114.22 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 172.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.3 t -102.99 99.73 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 CA-C-O 122.803 1.287 . . . . 0.0 111.093 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 7.4 t -133.3 -178.12 4.84 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 172.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 20.3 p -96.46 163.6 12.98 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.486 -174.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.413 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 72.2 tttt -59.31 -43.61 92.62 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.418 176.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.3 m -47.2 -54.47 10.67 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.391 174.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.478 ' CD1' HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -54.04 -62.29 1.75 Allowed 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.816 177.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 25.6 m -68.64 -22.17 64.42 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.351 -0.539 . . . . 0.0 112.361 -169.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 61.8 m -96.09 -27.8 14.91 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.376 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -66.59 -55.74 13.99 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 172.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.442 ' O ' ' N ' ' A' ' 214' ' ' GLY . 46.3 p -61.77 -154.04 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 112.519 -2.128 . . . . 0.0 112.405 176.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 36.0 m -36.89 -5.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 212' ' ' THR . . . 70.3 -153.77 52.06 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 120.565 1.53 . . . . 0.0 114.556 172.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.407 ' HE ' HG23 ' A' ' 188' ' ' THR . 1.7 mpp_? 99.41 -82.59 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.045 1.338 . . . . 0.0 110.131 169.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.447 ' HB3' ' HB2' ' A' ' 187' ' ' PHE . . . -174.29 168.11 3.99 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 118.026 0.375 . . . . 0.0 110.126 174.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . 0.6 ' O ' ' HB2' ' A' ' 222' ' ' GLU . 13.9 t90 -156.68 146.77 21.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 81.22 156.94 16.26 Favored Glycine 0 C--N 1.333 0.377 0 N-CA-C 114.63 0.612 . . . . 0.0 114.63 170.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.627 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 2.4 p-80 -130.91 136.29 28.67 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 172.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . 0.627 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 73.2 Cg_exo -50.94 143.13 8.05 Favored 'Cis proline' 0 C--N 1.352 0.745 0 C-N-CA 124.64 -0.983 . . . . 0.0 113.297 -0.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . 0.429 ' SG ' HD13 ' A' ' 190' ' ' ILE . 7.9 t -49.71 112.06 0.6 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.029 -171.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.6 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 49.8 mt-10 -103.09 103.71 13.81 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 34.4 mtm -87.81 131.14 34.63 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.846 -172.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 26.6 p -143.65 147.14 37.97 Favored Pre-proline 0 N--CA 1.466 0.354 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -173.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.04 169.33 6.16 Favored 'Trans proline' 0 CA--C 1.5 -1.191 0 C-N-CA 122.896 2.397 . . . . 0.0 112.293 165.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -78.9 -160.64 0.24 Allowed 'General case' 0 N--CA 1.414 -2.254 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 161.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -12.41 86.86 0.03 OUTLIER Pre-proline 0 C--N 1.299 -1.617 0 C-N-CA 126.413 1.885 . . . . 0.0 115.525 -170.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -73.23 -53.49 0.13 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.98 2.454 . . . . 0.0 111.118 174.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 -72.49 141.69 83.19 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.815 177.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -83.08 27.45 0.61 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.26 1.974 . . . . 0.0 113.841 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 68.4 m -83.48 -91.66 0.08 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.669 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 3.8 mpt_? -146.04 147.57 31.76 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 168.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -41.47 -46.83 3.57 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.464 0.477 . . . . 0.0 111.657 170.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 246' ' ' ASP . . . -77.44 7.0 41.65 Favored Glycine 0 C--O 1.224 -0.477 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.817 -176.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . 0.669 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 3.5 m-85 -119.36 142.19 48.38 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.075 0.941 . . . . 0.0 113.357 -170.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.1 125.76 25.72 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 113.918 -1.492 . . . . 0.0 108.975 174.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -67.14 123.3 10.74 Favored 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 122.498 2.132 . . . . 0.0 112.71 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -54.43 139.65 36.59 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.55 0.69 . . . . 0.0 111.033 175.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 31.0 mt -73.08 -16.81 17.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.36 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 47.2 mtm180 -101.34 -66.56 0.91 Allowed 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.682 0.753 . . . . 0.0 110.239 -176.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 28.9 p -76.17 -42.42 46.56 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.688 -175.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 99.26 7.87 53.99 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -85.3 127.27 34.27 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.896 0.855 . . . . 0.0 110.278 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 3.2 m -65.44 121.6 15.26 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.901 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 96.6 mt-30 -119.29 141.34 49.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.645 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.589 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 13.1 t70 -78.02 148.08 34.51 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.07 0.462 . . . . 0.0 110.321 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.487 HG23 ' HG3' ' A' ' 249' ' ' GLU . 5.4 m -100.05 151.28 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.848 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -73.24 77.43 1.31 Allowed 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 166.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.487 ' HG3' HG23 ' A' ' 247' ' ' VAL . 5.6 mp0 -51.26 -40.61 59.26 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.756 -175.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 32.0 m -35.83 -43.59 0.31 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 114.189 -1.369 . . . . 0.0 112.658 171.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -99.72 -31.77 11.38 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.188 0.518 . . . . 0.0 110.694 -174.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.01 -4.21 58.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.905 -170.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.567 ' HB ' ' CD2' ' A' ' 256' ' ' LEU . 54.8 mt -134.4 133.47 21.64 Favored Pre-proline 0 CA--C 1.557 1.243 0 CA-C-N 119.092 0.86 . . . . 0.0 113.193 -174.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -41.14 -73.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.078 1 C-N-CA 125.415 4.076 . . . . 0.0 115.171 -169.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -90.11 31.14 5.5 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.499 -169.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.567 ' CD2' ' HB ' ' A' ' 253' ' ' ILE . 0.6 OUTLIER -66.43 137.96 57.22 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.556 -0.857 . . . . 0.0 109.437 177.422 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . 0.458 ' SG ' ' HB3' ' A' ' 262' ' ' CYS . 7.9 p -55.82 99.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -167.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -92.07 -20.5 21.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.82 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -78.05 70.49 2.55 Favored Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 176.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 130.13 -148.48 18.55 Favored Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -174.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -109.08 146.12 34.53 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 117.033 0.417 . . . . 0.0 109.976 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . 0.458 ' HB3' ' SG ' ' A' ' 257' ' ' CYS . 17.8 p -127.91 147.38 50.46 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 172.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 53.3 mt -138.69 108.8 4.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.375 -167.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -73.36 114.45 11.59 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.747 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 268' ' ' SER . 0.2 OUTLIER -103.32 150.95 23.27 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 161.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.589 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 4.0 m -72.82 133.33 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 C-N-CA 117.553 -1.659 . . . . 0.0 107.503 177.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.545 ' N ' ' HE2' ' A' ' 235' ' ' PHE . . . 97.61 -19.54 54.25 Favored Glycine 0 N--CA 1.434 -1.494 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.607 -174.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.493 ' O ' HG23 ' A' ' 265' ' ' THR . 3.9 p 179.76 142.33 0.14 Allowed 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 117.399 0.599 . . . . 0.0 110.577 -175.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -97.98 156.74 16.49 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . 0.414 ' HG3' ' CG2' ' A' ' 265' ' ' THR . 8.8 mt-10 -117.83 155.69 29.67 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 58.4 m -123.21 154.89 38.13 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.948 0.88 . . . . 0.0 112.311 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -135.5 100.5 4.52 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.763 -1.562 . . . . 0.0 109.386 170.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 38.6 m -104.79 170.28 6.2 Favored Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.539 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.44 157.04 15.74 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 121.801 1.667 . . . . 0.0 111.019 171.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -58.27 154.24 13.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.185 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 87.46 -30.81 4.73 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.934 -176.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' HIS . . . . . 0.496 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 14.2 m-70 -70.66 155.4 40.8 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.176 0.512 . . . . 0.0 112.182 -176.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 99.2 mttt -138.68 133.81 32.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.284 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 15.5 tp -91.28 141.2 29.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.753 0.787 . . . . 0.0 111.44 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -126.76 101.59 6.68 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 174.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.66 -24.45 66.74 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 123.719 0.637 . . . . 0.0 111.387 -175.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 78.8 t -65.2 -43.97 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.488 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 47.3 t -118.92 20.56 12.74 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.276 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 36.13 43.48 0.22 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.737 -173.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 89.7 mttt -91.29 153.07 20.21 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 7.7 t -152.07 86.36 1.3 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.496 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 34.5 tt0 . . . . . 0 C--N 1.312 -1.06 0 CA-C-O 118.259 -0.877 . . . . 0.0 109.822 -173.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 26.1 m . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 121.286 0.565 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.17 140.6 21.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.679 -177.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.8 t -87.15 61.0 6.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -83.78 133.74 34.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.874 -173.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.5 p -70.41 -30.59 67.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.945 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 57.5 mt -70.56 128.27 33.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.738 173.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 63.11 56.14 1.81 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.673 0.749 . . . . 0.0 109.464 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -67.07 142.12 57.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.896 -176.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 58.4 m -71.13 -177.96 1.86 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.583 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -115.89 -20.68 9.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.356 0.598 . . . . 0.0 109.634 -176.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.59 125.38 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 CA-C-O 121.444 0.64 . . . . 0.0 110.268 176.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.28 128.21 24.47 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.55 175.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 42.3 m -116.51 115.58 26.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.605 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 85.8 mtp -90.75 156.5 18.02 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.361 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 66.72 47.59 1.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.142 0.496 . . . . 0.0 111.579 172.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 70.25 18.78 75.31 Favored Glycine 0 CA--C 1.516 0.108 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.311 173.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -54.28 131.48 45.61 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.636 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 22.8 m -79.23 158.55 27.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.416 -0.392 . . . . 0.0 110.386 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 53.8 t -86.97 99.1 11.63 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.386 0.612 . . . . 0.0 110.673 -176.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.581 ' HB3' ' O ' ' A' ' 133' ' ' HIS . 29.0 t -112.32 139.99 47.41 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 175.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' ' 132' ' ' ASP . 7.4 m-20 -43.14 72.85 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 116.172 1.916 . . . . 0.0 116.172 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 130' ' ' SER . 27.3 t70 109.53 -25.08 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.715 1.606 . . . . 0.0 110.048 164.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.581 ' O ' ' HB3' ' A' ' 130' ' ' SER . 0.3 OUTLIER -119.92 147.59 44.54 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.257 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 69.2 m -81.32 158.95 24.56 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.921 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 40.0 mt -123.63 104.53 9.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 31.3 m -69.32 176.44 3.34 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.804 -168.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -92.69 141.82 28.05 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 173.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -63.46 110.04 1.82 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.521 1.153 . . . . 0.0 110.929 -167.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 142.62 -15.94 2.45 Favored Glycine 0 N--CA 1.433 -1.542 0 CA-C-N 112.584 -2.098 . . . . 0.0 109.948 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.456 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 95.7 m-85 -118.99 153.19 35.05 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.548 170.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 33.9 pt -132.2 172.49 16.28 Favored 'Isoleucine or valine' 0 C--O 1.245 0.838 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 174.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.75 158.62 24.6 Favored Glycine 0 N--CA 1.45 -0.368 0 O-C-N 124.014 0.821 . . . . 0.0 112.208 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.7 p -70.76 -25.82 63.08 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.507 -0.407 . . . . 0.0 111.48 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -100.5 -8.29 23.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.932 0.396 . . . . 0.0 109.992 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 86.1 m 69.03 40.52 1.58 Allowed 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.483 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.98 3.97 48.87 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.194 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.31 111.54 61.59 Favored Pre-proline 0 N--CA 1.464 0.255 0 CA-C-N 117.502 0.651 . . . . 0.0 110.819 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -82.8 143.2 11.68 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.173 2.582 . . . . 0.0 112.998 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.3 p -71.75 115.87 12.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.641 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.547 ' HB3' ' O ' ' A' ' 153' ' ' GLY . 0.9 OUTLIER -80.73 78.25 7.51 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 172.343 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -52.27 -60.61 3.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.268 -173.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 17.8 m -94.84 14.52 21.18 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.057 0.456 . . . . 0.0 110.923 -175.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.547 ' O ' ' HB3' ' A' ' 150' ' ' CYS . . . 106.88 -117.32 5.29 Favored Glycine 0 N--CA 1.415 -2.701 0 CA-C-O 122.888 1.271 . . . . 0.0 111.601 -178.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . 0.42 ' O ' HD23 ' A' ' 155' ' ' LEU . 0.6 OUTLIER 162.22 141.24 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 -172.349 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.505 HD12 ' O ' ' A' ' 176' ' ' GLN . 39.1 mt -132.58 170.7 14.81 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 -163.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.661 ' HB3' ' CZ ' ' A' ' 172' ' ' PHE . 9.6 p30 45.5 21.61 0.08 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -174.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 67.37 37.87 90.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.296 -174.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -75.4 -146.76 1.56 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.575 -0.345 . . . . 0.0 112.689 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -157.95 124.87 4.96 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 122.68 -0.306 . . . . 0.0 110.955 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.4 m -61.96 125.39 23.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.62 0.248 . . . . 0.0 111.31 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 165' ' ' ARG . 4.2 m -112.18 -46.91 5.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.859 -0.337 . . . . 0.0 110.453 177.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -128.97 176.1 3.05 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 118.45 -0.786 . . . . 0.0 109.859 170.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.456 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 82.0 Cg_exo -50.67 103.78 0.07 OUTLIER 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 122.524 2.149 . . . . 0.0 113.298 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.1 t30 67.09 5.31 4.05 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.377 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.434 ' O ' HG22 ' A' ' 161' ' ' VAL . 1.7 ttm180 -89.02 82.5 6.65 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 169.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 35.8 t -85.48 137.73 32.71 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -88.9 127.87 35.65 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 35.2 m -109.94 134.03 52.53 Favored 'General case' 0 C--O 1.239 0.502 0 O-C-N 124.231 0.957 . . . . 0.0 112.028 -168.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 91.4 m -56.16 -56.28 22.87 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -165.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -161.9 -87.98 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.06 -1.056 . . . . 0.0 112.901 -166.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -85.81 46.95 3.71 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.564 -165.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.661 ' CZ ' ' HB3' ' A' ' 156' ' ' ASN . 6.9 m-85 -121.28 130.83 53.86 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.922 170.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.54 ' N ' ' HE1' ' A' ' 181' ' ' TYR . 3.5 t -97.37 138.28 35.07 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 173.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 99.12 126.06 5.56 Favored Glycine 0 C--N 1.299 -1.502 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -169.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -67.86 -0.22 5.15 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.55 1.5 . . . . 0.0 113.301 -170.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.505 ' O ' HD12 ' A' ' 155' ' ' LEU . 45.7 tt0 -111.64 24.34 12.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.39 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 1.2 p 23.96 60.92 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 117.506 2.41 . . . . 0.0 117.506 174.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -113.84 26.17 10.57 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.508 1.147 . . . . 0.0 109.441 169.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 17.6 mmt85 -120.9 84.66 2.27 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.597 -1.638 . . . . 0.0 108.592 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -82.72 76.88 9.54 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.828 -172.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.54 ' HE1' ' N ' ' A' ' 173' ' ' THR . 20.4 p90 -111.94 83.29 1.77 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.757 173.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 61.1 mtt85 -84.45 145.7 28.01 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 119.542 -1.974 . . . . 0.0 107.157 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 73.2 p -91.47 135.22 34.0 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.401 -175.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -159.49 162.5 32.92 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.162 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.21 128.56 10.63 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.215 1.943 . . . . 0.0 111.796 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 10.5 t -85.0 115.65 22.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.275 0.56 . . . . 0.0 110.452 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . 0.536 ' O ' ' HB2' ' A' ' 215' ' ' ARG . 42.6 m-85 -101.69 151.51 21.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.435 -175.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.52 ' HA ' ' CB ' ' A' ' 215' ' ' ARG . 15.4 p -114.42 -23.95 9.1 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -170.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 27.0 t -155.69 116.99 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -171.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 4.0 mt -130.14 118.42 43.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 119.012 -1.075 . . . . 0.0 113.892 -170.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.5 p -112.76 -166.81 1.11 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.566 161.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -67.51 -5.48 15.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.619 0.724 . . . . 0.0 110.388 172.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -92.47 -76.53 0.46 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.43 -173.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 53.1 ttm -136.17 136.31 39.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.826 -172.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 196' ' ' GLN . 29.0 m -84.9 -15.47 44.43 Favored 'General case' 0 C--O 1.247 0.925 0 O-C-N 123.342 0.401 . . . . 0.0 110.823 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 72.3 mm-40 95.09 -165.06 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.211 1.405 . . . . 0.0 112.658 174.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 69.17 -3.57 7.22 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 114.992 -1.003 . . . . 0.0 113.03 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 51.01 39.59 23.43 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.965 0.383 . . . . 0.0 110.263 -172.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 58.0 58.7 3.45 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.579 -177.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 33.5 t -72.85 147.83 45.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.692 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -91.01 26.46 11.13 Favored Glycine 0 CA--C 1.506 -0.511 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.08 106.47 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-O 121.95 0.881 . . . . 0.0 109.356 174.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 12.6 t -94.63 118.9 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.144 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 18.7 t -156.22 179.72 8.96 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 10.7 p -102.37 160.21 14.75 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 120.184 1.356 . . . . 0.0 109.736 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.49 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 37.8 tttm -59.01 -42.26 89.66 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.503 177.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.0 m -44.87 -56.62 4.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.332 174.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.09 -53.74 49.05 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.665 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 91.5 m -67.94 -23.48 65.07 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -174.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 61.4 m -93.84 -34.79 13.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.542 0.61 . . . . 0.0 111.649 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -72.67 -58.12 3.6 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.705 HG22 ' HA2' ' A' ' 234' ' ' GLY . 4.6 p -97.83 159.74 14.74 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.258 177.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.1 t 66.97 -48.42 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 122.565 0.346 . . . . 0.0 111.729 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 60.63 52.03 55.04 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 114.796 0.679 . . . . 0.0 114.796 171.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' A' ' 187' ' ' PHE . 0.0 OUTLIER -123.41 -78.2 0.6 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.813 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.402 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -173.28 167.24 4.81 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . 0.494 ' O ' ' HB2' ' A' ' 222' ' ' GLU . 19.5 t90 -159.61 148.16 17.62 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 92.59 177.48 41.32 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 114.74 0.656 . . . . 0.0 114.74 168.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.523 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 12.2 p80 -143.01 132.14 11.67 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.132 -0.534 . . . . 0.0 109.707 177.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . 0.523 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 52.1 Cg_exo -56.65 148.11 26.29 Favored 'Cis proline' 0 C--N 1.346 0.411 0 C-N-CA 123.694 -1.378 . . . . 0.0 111.444 -4.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 80.0 m -47.22 122.81 4.84 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.795 0.685 . . . . 0.0 111.845 -173.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 33.6 mm-40 -108.35 112.5 24.98 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' MET . . . . . 0.402 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 10.4 ptm -94.38 133.79 37.58 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.269 0.557 . . . . 0.0 110.911 -172.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 74.2 m -94.12 125.16 53.71 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.198 -0.91 . . . . 0.0 113.397 -164.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -64.76 154.21 73.79 Favored 'Trans proline' 0 CA--C 1.512 -0.584 0 C-N-CA 123.092 2.528 . . . . 0.0 113.188 166.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -38.29 104.4 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 122.772 1.272 . . . . 0.0 111.93 163.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 18.52 88.24 0.05 OUTLIER Pre-proline 0 N--CA 1.483 1.189 0 CA-C-N 110.507 -3.042 . . . . 0.0 114.778 174.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -38.04 -55.93 1.08 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 124.387 3.391 . . . . 0.0 113.246 173.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -80.51 106.0 4.59 Favored Pre-proline 0 CA--C 1.518 -0.277 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 170.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.1 35.53 0.3 Allowed 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.112 1.875 . . . . 0.0 114.247 -171.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 33.8 m -69.22 -74.81 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 169.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.458 ' HB3' ' CD2' ' A' ' 235' ' ' PHE . 24.0 tpt180 -149.47 140.4 22.85 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 165.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -36.3 -45.46 0.47 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -177.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.705 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -78.8 9.97 34.55 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.93 -174.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . 0.534 ' HE2' ' N ' ' A' ' 267' ' ' GLY . 2.2 m-85 -116.53 138.39 51.44 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 122.009 0.909 . . . . 0.0 113.426 -169.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.48 137.07 29.61 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.601 173.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.61 124.41 16.01 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.658 2.239 . . . . 0.0 112.92 -177.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -58.27 141.66 50.23 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.652 173.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 26.3 mt -81.45 -13.82 12.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.079 -174.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 65.1 mtt180 -99.57 -59.01 1.8 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.335 0.588 . . . . 0.0 109.823 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 43.8 p -86.63 -33.96 19.97 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.879 -176.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 90.3 5.77 69.5 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -177.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -83.46 134.02 34.88 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 121.591 0.71 . . . . 0.0 110.349 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 4.0 m -59.45 118.73 6.36 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.273 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 83.1 mm-40 -120.38 143.03 48.65 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.602 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 14.9 t70 -79.11 146.16 33.36 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -176.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.615 HG23 ' HG3' ' A' ' 249' ' ' GLU . 5.3 m -98.68 148.22 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.047 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.856 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -75.8 77.28 2.73 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 167.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.615 ' HG3' HG23 ' A' ' 247' ' ' VAL . 40.4 mp0 -53.57 -37.66 63.14 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 123.482 0.489 . . . . 0.0 111.689 -168.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 36.0 t -50.59 -40.47 52.64 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.121 0.486 . . . . 0.0 110.616 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -93.78 -40.32 10.26 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.591 0.71 . . . . 0.0 110.125 -172.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -67.49 -25.01 65.65 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.588 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.1 mp -121.3 83.76 40.11 Favored Pre-proline 0 N--CA 1.449 -0.525 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 173.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -65.34 8.81 0.21 Allowed 'Trans proline' 0 N--CA 1.482 0.813 0 C-N-CA 124.411 3.408 . . . . 0.0 116.379 -168.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -129.81 8.4 6.11 Favored Glycine 0 C--N 1.295 -1.708 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.755 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.65 136.41 42.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.212 0.529 . . . . 0.0 112.189 -174.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 10.7 t 56.78 54.43 7.22 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.681 178.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -94.28 -17.63 22.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.257 177.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -87.8 40.57 3.08 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.434 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 164.03 -160.6 33.52 Favored Glycine 0 N--CA 1.437 -1.234 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -81.41 156.47 25.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.921 0.361 . . . . 0.0 110.425 177.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 15.4 p -138.92 121.14 15.84 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 176.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 16.6 mt -136.16 164.1 32.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -174.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -134.61 132.12 38.65 Favored 'General case' 0 CA--C 1.496 -1.109 0 C-N-CA 117.789 -1.564 . . . . 0.0 114.36 -175.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.89 160.36 20.99 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.867 162.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.602 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 3.0 m -73.1 128.12 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 173.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.534 ' N ' ' HE2' ' A' ' 235' ' ' PHE . . . 112.45 -22.17 17.97 Favored Glycine 0 N--CA 1.419 -2.439 0 C-N-CA 119.977 -1.106 . . . . 0.0 112.147 -173.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 267' ' ' GLY . 8.5 t 166.77 165.04 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.342 0.592 . . . . 0.0 110.18 -177.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -101.15 155.45 18.0 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 119.864 -0.735 . . . . 0.0 109.965 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -109.93 123.86 50.37 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -177.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 66.3 m -114.0 129.07 56.63 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.399 0.618 . . . . 0.0 110.156 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -102.61 114.49 28.76 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.838 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 70.0 m -91.6 148.09 36.59 Favored Pre-proline 0 C--N 1.296 -1.74 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.311 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -52.81 152.67 16.68 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.006 1.804 . . . . 0.0 110.927 173.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -51.61 139.95 19.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.884 0.373 . . . . 0.0 111.115 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 86.92 -34.77 3.5 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.301 -0.952 . . . . 0.0 111.353 -176.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' HIS . . . . . 0.494 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 17.8 m-70 -80.24 163.33 24.08 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 120.968 0.413 . . . . 0.0 110.893 -176.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -146.29 133.71 20.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.561 -173.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.409 HD12 ' O ' ' A' ' 285' ' ' LYS . 46.8 tp -66.56 142.57 57.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.991 0.424 . . . . 0.0 111.063 -176.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -131.23 99.47 4.87 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -61.32 -17.15 52.37 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.861 0.725 . . . . 0.0 112.624 -176.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 215' ' ' ARG . 77.0 t -58.01 -39.48 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.183 0.516 . . . . 0.0 110.597 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 57.7 p -140.89 36.9 1.78 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.951 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 28.25 50.92 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.326 1.051 . . . . 0.0 112.897 -174.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . 0.409 ' O ' HD12 ' A' ' 279' ' ' LEU . 68.9 tttt -104.44 169.59 8.38 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.699 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 53.7 m -141.65 100.21 3.72 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 57.8 mm-40 . . . . . 0 C--O 1.24 0.563 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -173.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.5 t . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.01 -47.05 48.46 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.869 0.366 . . . . 0.0 110.408 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.4 p -123.0 169.25 11.36 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.855 176.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -57.46 -54.9 41.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.143 0.497 . . . . 0.0 109.948 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 46.4 m -105.45 133.09 50.78 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.335 172.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.4 tt -57.77 -29.88 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.856 -177.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -78.03 126.88 31.48 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -68.04 111.52 4.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.76 0.314 . . . . 0.0 110.327 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 26.7 p -114.38 -174.71 2.53 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -119.52 -50.01 2.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.898 0.38 . . . . 0.0 110.372 -176.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.67 -178.31 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.22 142.08 51.54 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.308 -175.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 65.6 m -116.09 134.97 54.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.13 0.491 . . . . 0.0 111.914 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -125.81 162.65 24.65 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 170.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 66.17 43.57 2.81 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.003 0.43 . . . . 0.0 111.9 174.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 65.84 30.84 78.01 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 116.011 -0.54 . . . . 0.0 113.868 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -84.46 143.47 20.93 Favored Glycine 0 C--O 1.234 0.151 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.292 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.9 t -93.23 134.39 35.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.31 0.576 . . . . 0.0 109.463 176.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 11.3 t -99.76 113.2 25.53 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.728 -172.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 40.3 t -130.06 125.26 34.79 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 43.86 -102.85 0.05 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.385 0.674 . . . . 0.0 112.406 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -123.38 34.13 5.18 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.711 -176.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -155.83 141.76 18.12 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.986 0.422 . . . . 0.0 110.348 177.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 38.3 t -102.87 131.79 49.53 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.831 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.8 mt -90.86 97.42 11.17 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.627 0.727 . . . . 0.0 109.349 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . 0.859 ' SG ' ' HB2' ' A' ' 140' ' ' TYR . 42.4 t -74.92 157.0 35.75 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.976 -173.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -85.54 156.18 20.87 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.48 176.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -69.83 110.6 5.05 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 122.923 1.344 . . . . 0.0 110.839 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 136.79 -6.52 3.8 Favored Glycine 0 C--N 1.293 -1.812 0 CA-C-N 111.94 -2.391 . . . . 0.0 110.258 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.859 ' HB2' ' SG ' ' A' ' 136' ' ' CYS . 67.7 m-85 -130.63 162.16 29.99 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 168.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 32.6 pt -138.4 -176.33 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.865 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.03 167.61 43.17 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.302 -174.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 34.4 p -77.99 -10.98 59.86 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.778 -0.248 . . . . 0.0 111.516 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 30.7 m80 -109.28 -3.76 16.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.047 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 9.5 t 66.1 26.26 10.71 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.35 0.595 . . . . 0.0 109.623 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -96.09 4.14 64.96 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.615 -0.721 . . . . 0.0 113.076 -173.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 140' ' ' TYR . 0.1 OUTLIER -110.91 108.08 57.74 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.027 -178.297 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -74.06 140.72 28.66 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.119 2.546 . . . . 0.0 112.983 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 149' ' ' VAL . 13.6 p -78.38 103.59 5.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.34 1.067 . . . . 0.0 111.363 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -81.95 82.89 7.42 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.646 174.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -56.33 -69.09 0.16 Allowed 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -173.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 64.9 m -83.05 10.5 7.92 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.78 0.8 . . . . 0.0 110.659 -163.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 71.72 132.31 0.12 Allowed Glycine 0 N--CA 1.424 -2.13 0 CA-C-N 114.374 -1.285 . . . . 0.0 111.491 -170.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 62.4 m -68.06 151.5 46.95 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.23 -0.985 . . . . 0.0 109.503 175.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 38.6 mt -132.36 175.39 9.32 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -172.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.672 ' HB2' ' CZ ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 66.88 11.52 8.36 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 123.791 0.682 . . . . 0.0 112.124 170.615 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.61 32.07 80.06 Favored Glycine 0 CA--C 1.507 -0.458 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -172.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -77.76 -145.55 2.44 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.276 -0.462 . . . . 0.0 114.1 -175.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -149.76 114.13 5.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.63 0.252 . . . . 0.0 110.491 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 35.1 t -58.78 113.77 2.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.891 0.377 . . . . 0.0 110.634 174.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 165' ' ' ARG . 13.0 m -106.96 -46.13 8.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.921 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.438 ' HB1' ' HD2' ' A' ' 163' ' ' PRO . . . -134.11 178.06 1.95 Allowed Pre-proline 0 CA--C 1.541 0.622 0 CA-C-O 118.72 -0.657 . . . . 0.0 109.981 175.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.438 ' HD2' ' HB1' ' A' ' 162' ' ' ALA . 96.2 Cg_exo -49.05 103.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 122.661 2.241 . . . . 0.0 113.589 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 66.31 8.94 6.01 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.238 1.015 . . . . 0.0 109.958 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.497 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -93.08 81.24 4.54 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.613 174.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 63.7 m -85.74 138.75 31.88 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.277 172.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.96 139.16 30.8 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 61.0 m -92.65 110.44 21.87 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 124.182 0.926 . . . . 0.0 111.601 -169.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 24.1 m -65.84 -55.28 17.88 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.44 ' CD2' ' N ' ' A' ' 171' ' ' GLY . 38.0 t80 -121.36 -116.41 0.31 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 118.89 -1.124 . . . . 0.0 112.532 -168.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.44 ' N ' ' CD2' ' A' ' 170' ' ' TYR . . . -91.77 52.13 2.95 Favored Glycine 0 CA--C 1.485 -1.799 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.163 -166.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.672 ' CZ ' ' HB2' ' A' ' 156' ' ' ASN . 6.9 m-85 -119.06 127.8 53.74 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 119.302 -0.959 . . . . 0.0 112.598 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 3.6 t -91.0 162.71 14.6 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 163.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 90.96 131.25 4.92 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.36 -13.2 30.48 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.312 1.341 . . . . 0.0 113.322 -166.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -106.83 14.41 26.71 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.246 0.546 . . . . 0.0 109.601 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 31.33 60.22 0.27 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.735 1.214 . . . . 0.0 113.958 177.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -115.94 -13.92 11.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.925 175.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -56.44 -61.91 2.09 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.907 -1.497 . . . . 0.0 107.967 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 32.8 t70 74.45 69.83 0.1 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.78 0.8 . . . . 0.0 109.524 160.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.474 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 45.3 p90 -94.75 66.22 3.13 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 174.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -57.19 123.74 16.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.136 171.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.429 ' HB ' HG13 ' A' ' 203' ' ' VAL . 41.3 p -73.22 138.02 45.34 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -163.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -140.51 141.61 11.58 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.79 -162.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -72.12 128.66 14.15 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.964 1.776 . . . . 0.0 111.382 172.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 6.4 t -84.53 113.6 21.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.131 0.491 . . . . 0.0 110.09 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -94.6 147.05 23.68 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.766 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.45 ' HA ' ' CB ' ' A' ' 215' ' ' ARG . 12.9 p -113.5 -2.92 13.77 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.5 t -130.35 159.23 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.639 HD11 ' HB2' ' A' ' 216' ' ' ALA . 40.5 mm -134.55 119.34 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.562 0.696 . . . . 0.0 111.336 174.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 48.2 t -143.17 169.18 18.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.308 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -79.37 -7.5 58.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 122.369 1.081 . . . . 0.0 108.106 167.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -92.44 -71.45 0.64 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.476 -1.693 . . . . 0.0 109.655 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 63.2 mtt -143.83 136.55 27.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.927 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 34.3 m -85.17 -38.79 18.6 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 168.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 157.11 -149.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 113.423 -1.717 . . . . 0.0 106.969 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 94.13 17.21 41.12 Favored Glycine 0 CA--C 1.509 -0.338 0 C-N-CA 119.743 -1.218 . . . . 0.0 112.747 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -90.58 -1.99 57.88 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.227 0.536 . . . . 0.0 110.204 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.412 ' N ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -160.53 8.97 0.09 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.755 -177.392 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 12.6 m -87.97 86.07 7.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.313 0.578 . . . . 0.0 112.248 -169.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -100.25 4.19 57.01 Favored Glycine 0 CA--C 1.506 -0.509 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 170.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.14 114.33 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 114.435 -0.882 . . . . 0.0 109.576 173.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.429 HG13 ' HB ' ' A' ' 183' ' ' THR . 23.0 t -104.68 101.1 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 CA-C-O 122.974 1.369 . . . . 0.0 110.728 176.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 9.6 t -129.27 -176.8 3.99 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 112.529 -2.123 . . . . 0.0 106.204 174.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 26.7 p -107.9 165.6 11.34 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.143 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.751 ' HB3' ' CE3' ' A' ' 217' ' ' TRP . 21.7 ptmt -69.58 -22.02 63.56 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.526 174.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 8.4 m -57.59 -53.07 62.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 172.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.69 -56.43 22.06 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.737 175.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 68.7 m -67.99 -24.15 65.1 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.253 -172.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 78.2 m -101.9 -11.08 19.27 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -82.47 -50.74 8.51 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 164.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 214' ' ' GLY . 40.0 p -78.15 -156.76 0.09 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.886 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.7 t -19.82 -33.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 212' ' ' THR . . . 81.41 -165.33 46.44 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 119.796 -1.192 . . . . 0.0 114.429 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.45 ' CB ' ' HA ' ' A' ' 188' ' ' THR . 72.6 mmt-85 102.72 -80.29 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.837 1.655 . . . . 0.0 109.932 174.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.639 ' HB2' HD11 ' A' ' 190' ' ' ILE . . . -173.53 168.25 4.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 119.101 0.864 . . . . 0.0 110.347 175.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . 0.751 ' CE3' ' HB3' ' A' ' 206' ' ' LYS . 20.7 t90 -164.28 144.44 7.94 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 76.99 -174.27 54.52 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.0 -0.619 . . . . 0.0 113.014 175.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.448 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 31.1 p80 -135.64 131.71 19.36 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . 0.448 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 31.6 Cg_exo -59.94 165.2 26.71 Favored 'Cis proline' 0 N--CA 1.477 0.505 0 C-N-CA 123.733 -1.361 . . . . 0.0 111.821 -5.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 55.9 m -62.63 81.32 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -173.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 216' ' ' ALA . 5.7 mm-40 -50.29 97.93 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.31 0.576 . . . . 0.0 110.438 167.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 19.8 ptt? -99.42 131.89 45.12 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.162 -173.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 18.5 m -142.11 144.17 30.74 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.386 -173.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -59.87 168.17 6.08 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.897 2.398 . . . . 0.0 110.046 160.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.01 -96.3 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.876 0.37 . . . . 0.0 111.213 -176.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.28 113.34 45.67 Favored Pre-proline 0 C--N 1.32 -0.689 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.725 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -83.48 -41.24 0.1 OUTLIER 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.621 2.214 . . . . 0.0 113.698 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -103.89 173.57 3.32 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -174.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -60.19 -18.35 51.28 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.026 1.817 . . . . 0.0 112.011 174.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 14.8 t -64.07 124.69 22.26 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 172.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.481 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 45.3 mtt180 -63.45 135.23 56.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.386 -172.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -30.43 -44.54 0.05 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 246' ' ' ASP . . . -79.78 12.02 31.08 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.895 -1.145 . . . . 0.0 113.952 -173.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . 0.481 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 44.2 m-85 -125.05 158.55 33.47 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 117.994 0.897 . . . . 0.0 112.769 -175.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.28 130.53 21.97 Favored Pre-proline 0 N--CA 1.445 -0.695 0 CA-C-N 113.388 -1.733 . . . . 0.0 107.443 170.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.09 113.03 1.86 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.059 1.839 . . . . 0.0 111.509 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -47.13 130.0 12.52 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.665 0.745 . . . . 0.0 110.959 177.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 29.6 mt -74.49 -3.83 5.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.145 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -104.63 -60.09 1.65 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.913 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 34.9 p -86.41 -44.03 12.35 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.56 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 104.01 6.97 42.05 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.608 -177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -96.55 130.37 43.75 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 122.039 0.923 . . . . 0.0 110.134 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 93.9 m -49.48 120.76 4.39 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 113.066 -1.879 . . . . 0.0 110.465 171.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -120.61 136.07 54.92 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.498 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 19.0 t70 -74.09 141.36 45.67 Favored 'General case' 0 CA--C 1.492 -1.256 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.502 -174.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.515 HG23 ' HG3' ' A' ' 249' ' ' GLU . 4.2 m -93.34 143.94 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.441 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -74.2 76.4 1.8 Allowed 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 166.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.515 ' HG3' HG23 ' A' ' 247' ' ' VAL . 29.7 mp0 -49.04 -38.4 23.78 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.896 0.748 . . . . 0.0 111.18 -171.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 15.5 m -53.19 -32.07 46.05 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.639 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -105.53 -50.29 3.24 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.499 0.72 . . . . 0.0 110.776 -175.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -59.88 -26.93 66.27 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.141 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.591 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.5 mp -118.14 79.88 14.83 Favored Pre-proline 0 N--CA 1.447 -0.575 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 169.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -38.0 103.14 0.04 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.564 0 C-N-CA 124.451 3.434 . . . . 0.0 115.509 -169.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 59.96 38.24 93.87 Favored Glycine 0 C--N 1.312 -0.787 0 CA-C-N 113.667 -1.606 . . . . 0.0 113.77 172.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.591 ' HB3' HG22 ' A' ' 253' ' ' ILE . 1.7 pt? -66.46 -31.31 71.98 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.004 177.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 51.7 t -119.74 81.19 1.69 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.281 0.562 . . . . 0.0 109.669 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -117.41 26.05 10.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.142 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -70.83 -27.32 72.51 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 172.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -149.49 -116.29 0.81 Allowed Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 175.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . 0.417 HD22 ' N ' ' A' ' 262' ' ' CYS . 0.2 OUTLIER -112.61 131.17 55.75 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.639 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . 0.417 ' N ' HD22 ' A' ' 261' ' ' ASN . 49.1 t -102.5 140.45 36.76 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 172.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 22.5 mt -130.97 163.31 37.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.7 127.36 38.68 Favored 'General case' 0 CA--C 1.496 -1.131 0 C-N-CA 117.615 -1.634 . . . . 0.0 113.895 -174.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.4 t -113.68 165.56 12.41 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.076 163.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.498 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 30.7 m -70.46 125.36 28.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.83 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.472 ' HA2' ' CE2' ' A' ' 235' ' ' PHE . . . 97.05 -13.07 65.29 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-O 118.962 -0.91 . . . . 0.0 113.935 -177.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.0 t 178.68 157.5 0.49 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.732 1.266 . . . . 0.0 109.874 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -105.97 159.2 16.23 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.872 -0.518 . . . . 0.0 109.876 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -114.84 121.33 42.93 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 68.1 m -111.71 150.75 29.77 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 122.037 0.922 . . . . 0.0 111.917 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.28 109.56 7.83 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 113.503 -1.68 . . . . 0.0 109.694 175.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 10.1 m -84.56 164.4 42.88 Favored Pre-proline 0 C--N 1.314 -0.978 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 51.6 Cg_exo -53.31 156.41 10.69 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 121.921 1.747 . . . . 0.0 111.696 175.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -53.92 140.59 30.34 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.162 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 87.08 -28.55 5.53 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.421 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' HIS . . . . . 0.483 ' HB2' ' O ' ' A' ' 274' ' ' PRO . 21.5 m-70 -81.97 165.82 20.38 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.0 0.429 . . . . 0.0 111.587 -176.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -139.69 137.52 35.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.143 -172.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.404 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 14.9 tp -85.48 139.91 31.11 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.116 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -131.42 98.76 4.62 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.415 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -56.19 -30.53 62.39 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.214 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.41 ' O ' ' HB ' ' A' ' 188' ' ' THR . 42.0 t -56.08 -29.78 27.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.189 -176.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 67.6 m -145.16 33.32 1.09 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.599 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 32.28 45.15 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.914 -1.039 . . . . 0.0 113.474 -174.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 51.1 mttp -88.13 154.84 20.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.006 0.431 . . . . 0.0 111.95 -176.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 5.4 m -139.42 80.81 1.8 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.089 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 N--CA 1.44 -0.964 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -178.892 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.473 0.719 0 CA-C-O 121.095 0.474 . . . . 0.0 110.017 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -119.08 -11.5 9.63 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.173 177.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.4 p -101.7 127.67 48.35 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.282 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -100.73 -177.13 3.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.061 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.9 t -64.67 -50.39 67.23 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.096 0.474 . . . . 0.0 110.475 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 65.9 mt -87.68 -49.89 14.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.991 0.424 . . . . 0.0 110.383 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -87.4 94.82 9.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.101 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -79.51 160.09 26.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.175 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 41.5 t -173.1 139.24 0.8 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -177.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -123.97 -27.71 3.87 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.336 0.589 . . . . 0.0 110.279 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -77.79 -168.27 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.772 -176.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.48 134.47 55.07 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.266 0.555 . . . . 0.0 110.67 -177.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 72.4 m -106.37 124.62 49.87 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.694 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -115.3 150.75 35.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.206 174.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 70.88 52.61 0.28 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.295 0.569 . . . . 0.0 111.344 176.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 64.51 30.38 77.73 Favored Glycine 0 C--O 1.224 -0.472 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.037 176.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -77.21 133.39 13.22 Favored Glycine 0 N--CA 1.428 -1.871 0 C-N-CA 120.017 -1.087 . . . . 0.0 111.93 -176.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.7 m -89.7 124.53 34.69 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 174.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.1 148.64 43.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.196 -171.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.52 ' HB2' ' O ' ' A' ' 133' ' ' HIS . 39.8 m -144.25 169.57 17.65 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -41.24 -81.0 0.01 OUTLIER 'General case' 0 C--O 1.245 0.821 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -90.84 -40.3 11.85 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.964 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.52 ' O ' ' HB2' ' A' ' 130' ' ' SER . 0.3 OUTLIER -111.67 -170.55 1.67 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.886 -176.008 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 35.0 t -122.81 150.32 42.98 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.334 176.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.3 mt -100.31 95.05 6.51 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.932 0.872 . . . . 0.0 109.704 176.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 3.3 m -60.9 163.73 5.51 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.324 -175.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -64.79 155.45 33.82 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 170.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -66.39 114.4 5.39 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 122.571 1.177 . . . . 0.0 110.668 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 114.92 4.61 20.97 Favored Glycine 0 C--N 1.294 -1.783 0 CA-C-N 112.831 -1.986 . . . . 0.0 111.234 -175.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.598 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 55.7 m-85 -125.0 154.46 41.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.772 0.32 . . . . 0.0 110.412 171.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 36.0 pt -138.81 -177.81 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.718 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.805 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.38 164.05 22.73 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.363 -175.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 43.5 p -78.16 -39.93 39.39 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.931 0.396 . . . . 0.0 110.905 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -98.67 -10.57 23.07 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.472 176.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 71.4 m 78.99 154.63 0.14 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.054 -1.43 . . . . 0.0 113.476 174.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.41 2.4 4.08 Favored Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 112.913 -1.949 . . . . 0.0 113.808 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.43 ' C ' HE21 ' A' ' 147' ' ' GLN . 0.0 OUTLIER -93.31 104.72 13.04 Favored Pre-proline 0 C--N 1.317 -0.806 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.199 174.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.71 149.96 14.41 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.4 2.066 . . . . 0.0 112.325 -175.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.6 p -78.89 105.93 8.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 122.439 1.114 . . . . 0.0 112.611 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.06 80.15 6.51 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.155 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -56.23 -67.84 0.26 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -172.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 37.6 m -89.18 7.02 37.38 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.166 0.508 . . . . 0.0 111.392 -167.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 73.6 128.06 0.13 Allowed Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.016 -172.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . 0.483 ' O ' HD23 ' A' ' 155' ' ' LEU . 57.1 m -71.22 164.09 26.34 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 113.944 -1.128 . . . . 0.0 109.309 176.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.62 HD12 ' O ' ' A' ' 176' ' ' GLN . 68.7 mt -139.96 162.74 34.46 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.697 -167.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.635 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 2.4 t-20 53.35 26.08 5.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.659 0.743 . . . . 0.0 110.475 -167.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.63 37.24 94.14 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.119 -1.038 . . . . 0.0 112.007 -174.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.46 -147.13 0.51 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.08 134.63 9.63 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 117.591 0.695 . . . . 0.0 110.477 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.43 110.41 9.78 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.246 0.546 . . . . 0.0 110.514 175.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.9 m -95.43 -29.59 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.521 0.677 . . . . 0.0 110.349 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.567 ' HB3' ' CB ' ' A' ' 165' ' ' ARG . . . -139.12 173.71 4.9 Favored Pre-proline 0 N--CA 1.451 -0.417 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.598 ' HD3' ' CE1' ' A' ' 140' ' ' TYR . 78.2 Cg_exo -54.54 105.07 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.199 1.933 . . . . 0.0 112.051 176.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 26.0 t30 66.2 9.83 6.63 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.097 0.959 . . . . 0.0 110.629 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.567 ' CB ' ' HB3' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -98.92 82.69 2.8 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.43 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 74.1 m -82.26 148.17 28.52 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.414 174.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -99.23 131.14 45.47 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 58.2 m -102.65 132.09 48.99 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 123.877 0.736 . . . . 0.0 111.302 -169.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.635 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 19.7 m -47.68 -54.47 11.95 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -168.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.403 ' HD2' ' N ' ' A' ' 171' ' ' GLY . 5.6 t80 -157.65 -83.53 0.05 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 118.716 -1.194 . . . . 0.0 112.51 -170.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.403 ' N ' ' HD2' ' A' ' 170' ' ' TYR . . . -97.69 49.96 1.42 Allowed Glycine 0 CA--C 1.496 -1.151 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.262 -166.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 172' ' ' PHE . 10.2 m-85 -116.79 129.43 56.1 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 118.529 -1.268 . . . . 0.0 113.461 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.49 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 3.3 t -97.29 143.78 27.72 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.438 173.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 93.3 130.75 5.64 Favored Glycine 0 C--N 1.297 -1.628 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 -175.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.21 17.95 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.611 1.54 . . . . 0.0 112.914 -169.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.62 ' O ' HD12 ' A' ' 155' ' ' LEU . 65.8 tt0 -128.15 12.14 6.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.211 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 27.17 59.08 0.09 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 116.885 2.18 . . . . 0.0 116.885 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -109.85 16.18 22.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.24 1.019 . . . . 0.0 109.352 169.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -120.39 91.1 3.46 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.409 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -89.11 86.69 6.95 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.164 0.983 . . . . 0.0 111.853 -170.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.49 ' HE2' ' N ' ' A' ' 173' ' ' THR . 32.4 p90 -116.89 96.2 5.36 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 175.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -74.04 130.73 40.41 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 119.49 -2.006 . . . . 0.0 108.222 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 67.6 p -79.99 168.06 19.68 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.06 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.42 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . 158.16 148.09 5.04 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.316 -164.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -76.25 132.8 14.14 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.15 1.9 . . . . 0.0 111.922 174.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 13.6 t -88.4 116.67 26.79 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . 0.535 ' CD2' ' HB2' ' A' ' 195' ' ' CYS . 16.1 m-85 -102.93 152.56 21.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.362 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.549 ' HA ' ' HB3' ' A' ' 215' ' ' ARG . 20.0 p -103.28 -54.9 2.51 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.1 p -140.54 120.03 12.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 O-C-N 120.914 -1.116 . . . . 0.0 112.645 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.418 ' CG1' ' SG ' ' A' ' 221' ' ' CYS . 2.1 mp -97.84 116.07 39.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-O 121.907 0.861 . . . . 0.0 111.612 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.0 p -106.86 -167.93 1.34 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 158.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -72.08 -4.83 31.19 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.367 0.604 . . . . 0.0 109.759 172.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -88.89 -69.8 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.482 -173.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.4 ' HG3' ' H ' ' A' ' 196' ' ' GLN . 33.0 tpp -162.99 135.62 5.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.189 -176.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.535 ' HB2' ' CD2' ' A' ' 187' ' ' PHE . 3.2 m -68.31 -19.41 64.67 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.877 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.53 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 44.8 mm-40 93.08 113.85 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.954 1.302 . . . . 0.0 113.34 173.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.04 -9.58 9.63 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.262 174.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 54.18 48.68 20.36 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.762 0.315 . . . . 0.0 110.82 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 6.6 mp 55.57 70.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.815 -175.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 46.3 t -72.2 148.36 45.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.475 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.33 21.55 12.71 Favored Glycine 0 CA--C 1.508 -0.366 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.898 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.3 98.12 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 163.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.39 118.66 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.383 0 CA-C-N 113.819 -1.537 . . . . 0.0 109.072 -175.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 10.1 t -158.11 -178.16 7.09 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 -175.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 26.7 p -108.24 168.44 9.3 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 120.278 1.399 . . . . 0.0 111.33 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.532 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 47.1 tttp -57.71 -44.33 85.84 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.406 174.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.1 m -47.01 -56.04 7.13 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.004 176.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.75 -55.33 36.47 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.206 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 84.7 m -67.36 -23.75 65.63 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -172.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 16.3 m -104.75 -26.69 12.17 Favored 'General case' 0 N--CA 1.429 -1.524 0 O-C-N 121.149 -0.969 . . . . 0.0 111.686 -175.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -71.8 -56.99 4.75 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 170.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.55 HG21 ' CG2' ' A' ' 247' ' ' VAL . 6.0 p -100.23 156.22 17.34 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.592 -1.64 . . . . 0.0 107.16 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.2 t 68.0 -39.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 118.841 -0.599 . . . . 0.0 111.713 -177.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 65.12 49.71 60.79 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 119.061 0.846 . . . . 0.0 113.499 166.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.549 ' HB3' ' HA ' ' A' ' 188' ' ' THR . 31.3 mmt180 -127.7 -90.37 0.52 Allowed 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 120.527 -0.469 . . . . 0.0 112.206 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -165.83 164.96 18.64 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -177.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . 0.718 ' O ' ' HB2' ' A' ' 222' ' ' GLU . 7.0 t90 -168.29 139.55 2.74 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 127.7 167.72 12.34 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 119.634 -1.27 . . . . 0.0 114.53 172.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -132.8 132.18 22.42 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.219 -0.491 . . . . 0.0 109.992 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.46 117.09 4.83 Favored 'Cis proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.011 -1.662 . . . . 0.0 111.61 -3.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . 0.418 ' SG ' ' CG1' ' A' ' 190' ' ' ILE . 34.1 t 39.0 92.89 0.01 OUTLIER 'General case' 0 C--O 1.243 0.751 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 175.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.718 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 34.7 mt-10 -105.48 110.12 22.34 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 2.8 tpt -90.31 138.74 31.29 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -173.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 54.6 m -111.48 129.49 24.05 Favored Pre-proline 0 C--O 1.234 0.277 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -169.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -80.03 151.12 20.97 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.513 2.809 . . . . 0.0 111.641 166.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 37.21 -86.54 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.276 0 O-C-N 124.799 1.312 . . . . 0.0 114.281 174.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.66 166.63 3.26 Favored Pre-proline 0 N--CA 1.44 -0.932 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -168.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -80.08 -85.91 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 121.884 1.722 . . . . 0.0 112.424 177.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -75.48 154.38 85.77 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.083 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -81.7 52.81 4.37 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.821 1.681 . . . . 0.0 113.775 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 71.9 m -104.78 -179.69 4.02 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 171.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.503 ' HB3' ' CD2' ' A' ' 235' ' ' PHE . 73.0 ttt180 -67.53 140.95 57.02 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 170.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -38.67 -50.92 1.66 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -175.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.527 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -70.26 9.27 3.28 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.41 -0.9 . . . . 0.0 114.145 -174.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . 0.503 ' CD2' ' HB3' ' A' ' 232' ' ' ARG . 5.3 m-85 -123.99 153.68 40.93 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 122.31 1.052 . . . . 0.0 113.721 -171.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.441 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.0 OUTLIER -130.19 133.23 24.7 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 113.619 -1.628 . . . . 0.0 108.227 168.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.76 116.39 3.52 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.329 2.019 . . . . 0.0 112.382 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -49.14 132.36 19.38 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.6 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 37.6 pt -73.8 1.2 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.316 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -111.89 -55.49 2.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.422 0.63 . . . . 0.0 110.181 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 66.3 p -92.96 -38.67 11.55 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.417 -175.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 98.33 4.47 57.35 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.394 -175.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -83.75 124.95 31.42 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 121.673 0.749 . . . . 0.0 109.662 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 10.8 m -57.91 114.69 2.44 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 113.446 -1.707 . . . . 0.0 109.401 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -117.1 141.07 48.72 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.505 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 16.3 t70 -76.32 146.27 38.97 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -175.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.55 ' CG2' HG21 ' A' ' 212' ' ' THR . 4.4 m -96.78 151.65 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.983 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.87 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.415 ' OD1' ' HB2' ' A' ' 250' ' ' CYS . 6.3 t0 -78.98 81.07 5.28 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 167.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.504 ' HG3' HG23 ' A' ' 247' ' ' VAL . 2.1 mp0 -52.57 -32.05 39.19 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 123.901 0.751 . . . . 0.0 110.467 -173.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.415 ' HB2' ' OD1' ' A' ' 248' ' ' ASP . 58.0 m -55.04 -42.79 73.09 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.676 172.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -89.96 -33.48 16.38 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 122.29 1.043 . . . . 0.0 109.581 -175.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -79.27 -23.3 43.71 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.087 -174.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.583 ' O ' ' HB3' ' A' ' 256' ' ' LEU . 5.3 mp -132.58 79.21 65.31 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 176.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -55.57 153.93 27.23 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 121.776 1.651 . . . . 0.0 112.289 177.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 78.55 -19.18 5.04 Favored Glycine 0 C--N 1.316 -0.579 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.833 -174.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.583 ' HB3' ' O ' ' A' ' 253' ' ' ILE . 2.1 tt -76.04 115.19 15.51 Favored 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 122.425 -0.456 . . . . 0.0 109.847 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 37.3 t 63.33 19.37 11.64 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.171 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -84.31 56.22 3.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.761 0.791 . . . . 0.0 110.259 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -120.81 7.52 10.99 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 173.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -179.14 -117.47 0.54 Allowed Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -117.4 116.35 27.0 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 17.7 p -108.36 157.86 18.01 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 170.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 21.1 mt -145.49 156.64 13.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -170.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.2 124.81 39.85 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -173.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.6 t -114.54 170.95 7.94 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.191 165.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.505 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 34.6 m -67.59 127.41 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 CA-C-O 121.826 0.822 . . . . 0.0 110.723 -176.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 88.38 -14.75 58.7 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-O 119.007 -0.885 . . . . 0.0 113.554 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 75.3 m -169.9 148.64 3.54 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 118.051 0.925 . . . . 0.0 110.52 -172.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -105.37 152.4 23.0 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.64 -0.662 . . . . 0.0 110.384 174.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.88 126.52 52.03 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 -177.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 18.4 m -106.22 152.06 23.97 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.815 0.817 . . . . 0.0 113.162 -176.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -141.52 96.93 3.06 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.59 171.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 11.7 m -83.55 164.87 43.15 Favored Pre-proline 0 C--N 1.314 -0.952 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -57.32 165.92 5.09 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.939 1.76 . . . . 0.0 111.385 176.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -53.7 137.22 38.07 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.356 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 82.87 -31.07 3.11 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.458 -178.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' HIS . . . . . 0.438 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 15.8 m-70 -74.2 163.18 28.15 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.604 0.24 . . . . 0.0 111.352 -177.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -148.01 148.22 30.47 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 16.3 tp -82.16 141.36 33.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.377 . . . . 0.0 110.817 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -133.14 98.98 4.41 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.001 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -61.45 -23.26 65.74 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.465 0.478 . . . . 0.0 112.164 -174.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.27 -18.06 17.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.327 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 44.4 m -152.4 31.39 0.53 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.791 175.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 25.1 46.3 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.04 1.336 . . . . 0.0 113.808 -173.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 68.3 tttt -98.35 167.53 10.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.361 -171.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 1.8 m -144.43 83.41 1.72 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.438 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 36.4 tt0 . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.779 -0.629 . . . . 0.0 110.092 -171.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 25.8 p . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.74 -19.25 55.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.127 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.8 t -75.1 -18.03 60.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.616 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -100.75 141.65 33.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.755 0.312 . . . . 0.0 110.791 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.9 m -77.13 80.77 3.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.336 0.589 . . . . 0.0 110.299 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 35.3 pt -69.21 145.95 12.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.759 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -121.07 174.77 6.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.005 -177.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -73.23 -33.65 65.44 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 23.2 p -99.95 -175.99 3.12 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.374 174.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -122.49 -47.78 2.09 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.796 0.331 . . . . 0.0 110.62 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.82 174.72 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -175.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.637 ' N ' ' HD2' ' A' ' 122' ' ' ARG . 0.9 OUTLIER -111.75 140.93 45.98 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.979 -1.464 . . . . 0.0 110.346 -173.215 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 58.0 m -114.69 130.67 56.85 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 58.5 mtm -139.09 162.45 34.91 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 175.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 67.62 51.44 0.83 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.991 0.424 . . . . 0.0 111.521 174.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 72.34 32.57 62.34 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.078 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -91.62 146.2 18.14 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.521 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.9 m -122.33 132.33 54.34 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 172.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 4.4 t -88.84 116.8 27.38 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.246 -171.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 21.1 t -144.33 137.79 27.41 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.5 t70 52.64 32.91 12.63 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.891 0.853 . . . . 0.0 112.589 173.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.5 t0 52.35 46.66 26.25 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.693 -1.594 . . . . 0.0 111.088 -178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -166.69 117.89 0.95 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 114.429 -1.259 . . . . 0.0 108.383 170.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . 0.462 ' SG ' ' SG ' ' A' ' 136' ' ' CYS . 5.9 t -69.72 130.87 43.52 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.13 -166.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 76.7 mt -106.35 105.12 15.0 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . 0.462 ' SG ' ' SG ' ' A' ' 134' ' ' CYS . 61.8 m -109.52 -96.49 0.4 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -161.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -152.08 145.83 25.07 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.082 -166.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.407 ' HD3' ' O ' ' A' ' 138' ' ' LYS . 1.1 tmtp? -67.43 113.71 5.52 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 122.483 1.135 . . . . 0.0 110.384 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 113.35 3.35 24.25 Favored Glycine 0 N--CA 1.43 -1.714 0 CA-C-N 113.113 -1.858 . . . . 0.0 112.296 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.478 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 75.3 m-85 -125.03 143.79 50.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.174 0.487 . . . . 0.0 109.901 172.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 145' ' ' CYS . 23.2 pt -139.82 178.42 3.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 CA-C-O 121.311 0.577 . . . . 0.0 111.214 -173.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.53 165.95 40.39 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.805 -169.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.9 m -70.73 -31.81 68.77 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.015 0.407 . . . . 0.0 110.785 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -89.84 -8.71 51.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.187 0.518 . . . . 0.0 109.927 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 141' ' ' ILE . 73.3 m 57.22 41.52 26.78 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.909 -175.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.23 2.3 59.42 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.588 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.51 104.39 55.17 Favored Pre-proline 0 C--N 1.329 -0.298 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.809 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.61 142.46 20.61 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.466 2.111 . . . . 0.0 111.661 177.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.8 p -66.64 106.72 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 122.569 1.176 . . . . 0.0 112.137 -173.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 20.8 m -80.23 66.1 5.61 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.831 173.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -52.16 -53.26 45.2 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.593 0.961 . . . . 0.0 113.593 -171.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 36.6 m -93.87 8.92 39.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.435 0.636 . . . . 0.0 110.576 -170.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 77.28 134.29 0.66 Allowed Glycine 0 N--CA 1.427 -1.964 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.266 -172.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.64 154.85 41.41 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 176' ' ' GLN . 42.7 mt -126.78 170.28 12.33 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -173.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 172' ' ' PHE . 0.1 OUTLIER 36.49 35.55 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.731 1.269 . . . . 0.0 113.598 -172.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.36 34.23 67.66 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.003 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -75.52 -151.54 3.17 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-O 121.466 0.481 . . . . 0.0 114.031 -172.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -145.7 122.41 11.18 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.102 0.477 . . . . 0.0 110.567 -179.146 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 19.1 m -68.79 112.12 5.31 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.833 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.8 m -92.39 -33.28 5.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.071 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.451 ' HB3' ' CB ' ' A' ' 165' ' ' ARG . . . -139.88 177.03 2.18 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.478 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 77.7 Cg_exo -53.55 111.64 0.74 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 121.73 1.62 . . . . 0.0 112.496 176.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 61.54 12.7 4.63 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.94 0.896 . . . . 0.0 110.879 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.451 ' CB ' ' HB3' ' A' ' 162' ' ' ALA . 0.4 OUTLIER -103.68 78.25 1.55 Allowed 'General case' 0 CA--C 1.499 -1.003 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.082 178.014 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 59.6 m -71.68 152.93 42.41 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.744 0.783 . . . . 0.0 110.54 171.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -106.28 141.72 37.15 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.629 169.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 29.2 m -97.68 128.68 44.54 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 124.346 1.029 . . . . 0.0 112.072 -163.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 77.9 m -62.96 -55.72 23.38 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 171' ' ' GLY . 40.1 t80 -128.18 -119.73 0.24 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 118.746 -1.181 . . . . 0.0 112.373 -169.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.401 ' N ' ' CD1' ' A' ' 170' ' ' TYR . . . -87.7 54.7 4.39 Favored Glycine 0 N--CA 1.428 -1.853 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.321 -167.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.559 ' CD2' ' N ' ' A' ' 172' ' ' PHE . 5.1 m-85 -119.14 122.24 41.59 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 119.247 -0.981 . . . . 0.0 112.331 173.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.432 ' N ' ' HE1' ' A' ' 181' ' ' TYR . 2.9 t -88.09 157.51 18.84 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 167.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.1 128.48 3.29 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.06 -0.07 7.4 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.498 1.465 . . . . 0.0 113.467 -166.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.466 ' O ' HD12 ' A' ' 155' ' ' LEU . 41.7 tt0 -109.71 8.35 24.71 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 32.87 57.09 0.44 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 177.222 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -114.06 -15.73 12.23 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.877 173.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -57.58 -68.92 0.19 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.157 -1.383 . . . . 0.0 108.645 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.0 t70 78.38 92.64 0.06 Allowed 'General case' 0 CA--C 1.509 -0.626 0 O-C-N 124.132 0.895 . . . . 0.0 110.102 164.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.436 ' CD2' ' O ' ' A' ' 181' ' ' TYR . 32.2 p90 -112.36 64.16 0.63 Allowed 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 173.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 25.7 tpt85 -42.42 121.15 1.85 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.408 171.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 38.9 p -82.28 136.63 35.01 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.347 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.444 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -159.92 155.47 26.59 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.048 -176.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -85.07 167.87 10.72 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.444 2.096 . . . . 0.0 111.847 172.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 69.6 m -116.92 121.06 40.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.155 0.502 . . . . 0.0 111.44 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . 0.65 ' O ' ' HB3' ' A' ' 215' ' ' ARG . 29.6 m-85 -93.36 131.71 38.27 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.441 ' HA ' ' CG ' ' A' ' 215' ' ' ARG . 19.0 m -89.32 -15.16 34.07 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 113.944 1.091 . . . . 0.0 113.944 -163.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.1 p -165.11 117.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.066 -174.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.404 HD11 ' HB3' ' A' ' 216' ' ' ALA . 6.7 mt -123.7 118.35 53.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -171.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 7.3 p -114.77 -167.11 1.18 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.419 160.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -68.07 -4.08 12.35 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.434 0.635 . . . . 0.0 110.275 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -75.55 -69.97 0.45 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.307 -177.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 22.4 ttt -169.7 152.68 4.68 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 21.8 m -77.24 -24.2 51.2 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 121.099 0.476 . . . . 0.0 111.475 -174.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 176.22 -92.1 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.845 173.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 124.55 11.14 4.66 Favored Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.939 171.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -89.04 -12.7 40.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.204 0.526 . . . . 0.0 109.992 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 65.17 -85.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.996 -177.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 71.1 m 68.93 125.85 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.574 0.702 . . . . 0.0 112.48 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.07 30.25 4.01 Favored Glycine 0 CA--C 1.508 -0.358 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.127 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.75 100.35 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 4.1 t -92.57 98.29 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-O 122.914 1.34 . . . . 0.0 109.751 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.465 ' OG ' HD23 ' A' ' 208' ' ' LEU . 8.4 t -117.69 179.94 3.92 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.659 -2.064 . . . . 0.0 105.976 169.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 19.0 p -107.63 161.93 14.42 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.399 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.413 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 46.3 tttm -61.91 -43.62 98.46 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.13 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 8.4 m -44.76 -55.13 5.59 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 122.22 1.009 . . . . 0.0 109.415 173.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.63 HD11 HG11 ' A' ' 247' ' ' VAL . 6.0 tp -63.7 -52.25 61.41 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.294 -1.775 . . . . 0.0 112.344 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 4.7 t -64.3 -37.29 86.97 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.441 0.638 . . . . 0.0 110.479 -175.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 52.2 m -85.07 -23.82 28.37 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.626 -177.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . 0.438 ' HA ' ' CD ' ' A' ' 228' ' ' PRO . . . -69.88 -52.75 22.12 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 173.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 214' ' ' GLY . 80.8 p -64.77 -156.43 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 113.101 -1.863 . . . . 0.0 111.85 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.414 HG11 HE21 ' A' ' 284' ' ' GLN . 1.6 t -44.25 -1.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.349 0 N-CA-C 116.276 1.954 . . . . 0.0 116.276 -176.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 212' ' ' THR . . . 85.72 -101.97 2.61 Favored Glycine 0 CA--C 1.507 -0.457 0 C-N-CA 119.086 -1.53 . . . . 0.0 113.549 175.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.65 ' HB3' ' O ' ' A' ' 187' ' ' PHE . 0.8 OUTLIER 50.78 -120.33 1.56 Allowed 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.143 0.497 . . . . 0.0 110.34 -169.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.419 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -158.44 159.88 36.19 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 172.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . 0.444 ' CZ2' ' HA3' ' A' ' 184' ' ' GLY . 26.9 t90 -136.07 146.33 46.94 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -174.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 82.25 177.44 51.87 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.735 171.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.524 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 8.0 p80 -143.01 133.4 12.26 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.626 -0.287 . . . . 0.0 110.252 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . 0.524 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 41.4 Cg_exo -57.8 154.03 34.38 Favored 'Cis proline' 0 C--N 1.345 0.366 0 C-N-CA 123.667 -1.389 . . . . 0.0 112.119 -3.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 9.5 m -49.54 123.01 6.97 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.193 -171.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -105.87 102.49 11.92 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' MET . . . . . 0.419 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 17.7 ptm -85.73 137.64 32.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.576 -169.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 99.3 m -135.3 143.17 44.39 Favored Pre-proline 0 C--O 1.235 0.294 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -171.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -64.45 169.17 11.53 Favored 'Trans proline' 0 CA--C 1.512 -0.579 0 C-N-CA 122.788 2.325 . . . . 0.0 110.346 155.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.0 -129.67 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.808 168.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -46.95 102.61 0.32 Allowed Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -166.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.438 ' CD ' ' HA ' ' A' ' 211' ' ' ALA . 63.9 Cg_endo -82.39 -59.68 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.628 2.218 . . . . 0.0 112.389 176.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -70.87 159.6 84.9 Favored Pre-proline 0 CA--C 1.515 -0.368 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.91 58.25 6.81 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 121.706 1.604 . . . . 0.0 113.381 -174.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 43.0 m -135.43 -173.83 3.46 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.563 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 25.7 mmt180 -73.19 144.74 46.7 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.315 174.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -39.29 -42.96 1.08 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 246' ' ' ASP . . . -77.72 7.72 39.74 Favored Glycine 0 C--O 1.222 -0.612 0 C-N-CA 120.342 -0.933 . . . . 0.0 113.187 -176.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . 0.563 ' CD1' ' HB2' ' A' ' 232' ' ' ARG . 3.3 m-85 -120.42 143.0 48.7 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.865 0.84 . . . . 0.0 112.706 -171.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -122.59 131.5 24.37 Favored Pre-proline 0 N--CA 1.439 -0.987 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.082 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -65.66 113.76 2.65 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.051 1.834 . . . . 0.0 111.356 174.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -49.21 135.9 16.08 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 123.492 0.717 . . . . 0.0 111.581 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 29.5 pt -75.63 2.87 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.165 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 49.8 mtm180 -113.29 -56.51 2.4 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.973 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 35.0 p -95.91 -40.56 9.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.749 -174.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 99.44 5.63 55.6 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -175.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -79.01 134.01 36.8 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.806 0.812 . . . . 0.0 110.128 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 4.6 m -68.96 113.99 6.85 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.022 -1.445 . . . . 0.0 109.299 173.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 89.3 mt-30 -116.33 141.26 48.39 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.558 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 12.5 t70 -77.58 144.65 37.38 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.63 HG11 HD11 ' A' ' 208' ' ' LEU . 4.3 m -95.56 146.11 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.082 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -178.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -73.88 75.98 1.64 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 169.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.553 ' HG3' HG23 ' A' ' 247' ' ' VAL . 14.4 mp0 -52.5 -37.12 56.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 123.931 0.77 . . . . 0.0 110.776 -168.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 52.7 m -49.24 -38.71 27.6 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.866 174.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -101.21 -35.78 9.16 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.879 0.847 . . . . 0.0 110.565 -176.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.451 ' HB1' HD21 ' A' ' 208' ' ' LEU . . . -70.38 -20.1 62.97 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.33 -1.305 . . . . 0.0 110.459 -177.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.585 HG22 ' HB3' ' A' ' 256' ' ' LEU . 5.0 mp -137.29 77.63 41.16 Favored Pre-proline 0 N--CA 1.445 -0.703 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 169.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -48.06 113.53 0.83 Allowed 'Trans proline' 0 CA--C 1.514 -0.508 0 C-N-CA 124.018 3.146 . . . . 0.0 114.39 -167.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 61.22 35.97 91.69 Favored Glycine 0 C--N 1.311 -0.824 0 CA-C-N 113.457 -1.702 . . . . 0.0 113.391 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.585 ' HB3' HG22 ' A' ' 253' ' ' ILE . 1.8 pt? -66.96 -23.1 65.92 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 117.367 0.584 . . . . 0.0 110.905 176.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 39.1 t -82.02 121.73 26.91 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -90.26 111.51 22.72 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -171.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 71.49 66.1 2.23 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.749 171.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 174.14 -170.17 43.27 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 119.967 -1.111 . . . . 0.0 112.792 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -88.79 159.08 17.92 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 21.2 t -141.49 125.03 16.71 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 18.2 mt -136.54 109.21 7.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.104 -170.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -72.17 117.17 13.46 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.281 -174.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.3 t -105.38 160.61 14.99 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 157.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.558 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 3.9 m -77.43 128.56 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 C-N-CA 118.344 -1.342 . . . . 0.0 107.924 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.529 ' N ' ' HE1' ' A' ' 235' ' ' PHE . . . 110.5 -30.79 7.88 Favored Glycine 0 C--N 1.311 -0.838 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.669 -170.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 31.7 m -179.11 158.36 0.9 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.079 0.939 . . . . 0.0 109.93 -168.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -104.96 152.36 22.78 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.818 -1.176 . . . . 0.0 108.63 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -107.45 127.89 54.01 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -176.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 92.7 m -106.88 152.43 23.92 Favored 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.342 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -124.07 100.03 6.53 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.033 175.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 4.3 m -81.81 149.32 63.42 Favored Pre-proline 0 C--N 1.31 -1.109 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.869 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.57 162.31 8.48 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.08 1.854 . . . . 0.0 111.25 175.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -53.1 143.08 18.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.519 0.2 . . . . 0.0 111.059 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.49 -31.27 3.57 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.828 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' HIS . . . . . 0.492 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 14.4 m-70 -78.83 169.79 17.67 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 122.708 -0.289 . . . . 0.0 111.372 -177.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -149.5 148.95 30.01 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 39.6 tp -84.94 136.11 33.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.075 0.464 . . . . 0.0 110.534 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -125.71 100.29 6.36 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 174.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.27 -21.11 61.52 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.829 0.705 . . . . 0.0 112.185 -174.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 68.3 t -60.47 -34.07 56.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.177 0.513 . . . . 0.0 110.45 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 20.3 p -132.97 23.49 4.21 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.55 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 0.414 HE21 HG11 ' A' ' 213' ' ' VAL . 12.5 mp0 29.62 46.63 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.062 -171.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -101.63 165.09 11.41 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.973 -172.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 5.7 m -140.89 88.42 2.18 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.492 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 7.1 tp10 . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.667 -0.682 . . . . 0.0 109.341 -173.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 N--CA 1.476 0.835 0 CA-C-O 120.763 0.316 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.06 -39.62 65.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.007 0.432 . . . . 0.0 110.53 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.8 p -97.07 150.06 21.25 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.271 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -92.92 -22.31 19.31 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.247 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 12.7 p -81.69 9.33 7.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.4 tp -87.8 -3.45 9.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.401 0.62 . . . . 0.0 109.985 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -63.58 117.4 6.73 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.788 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.409 ' O ' ' HB3' ' A' ' 119' ' ' CYS . 44.1 t-80 -70.23 -24.22 63.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.816 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 118' ' ' HIS . 53.2 t 74.86 145.41 0.08 Allowed 'General case' 0 C--O 1.235 0.291 0 O-C-N 123.983 0.802 . . . . 0.0 110.345 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -115.29 -32.59 5.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.764 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.488 HD12 ' O ' ' A' ' 132' ' ' ASP . 0.3 OUTLIER -92.84 -169.34 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-O 121.304 0.573 . . . . 0.0 112.518 -174.306 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.0 128.27 49.96 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.46 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.645 ' SG ' ' HA3' ' A' ' 127' ' ' GLY . 3.9 t -117.69 149.13 41.25 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.777 -177.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -127.66 166.44 18.09 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 66.52 45.14 2.15 Favored 'General case' 0 N--CA 1.462 0.165 0 O-C-N 123.598 0.561 . . . . 0.0 111.693 173.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 137' ' ' GLN . . . 75.27 21.32 78.04 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.245 176.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.645 ' HA3' ' SG ' ' A' ' 123' ' ' CYS . . . -79.11 114.38 3.88 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.949 -177.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 24.4 m -72.19 126.09 28.92 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 144.78 56.09 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.891 -173.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.657 ' HB2' ' O ' ' A' ' 133' ' ' HIS . 34.6 m -144.14 170.85 15.18 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -28.21 -94.51 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 O-C-N 125.036 1.46 . . . . 0.0 114.392 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.488 ' O ' HD12 ' A' ' 121' ' ' ILE . 35.9 m-20 -88.42 -38.6 14.92 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.663 176.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.657 ' O ' ' HB2' ' A' ' 130' ' ' SER . 0.3 OUTLIER -132.69 133.51 43.63 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.616 -176.34 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 24.7 p -75.12 160.24 30.69 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.118 -174.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 65.3 mt -96.57 138.06 34.72 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 71.3 m -91.3 156.17 17.99 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.548 -174.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 126' ' ' GLY . 44.6 mt-30 -80.48 145.12 32.04 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 167.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -62.9 113.54 3.12 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 122.658 1.218 . . . . 0.0 111.176 -172.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 128.68 -1.69 6.42 Favored Glycine 0 N--CA 1.433 -1.503 0 CA-C-N 112.625 -2.08 . . . . 0.0 111.314 -176.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.53 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 98.8 m-85 -121.1 149.47 42.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.343 0.572 . . . . 0.0 110.7 171.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 30.0 pt -132.88 174.6 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.967 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.99 174.15 33.23 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.737 -175.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.5 p -75.89 -29.74 58.57 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -111.32 12.61 21.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.34 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 46.2 m 59.67 35.91 22.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.091 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.59 -12.2 72.91 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.613 -0.721 . . . . 0.0 113.347 -174.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.28 110.42 56.05 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 117.336 0.568 . . . . 0.0 110.718 -176.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.37 147.85 18.3 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.931 2.421 . . . . 0.0 112.489 178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 12.4 p -75.14 109.87 8.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.943 0.878 . . . . 0.0 111.035 -176.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.24 77.54 5.75 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.24 173.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -56.54 -59.04 5.57 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -170.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.1 m -90.28 10.77 23.49 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.442 0.639 . . . . 0.0 111.267 -170.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 82.43 126.58 0.98 Allowed Glycine 0 N--CA 1.43 -1.761 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.654 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . 0.415 ' O ' HD23 ' A' ' 155' ' ' LEU . 3.6 m -71.94 153.51 41.79 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 113.854 -1.173 . . . . 0.0 109.559 171.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 154' ' ' CYS . 83.2 mt -141.3 172.7 12.32 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -169.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.635 ' ND2' ' HB2' ' A' ' 177' ' ' CYS . 8.5 p30 43.39 24.62 0.05 Allowed 'General case' 0 N--CA 1.478 0.949 0 O-C-N 124.108 0.88 . . . . 0.0 113.248 -174.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.1 36.8 93.71 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.199 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -73.76 -146.27 0.95 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 121.466 -0.397 . . . . 0.0 113.219 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.8 ttt85 -156.57 123.14 5.08 Favored 'General case' 0 C--O 1.222 -0.35 0 O-C-N 122.204 -0.586 . . . . 0.0 111.345 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 2.4 m -61.38 116.0 4.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.897 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 165' ' ' ARG . 11.2 m -102.1 -50.1 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.803 178.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -127.7 172.9 6.06 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.802 171.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.53 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 74.0 Cg_exo -51.15 107.78 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.128 1.885 . . . . 0.0 112.531 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 76.53 -14.2 0.84 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.816 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.439 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.6 OUTLIER -80.73 85.55 6.07 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.251 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 13.5 t -83.06 143.64 30.45 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.756 173.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -89.19 121.51 31.57 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 176.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 55.8 m -94.38 123.69 37.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.115 -169.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 85.1 m -53.74 -48.83 69.27 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 114.211 -1.359 . . . . 0.0 113.16 -170.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 10.0 t80 177.54 115.95 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.929 -175.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 78.76 43.44 11.61 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 120.356 -0.926 . . . . 0.0 113.522 169.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.565 ' CZ ' ' HB3' ' A' ' 156' ' ' ASN . 25.2 m-85 -124.8 128.25 48.43 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 117.951 0.876 . . . . 0.0 112.39 168.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.774 HG23 ' CE2' ' A' ' 181' ' ' TYR . 43.5 p -88.48 137.33 32.42 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.279 177.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.45 141.66 10.78 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.43 6.27 1.97 Allowed 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.451 1.434 . . . . 0.0 112.473 -170.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.401 ' O ' HD12 ' A' ' 155' ' ' LEU . 11.8 pt20 -129.3 24.64 5.52 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.32 177.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.635 ' HB2' ' ND2' ' A' ' 156' ' ' ASN . 0.0 OUTLIER 32.97 73.83 0.06 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 175.755 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -120.18 16.14 12.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.109 0.481 . . . . 0.0 111.406 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 15.9 mmt85 -123.33 96.26 4.92 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.547 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -80.05 84.36 5.79 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 122.241 1.02 . . . . 0.0 109.891 -173.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.774 ' CE2' HG23 ' A' ' 173' ' ' THR . 28.4 p90 -114.3 84.15 2.0 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 175.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -77.52 127.17 32.06 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 118.766 -2.459 . . . . 0.0 107.825 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 18.0 p -81.93 134.28 35.37 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.877 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -152.88 155.1 25.93 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.872 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.73 136.24 29.97 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.68 2.254 . . . . 0.0 111.012 172.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 5.8 t -108.28 115.65 30.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.92 0.391 . . . . 0.0 111.163 -174.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -95.54 160.4 14.53 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.512 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 24.7 p -111.68 -16.11 13.3 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 -167.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 7.5 p -163.75 123.63 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 119.628 1.104 . . . . 0.0 112.394 -173.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.507 ' CG1' ' HA ' ' A' ' 195' ' ' CYS . 51.7 mt -126.46 115.97 43.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-O 121.645 0.736 . . . . 0.0 112.833 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 25.0 p -115.8 -163.61 0.9 Allowed 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 158.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -61.47 -5.18 1.6 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.601 0.637 . . . . 0.0 110.553 172.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -69.56 -74.39 0.13 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.802 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.459 ' SD ' ' HA2' ' A' ' 197' ' ' GLY . 23.9 ttm -179.16 -171.66 0.21 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 176.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.507 ' HA ' ' CG1' ' A' ' 190' ' ' ILE . 14.0 m -88.08 -24.27 23.48 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 118.185 0.448 . . . . 0.0 111.928 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 12.9 tt0 165.65 -4.24 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 122.015 0.912 . . . . 0.0 109.444 -173.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.459 ' HA2' ' SD ' ' A' ' 194' ' ' MET . . . 103.61 5.13 45.65 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -172.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 61.71 52.66 3.47 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-O 121.466 0.651 . . . . 0.0 109.668 -176.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 63.7 mt -126.13 -179.73 4.86 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.964 -173.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 14.8 t 73.67 120.1 0.04 OUTLIER 'General case' 0 C--O 1.233 0.202 0 O-C-N 124.422 1.076 . . . . 0.0 111.285 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -93.42 33.23 5.25 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.606 177.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.78 97.7 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-O 122.238 1.018 . . . . 0.0 108.921 171.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 1.4 t -90.07 118.62 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.368 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 11.2 t -153.59 -178.63 7.15 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 103.129 -2.915 . . . . 0.0 103.129 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 10.5 p -106.33 163.7 12.62 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 120.538 1.517 . . . . 0.0 110.012 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.48 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 49.6 tttm -63.85 -38.48 91.26 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.486 0.66 . . . . 0.0 109.788 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.0 m -48.63 -56.38 8.62 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.045 171.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.98 -53.73 54.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.905 177.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 54.4 m -67.09 -23.0 65.8 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -175.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 56.3 m -106.56 -11.69 15.81 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 118.979 0.809 . . . . 0.0 113.168 -177.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -83.88 -51.21 7.37 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.961 0.886 . . . . 0.0 108.991 165.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 214' ' ' GLY . 6.7 p -101.66 151.9 21.47 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.275 -178.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 31.5 m 53.01 -37.19 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' A' ' 215' ' ' ARG . . . 78.63 -159.51 46.27 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 120.416 1.462 . . . . 0.0 112.236 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.463 ' HD3' ' O ' ' A' ' 214' ' ' GLY . 0.0 OUTLIER 104.07 -90.6 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.692 1.197 . . . . 0.0 109.497 163.124 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -169.17 160.82 9.96 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.875 0.761 . . . . 0.0 110.125 170.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . 0.48 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 18.8 t90 -152.48 147.83 26.7 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -177.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 78.98 173.18 43.34 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 115.389 0.916 . . . . 0.0 115.389 167.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.502 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 36.0 m-70 -127.79 133.11 24.75 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 114.838 -0.681 . . . . 0.0 109.445 171.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 19.7 Cg_endo -58.6 152.3 39.23 Favored 'Cis proline' 0 C--N 1.347 0.461 0 C-N-CA 123.705 -1.373 . . . . 0.0 111.772 -3.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 43.5 t -55.89 118.43 4.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.254 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -115.28 121.23 42.25 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 19.8 ptm -98.07 146.48 25.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.645 0.26 . . . . 0.0 111.304 -173.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 61.8 m -143.24 148.37 44.27 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.959 -178.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.7 167.65 23.75 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.615 2.21 . . . . 0.0 109.9 163.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.413 ' O ' ' HD3' ' A' ' 228' ' ' PRO . . . -58.62 -94.67 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 120.764 0.316 . . . . 0.0 110.814 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.55 106.75 14.95 Favored Pre-proline 0 C--N 1.315 -0.9 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.072 172.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 226' ' ' ALA . 60.2 Cg_endo -90.63 -43.68 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.491 2.128 . . . . 0.0 113.252 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -100.53 175.55 2.32 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.53 177.53 0.6 Allowed 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 121.656 1.571 . . . . 0.0 112.182 171.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 61.4 m 75.7 146.41 0.09 Allowed 'General case' 0 N--CA 1.47 0.575 0 O-C-N 124.112 0.883 . . . . 0.0 108.844 -166.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -63.13 140.48 58.88 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 118.997 -0.525 . . . . 0.0 109.905 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -32.86 -44.59 0.11 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -75.7 7.95 23.73 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.631 -175.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . 0.585 ' HE1' ' N ' ' A' ' 267' ' ' GLY . 2.5 m-85 -122.49 159.86 26.78 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.947 0.88 . . . . 0.0 112.085 -172.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.63 132.29 23.87 Favored Pre-proline 0 C--N 1.313 -1.018 0 CA-C-N 113.913 -1.494 . . . . 0.0 108.048 172.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -64.2 112.24 1.83 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.51 1.473 . . . . 0.0 110.635 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -51.81 134.44 30.9 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.781 0.8 . . . . 0.0 111.065 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 33.7 pt -78.52 -1.04 3.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 114.656 -1.156 . . . . 0.0 112.026 -174.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -111.27 -56.83 2.33 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.372 0.606 . . . . 0.0 110.057 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 44.3 p -84.52 -46.52 11.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.199 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 104.23 7.81 39.77 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.359 -175.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -92.6 126.61 37.76 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 122.005 0.907 . . . . 0.0 109.919 -177.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 3.8 m -53.89 124.18 14.64 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 113.433 -1.712 . . . . 0.0 110.359 174.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -124.54 135.51 53.22 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.594 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 15.2 t70 -77.49 146.0 36.7 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 121.165 0.507 . . . . 0.0 110.142 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.611 HG23 ' HG3' ' A' ' 249' ' ' GLU . 6.9 m -98.49 146.16 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -74.66 76.76 2.03 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 167.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.611 ' HG3' HG23 ' A' ' 247' ' ' VAL . 32.2 mp0 -52.51 -39.01 60.81 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.388 0.614 . . . . 0.0 110.489 -171.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 53.1 t -55.45 -30.63 60.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.943 176.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -97.42 -40.98 8.43 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 122.064 0.935 . . . . 0.0 109.62 -177.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.76 -16.91 63.94 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.947 -1.478 . . . . 0.0 110.836 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 2.6 mp -120.37 104.97 42.4 Favored Pre-proline 0 N--CA 1.447 -0.611 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 174.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -28.69 -47.88 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.604 1 C-N-CA 126.204 4.603 . . . . 0.0 116.87 -172.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -140.23 43.27 1.14 Allowed Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -174.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 11.1 tp -54.34 125.84 20.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.761 -0.72 . . . . 0.0 110.486 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 98.9 m 60.35 58.37 2.59 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.515 0.674 . . . . 0.0 109.888 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -60.44 120.89 10.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.381 -177.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 101.21 40.57 2.79 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.532 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 172.8 -156.49 25.01 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.787 179.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -111.93 156.82 21.48 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -137.86 132.88 33.19 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 170.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 58.5 mt -130.18 115.18 31.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.527 -170.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -73.61 121.84 21.33 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -172.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 268' ' ' SER . 0.5 OUTLIER -110.01 156.14 20.89 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 153.452 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.594 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 4.1 m -74.97 126.64 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 C-N-CA 117.861 -1.536 . . . . 0.0 107.605 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.585 ' N ' ' HE1' ' A' ' 235' ' ' PHE . . . 113.25 -26.62 10.2 Favored Glycine 0 C--N 1.309 -0.94 0 C-N-CA 119.764 -1.208 . . . . 0.0 111.807 -171.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 265' ' ' THR . 26.5 t 173.67 157.5 0.13 Allowed 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 121.315 0.579 . . . . 0.0 109.502 -174.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -101.81 153.05 20.17 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -109.41 114.05 27.38 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 55.4 m -99.96 160.97 13.91 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.856 -0.737 . . . . 0.0 111.779 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -134.19 112.55 11.19 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.306 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 79.8 m -91.93 158.95 38.94 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.129 177.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 32.0 Cg_exo -61.04 157.07 40.89 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.402 2.068 . . . . 0.0 111.052 171.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -54.8 139.63 39.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.835 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 82.99 -27.1 4.01 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.957 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' HIS . . . . . 0.421 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 13.6 m-70 -77.03 162.94 27.13 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 121.343 0.592 . . . . 0.0 111.286 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -131.9 143.13 49.92 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.379 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 57.0 tp -87.34 133.29 33.72 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.114 0.483 . . . . 0.0 110.532 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -114.48 106.27 14.08 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 172.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -66.8 -19.69 65.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.653 -173.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 47.6 t -62.75 -47.7 91.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.615 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 31.3 t -123.74 31.05 5.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.095 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 29.8 46.59 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.93 -172.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -92.08 120.41 32.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.3 -170.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 7.2 m -102.98 81.1 1.94 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.89 0.376 . . . . 0.0 110.092 173.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 29.9 mm-40 . . . . . 0 C--O 1.242 0.696 0 CA-C-O 118.203 -0.903 . . . . 0.0 109.051 -178.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.475 0.811 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.45 119.78 21.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.943 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.7 p -93.55 -27.45 16.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.109 0.481 . . . . 0.0 110.927 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -65.15 -40.21 94.07 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.284 0.564 . . . . 0.0 110.154 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.2 m -80.01 123.45 27.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.4 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 72.5 mt -62.02 -42.76 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -98.33 122.18 41.18 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.243 -0.89 . . . . 0.0 108.993 171.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -59.62 122.64 14.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.981 0.42 . . . . 0.0 110.438 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 26.3 p -146.71 -163.87 1.85 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.329 -173.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -98.91 -55.19 2.78 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.182 0.515 . . . . 0.0 111.901 -175.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 14.7 pt -88.95 -166.72 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 CA-C-N 115.087 -0.96 . . . . 0.0 113.575 -162.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.9 147.88 50.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.469 -171.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 96.4 m -117.96 154.75 31.43 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 67.0 mtm -140.95 165.81 26.52 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 170.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 68.35 49.83 0.78 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.264 0.484 . . . . 0.0 111.512 168.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 66.31 28.52 73.76 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.599 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -92.32 148.68 19.26 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.266 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.8 p -127.03 123.66 37.55 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 175.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.0 t -86.57 126.75 34.69 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.96 0.41 . . . . 0.0 111.662 -172.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 29.0 t -142.51 140.96 32.01 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.876 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.507 ' O ' ' HB2' ' A' ' 132' ' ' ASP . 26.7 t70 76.63 -34.16 0.22 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 174.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 20.6 t70 151.43 -42.84 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -168.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -92.99 -175.63 3.94 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.186 0.517 . . . . 0.0 111.425 176.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 41.2 t -110.8 134.94 52.08 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.614 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 88.9 mt -87.62 125.92 34.65 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 1.3 m -94.5 148.71 21.96 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -166.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -56.68 155.16 7.89 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.04 166.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -64.08 114.87 4.44 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.364 1.078 . . . . 0.0 111.479 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.401 ' CA ' HG12 ' A' ' 149' ' ' VAL . . . 99.27 18.37 24.25 Favored Glycine 0 C--N 1.3 -1.429 0 CA-C-N 112.891 -1.959 . . . . 0.0 111.473 -178.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.473 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 37.7 m-85 -123.43 150.67 43.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.188 0.518 . . . . 0.0 111.12 173.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 37.7 pt -140.1 -174.96 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.977 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.192 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.17 157.94 32.61 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.693 -175.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.1 p -61.66 -41.94 98.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.955 0.407 . . . . 0.0 111.685 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -108.15 18.89 20.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.378 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 64.6 28.92 13.23 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.281 173.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.4 9.27 71.14 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 119.77 -1.205 . . . . 0.0 114.548 -175.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.32 120.45 22.21 Favored Pre-proline 0 C--O 1.217 -0.624 0 CA-C-N 118.741 1.27 . . . . 0.0 112.24 -177.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -89.65 153.97 5.2 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.13 2.554 . . . . 0.0 112.973 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 163' ' ' PRO . 10.1 p -97.23 102.89 14.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 122.508 1.147 . . . . 0.0 111.942 -177.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 64.7 m -83.64 96.63 8.73 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 122.097 0.951 . . . . 0.0 110.224 170.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -54.12 -55.41 27.95 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.919 -1.491 . . . . 0.0 114.918 -168.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 47.4 m -94.3 17.05 13.51 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.205 0.526 . . . . 0.0 111.039 -165.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 73.07 131.55 0.16 Allowed Glycine 0 N--CA 1.432 -1.586 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.005 -175.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 69.7 m -69.07 150.95 47.04 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.099 -1.051 . . . . 0.0 110.614 175.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 58.7 mt -133.96 172.96 12.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.566 -170.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.622 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 0.0 OUTLIER 67.08 10.33 7.62 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.389 0.614 . . . . 0.0 111.188 178.05 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.87 36.26 91.72 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.079 -167.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -76.0 -145.23 1.54 Allowed Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.203 -0.498 . . . . 0.0 113.318 -175.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -150.86 118.02 5.95 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.665 -0.315 . . . . 0.0 111.111 -175.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 13.6 t -60.94 125.24 23.0 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.746 0.308 . . . . 0.0 110.34 176.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 165' ' ' ARG . 13.2 m -117.04 -49.28 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.922 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -133.79 173.68 5.56 Favored Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 176.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 149' ' ' VAL . 54.3 Cg_exo -53.91 107.32 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 121.987 1.791 . . . . 0.0 112.465 177.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 73.83 14.58 4.06 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.996 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.45 ' O ' HG22 ' A' ' 161' ' ' VAL . 2.0 mtm180 -113.35 89.45 3.09 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.027 174.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 82.4 m -88.32 141.69 28.34 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.0 169.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -90.32 131.28 36.21 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 60.0 m -104.53 130.96 52.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.901 0.857 . . . . 0.0 112.197 -169.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.622 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 82.2 m -71.02 -57.59 4.4 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 116.204 1.928 . . . . 0.0 116.204 -170.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -136.89 -100.31 0.2 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 118.329 -1.348 . . . . 0.0 113.205 -165.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -90.32 45.39 2.97 Favored Glycine 0 CA--C 1.492 -1.379 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.773 -165.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 172' ' ' PHE . 4.2 m-85 -120.23 127.22 52.22 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 119.502 -0.879 . . . . 0.0 112.186 173.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.402 ' O ' ' HG2' ' A' ' 179' ' ' ARG . 6.5 t -92.15 154.27 18.8 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 166.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 87.97 124.18 2.05 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.31 24.31 0.36 Allowed 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.053 1.836 . . . . 0.0 114.257 -166.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -126.57 5.11 6.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.896 0.855 . . . . 0.0 109.854 176.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 36.99 51.24 0.96 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 113.838 -1.528 . . . . 0.0 114.46 -177.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -109.72 -15.46 14.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.073 0.463 . . . . 0.0 110.656 174.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 173' ' ' THR . 14.4 mmm180 -59.88 -58.49 8.32 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.442 -1.253 . . . . 0.0 107.697 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 34.9 t70 72.71 62.24 0.11 Allowed 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 160.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.459 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 50.5 p90 -91.46 65.47 5.26 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 122.74 1.257 . . . . 0.0 108.478 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -53.76 125.86 19.98 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 168.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 82.1 p -72.25 143.75 48.68 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.345 -160.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -149.69 147.37 17.6 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -167.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -82.27 143.6 12.64 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.177 1.918 . . . . 0.0 111.241 173.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 1.8 m -76.34 116.64 17.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.21 0.529 . . . . 0.0 111.105 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . 0.577 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 21.9 m-30 -84.54 145.18 28.21 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.079 177.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 40.2 p -122.23 -18.35 6.86 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.489 -174.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 66.5 t -139.47 115.05 8.51 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -176.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.534 HD11 ' CB ' ' A' ' 216' ' ' ALA . 20.7 mm -83.71 119.44 32.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -168.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 35.0 t -143.55 138.43 29.12 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.537 -1.665 . . . . 0.0 107.344 170.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -62.73 -33.45 75.15 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 172.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -55.66 -63.02 1.3 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 113.358 -1.746 . . . . 0.0 110.02 171.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 61.3 mtt -154.78 119.26 4.78 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.037 176.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.477 ' HB2' ' CD1' ' A' ' 187' ' ' PHE . 62.9 m -80.65 1.24 30.77 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 110.588 -0.153 . . . . 0.0 110.588 176.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 31.6 mm-40 96.62 -138.49 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.578 1.551 . . . . 0.0 109.452 -172.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 73.56 -37.1 0.84 Allowed Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.131 -0.557 . . . . 0.0 114.468 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -63.71 -14.36 51.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.527 0.664 . . . . 0.0 111.129 -177.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.432 ' N ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -107.43 27.0 9.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.645 -179.952 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 27.0 t -156.6 155.35 31.69 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.214 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -125.88 23.19 5.95 Favored Glycine 0 CA--C 1.504 -0.596 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 175.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.438 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -60.9 112.18 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 175.245 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 46.4 t -104.88 100.02 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-O 122.632 1.206 . . . . 0.0 110.441 175.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 15.6 t -125.17 -175.23 3.25 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 112.575 -2.102 . . . . 0.0 105.862 173.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 12.0 p -101.42 163.17 12.41 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.664 173.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.833 ' HB3' ' CE3' ' A' ' 217' ' ' TRP . 41.4 pttt -68.98 -22.76 64.08 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.337 176.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 9.2 m -59.94 -51.42 69.74 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.13 -48.11 81.25 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.553 175.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.0 -21.98 61.49 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.168 -174.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 86.6 m -101.48 -17.67 16.33 Favored 'General case' 0 C--O 1.212 -0.892 0 O-C-N 121.549 -0.719 . . . . 0.0 112.064 -176.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -81.91 -48.9 10.93 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.915 0.865 . . . . 0.0 109.797 166.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.413 HG22 ' O ' ' A' ' 233' ' ' ARG . 6.4 p -102.4 141.63 34.91 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.675 -176.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 1.3 t 58.51 -38.08 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.455 ' O ' ' HD3' ' A' ' 215' ' ' ARG . . . 81.58 -161.11 42.27 Favored Glycine 0 CA--C 1.505 -0.566 0 CA-C-N 119.812 1.187 . . . . 0.0 112.915 -177.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.455 ' HD3' ' O ' ' A' ' 214' ' ' GLY . 0.0 OUTLIER 102.72 -93.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.487 1.115 . . . . 0.0 108.978 166.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.577 ' HB3' ' HB2' ' A' ' 187' ' ' PHE . . . -172.25 172.71 4.44 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 118.99 0.814 . . . . 0.0 109.24 173.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . 0.833 ' CE3' ' HB3' ' A' ' 206' ' ' LYS . 12.8 t90 -163.12 150.66 13.2 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -177.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 70.7 173.06 12.87 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 114.714 0.646 . . . . 0.0 114.714 170.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -123.97 131.73 24.25 Favored Pre-proline 0 C--N 1.334 -0.105 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.74 167.37 39.57 Favored 'Cis proline' 0 C--N 1.349 0.555 0 C-N-CA 123.806 -1.331 . . . . 0.0 112.616 -1.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 16.2 t -59.4 111.25 1.31 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.653 -176.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -106.12 102.07 11.51 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.02 141.9 35.01 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.381 -169.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 14.8 m -144.05 159.22 53.68 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.429 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.95 167.22 23.97 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.982 2.454 . . . . 0.0 109.769 164.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.458 ' O ' ' HD3' ' A' ' 228' ' ' PRO . . . -56.02 -92.23 0.0 OUTLIER 'General case' 0 C--O 1.211 -0.969 0 CA-C-N 117.957 0.344 . . . . 0.0 110.511 176.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.02 102.59 4.31 Favored Pre-proline 0 C--N 1.316 -0.861 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.057 169.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 226' ' ' ALA . 24.5 Cg_endo -93.52 -44.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.794 2.329 . . . . 0.0 113.858 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -103.15 -179.85 0.85 Allowed Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -173.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.06 174.24 0.99 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 121.849 1.699 . . . . 0.0 112.251 172.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 73.9 m 70.12 128.63 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -168.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -58.96 148.85 29.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -176.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.413 ' O ' HG22 ' A' ' 212' ' ' THR . 17.3 ptp180 -31.71 -47.03 0.12 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 246' ' ' ASP . . . -79.52 11.79 30.45 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.475 -0.869 . . . . 0.0 114.168 -174.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . 0.433 ' O ' HD13 ' A' ' 236' ' ' ILE . 78.5 m-85 -123.08 155.9 35.99 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.867 0.842 . . . . 0.0 113.061 -173.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.433 HD13 ' O ' ' A' ' 235' ' ' PHE . 0.3 OUTLIER -135.41 134.48 21.21 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 114.011 -1.45 . . . . 0.0 107.866 173.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.89 112.47 1.29 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 121.86 1.707 . . . . 0.0 110.932 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -53.48 135.3 40.0 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.832 0.825 . . . . 0.0 110.364 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 30.9 mt -69.69 -13.23 16.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.752 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -103.67 -60.8 1.51 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.388 0.613 . . . . 0.0 110.057 -176.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 44.7 p -84.38 -40.41 17.89 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.873 -175.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 97.6 5.0 57.95 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -83.79 133.3 34.77 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.706 0.765 . . . . 0.0 110.942 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 22.3 m -56.16 108.14 0.44 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.905 170.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -115.19 134.87 54.76 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -178.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.536 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 12.8 t70 -75.62 140.43 42.6 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -176.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.631 HG23 ' HG3' ' A' ' 249' ' ' GLU . 3.7 m -94.38 145.14 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -75.44 77.38 2.5 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 166.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.631 ' HG3' HG23 ' A' ' 247' ' ' VAL . 47.9 mp0 -50.04 -35.32 24.56 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.4 0.619 . . . . 0.0 110.716 -171.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 77.2 m -50.94 -34.83 30.35 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.069 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -103.94 -47.35 4.22 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.428 0.691 . . . . 0.0 110.466 -175.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -63.38 -26.52 68.79 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.935 -177.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.645 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.7 mp -121.38 78.43 35.83 Favored Pre-proline 0 N--CA 1.446 -0.635 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -57.31 112.75 1.22 Allowed 'Trans proline' 0 CA--C 1.514 -0.493 0 C-N-CA 123.358 2.705 . . . . 0.0 114.608 -164.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 74.46 24.51 72.72 Favored Glycine 0 C--N 1.308 -0.976 0 CA-C-N 113.561 -1.654 . . . . 0.0 113.665 175.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.645 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.6 OUTLIER -67.92 -32.94 73.75 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 117.615 0.707 . . . . 0.0 110.537 177.487 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . 0.474 ' HA ' ' HB3' ' A' ' 284' ' ' GLN . 35.3 t -104.05 83.28 2.08 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.488 0.661 . . . . 0.0 109.443 177.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -98.52 -2.79 37.97 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.927 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -60.21 -41.58 98.3 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.46 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -165.31 -109.85 0.23 Allowed Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.953 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 272' ' ' LYS . 10.0 m120 -86.68 162.08 18.1 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.162 0.506 . . . . 0.0 111.276 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 4.3 t -148.08 120.46 8.44 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.177 174.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 21.7 mt -128.29 165.2 28.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.58 125.86 33.35 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 117.95 -1.5 . . . . 0.0 113.559 -177.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.2 t -114.25 162.6 16.36 Favored 'General case' 0 C--O 1.259 1.558 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.131 163.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.536 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 27.2 m -72.55 124.84 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 C-N-CA 119.717 -0.793 . . . . 0.0 108.953 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.412 ' HA2' ' CE2' ' A' ' 235' ' ' PHE . . . 105.43 -17.61 43.05 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 119.997 -1.097 . . . . 0.0 112.784 -175.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 41.3 t 175.58 155.2 0.18 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.77 0.785 . . . . 0.0 110.302 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -102.33 155.96 17.9 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -113.18 116.96 30.64 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.057 -173.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 99.2 m -105.07 148.25 27.01 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 261' ' ' ASN . 21.2 ttpp -127.95 132.46 49.24 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -177.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 23.4 m -112.63 157.14 41.19 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.373 -175.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . 0.401 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 51.1 Cg_exo -55.41 156.84 16.19 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.189 1.926 . . . . 0.0 110.944 168.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -56.32 144.15 31.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.676 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.38 -34.31 2.89 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.283 -0.961 . . . . 0.0 112.036 -176.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' HIS . . . . . 0.513 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 16.0 m-70 -75.8 164.16 26.52 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.592 0.234 . . . . 0.0 110.56 -175.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -139.82 142.6 36.63 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -176.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 57.5 tp -73.07 125.01 26.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.112 0.482 . . . . 0.0 111.315 -178.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -102.48 95.6 6.36 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -68.0 -16.05 63.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.085 -172.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 84.7 t -56.33 -49.36 77.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.512 173.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 2.4 p -134.87 40.21 2.94 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.229 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 0.474 ' HB3' ' HA ' ' A' ' 257' ' ' CYS . 13.5 mp0 25.46 56.54 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.201 -1.363 . . . . 0.0 113.457 -173.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -101.29 176.16 5.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.77 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 38.8 m -147.61 97.64 2.86 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.486 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.513 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 65.7 mm-40 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.358 -0.829 . . . . 0.0 109.54 -174.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.2 m . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 120.791 0.329 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -91.97 -14.82 28.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.803 0.335 . . . . 0.0 110.85 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.1 m -86.3 101.64 13.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.231 0.539 . . . . 0.0 109.824 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -120.95 149.38 42.73 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.738 -175.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 31.1 p -79.95 -20.56 45.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.153 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.4 pt -87.16 57.74 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.275 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -68.43 170.66 8.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.528 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -100.26 60.72 1.04 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.038 0.447 . . . . 0.0 110.65 -176.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 4.1 m -71.88 166.8 21.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.474 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -113.05 -11.56 13.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.394 0.616 . . . . 0.0 111.303 -174.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.428 HD13 ' H ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -91.71 -164.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.482 0.658 . . . . 0.0 112.548 -177.802 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.445 ' N ' ' HD2' ' A' ' 122' ' ' ARG . 3.0 mpt_? -117.33 119.53 35.4 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.136 -174.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 78.0 m -107.43 98.46 8.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.031 -177.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 5.0 mpp? -107.49 165.11 11.65 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.577 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.5 m120 70.38 37.27 1.58 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.55 0.69 . . . . 0.0 110.704 173.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 82.33 8.89 85.72 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.527 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.14 124.56 34.06 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.161 -176.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 30.8 t -90.29 168.64 11.75 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.25 124.07 33.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.199 0.523 . . . . 0.0 112.257 -173.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 31.4 t -138.91 146.22 40.83 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.58 172.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.9 t70 25.79 -94.69 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 O-C-N 125.042 1.464 . . . . 0.0 111.785 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -141.44 16.01 2.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.229 1.014 . . . . 0.0 108.605 167.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.84 136.35 54.94 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.451 170.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 64.1 m -74.85 158.28 33.66 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -172.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.1 mt -103.86 107.67 18.64 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 39.8 m -67.07 160.44 26.64 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.613 -173.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -89.04 145.51 25.43 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 169.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -62.09 110.34 1.56 Allowed 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 122.939 1.352 . . . . 0.0 112.276 -170.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 132.47 -5.43 5.23 Favored Glycine 0 N--CA 1.432 -1.611 0 CA-C-N 111.808 -2.451 . . . . 0.0 111.53 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.58 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 98.0 m-85 -122.35 149.09 44.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.934 0.867 . . . . 0.0 110.207 171.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 30.7 pt -126.9 171.8 14.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 176.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.55 157.71 20.31 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.7 p -65.06 -34.71 79.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.248 0.524 . . . . 0.0 111.174 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -100.22 2.26 42.66 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.051 0.453 . . . . 0.0 110.427 174.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 60.2 m 61.9 43.64 9.1 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.496 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -104.27 3.53 43.89 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 119.953 -1.118 . . . . 0.0 113.646 -176.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.58 110.92 64.09 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 117.54 0.67 . . . . 0.0 109.422 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -80.81 140.3 12.82 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.846 2.364 . . . . 0.0 112.747 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.9 p -67.08 111.36 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.291 1.043 . . . . 0.0 112.364 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -80.21 73.53 7.05 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.541 171.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -50.65 -67.13 0.28 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.699 -1.591 . . . . 0.0 114.239 -171.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 19.4 m -98.22 13.78 30.08 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.394 0.616 . . . . 0.0 111.624 -166.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 79.2 123.35 0.37 Allowed Glycine 0 CA--C 1.5 -0.87 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.668 -175.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 86.4 m -77.0 -17.29 58.96 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -175.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 177' ' ' CYS . 2.2 mp 46.19 -172.37 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -172.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.418 ' ND2' ' SG ' ' A' ' 177' ' ' CYS . 0.8 OUTLIER 51.92 11.06 0.13 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.297 1.439 . . . . 0.0 113.902 171.586 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.31 36.7 84.55 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.799 -174.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -79.24 -145.65 3.31 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.446 -176.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -153.77 118.4 4.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.368 0.584 . . . . 0.0 110.823 -175.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.9 m -62.01 119.75 9.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.746 0.308 . . . . 0.0 111.554 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 165' ' ' ARG . 4.3 m -107.13 -35.85 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 121.134 0.493 . . . . 0.0 110.417 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -140.13 172.21 6.66 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.58 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 79.4 Cg_exo -52.73 106.06 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.175 1.916 . . . . 0.0 112.246 176.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 69.1 -0.04 2.62 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.483 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.504 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -90.41 83.99 5.96 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 172.405 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 40.5 m -84.12 145.33 28.48 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.2 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -92.67 124.66 36.84 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 37.1 m -104.07 135.62 45.23 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 124.142 0.901 . . . . 0.0 112.114 -168.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.4 m -48.73 -53.66 18.04 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -172.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -167.78 -88.16 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.366 -0.934 . . . . 0.0 112.55 -174.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -85.16 57.24 4.98 Favored Glycine 0 N--CA 1.435 -1.385 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.898 -167.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.503 ' CD2' ' N ' ' A' ' 172' ' ' PHE . 8.1 m-85 -122.91 128.49 50.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.223 1.012 . . . . 0.0 111.669 172.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.722 HG23 ' CE1' ' A' ' 181' ' ' TYR . 14.9 p -86.72 119.88 27.42 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.181 177.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 107.4 133.3 7.15 Favored Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -174.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.43 -0.45 8.19 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 120.956 1.104 . . . . 0.0 112.429 -173.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -107.96 19.23 20.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.496 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 155' ' ' LEU . 0.5 OUTLIER 17.66 79.67 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 118.301 2.704 . . . . 0.0 118.301 176.222 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.464 ' HB3' HD13 ' A' ' 155' ' ' LEU . 14.5 pt-20 -126.22 34.53 4.83 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.132 0.968 . . . . 0.0 109.517 167.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 23.0 mmt180 -132.63 88.22 2.5 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.724 -1.58 . . . . 0.0 107.248 176.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -81.0 49.83 1.29 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.808 0.813 . . . . 0.0 111.352 -169.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.722 ' CE1' HG23 ' A' ' 173' ' ' THR . 10.5 p90 -76.59 93.86 3.66 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 176.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -79.15 173.76 12.25 Favored 'General case' 0 N--CA 1.436 -1.15 0 O-C-N 119.733 -1.854 . . . . 0.0 106.162 174.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 81.6 p -98.76 138.87 35.3 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 118.851 -1.14 . . . . 0.0 108.889 169.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -159.75 149.78 19.66 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.727 -173.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.44 132.51 14.94 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.365 2.044 . . . . 0.0 111.041 171.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . 0.566 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 71.5 m -75.2 122.09 23.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.4 0.619 . . . . 0.0 110.236 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -107.55 153.47 22.81 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.793 -175.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.511 ' O ' ' HB3' ' A' ' 215' ' ' ARG . 29.1 p -100.94 -56.99 2.19 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.002 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 36.9 t -134.06 118.45 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 119.686 -0.805 . . . . 0.0 111.767 -172.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.548 HG13 ' SG ' ' A' ' 195' ' ' CYS . 2.1 mp -102.32 117.21 47.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.465 0.65 . . . . 0.0 111.736 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.3 p -110.98 -168.67 1.33 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 159.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -68.87 -4.84 17.9 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.383 0.611 . . . . 0.0 110.066 171.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -90.81 -76.43 0.44 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.394 -174.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 98.6 mmm -141.68 160.28 40.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.275 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.548 ' SG ' HG13 ' A' ' 190' ' ' ILE . 38.8 m -91.09 -8.15 49.69 Favored 'General case' 0 C--O 1.248 0.99 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.953 175.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 78.22 -140.49 0.02 OUTLIER 'General case' 0 C--N 1.347 0.464 0 CA-C-N 114.2 -1.364 . . . . 0.0 109.863 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 82.56 -7.06 66.31 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.796 172.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 59.1 27.98 17.12 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 122.577 0.351 . . . . 0.0 111.2 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 51.9 44.74 29.17 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.687 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 41.5 t -70.47 155.53 40.59 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.641 -174.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -109.33 20.01 28.58 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.332 177.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.11 113.57 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 173.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 48.9 t -102.46 99.11 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 122.346 1.069 . . . . 0.0 110.502 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 7.9 t -127.77 -175.4 3.46 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 112.479 -2.146 . . . . 0.0 105.436 170.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 30.6 p -101.72 165.29 11.29 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 119.648 1.113 . . . . 0.0 109.923 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.813 ' HB3' ' CE3' ' A' ' 217' ' ' TRP . 0.0 OUTLIER -66.64 -23.85 66.21 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 119.102 -1.039 . . . . 0.0 108.662 175.805 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.8 m -59.51 -55.93 28.4 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.03 -54.96 31.97 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.74 176.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 52.9 m -77.41 -20.51 54.52 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -170.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 226' ' ' ALA . 97.5 m -83.93 -41.73 17.07 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 119.123 0.874 . . . . 0.0 109.914 173.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -64.6 -58.32 6.67 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.494 HG22 ' HA2' ' A' ' 234' ' ' GLY . 5.1 p -91.25 140.69 29.55 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.896 -1.502 . . . . 0.0 108.998 178.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER 58.62 -30.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -177.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 75.82 -162.39 52.92 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 120.209 1.368 . . . . 0.0 114.449 177.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.511 ' HB3' ' O ' ' A' ' 188' ' ' THR . 2.1 mtt180 98.78 -83.3 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.546 1.138 . . . . 0.0 112.371 166.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -174.57 172.02 3.18 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.117 0.417 . . . . 0.0 110.521 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . 0.813 ' CE3' ' HB3' ' A' ' 206' ' ' LYS . 9.6 t90 -165.33 151.38 9.75 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.306 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 221' ' ' CYS . . . 77.23 174.88 41.67 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 115.06 0.784 . . . . 0.0 115.06 171.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.451 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 17.6 m80 -133.3 131.72 21.74 Favored Pre-proline 0 N--CA 1.462 0.172 0 CA-C-N 114.692 -0.754 . . . . 0.0 109.315 174.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 23.0 Cg_endo -61.18 142.93 36.62 Favored 'Cis proline' 0 C--N 1.346 0.409 0 C-N-CA 123.132 -1.612 . . . . 0.0 111.175 -3.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 81.0 m -49.49 121.42 5.06 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.733 0.646 . . . . 0.0 111.784 -172.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -93.44 95.64 9.41 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.22 122.7 33.39 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 -172.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 17.8 p -142.9 150.27 52.57 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.05 -165.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.34 167.11 13.47 Favored 'Trans proline' 0 CA--C 1.515 -0.437 0 C-N-CA 122.867 2.378 . . . . 0.0 110.672 162.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 210' ' ' CYS . . . -62.88 -119.74 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.853 0.835 . . . . 0.0 112.06 174.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -57.13 107.76 1.01 Allowed Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.13 -172.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.6 -55.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.146 2.564 . . . . 0.0 112.366 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -78.22 163.0 64.62 Favored Pre-proline 0 CA--C 1.511 -0.539 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.7 59.05 4.08 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 121.992 1.794 . . . . 0.0 112.031 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 59.3 m -131.23 162.58 29.67 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -66.02 139.8 58.23 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 175.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -36.22 -41.17 0.25 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.494 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -77.25 8.93 29.47 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.629 -175.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . 0.535 ' HE2' ' N ' ' A' ' 267' ' ' GLY . 2.3 m-85 -121.56 149.45 43.11 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.287 1.042 . . . . 0.0 113.067 -171.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.37 124.2 25.14 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 113.736 -1.575 . . . . 0.0 108.818 172.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -63.58 122.1 10.09 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.295 1.997 . . . . 0.0 111.573 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -53.78 131.03 38.81 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.875 177.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 40.9 pt -76.5 7.07 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.555 176.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -113.48 -59.82 1.97 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.547 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 42.1 p -91.31 -44.01 9.44 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.913 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 105.6 7.84 36.05 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -92.77 125.16 37.25 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 121.907 0.861 . . . . 0.0 109.938 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 10.2 m -60.47 122.2 14.01 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 113.296 -1.775 . . . . 0.0 109.938 174.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -119.37 139.21 52.36 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.671 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 17.4 t70 -74.46 143.68 44.54 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.699 HG23 ' HG3' ' A' ' 249' ' ' GLU . 10.0 m -94.52 145.98 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.252 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.89 77.04 1.64 Allowed 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 165.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.699 ' HG3' HG23 ' A' ' 247' ' ' VAL . 6.3 mp0 -52.73 -35.16 55.43 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.478 0.656 . . . . 0.0 109.56 -175.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 6.4 m -53.83 -29.51 41.15 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.211 174.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -103.72 -38.66 6.98 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.719 0.771 . . . . 0.0 109.906 -176.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -72.18 -19.8 61.69 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.869 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.542 HG22 ' HB3' ' A' ' 256' ' ' LEU . 46.7 mt -140.9 74.86 25.56 Favored Pre-proline 0 C--O 1.244 0.77 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -12.51 -80.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.947 1 C-N-CA 126.832 5.021 . . . . 0.0 116.174 -164.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -130.6 64.69 0.61 Allowed Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 119.464 -1.35 . . . . 0.0 111.472 176.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.542 ' HB3' HG22 ' A' ' 253' ' ' ILE . 1.4 pt? -68.63 8.19 0.53 Allowed 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -176.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 56.9 m -114.0 127.43 55.95 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 171.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . 0.405 ' O ' ' HB3' ' A' ' 286' ' ' CYS . 97.8 mt-30 -70.36 91.46 0.75 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.998 0.428 . . . . 0.0 111.962 -175.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 80.45 32.44 34.37 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.912 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -129.74 163.81 22.68 Favored Glycine 0 C--O 1.227 -0.308 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.06 -178.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -102.27 103.2 13.67 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 50.8 t -68.21 123.05 19.63 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.079 0.466 . . . . 0.0 111.072 176.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 47.3 mt -125.56 103.75 12.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.595 ' ND2' ' HB3' ' A' ' 269' ' ' PHE . 1.0 OUTLIER -81.12 128.3 33.59 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -160.798 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 268' ' ' SER . 0.2 OUTLIER -109.21 157.5 18.74 Favored 'General case' 0 C--O 1.257 1.449 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.722 163.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.671 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 3.2 m -72.87 128.68 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 C-N-CA 118.839 -1.144 . . . . 0.0 108.531 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.535 ' N ' ' HE2' ' A' ' 235' ' ' PHE . . . 105.19 -26.81 20.83 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.073 -1.06 . . . . 0.0 110.887 -174.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.481 ' O ' HG23 ' A' ' 265' ' ' THR . 32.6 t 176.09 151.71 0.15 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.124 0.488 . . . . 0.0 110.358 -175.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . 0.595 ' HB3' ' ND2' ' A' ' 264' ' ' ASN . 26.7 p90 -99.4 162.44 13.04 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.968 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -115.32 106.49 14.08 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.808 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 54.4 m -94.6 112.18 23.94 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.346 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -79.19 132.21 36.45 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.106 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 36.2 m -116.26 143.73 31.63 Favored Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.115 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . 0.459 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 36.6 Cg_exo -60.56 167.01 8.82 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.363 2.042 . . . . 0.0 110.89 173.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -59.44 144.35 47.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.711 0.291 . . . . 0.0 110.86 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.6 -27.69 4.66 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.625 -177.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' HIS . . . . . 0.523 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 18.0 m-70 -77.0 160.34 29.21 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.021 0.438 . . . . 0.0 111.317 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -145.97 121.34 10.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.396 -174.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 19.1 tp -77.32 141.47 39.89 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.77 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -133.16 100.09 4.75 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.178 175.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -60.56 -26.05 66.63 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.47 -175.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 58.0 t -58.06 -29.53 36.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.679 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 33.4 t -147.85 34.87 0.84 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.888 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 32.11 38.55 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.448 1.099 . . . . 0.0 113.664 -176.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 96.6 mttt -87.12 149.33 24.75 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.693 -175.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' CYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 258' ' ' GLN . 42.2 t -140.08 83.04 1.9 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.342 0.591 . . . . 0.0 109.507 178.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 3.8 mm-40 . . . . . 0 C--O 1.248 0.988 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.904 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.59 37.26 0.63 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.863 0.363 . . . . 0.0 111.913 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.9 p -86.64 0.3 54.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.451 0.643 . . . . 0.0 110.322 177.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -159.44 -172.65 3.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.295 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 32.6 m -81.35 -46.99 13.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.783 0.325 . . . . 0.0 110.179 178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.4 mt -67.44 114.02 3.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.148 0.499 . . . . 0.0 110.389 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -95.19 101.7 13.46 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.15 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -72.73 119.57 17.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.655 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.95 163.69 16.63 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.117 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -103.85 -62.94 1.24 Allowed 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.14 0.495 . . . . 0.0 109.879 -176.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -89.12 -173.45 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-O 121.449 0.642 . . . . 0.0 112.567 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.521 ' N ' ' HD2' ' A' ' 122' ' ' ARG . 1.2 mpt_? -100.43 137.41 38.89 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.932 -167.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.655 ' SG ' ' HA ' ' A' ' 129' ' ' CYS . 94.1 m -118.83 125.84 50.48 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.721 176.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -129.84 161.56 30.5 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.3 m120 70.92 40.09 0.96 Allowed 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.457 0.473 . . . . 0.0 111.64 172.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.627 ' O ' ' HG2' ' A' ' 137' ' ' GLN . . . 82.37 24.63 53.69 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.214 -179.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -89.38 127.71 8.83 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.169 -1.015 . . . . 0.0 112.596 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.7 m -86.4 124.02 32.28 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 176.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.655 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 27.6 p -82.81 116.31 22.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.725 0.774 . . . . 0.0 111.955 -170.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.0 t -108.37 -176.79 3.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.445 176.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -94.21 104.39 16.4 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.865 -176.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.1 t70 93.95 -6.82 0.13 Allowed 'General case' 0 N--CA 1.469 0.486 0 O-C-N 124.485 1.116 . . . . 0.0 109.586 171.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -160.21 171.47 19.14 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.607 173.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 34.9 t -122.58 132.99 54.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.276 -174.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 64.2 mt -82.98 120.65 25.98 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.487 0.66 . . . . 0.0 110.54 174.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 82.2 m -91.98 148.51 22.14 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.564 0.697 . . . . 0.0 112.39 -174.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 126' ' ' GLY . 24.8 mm-40 -66.37 152.07 45.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.314 166.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -66.14 113.41 4.49 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 122.045 0.926 . . . . 0.0 111.13 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 108.45 10.36 25.56 Favored Glycine 0 C--N 1.302 -1.337 0 CA-C-N 113.29 -1.777 . . . . 0.0 111.143 -175.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.479 ' CE2' ' HB3' ' A' ' 148' ' ' PRO . 78.9 m-85 -123.8 144.02 49.96 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 122.402 -0.469 . . . . 0.0 109.955 171.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 147' ' ' GLN . 25.1 pt -135.57 -176.66 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.024 -177.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 96.19 172.98 35.64 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.749 -176.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.0 m -76.51 -29.57 56.84 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 122.759 -0.259 . . . . 0.0 111.12 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -110.61 11.07 22.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.873 0.368 . . . . 0.0 110.425 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 58.1 m 63.5 30.09 15.28 Favored 'General case' 0 C--O 1.228 -0.037 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.129 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -94.26 4.83 70.89 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.873 -174.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.409 ' O ' HG12 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -120.21 97.59 49.1 Favored Pre-proline 0 C--O 1.22 -0.496 0 CA-C-N 117.702 0.751 . . . . 0.0 110.755 -179.458 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.479 ' HB3' ' CE2' ' A' ' 140' ' ' TYR . 52.4 Cg_endo -73.01 148.14 44.53 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.49 2.127 . . . . 0.0 112.19 176.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.17 108.89 3.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.237 -173.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.69 77.24 6.32 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.362 173.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -51.9 -65.97 0.46 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -173.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 60.7 m -86.98 12.43 11.25 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.074 0.464 . . . . 0.0 111.226 -168.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 81.6 127.47 0.91 Allowed Glycine 0 N--CA 1.429 -1.786 0 CA-C-O 122.19 0.883 . . . . 0.0 111.906 -173.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 1.7 m -73.56 152.93 40.45 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 113.989 -1.106 . . . . 0.0 109.307 171.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.631 HD12 ' O ' ' A' ' 176' ' ' GLN . 70.9 mt -135.34 162.89 31.31 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -168.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.65 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 2.6 t-20 48.76 24.88 0.88 Allowed 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.909 0.756 . . . . 0.0 111.605 -168.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 63.22 38.62 96.78 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.212 -176.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -76.28 -140.81 1.04 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.734 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.55 130.99 9.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.075 0.438 . . . . 0.0 111.081 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.26 110.12 5.71 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.265 0.555 . . . . 0.0 110.428 172.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.3 m -98.51 -28.72 3.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.631 -178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.613 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -140.28 173.11 5.33 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 174.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.461 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 49.4 Cg_exo -56.83 104.57 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 121.973 1.782 . . . . 0.0 112.348 178.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 68.06 9.97 7.52 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.216 1.006 . . . . 0.0 110.904 -176.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.613 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.3 OUTLIER -99.69 84.1 2.87 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 8.9 t -86.52 147.72 25.84 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.672 176.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -103.3 131.07 50.65 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.074 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 52.1 m -107.5 136.65 46.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.563 -165.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.65 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 25.4 m -53.12 -56.58 15.21 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -168.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' A' ' 171' ' ' GLY . 35.7 t80 -154.53 -87.61 0.05 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 119.043 -1.063 . . . . 0.0 112.729 -170.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.422 ' N ' ' CD1' ' A' ' 170' ' ' TYR . . . -92.21 52.33 2.81 Favored Glycine 0 CA--C 1.493 -1.305 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.725 -166.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.526 ' CD2' ' N ' ' A' ' 172' ' ' PHE . 3.3 m-85 -124.87 123.91 40.95 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.54 169.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.495 ' O ' ' HG3' ' A' ' 179' ' ' ARG . 2.9 t -91.54 145.39 24.65 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 174.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 87.76 127.86 2.67 Favored Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -173.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.35 24.76 0.35 Allowed 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 121.534 1.489 . . . . 0.0 113.327 -168.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.631 ' O ' HD12 ' A' ' 155' ' ' LEU . 59.4 tt0 -122.31 7.14 9.62 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.437 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.7 OUTLIER 25.65 59.53 0.06 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 -179.393 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -112.42 15.54 20.2 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 122.169 0.985 . . . . 0.0 109.479 171.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' A' ' 173' ' ' THR . 1.4 mmp_? -87.01 -73.33 0.47 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.556 -173.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 21.3 t70 88.38 78.32 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.09 0.948 . . . . 0.0 108.657 167.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.498 ' CG ' ' O ' ' A' ' 181' ' ' TYR . 13.4 p90 -149.46 108.78 3.95 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.678 -176.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -74.49 147.56 41.77 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 119.668 -1.895 . . . . 0.0 109.853 173.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 71.9 p -87.76 137.37 32.4 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.023 0.439 . . . . 0.0 110.337 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -151.25 153.3 24.88 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.435 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.414 ' HG2' ' CE1' ' A' ' 219' ' ' HIS . 5.0 Cg_exo -78.58 132.91 11.3 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.748 2.299 . . . . 0.0 110.696 170.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . 0.514 ' SG ' ' NE ' ' A' ' 215' ' ' ARG . 12.7 t -100.74 117.0 33.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.04 0.447 . . . . 0.0 111.031 -174.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . 0.74 ' O ' ' HB2' ' A' ' 215' ' ' ARG . 20.4 m-85 -98.62 174.67 6.31 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.216 178.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.489 ' HA ' ' CB ' ' A' ' 215' ' ' ARG . 1.3 p -129.28 -59.52 1.1 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -177.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.2 p -113.88 117.66 56.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.077 0.465 . . . . 0.0 111.151 -170.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.456 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.0 mt -131.17 117.11 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-O 121.781 0.801 . . . . 0.0 113.129 -168.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.9 p -119.13 -164.69 1.07 Allowed 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.038 163.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -60.25 -4.97 0.94 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.878 0.37 . . . . 0.0 111.032 174.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -87.53 -77.45 0.34 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.893 0.377 . . . . 0.0 110.99 -172.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 72.0 mtp -147.38 167.9 23.19 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.456 ' HA ' HG12 ' A' ' 190' ' ' ILE . 35.7 m -90.88 -27.55 18.71 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 121.471 0.653 . . . . 0.0 112.191 -178.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -164.61 5.9 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.904 -0.497 . . . . 0.0 111.638 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 68.36 -52.78 0.45 Allowed Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.976 -0.631 . . . . 0.0 113.221 -172.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -115.83 122.42 45.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.188 0.518 . . . . 0.0 110.501 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.3 tt -71.4 134.74 46.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.129 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 36.3 m -101.22 131.46 47.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.843 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -87.12 14.77 56.59 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.126 177.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.05 121.5 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 167.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 6.8 t -99.03 96.95 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.031 0 CA-C-O 123.026 1.393 . . . . 0.0 109.227 173.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 12.7 p -129.06 -179.29 5.03 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 112.268 -2.242 . . . . 0.0 106.075 176.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 53.4 p -102.02 163.2 12.37 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 119.034 -1.067 . . . . 0.0 111.728 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.697 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 42.4 tttm -56.25 -38.72 71.52 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.689 170.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.4 m -45.86 -55.55 6.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.144 174.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.433 ' CD1' HG11 ' A' ' 247' ' ' VAL . 0.3 OUTLIER -56.44 -53.37 58.19 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 120.229 -0.589 . . . . 0.0 110.133 176.103 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . 0.752 ' HA ' ' CZ ' ' A' ' 215' ' ' ARG . 76.1 m -52.5 -37.29 57.07 Favored 'General case' 0 C--O 1.247 0.922 0 O-C-N 124.088 0.867 . . . . 0.0 113.266 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 61.3 m -94.15 -33.65 13.24 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.47 -45.45 72.36 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 120.721 -1.237 . . . . 0.0 108.93 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 73.6 p -105.65 149.57 26.22 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.34 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.1 t 57.48 -53.46 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 86.06 146.53 9.41 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 119.297 -1.43 . . . . 0.0 111.429 -169.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.752 ' CZ ' ' HA ' ' A' ' 209' ' ' CYS . 0.1 OUTLIER 153.16 -135.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.014 0.526 . . . . 0.0 111.451 -162.491 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.437 ' HB3' HD11 ' A' ' 190' ' ' ILE . . . -160.59 165.95 29.82 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . 0.697 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 17.2 t90 -161.79 145.52 12.44 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 121.891 -0.506 . . . . 0.0 110.26 -173.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 99.01 -175.21 28.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.374 -0.917 . . . . 0.0 114.363 171.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.414 ' CE1' ' HG2' ' A' ' 185' ' ' PRO . 11.2 m170 -132.2 130.84 22.13 Favored Pre-proline 0 C--N 1.327 -0.411 0 O-C-N 122.818 -0.224 . . . . 0.0 110.54 176.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.19 169.31 50.53 Favored 'Cis proline' 0 C--N 1.342 0.22 0 C-N-CA 123.014 -1.661 . . . . 0.0 110.976 -9.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 93.7 m -42.34 113.72 0.48 Allowed 'General case' 0 C--O 1.234 0.239 0 O-C-N 123.354 0.409 . . . . 0.0 111.655 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -102.07 106.26 17.12 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' MET . . . . . 0.408 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 0.6 OUTLIER -99.15 134.19 42.35 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.639 -164.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 32.1 p -141.12 152.25 64.27 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.981 0.42 . . . . 0.0 111.624 -176.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -55.69 171.28 0.72 Allowed 'Trans proline' 0 CA--C 1.514 -0.498 0 C-N-CA 123.154 2.569 . . . . 0.0 111.585 164.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.19 -126.69 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.763 0.792 . . . . 0.0 110.451 169.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.69 109.3 6.32 Favored Pre-proline 0 C--N 1.303 -1.433 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.358 -176.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -82.21 -92.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.254 1.969 . . . . 0.0 111.306 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -125.82 86.94 56.79 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.237 172.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -106.9 -168.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.693 0 C-N-CA 123.182 2.588 . . . . 0.0 111.631 171.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 8.9 p -86.77 -51.49 6.07 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 167.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.562 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 58.6 mtt180 -143.9 133.43 23.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 174.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -45.49 -51.06 12.17 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -173.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 246' ' ' ASP . . . -77.66 11.91 17.78 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.566 -0.826 . . . . 0.0 114.286 -175.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . 0.562 ' CD1' ' HB2' ' A' ' 232' ' ' ARG . 8.1 m-85 -123.32 152.5 41.38 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 122.109 0.957 . . . . 0.0 111.864 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.22 122.92 25.25 Favored Pre-proline 0 N--CA 1.426 -1.641 0 CA-C-N 114.117 -1.401 . . . . 0.0 108.221 171.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -64.41 123.6 12.04 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.59 2.194 . . . . 0.0 112.094 178.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -57.69 126.01 25.5 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.667 174.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 29.1 pt -76.16 7.24 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.981 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 48.0 mtm180 -112.02 -60.92 1.79 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.734 177.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 37.6 p -86.89 -46.16 10.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.862 -176.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 108.71 6.52 30.56 Favored Glycine 0 N--CA 1.436 -1.314 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.487 -176.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -86.96 120.82 28.63 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-O 122.018 0.913 . . . . 0.0 110.505 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 78.1 m -62.82 122.22 15.41 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.397 -1.729 . . . . 0.0 109.884 172.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -114.37 135.73 53.76 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.464 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 4.2 t70 -73.97 147.94 42.56 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.531 HG23 ' HG3' ' A' ' 249' ' ' GLU . 5.3 m -100.19 147.38 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.084 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -177.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -78.06 79.25 4.52 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 167.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.531 ' HG3' HG23 ' A' ' 247' ' ' VAL . 49.8 mp0 -53.2 -36.6 61.14 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.505 -172.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 36.5 m -42.32 -40.16 2.38 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.34 171.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -100.12 -29.05 12.72 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.623 0.725 . . . . 0.0 110.321 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.413 ' C ' HD12 ' A' ' 253' ' ' ILE . . . -87.71 -5.88 58.47 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.2 -172.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.493 HG13 ' NH2' ' A' ' 215' ' ' ARG . 2.8 mp -124.82 125.77 25.4 Favored Pre-proline 0 C--O 1.24 0.573 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -34.14 -81.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 125.277 3.984 . . . . 0.0 114.208 -165.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -116.12 52.28 0.68 Allowed Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 174.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.567 ' HA ' ' OE1' ' A' ' 284' ' ' GLN . 20.0 tp -43.76 -64.92 0.57 Allowed 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.97 0.453 . . . . 0.0 112.172 -175.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 71.7 m -134.05 89.02 2.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -83.06 -59.2 2.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.474 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -79.85 93.79 1.41 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.847 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 124.89 -174.52 17.22 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.672 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -83.63 157.12 22.37 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.78 132.71 18.1 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 5.2 mt -137.71 156.07 31.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -172.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -121.61 117.33 26.45 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.335 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 5.6 t -110.53 166.77 10.73 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.559 164.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.464 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 29.5 m -70.44 130.46 34.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.476 -177.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 83.2 -9.49 60.79 Favored Glycine 0 N--CA 1.433 -1.557 0 C-N-CA 120.263 -0.97 . . . . 0.0 114.315 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 75.1 m -165.42 154.61 12.3 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 118.442 1.121 . . . . 0.0 111.184 -173.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -114.09 149.73 35.11 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.144 -0.972 . . . . 0.0 109.611 171.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -105.46 113.41 26.96 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 59.0 m -121.15 154.93 35.56 Favored 'General case' 0 CA--C 1.5 -0.953 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.504 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.05 106.27 2.61 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.663 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 64.2 m -77.0 172.97 8.3 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.25 152.44 15.12 Favored 'Trans proline' 0 C--O 1.239 0.533 0 C-N-CA 121.243 1.296 . . . . 0.0 110.481 168.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -57.97 156.88 8.53 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.928 -173.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 86.6 -38.01 3.13 Favored Glycine 0 N--CA 1.435 -1.427 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.588 -176.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -81.38 168.51 18.3 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 122.588 -0.36 . . . . 0.0 110.366 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 61.6 mttp -148.8 138.54 22.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.247 -175.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 46.7 tp -93.79 141.65 28.25 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.375 0.422 . . . . 0.0 110.267 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -122.84 106.7 11.12 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -65.15 -13.47 58.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -173.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 76.8 t -59.68 -38.31 75.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.109 0.48 . . . . 0.0 110.807 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 45.1 m -144.63 38.34 1.23 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.955 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 0.567 ' OE1' ' HA ' ' A' ' 256' ' ' LEU . 23.9 pt20 38.25 32.8 0.05 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.317 1.047 . . . . 0.0 112.81 -175.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -89.82 105.04 17.53 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 122.111 -0.368 . . . . 0.0 111.426 -172.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 45.7 t -108.99 163.9 12.89 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 174.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 C--O 1.248 1.026 0 O-C-N 124.057 0.848 . . . . 0.0 110.249 175.253 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 45.2 t . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -88.59 81.41 7.11 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 120.952 0.406 . . . . 0.0 110.216 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.3 t -67.7 109.46 3.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.72 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -83.92 64.21 7.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.435 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.9 m -75.18 123.22 24.87 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.608 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.43 HG23 ' SG ' ' A' ' 119' ' ' CYS . 69.1 mt -68.7 103.24 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.12 0.486 . . . . 0.0 109.781 174.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -80.59 61.07 4.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.983 -176.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 46.4 t60 41.65 62.14 1.65 Allowed 'General case' 0 N--CA 1.465 0.308 0 O-C-N 124.047 0.842 . . . . 0.0 110.529 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.43 ' SG ' HG23 ' A' ' 116' ' ' ILE . 24.2 p -88.21 162.05 16.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.271 -175.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -114.85 -38.08 4.03 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.98 178.22 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.331 176.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.447 ' H ' ' HD2' ' A' ' 122' ' ' ARG . 0.2 OUTLIER -127.55 134.39 49.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.522 -174.525 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.559 ' SG ' ' HB3' ' A' ' 129' ' ' CYS . 23.1 m -118.62 145.61 45.29 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -172.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.6 mtm -138.33 173.22 11.84 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 62.88 53.12 2.49 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.175 0.297 . . . . 0.0 111.471 175.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 61.86 25.24 65.59 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.891 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -98.61 129.47 9.91 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 119.944 -1.122 . . . . 0.0 111.677 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.2 m -107.85 133.12 52.67 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.559 ' HB3' ' SG ' ' A' ' 123' ' ' CYS . 14.0 p -72.98 134.84 44.86 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.983 0.421 . . . . 0.0 111.006 -173.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.4 t -137.73 104.92 5.44 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.2 t70 50.48 -110.08 0.44 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.985 -168.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -80.99 -41.95 21.95 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.15 -172.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -107.58 179.35 4.26 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.285 -176.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 80.9 m -104.15 146.33 28.91 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.658 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.0 mt -90.04 95.65 10.31 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 58.0 m -72.44 158.41 35.8 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.469 -174.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -80.37 144.66 32.53 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 168.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -63.57 110.83 2.12 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 122.832 1.301 . . . . 0.0 111.553 -174.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 132.82 -4.51 5.05 Favored Glycine 0 C--N 1.294 -1.774 0 CA-C-N 112.093 -2.321 . . . . 0.0 110.87 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.421 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 88.1 m-85 -127.32 149.24 50.13 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 172.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 28.5 pt -135.82 -171.63 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.962 0.41 . . . . 0.0 110.087 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.74 175.15 41.39 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.398 -172.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 37.5 p -71.38 -39.67 71.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.158 0.504 . . . . 0.0 110.738 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 25.9 p-80 -107.59 16.43 23.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.11 -176.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 56.3 m 62.34 28.79 17.1 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.921 174.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.04 -5.18 70.95 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.428 -0.892 . . . . 0.0 113.583 -174.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.407 HE21 ' C ' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -107.92 126.62 29.38 Favored Pre-proline 0 C--O 1.218 -0.565 0 CA-C-N 117.883 0.842 . . . . 0.0 110.562 -176.729 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -87.33 137.86 4.48 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 123.207 2.605 . . . . 0.0 113.078 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.5 p -69.48 122.51 21.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.876 0.846 . . . . 0.0 111.539 -176.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.614 ' HB3' ' SG ' ' A' ' 154' ' ' CYS . 1.4 m -80.08 120.03 23.68 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 168.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -95.33 -63.08 1.2 Allowed 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -172.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 5.4 p -76.75 27.04 0.13 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -172.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 80.27 -19.25 7.0 Favored Glycine 0 CA--C 1.494 -1.234 0 CA-C-O 121.807 0.67 . . . . 0.0 112.966 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . 0.614 ' SG ' ' HB3' ' A' ' 150' ' ' CYS . 68.4 m 62.94 133.81 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 113.201 -1.5 . . . . 0.0 112.208 -175.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 19.7 mt -128.19 167.82 16.3 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 113.484 -1.689 . . . . 0.0 108.69 -173.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.555 ' HB2' ' CZ ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 69.41 12.71 8.34 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.858 0.724 . . . . 0.0 111.526 174.669 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 72.1 33.9 61.91 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -168.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -56.66 130.49 50.38 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 114.966 -0.617 . . . . 0.0 113.428 -175.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -94.27 115.94 28.25 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.781 -0.709 . . . . 0.0 110.893 175.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 14.1 m -66.63 110.68 3.3 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.771 0.319 . . . . 0.0 110.725 -173.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 165' ' ' ARG . 5.7 m -104.27 -38.96 5.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.384 -177.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -140.39 171.9 7.06 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.421 ' HD3' ' CE1' ' A' ' 140' ' ' TYR . 88.5 Cg_exo -47.7 108.1 0.16 Allowed 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 122.137 1.892 . . . . 0.0 112.826 174.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 76.81 -18.33 0.49 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.736 1.215 . . . . 0.0 110.852 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.492 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.2 OUTLIER -78.12 81.68 4.49 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.355 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.35 142.77 29.94 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 169.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -88.36 131.28 34.89 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -175.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.485 ' HA ' ' ND2' ' A' ' 156' ' ' ASN . 27.8 m -87.63 115.03 24.78 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 124.239 0.962 . . . . 0.0 111.307 -175.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 16.8 m -51.71 -54.4 28.68 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -174.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -148.88 -94.4 0.07 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.111 -1.035 . . . . 0.0 112.848 -168.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -89.54 47.81 3.29 Favored Glycine 0 N--CA 1.434 -1.487 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.909 -168.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.555 ' CZ ' ' HB2' ' A' ' 156' ' ' ASN . 16.3 m-85 -122.27 121.91 37.87 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.973 175.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.402 ' O ' ' HG2' ' A' ' 179' ' ' ARG . 4.9 t -90.8 164.56 14.04 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 161.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.37 132.35 5.45 Favored Glycine 0 N--CA 1.438 -1.182 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.27 -24.83 64.88 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.401 1.401 . . . . 0.0 113.501 -167.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -93.18 -0.12 56.99 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.518 0.675 . . . . 0.0 110.697 -178.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.457 ' HB3' ' CB ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 43.11 55.2 4.66 Favored 'General case' 0 N--CA 1.46 0.075 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.676 -174.115 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -106.12 -14.49 15.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.515 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 173' ' ' THR . 14.0 mmt180 -60.03 -64.2 1.03 Allowed 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.263 -177.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 31.1 t0 72.35 64.81 0.12 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.515 0.674 . . . . 0.0 109.853 163.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.433 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 43.2 p90 -87.58 71.06 9.8 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 122.628 1.204 . . . . 0.0 108.026 177.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 -49.99 130.84 22.56 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.073 171.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 44.4 p -79.06 139.31 38.16 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.576 -0.45 . . . . 0.0 109.986 -176.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -157.02 154.8 25.84 Favored Glycine 0 C--N 1.321 -0.261 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -173.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -77.7 133.63 12.94 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.316 2.011 . . . . 0.0 111.889 175.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . 0.572 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 49.1 m -87.58 122.68 31.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.318 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -94.07 137.43 33.27 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.672 179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.487 ' C ' ' HG2' ' A' ' 215' ' ' ARG . 23.9 m -111.64 -11.44 14.01 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.346 -160.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.7 p -169.72 116.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 O-C-N 121.925 -0.485 . . . . 0.0 110.48 174.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.438 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.4 mt -119.67 118.42 57.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -170.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.3 p -112.21 -171.32 1.83 Allowed 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 156.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -67.89 -4.03 11.6 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.591 0.71 . . . . 0.0 109.877 172.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -89.84 -67.65 0.83 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.631 -176.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 62.7 mtm -136.86 145.47 44.43 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.179 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.438 ' HA ' HG12 ' A' ' 190' ' ' ILE . 74.1 m -85.43 -21.1 28.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.731 0.777 . . . . 0.0 109.676 174.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -162.78 -72.31 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 162.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 126.12 13.7 3.19 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.067 164.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -123.56 1.76 8.92 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 173.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 65.77 -75.03 0.05 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.552 0.741 . . . . 0.0 111.761 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 34.9 t 73.02 139.68 0.06 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.654 0.74 . . . . 0.0 112.362 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -98.93 25.28 28.81 Favored Glycine 0 CA--C 1.505 -0.57 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.593 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 1.7 tt -61.01 104.02 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-O 121.235 0.54 . . . . 0.0 109.849 173.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 10.7 t -96.28 97.43 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-O 122.603 1.192 . . . . 0.0 109.599 171.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.441 ' HB3' ' SG ' ' A' ' 209' ' ' CYS . 9.0 t -123.98 -179.51 4.43 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 172.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 10.4 p -103.17 161.39 13.84 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.659 -177.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.434 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 53.6 tttm -61.71 -44.29 97.21 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.177 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.6 m -46.87 -54.53 9.75 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.944 0.878 . . . . 0.0 110.133 174.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.455 HD21 ' HB1' ' A' ' 252' ' ' ALA . 4.3 tp -64.27 -52.91 56.32 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 113.423 -1.717 . . . . 0.0 112.774 -175.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 204' ' ' SER . 53.2 m -74.32 -18.31 60.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.99 0.424 . . . . 0.0 111.827 -175.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 68.8 m -96.58 -25.69 15.51 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.672 176.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -73.73 -60.51 2.22 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 172.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.664 HG22 ' HA2' ' A' ' 234' ' ' GLY . 15.4 p -92.04 162.77 14.23 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 65.11 -54.04 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 95.05 -122.24 7.13 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 120.248 -0.977 . . . . 0.0 113.849 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.487 ' HG2' ' C ' ' A' ' 188' ' ' THR . 6.4 mpt_? 27.17 -86.84 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -174.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.408 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -167.6 167.46 13.44 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 119.52 1.055 . . . . 0.0 110.985 -171.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . 0.632 ' O ' ' HB2' ' A' ' 222' ' ' GLU . 10.0 t90 -155.02 144.91 21.6 Favored 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 102.3 177.2 27.58 Favored Glycine 0 CA--C 1.505 -0.586 0 C-N-CA 120.159 -1.02 . . . . 0.0 114.147 169.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -129.61 133.97 25.68 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.251 -0.474 . . . . 0.0 110.804 -175.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -89.76 117.0 3.12 Favored 'Cis proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.17 -1.596 . . . . 0.0 111.815 -3.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 98.9 m 40.76 89.18 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 O-C-N 124.113 0.883 . . . . 0.0 112.928 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.632 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 23.8 mt-10 -102.68 111.48 23.82 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 177.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' MET . . . . . 0.408 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 18.9 ptt? -102.35 136.95 41.26 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.112 -166.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 59.4 m -119.24 147.58 43.3 Favored Pre-proline 0 C--O 1.233 0.212 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -167.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -60.27 153.67 57.86 Favored 'Trans proline' 0 CA--C 1.508 -0.812 0 C-N-CA 123.833 3.022 . . . . 0.0 113.495 167.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -42.23 113.27 0.42 Allowed 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.904 0.859 . . . . 0.0 110.508 160.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 23.95 99.66 0.02 OUTLIER Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 111.518 -2.583 . . . . 0.0 113.7 -177.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.65 -62.91 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.835 3.023 . . . . 0.0 113.627 -177.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -69.9 155.14 93.99 Favored Pre-proline 0 CA--C 1.514 -0.411 0 CA-C-O 120.691 0.282 . . . . 0.0 110.348 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.75 58.35 6.97 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 121.739 1.626 . . . . 0.0 113.799 -174.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 64.0 m -132.91 148.11 52.29 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 171.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.519 ' HG3' ' CD1' ' A' ' 235' ' ' PHE . 16.4 ptt180 -55.49 137.16 49.08 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.079 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -31.12 -47.15 0.1 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -166.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.664 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -68.58 5.87 3.93 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 114.981 0.753 . . . . 0.0 114.981 -174.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . 0.519 ' CD1' ' HG3' ' A' ' 232' ' ' ARG . 7.7 m-85 -122.77 150.29 42.99 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 122.089 0.947 . . . . 0.0 112.97 -169.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.425 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.1 OUTLIER -126.52 125.25 24.45 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 114.046 -1.433 . . . . 0.0 108.387 172.382 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -62.69 123.01 11.58 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.339 2.026 . . . . 0.0 111.679 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -54.08 127.25 25.86 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.354 0.597 . . . . 0.0 110.936 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 32.7 pt -65.8 -6.66 4.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.428 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 63.8 mtt85 -106.51 -68.1 0.9 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.491 0.662 . . . . 0.0 110.199 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 24.4 p -79.62 -43.17 23.39 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.351 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 102.72 8.0 43.7 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -176.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -82.28 127.11 32.89 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 122.056 0.932 . . . . 0.0 109.714 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 33.3 m -63.76 114.78 4.24 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 113.458 -1.701 . . . . 0.0 109.829 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -112.94 134.44 54.45 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 6.1 t70 -82.7 144.09 30.48 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.571 HG23 ' HG3' ' A' ' 249' ' ' GLU . 9.2 m -98.61 150.16 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.343 -174.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.67 76.39 2.04 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 169.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.571 ' HG3' HG23 ' A' ' 247' ' ' VAL . 9.7 mp0 -53.55 -39.9 65.1 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.191 0.596 . . . . 0.0 111.443 -167.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 49.2 t -51.54 -33.98 34.51 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.932 0.396 . . . . 0.0 111.284 175.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -98.67 -46.38 5.72 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.738 0.78 . . . . 0.0 110.05 -174.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.455 ' HB1' HD21 ' A' ' 208' ' ' LEU . . . -66.63 -21.55 66.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.813 -177.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.447 ' O ' ' N ' ' A' ' 255' ' ' GLY . 3.7 mp -120.39 79.56 28.64 Favored Pre-proline 0 N--CA 1.445 -0.716 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 175.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -21.61 -29.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 1 C-N-CA 128.256 5.97 . . . . 0.0 120.032 -164.204 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 253' ' ' ILE . . . -172.06 39.03 0.16 Allowed Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 119.265 -1.445 . . . . 0.0 111.915 -175.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.445 ' HB3' HG22 ' A' ' 253' ' ' ILE . 2.2 pt? -70.57 -49.65 45.62 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 119.879 -0.728 . . . . 0.0 111.287 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 47.5 t -124.28 133.49 53.47 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 120.839 0.352 . . . . 0.0 110.086 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -134.77 -89.11 0.35 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.934 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 71.34 -71.49 0.81 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.838 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -152.81 -78.48 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -101.47 147.31 26.51 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 15.0 p -137.56 140.74 41.21 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 6.9 mt -144.62 166.16 12.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -170.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.511 ' ND2' ' HB3' ' A' ' 269' ' ' PHE . 0.8 OUTLIER -131.45 132.91 44.67 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 118.673 -1.211 . . . . 0.0 112.938 177.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.85 161.05 18.75 Favored 'General case' 0 C--O 1.256 1.406 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.905 162.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.419 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 33.5 m -72.17 124.31 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 112.97 -29.5 8.03 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.057 -1.068 . . . . 0.0 112.895 -170.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 39.5 t 173.01 156.62 0.1 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 117.912 0.856 . . . . 0.0 109.465 -170.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . 0.511 ' HB3' ' ND2' ' A' ' 264' ' ' ASN . 40.2 p90 -98.43 161.4 13.7 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 121.832 -0.542 . . . . 0.0 110.029 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -114.93 141.18 48.31 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 95.5 m -124.83 161.53 26.31 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.472 0.653 . . . . 0.0 111.493 175.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -140.39 109.52 6.13 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.592 173.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 3.9 m -91.78 163.34 28.27 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.361 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.91 158.61 8.47 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.564 2.176 . . . . 0.0 111.473 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -57.13 145.06 32.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 86.55 -30.89 4.36 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -173.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' HIS . . . . . 0.513 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 27.3 m-70 -89.08 173.64 8.33 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.001 0.429 . . . . 0.0 110.833 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 95.6 mttt -162.38 153.19 17.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.903 -174.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 65.6 tp -87.57 136.82 32.79 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.45 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -126.6 101.23 6.56 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -63.4 -18.09 63.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.382 -174.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.404 ' HA ' ' NH2' ' A' ' 215' ' ' ARG . 93.9 t -57.08 -33.08 41.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.59 177.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 31.9 m -147.24 35.4 0.89 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.577 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 29.68 49.49 0.06 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.45 1.1 . . . . 0.0 113.368 -175.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -108.16 162.1 14.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.139 0.495 . . . . 0.0 111.768 -173.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' CYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 40.4 m -129.63 102.79 6.51 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 18.1 tt0 . . . . . 0 C--O 1.243 0.756 0 CA-C-O 118.554 -0.736 . . . . 0.0 109.855 -173.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 120.958 0.409 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.36 -17.85 16.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.142 0.496 . . . . 0.0 110.96 178.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.0 t -94.31 93.53 7.77 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.102 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 74.0 mtm180 -86.76 79.96 8.67 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 177.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.5 p -85.11 -65.88 0.96 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.761 0.315 . . . . 0.0 111.569 -176.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 66.0 mt -108.73 -44.9 6.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.197 -176.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -64.75 97.96 0.25 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.955 -176.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -138.12 36.39 2.33 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 172.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 5.7 p -159.02 -179.88 8.44 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.559 -164.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -110.47 -40.24 4.69 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.11 173.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.424 HD12 ' O ' ' A' ' 132' ' ' ASP . 0.2 OUTLIER -68.1 -172.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.341 -1.299 . . . . 0.0 113.143 -178.278 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.98 144.87 51.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.762 -174.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 20.4 m -116.19 161.61 18.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.855 0.836 . . . . 0.0 112.118 -175.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 12.1 mmm -161.66 161.7 29.61 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 64.62 50.29 2.16 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.365 0.603 . . . . 0.0 111.632 171.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.52 ' HA3' ' OE1' ' A' ' 137' ' ' GLN . . . 62.44 34.24 88.78 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.613 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.564 ' HA3' ' SG ' ' A' ' 134' ' ' CYS . . . -87.53 148.31 21.12 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.104 -1.046 . . . . 0.0 113.151 -176.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.1 m -115.3 150.21 36.62 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 172.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 6.4 m -78.36 77.6 4.85 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -174.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.87 178.93 0.3 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.712 171.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -50.59 -6.95 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 -167.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.424 ' O ' HD12 ' A' ' 121' ' ' ILE . 13.9 t70 173.66 -31.79 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -172.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -105.32 -168.51 1.47 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.816 174.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . 0.564 ' SG ' ' HA3' ' A' ' 127' ' ' GLY . 22.4 t -116.39 152.53 33.76 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.633 176.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.495 ' O ' ' HA2' ' A' ' 127' ' ' GLY . 69.4 mt -88.9 112.4 23.25 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . 0.67 ' SG ' ' HB2' ' A' ' 140' ' ' TYR . 9.3 t -91.95 145.59 24.42 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.275 -169.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.52 ' OE1' ' HA3' ' A' ' 126' ' ' GLY . 33.3 mt-30 -97.49 -164.61 1.16 Allowed 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.628 0.728 . . . . 0.0 112.156 -177.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -50.19 134.42 22.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.386 -1.279 . . . . 0.0 113.917 -171.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 54.31 16.86 7.17 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 112.746 -2.025 . . . . 0.0 114.791 177.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.67 ' HB2' ' SG ' ' A' ' 136' ' ' CYS . 23.9 m-85 -116.43 150.07 38.42 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 118.249 1.024 . . . . 0.0 111.664 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 28.8 pt -133.44 -178.13 2.49 Favored 'Isoleucine or valine' 0 C--O 1.251 1.139 0 O-C-N 124.234 0.958 . . . . 0.0 109.588 172.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.19 163.74 34.77 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.711 -178.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.0 p -76.88 -22.42 53.48 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.883 0.373 . . . . 0.0 111.604 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -97.32 -6.74 33.63 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 13.1 t 67.9 14.48 9.4 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.817 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -89.64 4.78 83.85 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.924 -173.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.7 118.85 54.35 Favored Pre-proline 0 C--O 1.219 -0.533 0 CA-C-N 117.69 0.745 . . . . 0.0 111.126 -176.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -87.22 140.23 5.48 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.695 2.263 . . . . 0.0 112.537 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.3 p -69.92 105.97 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 122.293 1.044 . . . . 0.0 111.934 -176.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.94 78.73 5.37 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.421 175.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -53.24 -70.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.606 -1.179 . . . . 0.0 113.924 -172.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.5 m -90.91 12.46 19.44 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.658 0.742 . . . . 0.0 111.17 -169.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 72.47 127.87 0.1 OUTLIER Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 114.161 -1.381 . . . . 0.0 111.713 -175.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . 0.472 ' O ' HD23 ' A' ' 155' ' ' LEU . 62.0 m -72.98 164.44 26.67 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.197 -1.002 . . . . 0.0 108.96 175.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 154' ' ' CYS . 62.6 mt -143.52 -178.49 5.91 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -166.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 44.44 24.48 0.09 Allowed 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 177.804 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 69.73 28.7 71.78 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.86 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -82.18 -138.7 2.88 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.306 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.25 140.68 4.37 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 117.396 0.598 . . . . 0.0 109.984 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.97 110.98 13.37 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.319 0.581 . . . . 0.0 109.907 171.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.5 m -99.67 -30.33 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.476 -176.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.47 ' HB3' ' CB ' ' A' ' 165' ' ' ARG . . . -140.36 171.73 7.33 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -48.64 96.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.499 2.133 . . . . 0.0 113.229 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 42.0 t30 69.03 15.28 8.82 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.726 0.774 . . . . 0.0 109.997 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.47 ' CB ' ' HB3' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -100.74 86.5 3.12 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.793 172.224 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 60.0 m -82.75 138.37 34.06 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.016 171.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.72 131.81 34.35 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 171.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 72.8 m -115.28 138.27 51.13 Favored 'General case' 0 C--N 1.315 -0.916 0 O-C-N 123.876 0.735 . . . . 0.0 111.474 -170.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 39.6 m -50.37 -55.04 17.38 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.681 -168.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -162.74 -86.29 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 118.578 -1.249 . . . . 0.0 113.516 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -93.83 51.97 2.28 Favored Glycine 0 CA--C 1.489 -1.583 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.003 -164.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.585 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 1.7 m-85 -121.07 134.49 55.27 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 118.563 -1.255 . . . . 0.0 112.841 173.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.771 HG23 ' CE2' ' A' ' 181' ' ' TYR . 8.7 p -87.89 123.61 32.82 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.718 177.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 104.75 133.56 7.79 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 108.991 -1.643 . . . . 0.0 108.991 -175.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.49 12.81 0.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.747 1.631 . . . . 0.0 112.896 -170.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.412 ' O ' HD12 ' A' ' 155' ' ' LEU . 15.7 tt0 -121.95 16.81 10.91 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.246 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.5 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.5 OUTLIER 33.65 69.42 0.14 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 175.578 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -117.41 7.15 12.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.634 0.731 . . . . 0.0 110.509 172.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.585 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 21.4 mmt85 -117.49 89.62 3.16 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.2 -178.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -80.35 54.16 1.95 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.614 -170.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.771 ' CE2' HG23 ' A' ' 173' ' ' THR . 18.7 p90 -84.42 78.38 9.83 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -77.2 140.22 40.08 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 118.976 -2.327 . . . . 0.0 107.682 -178.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 67.0 p -83.73 136.25 34.25 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.168 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -156.16 160.83 30.39 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -80.51 129.52 7.46 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.592 2.195 . . . . 0.0 111.554 175.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . 0.629 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 83.2 m -85.8 118.44 25.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.193 0.52 . . . . 0.0 110.589 177.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . 0.508 ' O ' ' HB2' ' A' ' 215' ' ' ARG . 9.2 m-85 -94.72 150.07 20.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.972 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 21.7 p -108.5 -1.8 19.46 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 28.3 m -141.62 174.37 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.48 HD11 ' HB2' ' A' ' 216' ' ' ALA . 12.8 mm -122.15 114.21 41.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.867 0.842 . . . . 0.0 111.327 176.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.1 t -143.16 127.93 18.23 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.198 175.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -63.87 -20.75 66.06 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 171.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -71.23 -69.36 0.38 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.339 169.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 64.2 mtt -151.39 101.88 2.86 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 176.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.442 ' O ' ' HB3' ' A' ' 187' ' ' PHE . 39.7 m -64.83 -24.76 67.64 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 122.201 0.2 . . . . 0.0 110.737 172.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 142.22 -139.52 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 126.959 2.104 . . . . 0.0 107.561 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 84.02 -50.12 4.35 Favored Glycine 0 C--N 1.332 0.35 0 N-CA-C 115.146 0.818 . . . . 0.0 115.146 170.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -72.36 29.01 0.05 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -171.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.473 ' N ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -156.87 18.22 0.31 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.933 0.397 . . . . 0.0 110.272 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 32.2 t -153.38 135.23 14.59 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.27 0.557 . . . . 0.0 111.115 -175.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -102.37 29.73 11.88 Favored Glycine 0 CA--C 1.502 -0.778 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 173.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.446 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -64.32 104.05 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-O 122.008 0.909 . . . . 0.0 109.425 176.497 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.32 99.05 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-O 122.42 1.105 . . . . 0.0 110.283 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.3 t -123.19 -178.27 3.93 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 113.241 -1.799 . . . . 0.0 106.724 169.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.8 p -100.76 164.4 11.88 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.385 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.519 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 45.5 tttm -60.6 -46.16 91.29 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.44 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.1 m -43.95 -56.23 4.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.88 174.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.451 ' CD1' HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -55.68 -57.47 11.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.53 179.296 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 40.0 m -72.5 -17.4 61.75 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -170.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 66.3 m -92.39 -31.61 15.26 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.021 175.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -70.84 -61.67 1.68 Allowed 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.588 HG22 ' HA2' ' A' ' 234' ' ' GLY . 32.4 p -92.26 152.52 19.78 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.105 174.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.1 t 70.3 -43.8 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.503 ' O ' ' HD2' ' A' ' 215' ' ' ARG . . . 55.97 61.97 6.85 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 115.767 1.067 . . . . 0.0 115.767 170.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 187' ' ' PHE . 14.4 mmm180 -126.43 -82.25 0.62 Allowed 'General case' 0 C--O 1.237 0.44 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.888 176.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.48 ' HB2' HD11 ' A' ' 190' ' ' ILE . . . -169.11 166.74 10.8 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . 0.629 ' HD1' ' SG ' ' A' ' 186' ' ' CYS . 11.6 t90 -159.12 149.42 19.37 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 121.23 -0.919 . . . . 0.0 109.461 -175.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 221' ' ' CYS . . . 87.13 156.68 29.9 Favored Glycine 0 C--O 1.223 -0.542 0 C-N-CA 120.363 -0.922 . . . . 0.0 114.695 168.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.541 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 17.0 p80 -130.57 135.46 27.42 Favored Pre-proline 0 C--O 1.236 0.354 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . 0.541 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 31.6 Cg_exo -59.31 143.37 29.79 Favored 'Cis proline' 0 N--CA 1.477 0.552 0 C-N-CA 124.16 -1.183 . . . . 0.0 111.71 -0.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 43.0 t -41.86 117.77 1.0 Allowed 'General case' 0 N--CA 1.464 0.257 0 O-C-N 124.222 0.951 . . . . 0.0 112.868 -170.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -109.41 120.25 41.95 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -80.29 148.28 30.8 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -176.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 5.8 m -85.4 123.34 73.09 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -172.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.2 167.56 19.89 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.394 2.73 . . . . 0.0 110.847 167.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -39.74 -60.06 1.05 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.12 -172.75 0.33 Allowed Pre-proline 0 N--CA 1.431 -1.418 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 -173.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -84.75 -98.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.801 1.667 . . . . 0.0 110.7 172.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -84.24 166.77 31.33 Favored Pre-proline 0 CA--C 1.513 -0.473 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 169.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.12 65.52 4.25 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.852 1.702 . . . . 0.0 113.162 -176.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 64.2 m -106.2 -173.88 2.4 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 170.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.614 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 86.3 mtt180 -67.75 147.57 52.44 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 119.701 -0.799 . . . . 0.0 108.927 172.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -37.92 -49.98 1.27 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 178.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.588 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -79.33 12.44 26.2 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.605 -0.807 . . . . 0.0 114.833 -174.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . 0.614 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 2.3 m-85 -122.86 146.82 47.22 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 122.093 0.949 . . . . 0.0 113.21 -172.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.87 132.74 24.36 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 114.098 -1.41 . . . . 0.0 107.967 170.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.38 118.85 5.77 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.13 1.887 . . . . 0.0 111.721 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -52.29 136.85 30.01 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 121.727 0.775 . . . . 0.0 110.582 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 33.2 mt -70.93 -16.37 19.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.404 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 42.0 mtm105 -102.52 -63.32 1.17 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.29 0.567 . . . . 0.0 110.248 -176.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 40.5 p -79.34 -38.46 35.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.75 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 94.89 5.41 61.11 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -176.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -86.67 124.36 32.85 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 121.935 0.874 . . . . 0.0 109.121 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 13.0 m -57.92 123.13 14.77 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 113.403 -1.726 . . . . 0.0 110.479 178.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -119.39 142.85 47.82 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.466 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 8.5 t70 -77.85 147.53 35.11 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.602 HG23 ' HG3' ' A' ' 249' ' ' GLU . 15.9 m -94.17 142.88 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.094 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.212 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -70.07 77.5 0.5 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 164.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.602 ' HG3' HG23 ' A' ' 247' ' ' VAL . 20.5 mp0 -52.7 -35.6 55.83 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 123.525 0.515 . . . . 0.0 110.498 -173.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 33.1 m -55.01 -29.33 57.12 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.176 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -103.93 -43.74 5.21 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.923 0.868 . . . . 0.0 109.7 -175.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.34 -22.1 64.71 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.024 -1.444 . . . . 0.0 111.286 -175.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.575 HG22 ' HB3' ' A' ' 256' ' ' LEU . 64.2 mt -131.34 75.61 77.17 Favored Pre-proline 0 N--CA 1.447 -0.603 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -13.04 -91.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.039 1 C-N-CA 126.106 4.537 . . . . 0.0 115.749 -162.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -119.69 59.41 0.53 Allowed Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 119.641 -1.266 . . . . 0.0 111.872 177.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.575 ' HB3' HG22 ' A' ' 253' ' ' ILE . 2.3 pt? -63.97 -38.91 92.79 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.139 177.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 45.8 t -104.86 107.36 18.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.492 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -116.68 35.69 4.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.903 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.577 ' HA3' ' SG ' ' A' ' 286' ' ' CYS . . . -87.96 -9.04 71.58 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.592 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 145.21 -100.11 0.22 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -89.09 158.01 18.12 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.733 0.301 . . . . 0.0 110.778 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.71 132.73 14.29 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 10.7 mt -142.34 165.46 16.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -173.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.93 126.53 43.39 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 118.556 -1.258 . . . . 0.0 113.525 -175.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 4.6 t -115.55 167.78 10.59 Favored 'General case' 0 C--O 1.258 1.52 0 CA-C-O 122.243 1.021 . . . . 0.0 110.322 162.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.432 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 30.4 m -71.11 131.27 34.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.849 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.426 ' CA ' ' HE2' ' A' ' 235' ' ' PHE . . . 88.95 -9.79 75.28 Favored Glycine 0 N--CA 1.423 -2.201 0 CA-C-O 119.264 -0.742 . . . . 0.0 113.527 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 48.3 t -179.51 150.03 0.41 Allowed 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 117.838 0.819 . . . . 0.0 111.255 -172.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -107.31 156.53 18.78 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.89 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -108.27 128.88 55.12 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.961 -176.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 54.9 m -120.56 160.38 23.32 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.313 0.578 . . . . 0.0 111.081 176.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -140.54 124.52 17.37 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.193 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 3.7 m -98.36 170.72 6.64 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 175.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -58.31 156.18 31.7 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.567 1.511 . . . . 0.0 110.611 170.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -59.34 149.39 29.15 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.25 -33.26 3.19 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.113 -174.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -78.69 167.37 21.32 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 120.987 0.422 . . . . 0.0 110.69 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 67.1 mttm -140.22 139.15 35.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.227 -179.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 21.4 tp -81.71 143.98 31.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.041 0.448 . . . . 0.0 110.75 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -124.55 98.46 5.74 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -68.04 -12.83 61.54 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -174.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 42.7 t -66.24 -25.42 35.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.252 0.548 . . . . 0.0 110.266 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 10.3 p -148.05 28.87 0.91 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.618 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 30.06 49.57 0.07 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.709 -1.132 . . . . 0.0 113.16 -171.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -102.65 175.65 5.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.754 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' CYS . . . . . 0.577 ' SG ' ' HA3' ' A' ' 259' ' ' GLY . 92.9 m -141.81 170.41 15.77 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 173.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.561 ' HB2' ' O ' ' A' ' 286' ' ' CYS . 2.4 mp0 . . . . . 0 C--O 1.25 1.099 0 C-N-CA 124.319 1.048 . . . . 0.0 109.408 170.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 39.8 t . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 121.102 0.477 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.9 30.28 7.42 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -176.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.1 m -82.83 15.27 2.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.545 0.688 . . . . 0.0 109.907 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.1 mtm180 -128.96 138.25 51.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.644 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 43.1 t -78.05 132.18 37.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.752 0.311 . . . . 0.0 110.722 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.8 pt -73.67 -11.33 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.246 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -72.98 -11.67 60.66 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.597 0.713 . . . . 0.0 109.691 174.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -97.6 35.84 1.6 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.743 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 39.0 t -159.24 140.51 12.95 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.872 -176.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.453 ' OD1' HG23 ' A' ' 121' ' ' ILE . 29.0 p-10 -122.55 -31.16 3.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.824 0.821 . . . . 0.0 110.322 175.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.453 HG23 ' OD1' ' A' ' 120' ' ' ASN . 0.2 OUTLIER -91.77 -164.18 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 122.075 0.94 . . . . 0.0 113.246 -176.673 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.456 ' N ' ' HD2' ' A' ' 122' ' ' ARG . 4.3 mpt_? -114.7 126.06 54.44 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.013 -178.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 65.2 m -116.55 117.05 28.8 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -114.53 165.74 12.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.268 -176.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 66.96 42.77 2.37 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.076 0.465 . . . . 0.0 110.889 173.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.66 22.17 75.53 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.467 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -73.36 124.1 8.7 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 -176.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.1 m -91.99 126.31 37.02 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 9.1 m -58.76 147.99 31.24 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 122.366 1.079 . . . . 0.0 113.668 -173.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.506 ' HB2' ' O ' ' A' ' 133' ' ' HIS . 50.8 m -142.73 169.86 16.78 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 173.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -38.61 -89.51 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 O-C-N 124.397 1.061 . . . . 0.0 112.206 176.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -82.98 -42.43 17.58 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.983 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.506 ' O ' ' HB2' ' A' ' 130' ' ' SER . 0.3 OUTLIER -108.98 -167.81 1.26 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -176.397 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 59.9 m -122.99 153.03 40.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.004 177.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.2 mt -92.51 120.47 33.01 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 74.5 m -84.93 153.95 22.51 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.403 -169.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -81.86 148.16 28.95 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -63.16 111.44 2.22 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 123.1 1.428 . . . . 0.0 111.929 -174.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 125.65 -4.34 8.08 Favored Glycine 0 N--CA 1.431 -1.683 0 CA-C-N 112.327 -2.215 . . . . 0.0 111.441 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.568 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 97.9 m-85 -119.58 145.81 46.06 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.157 0.504 . . . . 0.0 110.376 173.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 40.6 pt -131.08 175.03 12.14 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.312 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 101.29 174.18 28.68 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.851 -177.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.3 p -73.54 -31.61 63.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.316 0.579 . . . . 0.0 111.45 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -110.87 7.05 21.7 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.411 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 34.1 m 63.91 37.49 9.48 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 124.204 0.94 . . . . 0.0 111.181 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -93.62 -7.09 61.92 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.906 -176.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.27 112.72 65.9 Favored Pre-proline 0 C--N 1.327 -0.404 0 O-C-N 122.121 -0.635 . . . . 0.0 110.704 -177.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.67 142.45 14.34 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.342 2.695 . . . . 0.0 112.614 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.9 p -73.15 107.73 3.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 122.504 1.145 . . . . 0.0 111.284 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.86 88.03 5.29 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.298 175.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.34 -68.04 0.27 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -175.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 16.7 m -95.71 13.37 26.66 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.824 0.345 . . . . 0.0 111.628 -166.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.23 123.95 0.91 Allowed Glycine 0 N--CA 1.438 -1.221 0 CA-C-O 121.819 0.677 . . . . 0.0 113.066 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 80.4 m -81.14 162.23 23.75 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 172.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 176' ' ' GLN . 79.9 mt -148.22 167.27 25.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 118.04 0.382 . . . . 0.0 110.88 -162.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.523 ' HB2' ' CZ ' ' A' ' 172' ' ' PHE . 10.0 t30 48.31 23.72 0.6 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.327 -164.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 66.0 39.36 94.79 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.256 -0.974 . . . . 0.0 111.774 -177.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.62 -138.16 0.21 Allowed Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.772 -0.727 . . . . 0.0 111.313 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 13.1 ttt180 -159.47 128.99 5.41 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.08 -0.659 . . . . 0.0 111.221 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.4 m -62.91 119.99 10.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.59 0.233 . . . . 0.0 110.691 173.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 16.7 m -105.68 -35.84 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.947 0.403 . . . . 0.0 110.546 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.574 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -139.93 170.55 9.56 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.568 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 76.6 Cg_exo -51.58 109.17 0.29 Allowed 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.208 1.939 . . . . 0.0 112.133 174.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 72.96 -3.07 2.52 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.36 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.574 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.9 OUTLIER -90.92 86.35 6.26 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.516 175.857 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 72.6 m -78.65 141.07 38.27 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.234 171.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -97.79 117.54 32.34 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 172.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 83.0 m -101.18 141.17 34.45 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.036 -170.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 7.0 m -51.11 -53.9 29.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -168.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.42 ' HE2' ' HG1' ' A' ' 183' ' ' THR . 30.8 t80 -167.68 -84.72 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.36 -0.936 . . . . 0.0 113.227 -172.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -90.94 55.91 3.32 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.325 -167.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.564 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 7.0 m-85 -127.11 137.57 53.02 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.509 169.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.603 HG23 ' CE2' ' A' ' 181' ' ' TYR . 64.4 p -87.15 123.79 32.57 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.094 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 102.09 139.84 10.78 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.05 7.82 1.59 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 121.143 1.229 . . . . 0.0 112.449 -172.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.506 ' O ' HD12 ' A' ' 155' ' ' LEU . 18.9 tt0 -119.47 26.1 9.63 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.294 176.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.437 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.7 OUTLIER 23.89 72.72 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 118.693 2.849 . . . . 0.0 118.693 170.614 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -124.96 29.8 6.05 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.103 -0.998 . . . . 0.0 110.929 169.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.564 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 23.9 mmt180 -130.2 93.0 3.38 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.168 175.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.07 53.14 1.16 Allowed 'General case' 0 C--N 1.323 -0.55 0 O-C-N 123.402 0.439 . . . . 0.0 111.189 -169.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.603 ' CE2' HG23 ' A' ' 173' ' ' THR . 16.2 p90 -84.4 80.43 9.22 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -82.75 135.12 35.08 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 119.761 -1.837 . . . . 0.0 108.609 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.42 ' HG1' ' HE2' ' A' ' 170' ' ' TYR . 70.3 p -77.06 171.04 15.44 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 157.18 136.04 2.04 Favored Glycine 0 C--N 1.32 -0.322 0 C-N-CA 119.669 -1.253 . . . . 0.0 112.359 -163.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.62 128.23 15.86 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.133 1.889 . . . . 0.0 111.531 172.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . 0.6 ' SG ' ' HD2' ' A' ' 215' ' ' ARG . 16.5 t -102.18 114.28 28.29 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.474 0.654 . . . . 0.0 110.68 -178.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . 0.568 ' O ' ' HB3' ' A' ' 215' ' ' ARG . 16.8 m-85 -93.62 143.43 26.31 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.262 -177.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 2.4 m -96.23 -27.73 14.87 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -162.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.1 p -163.2 118.79 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.628 -171.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.482 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.4 mt -125.51 118.8 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 122.182 0.992 . . . . 0.0 113.486 -168.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.2 t -116.15 -164.56 0.97 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 113.766 -1.561 . . . . 0.0 106.934 163.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -63.87 -5.71 4.81 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.718 0.77 . . . . 0.0 110.008 170.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -69.84 -75.76 0.11 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.847 -178.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 46.0 ttm -171.2 151.37 3.15 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.957 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.482 ' HA ' HG12 ' A' ' 190' ' ' ILE . 72.8 m -57.43 -46.11 83.92 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 121.73 0.776 . . . . 0.0 110.91 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -151.54 -81.22 0.1 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 166.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.44 -24.33 6.91 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.569 172.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -131.14 45.3 2.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.393 0.616 . . . . 0.0 109.43 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 26.3 tp -169.82 132.76 1.17 Allowed 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.572 -173.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 34.7 t -149.04 -47.46 0.14 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.753 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.84 26.62 10.47 Favored Glycine 0 C--O 1.228 -0.225 0 C-N-CA 120.752 -0.737 . . . . 0.0 114.333 -171.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.29 91.58 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 165.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.49 112.47 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 CA-C-O 122.935 1.35 . . . . 0.0 110.171 -171.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 6.1 t -155.64 -178.74 7.5 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.559 HG21 ' HA ' ' A' ' 181' ' ' TYR . 17.8 p -106.35 171.5 7.32 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 120.883 1.674 . . . . 0.0 110.649 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.693 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 34.0 tttm -59.88 -47.43 85.77 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.777 175.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.9 m -45.21 -55.59 5.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.956 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.73 -48.76 80.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.257 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 97.2 m -61.18 -38.81 87.83 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 56.5 m -83.86 -37.19 22.77 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 121.65 -0.656 . . . . 0.0 111.249 -176.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.14 -57.69 5.66 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.499 HG22 ' HA2' ' A' ' 234' ' ' GLY . 30.5 p -104.05 144.16 31.92 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.152 -175.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.0 t 64.06 -22.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 63.55 51.86 50.85 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 120.435 1.47 . . . . 0.0 114.028 167.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.6 ' HD2' ' SG ' ' A' ' 186' ' ' CYS . 27.1 mtt85 -103.09 -123.03 0.19 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.797 0.808 . . . . 0.0 111.307 -178.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.472 ' CB ' HD11 ' A' ' 190' ' ' ILE . . . -156.8 168.52 27.21 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . 0.693 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 36.6 t90 -161.77 149.74 14.94 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 119.365 0.984 . . . . 0.0 111.188 -170.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 85.09 170.12 46.81 Favored Glycine 0 C--O 1.229 -0.186 0 N-CA-C 115.081 0.792 . . . . 0.0 115.081 170.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.511 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 85.8 m-70 -127.23 133.04 24.63 Favored Pre-proline 0 N--CA 1.457 -0.117 0 C-N-CA 122.949 0.5 . . . . 0.0 109.879 171.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 18.9 Cg_endo -58.73 157.67 36.99 Favored 'Cis proline' 0 C--O 1.236 0.393 0 C-N-CA 123.261 -1.558 . . . . 0.0 112.373 -4.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 33.2 t -53.41 115.56 1.99 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.586 -174.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -105.39 102.76 12.21 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' MET . . . . . 0.483 ' O ' ' HD3' ' A' ' 225' ' ' PRO . 1.3 tpt -79.09 132.42 36.59 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -175.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 92.7 m -83.29 112.58 40.06 Favored Pre-proline 0 C--N 1.332 -0.154 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -172.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 223' ' ' MET . 6.1 Cg_exo -81.41 124.92 4.9 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.598 2.865 . . . . 0.0 111.054 169.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 48.25 -79.16 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.899 0.88 . . . . 0.0 113.228 -174.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 225' ' ' PRO . 0.0 OUTLIER -162.27 -171.54 0.28 Allowed Pre-proline 0 N--CA 1.441 -0.903 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -168.317 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -87.85 -90.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 121.835 1.69 . . . . 0.0 111.478 170.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -87.66 158.12 51.48 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 172.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.02 61.87 7.8 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.19 1.927 . . . . 0.0 114.593 -171.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 92.2 m -110.39 -177.94 3.37 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 169.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.528 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 31.1 mmt180 -62.72 140.63 58.74 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 173.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -37.33 -50.72 1.05 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.499 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -70.1 1.14 19.45 Favored Glycine 0 C--N 1.313 -0.728 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.72 -174.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . 0.528 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 11.3 m-85 -123.17 151.32 42.3 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.159 0.981 . . . . 0.0 113.324 -169.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.32 128.7 24.02 Favored Pre-proline 0 N--CA 1.436 -1.143 0 CA-C-N 114.082 -1.417 . . . . 0.0 108.259 169.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.92 125.17 14.25 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.533 2.156 . . . . 0.0 111.802 178.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -62.61 136.64 57.98 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 35.5 pt -82.78 2.32 3.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.584 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -103.12 -57.37 2.05 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.853 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 52.3 p -89.06 -45.9 9.26 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.5 -178.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 103.06 11.02 35.35 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -96.17 125.23 40.55 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 121.95 0.881 . . . . 0.0 109.992 -177.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 4.3 m -59.06 122.56 14.06 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.832 172.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 75.5 mm-40 -123.37 137.9 54.72 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 6.1 t70 -75.32 147.21 40.33 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-O 121.283 0.563 . . . . 0.0 110.001 -176.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.484 HG23 ' HG3' ' A' ' 249' ' ' GLU . 11.4 m -93.53 144.27 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.426 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -75.03 77.28 2.22 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 168.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.484 ' HG3' HG23 ' A' ' 247' ' ' VAL . 36.2 mp0 -52.42 -35.73 52.7 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.651 0.739 . . . . 0.0 110.515 -171.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 9.5 m -53.39 -33.47 53.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.877 175.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -99.1 -37.42 9.34 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.78 0.8 . . . . 0.0 110.101 -177.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.23 -19.02 63.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.753 -175.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.2 mp -126.66 117.18 22.68 Favored Pre-proline 0 N--CA 1.446 -0.637 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 174.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -35.79 -91.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.483 0.911 1 C-N-CA 125.345 4.03 . . . . 0.0 114.39 -165.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -100.36 56.59 0.8 Allowed Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.406 171.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 22.6 tp -40.3 -65.33 0.42 Allowed 'General case' 0 C--O 1.224 -0.273 0 O-C-N 124.465 0.744 . . . . 0.0 112.894 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 11.3 t -87.62 62.72 7.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.104 0.478 . . . . 0.0 109.857 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -60.4 104.33 0.32 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.55 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 131.92 -17.35 4.92 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.764 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -150.78 -157.85 8.0 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.032 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -108.54 121.55 45.21 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 52.6 t -92.14 133.55 35.68 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 176.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 39.3 mt -132.24 112.51 19.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.442 0.639 . . . . 0.0 110.075 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -74.13 126.44 30.57 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -170.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 6.2 t -113.35 164.91 12.98 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.021 154.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.428 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 30.7 m -69.97 132.2 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 118.705 -1.198 . . . . 0.0 108.899 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 88.53 -10.87 70.11 Favored Glycine 0 C--N 1.314 -0.678 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.571 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.4 p -174.43 143.14 0.82 Allowed 'General case' 0 C--O 1.212 -0.872 0 CA-C-N 118.112 0.956 . . . . 0.0 110.705 -174.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -103.12 151.64 22.33 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -114.7 126.84 55.33 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -175.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 11.1 m -97.05 158.17 15.56 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.867 0.841 . . . . 0.0 111.961 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -134.71 106.26 6.86 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.278 172.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 4.6 m -96.52 156.03 37.21 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 52.2 Cg_exo -55.84 159.9 10.88 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.53 2.154 . . . . 0.0 111.425 172.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -56.17 146.02 24.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.551 0.215 . . . . 0.0 111.07 -177.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.26 -30.0 3.42 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.88 -176.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' HIS . . . . . 0.435 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 17.8 m-70 -78.84 165.01 24.01 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.135 0.493 . . . . 0.0 111.507 -177.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -146.4 135.0 22.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.605 -175.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.516 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 39.0 tp -71.34 140.85 50.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.223 0.535 . . . . 0.0 110.926 177.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -129.56 102.44 6.37 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 170.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -61.01 -24.38 66.12 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 123.521 0.513 . . . . 0.0 111.781 -173.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 16.4 t -62.66 -23.84 33.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.983 0.421 . . . . 0.0 110.826 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 28.1 p -141.63 24.86 2.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.668 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 25.53 48.85 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.142 0.977 . . . . 0.0 112.178 -169.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 81.8 tttt -97.87 159.14 15.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.16 -171.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 4.0 m -137.15 81.25 1.86 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.041 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.435 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 66.5 mm-40 . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.346 -0.835 . . . . 0.0 108.893 -174.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -94.81 144.97 25.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.115 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 41.0 m -81.66 71.54 8.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.89 0.376 . . . . 0.0 110.295 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -75.29 114.45 13.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.559 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.8 m -70.27 137.89 51.14 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.203 177.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.0 mt -98.61 108.96 23.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -74.82 140.52 44.0 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.459 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -60.34 121.73 12.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.16 0.505 . . . . 0.0 109.95 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 33.4 m -86.74 -177.18 6.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.321 -174.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 44.0 m-20 -96.14 -50.35 4.87 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 121.786 0.803 . . . . 0.0 109.907 -176.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 36.3 pt -98.5 -168.21 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-N 114.354 -1.293 . . . . 0.0 112.254 -167.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.88 142.79 51.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.341 -173.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 71.5 m -117.05 167.99 10.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.455 0.645 . . . . 0.0 112.554 -173.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 85.0 mtp -144.8 158.16 43.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.823 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 65.57 45.7 2.65 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.993 0.425 . . . . 0.0 111.528 169.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.529 ' O ' ' HG2' ' A' ' 137' ' ' GLN . . . 75.2 16.85 80.38 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.527 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.83 119.03 10.34 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.021 -177.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.6 t -84.21 126.64 33.33 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 19.1 p -76.88 160.7 29.01 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.189 0.518 . . . . 0.0 110.775 -170.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 133' ' ' HIS . 11.3 t -143.05 168.09 20.55 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 120' ' ' ASN . 13.0 t70 -30.76 -91.56 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 O-C-N 124.582 1.176 . . . . 0.0 113.024 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -83.53 -43.94 15.2 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.142 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.466 ' O ' ' HB3' ' A' ' 130' ' ' SER . 0.6 OUTLIER -110.63 -174.98 2.6 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.095 -1.042 . . . . 0.0 112.958 -178.209 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 44.9 t -122.71 149.43 44.08 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.697 -175.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 86.1 mt -107.55 114.62 28.74 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.3 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 59.8 m -74.38 162.49 28.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.133 -173.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 126' ' ' GLY . 14.8 mm-40 -78.44 150.87 32.96 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.515 168.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -65.98 112.5 3.86 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 122.59 1.186 . . . . 0.0 110.748 -176.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 123.04 -1.59 9.85 Favored Glycine 0 C--N 1.302 -1.325 0 CA-C-N 112.752 -2.022 . . . . 0.0 111.567 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.546 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 94.8 m-85 -122.03 142.75 50.02 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 122.43 -0.453 . . . . 0.0 110.133 172.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 26.6 pt -128.31 176.65 7.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.669 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 96.64 167.94 33.77 Favored Glycine 0 C--N 1.318 -0.457 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.761 -176.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.9 p -74.62 -23.61 58.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.176 0.488 . . . . 0.0 111.669 -177.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -109.54 7.3 24.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.534 176.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 30.9 m 64.29 30.05 13.53 Favored 'General case' 0 N--CA 1.462 0.168 0 O-C-N 123.672 0.607 . . . . 0.0 111.013 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.3 -12.22 67.95 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.571 -173.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.77 109.67 63.24 Favored Pre-proline 0 C--O 1.224 -0.259 0 CA-C-N 117.912 0.856 . . . . 0.0 110.745 -174.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.01 139.4 24.2 Favored 'Trans proline' 0 CA--C 1.522 -0.092 0 C-N-CA 123.625 2.884 . . . . 0.0 112.578 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.52 110.53 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.734 0.778 . . . . 0.0 111.479 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.38 77.18 7.17 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.972 176.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -53.86 -68.89 0.14 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -174.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.4 m -88.01 13.55 10.82 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.137 0.494 . . . . 0.0 111.679 -165.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 87.99 122.1 1.75 Allowed Glycine 0 N--CA 1.428 -1.841 0 CA-C-O 122.237 0.909 . . . . 0.0 112.608 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 5.7 m -78.32 155.13 30.3 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 113.185 -1.507 . . . . 0.0 109.034 168.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.556 HD12 ' O ' ' A' ' 176' ' ' GLN . 56.3 mt -149.71 163.22 38.55 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.858 -166.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 172' ' ' PHE . 61.4 t30 47.69 24.13 0.51 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.66 -164.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 67.71 38.3 89.71 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.74 -177.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.22 -152.84 0.59 Allowed Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.723 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -149.07 121.57 8.52 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.223 -0.575 . . . . 0.0 111.808 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.5 m -63.19 114.69 3.92 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.668 177.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 165' ' ' ARG . 8.8 m -104.17 -34.92 3.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.81 0.338 . . . . 0.0 110.935 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.57 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -140.1 171.68 7.47 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.546 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 73.9 Cg_exo -53.3 108.55 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.988 1.792 . . . . 0.0 112.434 177.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 72.81 -7.88 1.37 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.362 1.065 . . . . 0.0 110.423 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.57 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.5 OUTLIER -83.49 82.54 8.25 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 176.295 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 7.1 t -80.88 145.8 31.15 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -96.5 118.68 33.51 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 173.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 84.0 m -90.45 126.97 36.08 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.791 -167.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.0 m -42.62 -51.44 5.19 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 124.633 1.208 . . . . 0.0 112.531 -172.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -165.76 -89.75 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 119.481 -0.888 . . . . 0.0 112.234 -176.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -90.98 54.89 3.32 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.636 -167.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.527 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 7.8 m-85 -129.63 136.5 49.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.608 0.704 . . . . 0.0 111.654 169.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.61 HG23 ' CE2' ' A' ' 181' ' ' TYR . 80.1 p -87.49 132.79 33.9 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.383 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 92.06 146.75 19.14 Favored Glycine 0 N--CA 1.438 -1.167 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.799 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.32 22.89 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.616 1.544 . . . . 0.0 112.407 -174.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.556 ' O ' HD12 ' A' ' 155' ' ' LEU . 50.4 tt0 -120.85 3.28 10.57 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.512 176.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.45 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 32.15 57.59 0.36 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 176.639 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -115.84 17.21 16.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.501 0.667 . . . . 0.0 110.085 175.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 8.8 mmt180 -117.65 90.66 3.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.651 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -78.91 79.46 5.31 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.869 0.843 . . . . 0.0 110.97 -168.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.61 ' CE2' HG23 ' A' ' 173' ' ' THR . 17.4 p90 -112.13 79.97 1.28 Allowed 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 22.9 mtp85 -79.93 144.95 32.91 Favored 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 118.936 -2.352 . . . . 0.0 107.285 -176.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 82.3 p -78.65 138.22 38.21 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.083 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.407 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -151.91 149.78 21.55 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -70.62 128.44 15.25 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.76 1.64 . . . . 0.0 110.787 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 7.8 t -84.17 122.0 28.24 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.113 0.482 . . . . 0.0 109.824 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -107.07 149.03 28.03 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.758 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.495 ' HA ' ' HB3' ' A' ' 215' ' ' ARG . 17.7 p -102.44 -59.0 1.78 Allowed 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -173.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 p -121.95 117.83 53.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.673 -173.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 4.2 mt -124.28 120.73 60.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -170.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 63.9 p -117.32 -166.29 1.17 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.562 -1.199 . . . . 0.0 107.849 161.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -68.31 -5.59 19.48 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.692 0.678 . . . . 0.0 110.22 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -92.19 -75.83 0.47 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.099 -173.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 72.7 mtm -141.13 143.03 34.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.662 0.268 . . . . 0.0 110.725 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 8.5 m -90.37 -45.61 8.9 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.982 176.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -152.13 3.99 0.39 Allowed 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.253 165.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 92.99 -3.81 74.01 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.132 -175.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 74.31 6.58 4.65 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.277 0.631 . . . . 0.0 112.333 174.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.58 HD13 ' H ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -85.9 19.88 2.41 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.269 0.557 . . . . 0.0 110.957 177.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 15.2 t -102.96 142.83 33.4 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.662 -175.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -126.84 19.61 6.13 Favored Glycine 0 CA--C 1.504 -0.606 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.477 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -67.72 99.27 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 122.093 0.949 . . . . 0.0 109.05 173.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.99 123.1 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.097 174.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 22.9 t -154.33 -178.35 7.08 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.5 p -103.58 161.03 14.23 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 119.752 1.16 . . . . 0.0 108.811 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.435 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 45.4 tttm -59.82 -44.72 93.88 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.067 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.8 m -44.22 -56.2 4.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.931 172.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.443 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -53.77 -53.66 49.22 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.814 177.778 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 99.0 m -68.75 -22.92 64.28 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 45.0 m -96.1 -29.65 13.97 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.056 -178.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -74.08 -60.06 2.44 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 173.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.635 HG22 ' HA2' ' A' ' 234' ' ' GLY . 10.8 p -96.78 160.64 14.26 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.283 178.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 1.4 t 66.32 -41.98 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 118.784 -0.626 . . . . 0.0 111.922 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 62.32 46.75 93.24 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-N 119.155 0.889 . . . . 0.0 113.584 168.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.495 ' HB3' ' HA ' ' A' ' 188' ' ' THR . 0.9 OUTLIER -119.87 -92.47 0.54 Allowed 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.746 -178.22 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.4 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -167.67 166.88 13.69 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . 0.435 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 21.8 t90 -155.18 148.42 24.88 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 122.213 -0.305 . . . . 0.0 110.276 -174.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 221' ' ' CYS . . . 86.09 160.98 34.68 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.756 172.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.579 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 26.2 t60 -135.62 131.88 19.45 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . 0.579 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 51.6 Cg_exo -54.59 142.81 14.39 Favored 'Cis proline' 0 C--N 1.353 0.784 0 C-N-CA 123.896 -1.293 . . . . 0.0 112.282 -2.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 72.2 m -50.64 128.28 20.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.714 -172.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -116.19 121.71 42.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.818 175.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' MET . . . . . 0.4 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 5.1 ppp? -106.62 153.87 21.74 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.287 -171.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 97.8 m -135.07 135.47 22.99 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -173.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -56.99 166.91 3.53 Favored 'Trans proline' 0 CA--C 1.515 -0.447 0 C-N-CA 123.98 3.12 . . . . 0.0 114.111 167.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -39.01 111.59 0.19 Allowed 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.081 162.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 6.42 92.89 0.03 OUTLIER Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 110.137 -3.211 . . . . 0.0 114.162 177.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -58.07 -49.97 11.3 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.747 2.298 . . . . 0.0 113.256 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -49.72 134.58 19.9 Favored Pre-proline 0 CA--C 1.512 -0.488 0 C-N-CA 122.834 0.454 . . . . 0.0 110.521 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.49 45.29 1.93 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.006 1.804 . . . . 0.0 113.301 -172.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 48.8 m -127.7 -176.1 3.67 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.551 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 98.1 mtt180 -61.53 139.21 58.28 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 172.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -38.46 -42.74 0.77 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 177.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.635 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -77.48 9.28 29.18 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.033 -0.604 . . . . 0.0 114.018 -177.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . 0.585 ' HE2' ' N ' ' A' ' 267' ' ' GLY . 2.3 m-85 -121.53 147.5 45.71 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 122.044 0.926 . . . . 0.0 112.776 -172.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -123.23 130.37 24.58 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 113.667 -1.606 . . . . 0.0 108.851 173.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -58.42 112.42 1.17 Allowed 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.333 2.022 . . . . 0.0 111.564 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -51.47 138.88 21.12 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.359 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 23.6 mt -81.91 -6.03 9.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.034 -173.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -109.18 -55.45 2.41 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.452 0.644 . . . . 0.0 110.221 -177.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 47.6 p -90.45 -38.24 13.39 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.907 -176.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 96.79 6.53 58.14 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -176.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -89.11 124.54 34.42 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 122.015 0.912 . . . . 0.0 109.943 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 12.1 m -54.87 121.44 8.64 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.454 176.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -119.81 137.66 53.84 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.559 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 13.4 t70 -76.7 147.29 37.5 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.557 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.621 HG23 ' HG3' ' A' ' 249' ' ' GLU . 6.4 m -99.31 145.27 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.965 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.755 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -72.58 75.94 1.08 Allowed 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 167.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.621 ' HG3' HG23 ' A' ' 247' ' ' VAL . 21.3 mp0 -53.06 -34.62 57.31 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.746 0.784 . . . . 0.0 110.216 -170.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 11.9 m -48.39 -40.3 25.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.836 174.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -103.51 -41.5 5.97 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.856 0.836 . . . . 0.0 110.368 -175.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -66.76 -23.46 66.09 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.546 -1.207 . . . . 0.0 110.624 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.656 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.5 mp -127.54 78.57 74.59 Favored Pre-proline 0 N--CA 1.445 -0.679 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 172.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.32 112.26 0.7 Allowed 'Trans proline' 0 CA--C 1.507 -0.869 0 C-N-CA 124.112 3.208 . . . . 0.0 114.64 -164.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 59.09 35.12 82.61 Favored Glycine 0 C--N 1.307 -1.03 0 CA-C-N 113.233 -1.803 . . . . 0.0 113.811 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.656 ' HB3' HG22 ' A' ' 253' ' ' ILE . 2.2 pt? -63.99 -22.54 66.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 118.06 0.93 . . . . 0.0 110.593 177.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 14.5 t -78.01 4.51 12.03 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.152 0.501 . . . . 0.0 110.688 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 67.34 -86.84 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.809 0.844 . . . . 0.0 113.013 171.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -126.62 11.1 7.11 Favored Glycine 0 CA--C 1.507 -0.417 0 C-N-CA 120.207 -0.997 . . . . 0.0 112.279 -174.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -98.94 -173.92 31.8 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.314 175.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . 0.465 ' HB3' ' CG ' ' A' ' 272' ' ' LYS . 2.7 t-20 -107.0 116.99 32.88 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 176.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 269' ' ' PHE . 34.4 t -90.64 134.86 34.09 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 2.7 mp -127.48 112.13 27.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.609 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -74.56 123.52 24.95 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -172.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.4 t -110.74 160.04 17.08 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 155.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.559 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 4.1 m -76.42 128.4 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.886 0 C-N-CA 117.933 -1.507 . . . . 0.0 108.137 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.585 ' N ' ' HE2' ' A' ' 235' ' ' PHE . . . 112.57 -26.83 10.48 Favored Glycine 0 N--CA 1.432 -1.567 0 C-N-CA 119.904 -1.141 . . . . 0.0 111.338 -172.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 37.6 t 173.01 160.02 0.12 Allowed 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 121.112 0.482 . . . . 0.0 110.373 -172.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . 0.516 ' HB2' ' SG ' ' A' ' 262' ' ' CYS . 42.2 p90 -103.69 155.51 18.51 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 121.326 -0.859 . . . . 0.0 109.036 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -116.76 125.52 51.75 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 11.4 m -105.41 154.01 20.9 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.858 0.837 . . . . 0.0 112.203 -176.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.465 ' CG ' ' HB3' ' A' ' 261' ' ' ASN . 10.1 ptmm? -129.63 108.71 10.42 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.342 168.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 32.2 m -85.89 156.14 58.2 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.068 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . 0.491 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 71.8 Cg_exo -50.51 160.64 1.54 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.479 2.12 . . . . 0.0 112.351 173.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -58.25 136.49 57.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.903 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.08 -26.15 5.66 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' HIS . . . . . 0.491 ' HB2' ' O ' ' A' ' 274' ' ' PRO . 14.9 m-70 -79.43 176.78 9.38 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.18 0.514 . . . . 0.0 112.001 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -167.97 144.85 4.15 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.939 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 38.1 tp -91.66 137.99 31.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.033 0.444 . . . . 0.0 110.911 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -125.62 98.43 5.57 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.18 -19.38 61.51 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.629 0.581 . . . . 0.0 112.177 -172.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 79.7 t -58.07 -34.58 49.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.821 177.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 32.2 m -139.49 31.01 2.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.08 177.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 0.502 ' HB3' ' O ' ' A' ' 256' ' ' LEU . 82.0 mm-40 30.82 44.87 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.299 -0.864 . . . . 0.0 113.111 -173.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -91.43 110.15 21.45 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.49 -175.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 44.8 t -100.3 68.04 1.39 Allowed 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.481 ' HA ' ' ND1' ' A' ' 277' ' ' HIS . 42.3 mt-10 . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.423 -0.798 . . . . 0.0 109.491 -173.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 N--CA 1.474 0.729 0 CA-C-O 121.001 0.429 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.44 -32.0 71.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.63 0.729 . . . . 0.0 110.012 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.1 p -98.35 170.65 8.71 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.044 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -123.06 49.67 1.63 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.853 0.358 . . . . 0.0 110.905 -177.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.9 m 65.81 -177.39 0.19 Allowed 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.195 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 69.0 mt -115.71 108.95 26.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.102 176.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 65.14 23.01 12.33 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.505 0.669 . . . . 0.0 110.202 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -146.48 54.87 1.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.388 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 8.4 p -101.65 -103.36 0.26 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.204 0.526 . . . . 0.0 111.395 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -90.81 -48.58 6.94 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.447 HD11 ' N ' ' A' ' 134' ' ' CYS . 0.2 OUTLIER -164.38 144.75 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-N 113.102 -1.863 . . . . 0.0 108.625 160.513 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.62 121.09 11.92 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.478 0.656 . . . . 0.0 111.138 177.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 92.1 m -117.13 152.63 34.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.646 0.736 . . . . 0.0 112.942 -175.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 69.7 mmm -150.37 175.24 12.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.407 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 60.65 55.67 3.26 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.708 0.29 . . . . 0.0 111.715 170.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 63.98 32.99 86.04 Favored Glycine 0 C--O 1.218 -0.885 0 C-N-CA 120.424 -0.894 . . . . 0.0 112.431 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 135' ' ' LEU . . . -115.26 131.37 9.68 Favored Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.7 m -104.65 130.0 52.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.267 0.556 . . . . 0.0 111.032 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 18.2 t -60.75 103.3 0.25 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.322 178.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.0 m -126.22 135.3 51.43 Favored 'General case' 0 C--O 1.213 -0.832 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -31.7 99.61 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -175.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 80.5 -6.66 1.67 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.413 166.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.75 130.02 9.68 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 121.419 -0.801 . . . . 0.0 110.429 174.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . 0.447 ' N ' HD11 ' A' ' 121' ' ' ILE . 25.3 t -86.49 136.48 33.07 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.655 -173.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.437 ' O ' ' HA2' ' A' ' 127' ' ' GLY . 79.2 mt -81.32 90.64 6.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.371 0.605 . . . . 0.0 110.034 176.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 56.0 m -76.23 138.13 40.41 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.844 -178.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -51.62 152.48 2.75 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.145 171.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.41 ' HD3' ' O ' ' A' ' 138' ' ' LYS . 9.6 tmtt? -63.03 116.45 5.35 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.917 0.865 . . . . 0.0 111.207 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 100.1 14.12 34.53 Favored Glycine 0 C--N 1.304 -1.234 0 CA-C-N 113.29 -1.777 . . . . 0.0 111.894 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.446 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 46.4 m-85 -119.99 139.18 52.87 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.976 0.417 . . . . 0.0 111.191 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 25.7 pt -136.34 -166.01 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.748 -177.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.81 179.92 53.1 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.955 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 30.7 p -74.21 -37.36 63.89 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 122.827 0.451 . . . . 0.0 112.205 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -97.46 6.29 48.41 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 35.3 m 63.23 23.78 14.01 Favored 'General case' 0 C--O 1.22 -0.493 0 O-C-N 123.785 0.678 . . . . 0.0 109.497 -171.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -94.8 1.5 65.78 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.307 -0.473 . . . . 0.0 113.564 -171.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.87 105.7 52.17 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 117.409 0.604 . . . . 0.0 109.402 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -79.69 151.34 22.02 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.756 2.304 . . . . 0.0 112.783 -179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 149' ' ' VAL . 13.3 p -87.95 104.23 14.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 122.325 1.06 . . . . 0.0 111.706 -173.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.53 90.84 5.71 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.548 170.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -52.83 -63.12 1.25 Allowed 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -173.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 4.2 m -84.19 7.34 19.32 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.568 0.699 . . . . 0.0 109.948 -168.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.47 131.71 0.08 OUTLIER Glycine 0 N--CA 1.432 -1.579 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.132 -168.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 72.4 m -66.54 154.6 39.95 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 114.447 -0.877 . . . . 0.0 110.364 176.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 34.5 mt -123.23 162.97 21.55 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.647 -169.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.62 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 2.2 t-20 48.55 38.07 10.4 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.422 -167.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 55.94 38.48 74.98 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.743 -174.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.18 -155.06 0.88 Allowed Glycine 0 C--N 1.32 -0.322 0 CA-C-N 115.216 -0.492 . . . . 0.0 112.086 -176.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -144.95 122.36 11.65 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.746 -0.381 . . . . 0.0 111.232 -171.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.42 111.29 5.86 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.403 173.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 165' ' ' ARG . 14.8 m -101.08 -42.92 10.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 O-C-N 121.94 -0.475 . . . . 0.0 110.092 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -134.17 173.34 5.93 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.446 ' HD3' ' CE1' ' A' ' 140' ' ' TYR . 54.7 Cg_exo -54.29 113.01 1.16 Allowed 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 122.492 2.128 . . . . 0.0 112.033 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 75.2 -10.16 1.27 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.636 0.775 . . . . 0.0 109.642 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.455 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.9 OUTLIER -86.47 82.21 8.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.371 179.007 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 84.4 m -87.48 137.16 32.57 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.684 0.754 . . . . 0.0 110.288 172.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.51 134.74 33.64 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.309 174.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 86.3 m -102.2 124.07 47.15 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.288 0.992 . . . . 0.0 111.655 -169.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.62 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 65.2 m -56.34 -53.92 51.59 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -172.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -151.91 -87.75 0.06 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 118.482 -1.287 . . . . 0.0 114.135 -170.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -93.96 39.09 2.98 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.943 -166.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 172' ' ' PHE . 1.7 m-85 -123.72 125.28 44.46 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 118.188 0.994 . . . . 0.0 111.795 174.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.5 t -87.04 163.73 16.87 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 166.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.91 127.84 2.06 Favored Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -175.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -75.22 15.94 0.74 Allowed 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 121.128 1.219 . . . . 0.0 113.274 -166.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -120.89 2.12 10.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.747 0.784 . . . . 0.0 110.325 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 42.65 48.0 4.66 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 114.299 -1.319 . . . . 0.0 113.854 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -107.66 -18.13 13.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.286 0.565 . . . . 0.0 110.169 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.417 ' O ' ' HB3' ' A' ' 180' ' ' ASP . 6.8 mmt180 -55.95 -73.66 0.06 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.582 -176.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.417 ' HB3' ' O ' ' A' ' 179' ' ' ARG . 27.1 t70 84.96 75.16 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.642 0 O-C-N 124.122 0.889 . . . . 0.0 110.176 168.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.457 ' CD2' ' O ' ' A' ' 181' ' ' TYR . 44.6 p90 -94.72 61.56 2.64 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 169.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 22.1 ptt-85 -51.75 126.36 17.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.439 175.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 42.5 p -79.97 137.73 36.92 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 120.857 0.36 . . . . 0.0 110.188 -173.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.551 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -162.8 159.3 31.66 Favored Glycine 0 C--N 1.323 -0.154 0 CA-C-O 119.365 -0.686 . . . . 0.0 111.505 -175.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.11 141.6 11.79 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.421 2.081 . . . . 0.0 111.977 174.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . 0.615 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 74.7 m -91.03 123.25 34.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.445 0.641 . . . . 0.0 111.294 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . 0.469 ' O ' ' HB2' ' A' ' 215' ' ' ARG . 19.1 m-85 -86.47 144.68 27.16 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.989 176.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 5.0 m -108.39 -18.24 13.8 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -163.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 7.5 p -170.75 118.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 121.614 -0.678 . . . . 0.0 110.272 176.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.4 mt -114.72 120.92 65.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -171.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 11.4 m -110.09 173.57 6.26 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 105.194 -2.151 . . . . 0.0 105.194 152.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -67.45 -6.26 18.58 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.639 1.109 . . . . 0.0 109.902 177.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -77.01 -74.44 0.24 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.284 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 92.7 mmm -132.2 133.46 44.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.789 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 56.0 m -83.15 -31.52 27.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.724 174.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 68.42 117.49 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.425 174.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 118.96 21.25 3.87 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.162 -172.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -75.93 3.94 9.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.474 0.654 . . . . 0.0 110.425 -178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.448 ' N ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -122.53 15.25 10.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.588 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 1.4 t -87.19 128.24 35.14 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.948 -173.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -105.13 14.37 48.3 Favored Glycine 0 CA--C 1.505 -0.534 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.011 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.449 ' CD1' ' HA ' ' A' ' 253' ' ' ILE . 2.1 tt -60.95 103.7 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 171.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.7 t -88.77 95.78 5.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 123.31 1.528 . . . . 0.0 108.09 171.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 19.3 m -137.64 177.33 7.95 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 111.458 -2.61 . . . . 0.0 106.875 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 26.8 p -100.88 161.02 13.89 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.674 -174.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.564 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 44.5 tttm -58.84 -42.83 90.23 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.884 173.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 56.8 m -44.4 -56.39 4.27 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 122.78 1.276 . . . . 0.0 109.594 175.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.608 HD11 HG11 ' A' ' 247' ' ' VAL . 10.8 tp -59.71 -49.68 76.79 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 112.379 -2.191 . . . . 0.0 112.043 -175.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 50.6 m -77.49 -17.62 57.84 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.224 0.535 . . . . 0.0 111.78 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 72.4 m -87.4 -27.21 22.9 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.985 -0.447 . . . . 0.0 110.022 172.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . 0.486 ' HB2' ' CE1' ' A' ' 229' ' ' HIS . . . -73.57 -56.57 4.85 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.816 0.817 . . . . 0.0 109.296 175.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.535 ' CG2' ' HA2' ' A' ' 234' ' ' GLY . 25.5 p -106.02 149.93 26.21 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.488 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.0 t 69.14 -42.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 O-C-N 123.948 0.78 . . . . 0.0 111.628 -174.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 56.75 64.29 4.54 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 119.401 1.0 . . . . 0.0 114.842 171.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 187' ' ' PHE . 21.4 mmt85 -130.41 -80.23 0.54 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 117.707 0.753 . . . . 0.0 110.532 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -169.35 169.73 8.87 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . 0.615 ' HD1' ' SG ' ' A' ' 186' ' ' CYS . 16.0 t90 -157.8 147.4 20.01 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 89.47 169.46 44.12 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 170.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -128.04 131.38 23.76 Favored Pre-proline 0 C--N 1.341 0.237 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.456 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.99 159.94 66.32 Favored 'Cis proline' 0 C--N 1.348 0.524 0 C-N-CA 123.569 -1.429 . . . . 0.0 111.149 -4.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 63.5 m -45.17 121.33 2.82 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 123.563 0.539 . . . . 0.0 111.982 -176.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -107.94 114.51 28.48 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 172.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 47.0 ttp -83.55 129.87 34.98 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.238 0.542 . . . . 0.0 110.244 -170.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 63.9 m -77.27 129.15 78.72 Favored Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -171.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -64.75 173.41 5.69 Favored 'Trans proline' 0 C--N 1.329 -0.458 0 C-N-CA 123.806 3.004 . . . . 0.0 111.208 164.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -43.64 -54.15 5.22 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -169.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -164.22 28.67 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.809 0 CA-C-O 118.765 -0.636 . . . . 0.0 112.266 -176.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -19.63 63.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.237 1 C-N-CA 125.664 4.243 . . . . 0.0 116.77 -155.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.486 ' CE1' ' HB2' ' A' ' 211' ' ' ALA . 28.3 m80 -135.76 155.44 78.05 Favored Pre-proline 0 C--N 1.324 -0.521 0 O-C-N 121.982 -0.449 . . . . 0.0 110.469 -178.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -92.47 35.48 0.24 Allowed 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.35 2.033 . . . . 0.0 110.587 165.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 9.9 t -162.77 -167.36 1.52 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.636 -176.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.513 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 88.9 mtt180 -67.12 149.53 50.41 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -174.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 34.9 mmm-85 -35.11 -64.1 0.29 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.868 0.867 . . . . 0.0 112.921 175.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.535 ' HA2' ' CG2' ' A' ' 212' ' ' THR . . . -82.96 16.04 29.47 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.424 -0.894 . . . . 0.0 114.35 -168.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . 0.513 ' CD1' ' HB2' ' A' ' 232' ' ' ARG . 7.0 m-85 -119.96 137.98 53.73 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 121.847 0.832 . . . . 0.0 112.063 -173.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.79 141.74 34.54 Favored Pre-proline 0 C--N 1.311 -1.107 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 175.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.68 124.0 10.69 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.534 2.156 . . . . 0.0 112.473 -176.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -55.26 139.78 41.33 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.563 171.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 34.2 mt -77.29 -16.53 14.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.089 -173.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -101.13 -61.26 1.39 Allowed 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.775 -175.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 40.7 p -82.09 -38.95 24.09 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.377 -176.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 94.11 5.89 62.05 Favored Glycine 0 N--CA 1.437 -1.296 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.062 -176.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -78.23 139.88 38.91 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 121.79 0.805 . . . . 0.0 110.919 -178.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 63.7 m -62.64 122.41 15.76 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.743 -1.571 . . . . 0.0 110.146 174.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -122.7 133.16 54.51 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 176.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.504 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 1.8 t70 -75.54 151.57 37.9 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.608 HG11 HD11 ' A' ' 208' ' ' LEU . 8.6 m -97.02 145.25 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.451 -177.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -75.75 76.46 2.71 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 169.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.592 ' HG3' HG23 ' A' ' 247' ' ' VAL . 34.1 mp0 -54.11 -33.36 57.54 Favored 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 123.98 0.8 . . . . 0.0 110.359 -169.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 35.1 m -51.1 -42.67 60.79 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.812 174.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -96.58 -34.81 11.3 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.768 0.794 . . . . 0.0 110.268 -177.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -73.13 -20.03 61.01 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.482 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.594 ' O ' ' HG ' ' A' ' 256' ' ' LEU . 5.2 mp -140.54 81.46 17.32 Favored Pre-proline 0 N--CA 1.451 -0.376 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -71.37 31.53 0.24 Allowed 'Trans proline' 0 CA--C 1.515 -0.474 0 C-N-CA 123.373 2.716 . . . . 0.0 113.025 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 253' ' ' ILE . . . -123.39 2.39 9.59 Favored Glycine 0 C--N 1.288 -2.119 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.484 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 253' ' ' ILE . 23.2 mt -65.75 -147.17 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 175.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 284' ' ' GLN . 76.1 m -38.55 128.16 1.46 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.394 0.677 . . . . 0.0 112.698 -174.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -79.73 68.77 5.89 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.998 -174.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 107.24 171.35 22.27 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.914 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 85.66 -154.73 28.56 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.203 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -109.64 138.68 45.65 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 50.2 t -122.48 138.57 54.51 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 173.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 20.9 mt -131.26 164.9 33.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 -174.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.29 125.36 32.61 Favored 'General case' 0 CA--C 1.497 -1.062 0 C-N-CA 117.53 -1.668 . . . . 0.0 114.038 -175.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.0 t -109.26 163.87 12.98 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 122.333 1.063 . . . . 0.0 110.072 166.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.424 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 35.7 m -73.23 127.5 35.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 98.45 -12.63 63.19 Favored Glycine 0 C--N 1.311 -0.848 0 C-N-CA 119.523 -1.322 . . . . 0.0 111.999 -176.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 10.5 t 176.44 162.51 0.39 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.112 1.456 . . . . 0.0 110.858 -177.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . 0.421 ' CZ ' HD13 ' A' ' 256' ' ' LEU . 46.0 p90 -107.26 162.59 13.76 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.233 -0.917 . . . . 0.0 109.56 177.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -116.75 156.55 26.98 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.81 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 56.8 m -136.68 158.54 44.2 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.576 0.703 . . . . 0.0 112.338 172.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -139.68 130.13 25.55 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.141 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 19.6 m -122.12 173.03 4.47 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.992 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.21 155.07 25.77 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.862 1.708 . . . . 0.0 110.141 167.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -58.04 156.94 8.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.139 0.495 . . . . 0.0 111.376 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 86.51 -36.97 3.17 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.255 -176.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' HIS . . . . . 0.572 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 18.1 m-70 -69.63 153.41 43.47 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.08 0.466 . . . . 0.0 111.639 -177.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 54.7 mttp -144.96 139.44 27.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.487 -175.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 45.9 tp -76.07 140.93 42.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.396 0.617 . . . . 0.0 111.85 -175.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -127.07 102.54 7.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.903 173.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -57.8 -27.98 63.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.292 -175.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 66.4 t -56.3 -33.4 37.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.133 0.492 . . . . 0.0 111.513 -175.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 8.3 p -137.83 28.21 2.66 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.015 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 257' ' ' CYS . 0.9 OUTLIER 35.16 43.87 0.13 Allowed 'General case' 0 C--N 1.349 0.584 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.662 -169.602 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -94.64 166.15 12.16 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -172.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' CYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 12.4 t -156.93 106.06 2.21 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.596 -178.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 37.4 tt0 . . . . . 0 C--N 1.315 -0.901 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.86 -2.91 57.39 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.849 0.357 . . . . 0.0 110.846 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.5 t 63.23 30.91 15.79 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.536 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -127.71 117.24 21.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.29 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.7 p -79.8 118.75 21.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.438 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 74.5 mt -77.35 121.0 28.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.143 -175.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -82.58 178.51 8.17 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.191 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -61.67 -39.58 91.9 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.197 -0.201 . . . . 0.0 110.947 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 37.4 t -173.36 -97.15 0.01 OUTLIER 'General case' 0 C--O 1.231 0.101 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 173.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -128.91 -58.22 1.16 Allowed 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 119.826 -0.749 . . . . 0.0 112.599 -175.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.459 HD11 ' C ' ' A' ' 133' ' ' HIS . 0.2 OUTLIER -169.88 -165.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.646 -170.106 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.427 ' H ' ' HD3' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -100.96 123.58 45.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.035 171.438 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 39.1 m -118.93 144.1 46.64 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 54.0 mtm -135.24 165.9 24.35 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 172.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 63.87 49.65 2.8 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.23 0.538 . . . . 0.0 110.841 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 67.1 25.39 73.4 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.077 -0.965 . . . . 0.0 113.256 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -72.09 125.29 10.8 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.089 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.0 m -91.88 150.16 21.19 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -69.73 118.73 12.96 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.083 0.468 . . . . 0.0 110.012 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.9 p -142.33 162.94 34.2 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.308 -176.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -47.75 82.6 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -166.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 59.54 35.26 22.65 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.205 -1.361 . . . . 0.0 109.796 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.459 ' C ' HD11 ' A' ' 121' ' ' ILE . 2.5 p-80 -166.52 174.6 8.74 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.108 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 9.8 t -120.34 139.69 52.4 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.073 0.463 . . . . 0.0 111.403 -171.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.1 mt -95.78 103.82 15.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.454 176.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 60.5 m -72.12 147.83 46.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.743 -174.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -80.29 -177.94 6.37 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.047 174.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -52.77 113.23 1.01 Allowed 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.198 0.999 . . . . 0.0 111.64 -174.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.46 21.17 58.85 Favored Glycine 0 C--N 1.296 -1.684 0 CA-C-N 112.698 -2.046 . . . . 0.0 114.51 170.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -119.52 145.17 46.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 119.736 1.768 . . . . 0.0 111.545 177.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 34.0 pt -129.87 176.8 7.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.592 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.73 165.73 31.83 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.187 -176.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 40.3 p -64.98 -36.93 85.99 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -106.25 16.1 25.31 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.037 0.446 . . . . 0.0 110.264 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 60.3 m 55.98 36.82 28.04 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.131 173.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -94.25 -2.24 64.13 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.793 -175.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.88 113.67 60.87 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 117.752 0.776 . . . . 0.0 110.804 -176.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.89 143.87 23.72 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.96 2.44 . . . . 0.0 112.507 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.3 p -78.07 110.47 13.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.867 0.842 . . . . 0.0 111.953 -175.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.64 76.73 7.51 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.37 172.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -58.36 -62.61 1.72 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -170.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.3 m -86.36 8.87 19.81 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.586 0.708 . . . . 0.0 109.815 -170.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 74.7 131.78 0.25 Allowed Glycine 0 N--CA 1.428 -1.881 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.149 -172.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 77.3 m -71.86 157.75 37.31 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 175.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 55.6 mt -129.03 165.26 21.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.907 -170.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.699 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 2.3 t-20 49.53 30.97 3.76 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.837 0.711 . . . . 0.0 111.229 -168.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.68 37.25 82.56 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.219 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -73.65 -145.94 0.88 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.414 -0.422 . . . . 0.0 112.958 -175.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 166' ' ' CYS . 21.5 tpt180 -148.37 121.97 9.19 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.881 -174.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -72.96 108.34 5.83 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.41 173.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 165' ' ' ARG . 4.4 m -94.46 -37.25 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.392 -177.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -133.58 177.85 2.05 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 168.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -50.2 107.04 0.14 Allowed 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.383 2.055 . . . . 0.0 113.608 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 64.49 6.61 3.21 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.165 0.986 . . . . 0.0 110.517 -178.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.479 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -92.33 75.53 5.27 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.722 177.106 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 61.4 m -84.34 146.98 27.43 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.188 0.518 . . . . 0.0 110.334 176.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -98.07 144.5 27.5 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 57.7 m -102.96 122.88 45.5 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 124.449 1.093 . . . . 0.0 112.007 -166.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.699 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 93.7 m -61.24 -55.44 31.96 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.423 ' CG ' ' N ' ' A' ' 171' ' ' GLY . 79.6 t80 -132.2 -116.48 0.22 Allowed 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.269 -0.972 . . . . 0.0 112.277 -168.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.423 ' N ' ' CG ' ' A' ' 170' ' ' TYR . . . -87.63 55.51 4.43 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.742 -166.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.573 ' CD1' ' N ' ' A' ' 172' ' ' PHE . 2.1 m-85 -123.99 122.17 37.21 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.273 171.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.412 ' O ' ' HG2' ' A' ' 179' ' ' ARG . 3.1 t -86.36 163.65 17.52 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 166.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 84.75 125.19 1.33 Allowed Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 -176.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.56 19.86 0.53 Allowed 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 121.471 1.447 . . . . 0.0 114.033 -165.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -122.95 3.82 9.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.813 0.816 . . . . 0.0 109.682 175.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 39.06 51.79 1.97 Allowed 'General case' 0 C--N 1.346 0.444 0 CA-C-N 114.141 -1.391 . . . . 0.0 114.537 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -106.82 -16.62 14.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.283 0.563 . . . . 0.0 109.854 174.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 173' ' ' THR . 19.7 mmm180 -56.62 -70.38 0.12 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.809 -174.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 41.1 t0 77.02 69.6 0.06 Allowed 'General case' 0 CA--C 1.502 -0.866 0 CA-C-O 121.907 0.86 . . . . 0.0 109.519 166.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.444 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 38.6 p90 -86.13 65.85 9.29 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-O 122.741 1.258 . . . . 0.0 107.856 173.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -45.89 123.42 4.47 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.657 -1.61 . . . . 0.0 109.26 172.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 80.9 p -76.7 137.39 39.35 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -147.98 143.7 11.46 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -173.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.76 128.64 12.69 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.205 1.936 . . . . 0.0 111.337 174.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . 0.609 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 92.4 m -84.23 119.01 24.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.417 0.627 . . . . 0.0 110.947 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . 0.474 ' HB3' ' O ' ' A' ' 195' ' ' CYS . 69.1 m-85 -95.34 144.75 25.63 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.958 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.427 ' O ' ' HD2' ' A' ' 215' ' ' ARG . 20.2 p -108.98 -6.04 15.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -167.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.5 p -167.28 116.17 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.502 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.422 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.1 mt -133.86 127.07 51.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -170.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.9 m -128.33 -166.08 1.58 Allowed 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 160.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -63.04 -5.99 3.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 118.943 0.792 . . . . 0.0 110.453 173.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -76.95 -72.75 0.33 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.293 -177.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.418 ' SD ' ' HA2' ' A' ' 197' ' ' GLY . 13.6 ttt -149.96 160.09 43.88 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -173.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 187' ' ' PHE . 61.4 m -90.15 -32.17 16.76 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.167 0.508 . . . . 0.0 111.669 -176.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -148.09 -74.74 0.19 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.463 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.418 ' HA2' ' SD ' ' A' ' 194' ' ' MET . . . 125.78 -29.34 4.71 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -95.68 -24.2 16.65 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 119.845 -0.122 . . . . 0.0 111.206 173.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 58.57 79.81 0.2 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.266 0.555 . . . . 0.0 111.258 177.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 44.2 t -100.27 144.88 28.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.482 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -92.11 29.29 7.69 Favored Glycine 0 CA--C 1.499 -0.951 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 175.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.421 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -60.98 106.64 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 121.783 0.801 . . . . 0.0 108.843 173.107 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.0 t -94.69 123.9 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.816 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 16.7 t -155.24 -178.15 7.05 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.4 p -101.66 159.29 15.44 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 120.434 1.47 . . . . 0.0 109.311 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.436 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 42.2 tttm -56.11 -44.97 79.62 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 120.284 -0.567 . . . . 0.0 109.885 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.5 m -43.87 -56.81 3.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.371 173.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.58 -55.09 36.04 Favored 'General case' 0 CA--C 1.518 -0.261 0 O-C-N 123.755 0.659 . . . . 0.0 112.036 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 53.8 m -75.39 -18.7 59.88 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -171.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 79.9 m -89.67 -39.46 13.18 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 121.74 -0.6 . . . . 0.0 111.28 174.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -67.8 -57.0 7.04 Favored 'General case' 0 C--N 1.345 0.383 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.538 HG22 ' HA2' ' A' ' 234' ' ' GLY . 18.8 p -94.08 157.45 16.08 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.346 174.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.1 t 68.42 -46.73 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 176.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 60.05 59.51 10.3 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 120.737 -0.744 . . . . 0.0 114.638 170.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.427 ' HD2' ' O ' ' A' ' 188' ' ' THR . 30.1 mmt180 -124.85 -84.95 0.64 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 117.525 0.663 . . . . 0.0 110.466 177.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -169.32 165.75 10.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . 0.609 ' HD1' ' SG ' ' A' ' 186' ' ' CYS . 18.5 t90 -153.39 148.4 26.66 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.552 0.215 . . . . 0.0 110.656 -175.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 78.37 163.23 22.47 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 115.086 0.795 . . . . 0.0 115.086 167.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.427 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 6.6 m80 -116.09 132.22 23.36 Favored Pre-proline 0 N--CA 1.453 -0.294 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 168.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . 0.427 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 25.4 Cg_exo -63.3 151.28 69.42 Favored 'Cis proline' 0 C--O 1.232 0.18 0 C-N-CA 123.593 -1.419 . . . . 0.0 111.516 -2.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 84.9 m -54.99 120.19 6.53 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 124.175 0.922 . . . . 0.0 111.15 -175.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -115.85 121.41 42.3 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.89 150.23 23.05 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.604 -172.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 74.1 m -143.35 148.46 44.28 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 120.799 0.333 . . . . 0.0 111.687 -175.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -63.27 168.38 11.13 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.546 2.164 . . . . 0.0 109.94 155.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.8 -118.71 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.997 0.427 . . . . 0.0 110.971 171.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.07 108.52 1.26 Allowed Pre-proline 0 C--N 1.322 -0.623 0 CA-C-O 121.179 0.514 . . . . 0.0 111.91 -174.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.91 -49.53 0.15 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.214 1.943 . . . . 0.0 112.667 -175.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -94.36 178.99 1.32 Allowed Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -63.49 -7.5 12.63 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.0 1.134 . . . . 0.0 112.108 173.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 20.0 t -65.4 144.61 56.96 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.591 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 31.4 mmt180 -75.07 142.77 43.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.361 -174.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.414 ' HG3' ' N ' ' A' ' 234' ' ' GLY . 28.0 ptt-85 -37.78 -53.57 1.27 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.496 1.123 . . . . 0.0 113.06 -177.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.538 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -71.15 0.36 31.62 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.22 -0.514 . . . . 0.0 114.224 -172.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . 0.7 ' CE2' ' HA2' ' A' ' 267' ' ' GLY . 1.8 m-85 -123.1 166.67 14.78 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 118.352 1.076 . . . . 0.0 111.843 -175.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.54 128.0 22.47 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 113.623 -1.626 . . . . 0.0 107.59 169.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -61.03 117.61 4.4 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.321 2.014 . . . . 0.0 112.075 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -55.96 134.69 52.41 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.114 177.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 39.0 mt -73.98 -11.21 14.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.607 175.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -98.04 -58.1 2.06 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.296 -175.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 31.3 p -93.05 -43.8 8.71 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.777 -177.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 102.01 7.36 47.24 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -178.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -94.14 128.73 40.73 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.959 0.885 . . . . 0.0 109.797 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 86.6 m -51.32 117.92 2.93 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.167 -1.833 . . . . 0.0 109.867 169.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -121.24 131.24 54.11 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.482 ' HB3' HG13 ' A' ' 266' ' ' VAL . 4.3 t70 -79.14 150.34 31.77 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 121.297 0.57 . . . . 0.0 110.384 -170.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.583 HG23 ' HG3' ' A' ' 249' ' ' GLU . 8.9 m -100.79 145.39 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.948 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.552 -178.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.24 76.85 1.82 Allowed 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 167.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.583 ' HG3' HG23 ' A' ' 247' ' ' VAL . 55.4 mp0 -52.76 -35.07 55.67 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 123.722 0.639 . . . . 0.0 110.66 -170.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 32.3 m -53.88 -29.16 40.36 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.205 175.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -106.67 -47.44 3.75 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.633 0.73 . . . . 0.0 110.309 -175.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -63.15 -25.57 68.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.612 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.591 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.7 mp -122.65 79.96 47.97 Favored Pre-proline 0 C--O 1.243 0.726 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 173.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.27 118.79 4.65 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.489 2.793 . . . . 0.0 114.649 -165.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 59.11 30.83 67.68 Favored Glycine 0 C--N 1.317 -0.518 0 CA-C-N 113.839 -1.528 . . . . 0.0 114.103 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.591 ' HB3' HG22 ' A' ' 253' ' ' ILE . 1.3 pt? -68.27 -25.79 65.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.565 0.683 . . . . 0.0 111.44 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 48.2 t -102.66 82.39 2.13 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.581 0.705 . . . . 0.0 110.081 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -85.07 116.31 23.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.1 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 165.55 -41.25 0.28 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -170.63 -116.6 0.39 Allowed Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.502 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -98.78 157.56 16.21 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -175.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 32.6 t -140.45 133.61 29.55 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 28.4 mt -138.13 116.72 13.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.022 0.439 . . . . 0.0 110.54 -169.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -77.1 121.29 23.38 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.655 -174.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 8.4 t -106.3 160.9 15.02 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.661 157.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.663 HG12 ' CE1' ' A' ' 235' ' ' PHE . 1.7 t -72.39 119.52 19.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.7 ' HA2' ' CE2' ' A' ' 235' ' ' PHE . . . 113.71 -22.33 14.95 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.376 -174.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 15.6 t 174.21 163.65 0.2 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.566 0.698 . . . . 0.0 111.103 -173.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -111.48 153.53 26.03 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.231 -0.988 . . . . 0.0 108.759 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -111.64 135.85 51.67 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.444 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 64.7 m -109.48 160.33 16.3 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.656 -0.817 . . . . 0.0 111.142 178.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -135.35 95.38 3.27 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.47 176.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 13.7 m -76.05 161.29 75.98 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.161 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -61.66 159.55 32.13 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 121.907 1.738 . . . . 0.0 109.968 170.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -57.76 145.73 33.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.515 0.197 . . . . 0.0 111.059 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.86 -28.9 3.89 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.13 -177.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' HIS . . . . . 0.605 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 17.1 m-70 -78.68 166.37 22.58 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 120.833 0.349 . . . . 0.0 111.228 -177.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -137.82 138.76 39.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.147 -176.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.517 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 51.4 tp -80.01 123.7 28.06 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.819 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -113.85 110.25 19.82 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -64.25 -14.96 58.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.717 -170.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 63.7 t -56.51 -38.84 58.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.908 0.385 . . . . 0.0 110.978 178.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 42.6 m -146.02 36.22 1.03 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.644 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 34.49 48.32 0.28 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.41 0.684 . . . . 0.0 111.853 -170.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 84.8 tttt -82.68 154.9 24.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.583 -172.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 23.2 m -141.02 85.75 2.0 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.605 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 19.0 mm-40 . . . . . 0 C--O 1.239 0.54 0 CA-C-O 118.392 -0.813 . . . . 0.0 108.904 -173.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.619 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 44.6 m-85 . . . . . 0 N--CA 1.449 -0.514 0 CA-C-O 120.51 0.195 . . . . 0.0 110.572 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 145' ' ' CYS . 20.4 pt -134.96 177.46 6.8 Favored 'Isoleucine or valine' 0 C--O 1.246 0.876 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.498 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.13 174.03 30.22 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.936 -175.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.7 p -70.79 -48.22 55.41 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 120.753 0.311 . . . . 0.0 110.948 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -96.54 5.87 49.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.949 176.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 141' ' ' ILE . 61.8 m 63.86 42.1 6.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.903 172.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.72 9.18 56.85 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.792 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.424 ' O ' HG12 ' A' ' 141' ' ' ILE . 5.2 tm0? -115.13 113.63 43.71 Favored Pre-proline 0 C--O 1.222 -0.384 0 CA-C-N 117.645 0.723 . . . . 0.0 110.125 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.75 143.82 13.51 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.639 2.226 . . . . 0.0 112.612 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 12.7 p -71.08 112.84 6.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.655 -176.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.8 m -81.44 74.63 8.43 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.177 175.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -51.58 -64.33 0.85 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -173.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.6 m -91.9 13.33 18.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.47 0.652 . . . . 0.0 110.717 -169.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 74.13 131.96 0.23 Allowed Glycine 0 N--CA 1.436 -1.347 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.661 -177.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' CYS . . . . . 0.687 ' O ' HD23 ' A' ' 155' ' ' LEU . 1.7 m -61.49 156.9 18.3 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 113.942 -1.129 . . . . 0.0 109.858 171.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 154' ' ' CYS . 41.2 mt -137.93 178.1 7.37 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -174.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.636 HD22 ' C ' ' A' ' 155' ' ' LEU . 0.1 OUTLIER 35.43 31.25 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.979 1.312 . . . . 0.0 114.446 -178.842 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 63.31 35.54 92.2 Favored Glycine 0 N--CA 1.454 -0.132 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.593 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -79.24 -147.66 4.1 Favored Glycine 0 C--N 1.328 0.104 0 C-N-CA 121.286 -0.483 . . . . 0.0 113.442 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -157.93 126.44 5.53 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.251 -0.558 . . . . 0.0 110.624 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 166' ' ' CYS . 4.9 m -64.18 124.56 21.98 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 122.241 0.216 . . . . 0.0 110.942 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.812 HG22 ' HG2' ' A' ' 165' ' ' ARG . 1.3 m -116.31 -35.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.913 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.66 ' HB3' ' HB3' ' A' ' 165' ' ' ARG . . . -139.28 169.62 11.93 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.619 ' HD3' ' CE1' ' A' ' 140' ' ' TYR . 78.4 Cg_exo -51.16 107.14 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.316 2.01 . . . . 0.0 112.604 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 75.28 -11.35 1.1 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.471 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.812 ' HG2' HG22 ' A' ' 161' ' ' VAL . 18.3 ttp180 -83.45 90.74 7.24 Favored 'General case' 0 CA--C 1.488 -1.425 0 CA-C-O 121.652 0.739 . . . . 0.0 109.312 175.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 160' ' ' CYS . 34.5 t -84.61 145.04 28.23 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.648 167.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.538 ' HB2' HG11 ' A' ' 161' ' ' VAL . . . -92.38 129.23 38.37 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 35.7 m -106.6 132.53 52.49 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.267 0.979 . . . . 0.0 111.925 -167.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 52.6 m -57.07 -55.5 33.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 113.331 -1.759 . . . . 0.0 114.501 -167.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 17.1 t80 177.75 125.89 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.692 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 79.98 28.95 48.45 Favored Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.42 169.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.597 ' CE2' ' HA ' ' A' ' 180' ' ' ASP . 1.4 m-85 -118.34 121.25 39.92 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 118.797 -1.161 . . . . 0.0 110.502 166.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.561 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 4.3 t -89.23 140.11 29.81 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 96.45 128.59 5.81 Favored Glycine 0 N--CA 1.425 -2.038 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -171.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.18 9.76 0.81 Allowed 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.413 1.409 . . . . 0.0 113.229 -168.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.605 ' O ' HD12 ' A' ' 155' ' ' LEU . 41.3 tt0 -117.79 19.79 13.64 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.378 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.585 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.6 OUTLIER 24.31 59.54 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 117.228 2.307 . . . . 0.0 117.228 178.077 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -115.47 21.0 14.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.395 1.093 . . . . 0.0 109.028 168.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 20.6 mmt180 -113.3 81.53 1.52 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.658 -1.61 . . . . 0.0 107.603 175.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.597 ' HA ' ' CE2' ' A' ' 172' ' ' PHE . 2.3 m-20 -80.5 49.6 1.18 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.52 -167.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.561 ' HE2' ' N ' ' A' ' 173' ' ' THR . 20.4 p90 -86.32 98.64 11.08 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -87.27 155.14 20.19 Favored 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 118.296 -2.753 . . . . 0.0 106.763 175.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 19.8 p -86.06 135.45 33.62 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.049 -1.06 . . . . 0.0 109.618 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -153.64 155.09 25.94 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -73.77 129.25 13.29 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.16 1.907 . . . . 0.0 110.809 173.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 10.6 t -82.43 114.21 20.72 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' PHE . . . . . 0.538 ' HE1' ' O ' ' A' ' 218' ' ' GLY . 59.3 m-85 -94.29 138.93 31.71 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.773 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.554 ' O ' ' HD2' ' A' ' 215' ' ' ARG . 89.2 m -107.8 -19.76 13.43 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -163.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 25.4 t -150.47 115.62 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 121.467 -0.771 . . . . 0.0 109.613 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.731 ' CG1' ' HA ' ' A' ' 195' ' ' CYS . 16.5 mt -130.88 120.16 46.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 10.7 p -117.08 -166.5 1.18 Allowed 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 155.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -66.75 -5.29 11.48 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.841 0.829 . . . . 0.0 109.764 172.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -83.76 -73.79 0.4 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.224 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.475 ' O ' ' HA ' ' A' ' 190' ' ' ILE . 60.7 mtt -128.38 161.18 30.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.443 0.163 . . . . 0.0 110.966 -175.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.731 ' HA ' ' CG1' ' A' ' 190' ' ' ILE . 84.5 m -92.03 -25.55 18.76 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.572 173.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -161.27 -58.7 0.05 Allowed 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 169.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 125.78 -26.05 5.46 Favored Glycine 0 C--N 1.317 -0.48 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.619 170.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -118.13 -0.11 11.66 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 117.159 0.48 . . . . 0.0 111.294 176.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.444 ' O ' ' HB2' ' A' ' 200' ' ' SER . 4.1 mm? 62.75 175.48 0.15 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.83 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 199' ' ' LEU . 22.8 t 176.14 130.3 0.04 OUTLIER 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.543 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -84.23 36.32 2.92 Favored Glycine 0 CA--C 1.509 -0.343 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 174.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.97 104.3 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 122.331 1.062 . . . . 0.0 109.412 175.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 37.9 t -93.05 124.1 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 CA-C-N 113.841 -1.527 . . . . 0.0 109.631 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 20.2 t -154.64 -177.3 6.39 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 104.292 -2.484 . . . . 0.0 104.292 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.426 ' OG1' HD22 ' A' ' 208' ' ' LEU . 14.3 p -99.36 157.28 16.52 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 120.317 1.417 . . . . 0.0 109.014 176.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.699 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 36.5 tttm -56.61 -44.37 81.06 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 120.201 -0.599 . . . . 0.0 109.788 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.2 m -43.58 -54.87 4.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.892 174.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.52 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -55.14 -53.07 60.62 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 124.05 0.844 . . . . 0.0 111.322 177.811 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 94.6 m -63.69 -26.62 68.75 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -176.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 226' ' ' ALA . 60.9 m -85.79 -47.49 9.68 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 118.481 0.582 . . . . 0.0 110.008 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ALA . . . . . 0.554 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . . . -67.23 -54.44 21.0 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -173.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.77 HG22 ' HA2' ' A' ' 234' ' ' GLY . 16.2 p -102.8 152.86 20.76 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.851 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER 66.12 -40.5 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.336 0.654 . . . . 0.0 112.14 -176.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.413 ' O ' ' HD3' ' A' ' 215' ' ' ARG . . . 61.01 59.06 10.75 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 119.134 0.879 . . . . 0.0 114.785 169.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.554 ' HD2' ' O ' ' A' ' 188' ' ' THR . 8.6 mmt85 -128.64 -90.12 0.5 Allowed 'General case' 0 C--O 1.245 0.827 0 CA-C-N 117.845 0.822 . . . . 0.0 111.847 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.575 ' CB ' HD12 ' A' ' 190' ' ' ILE . . . -165.93 168.46 15.74 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' TRP . . . . . 0.699 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 11.2 t90 -164.96 150.15 9.53 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' GLY . . . . . 0.538 ' O ' ' HE1' ' A' ' 187' ' ' PHE . . . 95.84 -174.06 31.29 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.305 -0.95 . . . . 0.0 114.245 168.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 220' ' ' PRO . 20.2 p80 -137.09 133.55 18.57 Favored Pre-proline 0 N--CA 1.444 -0.729 0 CA-C-O 121.248 0.547 . . . . 0.0 111.163 -175.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 219' ' ' HIS . 72.2 Cg_endo -86.11 117.05 4.09 Favored 'Cis proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.408 -1.913 . . . . 0.0 112.233 -5.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 70.3 m 33.23 94.57 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.768 1.227 . . . . 0.0 113.781 177.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 36.3 mt-10 -101.17 113.63 26.84 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.76 139.5 35.34 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.779 0.323 . . . . 0.0 111.253 -170.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 5.9 p -145.62 155.98 52.74 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.926 -175.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.64 166.89 14.53 Favored 'Trans proline' 0 CA--C 1.504 -1.025 0 C-N-CA 122.27 1.98 . . . . 0.0 111.339 167.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 210' ' ' CYS . . . -63.75 -122.98 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 O-C-N 123.969 0.793 . . . . 0.0 111.794 171.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.68 108.97 1.22 Allowed Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.533 -173.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.554 ' HD3' ' HA ' ' A' ' 211' ' ' ALA . 73.8 Cg_endo -80.58 -57.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.71 2.273 . . . . 0.0 113.168 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 230' ' ' PRO . 13.6 m-70 -84.15 153.56 63.01 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 229' ' ' HIS . 6.1 Cg_exo -78.12 64.75 8.39 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.415 2.077 . . . . 0.0 112.543 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 80.6 m -119.48 -103.85 0.4 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 172.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.646 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 59.5 mtt180 -145.45 134.43 22.57 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 172.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -39.85 -41.97 1.23 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.77 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -73.45 9.7 7.44 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.417 -0.897 . . . . 0.0 113.882 -176.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' PHE . . . . . 0.646 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 6.1 m-85 -124.05 146.97 48.22 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 122.099 0.952 . . . . 0.0 112.595 -171.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.442 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.5 OUTLIER -122.6 129.02 25.2 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 114.009 -1.451 . . . . 0.0 108.432 171.828 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -62.04 113.39 1.85 Allowed 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.097 1.865 . . . . 0.0 111.202 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -48.48 128.67 15.16 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.512 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 26.9 pt -75.75 4.18 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.587 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -110.97 -56.73 2.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.008 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 36.0 p -94.42 -37.53 11.39 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.01 -176.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 100.93 0.17 55.06 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.175 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -81.62 129.94 34.87 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.784 0.802 . . . . 0.0 110.578 -176.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' CYS . . . . . 0.425 ' C ' ' HD1' ' A' ' 235' ' ' PHE . 2.2 m -61.44 115.05 3.58 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 113.816 -1.538 . . . . 0.0 109.371 173.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.496 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 45.4 tt0 -119.57 139.74 51.66 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.187 -177.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ASP . . . . . 0.695 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 20.0 t70 -77.24 145.43 37.55 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -177.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.654 HG23 ' HG3' ' A' ' 249' ' ' GLU . 15.1 m -100.15 145.26 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.533 ' HB3' ' HG2' ' A' ' 251' ' ' GLN . 10.4 t70 -73.63 80.51 1.51 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 165.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.654 ' HG3' HG23 ' A' ' 247' ' ' VAL . 36.8 mp0 -51.63 -34.85 39.56 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.175 0.512 . . . . 0.0 110.334 -174.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.524 ' HB2' ' OD2' ' A' ' 248' ' ' ASP . 62.8 m -52.58 -44.22 65.78 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.501 173.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' GLN . . . . . 0.533 ' HG2' ' HB3' ' A' ' 248' ' ' ASP . 2.2 pt20 -90.16 -32.09 16.78 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.68 0.752 . . . . 0.0 110.401 -173.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.1 -17.43 31.04 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.942 -170.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.757 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.1 mp -125.55 79.93 66.71 Favored Pre-proline 0 C--O 1.239 0.551 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -39.41 114.23 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 124.446 3.431 . . . . 0.0 115.48 -172.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 57.74 34.37 70.43 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 113.637 -1.619 . . . . 0.0 114.174 174.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.757 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.9 OUTLIER -73.54 -24.51 60.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 118.16 0.98 . . . . 0.0 110.905 177.538 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 257' ' ' CYS . . . . . 0.505 ' HA ' ' HB3' ' A' ' 284' ' ' GLN . 50.5 t -90.49 114.69 26.93 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -103.77 83.36 2.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.267 0.556 . . . . 0.0 110.609 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -158.9 -105.49 0.21 Allowed Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.185 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -124.29 -88.33 0.8 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.525 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' ASN . . . . . 0.618 ' HB2' ' HB3' ' A' ' 272' ' ' LYS . 10.2 m120 -94.84 157.65 15.83 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 11.8 t -137.85 126.12 23.14 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 173.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 41.0 mt -132.13 169.78 21.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -171.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.41 ' CG ' ' HA ' ' A' ' 248' ' ' ASP . 1.1 t30 -134.96 130.28 35.55 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 117.248 -1.781 . . . . 0.0 113.835 -174.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 1.7 t -113.61 163.96 14.29 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.532 163.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.695 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 4.1 m -73.12 130.0 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 C-N-CA 119.312 -0.955 . . . . 0.0 108.719 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.525 ' CA ' ' HE2' ' A' ' 235' ' ' PHE . . . 98.2 -17.52 58.49 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.959 -175.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 41.9 t -179.69 150.74 0.42 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.532 1.166 . . . . 0.0 110.524 -173.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -96.43 160.28 14.49 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.61 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -116.77 117.59 30.19 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -177.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' CYS . . . . . 0.477 ' HB2' HD22 ' A' ' 279' ' ' LEU . 68.8 m -102.61 132.39 48.74 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.237 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.618 ' HB3' ' HB2' ' A' ' 261' ' ' ASN . 22.7 ttpp -101.18 122.52 43.78 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.131 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 56.6 m -107.1 145.1 30.46 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.114 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.532 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 38.9 Cg_exo -57.97 156.34 29.27 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.636 2.224 . . . . 0.0 110.842 169.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -54.41 146.37 16.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.073 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.15 -29.67 3.44 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.803 -177.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' HIS . . . . . 0.682 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 29.8 m-70 -81.25 162.66 23.44 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 120.986 0.422 . . . . 0.0 110.728 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -146.63 116.83 7.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.044 -171.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.477 HD22 ' HB2' ' A' ' 271' ' ' CYS . 45.2 tp -63.13 127.75 32.68 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.977 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -114.8 101.57 9.19 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -70.17 -8.02 46.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.724 0.297 . . . . 0.0 111.339 -173.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 51.5 t -67.68 -31.77 53.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.514 0.674 . . . . 0.0 110.18 172.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 30.7 p -139.68 28.93 2.15 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.015 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' GLN . . . . . 0.505 ' HB3' ' HA ' ' A' ' 257' ' ' CYS . 0.9 OUTLIER 29.46 44.87 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.166 0.986 . . . . 0.0 113.292 -172.476 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -112.36 127.24 55.95 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.906 -172.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 98.0 m -88.03 107.62 18.83 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 171.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.682 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 8.9 tp10 . . . . . 0 C--O 1.244 0.792 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.669 ' CE2' ' HD3' ' A' ' 163' ' ' PRO . 51.6 m-85 . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 120.932 0.396 . . . . 0.0 110.001 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.507 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 23.9 pt -137.21 -173.15 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.179 -177.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.75 176.5 46.84 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.649 -174.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.8 p -75.08 -32.75 61.54 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.596 -0.355 . . . . 0.0 111.726 -176.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -109.72 16.01 22.38 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.981 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 60.7 m 61.71 30.19 18.36 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.634 175.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.05 2.86 61.8 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.733 -1.223 . . . . 0.0 113.112 -174.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.507 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 0.0 OUTLIER -109.72 103.93 54.27 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 117.434 0.617 . . . . 0.0 110.192 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.89 149.82 26.39 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.468 2.112 . . . . 0.0 112.553 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 149' ' ' VAL . 8.2 p -80.07 105.14 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 122.118 0.961 . . . . 0.0 112.179 -174.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.8 m -80.69 82.41 6.7 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.958 173.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -51.04 -64.91 0.66 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -175.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 31.2 m -97.07 9.55 41.77 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.083 0.468 . . . . 0.0 110.862 -166.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 80.23 131.67 0.99 Allowed Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.333 -174.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' CYS . . . . . 0.536 ' O ' HD23 ' A' ' 155' ' ' LEU . 85.7 m -72.21 159.43 34.11 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.323 -0.939 . . . . 0.0 108.881 172.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.651 HD12 ' O ' ' A' ' 176' ' ' GLN . 76.6 mt -141.79 164.35 30.43 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.719 0.295 . . . . 0.0 110.517 -167.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.451 ' HB2' ' CZ ' ' A' ' 172' ' ' PHE . 10.5 t30 52.0 24.43 2.63 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.413 1.07 . . . . 0.0 111.364 -166.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.05 38.41 95.96 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.39 -173.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.14 -151.6 0.45 Allowed Glycine 0 CA--C 1.524 0.596 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.42 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -151.51 119.29 6.14 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 122.0 -0.706 . . . . 0.0 111.894 -175.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.27 125.76 22.06 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 176.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 165' ' ' ARG . 20.0 m -118.06 -39.36 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 120.615 0.245 . . . . 0.0 110.966 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.627 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -140.63 171.19 8.05 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.669 ' HD3' ' CE2' ' A' ' 140' ' ' TYR . 87.3 Cg_exo -52.02 110.69 0.47 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 121.872 1.714 . . . . 0.0 111.988 175.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.9 t30 77.11 -14.35 0.85 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.97 0.908 . . . . 0.0 110.793 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.627 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 1.7 mtm-85 -86.65 88.51 7.68 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 121.19 0.519 . . . . 0.0 110.151 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 73.8 m -82.31 145.98 29.67 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.965 166.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -89.75 119.32 30.05 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 175.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 73.6 m -98.12 130.1 44.91 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.97 0.794 . . . . 0.0 111.249 -171.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 16.4 m -53.8 -56.86 13.73 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -167.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.441 ' HD2' ' N ' ' A' ' 171' ' ' GLY . 21.2 t80 -158.19 -86.51 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.131 -1.027 . . . . 0.0 112.332 -169.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.441 ' N ' ' HD2' ' A' ' 170' ' ' TYR . . . -90.76 44.64 2.88 Favored Glycine 0 CA--C 1.498 -1.028 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.378 -166.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.608 ' HB3' ' HA ' ' A' ' 177' ' ' CYS . 3.1 m-85 -118.69 129.49 55.31 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.401 173.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.719 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 7.4 t -103.4 141.44 35.95 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 94.59 124.65 4.16 Favored Glycine 0 C--N 1.298 -1.542 0 N-CA-C 107.916 -2.074 . . . . 0.0 107.916 -168.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -72.21 19.55 0.3 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.934 1.756 . . . . 0.0 113.175 -166.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.651 ' O ' HD12 ' A' ' 155' ' ' LEU . 45.2 tt0 -122.58 15.21 10.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 176.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.608 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.6 OUTLIER 28.68 56.37 0.11 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 117.314 2.339 . . . . 0.0 117.314 177.549 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -111.46 22.05 15.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 122.34 1.066 . . . . 0.0 108.873 167.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.588 ' HD2' ' O ' ' A' ' 173' ' ' THR . 92.3 mtt180 -116.07 86.88 2.56 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.222 -1.353 . . . . 0.0 109.007 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.483 ' HA ' ' CE2' ' A' ' 172' ' ' PHE . 12.0 p-10 -85.63 48.63 1.62 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.547 -168.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.719 ' HE2' ' N ' ' A' ' 173' ' ' THR . 25.0 p90 -85.6 95.67 9.41 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -78.28 162.63 26.38 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 118.781 -2.449 . . . . 0.0 108.681 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 75.3 p -96.26 138.64 33.56 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.227 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -159.19 162.12 32.51 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.095 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -83.13 143.86 11.58 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.842 2.361 . . . . 0.0 111.889 173.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 4.9 t -96.71 115.82 28.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.959 0.409 . . . . 0.0 110.252 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' PHE . . . . . 0.425 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 19.5 m-85 -95.73 149.09 21.87 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.982 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.496 ' HA ' ' CB ' ' A' ' 215' ' ' ARG . 6.6 m -117.13 -15.08 10.53 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -167.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 26.2 t -145.66 114.35 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 O-C-N 121.176 -0.953 . . . . 0.0 110.709 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.594 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.5 mt -134.87 118.95 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -173.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.3 m -115.56 -166.84 1.17 Allowed 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 155.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -68.49 -5.06 17.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.761 0.791 . . . . 0.0 109.991 172.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -73.3 -74.01 0.19 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.353 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 62.3 mtt -149.67 160.68 43.32 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.594 ' HA ' HG12 ' A' ' 190' ' ' ILE . 55.5 m -89.52 -19.48 24.98 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.652 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.581 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 36.6 tt0 166.06 -85.9 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.204 171.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.436 ' H ' ' HB3' ' A' ' 196' ' ' GLN . . . 126.43 -27.24 5.04 Favored Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 171.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -82.25 69.16 8.93 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 167.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.424 ' H ' ' CD1' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -63.73 142.44 58.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.36 0.6 . . . . 0.0 111.023 -175.606 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 29.7 t -113.84 143.52 44.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.471 -175.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.95 22.28 8.38 Favored Glycine 0 CA--C 1.501 -0.783 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.179 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.758 HD12 ' HA ' ' A' ' 253' ' ' ILE . 1.5 tt -60.09 99.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 171.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 25.2 t -86.91 95.11 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.533 0 CA-C-O 123.918 1.818 . . . . 0.0 108.36 171.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.461 ' HB3' HD23 ' A' ' 208' ' ' LEU . 4.9 m -133.45 -179.03 5.26 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 111.123 -2.762 . . . . 0.0 106.072 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 27.5 p -103.29 166.74 10.25 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.131 -1.028 . . . . 0.0 112.323 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.655 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 21.9 tttp -61.13 -41.79 97.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.345 173.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 30.3 m -45.05 -52.04 9.4 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 114.515 -1.22 . . . . 0.0 109.409 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.633 HD11 HG11 ' A' ' 247' ' ' VAL . 8.6 tp -63.09 -49.27 75.15 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 112.53 -2.123 . . . . 0.0 110.606 -174.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' CYS . . . . . 0.442 ' CB ' ' HB2' ' A' ' 217' ' ' TRP . 88.0 m -68.51 -22.4 64.53 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.543 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 20.9 m -81.18 -45.2 16.72 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 123.681 0.613 . . . . 0.0 110.672 173.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.17 -52.35 35.55 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -172.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.619 HG22 ' HA2' ' A' ' 234' ' ' GLY . 17.7 p -105.56 152.78 22.65 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.198 177.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 1.4 t 67.55 -45.05 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 123.584 0.754 . . . . 0.0 112.218 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.671 ' O ' ' HD2' ' A' ' 215' ' ' ARG . . . 55.35 59.43 10.48 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 118.559 0.618 . . . . 0.0 114.499 173.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.671 ' HD2' ' O ' ' A' ' 214' ' ' GLY . 17.4 mmm180 -125.64 -75.98 0.59 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.226 0.513 . . . . 0.0 111.048 177.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.514 ' CB ' HD11 ' A' ' 190' ' ' ILE . . . -171.1 163.39 7.29 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 118.642 0.656 . . . . 0.0 109.88 174.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' TRP . . . . . 0.684 ' O ' ' HB2' ' A' ' 222' ' ' GLU . 19.1 t90 -158.81 142.77 15.37 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 106.15 179.03 23.41 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.144 -1.027 . . . . 0.0 113.954 170.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 220' ' ' PRO . 36.2 t-80 -135.52 133.44 20.33 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -177.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 219' ' ' HIS . 11.1 Cg_endo -89.6 118.36 3.64 Favored 'Cis proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.496 -1.46 . . . . 0.0 111.733 -4.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 68.7 m 45.17 88.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.684 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 12.3 mt-10 -107.27 107.23 18.06 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' MET . . . . . 0.46 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 0.6 OUTLIER -75.21 144.06 42.85 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.746 -166.516 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 224' ' ' CYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 216' ' ' ALA . 0.8 OUTLIER -123.53 120.95 26.85 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -174.144 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -62.14 167.04 11.47 Favored 'Trans proline' 0 CA--C 1.499 -1.239 0 C-N-CA 122.089 1.859 . . . . 0.0 110.563 159.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.35 -142.24 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 122.289 1.042 . . . . 0.0 110.397 163.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.37 106.37 0.65 Allowed Pre-proline 0 C--N 1.298 -1.668 0 CA-C-N 113.82 -1.536 . . . . 0.0 112.168 -169.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.1 -57.57 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.234 2.623 . . . . 0.0 112.87 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.403 ' HB3' ' HD2' ' A' ' 230' ' ' PRO . 48.0 m80 -95.99 162.8 22.73 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 229' ' ' HIS . 26.4 Cg_endo -64.31 83.27 0.15 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.135 1.89 . . . . 0.0 112.271 174.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' CYS . . . . . 0.429 ' SG ' ' HB2' ' A' ' 235' ' ' PHE . 34.1 t -157.91 152.67 25.12 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.196 -1.365 . . . . 0.0 107.504 177.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.583 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 24.0 mtt180 -64.04 131.68 48.29 Favored 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.101 -176.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -38.56 -45.95 1.13 Allowed 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -175.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.619 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -72.99 7.22 10.05 Favored Glycine 0 C--N 1.319 -0.385 0 C-N-CA 120.718 -0.753 . . . . 0.0 114.256 -173.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' PHE . . . . . 0.583 ' CD1' ' HB2' ' A' ' 232' ' ' ARG . 3.5 m-85 -122.28 150.66 42.02 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.942 0.877 . . . . 0.0 112.61 -171.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.464 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.1 OUTLIER -124.62 121.34 25.78 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 114.309 -1.314 . . . . 0.0 107.819 169.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.49 115.27 2.33 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.093 2.529 . . . . 0.0 112.26 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -50.62 137.9 18.89 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.853 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 41.8 mt -71.17 -16.34 19.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.207 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 -100.9 -62.46 1.24 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.617 0.722 . . . . 0.0 109.973 -174.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 32.2 p -80.18 -40.1 27.95 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.382 -176.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 98.05 8.26 55.52 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -90.81 127.03 36.2 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 121.852 0.834 . . . . 0.0 110.615 -177.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 235' ' ' PHE . 95.8 m -50.49 121.0 5.12 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 113.227 -1.806 . . . . 0.0 110.85 172.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -120.36 133.32 55.46 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ASP . . . . . 0.582 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 7.2 t70 -77.18 149.68 35.54 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -173.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.701 HG23 ' HG3' ' A' ' 249' ' ' GLU . 11.0 m -100.15 145.26 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -177.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -72.54 75.89 1.07 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 167.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.701 ' HG3' HG23 ' A' ' 247' ' ' VAL . 17.1 mp0 -53.24 -37.59 62.21 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.271 0.628 . . . . 0.0 110.654 -169.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 56.4 m -51.13 -35.83 37.56 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.096 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -100.43 -37.63 8.76 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.865 0.84 . . . . 0.0 110.246 -176.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.432 ' HB1' HD21 ' A' ' 208' ' ' LEU . . . -71.13 -17.72 62.55 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.374 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.8 HG22 ' HB3' ' A' ' 256' ' ' LEU . 5.3 mp -135.31 73.24 64.25 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 173.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.592 ' HD2' HG13 ' A' ' 202' ' ' ILE . 36.0 Cg_endo -62.65 124.28 13.85 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.509 2.139 . . . . 0.0 112.902 -170.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' A' ' 258' ' ' GLN . . . 95.18 -4.95 67.9 Favored Glycine 0 C--N 1.308 -0.995 0 CA-C-N 114.429 -1.259 . . . . 0.0 113.437 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.8 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.5 OUTLIER -68.03 -39.73 83.04 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 118.392 1.096 . . . . 0.0 110.0 -176.948 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 46.6 t -122.95 69.47 0.99 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.493 0.663 . . . . 0.0 109.281 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' GLN . . . . . 0.41 ' HB2' ' HA2' ' A' ' 255' ' ' GLY . 27.4 tp60 -107.46 16.04 24.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.964 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -87.55 -4.73 79.69 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.796 178.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -169.08 -137.61 2.29 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' ASN . . . . . 0.538 ' OD1' ' HE2' ' A' ' 272' ' ' LYS . 2.9 t-20 -88.66 156.82 18.8 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 9.1 t -145.79 125.12 13.04 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.427 ' HB ' ' HB2' ' A' ' 270' ' ' GLU . 7.6 mt -130.05 165.74 29.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 -174.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.425 ' OD1' ' HB3' ' A' ' 269' ' ' PHE . 1.0 OUTLIER -132.2 121.49 23.76 Favored 'General case' 0 CA--C 1.494 -1.177 0 C-N-CA 117.461 -1.695 . . . . 0.0 114.627 -177.051 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.1 t -105.83 159.83 15.71 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.777 167.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.558 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 35.7 m -72.28 121.4 22.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.451 ' HA2' ' HE1' ' A' ' 235' ' ' PHE . . . 114.42 -30.77 6.78 Favored Glycine 0 C--N 1.316 -0.547 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.423 -169.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.0 m -179.22 163.97 1.34 Allowed 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 118.383 1.091 . . . . 0.0 110.164 -169.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' PHE . . . . . 0.425 ' HB3' ' OD1' ' A' ' 264' ' ' ASN . 34.9 p90 -104.7 153.24 21.52 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.803 174.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' GLU . . . . . 0.427 ' HB2' ' HB ' ' A' ' 263' ' ' ILE . 13.9 mt-10 -108.27 118.2 36.13 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.454 -175.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 99.5 m -105.71 160.52 15.15 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.415 0.626 . . . . 0.0 110.372 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.538 ' HE2' ' OD1' ' A' ' 261' ' ' ASN . 46.2 mtmt -138.69 123.27 18.52 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.194 176.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 68.0 m -99.45 137.28 20.28 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.091 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.459 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 86.3 Cg_exo -48.94 152.71 4.41 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.913 2.409 . . . . 0.0 111.055 170.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -48.96 134.27 17.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.054 0.454 . . . . 0.0 111.811 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 88.63 -36.21 3.48 Favored Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.53 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' HIS . . . . . 0.546 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 24.4 m-70 -71.1 156.99 38.95 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.565 0.698 . . . . 0.0 111.329 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -140.94 129.26 22.37 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.924 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 42.4 tp -62.18 125.24 23.21 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.423 0.63 . . . . 0.0 111.016 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.593 ' OD1' ' HB ' ' A' ' 282' ' ' VAL . 22.0 t-20 -111.52 97.16 6.54 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -64.6 -15.73 61.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.455 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.593 ' HB ' ' OD1' ' A' ' 280' ' ' ASN . 48.1 t -57.58 -29.39 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 120.83 0.348 . . . . 0.0 110.416 173.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.604 ' O ' ' HG3' ' A' ' 285' ' ' LYS . 19.5 p -142.47 25.75 1.83 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.543 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' GLN . . . . . 0.586 ' HB2' ' O ' ' A' ' 256' ' ' LEU . 79.0 mm-40 28.57 41.93 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -167.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 285' ' ' LYS . . . . . 0.604 ' HG3' ' O ' ' A' ' 283' ' ' SER . 90.7 mttt -115.65 135.72 53.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.306 0.575 . . . . 0.0 111.836 -173.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 94.1 m -87.61 112.45 22.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.825 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 10.8 tp10 . . . . . 0 N--CA 1.433 -1.289 0 CA-C-O 118.12 -0.943 . . . . 0.0 108.499 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.667 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 91.3 m-85 . . . . . 0 C--O 1.234 0.242 0 CA-C-O 121.14 0.495 . . . . 0.0 111.764 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.416 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 34.7 pt -132.71 -174.43 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.41 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.67 -170.81 34.04 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.904 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.1 p -77.83 -44.11 28.37 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.918 0.389 . . . . 0.0 111.7 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -111.35 21.12 16.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.084 -176.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 27.2 m 66.51 27.24 9.77 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 124.009 0.818 . . . . 0.0 110.551 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.2 -4.13 88.4 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.859 -172.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.416 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 2.6 tm0? -117.57 110.11 41.03 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 118.292 1.046 . . . . 0.0 110.976 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.437 ' HB3' ' CE1' ' A' ' 140' ' ' TYR . 94.2 Cg_endo -80.78 149.89 18.37 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.978 2.452 . . . . 0.0 112.385 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 149' ' ' VAL . 14.3 p -83.12 103.74 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-O 121.702 0.763 . . . . 0.0 111.089 -172.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.22 88.13 5.5 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.636 171.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -57.94 -53.85 53.62 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -169.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 34.7 m -95.82 16.87 16.41 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.199 0.524 . . . . 0.0 111.112 -169.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 77.26 129.5 0.41 Allowed Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.3 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' CYS . . . . . 0.405 ' O ' HD23 ' A' ' 155' ' ' LEU . 35.5 m -76.1 150.85 37.18 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.421 -1.389 . . . . 0.0 110.129 172.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.672 HD12 ' O ' ' A' ' 176' ' ' GLN . 76.7 mt -147.72 167.34 24.89 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.019 -168.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.676 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 2.3 t-20 48.87 27.02 1.46 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.03 -164.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 66.39 37.22 92.57 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.756 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -68.66 -150.87 0.33 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.64 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -157.35 126.76 6.0 Favored 'General case' 0 C--N 1.318 -0.761 0 O-C-N 122.191 -0.594 . . . . 0.0 111.214 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -67.28 120.19 13.4 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 175.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.819 HG22 ' HG2' ' A' ' 165' ' ' ARG . 1.0 OUTLIER -109.16 -43.77 6.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.211 179.232 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.639 ' HB3' ' HB3' ' A' ' 165' ' ' ARG . . . -134.28 170.77 10.42 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 173.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.667 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 75.7 Cg_exo -54.34 111.36 0.69 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.282 1.988 . . . . 0.0 112.681 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 69.91 -1.82 2.23 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.928 0.891 . . . . 0.0 110.736 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.819 ' HG2' HG22 ' A' ' 161' ' ' VAL . 5.7 ttp180 -93.45 89.24 6.23 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 121.5 0.667 . . . . 0.0 109.216 169.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 49.3 t -92.41 139.83 30.2 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.375 171.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -90.52 106.91 18.82 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 80.3 m -84.68 134.79 34.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.617 -171.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.406 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 28.6 m -55.21 -55.53 30.23 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -168.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -175.7 117.89 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.016 0.436 . . . . 0.0 111.328 -178.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 76.94 42.41 20.24 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.433 -0.803 . . . . 0.0 114.28 165.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.676 ' CE2' ' HB2' ' A' ' 156' ' ' ASN . 62.3 m-85 -120.93 140.31 52.02 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 117.59 0.695 . . . . 0.0 112.146 163.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.822 HG23 ' CE2' ' A' ' 181' ' ' TYR . 39.6 p -87.1 119.24 27.12 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.724 0.774 . . . . 0.0 110.617 -177.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' A' ' 176' ' ' GLN . . . 101.84 144.69 15.2 Favored Glycine 0 N--CA 1.425 -2.048 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.18 20.62 0.4 Allowed 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.162 1.241 . . . . 0.0 112.306 -172.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.672 ' O ' HD12 ' A' ' 155' ' ' LEU . 35.7 tt0 -113.73 1.04 14.73 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.789 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.672 ' HA ' ' CB ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 36.32 62.3 0.72 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 118.018 2.599 . . . . 0.0 118.018 178.044 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -120.63 1.04 10.55 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 119.869 -0.732 . . . . 0.0 111.835 174.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 32.7 mmt180 -106.62 100.35 9.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.335 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.665 ' HA ' ' CE1' ' A' ' 172' ' ' PHE . 1.3 m-20 -74.63 100.63 4.0 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.291 -170.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.822 ' CE2' HG23 ' A' ' 173' ' ' THR . 19.7 p90 -140.05 77.97 1.64 Allowed 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 172.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 63.5 mtt85 -73.3 127.43 32.63 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 118.597 -2.564 . . . . 0.0 108.503 175.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.401 HG22 ' CG1' ' A' ' 203' ' ' VAL . 3.9 p -78.13 164.52 24.91 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.978 -176.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.629 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . 157.29 142.31 3.37 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.651 -162.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.53 132.47 6.8 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.821 2.347 . . . . 0.0 112.096 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' CYS . . . . . 0.767 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 76.8 m -90.86 112.05 23.72 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.408 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' PHE . . . . . 0.47 ' HB3' ' O ' ' A' ' 195' ' ' CYS . 82.3 m-85 -89.0 154.81 19.91 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.17 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.451 ' OG1' ' HG3' ' A' ' 196' ' ' GLN . 35.1 p -105.27 -18.86 13.99 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -165.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 p -167.95 118.28 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-N 118.889 0.768 . . . . 0.0 110.474 -174.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.501 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.1 mt -130.35 123.11 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -169.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.402 ' C ' ' H ' ' A' ' 193' ' ' GLN . 15.1 m -126.44 -166.48 1.58 Allowed 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 162.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -61.08 -8.2 3.19 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.321 0.964 . . . . 0.0 110.251 174.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.402 ' H ' ' C ' ' A' ' 191' ' ' SER . 96.3 mt-30 -75.66 -76.05 0.16 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.114 -175.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.429 ' O ' ' HA ' ' A' ' 190' ' ' ILE . 70.7 mtm -144.42 168.58 19.76 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.501 ' HA ' HG12 ' A' ' 190' ' ' ILE . 67.6 m -86.67 -36.54 18.68 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 122.335 1.064 . . . . 0.0 109.292 175.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.451 ' HG3' ' OG1' ' A' ' 188' ' ' THR . 54.8 tt0 -148.14 -67.44 0.24 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.731 173.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 123.69 -0.26 9.28 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.508 171.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -119.0 -19.8 8.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.343 -0.428 . . . . 0.0 111.076 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 63.24 97.11 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.222 0.534 . . . . 0.0 111.077 -176.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 42.4 t -113.68 140.18 48.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.709 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -94.08 25.68 20.79 Favored Glycine 0 CA--C 1.505 -0.533 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.986 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.628 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -61.72 107.0 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 121.989 0.9 . . . . 0.0 109.388 174.62 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.401 ' CG1' HG22 ' A' ' 183' ' ' THR . 3.0 t -98.27 120.98 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 CA-C-O 122.734 1.254 . . . . 0.0 110.193 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 14.3 t -152.91 -178.76 7.11 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 103.137 -2.912 . . . . 0.0 103.137 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.707 HG21 ' HA ' ' A' ' 181' ' ' TYR . 8.0 p -102.38 161.44 13.7 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 121.197 1.817 . . . . 0.0 108.763 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.632 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 53.6 tttm -57.24 -43.22 82.73 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.997 177.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.5 m -47.9 -54.96 11.0 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.925 175.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.549 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -58.37 -55.07 39.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.716 179.574 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 65.8 m -74.45 -20.95 59.83 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -170.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 226' ' ' ALA . 80.0 m -90.22 -38.81 13.19 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 121.878 -0.514 . . . . 0.0 110.595 176.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ALA . . . . . 0.533 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . . . -67.74 -57.73 5.84 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.716 HG22 ' HA2' ' A' ' 234' ' ' GLY . 3.4 p -92.53 160.81 14.87 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.385 -1.279 . . . . 0.0 107.765 175.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 27.3 m 58.01 -35.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 125.196 1.398 . . . . 0.0 114.668 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 58.11 60.45 8.93 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 119.548 1.067 . . . . 0.0 114.8 167.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.401 ' HE ' ' HA ' ' A' ' 188' ' ' THR . 0.0 OUTLIER -118.85 -95.02 0.49 Allowed 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.356 175.476 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.405 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -164.02 163.17 23.41 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 174.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' TRP . . . . . 0.767 ' HD1' ' SG ' ' A' ' 186' ' ' CYS . 17.7 t90 -151.45 146.33 25.85 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 121.56 -0.712 . . . . 0.0 109.794 -174.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 221' ' ' CYS . . . 86.75 -179.93 48.97 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.167 -0.539 . . . . 0.0 113.774 171.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.646 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 8.9 p80 -141.28 131.1 12.89 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 175.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.646 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 10.5 Cg_endo -53.63 149.51 16.15 Favored 'Cis proline' 0 C--N 1.352 0.763 0 C-N-CA 123.772 -1.345 . . . . 0.0 111.856 -5.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 22.2 m -63.43 83.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.775 0.672 . . . . 0.0 112.52 -170.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -58.55 123.0 14.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.63 0.252 . . . . 0.0 110.619 173.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' MET . . . . . 0.405 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 0.0 OUTLIER -107.36 147.32 30.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.259 -175.722 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 18.8 m -142.0 148.51 49.02 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -173.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -65.2 166.1 20.04 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.059 1.839 . . . . 0.0 109.151 156.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 210' ' ' CYS . . . -67.27 -107.32 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.314 0.578 . . . . 0.0 111.564 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' GLN . . . . . 0.482 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . 0.0 OUTLIER -58.07 113.05 5.69 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.325 -172.772 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.533 ' HD3' ' HA ' ' A' ' 211' ' ' ALA . 18.8 Cg_endo -89.9 -61.75 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.111 2.54 . . . . 0.0 112.526 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.5 ' HB3' ' HD2' ' A' ' 230' ' ' PRO . 78.6 m-70 -78.73 163.36 61.3 Favored Pre-proline 0 CA--C 1.514 -0.44 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 229' ' ' HIS . 59.1 Cg_endo -72.79 52.69 2.18 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.753 1.636 . . . . 0.0 112.865 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 50.9 m -123.67 -178.0 3.9 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 171.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.636 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 26.0 mmt180 -76.72 142.18 40.58 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.169 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.451 ' CA ' ' HB3' ' A' ' 227' ' ' GLN . 32.5 ptt-85 -38.5 -40.37 0.56 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.716 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -75.15 5.56 33.29 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.626 -176.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' PHE . . . . . 0.636 ' CD1' ' HB2' ' A' ' 232' ' ' ARG . 2.0 m-85 -120.88 154.85 35.29 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.971 0.891 . . . . 0.0 112.493 -171.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.454 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.1 OUTLIER -128.39 130.5 23.54 Favored Pre-proline 0 N--CA 1.441 -0.877 0 CA-C-N 113.982 -1.463 . . . . 0.0 108.152 170.39 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -61.15 112.86 1.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.001 1.8 . . . . 0.0 111.126 175.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -48.02 135.06 13.17 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.719 0.771 . . . . 0.0 110.678 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 23.6 mt -71.21 -12.52 16.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.496 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -107.96 -59.45 1.84 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.395 0.617 . . . . 0.0 110.677 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 33.7 p -81.68 -39.81 23.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.187 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 100.32 4.18 55.18 Favored Glycine 0 N--CA 1.435 -1.367 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -84.5 126.96 33.76 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 121.853 0.835 . . . . 0.0 110.634 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 7.4 m -55.61 120.16 6.81 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.716 172.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -126.85 132.89 50.85 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 7.3 t70 -77.8 147.42 35.25 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 121.447 0.641 . . . . 0.0 109.632 -175.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.756 HG23 ' HG3' ' A' ' 249' ' ' GLU . 10.4 m -97.83 145.09 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.281 -177.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -74.28 76.86 1.84 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 168.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.756 ' HG3' HG23 ' A' ' 247' ' ' VAL . 28.2 mp0 -52.11 -37.8 55.3 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 124.021 0.826 . . . . 0.0 109.946 -171.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 42.6 m -47.7 -36.4 11.2 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.824 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -102.4 -42.88 5.84 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.685 0.755 . . . . 0.0 110.319 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -63.84 -23.07 67.21 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.8 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.71 ' O ' ' HB2' ' A' ' 256' ' ' LEU . 3.9 mp -124.05 88.2 52.74 Favored Pre-proline 0 N--CA 1.45 -0.434 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 174.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.415 ' O ' HG12 ' A' ' 202' ' ' ILE . 8.3 Cg_exo -73.1 142.46 34.35 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 121.301 1.334 . . . . 0.0 112.35 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 77.43 5.7 85.96 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.506 -170.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.71 ' HB2' ' O ' ' A' ' 253' ' ' ILE . 10.4 tp -53.24 -92.31 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 122.827 0.451 . . . . 0.0 111.285 175.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 22.9 t -96.08 61.52 2.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.502 0.668 . . . . 0.0 109.51 -175.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -86.6 51.9 2.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.628 0.728 . . . . 0.0 109.643 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.535 ' O ' ' HD3' ' A' ' 274' ' ' PRO . . . -137.6 28.35 2.76 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 272' ' ' LYS . . . 148.43 -133.24 4.5 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -177.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' ASN . . . . . 0.514 ' HB2' ' HB2' ' A' ' 272' ' ' LYS . 4.9 m-20 -103.28 158.02 16.61 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 177.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 42.7 t -142.76 124.44 14.98 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 50.6 mt -130.21 116.33 36.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.918 -167.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -76.23 120.4 21.45 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.85 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.7 t -107.21 158.77 16.85 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 158.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.504 ' HB ' ' CZ ' ' A' ' 235' ' ' PHE . 31.3 m -75.11 123.15 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 C-N-CA 118.612 -1.235 . . . . 0.0 108.498 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.615 ' N ' ' HE1' ' A' ' 235' ' ' PHE . . . 113.04 -24.22 13.07 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.669 -171.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.7 t 174.01 162.08 0.18 Allowed 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 117.471 0.636 . . . . 0.0 109.852 -172.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' PHE . . . . . 0.419 ' CE1' HD21 ' A' ' 256' ' ' LEU . 45.5 p90 -102.8 158.45 16.25 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 121.002 -1.061 . . . . 0.0 109.178 174.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -115.51 127.96 55.65 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' CYS . . . . . 0.417 ' HB2' HD22 ' A' ' 279' ' ' LEU . 56.7 m -100.43 152.01 20.86 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.529 0.68 . . . . 0.0 111.751 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.514 ' HB2' ' HB2' ' A' ' 261' ' ' ASN . 13.0 mmmm -121.59 100.42 7.0 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.08 171.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 286' ' ' CYS . 18.2 m -88.8 156.99 49.59 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.395 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.55 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 43.6 Cg_exo -58.07 156.03 31.2 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 121.831 1.687 . . . . 0.0 110.359 171.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -56.55 144.53 31.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.655 0.264 . . . . 0.0 110.842 -177.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.13 -32.69 3.48 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.237 -0.983 . . . . 0.0 111.968 -176.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' HIS . . . . . 0.55 ' HB2' ' O ' ' A' ' 274' ' ' PRO . 14.6 m-70 -72.42 154.69 40.75 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.06 0.457 . . . . 0.0 111.283 -175.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -137.68 121.27 17.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.862 -174.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.417 HD22 ' HB2' ' A' ' 271' ' ' CYS . 35.2 tp -69.52 136.95 52.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.114 0.483 . . . . 0.0 111.672 -175.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -124.11 100.51 6.75 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 171.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -65.16 -14.19 59.98 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.951 0.782 . . . . 0.0 112.533 -172.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 73.5 t -58.43 -36.93 61.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.629 0.728 . . . . 0.0 109.874 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 31.3 m -134.08 30.49 3.63 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.398 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 23.51 50.52 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 114.135 -1.393 . . . . 0.0 113.164 -172.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -102.36 130.79 49.2 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.439 -174.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 273' ' ' CYS . 33.3 m -94.87 97.8 10.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.652 173.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.435 ' HA ' ' ND1' ' A' ' 277' ' ' HIS . 38.5 tt0 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.668 -0.682 . . . . 0.0 109.305 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.534 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 90.6 m-85 . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.431 HG13 ' HB3' ' A' ' 147' ' ' GLN . 33.3 pt -141.41 -171.21 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 123.531 0.519 . . . . 0.0 110.376 -173.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 86.97 -174.08 45.51 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.254 -0.884 . . . . 0.0 112.369 -174.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.5 p -75.82 -34.36 60.13 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -110.78 12.44 22.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.034 -176.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 33.6 m 62.66 29.46 16.86 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 123.668 0.605 . . . . 0.0 110.258 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.17 -17.92 60.13 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.618 -172.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.431 ' HB3' HG13 ' A' ' 141' ' ' ILE . 4.9 tm0? -99.69 120.91 56.23 Favored Pre-proline 0 C--N 1.326 -0.428 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.315 -174.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 147' ' ' GLN . 78.7 Cg_endo -88.7 140.63 4.31 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.933 2.422 . . . . 0.0 112.605 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 149' ' ' VAL . 10.1 p -66.52 105.29 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 122.25 1.024 . . . . 0.0 111.731 -173.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 76.84 6.8 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.989 175.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -52.41 -65.82 0.49 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -176.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 37.7 m -85.6 23.37 1.39 Allowed 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 120.728 0.299 . . . . 0.0 111.63 -171.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 106.43 -101.6 1.79 Allowed Glycine 0 N--CA 1.436 -1.301 0 CA-C-O 122.21 0.895 . . . . 0.0 113.049 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 148.43 131.43 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 111.368 -2.416 . . . . 0.0 105.004 -175.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 176' ' ' GLN . 21.4 mt -117.49 171.58 7.9 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -168.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.663 ' HB3' ' CZ ' ' A' ' 172' ' ' PHE . 25.3 p30 42.43 30.11 0.19 Allowed 'General case' 0 N--CA 1.478 0.944 0 O-C-N 124.426 1.079 . . . . 0.0 113.157 -172.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.8 39.37 91.35 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 119.951 -1.118 . . . . 0.0 111.955 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -74.63 -144.54 0.98 Allowed Glycine 0 CA--C 1.511 -0.21 0 CA-C-N 115.426 -0.387 . . . . 0.0 113.685 -173.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.558 ' HG2' ' HB3' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -154.28 130.52 10.41 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.8 m -67.41 115.57 7.18 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 122.312 -0.242 . . . . 0.0 110.891 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 165' ' ' ARG . 3.7 m -101.43 -37.02 5.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.974 176.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.635 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -139.78 172.67 6.03 Favored Pre-proline 0 C--O 1.233 0.235 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.534 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 76.4 Cg_exo -54.09 107.1 0.19 Allowed 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.421 2.081 . . . . 0.0 112.869 176.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 70.52 8.68 6.69 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.044 0.938 . . . . 0.0 110.238 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.635 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 1.4 mmt180 -103.06 81.66 1.99 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.822 176.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 12.6 t -81.34 146.17 30.49 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 173.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.558 ' HB3' ' HG2' ' A' ' 159' ' ' ARG . . . -98.68 147.86 24.42 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.472 ' HA ' HD22 ' A' ' 156' ' ' ASN . 14.4 m -111.41 124.66 52.71 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 124.775 1.297 . . . . 0.0 112.66 -160.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 64.5 m -51.99 -54.46 29.57 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -176.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -154.84 -86.37 0.05 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 118.516 -1.274 . . . . 0.0 113.746 -165.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -92.11 39.6 3.0 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 119.651 -1.262 . . . . 0.0 112.826 -167.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.663 ' CZ ' ' HB3' ' A' ' 156' ' ' ASN . 9.1 m-85 -120.7 126.23 49.67 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 119.522 -0.871 . . . . 0.0 113.036 176.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.62 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 4.7 t -93.37 164.81 13.07 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 164.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.28 132.63 5.51 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.54 2.9 4.69 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 121.198 1.265 . . . . 0.0 112.962 -167.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.468 ' O ' HD12 ' A' ' 155' ' ' LEU . 47.9 tt0 -118.68 4.34 11.63 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.325 0.584 . . . . 0.0 110.661 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 39.32 50.6 2.0 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -177.284 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -106.03 -12.37 15.81 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.476 0.655 . . . . 0.0 110.321 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -60.85 -67.41 0.4 Allowed 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.802 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.8 t70 79.59 81.96 0.06 Allowed 'General case' 0 CA--C 1.509 -0.603 0 O-C-N 123.775 0.672 . . . . 0.0 109.445 163.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.62 ' HE2' ' N ' ' A' ' 173' ' ' THR . 37.0 p90 -102.42 66.06 0.96 Allowed 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 172.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -46.97 119.52 2.58 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 113.479 -1.691 . . . . 0.0 109.869 172.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.487 ' HB ' HG22 ' A' ' 203' ' ' VAL . 64.6 p -84.39 136.91 33.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.809 -172.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.495 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -158.27 145.79 12.27 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.86 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.41 ' HB3' ' O ' ' A' ' 200' ' ' SER . 39.5 Cg_exo -59.92 139.87 90.17 Favored 'Trans proline' 0 CA--C 1.529 0.232 0 C-N-CA 122.268 1.979 . . . . 0.0 111.47 171.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 5.8 t -96.44 133.94 40.23 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.123 -174.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' PHE . . . . . 0.574 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 24.4 m-85 -110.32 130.81 55.48 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.481 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.567 ' O ' ' HG2' ' A' ' 215' ' ' ARG . 48.9 p -112.52 -4.34 14.2 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -168.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 p -168.58 116.85 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 118.991 0.814 . . . . 0.0 111.504 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.696 HD11 ' CB ' ' A' ' 216' ' ' ALA . 3.7 mt -117.07 119.32 61.61 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -169.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 45.7 t -104.54 156.45 17.95 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 145.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -50.43 -31.26 14.58 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 119.988 1.267 . . . . 0.0 109.702 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -56.17 -59.22 5.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 113.526 -1.67 . . . . 0.0 111.591 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 5.7 mmt -136.87 126.12 24.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.559 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.554 ' HA ' HG12 ' A' ' 190' ' ' ILE . 79.9 m -76.79 -19.24 57.81 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.87 0.843 . . . . 0.0 110.716 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -146.97 -68.6 0.25 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 171.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 125.06 -18.42 7.0 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -96.72 -41.87 8.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.705 -0.747 . . . . 0.0 110.068 177.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 67.62 84.85 0.15 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.477 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 185' ' ' PRO . 48.0 t -99.44 148.15 24.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.109 -177.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -92.59 22.29 34.05 Favored Glycine 0 CA--C 1.504 -0.626 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.771 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.594 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -60.61 110.99 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 167.727 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.487 HG22 ' HB ' ' A' ' 183' ' ' THR . 0.4 OUTLIER -107.02 97.22 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-O 124.081 1.896 . . . . 0.0 109.482 -173.344 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 13.7 t -119.38 -175.69 2.99 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 112.232 -2.258 . . . . 0.0 106.986 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 7.6 p -100.97 164.04 12.0 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 119.281 -0.968 . . . . 0.0 108.872 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.469 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 45.3 tttm -61.94 -45.95 91.47 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.994 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.9 m -45.24 -55.05 6.24 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.537 173.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.485 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -58.51 -54.5 46.28 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.988 179.262 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 19.1 m -68.95 -22.08 64.15 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 84.6 m -94.42 -33.83 12.98 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.1 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -73.69 -58.49 3.27 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.659 HG22 ' HA2' ' A' ' 234' ' ' GLY . 20.0 p -99.62 157.59 16.35 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.944 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.43 HG21 HG12 ' A' ' 253' ' ' ILE . 2.2 t 66.86 -46.69 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 122.855 0.462 . . . . 0.0 112.022 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 215' ' ' ARG . . . 80.6 178.96 52.56 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 114.68 0.632 . . . . 0.0 114.68 171.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.567 ' HG2' ' O ' ' A' ' 188' ' ' THR . 8.0 mpt_? 92.08 -73.94 0.01 OUTLIER 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.647 1.179 . . . . 0.0 112.844 170.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.696 ' CB ' HD11 ' A' ' 190' ' ' ILE . . . -172.8 165.86 5.27 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.069 1.304 . . . . 0.0 111.855 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' TRP . . . . . 0.495 ' CZ2' ' HA3' ' A' ' 184' ' ' GLY . 22.0 t90 -150.9 149.2 29.36 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.869 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 77.74 166.32 27.32 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 115.674 1.03 . . . . 0.0 115.674 167.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.492 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 77.7 m-70 -122.32 134.62 24.92 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 114.706 -0.747 . . . . 0.0 109.755 175.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 22.7 Cg_exo -65.37 155.85 77.79 Favored 'Cis proline' 0 C--N 1.347 0.46 0 C-N-CA 123.287 -1.547 . . . . 0.0 111.225 -2.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 33.7 t -52.14 115.61 1.8 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.322 -171.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -107.66 115.01 29.39 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 13.3 ttp -89.03 138.85 31.04 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.43 -172.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 84.0 m -128.08 122.8 22.34 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -54.03 166.26 1.63 Allowed 'Trans proline' 0 CA--C 1.515 -0.462 0 C-N-CA 123.609 2.873 . . . . 0.0 113.622 165.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -39.09 106.7 0.06 Allowed 'General case' 0 CA--C 1.504 -0.801 0 O-C-N 123.962 0.789 . . . . 0.0 111.214 163.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 31.4 85.75 0.14 Allowed Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 111.633 -2.531 . . . . 0.0 111.99 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -39.57 -58.61 0.81 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.874 3.049 . . . . 0.0 115.182 -170.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -78.58 156.09 78.25 Favored Pre-proline 0 CA--C 1.515 -0.385 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -68.61 91.57 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.773 1.648 . . . . 0.0 112.474 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' CYS . . . . . 0.461 ' HB2' ' HG3' ' A' ' 237' ' ' PRO . 42.7 t -163.85 179.21 7.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.787 -177.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.743 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 22.6 mmm-85 -92.75 140.22 29.74 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.433 ' O ' HG22 ' A' ' 212' ' ' THR . 22.1 ptt85 -41.31 -57.14 2.23 Favored 'General case' 0 C--O 1.218 -0.574 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -175.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.659 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -67.52 6.79 2.33 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 115.123 0.809 . . . . 0.0 115.123 -174.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' PHE . . . . . 0.743 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 2.1 m-85 -131.07 173.47 10.98 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 118.238 1.019 . . . . 0.0 111.828 -174.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.544 HD13 ' O ' ' A' ' 235' ' ' PHE . 0.2 OUTLIER -135.48 130.56 19.04 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 113.562 -1.654 . . . . 0.0 107.504 172.021 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.461 ' HG3' ' HB2' ' A' ' 231' ' ' CYS . 27.0 Cg_exo -61.01 113.82 1.9 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 121.95 1.766 . . . . 0.0 111.641 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -50.71 132.21 26.02 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.669 0.747 . . . . 0.0 110.964 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 19.6 mt -76.48 -2.01 3.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.024 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 240' ' ' ARG . 43.1 mtm180 -104.43 -57.59 2.01 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.301 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 31.5 p -95.2 -45.36 7.22 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.366 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 104.11 12.64 28.99 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -95.45 131.35 41.7 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 122.009 0.909 . . . . 0.0 110.352 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 77.8 m -49.08 112.25 0.6 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 113.261 -1.791 . . . . 0.0 110.495 167.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -116.84 134.49 54.71 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ASP . . . . . 0.624 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 10.9 t70 -75.84 145.36 40.66 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 121.635 0.731 . . . . 0.0 111.122 -170.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.716 HG23 ' HG3' ' A' ' 249' ' ' GLU . 4.5 m -98.23 145.19 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.87 177.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -75.85 78.13 2.76 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 169.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.716 ' HG3' HG23 ' A' ' 247' ' ' VAL . 22.7 mp0 -53.03 -36.06 60.14 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 123.747 0.654 . . . . 0.0 110.017 -172.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 24.6 m -48.36 -39.15 21.2 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.432 173.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -96.45 -39.73 9.43 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.83 0.824 . . . . 0.0 110.313 -177.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -73.68 -20.25 60.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.202 -1.363 . . . . 0.0 111.757 -172.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.594 HG23 HD11 ' A' ' 202' ' ' ILE . 4.1 mp -121.83 81.5 41.82 Favored Pre-proline 0 N--CA 1.446 -0.672 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 253' ' ' ILE . 50.6 Cg_exo -24.02 -49.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.889 1 C-N-CA 127.169 5.246 . . . . 0.0 117.764 -170.516 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -124.93 28.99 5.03 Favored Glycine 0 CA--C 1.502 -0.745 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.906 -165.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.439 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -93.6 143.07 26.65 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.673 -0.764 . . . . 0.0 110.385 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 7.5 t 72.29 -72.27 0.12 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -169.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 60.02 -75.01 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.056 0.942 . . . . 0.0 113.202 175.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -75.48 71.18 1.85 Allowed Glycine 0 CA--C 1.508 -0.38 0 N-CA-C 111.694 -0.562 . . . . 0.0 111.694 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 154.54 -175.86 32.53 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -106.15 113.19 26.57 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 117.476 0.638 . . . . 0.0 109.774 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 48.7 t -89.3 133.15 34.59 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 46.5 mt -132.87 106.77 10.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.335 -174.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.603 ' OD1' ' HB3' ' A' ' 269' ' ' PHE . 1.1 t30 -83.83 129.39 34.94 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -167.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.8 t -111.13 163.86 13.45 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.908 163.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.624 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 2.4 p -70.07 120.39 17.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.415 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.658 ' HA2' ' CE2' ' A' ' 235' ' ' PHE . . . 114.42 -33.38 5.43 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.61 -172.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 7.5 p -179.81 161.51 0.98 Allowed 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 117.822 0.811 . . . . 0.0 109.765 -172.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' PHE . . . . . 0.603 ' HB3' ' OD1' ' A' ' 264' ' ' ASN . 43.1 p90 -101.38 157.94 16.43 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.823 175.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -120.67 122.0 39.52 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 52.8 m -101.21 143.18 31.6 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.725 0.774 . . . . 0.0 111.682 -176.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -103.04 104.71 14.91 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.436 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 56.8 m -86.3 138.42 34.3 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.552 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.518 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 52.5 Cg_exo -56.28 162.52 7.62 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.548 2.165 . . . . 0.0 111.308 172.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -54.35 136.83 43.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.179 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.15 -26.78 4.22 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.74 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' HIS . . . . . 0.602 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 16.1 m-70 -78.34 157.85 28.99 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.28 0.562 . . . . 0.0 111.613 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -145.99 140.87 27.18 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.417 -175.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 51.0 tp -74.78 126.53 31.11 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.19 0.519 . . . . 0.0 109.681 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 284' ' ' GLN . 52.7 t30 -120.29 112.13 18.64 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -78.99 -6.75 57.08 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.721 0.638 . . . . 0.0 112.263 -173.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 39.0 t -58.07 -21.21 16.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.116 0.484 . . . . 0.0 110.564 168.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 284' ' ' GLN . 24.8 t -146.93 -15.16 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.183 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 283' ' ' SER . 16.9 mp0 73.74 52.62 0.11 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.369 1.067 . . . . 0.0 109.481 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -130.99 149.9 52.39 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.289 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 86.8 m -101.35 94.71 6.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.294 176.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.602 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 76.4 mm-40 . . . . . 0 C--O 1.253 1.238 0 CA-C-O 118.755 -0.64 . . . . 0.0 109.483 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.548 ' HB2' ' SG ' ' A' ' 145' ' ' CYS . 89.7 m-85 . . . . . 0 CA--C 1.515 -0.387 0 CA-C-O 120.582 0.23 . . . . 0.0 110.993 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.475 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 30.6 pt -129.29 169.11 21.13 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.86 172.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.97 169.61 20.75 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.651 -176.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.2 p -77.62 -47.12 20.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.625 0.213 . . . . 0.0 110.528 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -88.04 2.81 50.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.236 0.541 . . . . 0.0 109.937 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.548 ' SG ' ' HB2' ' A' ' 140' ' ' TYR . 0.6 OUTLIER 61.93 44.69 8.09 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.667 171.679 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.22 8.65 55.64 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 119.641 -1.266 . . . . 0.0 112.493 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.475 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 5.4 tm0? -112.62 118.75 44.65 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.222 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -89.09 131.92 2.23 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.959 2.44 . . . . 0.0 113.725 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 149' ' ' VAL . 9.5 p -66.47 116.03 5.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.954 -178.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.629 ' HB3' ' SG ' ' A' ' 154' ' ' CYS . 0.0 OUTLIER -81.87 75.87 8.79 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.275 0.56 . . . . 0.0 109.844 171.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.98 -64.79 0.79 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.306 -0.861 . . . . 0.0 113.133 -171.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 55.8 m -91.88 19.03 6.98 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.158 0.504 . . . . 0.0 111.941 -168.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 80.73 120.29 0.44 Allowed Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.898 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' ' 150' ' ' CYS . 89.1 m -74.29 157.75 35.24 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 113.443 -1.378 . . . . 0.0 108.33 172.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.656 HD12 ' O ' ' A' ' 176' ' ' GLN . 76.9 mt -147.15 174.52 11.51 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -165.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.548 HD22 ' C ' ' A' ' 156' ' ' ASN . 0.2 OUTLIER 49.25 19.13 0.29 Allowed 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.274 0.984 . . . . 0.0 112.624 -172.159 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.6 37.29 93.45 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.247 -0.977 . . . . 0.0 111.949 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -80.76 -141.56 2.95 Favored Glycine 0 C--O 1.236 0.25 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.658 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -157.78 126.54 5.66 Favored 'General case' 0 C--O 1.218 -0.597 0 O-C-N 122.317 -0.519 . . . . 0.0 111.526 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.99 124.46 19.98 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 123.139 0.274 . . . . 0.0 111.142 176.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 165' ' ' ARG . 4.0 m -116.28 -35.3 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.191 0.519 . . . . 0.0 111.419 -178.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.61 ' HB3' ' CB ' ' A' ' 165' ' ' ARG . . . -137.11 175.86 3.18 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 174.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.541 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 22.9 Cg_exo -60.58 109.24 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 121.316 1.344 . . . . 0.0 111.889 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 71.73 3.23 4.59 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.591 1.156 . . . . 0.0 111.119 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.61 ' CB ' ' HB3' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -96.11 86.74 4.35 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.527 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 70.1 m -79.63 150.64 30.93 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.368 172.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.494 ' HB2' HG11 ' A' ' 161' ' ' VAL . . . -93.08 121.41 34.39 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 172.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 61.6 m -106.08 132.12 52.54 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.418 -175.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 89.6 m -60.78 -52.03 66.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.963 -1.471 . . . . 0.0 114.114 -164.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -161.76 -93.6 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 118.852 -1.139 . . . . 0.0 113.111 -170.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -85.44 55.19 4.89 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.878 -164.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.658 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 4.5 m-85 -124.48 137.89 54.39 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.832 171.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.64 ' OG1' ' HG3' ' A' ' 179' ' ' ARG . 27.0 p -88.32 121.07 30.29 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.508 176.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 99.82 134.11 8.37 Favored Glycine 0 N--CA 1.426 -1.967 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.91 9.59 1.31 Allowed 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 120.903 1.068 . . . . 0.0 112.431 -172.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.656 ' O ' HD12 ' A' ' 155' ' ' LEU . 39.2 tt0 -110.37 25.01 12.25 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 171.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.549 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.8 OUTLIER 18.69 71.76 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 173.345 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.577 ' O ' ' HD3' ' A' ' 179' ' ' ARG . 8.6 pt-20 -124.13 31.64 5.75 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.93 0.871 . . . . 0.0 110.604 172.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.658 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 24.0 mmt180 -135.71 93.25 2.92 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 113.729 -1.578 . . . . 0.0 108.582 177.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -87.67 61.32 6.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 122.045 0.926 . . . . 0.0 109.935 -171.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.563 ' CE2' HG23 ' A' ' 173' ' ' THR . 26.0 p90 -83.12 91.39 7.21 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 171.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -89.33 136.5 32.99 Favored 'General case' 0 N--CA 1.437 -1.077 0 O-C-N 119.988 -1.695 . . . . 0.0 107.186 -176.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 77.1 p -86.57 134.69 33.63 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.72 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -158.73 155.29 26.34 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.434 ' O ' ' HA ' ' A' ' 217' ' ' TRP . 12.2 Cg_exo -71.73 160.23 48.63 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.41 2.073 . . . . 0.0 111.904 175.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' CYS . . . . . 0.487 ' H ' HG23 ' A' ' 202' ' ' ILE . 3.6 t -117.73 105.83 12.4 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -177.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' PHE . . . . . 0.747 ' O ' ' HB3' ' A' ' 215' ' ' ARG . 37.4 m-85 -100.21 135.87 40.97 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.633 -172.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.6 m -97.45 -21.43 17.15 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -167.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.421 ' HB ' ' HG3' ' A' ' 196' ' ' GLN . 54.6 t -149.47 115.29 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -171.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.485 HD13 ' HB3' ' A' ' 221' ' ' CYS . 3.1 mt -134.73 119.67 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -164.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.4 p -116.56 -167.36 1.27 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.103 159.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -71.65 -5.61 34.95 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.024 0.916 . . . . 0.0 109.152 171.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -83.58 -67.26 0.8 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.551 -174.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.595 ' HG2' ' H ' ' A' ' 196' ' ' GLN . 43.0 ttp -146.53 139.28 25.3 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.666 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.759 ' O ' ' HB2' ' A' ' 196' ' ' GLN . 68.2 m -84.52 -15.43 45.88 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.586 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.759 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 3.9 mm-40 92.94 -158.8 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.568 1.147 . . . . 0.0 112.106 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.415 ' H ' ' HB3' ' A' ' 196' ' ' GLN . . . 64.71 8.24 32.51 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.274 -0.876 . . . . 0.0 113.693 176.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 55.59 25.94 8.6 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.865 0.332 . . . . 0.0 110.642 -175.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 61.68 27.93 17.2 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.312 -176.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 39.2 t -70.95 137.41 49.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.951 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.36 57.99 3.49 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.342 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.585 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -61.16 109.83 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 170.087 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 5.4 t -89.08 116.11 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 CA-C-O 122.527 1.156 . . . . 0.0 111.348 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 19.7 t -151.68 -179.7 7.65 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.442 ' OG1' HD22 ' A' ' 208' ' ' LEU . 18.5 p -105.66 161.58 14.26 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 120.64 1.564 . . . . 0.0 109.27 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.59 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 46.2 tttm -59.21 -41.51 88.77 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.609 0.718 . . . . 0.0 109.534 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.7 m -46.88 -54.91 8.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.826 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.49 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -57.93 -51.36 69.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.253 179.124 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 64.4 m -62.8 -39.53 94.55 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.497 ' HA ' ' HB3' ' A' ' 224' ' ' CYS . 60.2 m -79.95 -29.86 39.76 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.716 -175.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -71.1 -60.9 1.98 Allowed 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.79 HG22 ' HA2' ' A' ' 234' ' ' GLY . 24.6 p -97.29 144.4 27.11 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.89 -174.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.537 HG21 ' CD1' ' A' ' 256' ' ' LEU . 1.5 t 59.73 -36.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 96.15 -105.7 3.27 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 120.655 1.57 . . . . 0.0 112.498 -177.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.747 ' HB3' ' O ' ' A' ' 187' ' ' PHE . 78.1 mtt180 55.27 -131.84 1.83 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.648 0.737 . . . . 0.0 110.847 177.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.572 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -160.09 169.43 23.37 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 175.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' TRP . . . . . 0.59 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 24.9 t90 -149.69 145.4 26.68 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.606 -173.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 81.8 -178.33 53.71 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-O 121.527 0.515 . . . . 0.0 114.237 172.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.544 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 86.9 m-70 -131.62 130.29 22.35 Favored Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.544 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 18.8 Cg_endo -57.03 156.1 28.53 Favored 'Cis proline' 0 C--N 1.353 0.774 0 C-N-CA 124.002 -1.249 . . . . 0.0 111.044 -4.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' CYS . . . . . 0.485 ' HB3' HD13 ' A' ' 190' ' ' ILE . 58.3 m -67.51 78.46 0.17 Allowed 'General case' 0 C--N 1.32 -0.683 0 O-C-N 123.579 0.549 . . . . 0.0 111.923 -173.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.414 ' O ' ' HB1' ' A' ' 216' ' ' ALA . 12.4 mm-40 -53.94 115.15 1.87 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.034 0.445 . . . . 0.0 110.853 173.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' MET . . . . . 0.572 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 0.0 OUTLIER -91.1 132.66 35.91 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.032 -174.016 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 224' ' ' CYS . . . . . 0.497 ' HB3' ' HA ' ' A' ' 210' ' ' CYS . 70.8 m -97.94 124.04 49.18 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -167.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -62.26 152.63 75.26 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 123.968 3.112 . . . . 0.0 113.65 165.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -39.84 103.5 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.125 0 CA-C-O 122.284 1.04 . . . . 0.0 112.043 162.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 18.24 102.46 0.02 OUTLIER Pre-proline 0 C--N 1.311 -1.106 0 CA-C-N 111.335 -2.666 . . . . 0.0 114.42 -175.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -52.93 -49.88 16.04 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.893 2.395 . . . . 0.0 112.196 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -85.5 111.2 35.26 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.19 64.91 7.0 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.071 2.514 . . . . 0.0 114.265 -172.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 81.0 m -96.69 -84.52 0.36 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 168.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.522 ' HB3' ' CD2' ' A' ' 235' ' ' PHE . 14.4 ttm180 -145.98 135.72 23.34 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 168.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -39.16 -39.53 0.61 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -174.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.79 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -80.82 9.34 52.69 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 120.279 -0.963 . . . . 0.0 113.947 -176.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' PHE . . . . . 0.65 ' HE2' ' N ' ' A' ' 267' ' ' GLY . 1.9 m-85 -121.96 152.38 39.75 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -168.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.55 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.0 OUTLIER -129.89 131.82 23.75 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 114.047 -1.433 . . . . 0.0 107.778 169.797 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 244' ' ' CYS . 19.1 Cg_exo -63.41 111.59 1.51 Allowed 'Trans proline' 0 C--O 1.238 0.496 0 C-N-CA 122.173 1.915 . . . . 0.0 111.238 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -55.42 127.57 30.22 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.057 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 40.4 pt -80.9 12.35 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.14 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -110.46 -39.55 4.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.612 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 78.6 p -111.98 -39.51 4.49 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.95 0.881 . . . . 0.0 110.336 -177.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 102.03 6.07 49.27 Favored Glycine 0 N--CA 1.437 -1.253 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -175.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -97.39 119.7 36.4 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-O 122.079 0.942 . . . . 0.0 110.493 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 237' ' ' PRO . 3.7 m -55.62 123.54 14.39 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.266 176.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.42 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 41.3 tt0 -123.36 143.51 50.06 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ASP . . . . . 0.705 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 8.1 t70 -78.49 145.92 34.69 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.109 0.481 . . . . 0.0 110.32 -178.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.729 HG23 ' HG3' ' A' ' 249' ' ' GLU . 5.3 m -94.97 145.57 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.872 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.35 77.07 1.87 Allowed 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 168.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.729 ' HG3' HG23 ' A' ' 247' ' ' VAL . 35.9 mp0 -53.12 -33.94 54.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 124.375 1.047 . . . . 0.0 110.198 -172.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 7.7 m -46.91 -41.28 15.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.523 173.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -98.79 -42.17 7.32 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.648 0.737 . . . . 0.0 110.302 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.01 -28.62 69.63 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.463 -174.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.655 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.7 mp -123.72 83.13 54.25 Favored Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 173.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.43 ' HG2' HG12 ' A' ' 202' ' ' ILE . 19.3 Cg_endo -57.6 122.96 12.67 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.767 2.311 . . . . 0.0 113.919 -166.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 65.41 27.03 72.06 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 113.554 -1.657 . . . . 0.0 113.435 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.655 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.3 OUTLIER -74.46 -28.85 61.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 118.108 0.954 . . . . 0.0 110.407 177.657 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 257' ' ' CYS . . . . . 0.514 ' HA ' ' HB3' ' A' ' 284' ' ' GLN . 51.5 t -85.97 86.76 7.35 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.776 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -74.16 -19.49 60.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.448 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -54.02 -50.3 55.68 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.348 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 175.73 -93.45 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.069 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -110.25 135.76 50.5 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 269' ' ' PHE . 40.4 t -104.44 134.16 48.1 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 175.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 25.5 mt -131.01 105.78 11.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -70.08 125.4 26.66 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.534 -170.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' THR . . . . . 0.655 HG23 ' O ' ' A' ' 268' ' ' SER . 0.1 OUTLIER -110.83 156.23 21.42 Favored 'General case' 0 C--O 1.256 1.398 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.865 155.795 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.705 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 3.9 m -74.44 127.14 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 C-N-CA 118.155 -1.418 . . . . 0.0 107.876 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.65 ' N ' ' HE2' ' A' ' 235' ' ' PHE . . . 111.28 -25.13 14.37 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.521 -172.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.655 ' O ' HG23 ' A' ' 265' ' ' THR . 27.5 t 173.56 152.61 0.09 Allowed 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.476 0.655 . . . . 0.0 109.613 -174.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' PHE . . . . . 0.478 ' HB2' ' SG ' ' A' ' 262' ' ' CYS . 35.8 p90 -102.78 155.96 17.97 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -110.54 129.75 55.72 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 33.7 m -102.65 134.2 46.4 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.771 177.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -115.81 128.44 55.84 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.404 -177.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 19.3 m -129.57 168.52 16.08 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.724 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.62 155.35 21.87 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.212 1.941 . . . . 0.0 110.904 165.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.56 159.67 21.21 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.889 0.376 . . . . 0.0 110.779 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 89.41 -33.15 4.43 Favored Glycine 0 CA--C 1.504 -0.65 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.325 -174.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -72.15 156.22 39.41 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 120.806 0.336 . . . . 0.0 111.12 -176.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' LYS . . . . . 0.654 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 60.5 mttp -137.06 129.2 29.5 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -174.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.552 HD12 ' O ' ' A' ' 285' ' ' LYS . 32.7 tp -77.35 143.45 38.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 122.035 0.922 . . . . 0.0 112.622 -169.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.469 ' OD1' ' HB ' ' A' ' 282' ' ' VAL . 20.9 t-20 -124.12 100.45 6.72 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 114.366 -1.288 . . . . 0.0 107.833 175.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -69.94 -9.72 56.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.118 0.485 . . . . 0.0 111.691 -174.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.469 ' HB ' ' OD1' ' A' ' 280' ' ' ASN . 62.0 t -64.2 -59.02 4.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-O 121.193 0.521 . . . . 0.0 110.095 174.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 13.8 p -116.41 27.47 9.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.408 -176.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' GLN . . . . . 0.514 ' HB3' ' HA ' ' A' ' 257' ' ' CYS . 12.7 mp0 31.14 51.67 0.14 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.805 -170.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' LYS . . . . . 0.552 ' O ' HD12 ' A' ' 279' ' ' LEU . 85.2 tttt -106.79 171.36 7.41 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' CYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 25.5 p -160.6 114.79 2.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 118.018 0.372 . . . . 0.0 110.318 177.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 N--CA 1.441 -0.916 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -175.584 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.535 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 88.5 m-85 . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.483 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 31.8 pt -139.28 -178.15 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.758 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.697 -173.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.51 153.88 28.51 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.636 -168.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.0 p -64.55 -33.31 75.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.819 0.343 . . . . 0.0 111.788 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -110.87 28.1 9.04 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 79.1 m 56.69 -124.99 1.89 Allowed 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.029 -169.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.65 -39.69 2.55 Favored Glycine 0 C--N 1.292 -1.913 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.402 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.483 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 1.5 tm0? -99.88 118.91 60.91 Favored Pre-proline 0 C--O 1.219 -0.539 0 CA-C-N 117.828 0.814 . . . . 0.0 111.073 -174.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 147' ' ' GLN . 8.5 Cg_endo -87.21 139.68 5.28 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.966 2.444 . . . . 0.0 112.411 175.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 149' ' ' VAL . 10.7 p -71.15 103.29 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 122.261 1.029 . . . . 0.0 111.291 -175.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.38 74.39 9.36 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 121.668 -0.645 . . . . 0.0 110.153 175.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.419 ' HB2' ' ND2' ' A' ' 164' ' ' ASN . 40.2 mt-10 -54.3 -48.07 71.71 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -169.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 69.8 m -90.81 18.65 6.27 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.499 0.666 . . . . 0.0 110.546 -168.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 74.97 128.85 0.2 Allowed Glycine 0 N--CA 1.427 -1.926 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.676 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' CYS . . . . . 0.411 ' SG ' ' SG ' ' A' ' 160' ' ' CYS . 1.7 m -77.34 154.63 32.63 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.186 -1.007 . . . . 0.0 109.316 172.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 176' ' ' GLN . 50.1 mt -148.93 158.89 44.51 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.663 -166.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.609 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 2.8 t-20 52.58 27.88 5.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.899 -163.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.18 36.4 93.18 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.667 -172.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -64.88 151.77 51.08 Favored Glycine 0 N--CA 1.437 -1.279 0 CA-C-O 122.226 0.904 . . . . 0.0 114.257 -175.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.5 ttt85 -96.31 117.76 31.47 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 113.739 -1.23 . . . . 0.0 112.006 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' CYS . . . . . 0.411 ' SG ' ' SG ' ' A' ' 154' ' ' CYS . 3.7 m -62.83 126.18 26.48 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 165' ' ' ARG . 19.7 m -114.77 -41.82 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -176.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -138.26 175.49 3.33 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.535 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 17.1 Cg_exo -63.06 108.11 0.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 121.044 1.163 . . . . 0.0 111.721 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.419 ' ND2' ' HB2' ' A' ' 151' ' ' GLU . 6.8 t-20 74.4 16.17 3.36 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.703 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.535 ' O ' HG22 ' A' ' 161' ' ' VAL . 1.8 mtm180 -112.83 95.31 5.34 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.545 169.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 9.1 t -87.82 151.98 22.45 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.753 171.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.47 ' HB2' HG11 ' A' ' 161' ' ' VAL . . . -105.33 120.03 40.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.457 0.646 . . . . 0.0 109.639 177.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 63.7 m -74.88 124.12 26.31 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.002 -170.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.609 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 77.0 m -60.0 -41.43 92.07 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.455 177.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.48 ' CG ' ' N ' ' A' ' 171' ' ' GLY . 52.5 t80 -140.23 -131.04 0.11 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.296 -176.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.48 ' N ' ' CG ' ' A' ' 170' ' ' TYR . . . -80.82 57.9 4.78 Favored Glycine 0 N--CA 1.435 -1.416 0 CA-C-N 116.157 -0.474 . . . . 0.0 113.148 -165.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.591 ' HB3' ' HA ' ' A' ' 177' ' ' CYS . 4.3 m-85 -121.3 125.57 47.38 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 119.714 -0.795 . . . . 0.0 111.527 170.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.517 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 3.4 t -90.41 158.57 17.02 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 168.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 87.23 130.84 3.14 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -177.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -75.17 21.29 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 121.498 1.466 . . . . 0.0 114.23 -165.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.494 ' O ' HD12 ' A' ' 155' ' ' LEU . 38.2 tt0 -120.36 -6.34 9.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.458 0.647 . . . . 0.0 110.029 176.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.591 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.3 OUTLIER 42.81 49.82 5.09 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -175.449 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.434 ' HB3' ' CD1' ' A' ' 155' ' ' LEU . 6.4 pt-20 -106.27 -15.33 14.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.281 0.562 . . . . 0.0 109.664 174.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.414 ' O ' ' HB3' ' A' ' 180' ' ' ASP . 11.1 mmt85 -57.85 -68.64 0.22 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.183 -1.371 . . . . 0.0 109.062 -175.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' A' ' 179' ' ' ARG . 36.5 t70 78.98 73.76 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.395 0.617 . . . . 0.0 110.159 165.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.517 ' HE2' ' N ' ' A' ' 173' ' ' THR . 28.9 p90 -91.38 67.54 5.7 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.8 1.286 . . . . 0.0 107.704 172.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 21.2 ttp85 -40.1 124.24 1.81 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 112.664 -2.062 . . . . 0.0 110.791 173.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 54.2 p -88.19 139.4 30.54 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.063 -171.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -160.01 146.72 13.09 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.47 129.29 12.7 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.202 1.935 . . . . 0.0 111.609 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' CYS . . . . . 0.71 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 85.3 m -81.24 117.51 21.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.966 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' PHE . . . . . 0.678 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 43.8 m-85 -92.99 153.82 18.51 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.098 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.658 HG23 ' HE ' ' A' ' 215' ' ' ARG . 85.5 m -118.21 -18.79 9.22 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -162.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.2 p -164.9 116.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 O-C-N 121.417 -0.802 . . . . 0.0 110.043 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.494 HD13 ' SG ' ' A' ' 221' ' ' CYS . 2.7 mt -127.01 121.59 58.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -164.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.469 ' OG ' ' HB3' ' A' ' 193' ' ' GLN . 31.0 p -107.89 177.15 4.9 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 153.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -66.72 -12.4 58.41 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 122.477 1.132 . . . . 0.0 108.597 173.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.469 ' HB3' ' OG ' ' A' ' 191' ' ' SER . 60.2 tp60 -78.21 -38.8 42.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.235 -176.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.433 ' O ' ' HA ' ' A' ' 190' ' ' ILE . 41.9 ttm -162.31 140.63 8.86 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 -175.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.486 ' HA ' HG12 ' A' ' 190' ' ' ILE . 79.1 m -91.34 -23.91 19.95 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.257 0.551 . . . . 0.0 111.654 -176.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.467 ' HB2' ' H ' ' A' ' 188' ' ' THR . 55.0 tt0 -157.45 -73.69 0.09 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 170.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 127.78 -32.74 3.41 Favored Glycine 0 C--N 1.321 -0.262 0 C-N-CA 120.159 -1.02 . . . . 0.0 111.798 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 199' ' ' LEU . 92.1 mt-30 -74.61 -44.92 48.35 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 122.166 0.187 . . . . 0.0 110.701 171.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 198' ' ' GLN . 3.9 mm? 72.04 132.03 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.825 0.703 . . . . 0.0 110.735 -176.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 47.3 t -141.5 152.14 43.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.711 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -108.3 22.12 27.54 Favored Glycine 0 CA--C 1.502 -0.72 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.498 HG21 ' HB3' ' A' ' 254' ' ' PRO . 0.0 OUTLIER -60.74 114.22 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 172.418 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.3 t -102.99 99.73 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 CA-C-O 122.803 1.287 . . . . 0.0 111.093 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 7.4 t -133.3 -178.12 4.84 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 172.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 20.3 p -96.46 163.6 12.98 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.486 -174.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.508 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 72.2 tttt -59.31 -43.61 92.62 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.418 176.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.3 m -47.2 -54.47 10.67 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.391 174.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.589 ' CD1' HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -54.04 -62.29 1.75 Allowed 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.816 177.45 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 25.6 m -68.64 -22.17 64.42 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.351 -0.539 . . . . 0.0 112.361 -169.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 61.8 m -96.09 -27.8 14.91 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.376 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ALA . . . . . 0.484 ' HA ' ' CD ' ' A' ' 228' ' ' PRO . . . -66.59 -55.74 13.99 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 172.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.548 HG21 HD11 ' A' ' 253' ' ' ILE . 46.3 p -61.77 -154.04 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 112.519 -2.128 . . . . 0.0 112.405 176.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.413 HG21 HG21 ' A' ' 253' ' ' ILE . 36.0 m -36.89 -5.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.498 ' O ' ' HD3' ' A' ' 215' ' ' ARG . . . 70.3 -153.77 52.06 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 120.565 1.53 . . . . 0.0 114.556 172.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.658 ' HE ' HG23 ' A' ' 188' ' ' THR . 1.7 mpp_? 99.41 -82.59 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.045 1.338 . . . . 0.0 110.131 169.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.678 ' HB3' ' HB2' ' A' ' 187' ' ' PHE . . . -174.29 168.11 3.99 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 118.026 0.375 . . . . 0.0 110.126 174.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' TRP . . . . . 0.71 ' HD1' ' SG ' ' A' ' 186' ' ' CYS . 13.9 t90 -156.68 146.77 21.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 81.22 156.94 16.26 Favored Glycine 0 C--N 1.333 0.377 0 N-CA-C 114.63 0.612 . . . . 0.0 114.63 170.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.703 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 2.4 p-80 -130.91 136.29 28.67 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 172.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.703 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 73.2 Cg_exo -50.94 143.13 8.05 Favored 'Cis proline' 0 C--N 1.352 0.745 0 C-N-CA 124.64 -0.983 . . . . 0.0 113.297 -0.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' CYS . . . . . 0.494 ' SG ' HD13 ' A' ' 190' ' ' ILE . 7.9 t -49.71 112.06 0.6 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.029 -171.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.705 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 49.8 mt-10 -103.09 103.71 13.81 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' MET . . . . . 0.415 ' HG2' HD12 ' A' ' 190' ' ' ILE . 34.4 mtm -87.81 131.14 34.63 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.846 -172.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 26.6 p -143.65 147.14 37.97 Favored Pre-proline 0 N--CA 1.466 0.354 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -173.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.04 169.33 6.16 Favored 'Trans proline' 0 CA--C 1.5 -1.191 0 C-N-CA 122.896 2.397 . . . . 0.0 112.293 165.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -78.9 -160.64 0.24 Allowed 'General case' 0 N--CA 1.414 -2.254 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 161.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -12.41 86.86 0.03 OUTLIER Pre-proline 0 C--N 1.299 -1.617 0 C-N-CA 126.413 1.885 . . . . 0.0 115.525 -170.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.484 ' CD ' ' HA ' ' A' ' 211' ' ' ALA . 8.6 Cg_exo -73.23 -53.49 0.13 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.98 2.454 . . . . 0.0 111.118 174.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 -72.49 141.69 83.19 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.815 177.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -83.08 27.45 0.61 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.26 1.974 . . . . 0.0 113.841 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' CYS . . . . . 0.463 ' C ' ' HD2' ' A' ' 232' ' ' ARG . 68.4 m -83.48 -91.66 0.08 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 173.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.781 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 3.8 mpt_? -146.04 147.57 31.76 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 168.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -41.47 -46.83 3.57 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.464 0.477 . . . . 0.0 111.657 170.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' A' ' 246' ' ' ASP . . . -77.44 7.0 41.65 Favored Glycine 0 C--O 1.224 -0.477 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.817 -176.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' PHE . . . . . 0.781 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 3.5 m-85 -119.36 142.19 48.38 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.075 0.941 . . . . 0.0 113.357 -170.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 237' ' ' PRO . 0.3 OUTLIER -124.1 125.76 25.72 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 113.918 -1.492 . . . . 0.0 108.975 174.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 236' ' ' ILE . 19.1 Cg_exo -67.14 123.3 10.74 Favored 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 122.498 2.132 . . . . 0.0 112.71 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -54.43 139.65 36.59 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.55 0.69 . . . . 0.0 111.033 175.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 31.0 mt -73.08 -16.81 17.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.36 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 47.2 mtm180 -101.34 -66.56 0.91 Allowed 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.682 0.753 . . . . 0.0 110.239 -176.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 28.9 p -76.17 -42.42 46.56 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.688 -175.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 99.26 7.87 53.99 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -85.3 127.27 34.27 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.896 0.855 . . . . 0.0 110.278 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' CYS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 235' ' ' PHE . 3.2 m -65.44 121.6 15.26 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.901 175.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.542 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 96.6 mt-30 -119.29 141.34 49.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.645 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ASP . . . . . 0.706 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 13.1 t70 -78.02 148.08 34.51 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.07 0.462 . . . . 0.0 110.321 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.638 HG23 ' HG3' ' A' ' 249' ' ' GLU . 5.4 m -100.05 151.28 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.848 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -73.24 77.43 1.31 Allowed 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 166.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.638 ' HG3' HG23 ' A' ' 247' ' ' VAL . 5.6 mp0 -51.26 -40.61 59.26 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.756 -175.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 32.0 m -35.83 -43.59 0.31 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 114.189 -1.369 . . . . 0.0 112.658 171.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -99.72 -31.77 11.38 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.188 0.518 . . . . 0.0 110.694 -174.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.422 ' HB1' ' HG ' ' A' ' 208' ' ' LEU . . . -88.01 -4.21 58.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.905 -170.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.658 ' HB ' ' CD2' ' A' ' 256' ' ' LEU . 54.8 mt -134.4 133.47 21.64 Favored Pre-proline 0 CA--C 1.557 1.243 0 CA-C-N 119.092 0.86 . . . . 0.0 113.193 -174.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.533 ' HG3' ' HB2' ' A' ' 186' ' ' CYS . 3.4 Cg_endo -41.14 -73.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.078 1 C-N-CA 125.415 4.076 . . . . 0.0 115.171 -169.68 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -90.11 31.14 5.5 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.499 -169.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.658 ' CD2' ' HB ' ' A' ' 253' ' ' ILE . 0.6 OUTLIER -66.43 137.96 57.22 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.556 -0.857 . . . . 0.0 109.437 177.422 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 257' ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' ' 262' ' ' CYS . 7.9 p -55.82 99.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -167.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -92.07 -20.5 21.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.82 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -78.05 70.49 2.55 Favored Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 176.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 130.13 -148.48 18.55 Favored Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -174.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -109.08 146.12 34.53 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 117.033 0.417 . . . . 0.0 109.976 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' CYS . . . . . 0.521 ' HB3' ' SG ' ' A' ' 257' ' ' CYS . 17.8 p -127.91 147.38 50.46 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 172.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 53.3 mt -138.69 108.8 4.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.375 -167.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -73.36 114.45 11.59 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.747 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 268' ' ' SER . 0.2 OUTLIER -103.32 150.95 23.27 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 161.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.706 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 4.0 m -72.82 133.33 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 C-N-CA 117.553 -1.659 . . . . 0.0 107.503 177.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.684 ' N ' ' HE2' ' A' ' 235' ' ' PHE . . . 97.61 -19.54 54.25 Favored Glycine 0 N--CA 1.434 -1.494 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.607 -174.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.589 ' O ' HG23 ' A' ' 265' ' ' THR . 3.9 p 179.76 142.33 0.14 Allowed 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 117.399 0.599 . . . . 0.0 110.577 -175.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -97.98 156.74 16.49 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' GLU . . . . . 0.51 ' HG3' ' CG2' ' A' ' 265' ' ' THR . 8.8 mt-10 -117.83 155.69 29.67 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 58.4 m -123.21 154.89 38.13 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.948 0.88 . . . . 0.0 112.311 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.408 ' HB3' ' NZ ' ' A' ' 272' ' ' LYS . 9.2 mtpm? -135.5 100.5 4.52 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.763 -1.562 . . . . 0.0 109.386 170.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.429 ' HB3' ' HD2' ' A' ' 274' ' ' PRO . 38.6 m -104.79 170.28 6.2 Favored Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.539 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 273' ' ' CYS . 51.2 Cg_exo -55.44 157.04 15.74 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 121.801 1.667 . . . . 0.0 111.019 171.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -58.27 154.24 13.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.185 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 87.46 -30.81 4.73 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.934 -176.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' HIS . . . . . 0.608 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 14.2 m-70 -70.66 155.4 40.8 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.176 0.512 . . . . 0.0 112.182 -176.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' LYS . . . . . 0.643 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 99.2 mttt -138.68 133.81 32.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.284 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 15.5 tp -91.28 141.2 29.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.753 0.787 . . . . 0.0 111.44 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.481 ' OD1' ' HB ' ' A' ' 282' ' ' VAL . 55.2 t-20 -126.76 101.59 6.68 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 174.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.66 -24.45 66.74 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 123.719 0.637 . . . . 0.0 111.387 -175.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.481 ' HB ' ' OD1' ' A' ' 280' ' ' ASN . 78.8 t -65.2 -43.97 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.488 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 47.3 t -118.92 20.56 12.74 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.276 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 36.13 43.48 0.22 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.737 -173.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 89.7 mttt -91.29 153.07 20.21 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' CYS . . . . . 0.643 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 7.7 t -152.07 86.36 1.3 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.608 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 34.5 tt0 . . . . . 0 C--N 1.312 -1.06 0 CA-C-O 118.259 -0.877 . . . . 0.0 109.822 -173.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.535 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 95.7 m-85 . . . . . 0 CA--C 1.515 -0.375 0 CA-C-O 120.688 0.28 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.453 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 33.9 pt -132.2 172.49 16.28 Favored 'Isoleucine or valine' 0 C--O 1.245 0.838 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 174.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.75 158.62 24.6 Favored Glycine 0 N--CA 1.45 -0.368 0 O-C-N 124.014 0.821 . . . . 0.0 112.208 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.7 p -70.76 -25.82 63.08 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.507 -0.407 . . . . 0.0 111.48 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -100.5 -8.29 23.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.932 0.396 . . . . 0.0 109.992 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 86.1 m 69.03 40.52 1.58 Allowed 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.483 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.98 3.97 48.87 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.194 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.453 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 5.2 tm0? -108.31 111.54 61.59 Favored Pre-proline 0 N--CA 1.464 0.255 0 CA-C-N 117.502 0.651 . . . . 0.0 110.819 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -82.8 143.2 11.68 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.173 2.582 . . . . 0.0 112.998 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.3 p -71.75 115.87 12.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.641 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.641 ' HB3' ' O ' ' A' ' 153' ' ' GLY . 0.9 OUTLIER -80.73 78.25 7.51 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 172.343 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 164' ' ' ASN . 2.2 tt0 -52.27 -60.61 3.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.268 -173.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 17.8 m -94.84 14.52 21.18 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.057 0.456 . . . . 0.0 110.923 -175.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.641 ' O ' ' HB3' ' A' ' 150' ' ' CYS . . . 106.88 -117.32 5.29 Favored Glycine 0 N--CA 1.415 -2.701 0 CA-C-O 122.888 1.271 . . . . 0.0 111.601 -178.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' CYS . . . . . 0.534 ' O ' HD23 ' A' ' 155' ' ' LEU . 0.6 OUTLIER 162.22 141.24 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 -172.349 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 176' ' ' GLN . 39.1 mt -132.58 170.7 14.81 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 -163.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.753 ' HB3' ' CZ ' ' A' ' 172' ' ' PHE . 9.6 p30 45.5 21.61 0.08 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -174.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 67.37 37.87 90.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.296 -174.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -75.4 -146.76 1.56 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.575 -0.345 . . . . 0.0 112.689 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -157.95 124.87 4.96 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 122.68 -0.306 . . . . 0.0 110.955 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.4 m -61.96 125.39 23.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.62 0.248 . . . . 0.0 111.31 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 165' ' ' ARG . 4.2 m -112.18 -46.91 5.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.859 -0.337 . . . . 0.0 110.453 177.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.502 ' HB1' ' HD2' ' A' ' 163' ' ' PRO . . . -128.97 176.1 3.05 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 118.45 -0.786 . . . . 0.0 109.859 170.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.535 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 82.0 Cg_exo -50.67 103.78 0.07 OUTLIER 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 122.524 2.149 . . . . 0.0 113.298 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.422 ' HB2' ' HB2' ' A' ' 151' ' ' GLU . 9.1 t30 67.09 5.31 4.05 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.377 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.542 ' O ' HG22 ' A' ' 161' ' ' VAL . 1.7 ttm180 -89.02 82.5 6.65 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 169.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 35.8 t -85.48 137.73 32.71 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -88.9 127.87 35.65 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 35.2 m -109.94 134.03 52.53 Favored 'General case' 0 C--O 1.239 0.502 0 O-C-N 124.231 0.957 . . . . 0.0 112.028 -168.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 91.4 m -56.16 -56.28 22.87 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -165.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -161.9 -87.98 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.06 -1.056 . . . . 0.0 112.901 -166.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -85.81 46.95 3.71 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.564 -165.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.753 ' CZ ' ' HB3' ' A' ' 156' ' ' ASN . 6.9 m-85 -121.28 130.83 53.86 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.922 170.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.688 ' N ' ' HE1' ' A' ' 181' ' ' TYR . 3.5 t -97.37 138.28 35.07 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 173.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 99.12 126.06 5.56 Favored Glycine 0 C--N 1.299 -1.502 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -169.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -67.86 -0.22 5.15 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.55 1.5 . . . . 0.0 113.301 -170.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.609 ' O ' HD12 ' A' ' 155' ' ' LEU . 45.7 tt0 -111.64 24.34 12.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.39 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.494 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 1.2 p 23.96 60.92 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 117.506 2.41 . . . . 0.0 117.506 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -113.84 26.17 10.57 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.508 1.147 . . . . 0.0 109.441 169.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.547 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 17.6 mmt85 -120.9 84.66 2.27 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.597 -1.638 . . . . 0.0 108.592 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -82.72 76.88 9.54 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.828 -172.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.688 ' HE1' ' N ' ' A' ' 173' ' ' THR . 20.4 p90 -111.94 83.29 1.77 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.757 173.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 61.1 mtt85 -84.45 145.7 28.01 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 119.542 -1.974 . . . . 0.0 107.157 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 73.2 p -91.47 135.22 34.0 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.401 -175.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -159.49 162.5 32.92 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.162 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.21 128.56 10.63 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.215 1.943 . . . . 0.0 111.796 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' CYS . . . . . 0.537 ' H ' HG23 ' A' ' 202' ' ' ILE . 10.5 t -85.0 115.65 22.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.275 0.56 . . . . 0.0 110.452 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' PHE . . . . . 0.639 ' O ' ' HB2' ' A' ' 215' ' ' ARG . 42.6 m-85 -101.69 151.51 21.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.435 -175.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.624 ' HA ' ' CB ' ' A' ' 215' ' ' ARG . 15.4 p -114.42 -23.95 9.1 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -170.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.502 ' HB ' ' CG ' ' A' ' 196' ' ' GLN . 27.0 t -155.69 116.99 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -171.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.488 HG12 ' HA ' ' A' ' 195' ' ' CYS . 4.0 mt -130.14 118.42 43.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 119.012 -1.075 . . . . 0.0 113.892 -170.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.5 p -112.76 -166.81 1.11 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.566 161.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -67.51 -5.48 15.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.619 0.724 . . . . 0.0 110.388 172.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -92.47 -76.53 0.46 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.43 -173.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.598 ' HG2' ' H ' ' A' ' 196' ' ' GLN . 53.1 ttm -136.17 136.31 39.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.826 -172.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 196' ' ' GLN . 29.0 m -84.9 -15.47 44.43 Favored 'General case' 0 C--O 1.247 0.925 0 O-C-N 123.342 0.401 . . . . 0.0 110.823 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.598 ' H ' ' HG2' ' A' ' 194' ' ' MET . 72.3 mm-40 95.09 -165.06 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.211 1.405 . . . . 0.0 112.658 174.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.407 ' H ' ' HB3' ' A' ' 196' ' ' GLN . . . 69.17 -3.57 7.22 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 114.992 -1.003 . . . . 0.0 113.03 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 51.01 39.59 23.43 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.965 0.383 . . . . 0.0 110.263 -172.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 58.0 58.7 3.45 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.579 -177.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 33.5 t -72.85 147.83 45.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.692 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -91.01 26.46 11.13 Favored Glycine 0 CA--C 1.506 -0.511 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.537 HG23 ' H ' ' A' ' 186' ' ' CYS . 0.0 OUTLIER -63.08 106.47 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-O 121.95 0.881 . . . . 0.0 109.356 174.204 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 12.6 t -94.63 118.9 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.144 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 18.7 t -156.22 179.72 8.96 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.401 ' OG1' HD22 ' A' ' 208' ' ' LEU . 10.7 p -102.37 160.21 14.75 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 120.184 1.356 . . . . 0.0 109.736 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.588 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 37.8 tttm -59.01 -42.26 89.66 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.503 177.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.0 m -44.87 -56.62 4.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.332 174.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.499 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -54.09 -53.74 49.05 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.665 177.461 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 91.5 m -67.94 -23.48 65.07 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -174.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 61.4 m -93.84 -34.79 13.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.542 0.61 . . . . 0.0 111.649 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -72.67 -58.12 3.6 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.86 HG22 ' HA2' ' A' ' 234' ' ' GLY . 4.6 p -97.83 159.74 14.74 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.258 177.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.1 t 66.97 -48.42 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 122.565 0.346 . . . . 0.0 111.729 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 60.63 52.03 55.04 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 114.796 0.679 . . . . 0.0 114.796 171.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.639 ' HB2' ' O ' ' A' ' 187' ' ' PHE . 0.0 OUTLIER -123.41 -78.2 0.6 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.813 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.518 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -173.28 167.24 4.81 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' TRP . . . . . 0.605 ' O ' ' HB2' ' A' ' 222' ' ' GLU . 19.5 t90 -159.61 148.16 17.62 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 92.59 177.48 41.32 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 114.74 0.656 . . . . 0.0 114.74 168.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.59 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 12.2 p80 -143.01 132.14 11.67 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.132 -0.534 . . . . 0.0 109.707 177.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.59 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 52.1 Cg_exo -56.65 148.11 26.29 Favored 'Cis proline' 0 C--N 1.346 0.411 0 C-N-CA 123.694 -1.378 . . . . 0.0 111.444 -4.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' CYS . . . . . 0.467 ' HB3' HD13 ' A' ' 190' ' ' ILE . 80.0 m -47.22 122.81 4.84 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.795 0.685 . . . . 0.0 111.845 -173.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.605 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 33.6 mm-40 -108.35 112.5 24.98 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' MET . . . . . 0.518 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 10.4 ptm -94.38 133.79 37.58 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.269 0.557 . . . . 0.0 110.911 -172.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 74.2 m -94.12 125.16 53.71 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.198 -0.91 . . . . 0.0 113.397 -164.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -64.76 154.21 73.79 Favored 'Trans proline' 0 CA--C 1.512 -0.584 0 C-N-CA 123.092 2.528 . . . . 0.0 113.188 166.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -38.29 104.4 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 122.772 1.272 . . . . 0.0 111.93 163.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' GLN . . . . . 0.488 ' HA ' ' HD2' ' A' ' 228' ' ' PRO . 0.3 OUTLIER 18.52 88.24 0.05 OUTLIER Pre-proline 0 N--CA 1.483 1.189 0 CA-C-N 110.507 -3.042 . . . . 0.0 114.778 174.633 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.488 ' HD2' ' HA ' ' A' ' 227' ' ' GLN . 5.6 Cg_exo -38.04 -55.93 1.08 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 124.387 3.391 . . . . 0.0 113.246 173.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -80.51 106.0 4.59 Favored Pre-proline 0 CA--C 1.518 -0.277 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 170.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.1 35.53 0.3 Allowed 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.112 1.875 . . . . 0.0 114.247 -171.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' CYS . . . . . 0.421 ' HB2' ' H ' ' A' ' 232' ' ' ARG . 33.8 m -69.22 -74.81 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 169.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.577 ' HB3' ' CD2' ' A' ' 235' ' ' PHE . 24.0 tpt180 -149.47 140.4 22.85 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 165.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -36.3 -45.46 0.47 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -177.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.86 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -78.8 9.97 34.55 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.93 -174.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' PHE . . . . . 0.672 ' HE2' ' N ' ' A' ' 267' ' ' GLY . 2.2 m-85 -116.53 138.39 51.44 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 122.009 0.909 . . . . 0.0 113.426 -169.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.523 HG22 ' HD2' ' A' ' 237' ' ' PRO . 0.0 OUTLIER -126.48 137.07 29.61 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.601 173.281 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.523 ' HD2' HG22 ' A' ' 236' ' ' ILE . 19.7 Cg_endo -57.61 124.41 16.01 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.658 2.239 . . . . 0.0 112.92 -177.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.418 ' O ' ' HA2' ' A' ' 242' ' ' GLY . 22.9 t-20 -58.27 141.66 50.23 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.652 173.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 26.3 mt -81.45 -13.82 12.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.079 -174.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 65.1 mtt180 -99.57 -59.01 1.8 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.335 0.588 . . . . 0.0 109.823 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 43.8 p -86.63 -33.96 19.97 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.879 -176.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 238' ' ' ASN . . . 90.3 5.77 69.5 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -177.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -83.46 134.02 34.88 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 121.591 0.71 . . . . 0.0 110.349 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 4.0 m -59.45 118.73 6.36 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.273 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.557 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 83.1 mm-40 -120.38 143.03 48.65 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ASP . . . . . 0.722 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 14.9 t70 -79.11 146.16 33.36 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -176.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.755 HG23 ' HG3' ' A' ' 249' ' ' GLU . 5.3 m -98.68 148.22 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.047 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.856 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -75.8 77.28 2.73 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 167.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.755 ' HG3' HG23 ' A' ' 247' ' ' VAL . 40.4 mp0 -53.57 -37.66 63.14 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 123.482 0.489 . . . . 0.0 111.689 -168.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 36.0 t -50.59 -40.47 52.64 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.121 0.486 . . . . 0.0 110.616 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -93.78 -40.32 10.26 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.591 0.71 . . . . 0.0 110.125 -172.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -67.49 -25.01 65.65 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.588 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.471 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.1 mp -121.3 83.76 40.11 Favored Pre-proline 0 N--CA 1.449 -0.525 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 173.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -65.34 8.81 0.21 Allowed 'Trans proline' 0 N--CA 1.482 0.813 0 C-N-CA 124.411 3.408 . . . . 0.0 116.379 -168.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -129.81 8.4 6.11 Favored Glycine 0 C--N 1.295 -1.708 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.755 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.471 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.1 OUTLIER -102.65 136.41 42.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.212 0.529 . . . . 0.0 112.189 -174.295 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 10.7 t 56.78 54.43 7.22 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.681 178.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -94.28 -17.63 22.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.257 177.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -87.8 40.57 3.08 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.434 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 164.03 -160.6 33.52 Favored Glycine 0 N--CA 1.437 -1.234 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' ASN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 272' ' ' LYS . 13.7 m120 -81.41 156.47 25.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.921 0.361 . . . . 0.0 110.425 177.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 15.4 p -138.92 121.14 15.84 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 176.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 270' ' ' GLU . 16.6 mt -136.16 164.1 32.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -174.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.61 132.12 38.65 Favored 'General case' 0 CA--C 1.496 -1.109 0 C-N-CA 117.789 -1.564 . . . . 0.0 114.36 -175.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.89 160.36 20.99 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.867 162.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.722 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 3.0 m -73.1 128.12 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 173.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.672 ' N ' ' HE2' ' A' ' 235' ' ' PHE . . . 112.45 -22.17 17.97 Favored Glycine 0 N--CA 1.419 -2.439 0 C-N-CA 119.977 -1.106 . . . . 0.0 112.147 -173.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.566 ' HB2' ' O ' ' A' ' 267' ' ' GLY . 8.5 t 166.77 165.04 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.342 0.592 . . . . 0.0 110.18 -177.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' PHE . . . . . 0.423 ' CZ ' HD11 ' A' ' 256' ' ' LEU . 36.3 p90 -101.15 155.45 18.0 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 119.864 -0.735 . . . . 0.0 109.965 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' GLU . . . . . 0.405 ' HB2' ' HB ' ' A' ' 263' ' ' ILE . 3.6 mt-10 -109.93 123.86 50.37 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -177.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 66.3 m -114.0 129.07 56.63 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.399 0.618 . . . . 0.0 110.156 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 261' ' ' ASN . 18.6 ttpp -102.61 114.49 28.76 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.838 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 70.0 m -91.6 148.09 36.59 Favored Pre-proline 0 C--N 1.296 -1.74 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.311 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 70.3 Cg_exo -52.81 152.67 16.68 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.006 1.804 . . . . 0.0 110.927 173.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -51.61 139.95 19.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.884 0.373 . . . . 0.0 111.115 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 86.92 -34.77 3.5 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.301 -0.952 . . . . 0.0 111.353 -176.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' HIS . . . . . 0.605 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 17.8 m-70 -80.24 163.33 24.08 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 120.968 0.413 . . . . 0.0 110.893 -176.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -146.29 133.71 20.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.561 -173.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.528 HD12 ' O ' ' A' ' 285' ' ' LYS . 46.8 tp -66.56 142.57 57.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.991 0.424 . . . . 0.0 111.063 -176.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -131.23 99.47 4.87 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -61.32 -17.15 52.37 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.861 0.725 . . . . 0.0 112.624 -176.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.502 ' HA ' ' NH1' ' A' ' 215' ' ' ARG . 77.0 t -58.01 -39.48 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.183 0.516 . . . . 0.0 110.597 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 57.7 p -140.89 36.9 1.78 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.951 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' GLN . . . . . 0.443 ' OE1' ' HA ' ' A' ' 256' ' ' LEU . 0.0 OUTLIER 28.25 50.92 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.326 1.051 . . . . 0.0 112.897 -174.79 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 285' ' ' LYS . . . . . 0.528 ' O ' HD12 ' A' ' 279' ' ' LEU . 68.9 tttt -104.44 169.59 8.38 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.699 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 53.7 m -141.65 100.21 3.72 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.605 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 57.8 mm-40 . . . . . 0 C--O 1.24 0.563 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -173.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 147' ' ' GLN . 67.7 m-85 . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.491 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 32.6 pt -138.4 -176.33 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.865 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.03 167.61 43.17 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.302 -174.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 34.4 p -77.99 -10.98 59.86 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.778 -0.248 . . . . 0.0 111.516 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 30.7 m80 -109.28 -3.76 16.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.047 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 140' ' ' TYR . 9.5 t 66.1 26.26 10.71 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.35 0.595 . . . . 0.0 109.623 -177.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -96.09 4.14 64.96 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.615 -0.721 . . . . 0.0 113.076 -173.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.549 ' O ' ' HA ' ' A' ' 140' ' ' TYR . 8.5 tm0? -110.91 108.08 57.74 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.027 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -74.06 140.72 28.66 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.119 2.546 . . . . 0.0 112.983 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 149' ' ' VAL . 13.6 p -78.38 103.59 5.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.34 1.067 . . . . 0.0 111.363 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -81.95 82.89 7.42 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.646 174.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -56.33 -69.09 0.16 Allowed 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -173.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 64.9 m -83.05 10.5 7.92 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.78 0.8 . . . . 0.0 110.659 -163.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 71.72 132.31 0.12 Allowed Glycine 0 N--CA 1.424 -2.13 0 CA-C-N 114.374 -1.285 . . . . 0.0 111.491 -170.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 160' ' ' CYS . 62.4 m -68.06 151.5 46.95 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.23 -0.985 . . . . 0.0 109.503 175.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 38.6 mt -132.36 175.39 9.32 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -172.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.774 ' HB2' ' CZ ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 66.88 11.52 8.36 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 123.791 0.682 . . . . 0.0 112.124 170.615 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.61 32.07 80.06 Favored Glycine 0 CA--C 1.507 -0.458 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -172.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.443 ' HA2' ' OG1' ' A' ' 169' ' ' THR . . . -77.76 -145.55 2.44 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.276 -0.462 . . . . 0.0 114.1 -175.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -149.76 114.13 5.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.63 0.252 . . . . 0.0 110.491 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' CYS . . . . . 0.467 ' HB2' ' SG ' ' A' ' 154' ' ' CYS . 35.1 t -58.78 113.77 2.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.891 0.377 . . . . 0.0 110.634 174.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 165' ' ' ARG . 13.0 m -106.96 -46.13 8.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.921 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.577 ' HB1' ' HD2' ' A' ' 163' ' ' PRO . . . -134.11 178.06 1.95 Allowed Pre-proline 0 CA--C 1.541 0.622 0 CA-C-O 118.72 -0.657 . . . . 0.0 109.981 175.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.577 ' HD2' ' HB1' ' A' ' 162' ' ' ALA . 96.2 Cg_exo -49.05 103.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 122.661 2.241 . . . . 0.0 113.589 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 66.31 8.94 6.01 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.238 1.015 . . . . 0.0 109.958 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.597 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -93.08 81.24 4.54 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.613 174.824 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 63.7 m -85.74 138.75 31.88 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.277 172.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.96 139.16 30.8 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.498 ' HA ' HD21 ' A' ' 156' ' ' ASN . 61.0 m -92.65 110.44 21.87 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 124.182 0.926 . . . . 0.0 111.601 -169.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.443 ' OG1' ' HA2' ' A' ' 158' ' ' GLY . 24.1 m -65.84 -55.28 17.88 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.44 ' CD2' ' N ' ' A' ' 171' ' ' GLY . 38.0 t80 -121.36 -116.41 0.31 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 118.89 -1.124 . . . . 0.0 112.532 -168.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.44 ' N ' ' CD2' ' A' ' 170' ' ' TYR . . . -91.77 52.13 2.95 Favored Glycine 0 CA--C 1.485 -1.799 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.163 -166.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.774 ' CZ ' ' HB2' ' A' ' 156' ' ' ASN . 6.9 m-85 -119.06 127.8 53.74 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 119.302 -0.959 . . . . 0.0 112.598 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.478 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 3.6 t -91.0 162.71 14.6 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 163.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 90.96 131.25 4.92 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.36 -13.2 30.48 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.312 1.341 . . . . 0.0 113.322 -166.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -106.83 14.41 26.71 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.246 0.546 . . . . 0.0 109.601 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.531 ' HB3' ' HB2' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 31.33 60.22 0.27 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.735 1.214 . . . . 0.0 113.958 177.385 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -115.94 -13.92 11.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.925 175.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -56.44 -61.91 2.09 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.907 -1.497 . . . . 0.0 107.967 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 32.8 t70 74.45 69.83 0.1 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.78 0.8 . . . . 0.0 109.524 160.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.478 ' HE2' ' N ' ' A' ' 173' ' ' THR . 45.3 p90 -94.75 66.22 3.13 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 174.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -57.19 123.74 16.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.136 171.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.578 ' HB ' HG13 ' A' ' 203' ' ' VAL . 41.3 p -73.22 138.02 45.34 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -163.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -140.51 141.61 11.58 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.79 -162.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -72.12 128.66 14.15 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.964 1.776 . . . . 0.0 111.382 172.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 6.4 t -84.53 113.6 21.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.131 0.491 . . . . 0.0 110.09 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' PHE . . . . . 0.561 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 14.6 m-85 -94.6 147.05 23.68 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.766 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.548 ' HA ' ' CB ' ' A' ' 215' ' ' ARG . 12.9 p -113.5 -2.92 13.77 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.5 t -130.35 159.23 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.799 HD11 ' HB2' ' A' ' 216' ' ' ALA . 40.5 mm -134.55 119.34 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.562 0.696 . . . . 0.0 111.336 174.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.418 ' HB3' ' H ' ' A' ' 194' ' ' MET . 48.2 t -143.17 169.18 18.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.308 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -79.37 -7.5 58.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 122.369 1.081 . . . . 0.0 108.106 167.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -92.44 -71.45 0.64 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.476 -1.693 . . . . 0.0 109.655 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.418 ' H ' ' HB3' ' A' ' 191' ' ' SER . 63.2 mtt -143.83 136.55 27.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.927 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 196' ' ' GLN . 34.3 m -85.17 -38.79 18.6 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 168.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 1.8 mm-40 157.11 -149.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 113.423 -1.717 . . . . 0.0 106.969 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 94.13 17.21 41.12 Favored Glycine 0 CA--C 1.509 -0.338 0 C-N-CA 119.743 -1.218 . . . . 0.0 112.747 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -90.58 -1.99 57.88 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.227 0.536 . . . . 0.0 110.204 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.464 ' N ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -160.53 8.97 0.09 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.755 -177.392 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 12.6 m -87.97 86.07 7.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.313 0.578 . . . . 0.0 112.248 -169.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -100.25 4.19 57.01 Favored Glycine 0 CA--C 1.506 -0.509 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 170.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.467 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -60.14 114.33 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 114.435 -0.882 . . . . 0.0 109.576 173.145 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.578 HG13 ' HB ' ' A' ' 183' ' ' THR . 23.0 t -104.68 101.1 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 CA-C-O 122.974 1.369 . . . . 0.0 110.728 176.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.434 ' HB2' HD11 ' A' ' 202' ' ' ILE . 9.6 t -129.27 -176.8 3.99 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 112.529 -2.123 . . . . 0.0 106.204 174.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 26.7 p -107.9 165.6 11.34 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.143 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.862 ' HB3' ' CE3' ' A' ' 217' ' ' TRP . 21.7 ptmt -69.58 -22.02 63.56 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.526 174.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 8.4 m -57.59 -53.07 62.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 172.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.491 ' CD1' HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -57.69 -56.43 22.06 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.737 175.001 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 68.7 m -67.99 -24.15 65.1 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.253 -172.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 78.2 m -101.9 -11.08 19.27 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -82.47 -50.74 8.51 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 164.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 214' ' ' GLY . 40.0 p -78.15 -156.76 0.09 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.886 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.7 t -19.82 -33.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 212' ' ' THR . . . 81.41 -165.33 46.44 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 119.796 -1.192 . . . . 0.0 114.429 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.548 ' CB ' ' HA ' ' A' ' 188' ' ' THR . 72.6 mmt-85 102.72 -80.29 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.837 1.655 . . . . 0.0 109.932 174.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.799 ' HB2' HD11 ' A' ' 190' ' ' ILE . . . -173.53 168.25 4.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 119.101 0.864 . . . . 0.0 110.347 175.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' TRP . . . . . 0.862 ' CE3' ' HB3' ' A' ' 206' ' ' LYS . 20.7 t90 -164.28 144.44 7.94 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 76.99 -174.27 54.52 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.0 -0.619 . . . . 0.0 113.014 175.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.52 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 31.1 p80 -135.64 131.71 19.36 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 31.6 Cg_exo -59.94 165.2 26.71 Favored 'Cis proline' 0 N--CA 1.477 0.505 0 C-N-CA 123.733 -1.361 . . . . 0.0 111.821 -5.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 55.9 m -62.63 81.32 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -173.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 216' ' ' ALA . 5.7 mm-40 -50.29 97.93 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.31 0.576 . . . . 0.0 110.438 167.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 19.8 ptt? -99.42 131.89 45.12 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.162 -173.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 18.5 m -142.11 144.17 30.74 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.386 -173.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -59.87 168.17 6.08 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.897 2.398 . . . . 0.0 110.046 160.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.01 -96.3 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.876 0.37 . . . . 0.0 111.213 -176.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' GLN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -83.28 113.34 45.67 Favored Pre-proline 0 C--N 1.32 -0.689 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.725 178.587 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -83.48 -41.24 0.1 OUTLIER 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.621 2.214 . . . . 0.0 113.698 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.445 ' HB3' ' HD2' ' A' ' 230' ' ' PRO . 41.7 m80 -103.89 173.57 3.32 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -174.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 229' ' ' HIS . 45.5 Cg_exo -60.19 -18.35 51.28 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.026 1.817 . . . . 0.0 112.011 174.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 14.8 t -64.07 124.69 22.26 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 172.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.587 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 45.3 mtt180 -63.45 135.23 56.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.386 -172.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.525 ' HB3' ' HB3' ' A' ' 227' ' ' GLN . 30.4 ptt180 -30.43 -44.54 0.05 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 246' ' ' ASP . . . -79.78 12.02 31.08 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.895 -1.145 . . . . 0.0 113.952 -173.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' PHE . . . . . 0.587 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 44.2 m-85 -125.05 158.55 33.47 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 117.994 0.897 . . . . 0.0 112.769 -175.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.496 HD13 ' O ' ' A' ' 235' ' ' PHE . 0.2 OUTLIER -132.28 130.53 21.97 Favored Pre-proline 0 N--CA 1.445 -0.695 0 CA-C-N 113.388 -1.733 . . . . 0.0 107.443 170.537 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.09 113.03 1.86 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.059 1.839 . . . . 0.0 111.509 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -47.13 130.0 12.52 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.665 0.745 . . . . 0.0 110.959 177.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 29.6 mt -74.49 -3.83 5.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.145 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -104.63 -60.09 1.65 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.913 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 34.9 p -86.41 -44.03 12.35 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.56 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 104.01 6.97 42.05 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.608 -177.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -96.55 130.37 43.75 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 122.039 0.923 . . . . 0.0 110.134 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 93.9 m -49.48 120.76 4.39 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 113.066 -1.879 . . . . 0.0 110.465 171.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.4 ' OE1' ' HA ' ' A' ' 245' ' ' GLN . 5.3 tp60 -120.61 136.07 54.92 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ASP . . . . . 0.614 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 19.0 t70 -74.09 141.36 45.67 Favored 'General case' 0 CA--C 1.492 -1.256 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.502 -174.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.647 HG23 ' HG3' ' A' ' 249' ' ' GLU . 4.2 m -93.34 143.94 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.441 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -74.2 76.4 1.8 Allowed 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 166.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.647 ' HG3' HG23 ' A' ' 247' ' ' VAL . 29.7 mp0 -49.04 -38.4 23.78 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.896 0.748 . . . . 0.0 111.18 -171.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 15.5 m -53.19 -32.07 46.05 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.639 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -105.53 -50.29 3.24 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.499 0.72 . . . . 0.0 110.776 -175.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -59.88 -26.93 66.27 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.141 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.753 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.5 mp -118.14 79.88 14.83 Favored Pre-proline 0 N--CA 1.447 -0.575 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 169.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -38.0 103.14 0.04 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.564 0 C-N-CA 124.451 3.434 . . . . 0.0 115.509 -169.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 59.96 38.24 93.87 Favored Glycine 0 C--N 1.312 -0.787 0 CA-C-N 113.667 -1.606 . . . . 0.0 113.77 172.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.753 ' HB3' HG22 ' A' ' 253' ' ' ILE . 1.7 pt? -66.46 -31.31 71.98 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.004 177.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' CYS . . . . . 0.437 ' H ' HD23 ' A' ' 256' ' ' LEU . 51.7 t -119.74 81.19 1.69 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.281 0.562 . . . . 0.0 109.669 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -117.41 26.05 10.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.142 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -70.83 -27.32 72.51 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 172.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -149.49 -116.29 0.81 Allowed Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 175.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -112.61 131.17 55.75 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 49.1 t -102.5 140.45 36.76 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 172.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 22.5 mt -130.97 163.31 37.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -130.7 127.36 38.68 Favored 'General case' 0 CA--C 1.496 -1.131 0 C-N-CA 117.615 -1.634 . . . . 0.0 113.895 -174.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.4 t -113.68 165.56 12.41 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.076 163.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.614 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 30.7 m -70.46 125.36 28.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.83 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.527 ' HA2' ' CE2' ' A' ' 235' ' ' PHE . . . 97.05 -13.07 65.29 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-O 118.962 -0.91 . . . . 0.0 113.935 -177.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.0 t 178.68 157.5 0.49 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.732 1.266 . . . . 0.0 109.874 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -105.97 159.2 16.23 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.872 -0.518 . . . . 0.0 109.876 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -114.84 121.33 42.93 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' CYS . . . . . 0.585 ' HB2' HD22 ' A' ' 279' ' ' LEU . 68.1 m -111.71 150.75 29.77 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 122.037 0.922 . . . . 0.0 111.917 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.28 109.56 7.83 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 113.503 -1.68 . . . . 0.0 109.694 175.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 10.1 m -84.56 164.4 42.88 Favored Pre-proline 0 C--N 1.314 -0.978 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.578 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 51.6 Cg_exo -53.31 156.41 10.69 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 121.921 1.747 . . . . 0.0 111.696 175.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -53.92 140.59 30.34 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.162 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 87.08 -28.55 5.53 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.421 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' HIS . . . . . 0.578 ' HB2' ' O ' ' A' ' 274' ' ' PRO . 21.5 m-70 -81.97 165.82 20.38 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.0 0.429 . . . . 0.0 111.587 -176.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 34.4 mtmm -139.69 137.52 35.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.143 -172.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.585 HD22 ' HB2' ' A' ' 271' ' ' CYS . 14.9 tp -85.48 139.91 31.11 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.116 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.45 ' HB3' ' HB2' ' A' ' 285' ' ' LYS . 29.4 t30 -131.42 98.76 4.62 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.415 173.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.401 ' HA ' ' NE2' ' A' ' 284' ' ' GLN . 48.4 mt-10 -56.19 -30.53 62.39 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.214 -175.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.526 ' O ' ' HB ' ' A' ' 188' ' ' THR . 42.0 t -56.08 -29.78 27.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.189 -176.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 67.6 m -145.16 33.32 1.09 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.599 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' GLN . . . . . 0.412 ' OE1' ' HB2' ' A' ' 257' ' ' CYS . 35.6 mm-40 32.28 45.15 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.914 -1.039 . . . . 0.0 113.474 -174.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 51.1 mttp -88.13 154.84 20.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.006 0.431 . . . . 0.0 111.95 -176.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 286' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 5.4 m -139.42 80.81 1.8 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.089 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 33.7 tt0 . . . . . 0 N--CA 1.44 -0.964 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.691 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 55.7 m-85 . . . . . 0 CA--C 1.514 -0.413 0 CA-C-O 120.772 0.32 . . . . 0.0 110.412 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.512 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 36.0 pt -138.81 -177.81 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.718 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.805 177.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.38 164.05 22.73 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.363 -175.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 43.5 p -78.16 -39.93 39.39 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.931 0.396 . . . . 0.0 110.905 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -98.67 -10.57 23.07 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.472 176.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 71.4 m 78.99 154.63 0.14 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.054 -1.43 . . . . 0.0 113.476 174.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.453 ' O ' ' HD3' ' A' ' 148' ' ' PRO . . . 132.41 2.4 4.08 Favored Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 112.913 -1.949 . . . . 0.0 113.808 175.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.512 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 1.2 tm0? -93.31 104.72 13.04 Favored Pre-proline 0 C--N 1.317 -0.806 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.199 174.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 146' ' ' GLY . 68.8 Cg_endo -82.71 149.96 14.41 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.4 2.066 . . . . 0.0 112.325 -175.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 149' ' ' VAL . 10.6 p -78.89 105.93 8.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 122.439 1.114 . . . . 0.0 112.611 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.06 80.15 6.51 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.155 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -56.23 -67.84 0.26 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -172.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 37.6 m -89.18 7.02 37.38 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.166 0.508 . . . . 0.0 111.392 -167.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 73.6 128.06 0.13 Allowed Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.016 -172.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' CYS . . . . . 0.58 ' O ' HD23 ' A' ' 155' ' ' LEU . 57.1 m -71.22 164.09 26.34 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 113.944 -1.128 . . . . 0.0 109.309 176.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.731 HD12 ' O ' ' A' ' 176' ' ' GLN . 68.7 mt -139.96 162.74 34.46 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.697 -167.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.741 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 2.4 t-20 53.35 26.08 5.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.659 0.743 . . . . 0.0 110.475 -167.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.63 37.24 94.14 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.119 -1.038 . . . . 0.0 112.007 -174.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.46 -147.13 0.51 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.08 134.63 9.63 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 117.591 0.695 . . . . 0.0 110.477 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 166' ' ' CYS . 0.5 OUTLIER -75.43 110.41 9.78 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.246 0.546 . . . . 0.0 110.514 175.133 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 165' ' ' ARG . 2.9 m -95.43 -29.59 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.521 0.677 . . . . 0.0 110.349 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.681 ' HB3' ' CB ' ' A' ' 165' ' ' ARG . . . -139.12 173.71 4.9 Favored Pre-proline 0 N--CA 1.451 -0.417 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.691 ' HD3' ' CE1' ' A' ' 140' ' ' TYR . 78.2 Cg_exo -54.54 105.07 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.199 1.933 . . . . 0.0 112.051 176.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 26.0 t30 66.2 9.83 6.63 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.097 0.959 . . . . 0.0 110.629 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.681 ' CB ' ' HB3' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -98.92 82.69 2.8 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.43 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 160' ' ' CYS . 74.1 m -82.26 148.17 28.52 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.414 174.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -99.23 131.14 45.47 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 58.2 m -102.65 132.09 48.99 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 123.877 0.736 . . . . 0.0 111.302 -169.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.741 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 19.7 m -47.68 -54.47 11.95 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -168.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.514 ' HD2' ' N ' ' A' ' 171' ' ' GLY . 5.6 t80 -157.65 -83.53 0.05 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 118.716 -1.194 . . . . 0.0 112.51 -170.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.514 ' N ' ' HD2' ' A' ' 170' ' ' TYR . . . -97.69 49.96 1.42 Allowed Glycine 0 CA--C 1.496 -1.151 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.262 -166.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 156' ' ' ASN . 10.2 m-85 -116.79 129.43 56.1 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 118.529 -1.268 . . . . 0.0 113.461 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.627 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 3.3 t -97.29 143.78 27.72 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.438 173.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' A' ' 176' ' ' GLN . . . 93.3 130.75 5.64 Favored Glycine 0 C--N 1.297 -1.628 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 -175.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.21 17.95 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.611 1.54 . . . . 0.0 112.914 -169.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.731 ' O ' HD12 ' A' ' 155' ' ' LEU . 65.8 tt0 -128.15 12.14 6.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.211 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.508 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.8 OUTLIER 27.17 59.08 0.09 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 116.885 2.18 . . . . 0.0 116.885 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.469 ' C ' ' HD2' ' A' ' 179' ' ' ARG . 2.3 pt-20 -109.85 16.18 22.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.24 1.019 . . . . 0.0 109.352 169.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.469 ' HD2' ' C ' ' A' ' 178' ' ' GLU . 19.3 mmm180 -120.39 91.1 3.46 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.409 -178.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -89.11 86.69 6.95 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.164 0.983 . . . . 0.0 111.853 -170.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.627 ' HE2' ' N ' ' A' ' 173' ' ' THR . 32.4 p90 -116.89 96.2 5.36 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 175.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -74.04 130.73 40.41 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 119.49 -2.006 . . . . 0.0 108.222 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 67.6 p -79.99 168.06 19.68 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.06 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.517 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . 158.16 148.09 5.04 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.316 -164.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -76.25 132.8 14.14 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.15 1.9 . . . . 0.0 111.922 174.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' CYS . . . . . 0.426 ' CB ' HD12 ' A' ' 202' ' ' ILE . 13.6 t -88.4 116.67 26.79 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' PHE . . . . . 0.638 ' CD2' ' HB2' ' A' ' 195' ' ' CYS . 16.1 m-85 -102.93 152.56 21.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.362 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.67 ' HA ' ' HB3' ' A' ' 215' ' ' ARG . 20.0 p -103.28 -54.9 2.51 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.1 p -140.54 120.03 12.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 O-C-N 120.914 -1.116 . . . . 0.0 112.645 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.466 HG13 ' SG ' ' A' ' 195' ' ' CYS . 2.1 mp -97.84 116.07 39.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-O 121.907 0.861 . . . . 0.0 111.612 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.0 p -106.86 -167.93 1.34 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 158.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -72.08 -4.83 31.19 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.367 0.604 . . . . 0.0 109.759 172.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -88.89 -69.8 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.482 -173.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.556 ' HG3' ' H ' ' A' ' 196' ' ' GLN . 33.0 tpp -162.99 135.62 5.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.189 -176.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.638 ' HB2' ' CD2' ' A' ' 187' ' ' PHE . 3.2 m -68.31 -19.41 64.67 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.877 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.604 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 44.8 mm-40 93.08 113.85 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.954 1.302 . . . . 0.0 113.34 173.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.04 -9.58 9.63 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.262 174.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 54.18 48.68 20.36 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.762 0.315 . . . . 0.0 110.82 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 6.6 mp 55.57 70.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.815 -175.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 46.3 t -72.2 148.36 45.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.475 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.33 21.55 12.71 Favored Glycine 0 CA--C 1.508 -0.366 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.898 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 254' ' ' PRO . 0.0 OUTLIER -65.3 98.12 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 163.699 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.39 118.66 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.383 0 CA-C-N 113.819 -1.537 . . . . 0.0 109.072 -175.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 10.1 t -158.11 -178.16 7.09 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 -175.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.477 HG21 ' HA ' ' A' ' 181' ' ' TYR . 26.7 p -108.24 168.44 9.3 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 120.278 1.399 . . . . 0.0 111.33 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.614 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 47.1 tttp -57.71 -44.33 85.84 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.406 174.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.1 m -47.01 -56.04 7.13 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.004 176.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.434 ' HG ' ' HB1' ' A' ' 252' ' ' ALA . 0.2 OUTLIER -58.75 -55.33 36.47 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.206 178.785 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 84.7 m -67.36 -23.75 65.63 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -172.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 227' ' ' GLN . 16.3 m -104.75 -26.69 12.17 Favored 'General case' 0 N--CA 1.429 -1.524 0 O-C-N 121.149 -0.969 . . . . 0.0 111.686 -175.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . . . -71.8 -56.99 4.75 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 170.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.681 HG22 ' HA2' ' A' ' 234' ' ' GLY . 6.0 p -100.23 156.22 17.34 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.592 -1.64 . . . . 0.0 107.16 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.2 t 68.0 -39.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 118.841 -0.599 . . . . 0.0 111.713 -177.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 65.12 49.71 60.79 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 119.061 0.846 . . . . 0.0 113.499 166.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.67 ' HB3' ' HA ' ' A' ' 188' ' ' THR . 31.3 mmt180 -127.7 -90.37 0.52 Allowed 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 120.527 -0.469 . . . . 0.0 112.206 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.515 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -165.83 164.96 18.64 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -177.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' TRP . . . . . 0.834 ' O ' ' HB2' ' A' ' 222' ' ' GLU . 7.0 t90 -168.29 139.55 2.74 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 127.7 167.72 12.34 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 119.634 -1.27 . . . . 0.0 114.53 172.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 220' ' ' PRO . 11.7 p80 -132.8 132.18 22.42 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.219 -0.491 . . . . 0.0 109.992 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 219' ' ' HIS . 2.4 Cg_endo -82.46 117.09 4.83 Favored 'Cis proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.011 -1.662 . . . . 0.0 111.61 -3.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' CYS . . . . . 0.418 ' SG ' ' CG1' ' A' ' 190' ' ' ILE . 34.1 t 39.0 92.89 0.01 OUTLIER 'General case' 0 C--O 1.243 0.751 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 175.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.834 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 34.7 mt-10 -105.48 110.12 22.34 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' MET . . . . . 0.515 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 2.8 tpt -90.31 138.74 31.29 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -173.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 54.6 m -111.48 129.49 24.05 Favored Pre-proline 0 C--O 1.234 0.277 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -169.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -80.03 151.12 20.97 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.513 2.809 . . . . 0.0 111.641 166.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 37.21 -86.54 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.276 0 O-C-N 124.799 1.312 . . . . 0.0 114.281 174.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 210' ' ' CYS . 0.3 OUTLIER -172.66 166.63 3.26 Favored Pre-proline 0 N--CA 1.44 -0.932 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -168.823 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 211' ' ' ALA . 4.6 Cg_exo -80.08 -85.91 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 121.884 1.722 . . . . 0.0 112.424 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -75.48 154.38 85.77 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.083 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -81.7 52.81 4.37 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.821 1.681 . . . . 0.0 113.775 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 71.9 m -104.78 -179.69 4.02 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 171.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.616 ' HB3' ' CD2' ' A' ' 235' ' ' PHE . 73.0 ttt180 -67.53 140.95 57.02 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 170.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.405 ' O ' HG22 ' A' ' 212' ' ' THR . 98.8 mtt180 -38.67 -50.92 1.66 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -175.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.681 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -70.26 9.27 3.28 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.41 -0.9 . . . . 0.0 114.145 -174.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' PHE . . . . . 0.616 ' CD2' ' HB3' ' A' ' 232' ' ' ARG . 5.3 m-85 -123.99 153.68 40.93 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 122.31 1.052 . . . . 0.0 113.721 -171.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.538 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.0 OUTLIER -130.19 133.23 24.7 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 113.619 -1.628 . . . . 0.0 108.227 168.838 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.76 116.39 3.52 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.329 2.019 . . . . 0.0 112.382 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -49.14 132.36 19.38 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.6 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 37.6 pt -73.8 1.2 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.316 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -111.89 -55.49 2.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.422 0.63 . . . . 0.0 110.181 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 66.3 p -92.96 -38.67 11.55 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.417 -175.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 98.33 4.47 57.35 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.394 -175.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -83.75 124.95 31.42 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 121.673 0.749 . . . . 0.0 109.662 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 10.8 m -57.91 114.69 2.44 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 113.446 -1.707 . . . . 0.0 109.401 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -117.1 141.07 48.72 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ASP . . . . . 0.623 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 16.3 t70 -76.32 146.27 38.97 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -175.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.668 ' CG2' HG21 ' A' ' 212' ' ' THR . 4.4 m -96.78 151.65 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.983 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.87 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.534 ' OD1' ' HB2' ' A' ' 250' ' ' CYS . 6.3 t0 -78.98 81.07 5.28 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 167.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.648 ' HG3' HG23 ' A' ' 247' ' ' VAL . 2.1 mp0 -52.57 -32.05 39.19 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 123.901 0.751 . . . . 0.0 110.467 -173.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.534 ' HB2' ' OD1' ' A' ' 248' ' ' ASP . 58.0 m -55.04 -42.79 73.09 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.676 172.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -89.96 -33.48 16.38 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 122.29 1.043 . . . . 0.0 109.581 -175.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.434 ' HB1' ' HG ' ' A' ' 208' ' ' LEU . . . -79.27 -23.3 43.71 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.087 -174.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.672 ' O ' ' HB3' ' A' ' 256' ' ' LEU . 5.3 mp -132.58 79.21 65.31 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 176.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.468 ' O ' HG13 ' A' ' 202' ' ' ILE . 75.8 Cg_exo -55.57 153.93 27.23 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 121.776 1.651 . . . . 0.0 112.289 177.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 78.55 -19.18 5.04 Favored Glycine 0 C--N 1.316 -0.579 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.833 -174.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.672 ' HB3' ' O ' ' A' ' 253' ' ' ILE . 2.1 tt -76.04 115.19 15.51 Favored 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 122.425 -0.456 . . . . 0.0 109.847 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 37.3 t 63.33 19.37 11.64 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.171 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -84.31 56.22 3.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.761 0.791 . . . . 0.0 110.259 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -120.81 7.52 10.99 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 173.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -179.14 -117.47 0.54 Allowed Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -117.4 116.35 27.0 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 17.7 p -108.36 157.86 18.01 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 170.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 21.1 mt -145.49 156.64 13.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -170.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.6 HD22 ' CD ' ' A' ' 249' ' ' GLU . 0.6 OUTLIER -127.2 124.81 39.85 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -173.431 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.6 t -114.54 170.95 7.94 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.191 165.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.623 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 34.6 m -67.59 127.41 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 CA-C-O 121.826 0.822 . . . . 0.0 110.723 -176.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 88.38 -14.75 58.7 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-O 119.007 -0.885 . . . . 0.0 113.554 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 75.3 m -169.9 148.64 3.54 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 118.051 0.925 . . . . 0.0 110.52 -172.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' PHE . . . . . 0.449 ' HD2' ' OE2' ' A' ' 249' ' ' GLU . 26.8 p90 -105.37 152.4 23.0 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.64 -0.662 . . . . 0.0 110.384 174.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.88 126.52 52.03 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 -177.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' CYS . . . . . 0.485 ' SG ' HD22 ' A' ' 279' ' ' LEU . 18.4 m -106.22 152.06 23.97 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.815 0.817 . . . . 0.0 113.162 -176.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -141.52 96.93 3.06 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.59 171.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 11.7 m -83.55 164.87 43.15 Favored Pre-proline 0 C--N 1.314 -0.952 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 33.8 Cg_exo -57.32 165.92 5.09 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.939 1.76 . . . . 0.0 111.385 176.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -53.7 137.22 38.07 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.356 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 82.87 -31.07 3.11 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.458 -178.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' HIS . . . . . 0.546 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 15.8 m-70 -74.2 163.18 28.15 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.604 0.24 . . . . 0.0 111.352 -177.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -148.01 148.22 30.47 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.551 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 16.3 tp -82.16 141.36 33.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.377 . . . . 0.0 110.817 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -133.14 98.98 4.41 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.001 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -61.45 -23.26 65.74 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.465 0.478 . . . . 0.0 112.164 -174.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.27 -18.06 17.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.327 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 44.4 m -152.4 31.39 0.53 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.791 175.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 25.1 46.3 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.04 1.336 . . . . 0.0 113.808 -173.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 285' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 68.3 tttt -98.35 167.53 10.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.361 -171.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 1.8 m -144.43 83.41 1.72 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.546 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 36.4 tt0 . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.779 -0.629 . . . . 0.0 110.092 -171.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.592 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 75.3 m-85 . . . . . 0 C--O 1.235 0.338 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.547 ' O ' ' HA ' ' A' ' 145' ' ' CYS . 23.2 pt -139.82 178.42 3.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 CA-C-O 121.311 0.577 . . . . 0.0 111.214 -173.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.53 165.95 40.39 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.805 -169.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.9 m -70.73 -31.81 68.77 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.015 0.407 . . . . 0.0 110.785 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -89.84 -8.71 51.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.187 0.518 . . . . 0.0 109.927 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 141' ' ' ILE . 73.3 m 57.22 41.52 26.78 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.909 -175.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.23 2.3 59.42 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.588 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.502 ' O ' HG12 ' A' ' 141' ' ' ILE . 2.9 tm0? -109.51 104.39 55.17 Favored Pre-proline 0 C--N 1.329 -0.298 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.809 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.61 142.46 20.61 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.466 2.111 . . . . 0.0 111.661 177.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 149' ' ' VAL . 8.8 p -66.64 106.72 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 122.569 1.176 . . . . 0.0 112.137 -173.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 20.8 m -80.23 66.1 5.61 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.831 173.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -52.16 -53.26 45.2 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.593 0.961 . . . . 0.0 113.593 -171.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 36.6 m -93.87 8.92 39.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.435 0.636 . . . . 0.0 110.576 -170.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 77.28 134.29 0.66 Allowed Glycine 0 N--CA 1.427 -1.964 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.266 -172.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' CYS . . . . . 0.44 ' O ' HD23 ' A' ' 155' ' ' LEU . 0.1 OUTLIER -69.64 154.85 41.41 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.743 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.574 HD12 ' O ' ' A' ' 176' ' ' GLN . 42.7 mt -126.78 170.28 12.33 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -173.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.521 HD22 ' C ' ' A' ' 155' ' ' LEU . 0.1 OUTLIER 36.49 35.55 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.731 1.269 . . . . 0.0 113.598 -172.946 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.36 34.23 67.66 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.003 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -75.52 -151.54 3.17 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-O 121.466 0.481 . . . . 0.0 114.031 -172.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.553 ' HG2' ' HB3' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -145.7 122.41 11.18 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.102 0.477 . . . . 0.0 110.567 -179.146 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 160' ' ' CYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 166' ' ' CYS . 19.1 m -68.79 112.12 5.31 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.833 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 165' ' ' ARG . 3.8 m -92.39 -33.28 5.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.071 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.562 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -139.88 177.03 2.18 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.592 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 77.7 Cg_exo -53.55 111.64 0.74 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 121.73 1.62 . . . . 0.0 112.496 176.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 61.54 12.7 4.63 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.94 0.896 . . . . 0.0 110.879 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.562 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.4 OUTLIER -103.68 78.25 1.55 Allowed 'General case' 0 CA--C 1.499 -1.003 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.082 178.014 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 160' ' ' CYS . 59.6 m -71.68 152.93 42.41 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.744 0.783 . . . . 0.0 110.54 171.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.553 ' HB3' ' HG2' ' A' ' 159' ' ' ARG . . . -106.28 141.72 37.15 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.629 169.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.442 ' HA ' HD21 ' A' ' 156' ' ' ASN . 29.2 m -97.68 128.68 44.54 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 124.346 1.029 . . . . 0.0 112.072 -163.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 77.9 m -62.96 -55.72 23.38 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 171' ' ' GLY . 40.1 t80 -128.18 -119.73 0.24 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 118.746 -1.181 . . . . 0.0 112.373 -169.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.401 ' N ' ' CD1' ' A' ' 170' ' ' TYR . . . -87.7 54.7 4.39 Favored Glycine 0 N--CA 1.428 -1.853 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.321 -167.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.564 ' HB2' ' HB3' ' A' ' 177' ' ' CYS . 5.1 m-85 -119.14 122.24 41.59 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 119.247 -0.981 . . . . 0.0 112.331 173.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.572 ' N ' ' HE1' ' A' ' 181' ' ' TYR . 2.9 t -88.09 157.51 18.84 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 167.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.1 128.48 3.29 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -177.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.06 -0.07 7.4 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.498 1.465 . . . . 0.0 113.467 -166.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.574 ' O ' HD12 ' A' ' 155' ' ' LEU . 41.7 tt0 -109.71 8.35 24.71 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.564 ' HB3' ' HB2' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 32.87 57.09 0.44 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 177.222 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -114.06 -15.73 12.23 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.877 173.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 173' ' ' THR . 19.3 mmt180 -57.58 -68.92 0.19 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.157 -1.383 . . . . 0.0 108.645 -176.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.0 t70 78.38 92.64 0.06 Allowed 'General case' 0 CA--C 1.509 -0.626 0 O-C-N 124.132 0.895 . . . . 0.0 110.102 164.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.572 ' HE1' ' N ' ' A' ' 173' ' ' THR . 32.2 p90 -112.36 64.16 0.63 Allowed 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 173.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 25.7 tpt85 -42.42 121.15 1.85 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.408 171.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 38.9 p -82.28 136.63 35.01 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.347 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.509 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -159.92 155.47 26.59 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.048 -176.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -85.07 167.87 10.72 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.444 2.096 . . . . 0.0 111.847 172.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 69.6 m -116.92 121.06 40.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.155 0.502 . . . . 0.0 111.44 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' PHE . . . . . 0.761 ' O ' ' HB3' ' A' ' 215' ' ' ARG . 29.6 m-85 -93.36 131.71 38.27 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.555 ' HA ' ' CG ' ' A' ' 215' ' ' ARG . 19.0 m -89.32 -15.16 34.07 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 113.944 1.091 . . . . 0.0 113.944 -163.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.1 p -165.11 117.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.066 -174.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.548 HD11 ' HB3' ' A' ' 216' ' ' ALA . 6.7 mt -123.7 118.35 53.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -171.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 7.3 p -114.77 -167.11 1.18 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.419 160.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -68.07 -4.08 12.35 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.434 0.635 . . . . 0.0 110.275 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -75.55 -69.97 0.45 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.307 -177.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 22.4 ttt -169.7 152.68 4.68 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.542 ' HA ' HG12 ' A' ' 190' ' ' ILE . 21.8 m -77.24 -24.2 51.2 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 121.099 0.476 . . . . 0.0 111.475 -174.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 42.7 tt0 176.22 -92.1 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.845 173.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.418 ' H ' ' HB3' ' A' ' 196' ' ' GLN . . . 124.55 11.14 4.66 Favored Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.939 171.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -89.04 -12.7 40.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.204 0.526 . . . . 0.0 109.992 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 65.17 -85.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.996 -177.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 71.1 m 68.93 125.85 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.574 0.702 . . . . 0.0 112.48 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.07 30.25 4.01 Favored Glycine 0 CA--C 1.508 -0.358 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.127 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.432 HG12 ' HD2' ' A' ' 254' ' ' PRO . 0.0 OUTLIER -65.75 100.35 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.175 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 4.1 t -92.57 98.29 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-O 122.914 1.34 . . . . 0.0 109.751 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.573 ' OG ' HD23 ' A' ' 208' ' ' LEU . 8.4 t -117.69 179.94 3.92 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.659 -2.064 . . . . 0.0 105.976 169.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 19.0 p -107.63 161.93 14.42 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.399 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.515 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 46.3 tttm -61.91 -43.62 98.46 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.13 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 8.4 m -44.76 -55.13 5.59 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 122.22 1.009 . . . . 0.0 109.415 173.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.81 HD11 HG11 ' A' ' 247' ' ' VAL . 6.0 tp -63.7 -52.25 61.41 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.294 -1.775 . . . . 0.0 112.344 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 4.7 t -64.3 -37.29 86.97 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.441 0.638 . . . . 0.0 110.479 -175.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 52.2 m -85.07 -23.82 28.37 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.626 -177.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ALA . . . . . 0.556 ' HA ' ' CD ' ' A' ' 228' ' ' PRO . . . -69.88 -52.75 22.12 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 173.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 214' ' ' GLY . 80.8 p -64.77 -156.43 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 113.101 -1.863 . . . . 0.0 111.85 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.413 ' H ' HG23 ' A' ' 213' ' ' VAL . 1.6 t -44.25 -1.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.349 0 N-CA-C 116.276 1.954 . . . . 0.0 116.276 -176.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 212' ' ' THR . . . 85.72 -101.97 2.61 Favored Glycine 0 CA--C 1.507 -0.457 0 C-N-CA 119.086 -1.53 . . . . 0.0 113.549 175.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.761 ' HB3' ' O ' ' A' ' 187' ' ' PHE . 0.8 OUTLIER 50.78 -120.33 1.56 Allowed 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.143 0.497 . . . . 0.0 110.34 -169.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.548 ' HB3' HD11 ' A' ' 190' ' ' ILE . . . -158.44 159.88 36.19 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 172.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' TRP . . . . . 0.515 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 26.9 t90 -136.07 146.33 46.94 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -174.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 82.25 177.44 51.87 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.735 171.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.608 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 8.0 p80 -143.01 133.4 12.26 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.626 -0.287 . . . . 0.0 110.252 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.608 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 41.4 Cg_exo -57.8 154.03 34.38 Favored 'Cis proline' 0 C--N 1.345 0.366 0 C-N-CA 123.667 -1.389 . . . . 0.0 112.119 -3.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 9.5 m -49.54 123.01 6.97 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.193 -171.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 37.1 mt-10 -105.87 102.49 11.92 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' MET . . . . . 0.532 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 17.7 ptm -85.73 137.64 32.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.576 -169.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 99.3 m -135.3 143.17 44.39 Favored Pre-proline 0 C--O 1.235 0.294 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -171.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -64.45 169.17 11.53 Favored 'Trans proline' 0 CA--C 1.512 -0.579 0 C-N-CA 122.788 2.325 . . . . 0.0 110.346 155.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.0 -129.67 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.808 168.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' GLN . . . . . 0.405 ' H ' ' HG3' ' A' ' 227' ' ' GLN . 0.1 OUTLIER -46.95 102.61 0.32 Allowed Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -166.318 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.556 ' CD ' ' HA ' ' A' ' 211' ' ' ALA . 63.9 Cg_endo -82.39 -59.68 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.628 2.218 . . . . 0.0 112.389 176.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.416 ' HB3' ' HD2' ' A' ' 230' ' ' PRO . 90.1 m-70 -70.87 159.6 84.9 Favored Pre-proline 0 CA--C 1.515 -0.368 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 229' ' ' HIS . 73.3 Cg_endo -78.91 58.25 6.81 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 121.706 1.604 . . . . 0.0 113.381 -174.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 43.0 m -135.43 -173.83 3.46 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.683 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 25.7 mmt180 -73.19 144.74 46.7 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.315 174.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -39.29 -42.96 1.08 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.581 ' O ' ' HA ' ' A' ' 246' ' ' ASP . . . -77.72 7.72 39.74 Favored Glycine 0 C--O 1.222 -0.612 0 C-N-CA 120.342 -0.933 . . . . 0.0 113.187 -176.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' PHE . . . . . 0.683 ' CD1' ' HB2' ' A' ' 232' ' ' ARG . 3.3 m-85 -120.42 143.0 48.7 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.865 0.84 . . . . 0.0 112.706 -171.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.464 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.5 OUTLIER -122.59 131.5 24.37 Favored Pre-proline 0 N--CA 1.439 -0.987 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.082 175.762 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -65.66 113.76 2.65 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.051 1.834 . . . . 0.0 111.356 174.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -49.21 135.9 16.08 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 123.492 0.717 . . . . 0.0 111.581 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 29.5 pt -75.63 2.87 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.165 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 240' ' ' ARG . 49.8 mtm180 -113.29 -56.51 2.4 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.973 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 35.0 p -95.91 -40.56 9.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.749 -174.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 99.44 5.63 55.6 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -175.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -79.01 134.01 36.8 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.806 0.812 . . . . 0.0 110.128 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 4.6 m -68.96 113.99 6.85 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.022 -1.445 . . . . 0.0 109.299 173.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.543 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 89.3 mt-30 -116.33 141.26 48.39 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ASP . . . . . 0.675 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 12.5 t70 -77.58 144.65 37.38 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.81 HG11 HD11 ' A' ' 208' ' ' LEU . 4.3 m -95.56 146.11 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.082 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -178.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.442 ' HA ' ' ND2' ' A' ' 264' ' ' ASN . 4.9 m-20 -73.88 75.98 1.64 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 169.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.69 ' HG3' HG23 ' A' ' 247' ' ' VAL . 14.4 mp0 -52.5 -37.12 56.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 123.931 0.77 . . . . 0.0 110.776 -168.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 52.7 m -49.24 -38.71 27.6 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.866 174.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -101.21 -35.78 9.16 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.879 0.847 . . . . 0.0 110.565 -176.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.651 ' HB1' HD21 ' A' ' 208' ' ' LEU . . . -70.38 -20.1 62.97 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.33 -1.305 . . . . 0.0 110.459 -177.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.752 HG22 ' HB3' ' A' ' 256' ' ' LEU . 5.0 mp -137.29 77.63 41.16 Favored Pre-proline 0 N--CA 1.445 -0.703 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 169.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.432 ' HD2' HG12 ' A' ' 202' ' ' ILE . 9.8 Cg_endo -48.06 113.53 0.83 Allowed 'Trans proline' 0 CA--C 1.514 -0.508 0 C-N-CA 124.018 3.146 . . . . 0.0 114.39 -167.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 61.22 35.97 91.69 Favored Glycine 0 C--N 1.311 -0.824 0 CA-C-N 113.457 -1.702 . . . . 0.0 113.391 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.752 ' HB3' HG22 ' A' ' 253' ' ' ILE . 1.8 pt? -66.96 -23.1 65.92 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 117.367 0.584 . . . . 0.0 110.905 176.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 39.1 t -82.02 121.73 26.91 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' GLN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 285' ' ' LYS . 59.1 tp60 -90.26 111.51 22.72 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -171.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 71.49 66.1 2.23 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.749 171.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 174.14 -170.17 43.27 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 119.967 -1.111 . . . . 0.0 112.792 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' ASN . . . . . 0.483 ' HB3' ' HB2' ' A' ' 272' ' ' LYS . 2.5 t-20 -88.79 159.08 17.92 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 21.2 t -141.49 125.03 16.71 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.423 HD11 ' OD1' ' A' ' 261' ' ' ASN . 18.2 mt -136.54 109.21 7.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.104 -170.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.442 ' ND2' ' HA ' ' A' ' 248' ' ' ASP . 65.9 t30 -72.17 117.17 13.46 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.281 -174.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.3 t -105.38 160.61 14.99 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 157.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.675 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 3.9 m -77.43 128.56 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 C-N-CA 118.344 -1.342 . . . . 0.0 107.924 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.658 ' N ' ' HE1' ' A' ' 235' ' ' PHE . . . 110.5 -30.79 7.88 Favored Glycine 0 C--N 1.311 -0.838 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.669 -170.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 31.7 m -179.11 158.36 0.9 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.079 0.939 . . . . 0.0 109.93 -168.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -104.96 152.36 22.78 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.818 -1.176 . . . . 0.0 108.63 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -107.45 127.89 54.01 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -176.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 261' ' ' ASN . 92.7 m -106.88 152.43 23.92 Favored 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.342 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 261' ' ' ASN . 7.4 mtpm? -124.07 100.03 6.53 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.033 175.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 4.3 m -81.81 149.32 63.42 Favored Pre-proline 0 C--N 1.31 -1.109 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.869 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 32.3 Cg_exo -56.57 162.31 8.48 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.08 1.854 . . . . 0.0 111.25 175.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -53.1 143.08 18.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.519 0.2 . . . . 0.0 111.059 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.49 -31.27 3.57 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.828 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' HIS . . . . . 0.601 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 14.4 m-70 -78.83 169.79 17.67 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 122.708 -0.289 . . . . 0.0 111.372 -177.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 56.5 mtpt -149.5 148.95 30.01 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 39.6 tp -84.94 136.11 33.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.075 0.464 . . . . 0.0 110.534 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -125.71 100.29 6.36 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 174.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.27 -21.11 61.52 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.829 0.705 . . . . 0.0 112.185 -174.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 68.3 t -60.47 -34.07 56.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.177 0.513 . . . . 0.0 110.45 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.458 ' HA ' ' CG2' ' A' ' 188' ' ' THR . 20.3 p -132.97 23.49 4.21 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.55 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 29.62 46.63 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.062 -171.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 285' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 85.9 tttt -101.63 165.09 11.41 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.973 -172.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 5.7 m -140.89 88.42 2.18 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -177.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.601 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 7.1 tp10 . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.667 -0.682 . . . . 0.0 109.341 -173.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.617 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 98.8 m-85 . . . . . 0 CA--C 1.517 -0.315 0 CA-C-O 120.905 0.383 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.446 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 30.0 pt -132.88 174.6 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.967 177.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.99 174.15 33.23 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.737 -175.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.5 p -75.89 -29.74 58.57 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -111.32 12.61 21.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.34 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 46.2 m 59.67 35.91 22.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.091 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.59 -12.2 72.91 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.613 -0.721 . . . . 0.0 113.347 -174.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.446 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 5.4 tm0? -111.28 110.42 56.05 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 117.336 0.568 . . . . 0.0 110.718 -176.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.37 147.85 18.3 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.931 2.421 . . . . 0.0 112.489 178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 149' ' ' VAL . 12.4 p -75.14 109.87 8.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.943 0.878 . . . . 0.0 111.035 -176.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.24 77.54 5.75 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.24 173.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.412 ' OE1' ' HB2' ' A' ' 164' ' ' ASN . 49.0 mt-10 -56.54 -59.04 5.57 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -170.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.1 m -90.28 10.77 23.49 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.442 0.639 . . . . 0.0 111.267 -170.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 82.43 126.58 0.98 Allowed Glycine 0 N--CA 1.43 -1.761 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.654 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' CYS . . . . . 0.521 ' O ' HD23 ' A' ' 155' ' ' LEU . 3.6 m -71.94 153.51 41.79 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 113.854 -1.173 . . . . 0.0 109.559 171.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.521 HD23 ' O ' ' A' ' 154' ' ' CYS . 83.2 mt -141.3 172.7 12.32 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -169.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.715 ' ND2' ' HB2' ' A' ' 177' ' ' CYS . 8.5 p30 43.39 24.62 0.05 Allowed 'General case' 0 N--CA 1.478 0.949 0 O-C-N 124.108 0.88 . . . . 0.0 113.248 -174.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.1 36.8 93.71 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.199 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -73.76 -146.27 0.95 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 121.466 -0.397 . . . . 0.0 113.219 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.8 ttt85 -156.57 123.14 5.08 Favored 'General case' 0 C--O 1.222 -0.35 0 O-C-N 122.204 -0.586 . . . . 0.0 111.345 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 2.4 m -61.38 116.0 4.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.897 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 165' ' ' ARG . 11.2 m -102.1 -50.1 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.803 178.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.492 ' HB1' ' HD2' ' A' ' 163' ' ' PRO . . . -127.7 172.9 6.06 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.802 171.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.617 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 74.0 Cg_exo -51.15 107.78 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.128 1.885 . . . . 0.0 112.531 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.412 ' HB2' ' OE1' ' A' ' 151' ' ' GLU . 0.2 OUTLIER 76.53 -14.2 0.84 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.816 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.548 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.6 OUTLIER -80.73 85.55 6.07 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.251 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 13.5 t -83.06 143.64 30.45 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.756 173.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.42 ' HB2' ' CG1' ' A' ' 161' ' ' VAL . . . -89.19 121.51 31.57 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 176.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 55.8 m -94.38 123.69 37.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.115 -169.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 170' ' ' TYR . 85.1 m -53.74 -48.83 69.27 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 114.211 -1.359 . . . . 0.0 113.16 -170.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.429 ' HE2' ' H ' ' A' ' 183' ' ' THR . 10.0 t80 177.54 115.95 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.929 -175.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 78.76 43.44 11.61 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 120.356 -0.926 . . . . 0.0 113.522 169.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.662 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 25.2 m-85 -124.8 128.25 48.43 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 117.951 0.876 . . . . 0.0 112.39 168.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.886 HG23 ' CE2' ' A' ' 181' ' ' TYR . 43.5 p -88.48 137.33 32.42 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.279 177.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.45 141.66 10.78 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.43 6.27 1.97 Allowed 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.451 1.434 . . . . 0.0 112.473 -170.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.499 ' O ' HD12 ' A' ' 155' ' ' LEU . 11.8 pt20 -129.3 24.64 5.52 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.32 177.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.715 ' HB2' ' ND2' ' A' ' 156' ' ' ASN . 0.0 OUTLIER 32.97 73.83 0.06 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 175.755 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -120.18 16.14 12.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.109 0.481 . . . . 0.0 111.406 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.662 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 15.9 mmt85 -123.33 96.26 4.92 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.547 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -80.05 84.36 5.79 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 122.241 1.02 . . . . 0.0 109.891 -173.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.886 ' CE2' HG23 ' A' ' 173' ' ' THR . 28.4 p90 -114.3 84.15 2.0 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 175.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -77.52 127.17 32.06 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 118.766 -2.459 . . . . 0.0 107.825 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.429 ' H ' ' HE2' ' A' ' 170' ' ' TYR . 18.0 p -81.93 134.28 35.37 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.877 -178.072 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.462 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -152.88 155.1 25.93 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.872 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.73 136.24 29.97 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.68 2.254 . . . . 0.0 111.012 172.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' CYS . . . . . 0.405 ' H ' HG23 ' A' ' 202' ' ' ILE . 5.8 t -108.28 115.65 30.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.92 0.391 . . . . 0.0 111.163 -174.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' PHE . . . . . 0.472 ' CE1' ' HA ' ' A' ' 198' ' ' GLN . 7.0 m-85 -95.54 160.4 14.53 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.512 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.505 HG21 ' HA ' ' A' ' 283' ' ' SER . 24.7 p -111.68 -16.11 13.3 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 -167.024 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 7.5 p -163.75 123.63 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 119.628 1.104 . . . . 0.0 112.394 -173.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.609 HG12 ' HA ' ' A' ' 195' ' ' CYS . 51.7 mt -126.46 115.97 43.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-O 121.645 0.736 . . . . 0.0 112.833 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.422 ' C ' ' H ' ' A' ' 193' ' ' GLN . 25.0 p -115.8 -163.61 0.9 Allowed 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 158.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -61.47 -5.18 1.6 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.601 0.637 . . . . 0.0 110.553 172.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.422 ' H ' ' C ' ' A' ' 191' ' ' SER . 58.3 tp60 -69.56 -74.39 0.13 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.802 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.546 ' SD ' ' HA2' ' A' ' 197' ' ' GLY . 23.9 ttm -179.16 -171.66 0.21 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 176.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.609 ' HA ' HG12 ' A' ' 190' ' ' ILE . 14.0 m -88.08 -24.27 23.48 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 118.185 0.448 . . . . 0.0 111.928 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.504 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 12.9 tt0 165.65 -4.24 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 122.015 0.912 . . . . 0.0 109.444 -173.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.546 ' HA2' ' SD ' ' A' ' 194' ' ' MET . . . 103.61 5.13 45.65 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -172.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.472 ' HA ' ' CE1' ' A' ' 187' ' ' PHE . 93.4 mt-30 61.71 52.66 3.47 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-O 121.466 0.651 . . . . 0.0 109.668 -176.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 63.7 mt -126.13 -179.73 4.86 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.964 -173.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 14.8 t 73.67 120.1 0.04 OUTLIER 'General case' 0 C--O 1.233 0.202 0 O-C-N 124.422 1.076 . . . . 0.0 111.285 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -93.42 33.23 5.25 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.606 177.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.405 HG23 ' H ' ' A' ' 186' ' ' CYS . 0.0 OUTLIER -64.78 97.7 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-O 122.238 1.018 . . . . 0.0 108.921 171.505 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.426 ' N ' ' HG2' ' A' ' 254' ' ' PRO . 1.4 t -90.07 118.62 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.368 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 11.2 t -153.59 -178.63 7.15 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 103.129 -2.915 . . . . 0.0 103.129 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.434 HG21 ' HA ' ' A' ' 181' ' ' TYR . 10.5 p -106.33 163.7 12.62 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 120.538 1.517 . . . . 0.0 110.012 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.579 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 49.6 tttm -63.85 -38.48 91.26 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.486 0.66 . . . . 0.0 109.788 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.0 m -48.63 -56.38 8.62 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.045 171.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.544 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -56.98 -53.73 54.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.905 177.04 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 54.4 m -67.09 -23.0 65.8 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -175.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 56.3 m -106.56 -11.69 15.81 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 118.979 0.809 . . . . 0.0 113.168 -177.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -83.88 -51.21 7.37 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.961 0.886 . . . . 0.0 108.991 165.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.539 HG22 ' HA2' ' A' ' 234' ' ' GLY . 6.7 p -101.66 151.9 21.47 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.275 -178.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.447 HG11 HE21 ' A' ' 284' ' ' GLN . 31.5 m 53.01 -37.19 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.556 ' O ' ' HD3' ' A' ' 215' ' ' ARG . . . 78.63 -159.51 46.27 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 120.416 1.462 . . . . 0.0 112.236 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.556 ' HD3' ' O ' ' A' ' 214' ' ' GLY . 0.0 OUTLIER 104.07 -90.6 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.692 1.197 . . . . 0.0 109.497 163.124 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.45 ' HB2' HD12 ' A' ' 190' ' ' ILE . . . -169.17 160.82 9.96 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.875 0.761 . . . . 0.0 110.125 170.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' TRP . . . . . 0.579 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 18.8 t90 -152.48 147.83 26.7 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -177.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 78.98 173.18 43.34 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 115.389 0.916 . . . . 0.0 115.389 167.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.578 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 36.0 m-70 -127.79 133.11 24.75 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 114.838 -0.681 . . . . 0.0 109.445 171.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.578 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 19.7 Cg_endo -58.6 152.3 39.23 Favored 'Cis proline' 0 C--N 1.347 0.461 0 C-N-CA 123.705 -1.373 . . . . 0.0 111.772 -3.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 43.5 t -55.89 118.43 4.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.254 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -115.28 121.23 42.25 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' MET . . . . . 0.434 ' HB3' HD12 ' A' ' 190' ' ' ILE . 19.8 ptm -98.07 146.48 25.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.645 0.26 . . . . 0.0 111.304 -173.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 61.8 m -143.24 148.37 44.27 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.959 -178.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.7 167.65 23.75 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.615 2.21 . . . . 0.0 109.9 163.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.527 ' O ' ' HD3' ' A' ' 228' ' ' PRO . . . -58.62 -94.67 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 120.764 0.316 . . . . 0.0 110.814 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' GLN . . . . . 0.473 ' HB3' ' HB3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -89.55 106.75 14.95 Favored Pre-proline 0 C--N 1.315 -0.9 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.072 172.419 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 226' ' ' ALA . 60.2 Cg_endo -90.63 -43.68 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.491 2.128 . . . . 0.0 113.252 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.457 ' HB3' ' HD2' ' A' ' 230' ' ' PRO . 90.3 m-70 -100.53 175.55 2.32 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 229' ' ' HIS . 36.6 Cg_exo -60.53 177.53 0.6 Allowed 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 121.656 1.571 . . . . 0.0 112.182 171.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 61.4 m 75.7 146.41 0.09 Allowed 'General case' 0 N--CA 1.47 0.575 0 O-C-N 124.112 0.883 . . . . 0.0 108.844 -166.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.513 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 83.2 mtt180 -63.13 140.48 58.88 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 118.997 -0.525 . . . . 0.0 109.905 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.483 ' O ' HG22 ' A' ' 212' ' ' THR . 38.1 ptt180 -32.86 -44.59 0.11 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 175.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.539 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -75.7 7.95 23.73 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.631 -175.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' PHE . . . . . 0.724 ' HE1' ' N ' ' A' ' 267' ' ' GLY . 2.5 m-85 -122.49 159.86 26.78 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.947 0.88 . . . . 0.0 112.085 -172.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.446 HD13 ' O ' ' A' ' 235' ' ' PHE . 0.4 OUTLIER -130.63 132.29 23.87 Favored Pre-proline 0 C--N 1.313 -1.018 0 CA-C-N 113.913 -1.494 . . . . 0.0 108.048 172.006 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -64.2 112.24 1.83 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.51 1.473 . . . . 0.0 110.635 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.417 ' OD1' ' HB2' ' A' ' 240' ' ' ARG . 18.2 t-20 -51.81 134.44 30.9 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.781 0.8 . . . . 0.0 111.065 -178.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 33.7 pt -78.52 -1.04 3.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 114.656 -1.156 . . . . 0.0 112.026 -174.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.417 ' HB2' ' OD1' ' A' ' 238' ' ' ASN . 87.1 mtt180 -111.27 -56.83 2.33 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.372 0.606 . . . . 0.0 110.057 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 44.3 p -84.52 -46.52 11.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.199 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 104.23 7.81 39.77 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.359 -175.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -92.6 126.61 37.76 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 122.005 0.907 . . . . 0.0 109.919 -177.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 3.8 m -53.89 124.18 14.64 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 113.433 -1.712 . . . . 0.0 110.359 174.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 81.2 mm-40 -124.54 135.51 53.22 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' ASP . . . . . 0.71 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 15.2 t70 -77.49 146.0 36.7 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 121.165 0.507 . . . . 0.0 110.142 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.762 HG23 ' HG3' ' A' ' 249' ' ' GLU . 6.9 m -98.49 146.16 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -74.66 76.76 2.03 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 167.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.762 ' HG3' HG23 ' A' ' 247' ' ' VAL . 32.2 mp0 -52.51 -39.01 60.81 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.388 0.614 . . . . 0.0 110.489 -171.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 262' ' ' CYS . 53.1 t -55.45 -30.63 60.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.943 176.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -97.42 -40.98 8.43 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 122.064 0.935 . . . . 0.0 109.62 -177.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.76 -16.91 63.94 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.947 -1.478 . . . . 0.0 110.836 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 2.6 mp -120.37 104.97 42.4 Favored Pre-proline 0 N--CA 1.447 -0.611 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 174.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.426 ' HG2' ' N ' ' A' ' 203' ' ' VAL . 1.1 Cg_exo -28.69 -47.88 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.604 1 C-N-CA 126.204 4.603 . . . . 0.0 116.87 -172.147 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -140.23 43.27 1.14 Allowed Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -174.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.413 HD21 ' CE1' ' A' ' 269' ' ' PHE . 11.1 tp -54.34 125.84 20.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.761 -0.72 . . . . 0.0 110.486 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 284' ' ' GLN . 98.9 m 60.35 58.37 2.59 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.515 0.674 . . . . 0.0 109.888 -176.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -60.44 120.89 10.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.381 -177.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 101.21 40.57 2.79 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.532 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 172.8 -156.49 25.01 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.787 179.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' ASN . . . . . 0.429 ' HB2' ' HB2' ' A' ' 272' ' ' LYS . 4.9 m-20 -111.93 156.82 21.48 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 262' ' ' CYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 250' ' ' CYS . 0.9 OUTLIER -137.86 132.88 33.19 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 170.268 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 58.5 mt -130.18 115.18 31.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.527 -170.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -73.61 121.84 21.33 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -172.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 268' ' ' SER . 0.5 OUTLIER -110.01 156.14 20.89 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 153.452 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.71 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 4.1 m -74.97 126.64 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 C-N-CA 117.861 -1.536 . . . . 0.0 107.605 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.724 ' N ' ' HE1' ' A' ' 235' ' ' PHE . . . 113.25 -26.62 10.2 Favored Glycine 0 C--N 1.309 -0.94 0 C-N-CA 119.764 -1.208 . . . . 0.0 111.807 -171.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.468 ' O ' HG23 ' A' ' 265' ' ' THR . 26.5 t 173.67 157.5 0.13 Allowed 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 121.315 0.579 . . . . 0.0 109.502 -174.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 269' ' ' PHE . . . . . 0.413 ' CE1' HD21 ' A' ' 256' ' ' LEU . 35.3 p90 -101.81 153.05 20.17 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -109.41 114.05 27.38 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 55.4 m -99.96 160.97 13.91 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.856 -0.737 . . . . 0.0 111.779 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.429 ' HB2' ' HB2' ' A' ' 261' ' ' ASN . 28.5 mmmt -134.19 112.55 11.19 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.306 -178.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 79.8 m -91.93 158.95 38.94 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.129 177.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.511 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 32.0 Cg_exo -61.04 157.07 40.89 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.402 2.068 . . . . 0.0 111.052 171.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -54.8 139.63 39.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.835 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 82.99 -27.1 4.01 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.957 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' HIS . . . . . 0.517 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 13.6 m-70 -77.03 162.94 27.13 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 121.343 0.592 . . . . 0.0 111.286 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -131.9 143.13 49.92 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.379 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 57.0 tp -87.34 133.29 33.72 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.114 0.483 . . . . 0.0 110.532 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.569 ' HB3' ' HB3' ' A' ' 285' ' ' LYS . 16.5 t-20 -114.48 106.27 14.08 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 172.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -66.8 -19.69 65.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.653 -173.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.435 ' HB ' ' OD1' ' A' ' 280' ' ' ASN . 47.6 t -62.75 -47.7 91.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.615 176.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.505 ' HA ' HG21 ' A' ' 188' ' ' THR . 31.3 t -123.74 31.05 5.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.095 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' GLN . . . . . 0.447 HE21 HG11 ' A' ' 213' ' ' VAL . 23.2 mp0 29.8 46.59 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.93 -172.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 285' ' ' LYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 280' ' ' ASN . 81.1 tttt -92.08 120.41 32.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.3 -170.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 7.2 m -102.98 81.1 1.94 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.89 0.376 . . . . 0.0 110.092 173.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 29.9 mm-40 . . . . . 0 C--O 1.242 0.696 0 CA-C-O 118.203 -0.903 . . . . 0.0 109.051 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.557 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 37.7 m-85 . . . . . 0 N--CA 1.448 -0.563 0 CA-C-O 121.188 0.518 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.418 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 37.7 pt -140.1 -174.96 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.977 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.192 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.17 157.94 32.61 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.693 -175.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.1 p -61.66 -41.94 98.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.955 0.407 . . . . 0.0 111.685 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -108.15 18.89 20.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.378 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 64.6 28.92 13.23 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.281 173.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.4 9.27 71.14 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 119.77 -1.205 . . . . 0.0 114.548 -175.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.418 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 4.6 tm0? -127.32 120.45 22.21 Favored Pre-proline 0 C--O 1.217 -0.624 0 CA-C-N 118.741 1.27 . . . . 0.0 112.24 -177.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -89.65 153.97 5.2 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.13 2.554 . . . . 0.0 112.973 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 163' ' ' PRO . 10.1 p -97.23 102.89 14.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 122.508 1.147 . . . . 0.0 111.942 -177.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.458 ' HA ' ' H ' ' A' ' 164' ' ' ASN . 64.7 m -83.64 96.63 8.73 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 122.097 0.951 . . . . 0.0 110.224 170.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -54.12 -55.41 27.95 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.919 -1.491 . . . . 0.0 114.918 -168.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 47.4 m -94.3 17.05 13.51 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.205 0.526 . . . . 0.0 111.039 -165.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 73.07 131.55 0.16 Allowed Glycine 0 N--CA 1.432 -1.586 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.005 -175.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' CYS . . . . . 0.499 ' O ' HD23 ' A' ' 155' ' ' LEU . 69.7 m -69.07 150.95 47.04 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.099 -1.051 . . . . 0.0 110.614 175.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 154' ' ' CYS . 58.7 mt -133.96 172.96 12.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.566 -170.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.997 HD22 ' HB ' ' A' ' 169' ' ' THR . 0.1 OUTLIER 67.08 10.33 7.62 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.389 0.614 . . . . 0.0 111.188 178.05 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.87 36.26 91.72 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.079 -167.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -76.0 -145.23 1.54 Allowed Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.203 -0.498 . . . . 0.0 113.318 -175.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -150.86 118.02 5.95 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.665 -0.315 . . . . 0.0 111.111 -175.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 13.6 t -60.94 125.24 23.0 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.746 0.308 . . . . 0.0 110.34 176.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 165' ' ' ARG . 13.2 m -117.04 -49.28 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.922 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 163' ' ' PRO . . . -133.79 173.68 5.56 Favored Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 176.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.606 ' HA ' ' O ' ' A' ' 149' ' ' VAL . 54.3 Cg_exo -53.91 107.32 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 121.987 1.791 . . . . 0.0 112.465 177.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.458 ' H ' ' HA ' ' A' ' 150' ' ' CYS . 5.3 t-20 73.83 14.58 4.06 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.996 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.546 ' O ' HG22 ' A' ' 161' ' ' VAL . 2.0 mtm180 -113.35 89.45 3.09 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.027 174.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 82.4 m -88.32 141.69 28.34 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.0 169.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -90.32 131.28 36.21 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 60.0 m -104.53 130.96 52.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.901 0.857 . . . . 0.0 112.197 -169.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.997 ' HB ' HD22 ' A' ' 156' ' ' ASN . 82.2 m -71.02 -57.59 4.4 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 116.204 1.928 . . . . 0.0 116.204 -170.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -136.89 -100.31 0.2 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 118.329 -1.348 . . . . 0.0 113.205 -165.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -90.32 45.39 2.97 Favored Glycine 0 CA--C 1.492 -1.379 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.773 -165.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 156' ' ' ASN . 4.2 m-85 -120.23 127.22 52.22 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 119.502 -0.879 . . . . 0.0 112.186 173.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.532 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 6.5 t -92.15 154.27 18.8 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 166.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 87.97 124.18 2.05 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.31 24.31 0.36 Allowed 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.053 1.836 . . . . 0.0 114.257 -166.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.422 ' O ' HD12 ' A' ' 155' ' ' LEU . 45.9 tt0 -126.57 5.11 6.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.896 0.855 . . . . 0.0 109.854 176.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.551 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.1 OUTLIER 36.99 51.24 0.96 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 113.838 -1.528 . . . . 0.0 114.46 -177.897 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -109.72 -15.46 14.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.073 0.463 . . . . 0.0 110.656 174.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 173' ' ' THR . 14.4 mmm180 -59.88 -58.49 8.32 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.442 -1.253 . . . . 0.0 107.697 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.472 ' HA ' ' CD2' ' A' ' 172' ' ' PHE . 34.9 t70 72.71 62.24 0.11 Allowed 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 160.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.532 ' HE2' ' N ' ' A' ' 173' ' ' THR . 50.5 p90 -91.46 65.47 5.26 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 122.74 1.257 . . . . 0.0 108.478 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.461 ' O ' ' HH2' ' A' ' 217' ' ' TRP . 61.2 mtt180 -53.76 125.86 19.98 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 168.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.409 ' HB ' HG13 ' A' ' 203' ' ' VAL . 82.1 p -72.25 143.75 48.68 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.345 -160.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -149.69 147.37 17.6 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -167.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -82.27 143.6 12.64 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.177 1.918 . . . . 0.0 111.241 173.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' CYS . . . . . 0.423 ' H ' HG23 ' A' ' 202' ' ' ILE . 1.8 m -76.34 116.64 17.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.21 0.529 . . . . 0.0 111.105 176.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' PHE . . . . . 0.749 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 21.9 m-30 -84.54 145.18 28.21 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.079 177.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.491 HG22 ' NH2' ' A' ' 215' ' ' ARG . 40.2 p -122.23 -18.35 6.86 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.489 -174.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 66.5 t -139.47 115.05 8.51 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -176.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.688 HD11 ' HB2' ' A' ' 216' ' ' ALA . 20.7 mm -83.71 119.44 32.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -168.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.499 ' HB3' ' O ' ' A' ' 194' ' ' MET . 35.0 t -143.55 138.43 29.12 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.537 -1.665 . . . . 0.0 107.344 170.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -62.73 -33.45 75.15 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 172.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -55.66 -63.02 1.3 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 113.358 -1.746 . . . . 0.0 110.02 171.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.499 ' O ' ' HB3' ' A' ' 191' ' ' SER . 61.3 mtt -154.78 119.26 4.78 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.037 176.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.547 ' HB2' ' CD1' ' A' ' 187' ' ' PHE . 62.9 m -80.65 1.24 30.77 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 110.588 -0.153 . . . . 0.0 110.588 176.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.525 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 31.6 mm-40 96.62 -138.49 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.578 1.551 . . . . 0.0 109.452 -172.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.425 ' HA3' ' CE2' ' A' ' 187' ' ' PHE . . . 73.56 -37.1 0.84 Allowed Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.131 -0.557 . . . . 0.0 114.468 177.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -63.71 -14.36 51.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.527 0.664 . . . . 0.0 111.129 -177.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.496 ' N ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -107.43 27.0 9.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.645 -179.952 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.402 ' OG ' HG22 ' A' ' 202' ' ' ILE . 27.0 t -156.6 155.35 31.69 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.214 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -125.88 23.19 5.95 Favored Glycine 0 CA--C 1.504 -0.596 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 175.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.604 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -60.9 112.18 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 175.245 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.409 HG13 ' HB ' ' A' ' 183' ' ' THR . 46.4 t -104.88 100.02 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-O 122.632 1.206 . . . . 0.0 110.441 175.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.443 ' HB2' HD11 ' A' ' 202' ' ' ILE . 15.6 t -125.17 -175.23 3.25 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 112.575 -2.102 . . . . 0.0 105.862 173.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.401 HG22 ' HB2' ' A' ' 181' ' ' TYR . 12.0 p -101.42 163.17 12.41 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.664 173.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.953 ' HB3' ' CE3' ' A' ' 217' ' ' TRP . 41.4 pttt -68.98 -22.76 64.08 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.337 176.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 9.2 m -59.94 -51.42 69.74 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.429 ' CD1' HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -58.13 -48.11 81.25 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.553 175.006 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.0 -21.98 61.49 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.168 -174.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 86.6 m -101.48 -17.67 16.33 Favored 'General case' 0 C--O 1.212 -0.892 0 O-C-N 121.549 -0.719 . . . . 0.0 112.064 -176.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -81.91 -48.9 10.93 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.915 0.865 . . . . 0.0 109.797 166.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 233' ' ' ARG . 6.4 p -102.4 141.63 34.91 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.675 -176.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.468 HG13 HE22 ' A' ' 284' ' ' GLN . 1.3 t 58.51 -38.08 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -178.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.555 ' O ' ' HD3' ' A' ' 215' ' ' ARG . . . 81.58 -161.11 42.27 Favored Glycine 0 CA--C 1.505 -0.566 0 CA-C-N 119.812 1.187 . . . . 0.0 112.915 -177.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.555 ' HD3' ' O ' ' A' ' 214' ' ' GLY . 0.0 OUTLIER 102.72 -93.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.487 1.115 . . . . 0.0 108.978 166.851 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.749 ' HB3' ' HB2' ' A' ' 187' ' ' PHE . . . -172.25 172.71 4.44 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 118.99 0.814 . . . . 0.0 109.24 173.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 217' ' ' TRP . . . . . 0.953 ' CE3' ' HB3' ' A' ' 206' ' ' LYS . 12.8 t90 -163.12 150.66 13.2 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -177.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 70.7 173.06 12.87 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 114.714 0.646 . . . . 0.0 114.714 170.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.484 ' CD2' ' HZ ' ' A' ' 187' ' ' PHE . 48.4 m80 -123.97 131.73 24.25 Favored Pre-proline 0 C--N 1.334 -0.105 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 37.2 Cg_endo -63.74 167.37 39.57 Favored 'Cis proline' 0 C--N 1.349 0.555 0 C-N-CA 123.806 -1.331 . . . . 0.0 112.616 -1.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 16.2 t -59.4 111.25 1.31 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.653 -176.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -106.12 102.07 11.51 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.02 141.9 35.01 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.381 -169.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 14.8 m -144.05 159.22 53.68 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.429 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.95 167.22 23.97 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.982 2.454 . . . . 0.0 109.769 164.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.571 ' O ' ' HD3' ' A' ' 228' ' ' PRO . . . -56.02 -92.23 0.0 OUTLIER 'General case' 0 C--O 1.211 -0.969 0 CA-C-N 117.957 0.344 . . . . 0.0 110.511 176.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' GLN . . . . . 0.447 ' HB3' ' HB3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -89.02 102.59 4.31 Favored Pre-proline 0 C--N 1.316 -0.861 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.057 169.555 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.571 ' HD3' ' O ' ' A' ' 226' ' ' ALA . 24.5 Cg_endo -93.52 -44.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.794 2.329 . . . . 0.0 113.858 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.483 ' HB3' ' HD2' ' A' ' 230' ' ' PRO . 72.0 m-70 -103.15 -179.85 0.85 Allowed Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -173.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 229' ' ' HIS . 51.6 Cg_exo -59.06 174.24 0.99 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 121.849 1.699 . . . . 0.0 112.251 172.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 73.9 m 70.12 128.63 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -168.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.503 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 65.0 mtt180 -58.96 148.85 29.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -176.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.506 ' O ' HG22 ' A' ' 212' ' ' THR . 17.3 ptp180 -31.71 -47.03 0.12 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.57 ' O ' ' HA ' ' A' ' 246' ' ' ASP . . . -79.52 11.79 30.45 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.475 -0.869 . . . . 0.0 114.168 -174.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' PHE . . . . . 0.55 ' O ' HD13 ' A' ' 236' ' ' ILE . 78.5 m-85 -123.08 155.9 35.99 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.867 0.842 . . . . 0.0 113.061 -173.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.55 HD13 ' O ' ' A' ' 235' ' ' PHE . 0.3 OUTLIER -135.41 134.48 21.21 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 114.011 -1.45 . . . . 0.0 107.866 173.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.89 112.47 1.29 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 121.86 1.707 . . . . 0.0 110.932 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -53.48 135.3 40.0 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.832 0.825 . . . . 0.0 110.364 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 30.9 mt -69.69 -13.23 16.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.752 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -103.67 -60.8 1.51 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.388 0.613 . . . . 0.0 110.057 -176.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 44.7 p -84.38 -40.41 17.89 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.873 -175.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 97.6 5.0 57.95 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -83.79 133.3 34.77 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.706 0.765 . . . . 0.0 110.942 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 22.3 m -56.16 108.14 0.44 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.905 170.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 60.3 mm-40 -115.19 134.87 54.76 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' ASP . . . . . 0.655 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 12.8 t70 -75.62 140.43 42.6 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -176.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.769 HG23 ' HG3' ' A' ' 249' ' ' GLU . 3.7 m -94.38 145.14 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -75.44 77.38 2.5 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 166.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.769 ' HG3' HG23 ' A' ' 247' ' ' VAL . 47.9 mp0 -50.04 -35.32 24.56 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.4 0.619 . . . . 0.0 110.716 -171.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 77.2 m -50.94 -34.83 30.35 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.069 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -103.94 -47.35 4.22 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.428 0.691 . . . . 0.0 110.466 -175.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -63.38 -26.52 68.79 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.935 -177.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.802 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.7 mp -121.38 78.43 35.83 Favored Pre-proline 0 N--CA 1.446 -0.635 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -57.31 112.75 1.22 Allowed 'Trans proline' 0 CA--C 1.514 -0.493 0 C-N-CA 123.358 2.705 . . . . 0.0 114.608 -164.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 74.46 24.51 72.72 Favored Glycine 0 C--N 1.308 -0.976 0 CA-C-N 113.561 -1.654 . . . . 0.0 113.665 175.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.802 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.6 OUTLIER -67.92 -32.94 73.75 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 117.615 0.707 . . . . 0.0 110.537 177.487 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 257' ' ' CYS . . . . . 0.625 ' HA ' ' HB3' ' A' ' 284' ' ' GLN . 35.3 t -104.05 83.28 2.08 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.488 0.661 . . . . 0.0 109.443 177.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -98.52 -2.79 37.97 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.927 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -60.21 -41.58 98.3 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.46 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -165.31 -109.85 0.23 Allowed Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.953 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' ASN . . . . . 0.598 ' HB2' ' HB3' ' A' ' 272' ' ' LYS . 10.0 m120 -86.68 162.08 18.1 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.162 0.506 . . . . 0.0 111.276 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 4.3 t -148.08 120.46 8.44 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.177 174.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.477 ' HB ' ' HB2' ' A' ' 270' ' ' GLU . 21.7 mt -128.29 165.2 28.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 -176.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -131.58 125.86 33.35 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 117.95 -1.5 . . . . 0.0 113.559 -177.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.2 t -114.25 162.6 16.36 Favored 'General case' 0 C--O 1.259 1.558 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.131 163.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.655 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 27.2 m -72.55 124.84 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 C-N-CA 119.717 -0.793 . . . . 0.0 108.953 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.474 ' HA2' ' CE2' ' A' ' 235' ' ' PHE . . . 105.43 -17.61 43.05 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 119.997 -1.097 . . . . 0.0 112.784 -175.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 41.3 t 175.58 155.2 0.18 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.77 0.785 . . . . 0.0 110.302 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -102.33 155.96 17.9 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' GLU . . . . . 0.477 ' HB2' ' HB ' ' A' ' 263' ' ' ILE . 9.5 mt-10 -113.18 116.96 30.64 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.057 -173.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 99.2 m -105.07 148.25 27.01 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.598 ' HB3' ' HB2' ' A' ' 261' ' ' ASN . 21.2 ttpp -127.95 132.46 49.24 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -177.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 286' ' ' CYS . 23.4 m -112.63 157.14 41.19 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.373 -175.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.502 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 51.1 Cg_exo -55.41 156.84 16.19 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.189 1.926 . . . . 0.0 110.944 168.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -56.32 144.15 31.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.676 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.38 -34.31 2.89 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.283 -0.961 . . . . 0.0 112.036 -176.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' HIS . . . . . 0.623 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 16.0 m-70 -75.8 164.16 26.52 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.592 0.234 . . . . 0.0 110.56 -175.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -139.82 142.6 36.63 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -176.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 285' ' ' LYS . 57.5 tp -73.07 125.01 26.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.112 0.482 . . . . 0.0 111.315 -178.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.484 ' HB3' ' HB2' ' A' ' 285' ' ' LYS . 17.6 t-20 -102.48 95.6 6.36 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -68.0 -16.05 63.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.085 -172.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 84.7 t -56.33 -49.36 77.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.512 173.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 2.4 p -134.87 40.21 2.94 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.229 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 284' ' ' GLN . . . . . 0.625 ' HB3' ' HA ' ' A' ' 257' ' ' CYS . 13.5 mp0 25.46 56.54 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.201 -1.363 . . . . 0.0 113.457 -173.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 285' ' ' LYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 280' ' ' ASN . 98.5 mttt -101.29 176.16 5.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.77 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 286' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 273' ' ' CYS . 38.8 m -147.61 97.64 2.86 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.486 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.623 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 65.7 mm-40 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.358 -0.829 . . . . 0.0 109.54 -174.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.682 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 98.0 m-85 . . . . . 0 C--O 1.227 -0.093 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 30.7 pt -126.9 171.8 14.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 176.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.55 157.71 20.31 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.7 p -65.06 -34.71 79.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.248 0.524 . . . . 0.0 111.174 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -100.22 2.26 42.66 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.051 0.453 . . . . 0.0 110.427 174.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 60.2 m 61.9 43.64 9.1 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.496 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -104.27 3.53 43.89 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 119.953 -1.118 . . . . 0.0 113.646 -176.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 9.5 tm0? -106.58 110.92 64.09 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 117.54 0.67 . . . . 0.0 109.422 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -80.81 140.3 12.82 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.846 2.364 . . . . 0.0 112.747 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 149' ' ' VAL . 13.9 p -67.08 111.36 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.291 1.043 . . . . 0.0 112.364 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.508 ' HB3' ' SG ' ' A' ' 154' ' ' CYS . 0.8 OUTLIER -80.21 73.53 7.05 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.541 171.343 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -50.65 -67.13 0.28 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.699 -1.591 . . . . 0.0 114.239 -171.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 19.4 m -98.22 13.78 30.08 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.394 0.616 . . . . 0.0 111.624 -166.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 79.2 123.35 0.37 Allowed Glycine 0 CA--C 1.5 -0.87 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.668 -175.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' CYS . . . . . 0.508 ' SG ' ' HB3' ' A' ' 150' ' ' CYS . 86.4 m -77.0 -17.29 58.96 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -175.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.643 HD13 ' HB3' ' A' ' 178' ' ' GLU . 2.2 mp 46.19 -172.37 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -172.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.418 ' ND2' ' SG ' ' A' ' 177' ' ' CYS . 0.8 OUTLIER 51.92 11.06 0.13 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.297 1.439 . . . . 0.0 113.902 171.586 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.31 36.7 84.55 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.799 -174.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -79.24 -145.65 3.31 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.446 -176.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -153.77 118.4 4.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.368 0.584 . . . . 0.0 110.823 -175.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.9 m -62.01 119.75 9.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.746 0.308 . . . . 0.0 111.554 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 165' ' ' ARG . 4.3 m -107.13 -35.85 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 121.134 0.493 . . . . 0.0 110.417 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.638 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -140.13 172.21 6.66 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.682 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 79.4 Cg_exo -52.73 106.06 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.175 1.916 . . . . 0.0 112.246 176.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 69.1 -0.04 2.62 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.483 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.638 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -90.41 83.99 5.96 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 172.405 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 40.5 m -84.12 145.33 28.48 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.2 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -92.67 124.66 36.84 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 37.1 m -104.07 135.62 45.23 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 124.142 0.901 . . . . 0.0 112.114 -168.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.4 m -48.73 -53.66 18.04 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -172.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -167.78 -88.16 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.366 -0.934 . . . . 0.0 112.55 -174.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -85.16 57.24 4.98 Favored Glycine 0 N--CA 1.435 -1.385 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.898 -167.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.588 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 8.1 m-85 -122.91 128.49 50.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.223 1.012 . . . . 0.0 111.669 172.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.84 HG23 ' CE1' ' A' ' 181' ' ' TYR . 14.9 p -86.72 119.88 27.42 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.181 177.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 107.4 133.3 7.15 Favored Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -174.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.43 -0.45 8.19 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 120.956 1.104 . . . . 0.0 112.429 -173.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -107.96 19.23 20.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.496 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.572 ' O ' ' HB2' ' A' ' 155' ' ' LEU . 0.5 OUTLIER 17.66 79.67 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 118.301 2.704 . . . . 0.0 118.301 176.222 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.643 ' HB3' HD13 ' A' ' 155' ' ' LEU . 14.5 pt-20 -126.22 34.53 4.83 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.132 0.968 . . . . 0.0 109.517 167.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.588 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 23.0 mmt180 -132.63 88.22 2.5 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.724 -1.58 . . . . 0.0 107.248 176.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.425 ' HA ' ' CE1' ' A' ' 172' ' ' PHE . 9.2 p-10 -81.0 49.83 1.29 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.808 0.813 . . . . 0.0 111.352 -169.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.84 ' CE1' HG23 ' A' ' 173' ' ' THR . 10.5 p90 -76.59 93.86 3.66 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 176.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -79.15 173.76 12.25 Favored 'General case' 0 N--CA 1.436 -1.15 0 O-C-N 119.733 -1.854 . . . . 0.0 106.162 174.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 81.6 p -98.76 138.87 35.3 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 118.851 -1.14 . . . . 0.0 108.889 169.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.458 ' HA3' ' HA2' ' A' ' 218' ' ' GLY . . . -159.75 149.78 19.66 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.727 -173.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.416 ' HB3' ' O ' ' A' ' 200' ' ' SER . 59.4 Cg_endo -75.44 132.51 14.94 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.365 2.044 . . . . 0.0 111.041 171.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' CYS . . . . . 0.712 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 71.5 m -75.2 122.09 23.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.4 0.619 . . . . 0.0 110.236 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -107.55 153.47 22.81 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.793 -175.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.62 ' O ' ' HB3' ' A' ' 215' ' ' ARG . 29.1 p -100.94 -56.99 2.19 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.002 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 36.9 t -134.06 118.45 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 119.686 -0.805 . . . . 0.0 111.767 -172.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.637 HG13 ' SG ' ' A' ' 195' ' ' CYS . 2.1 mp -102.32 117.21 47.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.465 0.65 . . . . 0.0 111.736 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.3 p -110.98 -168.67 1.33 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 159.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -68.87 -4.84 17.9 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.383 0.611 . . . . 0.0 110.066 171.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -90.81 -76.43 0.44 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.394 -174.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 98.6 mmm -141.68 160.28 40.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.275 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.637 ' SG ' HG13 ' A' ' 190' ' ' ILE . 38.8 m -91.09 -8.15 49.69 Favored 'General case' 0 C--O 1.248 0.99 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.953 175.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.435 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 79.9 mm-40 78.22 -140.49 0.02 OUTLIER 'General case' 0 C--N 1.347 0.464 0 CA-C-N 114.2 -1.364 . . . . 0.0 109.863 -175.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 82.56 -7.06 66.31 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.796 172.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 59.1 27.98 17.12 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 122.577 0.351 . . . . 0.0 111.2 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 51.9 44.74 29.17 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.687 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.416 ' O ' ' HB3' ' A' ' 185' ' ' PRO . 41.5 t -70.47 155.53 40.59 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.641 -174.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -109.33 20.01 28.58 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.332 177.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.45 HD11 ' HB2' ' A' ' 204' ' ' SER . 0.0 OUTLIER -63.11 113.57 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 173.198 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 48.9 t -102.46 99.11 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 122.346 1.069 . . . . 0.0 110.502 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.45 ' HB2' HD11 ' A' ' 202' ' ' ILE . 7.9 t -127.77 -175.4 3.46 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 112.479 -2.146 . . . . 0.0 105.436 170.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 30.6 p -101.72 165.29 11.29 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 119.648 1.113 . . . . 0.0 109.923 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.923 ' HB3' ' CE3' ' A' ' 217' ' ' TRP . 0.0 OUTLIER -66.64 -23.85 66.21 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 119.102 -1.039 . . . . 0.0 108.662 175.805 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.8 m -59.51 -55.93 28.4 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.507 ' CD1' HG11 ' A' ' 247' ' ' VAL . 0.3 OUTLIER -54.03 -54.96 31.97 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.74 176.553 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 52.9 m -77.41 -20.51 54.52 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -170.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 226' ' ' ALA . 97.5 m -83.93 -41.73 17.07 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 119.123 0.874 . . . . 0.0 109.914 173.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ALA . . . . . 0.474 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . . . -64.6 -58.32 6.67 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.675 HG22 ' HA2' ' A' ' 234' ' ' GLY . 5.1 p -91.25 140.69 29.55 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.896 -1.502 . . . . 0.0 108.998 178.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.496 HG21 ' CD1' ' A' ' 256' ' ' LEU . 0.2 OUTLIER 58.62 -30.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -177.124 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.406 ' O ' ' HD2' ' A' ' 215' ' ' ARG . . . 75.82 -162.39 52.92 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 120.209 1.368 . . . . 0.0 114.449 177.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.62 ' HB3' ' O ' ' A' ' 188' ' ' THR . 2.1 mtt180 98.78 -83.3 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.546 1.138 . . . . 0.0 112.371 166.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' A' ' 223' ' ' MET . . . -174.57 172.02 3.18 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.117 0.417 . . . . 0.0 110.521 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' TRP . . . . . 0.923 ' CE3' ' HB3' ' A' ' 206' ' ' LYS . 9.6 t90 -165.33 151.38 9.75 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.306 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 221' ' ' CYS . . . 77.23 174.88 41.67 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 115.06 0.784 . . . . 0.0 115.06 171.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.525 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 17.6 m80 -133.3 131.72 21.74 Favored Pre-proline 0 N--CA 1.462 0.172 0 CA-C-N 114.692 -0.754 . . . . 0.0 109.315 174.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.525 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 23.0 Cg_endo -61.18 142.93 36.62 Favored 'Cis proline' 0 C--N 1.346 0.409 0 C-N-CA 123.132 -1.612 . . . . 0.0 111.175 -3.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' CYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 81.0 m -49.49 121.42 5.06 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.733 0.646 . . . . 0.0 111.784 -172.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -93.44 95.64 9.41 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' MET . . . . . 0.473 ' HA ' ' HB2' ' A' ' 216' ' ' ALA . 0.0 OUTLIER -90.22 122.7 33.39 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 -172.221 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 17.8 p -142.9 150.27 52.57 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.05 -165.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.34 167.11 13.47 Favored 'Trans proline' 0 CA--C 1.515 -0.437 0 C-N-CA 122.867 2.378 . . . . 0.0 110.672 162.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 210' ' ' CYS . . . -62.88 -119.74 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.853 0.835 . . . . 0.0 112.06 174.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 227' ' ' GLN . 6.8 pt20 -57.13 107.76 1.01 Allowed Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.13 -172.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 211' ' ' ALA . 1.9 Cg_endo -83.6 -55.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.146 2.564 . . . . 0.0 112.366 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -78.22 163.0 64.62 Favored Pre-proline 0 CA--C 1.511 -0.539 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.7 59.05 4.08 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 121.992 1.794 . . . . 0.0 112.031 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 59.3 m -131.23 162.58 29.67 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.466 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 20.8 mmt180 -66.02 139.8 58.23 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 175.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -36.22 -41.17 0.25 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.675 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -77.25 8.93 29.47 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.629 -175.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' PHE . . . . . 0.651 ' HE2' ' N ' ' A' ' 267' ' ' GLY . 2.3 m-85 -121.56 149.45 43.11 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.287 1.042 . . . . 0.0 113.067 -171.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.499 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.2 OUTLIER -125.37 124.2 25.14 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 113.736 -1.575 . . . . 0.0 108.818 172.204 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -63.58 122.1 10.09 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.295 1.997 . . . . 0.0 111.573 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -53.78 131.03 38.81 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.875 177.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 40.9 pt -76.5 7.07 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.555 176.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -113.48 -59.82 1.97 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.547 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 42.1 p -91.31 -44.01 9.44 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.913 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 105.6 7.84 36.05 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -92.77 125.16 37.25 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 121.907 0.861 . . . . 0.0 109.938 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 10.2 m -60.47 122.2 14.01 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 113.296 -1.775 . . . . 0.0 109.938 174.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.459 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 90.2 mt-30 -119.37 139.21 52.36 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' ASP . . . . . 0.787 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 17.4 t70 -74.46 143.68 44.54 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.845 HG23 ' HG3' ' A' ' 249' ' ' GLU . 10.0 m -94.52 145.98 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.252 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.89 77.04 1.64 Allowed 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 165.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.845 ' HG3' HG23 ' A' ' 247' ' ' VAL . 6.3 mp0 -52.73 -35.16 55.43 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.478 0.656 . . . . 0.0 109.56 -175.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 6.4 m -53.83 -29.51 41.15 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.211 174.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -103.72 -38.66 6.98 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.719 0.771 . . . . 0.0 109.906 -176.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -72.18 -19.8 61.69 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.869 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.684 HG22 ' HB3' ' A' ' 256' ' ' LEU . 46.7 mt -140.9 74.86 25.56 Favored Pre-proline 0 C--O 1.244 0.77 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -12.51 -80.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.947 1 C-N-CA 126.832 5.021 . . . . 0.0 116.174 -164.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -130.6 64.69 0.61 Allowed Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 119.464 -1.35 . . . . 0.0 111.472 176.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.684 ' HB3' HG22 ' A' ' 253' ' ' ILE . 1.4 pt? -68.63 8.19 0.53 Allowed 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -176.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 56.9 m -114.0 127.43 55.95 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 171.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' GLN . . . . . 0.518 ' O ' ' HB3' ' A' ' 286' ' ' CYS . 97.8 mt-30 -70.36 91.46 0.75 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.998 0.428 . . . . 0.0 111.962 -175.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 80.45 32.44 34.37 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.912 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -129.74 163.81 22.68 Favored Glycine 0 C--O 1.227 -0.308 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.06 -178.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -102.27 103.2 13.67 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 269' ' ' PHE . 50.8 t -68.21 123.05 19.63 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.079 0.466 . . . . 0.0 111.072 176.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 47.3 mt -125.56 103.75 12.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.55 ' OD1' ' HB3' ' A' ' 269' ' ' PHE . 1.5 t30 -81.12 128.3 33.59 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -160.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 265' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 268' ' ' SER . 0.2 OUTLIER -109.21 157.5 18.74 Favored 'General case' 0 C--O 1.257 1.449 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.722 163.812 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.787 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 3.2 m -72.87 128.68 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 C-N-CA 118.839 -1.144 . . . . 0.0 108.531 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.651 ' N ' ' HE2' ' A' ' 235' ' ' PHE . . . 105.19 -26.81 20.83 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.073 -1.06 . . . . 0.0 110.887 -174.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.581 ' O ' HG23 ' A' ' 265' ' ' THR . 32.6 t 176.09 151.71 0.15 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.124 0.488 . . . . 0.0 110.358 -175.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 269' ' ' PHE . . . . . 0.55 ' HB3' ' OD1' ' A' ' 264' ' ' ASN . 26.7 p90 -99.4 162.44 13.04 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.968 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -115.32 106.49 14.08 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.808 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 54.4 m -94.6 112.18 23.94 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.346 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -79.19 132.21 36.45 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.106 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.425 ' HB3' ' CB ' ' A' ' 277' ' ' HIS . 36.2 m -116.26 143.73 31.63 Favored Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.115 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.563 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 36.6 Cg_exo -60.56 167.01 8.82 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.363 2.042 . . . . 0.0 110.89 173.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -59.44 144.35 47.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.711 0.291 . . . . 0.0 110.86 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.6 -27.69 4.66 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.625 -177.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 277' ' ' HIS . . . . . 0.638 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 18.0 m-70 -77.0 160.34 29.21 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.021 0.438 . . . . 0.0 111.317 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' LYS . . . . . 0.421 ' NZ ' ' HB2' ' A' ' 278' ' ' LYS . 9.8 mtmp? -145.97 121.34 10.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.396 -174.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 19.1 tp -77.32 141.47 39.89 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.77 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.421 ' HB3' ' HB2' ' A' ' 285' ' ' LYS . 37.4 t30 -133.16 100.09 4.75 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.178 175.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -60.56 -26.05 66.63 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.47 -175.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 58.0 t -58.06 -29.53 36.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.679 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' A' ' 285' ' ' LYS . 33.4 t -147.85 34.87 0.84 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.888 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 32.11 38.55 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.448 1.099 . . . . 0.0 113.664 -176.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 96.6 mttt -87.12 149.33 24.75 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.693 -175.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 286' ' ' CYS . . . . . 0.518 ' HB3' ' O ' ' A' ' 258' ' ' GLN . 42.2 t -140.08 83.04 1.9 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.342 0.591 . . . . 0.0 109.507 178.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.638 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 3.8 mm-40 . . . . . 0 C--O 1.248 0.988 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.904 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.584 ' CE2' ' HB3' ' A' ' 148' ' ' PRO . 78.9 m-85 . . . . . 0 CA--C 1.512 -0.491 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 147' ' ' GLN . 25.1 pt -135.57 -176.66 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.024 -177.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 96.19 172.98 35.64 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.749 -176.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.0 m -76.51 -29.57 56.84 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 122.759 -0.259 . . . . 0.0 111.12 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -110.61 11.07 22.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.873 0.368 . . . . 0.0 110.425 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 58.1 m 63.5 30.09 15.28 Favored 'General case' 0 C--O 1.228 -0.037 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.129 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -94.26 4.83 70.89 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.873 -174.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.516 ' O ' HG12 ' A' ' 141' ' ' ILE . 1.9 tm0? -120.21 97.59 49.1 Favored Pre-proline 0 C--O 1.22 -0.496 0 CA-C-N 117.702 0.751 . . . . 0.0 110.755 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.584 ' HB3' ' CE2' ' A' ' 140' ' ' TYR . 52.4 Cg_endo -73.01 148.14 44.53 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.49 2.127 . . . . 0.0 112.19 176.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 149' ' ' VAL . 9.8 p -71.17 108.89 3.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.237 -173.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.69 77.24 6.32 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.362 173.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -51.9 -65.97 0.46 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -173.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 60.7 m -86.98 12.43 11.25 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.074 0.464 . . . . 0.0 111.226 -168.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 81.6 127.47 0.91 Allowed Glycine 0 N--CA 1.429 -1.786 0 CA-C-O 122.19 0.883 . . . . 0.0 111.906 -173.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' CYS . . . . . 0.496 ' O ' HD23 ' A' ' 155' ' ' LEU . 1.7 m -73.56 152.93 40.45 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 113.989 -1.106 . . . . 0.0 109.307 171.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.748 HD12 ' O ' ' A' ' 176' ' ' GLN . 70.9 mt -135.34 162.89 31.31 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -168.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.743 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 2.6 t-20 48.76 24.88 0.88 Allowed 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.909 0.756 . . . . 0.0 111.605 -168.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 63.22 38.62 96.78 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.212 -176.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -76.28 -140.81 1.04 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.734 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 159' ' ' ARG . 0.1 OUTLIER -155.55 130.99 9.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.075 0.438 . . . . 0.0 111.081 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 160' ' ' CYS . . . . . 0.442 ' O ' ' HG2' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -71.26 110.12 5.71 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.265 0.555 . . . . 0.0 110.428 172.483 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 165' ' ' ARG . 2.3 m -98.51 -28.72 3.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.631 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.745 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -140.28 173.11 5.33 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 174.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.577 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 49.4 Cg_exo -56.83 104.57 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 121.973 1.782 . . . . 0.0 112.348 178.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 68.06 9.97 7.52 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.216 1.006 . . . . 0.0 110.904 -176.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.745 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.3 OUTLIER -99.69 84.1 2.87 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.732 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 8.9 t -86.52 147.72 25.84 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.672 176.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.412 ' HB3' ' HD3' ' A' ' 159' ' ' ARG . . . -103.3 131.07 50.65 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.074 175.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 52.1 m -107.5 136.65 46.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.563 -165.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.743 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 25.4 m -53.12 -56.58 15.21 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -168.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.479 ' HE1' ' H ' ' A' ' 183' ' ' THR . 35.7 t80 -154.53 -87.61 0.05 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 119.043 -1.063 . . . . 0.0 112.729 -170.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.45 ' N ' ' HD1' ' A' ' 170' ' ' TYR . . . -92.21 52.33 2.81 Favored Glycine 0 CA--C 1.493 -1.305 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.725 -166.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.616 ' HB3' ' HA ' ' A' ' 177' ' ' CYS . 3.3 m-85 -124.87 123.91 40.95 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.54 169.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.58 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 2.9 t -91.54 145.39 24.65 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 174.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 87.76 127.86 2.67 Favored Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -173.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.35 24.76 0.35 Allowed 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 121.534 1.489 . . . . 0.0 113.327 -168.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.748 ' O ' HD12 ' A' ' 155' ' ' LEU . 59.4 tt0 -122.31 7.14 9.62 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.616 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.7 OUTLIER 25.65 59.53 0.06 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 -179.393 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -112.42 15.54 20.2 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 122.169 0.985 . . . . 0.0 109.479 171.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.579 ' HG3' ' O ' ' A' ' 173' ' ' THR . 1.4 mmp_? -87.01 -73.33 0.47 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.556 -173.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 179' ' ' ARG . 21.3 t70 88.38 78.32 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.09 0.948 . . . . 0.0 108.657 167.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.58 ' HE2' ' N ' ' A' ' 173' ' ' THR . 13.4 p90 -149.46 108.78 3.95 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.678 -176.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -74.49 147.56 41.77 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 119.668 -1.895 . . . . 0.0 109.853 173.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.479 ' H ' ' HE1' ' A' ' 170' ' ' TYR . 71.9 p -87.76 137.37 32.4 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.023 0.439 . . . . 0.0 110.337 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -151.25 153.3 24.88 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.435 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -78.58 132.91 11.3 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.748 2.299 . . . . 0.0 110.696 170.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' CYS . . . . . 0.514 ' SG ' ' NE ' ' A' ' 215' ' ' ARG . 12.7 t -100.74 117.0 33.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.04 0.447 . . . . 0.0 111.031 -174.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' PHE . . . . . 0.855 ' O ' ' HB2' ' A' ' 215' ' ' ARG . 20.4 m-85 -98.62 174.67 6.31 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.216 178.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.642 ' HA ' ' HB2' ' A' ' 215' ' ' ARG . 1.3 p -129.28 -59.52 1.1 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -177.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.2 p -113.88 117.66 56.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.077 0.465 . . . . 0.0 111.151 -170.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.599 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.0 mt -131.17 117.11 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-O 121.781 0.801 . . . . 0.0 113.129 -168.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.436 ' C ' ' H ' ' A' ' 193' ' ' GLN . 46.9 p -119.13 -164.69 1.07 Allowed 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.038 163.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -60.25 -4.97 0.94 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.878 0.37 . . . . 0.0 111.032 174.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.436 ' H ' ' C ' ' A' ' 191' ' ' SER . 94.7 mt-30 -87.53 -77.45 0.34 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.893 0.377 . . . . 0.0 110.99 -172.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.432 ' O ' ' HA ' ' A' ' 190' ' ' ILE . 72.0 mtp -147.38 167.9 23.19 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.599 ' HA ' HG12 ' A' ' 190' ' ' ILE . 35.7 m -90.88 -27.55 18.71 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 121.471 0.653 . . . . 0.0 112.191 -178.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -164.61 5.9 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.904 -0.497 . . . . 0.0 111.638 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 68.36 -52.78 0.45 Allowed Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.976 -0.631 . . . . 0.0 113.221 -172.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -115.83 122.42 45.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.188 0.518 . . . . 0.0 110.501 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.3 tt -71.4 134.74 46.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.129 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 36.3 m -101.22 131.46 47.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.843 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -87.12 14.77 56.59 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.126 177.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.431 HG21 ' HD3' ' A' ' 254' ' ' PRO . 1.0 OUTLIER -61.05 121.5 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 167.973 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 6.8 t -99.03 96.95 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.031 0 CA-C-O 123.026 1.393 . . . . 0.0 109.227 173.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 12.7 p -129.06 -179.29 5.03 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 112.268 -2.242 . . . . 0.0 106.075 176.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 53.4 p -102.02 163.2 12.37 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 119.034 -1.067 . . . . 0.0 111.728 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.807 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 42.4 tttm -56.25 -38.72 71.52 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.689 170.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.4 m -45.86 -55.55 6.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.144 174.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.616 ' HG ' ' HB1' ' A' ' 252' ' ' ALA . 0.3 OUTLIER -56.44 -53.37 58.19 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 120.229 -0.589 . . . . 0.0 110.133 176.103 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 209' ' ' CYS . . . . . 0.868 ' HA ' ' CZ ' ' A' ' 215' ' ' ARG . 76.1 m -52.5 -37.29 57.07 Favored 'General case' 0 C--O 1.247 0.922 0 O-C-N 124.088 0.867 . . . . 0.0 113.266 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 61.3 m -94.15 -33.65 13.24 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.47 -45.45 72.36 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 120.721 -1.237 . . . . 0.0 108.93 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.539 HG22 ' HA2' ' A' ' 234' ' ' GLY . 73.6 p -105.65 149.57 26.22 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.34 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.475 HG21 HG12 ' A' ' 253' ' ' ILE . 2.1 t 57.48 -53.46 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 178.011 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.477 ' CA ' ' HA ' ' A' ' 226' ' ' ALA . . . 86.06 146.53 9.41 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 119.297 -1.43 . . . . 0.0 111.429 -169.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.868 ' CZ ' ' HA ' ' A' ' 209' ' ' CYS . 0.1 OUTLIER 153.16 -135.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.014 0.526 . . . . 0.0 111.451 -162.491 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.589 ' HB3' HD11 ' A' ' 190' ' ' ILE . . . -160.59 165.95 29.82 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' TRP . . . . . 0.807 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 17.2 t90 -161.79 145.52 12.44 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 121.891 -0.506 . . . . 0.0 110.26 -173.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 99.01 -175.21 28.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.374 -0.917 . . . . 0.0 114.363 171.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -132.2 130.84 22.13 Favored Pre-proline 0 C--N 1.327 -0.411 0 O-C-N 122.818 -0.224 . . . . 0.0 110.54 176.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.19 169.31 50.53 Favored 'Cis proline' 0 C--N 1.342 0.22 0 C-N-CA 123.014 -1.661 . . . . 0.0 110.976 -9.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 93.7 m -42.34 113.72 0.48 Allowed 'General case' 0 C--O 1.234 0.239 0 O-C-N 123.354 0.409 . . . . 0.0 111.655 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -102.07 106.26 17.12 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' MET . . . . . 0.528 ' HA ' ' HB2' ' A' ' 216' ' ' ALA . 0.6 OUTLIER -99.15 134.19 42.35 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.639 -164.798 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 32.1 p -141.12 152.25 64.27 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.981 0.42 . . . . 0.0 111.624 -176.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -55.69 171.28 0.72 Allowed 'Trans proline' 0 CA--C 1.514 -0.498 0 C-N-CA 123.154 2.569 . . . . 0.0 111.585 164.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.477 ' HA ' ' CA ' ' A' ' 214' ' ' GLY . . . -61.19 -126.69 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.763 0.792 . . . . 0.0 110.451 169.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.69 109.3 6.32 Favored Pre-proline 0 C--N 1.303 -1.433 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.358 -176.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -82.21 -92.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.254 1.969 . . . . 0.0 111.306 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -125.82 86.94 56.79 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.237 172.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -106.9 -168.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.693 0 C-N-CA 123.182 2.588 . . . . 0.0 111.631 171.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 8.9 p -86.77 -51.49 6.07 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 167.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.665 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 58.6 mtt180 -143.9 133.43 23.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 174.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.441 ' HG3' ' N ' ' A' ' 234' ' ' GLY . 22.3 ptt180 -45.49 -51.06 12.17 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -173.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.539 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -77.66 11.91 17.78 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.566 -0.826 . . . . 0.0 114.286 -175.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' PHE . . . . . 0.665 ' CD1' ' HB2' ' A' ' 232' ' ' ARG . 8.1 m-85 -123.32 152.5 41.38 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 122.109 0.957 . . . . 0.0 111.864 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.455 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.2 OUTLIER -125.22 122.92 25.25 Favored Pre-proline 0 N--CA 1.426 -1.641 0 CA-C-N 114.117 -1.401 . . . . 0.0 108.221 171.133 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -64.41 123.6 12.04 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.59 2.194 . . . . 0.0 112.094 178.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -57.69 126.01 25.5 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.667 174.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 29.1 pt -76.16 7.24 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.981 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 48.0 mtm180 -112.02 -60.92 1.79 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.734 177.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 37.6 p -86.89 -46.16 10.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.862 -176.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 108.71 6.52 30.56 Favored Glycine 0 N--CA 1.436 -1.314 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.487 -176.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -86.96 120.82 28.63 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-O 122.018 0.913 . . . . 0.0 110.505 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' CYS . . . . . 0.494 ' HB3' ' HB3' ' A' ' 235' ' ' PHE . 78.1 m -62.82 122.22 15.41 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.397 -1.729 . . . . 0.0 109.884 172.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 66.0 mt-30 -114.37 135.73 53.76 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' ASP . . . . . 0.581 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 4.2 t70 -73.97 147.94 42.56 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.655 HG23 ' HG3' ' A' ' 249' ' ' GLU . 5.3 m -100.19 147.38 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.084 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -177.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.489 ' HA ' ' ND2' ' A' ' 264' ' ' ASN . 27.4 m-20 -78.06 79.25 4.52 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 167.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.655 ' HG3' HG23 ' A' ' 247' ' ' VAL . 49.8 mp0 -53.2 -36.6 61.14 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.505 -172.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 36.5 m -42.32 -40.16 2.38 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.34 171.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -100.12 -29.05 12.72 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.623 0.725 . . . . 0.0 110.321 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.616 ' HB1' ' HG ' ' A' ' 208' ' ' LEU . . . -87.71 -5.88 58.47 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.2 -172.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.61 HG13 ' NH2' ' A' ' 215' ' ' ARG . 2.8 mp -124.82 125.77 25.4 Favored Pre-proline 0 C--O 1.24 0.573 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.441 ' HD2' HG23 ' A' ' 253' ' ' ILE . 1.1 Cg_endo -34.14 -81.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 125.277 3.984 . . . . 0.0 114.208 -165.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -116.12 52.28 0.68 Allowed Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 174.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.666 ' HA ' ' OE1' ' A' ' 284' ' ' GLN . 20.0 tp -43.76 -64.92 0.57 Allowed 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.97 0.453 . . . . 0.0 112.172 -175.009 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 71.7 m -134.05 89.02 2.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -83.06 -59.2 2.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.474 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -79.85 93.79 1.41 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.847 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 273' ' ' CYS . . . 124.89 -174.52 17.22 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.672 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' ASN . . . . . 0.548 ' HB3' ' HG3' ' A' ' 272' ' ' LYS . 3.0 t-20 -83.63 157.12 22.37 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.78 132.71 18.1 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 5.2 mt -137.71 156.07 31.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -172.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.489 ' ND2' ' HA ' ' A' ' 248' ' ' ASP . 50.9 t30 -121.61 117.33 26.45 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.335 -176.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 5.6 t -110.53 166.77 10.73 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.559 164.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.581 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 29.5 m -70.44 130.46 34.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.476 -177.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.451 ' CA ' ' HE1' ' A' ' 235' ' ' PHE . . . 83.2 -9.49 60.79 Favored Glycine 0 N--CA 1.433 -1.557 0 C-N-CA 120.263 -0.97 . . . . 0.0 114.315 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 75.1 m -165.42 154.61 12.3 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 118.442 1.121 . . . . 0.0 111.184 -173.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' PHE . . . . . 0.428 ' CZ ' HD11 ' A' ' 256' ' ' LEU . 28.2 p90 -114.09 149.73 35.11 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.144 -0.972 . . . . 0.0 109.611 171.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -105.46 113.41 26.96 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 59.0 m -121.15 154.93 35.56 Favored 'General case' 0 CA--C 1.5 -0.953 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.504 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.548 ' HG3' ' HB3' ' A' ' 261' ' ' ASN . 0.0 OUTLIER -155.05 106.27 2.61 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.663 -179.713 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.449 ' HA ' ' HA3' ' A' ' 260' ' ' GLY . 64.2 m -77.0 172.97 8.3 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.25 152.44 15.12 Favored 'Trans proline' 0 C--O 1.239 0.533 0 C-N-CA 121.243 1.296 . . . . 0.0 110.481 168.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -57.97 156.88 8.53 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.928 -173.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 86.6 -38.01 3.13 Favored Glycine 0 N--CA 1.435 -1.427 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.588 -176.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -81.38 168.51 18.3 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 122.588 -0.36 . . . . 0.0 110.366 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 278' ' ' LYS . . . . . 0.639 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 61.6 mttp -148.8 138.54 22.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.247 -175.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 46.7 tp -93.79 141.65 28.25 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.375 0.422 . . . . 0.0 110.267 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -122.84 106.7 11.12 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -65.15 -13.47 58.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -173.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 76.8 t -59.68 -38.31 75.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.109 0.48 . . . . 0.0 110.807 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.409 ' O ' ' HG2' ' A' ' 284' ' ' GLN . 45.1 m -144.63 38.34 1.23 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.955 177.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 284' ' ' GLN . . . . . 0.666 ' OE1' ' HA ' ' A' ' 256' ' ' LEU . 23.9 pt20 38.25 32.8 0.05 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.317 1.047 . . . . 0.0 112.81 -175.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -89.82 105.04 17.53 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 122.111 -0.368 . . . . 0.0 111.426 -172.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 286' ' ' CYS . . . . . 0.639 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 45.7 t -108.99 163.9 12.89 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 174.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 C--O 1.248 1.026 0 O-C-N 124.057 0.848 . . . . 0.0 110.249 175.253 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.518 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 88.1 m-85 . . . . . 0 N--CA 1.451 -0.414 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 28.5 pt -135.82 -171.63 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.962 0.41 . . . . 0.0 110.087 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.74 175.15 41.39 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.398 -172.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 37.5 p -71.38 -39.67 71.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.158 0.504 . . . . 0.0 110.738 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 25.9 p-80 -107.59 16.43 23.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.11 -176.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 56.3 m 62.34 28.79 17.1 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.921 174.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.04 -5.18 70.95 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.428 -0.892 . . . . 0.0 113.583 -174.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.92 126.62 29.38 Favored Pre-proline 0 C--O 1.218 -0.565 0 CA-C-N 117.883 0.842 . . . . 0.0 110.562 -176.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -87.33 137.86 4.48 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 123.207 2.605 . . . . 0.0 113.078 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.5 p -69.48 122.51 21.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.876 0.846 . . . . 0.0 111.539 -176.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.734 ' HB3' ' SG ' ' A' ' 154' ' ' CYS . 1.4 m -80.08 120.03 23.68 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 168.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.437 ' OE2' ' HB2' ' A' ' 164' ' ' ASN . 7.1 mt-10 -95.33 -63.08 1.2 Allowed 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -172.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.44 ' C ' ' H ' ' A' ' 154' ' ' CYS . 5.4 p -76.75 27.04 0.13 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -172.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 80.27 -19.25 7.0 Favored Glycine 0 CA--C 1.494 -1.234 0 CA-C-O 121.807 0.67 . . . . 0.0 112.966 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' CYS . . . . . 0.734 ' SG ' ' HB3' ' A' ' 150' ' ' CYS . 68.4 m 62.94 133.81 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 113.201 -1.5 . . . . 0.0 112.208 -175.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.485 HD12 ' HB3' ' A' ' 178' ' ' GLU . 19.7 mt -128.19 167.82 16.3 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 113.484 -1.689 . . . . 0.0 108.69 -173.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.665 ' HB2' ' CZ ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 69.41 12.71 8.34 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.858 0.724 . . . . 0.0 111.526 174.669 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 72.1 33.9 61.91 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -168.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 167' ' ' ALA . . . -56.66 130.49 50.38 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 114.966 -0.617 . . . . 0.0 113.428 -175.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.474 ' O ' HG13 ' A' ' 161' ' ' VAL . 5.3 ttt180 -94.27 115.94 28.25 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.781 -0.709 . . . . 0.0 110.893 175.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 14.1 m -66.63 110.68 3.3 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.771 0.319 . . . . 0.0 110.725 -173.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.59 HG22 ' O ' ' A' ' 165' ' ' ARG . 5.7 m -104.27 -38.96 5.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.384 -177.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -140.39 171.9 7.06 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.518 ' HD3' ' CE1' ' A' ' 140' ' ' TYR . 88.5 Cg_exo -47.7 108.1 0.16 Allowed 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 122.137 1.892 . . . . 0.0 112.826 174.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.437 ' HB2' ' OE2' ' A' ' 151' ' ' GLU . 19.7 t-20 76.81 -18.33 0.49 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.736 1.215 . . . . 0.0 110.852 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.59 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.2 OUTLIER -78.12 81.68 4.49 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.355 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.35 142.77 29.94 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 169.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.438 ' O ' ' HA2' ' A' ' 158' ' ' GLY . . . -88.36 131.28 34.89 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -175.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.65 ' HA ' HD21 ' A' ' 156' ' ' ASN . 27.8 m -87.63 115.03 24.78 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 124.239 0.962 . . . . 0.0 111.307 -175.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 16.8 m -51.71 -54.4 28.68 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -174.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -148.88 -94.4 0.07 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.111 -1.035 . . . . 0.0 112.848 -168.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -89.54 47.81 3.29 Favored Glycine 0 N--CA 1.434 -1.487 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.909 -168.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.665 ' CZ ' ' HB2' ' A' ' 156' ' ' ASN . 16.3 m-85 -122.27 121.91 37.87 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.973 175.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.479 ' O ' ' HG2' ' A' ' 179' ' ' ARG . 4.9 t -90.8 164.56 14.04 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 161.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.37 132.35 5.45 Favored Glycine 0 N--CA 1.438 -1.182 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.27 -24.83 64.88 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.401 1.401 . . . . 0.0 113.501 -167.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -93.18 -0.12 56.99 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.518 0.675 . . . . 0.0 110.697 -178.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.55 ' HB3' ' CB ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 43.11 55.2 4.66 Favored 'General case' 0 N--CA 1.46 0.075 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.676 -174.115 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.485 ' HB3' HD12 ' A' ' 155' ' ' LEU . 13.7 pt-20 -106.12 -14.49 15.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.515 176.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 173' ' ' THR . 14.0 mmt180 -60.03 -64.2 1.03 Allowed 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.263 -177.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 31.1 t0 72.35 64.81 0.12 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.515 0.674 . . . . 0.0 109.853 163.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.433 ' CD1' ' O ' ' A' ' 181' ' ' TYR . 43.2 p90 -87.58 71.06 9.8 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 122.628 1.204 . . . . 0.0 108.026 177.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 -49.99 130.84 22.56 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.073 171.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 44.4 p -79.06 139.31 38.16 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.576 -0.45 . . . . 0.0 109.986 -176.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.423 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -157.02 154.8 25.84 Favored Glycine 0 C--N 1.321 -0.261 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -173.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -77.7 133.63 12.94 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.316 2.011 . . . . 0.0 111.889 175.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' CYS . . . . . 0.708 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 49.1 m -87.58 122.68 31.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.318 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' PHE . . . . . 0.508 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 36.5 m-85 -94.07 137.43 33.27 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.672 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.594 ' C ' ' HG2' ' A' ' 215' ' ' ARG . 23.9 m -111.64 -11.44 14.01 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.346 -160.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.7 p -169.72 116.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 O-C-N 121.925 -0.485 . . . . 0.0 110.48 174.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.591 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.4 mt -119.67 118.42 57.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -170.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.3 p -112.21 -171.32 1.83 Allowed 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 156.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -67.89 -4.03 11.6 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.591 0.71 . . . . 0.0 109.877 172.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -89.84 -67.65 0.83 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.631 -176.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.482 ' O ' ' HA ' ' A' ' 190' ' ' ILE . 62.7 mtm -136.86 145.47 44.43 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.179 -178.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.591 ' HA ' HG12 ' A' ' 190' ' ' ILE . 74.1 m -85.43 -21.1 28.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.731 0.777 . . . . 0.0 109.676 174.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.459 ' HB2' ' H ' ' A' ' 188' ' ' THR . 46.4 tt0 -162.78 -72.31 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 162.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 126.12 13.7 3.19 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.067 164.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -123.56 1.76 8.92 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 173.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 65.77 -75.03 0.05 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.552 0.741 . . . . 0.0 111.761 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 34.9 t 73.02 139.68 0.06 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.654 0.74 . . . . 0.0 112.362 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -98.93 25.28 28.81 Favored Glycine 0 CA--C 1.505 -0.57 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.593 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.524 HD11 HG23 ' A' ' 253' ' ' ILE . 1.7 tt -61.01 104.02 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-O 121.235 0.54 . . . . 0.0 109.849 173.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 10.7 t -96.28 97.43 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-O 122.603 1.192 . . . . 0.0 109.599 171.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.527 ' HB3' ' SG ' ' A' ' 209' ' ' CYS . 9.0 t -123.98 -179.51 4.43 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 172.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.431 HG22 ' HB2' ' A' ' 181' ' ' TYR . 10.4 p -103.17 161.39 13.84 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.659 -177.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.514 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 53.6 tttm -61.71 -44.29 97.21 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.177 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.6 m -46.87 -54.53 9.75 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.944 0.878 . . . . 0.0 110.133 174.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.668 HD21 ' HB1' ' A' ' 252' ' ' ALA . 4.3 tp -64.27 -52.91 56.32 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 113.423 -1.717 . . . . 0.0 112.774 -175.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' ' 204' ' ' SER . 53.2 m -74.32 -18.31 60.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.99 0.424 . . . . 0.0 111.827 -175.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 68.8 m -96.58 -25.69 15.51 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.672 176.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -73.73 -60.51 2.22 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 172.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.841 HG22 ' HA2' ' A' ' 234' ' ' GLY . 15.4 p -92.04 162.77 14.23 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 65.11 -54.04 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 95.05 -122.24 7.13 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 120.248 -0.977 . . . . 0.0 113.849 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.594 ' HG2' ' C ' ' A' ' 188' ' ' THR . 6.4 mpt_? 27.17 -86.84 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -174.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.518 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -167.6 167.46 13.44 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 119.52 1.055 . . . . 0.0 110.985 -171.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' TRP . . . . . 0.733 ' O ' ' HB2' ' A' ' 222' ' ' GLU . 10.0 t90 -155.02 144.91 21.6 Favored 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 102.3 177.2 27.58 Favored Glycine 0 CA--C 1.505 -0.586 0 C-N-CA 120.159 -1.02 . . . . 0.0 114.147 169.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 220' ' ' PRO . 13.8 p80 -129.61 133.97 25.68 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.251 -0.474 . . . . 0.0 110.804 -175.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 219' ' ' HIS . 9.7 Cg_endo -89.76 117.0 3.12 Favored 'Cis proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.17 -1.596 . . . . 0.0 111.815 -3.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 98.9 m 40.76 89.18 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 O-C-N 124.113 0.883 . . . . 0.0 112.928 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.733 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 23.8 mt-10 -102.68 111.48 23.82 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 177.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' MET . . . . . 0.518 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 18.9 ptt? -102.35 136.95 41.26 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.112 -166.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 59.4 m -119.24 147.58 43.3 Favored Pre-proline 0 C--O 1.233 0.212 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -167.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -60.27 153.67 57.86 Favored 'Trans proline' 0 CA--C 1.508 -0.812 0 C-N-CA 123.833 3.022 . . . . 0.0 113.495 167.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -42.23 113.27 0.42 Allowed 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.904 0.859 . . . . 0.0 110.508 160.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' GLN . . . . . 0.419 ' HB3' ' HA ' ' A' ' 233' ' ' ARG . 0.1 OUTLIER 23.95 99.66 0.02 OUTLIER Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 111.518 -2.583 . . . . 0.0 113.7 -177.884 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.65 -62.91 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.835 3.023 . . . . 0.0 113.627 -177.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -69.9 155.14 93.99 Favored Pre-proline 0 CA--C 1.514 -0.411 0 CA-C-O 120.691 0.282 . . . . 0.0 110.348 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.75 58.35 6.97 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 121.739 1.626 . . . . 0.0 113.799 -174.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 64.0 m -132.91 148.11 52.29 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 171.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.638 ' HG3' ' CD1' ' A' ' 235' ' ' PHE . 16.4 ptt180 -55.49 137.16 49.08 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.079 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.419 ' HA ' ' HB3' ' A' ' 227' ' ' GLN . 29.6 ptt180 -31.12 -47.15 0.1 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -166.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.841 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -68.58 5.87 3.93 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 114.981 0.753 . . . . 0.0 114.981 -174.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' PHE . . . . . 0.638 ' CD1' ' HG3' ' A' ' 232' ' ' ARG . 7.7 m-85 -122.77 150.29 42.99 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 122.089 0.947 . . . . 0.0 112.97 -169.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.524 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.1 OUTLIER -126.52 125.25 24.45 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 114.046 -1.433 . . . . 0.0 108.387 172.382 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -62.69 123.01 11.58 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.339 2.026 . . . . 0.0 111.679 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -54.08 127.25 25.86 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.354 0.597 . . . . 0.0 110.936 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 32.7 pt -65.8 -6.66 4.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.428 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 240' ' ' ARG . 63.8 mtt85 -106.51 -68.1 0.9 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.491 0.662 . . . . 0.0 110.199 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 24.4 p -79.62 -43.17 23.39 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.351 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 102.72 8.0 43.7 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -176.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -82.28 127.11 32.89 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 122.056 0.932 . . . . 0.0 109.714 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 33.3 m -63.76 114.78 4.24 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 113.458 -1.701 . . . . 0.0 109.829 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.474 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 79.3 mt-30 -112.94 134.44 54.45 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' ASP . . . . . 0.584 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 6.1 t70 -82.7 144.09 30.48 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.726 HG23 ' HG3' ' A' ' 249' ' ' GLU . 9.2 m -98.61 150.16 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.343 -174.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.67 76.39 2.04 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 169.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.726 ' HG3' HG23 ' A' ' 247' ' ' VAL . 9.7 mp0 -53.55 -39.9 65.1 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.191 0.596 . . . . 0.0 111.443 -167.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 49.2 t -51.54 -33.98 34.51 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.932 0.396 . . . . 0.0 111.284 175.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -98.67 -46.38 5.72 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.738 0.78 . . . . 0.0 110.05 -174.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.668 ' HB1' HD21 ' A' ' 208' ' ' LEU . . . -66.63 -21.55 66.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.813 -177.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.581 HG22 ' HB3' ' A' ' 256' ' ' LEU . 3.7 mp -120.39 79.56 28.64 Favored Pre-proline 0 N--CA 1.445 -0.716 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 175.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.446 ' CG ' HG13 ' A' ' 202' ' ' ILE . 0.1 OUTLIER -21.61 -29.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 1 C-N-CA 128.256 5.97 . . . . 0.0 120.032 -164.204 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 255' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 253' ' ' ILE . . . -172.06 39.03 0.16 Allowed Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 119.265 -1.445 . . . . 0.0 111.915 -175.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.581 ' HB3' HG22 ' A' ' 253' ' ' ILE . 2.2 pt? -70.57 -49.65 45.62 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 119.879 -0.728 . . . . 0.0 111.287 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' CYS . . . . . 0.557 ' H ' HD23 ' A' ' 256' ' ' LEU . 47.5 t -124.28 133.49 53.47 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 120.839 0.352 . . . . 0.0 110.086 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -134.77 -89.11 0.35 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.934 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 71.34 -71.49 0.81 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.838 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -152.81 -78.48 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' ASN . . . . . 0.548 ' HB3' ' HB2' ' A' ' 272' ' ' LYS . 3.9 t-20 -101.47 147.31 26.51 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 177.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 15.0 p -137.56 140.74 41.21 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 6.9 mt -144.62 166.16 12.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -170.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.458 ' OD1' ' HB3' ' A' ' 269' ' ' PHE . 1.0 OUTLIER -131.45 132.91 44.67 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 118.673 -1.211 . . . . 0.0 112.938 177.901 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 265' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 268' ' ' SER . 0.8 OUTLIER -114.85 161.05 18.75 Favored 'General case' 0 C--O 1.256 1.406 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.905 162.458 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.537 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 33.5 m -72.17 124.31 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.449 ' HA2' ' HE1' ' A' ' 235' ' ' PHE . . . 112.97 -29.5 8.03 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.057 -1.068 . . . . 0.0 112.895 -170.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.421 ' O ' HG23 ' A' ' 265' ' ' THR . 39.5 t 173.01 156.62 0.1 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 117.912 0.856 . . . . 0.0 109.465 -170.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 269' ' ' PHE . . . . . 0.458 ' HB3' ' OD1' ' A' ' 264' ' ' ASN . 40.2 p90 -98.43 161.4 13.7 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 121.832 -0.542 . . . . 0.0 110.029 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -114.93 141.18 48.31 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' CYS . . . . . 0.423 ' HB2' HD22 ' A' ' 279' ' ' LEU . 95.5 m -124.83 161.53 26.31 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.472 0.653 . . . . 0.0 111.493 175.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.548 ' HB2' ' HB3' ' A' ' 261' ' ' ASN . 61.1 mttp -140.39 109.52 6.13 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.592 173.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 286' ' ' CYS . 3.9 m -91.78 163.34 28.27 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.361 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 51.3 Cg_exo -53.91 158.61 8.47 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.564 2.176 . . . . 0.0 111.473 174.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -57.13 145.06 32.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 86.55 -30.89 4.36 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -173.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' HIS . . . . . 0.63 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 27.3 m-70 -89.08 173.64 8.33 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.001 0.429 . . . . 0.0 110.833 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 278' ' ' LYS . . . . . 0.667 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 95.6 mttt -162.38 153.19 17.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.903 -174.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.449 HD13 ' SG ' ' A' ' 257' ' ' CYS . 65.6 tp -87.57 136.82 32.79 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.45 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -126.6 101.23 6.56 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -63.4 -18.09 63.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.382 -174.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.509 ' HA ' ' NH2' ' A' ' 215' ' ' ARG . 93.9 t -57.08 -33.08 41.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.59 177.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 31.9 m -147.24 35.4 0.89 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.577 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 29.68 49.49 0.06 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.45 1.1 . . . . 0.0 113.368 -175.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 78.5 tttt -108.16 162.1 14.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.139 0.495 . . . . 0.0 111.768 -173.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 286' ' ' CYS . . . . . 0.667 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 40.4 m -129.63 102.79 6.51 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 18.1 tt0 . . . . . 0 C--O 1.243 0.756 0 CA-C-O 118.554 -0.736 . . . . 0.0 109.855 -173.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 147' ' ' GLN . 23.9 m-85 . . . . . 0 CA--C 1.509 -0.603 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.412 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 28.8 pt -133.44 -178.13 2.49 Favored 'Isoleucine or valine' 0 C--O 1.251 1.139 0 O-C-N 124.234 0.958 . . . . 0.0 109.588 172.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.19 163.74 34.77 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.711 -178.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.0 p -76.88 -22.42 53.48 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.883 0.373 . . . . 0.0 111.604 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -97.32 -6.74 33.63 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 13.1 t 67.9 14.48 9.4 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.817 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -89.64 4.78 83.85 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.924 -173.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.44 ' O ' ' HA ' ' A' ' 140' ' ' TYR . 2.3 tm0? -105.7 118.85 54.35 Favored Pre-proline 0 C--O 1.219 -0.533 0 CA-C-N 117.69 0.745 . . . . 0.0 111.126 -176.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -87.22 140.23 5.48 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.695 2.263 . . . . 0.0 112.537 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 149' ' ' VAL . 8.3 p -69.92 105.97 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 122.293 1.044 . . . . 0.0 111.934 -176.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.94 78.73 5.37 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.421 175.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -53.24 -70.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.606 -1.179 . . . . 0.0 113.924 -172.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.5 m -90.91 12.46 19.44 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.658 0.742 . . . . 0.0 111.17 -169.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 72.47 127.87 0.1 OUTLIER Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 114.161 -1.381 . . . . 0.0 111.713 -175.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' CYS . . . . . 0.579 ' O ' HD23 ' A' ' 155' ' ' LEU . 62.0 m -72.98 164.44 26.67 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.197 -1.002 . . . . 0.0 108.96 175.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.579 HD23 ' O ' ' A' ' 154' ' ' CYS . 62.6 mt -143.52 -178.49 5.91 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -166.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.554 ' HB2' ' CZ ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 44.44 24.48 0.09 Allowed 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 177.804 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 69.73 28.7 71.78 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.86 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -82.18 -138.7 2.88 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.306 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 166' ' ' CYS . 0.0 OUTLIER -166.25 140.68 4.37 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 117.396 0.598 . . . . 0.0 109.984 -179.192 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.97 110.98 13.37 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.319 0.581 . . . . 0.0 109.907 171.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 165' ' ' ARG . 2.5 m -99.67 -30.33 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.476 -176.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.582 ' HB3' ' CB ' ' A' ' 165' ' ' ARG . . . -140.36 171.73 7.33 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.462 ' HD2' ' HB1' ' A' ' 162' ' ' ALA . 96.6 Cg_exo -48.64 96.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.499 2.133 . . . . 0.0 113.229 177.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 42.0 t30 69.03 15.28 8.82 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.726 0.774 . . . . 0.0 109.997 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.582 ' CB ' ' HB3' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -100.74 86.5 3.12 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.793 172.224 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 60.0 m -82.75 138.37 34.06 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.016 171.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.72 131.81 34.35 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 171.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.435 ' HA ' HD21 ' A' ' 156' ' ' ASN . 72.8 m -115.28 138.27 51.13 Favored 'General case' 0 C--N 1.315 -0.916 0 O-C-N 123.876 0.735 . . . . 0.0 111.474 -170.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 39.6 m -50.37 -55.04 17.38 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.681 -168.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -162.74 -86.29 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 118.578 -1.249 . . . . 0.0 113.516 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -93.83 51.97 2.28 Favored Glycine 0 CA--C 1.489 -1.583 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.003 -164.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.692 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 1.7 m-85 -121.07 134.49 55.27 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 118.563 -1.255 . . . . 0.0 112.841 173.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.89 HG23 ' CE2' ' A' ' 181' ' ' TYR . 8.7 p -87.89 123.61 32.82 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.718 177.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' A' ' 176' ' ' GLN . . . 104.75 133.56 7.79 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 108.991 -1.643 . . . . 0.0 108.991 -175.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.49 12.81 0.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.747 1.631 . . . . 0.0 112.896 -170.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.51 ' O ' HD12 ' A' ' 155' ' ' LEU . 15.7 tt0 -121.95 16.81 10.91 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.246 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.657 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.5 OUTLIER 33.65 69.42 0.14 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 175.578 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -117.41 7.15 12.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.634 0.731 . . . . 0.0 110.509 172.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.692 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 21.4 mmt85 -117.49 89.62 3.16 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.2 -178.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -80.35 54.16 1.95 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.614 -170.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.89 ' CE2' HG23 ' A' ' 173' ' ' THR . 18.7 p90 -84.42 78.38 9.83 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -77.2 140.22 40.08 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 118.976 -2.327 . . . . 0.0 107.682 -178.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 67.0 p -83.73 136.25 34.25 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.168 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.45 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -156.16 160.83 30.39 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -80.51 129.52 7.46 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.592 2.195 . . . . 0.0 111.554 175.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' CYS . . . . . 0.775 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 83.2 m -85.8 118.44 25.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.193 0.52 . . . . 0.0 110.589 177.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' PHE . . . . . 0.595 ' O ' ' HB2' ' A' ' 215' ' ' ARG . 9.2 m-85 -94.72 150.07 20.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.972 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.444 ' HA ' ' CB ' ' A' ' 215' ' ' ARG . 21.7 p -108.5 -1.8 19.46 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 28.3 m -141.62 174.37 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.623 HD11 ' HB2' ' A' ' 216' ' ' ALA . 12.8 mm -122.15 114.21 41.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.867 0.842 . . . . 0.0 111.327 176.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.488 ' HB3' ' C ' ' A' ' 194' ' ' MET . 30.1 t -143.16 127.93 18.23 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.198 175.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -63.87 -20.75 66.06 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 171.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.46 ' HB3' ' OG ' ' A' ' 191' ' ' SER . 53.0 tt0 -71.23 -69.36 0.38 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.339 169.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.488 ' C ' ' HB3' ' A' ' 191' ' ' SER . 64.2 mtt -151.39 101.88 2.86 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 176.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 187' ' ' PHE . 39.7 m -64.83 -24.76 67.64 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 122.201 0.2 . . . . 0.0 110.737 172.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.503 ' HB2' ' HA ' ' A' ' 187' ' ' PHE . 7.7 mm-40 142.22 -139.52 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 126.959 2.104 . . . . 0.0 107.561 177.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.427 ' H ' ' HB3' ' A' ' 196' ' ' GLN . . . 84.02 -50.12 4.35 Favored Glycine 0 C--N 1.332 0.35 0 N-CA-C 115.146 0.818 . . . . 0.0 115.146 170.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -72.36 29.01 0.05 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -171.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.547 ' N ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -156.87 18.22 0.31 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.933 0.397 . . . . 0.0 110.272 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 32.2 t -153.38 135.23 14.59 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.27 0.557 . . . . 0.0 111.115 -175.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -102.37 29.73 11.88 Favored Glycine 0 CA--C 1.502 -0.778 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 173.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.626 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -64.32 104.05 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-O 122.008 0.909 . . . . 0.0 109.425 176.497 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.32 99.05 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-O 122.42 1.105 . . . . 0.0 110.283 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.3 t -123.19 -178.27 3.93 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 113.241 -1.799 . . . . 0.0 106.724 169.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.8 p -100.76 164.4 11.88 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.385 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.613 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 45.5 tttm -60.6 -46.16 91.29 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.44 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.1 m -43.95 -56.23 4.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.88 174.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.568 ' CD1' HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -55.68 -57.47 11.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.53 179.296 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 40.0 m -72.5 -17.4 61.75 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -170.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 66.3 m -92.39 -31.61 15.26 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.021 175.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -70.84 -61.67 1.68 Allowed 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.737 HG22 ' HA2' ' A' ' 234' ' ' GLY . 32.4 p -92.26 152.52 19.78 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.105 174.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.1 t 70.3 -43.8 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.618 ' O ' ' HD2' ' A' ' 215' ' ' ARG . . . 55.97 61.97 6.85 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 115.767 1.067 . . . . 0.0 115.767 170.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.618 ' HD2' ' O ' ' A' ' 214' ' ' GLY . 14.4 mmm180 -126.43 -82.25 0.62 Allowed 'General case' 0 C--O 1.237 0.44 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.888 176.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.623 ' HB2' HD11 ' A' ' 190' ' ' ILE . . . -169.11 166.74 10.8 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 217' ' ' TRP . . . . . 0.775 ' HD1' ' SG ' ' A' ' 186' ' ' CYS . 11.6 t90 -159.12 149.42 19.37 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 121.23 -0.919 . . . . 0.0 109.461 -175.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 221' ' ' CYS . . . 87.13 156.68 29.9 Favored Glycine 0 C--O 1.223 -0.542 0 C-N-CA 120.363 -0.922 . . . . 0.0 114.695 168.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.618 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 17.0 p80 -130.57 135.46 27.42 Favored Pre-proline 0 C--O 1.236 0.354 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.618 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 31.6 Cg_exo -59.31 143.37 29.79 Favored 'Cis proline' 0 N--CA 1.477 0.552 0 C-N-CA 124.16 -1.183 . . . . 0.0 111.71 -0.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 43.0 t -41.86 117.77 1.0 Allowed 'General case' 0 N--CA 1.464 0.257 0 O-C-N 124.222 0.951 . . . . 0.0 112.868 -170.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.45 ' HB3' ' HE3' ' A' ' 206' ' ' LYS . 22.9 mt-10 -109.41 120.25 41.95 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -80.29 148.28 30.8 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -176.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 5.8 m -85.4 123.34 73.09 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -172.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.2 167.56 19.89 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.394 2.73 . . . . 0.0 110.847 167.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -39.74 -60.06 1.05 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.12 -172.75 0.33 Allowed Pre-proline 0 N--CA 1.431 -1.418 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 -173.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -84.75 -98.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.801 1.667 . . . . 0.0 110.7 172.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.436 ' CG ' ' HG3' ' A' ' 237' ' ' PRO . 20.0 m-70 -84.24 166.77 31.33 Favored Pre-proline 0 CA--C 1.513 -0.473 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 169.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.12 65.52 4.25 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.852 1.702 . . . . 0.0 113.162 -176.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 64.2 m -106.2 -173.88 2.4 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 170.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.733 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 86.3 mtt180 -67.75 147.57 52.44 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 119.701 -0.799 . . . . 0.0 108.927 172.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -37.92 -49.98 1.27 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 178.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.737 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -79.33 12.44 26.2 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.605 -0.807 . . . . 0.0 114.833 -174.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' PHE . . . . . 0.733 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 2.3 m-85 -122.86 146.82 47.22 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 122.093 0.949 . . . . 0.0 113.21 -172.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.462 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.0 OUTLIER -124.87 132.74 24.36 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 114.098 -1.41 . . . . 0.0 107.967 170.543 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.436 ' HG3' ' CG ' ' A' ' 229' ' ' HIS . 18.1 Cg_endo -60.38 118.85 5.77 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.13 1.887 . . . . 0.0 111.721 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -52.29 136.85 30.01 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 121.727 0.775 . . . . 0.0 110.582 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 33.2 mt -70.93 -16.37 19.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.404 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 240' ' ' ARG . 42.0 mtm105 -102.52 -63.32 1.17 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.29 0.567 . . . . 0.0 110.248 -176.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 40.5 p -79.34 -38.46 35.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.75 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 94.89 5.41 61.11 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -176.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -86.67 124.36 32.85 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 121.935 0.874 . . . . 0.0 109.121 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 235' ' ' PHE . 13.0 m -57.92 123.13 14.77 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 113.403 -1.726 . . . . 0.0 110.479 178.042 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 80.7 mm-40 -119.39 142.85 47.82 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' ASP . . . . . 0.569 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 8.5 t70 -77.85 147.53 35.11 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.721 HG23 ' HG3' ' A' ' 249' ' ' GLU . 15.9 m -94.17 142.88 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.094 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.212 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -70.07 77.5 0.5 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 164.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.721 ' HG3' HG23 ' A' ' 247' ' ' VAL . 20.5 mp0 -52.7 -35.6 55.83 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 123.525 0.515 . . . . 0.0 110.498 -173.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 33.1 m -55.01 -29.33 57.12 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.176 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -103.93 -43.74 5.21 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.923 0.868 . . . . 0.0 109.7 -175.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.34 -22.1 64.71 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.024 -1.444 . . . . 0.0 111.286 -175.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.764 HG22 ' HB3' ' A' ' 256' ' ' LEU . 64.2 mt -131.34 75.61 77.17 Favored Pre-proline 0 N--CA 1.447 -0.603 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -13.04 -91.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.039 1 C-N-CA 126.106 4.537 . . . . 0.0 115.749 -162.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -119.69 59.41 0.53 Allowed Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 119.641 -1.266 . . . . 0.0 111.872 177.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.764 ' HB3' HG22 ' A' ' 253' ' ' ILE . 2.3 pt? -63.97 -38.91 92.79 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.139 177.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 45.8 t -104.86 107.36 18.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.492 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -116.68 35.69 4.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.903 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.678 ' HA3' ' SG ' ' A' ' 286' ' ' CYS . . . -87.96 -9.04 71.58 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.592 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 145.21 -100.11 0.22 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 261' ' ' ASN . . . . . 0.598 ' HB2' ' HB2' ' A' ' 272' ' ' LYS . 11.2 m120 -89.09 158.01 18.12 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.733 0.301 . . . . 0.0 110.778 177.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.71 132.73 14.29 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 10.7 mt -142.34 165.46 16.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -173.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.93 126.53 43.39 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 118.556 -1.258 . . . . 0.0 113.525 -175.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 4.6 t -115.55 167.78 10.59 Favored 'General case' 0 C--O 1.258 1.52 0 CA-C-O 122.243 1.021 . . . . 0.0 110.322 162.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.547 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 30.4 m -71.11 131.27 34.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.849 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.555 ' CA ' ' HE2' ' A' ' 235' ' ' PHE . . . 88.95 -9.79 75.28 Favored Glycine 0 N--CA 1.423 -2.201 0 CA-C-O 119.264 -0.742 . . . . 0.0 113.527 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 48.3 t -179.51 150.03 0.41 Allowed 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 117.838 0.819 . . . . 0.0 111.255 -172.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -107.31 156.53 18.78 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.89 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -108.27 128.88 55.12 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.961 -176.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 271' ' ' CYS . . . . . 0.421 ' HB2' HD22 ' A' ' 279' ' ' LEU . 54.9 m -120.56 160.38 23.32 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.313 0.578 . . . . 0.0 111.081 176.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.598 ' HB2' ' HB2' ' A' ' 261' ' ' ASN . 6.9 mtpm? -140.54 124.52 17.37 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.193 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 3.7 m -98.36 170.72 6.64 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 175.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 34.5 Cg_exo -58.31 156.18 31.7 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.567 1.511 . . . . 0.0 110.611 170.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -59.34 149.39 29.15 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.25 -33.26 3.19 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.113 -174.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' HIS . . . . . 0.473 ' HB2' ' O ' ' A' ' 274' ' ' PRO . 9.2 m170 -78.69 167.37 21.32 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 120.987 0.422 . . . . 0.0 110.69 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 278' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 67.1 mttm -140.22 139.15 35.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.227 -179.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.485 HD12 ' O ' ' A' ' 285' ' ' LYS . 21.4 tp -81.71 143.98 31.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.041 0.448 . . . . 0.0 110.75 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -124.55 98.46 5.74 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -68.04 -12.83 61.54 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -174.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 42.7 t -66.24 -25.42 35.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.252 0.548 . . . . 0.0 110.266 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 10.3 p -148.05 28.87 0.91 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.618 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' GLN . . . . . 0.402 ' HG3' ' HG ' ' A' ' 256' ' ' LEU . 13.8 mm100 30.06 49.57 0.07 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.709 -1.132 . . . . 0.0 113.16 -171.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 285' ' ' LYS . . . . . 0.485 ' O ' HD12 ' A' ' 279' ' ' LEU . 97.9 mttt -102.65 175.65 5.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.754 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 286' ' ' CYS . . . . . 0.678 ' SG ' ' HA3' ' A' ' 259' ' ' GLY . 92.9 m -141.81 170.41 15.77 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 173.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.643 ' HB2' ' O ' ' A' ' 286' ' ' CYS . 2.4 mp0 . . . . . 0 C--O 1.25 1.099 0 C-N-CA 124.319 1.048 . . . . 0.0 109.408 170.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.667 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 97.9 m-85 . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 121.157 0.504 . . . . 0.0 110.376 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.484 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 40.6 pt -131.08 175.03 12.14 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.312 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 101.29 174.18 28.68 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.851 -177.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.3 p -73.54 -31.61 63.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.316 0.579 . . . . 0.0 111.45 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -110.87 7.05 21.7 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.411 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 34.1 m 63.91 37.49 9.48 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 124.204 0.94 . . . . 0.0 111.181 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -93.62 -7.09 61.92 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.906 -176.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.484 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 2.0 tm0? -103.27 112.72 65.9 Favored Pre-proline 0 C--N 1.327 -0.404 0 O-C-N 122.121 -0.635 . . . . 0.0 110.704 -177.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.67 142.45 14.34 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.342 2.695 . . . . 0.0 112.614 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 149' ' ' VAL . 8.9 p -73.15 107.73 3.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 122.504 1.145 . . . . 0.0 111.284 -178.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.86 88.03 5.29 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.298 175.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.34 -68.04 0.27 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -175.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 16.7 m -95.71 13.37 26.66 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.824 0.345 . . . . 0.0 111.628 -166.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.23 123.95 0.91 Allowed Glycine 0 N--CA 1.438 -1.221 0 CA-C-O 121.819 0.677 . . . . 0.0 113.066 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' CYS . . . . . 0.437 ' O ' HD23 ' A' ' 155' ' ' LEU . 80.4 m -81.14 162.23 23.75 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 172.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.621 HD12 ' O ' ' A' ' 176' ' ' GLN . 79.9 mt -148.22 167.27 25.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 118.04 0.382 . . . . 0.0 110.88 -162.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.605 ' HB2' ' CZ ' ' A' ' 172' ' ' PHE . 10.0 t30 48.31 23.72 0.6 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.327 -164.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 66.0 39.36 94.79 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.256 -0.974 . . . . 0.0 111.774 -177.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.62 -138.16 0.21 Allowed Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.772 -0.727 . . . . 0.0 111.313 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 13.1 ttt180 -159.47 128.99 5.41 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.08 -0.659 . . . . 0.0 111.221 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.4 m -62.91 119.99 10.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.59 0.233 . . . . 0.0 110.691 173.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 165' ' ' ARG . 16.7 m -105.68 -35.84 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.947 0.403 . . . . 0.0 110.546 178.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.75 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -139.93 170.55 9.56 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.667 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 76.6 Cg_exo -51.58 109.17 0.29 Allowed 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.208 1.939 . . . . 0.0 112.133 174.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 72.96 -3.07 2.52 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.36 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.75 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.9 OUTLIER -90.92 86.35 6.26 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.516 175.857 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 72.6 m -78.65 141.07 38.27 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.234 171.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.439 ' HB2' ' CG1' ' A' ' 161' ' ' VAL . . . -97.79 117.54 32.34 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 172.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 83.0 m -101.18 141.17 34.45 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.036 -170.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 7.0 m -51.11 -53.9 29.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -168.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -167.68 -84.72 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.36 -0.936 . . . . 0.0 113.227 -172.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -90.94 55.91 3.32 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.325 -167.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.674 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 7.0 m-85 -127.11 137.57 53.02 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.509 169.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.679 HG23 ' CE2' ' A' ' 181' ' ' TYR . 64.4 p -87.15 123.79 32.57 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.094 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 102.09 139.84 10.78 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.05 7.82 1.59 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 121.143 1.229 . . . . 0.0 112.449 -172.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.621 ' O ' HD12 ' A' ' 155' ' ' LEU . 18.9 tt0 -119.47 26.1 9.63 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.294 176.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.572 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.7 OUTLIER 23.89 72.72 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 118.693 2.849 . . . . 0.0 118.693 170.614 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.418 ' O ' ' HD3' ' A' ' 179' ' ' ARG . 9.9 pt-20 -124.96 29.8 6.05 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.103 -0.998 . . . . 0.0 110.929 169.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.674 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 23.9 mmt180 -130.2 93.0 3.38 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.168 175.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.427 ' HA ' ' CE1' ' A' ' 172' ' ' PHE . 3.7 m-20 -78.07 53.14 1.16 Allowed 'General case' 0 C--N 1.323 -0.55 0 O-C-N 123.402 0.439 . . . . 0.0 111.189 -169.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.75 ' HA ' HG21 ' A' ' 205' ' ' THR . 16.2 p90 -84.4 80.43 9.22 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -82.75 135.12 35.08 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 119.761 -1.837 . . . . 0.0 108.609 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 70.3 p -77.06 171.04 15.44 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.463 ' HA3' ' CE2' ' A' ' 217' ' ' TRP . . . 157.18 136.04 2.04 Favored Glycine 0 C--N 1.32 -0.322 0 C-N-CA 119.669 -1.253 . . . . 0.0 112.359 -163.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.489 ' HG2' ' CD2' ' A' ' 219' ' ' HIS . 16.6 Cg_exo -69.62 128.23 15.86 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.133 1.889 . . . . 0.0 111.531 172.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' CYS . . . . . 0.715 ' SG ' ' HD2' ' A' ' 215' ' ' ARG . 16.5 t -102.18 114.28 28.29 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.474 0.654 . . . . 0.0 110.68 -178.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' PHE . . . . . 0.658 ' O ' ' HB3' ' A' ' 215' ' ' ARG . 16.8 m-85 -93.62 143.43 26.31 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.262 -177.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.467 ' HA ' ' HB3' ' A' ' 215' ' ' ARG . 2.4 m -96.23 -27.73 14.87 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -162.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.1 p -163.2 118.79 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.628 -171.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.634 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.4 mt -125.51 118.8 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 122.182 0.992 . . . . 0.0 113.486 -168.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.418 ' C ' ' H ' ' A' ' 193' ' ' GLN . 36.2 t -116.15 -164.56 0.97 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 113.766 -1.561 . . . . 0.0 106.934 163.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -63.87 -5.71 4.81 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.718 0.77 . . . . 0.0 110.008 170.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.418 ' H ' ' C ' ' A' ' 191' ' ' SER . 96.3 mt-30 -69.84 -75.76 0.11 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.847 -178.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 46.0 ttm -171.2 151.37 3.15 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.957 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.634 ' HA ' HG12 ' A' ' 190' ' ' ILE . 72.8 m -57.43 -46.11 83.92 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 121.73 0.776 . . . . 0.0 110.91 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -151.54 -81.22 0.1 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 166.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.44 -24.33 6.91 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.569 172.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -131.14 45.3 2.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.393 0.616 . . . . 0.0 109.43 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 26.3 tp -169.82 132.76 1.17 Allowed 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.572 -173.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 34.7 t -149.04 -47.46 0.14 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.753 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.84 26.62 10.47 Favored Glycine 0 C--O 1.228 -0.225 0 C-N-CA 120.752 -0.737 . . . . 0.0 114.333 -171.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.487 ' O ' HD13 ' A' ' 202' ' ' ILE . 0.0 OUTLIER -79.29 91.58 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 165.424 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.49 112.47 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 CA-C-O 122.935 1.35 . . . . 0.0 110.171 -171.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 6.1 t -155.64 -178.74 7.5 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.75 HG21 ' HA ' ' A' ' 181' ' ' TYR . 17.8 p -106.35 171.5 7.32 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 120.883 1.674 . . . . 0.0 110.649 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.806 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 34.0 tttm -59.88 -47.43 85.77 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.777 175.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.9 m -45.21 -55.59 5.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.956 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.512 HD11 HG11 ' A' ' 247' ' ' VAL . 0.3 OUTLIER -58.73 -48.76 80.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.257 178.249 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 97.2 m -61.18 -38.81 87.83 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 227' ' ' GLN . 56.5 m -83.86 -37.19 22.77 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 121.65 -0.656 . . . . 0.0 111.249 -176.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ALA . . . . . 0.5 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . . . -68.14 -57.69 5.66 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.695 HG22 ' HA2' ' A' ' 234' ' ' GLY . 30.5 p -104.05 144.16 31.92 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.152 -175.366 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.0 t 64.06 -22.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 63.55 51.86 50.85 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 120.435 1.47 . . . . 0.0 114.028 167.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.715 ' HD2' ' SG ' ' A' ' 186' ' ' CYS . 27.1 mtt85 -103.09 -123.03 0.19 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.797 0.808 . . . . 0.0 111.307 -178.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.574 ' HB3' HD11 ' A' ' 190' ' ' ILE . . . -156.8 168.52 27.21 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' TRP . . . . . 0.806 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 36.6 t90 -161.77 149.74 14.94 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 119.365 0.984 . . . . 0.0 111.188 -170.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 85.09 170.12 46.81 Favored Glycine 0 C--O 1.229 -0.186 0 N-CA-C 115.081 0.792 . . . . 0.0 115.081 170.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.584 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 85.8 m-70 -127.23 133.04 24.63 Favored Pre-proline 0 N--CA 1.457 -0.117 0 C-N-CA 122.949 0.5 . . . . 0.0 109.879 171.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.584 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 18.9 Cg_endo -58.73 157.67 36.99 Favored 'Cis proline' 0 C--O 1.236 0.393 0 C-N-CA 123.261 -1.558 . . . . 0.0 112.373 -4.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 33.2 t -53.41 115.56 1.99 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.586 -174.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 27.5 mt-10 -105.39 102.76 12.21 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' MET . . . . . 0.585 ' O ' ' HD3' ' A' ' 225' ' ' PRO . 1.3 tpt -79.09 132.42 36.59 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -175.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' CYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 215' ' ' ARG . 92.7 m -83.29 112.58 40.06 Favored Pre-proline 0 C--N 1.332 -0.154 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -172.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.585 ' HD3' ' O ' ' A' ' 223' ' ' MET . 6.1 Cg_exo -81.41 124.92 4.9 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.598 2.865 . . . . 0.0 111.054 169.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 48.25 -79.16 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.899 0.88 . . . . 0.0 113.228 -174.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 225' ' ' PRO . 0.0 OUTLIER -162.27 -171.54 0.28 Allowed Pre-proline 0 N--CA 1.441 -0.903 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -168.317 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 211' ' ' ALA . 6.9 Cg_endo -87.85 -90.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 121.835 1.69 . . . . 0.0 111.478 170.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -87.66 158.12 51.48 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 172.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.02 61.87 7.8 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.19 1.927 . . . . 0.0 114.593 -171.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 92.2 m -110.39 -177.94 3.37 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 169.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.643 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 31.1 mmt180 -62.72 140.63 58.74 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 173.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -37.33 -50.72 1.05 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.695 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -70.1 1.14 19.45 Favored Glycine 0 C--N 1.313 -0.728 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.72 -174.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' PHE . . . . . 0.643 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 11.3 m-85 -123.17 151.32 42.3 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.159 0.981 . . . . 0.0 113.324 -169.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.436 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.1 OUTLIER -127.32 128.7 24.02 Favored Pre-proline 0 N--CA 1.436 -1.143 0 CA-C-N 114.082 -1.417 . . . . 0.0 108.259 169.999 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.92 125.17 14.25 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.533 2.156 . . . . 0.0 111.802 178.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -62.61 136.64 57.98 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 35.5 pt -82.78 2.32 3.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.584 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -103.12 -57.37 2.05 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.853 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 52.3 p -89.06 -45.9 9.26 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.5 -178.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 103.06 11.02 35.35 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -96.17 125.23 40.55 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 121.95 0.881 . . . . 0.0 109.992 -177.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 4.3 m -59.06 122.56 14.06 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.832 172.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 75.5 mm-40 -123.37 137.9 54.72 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' ASP . . . . . 0.542 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 6.1 t70 -75.32 147.21 40.33 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-O 121.283 0.563 . . . . 0.0 110.001 -176.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.62 HG23 ' HG3' ' A' ' 249' ' ' GLU . 11.4 m -93.53 144.27 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.426 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.48 ' HA ' ' ND2' ' A' ' 264' ' ' ASN . 7.0 m-20 -75.03 77.28 2.22 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 168.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.62 ' HG3' HG23 ' A' ' 247' ' ' VAL . 36.2 mp0 -52.42 -35.73 52.7 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.651 0.739 . . . . 0.0 110.515 -171.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 9.5 m -53.39 -33.47 53.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.877 175.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -99.1 -37.42 9.34 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.78 0.8 . . . . 0.0 110.101 -177.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.23 -19.02 63.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.753 -175.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.403 HG12 HH22 ' A' ' 215' ' ' ARG . 3.2 mp -126.66 117.18 22.68 Favored Pre-proline 0 N--CA 1.446 -0.637 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 174.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -35.79 -91.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.483 0.911 1 C-N-CA 125.345 4.03 . . . . 0.0 114.39 -165.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -100.36 56.59 0.8 Allowed Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.406 171.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.409 ' O ' ' HG3' ' A' ' 284' ' ' GLN . 22.6 tp -40.3 -65.33 0.42 Allowed 'General case' 0 C--O 1.224 -0.273 0 O-C-N 124.465 0.744 . . . . 0.0 112.894 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 257' ' ' CYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 262' ' ' CYS . 11.3 t -87.62 62.72 7.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.104 0.478 . . . . 0.0 109.857 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -60.4 104.33 0.32 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.55 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 131.92 -17.35 4.92 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.764 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -150.78 -157.85 8.0 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.032 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -108.54 121.55 45.21 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 269' ' ' PHE . 52.6 t -92.14 133.55 35.68 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 176.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 39.3 mt -132.24 112.51 19.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.442 0.639 . . . . 0.0 110.075 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.48 ' ND2' ' HA ' ' A' ' 248' ' ' ASP . 66.1 t30 -74.13 126.44 30.57 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -170.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 6.2 t -113.35 164.91 12.98 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.021 154.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.542 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 30.7 m -69.97 132.2 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 118.705 -1.198 . . . . 0.0 108.899 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.502 ' CA ' ' HE2' ' A' ' 235' ' ' PHE . . . 88.53 -10.87 70.11 Favored Glycine 0 C--N 1.314 -0.678 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.571 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.4 p -174.43 143.14 0.82 Allowed 'General case' 0 C--O 1.212 -0.872 0 CA-C-N 118.112 0.956 . . . . 0.0 110.705 -174.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' PHE . . . . . 0.482 ' HB2' ' SG ' ' A' ' 262' ' ' CYS . 41.1 p90 -103.12 151.64 22.33 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -114.7 126.84 55.33 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -175.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' CYS . . . . . 0.433 ' HB2' HD22 ' A' ' 279' ' ' LEU . 11.1 m -97.05 158.17 15.56 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.867 0.841 . . . . 0.0 111.961 -178.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -134.71 106.26 6.86 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.278 172.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 4.6 m -96.52 156.03 37.21 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.502 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 52.2 Cg_exo -55.84 159.9 10.88 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.53 2.154 . . . . 0.0 111.425 172.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -56.17 146.02 24.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.551 0.215 . . . . 0.0 111.07 -177.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.26 -30.0 3.42 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.88 -176.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' HIS . . . . . 0.546 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 17.8 m-70 -78.84 165.01 24.01 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.135 0.493 . . . . 0.0 111.507 -177.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -146.4 135.0 22.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.605 -175.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.621 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 39.0 tp -71.34 140.85 50.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.223 0.535 . . . . 0.0 110.926 177.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -129.56 102.44 6.37 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 170.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -61.01 -24.38 66.12 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 123.521 0.513 . . . . 0.0 111.781 -173.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 16.4 t -62.66 -23.84 33.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.983 0.421 . . . . 0.0 110.826 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.4 ' C ' HE21 ' A' ' 284' ' ' GLN . 28.1 p -141.63 24.86 2.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.668 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 284' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 256' ' ' LEU . 0.0 OUTLIER 25.53 48.85 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.142 0.977 . . . . 0.0 112.178 -169.115 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 285' ' ' LYS . . . . . 0.621 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 81.8 tttt -97.87 159.14 15.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.16 -171.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 4.0 m -137.15 81.25 1.86 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.041 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.546 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 66.5 mm-40 . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.346 -0.835 . . . . 0.0 108.893 -174.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.657 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 94.8 m-85 . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 120.811 0.339 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 26.6 pt -128.31 176.65 7.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.669 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 96.64 167.94 33.77 Favored Glycine 0 C--N 1.318 -0.457 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.761 -176.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.9 p -74.62 -23.61 58.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.176 0.488 . . . . 0.0 111.669 -177.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -109.54 7.3 24.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.534 176.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 30.9 m 64.29 30.05 13.53 Favored 'General case' 0 N--CA 1.462 0.168 0 O-C-N 123.672 0.607 . . . . 0.0 111.013 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.3 -12.22 67.95 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.571 -173.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -106.77 109.67 63.24 Favored Pre-proline 0 C--O 1.224 -0.259 0 CA-C-N 117.912 0.856 . . . . 0.0 110.745 -174.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.01 139.4 24.2 Favored 'Trans proline' 0 CA--C 1.522 -0.092 0 C-N-CA 123.625 2.884 . . . . 0.0 112.578 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 149' ' ' VAL . 9.3 p -67.52 110.53 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.734 0.778 . . . . 0.0 111.479 -175.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.38 77.18 7.17 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.972 176.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -53.86 -68.89 0.14 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -174.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.4 m -88.01 13.55 10.82 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.137 0.494 . . . . 0.0 111.679 -165.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 87.99 122.1 1.75 Allowed Glycine 0 N--CA 1.428 -1.841 0 CA-C-O 122.237 0.909 . . . . 0.0 112.608 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' CYS . . . . . 0.414 ' C ' ' HG ' ' A' ' 155' ' ' LEU . 5.7 m -78.32 155.13 30.3 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 113.185 -1.507 . . . . 0.0 109.034 168.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.669 HD12 ' O ' ' A' ' 176' ' ' GLN . 56.3 mt -149.71 163.22 38.55 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.858 -166.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.577 HD22 ' HB ' ' A' ' 169' ' ' THR . 61.4 t30 47.69 24.13 0.51 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.66 -164.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 67.71 38.3 89.71 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.74 -177.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.22 -152.84 0.59 Allowed Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.723 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -149.07 121.57 8.52 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.223 -0.575 . . . . 0.0 111.808 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.5 m -63.19 114.69 3.92 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.668 177.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 165' ' ' ARG . 8.8 m -104.17 -34.92 3.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.81 0.338 . . . . 0.0 110.935 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.696 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -140.1 171.68 7.47 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.657 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 73.9 Cg_exo -53.3 108.55 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.988 1.792 . . . . 0.0 112.434 177.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 72.81 -7.88 1.37 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.362 1.065 . . . . 0.0 110.423 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.696 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.5 OUTLIER -83.49 82.54 8.25 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 176.295 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 7.1 t -80.88 145.8 31.15 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.463 ' HB2' ' CG1' ' A' ' 161' ' ' VAL . . . -96.5 118.68 33.51 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 173.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 84.0 m -90.45 126.97 36.08 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.791 -167.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.577 ' HB ' HD22 ' A' ' 156' ' ' ASN . 3.0 m -42.62 -51.44 5.19 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 124.633 1.208 . . . . 0.0 112.531 -172.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -165.76 -89.75 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 119.481 -0.888 . . . . 0.0 112.234 -176.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -90.98 54.89 3.32 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.636 -167.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.643 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 7.8 m-85 -129.63 136.5 49.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.608 0.704 . . . . 0.0 111.654 169.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.696 HG23 ' CE2' ' A' ' 181' ' ' TYR . 80.1 p -87.49 132.79 33.9 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.383 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 176' ' ' GLN . . . 92.06 146.75 19.14 Favored Glycine 0 N--CA 1.438 -1.167 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.799 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.32 22.89 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.616 1.544 . . . . 0.0 112.407 -174.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.669 ' O ' HD12 ' A' ' 155' ' ' LEU . 50.4 tt0 -120.85 3.28 10.57 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.512 176.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.596 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 32.15 57.59 0.36 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 176.639 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.454 ' HG3' ' HE ' ' A' ' 179' ' ' ARG . 15.7 pt-20 -115.84 17.21 16.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.501 0.667 . . . . 0.0 110.085 175.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.643 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 8.8 mmt180 -117.65 90.66 3.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.651 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -78.91 79.46 5.31 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.869 0.843 . . . . 0.0 110.97 -168.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.696 ' CE2' HG23 ' A' ' 173' ' ' THR . 17.4 p90 -112.13 79.97 1.28 Allowed 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 22.9 mtp85 -79.93 144.95 32.91 Favored 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 118.936 -2.352 . . . . 0.0 107.285 -176.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 82.3 p -78.65 138.22 38.21 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.083 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.488 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -151.91 149.78 21.55 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -70.62 128.44 15.25 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.76 1.64 . . . . 0.0 110.787 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' CYS . . . . . 0.507 ' H ' HG23 ' A' ' 202' ' ' ILE . 7.8 t -84.17 122.0 28.24 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.113 0.482 . . . . 0.0 109.824 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' PHE . . . . . 0.461 ' HB3' ' HB3' ' A' ' 195' ' ' CYS . 65.5 m-85 -107.07 149.03 28.03 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.758 -178.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.627 ' HA ' ' HB3' ' A' ' 215' ' ' ARG . 17.7 p -102.44 -59.0 1.78 Allowed 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -173.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 p -121.95 117.83 53.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.673 -173.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.522 HD13 ' HB3' ' A' ' 221' ' ' CYS . 4.2 mt -124.28 120.73 60.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -170.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 63.9 p -117.32 -166.29 1.17 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.562 -1.199 . . . . 0.0 107.849 161.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -68.31 -5.59 19.48 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.692 0.678 . . . . 0.0 110.22 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -92.19 -75.83 0.47 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.099 -173.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 72.7 mtm -141.13 143.03 34.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.662 0.268 . . . . 0.0 110.725 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.497 ' HA ' HG12 ' A' ' 190' ' ' ILE . 8.5 m -90.37 -45.61 8.9 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.982 176.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.405 ' HG3' ' H ' ' A' ' 188' ' ' THR . 20.0 mt-30 -152.13 3.99 0.39 Allowed 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.253 165.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 92.99 -3.81 74.01 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.132 -175.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 74.31 6.58 4.65 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.277 0.631 . . . . 0.0 112.333 174.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.795 ' H ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -85.9 19.88 2.41 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.269 0.557 . . . . 0.0 110.957 177.929 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.453 ' OG ' HG22 ' A' ' 202' ' ' ILE . 15.2 t -102.96 142.83 33.4 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.662 -175.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -126.84 19.61 6.13 Favored Glycine 0 CA--C 1.504 -0.606 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.611 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -67.72 99.27 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 122.093 0.949 . . . . 0.0 109.05 173.926 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.99 123.1 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.097 174.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 22.9 t -154.33 -178.35 7.08 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 181' ' ' TYR . 5.5 p -103.58 161.03 14.23 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 119.752 1.16 . . . . 0.0 108.811 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.527 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 45.4 tttm -59.82 -44.72 93.88 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.067 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.8 m -44.22 -56.2 4.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.931 172.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.573 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -53.77 -53.66 49.22 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.814 177.778 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 99.0 m -68.75 -22.92 64.28 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 45.0 m -96.1 -29.65 13.97 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.056 -178.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 227' ' ' GLN . . . -74.08 -60.06 2.44 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 173.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.775 HG22 ' HA2' ' A' ' 234' ' ' GLY . 10.8 p -96.78 160.64 14.26 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.283 178.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 1.4 t 66.32 -41.98 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 118.784 -0.626 . . . . 0.0 111.922 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 62.32 46.75 93.24 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-N 119.155 0.889 . . . . 0.0 113.584 168.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.627 ' HB3' ' HA ' ' A' ' 188' ' ' THR . 0.9 OUTLIER -119.87 -92.47 0.54 Allowed 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.746 -178.22 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.502 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -167.67 166.88 13.69 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' TRP . . . . . 0.527 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 21.8 t90 -155.18 148.42 24.88 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 122.213 -0.305 . . . . 0.0 110.276 -174.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 221' ' ' CYS . . . 86.09 160.98 34.68 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.756 172.285 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.657 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 26.2 t60 -135.62 131.88 19.45 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.657 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 51.6 Cg_exo -54.59 142.81 14.39 Favored 'Cis proline' 0 C--N 1.353 0.784 0 C-N-CA 123.896 -1.293 . . . . 0.0 112.282 -2.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' CYS . . . . . 0.66 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 72.2 m -50.64 128.28 20.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.714 -172.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -116.19 121.71 42.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.818 175.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' MET . . . . . 0.502 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 5.1 ppp? -106.62 153.87 21.74 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.287 -171.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 97.8 m -135.07 135.47 22.99 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -173.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -56.99 166.91 3.53 Favored 'Trans proline' 0 CA--C 1.515 -0.447 0 C-N-CA 123.98 3.12 . . . . 0.0 114.111 167.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -39.01 111.59 0.19 Allowed 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.081 162.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' GLN . . . . . 0.448 ' HB3' ' O ' ' A' ' 211' ' ' ALA . 0.0 OUTLIER 6.42 92.89 0.03 OUTLIER Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 110.137 -3.211 . . . . 0.0 114.162 177.734 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -58.07 -49.97 11.3 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.747 2.298 . . . . 0.0 113.256 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -49.72 134.58 19.9 Favored Pre-proline 0 CA--C 1.512 -0.488 0 C-N-CA 122.834 0.454 . . . . 0.0 110.521 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.49 45.29 1.93 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.006 1.804 . . . . 0.0 113.301 -172.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 48.8 m -127.7 -176.1 3.67 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.67 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 98.1 mtt180 -61.53 139.21 58.28 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 172.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.412 ' O ' HG22 ' A' ' 212' ' ' THR . 20.3 ptt180 -38.46 -42.74 0.77 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 177.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.775 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -77.48 9.28 29.18 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.033 -0.604 . . . . 0.0 114.018 -177.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' PHE . . . . . 0.717 ' HE2' ' N ' ' A' ' 267' ' ' GLY . 2.3 m-85 -121.53 147.5 45.71 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 122.044 0.926 . . . . 0.0 112.776 -172.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.41 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.5 OUTLIER -123.23 130.37 24.58 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 113.667 -1.606 . . . . 0.0 108.851 173.306 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -58.42 112.42 1.17 Allowed 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.333 2.022 . . . . 0.0 111.564 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -51.47 138.88 21.12 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.359 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 23.6 mt -81.91 -6.03 9.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.034 -173.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -109.18 -55.45 2.41 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.452 0.644 . . . . 0.0 110.221 -177.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 47.6 p -90.45 -38.24 13.39 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.907 -176.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 96.79 6.53 58.14 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -176.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -89.11 124.54 34.42 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 122.015 0.912 . . . . 0.0 109.943 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 12.1 m -54.87 121.44 8.64 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.454 176.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.451 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 84.5 mm-40 -119.81 137.66 53.84 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' ASP . . . . . 0.677 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 13.4 t70 -76.7 147.29 37.5 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.557 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.758 HG23 ' HG3' ' A' ' 249' ' ' GLU . 6.4 m -99.31 145.27 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.965 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.755 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -72.58 75.94 1.08 Allowed 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 167.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.758 ' HG3' HG23 ' A' ' 247' ' ' VAL . 21.3 mp0 -53.06 -34.62 57.31 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.746 0.784 . . . . 0.0 110.216 -170.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 11.9 m -48.39 -40.3 25.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.836 174.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -103.51 -41.5 5.97 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.856 0.836 . . . . 0.0 110.368 -175.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -66.76 -23.46 66.09 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.546 -1.207 . . . . 0.0 110.624 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.84 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.5 mp -127.54 78.57 74.59 Favored Pre-proline 0 N--CA 1.445 -0.679 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 172.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.465 ' HG2' HG12 ' A' ' 202' ' ' ILE . 9.7 Cg_endo -50.32 112.26 0.7 Allowed 'Trans proline' 0 CA--C 1.507 -0.869 0 C-N-CA 124.112 3.208 . . . . 0.0 114.64 -164.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 59.09 35.12 82.61 Favored Glycine 0 C--N 1.307 -1.03 0 CA-C-N 113.233 -1.803 . . . . 0.0 113.811 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.84 ' HB3' HG22 ' A' ' 253' ' ' ILE . 2.2 pt? -63.99 -22.54 66.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 118.06 0.93 . . . . 0.0 110.593 177.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 14.5 t -78.01 4.51 12.03 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.152 0.501 . . . . 0.0 110.688 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 67.34 -86.84 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.809 0.844 . . . . 0.0 113.013 171.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -126.62 11.1 7.11 Favored Glycine 0 CA--C 1.507 -0.417 0 C-N-CA 120.207 -0.997 . . . . 0.0 112.279 -174.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -98.94 -173.92 31.8 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.314 175.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' ASN . . . . . 0.582 ' HB3' ' CG ' ' A' ' 272' ' ' LYS . 2.7 t-20 -107.0 116.99 32.88 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 176.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 262' ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' ' 269' ' ' PHE . 34.4 t -90.64 134.86 34.09 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 2.7 mp -127.48 112.13 27.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.609 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -74.56 123.52 24.95 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -172.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.4 t -110.74 160.04 17.08 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 155.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.677 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 4.1 m -76.42 128.4 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.886 0 C-N-CA 117.933 -1.507 . . . . 0.0 108.137 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.717 ' N ' ' HE2' ' A' ' 235' ' ' PHE . . . 112.57 -26.83 10.48 Favored Glycine 0 N--CA 1.432 -1.567 0 C-N-CA 119.904 -1.141 . . . . 0.0 111.338 -172.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 37.6 t 173.01 160.02 0.12 Allowed 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 121.112 0.482 . . . . 0.0 110.373 -172.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' PHE . . . . . 0.598 ' HB2' ' SG ' ' A' ' 262' ' ' CYS . 42.2 p90 -103.69 155.51 18.51 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 121.326 -0.859 . . . . 0.0 109.036 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -116.76 125.52 51.75 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 11.4 m -105.41 154.01 20.9 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.858 0.837 . . . . 0.0 112.203 -176.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.582 ' CG ' ' HB3' ' A' ' 261' ' ' ASN . 10.1 ptmm? -129.63 108.71 10.42 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.342 168.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 32.2 m -85.89 156.14 58.2 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.068 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.588 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 71.8 Cg_exo -50.51 160.64 1.54 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.479 2.12 . . . . 0.0 112.351 173.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -58.25 136.49 57.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.903 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.08 -26.15 5.66 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 277' ' ' HIS . . . . . 0.59 ' ND1' ' HA ' ' A' ' 287' ' ' GLU . 14.9 m-70 -79.43 176.78 9.38 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.18 0.514 . . . . 0.0 112.001 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -167.97 144.85 4.15 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.939 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 38.1 tp -91.66 137.99 31.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.033 0.444 . . . . 0.0 110.911 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -125.62 98.43 5.57 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.18 -19.38 61.51 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.629 0.581 . . . . 0.0 112.177 -172.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.477 ' HA ' ' NH1' ' A' ' 215' ' ' ARG . 79.7 t -58.07 -34.58 49.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.821 177.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.434 ' HA ' ' HB ' ' A' ' 188' ' ' THR . 32.2 m -139.49 31.01 2.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.08 177.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 284' ' ' GLN . . . . . 0.611 ' HB3' ' O ' ' A' ' 256' ' ' LEU . 82.0 mm-40 30.82 44.87 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.299 -0.864 . . . . 0.0 113.111 -173.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 285' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' A' ' 287' ' ' GLU . 62.0 tttp -91.43 110.15 21.45 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.49 -175.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 44.8 t -100.3 68.04 1.39 Allowed 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.59 ' HA ' ' ND1' ' A' ' 277' ' ' HIS . 42.3 mt-10 . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.423 -0.798 . . . . 0.0 109.491 -173.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.526 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 46.4 m-85 . . . . . 0 N--CA 1.445 -0.682 0 CA-C-O 120.976 0.417 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.514 HG13 ' HB3' ' A' ' 147' ' ' GLN . 25.7 pt -136.34 -166.01 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.748 -177.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.81 179.92 53.1 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.955 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 30.7 p -74.21 -37.36 63.89 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 122.827 0.451 . . . . 0.0 112.205 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -97.46 6.29 48.41 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 35.3 m 63.23 23.78 14.01 Favored 'General case' 0 C--O 1.22 -0.493 0 O-C-N 123.785 0.678 . . . . 0.0 109.497 -171.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -94.8 1.5 65.78 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.307 -0.473 . . . . 0.0 113.564 -171.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.514 ' HB3' HG13 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -104.87 105.7 52.17 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 117.409 0.604 . . . . 0.0 109.402 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.442 ' HD2' ' OE1' ' A' ' 147' ' ' GLN . 92.7 Cg_endo -79.69 151.34 22.02 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.756 2.304 . . . . 0.0 112.783 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 149' ' ' VAL . 13.3 p -87.95 104.23 14.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 122.325 1.06 . . . . 0.0 111.706 -173.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.53 90.84 5.71 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.548 170.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -52.83 -63.12 1.25 Allowed 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -173.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 4.2 m -84.19 7.34 19.32 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.568 0.699 . . . . 0.0 109.948 -168.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.47 131.71 0.08 OUTLIER Glycine 0 N--CA 1.432 -1.579 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.132 -168.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' CYS . . . . . 0.434 ' O ' HD23 ' A' ' 155' ' ' LEU . 72.4 m -66.54 154.6 39.95 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 114.447 -0.877 . . . . 0.0 110.364 176.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.434 HD23 ' O ' ' A' ' 154' ' ' CYS . 34.5 mt -123.23 162.97 21.55 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.647 -169.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.737 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 2.2 t-20 48.55 38.07 10.4 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.422 -167.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 55.94 38.48 74.98 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.743 -174.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.18 -155.06 0.88 Allowed Glycine 0 C--N 1.32 -0.322 0 CA-C-N 115.216 -0.492 . . . . 0.0 112.086 -176.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -144.95 122.36 11.65 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.746 -0.381 . . . . 0.0 111.232 -171.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.42 111.29 5.86 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.403 173.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 165' ' ' ARG . 14.8 m -101.08 -42.92 10.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 O-C-N 121.94 -0.475 . . . . 0.0 110.092 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.575 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -134.17 173.34 5.93 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.526 ' HD3' ' CE1' ' A' ' 140' ' ' TYR . 54.7 Cg_exo -54.29 113.01 1.16 Allowed 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 122.492 2.128 . . . . 0.0 112.033 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 75.2 -10.16 1.27 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.636 0.775 . . . . 0.0 109.642 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.575 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.9 OUTLIER -86.47 82.21 8.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.371 179.007 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 84.4 m -87.48 137.16 32.57 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.684 0.754 . . . . 0.0 110.288 172.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.51 134.74 33.64 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.309 174.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 86.3 m -102.2 124.07 47.15 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.288 0.992 . . . . 0.0 111.655 -169.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.737 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 65.2 m -56.34 -53.92 51.59 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -172.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -151.91 -87.75 0.06 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 118.482 -1.287 . . . . 0.0 114.135 -170.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -93.96 39.09 2.98 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.943 -166.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.607 ' CZ ' ' HB2' ' A' ' 156' ' ' ASN . 1.7 m-85 -123.72 125.28 44.46 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 118.188 0.994 . . . . 0.0 111.795 174.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.521 ' N ' ' HE1' ' A' ' 181' ' ' TYR . 5.5 t -87.04 163.73 16.87 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 166.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.91 127.84 2.06 Favored Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -175.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -75.22 15.94 0.74 Allowed 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 121.128 1.219 . . . . 0.0 113.274 -166.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -120.89 2.12 10.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.747 0.784 . . . . 0.0 110.325 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.45 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 42.65 48.0 4.66 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 114.299 -1.319 . . . . 0.0 113.854 -179.185 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -107.66 -18.13 13.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.286 0.565 . . . . 0.0 110.169 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' A' ' 180' ' ' ASP . 6.8 mmt180 -55.95 -73.66 0.06 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.582 -176.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.481 ' HB3' ' O ' ' A' ' 179' ' ' ARG . 27.1 t70 84.96 75.16 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.642 0 O-C-N 124.122 0.889 . . . . 0.0 110.176 168.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.521 ' HE1' ' N ' ' A' ' 173' ' ' THR . 44.6 p90 -94.72 61.56 2.64 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 169.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.458 ' HG3' ' CH2' ' A' ' 217' ' ' TRP . 22.1 ptt-85 -51.75 126.36 17.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.439 175.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 42.5 p -79.97 137.73 36.92 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 120.857 0.36 . . . . 0.0 110.188 -173.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.624 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -162.8 159.3 31.66 Favored Glycine 0 C--N 1.323 -0.154 0 CA-C-O 119.365 -0.686 . . . . 0.0 111.505 -175.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.11 141.6 11.79 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.421 2.081 . . . . 0.0 111.977 174.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' CYS . . . . . 0.759 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 74.7 m -91.03 123.25 34.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.445 0.641 . . . . 0.0 111.294 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' PHE . . . . . 0.556 ' O ' ' HB2' ' A' ' 215' ' ' ARG . 19.1 m-85 -86.47 144.68 27.16 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.989 176.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 5.0 m -108.39 -18.24 13.8 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -163.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 7.5 p -170.75 118.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 121.614 -0.678 . . . . 0.0 110.272 176.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.511 HG12 ' HA ' ' A' ' 195' ' ' CYS . 5.4 mt -114.72 120.92 65.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -171.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 11.4 m -110.09 173.57 6.26 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 105.194 -2.151 . . . . 0.0 105.194 152.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -67.45 -6.26 18.58 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.639 1.109 . . . . 0.0 109.902 177.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -77.01 -74.44 0.24 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.284 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 92.7 mmm -132.2 133.46 44.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.789 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.511 ' HA ' HG12 ' A' ' 190' ' ' ILE . 56.0 m -83.15 -31.52 27.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.724 174.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.467 ' O ' ' HD1' ' A' ' 187' ' ' PHE . 77.9 mt-30 68.42 117.49 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.425 174.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 118.96 21.25 3.87 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.162 -172.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -75.93 3.94 9.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.474 0.654 . . . . 0.0 110.425 -178.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.52 ' N ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -122.53 15.25 10.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.588 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 1.4 t -87.19 128.24 35.14 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.948 -173.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -105.13 14.37 48.3 Favored Glycine 0 CA--C 1.505 -0.534 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.011 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.56 ' CD1' ' HA ' ' A' ' 253' ' ' ILE . 2.1 tt -60.95 103.7 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 171.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.7 t -88.77 95.78 5.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 123.31 1.528 . . . . 0.0 108.09 171.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 19.3 m -137.64 177.33 7.95 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 111.458 -2.61 . . . . 0.0 106.875 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.428 ' OG1' ' HB ' ' A' ' 207' ' ' THR . 26.8 p -100.88 161.02 13.89 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.674 -174.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.673 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 44.5 tttm -58.84 -42.83 90.23 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.884 173.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.428 ' HB ' ' OG1' ' A' ' 205' ' ' THR . 56.8 m -44.4 -56.39 4.27 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 122.78 1.276 . . . . 0.0 109.594 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.787 HD11 HG11 ' A' ' 247' ' ' VAL . 10.8 tp -59.71 -49.68 76.79 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 112.379 -2.191 . . . . 0.0 112.043 -175.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 50.6 m -77.49 -17.62 57.84 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.224 0.535 . . . . 0.0 111.78 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 72.4 m -87.4 -27.21 22.9 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.985 -0.447 . . . . 0.0 110.022 172.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ALA . . . . . 0.587 ' HB2' ' CE1' ' A' ' 229' ' ' HIS . . . -73.57 -56.57 4.85 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.816 0.817 . . . . 0.0 109.296 175.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.647 ' CG2' ' HA2' ' A' ' 234' ' ' GLY . 25.5 p -106.02 149.93 26.21 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.488 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.0 t 69.14 -42.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 O-C-N 123.948 0.78 . . . . 0.0 111.628 -174.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 56.75 64.29 4.54 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 119.401 1.0 . . . . 0.0 114.842 171.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.556 ' HB2' ' O ' ' A' ' 187' ' ' PHE . 21.4 mmt85 -130.41 -80.23 0.54 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 117.707 0.753 . . . . 0.0 110.532 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.43 ' HB3' ' HB2' ' A' ' 187' ' ' PHE . . . -169.35 169.73 8.87 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 176.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 217' ' ' TRP . . . . . 0.759 ' HD1' ' SG ' ' A' ' 186' ' ' CYS . 16.0 t90 -157.8 147.4 20.01 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 89.47 169.46 44.12 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 170.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.438 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 16.9 m-70 -128.04 131.38 23.76 Favored Pre-proline 0 C--N 1.341 0.237 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.456 175.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 23.4 Cg_exo -63.99 159.94 66.32 Favored 'Cis proline' 0 C--N 1.348 0.524 0 C-N-CA 123.569 -1.429 . . . . 0.0 111.149 -4.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 63.5 m -45.17 121.33 2.82 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 123.563 0.539 . . . . 0.0 111.982 -176.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.457 ' HB3' ' HE3' ' A' ' 206' ' ' LYS . 21.2 mt-10 -107.94 114.51 28.48 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 172.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 47.0 ttp -83.55 129.87 34.98 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.238 0.542 . . . . 0.0 110.244 -170.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 63.9 m -77.27 129.15 78.72 Favored Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -171.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.437 ' HB2' ' HD3' ' A' ' 228' ' ' PRO . 25.2 Cg_exo -64.75 173.41 5.69 Favored 'Trans proline' 0 C--N 1.329 -0.458 0 C-N-CA 123.806 3.004 . . . . 0.0 111.208 164.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.463 ' HB3' ' OE1' ' A' ' 227' ' ' GLN . . . -43.64 -54.15 5.22 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -169.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' GLN . . . . . 0.487 ' CB ' ' HD2' ' A' ' 233' ' ' ARG . 2.1 pm0 -164.22 28.67 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.809 0 CA-C-O 118.765 -0.636 . . . . 0.0 112.266 -176.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.437 ' HD3' ' HB2' ' A' ' 225' ' ' PRO . 63.3 Cg_exo -19.63 63.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.237 1 C-N-CA 125.664 4.243 . . . . 0.0 116.77 -155.899 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.587 ' CE1' ' HB2' ' A' ' 211' ' ' ALA . 28.3 m80 -135.76 155.44 78.05 Favored Pre-proline 0 C--N 1.324 -0.521 0 O-C-N 121.982 -0.449 . . . . 0.0 110.469 -178.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -92.47 35.48 0.24 Allowed 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.35 2.033 . . . . 0.0 110.587 165.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 9.9 t -162.77 -167.36 1.52 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.636 -176.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.622 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 88.9 mtt180 -67.12 149.53 50.41 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -174.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.487 ' HD2' ' CB ' ' A' ' 227' ' ' GLN . 34.9 mmm-85 -35.11 -64.1 0.29 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.868 0.867 . . . . 0.0 112.921 175.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.647 ' HA2' ' CG2' ' A' ' 212' ' ' THR . . . -82.96 16.04 29.47 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.424 -0.894 . . . . 0.0 114.35 -168.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' PHE . . . . . 0.622 ' CD1' ' HB2' ' A' ' 232' ' ' ARG . 7.0 m-85 -119.96 137.98 53.73 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 121.847 0.832 . . . . 0.0 112.063 -173.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.419 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.0 OUTLIER -121.79 141.74 34.54 Favored Pre-proline 0 C--N 1.311 -1.107 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 175.626 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.68 124.0 10.69 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.534 2.156 . . . . 0.0 112.473 -176.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -55.26 139.78 41.33 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.563 171.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 34.2 mt -77.29 -16.53 14.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.089 -173.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 240' ' ' ARG . 19.3 mtp180 -101.13 -61.26 1.39 Allowed 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.775 -175.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 40.7 p -82.09 -38.95 24.09 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.377 -176.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 94.11 5.89 62.05 Favored Glycine 0 N--CA 1.437 -1.296 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.062 -176.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -78.23 139.88 38.91 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 121.79 0.805 . . . . 0.0 110.919 -178.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' CYS . . . . . 0.402 ' HB3' ' HB3' ' A' ' 235' ' ' PHE . 63.7 m -62.64 122.41 15.76 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.743 -1.571 . . . . 0.0 110.146 174.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 81.0 mm-40 -122.7 133.16 54.51 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 176.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' ASP . . . . . 0.608 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 1.8 t70 -75.54 151.57 37.9 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.787 HG11 HD11 ' A' ' 208' ' ' LEU . 8.6 m -97.02 145.25 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.451 -177.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -75.75 76.46 2.71 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 169.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.711 ' HG3' HG23 ' A' ' 247' ' ' VAL . 34.1 mp0 -54.11 -33.36 57.54 Favored 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 123.98 0.8 . . . . 0.0 110.359 -169.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 35.1 m -51.1 -42.67 60.79 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.812 174.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -96.58 -34.81 11.3 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.768 0.794 . . . . 0.0 110.268 -177.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.532 ' HB1' HD21 ' A' ' 208' ' ' LEU . . . -73.13 -20.03 61.01 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.482 -176.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.714 ' O ' ' HG ' ' A' ' 256' ' ' LEU . 5.2 mp -140.54 81.46 17.32 Favored Pre-proline 0 N--CA 1.451 -0.376 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.464 ' HD2' HG13 ' A' ' 202' ' ' ILE . 16.5 Cg_exo -71.37 31.53 0.24 Allowed 'Trans proline' 0 CA--C 1.515 -0.474 0 C-N-CA 123.373 2.716 . . . . 0.0 113.025 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' GLY . . . . . 0.528 ' H ' ' C ' ' A' ' 253' ' ' ILE . . . -123.39 2.39 9.59 Favored Glycine 0 C--N 1.288 -2.119 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.484 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.714 ' HG ' ' O ' ' A' ' 253' ' ' ILE . 23.2 mt -65.75 -147.17 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 175.312 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 257' ' ' CYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 284' ' ' GLN . 76.1 m -38.55 128.16 1.46 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.394 0.677 . . . . 0.0 112.698 -174.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -79.73 68.77 5.89 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.998 -174.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 107.24 171.35 22.27 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.914 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 85.66 -154.73 28.56 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.203 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -109.64 138.68 45.65 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 50.2 t -122.48 138.57 54.51 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 173.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.489 HD11 ' HE2' ' A' ' 272' ' ' LYS . 20.9 mt -131.26 164.9 33.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 -174.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -131.29 125.36 32.61 Favored 'General case' 0 CA--C 1.497 -1.062 0 C-N-CA 117.53 -1.668 . . . . 0.0 114.038 -175.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.0 t -109.26 163.87 12.98 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 122.333 1.063 . . . . 0.0 110.072 166.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.54 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 35.7 m -73.23 127.5 35.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 268' ' ' SER . . . 98.45 -12.63 63.19 Favored Glycine 0 C--N 1.311 -0.848 0 C-N-CA 119.523 -1.322 . . . . 0.0 111.999 -176.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 267' ' ' GLY . 10.5 t 176.44 162.51 0.39 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.112 1.456 . . . . 0.0 110.858 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 269' ' ' PHE . . . . . 0.534 ' CZ ' HD13 ' A' ' 256' ' ' LEU . 46.0 p90 -107.26 162.59 13.76 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.233 -0.917 . . . . 0.0 109.56 177.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -116.75 156.55 26.98 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.81 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 56.8 m -136.68 158.54 44.2 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.576 0.703 . . . . 0.0 112.338 172.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.489 ' HE2' HD11 ' A' ' 263' ' ' ILE . 50.0 mtmt -139.68 130.13 25.55 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.141 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.427 ' HB3' ' HD2' ' A' ' 274' ' ' PRO . 19.6 m -122.12 173.03 4.47 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.992 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.446 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 53.1 Cg_exo -56.21 155.07 25.77 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.862 1.708 . . . . 0.0 110.141 167.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -58.04 156.94 8.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.139 0.495 . . . . 0.0 111.376 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 86.51 -36.97 3.17 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.255 -176.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 277' ' ' HIS . . . . . 0.69 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 18.1 m-70 -69.63 153.41 43.47 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.08 0.466 . . . . 0.0 111.639 -177.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 54.7 mttp -144.96 139.44 27.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.487 -175.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 285' ' ' LYS . 45.9 tp -76.07 140.93 42.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.396 0.617 . . . . 0.0 111.85 -175.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -127.07 102.54 7.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.903 173.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -57.8 -27.98 63.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.292 -175.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 66.4 t -56.3 -33.4 37.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.133 0.492 . . . . 0.0 111.513 -175.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 8.3 p -137.83 28.21 2.66 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.015 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' GLN . . . . . 0.607 ' O ' ' HA ' ' A' ' 257' ' ' CYS . 1.3 mp0 35.16 43.87 0.13 Allowed 'General case' 0 C--N 1.349 0.584 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.662 -169.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 285' ' ' LYS . . . . . 0.442 ' O ' HD12 ' A' ' 279' ' ' LEU . 66.6 tttt -94.64 166.15 12.16 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -172.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 286' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 12.4 t -156.93 106.06 2.21 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.596 -178.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.69 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 37.4 tt0 . . . . . 0 C--N 1.315 -0.901 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.411 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 74.4 m-85 . . . . . 0 CA--C 1.517 -0.315 0 CA-C-O 121.016 0.436 . . . . 0.0 111.545 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 34.0 pt -129.87 176.8 7.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.592 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.73 165.73 31.83 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.187 -176.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 40.3 p -64.98 -36.93 85.99 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -106.25 16.1 25.31 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.037 0.446 . . . . 0.0 110.264 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 60.3 m 55.98 36.82 28.04 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.131 173.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -94.25 -2.24 64.13 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.793 -175.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -107.88 113.67 60.87 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 117.752 0.776 . . . . 0.0 110.804 -176.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.89 143.87 23.72 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.96 2.44 . . . . 0.0 112.507 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 149' ' ' VAL . 9.3 p -78.07 110.47 13.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.867 0.842 . . . . 0.0 111.953 -175.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.64 76.73 7.51 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.37 172.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -58.36 -62.61 1.72 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -170.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.3 m -86.36 8.87 19.81 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.586 0.708 . . . . 0.0 109.815 -170.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 74.7 131.78 0.25 Allowed Glycine 0 N--CA 1.428 -1.881 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.149 -172.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' CYS . . . . . 0.442 ' O ' HD23 ' A' ' 155' ' ' LEU . 77.3 m -71.86 157.75 37.31 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 175.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 154' ' ' CYS . 55.6 mt -129.03 165.26 21.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.907 -170.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.807 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 2.3 t-20 49.53 30.97 3.76 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.837 0.711 . . . . 0.0 111.229 -168.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.68 37.25 82.56 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.219 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -73.65 -145.94 0.88 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.414 -0.422 . . . . 0.0 112.958 -175.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' A' ' 166' ' ' CYS . 21.5 tpt180 -148.37 121.97 9.19 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.881 -174.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 166' ' ' CYS . 0.8 OUTLIER -72.96 108.34 5.83 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.41 173.584 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 165' ' ' ARG . 4.4 m -94.46 -37.25 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.392 -177.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.546 ' HB1' ' HD2' ' A' ' 163' ' ' PRO . . . -133.58 177.85 2.05 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 168.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.546 ' HD2' ' HB1' ' A' ' 162' ' ' ALA . 88.0 Cg_exo -50.2 107.04 0.14 Allowed 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.383 2.055 . . . . 0.0 113.608 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 64.49 6.61 3.21 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.165 0.986 . . . . 0.0 110.517 -178.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.593 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -92.33 75.53 5.27 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.722 177.106 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 61.4 m -84.34 146.98 27.43 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.188 0.518 . . . . 0.0 110.334 176.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -98.07 144.5 27.5 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 57.7 m -102.96 122.88 45.5 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 124.449 1.093 . . . . 0.0 112.007 -166.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.807 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 93.7 m -61.24 -55.44 31.96 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.423 ' CG ' ' N ' ' A' ' 171' ' ' GLY . 79.6 t80 -132.2 -116.48 0.22 Allowed 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.269 -0.972 . . . . 0.0 112.277 -168.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.423 ' N ' ' CG ' ' A' ' 170' ' ' TYR . . . -87.63 55.51 4.43 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.742 -166.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.573 ' N ' ' CD1' ' A' ' 172' ' ' PHE . 2.1 m-85 -123.99 122.17 37.21 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.273 171.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.468 ' O ' ' HG2' ' A' ' 179' ' ' ARG . 3.1 t -86.36 163.65 17.52 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 166.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 84.75 125.19 1.33 Allowed Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 -176.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.56 19.86 0.53 Allowed 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 121.471 1.447 . . . . 0.0 114.033 -165.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -122.95 3.82 9.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.813 0.816 . . . . 0.0 109.682 175.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.481 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 39.06 51.79 1.97 Allowed 'General case' 0 C--N 1.346 0.444 0 CA-C-N 114.141 -1.391 . . . . 0.0 114.537 -179.44 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -106.82 -16.62 14.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.283 0.563 . . . . 0.0 109.854 174.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 173' ' ' THR . 19.7 mmm180 -56.62 -70.38 0.12 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.809 -174.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 41.1 t0 77.02 69.6 0.06 Allowed 'General case' 0 CA--C 1.502 -0.866 0 CA-C-O 121.907 0.86 . . . . 0.0 109.519 166.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.444 ' CD1' ' O ' ' A' ' 181' ' ' TYR . 38.6 p90 -86.13 65.85 9.29 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-O 122.741 1.258 . . . . 0.0 107.856 173.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.49 ' O ' ' HZ2' ' A' ' 217' ' ' TRP . 14.4 ptt180 -45.89 123.42 4.47 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.657 -1.61 . . . . 0.0 109.26 172.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 80.9 p -76.7 137.39 39.35 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.458 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -147.98 143.7 11.46 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -173.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.76 128.64 12.69 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.205 1.936 . . . . 0.0 111.337 174.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' CYS . . . . . 0.752 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 92.4 m -84.23 119.01 24.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.417 0.627 . . . . 0.0 110.947 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' PHE . . . . . 0.587 ' HB3' ' O ' ' A' ' 195' ' ' CYS . 69.1 m-85 -95.34 144.75 25.63 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.958 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.529 ' O ' ' HD2' ' A' ' 215' ' ' ARG . 20.2 p -108.98 -6.04 15.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -167.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.5 p -167.28 116.17 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.502 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.553 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.1 mt -133.86 127.07 51.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -170.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.9 m -128.33 -166.08 1.58 Allowed 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 160.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -63.04 -5.99 3.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 118.943 0.792 . . . . 0.0 110.453 173.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -76.95 -72.75 0.33 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.293 -177.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.517 ' SD ' ' HA2' ' A' ' 197' ' ' GLY . 13.6 ttt -149.96 160.09 43.88 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -173.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.587 ' O ' ' HB3' ' A' ' 187' ' ' PHE . 61.4 m -90.15 -32.17 16.76 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.167 0.508 . . . . 0.0 111.669 -176.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.469 ' HG3' ' OG1' ' A' ' 188' ' ' THR . 62.3 tt0 -148.09 -74.74 0.19 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.463 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.517 ' HA2' ' SD ' ' A' ' 194' ' ' MET . . . 125.78 -29.34 4.71 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -95.68 -24.2 16.65 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 119.845 -0.122 . . . . 0.0 111.206 173.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 58.57 79.81 0.2 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.266 0.555 . . . . 0.0 111.258 177.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 44.2 t -100.27 144.88 28.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.482 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -92.11 29.29 7.69 Favored Glycine 0 CA--C 1.499 -0.951 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 175.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.612 HG23 ' H ' ' A' ' 186' ' ' CYS . 0.0 OUTLIER -60.98 106.64 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 121.783 0.801 . . . . 0.0 108.843 173.107 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.0 t -94.69 123.9 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.816 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 16.7 t -155.24 -178.15 7.05 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.4 p -101.66 159.29 15.44 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 120.434 1.47 . . . . 0.0 109.311 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.54 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 42.2 tttm -56.11 -44.97 79.62 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 120.284 -0.567 . . . . 0.0 109.885 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.5 m -43.87 -56.81 3.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.371 173.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.526 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -55.58 -55.09 36.04 Favored 'General case' 0 CA--C 1.518 -0.261 0 O-C-N 123.755 0.659 . . . . 0.0 112.036 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 53.8 m -75.39 -18.7 59.88 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -171.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 79.9 m -89.67 -39.46 13.18 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 121.74 -0.6 . . . . 0.0 111.28 174.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . . . -67.8 -57.0 7.04 Favored 'General case' 0 C--N 1.345 0.383 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.689 HG22 ' HA2' ' A' ' 234' ' ' GLY . 18.8 p -94.08 157.45 16.08 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.346 174.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.1 t 68.42 -46.73 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 176.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 60.05 59.51 10.3 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 120.737 -0.744 . . . . 0.0 114.638 170.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.529 ' HD2' ' O ' ' A' ' 188' ' ' THR . 30.1 mmt180 -124.85 -84.95 0.64 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 117.525 0.663 . . . . 0.0 110.466 177.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.409 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -169.32 165.75 10.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 217' ' ' TRP . . . . . 0.752 ' HD1' ' SG ' ' A' ' 186' ' ' CYS . 18.5 t90 -153.39 148.4 26.66 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.552 0.215 . . . . 0.0 110.656 -175.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 221' ' ' CYS . . . 78.37 163.23 22.47 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 115.086 0.795 . . . . 0.0 115.086 167.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.513 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 21.6 m-70 -116.09 132.22 23.36 Favored Pre-proline 0 N--CA 1.453 -0.294 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 168.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.513 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 25.4 Cg_exo -63.3 151.28 69.42 Favored 'Cis proline' 0 C--O 1.232 0.18 0 C-N-CA 123.593 -1.419 . . . . 0.0 111.516 -2.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 84.9 m -54.99 120.19 6.53 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 124.175 0.922 . . . . 0.0 111.15 -175.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -115.85 121.41 42.3 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' MET . . . . . 0.409 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 0.0 OUTLIER -100.89 150.23 23.05 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.604 -172.444 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 74.1 m -143.35 148.46 44.28 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 120.799 0.333 . . . . 0.0 111.687 -175.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -63.27 168.38 11.13 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.546 2.164 . . . . 0.0 109.94 155.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.8 -118.71 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.997 0.427 . . . . 0.0 110.971 171.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.07 108.52 1.26 Allowed Pre-proline 0 C--N 1.322 -0.623 0 CA-C-O 121.179 0.514 . . . . 0.0 111.91 -174.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 211' ' ' ALA . 55.8 Cg_endo -74.91 -49.53 0.15 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.214 1.943 . . . . 0.0 112.667 -175.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.442 ' HB3' ' CD ' ' A' ' 230' ' ' PRO . 41.2 m80 -94.36 178.99 1.32 Allowed Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.442 ' CD ' ' HB3' ' A' ' 229' ' ' HIS . 36.6 Cg_exo -63.49 -7.5 12.63 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.0 1.134 . . . . 0.0 112.108 173.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' CYS . . . . . 0.495 ' SG ' ' HD3' ' A' ' 237' ' ' PRO . 20.0 t -65.4 144.61 56.96 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.712 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 31.4 mmt180 -75.07 142.77 43.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.361 -174.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.47 ' HG3' ' N ' ' A' ' 234' ' ' GLY . 28.0 ptt-85 -37.78 -53.57 1.27 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.496 1.123 . . . . 0.0 113.06 -177.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.689 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -71.15 0.36 31.62 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.22 -0.514 . . . . 0.0 114.224 -172.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' PHE . . . . . 0.801 ' CE2' ' HA2' ' A' ' 267' ' ' GLY . 1.8 m-85 -123.1 166.67 14.78 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 118.352 1.076 . . . . 0.0 111.843 -175.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.51 HD13 ' O ' ' A' ' 235' ' ' PHE . 0.2 OUTLIER -130.54 128.0 22.47 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 113.623 -1.626 . . . . 0.0 107.59 169.326 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.495 ' HD3' ' SG ' ' A' ' 231' ' ' CYS . 14.2 Cg_endo -61.03 117.61 4.4 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.321 2.014 . . . . 0.0 112.075 178.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -55.96 134.69 52.41 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.114 177.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 39.0 mt -73.98 -11.21 14.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.607 175.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -98.04 -58.1 2.06 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.296 -175.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 31.3 p -93.05 -43.8 8.71 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.777 -177.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 102.01 7.36 47.24 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -178.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -94.14 128.73 40.73 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.959 0.885 . . . . 0.0 109.797 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' CYS . . . . . 0.409 ' HB3' ' CB ' ' A' ' 235' ' ' PHE . 86.6 m -51.32 117.92 2.93 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.167 -1.833 . . . . 0.0 109.867 169.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -121.24 131.24 54.11 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' ASP . . . . . 0.642 ' HB3' HG13 ' A' ' 266' ' ' VAL . 4.3 t70 -79.14 150.34 31.77 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 121.297 0.57 . . . . 0.0 110.384 -170.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.734 HG23 ' HG3' ' A' ' 249' ' ' GLU . 8.9 m -100.79 145.39 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.948 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.552 -178.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.455 ' HA ' ' CG ' ' A' ' 264' ' ' ASN . 2.2 m-20 -74.24 76.85 1.82 Allowed 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 167.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.734 ' HG3' HG23 ' A' ' 247' ' ' VAL . 55.4 mp0 -52.76 -35.07 55.67 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 123.722 0.639 . . . . 0.0 110.66 -170.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 32.3 m -53.88 -29.16 40.36 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.205 175.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -106.67 -47.44 3.75 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.633 0.73 . . . . 0.0 110.309 -175.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -63.15 -25.57 68.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.612 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.755 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.7 mp -122.65 79.96 47.97 Favored Pre-proline 0 C--O 1.243 0.726 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 173.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.525 ' HG2' HG12 ' A' ' 202' ' ' ILE . 10.2 Cg_endo -51.27 118.79 4.65 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.489 2.793 . . . . 0.0 114.649 -165.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 59.11 30.83 67.68 Favored Glycine 0 C--N 1.317 -0.518 0 CA-C-N 113.839 -1.528 . . . . 0.0 114.103 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.755 ' HB3' HG22 ' A' ' 253' ' ' ILE . 1.3 pt? -68.27 -25.79 65.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.565 0.683 . . . . 0.0 111.44 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' CYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 284' ' ' GLN . 48.2 t -102.66 82.39 2.13 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.581 0.705 . . . . 0.0 110.081 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -85.07 116.31 23.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.1 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 165.55 -41.25 0.28 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -170.63 -116.6 0.39 Allowed Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.502 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 261' ' ' ASN . . . . . 0.534 ' ND2' HD11 ' A' ' 263' ' ' ILE . 61.7 t30 -98.78 157.56 16.21 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -175.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 32.6 t -140.45 133.61 29.55 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.534 HD11 ' ND2' ' A' ' 261' ' ' ASN . 28.4 mt -138.13 116.72 13.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.022 0.439 . . . . 0.0 110.54 -169.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.455 ' CG ' ' HA ' ' A' ' 248' ' ' ASP . 64.4 t30 -77.1 121.29 23.38 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.655 -174.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 8.4 t -106.3 160.9 15.02 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.661 157.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.768 HG12 ' CE1' ' A' ' 235' ' ' PHE . 1.7 t -72.39 119.52 19.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.801 ' HA2' ' CE2' ' A' ' 235' ' ' PHE . . . 113.71 -22.33 14.95 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.376 -174.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 267' ' ' GLY . 15.6 t 174.21 163.65 0.2 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.566 0.698 . . . . 0.0 111.103 -173.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 269' ' ' PHE . . . . . 0.402 ' CD1' ' HB2' ' A' ' 249' ' ' GLU . 13.1 p90 -111.48 153.53 26.03 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.231 -0.988 . . . . 0.0 108.759 177.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -111.64 135.85 51.67 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.444 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 64.7 m -109.48 160.33 16.3 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.656 -0.817 . . . . 0.0 111.142 178.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 261' ' ' ASN . 28.5 mmmt -135.35 95.38 3.27 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.47 176.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 13.7 m -76.05 161.29 75.98 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.161 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.433 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 27.7 Cg_exo -61.66 159.55 32.13 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 121.907 1.738 . . . . 0.0 109.968 170.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -57.76 145.73 33.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.515 0.197 . . . . 0.0 111.059 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.86 -28.9 3.89 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.13 -177.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 277' ' ' HIS . . . . . 0.707 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 17.1 m-70 -78.68 166.37 22.58 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 120.833 0.349 . . . . 0.0 111.228 -177.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -137.82 138.76 39.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.147 -176.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.625 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 51.4 tp -80.01 123.7 28.06 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.819 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.598 ' HB3' ' HB3' ' A' ' 285' ' ' LYS . 47.0 t30 -113.85 110.25 19.82 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.418 ' HA ' ' OE1' ' A' ' 284' ' ' GLN . 32.6 mt-10 -64.25 -14.96 58.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.717 -170.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.489 ' O ' ' HB ' ' A' ' 188' ' ' THR . 63.7 t -56.51 -38.84 58.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.908 0.385 . . . . 0.0 110.978 178.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 42.6 m -146.02 36.22 1.03 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.644 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 284' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 256' ' ' LEU . 8.3 mm100 34.49 48.32 0.28 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.41 0.684 . . . . 0.0 111.853 -170.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 285' ' ' LYS . . . . . 0.625 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 84.8 tttt -82.68 154.9 24.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.583 -172.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 23.2 m -141.02 85.75 2.0 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.707 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 19.0 mm-40 . . . . . 0 C--O 1.239 0.54 0 CA-C-O 118.392 -0.813 . . . . 0.0 108.904 -173.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -149.13 148.89 30.19 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.6 t -150.05 140.79 22.67 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.802 0.334 . . . . 0.0 110.487 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -92.38 -2.94 56.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.448 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.1 m -67.93 138.69 56.18 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.327 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.9 mm -82.32 114.75 23.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.975 0.417 . . . . 0.0 110.0 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -88.14 47.51 1.51 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.572 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.496 ' CG ' ' H ' ' A' ' 119' ' ' CYS . 5.6 t-80 -166.47 -153.78 0.17 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 -178.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.496 ' H ' ' CG ' ' A' ' 118' ' ' HIS . 28.2 p -76.46 -171.37 1.79 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 177.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -121.38 -39.64 2.65 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.924 0.392 . . . . 0.0 110.908 175.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.646 HD12 ' O ' ' A' ' 132' ' ' ASP . 0.3 OUTLIER -69.97 -169.89 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.051 -178.063 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.556 ' H ' ' HD2' ' A' ' 122' ' ' ARG . 0.5 OUTLIER -120.65 139.57 52.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.041 -176.544 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 10.2 m -117.17 134.83 54.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.38 0.609 . . . . 0.0 112.033 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 5.1 mpp? -138.41 166.22 24.81 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 173.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.532 ' O ' ' HB2' ' A' ' 137' ' ' GLN . 17.3 m120 64.41 54.93 1.45 Allowed 'General case' 0 N--CA 1.463 0.202 0 O-C-N 123.313 0.383 . . . . 0.0 111.493 173.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 65.81 21.33 69.26 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.341 174.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.441 ' HA3' ' SG ' ' A' ' 134' ' ' CYS . . . -89.41 136.0 13.3 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.076 -0.583 . . . . 0.0 113.633 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.51 ' HB2' ' HB2' ' A' ' 135' ' ' LEU . 1.9 m -90.25 126.55 35.87 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 173.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 10.6 t -90.67 91.0 8.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.896 -173.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 10.7 t -142.49 151.87 42.12 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.641 -0.662 . . . . 0.0 110.944 -175.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.486 ' O ' ' HB3' ' A' ' 132' ' ' ASP . 35.6 t0 77.66 -44.23 0.42 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 124.642 1.214 . . . . 0.0 112.879 170.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.646 ' O ' HD12 ' A' ' 121' ' ' ILE . 3.2 p30 156.53 -39.63 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 123.814 0.846 . . . . 0.0 110.228 -174.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.95 156.13 19.55 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.163 175.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.549 ' HB3' ' SG ' ' A' ' 145' ' ' CYS . 8.6 t -76.47 137.61 39.78 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.949 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 128' ' ' SER . 74.3 mt -89.48 96.61 10.78 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 176.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 61.4 m -62.62 145.91 53.34 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.29 -1.323 . . . . 0.0 113.22 -167.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.532 ' HB2' ' O ' ' A' ' 125' ' ' ASN . 32.7 tt0 -59.43 159.93 7.47 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.284 169.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -63.23 114.49 3.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.009 0.909 . . . . 0.0 111.695 -177.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 95.17 14.32 48.96 Favored Glycine 0 C--N 1.301 -1.381 0 CA-C-N 112.922 -1.945 . . . . 0.0 112.126 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.619 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 44.6 m-85 -115.55 146.97 41.25 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.572 174.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 145' ' ' CYS . 20.4 pt -134.96 177.46 6.8 Favored 'Isoleucine or valine' 0 C--O 1.246 0.876 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.498 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.13 174.03 30.22 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.936 -175.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.7 p -70.79 -48.22 55.41 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 120.753 0.311 . . . . 0.0 110.948 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -96.54 5.87 49.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.949 176.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.549 ' SG ' ' HB3' ' A' ' 134' ' ' CYS . 61.8 m 63.86 42.1 6.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.903 172.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.72 9.18 56.85 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.792 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.424 ' O ' HG12 ' A' ' 141' ' ' ILE . 5.2 tm0? -115.13 113.63 43.71 Favored Pre-proline 0 C--O 1.222 -0.384 0 CA-C-N 117.645 0.723 . . . . 0.0 110.125 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.75 143.82 13.51 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.639 2.226 . . . . 0.0 112.612 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 12.7 p -71.08 112.84 6.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.655 -176.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.8 m -81.44 74.63 8.43 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.177 175.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -51.58 -64.33 0.85 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -173.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.6 m -91.9 13.33 18.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.47 0.652 . . . . 0.0 110.717 -169.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 74.13 131.96 0.23 Allowed Glycine 0 N--CA 1.436 -1.347 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.661 -177.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.687 ' O ' HD23 ' A' ' 155' ' ' LEU . 1.7 m -61.49 156.9 18.3 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 113.942 -1.129 . . . . 0.0 109.858 171.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 154' ' ' CYS . 41.2 mt -137.93 178.1 7.37 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -174.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.636 HD22 ' C ' ' A' ' 155' ' ' LEU . 0.1 OUTLIER 35.43 31.25 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.979 1.312 . . . . 0.0 114.446 -178.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 63.31 35.54 92.2 Favored Glycine 0 N--CA 1.454 -0.132 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.593 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -79.24 -147.66 4.1 Favored Glycine 0 C--N 1.328 0.104 0 C-N-CA 121.286 -0.483 . . . . 0.0 113.442 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -157.93 126.44 5.53 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.251 -0.558 . . . . 0.0 110.624 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 166' ' ' CYS . 4.9 m -64.18 124.56 21.98 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 122.241 0.216 . . . . 0.0 110.942 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.812 HG22 ' HG2' ' A' ' 165' ' ' ARG . 1.3 m -116.31 -35.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.913 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.66 ' HB3' ' HB3' ' A' ' 165' ' ' ARG . . . -139.28 169.62 11.93 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.619 ' HD3' ' CE1' ' A' ' 140' ' ' TYR . 78.4 Cg_exo -51.16 107.14 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.316 2.01 . . . . 0.0 112.604 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 75.28 -11.35 1.1 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.471 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.812 ' HG2' HG22 ' A' ' 161' ' ' VAL . 18.3 ttp180 -83.45 90.74 7.24 Favored 'General case' 0 CA--C 1.488 -1.425 0 CA-C-O 121.652 0.739 . . . . 0.0 109.312 175.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 160' ' ' CYS . 34.5 t -84.61 145.04 28.23 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.648 167.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.538 ' HB2' HG11 ' A' ' 161' ' ' VAL . . . -92.38 129.23 38.37 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 35.7 m -106.6 132.53 52.49 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.267 0.979 . . . . 0.0 111.925 -167.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 52.6 m -57.07 -55.5 33.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 113.331 -1.759 . . . . 0.0 114.501 -167.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 17.1 t80 177.75 125.89 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.692 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 79.98 28.95 48.45 Favored Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.42 169.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.597 ' CE2' ' HA ' ' A' ' 180' ' ' ASP . 1.4 m-85 -118.34 121.25 39.92 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 118.797 -1.161 . . . . 0.0 110.502 166.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.561 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 4.3 t -89.23 140.11 29.81 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 96.45 128.59 5.81 Favored Glycine 0 N--CA 1.425 -2.038 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -171.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.18 9.76 0.81 Allowed 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.413 1.409 . . . . 0.0 113.229 -168.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.605 ' O ' HD12 ' A' ' 155' ' ' LEU . 41.3 tt0 -117.79 19.79 13.64 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.378 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.585 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.6 OUTLIER 24.31 59.54 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 117.228 2.307 . . . . 0.0 117.228 178.077 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -115.47 21.0 14.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.395 1.093 . . . . 0.0 109.028 168.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 20.6 mmt180 -113.3 81.53 1.52 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.658 -1.61 . . . . 0.0 107.603 175.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.597 ' HA ' ' CE2' ' A' ' 172' ' ' PHE . 2.3 m-20 -80.5 49.6 1.18 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.52 -167.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.561 ' HE2' ' N ' ' A' ' 173' ' ' THR . 20.4 p90 -86.32 98.64 11.08 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -87.27 155.14 20.19 Favored 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 118.296 -2.753 . . . . 0.0 106.763 175.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 19.8 p -86.06 135.45 33.62 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.049 -1.06 . . . . 0.0 109.618 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -153.64 155.09 25.94 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -73.77 129.25 13.29 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.16 1.907 . . . . 0.0 110.809 173.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 10.6 t -82.43 114.21 20.72 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PHE . . . . . 0.538 ' HE1' ' O ' ' A' ' 218' ' ' GLY . 59.3 m-85 -94.29 138.93 31.71 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.773 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.554 ' O ' ' HD2' ' A' ' 215' ' ' ARG . 89.2 m -107.8 -19.76 13.43 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -163.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 25.4 t -150.47 115.62 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 121.467 -0.771 . . . . 0.0 109.613 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.731 ' CG1' ' HA ' ' A' ' 195' ' ' CYS . 16.5 mt -130.88 120.16 46.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 10.7 p -117.08 -166.5 1.18 Allowed 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 155.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -66.75 -5.29 11.48 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.841 0.829 . . . . 0.0 109.764 172.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -83.76 -73.79 0.4 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.224 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.475 ' O ' ' HA ' ' A' ' 190' ' ' ILE . 60.7 mtt -128.38 161.18 30.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.443 0.163 . . . . 0.0 110.966 -175.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.731 ' HA ' ' CG1' ' A' ' 190' ' ' ILE . 84.5 m -92.03 -25.55 18.76 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.572 173.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -161.27 -58.7 0.05 Allowed 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 169.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 125.78 -26.05 5.46 Favored Glycine 0 C--N 1.317 -0.48 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.619 170.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -118.13 -0.11 11.66 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 117.159 0.48 . . . . 0.0 111.294 176.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.444 ' O ' ' HB2' ' A' ' 200' ' ' SER . 4.1 mm? 62.75 175.48 0.15 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.83 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 199' ' ' LEU . 22.8 t 176.14 130.3 0.04 OUTLIER 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.543 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -84.23 36.32 2.92 Favored Glycine 0 CA--C 1.509 -0.343 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 174.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.97 104.3 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 122.331 1.062 . . . . 0.0 109.412 175.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 37.9 t -93.05 124.1 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 CA-C-N 113.841 -1.527 . . . . 0.0 109.631 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 20.2 t -154.64 -177.3 6.39 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 104.292 -2.484 . . . . 0.0 104.292 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.426 ' OG1' HD22 ' A' ' 208' ' ' LEU . 14.3 p -99.36 157.28 16.52 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 120.317 1.417 . . . . 0.0 109.014 176.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.699 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 36.5 tttm -56.61 -44.37 81.06 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 120.201 -0.599 . . . . 0.0 109.788 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.2 m -43.58 -54.87 4.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.892 174.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.52 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -55.14 -53.07 60.62 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 124.05 0.844 . . . . 0.0 111.322 177.811 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 94.6 m -63.69 -26.62 68.75 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -176.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 226' ' ' ALA . 60.9 m -85.79 -47.49 9.68 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 118.481 0.582 . . . . 0.0 110.008 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ALA . . . . . 0.554 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . . . -67.23 -54.44 21.0 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -173.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.77 HG22 ' HA2' ' A' ' 234' ' ' GLY . 16.2 p -102.8 152.86 20.76 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.851 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER 66.12 -40.5 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.336 0.654 . . . . 0.0 112.14 -176.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.413 ' O ' ' HD3' ' A' ' 215' ' ' ARG . . . 61.01 59.06 10.75 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 119.134 0.879 . . . . 0.0 114.785 169.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.554 ' HD2' ' O ' ' A' ' 188' ' ' THR . 8.6 mmt85 -128.64 -90.12 0.5 Allowed 'General case' 0 C--O 1.245 0.827 0 CA-C-N 117.845 0.822 . . . . 0.0 111.847 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.575 ' CB ' HD12 ' A' ' 190' ' ' ILE . . . -165.93 168.46 15.74 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' TRP . . . . . 0.699 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 11.2 t90 -164.96 150.15 9.53 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.538 ' O ' ' HE1' ' A' ' 187' ' ' PHE . . . 95.84 -174.06 31.29 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.305 -0.95 . . . . 0.0 114.245 168.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 220' ' ' PRO . 20.2 p80 -137.09 133.55 18.57 Favored Pre-proline 0 N--CA 1.444 -0.729 0 CA-C-O 121.248 0.547 . . . . 0.0 111.163 -175.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 219' ' ' HIS . 72.2 Cg_endo -86.11 117.05 4.09 Favored 'Cis proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.408 -1.913 . . . . 0.0 112.233 -5.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 70.3 m 33.23 94.57 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.768 1.227 . . . . 0.0 113.781 177.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 36.3 mt-10 -101.17 113.63 26.84 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.76 139.5 35.34 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.779 0.323 . . . . 0.0 111.253 -170.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 5.9 p -145.62 155.98 52.74 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.926 -175.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.64 166.89 14.53 Favored 'Trans proline' 0 CA--C 1.504 -1.025 0 C-N-CA 122.27 1.98 . . . . 0.0 111.339 167.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 210' ' ' CYS . . . -63.75 -122.98 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 O-C-N 123.969 0.793 . . . . 0.0 111.794 171.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.68 108.97 1.22 Allowed Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.533 -173.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.554 ' HD3' ' HA ' ' A' ' 211' ' ' ALA . 73.8 Cg_endo -80.58 -57.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.71 2.273 . . . . 0.0 113.168 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 230' ' ' PRO . 13.6 m-70 -84.15 153.56 63.01 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 229' ' ' HIS . 6.1 Cg_exo -78.12 64.75 8.39 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.415 2.077 . . . . 0.0 112.543 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 80.6 m -119.48 -103.85 0.4 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 172.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.646 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 59.5 mtt180 -145.45 134.43 22.57 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 172.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -39.85 -41.97 1.23 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.77 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -73.45 9.7 7.44 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.417 -0.897 . . . . 0.0 113.882 -176.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' PHE . . . . . 0.646 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 6.1 m-85 -124.05 146.97 48.22 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 122.099 0.952 . . . . 0.0 112.595 -171.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.442 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.5 OUTLIER -122.6 129.02 25.2 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 114.009 -1.451 . . . . 0.0 108.432 171.828 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -62.04 113.39 1.85 Allowed 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.097 1.865 . . . . 0.0 111.202 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -48.48 128.67 15.16 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.512 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 26.9 pt -75.75 4.18 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.587 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -110.97 -56.73 2.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.008 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 36.0 p -94.42 -37.53 11.39 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.01 -176.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 100.93 0.17 55.06 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.175 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -81.62 129.94 34.87 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.784 0.802 . . . . 0.0 110.578 -176.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' CYS . . . . . 0.425 ' C ' ' HD1' ' A' ' 235' ' ' PHE . 2.2 m -61.44 115.05 3.58 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 113.816 -1.538 . . . . 0.0 109.371 173.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.496 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 45.4 tt0 -119.57 139.74 51.66 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.187 -177.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.695 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 20.0 t70 -77.24 145.43 37.55 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -177.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.654 HG23 ' HG3' ' A' ' 249' ' ' GLU . 15.1 m -100.15 145.26 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.533 ' HB3' ' HG2' ' A' ' 251' ' ' GLN . 10.4 t70 -73.63 80.51 1.51 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 165.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.654 ' HG3' HG23 ' A' ' 247' ' ' VAL . 36.8 mp0 -51.63 -34.85 39.56 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.175 0.512 . . . . 0.0 110.334 -174.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.524 ' HB2' ' OD2' ' A' ' 248' ' ' ASP . 62.8 m -52.58 -44.22 65.78 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.501 173.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' GLN . . . . . 0.533 ' HG2' ' HB3' ' A' ' 248' ' ' ASP . 2.2 pt20 -90.16 -32.09 16.78 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.68 0.752 . . . . 0.0 110.401 -173.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.1 -17.43 31.04 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.942 -170.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.757 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.1 mp -125.55 79.93 66.71 Favored Pre-proline 0 C--O 1.239 0.551 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -39.41 114.23 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 124.446 3.431 . . . . 0.0 115.48 -172.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 57.74 34.37 70.43 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 113.637 -1.619 . . . . 0.0 114.174 174.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.757 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.9 OUTLIER -73.54 -24.51 60.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 118.16 0.98 . . . . 0.0 110.905 177.538 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 257' ' ' CYS . . . . . 0.505 ' HA ' ' HB3' ' A' ' 284' ' ' GLN . 50.5 t -90.49 114.69 26.93 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -103.77 83.36 2.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.267 0.556 . . . . 0.0 110.609 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -158.9 -105.49 0.21 Allowed Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.185 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -124.29 -88.33 0.8 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.525 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' ASN . . . . . 0.618 ' HB2' ' HB3' ' A' ' 272' ' ' LYS . 10.2 m120 -94.84 157.65 15.83 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 11.8 t -137.85 126.12 23.14 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 173.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 41.0 mt -132.13 169.78 21.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -171.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.525 ' ND2' ' HB3' ' A' ' 269' ' ' PHE . 0.9 OUTLIER -134.96 130.28 35.55 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 117.248 -1.781 . . . . 0.0 113.835 -174.249 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 1.7 t -113.61 163.96 14.29 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.532 163.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.695 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 4.1 m -73.12 130.0 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 C-N-CA 119.312 -0.955 . . . . 0.0 108.719 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.525 ' CA ' ' HE2' ' A' ' 235' ' ' PHE . . . 98.2 -17.52 58.49 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.959 -175.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 41.9 t -179.69 150.74 0.42 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.532 1.166 . . . . 0.0 110.524 -173.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' PHE . . . . . 0.525 ' HB3' ' ND2' ' A' ' 264' ' ' ASN . 30.2 p90 -96.43 160.28 14.49 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.61 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -116.77 117.59 30.19 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -177.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' CYS . . . . . 0.477 ' HB2' HD22 ' A' ' 279' ' ' LEU . 68.8 m -102.61 132.39 48.74 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.237 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.618 ' HB3' ' HB2' ' A' ' 261' ' ' ASN . 22.7 ttpp -101.18 122.52 43.78 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.131 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 56.6 m -107.1 145.1 30.46 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.114 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.532 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 38.9 Cg_exo -57.97 156.34 29.27 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.636 2.224 . . . . 0.0 110.842 169.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -54.41 146.37 16.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.073 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.15 -29.67 3.44 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.803 -177.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' HIS . . . . . 0.682 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 29.8 m-70 -81.25 162.66 23.44 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 120.986 0.422 . . . . 0.0 110.728 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -146.63 116.83 7.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.044 -171.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.477 HD22 ' HB2' ' A' ' 271' ' ' CYS . 45.2 tp -63.13 127.75 32.68 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.977 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -114.8 101.57 9.19 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -70.17 -8.02 46.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.724 0.297 . . . . 0.0 111.339 -173.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 51.5 t -67.68 -31.77 53.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.514 0.674 . . . . 0.0 110.18 172.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 30.7 p -139.68 28.93 2.15 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.015 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 0.505 ' HB3' ' HA ' ' A' ' 257' ' ' CYS . 0.9 OUTLIER 29.46 44.87 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.166 0.986 . . . . 0.0 113.292 -172.476 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -112.36 127.24 55.95 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.906 -172.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 98.0 m -88.03 107.62 18.83 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 171.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.682 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 8.9 tp10 . . . . . 0 C--O 1.244 0.792 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 10.3 p . . . . . 0 N--CA 1.475 0.775 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -131.34 85.66 2.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.953 0.406 . . . . 0.0 110.466 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 26.7 m -67.23 112.52 4.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.968 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -67.11 -44.95 78.64 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.565 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 32.6 t 56.64 86.26 0.07 Allowed 'General case' 0 C--O 1.234 0.26 0 O-C-N 123.703 0.627 . . . . 0.0 111.02 177.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 80.8 mt -61.45 -57.24 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-O 121.317 0.58 . . . . 0.0 109.483 175.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -99.42 92.73 5.54 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.095 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -61.07 131.97 52.29 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 123.646 0.591 . . . . 0.0 110.278 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 21.0 p -75.59 -175.96 3.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.871 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -98.79 -58.11 2.02 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-O 122.192 0.996 . . . . 0.0 110.368 -175.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.505 HD11 ' CA ' ' A' ' 133' ' ' HIS . 25.0 pt -72.13 -177.31 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 113.303 -1.771 . . . . 0.0 114.523 -169.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.558 ' H ' ' HD2' ' A' ' 122' ' ' ARG . 0.1 OUTLIER -130.27 130.65 44.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.72 -172.445 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' A' ' 129' ' ' CYS . 26.5 m -117.9 139.46 51.11 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -173.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.2 mtm -130.18 179.4 5.91 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 171.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.2 m120 66.26 52.93 1.07 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.022 0.439 . . . . 0.0 110.767 171.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.458 ' HA3' ' HG3' ' A' ' 137' ' ' GLN . . . 59.6 32.81 74.6 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 115.149 -0.932 . . . . 0.0 113.386 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 135' ' ' LEU . . . -113.12 129.89 9.16 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.015 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.3 m -94.29 146.32 24.11 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.521 ' HB2' ' SG ' ' A' ' 123' ' ' CYS . 50.1 t -96.59 123.1 40.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.9 0.381 . . . . 0.0 110.58 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.438 ' C ' ' H ' ' A' ' 132' ' ' ASP . 22.6 t -141.65 138.4 32.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.467 177.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.609 ' O ' ' HB2' ' A' ' 132' ' ' ASP . 7.8 t70 63.1 -9.57 0.11 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 172.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.609 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 15.5 m-20 108.52 38.65 0.0 OUTLIER 'General case' 0 C--N 1.355 0.832 0 C-N-CA 125.4 1.48 . . . . 0.0 108.119 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.505 ' CA ' HD11 ' A' ' 121' ' ' ILE . 2.6 p-80 -157.74 154.17 27.76 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.911 177.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 81.2 m -101.02 132.2 46.54 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.311 0.577 . . . . 0.0 112.01 -173.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.511 ' O ' ' HA2' ' A' ' 127' ' ' GLY . 94.0 mt -88.16 92.46 9.16 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.385 174.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 61.8 m -72.96 150.53 42.42 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.262 -171.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.458 ' HG3' ' HA3' ' A' ' 126' ' ' GLY . 78.4 mt-30 -62.01 142.04 57.72 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 167.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -62.45 113.4 2.92 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 122.554 1.169 . . . . 0.0 111.368 -176.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 116.29 5.88 16.37 Favored Glycine 0 N--CA 1.431 -1.644 0 CA-C-N 112.825 -1.989 . . . . 0.0 111.71 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.669 ' CE2' ' HD3' ' A' ' 163' ' ' PRO . 51.6 m-85 -120.46 146.54 46.14 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.932 0.396 . . . . 0.0 110.001 174.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.507 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 23.9 pt -137.21 -173.15 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.179 -177.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.75 176.5 46.84 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.649 -174.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.8 p -75.08 -32.75 61.54 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.596 -0.355 . . . . 0.0 111.726 -176.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -109.72 16.01 22.38 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.981 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 60.7 m 61.71 30.19 18.36 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.634 175.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.05 2.86 61.8 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.733 -1.223 . . . . 0.0 113.112 -174.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.507 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 0.0 OUTLIER -109.72 103.93 54.27 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 117.434 0.617 . . . . 0.0 110.192 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.89 149.82 26.39 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.468 2.112 . . . . 0.0 112.553 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 149' ' ' VAL . 8.2 p -80.07 105.14 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 122.118 0.961 . . . . 0.0 112.179 -174.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.8 m -80.69 82.41 6.7 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.958 173.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -51.04 -64.91 0.66 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -175.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 31.2 m -97.07 9.55 41.77 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.083 0.468 . . . . 0.0 110.862 -166.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 80.23 131.67 0.99 Allowed Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.333 -174.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.536 ' O ' HD23 ' A' ' 155' ' ' LEU . 85.7 m -72.21 159.43 34.11 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.323 -0.939 . . . . 0.0 108.881 172.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.651 HD12 ' O ' ' A' ' 176' ' ' GLN . 76.6 mt -141.79 164.35 30.43 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.719 0.295 . . . . 0.0 110.517 -167.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.451 ' HB2' ' CZ ' ' A' ' 172' ' ' PHE . 10.5 t30 52.0 24.43 2.63 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.413 1.07 . . . . 0.0 111.364 -166.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.05 38.41 95.96 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.39 -173.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.14 -151.6 0.45 Allowed Glycine 0 CA--C 1.524 0.596 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.42 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -151.51 119.29 6.14 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 122.0 -0.706 . . . . 0.0 111.894 -175.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.27 125.76 22.06 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 176.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 165' ' ' ARG . 20.0 m -118.06 -39.36 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 120.615 0.245 . . . . 0.0 110.966 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.627 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -140.63 171.19 8.05 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.669 ' HD3' ' CE2' ' A' ' 140' ' ' TYR . 87.3 Cg_exo -52.02 110.69 0.47 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 121.872 1.714 . . . . 0.0 111.988 175.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.9 t30 77.11 -14.35 0.85 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.97 0.908 . . . . 0.0 110.793 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.627 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 1.7 mtm-85 -86.65 88.51 7.68 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 121.19 0.519 . . . . 0.0 110.151 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 73.8 m -82.31 145.98 29.67 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.965 166.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -89.75 119.32 30.05 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 175.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 73.6 m -98.12 130.1 44.91 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.97 0.794 . . . . 0.0 111.249 -171.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 16.4 m -53.8 -56.86 13.73 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -167.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.441 ' HD2' ' N ' ' A' ' 171' ' ' GLY . 21.2 t80 -158.19 -86.51 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.131 -1.027 . . . . 0.0 112.332 -169.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.441 ' N ' ' HD2' ' A' ' 170' ' ' TYR . . . -90.76 44.64 2.88 Favored Glycine 0 CA--C 1.498 -1.028 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.378 -166.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.608 ' HB3' ' HA ' ' A' ' 177' ' ' CYS . 3.1 m-85 -118.69 129.49 55.31 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.401 173.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.719 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 7.4 t -103.4 141.44 35.95 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 94.59 124.65 4.16 Favored Glycine 0 C--N 1.298 -1.542 0 N-CA-C 107.916 -2.074 . . . . 0.0 107.916 -168.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -72.21 19.55 0.3 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.934 1.756 . . . . 0.0 113.175 -166.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.651 ' O ' HD12 ' A' ' 155' ' ' LEU . 45.2 tt0 -122.58 15.21 10.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 176.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.608 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.6 OUTLIER 28.68 56.37 0.11 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 117.314 2.339 . . . . 0.0 117.314 177.549 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -111.46 22.05 15.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 122.34 1.066 . . . . 0.0 108.873 167.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.588 ' HD2' ' O ' ' A' ' 173' ' ' THR . 92.3 mtt180 -116.07 86.88 2.56 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.222 -1.353 . . . . 0.0 109.007 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.483 ' HA ' ' CE2' ' A' ' 172' ' ' PHE . 12.0 p-10 -85.63 48.63 1.62 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.547 -168.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.719 ' HE2' ' N ' ' A' ' 173' ' ' THR . 25.0 p90 -85.6 95.67 9.41 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -78.28 162.63 26.38 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 118.781 -2.449 . . . . 0.0 108.681 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 75.3 p -96.26 138.64 33.56 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.227 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -159.19 162.12 32.51 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.095 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -83.13 143.86 11.58 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.842 2.361 . . . . 0.0 111.889 173.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 4.9 t -96.71 115.82 28.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.959 0.409 . . . . 0.0 110.252 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' PHE . . . . . 0.425 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 19.5 m-85 -95.73 149.09 21.87 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.982 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.496 ' HA ' ' CB ' ' A' ' 215' ' ' ARG . 6.6 m -117.13 -15.08 10.53 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -167.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 26.2 t -145.66 114.35 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 O-C-N 121.176 -0.953 . . . . 0.0 110.709 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.594 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.5 mt -134.87 118.95 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -173.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.3 m -115.56 -166.84 1.17 Allowed 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 155.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -68.49 -5.06 17.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.761 0.791 . . . . 0.0 109.991 172.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -73.3 -74.01 0.19 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.353 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 62.3 mtt -149.67 160.68 43.32 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.594 ' HA ' HG12 ' A' ' 190' ' ' ILE . 55.5 m -89.52 -19.48 24.98 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.652 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.581 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 36.6 tt0 166.06 -85.9 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.204 171.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.436 ' H ' ' HB3' ' A' ' 196' ' ' GLN . . . 126.43 -27.24 5.04 Favored Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 171.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -82.25 69.16 8.93 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 167.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.424 ' H ' ' CD1' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -63.73 142.44 58.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.36 0.6 . . . . 0.0 111.023 -175.606 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 29.7 t -113.84 143.52 44.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.471 -175.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.95 22.28 8.38 Favored Glycine 0 CA--C 1.501 -0.783 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.179 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.758 HD12 ' HA ' ' A' ' 253' ' ' ILE . 1.5 tt -60.09 99.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 171.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 25.2 t -86.91 95.11 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.533 0 CA-C-O 123.918 1.818 . . . . 0.0 108.36 171.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.461 ' HB3' HD23 ' A' ' 208' ' ' LEU . 4.9 m -133.45 -179.03 5.26 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 111.123 -2.762 . . . . 0.0 106.072 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 27.5 p -103.29 166.74 10.25 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.131 -1.028 . . . . 0.0 112.323 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.655 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 21.9 tttp -61.13 -41.79 97.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.345 173.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 30.3 m -45.05 -52.04 9.4 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 114.515 -1.22 . . . . 0.0 109.409 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.633 HD11 HG11 ' A' ' 247' ' ' VAL . 8.6 tp -63.09 -49.27 75.15 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 112.53 -2.123 . . . . 0.0 110.606 -174.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' CYS . . . . . 0.442 ' CB ' ' HB2' ' A' ' 217' ' ' TRP . 88.0 m -68.51 -22.4 64.53 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.543 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 20.9 m -81.18 -45.2 16.72 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 123.681 0.613 . . . . 0.0 110.672 173.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.17 -52.35 35.55 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -172.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.619 HG22 ' HA2' ' A' ' 234' ' ' GLY . 17.7 p -105.56 152.78 22.65 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.198 177.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 1.4 t 67.55 -45.05 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 123.584 0.754 . . . . 0.0 112.218 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.671 ' O ' ' HD2' ' A' ' 215' ' ' ARG . . . 55.35 59.43 10.48 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 118.559 0.618 . . . . 0.0 114.499 173.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.671 ' HD2' ' O ' ' A' ' 214' ' ' GLY . 17.4 mmm180 -125.64 -75.98 0.59 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.226 0.513 . . . . 0.0 111.048 177.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.514 ' CB ' HD11 ' A' ' 190' ' ' ILE . . . -171.1 163.39 7.29 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 118.642 0.656 . . . . 0.0 109.88 174.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' TRP . . . . . 0.684 ' O ' ' HB2' ' A' ' 222' ' ' GLU . 19.1 t90 -158.81 142.77 15.37 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 106.15 179.03 23.41 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.144 -1.027 . . . . 0.0 113.954 170.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 220' ' ' PRO . 36.2 t-80 -135.52 133.44 20.33 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -177.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 219' ' ' HIS . 11.1 Cg_endo -89.6 118.36 3.64 Favored 'Cis proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.496 -1.46 . . . . 0.0 111.733 -4.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 68.7 m 45.17 88.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.684 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 12.3 mt-10 -107.27 107.23 18.06 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' MET . . . . . 0.46 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 0.6 OUTLIER -75.21 144.06 42.85 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.746 -166.516 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 224' ' ' CYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 216' ' ' ALA . 0.8 OUTLIER -123.53 120.95 26.85 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -174.144 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -62.14 167.04 11.47 Favored 'Trans proline' 0 CA--C 1.499 -1.239 0 C-N-CA 122.089 1.859 . . . . 0.0 110.563 159.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.35 -142.24 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 122.289 1.042 . . . . 0.0 110.397 163.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.37 106.37 0.65 Allowed Pre-proline 0 C--N 1.298 -1.668 0 CA-C-N 113.82 -1.536 . . . . 0.0 112.168 -169.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.1 -57.57 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.234 2.623 . . . . 0.0 112.87 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.403 ' HB3' ' HD2' ' A' ' 230' ' ' PRO . 48.0 m80 -95.99 162.8 22.73 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 229' ' ' HIS . 26.4 Cg_endo -64.31 83.27 0.15 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.135 1.89 . . . . 0.0 112.271 174.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' CYS . . . . . 0.429 ' SG ' ' HB2' ' A' ' 235' ' ' PHE . 34.1 t -157.91 152.67 25.12 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.196 -1.365 . . . . 0.0 107.504 177.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.583 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 24.0 mtt180 -64.04 131.68 48.29 Favored 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.101 -176.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -38.56 -45.95 1.13 Allowed 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -175.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.619 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -72.99 7.22 10.05 Favored Glycine 0 C--N 1.319 -0.385 0 C-N-CA 120.718 -0.753 . . . . 0.0 114.256 -173.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' PHE . . . . . 0.583 ' CD1' ' HB2' ' A' ' 232' ' ' ARG . 3.5 m-85 -122.28 150.66 42.02 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.942 0.877 . . . . 0.0 112.61 -171.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.464 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.1 OUTLIER -124.62 121.34 25.78 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 114.309 -1.314 . . . . 0.0 107.819 169.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.49 115.27 2.33 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.093 2.529 . . . . 0.0 112.26 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -50.62 137.9 18.89 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.853 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 41.8 mt -71.17 -16.34 19.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.207 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 -100.9 -62.46 1.24 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.617 0.722 . . . . 0.0 109.973 -174.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 32.2 p -80.18 -40.1 27.95 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.382 -176.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 98.05 8.26 55.52 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -90.81 127.03 36.2 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 121.852 0.834 . . . . 0.0 110.615 -177.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 235' ' ' PHE . 95.8 m -50.49 121.0 5.12 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 113.227 -1.806 . . . . 0.0 110.85 172.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -120.36 133.32 55.46 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.582 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 7.2 t70 -77.18 149.68 35.54 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -173.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.701 HG23 ' HG3' ' A' ' 249' ' ' GLU . 11.0 m -100.15 145.26 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -177.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -72.54 75.89 1.07 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 167.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.701 ' HG3' HG23 ' A' ' 247' ' ' VAL . 17.1 mp0 -53.24 -37.59 62.21 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.271 0.628 . . . . 0.0 110.654 -169.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 56.4 m -51.13 -35.83 37.56 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.096 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -100.43 -37.63 8.76 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.865 0.84 . . . . 0.0 110.246 -176.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.432 ' HB1' HD21 ' A' ' 208' ' ' LEU . . . -71.13 -17.72 62.55 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.374 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.8 HG22 ' HB3' ' A' ' 256' ' ' LEU . 5.3 mp -135.31 73.24 64.25 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 173.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.592 ' HD2' HG13 ' A' ' 202' ' ' ILE . 36.0 Cg_endo -62.65 124.28 13.85 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.509 2.139 . . . . 0.0 112.902 -170.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' A' ' 258' ' ' GLN . . . 95.18 -4.95 67.9 Favored Glycine 0 C--N 1.308 -0.995 0 CA-C-N 114.429 -1.259 . . . . 0.0 113.437 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.8 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.5 OUTLIER -68.03 -39.73 83.04 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 118.392 1.096 . . . . 0.0 110.0 -176.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 46.6 t -122.95 69.47 0.99 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.493 0.663 . . . . 0.0 109.281 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' GLN . . . . . 0.41 ' HB2' ' HA2' ' A' ' 255' ' ' GLY . 27.4 tp60 -107.46 16.04 24.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.964 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -87.55 -4.73 79.69 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.796 178.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -169.08 -137.61 2.29 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' ASN . . . . . 0.538 ' OD1' ' HE2' ' A' ' 272' ' ' LYS . 2.9 t-20 -88.66 156.82 18.8 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 9.1 t -145.79 125.12 13.04 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.427 ' HB ' ' HB2' ' A' ' 270' ' ' GLU . 7.6 mt -130.05 165.74 29.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 -174.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.562 ' ND2' ' HB3' ' A' ' 269' ' ' PHE . 0.8 OUTLIER -132.2 121.49 23.76 Favored 'General case' 0 CA--C 1.494 -1.177 0 C-N-CA 117.461 -1.695 . . . . 0.0 114.627 -177.051 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.1 t -105.83 159.83 15.71 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.777 167.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.558 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 35.7 m -72.28 121.4 22.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.451 ' HA2' ' HE1' ' A' ' 235' ' ' PHE . . . 114.42 -30.77 6.78 Favored Glycine 0 C--N 1.316 -0.547 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.423 -169.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.0 m -179.22 163.97 1.34 Allowed 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 118.383 1.091 . . . . 0.0 110.164 -169.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' PHE . . . . . 0.562 ' HB3' ' ND2' ' A' ' 264' ' ' ASN . 34.9 p90 -104.7 153.24 21.52 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.803 174.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' GLU . . . . . 0.427 ' HB2' ' HB ' ' A' ' 263' ' ' ILE . 13.9 mt-10 -108.27 118.2 36.13 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.454 -175.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 99.5 m -105.71 160.52 15.15 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.415 0.626 . . . . 0.0 110.372 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.538 ' HE2' ' OD1' ' A' ' 261' ' ' ASN . 46.2 mtmt -138.69 123.27 18.52 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.194 176.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 68.0 m -99.45 137.28 20.28 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.091 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.459 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 86.3 Cg_exo -48.94 152.71 4.41 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.913 2.409 . . . . 0.0 111.055 170.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -48.96 134.27 17.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.054 0.454 . . . . 0.0 111.811 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 88.63 -36.21 3.48 Favored Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.53 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' HIS . . . . . 0.546 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 24.4 m-70 -71.1 156.99 38.95 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.565 0.698 . . . . 0.0 111.329 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -140.94 129.26 22.37 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.924 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 42.4 tp -62.18 125.24 23.21 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.423 0.63 . . . . 0.0 111.016 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.593 ' OD1' ' HB ' ' A' ' 282' ' ' VAL . 22.0 t-20 -111.52 97.16 6.54 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -64.6 -15.73 61.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.455 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.593 ' HB ' ' OD1' ' A' ' 280' ' ' ASN . 48.1 t -57.58 -29.39 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 120.83 0.348 . . . . 0.0 110.416 173.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.604 ' O ' ' HG3' ' A' ' 285' ' ' LYS . 19.5 p -142.47 25.75 1.83 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.543 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 0.586 ' HB2' ' O ' ' A' ' 256' ' ' LEU . 79.0 mm-40 28.57 41.93 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -167.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' LYS . . . . . 0.604 ' HG3' ' O ' ' A' ' 283' ' ' SER . 90.7 mttt -115.65 135.72 53.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.306 0.575 . . . . 0.0 111.836 -173.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 94.1 m -87.61 112.45 22.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.825 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 10.8 tp10 . . . . . 0 N--CA 1.433 -1.289 0 CA-C-O 118.12 -0.943 . . . . 0.0 108.499 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.8 p . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 120.752 0.31 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.27 -34.81 78.2 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.154 0.502 . . . . 0.0 110.26 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 34.0 m -103.14 46.9 0.9 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.962 176.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -59.54 143.11 51.11 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.218 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.1 m -82.74 -22.89 34.23 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.542 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 79.8 mt -95.93 118.59 42.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.558 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -92.02 138.11 31.81 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.428 174.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -89.24 -3.2 58.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.751 -172.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 33.6 t -147.75 149.55 32.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.969 0.414 . . . . 0.0 110.637 176.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -107.08 -50.95 3.0 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.749 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.402 ' HB ' ' H ' ' A' ' 122' ' ' ARG . 37.7 pt -86.14 -161.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.409 -173.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.402 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -128.89 136.07 49.93 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.986 178.437 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.537 ' SG ' ' HA ' ' A' ' 129' ' ' CYS . 72.0 m -117.69 152.76 34.59 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.803 0.335 . . . . 0.0 111.817 -176.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 76.9 mtp -133.95 167.33 20.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.831 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 61.2 53.18 3.64 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 172.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.587 ' O ' ' HG3' ' A' ' 137' ' ' GLN . . . 64.0 30.0 76.48 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.304 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -99.09 125.86 8.72 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.009 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.559 ' HB2' ' HB2' ' A' ' 135' ' ' LEU . 18.7 m -74.16 125.58 28.67 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.819 0.342 . . . . 0.0 110.415 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.537 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 4.4 t -76.39 100.15 5.08 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.34 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.1 m -130.68 122.82 28.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -177.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.6 t70 49.75 -113.32 0.63 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -122.95 39.96 3.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.874 0.845 . . . . 0.0 109.455 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -166.11 167.28 16.48 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.527 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 78.7 m -115.78 124.05 49.77 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.985 -174.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 128' ' ' SER . 91.9 mt -86.49 97.3 10.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.09 0.948 . . . . 0.0 110.014 174.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 56.5 m -76.02 152.47 36.93 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 114.596 -1.184 . . . . 0.0 112.119 -170.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.587 ' HG3' ' O ' ' A' ' 126' ' ' GLY . 41.9 mt-30 -78.81 158.4 28.19 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 170.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -67.16 111.61 4.01 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 122.73 1.252 . . . . 0.0 112.105 -171.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 125.63 0.44 7.84 Favored Glycine 0 C--N 1.295 -1.745 0 CA-C-N 112.41 -2.177 . . . . 0.0 111.362 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.667 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 91.3 m-85 -118.81 138.88 52.39 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.14 0.495 . . . . 0.0 111.764 174.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.416 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 34.7 pt -132.71 -174.43 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.41 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.67 -170.81 34.04 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.904 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.1 p -77.83 -44.11 28.37 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.918 0.389 . . . . 0.0 111.7 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -111.35 21.12 16.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.084 -176.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 27.2 m 66.51 27.24 9.77 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 124.009 0.818 . . . . 0.0 110.551 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.2 -4.13 88.4 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.859 -172.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.416 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 2.6 tm0? -117.57 110.11 41.03 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 118.292 1.046 . . . . 0.0 110.976 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.437 ' HB3' ' CE1' ' A' ' 140' ' ' TYR . 94.2 Cg_endo -80.78 149.89 18.37 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.978 2.452 . . . . 0.0 112.385 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 149' ' ' VAL . 14.3 p -83.12 103.74 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-O 121.702 0.763 . . . . 0.0 111.089 -172.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.22 88.13 5.5 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.636 171.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -57.94 -53.85 53.62 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -169.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 34.7 m -95.82 16.87 16.41 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.199 0.524 . . . . 0.0 111.112 -169.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 77.26 129.5 0.41 Allowed Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.3 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.405 ' O ' HD23 ' A' ' 155' ' ' LEU . 35.5 m -76.1 150.85 37.18 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.421 -1.389 . . . . 0.0 110.129 172.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.672 HD12 ' O ' ' A' ' 176' ' ' GLN . 76.7 mt -147.72 167.34 24.89 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.019 -168.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.676 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 2.3 t-20 48.87 27.02 1.46 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.03 -164.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 66.39 37.22 92.57 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.756 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -68.66 -150.87 0.33 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.64 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -157.35 126.76 6.0 Favored 'General case' 0 C--N 1.318 -0.761 0 O-C-N 122.191 -0.594 . . . . 0.0 111.214 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -67.28 120.19 13.4 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 175.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.819 HG22 ' HG2' ' A' ' 165' ' ' ARG . 1.0 OUTLIER -109.16 -43.77 6.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.211 179.232 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.639 ' HB3' ' HB3' ' A' ' 165' ' ' ARG . . . -134.28 170.77 10.42 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 173.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.667 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 75.7 Cg_exo -54.34 111.36 0.69 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.282 1.988 . . . . 0.0 112.681 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 69.91 -1.82 2.23 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.928 0.891 . . . . 0.0 110.736 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.819 ' HG2' HG22 ' A' ' 161' ' ' VAL . 5.7 ttp180 -93.45 89.24 6.23 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 121.5 0.667 . . . . 0.0 109.216 169.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 49.3 t -92.41 139.83 30.2 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.375 171.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -90.52 106.91 18.82 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 80.3 m -84.68 134.79 34.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.617 -171.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.406 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 28.6 m -55.21 -55.53 30.23 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -168.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -175.7 117.89 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.016 0.436 . . . . 0.0 111.328 -178.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 76.94 42.41 20.24 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.433 -0.803 . . . . 0.0 114.28 165.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.676 ' CE2' ' HB2' ' A' ' 156' ' ' ASN . 62.3 m-85 -120.93 140.31 52.02 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 117.59 0.695 . . . . 0.0 112.146 163.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.822 HG23 ' CE2' ' A' ' 181' ' ' TYR . 39.6 p -87.1 119.24 27.12 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.724 0.774 . . . . 0.0 110.617 -177.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' A' ' 176' ' ' GLN . . . 101.84 144.69 15.2 Favored Glycine 0 N--CA 1.425 -2.048 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.18 20.62 0.4 Allowed 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.162 1.241 . . . . 0.0 112.306 -172.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.672 ' O ' HD12 ' A' ' 155' ' ' LEU . 35.7 tt0 -113.73 1.04 14.73 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.789 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.672 ' HA ' ' CB ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 36.32 62.3 0.72 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 118.018 2.599 . . . . 0.0 118.018 178.044 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -120.63 1.04 10.55 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 119.869 -0.732 . . . . 0.0 111.835 174.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 32.7 mmt180 -106.62 100.35 9.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.335 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.665 ' HA ' ' CE1' ' A' ' 172' ' ' PHE . 1.3 m-20 -74.63 100.63 4.0 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.291 -170.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.822 ' CE2' HG23 ' A' ' 173' ' ' THR . 19.7 p90 -140.05 77.97 1.64 Allowed 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 172.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 63.5 mtt85 -73.3 127.43 32.63 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 118.597 -2.564 . . . . 0.0 108.503 175.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.401 HG22 ' CG1' ' A' ' 203' ' ' VAL . 3.9 p -78.13 164.52 24.91 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.978 -176.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.629 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . 157.29 142.31 3.37 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.651 -162.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.53 132.47 6.8 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.821 2.347 . . . . 0.0 112.096 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.767 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 76.8 m -90.86 112.05 23.72 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.408 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' PHE . . . . . 0.47 ' HB3' ' O ' ' A' ' 195' ' ' CYS . 82.3 m-85 -89.0 154.81 19.91 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.17 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.451 ' OG1' ' HG3' ' A' ' 196' ' ' GLN . 35.1 p -105.27 -18.86 13.99 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -165.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 p -167.95 118.28 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-N 118.889 0.768 . . . . 0.0 110.474 -174.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.501 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.1 mt -130.35 123.11 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -169.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.402 ' C ' ' H ' ' A' ' 193' ' ' GLN . 15.1 m -126.44 -166.48 1.58 Allowed 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 162.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -61.08 -8.2 3.19 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.321 0.964 . . . . 0.0 110.251 174.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.402 ' H ' ' C ' ' A' ' 191' ' ' SER . 96.3 mt-30 -75.66 -76.05 0.16 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.114 -175.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.429 ' O ' ' HA ' ' A' ' 190' ' ' ILE . 70.7 mtm -144.42 168.58 19.76 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.501 ' HA ' HG12 ' A' ' 190' ' ' ILE . 67.6 m -86.67 -36.54 18.68 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 122.335 1.064 . . . . 0.0 109.292 175.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.451 ' HG3' ' OG1' ' A' ' 188' ' ' THR . 54.8 tt0 -148.14 -67.44 0.24 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.731 173.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 123.69 -0.26 9.28 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.508 171.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -119.0 -19.8 8.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.343 -0.428 . . . . 0.0 111.076 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 63.24 97.11 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.222 0.534 . . . . 0.0 111.077 -176.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 42.4 t -113.68 140.18 48.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.709 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -94.08 25.68 20.79 Favored Glycine 0 CA--C 1.505 -0.533 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.986 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.628 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -61.72 107.0 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 121.989 0.9 . . . . 0.0 109.388 174.62 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.401 ' CG1' HG22 ' A' ' 183' ' ' THR . 3.0 t -98.27 120.98 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 CA-C-O 122.734 1.254 . . . . 0.0 110.193 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 14.3 t -152.91 -178.76 7.11 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 103.137 -2.912 . . . . 0.0 103.137 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.707 HG21 ' HA ' ' A' ' 181' ' ' TYR . 8.0 p -102.38 161.44 13.7 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 121.197 1.817 . . . . 0.0 108.763 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.632 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 53.6 tttm -57.24 -43.22 82.73 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.997 177.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.5 m -47.9 -54.96 11.0 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.925 175.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.549 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -58.37 -55.07 39.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.716 179.574 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 65.8 m -74.45 -20.95 59.83 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -170.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 226' ' ' ALA . 80.0 m -90.22 -38.81 13.19 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 121.878 -0.514 . . . . 0.0 110.595 176.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ALA . . . . . 0.533 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . . . -67.74 -57.73 5.84 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.716 HG22 ' HA2' ' A' ' 234' ' ' GLY . 3.4 p -92.53 160.81 14.87 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.385 -1.279 . . . . 0.0 107.765 175.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 27.3 m 58.01 -35.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 125.196 1.398 . . . . 0.0 114.668 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 58.11 60.45 8.93 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 119.548 1.067 . . . . 0.0 114.8 167.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.401 ' HE ' ' HA ' ' A' ' 188' ' ' THR . 0.0 OUTLIER -118.85 -95.02 0.49 Allowed 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.356 175.476 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.405 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -164.02 163.17 23.41 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 174.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' TRP . . . . . 0.767 ' HD1' ' SG ' ' A' ' 186' ' ' CYS . 17.7 t90 -151.45 146.33 25.85 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 121.56 -0.712 . . . . 0.0 109.794 -174.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 221' ' ' CYS . . . 86.75 -179.93 48.97 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.167 -0.539 . . . . 0.0 113.774 171.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.646 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 8.9 p80 -141.28 131.1 12.89 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 175.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.646 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 10.5 Cg_endo -53.63 149.51 16.15 Favored 'Cis proline' 0 C--N 1.352 0.763 0 C-N-CA 123.772 -1.345 . . . . 0.0 111.856 -5.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 22.2 m -63.43 83.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.775 0.672 . . . . 0.0 112.52 -170.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -58.55 123.0 14.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.63 0.252 . . . . 0.0 110.619 173.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' MET . . . . . 0.405 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 0.0 OUTLIER -107.36 147.32 30.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.259 -175.722 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 18.8 m -142.0 148.51 49.02 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -173.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -65.2 166.1 20.04 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.059 1.839 . . . . 0.0 109.151 156.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 210' ' ' CYS . . . -67.27 -107.32 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.314 0.578 . . . . 0.0 111.564 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' GLN . . . . . 0.482 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . 0.0 OUTLIER -58.07 113.05 5.69 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.325 -172.772 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.533 ' HD3' ' HA ' ' A' ' 211' ' ' ALA . 18.8 Cg_endo -89.9 -61.75 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.111 2.54 . . . . 0.0 112.526 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.5 ' HB3' ' HD2' ' A' ' 230' ' ' PRO . 78.6 m-70 -78.73 163.36 61.3 Favored Pre-proline 0 CA--C 1.514 -0.44 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 229' ' ' HIS . 59.1 Cg_endo -72.79 52.69 2.18 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.753 1.636 . . . . 0.0 112.865 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 50.9 m -123.67 -178.0 3.9 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 171.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.636 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 26.0 mmt180 -76.72 142.18 40.58 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.169 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.451 ' CA ' ' HB3' ' A' ' 227' ' ' GLN . 32.5 ptt-85 -38.5 -40.37 0.56 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.716 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -75.15 5.56 33.29 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.626 -176.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' PHE . . . . . 0.636 ' CD1' ' HB2' ' A' ' 232' ' ' ARG . 2.0 m-85 -120.88 154.85 35.29 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.971 0.891 . . . . 0.0 112.493 -171.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.454 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.1 OUTLIER -128.39 130.5 23.54 Favored Pre-proline 0 N--CA 1.441 -0.877 0 CA-C-N 113.982 -1.463 . . . . 0.0 108.152 170.39 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -61.15 112.86 1.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.001 1.8 . . . . 0.0 111.126 175.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -48.02 135.06 13.17 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.719 0.771 . . . . 0.0 110.678 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 23.6 mt -71.21 -12.52 16.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.496 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -107.96 -59.45 1.84 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.395 0.617 . . . . 0.0 110.677 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 33.7 p -81.68 -39.81 23.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.187 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 100.32 4.18 55.18 Favored Glycine 0 N--CA 1.435 -1.367 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -84.5 126.96 33.76 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 121.853 0.835 . . . . 0.0 110.634 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 7.4 m -55.61 120.16 6.81 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.716 172.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -126.85 132.89 50.85 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 7.3 t70 -77.8 147.42 35.25 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 121.447 0.641 . . . . 0.0 109.632 -175.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.756 HG23 ' HG3' ' A' ' 249' ' ' GLU . 10.4 m -97.83 145.09 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.281 -177.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -74.28 76.86 1.84 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 168.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.756 ' HG3' HG23 ' A' ' 247' ' ' VAL . 28.2 mp0 -52.11 -37.8 55.3 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 124.021 0.826 . . . . 0.0 109.946 -171.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 42.6 m -47.7 -36.4 11.2 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.824 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -102.4 -42.88 5.84 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.685 0.755 . . . . 0.0 110.319 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -63.84 -23.07 67.21 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.8 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.71 ' O ' ' HB2' ' A' ' 256' ' ' LEU . 3.9 mp -124.05 88.2 52.74 Favored Pre-proline 0 N--CA 1.45 -0.434 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 174.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.415 ' O ' HG12 ' A' ' 202' ' ' ILE . 8.3 Cg_exo -73.1 142.46 34.35 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 121.301 1.334 . . . . 0.0 112.35 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 77.43 5.7 85.96 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.506 -170.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.71 ' HB2' ' O ' ' A' ' 253' ' ' ILE . 10.4 tp -53.24 -92.31 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 122.827 0.451 . . . . 0.0 111.285 175.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 22.9 t -96.08 61.52 2.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.502 0.668 . . . . 0.0 109.51 -175.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -86.6 51.9 2.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.628 0.728 . . . . 0.0 109.643 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.535 ' O ' ' HD3' ' A' ' 274' ' ' PRO . . . -137.6 28.35 2.76 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 272' ' ' LYS . . . 148.43 -133.24 4.5 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -177.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' ASN . . . . . 0.514 ' HB2' ' HB2' ' A' ' 272' ' ' LYS . 4.9 m-20 -103.28 158.02 16.61 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 177.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 42.7 t -142.76 124.44 14.98 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 50.6 mt -130.21 116.33 36.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.918 -167.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -76.23 120.4 21.45 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.85 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.7 t -107.21 158.77 16.85 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 158.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.504 ' HB ' ' CZ ' ' A' ' 235' ' ' PHE . 31.3 m -75.11 123.15 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 C-N-CA 118.612 -1.235 . . . . 0.0 108.498 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.615 ' N ' ' HE1' ' A' ' 235' ' ' PHE . . . 113.04 -24.22 13.07 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.669 -171.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.7 t 174.01 162.08 0.18 Allowed 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 117.471 0.636 . . . . 0.0 109.852 -172.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' PHE . . . . . 0.419 ' CE1' HD21 ' A' ' 256' ' ' LEU . 45.5 p90 -102.8 158.45 16.25 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 121.002 -1.061 . . . . 0.0 109.178 174.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -115.51 127.96 55.65 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' CYS . . . . . 0.417 ' HB2' HD22 ' A' ' 279' ' ' LEU . 56.7 m -100.43 152.01 20.86 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.529 0.68 . . . . 0.0 111.751 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.514 ' HB2' ' HB2' ' A' ' 261' ' ' ASN . 13.0 mmmm -121.59 100.42 7.0 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.08 171.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 286' ' ' CYS . 18.2 m -88.8 156.99 49.59 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.395 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.55 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 43.6 Cg_exo -58.07 156.03 31.2 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 121.831 1.687 . . . . 0.0 110.359 171.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -56.55 144.53 31.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.655 0.264 . . . . 0.0 110.842 -177.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.13 -32.69 3.48 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.237 -0.983 . . . . 0.0 111.968 -176.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' HIS . . . . . 0.55 ' HB2' ' O ' ' A' ' 274' ' ' PRO . 14.6 m-70 -72.42 154.69 40.75 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.06 0.457 . . . . 0.0 111.283 -175.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -137.68 121.27 17.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.862 -174.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.417 HD22 ' HB2' ' A' ' 271' ' ' CYS . 35.2 tp -69.52 136.95 52.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.114 0.483 . . . . 0.0 111.672 -175.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -124.11 100.51 6.75 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 171.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -65.16 -14.19 59.98 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.951 0.782 . . . . 0.0 112.533 -172.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 73.5 t -58.43 -36.93 61.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.629 0.728 . . . . 0.0 109.874 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 31.3 m -134.08 30.49 3.63 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.398 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 23.51 50.52 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 114.135 -1.393 . . . . 0.0 113.164 -172.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -102.36 130.79 49.2 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.439 -174.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 273' ' ' CYS . 33.3 m -94.87 97.8 10.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.652 173.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.435 ' HA ' ' ND1' ' A' ' 277' ' ' HIS . 38.5 tt0 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.668 -0.682 . . . . 0.0 109.305 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.9 p . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.677 0.275 . . . . 0.0 111.526 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.55 105.97 5.8 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.816 0.341 . . . . 0.0 111.307 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.3 p -160.66 -57.58 0.05 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.207 176.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -172.46 156.4 3.71 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 52.1 m -73.45 71.89 1.33 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.459 0.647 . . . . 0.0 111.075 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.451 ' O ' HG12 ' A' ' 116' ' ' ILE . 14.6 tt -155.81 25.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.295 178.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -92.16 64.27 4.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.144 -174.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -135.03 85.93 2.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.307 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 23.8 p -151.89 -169.62 3.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.577 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -120.73 -56.56 1.94 Allowed 'General case' 0 CA--C 1.498 -1.023 0 CA-C-O 121.598 0.713 . . . . 0.0 109.992 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 33.7 pt -79.24 -168.68 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 114.415 -1.266 . . . . 0.0 113.352 -170.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.605 ' HD2' ' N ' ' A' ' 122' ' ' ARG . 2.0 mpt_? -118.95 122.79 43.05 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.91 -173.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.637 ' SG ' ' HA ' ' A' ' 129' ' ' CYS . 60.2 m -115.09 129.59 56.72 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.697 0.284 . . . . 0.0 110.973 -176.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.0 mtm -126.28 169.8 12.53 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.199 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 65.23 45.85 2.84 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.188 0.518 . . . . 0.0 111.121 174.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.666 ' HA3' ' OE1' ' A' ' 137' ' ' GLN . . . 70.1 27.15 73.34 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.114 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -96.21 126.87 8.96 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 119.608 -1.282 . . . . 0.0 111.1 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.436 ' HB3' ' HB2' ' A' ' 135' ' ' LEU . 4.9 t -77.89 130.64 36.85 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 117.222 0.511 . . . . 0.0 109.941 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.637 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 17.0 t -85.97 108.93 18.43 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -176.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.9 m -130.51 127.44 39.14 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.842 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.6 t70 53.98 -109.85 0.51 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.202 0.525 . . . . 0.0 111.359 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -126.15 36.13 4.56 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -157.29 171.18 20.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.525 -177.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 79.6 m -123.19 124.07 42.21 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.103 -174.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.436 ' HB2' ' HB3' ' A' ' 128' ' ' SER . 97.9 mt -85.01 99.42 11.0 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 172.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 56.1 m -80.76 160.48 24.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.152 -170.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.666 ' OE1' ' HA3' ' A' ' 126' ' ' GLY . 53.9 mt-30 -81.0 143.65 32.37 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 167.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.7 tptm -68.34 111.39 4.58 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 122.768 1.27 . . . . 0.0 110.866 -175.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.403 ' HA2' ' CG1' ' A' ' 149' ' ' VAL . . . 135.93 -10.58 4.22 Favored Glycine 0 C--N 1.3 -1.429 0 CA-C-N 112.459 -2.155 . . . . 0.0 110.218 -173.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.534 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 90.6 m-85 -125.95 145.92 50.08 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 171.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.431 HG13 ' HB3' ' A' ' 147' ' ' GLN . 33.3 pt -141.41 -171.21 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 123.531 0.519 . . . . 0.0 110.376 -173.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 86.97 -174.08 45.51 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.254 -0.884 . . . . 0.0 112.369 -174.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.5 p -75.82 -34.36 60.13 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -110.78 12.44 22.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.034 -176.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 33.6 m 62.66 29.46 16.86 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 123.668 0.605 . . . . 0.0 110.258 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.17 -17.92 60.13 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.618 -172.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.431 ' HB3' HG13 ' A' ' 141' ' ' ILE . 4.9 tm0? -99.69 120.91 56.23 Favored Pre-proline 0 C--N 1.326 -0.428 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.315 -174.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 147' ' ' GLN . 78.7 Cg_endo -88.7 140.63 4.31 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.933 2.422 . . . . 0.0 112.605 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 149' ' ' VAL . 10.1 p -66.52 105.29 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 122.25 1.024 . . . . 0.0 111.731 -173.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 76.84 6.8 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.989 175.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -52.41 -65.82 0.49 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -176.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 37.7 m -85.6 23.37 1.39 Allowed 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 120.728 0.299 . . . . 0.0 111.63 -171.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 106.43 -101.6 1.79 Allowed Glycine 0 N--CA 1.436 -1.301 0 CA-C-O 122.21 0.895 . . . . 0.0 113.049 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 148.43 131.43 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 111.368 -2.416 . . . . 0.0 105.004 -175.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 176' ' ' GLN . 21.4 mt -117.49 171.58 7.9 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -168.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.663 ' HB3' ' CZ ' ' A' ' 172' ' ' PHE . 25.3 p30 42.43 30.11 0.19 Allowed 'General case' 0 N--CA 1.478 0.944 0 O-C-N 124.426 1.079 . . . . 0.0 113.157 -172.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.8 39.37 91.35 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 119.951 -1.118 . . . . 0.0 111.955 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -74.63 -144.54 0.98 Allowed Glycine 0 CA--C 1.511 -0.21 0 CA-C-N 115.426 -0.387 . . . . 0.0 113.685 -173.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.558 ' HG2' ' HB3' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -154.28 130.52 10.41 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.8 m -67.41 115.57 7.18 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 122.312 -0.242 . . . . 0.0 110.891 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 165' ' ' ARG . 3.7 m -101.43 -37.02 5.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.974 176.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.635 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -139.78 172.67 6.03 Favored Pre-proline 0 C--O 1.233 0.235 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.534 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 76.4 Cg_exo -54.09 107.1 0.19 Allowed 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.421 2.081 . . . . 0.0 112.869 176.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 70.52 8.68 6.69 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.044 0.938 . . . . 0.0 110.238 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.635 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 1.4 mmt180 -103.06 81.66 1.99 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.822 176.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 12.6 t -81.34 146.17 30.49 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 173.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.558 ' HB3' ' HG2' ' A' ' 159' ' ' ARG . . . -98.68 147.86 24.42 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.472 ' HA ' HD22 ' A' ' 156' ' ' ASN . 14.4 m -111.41 124.66 52.71 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 124.775 1.297 . . . . 0.0 112.66 -160.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 64.5 m -51.99 -54.46 29.57 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -176.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -154.84 -86.37 0.05 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 118.516 -1.274 . . . . 0.0 113.746 -165.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -92.11 39.6 3.0 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 119.651 -1.262 . . . . 0.0 112.826 -167.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.663 ' CZ ' ' HB3' ' A' ' 156' ' ' ASN . 9.1 m-85 -120.7 126.23 49.67 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 119.522 -0.871 . . . . 0.0 113.036 176.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.62 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 4.7 t -93.37 164.81 13.07 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 164.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.28 132.63 5.51 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.54 2.9 4.69 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 121.198 1.265 . . . . 0.0 112.962 -167.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.468 ' O ' HD12 ' A' ' 155' ' ' LEU . 47.9 tt0 -118.68 4.34 11.63 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.325 0.584 . . . . 0.0 110.661 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 39.32 50.6 2.0 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -177.284 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -106.03 -12.37 15.81 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.476 0.655 . . . . 0.0 110.321 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -60.85 -67.41 0.4 Allowed 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.802 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.8 t70 79.59 81.96 0.06 Allowed 'General case' 0 CA--C 1.509 -0.603 0 O-C-N 123.775 0.672 . . . . 0.0 109.445 163.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.62 ' HE2' ' N ' ' A' ' 173' ' ' THR . 37.0 p90 -102.42 66.06 0.96 Allowed 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 172.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -46.97 119.52 2.58 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 113.479 -1.691 . . . . 0.0 109.869 172.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.487 ' HB ' HG22 ' A' ' 203' ' ' VAL . 64.6 p -84.39 136.91 33.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.809 -172.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.495 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -158.27 145.79 12.27 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.86 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.41 ' HB3' ' O ' ' A' ' 200' ' ' SER . 39.5 Cg_exo -59.92 139.87 90.17 Favored 'Trans proline' 0 CA--C 1.529 0.232 0 C-N-CA 122.268 1.979 . . . . 0.0 111.47 171.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 5.8 t -96.44 133.94 40.23 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.123 -174.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' PHE . . . . . 0.574 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 24.4 m-85 -110.32 130.81 55.48 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.481 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.567 ' O ' ' HG2' ' A' ' 215' ' ' ARG . 48.9 p -112.52 -4.34 14.2 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -168.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 p -168.58 116.85 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 118.991 0.814 . . . . 0.0 111.504 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.696 HD11 ' CB ' ' A' ' 216' ' ' ALA . 3.7 mt -117.07 119.32 61.61 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -169.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 45.7 t -104.54 156.45 17.95 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 145.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -50.43 -31.26 14.58 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 119.988 1.267 . . . . 0.0 109.702 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -56.17 -59.22 5.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 113.526 -1.67 . . . . 0.0 111.591 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 5.7 mmt -136.87 126.12 24.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.559 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.554 ' HA ' HG12 ' A' ' 190' ' ' ILE . 79.9 m -76.79 -19.24 57.81 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.87 0.843 . . . . 0.0 110.716 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -146.97 -68.6 0.25 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 171.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 125.06 -18.42 7.0 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -96.72 -41.87 8.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.705 -0.747 . . . . 0.0 110.068 177.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 67.62 84.85 0.15 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.477 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 185' ' ' PRO . 48.0 t -99.44 148.15 24.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.109 -177.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -92.59 22.29 34.05 Favored Glycine 0 CA--C 1.504 -0.626 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.771 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.594 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -60.61 110.99 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 167.727 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.487 HG22 ' HB ' ' A' ' 183' ' ' THR . 0.4 OUTLIER -107.02 97.22 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-O 124.081 1.896 . . . . 0.0 109.482 -173.344 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 13.7 t -119.38 -175.69 2.99 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 112.232 -2.258 . . . . 0.0 106.986 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 7.6 p -100.97 164.04 12.0 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 119.281 -0.968 . . . . 0.0 108.872 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.469 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 45.3 tttm -61.94 -45.95 91.47 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.994 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.9 m -45.24 -55.05 6.24 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.537 173.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.485 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -58.51 -54.5 46.28 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.988 179.262 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 19.1 m -68.95 -22.08 64.15 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 84.6 m -94.42 -33.83 12.98 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.1 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -73.69 -58.49 3.27 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.659 HG22 ' HA2' ' A' ' 234' ' ' GLY . 20.0 p -99.62 157.59 16.35 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.944 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.43 HG21 HG12 ' A' ' 253' ' ' ILE . 2.2 t 66.86 -46.69 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 122.855 0.462 . . . . 0.0 112.022 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 215' ' ' ARG . . . 80.6 178.96 52.56 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 114.68 0.632 . . . . 0.0 114.68 171.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.567 ' HG2' ' O ' ' A' ' 188' ' ' THR . 8.0 mpt_? 92.08 -73.94 0.01 OUTLIER 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.647 1.179 . . . . 0.0 112.844 170.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.696 ' CB ' HD11 ' A' ' 190' ' ' ILE . . . -172.8 165.86 5.27 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.069 1.304 . . . . 0.0 111.855 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' TRP . . . . . 0.495 ' CZ2' ' HA3' ' A' ' 184' ' ' GLY . 22.0 t90 -150.9 149.2 29.36 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.869 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 77.74 166.32 27.32 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 115.674 1.03 . . . . 0.0 115.674 167.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.492 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 77.7 m-70 -122.32 134.62 24.92 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 114.706 -0.747 . . . . 0.0 109.755 175.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 22.7 Cg_exo -65.37 155.85 77.79 Favored 'Cis proline' 0 C--N 1.347 0.46 0 C-N-CA 123.287 -1.547 . . . . 0.0 111.225 -2.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 33.7 t -52.14 115.61 1.8 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.322 -171.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -107.66 115.01 29.39 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 13.3 ttp -89.03 138.85 31.04 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.43 -172.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 84.0 m -128.08 122.8 22.34 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -54.03 166.26 1.63 Allowed 'Trans proline' 0 CA--C 1.515 -0.462 0 C-N-CA 123.609 2.873 . . . . 0.0 113.622 165.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -39.09 106.7 0.06 Allowed 'General case' 0 CA--C 1.504 -0.801 0 O-C-N 123.962 0.789 . . . . 0.0 111.214 163.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 31.4 85.75 0.14 Allowed Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 111.633 -2.531 . . . . 0.0 111.99 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -39.57 -58.61 0.81 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.874 3.049 . . . . 0.0 115.182 -170.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -78.58 156.09 78.25 Favored Pre-proline 0 CA--C 1.515 -0.385 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -68.61 91.57 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.773 1.648 . . . . 0.0 112.474 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' CYS . . . . . 0.461 ' HB2' ' HG3' ' A' ' 237' ' ' PRO . 42.7 t -163.85 179.21 7.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.787 -177.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.743 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 22.6 mmm-85 -92.75 140.22 29.74 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.433 ' O ' HG22 ' A' ' 212' ' ' THR . 22.1 ptt85 -41.31 -57.14 2.23 Favored 'General case' 0 C--O 1.218 -0.574 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -175.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.659 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -67.52 6.79 2.33 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 115.123 0.809 . . . . 0.0 115.123 -174.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' PHE . . . . . 0.743 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 2.1 m-85 -131.07 173.47 10.98 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 118.238 1.019 . . . . 0.0 111.828 -174.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.544 HD13 ' O ' ' A' ' 235' ' ' PHE . 0.2 OUTLIER -135.48 130.56 19.04 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 113.562 -1.654 . . . . 0.0 107.504 172.021 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.461 ' HG3' ' HB2' ' A' ' 231' ' ' CYS . 27.0 Cg_exo -61.01 113.82 1.9 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 121.95 1.766 . . . . 0.0 111.641 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -50.71 132.21 26.02 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.669 0.747 . . . . 0.0 110.964 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 19.6 mt -76.48 -2.01 3.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.024 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 240' ' ' ARG . 43.1 mtm180 -104.43 -57.59 2.01 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.301 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 31.5 p -95.2 -45.36 7.22 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.366 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 104.11 12.64 28.99 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -95.45 131.35 41.7 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 122.009 0.909 . . . . 0.0 110.352 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 77.8 m -49.08 112.25 0.6 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 113.261 -1.791 . . . . 0.0 110.495 167.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -116.84 134.49 54.71 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.624 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 10.9 t70 -75.84 145.36 40.66 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 121.635 0.731 . . . . 0.0 111.122 -170.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.716 HG23 ' HG3' ' A' ' 249' ' ' GLU . 4.5 m -98.23 145.19 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.87 177.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -75.85 78.13 2.76 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 169.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.716 ' HG3' HG23 ' A' ' 247' ' ' VAL . 22.7 mp0 -53.03 -36.06 60.14 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 123.747 0.654 . . . . 0.0 110.017 -172.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 24.6 m -48.36 -39.15 21.2 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.432 173.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -96.45 -39.73 9.43 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.83 0.824 . . . . 0.0 110.313 -177.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -73.68 -20.25 60.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.202 -1.363 . . . . 0.0 111.757 -172.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.594 HG23 HD11 ' A' ' 202' ' ' ILE . 4.1 mp -121.83 81.5 41.82 Favored Pre-proline 0 N--CA 1.446 -0.672 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 253' ' ' ILE . 50.6 Cg_exo -24.02 -49.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.889 1 C-N-CA 127.169 5.246 . . . . 0.0 117.764 -170.516 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -124.93 28.99 5.03 Favored Glycine 0 CA--C 1.502 -0.745 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.906 -165.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.439 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -93.6 143.07 26.65 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.673 -0.764 . . . . 0.0 110.385 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 7.5 t 72.29 -72.27 0.12 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -169.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 60.02 -75.01 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.056 0.942 . . . . 0.0 113.202 175.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -75.48 71.18 1.85 Allowed Glycine 0 CA--C 1.508 -0.38 0 N-CA-C 111.694 -0.562 . . . . 0.0 111.694 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 154.54 -175.86 32.53 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -106.15 113.19 26.57 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 117.476 0.638 . . . . 0.0 109.774 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 48.7 t -89.3 133.15 34.59 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 46.5 mt -132.87 106.77 10.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.335 -174.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.753 ' ND2' ' HB3' ' A' ' 269' ' ' PHE . 0.9 OUTLIER -83.83 129.39 34.94 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -167.255 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.8 t -111.13 163.86 13.45 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.908 163.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.624 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 2.4 p -70.07 120.39 17.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.415 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.658 ' HA2' ' CE2' ' A' ' 235' ' ' PHE . . . 114.42 -33.38 5.43 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.61 -172.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 7.5 p -179.81 161.51 0.98 Allowed 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 117.822 0.811 . . . . 0.0 109.765 -172.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' PHE . . . . . 0.753 ' HB3' ' ND2' ' A' ' 264' ' ' ASN . 43.1 p90 -101.38 157.94 16.43 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.823 175.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -120.67 122.0 39.52 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 52.8 m -101.21 143.18 31.6 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.725 0.774 . . . . 0.0 111.682 -176.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -103.04 104.71 14.91 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.436 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 56.8 m -86.3 138.42 34.3 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.552 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.518 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 52.5 Cg_exo -56.28 162.52 7.62 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.548 2.165 . . . . 0.0 111.308 172.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -54.35 136.83 43.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.179 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.15 -26.78 4.22 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.74 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' HIS . . . . . 0.602 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 16.1 m-70 -78.34 157.85 28.99 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.28 0.562 . . . . 0.0 111.613 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -145.99 140.87 27.18 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.417 -175.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 51.0 tp -74.78 126.53 31.11 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.19 0.519 . . . . 0.0 109.681 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 284' ' ' GLN . 52.7 t30 -120.29 112.13 18.64 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -78.99 -6.75 57.08 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.721 0.638 . . . . 0.0 112.263 -173.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 39.0 t -58.07 -21.21 16.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.116 0.484 . . . . 0.0 110.564 168.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 284' ' ' GLN . 24.8 t -146.93 -15.16 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.183 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 283' ' ' SER . 16.9 mp0 73.74 52.62 0.11 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.369 1.067 . . . . 0.0 109.481 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -130.99 149.9 52.39 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.289 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 86.8 m -101.35 94.71 6.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.294 176.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.602 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 76.4 mm-40 . . . . . 0 C--O 1.253 1.238 0 CA-C-O 118.755 -0.64 . . . . 0.0 109.483 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 54.5 m . . . . . 0 N--CA 1.478 0.95 0 CA-C-O 120.859 0.361 . . . . 0.0 111.279 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.74 -42.47 28.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.161 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.4 p -75.09 115.62 14.92 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.733 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -73.0 -34.14 66.22 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.5 m -78.61 72.23 5.12 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 172.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.1 mt -58.48 115.7 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.346 -173.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -77.52 -25.78 50.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.554 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -92.83 -173.7 3.39 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.427 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 43.3 m -85.03 165.49 17.49 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.866 0.365 . . . . 0.0 110.069 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -123.91 -44.48 2.06 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.859 0.838 . . . . 0.0 110.33 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.658 HG13 ' SG ' ' A' ' 134' ' ' CYS . 0.2 OUTLIER -74.28 178.65 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.716 -178.76 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.624 ' H ' ' HD2' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -107.36 104.54 14.16 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.795 -175.459 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 72.4 m -100.47 117.07 33.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.272 0.558 . . . . 0.0 110.615 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.451 ' HB2' ' O ' ' A' ' 144' ' ' HIS . 25.0 mmm -117.57 158.99 23.62 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.36 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.414 ' HB2' ' HB3' ' A' ' 145' ' ' CYS . 5.0 m-20 63.22 41.82 7.59 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.118 0.886 . . . . 0.0 110.232 174.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 78.38 7.15 87.99 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.196 -0.911 . . . . 0.0 113.067 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -49.36 124.71 14.83 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.172 -0.537 . . . . 0.0 113.262 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.0 m -79.84 149.26 31.06 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.688 0.28 . . . . 0.0 110.377 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 12.2 t -83.53 101.53 11.5 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.8 m -125.95 134.41 51.54 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.734 -174.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 33.95 -98.12 0.02 OUTLIER 'General case' 0 C--N 1.35 0.609 0 O-C-N 124.87 1.356 . . . . 0.0 112.36 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -134.72 20.25 3.56 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.947 -0.47 . . . . 0.0 110.722 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.454 ' HA ' HD12 ' A' ' 121' ' ' ILE . 0.1 OUTLIER -149.08 141.42 24.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.338 0.59 . . . . 0.0 110.449 174.657 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.658 ' SG ' HG13 ' A' ' 121' ' ' ILE . 30.1 m -69.04 160.55 30.77 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.329 0.585 . . . . 0.0 112.342 -173.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 26.9 mt -123.74 129.82 51.68 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 1.5 m -70.81 163.79 26.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 122.205 1.002 . . . . 0.0 113.337 -172.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -95.13 157.23 15.98 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.447 -1.706 . . . . 0.0 107.348 172.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -61.38 109.11 1.06 Allowed 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 123.051 1.405 . . . . 0.0 110.879 -174.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 131.91 -12.36 5.34 Favored Glycine 0 C--N 1.287 -2.186 0 CA-C-N 112.573 -2.103 . . . . 0.0 111.793 173.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.548 ' HB2' ' SG ' ' A' ' 145' ' ' CYS . 89.7 m-85 -123.71 157.54 33.69 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 118.173 0.987 . . . . 0.0 110.993 173.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.475 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 30.6 pt -129.29 169.11 21.13 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.86 172.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.97 169.61 20.75 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.651 -176.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 134' ' ' CYS . 14.2 p -77.62 -47.12 20.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.625 0.213 . . . . 0.0 110.528 177.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.451 ' O ' ' HB2' ' A' ' 124' ' ' MET . 25.8 p-80 -88.04 2.81 50.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.236 0.541 . . . . 0.0 109.937 175.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.548 ' SG ' ' HB2' ' A' ' 140' ' ' TYR . 0.6 OUTLIER 61.93 44.69 8.09 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.667 171.679 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.22 8.65 55.64 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 119.641 -1.266 . . . . 0.0 112.493 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.475 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 5.4 tm0? -112.62 118.75 44.65 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.222 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -89.09 131.92 2.23 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.959 2.44 . . . . 0.0 113.725 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 149' ' ' VAL . 9.5 p -66.47 116.03 5.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.954 -178.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.629 ' HB3' ' SG ' ' A' ' 154' ' ' CYS . 0.0 OUTLIER -81.87 75.87 8.79 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.275 0.56 . . . . 0.0 109.844 171.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.98 -64.79 0.79 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.306 -0.861 . . . . 0.0 113.133 -171.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 55.8 m -91.88 19.03 6.98 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.158 0.504 . . . . 0.0 111.941 -168.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 80.73 120.29 0.44 Allowed Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.898 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' ' 150' ' ' CYS . 89.1 m -74.29 157.75 35.24 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 113.443 -1.378 . . . . 0.0 108.33 172.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.656 HD12 ' O ' ' A' ' 176' ' ' GLN . 76.9 mt -147.15 174.52 11.51 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -165.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.548 HD22 ' C ' ' A' ' 156' ' ' ASN . 0.2 OUTLIER 49.25 19.13 0.29 Allowed 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.274 0.984 . . . . 0.0 112.624 -172.159 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.6 37.29 93.45 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.247 -0.977 . . . . 0.0 111.949 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -80.76 -141.56 2.95 Favored Glycine 0 C--O 1.236 0.25 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.658 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -157.78 126.54 5.66 Favored 'General case' 0 C--O 1.218 -0.597 0 O-C-N 122.317 -0.519 . . . . 0.0 111.526 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.99 124.46 19.98 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 123.139 0.274 . . . . 0.0 111.142 176.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 165' ' ' ARG . 4.0 m -116.28 -35.3 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.191 0.519 . . . . 0.0 111.419 -178.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.61 ' HB3' ' CB ' ' A' ' 165' ' ' ARG . . . -137.11 175.86 3.18 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 174.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.541 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 22.9 Cg_exo -60.58 109.24 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 121.316 1.344 . . . . 0.0 111.889 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 71.73 3.23 4.59 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.591 1.156 . . . . 0.0 111.119 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.61 ' CB ' ' HB3' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -96.11 86.74 4.35 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.527 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 70.1 m -79.63 150.64 30.93 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.368 172.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.494 ' HB2' HG11 ' A' ' 161' ' ' VAL . . . -93.08 121.41 34.39 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 172.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 61.6 m -106.08 132.12 52.54 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.418 -175.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 89.6 m -60.78 -52.03 66.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.963 -1.471 . . . . 0.0 114.114 -164.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -161.76 -93.6 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 118.852 -1.139 . . . . 0.0 113.111 -170.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -85.44 55.19 4.89 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.878 -164.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.658 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 4.5 m-85 -124.48 137.89 54.39 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.832 171.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.64 ' OG1' ' HG3' ' A' ' 179' ' ' ARG . 27.0 p -88.32 121.07 30.29 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.508 176.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 99.82 134.11 8.37 Favored Glycine 0 N--CA 1.426 -1.967 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.91 9.59 1.31 Allowed 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 120.903 1.068 . . . . 0.0 112.431 -172.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.656 ' O ' HD12 ' A' ' 155' ' ' LEU . 39.2 tt0 -110.37 25.01 12.25 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 171.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.549 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.8 OUTLIER 18.69 71.76 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 173.345 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.577 ' O ' ' HD3' ' A' ' 179' ' ' ARG . 8.6 pt-20 -124.13 31.64 5.75 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.93 0.871 . . . . 0.0 110.604 172.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.658 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 24.0 mmt180 -135.71 93.25 2.92 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 113.729 -1.578 . . . . 0.0 108.582 177.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -87.67 61.32 6.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 122.045 0.926 . . . . 0.0 109.935 -171.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.563 ' CE2' HG23 ' A' ' 173' ' ' THR . 26.0 p90 -83.12 91.39 7.21 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 171.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -89.33 136.5 32.99 Favored 'General case' 0 N--CA 1.437 -1.077 0 O-C-N 119.988 -1.695 . . . . 0.0 107.186 -176.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 77.1 p -86.57 134.69 33.63 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.72 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -158.73 155.29 26.34 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.434 ' O ' ' HA ' ' A' ' 217' ' ' TRP . 12.2 Cg_exo -71.73 160.23 48.63 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.41 2.073 . . . . 0.0 111.904 175.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.487 ' H ' HG23 ' A' ' 202' ' ' ILE . 3.6 t -117.73 105.83 12.4 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -177.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' PHE . . . . . 0.747 ' O ' ' HB3' ' A' ' 215' ' ' ARG . 37.4 m-85 -100.21 135.87 40.97 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.633 -172.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.6 m -97.45 -21.43 17.15 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -167.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.421 ' HB ' ' HG3' ' A' ' 196' ' ' GLN . 54.6 t -149.47 115.29 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -171.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.485 HD13 ' HB3' ' A' ' 221' ' ' CYS . 3.1 mt -134.73 119.67 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -164.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.4 p -116.56 -167.36 1.27 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.103 159.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -71.65 -5.61 34.95 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.024 0.916 . . . . 0.0 109.152 171.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -83.58 -67.26 0.8 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.551 -174.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.595 ' HG2' ' H ' ' A' ' 196' ' ' GLN . 43.0 ttp -146.53 139.28 25.3 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.666 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.759 ' O ' ' HB2' ' A' ' 196' ' ' GLN . 68.2 m -84.52 -15.43 45.88 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.586 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.759 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 3.9 mm-40 92.94 -158.8 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.568 1.147 . . . . 0.0 112.106 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.415 ' H ' ' HB3' ' A' ' 196' ' ' GLN . . . 64.71 8.24 32.51 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.274 -0.876 . . . . 0.0 113.693 176.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 55.59 25.94 8.6 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.865 0.332 . . . . 0.0 110.642 -175.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 61.68 27.93 17.2 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.312 -176.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 39.2 t -70.95 137.41 49.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.951 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.36 57.99 3.49 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.342 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.585 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -61.16 109.83 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 170.087 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 5.4 t -89.08 116.11 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 CA-C-O 122.527 1.156 . . . . 0.0 111.348 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 19.7 t -151.68 -179.7 7.65 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.442 ' OG1' HD22 ' A' ' 208' ' ' LEU . 18.5 p -105.66 161.58 14.26 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 120.64 1.564 . . . . 0.0 109.27 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.59 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 46.2 tttm -59.21 -41.51 88.77 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.609 0.718 . . . . 0.0 109.534 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.7 m -46.88 -54.91 8.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.826 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.49 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -57.93 -51.36 69.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.253 179.124 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 64.4 m -62.8 -39.53 94.55 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.497 ' HA ' ' HB3' ' A' ' 224' ' ' CYS . 60.2 m -79.95 -29.86 39.76 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.716 -175.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -71.1 -60.9 1.98 Allowed 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.79 HG22 ' HA2' ' A' ' 234' ' ' GLY . 24.6 p -97.29 144.4 27.11 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.89 -174.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.537 HG21 ' CD1' ' A' ' 256' ' ' LEU . 1.5 t 59.73 -36.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 96.15 -105.7 3.27 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 120.655 1.57 . . . . 0.0 112.498 -177.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.747 ' HB3' ' O ' ' A' ' 187' ' ' PHE . 78.1 mtt180 55.27 -131.84 1.83 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.648 0.737 . . . . 0.0 110.847 177.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.572 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -160.09 169.43 23.37 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 175.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' TRP . . . . . 0.59 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 24.9 t90 -149.69 145.4 26.68 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.606 -173.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 81.8 -178.33 53.71 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-O 121.527 0.515 . . . . 0.0 114.237 172.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.544 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 86.9 m-70 -131.62 130.29 22.35 Favored Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.544 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 18.8 Cg_endo -57.03 156.1 28.53 Favored 'Cis proline' 0 C--N 1.353 0.774 0 C-N-CA 124.002 -1.249 . . . . 0.0 111.044 -4.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' CYS . . . . . 0.485 ' HB3' HD13 ' A' ' 190' ' ' ILE . 58.3 m -67.51 78.46 0.17 Allowed 'General case' 0 C--N 1.32 -0.683 0 O-C-N 123.579 0.549 . . . . 0.0 111.923 -173.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.414 ' O ' ' HB1' ' A' ' 216' ' ' ALA . 12.4 mm-40 -53.94 115.15 1.87 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.034 0.445 . . . . 0.0 110.853 173.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' MET . . . . . 0.572 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 0.0 OUTLIER -91.1 132.66 35.91 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.032 -174.016 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 224' ' ' CYS . . . . . 0.497 ' HB3' ' HA ' ' A' ' 210' ' ' CYS . 70.8 m -97.94 124.04 49.18 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -167.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -62.26 152.63 75.26 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 123.968 3.112 . . . . 0.0 113.65 165.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -39.84 103.5 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.125 0 CA-C-O 122.284 1.04 . . . . 0.0 112.043 162.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 18.24 102.46 0.02 OUTLIER Pre-proline 0 C--N 1.311 -1.106 0 CA-C-N 111.335 -2.666 . . . . 0.0 114.42 -175.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -52.93 -49.88 16.04 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.893 2.395 . . . . 0.0 112.196 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -85.5 111.2 35.26 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.19 64.91 7.0 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.071 2.514 . . . . 0.0 114.265 -172.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 81.0 m -96.69 -84.52 0.36 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 168.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.522 ' HB3' ' CD2' ' A' ' 235' ' ' PHE . 14.4 ttm180 -145.98 135.72 23.34 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 168.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -39.16 -39.53 0.61 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -174.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.79 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -80.82 9.34 52.69 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 120.279 -0.963 . . . . 0.0 113.947 -176.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' PHE . . . . . 0.65 ' HE2' ' N ' ' A' ' 267' ' ' GLY . 1.9 m-85 -121.96 152.38 39.75 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -168.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.55 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.0 OUTLIER -129.89 131.82 23.75 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 114.047 -1.433 . . . . 0.0 107.778 169.797 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 244' ' ' CYS . 19.1 Cg_exo -63.41 111.59 1.51 Allowed 'Trans proline' 0 C--O 1.238 0.496 0 C-N-CA 122.173 1.915 . . . . 0.0 111.238 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -55.42 127.57 30.22 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.057 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 40.4 pt -80.9 12.35 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.14 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -110.46 -39.55 4.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.612 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 78.6 p -111.98 -39.51 4.49 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.95 0.881 . . . . 0.0 110.336 -177.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 102.03 6.07 49.27 Favored Glycine 0 N--CA 1.437 -1.253 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -175.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -97.39 119.7 36.4 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-O 122.079 0.942 . . . . 0.0 110.493 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 237' ' ' PRO . 3.7 m -55.62 123.54 14.39 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.266 176.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.42 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 41.3 tt0 -123.36 143.51 50.06 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.705 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 8.1 t70 -78.49 145.92 34.69 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.109 0.481 . . . . 0.0 110.32 -178.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.729 HG23 ' HG3' ' A' ' 249' ' ' GLU . 5.3 m -94.97 145.57 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.872 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.35 77.07 1.87 Allowed 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 168.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.729 ' HG3' HG23 ' A' ' 247' ' ' VAL . 35.9 mp0 -53.12 -33.94 54.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 124.375 1.047 . . . . 0.0 110.198 -172.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 7.7 m -46.91 -41.28 15.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.523 173.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -98.79 -42.17 7.32 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.648 0.737 . . . . 0.0 110.302 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.01 -28.62 69.63 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.463 -174.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.655 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.7 mp -123.72 83.13 54.25 Favored Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 173.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.43 ' HG2' HG12 ' A' ' 202' ' ' ILE . 19.3 Cg_endo -57.6 122.96 12.67 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.767 2.311 . . . . 0.0 113.919 -166.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 65.41 27.03 72.06 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 113.554 -1.657 . . . . 0.0 113.435 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.655 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.3 OUTLIER -74.46 -28.85 61.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 118.108 0.954 . . . . 0.0 110.407 177.657 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 257' ' ' CYS . . . . . 0.514 ' HA ' ' HB3' ' A' ' 284' ' ' GLN . 51.5 t -85.97 86.76 7.35 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.776 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -74.16 -19.49 60.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.448 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -54.02 -50.3 55.68 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.348 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 175.73 -93.45 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.069 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -110.25 135.76 50.5 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 269' ' ' PHE . 40.4 t -104.44 134.16 48.1 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 175.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 25.5 mt -131.01 105.78 11.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -70.08 125.4 26.66 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.534 -170.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.655 HG23 ' O ' ' A' ' 268' ' ' SER . 0.1 OUTLIER -110.83 156.23 21.42 Favored 'General case' 0 C--O 1.256 1.398 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.865 155.795 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.705 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 3.9 m -74.44 127.14 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 C-N-CA 118.155 -1.418 . . . . 0.0 107.876 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.65 ' N ' ' HE2' ' A' ' 235' ' ' PHE . . . 111.28 -25.13 14.37 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.521 -172.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.655 ' O ' HG23 ' A' ' 265' ' ' THR . 27.5 t 173.56 152.61 0.09 Allowed 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.476 0.655 . . . . 0.0 109.613 -174.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' PHE . . . . . 0.478 ' HB2' ' SG ' ' A' ' 262' ' ' CYS . 35.8 p90 -102.78 155.96 17.97 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -110.54 129.75 55.72 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 33.7 m -102.65 134.2 46.4 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.771 177.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -115.81 128.44 55.84 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.404 -177.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 19.3 m -129.57 168.52 16.08 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.724 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.62 155.35 21.87 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.212 1.941 . . . . 0.0 110.904 165.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.56 159.67 21.21 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.889 0.376 . . . . 0.0 110.779 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 89.41 -33.15 4.43 Favored Glycine 0 CA--C 1.504 -0.65 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.325 -174.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -72.15 156.22 39.41 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 120.806 0.336 . . . . 0.0 111.12 -176.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' LYS . . . . . 0.654 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 60.5 mttp -137.06 129.2 29.5 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -174.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.552 HD12 ' O ' ' A' ' 285' ' ' LYS . 32.7 tp -77.35 143.45 38.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 122.035 0.922 . . . . 0.0 112.622 -169.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.469 ' OD1' ' HB ' ' A' ' 282' ' ' VAL . 20.9 t-20 -124.12 100.45 6.72 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 114.366 -1.288 . . . . 0.0 107.833 175.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -69.94 -9.72 56.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.118 0.485 . . . . 0.0 111.691 -174.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.469 ' HB ' ' OD1' ' A' ' 280' ' ' ASN . 62.0 t -64.2 -59.02 4.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-O 121.193 0.521 . . . . 0.0 110.095 174.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 13.8 p -116.41 27.47 9.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.408 -176.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 0.514 ' HB3' ' HA ' ' A' ' 257' ' ' CYS . 12.7 mp0 31.14 51.67 0.14 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.805 -170.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' LYS . . . . . 0.552 ' O ' HD12 ' A' ' 279' ' ' LEU . 85.2 tttt -106.79 171.36 7.41 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' CYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 25.5 p -160.6 114.79 2.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 118.018 0.372 . . . . 0.0 110.318 177.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 N--CA 1.441 -0.916 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -175.584 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -92.59 11.37 26.78 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.756 0.312 . . . . 0.0 111.468 -177.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.3 m -101.32 26.03 7.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.245 0.545 . . . . 0.0 110.681 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -118.34 158.75 24.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.809 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.0 t -80.35 77.87 7.09 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 174.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.439 HG22 ' HG3' ' A' ' 117' ' ' GLN . 41.6 mt -85.18 142.79 12.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.157 -177.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.439 ' HG3' HG22 ' A' ' 116' ' ' ILE . 91.2 mt-30 64.71 44.93 3.61 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.42 0.629 . . . . 0.0 110.775 -176.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -78.9 -24.9 43.84 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.097 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 16.9 p -75.15 -179.33 4.33 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.352 176.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -115.86 -55.28 2.44 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 132' ' ' ASP . 0.2 OUTLIER -65.97 -176.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -178.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.6 ' HD2' ' N ' ' A' ' 122' ' ' ARG . 0.2 OUTLIER -119.03 156.61 29.34 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.426 -178.156 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 86.7 m -117.35 137.02 52.73 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.785 0.326 . . . . 0.0 111.621 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 63.6 mtm -141.83 140.45 32.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.828 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 70.12 55.91 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.088 0.47 . . . . 0.0 111.898 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.541 ' O ' ' HG3' ' A' ' 137' ' ' GLN . . . 79.12 39.01 20.94 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.787 171.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.405 ' HA3' ' SG ' ' A' ' 134' ' ' CYS . . . -112.4 151.98 17.96 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 119.609 -1.281 . . . . 0.0 113.853 176.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.0 m -111.28 126.76 55.23 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 175.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 9.6 t -75.35 122.07 23.19 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 -171.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 69.9 m -139.59 133.91 31.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.05 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.3 t70 44.06 -105.64 0.09 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.625 0.77 . . . . 0.0 112.468 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.474 ' HA ' HD12 ' A' ' 121' ' ' ILE . 25.7 t70 -130.25 27.96 5.03 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.952 0.882 . . . . 0.0 109.731 177.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -157.95 121.49 4.01 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.646 0.736 . . . . 0.0 109.621 -177.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.405 ' SG ' ' HA3' ' A' ' 127' ' ' GLY . 44.8 t -85.72 134.93 33.93 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.205 -170.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 49.4 mt -83.07 126.17 32.27 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 72.3 m -102.33 149.17 24.61 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.436 -171.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.541 ' HG3' ' O ' ' A' ' 126' ' ' GLY . 51.3 mt-30 -69.17 152.55 44.98 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 170.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -59.37 114.63 2.76 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 122.28 1.038 . . . . 0.0 111.353 -176.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.507 ' HA3' ' HB3' ' A' ' 163' ' ' PRO . . . 117.23 3.89 16.69 Favored Glycine 0 C--N 1.3 -1.462 0 CA-C-N 112.838 -1.983 . . . . 0.0 111.447 -178.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.535 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 88.5 m-85 -126.38 145.94 50.26 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.442 -0.446 . . . . 0.0 109.995 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.483 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 31.8 pt -139.28 -178.15 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.758 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.697 -173.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.51 153.88 28.51 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.636 -168.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.0 p -64.55 -33.31 75.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.819 0.343 . . . . 0.0 111.788 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -110.87 28.1 9.04 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 79.1 m 56.69 -124.99 1.89 Allowed 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.029 -169.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.65 -39.69 2.55 Favored Glycine 0 C--N 1.292 -1.913 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.402 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.483 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 1.5 tm0? -99.88 118.91 60.91 Favored Pre-proline 0 C--O 1.219 -0.539 0 CA-C-N 117.828 0.814 . . . . 0.0 111.073 -174.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 147' ' ' GLN . 8.5 Cg_endo -87.21 139.68 5.28 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.966 2.444 . . . . 0.0 112.411 175.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 149' ' ' VAL . 10.7 p -71.15 103.29 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 122.261 1.029 . . . . 0.0 111.291 -175.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.38 74.39 9.36 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 121.668 -0.645 . . . . 0.0 110.153 175.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.419 ' HB2' ' ND2' ' A' ' 164' ' ' ASN . 40.2 mt-10 -54.3 -48.07 71.71 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -169.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 69.8 m -90.81 18.65 6.27 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.499 0.666 . . . . 0.0 110.546 -168.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 74.97 128.85 0.2 Allowed Glycine 0 N--CA 1.427 -1.926 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.676 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.411 ' SG ' ' SG ' ' A' ' 160' ' ' CYS . 1.7 m -77.34 154.63 32.63 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.186 -1.007 . . . . 0.0 109.316 172.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 176' ' ' GLN . 50.1 mt -148.93 158.89 44.51 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.663 -166.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.609 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 2.8 t-20 52.58 27.88 5.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.899 -163.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.18 36.4 93.18 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.667 -172.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -64.88 151.77 51.08 Favored Glycine 0 N--CA 1.437 -1.279 0 CA-C-O 122.226 0.904 . . . . 0.0 114.257 -175.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.5 ttt85 -96.31 117.76 31.47 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 113.739 -1.23 . . . . 0.0 112.006 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.411 ' SG ' ' SG ' ' A' ' 154' ' ' CYS . 3.7 m -62.83 126.18 26.48 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 165' ' ' ARG . 19.7 m -114.77 -41.82 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -176.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -138.26 175.49 3.33 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.535 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 17.1 Cg_exo -63.06 108.11 0.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 121.044 1.163 . . . . 0.0 111.721 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.419 ' ND2' ' HB2' ' A' ' 151' ' ' GLU . 6.8 t-20 74.4 16.17 3.36 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.703 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.535 ' O ' HG22 ' A' ' 161' ' ' VAL . 1.8 mtm180 -112.83 95.31 5.34 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.545 169.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 9.1 t -87.82 151.98 22.45 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.753 171.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.47 ' HB2' HG11 ' A' ' 161' ' ' VAL . . . -105.33 120.03 40.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.457 0.646 . . . . 0.0 109.639 177.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 63.7 m -74.88 124.12 26.31 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.002 -170.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.609 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 77.0 m -60.0 -41.43 92.07 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.455 177.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.48 ' CG ' ' N ' ' A' ' 171' ' ' GLY . 52.5 t80 -140.23 -131.04 0.11 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.296 -176.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.48 ' N ' ' CG ' ' A' ' 170' ' ' TYR . . . -80.82 57.9 4.78 Favored Glycine 0 N--CA 1.435 -1.416 0 CA-C-N 116.157 -0.474 . . . . 0.0 113.148 -165.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.591 ' HB3' ' HA ' ' A' ' 177' ' ' CYS . 4.3 m-85 -121.3 125.57 47.38 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 119.714 -0.795 . . . . 0.0 111.527 170.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.517 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 3.4 t -90.41 158.57 17.02 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 168.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 87.23 130.84 3.14 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -177.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -75.17 21.29 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 121.498 1.466 . . . . 0.0 114.23 -165.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.494 ' O ' HD12 ' A' ' 155' ' ' LEU . 38.2 tt0 -120.36 -6.34 9.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.458 0.647 . . . . 0.0 110.029 176.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.591 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.3 OUTLIER 42.81 49.82 5.09 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -175.449 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.434 ' HB3' ' CD1' ' A' ' 155' ' ' LEU . 6.4 pt-20 -106.27 -15.33 14.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.281 0.562 . . . . 0.0 109.664 174.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.414 ' O ' ' HB3' ' A' ' 180' ' ' ASP . 11.1 mmt85 -57.85 -68.64 0.22 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.183 -1.371 . . . . 0.0 109.062 -175.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' A' ' 179' ' ' ARG . 36.5 t70 78.98 73.76 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.395 0.617 . . . . 0.0 110.159 165.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.517 ' HE2' ' N ' ' A' ' 173' ' ' THR . 28.9 p90 -91.38 67.54 5.7 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.8 1.286 . . . . 0.0 107.704 172.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 21.2 ttp85 -40.1 124.24 1.81 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 112.664 -2.062 . . . . 0.0 110.791 173.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 54.2 p -88.19 139.4 30.54 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.063 -171.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -160.01 146.72 13.09 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.47 129.29 12.7 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.202 1.935 . . . . 0.0 111.609 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.71 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 85.3 m -81.24 117.51 21.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.966 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' PHE . . . . . 0.678 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 43.8 m-85 -92.99 153.82 18.51 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.098 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.658 HG23 ' HE ' ' A' ' 215' ' ' ARG . 85.5 m -118.21 -18.79 9.22 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -162.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.2 p -164.9 116.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 O-C-N 121.417 -0.802 . . . . 0.0 110.043 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.494 HD13 ' SG ' ' A' ' 221' ' ' CYS . 2.7 mt -127.01 121.59 58.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -164.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.469 ' OG ' ' HB3' ' A' ' 193' ' ' GLN . 31.0 p -107.89 177.15 4.9 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 153.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -66.72 -12.4 58.41 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 122.477 1.132 . . . . 0.0 108.597 173.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.469 ' HB3' ' OG ' ' A' ' 191' ' ' SER . 60.2 tp60 -78.21 -38.8 42.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.235 -176.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.433 ' O ' ' HA ' ' A' ' 190' ' ' ILE . 41.9 ttm -162.31 140.63 8.86 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 -175.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.486 ' HA ' HG12 ' A' ' 190' ' ' ILE . 79.1 m -91.34 -23.91 19.95 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.257 0.551 . . . . 0.0 111.654 -176.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.467 ' HB2' ' H ' ' A' ' 188' ' ' THR . 55.0 tt0 -157.45 -73.69 0.09 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 170.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 127.78 -32.74 3.41 Favored Glycine 0 C--N 1.321 -0.262 0 C-N-CA 120.159 -1.02 . . . . 0.0 111.798 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 199' ' ' LEU . 92.1 mt-30 -74.61 -44.92 48.35 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 122.166 0.187 . . . . 0.0 110.701 171.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 198' ' ' GLN . 3.9 mm? 72.04 132.03 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.825 0.703 . . . . 0.0 110.735 -176.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 47.3 t -141.5 152.14 43.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.711 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -108.3 22.12 27.54 Favored Glycine 0 CA--C 1.502 -0.72 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.498 HG21 ' HB3' ' A' ' 254' ' ' PRO . 0.0 OUTLIER -60.74 114.22 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 172.418 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.3 t -102.99 99.73 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 CA-C-O 122.803 1.287 . . . . 0.0 111.093 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 7.4 t -133.3 -178.12 4.84 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 172.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 20.3 p -96.46 163.6 12.98 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.486 -174.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.508 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 72.2 tttt -59.31 -43.61 92.62 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.418 176.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.3 m -47.2 -54.47 10.67 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.391 174.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.589 ' CD1' HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -54.04 -62.29 1.75 Allowed 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.816 177.45 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 25.6 m -68.64 -22.17 64.42 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.351 -0.539 . . . . 0.0 112.361 -169.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 61.8 m -96.09 -27.8 14.91 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.376 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ALA . . . . . 0.484 ' HA ' ' CD ' ' A' ' 228' ' ' PRO . . . -66.59 -55.74 13.99 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 172.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.548 HG21 HD11 ' A' ' 253' ' ' ILE . 46.3 p -61.77 -154.04 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 112.519 -2.128 . . . . 0.0 112.405 176.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.413 HG21 HG21 ' A' ' 253' ' ' ILE . 36.0 m -36.89 -5.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.498 ' O ' ' HD3' ' A' ' 215' ' ' ARG . . . 70.3 -153.77 52.06 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 120.565 1.53 . . . . 0.0 114.556 172.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.658 ' HE ' HG23 ' A' ' 188' ' ' THR . 1.7 mpp_? 99.41 -82.59 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.045 1.338 . . . . 0.0 110.131 169.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.678 ' HB3' ' HB2' ' A' ' 187' ' ' PHE . . . -174.29 168.11 3.99 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 118.026 0.375 . . . . 0.0 110.126 174.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' TRP . . . . . 0.71 ' HD1' ' SG ' ' A' ' 186' ' ' CYS . 13.9 t90 -156.68 146.77 21.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 81.22 156.94 16.26 Favored Glycine 0 C--N 1.333 0.377 0 N-CA-C 114.63 0.612 . . . . 0.0 114.63 170.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.703 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 2.4 p-80 -130.91 136.29 28.67 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 172.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.703 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 73.2 Cg_exo -50.94 143.13 8.05 Favored 'Cis proline' 0 C--N 1.352 0.745 0 C-N-CA 124.64 -0.983 . . . . 0.0 113.297 -0.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' CYS . . . . . 0.494 ' SG ' HD13 ' A' ' 190' ' ' ILE . 7.9 t -49.71 112.06 0.6 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.029 -171.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.705 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 49.8 mt-10 -103.09 103.71 13.81 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' MET . . . . . 0.415 ' HG2' HD12 ' A' ' 190' ' ' ILE . 34.4 mtm -87.81 131.14 34.63 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.846 -172.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 26.6 p -143.65 147.14 37.97 Favored Pre-proline 0 N--CA 1.466 0.354 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -173.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.04 169.33 6.16 Favored 'Trans proline' 0 CA--C 1.5 -1.191 0 C-N-CA 122.896 2.397 . . . . 0.0 112.293 165.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -78.9 -160.64 0.24 Allowed 'General case' 0 N--CA 1.414 -2.254 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 161.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -12.41 86.86 0.03 OUTLIER Pre-proline 0 C--N 1.299 -1.617 0 C-N-CA 126.413 1.885 . . . . 0.0 115.525 -170.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.484 ' CD ' ' HA ' ' A' ' 211' ' ' ALA . 8.6 Cg_exo -73.23 -53.49 0.13 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.98 2.454 . . . . 0.0 111.118 174.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 -72.49 141.69 83.19 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.815 177.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -83.08 27.45 0.61 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.26 1.974 . . . . 0.0 113.841 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' CYS . . . . . 0.463 ' C ' ' HD2' ' A' ' 232' ' ' ARG . 68.4 m -83.48 -91.66 0.08 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 173.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.781 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 3.8 mpt_? -146.04 147.57 31.76 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 168.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -41.47 -46.83 3.57 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.464 0.477 . . . . 0.0 111.657 170.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' A' ' 246' ' ' ASP . . . -77.44 7.0 41.65 Favored Glycine 0 C--O 1.224 -0.477 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.817 -176.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' PHE . . . . . 0.781 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 3.5 m-85 -119.36 142.19 48.38 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.075 0.941 . . . . 0.0 113.357 -170.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 237' ' ' PRO . 0.3 OUTLIER -124.1 125.76 25.72 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 113.918 -1.492 . . . . 0.0 108.975 174.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 236' ' ' ILE . 19.1 Cg_exo -67.14 123.3 10.74 Favored 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 122.498 2.132 . . . . 0.0 112.71 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -54.43 139.65 36.59 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.55 0.69 . . . . 0.0 111.033 175.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 31.0 mt -73.08 -16.81 17.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.36 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 47.2 mtm180 -101.34 -66.56 0.91 Allowed 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.682 0.753 . . . . 0.0 110.239 -176.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 28.9 p -76.17 -42.42 46.56 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.688 -175.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 99.26 7.87 53.99 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -85.3 127.27 34.27 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.896 0.855 . . . . 0.0 110.278 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' CYS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 235' ' ' PHE . 3.2 m -65.44 121.6 15.26 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.901 175.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.542 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 96.6 mt-30 -119.29 141.34 49.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.645 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.706 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 13.1 t70 -78.02 148.08 34.51 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.07 0.462 . . . . 0.0 110.321 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.638 HG23 ' HG3' ' A' ' 249' ' ' GLU . 5.4 m -100.05 151.28 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.848 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -73.24 77.43 1.31 Allowed 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 166.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.638 ' HG3' HG23 ' A' ' 247' ' ' VAL . 5.6 mp0 -51.26 -40.61 59.26 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.756 -175.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 32.0 m -35.83 -43.59 0.31 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 114.189 -1.369 . . . . 0.0 112.658 171.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -99.72 -31.77 11.38 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.188 0.518 . . . . 0.0 110.694 -174.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.422 ' HB1' ' HG ' ' A' ' 208' ' ' LEU . . . -88.01 -4.21 58.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.905 -170.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.658 ' HB ' ' CD2' ' A' ' 256' ' ' LEU . 54.8 mt -134.4 133.47 21.64 Favored Pre-proline 0 CA--C 1.557 1.243 0 CA-C-N 119.092 0.86 . . . . 0.0 113.193 -174.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.533 ' HG3' ' HB2' ' A' ' 186' ' ' CYS . 3.4 Cg_endo -41.14 -73.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.078 1 C-N-CA 125.415 4.076 . . . . 0.0 115.171 -169.68 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -90.11 31.14 5.5 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.499 -169.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.658 ' CD2' ' HB ' ' A' ' 253' ' ' ILE . 0.6 OUTLIER -66.43 137.96 57.22 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.556 -0.857 . . . . 0.0 109.437 177.422 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 257' ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' ' 262' ' ' CYS . 7.9 p -55.82 99.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -167.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -92.07 -20.5 21.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.82 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -78.05 70.49 2.55 Favored Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 176.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 130.13 -148.48 18.55 Favored Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -174.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -109.08 146.12 34.53 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 117.033 0.417 . . . . 0.0 109.976 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' CYS . . . . . 0.521 ' HB3' ' SG ' ' A' ' 257' ' ' CYS . 17.8 p -127.91 147.38 50.46 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 172.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 53.3 mt -138.69 108.8 4.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.375 -167.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -73.36 114.45 11.59 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.747 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 268' ' ' SER . 0.2 OUTLIER -103.32 150.95 23.27 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 161.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.706 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 4.0 m -72.82 133.33 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 C-N-CA 117.553 -1.659 . . . . 0.0 107.503 177.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.684 ' N ' ' HE2' ' A' ' 235' ' ' PHE . . . 97.61 -19.54 54.25 Favored Glycine 0 N--CA 1.434 -1.494 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.607 -174.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.589 ' O ' HG23 ' A' ' 265' ' ' THR . 3.9 p 179.76 142.33 0.14 Allowed 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 117.399 0.599 . . . . 0.0 110.577 -175.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -97.98 156.74 16.49 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' GLU . . . . . 0.51 ' HG3' ' CG2' ' A' ' 265' ' ' THR . 8.8 mt-10 -117.83 155.69 29.67 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 58.4 m -123.21 154.89 38.13 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.948 0.88 . . . . 0.0 112.311 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.408 ' HB3' ' NZ ' ' A' ' 272' ' ' LYS . 9.2 mtpm? -135.5 100.5 4.52 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.763 -1.562 . . . . 0.0 109.386 170.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' CYS . . . . . 0.429 ' HB3' ' HD2' ' A' ' 274' ' ' PRO . 38.6 m -104.79 170.28 6.2 Favored Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.539 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 273' ' ' CYS . 51.2 Cg_exo -55.44 157.04 15.74 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 121.801 1.667 . . . . 0.0 111.019 171.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -58.27 154.24 13.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.185 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 87.46 -30.81 4.73 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.934 -176.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' HIS . . . . . 0.608 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 14.2 m-70 -70.66 155.4 40.8 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.176 0.512 . . . . 0.0 112.182 -176.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' LYS . . . . . 0.643 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 99.2 mttt -138.68 133.81 32.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.284 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 15.5 tp -91.28 141.2 29.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.753 0.787 . . . . 0.0 111.44 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.481 ' OD1' ' HB ' ' A' ' 282' ' ' VAL . 55.2 t-20 -126.76 101.59 6.68 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 174.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.66 -24.45 66.74 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 123.719 0.637 . . . . 0.0 111.387 -175.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.481 ' HB ' ' OD1' ' A' ' 280' ' ' ASN . 78.8 t -65.2 -43.97 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.488 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 47.3 t -118.92 20.56 12.74 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.276 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 36.13 43.48 0.22 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.737 -173.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 89.7 mttt -91.29 153.07 20.21 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' CYS . . . . . 0.643 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 7.7 t -152.07 86.36 1.3 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.608 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 34.5 tt0 . . . . . 0 C--N 1.312 -1.06 0 CA-C-O 118.259 -0.877 . . . . 0.0 109.822 -173.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 26.1 m . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 121.286 0.565 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.17 140.6 21.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.679 -177.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.8 t -87.15 61.0 6.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -83.78 133.74 34.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.874 -173.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.5 p -70.41 -30.59 67.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.945 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 57.5 mt -70.56 128.27 33.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.738 173.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 63.11 56.14 1.81 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.673 0.749 . . . . 0.0 109.464 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -67.07 142.12 57.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.896 -176.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 58.4 m -71.13 -177.96 1.86 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.583 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -115.89 -20.68 9.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.356 0.598 . . . . 0.0 109.634 -176.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.491 HD13 ' H ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -98.59 125.38 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 CA-C-O 121.444 0.64 . . . . 0.0 110.268 176.849 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.471 ' H ' ' NE ' ' A' ' 122' ' ' ARG . 0.1 OUTLIER -52.28 128.21 24.47 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.55 175.474 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.432 ' HB3' ' HA3' ' A' ' 127' ' ' GLY . 42.3 m -116.51 115.58 26.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.605 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 85.8 mtp -90.75 156.5 18.02 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.361 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 66.72 47.59 1.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.142 0.496 . . . . 0.0 111.579 172.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 70.25 18.78 75.31 Favored Glycine 0 CA--C 1.516 0.108 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.311 173.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.432 ' HA3' ' HB3' ' A' ' 123' ' ' CYS . . . -54.28 131.48 45.61 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.636 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.476 ' HB2' ' HB2' ' A' ' 135' ' ' LEU . 22.8 m -79.23 158.55 27.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.416 -0.392 . . . . 0.0 110.386 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 53.8 t -86.97 99.1 11.63 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.386 0.612 . . . . 0.0 110.673 -176.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.685 ' HB3' ' O ' ' A' ' 133' ' ' HIS . 29.0 t -112.32 139.99 47.41 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 175.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 132' ' ' ASP . 7.4 m-20 -43.14 72.85 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 116.172 1.916 . . . . 0.0 116.172 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.503 ' HB3' ' O ' ' A' ' 131' ' ' ASP . 27.3 t70 109.53 -25.08 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.715 1.606 . . . . 0.0 110.048 164.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.685 ' O ' ' HB3' ' A' ' 130' ' ' SER . 0.3 OUTLIER -119.92 147.59 44.54 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.257 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 69.2 m -81.32 158.95 24.56 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.921 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 128' ' ' SER . 40.0 mt -123.63 104.53 9.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 176.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 31.3 m -69.32 176.44 3.34 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.804 -168.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -92.69 141.82 28.05 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 173.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.44 ' HA ' ' HD2' ' A' ' 138' ' ' LYS . 43.7 tptt -63.46 110.04 1.82 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.521 1.153 . . . . 0.0 110.929 -167.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 142.62 -15.94 2.45 Favored Glycine 0 N--CA 1.433 -1.542 0 CA-C-N 112.584 -2.098 . . . . 0.0 109.948 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.535 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 95.7 m-85 -118.99 153.19 35.05 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.548 170.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.453 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 33.9 pt -132.2 172.49 16.28 Favored 'Isoleucine or valine' 0 C--O 1.245 0.838 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 174.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.75 158.62 24.6 Favored Glycine 0 N--CA 1.45 -0.368 0 O-C-N 124.014 0.821 . . . . 0.0 112.208 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.7 p -70.76 -25.82 63.08 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.507 -0.407 . . . . 0.0 111.48 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -100.5 -8.29 23.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.932 0.396 . . . . 0.0 109.992 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 86.1 m 69.03 40.52 1.58 Allowed 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.483 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.98 3.97 48.87 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.194 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.453 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 5.2 tm0? -108.31 111.54 61.59 Favored Pre-proline 0 N--CA 1.464 0.255 0 CA-C-N 117.502 0.651 . . . . 0.0 110.819 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -82.8 143.2 11.68 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.173 2.582 . . . . 0.0 112.998 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.3 p -71.75 115.87 12.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.641 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.641 ' HB3' ' O ' ' A' ' 153' ' ' GLY . 0.9 OUTLIER -80.73 78.25 7.51 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 172.343 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 164' ' ' ASN . 2.2 tt0 -52.27 -60.61 3.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.268 -173.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 17.8 m -94.84 14.52 21.18 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.057 0.456 . . . . 0.0 110.923 -175.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.641 ' O ' ' HB3' ' A' ' 150' ' ' CYS . . . 106.88 -117.32 5.29 Favored Glycine 0 N--CA 1.415 -2.701 0 CA-C-O 122.888 1.271 . . . . 0.0 111.601 -178.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.534 ' O ' HD23 ' A' ' 155' ' ' LEU . 0.6 OUTLIER 162.22 141.24 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 -172.349 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 176' ' ' GLN . 39.1 mt -132.58 170.7 14.81 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 -163.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.753 ' HB3' ' CZ ' ' A' ' 172' ' ' PHE . 9.6 p30 45.5 21.61 0.08 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -174.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 67.37 37.87 90.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.296 -174.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -75.4 -146.76 1.56 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.575 -0.345 . . . . 0.0 112.689 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -157.95 124.87 4.96 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 122.68 -0.306 . . . . 0.0 110.955 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.4 m -61.96 125.39 23.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.62 0.248 . . . . 0.0 111.31 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 165' ' ' ARG . 4.2 m -112.18 -46.91 5.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.859 -0.337 . . . . 0.0 110.453 177.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.502 ' HB1' ' HD2' ' A' ' 163' ' ' PRO . . . -128.97 176.1 3.05 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 118.45 -0.786 . . . . 0.0 109.859 170.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.535 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 82.0 Cg_exo -50.67 103.78 0.07 OUTLIER 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 122.524 2.149 . . . . 0.0 113.298 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.422 ' HB2' ' HB2' ' A' ' 151' ' ' GLU . 9.1 t30 67.09 5.31 4.05 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.377 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.542 ' O ' HG22 ' A' ' 161' ' ' VAL . 1.7 ttm180 -89.02 82.5 6.65 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 169.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 35.8 t -85.48 137.73 32.71 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -88.9 127.87 35.65 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 35.2 m -109.94 134.03 52.53 Favored 'General case' 0 C--O 1.239 0.502 0 O-C-N 124.231 0.957 . . . . 0.0 112.028 -168.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 91.4 m -56.16 -56.28 22.87 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -165.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -161.9 -87.98 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.06 -1.056 . . . . 0.0 112.901 -166.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -85.81 46.95 3.71 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.564 -165.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.753 ' CZ ' ' HB3' ' A' ' 156' ' ' ASN . 6.9 m-85 -121.28 130.83 53.86 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.922 170.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.688 ' N ' ' HE1' ' A' ' 181' ' ' TYR . 3.5 t -97.37 138.28 35.07 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 173.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 99.12 126.06 5.56 Favored Glycine 0 C--N 1.299 -1.502 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -169.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -67.86 -0.22 5.15 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.55 1.5 . . . . 0.0 113.301 -170.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.609 ' O ' HD12 ' A' ' 155' ' ' LEU . 45.7 tt0 -111.64 24.34 12.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.39 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.494 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 1.2 p 23.96 60.92 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 117.506 2.41 . . . . 0.0 117.506 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -113.84 26.17 10.57 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.508 1.147 . . . . 0.0 109.441 169.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.547 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 17.6 mmt85 -120.9 84.66 2.27 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.597 -1.638 . . . . 0.0 108.592 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -82.72 76.88 9.54 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.828 -172.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.688 ' HE1' ' N ' ' A' ' 173' ' ' THR . 20.4 p90 -111.94 83.29 1.77 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.757 173.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 61.1 mtt85 -84.45 145.7 28.01 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 119.542 -1.974 . . . . 0.0 107.157 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 73.2 p -91.47 135.22 34.0 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.401 -175.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -159.49 162.5 32.92 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.162 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.21 128.56 10.63 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.215 1.943 . . . . 0.0 111.796 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.537 ' H ' HG23 ' A' ' 202' ' ' ILE . 10.5 t -85.0 115.65 22.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.275 0.56 . . . . 0.0 110.452 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' PHE . . . . . 0.639 ' O ' ' HB2' ' A' ' 215' ' ' ARG . 42.6 m-85 -101.69 151.51 21.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.435 -175.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.624 ' HA ' ' CB ' ' A' ' 215' ' ' ARG . 15.4 p -114.42 -23.95 9.1 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -170.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.502 ' HB ' ' CG ' ' A' ' 196' ' ' GLN . 27.0 t -155.69 116.99 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -171.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.488 HG12 ' HA ' ' A' ' 195' ' ' CYS . 4.0 mt -130.14 118.42 43.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 119.012 -1.075 . . . . 0.0 113.892 -170.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.5 p -112.76 -166.81 1.11 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.566 161.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -67.51 -5.48 15.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.619 0.724 . . . . 0.0 110.388 172.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -92.47 -76.53 0.46 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.43 -173.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.598 ' HG2' ' H ' ' A' ' 196' ' ' GLN . 53.1 ttm -136.17 136.31 39.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.826 -172.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 196' ' ' GLN . 29.0 m -84.9 -15.47 44.43 Favored 'General case' 0 C--O 1.247 0.925 0 O-C-N 123.342 0.401 . . . . 0.0 110.823 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.598 ' H ' ' HG2' ' A' ' 194' ' ' MET . 72.3 mm-40 95.09 -165.06 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.211 1.405 . . . . 0.0 112.658 174.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.407 ' H ' ' HB3' ' A' ' 196' ' ' GLN . . . 69.17 -3.57 7.22 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 114.992 -1.003 . . . . 0.0 113.03 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 51.01 39.59 23.43 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.965 0.383 . . . . 0.0 110.263 -172.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 58.0 58.7 3.45 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.579 -177.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 33.5 t -72.85 147.83 45.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.692 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -91.01 26.46 11.13 Favored Glycine 0 CA--C 1.506 -0.511 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.537 HG23 ' H ' ' A' ' 186' ' ' CYS . 0.0 OUTLIER -63.08 106.47 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-O 121.95 0.881 . . . . 0.0 109.356 174.204 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 12.6 t -94.63 118.9 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.144 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 18.7 t -156.22 179.72 8.96 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.401 ' OG1' HD22 ' A' ' 208' ' ' LEU . 10.7 p -102.37 160.21 14.75 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 120.184 1.356 . . . . 0.0 109.736 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.588 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 37.8 tttm -59.01 -42.26 89.66 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.503 177.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.0 m -44.87 -56.62 4.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.332 174.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.499 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -54.09 -53.74 49.05 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.665 177.461 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 91.5 m -67.94 -23.48 65.07 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -174.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 61.4 m -93.84 -34.79 13.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.542 0.61 . . . . 0.0 111.649 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -72.67 -58.12 3.6 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.86 HG22 ' HA2' ' A' ' 234' ' ' GLY . 4.6 p -97.83 159.74 14.74 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.258 177.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.1 t 66.97 -48.42 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 122.565 0.346 . . . . 0.0 111.729 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 60.63 52.03 55.04 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 114.796 0.679 . . . . 0.0 114.796 171.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.639 ' HB2' ' O ' ' A' ' 187' ' ' PHE . 0.0 OUTLIER -123.41 -78.2 0.6 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.813 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.518 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -173.28 167.24 4.81 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' TRP . . . . . 0.605 ' O ' ' HB2' ' A' ' 222' ' ' GLU . 19.5 t90 -159.61 148.16 17.62 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 92.59 177.48 41.32 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 114.74 0.656 . . . . 0.0 114.74 168.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.59 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 12.2 p80 -143.01 132.14 11.67 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.132 -0.534 . . . . 0.0 109.707 177.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.59 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 52.1 Cg_exo -56.65 148.11 26.29 Favored 'Cis proline' 0 C--N 1.346 0.411 0 C-N-CA 123.694 -1.378 . . . . 0.0 111.444 -4.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' CYS . . . . . 0.467 ' HB3' HD13 ' A' ' 190' ' ' ILE . 80.0 m -47.22 122.81 4.84 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.795 0.685 . . . . 0.0 111.845 -173.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.605 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 33.6 mm-40 -108.35 112.5 24.98 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' MET . . . . . 0.518 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 10.4 ptm -94.38 133.79 37.58 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.269 0.557 . . . . 0.0 110.911 -172.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 74.2 m -94.12 125.16 53.71 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.198 -0.91 . . . . 0.0 113.397 -164.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -64.76 154.21 73.79 Favored 'Trans proline' 0 CA--C 1.512 -0.584 0 C-N-CA 123.092 2.528 . . . . 0.0 113.188 166.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -38.29 104.4 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 122.772 1.272 . . . . 0.0 111.93 163.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' GLN . . . . . 0.488 ' HA ' ' HD2' ' A' ' 228' ' ' PRO . 0.3 OUTLIER 18.52 88.24 0.05 OUTLIER Pre-proline 0 N--CA 1.483 1.189 0 CA-C-N 110.507 -3.042 . . . . 0.0 114.778 174.633 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.488 ' HD2' ' HA ' ' A' ' 227' ' ' GLN . 5.6 Cg_exo -38.04 -55.93 1.08 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 124.387 3.391 . . . . 0.0 113.246 173.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -80.51 106.0 4.59 Favored Pre-proline 0 CA--C 1.518 -0.277 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 170.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.1 35.53 0.3 Allowed 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.112 1.875 . . . . 0.0 114.247 -171.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' CYS . . . . . 0.421 ' HB2' ' H ' ' A' ' 232' ' ' ARG . 33.8 m -69.22 -74.81 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 169.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.577 ' HB3' ' CD2' ' A' ' 235' ' ' PHE . 24.0 tpt180 -149.47 140.4 22.85 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 165.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -36.3 -45.46 0.47 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -177.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.86 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -78.8 9.97 34.55 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.93 -174.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' PHE . . . . . 0.672 ' HE2' ' N ' ' A' ' 267' ' ' GLY . 2.2 m-85 -116.53 138.39 51.44 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 122.009 0.909 . . . . 0.0 113.426 -169.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.523 HG22 ' HD2' ' A' ' 237' ' ' PRO . 0.0 OUTLIER -126.48 137.07 29.61 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.601 173.281 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.523 ' HD2' HG22 ' A' ' 236' ' ' ILE . 19.7 Cg_endo -57.61 124.41 16.01 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.658 2.239 . . . . 0.0 112.92 -177.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.418 ' O ' ' HA2' ' A' ' 242' ' ' GLY . 22.9 t-20 -58.27 141.66 50.23 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.652 173.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 26.3 mt -81.45 -13.82 12.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.079 -174.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 65.1 mtt180 -99.57 -59.01 1.8 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.335 0.588 . . . . 0.0 109.823 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 43.8 p -86.63 -33.96 19.97 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.879 -176.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 238' ' ' ASN . . . 90.3 5.77 69.5 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -177.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -83.46 134.02 34.88 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 121.591 0.71 . . . . 0.0 110.349 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 4.0 m -59.45 118.73 6.36 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.273 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.557 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 83.1 mm-40 -120.38 143.03 48.65 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.722 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 14.9 t70 -79.11 146.16 33.36 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -176.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.755 HG23 ' HG3' ' A' ' 249' ' ' GLU . 5.3 m -98.68 148.22 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.047 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.856 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -75.8 77.28 2.73 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 167.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.755 ' HG3' HG23 ' A' ' 247' ' ' VAL . 40.4 mp0 -53.57 -37.66 63.14 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 123.482 0.489 . . . . 0.0 111.689 -168.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 36.0 t -50.59 -40.47 52.64 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.121 0.486 . . . . 0.0 110.616 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -93.78 -40.32 10.26 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.591 0.71 . . . . 0.0 110.125 -172.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -67.49 -25.01 65.65 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.588 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.471 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.1 mp -121.3 83.76 40.11 Favored Pre-proline 0 N--CA 1.449 -0.525 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 173.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -65.34 8.81 0.21 Allowed 'Trans proline' 0 N--CA 1.482 0.813 0 C-N-CA 124.411 3.408 . . . . 0.0 116.379 -168.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -129.81 8.4 6.11 Favored Glycine 0 C--N 1.295 -1.708 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.755 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.471 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.1 OUTLIER -102.65 136.41 42.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.212 0.529 . . . . 0.0 112.189 -174.295 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 10.7 t 56.78 54.43 7.22 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.681 178.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -94.28 -17.63 22.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.257 177.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -87.8 40.57 3.08 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.434 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 164.03 -160.6 33.52 Favored Glycine 0 N--CA 1.437 -1.234 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' ASN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 272' ' ' LYS . 13.7 m120 -81.41 156.47 25.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.921 0.361 . . . . 0.0 110.425 177.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 15.4 p -138.92 121.14 15.84 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 176.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 270' ' ' GLU . 16.6 mt -136.16 164.1 32.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -174.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.413 HD21 ' H ' ' A' ' 249' ' ' GLU . 0.6 OUTLIER -134.61 132.12 38.65 Favored 'General case' 0 CA--C 1.496 -1.109 0 C-N-CA 117.789 -1.564 . . . . 0.0 114.36 -175.35 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.89 160.36 20.99 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.867 162.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.722 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 3.0 m -73.1 128.12 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 173.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.672 ' N ' ' HE2' ' A' ' 235' ' ' PHE . . . 112.45 -22.17 17.97 Favored Glycine 0 N--CA 1.419 -2.439 0 C-N-CA 119.977 -1.106 . . . . 0.0 112.147 -173.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.566 ' HB2' ' O ' ' A' ' 267' ' ' GLY . 8.5 t 166.77 165.04 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.342 0.592 . . . . 0.0 110.18 -177.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' PHE . . . . . 0.423 ' CZ ' HD11 ' A' ' 256' ' ' LEU . 36.3 p90 -101.15 155.45 18.0 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 119.864 -0.735 . . . . 0.0 109.965 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' GLU . . . . . 0.405 ' HB2' ' HB ' ' A' ' 263' ' ' ILE . 3.6 mt-10 -109.93 123.86 50.37 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -177.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 66.3 m -114.0 129.07 56.63 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.399 0.618 . . . . 0.0 110.156 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 261' ' ' ASN . 18.6 ttpp -102.61 114.49 28.76 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.838 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 70.0 m -91.6 148.09 36.59 Favored Pre-proline 0 C--N 1.296 -1.74 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.311 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 70.3 Cg_exo -52.81 152.67 16.68 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.006 1.804 . . . . 0.0 110.927 173.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -51.61 139.95 19.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.884 0.373 . . . . 0.0 111.115 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 86.92 -34.77 3.5 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.301 -0.952 . . . . 0.0 111.353 -176.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' HIS . . . . . 0.605 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 17.8 m-70 -80.24 163.33 24.08 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 120.968 0.413 . . . . 0.0 110.893 -176.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -146.29 133.71 20.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.561 -173.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.528 HD12 ' O ' ' A' ' 285' ' ' LYS . 46.8 tp -66.56 142.57 57.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.991 0.424 . . . . 0.0 111.063 -176.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -131.23 99.47 4.87 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -61.32 -17.15 52.37 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.861 0.725 . . . . 0.0 112.624 -176.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.502 ' HA ' ' NH1' ' A' ' 215' ' ' ARG . 77.0 t -58.01 -39.48 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.183 0.516 . . . . 0.0 110.597 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 57.7 p -140.89 36.9 1.78 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.951 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 0.443 ' OE1' ' HA ' ' A' ' 256' ' ' LEU . 0.0 OUTLIER 28.25 50.92 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.326 1.051 . . . . 0.0 112.897 -174.79 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 285' ' ' LYS . . . . . 0.528 ' O ' HD12 ' A' ' 279' ' ' LEU . 68.9 tttt -104.44 169.59 8.38 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.699 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 53.7 m -141.65 100.21 3.72 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.605 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 57.8 mm-40 . . . . . 0 C--O 1.24 0.563 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -173.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.5 t . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.01 -47.05 48.46 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.869 0.366 . . . . 0.0 110.408 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.4 p -123.0 169.25 11.36 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.855 176.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -57.46 -54.9 41.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.143 0.497 . . . . 0.0 109.948 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 46.4 m -105.45 133.09 50.78 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.335 172.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.4 tt -57.77 -29.88 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.856 -177.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -78.03 126.88 31.48 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -68.04 111.52 4.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.76 0.314 . . . . 0.0 110.327 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 26.7 p -114.38 -174.71 2.53 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -119.52 -50.01 2.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.898 0.38 . . . . 0.0 110.372 -176.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.67 -178.31 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.583 ' H ' ' HD2' ' A' ' 122' ' ' ARG . 0.2 OUTLIER -124.22 142.08 51.54 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.308 -175.791 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 65.6 m -116.09 134.97 54.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.13 0.491 . . . . 0.0 111.914 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -125.81 162.65 24.65 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 170.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.497 ' HB3' ' CE1' ' A' ' 140' ' ' TYR . 90.5 m-20 66.17 43.57 2.81 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.003 0.43 . . . . 0.0 111.9 174.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.414 ' HA3' ' OE1' ' A' ' 137' ' ' GLN . . . 65.84 30.84 78.01 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 116.011 -0.54 . . . . 0.0 113.868 177.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -84.46 143.47 20.93 Favored Glycine 0 C--O 1.234 0.151 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.292 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.491 ' HB3' ' HB2' ' A' ' 135' ' ' LEU . 8.9 t -93.23 134.39 35.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.31 0.576 . . . . 0.0 109.463 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 11.3 t -99.76 113.2 25.53 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.728 -172.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 40.3 t -130.06 125.26 34.79 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 43.86 -102.85 0.05 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.385 0.674 . . . . 0.0 112.406 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -123.38 34.13 5.18 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.711 -176.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -155.83 141.76 18.12 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.986 0.422 . . . . 0.0 110.348 177.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.432 ' HB3' ' O ' ' A' ' 143' ' ' THR . 38.3 t -102.87 131.79 49.53 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.831 -178.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.491 ' HB2' ' HB3' ' A' ' 128' ' ' SER . 60.8 mt -90.86 97.42 11.17 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.627 0.727 . . . . 0.0 109.349 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' CYS . . . . . 0.954 ' SG ' ' HB2' ' A' ' 140' ' ' TYR . 42.4 t -74.92 157.0 35.75 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.976 -173.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.414 ' OE1' ' HA3' ' A' ' 126' ' ' GLY . 47.1 mt-30 -85.54 156.18 20.87 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.48 176.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -69.83 110.6 5.05 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 122.923 1.344 . . . . 0.0 110.839 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.46 ' HA2' ' CG1' ' A' ' 149' ' ' VAL . . . 136.79 -6.52 3.8 Favored Glycine 0 C--N 1.293 -1.812 0 CA-C-N 111.94 -2.391 . . . . 0.0 110.258 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.954 ' HB2' ' SG ' ' A' ' 136' ' ' CYS . 67.7 m-85 -130.63 162.16 29.99 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 168.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.491 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 32.6 pt -138.4 -176.33 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.865 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.03 167.61 43.17 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.302 -174.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.432 ' O ' ' HB3' ' A' ' 134' ' ' CYS . 34.4 p -77.99 -10.98 59.86 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.778 -0.248 . . . . 0.0 111.516 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 30.7 m80 -109.28 -3.76 16.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.047 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 140' ' ' TYR . 9.5 t 66.1 26.26 10.71 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.35 0.595 . . . . 0.0 109.623 -177.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -96.09 4.14 64.96 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.615 -0.721 . . . . 0.0 113.076 -173.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.549 ' O ' ' HA ' ' A' ' 140' ' ' TYR . 8.5 tm0? -110.91 108.08 57.74 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.027 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -74.06 140.72 28.66 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.119 2.546 . . . . 0.0 112.983 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 149' ' ' VAL . 13.6 p -78.38 103.59 5.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.34 1.067 . . . . 0.0 111.363 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -81.95 82.89 7.42 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.646 174.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -56.33 -69.09 0.16 Allowed 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -173.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 64.9 m -83.05 10.5 7.92 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.78 0.8 . . . . 0.0 110.659 -163.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 71.72 132.31 0.12 Allowed Glycine 0 N--CA 1.424 -2.13 0 CA-C-N 114.374 -1.285 . . . . 0.0 111.491 -170.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 160' ' ' CYS . 62.4 m -68.06 151.5 46.95 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.23 -0.985 . . . . 0.0 109.503 175.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 38.6 mt -132.36 175.39 9.32 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -172.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.774 ' HB2' ' CZ ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 66.88 11.52 8.36 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 123.791 0.682 . . . . 0.0 112.124 170.615 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.61 32.07 80.06 Favored Glycine 0 CA--C 1.507 -0.458 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -172.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.443 ' HA2' ' OG1' ' A' ' 169' ' ' THR . . . -77.76 -145.55 2.44 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.276 -0.462 . . . . 0.0 114.1 -175.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -149.76 114.13 5.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.63 0.252 . . . . 0.0 110.491 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.467 ' HB2' ' SG ' ' A' ' 154' ' ' CYS . 35.1 t -58.78 113.77 2.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.891 0.377 . . . . 0.0 110.634 174.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 165' ' ' ARG . 13.0 m -106.96 -46.13 8.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.921 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.577 ' HB1' ' HD2' ' A' ' 163' ' ' PRO . . . -134.11 178.06 1.95 Allowed Pre-proline 0 CA--C 1.541 0.622 0 CA-C-O 118.72 -0.657 . . . . 0.0 109.981 175.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.577 ' HD2' ' HB1' ' A' ' 162' ' ' ALA . 96.2 Cg_exo -49.05 103.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 122.661 2.241 . . . . 0.0 113.589 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 66.31 8.94 6.01 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.238 1.015 . . . . 0.0 109.958 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.597 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -93.08 81.24 4.54 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.613 174.824 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 63.7 m -85.74 138.75 31.88 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.277 172.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.96 139.16 30.8 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.498 ' HA ' HD21 ' A' ' 156' ' ' ASN . 61.0 m -92.65 110.44 21.87 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 124.182 0.926 . . . . 0.0 111.601 -169.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.443 ' OG1' ' HA2' ' A' ' 158' ' ' GLY . 24.1 m -65.84 -55.28 17.88 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.44 ' CD2' ' N ' ' A' ' 171' ' ' GLY . 38.0 t80 -121.36 -116.41 0.31 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 118.89 -1.124 . . . . 0.0 112.532 -168.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.44 ' N ' ' CD2' ' A' ' 170' ' ' TYR . . . -91.77 52.13 2.95 Favored Glycine 0 CA--C 1.485 -1.799 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.163 -166.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.774 ' CZ ' ' HB2' ' A' ' 156' ' ' ASN . 6.9 m-85 -119.06 127.8 53.74 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 119.302 -0.959 . . . . 0.0 112.598 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.478 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 3.6 t -91.0 162.71 14.6 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 163.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 90.96 131.25 4.92 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.36 -13.2 30.48 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.312 1.341 . . . . 0.0 113.322 -166.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -106.83 14.41 26.71 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.246 0.546 . . . . 0.0 109.601 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.531 ' HB3' ' HB2' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 31.33 60.22 0.27 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.735 1.214 . . . . 0.0 113.958 177.385 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -115.94 -13.92 11.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.925 175.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -56.44 -61.91 2.09 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.907 -1.497 . . . . 0.0 107.967 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 32.8 t70 74.45 69.83 0.1 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.78 0.8 . . . . 0.0 109.524 160.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.478 ' HE2' ' N ' ' A' ' 173' ' ' THR . 45.3 p90 -94.75 66.22 3.13 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 174.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -57.19 123.74 16.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.136 171.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.578 ' HB ' HG13 ' A' ' 203' ' ' VAL . 41.3 p -73.22 138.02 45.34 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -163.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -140.51 141.61 11.58 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.79 -162.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -72.12 128.66 14.15 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.964 1.776 . . . . 0.0 111.382 172.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 6.4 t -84.53 113.6 21.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.131 0.491 . . . . 0.0 110.09 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' PHE . . . . . 0.561 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 14.6 m-85 -94.6 147.05 23.68 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.766 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.548 ' HA ' ' CB ' ' A' ' 215' ' ' ARG . 12.9 p -113.5 -2.92 13.77 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.5 t -130.35 159.23 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.799 HD11 ' HB2' ' A' ' 216' ' ' ALA . 40.5 mm -134.55 119.34 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.562 0.696 . . . . 0.0 111.336 174.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.418 ' HB3' ' H ' ' A' ' 194' ' ' MET . 48.2 t -143.17 169.18 18.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.308 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -79.37 -7.5 58.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 122.369 1.081 . . . . 0.0 108.106 167.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -92.44 -71.45 0.64 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.476 -1.693 . . . . 0.0 109.655 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.418 ' H ' ' HB3' ' A' ' 191' ' ' SER . 63.2 mtt -143.83 136.55 27.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.927 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 196' ' ' GLN . 34.3 m -85.17 -38.79 18.6 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 168.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 1.8 mm-40 157.11 -149.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 113.423 -1.717 . . . . 0.0 106.969 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 94.13 17.21 41.12 Favored Glycine 0 CA--C 1.509 -0.338 0 C-N-CA 119.743 -1.218 . . . . 0.0 112.747 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -90.58 -1.99 57.88 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.227 0.536 . . . . 0.0 110.204 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.464 ' N ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -160.53 8.97 0.09 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.755 -177.392 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 12.6 m -87.97 86.07 7.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.313 0.578 . . . . 0.0 112.248 -169.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -100.25 4.19 57.01 Favored Glycine 0 CA--C 1.506 -0.509 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 170.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.467 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -60.14 114.33 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 114.435 -0.882 . . . . 0.0 109.576 173.145 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.578 HG13 ' HB ' ' A' ' 183' ' ' THR . 23.0 t -104.68 101.1 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 CA-C-O 122.974 1.369 . . . . 0.0 110.728 176.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.434 ' HB2' HD11 ' A' ' 202' ' ' ILE . 9.6 t -129.27 -176.8 3.99 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 112.529 -2.123 . . . . 0.0 106.204 174.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 26.7 p -107.9 165.6 11.34 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.143 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.862 ' HB3' ' CE3' ' A' ' 217' ' ' TRP . 21.7 ptmt -69.58 -22.02 63.56 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.526 174.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 8.4 m -57.59 -53.07 62.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 172.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.491 ' CD1' HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -57.69 -56.43 22.06 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.737 175.001 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 68.7 m -67.99 -24.15 65.1 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.253 -172.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 78.2 m -101.9 -11.08 19.27 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -82.47 -50.74 8.51 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 164.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 214' ' ' GLY . 40.0 p -78.15 -156.76 0.09 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.886 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.7 t -19.82 -33.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 212' ' ' THR . . . 81.41 -165.33 46.44 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 119.796 -1.192 . . . . 0.0 114.429 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.548 ' CB ' ' HA ' ' A' ' 188' ' ' THR . 72.6 mmt-85 102.72 -80.29 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.837 1.655 . . . . 0.0 109.932 174.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.799 ' HB2' HD11 ' A' ' 190' ' ' ILE . . . -173.53 168.25 4.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 119.101 0.864 . . . . 0.0 110.347 175.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' TRP . . . . . 0.862 ' CE3' ' HB3' ' A' ' 206' ' ' LYS . 20.7 t90 -164.28 144.44 7.94 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 76.99 -174.27 54.52 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.0 -0.619 . . . . 0.0 113.014 175.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.52 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 31.1 p80 -135.64 131.71 19.36 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 31.6 Cg_exo -59.94 165.2 26.71 Favored 'Cis proline' 0 N--CA 1.477 0.505 0 C-N-CA 123.733 -1.361 . . . . 0.0 111.821 -5.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 55.9 m -62.63 81.32 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -173.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 216' ' ' ALA . 5.7 mm-40 -50.29 97.93 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.31 0.576 . . . . 0.0 110.438 167.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 19.8 ptt? -99.42 131.89 45.12 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.162 -173.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 18.5 m -142.11 144.17 30.74 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.386 -173.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -59.87 168.17 6.08 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.897 2.398 . . . . 0.0 110.046 160.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.01 -96.3 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.876 0.37 . . . . 0.0 111.213 -176.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' GLN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -83.28 113.34 45.67 Favored Pre-proline 0 C--N 1.32 -0.689 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.725 178.587 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -83.48 -41.24 0.1 OUTLIER 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.621 2.214 . . . . 0.0 113.698 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.445 ' HB3' ' HD2' ' A' ' 230' ' ' PRO . 41.7 m80 -103.89 173.57 3.32 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -174.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 229' ' ' HIS . 45.5 Cg_exo -60.19 -18.35 51.28 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.026 1.817 . . . . 0.0 112.011 174.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 14.8 t -64.07 124.69 22.26 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 172.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.587 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 45.3 mtt180 -63.45 135.23 56.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.386 -172.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.525 ' HB3' ' HB3' ' A' ' 227' ' ' GLN . 30.4 ptt180 -30.43 -44.54 0.05 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 246' ' ' ASP . . . -79.78 12.02 31.08 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.895 -1.145 . . . . 0.0 113.952 -173.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' PHE . . . . . 0.587 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 44.2 m-85 -125.05 158.55 33.47 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 117.994 0.897 . . . . 0.0 112.769 -175.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.496 HD13 ' O ' ' A' ' 235' ' ' PHE . 0.2 OUTLIER -132.28 130.53 21.97 Favored Pre-proline 0 N--CA 1.445 -0.695 0 CA-C-N 113.388 -1.733 . . . . 0.0 107.443 170.537 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.09 113.03 1.86 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.059 1.839 . . . . 0.0 111.509 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -47.13 130.0 12.52 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.665 0.745 . . . . 0.0 110.959 177.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 29.6 mt -74.49 -3.83 5.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.145 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -104.63 -60.09 1.65 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.913 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 34.9 p -86.41 -44.03 12.35 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.56 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 104.01 6.97 42.05 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.608 -177.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -96.55 130.37 43.75 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 122.039 0.923 . . . . 0.0 110.134 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 93.9 m -49.48 120.76 4.39 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 113.066 -1.879 . . . . 0.0 110.465 171.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.4 ' OE1' ' HA ' ' A' ' 245' ' ' GLN . 5.3 tp60 -120.61 136.07 54.92 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.614 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 19.0 t70 -74.09 141.36 45.67 Favored 'General case' 0 CA--C 1.492 -1.256 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.502 -174.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.647 HG23 ' HG3' ' A' ' 249' ' ' GLU . 4.2 m -93.34 143.94 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.441 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -74.2 76.4 1.8 Allowed 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 166.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.647 ' HG3' HG23 ' A' ' 247' ' ' VAL . 29.7 mp0 -49.04 -38.4 23.78 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.896 0.748 . . . . 0.0 111.18 -171.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 15.5 m -53.19 -32.07 46.05 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.639 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -105.53 -50.29 3.24 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.499 0.72 . . . . 0.0 110.776 -175.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -59.88 -26.93 66.27 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.141 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.753 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.5 mp -118.14 79.88 14.83 Favored Pre-proline 0 N--CA 1.447 -0.575 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 169.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -38.0 103.14 0.04 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.564 0 C-N-CA 124.451 3.434 . . . . 0.0 115.509 -169.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 59.96 38.24 93.87 Favored Glycine 0 C--N 1.312 -0.787 0 CA-C-N 113.667 -1.606 . . . . 0.0 113.77 172.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.753 ' HB3' HG22 ' A' ' 253' ' ' ILE . 1.7 pt? -66.46 -31.31 71.98 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.004 177.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' CYS . . . . . 0.437 ' H ' HD23 ' A' ' 256' ' ' LEU . 51.7 t -119.74 81.19 1.69 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.281 0.562 . . . . 0.0 109.669 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -117.41 26.05 10.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.142 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -70.83 -27.32 72.51 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 172.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -149.49 -116.29 0.81 Allowed Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 175.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -112.61 131.17 55.75 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 49.1 t -102.5 140.45 36.76 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 172.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 22.5 mt -130.97 163.31 37.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.493 ' ND2' ' HB3' ' A' ' 269' ' ' PHE . 0.7 OUTLIER -130.7 127.36 38.68 Favored 'General case' 0 CA--C 1.496 -1.131 0 C-N-CA 117.615 -1.634 . . . . 0.0 113.895 -174.392 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.4 t -113.68 165.56 12.41 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.076 163.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.614 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 30.7 m -70.46 125.36 28.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.83 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.527 ' HA2' ' CE2' ' A' ' 235' ' ' PHE . . . 97.05 -13.07 65.29 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-O 118.962 -0.91 . . . . 0.0 113.935 -177.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.0 t 178.68 157.5 0.49 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.732 1.266 . . . . 0.0 109.874 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' PHE . . . . . 0.493 ' HB3' ' ND2' ' A' ' 264' ' ' ASN . 24.1 p90 -105.97 159.2 16.23 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.872 -0.518 . . . . 0.0 109.876 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -114.84 121.33 42.93 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' CYS . . . . . 0.585 ' HB2' HD22 ' A' ' 279' ' ' LEU . 68.1 m -111.71 150.75 29.77 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 122.037 0.922 . . . . 0.0 111.917 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.28 109.56 7.83 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 113.503 -1.68 . . . . 0.0 109.694 175.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 10.1 m -84.56 164.4 42.88 Favored Pre-proline 0 C--N 1.314 -0.978 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.578 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 51.6 Cg_exo -53.31 156.41 10.69 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 121.921 1.747 . . . . 0.0 111.696 175.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -53.92 140.59 30.34 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.162 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 87.08 -28.55 5.53 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.421 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' HIS . . . . . 0.578 ' HB2' ' O ' ' A' ' 274' ' ' PRO . 21.5 m-70 -81.97 165.82 20.38 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.0 0.429 . . . . 0.0 111.587 -176.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 34.4 mtmm -139.69 137.52 35.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.143 -172.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.585 HD22 ' HB2' ' A' ' 271' ' ' CYS . 14.9 tp -85.48 139.91 31.11 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.116 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.45 ' HB3' ' HB2' ' A' ' 285' ' ' LYS . 29.4 t30 -131.42 98.76 4.62 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.415 173.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.401 ' HA ' ' NE2' ' A' ' 284' ' ' GLN . 48.4 mt-10 -56.19 -30.53 62.39 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.214 -175.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.526 ' O ' ' HB ' ' A' ' 188' ' ' THR . 42.0 t -56.08 -29.78 27.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.189 -176.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 67.6 m -145.16 33.32 1.09 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.599 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 0.412 ' OE1' ' HB2' ' A' ' 257' ' ' CYS . 35.6 mm-40 32.28 45.15 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.914 -1.039 . . . . 0.0 113.474 -174.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 51.1 mttp -88.13 154.84 20.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.006 0.431 . . . . 0.0 111.95 -176.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 5.4 m -139.42 80.81 1.8 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.089 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 33.7 tt0 . . . . . 0 N--CA 1.44 -0.964 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.473 0.719 0 CA-C-O 121.095 0.474 . . . . 0.0 110.017 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.493 ' HB1' ' SG ' ' A' ' 129' ' ' CYS . . . -119.08 -11.5 9.63 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.173 177.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' A' ' 119' ' ' CYS . 11.4 p -101.7 127.67 48.35 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.282 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -100.73 -177.13 3.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.061 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.9 t -64.67 -50.39 67.23 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.096 0.474 . . . . 0.0 110.475 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 65.9 mt -87.68 -49.89 14.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.991 0.424 . . . . 0.0 110.383 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -87.4 94.82 9.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.101 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -79.51 160.09 26.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.175 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 113' ' ' SER . 41.5 t -173.1 139.24 0.8 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -177.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -123.97 -27.71 3.87 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.336 0.589 . . . . 0.0 110.279 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.477 HD13 ' H ' ' A' ' 121' ' ' ILE . 0.3 OUTLIER -77.79 -168.27 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.772 -176.261 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.492 ' HD3' ' H ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -121.48 134.47 55.07 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.266 0.555 . . . . 0.0 110.67 -177.444 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 72.4 m -106.37 124.62 49.87 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.694 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -115.3 150.75 35.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.206 174.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 70.88 52.61 0.28 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.295 0.569 . . . . 0.0 111.344 176.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 64.51 30.38 77.73 Favored Glycine 0 C--O 1.224 -0.472 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.037 176.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -77.21 133.39 13.22 Favored Glycine 0 N--CA 1.428 -1.871 0 C-N-CA 120.017 -1.087 . . . . 0.0 111.93 -176.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.7 m -89.7 124.53 34.69 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 174.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.493 ' SG ' ' HB1' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -62.1 148.64 43.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.196 -171.385 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.617 ' HB2' ' O ' ' A' ' 133' ' ' HIS . 39.8 m -144.25 169.57 17.65 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.406 ' HB3' ' H ' ' A' ' 132' ' ' ASP . 9.9 t70 -41.24 -81.0 0.01 OUTLIER 'General case' 0 C--O 1.245 0.821 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.406 ' H ' ' HB3' ' A' ' 131' ' ' ASP . 3.9 p-10 -90.84 -40.3 11.85 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.964 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.617 ' O ' ' HB2' ' A' ' 130' ' ' SER . 0.3 OUTLIER -111.67 -170.55 1.67 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.886 -176.008 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 35.0 t -122.81 150.32 42.98 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.334 176.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.3 mt -100.31 95.05 6.51 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.932 0.872 . . . . 0.0 109.704 176.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 3.3 m -60.9 163.73 5.51 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.324 -175.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -64.79 155.45 33.82 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 170.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -66.39 114.4 5.39 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 122.571 1.177 . . . . 0.0 110.668 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 148' ' ' PRO . . . 114.92 4.61 20.97 Favored Glycine 0 C--N 1.294 -1.783 0 CA-C-N 112.831 -1.986 . . . . 0.0 111.234 -175.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.691 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 55.7 m-85 -125.0 154.46 41.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.772 0.32 . . . . 0.0 110.412 171.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.512 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 36.0 pt -138.81 -177.81 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.718 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.805 177.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.38 164.05 22.73 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.363 -175.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 43.5 p -78.16 -39.93 39.39 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.931 0.396 . . . . 0.0 110.905 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -98.67 -10.57 23.07 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.472 176.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 71.4 m 78.99 154.63 0.14 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.054 -1.43 . . . . 0.0 113.476 174.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.453 ' O ' ' HD3' ' A' ' 148' ' ' PRO . . . 132.41 2.4 4.08 Favored Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 112.913 -1.949 . . . . 0.0 113.808 175.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.512 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 1.2 tm0? -93.31 104.72 13.04 Favored Pre-proline 0 C--N 1.317 -0.806 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.199 174.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 146' ' ' GLY . 68.8 Cg_endo -82.71 149.96 14.41 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.4 2.066 . . . . 0.0 112.325 -175.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 149' ' ' VAL . 10.6 p -78.89 105.93 8.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 122.439 1.114 . . . . 0.0 112.611 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.06 80.15 6.51 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.155 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -56.23 -67.84 0.26 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -172.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 37.6 m -89.18 7.02 37.38 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.166 0.508 . . . . 0.0 111.392 -167.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 73.6 128.06 0.13 Allowed Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.016 -172.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.58 ' O ' HD23 ' A' ' 155' ' ' LEU . 57.1 m -71.22 164.09 26.34 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 113.944 -1.128 . . . . 0.0 109.309 176.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.731 HD12 ' O ' ' A' ' 176' ' ' GLN . 68.7 mt -139.96 162.74 34.46 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.697 -167.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.741 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 2.4 t-20 53.35 26.08 5.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.659 0.743 . . . . 0.0 110.475 -167.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.63 37.24 94.14 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.119 -1.038 . . . . 0.0 112.007 -174.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.46 -147.13 0.51 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.08 134.63 9.63 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 117.591 0.695 . . . . 0.0 110.477 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 166' ' ' CYS . 0.5 OUTLIER -75.43 110.41 9.78 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.246 0.546 . . . . 0.0 110.514 175.133 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 165' ' ' ARG . 2.9 m -95.43 -29.59 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.521 0.677 . . . . 0.0 110.349 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.681 ' HB3' ' CB ' ' A' ' 165' ' ' ARG . . . -139.12 173.71 4.9 Favored Pre-proline 0 N--CA 1.451 -0.417 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.691 ' HD3' ' CE1' ' A' ' 140' ' ' TYR . 78.2 Cg_exo -54.54 105.07 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.199 1.933 . . . . 0.0 112.051 176.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 26.0 t30 66.2 9.83 6.63 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.097 0.959 . . . . 0.0 110.629 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.681 ' CB ' ' HB3' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -98.92 82.69 2.8 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.43 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 160' ' ' CYS . 74.1 m -82.26 148.17 28.52 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.414 174.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -99.23 131.14 45.47 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 58.2 m -102.65 132.09 48.99 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 123.877 0.736 . . . . 0.0 111.302 -169.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.741 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 19.7 m -47.68 -54.47 11.95 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -168.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.514 ' HD2' ' N ' ' A' ' 171' ' ' GLY . 5.6 t80 -157.65 -83.53 0.05 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 118.716 -1.194 . . . . 0.0 112.51 -170.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.514 ' N ' ' HD2' ' A' ' 170' ' ' TYR . . . -97.69 49.96 1.42 Allowed Glycine 0 CA--C 1.496 -1.151 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.262 -166.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 156' ' ' ASN . 10.2 m-85 -116.79 129.43 56.1 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 118.529 -1.268 . . . . 0.0 113.461 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.627 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 3.3 t -97.29 143.78 27.72 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.438 173.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' A' ' 176' ' ' GLN . . . 93.3 130.75 5.64 Favored Glycine 0 C--N 1.297 -1.628 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 -175.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.21 17.95 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.611 1.54 . . . . 0.0 112.914 -169.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.731 ' O ' HD12 ' A' ' 155' ' ' LEU . 65.8 tt0 -128.15 12.14 6.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.211 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.508 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.8 OUTLIER 27.17 59.08 0.09 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 116.885 2.18 . . . . 0.0 116.885 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.469 ' C ' ' HD2' ' A' ' 179' ' ' ARG . 2.3 pt-20 -109.85 16.18 22.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.24 1.019 . . . . 0.0 109.352 169.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.469 ' HD2' ' C ' ' A' ' 178' ' ' GLU . 19.3 mmm180 -120.39 91.1 3.46 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.409 -178.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -89.11 86.69 6.95 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.164 0.983 . . . . 0.0 111.853 -170.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.627 ' HE2' ' N ' ' A' ' 173' ' ' THR . 32.4 p90 -116.89 96.2 5.36 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 175.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -74.04 130.73 40.41 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 119.49 -2.006 . . . . 0.0 108.222 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 67.6 p -79.99 168.06 19.68 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.06 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.517 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . 158.16 148.09 5.04 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.316 -164.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -76.25 132.8 14.14 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.15 1.9 . . . . 0.0 111.922 174.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.426 ' CB ' HD12 ' A' ' 202' ' ' ILE . 13.6 t -88.4 116.67 26.79 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' PHE . . . . . 0.638 ' CD2' ' HB2' ' A' ' 195' ' ' CYS . 16.1 m-85 -102.93 152.56 21.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.362 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.67 ' HA ' ' HB3' ' A' ' 215' ' ' ARG . 20.0 p -103.28 -54.9 2.51 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.1 p -140.54 120.03 12.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 O-C-N 120.914 -1.116 . . . . 0.0 112.645 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.466 HG13 ' SG ' ' A' ' 195' ' ' CYS . 2.1 mp -97.84 116.07 39.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-O 121.907 0.861 . . . . 0.0 111.612 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.0 p -106.86 -167.93 1.34 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 158.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -72.08 -4.83 31.19 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.367 0.604 . . . . 0.0 109.759 172.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -88.89 -69.8 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.482 -173.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.556 ' HG3' ' H ' ' A' ' 196' ' ' GLN . 33.0 tpp -162.99 135.62 5.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.189 -176.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.638 ' HB2' ' CD2' ' A' ' 187' ' ' PHE . 3.2 m -68.31 -19.41 64.67 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.877 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.604 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 44.8 mm-40 93.08 113.85 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.954 1.302 . . . . 0.0 113.34 173.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.04 -9.58 9.63 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.262 174.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 54.18 48.68 20.36 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.762 0.315 . . . . 0.0 110.82 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 6.6 mp 55.57 70.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.815 -175.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 46.3 t -72.2 148.36 45.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.475 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.33 21.55 12.71 Favored Glycine 0 CA--C 1.508 -0.366 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.898 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 254' ' ' PRO . 0.0 OUTLIER -65.3 98.12 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 163.699 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.39 118.66 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.383 0 CA-C-N 113.819 -1.537 . . . . 0.0 109.072 -175.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 10.1 t -158.11 -178.16 7.09 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 -175.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.477 HG21 ' HA ' ' A' ' 181' ' ' TYR . 26.7 p -108.24 168.44 9.3 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 120.278 1.399 . . . . 0.0 111.33 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.614 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 47.1 tttp -57.71 -44.33 85.84 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.406 174.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.1 m -47.01 -56.04 7.13 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.004 176.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.434 ' HG ' ' HB1' ' A' ' 252' ' ' ALA . 0.2 OUTLIER -58.75 -55.33 36.47 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.206 178.785 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 84.7 m -67.36 -23.75 65.63 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -172.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 227' ' ' GLN . 16.3 m -104.75 -26.69 12.17 Favored 'General case' 0 N--CA 1.429 -1.524 0 O-C-N 121.149 -0.969 . . . . 0.0 111.686 -175.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . . . -71.8 -56.99 4.75 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 170.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.681 HG22 ' HA2' ' A' ' 234' ' ' GLY . 6.0 p -100.23 156.22 17.34 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.592 -1.64 . . . . 0.0 107.16 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.2 t 68.0 -39.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 118.841 -0.599 . . . . 0.0 111.713 -177.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 65.12 49.71 60.79 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 119.061 0.846 . . . . 0.0 113.499 166.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.67 ' HB3' ' HA ' ' A' ' 188' ' ' THR . 31.3 mmt180 -127.7 -90.37 0.52 Allowed 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 120.527 -0.469 . . . . 0.0 112.206 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.515 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -165.83 164.96 18.64 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -177.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' TRP . . . . . 0.834 ' O ' ' HB2' ' A' ' 222' ' ' GLU . 7.0 t90 -168.29 139.55 2.74 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 127.7 167.72 12.34 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 119.634 -1.27 . . . . 0.0 114.53 172.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 220' ' ' PRO . 11.7 p80 -132.8 132.18 22.42 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.219 -0.491 . . . . 0.0 109.992 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 219' ' ' HIS . 2.4 Cg_endo -82.46 117.09 4.83 Favored 'Cis proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.011 -1.662 . . . . 0.0 111.61 -3.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' CYS . . . . . 0.418 ' SG ' ' CG1' ' A' ' 190' ' ' ILE . 34.1 t 39.0 92.89 0.01 OUTLIER 'General case' 0 C--O 1.243 0.751 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 175.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.834 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 34.7 mt-10 -105.48 110.12 22.34 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' MET . . . . . 0.515 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 2.8 tpt -90.31 138.74 31.29 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -173.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 54.6 m -111.48 129.49 24.05 Favored Pre-proline 0 C--O 1.234 0.277 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -169.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -80.03 151.12 20.97 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.513 2.809 . . . . 0.0 111.641 166.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 37.21 -86.54 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.276 0 O-C-N 124.799 1.312 . . . . 0.0 114.281 174.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 210' ' ' CYS . 0.3 OUTLIER -172.66 166.63 3.26 Favored Pre-proline 0 N--CA 1.44 -0.932 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -168.823 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 211' ' ' ALA . 4.6 Cg_exo -80.08 -85.91 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 121.884 1.722 . . . . 0.0 112.424 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -75.48 154.38 85.77 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.083 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -81.7 52.81 4.37 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.821 1.681 . . . . 0.0 113.775 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 71.9 m -104.78 -179.69 4.02 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 171.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.616 ' HB3' ' CD2' ' A' ' 235' ' ' PHE . 73.0 ttt180 -67.53 140.95 57.02 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 170.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.405 ' O ' HG22 ' A' ' 212' ' ' THR . 98.8 mtt180 -38.67 -50.92 1.66 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -175.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.681 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -70.26 9.27 3.28 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.41 -0.9 . . . . 0.0 114.145 -174.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' PHE . . . . . 0.616 ' CD2' ' HB3' ' A' ' 232' ' ' ARG . 5.3 m-85 -123.99 153.68 40.93 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 122.31 1.052 . . . . 0.0 113.721 -171.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.538 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.0 OUTLIER -130.19 133.23 24.7 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 113.619 -1.628 . . . . 0.0 108.227 168.838 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.76 116.39 3.52 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.329 2.019 . . . . 0.0 112.382 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -49.14 132.36 19.38 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.6 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 37.6 pt -73.8 1.2 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.316 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -111.89 -55.49 2.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.422 0.63 . . . . 0.0 110.181 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 66.3 p -92.96 -38.67 11.55 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.417 -175.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 98.33 4.47 57.35 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.394 -175.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -83.75 124.95 31.42 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 121.673 0.749 . . . . 0.0 109.662 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 10.8 m -57.91 114.69 2.44 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 113.446 -1.707 . . . . 0.0 109.401 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -117.1 141.07 48.72 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.623 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 16.3 t70 -76.32 146.27 38.97 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -175.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.668 ' CG2' HG21 ' A' ' 212' ' ' THR . 4.4 m -96.78 151.65 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.983 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.87 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.534 ' OD1' ' HB2' ' A' ' 250' ' ' CYS . 6.3 t0 -78.98 81.07 5.28 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 167.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.648 ' HG3' HG23 ' A' ' 247' ' ' VAL . 2.1 mp0 -52.57 -32.05 39.19 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 123.901 0.751 . . . . 0.0 110.467 -173.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.534 ' HB2' ' OD1' ' A' ' 248' ' ' ASP . 58.0 m -55.04 -42.79 73.09 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.676 172.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -89.96 -33.48 16.38 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 122.29 1.043 . . . . 0.0 109.581 -175.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.434 ' HB1' ' HG ' ' A' ' 208' ' ' LEU . . . -79.27 -23.3 43.71 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.087 -174.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.672 ' O ' ' HB3' ' A' ' 256' ' ' LEU . 5.3 mp -132.58 79.21 65.31 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 176.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.468 ' O ' HG13 ' A' ' 202' ' ' ILE . 75.8 Cg_exo -55.57 153.93 27.23 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 121.776 1.651 . . . . 0.0 112.289 177.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 78.55 -19.18 5.04 Favored Glycine 0 C--N 1.316 -0.579 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.833 -174.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.672 ' HB3' ' O ' ' A' ' 253' ' ' ILE . 2.1 tt -76.04 115.19 15.51 Favored 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 122.425 -0.456 . . . . 0.0 109.847 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 37.3 t 63.33 19.37 11.64 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.171 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -84.31 56.22 3.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.761 0.791 . . . . 0.0 110.259 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -120.81 7.52 10.99 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 173.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -179.14 -117.47 0.54 Allowed Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -117.4 116.35 27.0 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 17.7 p -108.36 157.86 18.01 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 170.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 21.1 mt -145.49 156.64 13.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -170.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.588 HD21 ' HB2' ' A' ' 249' ' ' GLU . 0.4 OUTLIER -127.2 124.81 39.85 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -173.431 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.6 t -114.54 170.95 7.94 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.191 165.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.623 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 34.6 m -67.59 127.41 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 CA-C-O 121.826 0.822 . . . . 0.0 110.723 -176.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 88.38 -14.75 58.7 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-O 119.007 -0.885 . . . . 0.0 113.554 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 75.3 m -169.9 148.64 3.54 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 118.051 0.925 . . . . 0.0 110.52 -172.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' PHE . . . . . 0.449 ' HD2' ' OE2' ' A' ' 249' ' ' GLU . 26.8 p90 -105.37 152.4 23.0 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.64 -0.662 . . . . 0.0 110.384 174.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.88 126.52 52.03 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 -177.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' CYS . . . . . 0.485 ' SG ' HD22 ' A' ' 279' ' ' LEU . 18.4 m -106.22 152.06 23.97 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.815 0.817 . . . . 0.0 113.162 -176.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -141.52 96.93 3.06 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.59 171.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 11.7 m -83.55 164.87 43.15 Favored Pre-proline 0 C--N 1.314 -0.952 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 33.8 Cg_exo -57.32 165.92 5.09 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.939 1.76 . . . . 0.0 111.385 176.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -53.7 137.22 38.07 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.356 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 82.87 -31.07 3.11 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.458 -178.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' HIS . . . . . 0.546 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 15.8 m-70 -74.2 163.18 28.15 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.604 0.24 . . . . 0.0 111.352 -177.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -148.01 148.22 30.47 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.551 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 16.3 tp -82.16 141.36 33.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.377 . . . . 0.0 110.817 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -133.14 98.98 4.41 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.001 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -61.45 -23.26 65.74 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.465 0.478 . . . . 0.0 112.164 -174.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.27 -18.06 17.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.327 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 44.4 m -152.4 31.39 0.53 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.791 175.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 25.1 46.3 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.04 1.336 . . . . 0.0 113.808 -173.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 68.3 tttt -98.35 167.53 10.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.361 -171.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 1.8 m -144.43 83.41 1.72 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.546 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 36.4 tt0 . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.779 -0.629 . . . . 0.0 110.092 -171.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 25.8 p . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.74 -19.25 55.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.127 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.8 t -75.1 -18.03 60.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.616 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -100.75 141.65 33.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.755 0.312 . . . . 0.0 110.791 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.9 m -77.13 80.77 3.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.336 0.589 . . . . 0.0 110.299 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 35.3 pt -69.21 145.95 12.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.759 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -121.07 174.77 6.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.005 -177.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -73.23 -33.65 65.44 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 23.2 p -99.95 -175.99 3.12 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.374 174.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -122.49 -47.78 2.09 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.796 0.331 . . . . 0.0 110.62 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.513 ' HA ' ' NH1' ' A' ' 122' ' ' ARG . 0.2 OUTLIER -59.82 174.72 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -175.15 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.712 ' HD2' ' N ' ' A' ' 122' ' ' ARG . 0.9 OUTLIER -111.75 140.93 45.98 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.979 -1.464 . . . . 0.0 110.346 -173.215 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 58.0 m -114.69 130.67 56.85 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 58.5 mtm -139.09 162.45 34.91 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 175.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 67.62 51.44 0.83 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.991 0.424 . . . . 0.0 111.521 174.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 72.34 32.57 62.34 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.078 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' A' ' 136' ' ' CYS . . . -91.62 146.2 18.14 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.521 -176.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.9 m -122.33 132.33 54.34 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 172.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 4.4 t -88.84 116.8 27.38 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.246 -171.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 21.1 t -144.33 137.79 27.41 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.5 t70 52.64 32.91 12.63 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.891 0.853 . . . . 0.0 112.589 173.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.428 ' OD1' HG23 ' A' ' 121' ' ' ILE . 21.5 t0 52.35 46.66 26.25 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.693 -1.594 . . . . 0.0 111.088 -178.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -166.69 117.89 0.95 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 114.429 -1.259 . . . . 0.0 108.383 170.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.462 ' SG ' ' SG ' ' A' ' 136' ' ' CYS . 5.9 t -69.72 130.87 43.52 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.13 -166.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 76.7 mt -106.35 105.12 15.0 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' CYS . . . . . 0.542 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 61.8 m -109.52 -96.49 0.4 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -161.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -152.08 145.83 25.07 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.082 -166.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.492 ' HD3' ' O ' ' A' ' 138' ' ' LYS . 1.1 tmtp? -67.43 113.71 5.52 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 122.483 1.135 . . . . 0.0 110.384 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 113.35 3.35 24.25 Favored Glycine 0 N--CA 1.43 -1.714 0 CA-C-N 113.113 -1.858 . . . . 0.0 112.296 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.592 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 75.3 m-85 -125.03 143.79 50.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.174 0.487 . . . . 0.0 109.901 172.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.547 ' O ' ' HA ' ' A' ' 145' ' ' CYS . 23.2 pt -139.82 178.42 3.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 CA-C-O 121.311 0.577 . . . . 0.0 111.214 -173.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.53 165.95 40.39 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.805 -169.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.9 m -70.73 -31.81 68.77 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.015 0.407 . . . . 0.0 110.785 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -89.84 -8.71 51.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.187 0.518 . . . . 0.0 109.927 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 141' ' ' ILE . 73.3 m 57.22 41.52 26.78 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.909 -175.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.23 2.3 59.42 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.588 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.502 ' O ' HG12 ' A' ' 141' ' ' ILE . 2.9 tm0? -109.51 104.39 55.17 Favored Pre-proline 0 C--N 1.329 -0.298 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.809 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.61 142.46 20.61 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.466 2.111 . . . . 0.0 111.661 177.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 149' ' ' VAL . 8.8 p -66.64 106.72 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 122.569 1.176 . . . . 0.0 112.137 -173.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 20.8 m -80.23 66.1 5.61 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.831 173.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -52.16 -53.26 45.2 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.593 0.961 . . . . 0.0 113.593 -171.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 36.6 m -93.87 8.92 39.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.435 0.636 . . . . 0.0 110.576 -170.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 77.28 134.29 0.66 Allowed Glycine 0 N--CA 1.427 -1.964 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.266 -172.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.44 ' O ' HD23 ' A' ' 155' ' ' LEU . 0.1 OUTLIER -69.64 154.85 41.41 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.743 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.574 HD12 ' O ' ' A' ' 176' ' ' GLN . 42.7 mt -126.78 170.28 12.33 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -173.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.521 HD22 ' C ' ' A' ' 155' ' ' LEU . 0.1 OUTLIER 36.49 35.55 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.731 1.269 . . . . 0.0 113.598 -172.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.36 34.23 67.66 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.003 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -75.52 -151.54 3.17 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-O 121.466 0.481 . . . . 0.0 114.031 -172.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.553 ' HG2' ' HB3' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -145.7 122.41 11.18 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.102 0.477 . . . . 0.0 110.567 -179.146 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 166' ' ' CYS . 19.1 m -68.79 112.12 5.31 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.833 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 165' ' ' ARG . 3.8 m -92.39 -33.28 5.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.071 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.562 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -139.88 177.03 2.18 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.592 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 77.7 Cg_exo -53.55 111.64 0.74 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 121.73 1.62 . . . . 0.0 112.496 176.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 61.54 12.7 4.63 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.94 0.896 . . . . 0.0 110.879 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.562 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.4 OUTLIER -103.68 78.25 1.55 Allowed 'General case' 0 CA--C 1.499 -1.003 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.082 178.014 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 160' ' ' CYS . 59.6 m -71.68 152.93 42.41 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.744 0.783 . . . . 0.0 110.54 171.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.553 ' HB3' ' HG2' ' A' ' 159' ' ' ARG . . . -106.28 141.72 37.15 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.629 169.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.442 ' HA ' HD21 ' A' ' 156' ' ' ASN . 29.2 m -97.68 128.68 44.54 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 124.346 1.029 . . . . 0.0 112.072 -163.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 77.9 m -62.96 -55.72 23.38 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 171' ' ' GLY . 40.1 t80 -128.18 -119.73 0.24 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 118.746 -1.181 . . . . 0.0 112.373 -169.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.401 ' N ' ' CD1' ' A' ' 170' ' ' TYR . . . -87.7 54.7 4.39 Favored Glycine 0 N--CA 1.428 -1.853 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.321 -167.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.564 ' HB2' ' HB3' ' A' ' 177' ' ' CYS . 5.1 m-85 -119.14 122.24 41.59 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 119.247 -0.981 . . . . 0.0 112.331 173.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.572 ' N ' ' HE1' ' A' ' 181' ' ' TYR . 2.9 t -88.09 157.51 18.84 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 167.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.1 128.48 3.29 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -177.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.06 -0.07 7.4 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.498 1.465 . . . . 0.0 113.467 -166.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.574 ' O ' HD12 ' A' ' 155' ' ' LEU . 41.7 tt0 -109.71 8.35 24.71 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.564 ' HB3' ' HB2' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 32.87 57.09 0.44 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 177.222 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -114.06 -15.73 12.23 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.877 173.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 173' ' ' THR . 19.3 mmt180 -57.58 -68.92 0.19 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.157 -1.383 . . . . 0.0 108.645 -176.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.0 t70 78.38 92.64 0.06 Allowed 'General case' 0 CA--C 1.509 -0.626 0 O-C-N 124.132 0.895 . . . . 0.0 110.102 164.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.572 ' HE1' ' N ' ' A' ' 173' ' ' THR . 32.2 p90 -112.36 64.16 0.63 Allowed 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 173.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 25.7 tpt85 -42.42 121.15 1.85 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.408 171.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 38.9 p -82.28 136.63 35.01 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.347 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.509 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -159.92 155.47 26.59 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.048 -176.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -85.07 167.87 10.72 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.444 2.096 . . . . 0.0 111.847 172.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 69.6 m -116.92 121.06 40.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.155 0.502 . . . . 0.0 111.44 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' PHE . . . . . 0.761 ' O ' ' HB3' ' A' ' 215' ' ' ARG . 29.6 m-85 -93.36 131.71 38.27 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.555 ' HA ' ' CG ' ' A' ' 215' ' ' ARG . 19.0 m -89.32 -15.16 34.07 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 113.944 1.091 . . . . 0.0 113.944 -163.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.1 p -165.11 117.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.066 -174.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.548 HD11 ' HB3' ' A' ' 216' ' ' ALA . 6.7 mt -123.7 118.35 53.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -171.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 7.3 p -114.77 -167.11 1.18 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.419 160.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -68.07 -4.08 12.35 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.434 0.635 . . . . 0.0 110.275 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -75.55 -69.97 0.45 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.307 -177.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 22.4 ttt -169.7 152.68 4.68 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.542 ' HA ' HG12 ' A' ' 190' ' ' ILE . 21.8 m -77.24 -24.2 51.2 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 121.099 0.476 . . . . 0.0 111.475 -174.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 42.7 tt0 176.22 -92.1 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.845 173.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.418 ' H ' ' HB3' ' A' ' 196' ' ' GLN . . . 124.55 11.14 4.66 Favored Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.939 171.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -89.04 -12.7 40.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.204 0.526 . . . . 0.0 109.992 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 65.17 -85.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.996 -177.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 71.1 m 68.93 125.85 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.574 0.702 . . . . 0.0 112.48 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.07 30.25 4.01 Favored Glycine 0 CA--C 1.508 -0.358 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.127 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.432 HG12 ' HD2' ' A' ' 254' ' ' PRO . 0.0 OUTLIER -65.75 100.35 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.175 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 4.1 t -92.57 98.29 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-O 122.914 1.34 . . . . 0.0 109.751 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.573 ' OG ' HD23 ' A' ' 208' ' ' LEU . 8.4 t -117.69 179.94 3.92 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.659 -2.064 . . . . 0.0 105.976 169.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 19.0 p -107.63 161.93 14.42 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.399 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.515 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 46.3 tttm -61.91 -43.62 98.46 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.13 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 8.4 m -44.76 -55.13 5.59 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 122.22 1.009 . . . . 0.0 109.415 173.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.81 HD11 HG11 ' A' ' 247' ' ' VAL . 6.0 tp -63.7 -52.25 61.41 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.294 -1.775 . . . . 0.0 112.344 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 4.7 t -64.3 -37.29 86.97 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.441 0.638 . . . . 0.0 110.479 -175.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 52.2 m -85.07 -23.82 28.37 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.626 -177.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ALA . . . . . 0.556 ' HA ' ' CD ' ' A' ' 228' ' ' PRO . . . -69.88 -52.75 22.12 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 173.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 214' ' ' GLY . 80.8 p -64.77 -156.43 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 113.101 -1.863 . . . . 0.0 111.85 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.413 ' H ' HG23 ' A' ' 213' ' ' VAL . 1.6 t -44.25 -1.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.349 0 N-CA-C 116.276 1.954 . . . . 0.0 116.276 -176.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 212' ' ' THR . . . 85.72 -101.97 2.61 Favored Glycine 0 CA--C 1.507 -0.457 0 C-N-CA 119.086 -1.53 . . . . 0.0 113.549 175.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.761 ' HB3' ' O ' ' A' ' 187' ' ' PHE . 0.8 OUTLIER 50.78 -120.33 1.56 Allowed 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.143 0.497 . . . . 0.0 110.34 -169.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.548 ' HB3' HD11 ' A' ' 190' ' ' ILE . . . -158.44 159.88 36.19 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 172.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' TRP . . . . . 0.515 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 26.9 t90 -136.07 146.33 46.94 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -174.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 82.25 177.44 51.87 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.735 171.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.608 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 8.0 p80 -143.01 133.4 12.26 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.626 -0.287 . . . . 0.0 110.252 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.608 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 41.4 Cg_exo -57.8 154.03 34.38 Favored 'Cis proline' 0 C--N 1.345 0.366 0 C-N-CA 123.667 -1.389 . . . . 0.0 112.119 -3.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 9.5 m -49.54 123.01 6.97 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.193 -171.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 37.1 mt-10 -105.87 102.49 11.92 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' MET . . . . . 0.532 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 17.7 ptm -85.73 137.64 32.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.576 -169.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 99.3 m -135.3 143.17 44.39 Favored Pre-proline 0 C--O 1.235 0.294 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -171.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -64.45 169.17 11.53 Favored 'Trans proline' 0 CA--C 1.512 -0.579 0 C-N-CA 122.788 2.325 . . . . 0.0 110.346 155.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.0 -129.67 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.808 168.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' GLN . . . . . 0.405 ' H ' ' HG3' ' A' ' 227' ' ' GLN . 0.1 OUTLIER -46.95 102.61 0.32 Allowed Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -166.318 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.556 ' CD ' ' HA ' ' A' ' 211' ' ' ALA . 63.9 Cg_endo -82.39 -59.68 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.628 2.218 . . . . 0.0 112.389 176.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.416 ' HB3' ' HD2' ' A' ' 230' ' ' PRO . 90.1 m-70 -70.87 159.6 84.9 Favored Pre-proline 0 CA--C 1.515 -0.368 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 229' ' ' HIS . 73.3 Cg_endo -78.91 58.25 6.81 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 121.706 1.604 . . . . 0.0 113.381 -174.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 43.0 m -135.43 -173.83 3.46 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.683 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 25.7 mmt180 -73.19 144.74 46.7 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.315 174.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -39.29 -42.96 1.08 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.581 ' O ' ' HA ' ' A' ' 246' ' ' ASP . . . -77.72 7.72 39.74 Favored Glycine 0 C--O 1.222 -0.612 0 C-N-CA 120.342 -0.933 . . . . 0.0 113.187 -176.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' PHE . . . . . 0.683 ' CD1' ' HB2' ' A' ' 232' ' ' ARG . 3.3 m-85 -120.42 143.0 48.7 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.865 0.84 . . . . 0.0 112.706 -171.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.464 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.5 OUTLIER -122.59 131.5 24.37 Favored Pre-proline 0 N--CA 1.439 -0.987 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.082 175.762 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -65.66 113.76 2.65 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.051 1.834 . . . . 0.0 111.356 174.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -49.21 135.9 16.08 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 123.492 0.717 . . . . 0.0 111.581 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 29.5 pt -75.63 2.87 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.165 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 240' ' ' ARG . 49.8 mtm180 -113.29 -56.51 2.4 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.973 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 35.0 p -95.91 -40.56 9.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.749 -174.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 99.44 5.63 55.6 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -175.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -79.01 134.01 36.8 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.806 0.812 . . . . 0.0 110.128 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 4.6 m -68.96 113.99 6.85 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.022 -1.445 . . . . 0.0 109.299 173.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.543 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 89.3 mt-30 -116.33 141.26 48.39 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.675 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 12.5 t70 -77.58 144.65 37.38 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.81 HG11 HD11 ' A' ' 208' ' ' LEU . 4.3 m -95.56 146.11 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.082 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -178.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.442 ' HA ' ' ND2' ' A' ' 264' ' ' ASN . 4.9 m-20 -73.88 75.98 1.64 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 169.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.69 ' HG3' HG23 ' A' ' 247' ' ' VAL . 14.4 mp0 -52.5 -37.12 56.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 123.931 0.77 . . . . 0.0 110.776 -168.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 52.7 m -49.24 -38.71 27.6 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.866 174.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -101.21 -35.78 9.16 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.879 0.847 . . . . 0.0 110.565 -176.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.651 ' HB1' HD21 ' A' ' 208' ' ' LEU . . . -70.38 -20.1 62.97 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.33 -1.305 . . . . 0.0 110.459 -177.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.752 HG22 ' HB3' ' A' ' 256' ' ' LEU . 5.0 mp -137.29 77.63 41.16 Favored Pre-proline 0 N--CA 1.445 -0.703 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 169.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.432 ' HD2' HG12 ' A' ' 202' ' ' ILE . 9.8 Cg_endo -48.06 113.53 0.83 Allowed 'Trans proline' 0 CA--C 1.514 -0.508 0 C-N-CA 124.018 3.146 . . . . 0.0 114.39 -167.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 61.22 35.97 91.69 Favored Glycine 0 C--N 1.311 -0.824 0 CA-C-N 113.457 -1.702 . . . . 0.0 113.391 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.752 ' HB3' HG22 ' A' ' 253' ' ' ILE . 1.8 pt? -66.96 -23.1 65.92 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 117.367 0.584 . . . . 0.0 110.905 176.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 39.1 t -82.02 121.73 26.91 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' GLN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 285' ' ' LYS . 59.1 tp60 -90.26 111.51 22.72 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -171.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 71.49 66.1 2.23 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.749 171.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 174.14 -170.17 43.27 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 119.967 -1.111 . . . . 0.0 112.792 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' ASN . . . . . 0.483 ' HB3' ' HB2' ' A' ' 272' ' ' LYS . 2.5 t-20 -88.79 159.08 17.92 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 21.2 t -141.49 125.03 16.71 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.423 HD11 ' OD1' ' A' ' 261' ' ' ASN . 18.2 mt -136.54 109.21 7.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.104 -170.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.442 ' ND2' ' HA ' ' A' ' 248' ' ' ASP . 65.9 t30 -72.17 117.17 13.46 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.281 -174.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.3 t -105.38 160.61 14.99 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 157.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.675 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 3.9 m -77.43 128.56 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 C-N-CA 118.344 -1.342 . . . . 0.0 107.924 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.658 ' N ' ' HE1' ' A' ' 235' ' ' PHE . . . 110.5 -30.79 7.88 Favored Glycine 0 C--N 1.311 -0.838 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.669 -170.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 31.7 m -179.11 158.36 0.9 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.079 0.939 . . . . 0.0 109.93 -168.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -104.96 152.36 22.78 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.818 -1.176 . . . . 0.0 108.63 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -107.45 127.89 54.01 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -176.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 261' ' ' ASN . 92.7 m -106.88 152.43 23.92 Favored 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.342 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 261' ' ' ASN . 7.4 mtpm? -124.07 100.03 6.53 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.033 175.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 4.3 m -81.81 149.32 63.42 Favored Pre-proline 0 C--N 1.31 -1.109 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.869 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 32.3 Cg_exo -56.57 162.31 8.48 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.08 1.854 . . . . 0.0 111.25 175.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -53.1 143.08 18.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.519 0.2 . . . . 0.0 111.059 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.49 -31.27 3.57 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.828 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' HIS . . . . . 0.601 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 14.4 m-70 -78.83 169.79 17.67 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 122.708 -0.289 . . . . 0.0 111.372 -177.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 56.5 mtpt -149.5 148.95 30.01 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 39.6 tp -84.94 136.11 33.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.075 0.464 . . . . 0.0 110.534 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -125.71 100.29 6.36 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 174.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.27 -21.11 61.52 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.829 0.705 . . . . 0.0 112.185 -174.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 68.3 t -60.47 -34.07 56.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.177 0.513 . . . . 0.0 110.45 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.458 ' HA ' ' CG2' ' A' ' 188' ' ' THR . 20.3 p -132.97 23.49 4.21 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.55 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 29.62 46.63 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.062 -171.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 285' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 85.9 tttt -101.63 165.09 11.41 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.973 -172.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 5.7 m -140.89 88.42 2.18 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -177.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.601 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 7.1 tp10 . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.667 -0.682 . . . . 0.0 109.341 -173.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 N--CA 1.476 0.835 0 CA-C-O 120.763 0.316 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.06 -39.62 65.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.007 0.432 . . . . 0.0 110.53 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.8 p -97.07 150.06 21.25 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.271 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -92.92 -22.31 19.31 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.247 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 12.7 p -81.69 9.33 7.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.4 tp -87.8 -3.45 9.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.401 0.62 . . . . 0.0 109.985 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -63.58 117.4 6.73 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.788 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.478 ' O ' ' HB3' ' A' ' 119' ' ' CYS . 44.1 t-80 -70.23 -24.22 63.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.816 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 118' ' ' HIS . 53.2 t 74.86 145.41 0.08 Allowed 'General case' 0 C--O 1.235 0.291 0 O-C-N 123.983 0.802 . . . . 0.0 110.345 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -115.29 -32.59 5.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.764 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.606 HD12 ' O ' ' A' ' 132' ' ' ASP . 0.3 OUTLIER -92.84 -169.34 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-O 121.304 0.573 . . . . 0.0 112.518 -174.306 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.501 ' H ' ' HD2' ' A' ' 122' ' ' ARG . 0.1 OUTLIER -123.0 128.27 49.96 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.46 -179.157 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.754 ' SG ' ' HA3' ' A' ' 127' ' ' GLY . 3.9 t -117.69 149.13 41.25 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.777 -177.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -127.66 166.44 18.09 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.402 ' HB3' ' CE2' ' A' ' 140' ' ' TYR . 93.8 m-20 66.52 45.14 2.15 Favored 'General case' 0 N--CA 1.462 0.165 0 O-C-N 123.598 0.561 . . . . 0.0 111.693 173.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.534 ' O ' ' HG3' ' A' ' 137' ' ' GLN . . . 75.27 21.32 78.04 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.245 176.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.754 ' HA3' ' SG ' ' A' ' 123' ' ' CYS . . . -79.11 114.38 3.88 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.949 -177.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 24.4 m -72.19 126.09 28.92 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -66.83 144.78 56.09 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.891 -173.798 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.762 ' HB2' ' O ' ' A' ' 133' ' ' HIS . 34.6 m -144.14 170.85 15.18 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -28.21 -94.51 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 O-C-N 125.036 1.46 . . . . 0.0 114.392 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.606 ' O ' HD12 ' A' ' 121' ' ' ILE . 35.9 m-20 -88.42 -38.6 14.92 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.663 176.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.762 ' O ' ' HB2' ' A' ' 130' ' ' SER . 0.0 OUTLIER -132.69 133.51 43.63 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.616 -176.34 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 24.7 p -75.12 160.24 30.69 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.118 -174.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 65.3 mt -96.57 138.06 34.72 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 71.3 m -91.3 156.17 17.99 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.548 -174.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 126' ' ' GLY . 44.6 mt-30 -80.48 145.12 32.04 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 167.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -62.9 113.54 3.12 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 122.658 1.218 . . . . 0.0 111.176 -172.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 128.68 -1.69 6.42 Favored Glycine 0 N--CA 1.433 -1.503 0 CA-C-N 112.625 -2.08 . . . . 0.0 111.314 -176.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.617 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 98.8 m-85 -121.1 149.47 42.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.343 0.572 . . . . 0.0 110.7 171.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.446 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 30.0 pt -132.88 174.6 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.967 177.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.99 174.15 33.23 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.737 -175.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.5 p -75.89 -29.74 58.57 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -111.32 12.61 21.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.34 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 46.2 m 59.67 35.91 22.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.091 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.59 -12.2 72.91 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.613 -0.721 . . . . 0.0 113.347 -174.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.446 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 5.4 tm0? -111.28 110.42 56.05 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 117.336 0.568 . . . . 0.0 110.718 -176.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.37 147.85 18.3 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.931 2.421 . . . . 0.0 112.489 178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 149' ' ' VAL . 12.4 p -75.14 109.87 8.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.943 0.878 . . . . 0.0 111.035 -176.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.24 77.54 5.75 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.24 173.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.412 ' OE1' ' HB2' ' A' ' 164' ' ' ASN . 49.0 mt-10 -56.54 -59.04 5.57 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -170.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.1 m -90.28 10.77 23.49 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.442 0.639 . . . . 0.0 111.267 -170.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 82.43 126.58 0.98 Allowed Glycine 0 N--CA 1.43 -1.761 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.654 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.521 ' O ' HD23 ' A' ' 155' ' ' LEU . 3.6 m -71.94 153.51 41.79 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 113.854 -1.173 . . . . 0.0 109.559 171.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.521 HD23 ' O ' ' A' ' 154' ' ' CYS . 83.2 mt -141.3 172.7 12.32 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -169.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.715 ' ND2' ' HB2' ' A' ' 177' ' ' CYS . 8.5 p30 43.39 24.62 0.05 Allowed 'General case' 0 N--CA 1.478 0.949 0 O-C-N 124.108 0.88 . . . . 0.0 113.248 -174.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.1 36.8 93.71 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.199 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -73.76 -146.27 0.95 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 121.466 -0.397 . . . . 0.0 113.219 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.8 ttt85 -156.57 123.14 5.08 Favored 'General case' 0 C--O 1.222 -0.35 0 O-C-N 122.204 -0.586 . . . . 0.0 111.345 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 2.4 m -61.38 116.0 4.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.897 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 165' ' ' ARG . 11.2 m -102.1 -50.1 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.803 178.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.492 ' HB1' ' HD2' ' A' ' 163' ' ' PRO . . . -127.7 172.9 6.06 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.802 171.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.617 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 74.0 Cg_exo -51.15 107.78 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.128 1.885 . . . . 0.0 112.531 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.412 ' HB2' ' OE1' ' A' ' 151' ' ' GLU . 0.2 OUTLIER 76.53 -14.2 0.84 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.816 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.548 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.6 OUTLIER -80.73 85.55 6.07 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.251 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 13.5 t -83.06 143.64 30.45 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.756 173.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.42 ' HB2' ' CG1' ' A' ' 161' ' ' VAL . . . -89.19 121.51 31.57 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 176.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 55.8 m -94.38 123.69 37.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.115 -169.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 170' ' ' TYR . 85.1 m -53.74 -48.83 69.27 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 114.211 -1.359 . . . . 0.0 113.16 -170.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.429 ' HE2' ' H ' ' A' ' 183' ' ' THR . 10.0 t80 177.54 115.95 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.929 -175.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 78.76 43.44 11.61 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 120.356 -0.926 . . . . 0.0 113.522 169.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.662 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 25.2 m-85 -124.8 128.25 48.43 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 117.951 0.876 . . . . 0.0 112.39 168.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.886 HG23 ' CE2' ' A' ' 181' ' ' TYR . 43.5 p -88.48 137.33 32.42 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.279 177.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.45 141.66 10.78 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.43 6.27 1.97 Allowed 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.451 1.434 . . . . 0.0 112.473 -170.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.499 ' O ' HD12 ' A' ' 155' ' ' LEU . 11.8 pt20 -129.3 24.64 5.52 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.32 177.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.715 ' HB2' ' ND2' ' A' ' 156' ' ' ASN . 0.0 OUTLIER 32.97 73.83 0.06 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 175.755 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -120.18 16.14 12.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.109 0.481 . . . . 0.0 111.406 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.662 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 15.9 mmt85 -123.33 96.26 4.92 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.547 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -80.05 84.36 5.79 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 122.241 1.02 . . . . 0.0 109.891 -173.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.886 ' CE2' HG23 ' A' ' 173' ' ' THR . 28.4 p90 -114.3 84.15 2.0 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 175.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -77.52 127.17 32.06 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 118.766 -2.459 . . . . 0.0 107.825 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.429 ' H ' ' HE2' ' A' ' 170' ' ' TYR . 18.0 p -81.93 134.28 35.37 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.877 -178.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.462 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -152.88 155.1 25.93 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.872 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.73 136.24 29.97 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.68 2.254 . . . . 0.0 111.012 172.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.405 ' H ' HG23 ' A' ' 202' ' ' ILE . 5.8 t -108.28 115.65 30.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.92 0.391 . . . . 0.0 111.163 -174.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' PHE . . . . . 0.472 ' CE1' ' HA ' ' A' ' 198' ' ' GLN . 7.0 m-85 -95.54 160.4 14.53 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.512 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.505 HG21 ' HA ' ' A' ' 283' ' ' SER . 24.7 p -111.68 -16.11 13.3 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 -167.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 7.5 p -163.75 123.63 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 119.628 1.104 . . . . 0.0 112.394 -173.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.609 HG12 ' HA ' ' A' ' 195' ' ' CYS . 51.7 mt -126.46 115.97 43.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-O 121.645 0.736 . . . . 0.0 112.833 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.422 ' C ' ' H ' ' A' ' 193' ' ' GLN . 25.0 p -115.8 -163.61 0.9 Allowed 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 158.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -61.47 -5.18 1.6 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.601 0.637 . . . . 0.0 110.553 172.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.422 ' H ' ' C ' ' A' ' 191' ' ' SER . 58.3 tp60 -69.56 -74.39 0.13 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.802 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.546 ' SD ' ' HA2' ' A' ' 197' ' ' GLY . 23.9 ttm -179.16 -171.66 0.21 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 176.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.609 ' HA ' HG12 ' A' ' 190' ' ' ILE . 14.0 m -88.08 -24.27 23.48 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 118.185 0.448 . . . . 0.0 111.928 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.504 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 12.9 tt0 165.65 -4.24 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 122.015 0.912 . . . . 0.0 109.444 -173.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.546 ' HA2' ' SD ' ' A' ' 194' ' ' MET . . . 103.61 5.13 45.65 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -172.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.472 ' HA ' ' CE1' ' A' ' 187' ' ' PHE . 93.4 mt-30 61.71 52.66 3.47 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-O 121.466 0.651 . . . . 0.0 109.668 -176.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 63.7 mt -126.13 -179.73 4.86 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.964 -173.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 14.8 t 73.67 120.1 0.04 OUTLIER 'General case' 0 C--O 1.233 0.202 0 O-C-N 124.422 1.076 . . . . 0.0 111.285 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -93.42 33.23 5.25 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.606 177.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.405 HG23 ' H ' ' A' ' 186' ' ' CYS . 0.0 OUTLIER -64.78 97.7 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-O 122.238 1.018 . . . . 0.0 108.921 171.505 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.426 ' N ' ' HG2' ' A' ' 254' ' ' PRO . 1.4 t -90.07 118.62 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.368 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 11.2 t -153.59 -178.63 7.15 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 103.129 -2.915 . . . . 0.0 103.129 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.434 HG21 ' HA ' ' A' ' 181' ' ' TYR . 10.5 p -106.33 163.7 12.62 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 120.538 1.517 . . . . 0.0 110.012 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.579 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 49.6 tttm -63.85 -38.48 91.26 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.486 0.66 . . . . 0.0 109.788 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.0 m -48.63 -56.38 8.62 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.045 171.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.544 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -56.98 -53.73 54.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.905 177.04 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 54.4 m -67.09 -23.0 65.8 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -175.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 56.3 m -106.56 -11.69 15.81 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 118.979 0.809 . . . . 0.0 113.168 -177.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -83.88 -51.21 7.37 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.961 0.886 . . . . 0.0 108.991 165.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.539 HG22 ' HA2' ' A' ' 234' ' ' GLY . 6.7 p -101.66 151.9 21.47 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.275 -178.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.447 HG11 HE21 ' A' ' 284' ' ' GLN . 31.5 m 53.01 -37.19 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.556 ' O ' ' HD3' ' A' ' 215' ' ' ARG . . . 78.63 -159.51 46.27 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 120.416 1.462 . . . . 0.0 112.236 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.556 ' HD3' ' O ' ' A' ' 214' ' ' GLY . 0.0 OUTLIER 104.07 -90.6 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.692 1.197 . . . . 0.0 109.497 163.124 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.45 ' HB2' HD12 ' A' ' 190' ' ' ILE . . . -169.17 160.82 9.96 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.875 0.761 . . . . 0.0 110.125 170.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' TRP . . . . . 0.579 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 18.8 t90 -152.48 147.83 26.7 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -177.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 78.98 173.18 43.34 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 115.389 0.916 . . . . 0.0 115.389 167.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.578 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 36.0 m-70 -127.79 133.11 24.75 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 114.838 -0.681 . . . . 0.0 109.445 171.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.578 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 19.7 Cg_endo -58.6 152.3 39.23 Favored 'Cis proline' 0 C--N 1.347 0.461 0 C-N-CA 123.705 -1.373 . . . . 0.0 111.772 -3.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 43.5 t -55.89 118.43 4.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.254 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -115.28 121.23 42.25 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' MET . . . . . 0.434 ' HB3' HD12 ' A' ' 190' ' ' ILE . 19.8 ptm -98.07 146.48 25.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.645 0.26 . . . . 0.0 111.304 -173.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 61.8 m -143.24 148.37 44.27 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.959 -178.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.7 167.65 23.75 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.615 2.21 . . . . 0.0 109.9 163.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.527 ' O ' ' HD3' ' A' ' 228' ' ' PRO . . . -58.62 -94.67 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 120.764 0.316 . . . . 0.0 110.814 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' GLN . . . . . 0.473 ' HB3' ' HB3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -89.55 106.75 14.95 Favored Pre-proline 0 C--N 1.315 -0.9 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.072 172.419 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 226' ' ' ALA . 60.2 Cg_endo -90.63 -43.68 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.491 2.128 . . . . 0.0 113.252 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.457 ' HB3' ' HD2' ' A' ' 230' ' ' PRO . 90.3 m-70 -100.53 175.55 2.32 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 229' ' ' HIS . 36.6 Cg_exo -60.53 177.53 0.6 Allowed 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 121.656 1.571 . . . . 0.0 112.182 171.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 61.4 m 75.7 146.41 0.09 Allowed 'General case' 0 N--CA 1.47 0.575 0 O-C-N 124.112 0.883 . . . . 0.0 108.844 -166.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.513 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 83.2 mtt180 -63.13 140.48 58.88 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 118.997 -0.525 . . . . 0.0 109.905 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.483 ' O ' HG22 ' A' ' 212' ' ' THR . 38.1 ptt180 -32.86 -44.59 0.11 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 175.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.539 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -75.7 7.95 23.73 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.631 -175.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' PHE . . . . . 0.724 ' HE1' ' N ' ' A' ' 267' ' ' GLY . 2.5 m-85 -122.49 159.86 26.78 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.947 0.88 . . . . 0.0 112.085 -172.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.446 HD13 ' O ' ' A' ' 235' ' ' PHE . 0.4 OUTLIER -130.63 132.29 23.87 Favored Pre-proline 0 C--N 1.313 -1.018 0 CA-C-N 113.913 -1.494 . . . . 0.0 108.048 172.006 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -64.2 112.24 1.83 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.51 1.473 . . . . 0.0 110.635 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.417 ' OD1' ' HB2' ' A' ' 240' ' ' ARG . 18.2 t-20 -51.81 134.44 30.9 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.781 0.8 . . . . 0.0 111.065 -178.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 33.7 pt -78.52 -1.04 3.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 114.656 -1.156 . . . . 0.0 112.026 -174.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.417 ' HB2' ' OD1' ' A' ' 238' ' ' ASN . 87.1 mtt180 -111.27 -56.83 2.33 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.372 0.606 . . . . 0.0 110.057 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 44.3 p -84.52 -46.52 11.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.199 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 104.23 7.81 39.77 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.359 -175.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -92.6 126.61 37.76 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 122.005 0.907 . . . . 0.0 109.919 -177.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 3.8 m -53.89 124.18 14.64 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 113.433 -1.712 . . . . 0.0 110.359 174.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 81.2 mm-40 -124.54 135.51 53.22 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.71 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 15.2 t70 -77.49 146.0 36.7 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 121.165 0.507 . . . . 0.0 110.142 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.762 HG23 ' HG3' ' A' ' 249' ' ' GLU . 6.9 m -98.49 146.16 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -74.66 76.76 2.03 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 167.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.762 ' HG3' HG23 ' A' ' 247' ' ' VAL . 32.2 mp0 -52.51 -39.01 60.81 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.388 0.614 . . . . 0.0 110.489 -171.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 262' ' ' CYS . 53.1 t -55.45 -30.63 60.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.943 176.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -97.42 -40.98 8.43 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 122.064 0.935 . . . . 0.0 109.62 -177.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.76 -16.91 63.94 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.947 -1.478 . . . . 0.0 110.836 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 2.6 mp -120.37 104.97 42.4 Favored Pre-proline 0 N--CA 1.447 -0.611 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 174.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.426 ' HG2' ' N ' ' A' ' 203' ' ' VAL . 1.1 Cg_exo -28.69 -47.88 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.604 1 C-N-CA 126.204 4.603 . . . . 0.0 116.87 -172.147 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -140.23 43.27 1.14 Allowed Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -174.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.413 HD21 ' CE1' ' A' ' 269' ' ' PHE . 11.1 tp -54.34 125.84 20.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.761 -0.72 . . . . 0.0 110.486 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 284' ' ' GLN . 98.9 m 60.35 58.37 2.59 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.515 0.674 . . . . 0.0 109.888 -176.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -60.44 120.89 10.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.381 -177.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 101.21 40.57 2.79 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.532 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 172.8 -156.49 25.01 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.787 179.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' ASN . . . . . 0.429 ' HB2' ' HB2' ' A' ' 272' ' ' LYS . 4.9 m-20 -111.93 156.82 21.48 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' CYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 250' ' ' CYS . 0.9 OUTLIER -137.86 132.88 33.19 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 170.268 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 58.5 mt -130.18 115.18 31.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.527 -170.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -73.61 121.84 21.33 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -172.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 268' ' ' SER . 0.5 OUTLIER -110.01 156.14 20.89 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 153.452 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.71 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 4.1 m -74.97 126.64 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 C-N-CA 117.861 -1.536 . . . . 0.0 107.605 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.724 ' N ' ' HE1' ' A' ' 235' ' ' PHE . . . 113.25 -26.62 10.2 Favored Glycine 0 C--N 1.309 -0.94 0 C-N-CA 119.764 -1.208 . . . . 0.0 111.807 -171.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.468 ' O ' HG23 ' A' ' 265' ' ' THR . 26.5 t 173.67 157.5 0.13 Allowed 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 121.315 0.579 . . . . 0.0 109.502 -174.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 269' ' ' PHE . . . . . 0.413 ' CE1' HD21 ' A' ' 256' ' ' LEU . 35.3 p90 -101.81 153.05 20.17 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -109.41 114.05 27.38 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 55.4 m -99.96 160.97 13.91 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.856 -0.737 . . . . 0.0 111.779 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.429 ' HB2' ' HB2' ' A' ' 261' ' ' ASN . 28.5 mmmt -134.19 112.55 11.19 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.306 -178.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 79.8 m -91.93 158.95 38.94 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.129 177.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.511 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 32.0 Cg_exo -61.04 157.07 40.89 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.402 2.068 . . . . 0.0 111.052 171.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -54.8 139.63 39.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.835 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 82.99 -27.1 4.01 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.957 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' HIS . . . . . 0.517 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 13.6 m-70 -77.03 162.94 27.13 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 121.343 0.592 . . . . 0.0 111.286 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -131.9 143.13 49.92 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.379 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 57.0 tp -87.34 133.29 33.72 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.114 0.483 . . . . 0.0 110.532 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.569 ' HB3' ' HB3' ' A' ' 285' ' ' LYS . 16.5 t-20 -114.48 106.27 14.08 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 172.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -66.8 -19.69 65.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.653 -173.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.435 ' HB ' ' OD1' ' A' ' 280' ' ' ASN . 47.6 t -62.75 -47.7 91.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.615 176.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.505 ' HA ' HG21 ' A' ' 188' ' ' THR . 31.3 t -123.74 31.05 5.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.095 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 0.447 HE21 HG11 ' A' ' 213' ' ' VAL . 23.2 mp0 29.8 46.59 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.93 -172.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 285' ' ' LYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 280' ' ' ASN . 81.1 tttt -92.08 120.41 32.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.3 -170.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 7.2 m -102.98 81.1 1.94 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.89 0.376 . . . . 0.0 110.092 173.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 29.9 mm-40 . . . . . 0 C--O 1.242 0.696 0 CA-C-O 118.203 -0.903 . . . . 0.0 109.051 -178.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.475 0.811 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.45 119.78 21.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.943 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.7 p -93.55 -27.45 16.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.109 0.481 . . . . 0.0 110.927 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -65.15 -40.21 94.07 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.284 0.564 . . . . 0.0 110.154 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.2 m -80.01 123.45 27.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.4 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 72.5 mt -62.02 -42.76 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -98.33 122.18 41.18 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.243 -0.89 . . . . 0.0 108.993 171.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -59.62 122.64 14.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.981 0.42 . . . . 0.0 110.438 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 26.3 p -146.71 -163.87 1.85 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.329 -173.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -98.91 -55.19 2.78 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.182 0.515 . . . . 0.0 111.901 -175.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 14.7 pt -88.95 -166.72 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 CA-C-N 115.087 -0.96 . . . . 0.0 113.575 -162.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.588 ' HD3' ' H ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -127.9 147.88 50.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.469 -171.369 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 129' ' ' CYS . 96.4 m -117.96 154.75 31.43 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 67.0 mtm -140.95 165.81 26.52 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 170.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.427 ' HB3' ' CE2' ' A' ' 140' ' ' TYR . 78.4 m-20 68.35 49.83 0.78 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.264 0.484 . . . . 0.0 111.512 168.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 66.31 28.52 73.76 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.599 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -92.32 148.68 19.26 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.266 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.8 p -127.03 123.66 37.55 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 175.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 134' ' ' CYS . 43.0 t -86.57 126.75 34.69 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.96 0.41 . . . . 0.0 111.662 -172.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 29.0 t -142.51 140.96 32.01 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.876 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.596 ' O ' ' HB2' ' A' ' 132' ' ' ASP . 26.7 t70 76.63 -34.16 0.22 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 174.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 20.6 t70 151.43 -42.84 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -168.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -92.99 -175.63 3.94 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.186 0.517 . . . . 0.0 111.425 176.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 129' ' ' CYS . 41.2 t -110.8 134.94 52.08 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.614 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 88.9 mt -87.62 125.92 34.65 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 1.3 m -94.5 148.71 21.96 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -166.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -56.68 155.16 7.89 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.04 166.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -64.08 114.87 4.44 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.364 1.078 . . . . 0.0 111.479 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.48 ' CA ' HG12 ' A' ' 149' ' ' VAL . . . 99.27 18.37 24.25 Favored Glycine 0 C--N 1.3 -1.429 0 CA-C-N 112.891 -1.959 . . . . 0.0 111.473 -178.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.557 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 37.7 m-85 -123.43 150.67 43.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.188 0.518 . . . . 0.0 111.12 173.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.418 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 37.7 pt -140.1 -174.96 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.977 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.192 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.17 157.94 32.61 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.693 -175.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.1 p -61.66 -41.94 98.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.955 0.407 . . . . 0.0 111.685 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -108.15 18.89 20.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.378 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 64.6 28.92 13.23 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.281 173.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.4 9.27 71.14 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 119.77 -1.205 . . . . 0.0 114.548 -175.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.418 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 4.6 tm0? -127.32 120.45 22.21 Favored Pre-proline 0 C--O 1.217 -0.624 0 CA-C-N 118.741 1.27 . . . . 0.0 112.24 -177.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -89.65 153.97 5.2 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.13 2.554 . . . . 0.0 112.973 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 163' ' ' PRO . 10.1 p -97.23 102.89 14.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 122.508 1.147 . . . . 0.0 111.942 -177.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.458 ' HA ' ' H ' ' A' ' 164' ' ' ASN . 64.7 m -83.64 96.63 8.73 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 122.097 0.951 . . . . 0.0 110.224 170.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -54.12 -55.41 27.95 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.919 -1.491 . . . . 0.0 114.918 -168.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 47.4 m -94.3 17.05 13.51 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.205 0.526 . . . . 0.0 111.039 -165.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 73.07 131.55 0.16 Allowed Glycine 0 N--CA 1.432 -1.586 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.005 -175.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.499 ' O ' HD23 ' A' ' 155' ' ' LEU . 69.7 m -69.07 150.95 47.04 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.099 -1.051 . . . . 0.0 110.614 175.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 154' ' ' CYS . 58.7 mt -133.96 172.96 12.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.566 -170.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.997 HD22 ' HB ' ' A' ' 169' ' ' THR . 0.1 OUTLIER 67.08 10.33 7.62 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.389 0.614 . . . . 0.0 111.188 178.05 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.87 36.26 91.72 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.079 -167.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -76.0 -145.23 1.54 Allowed Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.203 -0.498 . . . . 0.0 113.318 -175.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -150.86 118.02 5.95 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.665 -0.315 . . . . 0.0 111.111 -175.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 13.6 t -60.94 125.24 23.0 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.746 0.308 . . . . 0.0 110.34 176.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 165' ' ' ARG . 13.2 m -117.04 -49.28 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.922 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 163' ' ' PRO . . . -133.79 173.68 5.56 Favored Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 176.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.606 ' HA ' ' O ' ' A' ' 149' ' ' VAL . 54.3 Cg_exo -53.91 107.32 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 121.987 1.791 . . . . 0.0 112.465 177.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.458 ' H ' ' HA ' ' A' ' 150' ' ' CYS . 5.3 t-20 73.83 14.58 4.06 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.996 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.546 ' O ' HG22 ' A' ' 161' ' ' VAL . 2.0 mtm180 -113.35 89.45 3.09 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.027 174.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 82.4 m -88.32 141.69 28.34 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.0 169.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -90.32 131.28 36.21 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 60.0 m -104.53 130.96 52.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.901 0.857 . . . . 0.0 112.197 -169.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.997 ' HB ' HD22 ' A' ' 156' ' ' ASN . 82.2 m -71.02 -57.59 4.4 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 116.204 1.928 . . . . 0.0 116.204 -170.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -136.89 -100.31 0.2 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 118.329 -1.348 . . . . 0.0 113.205 -165.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -90.32 45.39 2.97 Favored Glycine 0 CA--C 1.492 -1.379 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.773 -165.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 156' ' ' ASN . 4.2 m-85 -120.23 127.22 52.22 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 119.502 -0.879 . . . . 0.0 112.186 173.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.532 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 6.5 t -92.15 154.27 18.8 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 166.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 87.97 124.18 2.05 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.31 24.31 0.36 Allowed 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.053 1.836 . . . . 0.0 114.257 -166.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.422 ' O ' HD12 ' A' ' 155' ' ' LEU . 45.9 tt0 -126.57 5.11 6.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.896 0.855 . . . . 0.0 109.854 176.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.551 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.1 OUTLIER 36.99 51.24 0.96 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 113.838 -1.528 . . . . 0.0 114.46 -177.897 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -109.72 -15.46 14.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.073 0.463 . . . . 0.0 110.656 174.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 173' ' ' THR . 14.4 mmm180 -59.88 -58.49 8.32 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.442 -1.253 . . . . 0.0 107.697 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.472 ' HA ' ' CD2' ' A' ' 172' ' ' PHE . 34.9 t70 72.71 62.24 0.11 Allowed 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 160.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.532 ' HE2' ' N ' ' A' ' 173' ' ' THR . 50.5 p90 -91.46 65.47 5.26 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 122.74 1.257 . . . . 0.0 108.478 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.461 ' O ' ' HH2' ' A' ' 217' ' ' TRP . 61.2 mtt180 -53.76 125.86 19.98 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 168.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.409 ' HB ' HG13 ' A' ' 203' ' ' VAL . 82.1 p -72.25 143.75 48.68 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.345 -160.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -149.69 147.37 17.6 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -167.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -82.27 143.6 12.64 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.177 1.918 . . . . 0.0 111.241 173.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.423 ' H ' HG23 ' A' ' 202' ' ' ILE . 1.8 m -76.34 116.64 17.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.21 0.529 . . . . 0.0 111.105 176.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' PHE . . . . . 0.749 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 21.9 m-30 -84.54 145.18 28.21 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.079 177.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.491 HG22 ' NH2' ' A' ' 215' ' ' ARG . 40.2 p -122.23 -18.35 6.86 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.489 -174.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 66.5 t -139.47 115.05 8.51 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -176.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.688 HD11 ' HB2' ' A' ' 216' ' ' ALA . 20.7 mm -83.71 119.44 32.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -168.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.499 ' HB3' ' O ' ' A' ' 194' ' ' MET . 35.0 t -143.55 138.43 29.12 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.537 -1.665 . . . . 0.0 107.344 170.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -62.73 -33.45 75.15 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 172.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -55.66 -63.02 1.3 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 113.358 -1.746 . . . . 0.0 110.02 171.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.499 ' O ' ' HB3' ' A' ' 191' ' ' SER . 61.3 mtt -154.78 119.26 4.78 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.037 176.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.547 ' HB2' ' CD1' ' A' ' 187' ' ' PHE . 62.9 m -80.65 1.24 30.77 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 110.588 -0.153 . . . . 0.0 110.588 176.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.525 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 31.6 mm-40 96.62 -138.49 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.578 1.551 . . . . 0.0 109.452 -172.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.425 ' HA3' ' CE2' ' A' ' 187' ' ' PHE . . . 73.56 -37.1 0.84 Allowed Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.131 -0.557 . . . . 0.0 114.468 177.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -63.71 -14.36 51.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.527 0.664 . . . . 0.0 111.129 -177.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.496 ' N ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -107.43 27.0 9.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.645 -179.952 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.402 ' OG ' HG22 ' A' ' 202' ' ' ILE . 27.0 t -156.6 155.35 31.69 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.214 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -125.88 23.19 5.95 Favored Glycine 0 CA--C 1.504 -0.596 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 175.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.604 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -60.9 112.18 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 175.245 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.409 HG13 ' HB ' ' A' ' 183' ' ' THR . 46.4 t -104.88 100.02 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-O 122.632 1.206 . . . . 0.0 110.441 175.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.443 ' HB2' HD11 ' A' ' 202' ' ' ILE . 15.6 t -125.17 -175.23 3.25 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 112.575 -2.102 . . . . 0.0 105.862 173.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.401 HG22 ' HB2' ' A' ' 181' ' ' TYR . 12.0 p -101.42 163.17 12.41 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.664 173.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.953 ' HB3' ' CE3' ' A' ' 217' ' ' TRP . 41.4 pttt -68.98 -22.76 64.08 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.337 176.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 9.2 m -59.94 -51.42 69.74 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.429 ' CD1' HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -58.13 -48.11 81.25 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.553 175.006 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.0 -21.98 61.49 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.168 -174.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 86.6 m -101.48 -17.67 16.33 Favored 'General case' 0 C--O 1.212 -0.892 0 O-C-N 121.549 -0.719 . . . . 0.0 112.064 -176.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -81.91 -48.9 10.93 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.915 0.865 . . . . 0.0 109.797 166.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 233' ' ' ARG . 6.4 p -102.4 141.63 34.91 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.675 -176.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.468 HG13 HE22 ' A' ' 284' ' ' GLN . 1.3 t 58.51 -38.08 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -178.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.555 ' O ' ' HD3' ' A' ' 215' ' ' ARG . . . 81.58 -161.11 42.27 Favored Glycine 0 CA--C 1.505 -0.566 0 CA-C-N 119.812 1.187 . . . . 0.0 112.915 -177.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.555 ' HD3' ' O ' ' A' ' 214' ' ' GLY . 0.0 OUTLIER 102.72 -93.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.487 1.115 . . . . 0.0 108.978 166.851 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.749 ' HB3' ' HB2' ' A' ' 187' ' ' PHE . . . -172.25 172.71 4.44 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 118.99 0.814 . . . . 0.0 109.24 173.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' TRP . . . . . 0.953 ' CE3' ' HB3' ' A' ' 206' ' ' LYS . 12.8 t90 -163.12 150.66 13.2 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -177.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 70.7 173.06 12.87 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 114.714 0.646 . . . . 0.0 114.714 170.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.484 ' CD2' ' HZ ' ' A' ' 187' ' ' PHE . 48.4 m80 -123.97 131.73 24.25 Favored Pre-proline 0 C--N 1.334 -0.105 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 37.2 Cg_endo -63.74 167.37 39.57 Favored 'Cis proline' 0 C--N 1.349 0.555 0 C-N-CA 123.806 -1.331 . . . . 0.0 112.616 -1.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 16.2 t -59.4 111.25 1.31 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.653 -176.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -106.12 102.07 11.51 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.02 141.9 35.01 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.381 -169.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 14.8 m -144.05 159.22 53.68 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.429 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.95 167.22 23.97 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.982 2.454 . . . . 0.0 109.769 164.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.571 ' O ' ' HD3' ' A' ' 228' ' ' PRO . . . -56.02 -92.23 0.0 OUTLIER 'General case' 0 C--O 1.211 -0.969 0 CA-C-N 117.957 0.344 . . . . 0.0 110.511 176.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' GLN . . . . . 0.447 ' HB3' ' HB3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -89.02 102.59 4.31 Favored Pre-proline 0 C--N 1.316 -0.861 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.057 169.555 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.571 ' HD3' ' O ' ' A' ' 226' ' ' ALA . 24.5 Cg_endo -93.52 -44.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.794 2.329 . . . . 0.0 113.858 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.483 ' HB3' ' HD2' ' A' ' 230' ' ' PRO . 72.0 m-70 -103.15 -179.85 0.85 Allowed Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -173.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 229' ' ' HIS . 51.6 Cg_exo -59.06 174.24 0.99 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 121.849 1.699 . . . . 0.0 112.251 172.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 73.9 m 70.12 128.63 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -168.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.503 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 65.0 mtt180 -58.96 148.85 29.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -176.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.506 ' O ' HG22 ' A' ' 212' ' ' THR . 17.3 ptp180 -31.71 -47.03 0.12 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.57 ' O ' ' HA ' ' A' ' 246' ' ' ASP . . . -79.52 11.79 30.45 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.475 -0.869 . . . . 0.0 114.168 -174.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' PHE . . . . . 0.55 ' O ' HD13 ' A' ' 236' ' ' ILE . 78.5 m-85 -123.08 155.9 35.99 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.867 0.842 . . . . 0.0 113.061 -173.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.55 HD13 ' O ' ' A' ' 235' ' ' PHE . 0.3 OUTLIER -135.41 134.48 21.21 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 114.011 -1.45 . . . . 0.0 107.866 173.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.89 112.47 1.29 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 121.86 1.707 . . . . 0.0 110.932 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -53.48 135.3 40.0 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.832 0.825 . . . . 0.0 110.364 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 30.9 mt -69.69 -13.23 16.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.752 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -103.67 -60.8 1.51 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.388 0.613 . . . . 0.0 110.057 -176.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 44.7 p -84.38 -40.41 17.89 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.873 -175.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 97.6 5.0 57.95 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -83.79 133.3 34.77 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.706 0.765 . . . . 0.0 110.942 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 22.3 m -56.16 108.14 0.44 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.905 170.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 60.3 mm-40 -115.19 134.87 54.76 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.655 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 12.8 t70 -75.62 140.43 42.6 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -176.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.769 HG23 ' HG3' ' A' ' 249' ' ' GLU . 3.7 m -94.38 145.14 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -75.44 77.38 2.5 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 166.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.769 ' HG3' HG23 ' A' ' 247' ' ' VAL . 47.9 mp0 -50.04 -35.32 24.56 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.4 0.619 . . . . 0.0 110.716 -171.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 77.2 m -50.94 -34.83 30.35 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.069 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -103.94 -47.35 4.22 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.428 0.691 . . . . 0.0 110.466 -175.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -63.38 -26.52 68.79 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.935 -177.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.802 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.7 mp -121.38 78.43 35.83 Favored Pre-proline 0 N--CA 1.446 -0.635 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -57.31 112.75 1.22 Allowed 'Trans proline' 0 CA--C 1.514 -0.493 0 C-N-CA 123.358 2.705 . . . . 0.0 114.608 -164.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 74.46 24.51 72.72 Favored Glycine 0 C--N 1.308 -0.976 0 CA-C-N 113.561 -1.654 . . . . 0.0 113.665 175.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.802 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.6 OUTLIER -67.92 -32.94 73.75 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 117.615 0.707 . . . . 0.0 110.537 177.487 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 257' ' ' CYS . . . . . 0.625 ' HA ' ' HB3' ' A' ' 284' ' ' GLN . 35.3 t -104.05 83.28 2.08 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.488 0.661 . . . . 0.0 109.443 177.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -98.52 -2.79 37.97 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.927 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -60.21 -41.58 98.3 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.46 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -165.31 -109.85 0.23 Allowed Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.953 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' ASN . . . . . 0.598 ' HB2' ' HB3' ' A' ' 272' ' ' LYS . 10.0 m120 -86.68 162.08 18.1 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.162 0.506 . . . . 0.0 111.276 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 4.3 t -148.08 120.46 8.44 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.177 174.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.477 ' HB ' ' HB2' ' A' ' 270' ' ' GLU . 21.7 mt -128.29 165.2 28.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 -176.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.58 125.86 33.35 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 117.95 -1.5 . . . . 0.0 113.559 -177.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.2 t -114.25 162.6 16.36 Favored 'General case' 0 C--O 1.259 1.558 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.131 163.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.655 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 27.2 m -72.55 124.84 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 C-N-CA 119.717 -0.793 . . . . 0.0 108.953 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.474 ' HA2' ' CE2' ' A' ' 235' ' ' PHE . . . 105.43 -17.61 43.05 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 119.997 -1.097 . . . . 0.0 112.784 -175.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 41.3 t 175.58 155.2 0.18 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.77 0.785 . . . . 0.0 110.302 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -102.33 155.96 17.9 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' GLU . . . . . 0.477 ' HB2' ' HB ' ' A' ' 263' ' ' ILE . 9.5 mt-10 -113.18 116.96 30.64 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.057 -173.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 99.2 m -105.07 148.25 27.01 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.598 ' HB3' ' HB2' ' A' ' 261' ' ' ASN . 21.2 ttpp -127.95 132.46 49.24 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -177.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 273' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 286' ' ' CYS . 23.4 m -112.63 157.14 41.19 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.373 -175.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.502 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 51.1 Cg_exo -55.41 156.84 16.19 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.189 1.926 . . . . 0.0 110.944 168.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -56.32 144.15 31.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.676 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.38 -34.31 2.89 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.283 -0.961 . . . . 0.0 112.036 -176.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' HIS . . . . . 0.623 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 16.0 m-70 -75.8 164.16 26.52 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.592 0.234 . . . . 0.0 110.56 -175.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -139.82 142.6 36.63 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -176.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 285' ' ' LYS . 57.5 tp -73.07 125.01 26.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.112 0.482 . . . . 0.0 111.315 -178.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.484 ' HB3' ' HB2' ' A' ' 285' ' ' LYS . 17.6 t-20 -102.48 95.6 6.36 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -68.0 -16.05 63.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.085 -172.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 84.7 t -56.33 -49.36 77.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.512 173.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 2.4 p -134.87 40.21 2.94 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.229 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 0.625 ' HB3' ' HA ' ' A' ' 257' ' ' CYS . 13.5 mp0 25.46 56.54 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.201 -1.363 . . . . 0.0 113.457 -173.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 285' ' ' LYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 280' ' ' ASN . 98.5 mttt -101.29 176.16 5.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.77 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 286' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 273' ' ' CYS . 38.8 m -147.61 97.64 2.86 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.486 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.623 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 65.7 mm-40 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.358 -0.829 . . . . 0.0 109.54 -174.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.2 m . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 120.791 0.329 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -91.97 -14.82 28.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.803 0.335 . . . . 0.0 110.85 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.1 m -86.3 101.64 13.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.231 0.539 . . . . 0.0 109.824 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -120.95 149.38 42.73 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.738 -175.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 31.1 p -79.95 -20.56 45.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.153 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.4 pt -87.16 57.74 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.275 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -68.43 170.66 8.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.528 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -100.26 60.72 1.04 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.038 0.447 . . . . 0.0 110.65 -176.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 4.1 m -71.88 166.8 21.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.474 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -113.05 -11.56 13.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.394 0.616 . . . . 0.0 111.303 -174.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.612 HD13 ' H ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -91.71 -164.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.482 0.658 . . . . 0.0 112.548 -177.802 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.527 ' HD2' ' N ' ' A' ' 122' ' ' ARG . 3.0 mpt_? -117.33 119.53 35.4 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.136 -174.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 78.0 m -107.43 98.46 8.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.031 -177.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 5.0 mpp? -107.49 165.11 11.65 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.577 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.5 m120 70.38 37.27 1.58 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.55 0.69 . . . . 0.0 110.704 173.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 82.33 8.89 85.72 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.527 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.14 124.56 34.06 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.161 -176.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.525 ' HB3' ' HB2' ' A' ' 135' ' ' LEU . 30.8 t -90.29 168.64 11.75 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.25 124.07 33.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.199 0.523 . . . . 0.0 112.257 -173.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.477 ' HB2' ' HG ' ' A' ' 135' ' ' LEU . 31.4 t -138.91 146.22 40.83 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.58 172.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.9 t70 25.79 -94.69 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 O-C-N 125.042 1.464 . . . . 0.0 111.785 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -141.44 16.01 2.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.229 1.014 . . . . 0.0 108.605 167.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.446 ' O ' ' HB3' ' A' ' 130' ' ' SER . 0.1 OUTLIER -120.84 136.35 54.94 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.451 170.607 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 64.1 m -74.85 158.28 33.66 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -172.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 128' ' ' SER . 96.1 mt -103.86 107.67 18.64 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 39.8 m -67.07 160.44 26.64 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.613 -173.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -89.04 145.51 25.43 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 169.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -62.09 110.34 1.56 Allowed 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 122.939 1.352 . . . . 0.0 112.276 -170.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 132.47 -5.43 5.23 Favored Glycine 0 N--CA 1.432 -1.611 0 CA-C-N 111.808 -2.451 . . . . 0.0 111.53 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.682 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 98.0 m-85 -122.35 149.09 44.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.934 0.867 . . . . 0.0 110.207 171.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 30.7 pt -126.9 171.8 14.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 176.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.55 157.71 20.31 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.7 p -65.06 -34.71 79.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.248 0.524 . . . . 0.0 111.174 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -100.22 2.26 42.66 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.051 0.453 . . . . 0.0 110.427 174.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 60.2 m 61.9 43.64 9.1 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.496 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -104.27 3.53 43.89 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 119.953 -1.118 . . . . 0.0 113.646 -176.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 9.5 tm0? -106.58 110.92 64.09 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 117.54 0.67 . . . . 0.0 109.422 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -80.81 140.3 12.82 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.846 2.364 . . . . 0.0 112.747 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 149' ' ' VAL . 13.9 p -67.08 111.36 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.291 1.043 . . . . 0.0 112.364 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.508 ' HB3' ' SG ' ' A' ' 154' ' ' CYS . 0.8 OUTLIER -80.21 73.53 7.05 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.541 171.343 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -50.65 -67.13 0.28 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.699 -1.591 . . . . 0.0 114.239 -171.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 19.4 m -98.22 13.78 30.08 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.394 0.616 . . . . 0.0 111.624 -166.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 79.2 123.35 0.37 Allowed Glycine 0 CA--C 1.5 -0.87 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.668 -175.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.508 ' SG ' ' HB3' ' A' ' 150' ' ' CYS . 86.4 m -77.0 -17.29 58.96 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -175.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.643 HD13 ' HB3' ' A' ' 178' ' ' GLU . 2.2 mp 46.19 -172.37 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -172.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.418 ' ND2' ' SG ' ' A' ' 177' ' ' CYS . 0.8 OUTLIER 51.92 11.06 0.13 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.297 1.439 . . . . 0.0 113.902 171.586 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.31 36.7 84.55 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.799 -174.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -79.24 -145.65 3.31 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.446 -176.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -153.77 118.4 4.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.368 0.584 . . . . 0.0 110.823 -175.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.9 m -62.01 119.75 9.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.746 0.308 . . . . 0.0 111.554 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 165' ' ' ARG . 4.3 m -107.13 -35.85 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 121.134 0.493 . . . . 0.0 110.417 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.638 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -140.13 172.21 6.66 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.682 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 79.4 Cg_exo -52.73 106.06 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.175 1.916 . . . . 0.0 112.246 176.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 69.1 -0.04 2.62 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.483 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.638 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -90.41 83.99 5.96 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 172.405 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 40.5 m -84.12 145.33 28.48 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.2 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -92.67 124.66 36.84 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 37.1 m -104.07 135.62 45.23 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 124.142 0.901 . . . . 0.0 112.114 -168.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.4 m -48.73 -53.66 18.04 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -172.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -167.78 -88.16 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.366 -0.934 . . . . 0.0 112.55 -174.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -85.16 57.24 4.98 Favored Glycine 0 N--CA 1.435 -1.385 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.898 -167.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.588 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 8.1 m-85 -122.91 128.49 50.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.223 1.012 . . . . 0.0 111.669 172.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.84 HG23 ' CE1' ' A' ' 181' ' ' TYR . 14.9 p -86.72 119.88 27.42 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.181 177.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 107.4 133.3 7.15 Favored Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -174.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.43 -0.45 8.19 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 120.956 1.104 . . . . 0.0 112.429 -173.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -107.96 19.23 20.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.496 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.572 ' O ' ' HB2' ' A' ' 155' ' ' LEU . 0.5 OUTLIER 17.66 79.67 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 118.301 2.704 . . . . 0.0 118.301 176.222 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.643 ' HB3' HD13 ' A' ' 155' ' ' LEU . 14.5 pt-20 -126.22 34.53 4.83 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.132 0.968 . . . . 0.0 109.517 167.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.588 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 23.0 mmt180 -132.63 88.22 2.5 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.724 -1.58 . . . . 0.0 107.248 176.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.425 ' HA ' ' CE1' ' A' ' 172' ' ' PHE . 9.2 p-10 -81.0 49.83 1.29 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.808 0.813 . . . . 0.0 111.352 -169.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.84 ' CE1' HG23 ' A' ' 173' ' ' THR . 10.5 p90 -76.59 93.86 3.66 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 176.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -79.15 173.76 12.25 Favored 'General case' 0 N--CA 1.436 -1.15 0 O-C-N 119.733 -1.854 . . . . 0.0 106.162 174.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 81.6 p -98.76 138.87 35.3 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 118.851 -1.14 . . . . 0.0 108.889 169.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.458 ' HA3' ' HA2' ' A' ' 218' ' ' GLY . . . -159.75 149.78 19.66 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.727 -173.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.416 ' HB3' ' O ' ' A' ' 200' ' ' SER . 59.4 Cg_endo -75.44 132.51 14.94 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.365 2.044 . . . . 0.0 111.041 171.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.712 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 71.5 m -75.2 122.09 23.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.4 0.619 . . . . 0.0 110.236 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -107.55 153.47 22.81 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.793 -175.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.62 ' O ' ' HB3' ' A' ' 215' ' ' ARG . 29.1 p -100.94 -56.99 2.19 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.002 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 36.9 t -134.06 118.45 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 119.686 -0.805 . . . . 0.0 111.767 -172.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.637 HG13 ' SG ' ' A' ' 195' ' ' CYS . 2.1 mp -102.32 117.21 47.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.465 0.65 . . . . 0.0 111.736 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.3 p -110.98 -168.67 1.33 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 159.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -68.87 -4.84 17.9 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.383 0.611 . . . . 0.0 110.066 171.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -90.81 -76.43 0.44 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.394 -174.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 98.6 mmm -141.68 160.28 40.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.275 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.637 ' SG ' HG13 ' A' ' 190' ' ' ILE . 38.8 m -91.09 -8.15 49.69 Favored 'General case' 0 C--O 1.248 0.99 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.953 175.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.435 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 79.9 mm-40 78.22 -140.49 0.02 OUTLIER 'General case' 0 C--N 1.347 0.464 0 CA-C-N 114.2 -1.364 . . . . 0.0 109.863 -175.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 82.56 -7.06 66.31 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.796 172.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 59.1 27.98 17.12 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 122.577 0.351 . . . . 0.0 111.2 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 51.9 44.74 29.17 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.687 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.416 ' O ' ' HB3' ' A' ' 185' ' ' PRO . 41.5 t -70.47 155.53 40.59 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.641 -174.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -109.33 20.01 28.58 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.332 177.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.45 HD11 ' HB2' ' A' ' 204' ' ' SER . 0.0 OUTLIER -63.11 113.57 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 173.198 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 48.9 t -102.46 99.11 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 122.346 1.069 . . . . 0.0 110.502 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.45 ' HB2' HD11 ' A' ' 202' ' ' ILE . 7.9 t -127.77 -175.4 3.46 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 112.479 -2.146 . . . . 0.0 105.436 170.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 30.6 p -101.72 165.29 11.29 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 119.648 1.113 . . . . 0.0 109.923 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.923 ' HB3' ' CE3' ' A' ' 217' ' ' TRP . 0.0 OUTLIER -66.64 -23.85 66.21 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 119.102 -1.039 . . . . 0.0 108.662 175.805 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.8 m -59.51 -55.93 28.4 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.507 ' CD1' HG11 ' A' ' 247' ' ' VAL . 0.3 OUTLIER -54.03 -54.96 31.97 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.74 176.553 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 52.9 m -77.41 -20.51 54.52 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -170.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 226' ' ' ALA . 97.5 m -83.93 -41.73 17.07 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 119.123 0.874 . . . . 0.0 109.914 173.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ALA . . . . . 0.474 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . . . -64.6 -58.32 6.67 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.675 HG22 ' HA2' ' A' ' 234' ' ' GLY . 5.1 p -91.25 140.69 29.55 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.896 -1.502 . . . . 0.0 108.998 178.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.496 HG21 ' CD1' ' A' ' 256' ' ' LEU . 0.2 OUTLIER 58.62 -30.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -177.124 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.406 ' O ' ' HD2' ' A' ' 215' ' ' ARG . . . 75.82 -162.39 52.92 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 120.209 1.368 . . . . 0.0 114.449 177.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.62 ' HB3' ' O ' ' A' ' 188' ' ' THR . 2.1 mtt180 98.78 -83.3 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.546 1.138 . . . . 0.0 112.371 166.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' A' ' 223' ' ' MET . . . -174.57 172.02 3.18 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.117 0.417 . . . . 0.0 110.521 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' TRP . . . . . 0.923 ' CE3' ' HB3' ' A' ' 206' ' ' LYS . 9.6 t90 -165.33 151.38 9.75 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.306 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 221' ' ' CYS . . . 77.23 174.88 41.67 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 115.06 0.784 . . . . 0.0 115.06 171.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.525 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 17.6 m80 -133.3 131.72 21.74 Favored Pre-proline 0 N--CA 1.462 0.172 0 CA-C-N 114.692 -0.754 . . . . 0.0 109.315 174.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.525 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 23.0 Cg_endo -61.18 142.93 36.62 Favored 'Cis proline' 0 C--N 1.346 0.409 0 C-N-CA 123.132 -1.612 . . . . 0.0 111.175 -3.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' CYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 81.0 m -49.49 121.42 5.06 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.733 0.646 . . . . 0.0 111.784 -172.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -93.44 95.64 9.41 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' MET . . . . . 0.473 ' HA ' ' HB2' ' A' ' 216' ' ' ALA . 0.0 OUTLIER -90.22 122.7 33.39 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 -172.221 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 17.8 p -142.9 150.27 52.57 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.05 -165.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.34 167.11 13.47 Favored 'Trans proline' 0 CA--C 1.515 -0.437 0 C-N-CA 122.867 2.378 . . . . 0.0 110.672 162.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 210' ' ' CYS . . . -62.88 -119.74 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.853 0.835 . . . . 0.0 112.06 174.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 227' ' ' GLN . 6.8 pt20 -57.13 107.76 1.01 Allowed Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.13 -172.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 211' ' ' ALA . 1.9 Cg_endo -83.6 -55.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.146 2.564 . . . . 0.0 112.366 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -78.22 163.0 64.62 Favored Pre-proline 0 CA--C 1.511 -0.539 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.7 59.05 4.08 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 121.992 1.794 . . . . 0.0 112.031 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 59.3 m -131.23 162.58 29.67 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.466 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 20.8 mmt180 -66.02 139.8 58.23 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 175.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -36.22 -41.17 0.25 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.675 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -77.25 8.93 29.47 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.629 -175.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' PHE . . . . . 0.651 ' HE2' ' N ' ' A' ' 267' ' ' GLY . 2.3 m-85 -121.56 149.45 43.11 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.287 1.042 . . . . 0.0 113.067 -171.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.499 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.2 OUTLIER -125.37 124.2 25.14 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 113.736 -1.575 . . . . 0.0 108.818 172.204 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -63.58 122.1 10.09 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.295 1.997 . . . . 0.0 111.573 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -53.78 131.03 38.81 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.875 177.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 40.9 pt -76.5 7.07 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.555 176.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -113.48 -59.82 1.97 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.547 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 42.1 p -91.31 -44.01 9.44 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.913 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 105.6 7.84 36.05 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -92.77 125.16 37.25 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 121.907 0.861 . . . . 0.0 109.938 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 10.2 m -60.47 122.2 14.01 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 113.296 -1.775 . . . . 0.0 109.938 174.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.459 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 90.2 mt-30 -119.37 139.21 52.36 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.787 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 17.4 t70 -74.46 143.68 44.54 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.845 HG23 ' HG3' ' A' ' 249' ' ' GLU . 10.0 m -94.52 145.98 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.252 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.89 77.04 1.64 Allowed 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 165.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.845 ' HG3' HG23 ' A' ' 247' ' ' VAL . 6.3 mp0 -52.73 -35.16 55.43 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.478 0.656 . . . . 0.0 109.56 -175.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 6.4 m -53.83 -29.51 41.15 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.211 174.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -103.72 -38.66 6.98 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.719 0.771 . . . . 0.0 109.906 -176.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -72.18 -19.8 61.69 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.869 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.684 HG22 ' HB3' ' A' ' 256' ' ' LEU . 46.7 mt -140.9 74.86 25.56 Favored Pre-proline 0 C--O 1.244 0.77 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -12.51 -80.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.947 1 C-N-CA 126.832 5.021 . . . . 0.0 116.174 -164.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -130.6 64.69 0.61 Allowed Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 119.464 -1.35 . . . . 0.0 111.472 176.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.684 ' HB3' HG22 ' A' ' 253' ' ' ILE . 1.4 pt? -68.63 8.19 0.53 Allowed 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -176.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 56.9 m -114.0 127.43 55.95 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 171.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' GLN . . . . . 0.518 ' O ' ' HB3' ' A' ' 286' ' ' CYS . 97.8 mt-30 -70.36 91.46 0.75 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.998 0.428 . . . . 0.0 111.962 -175.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 80.45 32.44 34.37 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.912 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -129.74 163.81 22.68 Favored Glycine 0 C--O 1.227 -0.308 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.06 -178.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -102.27 103.2 13.67 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 269' ' ' PHE . 50.8 t -68.21 123.05 19.63 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.079 0.466 . . . . 0.0 111.072 176.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 47.3 mt -125.56 103.75 12.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.707 ' ND2' ' HB3' ' A' ' 269' ' ' PHE . 1.0 OUTLIER -81.12 128.3 33.59 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -160.798 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 268' ' ' SER . 0.2 OUTLIER -109.21 157.5 18.74 Favored 'General case' 0 C--O 1.257 1.449 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.722 163.812 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.787 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 3.2 m -72.87 128.68 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 C-N-CA 118.839 -1.144 . . . . 0.0 108.531 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.651 ' N ' ' HE2' ' A' ' 235' ' ' PHE . . . 105.19 -26.81 20.83 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.073 -1.06 . . . . 0.0 110.887 -174.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.581 ' O ' HG23 ' A' ' 265' ' ' THR . 32.6 t 176.09 151.71 0.15 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.124 0.488 . . . . 0.0 110.358 -175.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 269' ' ' PHE . . . . . 0.707 ' HB3' ' ND2' ' A' ' 264' ' ' ASN . 26.7 p90 -99.4 162.44 13.04 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.968 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -115.32 106.49 14.08 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.808 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 54.4 m -94.6 112.18 23.94 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.346 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -79.19 132.21 36.45 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.106 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' CYS . . . . . 0.425 ' HB3' ' CB ' ' A' ' 277' ' ' HIS . 36.2 m -116.26 143.73 31.63 Favored Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.115 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.563 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 36.6 Cg_exo -60.56 167.01 8.82 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.363 2.042 . . . . 0.0 110.89 173.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -59.44 144.35 47.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.711 0.291 . . . . 0.0 110.86 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.6 -27.69 4.66 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.625 -177.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' HIS . . . . . 0.638 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 18.0 m-70 -77.0 160.34 29.21 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.021 0.438 . . . . 0.0 111.317 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' LYS . . . . . 0.421 ' NZ ' ' HB2' ' A' ' 278' ' ' LYS . 9.8 mtmp? -145.97 121.34 10.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.396 -174.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 19.1 tp -77.32 141.47 39.89 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.77 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.421 ' HB3' ' HB2' ' A' ' 285' ' ' LYS . 37.4 t30 -133.16 100.09 4.75 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.178 175.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -60.56 -26.05 66.63 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.47 -175.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 58.0 t -58.06 -29.53 36.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.679 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' A' ' 285' ' ' LYS . 33.4 t -147.85 34.87 0.84 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.888 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 32.11 38.55 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.448 1.099 . . . . 0.0 113.664 -176.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 96.6 mttt -87.12 149.33 24.75 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.693 -175.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 286' ' ' CYS . . . . . 0.518 ' HB3' ' O ' ' A' ' 258' ' ' GLN . 42.2 t -140.08 83.04 1.9 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.342 0.591 . . . . 0.0 109.507 178.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.638 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 3.8 mm-40 . . . . . 0 C--O 1.248 0.988 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.904 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.59 37.26 0.63 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.863 0.363 . . . . 0.0 111.913 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.9 p -86.64 0.3 54.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.451 0.643 . . . . 0.0 110.322 177.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -159.44 -172.65 3.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.295 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 32.6 m -81.35 -46.99 13.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.783 0.325 . . . . 0.0 110.179 178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.4 mt -67.44 114.02 3.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.148 0.499 . . . . 0.0 110.389 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -95.19 101.7 13.46 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.15 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -72.73 119.57 17.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.655 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.95 163.69 16.63 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.117 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -103.85 -62.94 1.24 Allowed 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.14 0.495 . . . . 0.0 109.879 -176.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.413 ' HA ' HH11 ' A' ' 122' ' ' ARG . 0.4 OUTLIER -89.12 -173.45 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-O 121.449 0.642 . . . . 0.0 112.567 179.001 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.595 ' HD2' ' N ' ' A' ' 122' ' ' ARG . 1.2 mpt_? -100.43 137.41 38.89 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.932 -167.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.741 ' SG ' ' HA ' ' A' ' 129' ' ' CYS . 94.1 m -118.83 125.84 50.48 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.721 176.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -129.84 161.56 30.5 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.479 ' HB3' ' CE2' ' A' ' 140' ' ' TYR . 16.3 m120 70.92 40.09 0.96 Allowed 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.457 0.473 . . . . 0.0 111.64 172.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.733 ' O ' ' HG2' ' A' ' 137' ' ' GLN . . . 82.37 24.63 53.69 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.214 -179.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -89.38 127.71 8.83 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.169 -1.015 . . . . 0.0 112.596 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 135' ' ' LEU . 23.7 m -86.4 124.02 32.28 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 176.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.741 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 27.6 p -82.81 116.31 22.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.725 0.774 . . . . 0.0 111.955 -170.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 133' ' ' HIS . 48.0 t -108.37 -176.79 3.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.445 176.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -94.21 104.39 16.4 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.865 -176.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.1 t70 93.95 -6.82 0.13 Allowed 'General case' 0 N--CA 1.469 0.486 0 O-C-N 124.485 1.116 . . . . 0.0 109.586 171.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.451 ' O ' ' HB3' ' A' ' 130' ' ' SER . 0.3 OUTLIER -160.21 171.47 19.14 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.607 173.606 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 34.9 t -122.58 132.99 54.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.276 -174.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 128' ' ' SER . 64.2 mt -82.98 120.65 25.98 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.487 0.66 . . . . 0.0 110.54 174.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 82.2 m -91.98 148.51 22.14 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.564 0.697 . . . . 0.0 112.39 -174.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.733 ' HG2' ' O ' ' A' ' 126' ' ' GLY . 24.8 mm-40 -66.37 152.07 45.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.314 166.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -66.14 113.41 4.49 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 122.045 0.926 . . . . 0.0 111.13 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 108.45 10.36 25.56 Favored Glycine 0 C--N 1.302 -1.337 0 CA-C-N 113.29 -1.777 . . . . 0.0 111.143 -175.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.584 ' CE2' ' HB3' ' A' ' 148' ' ' PRO . 78.9 m-85 -123.8 144.02 49.96 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 122.402 -0.469 . . . . 0.0 109.955 171.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 147' ' ' GLN . 25.1 pt -135.57 -176.66 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.024 -177.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 96.19 172.98 35.64 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.749 -176.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.0 m -76.51 -29.57 56.84 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 122.759 -0.259 . . . . 0.0 111.12 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -110.61 11.07 22.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.873 0.368 . . . . 0.0 110.425 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 58.1 m 63.5 30.09 15.28 Favored 'General case' 0 C--O 1.228 -0.037 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.129 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -94.26 4.83 70.89 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.873 -174.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.516 ' O ' HG12 ' A' ' 141' ' ' ILE . 1.9 tm0? -120.21 97.59 49.1 Favored Pre-proline 0 C--O 1.22 -0.496 0 CA-C-N 117.702 0.751 . . . . 0.0 110.755 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.584 ' HB3' ' CE2' ' A' ' 140' ' ' TYR . 52.4 Cg_endo -73.01 148.14 44.53 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.49 2.127 . . . . 0.0 112.19 176.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 149' ' ' VAL . 9.8 p -71.17 108.89 3.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.237 -173.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.69 77.24 6.32 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.362 173.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -51.9 -65.97 0.46 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -173.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 60.7 m -86.98 12.43 11.25 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.074 0.464 . . . . 0.0 111.226 -168.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 81.6 127.47 0.91 Allowed Glycine 0 N--CA 1.429 -1.786 0 CA-C-O 122.19 0.883 . . . . 0.0 111.906 -173.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.496 ' O ' HD23 ' A' ' 155' ' ' LEU . 1.7 m -73.56 152.93 40.45 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 113.989 -1.106 . . . . 0.0 109.307 171.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.748 HD12 ' O ' ' A' ' 176' ' ' GLN . 70.9 mt -135.34 162.89 31.31 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -168.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.743 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 2.6 t-20 48.76 24.88 0.88 Allowed 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.909 0.756 . . . . 0.0 111.605 -168.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 63.22 38.62 96.78 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.212 -176.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -76.28 -140.81 1.04 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.734 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 159' ' ' ARG . 0.1 OUTLIER -155.55 130.99 9.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.075 0.438 . . . . 0.0 111.081 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.442 ' O ' ' HG2' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -71.26 110.12 5.71 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.265 0.555 . . . . 0.0 110.428 172.483 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 165' ' ' ARG . 2.3 m -98.51 -28.72 3.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.631 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.745 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -140.28 173.11 5.33 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 174.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.577 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 49.4 Cg_exo -56.83 104.57 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 121.973 1.782 . . . . 0.0 112.348 178.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 68.06 9.97 7.52 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.216 1.006 . . . . 0.0 110.904 -176.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.745 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.3 OUTLIER -99.69 84.1 2.87 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.732 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 8.9 t -86.52 147.72 25.84 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.672 176.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.412 ' HB3' ' HD3' ' A' ' 159' ' ' ARG . . . -103.3 131.07 50.65 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.074 175.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 52.1 m -107.5 136.65 46.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.563 -165.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.743 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 25.4 m -53.12 -56.58 15.21 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -168.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.479 ' HE1' ' H ' ' A' ' 183' ' ' THR . 35.7 t80 -154.53 -87.61 0.05 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 119.043 -1.063 . . . . 0.0 112.729 -170.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.45 ' N ' ' HD1' ' A' ' 170' ' ' TYR . . . -92.21 52.33 2.81 Favored Glycine 0 CA--C 1.493 -1.305 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.725 -166.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.616 ' HB3' ' HA ' ' A' ' 177' ' ' CYS . 3.3 m-85 -124.87 123.91 40.95 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.54 169.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.58 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 2.9 t -91.54 145.39 24.65 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 174.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 87.76 127.86 2.67 Favored Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -173.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.35 24.76 0.35 Allowed 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 121.534 1.489 . . . . 0.0 113.327 -168.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.748 ' O ' HD12 ' A' ' 155' ' ' LEU . 59.4 tt0 -122.31 7.14 9.62 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.616 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.7 OUTLIER 25.65 59.53 0.06 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 -179.393 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -112.42 15.54 20.2 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 122.169 0.985 . . . . 0.0 109.479 171.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.579 ' HG3' ' O ' ' A' ' 173' ' ' THR . 1.4 mmp_? -87.01 -73.33 0.47 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.556 -173.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 179' ' ' ARG . 21.3 t70 88.38 78.32 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.09 0.948 . . . . 0.0 108.657 167.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.58 ' HE2' ' N ' ' A' ' 173' ' ' THR . 13.4 p90 -149.46 108.78 3.95 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.678 -176.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -74.49 147.56 41.77 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 119.668 -1.895 . . . . 0.0 109.853 173.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.479 ' H ' ' HE1' ' A' ' 170' ' ' TYR . 71.9 p -87.76 137.37 32.4 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.023 0.439 . . . . 0.0 110.337 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -151.25 153.3 24.88 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.435 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -78.58 132.91 11.3 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.748 2.299 . . . . 0.0 110.696 170.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.514 ' SG ' ' NE ' ' A' ' 215' ' ' ARG . 12.7 t -100.74 117.0 33.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.04 0.447 . . . . 0.0 111.031 -174.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' PHE . . . . . 0.855 ' O ' ' HB2' ' A' ' 215' ' ' ARG . 20.4 m-85 -98.62 174.67 6.31 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.216 178.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.642 ' HA ' ' HB2' ' A' ' 215' ' ' ARG . 1.3 p -129.28 -59.52 1.1 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -177.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.2 p -113.88 117.66 56.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.077 0.465 . . . . 0.0 111.151 -170.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.599 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.0 mt -131.17 117.11 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-O 121.781 0.801 . . . . 0.0 113.129 -168.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.436 ' C ' ' H ' ' A' ' 193' ' ' GLN . 46.9 p -119.13 -164.69 1.07 Allowed 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.038 163.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -60.25 -4.97 0.94 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.878 0.37 . . . . 0.0 111.032 174.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.436 ' H ' ' C ' ' A' ' 191' ' ' SER . 94.7 mt-30 -87.53 -77.45 0.34 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.893 0.377 . . . . 0.0 110.99 -172.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.432 ' O ' ' HA ' ' A' ' 190' ' ' ILE . 72.0 mtp -147.38 167.9 23.19 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.599 ' HA ' HG12 ' A' ' 190' ' ' ILE . 35.7 m -90.88 -27.55 18.71 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 121.471 0.653 . . . . 0.0 112.191 -178.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -164.61 5.9 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.904 -0.497 . . . . 0.0 111.638 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 68.36 -52.78 0.45 Allowed Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.976 -0.631 . . . . 0.0 113.221 -172.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -115.83 122.42 45.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.188 0.518 . . . . 0.0 110.501 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.3 tt -71.4 134.74 46.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.129 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 36.3 m -101.22 131.46 47.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.843 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -87.12 14.77 56.59 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.126 177.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.431 HG21 ' HD3' ' A' ' 254' ' ' PRO . 1.0 OUTLIER -61.05 121.5 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 167.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 6.8 t -99.03 96.95 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.031 0 CA-C-O 123.026 1.393 . . . . 0.0 109.227 173.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 12.7 p -129.06 -179.29 5.03 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 112.268 -2.242 . . . . 0.0 106.075 176.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 53.4 p -102.02 163.2 12.37 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 119.034 -1.067 . . . . 0.0 111.728 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.807 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 42.4 tttm -56.25 -38.72 71.52 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.689 170.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.4 m -45.86 -55.55 6.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.144 174.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.616 ' HG ' ' HB1' ' A' ' 252' ' ' ALA . 0.3 OUTLIER -56.44 -53.37 58.19 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 120.229 -0.589 . . . . 0.0 110.133 176.103 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 209' ' ' CYS . . . . . 0.868 ' HA ' ' CZ ' ' A' ' 215' ' ' ARG . 76.1 m -52.5 -37.29 57.07 Favored 'General case' 0 C--O 1.247 0.922 0 O-C-N 124.088 0.867 . . . . 0.0 113.266 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 61.3 m -94.15 -33.65 13.24 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.47 -45.45 72.36 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 120.721 -1.237 . . . . 0.0 108.93 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.539 HG22 ' HA2' ' A' ' 234' ' ' GLY . 73.6 p -105.65 149.57 26.22 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.34 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.475 HG21 HG12 ' A' ' 253' ' ' ILE . 2.1 t 57.48 -53.46 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 178.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.477 ' CA ' ' HA ' ' A' ' 226' ' ' ALA . . . 86.06 146.53 9.41 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 119.297 -1.43 . . . . 0.0 111.429 -169.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.868 ' CZ ' ' HA ' ' A' ' 209' ' ' CYS . 0.1 OUTLIER 153.16 -135.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.014 0.526 . . . . 0.0 111.451 -162.491 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.589 ' HB3' HD11 ' A' ' 190' ' ' ILE . . . -160.59 165.95 29.82 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' TRP . . . . . 0.807 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 17.2 t90 -161.79 145.52 12.44 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 121.891 -0.506 . . . . 0.0 110.26 -173.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 99.01 -175.21 28.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.374 -0.917 . . . . 0.0 114.363 171.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -132.2 130.84 22.13 Favored Pre-proline 0 C--N 1.327 -0.411 0 O-C-N 122.818 -0.224 . . . . 0.0 110.54 176.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.19 169.31 50.53 Favored 'Cis proline' 0 C--N 1.342 0.22 0 C-N-CA 123.014 -1.661 . . . . 0.0 110.976 -9.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 93.7 m -42.34 113.72 0.48 Allowed 'General case' 0 C--O 1.234 0.239 0 O-C-N 123.354 0.409 . . . . 0.0 111.655 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -102.07 106.26 17.12 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' MET . . . . . 0.528 ' HA ' ' HB2' ' A' ' 216' ' ' ALA . 0.6 OUTLIER -99.15 134.19 42.35 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.639 -164.798 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 32.1 p -141.12 152.25 64.27 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.981 0.42 . . . . 0.0 111.624 -176.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -55.69 171.28 0.72 Allowed 'Trans proline' 0 CA--C 1.514 -0.498 0 C-N-CA 123.154 2.569 . . . . 0.0 111.585 164.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.477 ' HA ' ' CA ' ' A' ' 214' ' ' GLY . . . -61.19 -126.69 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.763 0.792 . . . . 0.0 110.451 169.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.69 109.3 6.32 Favored Pre-proline 0 C--N 1.303 -1.433 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.358 -176.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -82.21 -92.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.254 1.969 . . . . 0.0 111.306 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -125.82 86.94 56.79 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.237 172.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -106.9 -168.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.693 0 C-N-CA 123.182 2.588 . . . . 0.0 111.631 171.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 8.9 p -86.77 -51.49 6.07 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 167.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.665 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 58.6 mtt180 -143.9 133.43 23.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 174.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.441 ' HG3' ' N ' ' A' ' 234' ' ' GLY . 22.3 ptt180 -45.49 -51.06 12.17 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -173.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.539 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -77.66 11.91 17.78 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.566 -0.826 . . . . 0.0 114.286 -175.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' PHE . . . . . 0.665 ' CD1' ' HB2' ' A' ' 232' ' ' ARG . 8.1 m-85 -123.32 152.5 41.38 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 122.109 0.957 . . . . 0.0 111.864 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.455 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.2 OUTLIER -125.22 122.92 25.25 Favored Pre-proline 0 N--CA 1.426 -1.641 0 CA-C-N 114.117 -1.401 . . . . 0.0 108.221 171.133 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -64.41 123.6 12.04 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.59 2.194 . . . . 0.0 112.094 178.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -57.69 126.01 25.5 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.667 174.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 29.1 pt -76.16 7.24 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.981 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 48.0 mtm180 -112.02 -60.92 1.79 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.734 177.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 37.6 p -86.89 -46.16 10.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.862 -176.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 108.71 6.52 30.56 Favored Glycine 0 N--CA 1.436 -1.314 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.487 -176.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -86.96 120.82 28.63 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-O 122.018 0.913 . . . . 0.0 110.505 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' CYS . . . . . 0.494 ' HB3' ' HB3' ' A' ' 235' ' ' PHE . 78.1 m -62.82 122.22 15.41 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.397 -1.729 . . . . 0.0 109.884 172.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 66.0 mt-30 -114.37 135.73 53.76 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.581 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 4.2 t70 -73.97 147.94 42.56 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.655 HG23 ' HG3' ' A' ' 249' ' ' GLU . 5.3 m -100.19 147.38 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.084 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -177.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.489 ' HA ' ' ND2' ' A' ' 264' ' ' ASN . 27.4 m-20 -78.06 79.25 4.52 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 167.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.655 ' HG3' HG23 ' A' ' 247' ' ' VAL . 49.8 mp0 -53.2 -36.6 61.14 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.505 -172.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 36.5 m -42.32 -40.16 2.38 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.34 171.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -100.12 -29.05 12.72 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.623 0.725 . . . . 0.0 110.321 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.616 ' HB1' ' HG ' ' A' ' 208' ' ' LEU . . . -87.71 -5.88 58.47 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.2 -172.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.61 HG13 ' NH2' ' A' ' 215' ' ' ARG . 2.8 mp -124.82 125.77 25.4 Favored Pre-proline 0 C--O 1.24 0.573 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.441 ' HD2' HG23 ' A' ' 253' ' ' ILE . 1.1 Cg_endo -34.14 -81.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 125.277 3.984 . . . . 0.0 114.208 -165.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -116.12 52.28 0.68 Allowed Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 174.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.666 ' HA ' ' OE1' ' A' ' 284' ' ' GLN . 20.0 tp -43.76 -64.92 0.57 Allowed 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.97 0.453 . . . . 0.0 112.172 -175.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 71.7 m -134.05 89.02 2.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -83.06 -59.2 2.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.474 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -79.85 93.79 1.41 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.847 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 273' ' ' CYS . . . 124.89 -174.52 17.22 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.672 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' ASN . . . . . 0.548 ' HB3' ' HG3' ' A' ' 272' ' ' LYS . 3.0 t-20 -83.63 157.12 22.37 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.78 132.71 18.1 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 5.2 mt -137.71 156.07 31.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -172.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.489 ' ND2' ' HA ' ' A' ' 248' ' ' ASP . 50.9 t30 -121.61 117.33 26.45 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.335 -176.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 5.6 t -110.53 166.77 10.73 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.559 164.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.581 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 29.5 m -70.44 130.46 34.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.476 -177.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.451 ' CA ' ' HE1' ' A' ' 235' ' ' PHE . . . 83.2 -9.49 60.79 Favored Glycine 0 N--CA 1.433 -1.557 0 C-N-CA 120.263 -0.97 . . . . 0.0 114.315 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 75.1 m -165.42 154.61 12.3 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 118.442 1.121 . . . . 0.0 111.184 -173.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' PHE . . . . . 0.428 ' CZ ' HD11 ' A' ' 256' ' ' LEU . 28.2 p90 -114.09 149.73 35.11 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.144 -0.972 . . . . 0.0 109.611 171.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -105.46 113.41 26.96 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 59.0 m -121.15 154.93 35.56 Favored 'General case' 0 CA--C 1.5 -0.953 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.504 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.548 ' HG3' ' HB3' ' A' ' 261' ' ' ASN . 0.0 OUTLIER -155.05 106.27 2.61 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.663 -179.713 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 273' ' ' CYS . . . . . 0.449 ' HA ' ' HA3' ' A' ' 260' ' ' GLY . 64.2 m -77.0 172.97 8.3 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.25 152.44 15.12 Favored 'Trans proline' 0 C--O 1.239 0.533 0 C-N-CA 121.243 1.296 . . . . 0.0 110.481 168.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -57.97 156.88 8.53 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.928 -173.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 86.6 -38.01 3.13 Favored Glycine 0 N--CA 1.435 -1.427 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.588 -176.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -81.38 168.51 18.3 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 122.588 -0.36 . . . . 0.0 110.366 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 278' ' ' LYS . . . . . 0.639 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 61.6 mttp -148.8 138.54 22.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.247 -175.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 46.7 tp -93.79 141.65 28.25 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.375 0.422 . . . . 0.0 110.267 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -122.84 106.7 11.12 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -65.15 -13.47 58.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -173.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 76.8 t -59.68 -38.31 75.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.109 0.48 . . . . 0.0 110.807 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.409 ' O ' ' HG2' ' A' ' 284' ' ' GLN . 45.1 m -144.63 38.34 1.23 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.955 177.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 0.666 ' OE1' ' HA ' ' A' ' 256' ' ' LEU . 23.9 pt20 38.25 32.8 0.05 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.317 1.047 . . . . 0.0 112.81 -175.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -89.82 105.04 17.53 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 122.111 -0.368 . . . . 0.0 111.426 -172.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' CYS . . . . . 0.639 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 45.7 t -108.99 163.9 12.89 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 174.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 C--O 1.248 1.026 0 O-C-N 124.057 0.848 . . . . 0.0 110.249 175.253 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 45.2 t . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -88.59 81.41 7.11 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 120.952 0.406 . . . . 0.0 110.216 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.3 t -67.7 109.46 3.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.72 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -83.92 64.21 7.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.435 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.9 m -75.18 123.22 24.87 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.608 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.525 HG23 ' SG ' ' A' ' 119' ' ' CYS . 69.1 mt -68.7 103.24 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.12 0.486 . . . . 0.0 109.781 174.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -80.59 61.07 4.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.983 -176.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 46.4 t60 41.65 62.14 1.65 Allowed 'General case' 0 N--CA 1.465 0.308 0 O-C-N 124.047 0.842 . . . . 0.0 110.529 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.525 ' SG ' HG23 ' A' ' 116' ' ' ILE . 24.2 p -88.21 162.05 16.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.271 -175.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -114.85 -38.08 4.03 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.453 HD13 ' HB2' ' A' ' 119' ' ' CYS . 0.2 OUTLIER -65.98 178.22 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.331 176.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.641 ' H ' ' HD2' ' A' ' 122' ' ' ARG . 0.2 OUTLIER -127.55 134.39 49.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.522 -174.525 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.655 ' SG ' ' HB3' ' A' ' 129' ' ' CYS . 23.1 m -118.62 145.61 45.29 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -172.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.6 mtm -138.33 173.22 11.84 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 62.88 53.12 2.49 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.175 0.297 . . . . 0.0 111.471 175.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.458 ' HA3' ' OE1' ' A' ' 137' ' ' GLN . . . 61.86 25.24 65.59 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.891 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 135' ' ' LEU . . . -98.61 129.47 9.91 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 119.944 -1.122 . . . . 0.0 111.677 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.2 m -107.85 133.12 52.67 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.655 ' HB3' ' SG ' ' A' ' 123' ' ' CYS . 14.0 p -72.98 134.84 44.86 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.983 0.421 . . . . 0.0 111.006 -173.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.4 t -137.73 104.92 5.44 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.2 t70 50.48 -110.08 0.44 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.985 -168.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.422 ' O ' HG21 ' A' ' 121' ' ' ILE . 6.4 p-10 -80.99 -41.95 21.95 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.15 -172.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -107.58 179.35 4.26 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.285 -176.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 129' ' ' CYS . 80.9 m -104.15 146.33 28.91 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.658 176.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.405 ' O ' ' HA2' ' A' ' 127' ' ' GLY . 90.0 mt -90.04 95.65 10.31 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 58.0 m -72.44 158.41 35.8 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.469 -174.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.458 ' OE1' ' HA3' ' A' ' 126' ' ' GLY . 42.4 mt-30 -80.37 144.66 32.53 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 168.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -63.57 110.83 2.12 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 122.832 1.301 . . . . 0.0 111.553 -174.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.403 ' HA2' ' CG1' ' A' ' 149' ' ' VAL . . . 132.82 -4.51 5.05 Favored Glycine 0 C--N 1.294 -1.774 0 CA-C-N 112.093 -2.321 . . . . 0.0 110.87 -177.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.518 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 88.1 m-85 -127.32 149.24 50.13 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 172.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 28.5 pt -135.82 -171.63 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.962 0.41 . . . . 0.0 110.087 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.74 175.15 41.39 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.398 -172.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 37.5 p -71.38 -39.67 71.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.158 0.504 . . . . 0.0 110.738 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 25.9 p-80 -107.59 16.43 23.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.11 -176.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 56.3 m 62.34 28.79 17.1 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.921 174.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.04 -5.18 70.95 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.428 -0.892 . . . . 0.0 113.583 -174.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.92 126.62 29.38 Favored Pre-proline 0 C--O 1.218 -0.565 0 CA-C-N 117.883 0.842 . . . . 0.0 110.562 -176.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -87.33 137.86 4.48 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 123.207 2.605 . . . . 0.0 113.078 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.403 ' CG1' ' HA2' ' A' ' 139' ' ' GLY . 11.5 p -69.48 122.51 21.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.876 0.846 . . . . 0.0 111.539 -176.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.734 ' HB3' ' SG ' ' A' ' 154' ' ' CYS . 1.4 m -80.08 120.03 23.68 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 168.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.437 ' OE2' ' HB2' ' A' ' 164' ' ' ASN . 7.1 mt-10 -95.33 -63.08 1.2 Allowed 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -172.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.44 ' C ' ' H ' ' A' ' 154' ' ' CYS . 5.4 p -76.75 27.04 0.13 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -172.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 80.27 -19.25 7.0 Favored Glycine 0 CA--C 1.494 -1.234 0 CA-C-O 121.807 0.67 . . . . 0.0 112.966 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.734 ' SG ' ' HB3' ' A' ' 150' ' ' CYS . 68.4 m 62.94 133.81 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 113.201 -1.5 . . . . 0.0 112.208 -175.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.485 HD12 ' HB3' ' A' ' 178' ' ' GLU . 19.7 mt -128.19 167.82 16.3 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 113.484 -1.689 . . . . 0.0 108.69 -173.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.665 ' HB2' ' CZ ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 69.41 12.71 8.34 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.858 0.724 . . . . 0.0 111.526 174.669 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 72.1 33.9 61.91 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -168.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 167' ' ' ALA . . . -56.66 130.49 50.38 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 114.966 -0.617 . . . . 0.0 113.428 -175.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.474 ' O ' HG13 ' A' ' 161' ' ' VAL . 5.3 ttt180 -94.27 115.94 28.25 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.781 -0.709 . . . . 0.0 110.893 175.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 14.1 m -66.63 110.68 3.3 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.771 0.319 . . . . 0.0 110.725 -173.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.59 HG22 ' O ' ' A' ' 165' ' ' ARG . 5.7 m -104.27 -38.96 5.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.384 -177.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -140.39 171.9 7.06 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.518 ' HD3' ' CE1' ' A' ' 140' ' ' TYR . 88.5 Cg_exo -47.7 108.1 0.16 Allowed 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 122.137 1.892 . . . . 0.0 112.826 174.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.437 ' HB2' ' OE2' ' A' ' 151' ' ' GLU . 19.7 t-20 76.81 -18.33 0.49 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.736 1.215 . . . . 0.0 110.852 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.59 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.2 OUTLIER -78.12 81.68 4.49 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.355 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.35 142.77 29.94 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 169.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.438 ' O ' ' HA2' ' A' ' 158' ' ' GLY . . . -88.36 131.28 34.89 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -175.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.65 ' HA ' HD21 ' A' ' 156' ' ' ASN . 27.8 m -87.63 115.03 24.78 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 124.239 0.962 . . . . 0.0 111.307 -175.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 16.8 m -51.71 -54.4 28.68 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -174.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -148.88 -94.4 0.07 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.111 -1.035 . . . . 0.0 112.848 -168.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -89.54 47.81 3.29 Favored Glycine 0 N--CA 1.434 -1.487 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.909 -168.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.665 ' CZ ' ' HB2' ' A' ' 156' ' ' ASN . 16.3 m-85 -122.27 121.91 37.87 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.973 175.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.479 ' O ' ' HG2' ' A' ' 179' ' ' ARG . 4.9 t -90.8 164.56 14.04 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 161.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.37 132.35 5.45 Favored Glycine 0 N--CA 1.438 -1.182 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.27 -24.83 64.88 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.401 1.401 . . . . 0.0 113.501 -167.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -93.18 -0.12 56.99 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.518 0.675 . . . . 0.0 110.697 -178.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.55 ' HB3' ' CB ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 43.11 55.2 4.66 Favored 'General case' 0 N--CA 1.46 0.075 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.676 -174.115 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.485 ' HB3' HD12 ' A' ' 155' ' ' LEU . 13.7 pt-20 -106.12 -14.49 15.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.515 176.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 173' ' ' THR . 14.0 mmt180 -60.03 -64.2 1.03 Allowed 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.263 -177.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 31.1 t0 72.35 64.81 0.12 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.515 0.674 . . . . 0.0 109.853 163.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.433 ' CD1' ' O ' ' A' ' 181' ' ' TYR . 43.2 p90 -87.58 71.06 9.8 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 122.628 1.204 . . . . 0.0 108.026 177.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 -49.99 130.84 22.56 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.073 171.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 44.4 p -79.06 139.31 38.16 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.576 -0.45 . . . . 0.0 109.986 -176.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.423 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -157.02 154.8 25.84 Favored Glycine 0 C--N 1.321 -0.261 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -173.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -77.7 133.63 12.94 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.316 2.011 . . . . 0.0 111.889 175.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.708 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 49.1 m -87.58 122.68 31.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.318 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' PHE . . . . . 0.508 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 36.5 m-85 -94.07 137.43 33.27 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.672 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.594 ' C ' ' HG2' ' A' ' 215' ' ' ARG . 23.9 m -111.64 -11.44 14.01 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.346 -160.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.7 p -169.72 116.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 O-C-N 121.925 -0.485 . . . . 0.0 110.48 174.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.591 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.4 mt -119.67 118.42 57.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -170.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.3 p -112.21 -171.32 1.83 Allowed 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 156.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -67.89 -4.03 11.6 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.591 0.71 . . . . 0.0 109.877 172.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -89.84 -67.65 0.83 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.631 -176.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.482 ' O ' ' HA ' ' A' ' 190' ' ' ILE . 62.7 mtm -136.86 145.47 44.43 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.179 -178.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.591 ' HA ' HG12 ' A' ' 190' ' ' ILE . 74.1 m -85.43 -21.1 28.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.731 0.777 . . . . 0.0 109.676 174.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.459 ' HB2' ' H ' ' A' ' 188' ' ' THR . 46.4 tt0 -162.78 -72.31 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 162.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 126.12 13.7 3.19 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.067 164.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -123.56 1.76 8.92 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 173.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 65.77 -75.03 0.05 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.552 0.741 . . . . 0.0 111.761 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 34.9 t 73.02 139.68 0.06 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.654 0.74 . . . . 0.0 112.362 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -98.93 25.28 28.81 Favored Glycine 0 CA--C 1.505 -0.57 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.593 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.524 HD11 HG23 ' A' ' 253' ' ' ILE . 1.7 tt -61.01 104.02 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-O 121.235 0.54 . . . . 0.0 109.849 173.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 10.7 t -96.28 97.43 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-O 122.603 1.192 . . . . 0.0 109.599 171.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.527 ' HB3' ' SG ' ' A' ' 209' ' ' CYS . 9.0 t -123.98 -179.51 4.43 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 172.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.431 HG22 ' HB2' ' A' ' 181' ' ' TYR . 10.4 p -103.17 161.39 13.84 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.659 -177.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.514 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 53.6 tttm -61.71 -44.29 97.21 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.177 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.6 m -46.87 -54.53 9.75 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.944 0.878 . . . . 0.0 110.133 174.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.668 HD21 ' HB1' ' A' ' 252' ' ' ALA . 4.3 tp -64.27 -52.91 56.32 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 113.423 -1.717 . . . . 0.0 112.774 -175.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' ' 204' ' ' SER . 53.2 m -74.32 -18.31 60.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.99 0.424 . . . . 0.0 111.827 -175.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 68.8 m -96.58 -25.69 15.51 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.672 176.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -73.73 -60.51 2.22 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 172.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.841 HG22 ' HA2' ' A' ' 234' ' ' GLY . 15.4 p -92.04 162.77 14.23 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 65.11 -54.04 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 95.05 -122.24 7.13 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 120.248 -0.977 . . . . 0.0 113.849 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.594 ' HG2' ' C ' ' A' ' 188' ' ' THR . 6.4 mpt_? 27.17 -86.84 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -174.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.518 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -167.6 167.46 13.44 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 119.52 1.055 . . . . 0.0 110.985 -171.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' TRP . . . . . 0.733 ' O ' ' HB2' ' A' ' 222' ' ' GLU . 10.0 t90 -155.02 144.91 21.6 Favored 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 102.3 177.2 27.58 Favored Glycine 0 CA--C 1.505 -0.586 0 C-N-CA 120.159 -1.02 . . . . 0.0 114.147 169.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 220' ' ' PRO . 13.8 p80 -129.61 133.97 25.68 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.251 -0.474 . . . . 0.0 110.804 -175.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 219' ' ' HIS . 9.7 Cg_endo -89.76 117.0 3.12 Favored 'Cis proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.17 -1.596 . . . . 0.0 111.815 -3.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 98.9 m 40.76 89.18 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 O-C-N 124.113 0.883 . . . . 0.0 112.928 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.733 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 23.8 mt-10 -102.68 111.48 23.82 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 177.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' MET . . . . . 0.518 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 18.9 ptt? -102.35 136.95 41.26 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.112 -166.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 59.4 m -119.24 147.58 43.3 Favored Pre-proline 0 C--O 1.233 0.212 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -167.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -60.27 153.67 57.86 Favored 'Trans proline' 0 CA--C 1.508 -0.812 0 C-N-CA 123.833 3.022 . . . . 0.0 113.495 167.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -42.23 113.27 0.42 Allowed 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.904 0.859 . . . . 0.0 110.508 160.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' GLN . . . . . 0.419 ' HB3' ' HA ' ' A' ' 233' ' ' ARG . 0.1 OUTLIER 23.95 99.66 0.02 OUTLIER Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 111.518 -2.583 . . . . 0.0 113.7 -177.884 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.65 -62.91 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.835 3.023 . . . . 0.0 113.627 -177.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -69.9 155.14 93.99 Favored Pre-proline 0 CA--C 1.514 -0.411 0 CA-C-O 120.691 0.282 . . . . 0.0 110.348 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.75 58.35 6.97 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 121.739 1.626 . . . . 0.0 113.799 -174.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 64.0 m -132.91 148.11 52.29 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 171.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.638 ' HG3' ' CD1' ' A' ' 235' ' ' PHE . 16.4 ptt180 -55.49 137.16 49.08 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.079 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.419 ' HA ' ' HB3' ' A' ' 227' ' ' GLN . 29.6 ptt180 -31.12 -47.15 0.1 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -166.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.841 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -68.58 5.87 3.93 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 114.981 0.753 . . . . 0.0 114.981 -174.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' PHE . . . . . 0.638 ' CD1' ' HG3' ' A' ' 232' ' ' ARG . 7.7 m-85 -122.77 150.29 42.99 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 122.089 0.947 . . . . 0.0 112.97 -169.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.524 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.1 OUTLIER -126.52 125.25 24.45 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 114.046 -1.433 . . . . 0.0 108.387 172.382 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -62.69 123.01 11.58 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.339 2.026 . . . . 0.0 111.679 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -54.08 127.25 25.86 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.354 0.597 . . . . 0.0 110.936 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 32.7 pt -65.8 -6.66 4.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.428 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 240' ' ' ARG . 63.8 mtt85 -106.51 -68.1 0.9 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.491 0.662 . . . . 0.0 110.199 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 24.4 p -79.62 -43.17 23.39 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.351 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 102.72 8.0 43.7 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -176.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -82.28 127.11 32.89 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 122.056 0.932 . . . . 0.0 109.714 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 33.3 m -63.76 114.78 4.24 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 113.458 -1.701 . . . . 0.0 109.829 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.474 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 79.3 mt-30 -112.94 134.44 54.45 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.584 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 6.1 t70 -82.7 144.09 30.48 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.726 HG23 ' HG3' ' A' ' 249' ' ' GLU . 9.2 m -98.61 150.16 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.343 -174.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.67 76.39 2.04 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 169.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.726 ' HG3' HG23 ' A' ' 247' ' ' VAL . 9.7 mp0 -53.55 -39.9 65.1 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.191 0.596 . . . . 0.0 111.443 -167.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 49.2 t -51.54 -33.98 34.51 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.932 0.396 . . . . 0.0 111.284 175.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -98.67 -46.38 5.72 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.738 0.78 . . . . 0.0 110.05 -174.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.668 ' HB1' HD21 ' A' ' 208' ' ' LEU . . . -66.63 -21.55 66.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.813 -177.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.581 HG22 ' HB3' ' A' ' 256' ' ' LEU . 3.7 mp -120.39 79.56 28.64 Favored Pre-proline 0 N--CA 1.445 -0.716 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 175.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.446 ' CG ' HG13 ' A' ' 202' ' ' ILE . 0.1 OUTLIER -21.61 -29.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 1 C-N-CA 128.256 5.97 . . . . 0.0 120.032 -164.204 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 255' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 253' ' ' ILE . . . -172.06 39.03 0.16 Allowed Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 119.265 -1.445 . . . . 0.0 111.915 -175.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.581 ' HB3' HG22 ' A' ' 253' ' ' ILE . 2.2 pt? -70.57 -49.65 45.62 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 119.879 -0.728 . . . . 0.0 111.287 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' CYS . . . . . 0.557 ' H ' HD23 ' A' ' 256' ' ' LEU . 47.5 t -124.28 133.49 53.47 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 120.839 0.352 . . . . 0.0 110.086 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -134.77 -89.11 0.35 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.934 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 71.34 -71.49 0.81 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.838 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -152.81 -78.48 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' ASN . . . . . 0.548 ' HB3' ' HB2' ' A' ' 272' ' ' LYS . 3.9 t-20 -101.47 147.31 26.51 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 177.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 15.0 p -137.56 140.74 41.21 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 6.9 mt -144.62 166.16 12.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -170.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.61 ' ND2' ' HB3' ' A' ' 269' ' ' PHE . 0.8 OUTLIER -131.45 132.91 44.67 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 118.673 -1.211 . . . . 0.0 112.938 177.901 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 268' ' ' SER . 0.8 OUTLIER -114.85 161.05 18.75 Favored 'General case' 0 C--O 1.256 1.406 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.905 162.458 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.537 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 33.5 m -72.17 124.31 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.449 ' HA2' ' HE1' ' A' ' 235' ' ' PHE . . . 112.97 -29.5 8.03 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.057 -1.068 . . . . 0.0 112.895 -170.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.421 ' O ' HG23 ' A' ' 265' ' ' THR . 39.5 t 173.01 156.62 0.1 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 117.912 0.856 . . . . 0.0 109.465 -170.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 269' ' ' PHE . . . . . 0.61 ' HB3' ' ND2' ' A' ' 264' ' ' ASN . 40.2 p90 -98.43 161.4 13.7 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 121.832 -0.542 . . . . 0.0 110.029 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -114.93 141.18 48.31 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' CYS . . . . . 0.423 ' HB2' HD22 ' A' ' 279' ' ' LEU . 95.5 m -124.83 161.53 26.31 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.472 0.653 . . . . 0.0 111.493 175.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.548 ' HB2' ' HB3' ' A' ' 261' ' ' ASN . 61.1 mttp -140.39 109.52 6.13 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.592 173.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 273' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 286' ' ' CYS . 3.9 m -91.78 163.34 28.27 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.361 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 51.3 Cg_exo -53.91 158.61 8.47 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.564 2.176 . . . . 0.0 111.473 174.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -57.13 145.06 32.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 86.55 -30.89 4.36 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -173.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' HIS . . . . . 0.63 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 27.3 m-70 -89.08 173.64 8.33 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.001 0.429 . . . . 0.0 110.833 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' LYS . . . . . 0.667 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 95.6 mttt -162.38 153.19 17.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.903 -174.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.449 HD13 ' SG ' ' A' ' 257' ' ' CYS . 65.6 tp -87.57 136.82 32.79 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.45 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -126.6 101.23 6.56 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -63.4 -18.09 63.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.382 -174.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.509 ' HA ' ' NH2' ' A' ' 215' ' ' ARG . 93.9 t -57.08 -33.08 41.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.59 177.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 31.9 m -147.24 35.4 0.89 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.577 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 29.68 49.49 0.06 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.45 1.1 . . . . 0.0 113.368 -175.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 78.5 tttt -108.16 162.1 14.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.139 0.495 . . . . 0.0 111.768 -173.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 286' ' ' CYS . . . . . 0.667 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 40.4 m -129.63 102.79 6.51 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 18.1 tt0 . . . . . 0 C--O 1.243 0.756 0 CA-C-O 118.554 -0.736 . . . . 0.0 109.855 -173.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 120.958 0.409 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.36 -17.85 16.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.142 0.496 . . . . 0.0 110.96 178.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.0 t -94.31 93.53 7.77 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.102 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 74.0 mtm180 -86.76 79.96 8.67 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 177.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.5 p -85.11 -65.88 0.96 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.761 0.315 . . . . 0.0 111.569 -176.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 66.0 mt -108.73 -44.9 6.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.197 -176.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -64.75 97.96 0.25 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.955 -176.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -138.12 36.39 2.33 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 172.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 129' ' ' CYS . 5.7 p -159.02 -179.88 8.44 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.559 -164.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -110.47 -40.24 4.69 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.11 173.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.538 HD12 ' O ' ' A' ' 132' ' ' ASP . 0.2 OUTLIER -68.1 -172.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.341 -1.299 . . . . 0.0 113.143 -178.278 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.532 ' H ' ' HD2' ' A' ' 122' ' ' ARG . 0.3 OUTLIER -128.98 144.87 51.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.762 -174.858 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 20.4 m -116.19 161.61 18.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.855 0.836 . . . . 0.0 112.118 -175.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 12.1 mmm -161.66 161.7 29.61 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 64.62 50.29 2.16 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.365 0.603 . . . . 0.0 111.632 171.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.639 ' HA3' ' OE1' ' A' ' 137' ' ' GLN . . . 62.44 34.24 88.78 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.613 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.649 ' HA3' ' SG ' ' A' ' 134' ' ' CYS . . . -87.53 148.31 21.12 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.104 -1.046 . . . . 0.0 113.151 -176.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.1 m -115.3 150.21 36.62 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 172.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 119' ' ' CYS . 6.4 m -78.36 77.6 4.85 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -174.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.87 178.93 0.3 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.712 171.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -50.59 -6.95 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 -167.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.538 ' O ' HD12 ' A' ' 121' ' ' ILE . 13.9 t70 173.66 -31.79 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -172.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 8.0 p-80 -105.32 -168.51 1.47 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.816 174.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.649 ' SG ' ' HA3' ' A' ' 127' ' ' GLY . 22.4 t -116.39 152.53 33.76 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.633 176.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.608 ' O ' ' HA2' ' A' ' 127' ' ' GLY . 69.4 mt -88.9 112.4 23.25 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' CYS . . . . . 0.727 ' SG ' ' HB2' ' A' ' 140' ' ' TYR . 9.3 t -91.95 145.59 24.42 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.275 -169.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.639 ' OE1' ' HA3' ' A' ' 126' ' ' GLY . 33.3 mt-30 -97.49 -164.61 1.16 Allowed 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.628 0.728 . . . . 0.0 112.156 -177.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -50.19 134.42 22.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.386 -1.279 . . . . 0.0 113.917 -171.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 54.31 16.86 7.17 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 112.746 -2.025 . . . . 0.0 114.791 177.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.727 ' HB2' ' SG ' ' A' ' 136' ' ' CYS . 23.9 m-85 -116.43 150.07 38.42 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 118.249 1.024 . . . . 0.0 111.664 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.412 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 28.8 pt -133.44 -178.13 2.49 Favored 'Isoleucine or valine' 0 C--O 1.251 1.139 0 O-C-N 124.234 0.958 . . . . 0.0 109.588 172.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.19 163.74 34.77 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.711 -178.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.0 p -76.88 -22.42 53.48 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.883 0.373 . . . . 0.0 111.604 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -97.32 -6.74 33.63 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 13.1 t 67.9 14.48 9.4 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.817 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -89.64 4.78 83.85 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.924 -173.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.44 ' O ' ' HA ' ' A' ' 140' ' ' TYR . 2.3 tm0? -105.7 118.85 54.35 Favored Pre-proline 0 C--O 1.219 -0.533 0 CA-C-N 117.69 0.745 . . . . 0.0 111.126 -176.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -87.22 140.23 5.48 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.695 2.263 . . . . 0.0 112.537 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 149' ' ' VAL . 8.3 p -69.92 105.97 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 122.293 1.044 . . . . 0.0 111.934 -176.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.94 78.73 5.37 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.421 175.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -53.24 -70.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.606 -1.179 . . . . 0.0 113.924 -172.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.5 m -90.91 12.46 19.44 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.658 0.742 . . . . 0.0 111.17 -169.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 72.47 127.87 0.1 OUTLIER Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 114.161 -1.381 . . . . 0.0 111.713 -175.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.579 ' O ' HD23 ' A' ' 155' ' ' LEU . 62.0 m -72.98 164.44 26.67 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.197 -1.002 . . . . 0.0 108.96 175.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.579 HD23 ' O ' ' A' ' 154' ' ' CYS . 62.6 mt -143.52 -178.49 5.91 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -166.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.554 ' HB2' ' CZ ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 44.44 24.48 0.09 Allowed 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 177.804 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 69.73 28.7 71.78 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.86 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -82.18 -138.7 2.88 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.306 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 166' ' ' CYS . 0.0 OUTLIER -166.25 140.68 4.37 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 117.396 0.598 . . . . 0.0 109.984 -179.192 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.97 110.98 13.37 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.319 0.581 . . . . 0.0 109.907 171.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 165' ' ' ARG . 2.5 m -99.67 -30.33 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.476 -176.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.582 ' HB3' ' CB ' ' A' ' 165' ' ' ARG . . . -140.36 171.73 7.33 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.462 ' HD2' ' HB1' ' A' ' 162' ' ' ALA . 96.6 Cg_exo -48.64 96.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.499 2.133 . . . . 0.0 113.229 177.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 42.0 t30 69.03 15.28 8.82 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.726 0.774 . . . . 0.0 109.997 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.582 ' CB ' ' HB3' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -100.74 86.5 3.12 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.793 172.224 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 60.0 m -82.75 138.37 34.06 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.016 171.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.72 131.81 34.35 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 171.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.435 ' HA ' HD21 ' A' ' 156' ' ' ASN . 72.8 m -115.28 138.27 51.13 Favored 'General case' 0 C--N 1.315 -0.916 0 O-C-N 123.876 0.735 . . . . 0.0 111.474 -170.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 39.6 m -50.37 -55.04 17.38 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.681 -168.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -162.74 -86.29 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 118.578 -1.249 . . . . 0.0 113.516 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -93.83 51.97 2.28 Favored Glycine 0 CA--C 1.489 -1.583 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.003 -164.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.692 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 1.7 m-85 -121.07 134.49 55.27 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 118.563 -1.255 . . . . 0.0 112.841 173.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.89 HG23 ' CE2' ' A' ' 181' ' ' TYR . 8.7 p -87.89 123.61 32.82 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.718 177.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' A' ' 176' ' ' GLN . . . 104.75 133.56 7.79 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 108.991 -1.643 . . . . 0.0 108.991 -175.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.49 12.81 0.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.747 1.631 . . . . 0.0 112.896 -170.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.51 ' O ' HD12 ' A' ' 155' ' ' LEU . 15.7 tt0 -121.95 16.81 10.91 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.246 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.657 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.5 OUTLIER 33.65 69.42 0.14 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 175.578 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -117.41 7.15 12.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.634 0.731 . . . . 0.0 110.509 172.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.692 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 21.4 mmt85 -117.49 89.62 3.16 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.2 -178.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -80.35 54.16 1.95 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.614 -170.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.89 ' CE2' HG23 ' A' ' 173' ' ' THR . 18.7 p90 -84.42 78.38 9.83 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -77.2 140.22 40.08 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 118.976 -2.327 . . . . 0.0 107.682 -178.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 67.0 p -83.73 136.25 34.25 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.168 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.45 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -156.16 160.83 30.39 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -80.51 129.52 7.46 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.592 2.195 . . . . 0.0 111.554 175.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.775 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 83.2 m -85.8 118.44 25.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.193 0.52 . . . . 0.0 110.589 177.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' PHE . . . . . 0.595 ' O ' ' HB2' ' A' ' 215' ' ' ARG . 9.2 m-85 -94.72 150.07 20.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.972 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.444 ' HA ' ' CB ' ' A' ' 215' ' ' ARG . 21.7 p -108.5 -1.8 19.46 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 28.3 m -141.62 174.37 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.623 HD11 ' HB2' ' A' ' 216' ' ' ALA . 12.8 mm -122.15 114.21 41.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.867 0.842 . . . . 0.0 111.327 176.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.488 ' HB3' ' C ' ' A' ' 194' ' ' MET . 30.1 t -143.16 127.93 18.23 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.198 175.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -63.87 -20.75 66.06 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 171.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.46 ' HB3' ' OG ' ' A' ' 191' ' ' SER . 53.0 tt0 -71.23 -69.36 0.38 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.339 169.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.488 ' C ' ' HB3' ' A' ' 191' ' ' SER . 64.2 mtt -151.39 101.88 2.86 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 176.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 187' ' ' PHE . 39.7 m -64.83 -24.76 67.64 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 122.201 0.2 . . . . 0.0 110.737 172.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.503 ' HB2' ' HA ' ' A' ' 187' ' ' PHE . 7.7 mm-40 142.22 -139.52 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 126.959 2.104 . . . . 0.0 107.561 177.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.427 ' H ' ' HB3' ' A' ' 196' ' ' GLN . . . 84.02 -50.12 4.35 Favored Glycine 0 C--N 1.332 0.35 0 N-CA-C 115.146 0.818 . . . . 0.0 115.146 170.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -72.36 29.01 0.05 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -171.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.547 ' N ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -156.87 18.22 0.31 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.933 0.397 . . . . 0.0 110.272 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 32.2 t -153.38 135.23 14.59 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.27 0.557 . . . . 0.0 111.115 -175.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -102.37 29.73 11.88 Favored Glycine 0 CA--C 1.502 -0.778 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 173.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.626 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -64.32 104.05 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-O 122.008 0.909 . . . . 0.0 109.425 176.497 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.32 99.05 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-O 122.42 1.105 . . . . 0.0 110.283 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.3 t -123.19 -178.27 3.93 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 113.241 -1.799 . . . . 0.0 106.724 169.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.8 p -100.76 164.4 11.88 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.385 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.613 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 45.5 tttm -60.6 -46.16 91.29 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.44 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.1 m -43.95 -56.23 4.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.88 174.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.568 ' CD1' HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -55.68 -57.47 11.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.53 179.296 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 40.0 m -72.5 -17.4 61.75 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -170.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 66.3 m -92.39 -31.61 15.26 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.021 175.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -70.84 -61.67 1.68 Allowed 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.737 HG22 ' HA2' ' A' ' 234' ' ' GLY . 32.4 p -92.26 152.52 19.78 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.105 174.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.1 t 70.3 -43.8 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.618 ' O ' ' HD2' ' A' ' 215' ' ' ARG . . . 55.97 61.97 6.85 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 115.767 1.067 . . . . 0.0 115.767 170.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.618 ' HD2' ' O ' ' A' ' 214' ' ' GLY . 14.4 mmm180 -126.43 -82.25 0.62 Allowed 'General case' 0 C--O 1.237 0.44 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.888 176.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.623 ' HB2' HD11 ' A' ' 190' ' ' ILE . . . -169.11 166.74 10.8 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' TRP . . . . . 0.775 ' HD1' ' SG ' ' A' ' 186' ' ' CYS . 11.6 t90 -159.12 149.42 19.37 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 121.23 -0.919 . . . . 0.0 109.461 -175.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 221' ' ' CYS . . . 87.13 156.68 29.9 Favored Glycine 0 C--O 1.223 -0.542 0 C-N-CA 120.363 -0.922 . . . . 0.0 114.695 168.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.618 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 17.0 p80 -130.57 135.46 27.42 Favored Pre-proline 0 C--O 1.236 0.354 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.618 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 31.6 Cg_exo -59.31 143.37 29.79 Favored 'Cis proline' 0 N--CA 1.477 0.552 0 C-N-CA 124.16 -1.183 . . . . 0.0 111.71 -0.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 43.0 t -41.86 117.77 1.0 Allowed 'General case' 0 N--CA 1.464 0.257 0 O-C-N 124.222 0.951 . . . . 0.0 112.868 -170.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.45 ' HB3' ' HE3' ' A' ' 206' ' ' LYS . 22.9 mt-10 -109.41 120.25 41.95 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -80.29 148.28 30.8 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -176.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 5.8 m -85.4 123.34 73.09 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -172.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.2 167.56 19.89 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.394 2.73 . . . . 0.0 110.847 167.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -39.74 -60.06 1.05 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.12 -172.75 0.33 Allowed Pre-proline 0 N--CA 1.431 -1.418 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 -173.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -84.75 -98.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.801 1.667 . . . . 0.0 110.7 172.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.436 ' CG ' ' HG3' ' A' ' 237' ' ' PRO . 20.0 m-70 -84.24 166.77 31.33 Favored Pre-proline 0 CA--C 1.513 -0.473 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 169.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.12 65.52 4.25 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.852 1.702 . . . . 0.0 113.162 -176.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 64.2 m -106.2 -173.88 2.4 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 170.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.733 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 86.3 mtt180 -67.75 147.57 52.44 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 119.701 -0.799 . . . . 0.0 108.927 172.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -37.92 -49.98 1.27 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 178.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.737 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -79.33 12.44 26.2 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.605 -0.807 . . . . 0.0 114.833 -174.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' PHE . . . . . 0.733 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 2.3 m-85 -122.86 146.82 47.22 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 122.093 0.949 . . . . 0.0 113.21 -172.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.462 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.0 OUTLIER -124.87 132.74 24.36 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 114.098 -1.41 . . . . 0.0 107.967 170.543 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.436 ' HG3' ' CG ' ' A' ' 229' ' ' HIS . 18.1 Cg_endo -60.38 118.85 5.77 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.13 1.887 . . . . 0.0 111.721 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -52.29 136.85 30.01 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 121.727 0.775 . . . . 0.0 110.582 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 33.2 mt -70.93 -16.37 19.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.404 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 240' ' ' ARG . 42.0 mtm105 -102.52 -63.32 1.17 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.29 0.567 . . . . 0.0 110.248 -176.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 40.5 p -79.34 -38.46 35.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.75 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 94.89 5.41 61.11 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -176.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -86.67 124.36 32.85 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 121.935 0.874 . . . . 0.0 109.121 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 235' ' ' PHE . 13.0 m -57.92 123.13 14.77 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 113.403 -1.726 . . . . 0.0 110.479 178.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 80.7 mm-40 -119.39 142.85 47.82 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.569 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 8.5 t70 -77.85 147.53 35.11 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.721 HG23 ' HG3' ' A' ' 249' ' ' GLU . 15.9 m -94.17 142.88 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.094 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.212 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -70.07 77.5 0.5 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 164.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.721 ' HG3' HG23 ' A' ' 247' ' ' VAL . 20.5 mp0 -52.7 -35.6 55.83 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 123.525 0.515 . . . . 0.0 110.498 -173.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 33.1 m -55.01 -29.33 57.12 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.176 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -103.93 -43.74 5.21 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.923 0.868 . . . . 0.0 109.7 -175.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.34 -22.1 64.71 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.024 -1.444 . . . . 0.0 111.286 -175.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.764 HG22 ' HB3' ' A' ' 256' ' ' LEU . 64.2 mt -131.34 75.61 77.17 Favored Pre-proline 0 N--CA 1.447 -0.603 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -13.04 -91.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.039 1 C-N-CA 126.106 4.537 . . . . 0.0 115.749 -162.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -119.69 59.41 0.53 Allowed Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 119.641 -1.266 . . . . 0.0 111.872 177.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.764 ' HB3' HG22 ' A' ' 253' ' ' ILE . 2.3 pt? -63.97 -38.91 92.79 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.139 177.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 45.8 t -104.86 107.36 18.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.492 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -116.68 35.69 4.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.903 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.678 ' HA3' ' SG ' ' A' ' 286' ' ' CYS . . . -87.96 -9.04 71.58 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.592 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 145.21 -100.11 0.22 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' ASN . . . . . 0.598 ' HB2' ' HB2' ' A' ' 272' ' ' LYS . 11.2 m120 -89.09 158.01 18.12 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.733 0.301 . . . . 0.0 110.778 177.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.71 132.73 14.29 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 10.7 mt -142.34 165.46 16.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -173.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.93 126.53 43.39 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 118.556 -1.258 . . . . 0.0 113.525 -175.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 4.6 t -115.55 167.78 10.59 Favored 'General case' 0 C--O 1.258 1.52 0 CA-C-O 122.243 1.021 . . . . 0.0 110.322 162.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.547 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 30.4 m -71.11 131.27 34.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.849 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.555 ' CA ' ' HE2' ' A' ' 235' ' ' PHE . . . 88.95 -9.79 75.28 Favored Glycine 0 N--CA 1.423 -2.201 0 CA-C-O 119.264 -0.742 . . . . 0.0 113.527 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 48.3 t -179.51 150.03 0.41 Allowed 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 117.838 0.819 . . . . 0.0 111.255 -172.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -107.31 156.53 18.78 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.89 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -108.27 128.88 55.12 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.961 -176.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' CYS . . . . . 0.421 ' HB2' HD22 ' A' ' 279' ' ' LEU . 54.9 m -120.56 160.38 23.32 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.313 0.578 . . . . 0.0 111.081 176.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.598 ' HB2' ' HB2' ' A' ' 261' ' ' ASN . 6.9 mtpm? -140.54 124.52 17.37 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.193 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 3.7 m -98.36 170.72 6.64 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 175.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 34.5 Cg_exo -58.31 156.18 31.7 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.567 1.511 . . . . 0.0 110.611 170.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -59.34 149.39 29.15 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.25 -33.26 3.19 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.113 -174.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' HIS . . . . . 0.473 ' HB2' ' O ' ' A' ' 274' ' ' PRO . 9.2 m170 -78.69 167.37 21.32 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 120.987 0.422 . . . . 0.0 110.69 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 278' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 67.1 mttm -140.22 139.15 35.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.227 -179.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.485 HD12 ' O ' ' A' ' 285' ' ' LYS . 21.4 tp -81.71 143.98 31.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.041 0.448 . . . . 0.0 110.75 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -124.55 98.46 5.74 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -68.04 -12.83 61.54 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -174.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 42.7 t -66.24 -25.42 35.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.252 0.548 . . . . 0.0 110.266 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 10.3 p -148.05 28.87 0.91 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.618 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 0.402 ' HG3' ' HG ' ' A' ' 256' ' ' LEU . 13.8 mm100 30.06 49.57 0.07 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.709 -1.132 . . . . 0.0 113.16 -171.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 285' ' ' LYS . . . . . 0.485 ' O ' HD12 ' A' ' 279' ' ' LEU . 97.9 mttt -102.65 175.65 5.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.754 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 286' ' ' CYS . . . . . 0.678 ' SG ' ' HA3' ' A' ' 259' ' ' GLY . 92.9 m -141.81 170.41 15.77 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 173.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.643 ' HB2' ' O ' ' A' ' 286' ' ' CYS . 2.4 mp0 . . . . . 0 C--O 1.25 1.099 0 C-N-CA 124.319 1.048 . . . . 0.0 109.408 170.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 39.8 t . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 121.102 0.477 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.9 30.28 7.42 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -176.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.1 m -82.83 15.27 2.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.545 0.688 . . . . 0.0 109.907 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.1 mtm180 -128.96 138.25 51.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.644 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 43.1 t -78.05 132.18 37.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.752 0.311 . . . . 0.0 110.722 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.8 pt -73.67 -11.33 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.246 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -72.98 -11.67 60.66 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.597 0.713 . . . . 0.0 109.691 174.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -97.6 35.84 1.6 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.743 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 39.0 t -159.24 140.51 12.95 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.872 -176.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.569 ' OD1' HG23 ' A' ' 121' ' ' ILE . 29.0 p-10 -122.55 -31.16 3.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.824 0.821 . . . . 0.0 110.322 175.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.569 HG23 ' OD1' ' A' ' 120' ' ' ASN . 0.2 OUTLIER -91.77 -164.18 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 122.075 0.94 . . . . 0.0 113.246 -176.673 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.536 ' HD2' ' N ' ' A' ' 122' ' ' ARG . 4.3 mpt_? -114.7 126.06 54.44 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.013 -178.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.494 ' SG ' ' HA ' ' A' ' 129' ' ' CYS . 65.2 m -116.55 117.05 28.8 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -114.53 165.74 12.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.268 -176.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 66.96 42.77 2.37 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.076 0.465 . . . . 0.0 110.889 173.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.451 ' O ' ' HG2' ' A' ' 137' ' ' GLN . . . 75.66 22.17 75.53 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.467 -178.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -73.36 124.1 8.7 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 -176.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.474 ' HB2' ' HB2' ' A' ' 135' ' ' LEU . 19.1 m -91.99 126.31 37.02 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.494 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 9.1 m -58.76 147.99 31.24 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 122.366 1.079 . . . . 0.0 113.668 -173.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.59 ' HB2' ' O ' ' A' ' 133' ' ' HIS . 50.8 m -142.73 169.86 16.78 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 173.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.408 ' HB3' ' H ' ' A' ' 132' ' ' ASP . 15.1 t70 -38.61 -89.51 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 O-C-N 124.397 1.061 . . . . 0.0 112.206 176.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.408 ' H ' ' HB3' ' A' ' 131' ' ' ASP . 33.1 t70 -82.98 -42.43 17.58 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.983 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.59 ' O ' ' HB2' ' A' ' 130' ' ' SER . 0.3 OUTLIER -108.98 -167.81 1.26 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -176.397 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 59.9 m -122.99 153.03 40.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.004 177.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.474 ' HB2' ' HB2' ' A' ' 128' ' ' SER . 97.2 mt -92.51 120.47 33.01 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 74.5 m -84.93 153.95 22.51 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.403 -169.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 126' ' ' GLY . 26.7 mm-40 -81.86 148.16 28.95 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 169.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -63.16 111.44 2.22 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 123.1 1.428 . . . . 0.0 111.929 -174.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 125.65 -4.34 8.08 Favored Glycine 0 N--CA 1.431 -1.683 0 CA-C-N 112.327 -2.215 . . . . 0.0 111.441 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.667 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 97.9 m-85 -119.58 145.81 46.06 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.157 0.504 . . . . 0.0 110.376 173.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.484 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 40.6 pt -131.08 175.03 12.14 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.312 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 101.29 174.18 28.68 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.851 -177.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.3 p -73.54 -31.61 63.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.316 0.579 . . . . 0.0 111.45 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -110.87 7.05 21.7 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.411 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 34.1 m 63.91 37.49 9.48 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 124.204 0.94 . . . . 0.0 111.181 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -93.62 -7.09 61.92 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.906 -176.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.484 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 2.0 tm0? -103.27 112.72 65.9 Favored Pre-proline 0 C--N 1.327 -0.404 0 O-C-N 122.121 -0.635 . . . . 0.0 110.704 -177.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.67 142.45 14.34 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.342 2.695 . . . . 0.0 112.614 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 149' ' ' VAL . 8.9 p -73.15 107.73 3.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 122.504 1.145 . . . . 0.0 111.284 -178.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.86 88.03 5.29 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.298 175.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.34 -68.04 0.27 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -175.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 16.7 m -95.71 13.37 26.66 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.824 0.345 . . . . 0.0 111.628 -166.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.23 123.95 0.91 Allowed Glycine 0 N--CA 1.438 -1.221 0 CA-C-O 121.819 0.677 . . . . 0.0 113.066 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.437 ' O ' HD23 ' A' ' 155' ' ' LEU . 80.4 m -81.14 162.23 23.75 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 172.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.621 HD12 ' O ' ' A' ' 176' ' ' GLN . 79.9 mt -148.22 167.27 25.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 118.04 0.382 . . . . 0.0 110.88 -162.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.605 ' HB2' ' CZ ' ' A' ' 172' ' ' PHE . 10.0 t30 48.31 23.72 0.6 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.327 -164.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 66.0 39.36 94.79 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.256 -0.974 . . . . 0.0 111.774 -177.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.62 -138.16 0.21 Allowed Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.772 -0.727 . . . . 0.0 111.313 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 13.1 ttt180 -159.47 128.99 5.41 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.08 -0.659 . . . . 0.0 111.221 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.4 m -62.91 119.99 10.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.59 0.233 . . . . 0.0 110.691 173.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 165' ' ' ARG . 16.7 m -105.68 -35.84 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.947 0.403 . . . . 0.0 110.546 178.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.75 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -139.93 170.55 9.56 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.667 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 76.6 Cg_exo -51.58 109.17 0.29 Allowed 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.208 1.939 . . . . 0.0 112.133 174.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 72.96 -3.07 2.52 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.36 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.75 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.9 OUTLIER -90.92 86.35 6.26 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.516 175.857 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 72.6 m -78.65 141.07 38.27 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.234 171.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.439 ' HB2' ' CG1' ' A' ' 161' ' ' VAL . . . -97.79 117.54 32.34 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 172.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 83.0 m -101.18 141.17 34.45 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.036 -170.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 7.0 m -51.11 -53.9 29.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -168.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -167.68 -84.72 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.36 -0.936 . . . . 0.0 113.227 -172.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -90.94 55.91 3.32 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.325 -167.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.674 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 7.0 m-85 -127.11 137.57 53.02 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.509 169.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.679 HG23 ' CE2' ' A' ' 181' ' ' TYR . 64.4 p -87.15 123.79 32.57 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.094 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 102.09 139.84 10.78 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.05 7.82 1.59 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 121.143 1.229 . . . . 0.0 112.449 -172.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.621 ' O ' HD12 ' A' ' 155' ' ' LEU . 18.9 tt0 -119.47 26.1 9.63 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.294 176.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.572 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.7 OUTLIER 23.89 72.72 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 118.693 2.849 . . . . 0.0 118.693 170.614 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.418 ' O ' ' HD3' ' A' ' 179' ' ' ARG . 9.9 pt-20 -124.96 29.8 6.05 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.103 -0.998 . . . . 0.0 110.929 169.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.674 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 23.9 mmt180 -130.2 93.0 3.38 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.168 175.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.427 ' HA ' ' CE1' ' A' ' 172' ' ' PHE . 3.7 m-20 -78.07 53.14 1.16 Allowed 'General case' 0 C--N 1.323 -0.55 0 O-C-N 123.402 0.439 . . . . 0.0 111.189 -169.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.75 ' HA ' HG21 ' A' ' 205' ' ' THR . 16.2 p90 -84.4 80.43 9.22 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -82.75 135.12 35.08 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 119.761 -1.837 . . . . 0.0 108.609 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 70.3 p -77.06 171.04 15.44 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.463 ' HA3' ' CE2' ' A' ' 217' ' ' TRP . . . 157.18 136.04 2.04 Favored Glycine 0 C--N 1.32 -0.322 0 C-N-CA 119.669 -1.253 . . . . 0.0 112.359 -163.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.489 ' HG2' ' CD2' ' A' ' 219' ' ' HIS . 16.6 Cg_exo -69.62 128.23 15.86 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.133 1.889 . . . . 0.0 111.531 172.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.715 ' SG ' ' HD2' ' A' ' 215' ' ' ARG . 16.5 t -102.18 114.28 28.29 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.474 0.654 . . . . 0.0 110.68 -178.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' PHE . . . . . 0.658 ' O ' ' HB3' ' A' ' 215' ' ' ARG . 16.8 m-85 -93.62 143.43 26.31 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.262 -177.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.467 ' HA ' ' HB3' ' A' ' 215' ' ' ARG . 2.4 m -96.23 -27.73 14.87 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -162.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.1 p -163.2 118.79 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.628 -171.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.634 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.4 mt -125.51 118.8 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 122.182 0.992 . . . . 0.0 113.486 -168.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.418 ' C ' ' H ' ' A' ' 193' ' ' GLN . 36.2 t -116.15 -164.56 0.97 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 113.766 -1.561 . . . . 0.0 106.934 163.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -63.87 -5.71 4.81 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.718 0.77 . . . . 0.0 110.008 170.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.418 ' H ' ' C ' ' A' ' 191' ' ' SER . 96.3 mt-30 -69.84 -75.76 0.11 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.847 -178.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 46.0 ttm -171.2 151.37 3.15 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.957 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.634 ' HA ' HG12 ' A' ' 190' ' ' ILE . 72.8 m -57.43 -46.11 83.92 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 121.73 0.776 . . . . 0.0 110.91 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -151.54 -81.22 0.1 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 166.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.44 -24.33 6.91 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.569 172.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -131.14 45.3 2.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.393 0.616 . . . . 0.0 109.43 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 26.3 tp -169.82 132.76 1.17 Allowed 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.572 -173.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 34.7 t -149.04 -47.46 0.14 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.753 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.84 26.62 10.47 Favored Glycine 0 C--O 1.228 -0.225 0 C-N-CA 120.752 -0.737 . . . . 0.0 114.333 -171.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.487 ' O ' HD13 ' A' ' 202' ' ' ILE . 0.0 OUTLIER -79.29 91.58 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 165.424 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.49 112.47 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 CA-C-O 122.935 1.35 . . . . 0.0 110.171 -171.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 6.1 t -155.64 -178.74 7.5 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.75 HG21 ' HA ' ' A' ' 181' ' ' TYR . 17.8 p -106.35 171.5 7.32 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 120.883 1.674 . . . . 0.0 110.649 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.806 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 34.0 tttm -59.88 -47.43 85.77 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.777 175.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.9 m -45.21 -55.59 5.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.956 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.512 HD11 HG11 ' A' ' 247' ' ' VAL . 0.3 OUTLIER -58.73 -48.76 80.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.257 178.249 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 97.2 m -61.18 -38.81 87.83 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 227' ' ' GLN . 56.5 m -83.86 -37.19 22.77 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 121.65 -0.656 . . . . 0.0 111.249 -176.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ALA . . . . . 0.5 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . . . -68.14 -57.69 5.66 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.695 HG22 ' HA2' ' A' ' 234' ' ' GLY . 30.5 p -104.05 144.16 31.92 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.152 -175.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.0 t 64.06 -22.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 63.55 51.86 50.85 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 120.435 1.47 . . . . 0.0 114.028 167.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.715 ' HD2' ' SG ' ' A' ' 186' ' ' CYS . 27.1 mtt85 -103.09 -123.03 0.19 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.797 0.808 . . . . 0.0 111.307 -178.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.574 ' HB3' HD11 ' A' ' 190' ' ' ILE . . . -156.8 168.52 27.21 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' TRP . . . . . 0.806 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 36.6 t90 -161.77 149.74 14.94 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 119.365 0.984 . . . . 0.0 111.188 -170.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 85.09 170.12 46.81 Favored Glycine 0 C--O 1.229 -0.186 0 N-CA-C 115.081 0.792 . . . . 0.0 115.081 170.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.584 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 85.8 m-70 -127.23 133.04 24.63 Favored Pre-proline 0 N--CA 1.457 -0.117 0 C-N-CA 122.949 0.5 . . . . 0.0 109.879 171.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.584 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 18.9 Cg_endo -58.73 157.67 36.99 Favored 'Cis proline' 0 C--O 1.236 0.393 0 C-N-CA 123.261 -1.558 . . . . 0.0 112.373 -4.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 33.2 t -53.41 115.56 1.99 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.586 -174.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 27.5 mt-10 -105.39 102.76 12.21 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' MET . . . . . 0.585 ' O ' ' HD3' ' A' ' 225' ' ' PRO . 1.3 tpt -79.09 132.42 36.59 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -175.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' CYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 215' ' ' ARG . 92.7 m -83.29 112.58 40.06 Favored Pre-proline 0 C--N 1.332 -0.154 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -172.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.585 ' HD3' ' O ' ' A' ' 223' ' ' MET . 6.1 Cg_exo -81.41 124.92 4.9 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.598 2.865 . . . . 0.0 111.054 169.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 48.25 -79.16 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.899 0.88 . . . . 0.0 113.228 -174.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 225' ' ' PRO . 0.0 OUTLIER -162.27 -171.54 0.28 Allowed Pre-proline 0 N--CA 1.441 -0.903 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -168.317 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 211' ' ' ALA . 6.9 Cg_endo -87.85 -90.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 121.835 1.69 . . . . 0.0 111.478 170.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -87.66 158.12 51.48 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 172.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.02 61.87 7.8 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.19 1.927 . . . . 0.0 114.593 -171.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 92.2 m -110.39 -177.94 3.37 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 169.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.643 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 31.1 mmt180 -62.72 140.63 58.74 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 173.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -37.33 -50.72 1.05 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.695 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -70.1 1.14 19.45 Favored Glycine 0 C--N 1.313 -0.728 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.72 -174.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' PHE . . . . . 0.643 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 11.3 m-85 -123.17 151.32 42.3 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.159 0.981 . . . . 0.0 113.324 -169.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.436 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.1 OUTLIER -127.32 128.7 24.02 Favored Pre-proline 0 N--CA 1.436 -1.143 0 CA-C-N 114.082 -1.417 . . . . 0.0 108.259 169.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.92 125.17 14.25 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.533 2.156 . . . . 0.0 111.802 178.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -62.61 136.64 57.98 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 35.5 pt -82.78 2.32 3.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.584 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -103.12 -57.37 2.05 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.853 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 52.3 p -89.06 -45.9 9.26 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.5 -178.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 103.06 11.02 35.35 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -96.17 125.23 40.55 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 121.95 0.881 . . . . 0.0 109.992 -177.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 4.3 m -59.06 122.56 14.06 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.832 172.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 75.5 mm-40 -123.37 137.9 54.72 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.542 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 6.1 t70 -75.32 147.21 40.33 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-O 121.283 0.563 . . . . 0.0 110.001 -176.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.62 HG23 ' HG3' ' A' ' 249' ' ' GLU . 11.4 m -93.53 144.27 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.426 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.48 ' HA ' ' ND2' ' A' ' 264' ' ' ASN . 7.0 m-20 -75.03 77.28 2.22 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 168.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.62 ' HG3' HG23 ' A' ' 247' ' ' VAL . 36.2 mp0 -52.42 -35.73 52.7 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.651 0.739 . . . . 0.0 110.515 -171.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 9.5 m -53.39 -33.47 53.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.877 175.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -99.1 -37.42 9.34 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.78 0.8 . . . . 0.0 110.101 -177.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.23 -19.02 63.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.753 -175.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.403 HG12 HH22 ' A' ' 215' ' ' ARG . 3.2 mp -126.66 117.18 22.68 Favored Pre-proline 0 N--CA 1.446 -0.637 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 174.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -35.79 -91.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.483 0.911 1 C-N-CA 125.345 4.03 . . . . 0.0 114.39 -165.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -100.36 56.59 0.8 Allowed Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.406 171.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.409 ' O ' ' HG3' ' A' ' 284' ' ' GLN . 22.6 tp -40.3 -65.33 0.42 Allowed 'General case' 0 C--O 1.224 -0.273 0 O-C-N 124.465 0.744 . . . . 0.0 112.894 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 257' ' ' CYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 262' ' ' CYS . 11.3 t -87.62 62.72 7.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.104 0.478 . . . . 0.0 109.857 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -60.4 104.33 0.32 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.55 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 131.92 -17.35 4.92 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.764 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -150.78 -157.85 8.0 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.032 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -108.54 121.55 45.21 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 269' ' ' PHE . 52.6 t -92.14 133.55 35.68 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 176.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 39.3 mt -132.24 112.51 19.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.442 0.639 . . . . 0.0 110.075 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.48 ' ND2' ' HA ' ' A' ' 248' ' ' ASP . 66.1 t30 -74.13 126.44 30.57 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -170.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 6.2 t -113.35 164.91 12.98 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.021 154.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.542 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 30.7 m -69.97 132.2 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 118.705 -1.198 . . . . 0.0 108.899 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.502 ' CA ' ' HE2' ' A' ' 235' ' ' PHE . . . 88.53 -10.87 70.11 Favored Glycine 0 C--N 1.314 -0.678 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.571 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.4 p -174.43 143.14 0.82 Allowed 'General case' 0 C--O 1.212 -0.872 0 CA-C-N 118.112 0.956 . . . . 0.0 110.705 -174.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' PHE . . . . . 0.482 ' HB2' ' SG ' ' A' ' 262' ' ' CYS . 41.1 p90 -103.12 151.64 22.33 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -114.7 126.84 55.33 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -175.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' CYS . . . . . 0.433 ' HB2' HD22 ' A' ' 279' ' ' LEU . 11.1 m -97.05 158.17 15.56 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.867 0.841 . . . . 0.0 111.961 -178.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -134.71 106.26 6.86 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.278 172.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 4.6 m -96.52 156.03 37.21 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.502 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 52.2 Cg_exo -55.84 159.9 10.88 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.53 2.154 . . . . 0.0 111.425 172.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -56.17 146.02 24.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.551 0.215 . . . . 0.0 111.07 -177.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.26 -30.0 3.42 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.88 -176.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' HIS . . . . . 0.546 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 17.8 m-70 -78.84 165.01 24.01 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.135 0.493 . . . . 0.0 111.507 -177.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -146.4 135.0 22.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.605 -175.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.621 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 39.0 tp -71.34 140.85 50.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.223 0.535 . . . . 0.0 110.926 177.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -129.56 102.44 6.37 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 170.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -61.01 -24.38 66.12 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 123.521 0.513 . . . . 0.0 111.781 -173.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 16.4 t -62.66 -23.84 33.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.983 0.421 . . . . 0.0 110.826 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.4 ' C ' HE21 ' A' ' 284' ' ' GLN . 28.1 p -141.63 24.86 2.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.668 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 256' ' ' LEU . 0.0 OUTLIER 25.53 48.85 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.142 0.977 . . . . 0.0 112.178 -169.115 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 285' ' ' LYS . . . . . 0.621 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 81.8 tttt -97.87 159.14 15.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.16 -171.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 4.0 m -137.15 81.25 1.86 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.041 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.546 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 66.5 mm-40 . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.346 -0.835 . . . . 0.0 108.893 -174.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -94.81 144.97 25.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.115 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 41.0 m -81.66 71.54 8.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.89 0.376 . . . . 0.0 110.295 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -75.29 114.45 13.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.559 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.8 m -70.27 137.89 51.14 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.203 177.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.0 mt -98.61 108.96 23.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -74.82 140.52 44.0 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.459 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -60.34 121.73 12.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.16 0.505 . . . . 0.0 109.95 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.447 ' HB3' ' O ' ' A' ' 130' ' ' SER . 33.4 m -86.74 -177.18 6.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.321 -174.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 44.0 m-20 -96.14 -50.35 4.87 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 121.786 0.803 . . . . 0.0 109.907 -176.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 133' ' ' HIS . 36.3 pt -98.5 -168.21 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-N 114.354 -1.293 . . . . 0.0 112.254 -167.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.472 ' HD3' ' H ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -127.88 142.79 51.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.341 -173.397 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 71.5 m -117.05 167.99 10.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.455 0.645 . . . . 0.0 112.554 -173.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 85.0 mtp -144.8 158.16 43.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.823 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 65.57 45.7 2.65 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.993 0.425 . . . . 0.0 111.528 169.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.644 ' O ' ' HG2' ' A' ' 137' ' ' GLN . . . 75.2 16.85 80.38 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.527 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.83 119.03 10.34 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.021 -177.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.6 t -84.21 126.64 33.33 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 19.1 p -76.88 160.7 29.01 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.189 0.518 . . . . 0.0 110.775 -170.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.55 ' HB3' ' O ' ' A' ' 133' ' ' HIS . 11.3 t -143.05 168.09 20.55 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 120' ' ' ASN . 13.0 t70 -30.76 -91.56 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 O-C-N 124.582 1.176 . . . . 0.0 113.024 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -83.53 -43.94 15.2 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.142 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.55 ' O ' ' HB3' ' A' ' 130' ' ' SER . 0.0 OUTLIER -110.63 -174.98 2.6 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.095 -1.042 . . . . 0.0 112.958 -178.209 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 44.9 t -122.71 149.43 44.08 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.697 -175.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 86.1 mt -107.55 114.62 28.74 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.3 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 59.8 m -74.38 162.49 28.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.133 -173.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.644 ' HG2' ' O ' ' A' ' 126' ' ' GLY . 14.8 mm-40 -78.44 150.87 32.96 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.515 168.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' A' ' 138' ' ' LYS . 13.5 tmtt? -65.98 112.5 3.86 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 122.59 1.186 . . . . 0.0 110.748 -176.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 123.04 -1.59 9.85 Favored Glycine 0 C--N 1.302 -1.325 0 CA-C-N 112.752 -2.022 . . . . 0.0 111.567 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.657 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 94.8 m-85 -122.03 142.75 50.02 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 122.43 -0.453 . . . . 0.0 110.133 172.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 26.6 pt -128.31 176.65 7.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.669 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 96.64 167.94 33.77 Favored Glycine 0 C--N 1.318 -0.457 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.761 -176.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.9 p -74.62 -23.61 58.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.176 0.488 . . . . 0.0 111.669 -177.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -109.54 7.3 24.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.534 176.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 30.9 m 64.29 30.05 13.53 Favored 'General case' 0 N--CA 1.462 0.168 0 O-C-N 123.672 0.607 . . . . 0.0 111.013 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.3 -12.22 67.95 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.571 -173.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -106.77 109.67 63.24 Favored Pre-proline 0 C--O 1.224 -0.259 0 CA-C-N 117.912 0.856 . . . . 0.0 110.745 -174.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.01 139.4 24.2 Favored 'Trans proline' 0 CA--C 1.522 -0.092 0 C-N-CA 123.625 2.884 . . . . 0.0 112.578 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 149' ' ' VAL . 9.3 p -67.52 110.53 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.734 0.778 . . . . 0.0 111.479 -175.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.38 77.18 7.17 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.972 176.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -53.86 -68.89 0.14 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -174.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.4 m -88.01 13.55 10.82 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.137 0.494 . . . . 0.0 111.679 -165.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 87.99 122.1 1.75 Allowed Glycine 0 N--CA 1.428 -1.841 0 CA-C-O 122.237 0.909 . . . . 0.0 112.608 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.414 ' C ' ' HG ' ' A' ' 155' ' ' LEU . 5.7 m -78.32 155.13 30.3 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 113.185 -1.507 . . . . 0.0 109.034 168.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.669 HD12 ' O ' ' A' ' 176' ' ' GLN . 56.3 mt -149.71 163.22 38.55 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.858 -166.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.577 HD22 ' HB ' ' A' ' 169' ' ' THR . 61.4 t30 47.69 24.13 0.51 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.66 -164.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 67.71 38.3 89.71 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.74 -177.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.22 -152.84 0.59 Allowed Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.723 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -149.07 121.57 8.52 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.223 -0.575 . . . . 0.0 111.808 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.5 m -63.19 114.69 3.92 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.668 177.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 165' ' ' ARG . 8.8 m -104.17 -34.92 3.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.81 0.338 . . . . 0.0 110.935 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.696 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -140.1 171.68 7.47 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.657 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 73.9 Cg_exo -53.3 108.55 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.988 1.792 . . . . 0.0 112.434 177.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 72.81 -7.88 1.37 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.362 1.065 . . . . 0.0 110.423 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.696 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.5 OUTLIER -83.49 82.54 8.25 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 176.295 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 7.1 t -80.88 145.8 31.15 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.463 ' HB2' ' CG1' ' A' ' 161' ' ' VAL . . . -96.5 118.68 33.51 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 173.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 84.0 m -90.45 126.97 36.08 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.791 -167.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.577 ' HB ' HD22 ' A' ' 156' ' ' ASN . 3.0 m -42.62 -51.44 5.19 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 124.633 1.208 . . . . 0.0 112.531 -172.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -165.76 -89.75 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 119.481 -0.888 . . . . 0.0 112.234 -176.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -90.98 54.89 3.32 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.636 -167.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.643 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 7.8 m-85 -129.63 136.5 49.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.608 0.704 . . . . 0.0 111.654 169.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.696 HG23 ' CE2' ' A' ' 181' ' ' TYR . 80.1 p -87.49 132.79 33.9 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.383 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 176' ' ' GLN . . . 92.06 146.75 19.14 Favored Glycine 0 N--CA 1.438 -1.167 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.799 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.32 22.89 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.616 1.544 . . . . 0.0 112.407 -174.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.669 ' O ' HD12 ' A' ' 155' ' ' LEU . 50.4 tt0 -120.85 3.28 10.57 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.512 176.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.596 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 32.15 57.59 0.36 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 176.639 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.454 ' HG3' ' HE ' ' A' ' 179' ' ' ARG . 15.7 pt-20 -115.84 17.21 16.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.501 0.667 . . . . 0.0 110.085 175.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.643 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 8.8 mmt180 -117.65 90.66 3.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.651 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -78.91 79.46 5.31 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.869 0.843 . . . . 0.0 110.97 -168.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.696 ' CE2' HG23 ' A' ' 173' ' ' THR . 17.4 p90 -112.13 79.97 1.28 Allowed 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 22.9 mtp85 -79.93 144.95 32.91 Favored 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 118.936 -2.352 . . . . 0.0 107.285 -176.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 82.3 p -78.65 138.22 38.21 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.083 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.488 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -151.91 149.78 21.55 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -70.62 128.44 15.25 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.76 1.64 . . . . 0.0 110.787 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.507 ' H ' HG23 ' A' ' 202' ' ' ILE . 7.8 t -84.17 122.0 28.24 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.113 0.482 . . . . 0.0 109.824 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' PHE . . . . . 0.461 ' HB3' ' HB3' ' A' ' 195' ' ' CYS . 65.5 m-85 -107.07 149.03 28.03 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.758 -178.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.627 ' HA ' ' HB3' ' A' ' 215' ' ' ARG . 17.7 p -102.44 -59.0 1.78 Allowed 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -173.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 p -121.95 117.83 53.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.673 -173.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.522 HD13 ' HB3' ' A' ' 221' ' ' CYS . 4.2 mt -124.28 120.73 60.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -170.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 63.9 p -117.32 -166.29 1.17 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.562 -1.199 . . . . 0.0 107.849 161.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -68.31 -5.59 19.48 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.692 0.678 . . . . 0.0 110.22 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -92.19 -75.83 0.47 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.099 -173.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 72.7 mtm -141.13 143.03 34.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.662 0.268 . . . . 0.0 110.725 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.497 ' HA ' HG12 ' A' ' 190' ' ' ILE . 8.5 m -90.37 -45.61 8.9 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.982 176.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.405 ' HG3' ' H ' ' A' ' 188' ' ' THR . 20.0 mt-30 -152.13 3.99 0.39 Allowed 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.253 165.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 92.99 -3.81 74.01 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.132 -175.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 74.31 6.58 4.65 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.277 0.631 . . . . 0.0 112.333 174.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.795 ' H ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -85.9 19.88 2.41 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.269 0.557 . . . . 0.0 110.957 177.929 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.453 ' OG ' HG22 ' A' ' 202' ' ' ILE . 15.2 t -102.96 142.83 33.4 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.662 -175.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -126.84 19.61 6.13 Favored Glycine 0 CA--C 1.504 -0.606 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.611 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -67.72 99.27 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 122.093 0.949 . . . . 0.0 109.05 173.926 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.99 123.1 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.097 174.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 22.9 t -154.33 -178.35 7.08 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 181' ' ' TYR . 5.5 p -103.58 161.03 14.23 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 119.752 1.16 . . . . 0.0 108.811 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.527 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 45.4 tttm -59.82 -44.72 93.88 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.067 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.8 m -44.22 -56.2 4.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.931 172.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.573 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -53.77 -53.66 49.22 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.814 177.778 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 99.0 m -68.75 -22.92 64.28 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 45.0 m -96.1 -29.65 13.97 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.056 -178.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 227' ' ' GLN . . . -74.08 -60.06 2.44 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 173.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.775 HG22 ' HA2' ' A' ' 234' ' ' GLY . 10.8 p -96.78 160.64 14.26 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.283 178.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 1.4 t 66.32 -41.98 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 118.784 -0.626 . . . . 0.0 111.922 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 62.32 46.75 93.24 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-N 119.155 0.889 . . . . 0.0 113.584 168.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.627 ' HB3' ' HA ' ' A' ' 188' ' ' THR . 0.9 OUTLIER -119.87 -92.47 0.54 Allowed 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.746 -178.22 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.502 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -167.67 166.88 13.69 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' TRP . . . . . 0.527 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 21.8 t90 -155.18 148.42 24.88 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 122.213 -0.305 . . . . 0.0 110.276 -174.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 221' ' ' CYS . . . 86.09 160.98 34.68 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.756 172.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.657 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 26.2 t60 -135.62 131.88 19.45 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.657 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 51.6 Cg_exo -54.59 142.81 14.39 Favored 'Cis proline' 0 C--N 1.353 0.784 0 C-N-CA 123.896 -1.293 . . . . 0.0 112.282 -2.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' CYS . . . . . 0.66 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 72.2 m -50.64 128.28 20.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.714 -172.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -116.19 121.71 42.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.818 175.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' MET . . . . . 0.502 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 5.1 ppp? -106.62 153.87 21.74 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.287 -171.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 97.8 m -135.07 135.47 22.99 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -173.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -56.99 166.91 3.53 Favored 'Trans proline' 0 CA--C 1.515 -0.447 0 C-N-CA 123.98 3.12 . . . . 0.0 114.111 167.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -39.01 111.59 0.19 Allowed 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.081 162.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' GLN . . . . . 0.448 ' HB3' ' O ' ' A' ' 211' ' ' ALA . 0.0 OUTLIER 6.42 92.89 0.03 OUTLIER Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 110.137 -3.211 . . . . 0.0 114.162 177.734 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -58.07 -49.97 11.3 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.747 2.298 . . . . 0.0 113.256 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -49.72 134.58 19.9 Favored Pre-proline 0 CA--C 1.512 -0.488 0 C-N-CA 122.834 0.454 . . . . 0.0 110.521 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.49 45.29 1.93 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.006 1.804 . . . . 0.0 113.301 -172.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 48.8 m -127.7 -176.1 3.67 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.67 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 98.1 mtt180 -61.53 139.21 58.28 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 172.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.412 ' O ' HG22 ' A' ' 212' ' ' THR . 20.3 ptt180 -38.46 -42.74 0.77 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 177.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.775 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -77.48 9.28 29.18 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.033 -0.604 . . . . 0.0 114.018 -177.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' PHE . . . . . 0.717 ' HE2' ' N ' ' A' ' 267' ' ' GLY . 2.3 m-85 -121.53 147.5 45.71 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 122.044 0.926 . . . . 0.0 112.776 -172.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.41 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.5 OUTLIER -123.23 130.37 24.58 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 113.667 -1.606 . . . . 0.0 108.851 173.306 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -58.42 112.42 1.17 Allowed 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.333 2.022 . . . . 0.0 111.564 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -51.47 138.88 21.12 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.359 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 23.6 mt -81.91 -6.03 9.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.034 -173.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -109.18 -55.45 2.41 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.452 0.644 . . . . 0.0 110.221 -177.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 47.6 p -90.45 -38.24 13.39 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.907 -176.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 96.79 6.53 58.14 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -176.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -89.11 124.54 34.42 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 122.015 0.912 . . . . 0.0 109.943 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 12.1 m -54.87 121.44 8.64 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.454 176.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.451 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 84.5 mm-40 -119.81 137.66 53.84 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.677 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 13.4 t70 -76.7 147.29 37.5 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.557 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.758 HG23 ' HG3' ' A' ' 249' ' ' GLU . 6.4 m -99.31 145.27 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.965 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.755 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -72.58 75.94 1.08 Allowed 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 167.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.758 ' HG3' HG23 ' A' ' 247' ' ' VAL . 21.3 mp0 -53.06 -34.62 57.31 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.746 0.784 . . . . 0.0 110.216 -170.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 11.9 m -48.39 -40.3 25.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.836 174.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -103.51 -41.5 5.97 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.856 0.836 . . . . 0.0 110.368 -175.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -66.76 -23.46 66.09 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.546 -1.207 . . . . 0.0 110.624 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.84 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.5 mp -127.54 78.57 74.59 Favored Pre-proline 0 N--CA 1.445 -0.679 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 172.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.465 ' HG2' HG12 ' A' ' 202' ' ' ILE . 9.7 Cg_endo -50.32 112.26 0.7 Allowed 'Trans proline' 0 CA--C 1.507 -0.869 0 C-N-CA 124.112 3.208 . . . . 0.0 114.64 -164.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 59.09 35.12 82.61 Favored Glycine 0 C--N 1.307 -1.03 0 CA-C-N 113.233 -1.803 . . . . 0.0 113.811 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.84 ' HB3' HG22 ' A' ' 253' ' ' ILE . 2.2 pt? -63.99 -22.54 66.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 118.06 0.93 . . . . 0.0 110.593 177.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 14.5 t -78.01 4.51 12.03 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.152 0.501 . . . . 0.0 110.688 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 67.34 -86.84 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.809 0.844 . . . . 0.0 113.013 171.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -126.62 11.1 7.11 Favored Glycine 0 CA--C 1.507 -0.417 0 C-N-CA 120.207 -0.997 . . . . 0.0 112.279 -174.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -98.94 -173.92 31.8 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.314 175.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' ASN . . . . . 0.582 ' HB3' ' CG ' ' A' ' 272' ' ' LYS . 2.7 t-20 -107.0 116.99 32.88 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 176.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 262' ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' ' 269' ' ' PHE . 34.4 t -90.64 134.86 34.09 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 2.7 mp -127.48 112.13 27.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.609 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -74.56 123.52 24.95 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -172.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.4 t -110.74 160.04 17.08 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 155.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.677 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 4.1 m -76.42 128.4 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.886 0 C-N-CA 117.933 -1.507 . . . . 0.0 108.137 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.717 ' N ' ' HE2' ' A' ' 235' ' ' PHE . . . 112.57 -26.83 10.48 Favored Glycine 0 N--CA 1.432 -1.567 0 C-N-CA 119.904 -1.141 . . . . 0.0 111.338 -172.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 37.6 t 173.01 160.02 0.12 Allowed 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 121.112 0.482 . . . . 0.0 110.373 -172.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' PHE . . . . . 0.598 ' HB2' ' SG ' ' A' ' 262' ' ' CYS . 42.2 p90 -103.69 155.51 18.51 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 121.326 -0.859 . . . . 0.0 109.036 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -116.76 125.52 51.75 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 11.4 m -105.41 154.01 20.9 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.858 0.837 . . . . 0.0 112.203 -176.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.582 ' CG ' ' HB3' ' A' ' 261' ' ' ASN . 10.1 ptmm? -129.63 108.71 10.42 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.342 168.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 32.2 m -85.89 156.14 58.2 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.068 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.588 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 71.8 Cg_exo -50.51 160.64 1.54 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.479 2.12 . . . . 0.0 112.351 173.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -58.25 136.49 57.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.903 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.08 -26.15 5.66 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' HIS . . . . . 0.59 ' ND1' ' HA ' ' A' ' 287' ' ' GLU . 14.9 m-70 -79.43 176.78 9.38 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.18 0.514 . . . . 0.0 112.001 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -167.97 144.85 4.15 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.939 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 38.1 tp -91.66 137.99 31.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.033 0.444 . . . . 0.0 110.911 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -125.62 98.43 5.57 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.18 -19.38 61.51 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.629 0.581 . . . . 0.0 112.177 -172.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.477 ' HA ' ' NH1' ' A' ' 215' ' ' ARG . 79.7 t -58.07 -34.58 49.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.821 177.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.434 ' HA ' ' HB ' ' A' ' 188' ' ' THR . 32.2 m -139.49 31.01 2.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.08 177.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 0.611 ' HB3' ' O ' ' A' ' 256' ' ' LEU . 82.0 mm-40 30.82 44.87 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.299 -0.864 . . . . 0.0 113.111 -173.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 285' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' A' ' 287' ' ' GLU . 62.0 tttp -91.43 110.15 21.45 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.49 -175.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 44.8 t -100.3 68.04 1.39 Allowed 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.59 ' HA ' ' ND1' ' A' ' 277' ' ' HIS . 42.3 mt-10 . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.423 -0.798 . . . . 0.0 109.491 -173.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 N--CA 1.474 0.729 0 CA-C-O 121.001 0.429 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.44 -32.0 71.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.63 0.729 . . . . 0.0 110.012 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.1 p -98.35 170.65 8.71 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.044 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -123.06 49.67 1.63 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.853 0.358 . . . . 0.0 110.905 -177.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.9 m 65.81 -177.39 0.19 Allowed 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.195 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 69.0 mt -115.71 108.95 26.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.102 176.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 117' ' ' GLN . 20.9 tt0 65.14 23.01 12.33 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.505 0.669 . . . . 0.0 110.202 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -146.48 54.87 1.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.388 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 8.4 p -101.65 -103.36 0.26 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.204 0.526 . . . . 0.0 111.395 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.519 ' HB3' ' H ' ' A' ' 132' ' ' ASP . 75.6 m-20 -90.81 -48.58 6.94 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.535 HD11 ' N ' ' A' ' 134' ' ' CYS . 0.2 OUTLIER -164.38 144.75 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-N 113.102 -1.863 . . . . 0.0 108.625 160.513 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.405 ' CD ' ' H ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -61.62 121.09 11.92 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.478 0.656 . . . . 0.0 111.138 177.126 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 92.1 m -117.13 152.63 34.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.646 0.736 . . . . 0.0 112.942 -175.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 69.7 mmm -150.37 175.24 12.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.407 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 60.65 55.67 3.26 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.708 0.29 . . . . 0.0 111.715 170.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.504 ' O ' ' HG3' ' A' ' 137' ' ' GLN . . . 63.98 32.99 86.04 Favored Glycine 0 C--O 1.218 -0.885 0 C-N-CA 120.424 -0.894 . . . . 0.0 112.431 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 135' ' ' LEU . . . -115.26 131.37 9.68 Favored Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.7 m -104.65 130.0 52.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.267 0.556 . . . . 0.0 111.032 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.408 ' SG ' ' HB2' ' A' ' 120' ' ' ASN . 18.2 t -60.75 103.3 0.25 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.322 178.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.0 m -126.22 135.3 51.43 Favored 'General case' 0 C--O 1.213 -0.832 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.412 ' HA ' ' HB3' ' A' ' 120' ' ' ASN . 8.9 m-20 -31.7 99.61 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -175.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.519 ' H ' ' HB3' ' A' ' 120' ' ' ASN . 11.0 m-20 80.5 -6.66 1.67 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.413 166.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -154.75 130.02 9.68 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 121.419 -0.801 . . . . 0.0 110.429 174.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.535 ' N ' HD11 ' A' ' 121' ' ' ILE . 25.3 t -86.49 136.48 33.07 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.655 -173.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.552 ' O ' ' HA2' ' A' ' 127' ' ' GLY . 79.2 mt -81.32 90.64 6.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.371 0.605 . . . . 0.0 110.034 176.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 56.0 m -76.23 138.13 40.41 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.844 -178.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 126' ' ' GLY . 38.5 mt-30 -51.62 152.48 2.75 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.145 171.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.504 ' HD3' ' O ' ' A' ' 138' ' ' LYS . 9.6 tmtt? -63.03 116.45 5.35 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.917 0.865 . . . . 0.0 111.207 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 100.1 14.12 34.53 Favored Glycine 0 C--N 1.304 -1.234 0 CA-C-N 113.29 -1.777 . . . . 0.0 111.894 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.526 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 46.4 m-85 -119.99 139.18 52.87 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.976 0.417 . . . . 0.0 111.191 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.514 HG13 ' HB3' ' A' ' 147' ' ' GLN . 25.7 pt -136.34 -166.01 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.748 -177.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.81 179.92 53.1 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.955 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 30.7 p -74.21 -37.36 63.89 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 122.827 0.451 . . . . 0.0 112.205 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -97.46 6.29 48.41 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 35.3 m 63.23 23.78 14.01 Favored 'General case' 0 C--O 1.22 -0.493 0 O-C-N 123.785 0.678 . . . . 0.0 109.497 -171.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -94.8 1.5 65.78 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.307 -0.473 . . . . 0.0 113.564 -171.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.514 ' HB3' HG13 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -104.87 105.7 52.17 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 117.409 0.604 . . . . 0.0 109.402 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.442 ' HD2' ' OE1' ' A' ' 147' ' ' GLN . 92.7 Cg_endo -79.69 151.34 22.02 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.756 2.304 . . . . 0.0 112.783 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 149' ' ' VAL . 13.3 p -87.95 104.23 14.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 122.325 1.06 . . . . 0.0 111.706 -173.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.53 90.84 5.71 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.548 170.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -52.83 -63.12 1.25 Allowed 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -173.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 4.2 m -84.19 7.34 19.32 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.568 0.699 . . . . 0.0 109.948 -168.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.47 131.71 0.08 OUTLIER Glycine 0 N--CA 1.432 -1.579 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.132 -168.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.434 ' O ' HD23 ' A' ' 155' ' ' LEU . 72.4 m -66.54 154.6 39.95 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 114.447 -0.877 . . . . 0.0 110.364 176.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.434 HD23 ' O ' ' A' ' 154' ' ' CYS . 34.5 mt -123.23 162.97 21.55 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.647 -169.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.737 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 2.2 t-20 48.55 38.07 10.4 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.422 -167.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 55.94 38.48 74.98 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.743 -174.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.18 -155.06 0.88 Allowed Glycine 0 C--N 1.32 -0.322 0 CA-C-N 115.216 -0.492 . . . . 0.0 112.086 -176.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -144.95 122.36 11.65 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.746 -0.381 . . . . 0.0 111.232 -171.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.42 111.29 5.86 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.403 173.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 165' ' ' ARG . 14.8 m -101.08 -42.92 10.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 O-C-N 121.94 -0.475 . . . . 0.0 110.092 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.575 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -134.17 173.34 5.93 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.526 ' HD3' ' CE1' ' A' ' 140' ' ' TYR . 54.7 Cg_exo -54.29 113.01 1.16 Allowed 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 122.492 2.128 . . . . 0.0 112.033 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 75.2 -10.16 1.27 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.636 0.775 . . . . 0.0 109.642 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.575 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.9 OUTLIER -86.47 82.21 8.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.371 179.007 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 84.4 m -87.48 137.16 32.57 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.684 0.754 . . . . 0.0 110.288 172.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.51 134.74 33.64 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.309 174.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 86.3 m -102.2 124.07 47.15 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.288 0.992 . . . . 0.0 111.655 -169.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.737 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 65.2 m -56.34 -53.92 51.59 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -172.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -151.91 -87.75 0.06 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 118.482 -1.287 . . . . 0.0 114.135 -170.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -93.96 39.09 2.98 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.943 -166.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.607 ' CZ ' ' HB2' ' A' ' 156' ' ' ASN . 1.7 m-85 -123.72 125.28 44.46 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 118.188 0.994 . . . . 0.0 111.795 174.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.521 ' N ' ' HE1' ' A' ' 181' ' ' TYR . 5.5 t -87.04 163.73 16.87 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 166.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.91 127.84 2.06 Favored Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -175.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -75.22 15.94 0.74 Allowed 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 121.128 1.219 . . . . 0.0 113.274 -166.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -120.89 2.12 10.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.747 0.784 . . . . 0.0 110.325 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.45 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 42.65 48.0 4.66 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 114.299 -1.319 . . . . 0.0 113.854 -179.185 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -107.66 -18.13 13.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.286 0.565 . . . . 0.0 110.169 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' A' ' 180' ' ' ASP . 6.8 mmt180 -55.95 -73.66 0.06 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.582 -176.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.481 ' HB3' ' O ' ' A' ' 179' ' ' ARG . 27.1 t70 84.96 75.16 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.642 0 O-C-N 124.122 0.889 . . . . 0.0 110.176 168.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.521 ' HE1' ' N ' ' A' ' 173' ' ' THR . 44.6 p90 -94.72 61.56 2.64 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 169.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.458 ' HG3' ' CH2' ' A' ' 217' ' ' TRP . 22.1 ptt-85 -51.75 126.36 17.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.439 175.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 42.5 p -79.97 137.73 36.92 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 120.857 0.36 . . . . 0.0 110.188 -173.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.624 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -162.8 159.3 31.66 Favored Glycine 0 C--N 1.323 -0.154 0 CA-C-O 119.365 -0.686 . . . . 0.0 111.505 -175.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.11 141.6 11.79 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.421 2.081 . . . . 0.0 111.977 174.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.759 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 74.7 m -91.03 123.25 34.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.445 0.641 . . . . 0.0 111.294 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' PHE . . . . . 0.556 ' O ' ' HB2' ' A' ' 215' ' ' ARG . 19.1 m-85 -86.47 144.68 27.16 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.989 176.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 5.0 m -108.39 -18.24 13.8 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -163.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 7.5 p -170.75 118.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 121.614 -0.678 . . . . 0.0 110.272 176.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.511 HG12 ' HA ' ' A' ' 195' ' ' CYS . 5.4 mt -114.72 120.92 65.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -171.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 11.4 m -110.09 173.57 6.26 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 105.194 -2.151 . . . . 0.0 105.194 152.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -67.45 -6.26 18.58 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.639 1.109 . . . . 0.0 109.902 177.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -77.01 -74.44 0.24 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.284 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 92.7 mmm -132.2 133.46 44.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.789 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.511 ' HA ' HG12 ' A' ' 190' ' ' ILE . 56.0 m -83.15 -31.52 27.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.724 174.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.467 ' O ' ' HD1' ' A' ' 187' ' ' PHE . 77.9 mt-30 68.42 117.49 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.425 174.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 118.96 21.25 3.87 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.162 -172.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -75.93 3.94 9.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.474 0.654 . . . . 0.0 110.425 -178.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.52 ' N ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -122.53 15.25 10.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.588 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 1.4 t -87.19 128.24 35.14 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.948 -173.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -105.13 14.37 48.3 Favored Glycine 0 CA--C 1.505 -0.534 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.011 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.56 ' CD1' ' HA ' ' A' ' 253' ' ' ILE . 2.1 tt -60.95 103.7 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 171.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.7 t -88.77 95.78 5.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 123.31 1.528 . . . . 0.0 108.09 171.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 19.3 m -137.64 177.33 7.95 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 111.458 -2.61 . . . . 0.0 106.875 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.428 ' OG1' ' HB ' ' A' ' 207' ' ' THR . 26.8 p -100.88 161.02 13.89 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.674 -174.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.673 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 44.5 tttm -58.84 -42.83 90.23 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.884 173.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.428 ' HB ' ' OG1' ' A' ' 205' ' ' THR . 56.8 m -44.4 -56.39 4.27 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 122.78 1.276 . . . . 0.0 109.594 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.787 HD11 HG11 ' A' ' 247' ' ' VAL . 10.8 tp -59.71 -49.68 76.79 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 112.379 -2.191 . . . . 0.0 112.043 -175.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 50.6 m -77.49 -17.62 57.84 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.224 0.535 . . . . 0.0 111.78 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 72.4 m -87.4 -27.21 22.9 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.985 -0.447 . . . . 0.0 110.022 172.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ALA . . . . . 0.587 ' HB2' ' CE1' ' A' ' 229' ' ' HIS . . . -73.57 -56.57 4.85 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.816 0.817 . . . . 0.0 109.296 175.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.647 ' CG2' ' HA2' ' A' ' 234' ' ' GLY . 25.5 p -106.02 149.93 26.21 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.488 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.0 t 69.14 -42.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 O-C-N 123.948 0.78 . . . . 0.0 111.628 -174.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 56.75 64.29 4.54 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 119.401 1.0 . . . . 0.0 114.842 171.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.556 ' HB2' ' O ' ' A' ' 187' ' ' PHE . 21.4 mmt85 -130.41 -80.23 0.54 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 117.707 0.753 . . . . 0.0 110.532 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.43 ' HB3' ' HB2' ' A' ' 187' ' ' PHE . . . -169.35 169.73 8.87 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 176.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' TRP . . . . . 0.759 ' HD1' ' SG ' ' A' ' 186' ' ' CYS . 16.0 t90 -157.8 147.4 20.01 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 89.47 169.46 44.12 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 170.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.438 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 16.9 m-70 -128.04 131.38 23.76 Favored Pre-proline 0 C--N 1.341 0.237 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.456 175.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 23.4 Cg_exo -63.99 159.94 66.32 Favored 'Cis proline' 0 C--N 1.348 0.524 0 C-N-CA 123.569 -1.429 . . . . 0.0 111.149 -4.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 63.5 m -45.17 121.33 2.82 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 123.563 0.539 . . . . 0.0 111.982 -176.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.457 ' HB3' ' HE3' ' A' ' 206' ' ' LYS . 21.2 mt-10 -107.94 114.51 28.48 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 172.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 47.0 ttp -83.55 129.87 34.98 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.238 0.542 . . . . 0.0 110.244 -170.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 63.9 m -77.27 129.15 78.72 Favored Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -171.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.437 ' HB2' ' HD3' ' A' ' 228' ' ' PRO . 25.2 Cg_exo -64.75 173.41 5.69 Favored 'Trans proline' 0 C--N 1.329 -0.458 0 C-N-CA 123.806 3.004 . . . . 0.0 111.208 164.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.463 ' HB3' ' OE1' ' A' ' 227' ' ' GLN . . . -43.64 -54.15 5.22 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -169.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' GLN . . . . . 0.487 ' CB ' ' HD2' ' A' ' 233' ' ' ARG . 2.1 pm0 -164.22 28.67 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.809 0 CA-C-O 118.765 -0.636 . . . . 0.0 112.266 -176.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.437 ' HD3' ' HB2' ' A' ' 225' ' ' PRO . 63.3 Cg_exo -19.63 63.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.237 1 C-N-CA 125.664 4.243 . . . . 0.0 116.77 -155.899 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.587 ' CE1' ' HB2' ' A' ' 211' ' ' ALA . 28.3 m80 -135.76 155.44 78.05 Favored Pre-proline 0 C--N 1.324 -0.521 0 O-C-N 121.982 -0.449 . . . . 0.0 110.469 -178.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -92.47 35.48 0.24 Allowed 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.35 2.033 . . . . 0.0 110.587 165.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 9.9 t -162.77 -167.36 1.52 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.636 -176.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.622 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 88.9 mtt180 -67.12 149.53 50.41 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -174.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.487 ' HD2' ' CB ' ' A' ' 227' ' ' GLN . 34.9 mmm-85 -35.11 -64.1 0.29 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.868 0.867 . . . . 0.0 112.921 175.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.647 ' HA2' ' CG2' ' A' ' 212' ' ' THR . . . -82.96 16.04 29.47 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.424 -0.894 . . . . 0.0 114.35 -168.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' PHE . . . . . 0.622 ' CD1' ' HB2' ' A' ' 232' ' ' ARG . 7.0 m-85 -119.96 137.98 53.73 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 121.847 0.832 . . . . 0.0 112.063 -173.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.419 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.0 OUTLIER -121.79 141.74 34.54 Favored Pre-proline 0 C--N 1.311 -1.107 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 175.626 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.68 124.0 10.69 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.534 2.156 . . . . 0.0 112.473 -176.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -55.26 139.78 41.33 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.563 171.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 34.2 mt -77.29 -16.53 14.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.089 -173.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 240' ' ' ARG . 19.3 mtp180 -101.13 -61.26 1.39 Allowed 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.775 -175.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 40.7 p -82.09 -38.95 24.09 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.377 -176.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 94.11 5.89 62.05 Favored Glycine 0 N--CA 1.437 -1.296 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.062 -176.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -78.23 139.88 38.91 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 121.79 0.805 . . . . 0.0 110.919 -178.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' CYS . . . . . 0.402 ' HB3' ' HB3' ' A' ' 235' ' ' PHE . 63.7 m -62.64 122.41 15.76 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.743 -1.571 . . . . 0.0 110.146 174.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 81.0 mm-40 -122.7 133.16 54.51 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 176.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.608 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 1.8 t70 -75.54 151.57 37.9 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.787 HG11 HD11 ' A' ' 208' ' ' LEU . 8.6 m -97.02 145.25 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.451 -177.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -75.75 76.46 2.71 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 169.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.711 ' HG3' HG23 ' A' ' 247' ' ' VAL . 34.1 mp0 -54.11 -33.36 57.54 Favored 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 123.98 0.8 . . . . 0.0 110.359 -169.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 35.1 m -51.1 -42.67 60.79 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.812 174.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -96.58 -34.81 11.3 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.768 0.794 . . . . 0.0 110.268 -177.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.532 ' HB1' HD21 ' A' ' 208' ' ' LEU . . . -73.13 -20.03 61.01 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.482 -176.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.714 ' O ' ' HG ' ' A' ' 256' ' ' LEU . 5.2 mp -140.54 81.46 17.32 Favored Pre-proline 0 N--CA 1.451 -0.376 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.464 ' HD2' HG13 ' A' ' 202' ' ' ILE . 16.5 Cg_exo -71.37 31.53 0.24 Allowed 'Trans proline' 0 CA--C 1.515 -0.474 0 C-N-CA 123.373 2.716 . . . . 0.0 113.025 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' GLY . . . . . 0.528 ' H ' ' C ' ' A' ' 253' ' ' ILE . . . -123.39 2.39 9.59 Favored Glycine 0 C--N 1.288 -2.119 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.484 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.714 ' HG ' ' O ' ' A' ' 253' ' ' ILE . 23.2 mt -65.75 -147.17 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 175.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' CYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 284' ' ' GLN . 76.1 m -38.55 128.16 1.46 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.394 0.677 . . . . 0.0 112.698 -174.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -79.73 68.77 5.89 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.998 -174.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 107.24 171.35 22.27 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.914 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 85.66 -154.73 28.56 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.203 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -109.64 138.68 45.65 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 50.2 t -122.48 138.57 54.51 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 173.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.489 HD11 ' HE2' ' A' ' 272' ' ' LYS . 20.9 mt -131.26 164.9 33.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 -174.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.454 ' ND2' ' HB3' ' A' ' 269' ' ' PHE . 0.8 OUTLIER -131.29 125.36 32.61 Favored 'General case' 0 CA--C 1.497 -1.062 0 C-N-CA 117.53 -1.668 . . . . 0.0 114.038 -175.375 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.0 t -109.26 163.87 12.98 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 122.333 1.063 . . . . 0.0 110.072 166.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.54 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 35.7 m -73.23 127.5 35.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 268' ' ' SER . . . 98.45 -12.63 63.19 Favored Glycine 0 C--N 1.311 -0.848 0 C-N-CA 119.523 -1.322 . . . . 0.0 111.999 -176.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 267' ' ' GLY . 10.5 t 176.44 162.51 0.39 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.112 1.456 . . . . 0.0 110.858 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 269' ' ' PHE . . . . . 0.534 ' CZ ' HD13 ' A' ' 256' ' ' LEU . 46.0 p90 -107.26 162.59 13.76 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.233 -0.917 . . . . 0.0 109.56 177.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -116.75 156.55 26.98 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.81 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 56.8 m -136.68 158.54 44.2 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.576 0.703 . . . . 0.0 112.338 172.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.489 ' HE2' HD11 ' A' ' 263' ' ' ILE . 50.0 mtmt -139.68 130.13 25.55 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.141 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 273' ' ' CYS . . . . . 0.427 ' HB3' ' HD2' ' A' ' 274' ' ' PRO . 19.6 m -122.12 173.03 4.47 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.992 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.446 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 53.1 Cg_exo -56.21 155.07 25.77 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.862 1.708 . . . . 0.0 110.141 167.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -58.04 156.94 8.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.139 0.495 . . . . 0.0 111.376 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 86.51 -36.97 3.17 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.255 -176.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' HIS . . . . . 0.69 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 18.1 m-70 -69.63 153.41 43.47 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.08 0.466 . . . . 0.0 111.639 -177.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 54.7 mttp -144.96 139.44 27.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.487 -175.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 285' ' ' LYS . 45.9 tp -76.07 140.93 42.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.396 0.617 . . . . 0.0 111.85 -175.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -127.07 102.54 7.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.903 173.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -57.8 -27.98 63.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.292 -175.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 66.4 t -56.3 -33.4 37.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.133 0.492 . . . . 0.0 111.513 -175.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 8.3 p -137.83 28.21 2.66 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.015 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 0.607 ' O ' ' HA ' ' A' ' 257' ' ' CYS . 1.3 mp0 35.16 43.87 0.13 Allowed 'General case' 0 C--N 1.349 0.584 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.662 -169.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 285' ' ' LYS . . . . . 0.442 ' O ' HD12 ' A' ' 279' ' ' LEU . 66.6 tttt -94.64 166.15 12.16 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -172.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 286' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 12.4 t -156.93 106.06 2.21 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.596 -178.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.69 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 37.4 tt0 . . . . . 0 C--N 1.315 -0.901 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.86 -2.91 57.39 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.849 0.357 . . . . 0.0 110.846 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.5 t 63.23 30.91 15.79 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.536 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -127.71 117.24 21.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.29 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.7 p -79.8 118.75 21.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.438 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 74.5 mt -77.35 121.0 28.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.143 -175.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -82.58 178.51 8.17 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.191 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -61.67 -39.58 91.9 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.197 -0.201 . . . . 0.0 110.947 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 37.4 t -173.36 -97.15 0.01 OUTLIER 'General case' 0 C--O 1.231 0.101 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 173.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -128.91 -58.22 1.16 Allowed 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 119.826 -0.749 . . . . 0.0 112.599 -175.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.564 HD11 ' C ' ' A' ' 133' ' ' HIS . 0.2 OUTLIER -169.88 -165.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.646 -170.106 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.652 ' HD3' ' H ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -100.96 123.58 45.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.035 171.438 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 39.1 m -118.93 144.1 46.64 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 54.0 mtm -135.24 165.9 24.35 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 172.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.406 ' ND2' ' HA2' ' A' ' 146' ' ' GLY . 90.1 m-20 63.87 49.65 2.8 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.23 0.538 . . . . 0.0 110.841 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.472 ' HA3' ' CD ' ' A' ' 137' ' ' GLN . . . 67.1 25.39 73.4 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.077 -0.965 . . . . 0.0 113.256 176.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 135' ' ' LEU . . . -72.09 125.29 10.8 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.089 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 135' ' ' LEU . 36.0 m -91.88 150.16 21.19 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -69.73 118.73 12.96 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.083 0.468 . . . . 0.0 110.012 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.432 ' OG ' ' HG ' ' A' ' 135' ' ' LEU . 5.9 p -142.33 162.94 34.2 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.308 -176.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -47.75 82.6 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -166.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 59.54 35.26 22.65 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.205 -1.361 . . . . 0.0 109.796 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.564 ' C ' HD11 ' A' ' 121' ' ' ILE . 2.5 p-80 -166.52 174.6 8.74 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.108 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 9.8 t -120.34 139.69 52.4 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.073 0.463 . . . . 0.0 111.403 -171.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.445 ' O ' ' HA2' ' A' ' 127' ' ' GLY . 94.1 mt -95.78 103.82 15.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.454 176.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 60.5 m -72.12 147.83 46.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.743 -174.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.472 ' CD ' ' HA3' ' A' ' 126' ' ' GLY . 24.6 mt-30 -80.29 -177.94 6.37 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.047 174.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -52.77 113.23 1.01 Allowed 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.198 0.999 . . . . 0.0 111.64 -174.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.46 21.17 58.85 Favored Glycine 0 C--N 1.296 -1.684 0 CA-C-N 112.698 -2.046 . . . . 0.0 114.51 170.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.411 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 74.4 m-85 -119.52 145.17 46.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 119.736 1.768 . . . . 0.0 111.545 177.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 34.0 pt -129.87 176.8 7.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.592 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.73 165.73 31.83 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.187 -176.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 40.3 p -64.98 -36.93 85.99 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -106.25 16.1 25.31 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.037 0.446 . . . . 0.0 110.264 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 60.3 m 55.98 36.82 28.04 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.131 173.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.406 ' HA2' ' ND2' ' A' ' 125' ' ' ASN . . . -94.25 -2.24 64.13 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.793 -175.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -107.88 113.67 60.87 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 117.752 0.776 . . . . 0.0 110.804 -176.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.89 143.87 23.72 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.96 2.44 . . . . 0.0 112.507 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 149' ' ' VAL . 9.3 p -78.07 110.47 13.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.867 0.842 . . . . 0.0 111.953 -175.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.64 76.73 7.51 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.37 172.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -58.36 -62.61 1.72 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -170.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.3 m -86.36 8.87 19.81 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.586 0.708 . . . . 0.0 109.815 -170.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 74.7 131.78 0.25 Allowed Glycine 0 N--CA 1.428 -1.881 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.149 -172.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.442 ' O ' HD23 ' A' ' 155' ' ' LEU . 77.3 m -71.86 157.75 37.31 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 175.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 154' ' ' CYS . 55.6 mt -129.03 165.26 21.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.907 -170.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.807 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 2.3 t-20 49.53 30.97 3.76 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.837 0.711 . . . . 0.0 111.229 -168.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.68 37.25 82.56 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.219 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -73.65 -145.94 0.88 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.414 -0.422 . . . . 0.0 112.958 -175.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' A' ' 166' ' ' CYS . 21.5 tpt180 -148.37 121.97 9.19 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.881 -174.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 166' ' ' CYS . 0.8 OUTLIER -72.96 108.34 5.83 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.41 173.584 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 165' ' ' ARG . 4.4 m -94.46 -37.25 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.392 -177.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.546 ' HB1' ' HD2' ' A' ' 163' ' ' PRO . . . -133.58 177.85 2.05 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 168.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.546 ' HD2' ' HB1' ' A' ' 162' ' ' ALA . 88.0 Cg_exo -50.2 107.04 0.14 Allowed 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.383 2.055 . . . . 0.0 113.608 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 64.49 6.61 3.21 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.165 0.986 . . . . 0.0 110.517 -178.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.593 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -92.33 75.53 5.27 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.722 177.106 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 61.4 m -84.34 146.98 27.43 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.188 0.518 . . . . 0.0 110.334 176.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -98.07 144.5 27.5 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 57.7 m -102.96 122.88 45.5 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 124.449 1.093 . . . . 0.0 112.007 -166.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.807 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 93.7 m -61.24 -55.44 31.96 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.423 ' CG ' ' N ' ' A' ' 171' ' ' GLY . 79.6 t80 -132.2 -116.48 0.22 Allowed 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.269 -0.972 . . . . 0.0 112.277 -168.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.423 ' N ' ' CG ' ' A' ' 170' ' ' TYR . . . -87.63 55.51 4.43 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.742 -166.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.573 ' N ' ' CD1' ' A' ' 172' ' ' PHE . 2.1 m-85 -123.99 122.17 37.21 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.273 171.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.468 ' O ' ' HG2' ' A' ' 179' ' ' ARG . 3.1 t -86.36 163.65 17.52 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 166.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 84.75 125.19 1.33 Allowed Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 -176.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.56 19.86 0.53 Allowed 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 121.471 1.447 . . . . 0.0 114.033 -165.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -122.95 3.82 9.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.813 0.816 . . . . 0.0 109.682 175.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.481 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 39.06 51.79 1.97 Allowed 'General case' 0 C--N 1.346 0.444 0 CA-C-N 114.141 -1.391 . . . . 0.0 114.537 -179.44 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -106.82 -16.62 14.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.283 0.563 . . . . 0.0 109.854 174.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 173' ' ' THR . 19.7 mmm180 -56.62 -70.38 0.12 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.809 -174.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 41.1 t0 77.02 69.6 0.06 Allowed 'General case' 0 CA--C 1.502 -0.866 0 CA-C-O 121.907 0.86 . . . . 0.0 109.519 166.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.444 ' CD1' ' O ' ' A' ' 181' ' ' TYR . 38.6 p90 -86.13 65.85 9.29 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-O 122.741 1.258 . . . . 0.0 107.856 173.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.49 ' O ' ' HZ2' ' A' ' 217' ' ' TRP . 14.4 ptt180 -45.89 123.42 4.47 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.657 -1.61 . . . . 0.0 109.26 172.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 80.9 p -76.7 137.39 39.35 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.458 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -147.98 143.7 11.46 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -173.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.76 128.64 12.69 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.205 1.936 . . . . 0.0 111.337 174.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.752 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 92.4 m -84.23 119.01 24.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.417 0.627 . . . . 0.0 110.947 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' PHE . . . . . 0.587 ' HB3' ' O ' ' A' ' 195' ' ' CYS . 69.1 m-85 -95.34 144.75 25.63 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.958 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.529 ' O ' ' HD2' ' A' ' 215' ' ' ARG . 20.2 p -108.98 -6.04 15.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -167.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.5 p -167.28 116.17 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.502 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.553 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.1 mt -133.86 127.07 51.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -170.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.9 m -128.33 -166.08 1.58 Allowed 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 160.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -63.04 -5.99 3.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 118.943 0.792 . . . . 0.0 110.453 173.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -76.95 -72.75 0.33 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.293 -177.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.517 ' SD ' ' HA2' ' A' ' 197' ' ' GLY . 13.6 ttt -149.96 160.09 43.88 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -173.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.587 ' O ' ' HB3' ' A' ' 187' ' ' PHE . 61.4 m -90.15 -32.17 16.76 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.167 0.508 . . . . 0.0 111.669 -176.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.469 ' HG3' ' OG1' ' A' ' 188' ' ' THR . 62.3 tt0 -148.09 -74.74 0.19 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.463 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.517 ' HA2' ' SD ' ' A' ' 194' ' ' MET . . . 125.78 -29.34 4.71 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -95.68 -24.2 16.65 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 119.845 -0.122 . . . . 0.0 111.206 173.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 58.57 79.81 0.2 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.266 0.555 . . . . 0.0 111.258 177.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 44.2 t -100.27 144.88 28.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.482 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -92.11 29.29 7.69 Favored Glycine 0 CA--C 1.499 -0.951 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 175.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.612 HG23 ' H ' ' A' ' 186' ' ' CYS . 0.0 OUTLIER -60.98 106.64 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 121.783 0.801 . . . . 0.0 108.843 173.107 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.0 t -94.69 123.9 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.816 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 16.7 t -155.24 -178.15 7.05 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.4 p -101.66 159.29 15.44 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 120.434 1.47 . . . . 0.0 109.311 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.54 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 42.2 tttm -56.11 -44.97 79.62 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 120.284 -0.567 . . . . 0.0 109.885 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.5 m -43.87 -56.81 3.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.371 173.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.526 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -55.58 -55.09 36.04 Favored 'General case' 0 CA--C 1.518 -0.261 0 O-C-N 123.755 0.659 . . . . 0.0 112.036 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 53.8 m -75.39 -18.7 59.88 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -171.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 79.9 m -89.67 -39.46 13.18 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 121.74 -0.6 . . . . 0.0 111.28 174.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . . . -67.8 -57.0 7.04 Favored 'General case' 0 C--N 1.345 0.383 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.689 HG22 ' HA2' ' A' ' 234' ' ' GLY . 18.8 p -94.08 157.45 16.08 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.346 174.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.1 t 68.42 -46.73 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 176.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 60.05 59.51 10.3 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 120.737 -0.744 . . . . 0.0 114.638 170.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.529 ' HD2' ' O ' ' A' ' 188' ' ' THR . 30.1 mmt180 -124.85 -84.95 0.64 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 117.525 0.663 . . . . 0.0 110.466 177.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.409 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -169.32 165.75 10.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' TRP . . . . . 0.752 ' HD1' ' SG ' ' A' ' 186' ' ' CYS . 18.5 t90 -153.39 148.4 26.66 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.552 0.215 . . . . 0.0 110.656 -175.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 221' ' ' CYS . . . 78.37 163.23 22.47 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 115.086 0.795 . . . . 0.0 115.086 167.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.513 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 21.6 m-70 -116.09 132.22 23.36 Favored Pre-proline 0 N--CA 1.453 -0.294 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 168.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.513 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 25.4 Cg_exo -63.3 151.28 69.42 Favored 'Cis proline' 0 C--O 1.232 0.18 0 C-N-CA 123.593 -1.419 . . . . 0.0 111.516 -2.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 84.9 m -54.99 120.19 6.53 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 124.175 0.922 . . . . 0.0 111.15 -175.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -115.85 121.41 42.3 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' MET . . . . . 0.409 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 0.0 OUTLIER -100.89 150.23 23.05 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.604 -172.444 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 74.1 m -143.35 148.46 44.28 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 120.799 0.333 . . . . 0.0 111.687 -175.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -63.27 168.38 11.13 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.546 2.164 . . . . 0.0 109.94 155.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.8 -118.71 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.997 0.427 . . . . 0.0 110.971 171.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.07 108.52 1.26 Allowed Pre-proline 0 C--N 1.322 -0.623 0 CA-C-O 121.179 0.514 . . . . 0.0 111.91 -174.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 211' ' ' ALA . 55.8 Cg_endo -74.91 -49.53 0.15 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.214 1.943 . . . . 0.0 112.667 -175.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.442 ' HB3' ' CD ' ' A' ' 230' ' ' PRO . 41.2 m80 -94.36 178.99 1.32 Allowed Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.442 ' CD ' ' HB3' ' A' ' 229' ' ' HIS . 36.6 Cg_exo -63.49 -7.5 12.63 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.0 1.134 . . . . 0.0 112.108 173.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' CYS . . . . . 0.495 ' SG ' ' HD3' ' A' ' 237' ' ' PRO . 20.0 t -65.4 144.61 56.96 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.712 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 31.4 mmt180 -75.07 142.77 43.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.361 -174.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.47 ' HG3' ' N ' ' A' ' 234' ' ' GLY . 28.0 ptt-85 -37.78 -53.57 1.27 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.496 1.123 . . . . 0.0 113.06 -177.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.689 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -71.15 0.36 31.62 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.22 -0.514 . . . . 0.0 114.224 -172.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' PHE . . . . . 0.801 ' CE2' ' HA2' ' A' ' 267' ' ' GLY . 1.8 m-85 -123.1 166.67 14.78 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 118.352 1.076 . . . . 0.0 111.843 -175.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.51 HD13 ' O ' ' A' ' 235' ' ' PHE . 0.2 OUTLIER -130.54 128.0 22.47 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 113.623 -1.626 . . . . 0.0 107.59 169.326 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.495 ' HD3' ' SG ' ' A' ' 231' ' ' CYS . 14.2 Cg_endo -61.03 117.61 4.4 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.321 2.014 . . . . 0.0 112.075 178.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -55.96 134.69 52.41 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.114 177.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 39.0 mt -73.98 -11.21 14.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.607 175.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -98.04 -58.1 2.06 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.296 -175.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 31.3 p -93.05 -43.8 8.71 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.777 -177.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 102.01 7.36 47.24 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -178.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -94.14 128.73 40.73 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.959 0.885 . . . . 0.0 109.797 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' CYS . . . . . 0.409 ' HB3' ' CB ' ' A' ' 235' ' ' PHE . 86.6 m -51.32 117.92 2.93 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.167 -1.833 . . . . 0.0 109.867 169.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -121.24 131.24 54.11 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.642 ' HB3' HG13 ' A' ' 266' ' ' VAL . 4.3 t70 -79.14 150.34 31.77 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 121.297 0.57 . . . . 0.0 110.384 -170.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.734 HG23 ' HG3' ' A' ' 249' ' ' GLU . 8.9 m -100.79 145.39 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.948 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.552 -178.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.455 ' HA ' ' CG ' ' A' ' 264' ' ' ASN . 2.2 m-20 -74.24 76.85 1.82 Allowed 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 167.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.734 ' HG3' HG23 ' A' ' 247' ' ' VAL . 55.4 mp0 -52.76 -35.07 55.67 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 123.722 0.639 . . . . 0.0 110.66 -170.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 32.3 m -53.88 -29.16 40.36 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.205 175.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -106.67 -47.44 3.75 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.633 0.73 . . . . 0.0 110.309 -175.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -63.15 -25.57 68.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.612 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.755 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.7 mp -122.65 79.96 47.97 Favored Pre-proline 0 C--O 1.243 0.726 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 173.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.525 ' HG2' HG12 ' A' ' 202' ' ' ILE . 10.2 Cg_endo -51.27 118.79 4.65 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.489 2.793 . . . . 0.0 114.649 -165.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 59.11 30.83 67.68 Favored Glycine 0 C--N 1.317 -0.518 0 CA-C-N 113.839 -1.528 . . . . 0.0 114.103 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.755 ' HB3' HG22 ' A' ' 253' ' ' ILE . 1.3 pt? -68.27 -25.79 65.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.565 0.683 . . . . 0.0 111.44 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' CYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 284' ' ' GLN . 48.2 t -102.66 82.39 2.13 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.581 0.705 . . . . 0.0 110.081 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -85.07 116.31 23.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.1 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 165.55 -41.25 0.28 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -170.63 -116.6 0.39 Allowed Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.502 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' ASN . . . . . 0.534 ' ND2' HD11 ' A' ' 263' ' ' ILE . 61.7 t30 -98.78 157.56 16.21 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -175.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 32.6 t -140.45 133.61 29.55 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.534 HD11 ' ND2' ' A' ' 261' ' ' ASN . 28.4 mt -138.13 116.72 13.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.022 0.439 . . . . 0.0 110.54 -169.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.455 ' CG ' ' HA ' ' A' ' 248' ' ' ASP . 64.4 t30 -77.1 121.29 23.38 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.655 -174.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 8.4 t -106.3 160.9 15.02 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.661 157.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.768 HG12 ' CE1' ' A' ' 235' ' ' PHE . 1.7 t -72.39 119.52 19.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.801 ' HA2' ' CE2' ' A' ' 235' ' ' PHE . . . 113.71 -22.33 14.95 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.376 -174.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 267' ' ' GLY . 15.6 t 174.21 163.65 0.2 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.566 0.698 . . . . 0.0 111.103 -173.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 269' ' ' PHE . . . . . 0.402 ' CD1' ' HB2' ' A' ' 249' ' ' GLU . 13.1 p90 -111.48 153.53 26.03 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.231 -0.988 . . . . 0.0 108.759 177.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -111.64 135.85 51.67 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.444 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 64.7 m -109.48 160.33 16.3 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.656 -0.817 . . . . 0.0 111.142 178.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 261' ' ' ASN . 28.5 mmmt -135.35 95.38 3.27 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.47 176.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 13.7 m -76.05 161.29 75.98 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.161 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.433 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 27.7 Cg_exo -61.66 159.55 32.13 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 121.907 1.738 . . . . 0.0 109.968 170.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -57.76 145.73 33.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.515 0.197 . . . . 0.0 111.059 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.86 -28.9 3.89 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.13 -177.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 277' ' ' HIS . . . . . 0.707 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 17.1 m-70 -78.68 166.37 22.58 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 120.833 0.349 . . . . 0.0 111.228 -177.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -137.82 138.76 39.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.147 -176.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.625 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 51.4 tp -80.01 123.7 28.06 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.819 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.598 ' HB3' ' HB3' ' A' ' 285' ' ' LYS . 47.0 t30 -113.85 110.25 19.82 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.418 ' HA ' ' OE1' ' A' ' 284' ' ' GLN . 32.6 mt-10 -64.25 -14.96 58.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.717 -170.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.489 ' O ' ' HB ' ' A' ' 188' ' ' THR . 63.7 t -56.51 -38.84 58.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.908 0.385 . . . . 0.0 110.978 178.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 42.6 m -146.02 36.22 1.03 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.644 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 256' ' ' LEU . 8.3 mm100 34.49 48.32 0.28 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.41 0.684 . . . . 0.0 111.853 -170.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 285' ' ' LYS . . . . . 0.625 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 84.8 tttt -82.68 154.9 24.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.583 -172.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 23.2 m -141.02 85.75 2.0 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.707 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 19.0 mm-40 . . . . . 0 C--O 1.239 0.54 0 CA-C-O 118.392 -0.813 . . . . 0.0 108.904 -173.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.619 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 44.6 m-85 . . . . . 0 N--CA 1.449 -0.514 0 CA-C-O 120.51 0.195 . . . . 0.0 110.572 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 145' ' ' CYS . 20.4 pt -134.96 177.46 6.8 Favored 'Isoleucine or valine' 0 C--O 1.246 0.876 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.498 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.13 174.03 30.22 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.936 -175.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.7 p -70.79 -48.22 55.41 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 120.753 0.311 . . . . 0.0 110.948 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -96.54 5.87 49.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.949 176.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 141' ' ' ILE . 61.8 m 63.86 42.1 6.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.903 172.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.72 9.18 56.85 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.792 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.424 ' O ' HG12 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -115.13 113.63 43.71 Favored Pre-proline 0 C--O 1.222 -0.384 0 CA-C-N 117.645 0.723 . . . . 0.0 110.125 179.189 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.75 143.82 13.51 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.639 2.226 . . . . 0.0 112.612 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 12.7 p -71.08 112.84 6.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.655 -176.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.8 m -81.44 74.63 8.43 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.177 175.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -51.58 -64.33 0.85 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -173.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.6 m -91.9 13.33 18.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.47 0.652 . . . . 0.0 110.717 -169.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 74.13 131.96 0.23 Allowed Glycine 0 N--CA 1.436 -1.347 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.661 -177.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . 0.687 ' O ' HD23 ' A' ' 155' ' ' LEU . 1.7 m -61.49 156.9 18.3 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 113.942 -1.129 . . . . 0.0 109.858 171.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 154' ' ' CYS . 41.2 mt -137.93 178.1 7.37 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -174.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.636 HD22 ' C ' ' A' ' 155' ' ' LEU . 0.1 OUTLIER 35.43 31.25 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.979 1.312 . . . . 0.0 114.446 -178.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 63.31 35.54 92.2 Favored Glycine 0 N--CA 1.454 -0.132 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.593 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -79.24 -147.66 4.1 Favored Glycine 0 C--N 1.328 0.104 0 C-N-CA 121.286 -0.483 . . . . 0.0 113.442 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -157.93 126.44 5.53 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.251 -0.558 . . . . 0.0 110.624 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 166' ' ' CYS . 4.9 m -64.18 124.56 21.98 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 122.241 0.216 . . . . 0.0 110.942 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.812 HG22 ' HG2' ' A' ' 165' ' ' ARG . 1.3 m -116.31 -35.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.913 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.66 ' HB3' ' HB3' ' A' ' 165' ' ' ARG . . . -139.28 169.62 11.93 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.619 ' HD3' ' CE1' ' A' ' 140' ' ' TYR . 78.4 Cg_exo -51.16 107.14 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.316 2.01 . . . . 0.0 112.604 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 75.28 -11.35 1.1 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.471 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.812 ' HG2' HG22 ' A' ' 161' ' ' VAL . 18.3 ttp180 -83.45 90.74 7.24 Favored 'General case' 0 CA--C 1.488 -1.425 0 CA-C-O 121.652 0.739 . . . . 0.0 109.312 175.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 160' ' ' CYS . 34.5 t -84.61 145.04 28.23 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.648 167.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.538 ' HB2' HG11 ' A' ' 161' ' ' VAL . . . -92.38 129.23 38.37 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 35.7 m -106.6 132.53 52.49 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.267 0.979 . . . . 0.0 111.925 -167.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 52.6 m -57.07 -55.5 33.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 113.331 -1.759 . . . . 0.0 114.501 -167.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 17.1 t80 177.75 125.89 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.692 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 79.98 28.95 48.45 Favored Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.42 169.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.597 ' CE2' ' HA ' ' A' ' 180' ' ' ASP . 1.4 m-85 -118.34 121.25 39.92 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 118.797 -1.161 . . . . 0.0 110.502 166.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.561 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 4.3 t -89.23 140.11 29.81 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 96.45 128.59 5.81 Favored Glycine 0 N--CA 1.425 -2.038 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -171.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.18 9.76 0.81 Allowed 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.413 1.409 . . . . 0.0 113.229 -168.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.605 ' O ' HD12 ' A' ' 155' ' ' LEU . 41.3 tt0 -117.79 19.79 13.64 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.378 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.585 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.6 OUTLIER 24.31 59.54 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 117.228 2.307 . . . . 0.0 117.228 178.077 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -115.47 21.0 14.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.395 1.093 . . . . 0.0 109.028 168.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 20.6 mmt180 -113.3 81.53 1.52 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.658 -1.61 . . . . 0.0 107.603 175.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.597 ' HA ' ' CE2' ' A' ' 172' ' ' PHE . 2.3 m-20 -80.5 49.6 1.18 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.52 -167.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.561 ' HE2' ' N ' ' A' ' 173' ' ' THR . 20.4 p90 -86.32 98.64 11.08 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -87.27 155.14 20.19 Favored 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 118.296 -2.753 . . . . 0.0 106.763 175.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 19.8 p -86.06 135.45 33.62 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.049 -1.06 . . . . 0.0 109.618 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -153.64 155.09 25.94 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -73.77 129.25 13.29 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.16 1.907 . . . . 0.0 110.809 173.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 10.6 t -82.43 114.21 20.72 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . 0.538 ' HE1' ' O ' ' A' ' 218' ' ' GLY . 59.3 m-85 -94.29 138.93 31.71 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.773 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.554 ' O ' ' HD2' ' A' ' 215' ' ' ARG . 89.2 m -107.8 -19.76 13.43 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -163.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 25.4 t -150.47 115.62 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 121.467 -0.771 . . . . 0.0 109.613 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.731 ' CG1' ' HA ' ' A' ' 195' ' ' CYS . 16.5 mt -130.88 120.16 46.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 10.7 p -117.08 -166.5 1.18 Allowed 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 155.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -66.75 -5.29 11.48 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.841 0.829 . . . . 0.0 109.764 172.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -83.76 -73.79 0.4 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.224 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.475 ' O ' ' HA ' ' A' ' 190' ' ' ILE . 60.7 mtt -128.38 161.18 30.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.443 0.163 . . . . 0.0 110.966 -175.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.731 ' HA ' ' CG1' ' A' ' 190' ' ' ILE . 84.5 m -92.03 -25.55 18.76 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.572 173.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -161.27 -58.7 0.05 Allowed 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 169.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 125.78 -26.05 5.46 Favored Glycine 0 C--N 1.317 -0.48 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.619 170.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -118.13 -0.11 11.66 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 117.159 0.48 . . . . 0.0 111.294 176.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.444 ' O ' ' HB2' ' A' ' 200' ' ' SER . 4.1 mm? 62.75 175.48 0.15 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.83 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 199' ' ' LEU . 22.8 t 176.14 130.3 0.04 OUTLIER 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.543 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -84.23 36.32 2.92 Favored Glycine 0 CA--C 1.509 -0.343 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 174.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.97 104.3 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 122.331 1.062 . . . . 0.0 109.412 175.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 37.9 t -93.05 124.1 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 CA-C-N 113.841 -1.527 . . . . 0.0 109.631 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 20.2 t -154.64 -177.3 6.39 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 104.292 -2.484 . . . . 0.0 104.292 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.426 ' OG1' HD22 ' A' ' 208' ' ' LEU . 14.3 p -99.36 157.28 16.52 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 120.317 1.417 . . . . 0.0 109.014 176.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.699 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 36.5 tttm -56.61 -44.37 81.06 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 120.201 -0.599 . . . . 0.0 109.788 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.2 m -43.58 -54.87 4.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.892 174.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.52 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -55.14 -53.07 60.62 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 124.05 0.844 . . . . 0.0 111.322 177.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 94.6 m -63.69 -26.62 68.75 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -176.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 226' ' ' ALA . 60.9 m -85.79 -47.49 9.68 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 118.481 0.582 . . . . 0.0 110.008 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . 0.554 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . . . -67.23 -54.44 21.0 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -173.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.77 HG22 ' HA2' ' A' ' 234' ' ' GLY . 16.2 p -102.8 152.86 20.76 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.851 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER 66.12 -40.5 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.336 0.654 . . . . 0.0 112.14 -176.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.413 ' O ' ' HD3' ' A' ' 215' ' ' ARG . . . 61.01 59.06 10.75 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 119.134 0.879 . . . . 0.0 114.785 169.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.554 ' HD2' ' O ' ' A' ' 188' ' ' THR . 8.6 mmt85 -128.64 -90.12 0.5 Allowed 'General case' 0 C--O 1.245 0.827 0 CA-C-N 117.845 0.822 . . . . 0.0 111.847 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.575 ' CB ' HD12 ' A' ' 190' ' ' ILE . . . -165.93 168.46 15.74 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . 0.699 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 11.2 t90 -164.96 150.15 9.53 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . 0.538 ' O ' ' HE1' ' A' ' 187' ' ' PHE . . . 95.84 -174.06 31.29 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.305 -0.95 . . . . 0.0 114.245 168.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 220' ' ' PRO . 20.2 p80 -137.09 133.55 18.57 Favored Pre-proline 0 N--CA 1.444 -0.729 0 CA-C-O 121.248 0.547 . . . . 0.0 111.163 -175.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 219' ' ' HIS . 72.2 Cg_endo -86.11 117.05 4.09 Favored 'Cis proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.408 -1.913 . . . . 0.0 112.233 -5.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 70.3 m 33.23 94.57 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.768 1.227 . . . . 0.0 113.781 177.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 36.3 mt-10 -101.17 113.63 26.84 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.76 139.5 35.34 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.779 0.323 . . . . 0.0 111.253 -170.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 5.9 p -145.62 155.98 52.74 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.926 -175.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.64 166.89 14.53 Favored 'Trans proline' 0 CA--C 1.504 -1.025 0 C-N-CA 122.27 1.98 . . . . 0.0 111.339 167.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 210' ' ' CYS . . . -63.75 -122.98 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 O-C-N 123.969 0.793 . . . . 0.0 111.794 171.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.68 108.97 1.22 Allowed Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.533 -173.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.554 ' HD3' ' HA ' ' A' ' 211' ' ' ALA . 73.8 Cg_endo -80.58 -57.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.71 2.273 . . . . 0.0 113.168 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 230' ' ' PRO . 13.6 m-70 -84.15 153.56 63.01 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 229' ' ' HIS . 6.1 Cg_exo -78.12 64.75 8.39 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.415 2.077 . . . . 0.0 112.543 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 80.6 m -119.48 -103.85 0.4 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 172.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.646 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 59.5 mtt180 -145.45 134.43 22.57 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 172.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -39.85 -41.97 1.23 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.77 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -73.45 9.7 7.44 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.417 -0.897 . . . . 0.0 113.882 -176.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . 0.646 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 6.1 m-85 -124.05 146.97 48.22 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 122.099 0.952 . . . . 0.0 112.595 -171.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.442 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.5 OUTLIER -122.6 129.02 25.2 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 114.009 -1.451 . . . . 0.0 108.432 171.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -62.04 113.39 1.85 Allowed 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.097 1.865 . . . . 0.0 111.202 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -48.48 128.67 15.16 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.512 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 26.9 pt -75.75 4.18 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.587 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -110.97 -56.73 2.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.008 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 36.0 p -94.42 -37.53 11.39 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.01 -176.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 100.93 0.17 55.06 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.175 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -81.62 129.94 34.87 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.784 0.802 . . . . 0.0 110.578 -176.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' CYS . . . . . 0.425 ' C ' ' HD1' ' A' ' 235' ' ' PHE . 2.2 m -61.44 115.05 3.58 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 113.816 -1.538 . . . . 0.0 109.371 173.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.496 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 45.4 tt0 -119.57 139.74 51.66 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.187 -177.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . 0.695 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 20.0 t70 -77.24 145.43 37.55 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -177.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.654 HG23 ' HG3' ' A' ' 249' ' ' GLU . 15.1 m -100.15 145.26 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.533 ' HB3' ' HG2' ' A' ' 251' ' ' GLN . 10.4 t70 -73.63 80.51 1.51 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 165.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.654 ' HG3' HG23 ' A' ' 247' ' ' VAL . 36.8 mp0 -51.63 -34.85 39.56 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.175 0.512 . . . . 0.0 110.334 -174.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.524 ' HB2' ' OD2' ' A' ' 248' ' ' ASP . 62.8 m -52.58 -44.22 65.78 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.501 173.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . 0.533 ' HG2' ' HB3' ' A' ' 248' ' ' ASP . 2.2 pt20 -90.16 -32.09 16.78 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.68 0.752 . . . . 0.0 110.401 -173.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.1 -17.43 31.04 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.942 -170.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.757 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.1 mp -125.55 79.93 66.71 Favored Pre-proline 0 C--O 1.239 0.551 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -39.41 114.23 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 124.446 3.431 . . . . 0.0 115.48 -172.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 57.74 34.37 70.43 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 113.637 -1.619 . . . . 0.0 114.174 174.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.757 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.9 OUTLIER -73.54 -24.51 60.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 118.16 0.98 . . . . 0.0 110.905 177.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . 0.505 ' HA ' ' HB3' ' A' ' 284' ' ' GLN . 50.5 t -90.49 114.69 26.93 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -103.77 83.36 2.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.267 0.556 . . . . 0.0 110.609 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -158.9 -105.49 0.21 Allowed Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.185 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -124.29 -88.33 0.8 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.525 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' ASN . . . . . 0.618 ' HB2' ' HB3' ' A' ' 272' ' ' LYS . 10.2 m120 -94.84 157.65 15.83 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 11.8 t -137.85 126.12 23.14 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 173.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 41.0 mt -132.13 169.78 21.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -171.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.525 ' ND2' ' HB3' ' A' ' 269' ' ' PHE . 0.9 OUTLIER -134.96 130.28 35.55 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 117.248 -1.781 . . . . 0.0 113.835 -174.249 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 1.7 t -113.61 163.96 14.29 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.532 163.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.695 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 4.1 m -73.12 130.0 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 C-N-CA 119.312 -0.955 . . . . 0.0 108.719 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.525 ' CA ' ' HE2' ' A' ' 235' ' ' PHE . . . 98.2 -17.52 58.49 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.959 -175.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 41.9 t -179.69 150.74 0.42 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.532 1.166 . . . . 0.0 110.524 -173.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . 0.525 ' HB3' ' ND2' ' A' ' 264' ' ' ASN . 30.2 p90 -96.43 160.28 14.49 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.61 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -116.77 117.59 30.19 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -177.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . 0.477 ' HB2' HD22 ' A' ' 279' ' ' LEU . 68.8 m -102.61 132.39 48.74 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.237 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.618 ' HB3' ' HB2' ' A' ' 261' ' ' ASN . 22.7 ttpp -101.18 122.52 43.78 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.131 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 56.6 m -107.1 145.1 30.46 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.114 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.532 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 38.9 Cg_exo -57.97 156.34 29.27 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.636 2.224 . . . . 0.0 110.842 169.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -54.41 146.37 16.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.073 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.15 -29.67 3.44 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.803 -177.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' HIS . . . . . 0.682 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 29.8 m-70 -81.25 162.66 23.44 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 120.986 0.422 . . . . 0.0 110.728 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -146.63 116.83 7.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.044 -171.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.477 HD22 ' HB2' ' A' ' 271' ' ' CYS . 45.2 tp -63.13 127.75 32.68 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.977 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -114.8 101.57 9.19 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -70.17 -8.02 46.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.724 0.297 . . . . 0.0 111.339 -173.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 51.5 t -67.68 -31.77 53.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.514 0.674 . . . . 0.0 110.18 172.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 30.7 p -139.68 28.93 2.15 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.015 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . 0.505 ' HB3' ' HA ' ' A' ' 257' ' ' CYS . 0.9 OUTLIER 29.46 44.87 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.166 0.986 . . . . 0.0 113.292 -172.476 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -112.36 127.24 55.95 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.906 -172.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 98.0 m -88.03 107.62 18.83 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 171.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.682 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 8.9 tp10 . . . . . 0 C--O 1.244 0.792 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.669 ' CE2' ' HD3' ' A' ' 163' ' ' PRO . 51.6 m-85 . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 120.932 0.396 . . . . 0.0 110.001 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.507 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 23.9 pt -137.21 -173.15 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.179 -177.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.75 176.5 46.84 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.649 -174.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.8 p -75.08 -32.75 61.54 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.596 -0.355 . . . . 0.0 111.726 -176.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -109.72 16.01 22.38 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.981 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 60.7 m 61.71 30.19 18.36 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.634 175.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.05 2.86 61.8 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.733 -1.223 . . . . 0.0 113.112 -174.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.507 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 0.0 OUTLIER -109.72 103.93 54.27 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 117.434 0.617 . . . . 0.0 110.192 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.89 149.82 26.39 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.468 2.112 . . . . 0.0 112.553 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 149' ' ' VAL . 8.2 p -80.07 105.14 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 122.118 0.961 . . . . 0.0 112.179 -174.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.8 m -80.69 82.41 6.7 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.958 173.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.496 ' HB2' HD22 ' A' ' 164' ' ' ASN . 2.9 mt-10 -51.04 -64.91 0.66 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -175.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 31.2 m -97.07 9.55 41.77 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.083 0.468 . . . . 0.0 110.862 -166.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 80.23 131.67 0.99 Allowed Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.333 -174.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . 0.536 ' O ' HD23 ' A' ' 155' ' ' LEU . 85.7 m -72.21 159.43 34.11 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.323 -0.939 . . . . 0.0 108.881 172.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.651 HD12 ' O ' ' A' ' 176' ' ' GLN . 76.6 mt -141.79 164.35 30.43 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.719 0.295 . . . . 0.0 110.517 -167.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.451 ' HB2' ' CZ ' ' A' ' 172' ' ' PHE . 10.5 t30 52.0 24.43 2.63 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.413 1.07 . . . . 0.0 111.364 -166.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.05 38.41 95.96 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.39 -173.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.14 -151.6 0.45 Allowed Glycine 0 CA--C 1.524 0.596 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.42 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -151.51 119.29 6.14 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 122.0 -0.706 . . . . 0.0 111.894 -175.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.27 125.76 22.06 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 176.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 165' ' ' ARG . 20.0 m -118.06 -39.36 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 120.615 0.245 . . . . 0.0 110.966 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.627 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -140.63 171.19 8.05 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.669 ' HD3' ' CE2' ' A' ' 140' ' ' TYR . 87.3 Cg_exo -52.02 110.69 0.47 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 121.872 1.714 . . . . 0.0 111.988 175.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.496 HD22 ' HB2' ' A' ' 151' ' ' GLU . 17.6 t-20 77.11 -14.35 0.85 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.97 0.908 . . . . 0.0 110.793 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.627 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 1.7 mtm-85 -86.65 88.51 7.68 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 121.19 0.519 . . . . 0.0 110.151 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 73.8 m -82.31 145.98 29.67 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.965 166.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -89.75 119.32 30.05 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 175.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 73.6 m -98.12 130.1 44.91 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.97 0.794 . . . . 0.0 111.249 -171.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 16.4 m -53.8 -56.86 13.73 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -167.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.441 ' HD2' ' N ' ' A' ' 171' ' ' GLY . 21.2 t80 -158.19 -86.51 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.131 -1.027 . . . . 0.0 112.332 -169.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.441 ' N ' ' HD2' ' A' ' 170' ' ' TYR . . . -90.76 44.64 2.88 Favored Glycine 0 CA--C 1.498 -1.028 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.378 -166.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.608 ' HB3' ' HA ' ' A' ' 177' ' ' CYS . 3.1 m-85 -118.69 129.49 55.31 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.401 173.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.719 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 7.4 t -103.4 141.44 35.95 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 94.59 124.65 4.16 Favored Glycine 0 C--N 1.298 -1.542 0 N-CA-C 107.916 -2.074 . . . . 0.0 107.916 -168.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -72.21 19.55 0.3 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.934 1.756 . . . . 0.0 113.175 -166.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.651 ' O ' HD12 ' A' ' 155' ' ' LEU . 45.2 tt0 -122.58 15.21 10.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 176.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.608 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.6 OUTLIER 28.68 56.37 0.11 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 117.314 2.339 . . . . 0.0 117.314 177.549 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -111.46 22.05 15.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 122.34 1.066 . . . . 0.0 108.873 167.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.588 ' HD2' ' O ' ' A' ' 173' ' ' THR . 92.3 mtt180 -116.07 86.88 2.56 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.222 -1.353 . . . . 0.0 109.007 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.483 ' HA ' ' CE2' ' A' ' 172' ' ' PHE . 12.0 p-10 -85.63 48.63 1.62 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.547 -168.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.719 ' HE2' ' N ' ' A' ' 173' ' ' THR . 25.0 p90 -85.6 95.67 9.41 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -78.28 162.63 26.38 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 118.781 -2.449 . . . . 0.0 108.681 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 75.3 p -96.26 138.64 33.56 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.227 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -159.19 162.12 32.51 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.095 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -83.13 143.86 11.58 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.842 2.361 . . . . 0.0 111.889 173.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 4.9 t -96.71 115.82 28.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.959 0.409 . . . . 0.0 110.252 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . 0.425 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 19.5 m-85 -95.73 149.09 21.87 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.982 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.496 ' HA ' ' CB ' ' A' ' 215' ' ' ARG . 6.6 m -117.13 -15.08 10.53 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -167.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 26.2 t -145.66 114.35 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 O-C-N 121.176 -0.953 . . . . 0.0 110.709 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.594 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.5 mt -134.87 118.95 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -173.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.3 m -115.56 -166.84 1.17 Allowed 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 155.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -68.49 -5.06 17.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.761 0.791 . . . . 0.0 109.991 172.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -73.3 -74.01 0.19 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.353 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 62.3 mtt -149.67 160.68 43.32 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.594 ' HA ' HG12 ' A' ' 190' ' ' ILE . 55.5 m -89.52 -19.48 24.98 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.652 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.581 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 36.6 tt0 166.06 -85.9 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.204 171.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.436 ' H ' ' HB3' ' A' ' 196' ' ' GLN . . . 126.43 -27.24 5.04 Favored Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 171.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -82.25 69.16 8.93 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 167.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.424 ' H ' ' CD1' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -63.73 142.44 58.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.36 0.6 . . . . 0.0 111.023 -175.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 29.7 t -113.84 143.52 44.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.471 -175.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.95 22.28 8.38 Favored Glycine 0 CA--C 1.501 -0.783 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.179 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.758 HD12 ' HA ' ' A' ' 253' ' ' ILE . 1.5 tt -60.09 99.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 171.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 25.2 t -86.91 95.11 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.533 0 CA-C-O 123.918 1.818 . . . . 0.0 108.36 171.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.461 ' HB3' HD23 ' A' ' 208' ' ' LEU . 4.9 m -133.45 -179.03 5.26 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 111.123 -2.762 . . . . 0.0 106.072 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 27.5 p -103.29 166.74 10.25 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.131 -1.028 . . . . 0.0 112.323 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.655 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 21.9 tttp -61.13 -41.79 97.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.345 173.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 30.3 m -45.05 -52.04 9.4 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 114.515 -1.22 . . . . 0.0 109.409 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.633 HD11 HG11 ' A' ' 247' ' ' VAL . 8.6 tp -63.09 -49.27 75.15 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 112.53 -2.123 . . . . 0.0 110.606 -174.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . 0.442 ' CB ' ' HB2' ' A' ' 217' ' ' TRP . 88.0 m -68.51 -22.4 64.53 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.543 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 20.9 m -81.18 -45.2 16.72 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 123.681 0.613 . . . . 0.0 110.672 173.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.17 -52.35 35.55 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -172.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.619 HG22 ' HA2' ' A' ' 234' ' ' GLY . 17.7 p -105.56 152.78 22.65 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.198 177.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 1.4 t 67.55 -45.05 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 123.584 0.754 . . . . 0.0 112.218 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.671 ' O ' ' HD2' ' A' ' 215' ' ' ARG . . . 55.35 59.43 10.48 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 118.559 0.618 . . . . 0.0 114.499 173.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.671 ' HD2' ' O ' ' A' ' 214' ' ' GLY . 17.4 mmm180 -125.64 -75.98 0.59 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.226 0.513 . . . . 0.0 111.048 177.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.514 ' CB ' HD11 ' A' ' 190' ' ' ILE . . . -171.1 163.39 7.29 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 118.642 0.656 . . . . 0.0 109.88 174.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . 0.684 ' O ' ' HB2' ' A' ' 222' ' ' GLU . 19.1 t90 -158.81 142.77 15.37 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 106.15 179.03 23.41 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.144 -1.027 . . . . 0.0 113.954 170.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 220' ' ' PRO . 36.2 t-80 -135.52 133.44 20.33 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -177.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 219' ' ' HIS . 11.1 Cg_endo -89.6 118.36 3.64 Favored 'Cis proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.496 -1.46 . . . . 0.0 111.733 -4.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 68.7 m 45.17 88.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.684 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 12.3 mt-10 -107.27 107.23 18.06 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' MET . . . . . 0.46 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 0.6 OUTLIER -75.21 144.06 42.85 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.746 -166.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' CYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 216' ' ' ALA . 0.8 OUTLIER -123.53 120.95 26.85 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -174.144 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -62.14 167.04 11.47 Favored 'Trans proline' 0 CA--C 1.499 -1.239 0 C-N-CA 122.089 1.859 . . . . 0.0 110.563 159.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.35 -142.24 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 122.289 1.042 . . . . 0.0 110.397 163.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.37 106.37 0.65 Allowed Pre-proline 0 C--N 1.298 -1.668 0 CA-C-N 113.82 -1.536 . . . . 0.0 112.168 -169.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.1 -57.57 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.234 2.623 . . . . 0.0 112.87 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.403 ' HB3' ' HD2' ' A' ' 230' ' ' PRO . 48.0 m80 -95.99 162.8 22.73 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 229' ' ' HIS . 26.4 Cg_endo -64.31 83.27 0.15 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.135 1.89 . . . . 0.0 112.271 174.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' CYS . . . . . 0.429 ' SG ' ' HB2' ' A' ' 235' ' ' PHE . 34.1 t -157.91 152.67 25.12 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.196 -1.365 . . . . 0.0 107.504 177.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.583 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 24.0 mtt180 -64.04 131.68 48.29 Favored 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.101 -176.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -38.56 -45.95 1.13 Allowed 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -175.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.619 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -72.99 7.22 10.05 Favored Glycine 0 C--N 1.319 -0.385 0 C-N-CA 120.718 -0.753 . . . . 0.0 114.256 -173.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . 0.583 ' CD1' ' HB2' ' A' ' 232' ' ' ARG . 3.5 m-85 -122.28 150.66 42.02 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.942 0.877 . . . . 0.0 112.61 -171.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.464 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.1 OUTLIER -124.62 121.34 25.78 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 114.309 -1.314 . . . . 0.0 107.819 169.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.49 115.27 2.33 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.093 2.529 . . . . 0.0 112.26 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -50.62 137.9 18.89 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.853 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 41.8 mt -71.17 -16.34 19.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.207 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 -100.9 -62.46 1.24 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.617 0.722 . . . . 0.0 109.973 -174.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 32.2 p -80.18 -40.1 27.95 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.382 -176.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 98.05 8.26 55.52 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -90.81 127.03 36.2 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 121.852 0.834 . . . . 0.0 110.615 -177.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 235' ' ' PHE . 95.8 m -50.49 121.0 5.12 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 113.227 -1.806 . . . . 0.0 110.85 172.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -120.36 133.32 55.46 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . 0.582 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 7.2 t70 -77.18 149.68 35.54 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -173.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.701 HG23 ' HG3' ' A' ' 249' ' ' GLU . 11.0 m -100.15 145.26 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -177.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -72.54 75.89 1.07 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 167.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.701 ' HG3' HG23 ' A' ' 247' ' ' VAL . 17.1 mp0 -53.24 -37.59 62.21 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.271 0.628 . . . . 0.0 110.654 -169.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 56.4 m -51.13 -35.83 37.56 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.096 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -100.43 -37.63 8.76 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.865 0.84 . . . . 0.0 110.246 -176.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.432 ' HB1' HD21 ' A' ' 208' ' ' LEU . . . -71.13 -17.72 62.55 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.374 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.8 HG22 ' HB3' ' A' ' 256' ' ' LEU . 5.3 mp -135.31 73.24 64.25 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 173.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.592 ' HD2' HG13 ' A' ' 202' ' ' ILE . 36.0 Cg_endo -62.65 124.28 13.85 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.509 2.139 . . . . 0.0 112.902 -170.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' A' ' 258' ' ' GLN . . . 95.18 -4.95 67.9 Favored Glycine 0 C--N 1.308 -0.995 0 CA-C-N 114.429 -1.259 . . . . 0.0 113.437 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.8 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.5 OUTLIER -68.03 -39.73 83.04 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 118.392 1.096 . . . . 0.0 110.0 -176.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 46.6 t -122.95 69.47 0.99 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.493 0.663 . . . . 0.0 109.281 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . 0.41 ' HB2' ' HA2' ' A' ' 255' ' ' GLY . 27.4 tp60 -107.46 16.04 24.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.964 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -87.55 -4.73 79.69 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.796 178.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -169.08 -137.61 2.29 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' ASN . . . . . 0.538 ' OD1' ' HE2' ' A' ' 272' ' ' LYS . 2.9 t-20 -88.66 156.82 18.8 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 9.1 t -145.79 125.12 13.04 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.427 ' HB ' ' HB2' ' A' ' 270' ' ' GLU . 7.6 mt -130.05 165.74 29.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 -174.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.562 ' ND2' ' HB3' ' A' ' 269' ' ' PHE . 0.8 OUTLIER -132.2 121.49 23.76 Favored 'General case' 0 CA--C 1.494 -1.177 0 C-N-CA 117.461 -1.695 . . . . 0.0 114.627 -177.051 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.1 t -105.83 159.83 15.71 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.777 167.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.558 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 35.7 m -72.28 121.4 22.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.451 ' HA2' ' HE1' ' A' ' 235' ' ' PHE . . . 114.42 -30.77 6.78 Favored Glycine 0 C--N 1.316 -0.547 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.423 -169.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.0 m -179.22 163.97 1.34 Allowed 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 118.383 1.091 . . . . 0.0 110.164 -169.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . 0.562 ' HB3' ' ND2' ' A' ' 264' ' ' ASN . 34.9 p90 -104.7 153.24 21.52 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.803 174.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . 0.427 ' HB2' ' HB ' ' A' ' 263' ' ' ILE . 13.9 mt-10 -108.27 118.2 36.13 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.454 -175.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 99.5 m -105.71 160.52 15.15 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.415 0.626 . . . . 0.0 110.372 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.538 ' HE2' ' OD1' ' A' ' 261' ' ' ASN . 46.2 mtmt -138.69 123.27 18.52 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.194 176.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 68.0 m -99.45 137.28 20.28 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.091 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.459 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 86.3 Cg_exo -48.94 152.71 4.41 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.913 2.409 . . . . 0.0 111.055 170.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -48.96 134.27 17.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.054 0.454 . . . . 0.0 111.811 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 88.63 -36.21 3.48 Favored Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.53 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' HIS . . . . . 0.546 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 24.4 m-70 -71.1 156.99 38.95 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.565 0.698 . . . . 0.0 111.329 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -140.94 129.26 22.37 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.924 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 42.4 tp -62.18 125.24 23.21 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.423 0.63 . . . . 0.0 111.016 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.593 ' OD1' ' HB ' ' A' ' 282' ' ' VAL . 22.0 t-20 -111.52 97.16 6.54 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -64.6 -15.73 61.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.455 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.593 ' HB ' ' OD1' ' A' ' 280' ' ' ASN . 48.1 t -57.58 -29.39 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 120.83 0.348 . . . . 0.0 110.416 173.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.604 ' O ' ' HG3' ' A' ' 285' ' ' LYS . 19.5 p -142.47 25.75 1.83 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.543 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . 0.586 ' HB2' ' O ' ' A' ' 256' ' ' LEU . 79.0 mm-40 28.57 41.93 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -167.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . 0.604 ' HG3' ' O ' ' A' ' 283' ' ' SER . 90.7 mttt -115.65 135.72 53.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.306 0.575 . . . . 0.0 111.836 -173.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 94.1 m -87.61 112.45 22.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.825 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 10.8 tp10 . . . . . 0 N--CA 1.433 -1.289 0 CA-C-O 118.12 -0.943 . . . . 0.0 108.499 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.667 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 91.3 m-85 . . . . . 0 C--O 1.234 0.242 0 CA-C-O 121.14 0.495 . . . . 0.0 111.764 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.416 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 34.7 pt -132.71 -174.43 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.41 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.67 -170.81 34.04 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.904 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.1 p -77.83 -44.11 28.37 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.918 0.389 . . . . 0.0 111.7 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -111.35 21.12 16.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.084 -176.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 27.2 m 66.51 27.24 9.77 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 124.009 0.818 . . . . 0.0 110.551 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.2 -4.13 88.4 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.859 -172.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.416 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 0.0 OUTLIER -117.57 110.11 41.03 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 118.292 1.046 . . . . 0.0 110.976 179.089 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.437 ' HB3' ' CE1' ' A' ' 140' ' ' TYR . 94.2 Cg_endo -80.78 149.89 18.37 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.978 2.452 . . . . 0.0 112.385 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 149' ' ' VAL . 14.3 p -83.12 103.74 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-O 121.702 0.763 . . . . 0.0 111.089 -172.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.22 88.13 5.5 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.636 171.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -57.94 -53.85 53.62 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -169.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 34.7 m -95.82 16.87 16.41 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.199 0.524 . . . . 0.0 111.112 -169.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 77.26 129.5 0.41 Allowed Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.3 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . 0.405 ' O ' HD23 ' A' ' 155' ' ' LEU . 35.5 m -76.1 150.85 37.18 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.421 -1.389 . . . . 0.0 110.129 172.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.672 HD12 ' O ' ' A' ' 176' ' ' GLN . 76.7 mt -147.72 167.34 24.89 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.019 -168.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.676 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 2.3 t-20 48.87 27.02 1.46 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.03 -164.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 66.39 37.22 92.57 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.756 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -68.66 -150.87 0.33 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.64 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -157.35 126.76 6.0 Favored 'General case' 0 C--N 1.318 -0.761 0 O-C-N 122.191 -0.594 . . . . 0.0 111.214 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -67.28 120.19 13.4 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 175.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.819 HG22 ' HG2' ' A' ' 165' ' ' ARG . 1.0 OUTLIER -109.16 -43.77 6.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.211 179.232 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.639 ' HB3' ' HB3' ' A' ' 165' ' ' ARG . . . -134.28 170.77 10.42 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 173.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.667 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 75.7 Cg_exo -54.34 111.36 0.69 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.282 1.988 . . . . 0.0 112.681 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 69.91 -1.82 2.23 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.928 0.891 . . . . 0.0 110.736 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.819 ' HG2' HG22 ' A' ' 161' ' ' VAL . 5.7 ttp180 -93.45 89.24 6.23 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 121.5 0.667 . . . . 0.0 109.216 169.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 49.3 t -92.41 139.83 30.2 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.375 171.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -90.52 106.91 18.82 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 80.3 m -84.68 134.79 34.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.617 -171.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.406 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 28.6 m -55.21 -55.53 30.23 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -168.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -175.7 117.89 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.016 0.436 . . . . 0.0 111.328 -178.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 76.94 42.41 20.24 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.433 -0.803 . . . . 0.0 114.28 165.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.676 ' CE2' ' HB2' ' A' ' 156' ' ' ASN . 62.3 m-85 -120.93 140.31 52.02 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 117.59 0.695 . . . . 0.0 112.146 163.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.822 HG23 ' CE2' ' A' ' 181' ' ' TYR . 39.6 p -87.1 119.24 27.12 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.724 0.774 . . . . 0.0 110.617 -177.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' A' ' 176' ' ' GLN . . . 101.84 144.69 15.2 Favored Glycine 0 N--CA 1.425 -2.048 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.18 20.62 0.4 Allowed 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.162 1.241 . . . . 0.0 112.306 -172.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.672 ' O ' HD12 ' A' ' 155' ' ' LEU . 35.7 tt0 -113.73 1.04 14.73 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.789 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.672 ' HA ' ' CB ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 36.32 62.3 0.72 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 118.018 2.599 . . . . 0.0 118.018 178.044 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -120.63 1.04 10.55 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 119.869 -0.732 . . . . 0.0 111.835 174.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 32.7 mmt180 -106.62 100.35 9.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.335 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.665 ' HA ' ' CE1' ' A' ' 172' ' ' PHE . 1.3 m-20 -74.63 100.63 4.0 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.291 -170.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.822 ' CE2' HG23 ' A' ' 173' ' ' THR . 19.7 p90 -140.05 77.97 1.64 Allowed 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 172.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 63.5 mtt85 -73.3 127.43 32.63 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 118.597 -2.564 . . . . 0.0 108.503 175.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.401 HG22 ' CG1' ' A' ' 203' ' ' VAL . 3.9 p -78.13 164.52 24.91 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.978 -176.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.629 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . 157.29 142.31 3.37 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.651 -162.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.53 132.47 6.8 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.821 2.347 . . . . 0.0 112.096 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . 0.767 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 76.8 m -90.86 112.05 23.72 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.408 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . 0.47 ' HB3' ' O ' ' A' ' 195' ' ' CYS . 82.3 m-85 -89.0 154.81 19.91 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.17 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.451 ' OG1' ' HG3' ' A' ' 196' ' ' GLN . 35.1 p -105.27 -18.86 13.99 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -165.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 p -167.95 118.28 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-N 118.889 0.768 . . . . 0.0 110.474 -174.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.501 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.1 mt -130.35 123.11 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -169.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.402 ' C ' ' H ' ' A' ' 193' ' ' GLN . 15.1 m -126.44 -166.48 1.58 Allowed 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 162.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -61.08 -8.2 3.19 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.321 0.964 . . . . 0.0 110.251 174.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.402 ' H ' ' C ' ' A' ' 191' ' ' SER . 96.3 mt-30 -75.66 -76.05 0.16 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.114 -175.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.429 ' O ' ' HA ' ' A' ' 190' ' ' ILE . 70.7 mtm -144.42 168.58 19.76 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.501 ' HA ' HG12 ' A' ' 190' ' ' ILE . 67.6 m -86.67 -36.54 18.68 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 122.335 1.064 . . . . 0.0 109.292 175.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.451 ' HG3' ' OG1' ' A' ' 188' ' ' THR . 54.8 tt0 -148.14 -67.44 0.24 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.731 173.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 123.69 -0.26 9.28 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.508 171.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -119.0 -19.8 8.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.343 -0.428 . . . . 0.0 111.076 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 63.24 97.11 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.222 0.534 . . . . 0.0 111.077 -176.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 42.4 t -113.68 140.18 48.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.709 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -94.08 25.68 20.79 Favored Glycine 0 CA--C 1.505 -0.533 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.986 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.628 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -61.72 107.0 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 121.989 0.9 . . . . 0.0 109.388 174.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.401 ' CG1' HG22 ' A' ' 183' ' ' THR . 3.0 t -98.27 120.98 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 CA-C-O 122.734 1.254 . . . . 0.0 110.193 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 14.3 t -152.91 -178.76 7.11 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 103.137 -2.912 . . . . 0.0 103.137 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.707 HG21 ' HA ' ' A' ' 181' ' ' TYR . 8.0 p -102.38 161.44 13.7 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 121.197 1.817 . . . . 0.0 108.763 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.632 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 53.6 tttm -57.24 -43.22 82.73 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.997 177.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.5 m -47.9 -54.96 11.0 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.925 175.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.549 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -58.37 -55.07 39.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.716 179.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 65.8 m -74.45 -20.95 59.83 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -170.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 226' ' ' ALA . 80.0 m -90.22 -38.81 13.19 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 121.878 -0.514 . . . . 0.0 110.595 176.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . 0.533 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . . . -67.74 -57.73 5.84 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.716 HG22 ' HA2' ' A' ' 234' ' ' GLY . 3.4 p -92.53 160.81 14.87 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.385 -1.279 . . . . 0.0 107.765 175.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 27.3 m 58.01 -35.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 125.196 1.398 . . . . 0.0 114.668 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 58.11 60.45 8.93 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 119.548 1.067 . . . . 0.0 114.8 167.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.401 ' HE ' ' HA ' ' A' ' 188' ' ' THR . 0.0 OUTLIER -118.85 -95.02 0.49 Allowed 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.356 175.476 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.405 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -164.02 163.17 23.41 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 174.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . 0.767 ' HD1' ' SG ' ' A' ' 186' ' ' CYS . 17.7 t90 -151.45 146.33 25.85 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 121.56 -0.712 . . . . 0.0 109.794 -174.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 221' ' ' CYS . . . 86.75 -179.93 48.97 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.167 -0.539 . . . . 0.0 113.774 171.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.646 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 8.9 p80 -141.28 131.1 12.89 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 175.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.646 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 10.5 Cg_endo -53.63 149.51 16.15 Favored 'Cis proline' 0 C--N 1.352 0.763 0 C-N-CA 123.772 -1.345 . . . . 0.0 111.856 -5.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 22.2 m -63.43 83.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.775 0.672 . . . . 0.0 112.52 -170.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -58.55 123.0 14.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.63 0.252 . . . . 0.0 110.619 173.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' MET . . . . . 0.405 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 0.0 OUTLIER -107.36 147.32 30.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.259 -175.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 18.8 m -142.0 148.51 49.02 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -173.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -65.2 166.1 20.04 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.059 1.839 . . . . 0.0 109.151 156.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 210' ' ' CYS . . . -67.27 -107.32 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.314 0.578 . . . . 0.0 111.564 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' GLN . . . . . 0.482 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . 0.7 OUTLIER -58.07 113.05 5.69 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.325 -172.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.533 ' HD3' ' HA ' ' A' ' 211' ' ' ALA . 18.8 Cg_endo -89.9 -61.75 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.111 2.54 . . . . 0.0 112.526 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.5 ' HB3' ' HD2' ' A' ' 230' ' ' PRO . 78.6 m-70 -78.73 163.36 61.3 Favored Pre-proline 0 CA--C 1.514 -0.44 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 229' ' ' HIS . 59.1 Cg_endo -72.79 52.69 2.18 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.753 1.636 . . . . 0.0 112.865 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 50.9 m -123.67 -178.0 3.9 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 171.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.636 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 26.0 mmt180 -76.72 142.18 40.58 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.169 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.451 ' CA ' ' HB3' ' A' ' 227' ' ' GLN . 32.5 ptt-85 -38.5 -40.37 0.56 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.716 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -75.15 5.56 33.29 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.626 -176.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . 0.636 ' CD1' ' HB2' ' A' ' 232' ' ' ARG . 2.0 m-85 -120.88 154.85 35.29 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.971 0.891 . . . . 0.0 112.493 -171.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.454 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.1 OUTLIER -128.39 130.5 23.54 Favored Pre-proline 0 N--CA 1.441 -0.877 0 CA-C-N 113.982 -1.463 . . . . 0.0 108.152 170.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -61.15 112.86 1.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.001 1.8 . . . . 0.0 111.126 175.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -48.02 135.06 13.17 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.719 0.771 . . . . 0.0 110.678 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 23.6 mt -71.21 -12.52 16.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.496 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -107.96 -59.45 1.84 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.395 0.617 . . . . 0.0 110.677 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 33.7 p -81.68 -39.81 23.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.187 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 100.32 4.18 55.18 Favored Glycine 0 N--CA 1.435 -1.367 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -84.5 126.96 33.76 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 121.853 0.835 . . . . 0.0 110.634 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 7.4 m -55.61 120.16 6.81 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.716 172.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -126.85 132.89 50.85 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 7.3 t70 -77.8 147.42 35.25 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 121.447 0.641 . . . . 0.0 109.632 -175.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.756 HG23 ' HG3' ' A' ' 249' ' ' GLU . 10.4 m -97.83 145.09 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.281 -177.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -74.28 76.86 1.84 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 168.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.756 ' HG3' HG23 ' A' ' 247' ' ' VAL . 28.2 mp0 -52.11 -37.8 55.3 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 124.021 0.826 . . . . 0.0 109.946 -171.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 42.6 m -47.7 -36.4 11.2 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.824 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -102.4 -42.88 5.84 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.685 0.755 . . . . 0.0 110.319 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -63.84 -23.07 67.21 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.8 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.71 ' O ' ' HB2' ' A' ' 256' ' ' LEU . 3.9 mp -124.05 88.2 52.74 Favored Pre-proline 0 N--CA 1.45 -0.434 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 174.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.415 ' O ' HG12 ' A' ' 202' ' ' ILE . 8.3 Cg_exo -73.1 142.46 34.35 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 121.301 1.334 . . . . 0.0 112.35 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 77.43 5.7 85.96 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.506 -170.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.71 ' HB2' ' O ' ' A' ' 253' ' ' ILE . 10.4 tp -53.24 -92.31 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 122.827 0.451 . . . . 0.0 111.285 175.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 22.9 t -96.08 61.52 2.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.502 0.668 . . . . 0.0 109.51 -175.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -86.6 51.9 2.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.628 0.728 . . . . 0.0 109.643 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.535 ' O ' ' HD3' ' A' ' 274' ' ' PRO . . . -137.6 28.35 2.76 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 272' ' ' LYS . . . 148.43 -133.24 4.5 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -177.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' ASN . . . . . 0.514 ' HB2' ' HB2' ' A' ' 272' ' ' LYS . 4.9 m-20 -103.28 158.02 16.61 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 177.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 42.7 t -142.76 124.44 14.98 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 50.6 mt -130.21 116.33 36.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.918 -167.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -76.23 120.4 21.45 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.85 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.7 t -107.21 158.77 16.85 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 158.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.504 ' HB ' ' CZ ' ' A' ' 235' ' ' PHE . 31.3 m -75.11 123.15 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 C-N-CA 118.612 -1.235 . . . . 0.0 108.498 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.615 ' N ' ' HE1' ' A' ' 235' ' ' PHE . . . 113.04 -24.22 13.07 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.669 -171.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.7 t 174.01 162.08 0.18 Allowed 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 117.471 0.636 . . . . 0.0 109.852 -172.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . 0.419 ' CE1' HD21 ' A' ' 256' ' ' LEU . 45.5 p90 -102.8 158.45 16.25 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 121.002 -1.061 . . . . 0.0 109.178 174.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -115.51 127.96 55.65 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . 0.417 ' HB2' HD22 ' A' ' 279' ' ' LEU . 56.7 m -100.43 152.01 20.86 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.529 0.68 . . . . 0.0 111.751 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.514 ' HB2' ' HB2' ' A' ' 261' ' ' ASN . 13.0 mmmm -121.59 100.42 7.0 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.08 171.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 286' ' ' CYS . 18.2 m -88.8 156.99 49.59 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.395 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.55 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 43.6 Cg_exo -58.07 156.03 31.2 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 121.831 1.687 . . . . 0.0 110.359 171.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -56.55 144.53 31.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.655 0.264 . . . . 0.0 110.842 -177.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.13 -32.69 3.48 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.237 -0.983 . . . . 0.0 111.968 -176.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' HIS . . . . . 0.55 ' HB2' ' O ' ' A' ' 274' ' ' PRO . 14.6 m-70 -72.42 154.69 40.75 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.06 0.457 . . . . 0.0 111.283 -175.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -137.68 121.27 17.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.862 -174.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.417 HD22 ' HB2' ' A' ' 271' ' ' CYS . 35.2 tp -69.52 136.95 52.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.114 0.483 . . . . 0.0 111.672 -175.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -124.11 100.51 6.75 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 171.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -65.16 -14.19 59.98 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.951 0.782 . . . . 0.0 112.533 -172.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 73.5 t -58.43 -36.93 61.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.629 0.728 . . . . 0.0 109.874 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 31.3 m -134.08 30.49 3.63 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.398 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 23.51 50.52 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 114.135 -1.393 . . . . 0.0 113.164 -172.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -102.36 130.79 49.2 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.439 -174.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 273' ' ' CYS . 33.3 m -94.87 97.8 10.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.652 173.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.435 ' HA ' ' ND1' ' A' ' 277' ' ' HIS . 38.5 tt0 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.668 -0.682 . . . . 0.0 109.305 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.534 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 90.6 m-85 . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.431 HG13 ' HB3' ' A' ' 147' ' ' GLN . 33.3 pt -141.41 -171.21 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 123.531 0.519 . . . . 0.0 110.376 -173.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 86.97 -174.08 45.51 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.254 -0.884 . . . . 0.0 112.369 -174.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.5 p -75.82 -34.36 60.13 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -110.78 12.44 22.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.034 -176.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 33.6 m 62.66 29.46 16.86 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 123.668 0.605 . . . . 0.0 110.258 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.17 -17.92 60.13 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.618 -172.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.431 ' HB3' HG13 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -99.69 120.91 56.23 Favored Pre-proline 0 C--N 1.326 -0.428 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.315 -174.754 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 147' ' ' GLN . 78.7 Cg_endo -88.7 140.63 4.31 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.933 2.422 . . . . 0.0 112.605 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 149' ' ' VAL . 10.1 p -66.52 105.29 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 122.25 1.024 . . . . 0.0 111.731 -173.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 76.84 6.8 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.989 175.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -52.41 -65.82 0.49 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -176.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 37.7 m -85.6 23.37 1.39 Allowed 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 120.728 0.299 . . . . 0.0 111.63 -171.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 106.43 -101.6 1.79 Allowed Glycine 0 N--CA 1.436 -1.301 0 CA-C-O 122.21 0.895 . . . . 0.0 113.049 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 148.43 131.43 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 111.368 -2.416 . . . . 0.0 105.004 -175.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 176' ' ' GLN . 21.4 mt -117.49 171.58 7.9 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -168.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.663 ' HB3' ' CZ ' ' A' ' 172' ' ' PHE . 0.2 OUTLIER 42.43 30.11 0.19 Allowed 'General case' 0 N--CA 1.478 0.944 0 O-C-N 124.426 1.079 . . . . 0.0 113.157 -172.374 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.8 39.37 91.35 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 119.951 -1.118 . . . . 0.0 111.955 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -74.63 -144.54 0.98 Allowed Glycine 0 CA--C 1.511 -0.21 0 CA-C-N 115.426 -0.387 . . . . 0.0 113.685 -173.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.558 ' HG2' ' HB3' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -154.28 130.52 10.41 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.8 m -67.41 115.57 7.18 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 122.312 -0.242 . . . . 0.0 110.891 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 165' ' ' ARG . 3.7 m -101.43 -37.02 5.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.974 176.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.635 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -139.78 172.67 6.03 Favored Pre-proline 0 C--O 1.233 0.235 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.534 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 76.4 Cg_exo -54.09 107.1 0.19 Allowed 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.421 2.081 . . . . 0.0 112.869 176.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 70.52 8.68 6.69 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.044 0.938 . . . . 0.0 110.238 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.635 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 1.4 mmt180 -103.06 81.66 1.99 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.822 176.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 12.6 t -81.34 146.17 30.49 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 173.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.558 ' HB3' ' HG2' ' A' ' 159' ' ' ARG . . . -98.68 147.86 24.42 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.427 ' HA ' HD21 ' A' ' 156' ' ' ASN . 14.4 m -111.41 124.66 52.71 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 124.775 1.297 . . . . 0.0 112.66 -160.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.635 ' H ' ' ND2' ' A' ' 156' ' ' ASN . 64.5 m -51.99 -54.46 29.57 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -154.84 -86.37 0.05 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 118.516 -1.274 . . . . 0.0 113.746 -165.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -92.11 39.6 3.0 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 119.651 -1.262 . . . . 0.0 112.826 -167.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.663 ' CZ ' ' HB3' ' A' ' 156' ' ' ASN . 9.1 m-85 -120.7 126.23 49.67 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 119.522 -0.871 . . . . 0.0 113.036 176.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.62 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 4.7 t -93.37 164.81 13.07 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 164.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.28 132.63 5.51 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.54 2.9 4.69 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 121.198 1.265 . . . . 0.0 112.962 -167.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.468 ' O ' HD12 ' A' ' 155' ' ' LEU . 47.9 tt0 -118.68 4.34 11.63 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.325 0.584 . . . . 0.0 110.661 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 39.32 50.6 2.0 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -177.284 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -106.03 -12.37 15.81 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.476 0.655 . . . . 0.0 110.321 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -60.85 -67.41 0.4 Allowed 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.802 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.8 t70 79.59 81.96 0.06 Allowed 'General case' 0 CA--C 1.509 -0.603 0 O-C-N 123.775 0.672 . . . . 0.0 109.445 163.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.62 ' HE2' ' N ' ' A' ' 173' ' ' THR . 37.0 p90 -102.42 66.06 0.96 Allowed 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 172.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -46.97 119.52 2.58 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 113.479 -1.691 . . . . 0.0 109.869 172.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.487 ' HB ' HG22 ' A' ' 203' ' ' VAL . 64.6 p -84.39 136.91 33.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.809 -172.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.495 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -158.27 145.79 12.27 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.86 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.41 ' HB3' ' O ' ' A' ' 200' ' ' SER . 39.5 Cg_exo -59.92 139.87 90.17 Favored 'Trans proline' 0 CA--C 1.529 0.232 0 C-N-CA 122.268 1.979 . . . . 0.0 111.47 171.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 5.8 t -96.44 133.94 40.23 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.123 -174.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . 0.574 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 24.4 m-85 -110.32 130.81 55.48 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.481 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.567 ' O ' ' HG2' ' A' ' 215' ' ' ARG . 48.9 p -112.52 -4.34 14.2 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -168.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 p -168.58 116.85 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 118.991 0.814 . . . . 0.0 111.504 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.696 HD11 ' CB ' ' A' ' 216' ' ' ALA . 3.7 mt -117.07 119.32 61.61 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -169.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 45.7 t -104.54 156.45 17.95 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 145.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -50.43 -31.26 14.58 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 119.988 1.267 . . . . 0.0 109.702 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -56.17 -59.22 5.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 113.526 -1.67 . . . . 0.0 111.591 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 5.7 mmt -136.87 126.12 24.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.559 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.554 ' HA ' HG12 ' A' ' 190' ' ' ILE . 79.9 m -76.79 -19.24 57.81 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.87 0.843 . . . . 0.0 110.716 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -146.97 -68.6 0.25 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 171.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 125.06 -18.42 7.0 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -96.72 -41.87 8.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.705 -0.747 . . . . 0.0 110.068 177.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 67.62 84.85 0.15 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.477 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 185' ' ' PRO . 48.0 t -99.44 148.15 24.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.109 -177.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -92.59 22.29 34.05 Favored Glycine 0 CA--C 1.504 -0.626 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.771 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.594 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -60.61 110.99 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 167.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.487 HG22 ' HB ' ' A' ' 183' ' ' THR . 0.4 OUTLIER -107.02 97.22 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-O 124.081 1.896 . . . . 0.0 109.482 -173.344 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 13.7 t -119.38 -175.69 2.99 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 112.232 -2.258 . . . . 0.0 106.986 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 7.6 p -100.97 164.04 12.0 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 119.281 -0.968 . . . . 0.0 108.872 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.469 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 45.3 tttm -61.94 -45.95 91.47 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.994 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.9 m -45.24 -55.05 6.24 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.537 173.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.485 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -58.51 -54.5 46.28 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.988 179.262 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 19.1 m -68.95 -22.08 64.15 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 84.6 m -94.42 -33.83 12.98 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.1 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -73.69 -58.49 3.27 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.659 HG22 ' HA2' ' A' ' 234' ' ' GLY . 20.0 p -99.62 157.59 16.35 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.944 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.43 HG21 HG12 ' A' ' 253' ' ' ILE . 2.2 t 66.86 -46.69 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 122.855 0.462 . . . . 0.0 112.022 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 215' ' ' ARG . . . 80.6 178.96 52.56 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 114.68 0.632 . . . . 0.0 114.68 171.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.567 ' HG2' ' O ' ' A' ' 188' ' ' THR . 8.0 mpt_? 92.08 -73.94 0.01 OUTLIER 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.647 1.179 . . . . 0.0 112.844 170.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.696 ' CB ' HD11 ' A' ' 190' ' ' ILE . . . -172.8 165.86 5.27 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.069 1.304 . . . . 0.0 111.855 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . 0.495 ' CZ2' ' HA3' ' A' ' 184' ' ' GLY . 22.0 t90 -150.9 149.2 29.36 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.869 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 77.74 166.32 27.32 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 115.674 1.03 . . . . 0.0 115.674 167.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.492 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 77.7 m-70 -122.32 134.62 24.92 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 114.706 -0.747 . . . . 0.0 109.755 175.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 22.7 Cg_exo -65.37 155.85 77.79 Favored 'Cis proline' 0 C--N 1.347 0.46 0 C-N-CA 123.287 -1.547 . . . . 0.0 111.225 -2.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 33.7 t -52.14 115.61 1.8 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.322 -171.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -107.66 115.01 29.39 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 13.3 ttp -89.03 138.85 31.04 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.43 -172.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 84.0 m -128.08 122.8 22.34 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -54.03 166.26 1.63 Allowed 'Trans proline' 0 CA--C 1.515 -0.462 0 C-N-CA 123.609 2.873 . . . . 0.0 113.622 165.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -39.09 106.7 0.06 Allowed 'General case' 0 CA--C 1.504 -0.801 0 O-C-N 123.962 0.789 . . . . 0.0 111.214 163.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 31.4 85.75 0.14 Allowed Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 111.633 -2.531 . . . . 0.0 111.99 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -39.57 -58.61 0.81 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.874 3.049 . . . . 0.0 115.182 -170.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -78.58 156.09 78.25 Favored Pre-proline 0 CA--C 1.515 -0.385 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -68.61 91.57 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.773 1.648 . . . . 0.0 112.474 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' CYS . . . . . 0.461 ' HB2' ' HG3' ' A' ' 237' ' ' PRO . 42.7 t -163.85 179.21 7.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.787 -177.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.743 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 22.6 mmm-85 -92.75 140.22 29.74 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.433 ' O ' HG22 ' A' ' 212' ' ' THR . 22.1 ptt85 -41.31 -57.14 2.23 Favored 'General case' 0 C--O 1.218 -0.574 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -175.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.659 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -67.52 6.79 2.33 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 115.123 0.809 . . . . 0.0 115.123 -174.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . 0.743 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 2.1 m-85 -131.07 173.47 10.98 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 118.238 1.019 . . . . 0.0 111.828 -174.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.544 HD13 ' O ' ' A' ' 235' ' ' PHE . 0.2 OUTLIER -135.48 130.56 19.04 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 113.562 -1.654 . . . . 0.0 107.504 172.021 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.461 ' HG3' ' HB2' ' A' ' 231' ' ' CYS . 27.0 Cg_exo -61.01 113.82 1.9 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 121.95 1.766 . . . . 0.0 111.641 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -50.71 132.21 26.02 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.669 0.747 . . . . 0.0 110.964 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 19.6 mt -76.48 -2.01 3.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.024 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 240' ' ' ARG . 43.1 mtm180 -104.43 -57.59 2.01 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.301 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 31.5 p -95.2 -45.36 7.22 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.366 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 104.11 12.64 28.99 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -95.45 131.35 41.7 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 122.009 0.909 . . . . 0.0 110.352 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 77.8 m -49.08 112.25 0.6 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 113.261 -1.791 . . . . 0.0 110.495 167.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -116.84 134.49 54.71 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . 0.624 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 10.9 t70 -75.84 145.36 40.66 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 121.635 0.731 . . . . 0.0 111.122 -170.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.716 HG23 ' HG3' ' A' ' 249' ' ' GLU . 4.5 m -98.23 145.19 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.87 177.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -75.85 78.13 2.76 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 169.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.716 ' HG3' HG23 ' A' ' 247' ' ' VAL . 22.7 mp0 -53.03 -36.06 60.14 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 123.747 0.654 . . . . 0.0 110.017 -172.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 24.6 m -48.36 -39.15 21.2 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.432 173.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -96.45 -39.73 9.43 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.83 0.824 . . . . 0.0 110.313 -177.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -73.68 -20.25 60.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.202 -1.363 . . . . 0.0 111.757 -172.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.594 HG23 HD11 ' A' ' 202' ' ' ILE . 4.1 mp -121.83 81.5 41.82 Favored Pre-proline 0 N--CA 1.446 -0.672 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 253' ' ' ILE . 50.6 Cg_exo -24.02 -49.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.889 1 C-N-CA 127.169 5.246 . . . . 0.0 117.764 -170.516 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -124.93 28.99 5.03 Favored Glycine 0 CA--C 1.502 -0.745 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.906 -165.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.439 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -93.6 143.07 26.65 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.673 -0.764 . . . . 0.0 110.385 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 7.5 t 72.29 -72.27 0.12 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -169.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 60.02 -75.01 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.056 0.942 . . . . 0.0 113.202 175.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -75.48 71.18 1.85 Allowed Glycine 0 CA--C 1.508 -0.38 0 N-CA-C 111.694 -0.562 . . . . 0.0 111.694 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 154.54 -175.86 32.53 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -106.15 113.19 26.57 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 117.476 0.638 . . . . 0.0 109.774 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 48.7 t -89.3 133.15 34.59 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 46.5 mt -132.87 106.77 10.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.335 -174.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.753 ' ND2' ' HB3' ' A' ' 269' ' ' PHE . 0.9 OUTLIER -83.83 129.39 34.94 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -167.255 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.8 t -111.13 163.86 13.45 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.908 163.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.624 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 2.4 p -70.07 120.39 17.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.415 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.658 ' HA2' ' CE2' ' A' ' 235' ' ' PHE . . . 114.42 -33.38 5.43 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.61 -172.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 7.5 p -179.81 161.51 0.98 Allowed 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 117.822 0.811 . . . . 0.0 109.765 -172.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . 0.753 ' HB3' ' ND2' ' A' ' 264' ' ' ASN . 43.1 p90 -101.38 157.94 16.43 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.823 175.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -120.67 122.0 39.52 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 52.8 m -101.21 143.18 31.6 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.725 0.774 . . . . 0.0 111.682 -176.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -103.04 104.71 14.91 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.436 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 56.8 m -86.3 138.42 34.3 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.552 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.518 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 52.5 Cg_exo -56.28 162.52 7.62 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.548 2.165 . . . . 0.0 111.308 172.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -54.35 136.83 43.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.179 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.15 -26.78 4.22 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.74 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' HIS . . . . . 0.602 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 16.1 m-70 -78.34 157.85 28.99 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.28 0.562 . . . . 0.0 111.613 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -145.99 140.87 27.18 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.417 -175.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 51.0 tp -74.78 126.53 31.11 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.19 0.519 . . . . 0.0 109.681 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 284' ' ' GLN . 52.7 t30 -120.29 112.13 18.64 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -78.99 -6.75 57.08 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.721 0.638 . . . . 0.0 112.263 -173.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 39.0 t -58.07 -21.21 16.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.116 0.484 . . . . 0.0 110.564 168.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 284' ' ' GLN . 24.8 t -146.93 -15.16 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.183 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 283' ' ' SER . 16.9 mp0 73.74 52.62 0.11 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.369 1.067 . . . . 0.0 109.481 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -130.99 149.9 52.39 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.289 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 86.8 m -101.35 94.71 6.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.294 176.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.602 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 76.4 mm-40 . . . . . 0 C--O 1.253 1.238 0 CA-C-O 118.755 -0.64 . . . . 0.0 109.483 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.548 ' HB2' ' SG ' ' A' ' 145' ' ' CYS . 89.7 m-85 . . . . . 0 CA--C 1.515 -0.387 0 CA-C-O 120.582 0.23 . . . . 0.0 110.993 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.475 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 30.6 pt -129.29 169.11 21.13 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.86 172.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.97 169.61 20.75 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.651 -176.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.2 p -77.62 -47.12 20.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.625 0.213 . . . . 0.0 110.528 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -88.04 2.81 50.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.236 0.541 . . . . 0.0 109.937 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.548 ' SG ' ' HB2' ' A' ' 140' ' ' TYR . 0.6 OUTLIER 61.93 44.69 8.09 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.667 171.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.22 8.65 55.64 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 119.641 -1.266 . . . . 0.0 112.493 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.475 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 0.0 OUTLIER -112.62 118.75 44.65 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.222 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -89.09 131.92 2.23 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.959 2.44 . . . . 0.0 113.725 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 149' ' ' VAL . 9.5 p -66.47 116.03 5.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.954 -178.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.629 ' HB3' ' SG ' ' A' ' 154' ' ' CYS . 0.0 OUTLIER -81.87 75.87 8.79 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.275 0.56 . . . . 0.0 109.844 171.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.98 -64.79 0.79 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.306 -0.861 . . . . 0.0 113.133 -171.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 55.8 m -91.88 19.03 6.98 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.158 0.504 . . . . 0.0 111.941 -168.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 80.73 120.29 0.44 Allowed Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.898 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' ' 150' ' ' CYS . 89.1 m -74.29 157.75 35.24 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 113.443 -1.378 . . . . 0.0 108.33 172.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.656 HD12 ' O ' ' A' ' 176' ' ' GLN . 76.9 mt -147.15 174.52 11.51 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -165.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.548 HD22 ' C ' ' A' ' 156' ' ' ASN . 0.2 OUTLIER 49.25 19.13 0.29 Allowed 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.274 0.984 . . . . 0.0 112.624 -172.159 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.6 37.29 93.45 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.247 -0.977 . . . . 0.0 111.949 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -80.76 -141.56 2.95 Favored Glycine 0 C--O 1.236 0.25 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.658 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -157.78 126.54 5.66 Favored 'General case' 0 C--O 1.218 -0.597 0 O-C-N 122.317 -0.519 . . . . 0.0 111.526 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.99 124.46 19.98 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 123.139 0.274 . . . . 0.0 111.142 176.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 165' ' ' ARG . 4.0 m -116.28 -35.3 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.191 0.519 . . . . 0.0 111.419 -178.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.61 ' HB3' ' CB ' ' A' ' 165' ' ' ARG . . . -137.11 175.86 3.18 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 174.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.541 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 22.9 Cg_exo -60.58 109.24 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 121.316 1.344 . . . . 0.0 111.889 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 71.73 3.23 4.59 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.591 1.156 . . . . 0.0 111.119 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.61 ' CB ' ' HB3' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -96.11 86.74 4.35 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.527 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 70.1 m -79.63 150.64 30.93 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.368 172.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.494 ' HB2' HG11 ' A' ' 161' ' ' VAL . . . -93.08 121.41 34.39 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 172.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 61.6 m -106.08 132.12 52.54 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.418 -175.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 89.6 m -60.78 -52.03 66.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.963 -1.471 . . . . 0.0 114.114 -164.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -161.76 -93.6 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 118.852 -1.139 . . . . 0.0 113.111 -170.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -85.44 55.19 4.89 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.878 -164.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.658 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 4.5 m-85 -124.48 137.89 54.39 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.832 171.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.64 ' OG1' ' HG3' ' A' ' 179' ' ' ARG . 27.0 p -88.32 121.07 30.29 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.508 176.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 99.82 134.11 8.37 Favored Glycine 0 N--CA 1.426 -1.967 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.91 9.59 1.31 Allowed 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 120.903 1.068 . . . . 0.0 112.431 -172.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.656 ' O ' HD12 ' A' ' 155' ' ' LEU . 39.2 tt0 -110.37 25.01 12.25 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 171.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.549 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.8 OUTLIER 18.69 71.76 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 173.345 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.577 ' O ' ' HD3' ' A' ' 179' ' ' ARG . 8.6 pt-20 -124.13 31.64 5.75 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.93 0.871 . . . . 0.0 110.604 172.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.658 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 24.0 mmt180 -135.71 93.25 2.92 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 113.729 -1.578 . . . . 0.0 108.582 177.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -87.67 61.32 6.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 122.045 0.926 . . . . 0.0 109.935 -171.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.563 ' CE2' HG23 ' A' ' 173' ' ' THR . 26.0 p90 -83.12 91.39 7.21 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 171.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -89.33 136.5 32.99 Favored 'General case' 0 N--CA 1.437 -1.077 0 O-C-N 119.988 -1.695 . . . . 0.0 107.186 -176.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 77.1 p -86.57 134.69 33.63 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.72 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -158.73 155.29 26.34 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.434 ' O ' ' HA ' ' A' ' 217' ' ' TRP . 12.2 Cg_exo -71.73 160.23 48.63 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.41 2.073 . . . . 0.0 111.904 175.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . 0.487 ' H ' HG23 ' A' ' 202' ' ' ILE . 3.6 t -117.73 105.83 12.4 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -177.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . 0.747 ' O ' ' HB3' ' A' ' 215' ' ' ARG . 37.4 m-85 -100.21 135.87 40.97 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.633 -172.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.6 m -97.45 -21.43 17.15 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -167.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.421 ' HB ' ' HG3' ' A' ' 196' ' ' GLN . 54.6 t -149.47 115.29 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -171.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.485 HD13 ' HB3' ' A' ' 221' ' ' CYS . 3.1 mt -134.73 119.67 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -164.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.4 p -116.56 -167.36 1.27 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.103 159.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -71.65 -5.61 34.95 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.024 0.916 . . . . 0.0 109.152 171.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -83.58 -67.26 0.8 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.551 -174.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.595 ' HG2' ' H ' ' A' ' 196' ' ' GLN . 43.0 ttp -146.53 139.28 25.3 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.666 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.759 ' O ' ' HB2' ' A' ' 196' ' ' GLN . 68.2 m -84.52 -15.43 45.88 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.586 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.759 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 3.9 mm-40 92.94 -158.8 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.568 1.147 . . . . 0.0 112.106 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.415 ' H ' ' HB3' ' A' ' 196' ' ' GLN . . . 64.71 8.24 32.51 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.274 -0.876 . . . . 0.0 113.693 176.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 55.59 25.94 8.6 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.865 0.332 . . . . 0.0 110.642 -175.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 61.68 27.93 17.2 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.312 -176.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 39.2 t -70.95 137.41 49.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.951 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.36 57.99 3.49 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.342 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.585 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -61.16 109.83 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 170.087 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 5.4 t -89.08 116.11 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 CA-C-O 122.527 1.156 . . . . 0.0 111.348 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 19.7 t -151.68 -179.7 7.65 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.442 ' OG1' HD22 ' A' ' 208' ' ' LEU . 18.5 p -105.66 161.58 14.26 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 120.64 1.564 . . . . 0.0 109.27 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.59 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 46.2 tttm -59.21 -41.51 88.77 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.609 0.718 . . . . 0.0 109.534 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.7 m -46.88 -54.91 8.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.826 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.49 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -57.93 -51.36 69.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.253 179.124 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 64.4 m -62.8 -39.53 94.55 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.497 ' HA ' ' HB3' ' A' ' 224' ' ' CYS . 60.2 m -79.95 -29.86 39.76 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.716 -175.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -71.1 -60.9 1.98 Allowed 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.79 HG22 ' HA2' ' A' ' 234' ' ' GLY . 24.6 p -97.29 144.4 27.11 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.89 -174.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.537 HG21 ' CD1' ' A' ' 256' ' ' LEU . 1.5 t 59.73 -36.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 96.15 -105.7 3.27 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 120.655 1.57 . . . . 0.0 112.498 -177.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.747 ' HB3' ' O ' ' A' ' 187' ' ' PHE . 78.1 mtt180 55.27 -131.84 1.83 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.648 0.737 . . . . 0.0 110.847 177.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.572 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -160.09 169.43 23.37 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 175.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . 0.59 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 24.9 t90 -149.69 145.4 26.68 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.606 -173.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 81.8 -178.33 53.71 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-O 121.527 0.515 . . . . 0.0 114.237 172.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.544 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 86.9 m-70 -131.62 130.29 22.35 Favored Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.544 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 18.8 Cg_endo -57.03 156.1 28.53 Favored 'Cis proline' 0 C--N 1.353 0.774 0 C-N-CA 124.002 -1.249 . . . . 0.0 111.044 -4.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . 0.485 ' HB3' HD13 ' A' ' 190' ' ' ILE . 58.3 m -67.51 78.46 0.17 Allowed 'General case' 0 C--N 1.32 -0.683 0 O-C-N 123.579 0.549 . . . . 0.0 111.923 -173.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.414 ' O ' ' HB1' ' A' ' 216' ' ' ALA . 12.4 mm-40 -53.94 115.15 1.87 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.034 0.445 . . . . 0.0 110.853 173.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' MET . . . . . 0.572 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 0.0 OUTLIER -91.1 132.66 35.91 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.032 -174.016 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' CYS . . . . . 0.497 ' HB3' ' HA ' ' A' ' 210' ' ' CYS . 70.8 m -97.94 124.04 49.18 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -167.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -62.26 152.63 75.26 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 123.968 3.112 . . . . 0.0 113.65 165.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -39.84 103.5 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.125 0 CA-C-O 122.284 1.04 . . . . 0.0 112.043 162.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 18.24 102.46 0.02 OUTLIER Pre-proline 0 C--N 1.311 -1.106 0 CA-C-N 111.335 -2.666 . . . . 0.0 114.42 -175.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -52.93 -49.88 16.04 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.893 2.395 . . . . 0.0 112.196 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -85.5 111.2 35.26 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.19 64.91 7.0 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.071 2.514 . . . . 0.0 114.265 -172.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 81.0 m -96.69 -84.52 0.36 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 168.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.522 ' HB3' ' CD2' ' A' ' 235' ' ' PHE . 14.4 ttm180 -145.98 135.72 23.34 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 168.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -39.16 -39.53 0.61 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -174.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.79 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -80.82 9.34 52.69 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 120.279 -0.963 . . . . 0.0 113.947 -176.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . 0.65 ' HE2' ' N ' ' A' ' 267' ' ' GLY . 1.9 m-85 -121.96 152.38 39.75 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -168.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.55 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.0 OUTLIER -129.89 131.82 23.75 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 114.047 -1.433 . . . . 0.0 107.778 169.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 244' ' ' CYS . 19.1 Cg_exo -63.41 111.59 1.51 Allowed 'Trans proline' 0 C--O 1.238 0.496 0 C-N-CA 122.173 1.915 . . . . 0.0 111.238 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -55.42 127.57 30.22 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.057 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 40.4 pt -80.9 12.35 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.14 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -110.46 -39.55 4.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.612 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 78.6 p -111.98 -39.51 4.49 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.95 0.881 . . . . 0.0 110.336 -177.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 102.03 6.07 49.27 Favored Glycine 0 N--CA 1.437 -1.253 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -175.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -97.39 119.7 36.4 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-O 122.079 0.942 . . . . 0.0 110.493 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 237' ' ' PRO . 3.7 m -55.62 123.54 14.39 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.266 176.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.42 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 41.3 tt0 -123.36 143.51 50.06 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . 0.705 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 8.1 t70 -78.49 145.92 34.69 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.109 0.481 . . . . 0.0 110.32 -178.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.729 HG23 ' HG3' ' A' ' 249' ' ' GLU . 5.3 m -94.97 145.57 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.872 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.35 77.07 1.87 Allowed 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 168.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.729 ' HG3' HG23 ' A' ' 247' ' ' VAL . 35.9 mp0 -53.12 -33.94 54.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 124.375 1.047 . . . . 0.0 110.198 -172.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 7.7 m -46.91 -41.28 15.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.523 173.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -98.79 -42.17 7.32 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.648 0.737 . . . . 0.0 110.302 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.01 -28.62 69.63 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.463 -174.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.655 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.7 mp -123.72 83.13 54.25 Favored Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 173.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.43 ' HG2' HG12 ' A' ' 202' ' ' ILE . 19.3 Cg_endo -57.6 122.96 12.67 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.767 2.311 . . . . 0.0 113.919 -166.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 65.41 27.03 72.06 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 113.554 -1.657 . . . . 0.0 113.435 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.655 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.3 OUTLIER -74.46 -28.85 61.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 118.108 0.954 . . . . 0.0 110.407 177.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . 0.514 ' HA ' ' HB3' ' A' ' 284' ' ' GLN . 51.5 t -85.97 86.76 7.35 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.776 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -74.16 -19.49 60.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.448 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -54.02 -50.3 55.68 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.348 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 175.73 -93.45 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.069 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -110.25 135.76 50.5 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 269' ' ' PHE . 40.4 t -104.44 134.16 48.1 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 175.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 25.5 mt -131.01 105.78 11.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -70.08 125.4 26.66 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.534 -170.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . 0.655 HG23 ' O ' ' A' ' 268' ' ' SER . 0.1 OUTLIER -110.83 156.23 21.42 Favored 'General case' 0 C--O 1.256 1.398 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.865 155.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.705 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 3.9 m -74.44 127.14 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 C-N-CA 118.155 -1.418 . . . . 0.0 107.876 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.65 ' N ' ' HE2' ' A' ' 235' ' ' PHE . . . 111.28 -25.13 14.37 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.521 -172.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.655 ' O ' HG23 ' A' ' 265' ' ' THR . 27.5 t 173.56 152.61 0.09 Allowed 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.476 0.655 . . . . 0.0 109.613 -174.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . 0.478 ' HB2' ' SG ' ' A' ' 262' ' ' CYS . 35.8 p90 -102.78 155.96 17.97 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -110.54 129.75 55.72 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 33.7 m -102.65 134.2 46.4 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.771 177.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -115.81 128.44 55.84 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.404 -177.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 19.3 m -129.57 168.52 16.08 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.724 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.62 155.35 21.87 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.212 1.941 . . . . 0.0 110.904 165.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.56 159.67 21.21 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.889 0.376 . . . . 0.0 110.779 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 89.41 -33.15 4.43 Favored Glycine 0 CA--C 1.504 -0.65 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.325 -174.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -72.15 156.22 39.41 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 120.806 0.336 . . . . 0.0 111.12 -176.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . 0.654 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 60.5 mttp -137.06 129.2 29.5 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -174.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.552 HD12 ' O ' ' A' ' 285' ' ' LYS . 32.7 tp -77.35 143.45 38.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 122.035 0.922 . . . . 0.0 112.622 -169.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.469 ' OD1' ' HB ' ' A' ' 282' ' ' VAL . 20.9 t-20 -124.12 100.45 6.72 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 114.366 -1.288 . . . . 0.0 107.833 175.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -69.94 -9.72 56.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.118 0.485 . . . . 0.0 111.691 -174.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.469 ' HB ' ' OD1' ' A' ' 280' ' ' ASN . 62.0 t -64.2 -59.02 4.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-O 121.193 0.521 . . . . 0.0 110.095 174.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 13.8 p -116.41 27.47 9.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.408 -176.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . 0.514 ' HB3' ' HA ' ' A' ' 257' ' ' CYS . 12.7 mp0 31.14 51.67 0.14 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.805 -170.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . 0.552 ' O ' HD12 ' A' ' 279' ' ' LEU . 85.2 tttt -106.79 171.36 7.41 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' CYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 25.5 p -160.6 114.79 2.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 118.018 0.372 . . . . 0.0 110.318 177.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 N--CA 1.441 -0.916 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -175.584 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.535 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 88.5 m-85 . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.483 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 31.8 pt -139.28 -178.15 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.758 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.697 -173.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.51 153.88 28.51 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.636 -168.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.0 p -64.55 -33.31 75.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.819 0.343 . . . . 0.0 111.788 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -110.87 28.1 9.04 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 79.1 m 56.69 -124.99 1.89 Allowed 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.029 -169.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.65 -39.69 2.55 Favored Glycine 0 C--N 1.292 -1.913 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.402 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.483 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 0.0 OUTLIER -99.88 118.91 60.91 Favored Pre-proline 0 C--O 1.219 -0.539 0 CA-C-N 117.828 0.814 . . . . 0.0 111.073 -174.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 147' ' ' GLN . 8.5 Cg_endo -87.21 139.68 5.28 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.966 2.444 . . . . 0.0 112.411 175.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 149' ' ' VAL . 10.7 p -71.15 103.29 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 122.261 1.029 . . . . 0.0 111.291 -175.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.38 74.39 9.36 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 121.668 -0.645 . . . . 0.0 110.153 175.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.419 ' HB2' ' ND2' ' A' ' 164' ' ' ASN . 40.2 mt-10 -54.3 -48.07 71.71 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -169.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 69.8 m -90.81 18.65 6.27 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.499 0.666 . . . . 0.0 110.546 -168.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 74.97 128.85 0.2 Allowed Glycine 0 N--CA 1.427 -1.926 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.676 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . 0.411 ' SG ' ' SG ' ' A' ' 160' ' ' CYS . 1.7 m -77.34 154.63 32.63 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.186 -1.007 . . . . 0.0 109.316 172.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 176' ' ' GLN . 50.1 mt -148.93 158.89 44.51 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.663 -166.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.609 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 2.8 t-20 52.58 27.88 5.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.899 -163.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.18 36.4 93.18 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.667 -172.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -64.88 151.77 51.08 Favored Glycine 0 N--CA 1.437 -1.279 0 CA-C-O 122.226 0.904 . . . . 0.0 114.257 -175.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.5 ttt85 -96.31 117.76 31.47 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 113.739 -1.23 . . . . 0.0 112.006 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . 0.411 ' SG ' ' SG ' ' A' ' 154' ' ' CYS . 3.7 m -62.83 126.18 26.48 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 165' ' ' ARG . 19.7 m -114.77 -41.82 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -176.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -138.26 175.49 3.33 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.535 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 17.1 Cg_exo -63.06 108.11 0.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 121.044 1.163 . . . . 0.0 111.721 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.419 ' ND2' ' HB2' ' A' ' 151' ' ' GLU . 6.8 t-20 74.4 16.17 3.36 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.703 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.535 ' O ' HG22 ' A' ' 161' ' ' VAL . 1.8 mtm180 -112.83 95.31 5.34 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.545 169.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 9.1 t -87.82 151.98 22.45 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.753 171.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.47 ' HB2' HG11 ' A' ' 161' ' ' VAL . . . -105.33 120.03 40.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.457 0.646 . . . . 0.0 109.639 177.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 63.7 m -74.88 124.12 26.31 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.002 -170.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.609 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 77.0 m -60.0 -41.43 92.07 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.455 177.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.48 ' CG ' ' N ' ' A' ' 171' ' ' GLY . 52.5 t80 -140.23 -131.04 0.11 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.296 -176.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.48 ' N ' ' CG ' ' A' ' 170' ' ' TYR . . . -80.82 57.9 4.78 Favored Glycine 0 N--CA 1.435 -1.416 0 CA-C-N 116.157 -0.474 . . . . 0.0 113.148 -165.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.591 ' HB3' ' HA ' ' A' ' 177' ' ' CYS . 4.3 m-85 -121.3 125.57 47.38 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 119.714 -0.795 . . . . 0.0 111.527 170.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.517 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 3.4 t -90.41 158.57 17.02 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 168.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 87.23 130.84 3.14 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -177.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -75.17 21.29 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 121.498 1.466 . . . . 0.0 114.23 -165.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.494 ' O ' HD12 ' A' ' 155' ' ' LEU . 38.2 tt0 -120.36 -6.34 9.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.458 0.647 . . . . 0.0 110.029 176.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.591 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.3 OUTLIER 42.81 49.82 5.09 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -175.449 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.434 ' HB3' ' CD1' ' A' ' 155' ' ' LEU . 6.4 pt-20 -106.27 -15.33 14.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.281 0.562 . . . . 0.0 109.664 174.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.414 ' O ' ' HB3' ' A' ' 180' ' ' ASP . 11.1 mmt85 -57.85 -68.64 0.22 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.183 -1.371 . . . . 0.0 109.062 -175.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' A' ' 179' ' ' ARG . 36.5 t70 78.98 73.76 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.395 0.617 . . . . 0.0 110.159 165.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.517 ' HE2' ' N ' ' A' ' 173' ' ' THR . 28.9 p90 -91.38 67.54 5.7 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.8 1.286 . . . . 0.0 107.704 172.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 21.2 ttp85 -40.1 124.24 1.81 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 112.664 -2.062 . . . . 0.0 110.791 173.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 54.2 p -88.19 139.4 30.54 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.063 -171.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -160.01 146.72 13.09 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.47 129.29 12.7 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.202 1.935 . . . . 0.0 111.609 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . 0.71 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 85.3 m -81.24 117.51 21.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.966 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . 0.678 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 43.8 m-85 -92.99 153.82 18.51 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.098 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.658 HG23 ' HE ' ' A' ' 215' ' ' ARG . 85.5 m -118.21 -18.79 9.22 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -162.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.2 p -164.9 116.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 O-C-N 121.417 -0.802 . . . . 0.0 110.043 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.494 HD13 ' SG ' ' A' ' 221' ' ' CYS . 2.7 mt -127.01 121.59 58.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -164.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.469 ' OG ' ' HB3' ' A' ' 193' ' ' GLN . 31.0 p -107.89 177.15 4.9 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 153.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -66.72 -12.4 58.41 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 122.477 1.132 . . . . 0.0 108.597 173.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.469 ' HB3' ' OG ' ' A' ' 191' ' ' SER . 60.2 tp60 -78.21 -38.8 42.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.235 -176.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.433 ' O ' ' HA ' ' A' ' 190' ' ' ILE . 41.9 ttm -162.31 140.63 8.86 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 -175.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.486 ' HA ' HG12 ' A' ' 190' ' ' ILE . 79.1 m -91.34 -23.91 19.95 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.257 0.551 . . . . 0.0 111.654 -176.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.467 ' HB2' ' H ' ' A' ' 188' ' ' THR . 55.0 tt0 -157.45 -73.69 0.09 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 170.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 127.78 -32.74 3.41 Favored Glycine 0 C--N 1.321 -0.262 0 C-N-CA 120.159 -1.02 . . . . 0.0 111.798 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 199' ' ' LEU . 92.1 mt-30 -74.61 -44.92 48.35 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 122.166 0.187 . . . . 0.0 110.701 171.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 198' ' ' GLN . 3.9 mm? 72.04 132.03 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.825 0.703 . . . . 0.0 110.735 -176.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 47.3 t -141.5 152.14 43.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.711 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -108.3 22.12 27.54 Favored Glycine 0 CA--C 1.502 -0.72 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.498 HG21 ' HB3' ' A' ' 254' ' ' PRO . 0.0 OUTLIER -60.74 114.22 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 172.418 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.3 t -102.99 99.73 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 CA-C-O 122.803 1.287 . . . . 0.0 111.093 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 7.4 t -133.3 -178.12 4.84 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 172.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 20.3 p -96.46 163.6 12.98 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.486 -174.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.508 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 72.2 tttt -59.31 -43.61 92.62 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.418 176.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.3 m -47.2 -54.47 10.67 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.391 174.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.589 ' CD1' HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -54.04 -62.29 1.75 Allowed 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.816 177.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 25.6 m -68.64 -22.17 64.42 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.351 -0.539 . . . . 0.0 112.361 -169.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 61.8 m -96.09 -27.8 14.91 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.376 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . 0.484 ' HA ' ' CD ' ' A' ' 228' ' ' PRO . . . -66.59 -55.74 13.99 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 172.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.548 HG21 HD11 ' A' ' 253' ' ' ILE . 46.3 p -61.77 -154.04 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 112.519 -2.128 . . . . 0.0 112.405 176.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.413 HG21 HG21 ' A' ' 253' ' ' ILE . 36.0 m -36.89 -5.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.498 ' O ' ' HD3' ' A' ' 215' ' ' ARG . . . 70.3 -153.77 52.06 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 120.565 1.53 . . . . 0.0 114.556 172.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.658 ' HE ' HG23 ' A' ' 188' ' ' THR . 1.7 mpp_? 99.41 -82.59 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.045 1.338 . . . . 0.0 110.131 169.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.678 ' HB3' ' HB2' ' A' ' 187' ' ' PHE . . . -174.29 168.11 3.99 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 118.026 0.375 . . . . 0.0 110.126 174.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . 0.71 ' HD1' ' SG ' ' A' ' 186' ' ' CYS . 13.9 t90 -156.68 146.77 21.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 81.22 156.94 16.26 Favored Glycine 0 C--N 1.333 0.377 0 N-CA-C 114.63 0.612 . . . . 0.0 114.63 170.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.703 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 2.4 p-80 -130.91 136.29 28.67 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 172.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.703 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 73.2 Cg_exo -50.94 143.13 8.05 Favored 'Cis proline' 0 C--N 1.352 0.745 0 C-N-CA 124.64 -0.983 . . . . 0.0 113.297 -0.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . 0.494 ' SG ' HD13 ' A' ' 190' ' ' ILE . 7.9 t -49.71 112.06 0.6 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.029 -171.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.705 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 49.8 mt-10 -103.09 103.71 13.81 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' MET . . . . . 0.415 ' HG2' HD12 ' A' ' 190' ' ' ILE . 34.4 mtm -87.81 131.14 34.63 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.846 -172.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 26.6 p -143.65 147.14 37.97 Favored Pre-proline 0 N--CA 1.466 0.354 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -173.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.04 169.33 6.16 Favored 'Trans proline' 0 CA--C 1.5 -1.191 0 C-N-CA 122.896 2.397 . . . . 0.0 112.293 165.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -78.9 -160.64 0.24 Allowed 'General case' 0 N--CA 1.414 -2.254 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 161.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -12.41 86.86 0.03 OUTLIER Pre-proline 0 C--N 1.299 -1.617 0 C-N-CA 126.413 1.885 . . . . 0.0 115.525 -170.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.484 ' CD ' ' HA ' ' A' ' 211' ' ' ALA . 8.6 Cg_exo -73.23 -53.49 0.13 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.98 2.454 . . . . 0.0 111.118 174.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 -72.49 141.69 83.19 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.815 177.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -83.08 27.45 0.61 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.26 1.974 . . . . 0.0 113.841 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' CYS . . . . . 0.463 ' C ' ' HD2' ' A' ' 232' ' ' ARG . 68.4 m -83.48 -91.66 0.08 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 173.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.781 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 3.8 mpt_? -146.04 147.57 31.76 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 168.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -41.47 -46.83 3.57 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.464 0.477 . . . . 0.0 111.657 170.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' A' ' 246' ' ' ASP . . . -77.44 7.0 41.65 Favored Glycine 0 C--O 1.224 -0.477 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.817 -176.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . 0.781 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 3.5 m-85 -119.36 142.19 48.38 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.075 0.941 . . . . 0.0 113.357 -170.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 237' ' ' PRO . 0.3 OUTLIER -124.1 125.76 25.72 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 113.918 -1.492 . . . . 0.0 108.975 174.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 236' ' ' ILE . 19.1 Cg_exo -67.14 123.3 10.74 Favored 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 122.498 2.132 . . . . 0.0 112.71 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -54.43 139.65 36.59 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.55 0.69 . . . . 0.0 111.033 175.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 31.0 mt -73.08 -16.81 17.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.36 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 47.2 mtm180 -101.34 -66.56 0.91 Allowed 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.682 0.753 . . . . 0.0 110.239 -176.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 28.9 p -76.17 -42.42 46.56 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.688 -175.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 99.26 7.87 53.99 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -85.3 127.27 34.27 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.896 0.855 . . . . 0.0 110.278 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' CYS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 235' ' ' PHE . 3.2 m -65.44 121.6 15.26 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.901 175.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.542 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 96.6 mt-30 -119.29 141.34 49.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.645 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . 0.706 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 13.1 t70 -78.02 148.08 34.51 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.07 0.462 . . . . 0.0 110.321 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.638 HG23 ' HG3' ' A' ' 249' ' ' GLU . 5.4 m -100.05 151.28 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.848 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -73.24 77.43 1.31 Allowed 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 166.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.638 ' HG3' HG23 ' A' ' 247' ' ' VAL . 5.6 mp0 -51.26 -40.61 59.26 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.756 -175.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 32.0 m -35.83 -43.59 0.31 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 114.189 -1.369 . . . . 0.0 112.658 171.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -99.72 -31.77 11.38 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.188 0.518 . . . . 0.0 110.694 -174.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.422 ' HB1' ' HG ' ' A' ' 208' ' ' LEU . . . -88.01 -4.21 58.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.905 -170.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.658 ' HB ' ' CD2' ' A' ' 256' ' ' LEU . 54.8 mt -134.4 133.47 21.64 Favored Pre-proline 0 CA--C 1.557 1.243 0 CA-C-N 119.092 0.86 . . . . 0.0 113.193 -174.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.533 ' HG3' ' HB2' ' A' ' 186' ' ' CYS . 3.4 Cg_endo -41.14 -73.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.078 1 C-N-CA 125.415 4.076 . . . . 0.0 115.171 -169.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -90.11 31.14 5.5 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.499 -169.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.658 ' CD2' ' HB ' ' A' ' 253' ' ' ILE . 0.6 OUTLIER -66.43 137.96 57.22 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.556 -0.857 . . . . 0.0 109.437 177.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' ' 262' ' ' CYS . 7.9 p -55.82 99.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -167.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -92.07 -20.5 21.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.82 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -78.05 70.49 2.55 Favored Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 176.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 130.13 -148.48 18.55 Favored Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -174.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -109.08 146.12 34.53 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 117.033 0.417 . . . . 0.0 109.976 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . 0.521 ' HB3' ' SG ' ' A' ' 257' ' ' CYS . 17.8 p -127.91 147.38 50.46 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 172.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 53.3 mt -138.69 108.8 4.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.375 -167.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -73.36 114.45 11.59 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.747 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 268' ' ' SER . 0.2 OUTLIER -103.32 150.95 23.27 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 161.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.706 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 4.0 m -72.82 133.33 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 C-N-CA 117.553 -1.659 . . . . 0.0 107.503 177.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.684 ' N ' ' HE2' ' A' ' 235' ' ' PHE . . . 97.61 -19.54 54.25 Favored Glycine 0 N--CA 1.434 -1.494 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.607 -174.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.589 ' O ' HG23 ' A' ' 265' ' ' THR . 3.9 p 179.76 142.33 0.14 Allowed 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 117.399 0.599 . . . . 0.0 110.577 -175.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -97.98 156.74 16.49 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . 0.51 ' HG3' ' CG2' ' A' ' 265' ' ' THR . 8.8 mt-10 -117.83 155.69 29.67 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 58.4 m -123.21 154.89 38.13 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.948 0.88 . . . . 0.0 112.311 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.408 ' HB3' ' NZ ' ' A' ' 272' ' ' LYS . 9.2 mtpm? -135.5 100.5 4.52 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.763 -1.562 . . . . 0.0 109.386 170.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.429 ' HB3' ' HD2' ' A' ' 274' ' ' PRO . 38.6 m -104.79 170.28 6.2 Favored Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.539 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 273' ' ' CYS . 51.2 Cg_exo -55.44 157.04 15.74 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 121.801 1.667 . . . . 0.0 111.019 171.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -58.27 154.24 13.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.185 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 87.46 -30.81 4.73 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.934 -176.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' HIS . . . . . 0.608 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 14.2 m-70 -70.66 155.4 40.8 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.176 0.512 . . . . 0.0 112.182 -176.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . 0.643 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 99.2 mttt -138.68 133.81 32.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.284 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 15.5 tp -91.28 141.2 29.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.753 0.787 . . . . 0.0 111.44 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.481 ' OD1' ' HB ' ' A' ' 282' ' ' VAL . 55.2 t-20 -126.76 101.59 6.68 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 174.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.66 -24.45 66.74 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 123.719 0.637 . . . . 0.0 111.387 -175.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.481 ' HB ' ' OD1' ' A' ' 280' ' ' ASN . 78.8 t -65.2 -43.97 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.488 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 47.3 t -118.92 20.56 12.74 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.276 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 36.13 43.48 0.22 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.737 -173.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 89.7 mttt -91.29 153.07 20.21 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' CYS . . . . . 0.643 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 7.7 t -152.07 86.36 1.3 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.608 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 34.5 tt0 . . . . . 0 C--N 1.312 -1.06 0 CA-C-O 118.259 -0.877 . . . . 0.0 109.822 -173.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.535 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 95.7 m-85 . . . . . 0 CA--C 1.515 -0.375 0 CA-C-O 120.688 0.28 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.453 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 33.9 pt -132.2 172.49 16.28 Favored 'Isoleucine or valine' 0 C--O 1.245 0.838 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 174.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.75 158.62 24.6 Favored Glycine 0 N--CA 1.45 -0.368 0 O-C-N 124.014 0.821 . . . . 0.0 112.208 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.7 p -70.76 -25.82 63.08 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.507 -0.407 . . . . 0.0 111.48 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -100.5 -8.29 23.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.932 0.396 . . . . 0.0 109.992 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 86.1 m 69.03 40.52 1.58 Allowed 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.483 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.98 3.97 48.87 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.194 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.453 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 0.0 OUTLIER -108.31 111.54 61.59 Favored Pre-proline 0 N--CA 1.464 0.255 0 CA-C-N 117.502 0.651 . . . . 0.0 110.819 179.464 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -82.8 143.2 11.68 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.173 2.582 . . . . 0.0 112.998 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.3 p -71.75 115.87 12.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.641 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.641 ' HB3' ' O ' ' A' ' 153' ' ' GLY . 0.9 OUTLIER -80.73 78.25 7.51 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 172.343 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 164' ' ' ASN . 2.2 tt0 -52.27 -60.61 3.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.268 -173.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 17.8 m -94.84 14.52 21.18 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.057 0.456 . . . . 0.0 110.923 -175.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.641 ' O ' ' HB3' ' A' ' 150' ' ' CYS . . . 106.88 -117.32 5.29 Favored Glycine 0 N--CA 1.415 -2.701 0 CA-C-O 122.888 1.271 . . . . 0.0 111.601 -178.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . 0.534 ' O ' HD23 ' A' ' 155' ' ' LEU . 0.6 OUTLIER 162.22 141.24 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 -172.349 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 176' ' ' GLN . 39.1 mt -132.58 170.7 14.81 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 -163.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.753 ' HB3' ' CZ ' ' A' ' 172' ' ' PHE . 9.6 p30 45.5 21.61 0.08 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -174.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 67.37 37.87 90.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.296 -174.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -75.4 -146.76 1.56 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.575 -0.345 . . . . 0.0 112.689 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -157.95 124.87 4.96 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 122.68 -0.306 . . . . 0.0 110.955 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.4 m -61.96 125.39 23.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.62 0.248 . . . . 0.0 111.31 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 165' ' ' ARG . 4.2 m -112.18 -46.91 5.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.859 -0.337 . . . . 0.0 110.453 177.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.502 ' HB1' ' HD2' ' A' ' 163' ' ' PRO . . . -128.97 176.1 3.05 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 118.45 -0.786 . . . . 0.0 109.859 170.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.535 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 82.0 Cg_exo -50.67 103.78 0.07 OUTLIER 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 122.524 2.149 . . . . 0.0 113.298 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.422 ' HB2' ' HB2' ' A' ' 151' ' ' GLU . 9.1 t30 67.09 5.31 4.05 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.377 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.542 ' O ' HG22 ' A' ' 161' ' ' VAL . 1.7 ttm180 -89.02 82.5 6.65 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 169.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 35.8 t -85.48 137.73 32.71 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -88.9 127.87 35.65 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 35.2 m -109.94 134.03 52.53 Favored 'General case' 0 C--O 1.239 0.502 0 O-C-N 124.231 0.957 . . . . 0.0 112.028 -168.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 91.4 m -56.16 -56.28 22.87 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -165.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -161.9 -87.98 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.06 -1.056 . . . . 0.0 112.901 -166.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -85.81 46.95 3.71 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.564 -165.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.753 ' CZ ' ' HB3' ' A' ' 156' ' ' ASN . 6.9 m-85 -121.28 130.83 53.86 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.922 170.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.688 ' N ' ' HE1' ' A' ' 181' ' ' TYR . 3.5 t -97.37 138.28 35.07 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 173.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 99.12 126.06 5.56 Favored Glycine 0 C--N 1.299 -1.502 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -169.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -67.86 -0.22 5.15 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.55 1.5 . . . . 0.0 113.301 -170.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.609 ' O ' HD12 ' A' ' 155' ' ' LEU . 45.7 tt0 -111.64 24.34 12.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.39 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.494 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 1.2 p 23.96 60.92 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 117.506 2.41 . . . . 0.0 117.506 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -113.84 26.17 10.57 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.508 1.147 . . . . 0.0 109.441 169.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.547 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 17.6 mmt85 -120.9 84.66 2.27 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.597 -1.638 . . . . 0.0 108.592 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -82.72 76.88 9.54 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.828 -172.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.688 ' HE1' ' N ' ' A' ' 173' ' ' THR . 20.4 p90 -111.94 83.29 1.77 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.757 173.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 61.1 mtt85 -84.45 145.7 28.01 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 119.542 -1.974 . . . . 0.0 107.157 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 73.2 p -91.47 135.22 34.0 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.401 -175.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -159.49 162.5 32.92 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.162 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.21 128.56 10.63 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.215 1.943 . . . . 0.0 111.796 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . 0.537 ' H ' HG23 ' A' ' 202' ' ' ILE . 10.5 t -85.0 115.65 22.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.275 0.56 . . . . 0.0 110.452 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . 0.639 ' O ' ' HB2' ' A' ' 215' ' ' ARG . 42.6 m-85 -101.69 151.51 21.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.435 -175.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.624 ' HA ' ' CB ' ' A' ' 215' ' ' ARG . 15.4 p -114.42 -23.95 9.1 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -170.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.502 ' HB ' ' CG ' ' A' ' 196' ' ' GLN . 27.0 t -155.69 116.99 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -171.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.488 HG12 ' HA ' ' A' ' 195' ' ' CYS . 4.0 mt -130.14 118.42 43.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 119.012 -1.075 . . . . 0.0 113.892 -170.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.5 p -112.76 -166.81 1.11 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.566 161.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -67.51 -5.48 15.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.619 0.724 . . . . 0.0 110.388 172.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -92.47 -76.53 0.46 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.43 -173.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.598 ' HG2' ' H ' ' A' ' 196' ' ' GLN . 53.1 ttm -136.17 136.31 39.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.826 -172.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 196' ' ' GLN . 29.0 m -84.9 -15.47 44.43 Favored 'General case' 0 C--O 1.247 0.925 0 O-C-N 123.342 0.401 . . . . 0.0 110.823 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.598 ' H ' ' HG2' ' A' ' 194' ' ' MET . 72.3 mm-40 95.09 -165.06 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.211 1.405 . . . . 0.0 112.658 174.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.407 ' H ' ' HB3' ' A' ' 196' ' ' GLN . . . 69.17 -3.57 7.22 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 114.992 -1.003 . . . . 0.0 113.03 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 51.01 39.59 23.43 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.965 0.383 . . . . 0.0 110.263 -172.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 58.0 58.7 3.45 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.579 -177.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 33.5 t -72.85 147.83 45.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.692 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -91.01 26.46 11.13 Favored Glycine 0 CA--C 1.506 -0.511 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.537 HG23 ' H ' ' A' ' 186' ' ' CYS . 0.0 OUTLIER -63.08 106.47 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-O 121.95 0.881 . . . . 0.0 109.356 174.204 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 12.6 t -94.63 118.9 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.144 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 18.7 t -156.22 179.72 8.96 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.401 ' OG1' HD22 ' A' ' 208' ' ' LEU . 10.7 p -102.37 160.21 14.75 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 120.184 1.356 . . . . 0.0 109.736 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.588 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 37.8 tttm -59.01 -42.26 89.66 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.503 177.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.0 m -44.87 -56.62 4.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.332 174.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.499 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -54.09 -53.74 49.05 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.665 177.461 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 91.5 m -67.94 -23.48 65.07 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -174.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 61.4 m -93.84 -34.79 13.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.542 0.61 . . . . 0.0 111.649 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -72.67 -58.12 3.6 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.86 HG22 ' HA2' ' A' ' 234' ' ' GLY . 4.6 p -97.83 159.74 14.74 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.258 177.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.1 t 66.97 -48.42 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 122.565 0.346 . . . . 0.0 111.729 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 60.63 52.03 55.04 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 114.796 0.679 . . . . 0.0 114.796 171.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.639 ' HB2' ' O ' ' A' ' 187' ' ' PHE . 0.0 OUTLIER -123.41 -78.2 0.6 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.813 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.518 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -173.28 167.24 4.81 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . 0.605 ' O ' ' HB2' ' A' ' 222' ' ' GLU . 19.5 t90 -159.61 148.16 17.62 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 92.59 177.48 41.32 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 114.74 0.656 . . . . 0.0 114.74 168.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.59 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 12.2 p80 -143.01 132.14 11.67 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.132 -0.534 . . . . 0.0 109.707 177.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.59 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 52.1 Cg_exo -56.65 148.11 26.29 Favored 'Cis proline' 0 C--N 1.346 0.411 0 C-N-CA 123.694 -1.378 . . . . 0.0 111.444 -4.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . 0.467 ' HB3' HD13 ' A' ' 190' ' ' ILE . 80.0 m -47.22 122.81 4.84 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.795 0.685 . . . . 0.0 111.845 -173.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.605 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 33.6 mm-40 -108.35 112.5 24.98 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' MET . . . . . 0.518 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 10.4 ptm -94.38 133.79 37.58 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.269 0.557 . . . . 0.0 110.911 -172.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 74.2 m -94.12 125.16 53.71 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.198 -0.91 . . . . 0.0 113.397 -164.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -64.76 154.21 73.79 Favored 'Trans proline' 0 CA--C 1.512 -0.584 0 C-N-CA 123.092 2.528 . . . . 0.0 113.188 166.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -38.29 104.4 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 122.772 1.272 . . . . 0.0 111.93 163.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' GLN . . . . . 0.488 ' HA ' ' HD2' ' A' ' 228' ' ' PRO . 0.3 OUTLIER 18.52 88.24 0.05 OUTLIER Pre-proline 0 N--CA 1.483 1.189 0 CA-C-N 110.507 -3.042 . . . . 0.0 114.778 174.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.488 ' HD2' ' HA ' ' A' ' 227' ' ' GLN . 5.6 Cg_exo -38.04 -55.93 1.08 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 124.387 3.391 . . . . 0.0 113.246 173.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.441 ' CE1' ' HG3' ' A' ' 237' ' ' PRO . 90.6 m-70 -80.51 106.0 4.59 Favored Pre-proline 0 CA--C 1.518 -0.277 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 170.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.1 35.53 0.3 Allowed 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.112 1.875 . . . . 0.0 114.247 -171.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' CYS . . . . . 0.421 ' HB2' ' H ' ' A' ' 232' ' ' ARG . 33.8 m -69.22 -74.81 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 169.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.577 ' HB3' ' CD2' ' A' ' 235' ' ' PHE . 24.0 tpt180 -149.47 140.4 22.85 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 165.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -36.3 -45.46 0.47 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -177.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.86 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -78.8 9.97 34.55 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.93 -174.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . 0.672 ' HE2' ' N ' ' A' ' 267' ' ' GLY . 2.2 m-85 -116.53 138.39 51.44 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 122.009 0.909 . . . . 0.0 113.426 -169.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.523 HG22 ' HD2' ' A' ' 237' ' ' PRO . 0.0 OUTLIER -126.48 137.07 29.61 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.601 173.281 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.523 ' HD2' HG22 ' A' ' 236' ' ' ILE . 19.7 Cg_endo -57.61 124.41 16.01 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.658 2.239 . . . . 0.0 112.92 -177.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.418 ' O ' ' HA2' ' A' ' 242' ' ' GLY . 22.9 t-20 -58.27 141.66 50.23 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.652 173.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 26.3 mt -81.45 -13.82 12.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.079 -174.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 65.1 mtt180 -99.57 -59.01 1.8 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.335 0.588 . . . . 0.0 109.823 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 43.8 p -86.63 -33.96 19.97 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.879 -176.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 238' ' ' ASN . . . 90.3 5.77 69.5 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -177.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -83.46 134.02 34.88 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 121.591 0.71 . . . . 0.0 110.349 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 4.0 m -59.45 118.73 6.36 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.273 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.557 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 83.1 mm-40 -120.38 143.03 48.65 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . 0.722 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 14.9 t70 -79.11 146.16 33.36 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -176.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.755 HG23 ' HG3' ' A' ' 249' ' ' GLU . 5.3 m -98.68 148.22 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.047 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.856 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -75.8 77.28 2.73 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 167.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.755 ' HG3' HG23 ' A' ' 247' ' ' VAL . 40.4 mp0 -53.57 -37.66 63.14 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 123.482 0.489 . . . . 0.0 111.689 -168.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 36.0 t -50.59 -40.47 52.64 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.121 0.486 . . . . 0.0 110.616 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -93.78 -40.32 10.26 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.591 0.71 . . . . 0.0 110.125 -172.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -67.49 -25.01 65.65 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.588 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.471 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.1 mp -121.3 83.76 40.11 Favored Pre-proline 0 N--CA 1.449 -0.525 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 173.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -65.34 8.81 0.21 Allowed 'Trans proline' 0 N--CA 1.482 0.813 0 C-N-CA 124.411 3.408 . . . . 0.0 116.379 -168.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -129.81 8.4 6.11 Favored Glycine 0 C--N 1.295 -1.708 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.755 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.471 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.1 OUTLIER -102.65 136.41 42.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.212 0.529 . . . . 0.0 112.189 -174.295 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 10.7 t 56.78 54.43 7.22 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.681 178.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -94.28 -17.63 22.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.257 177.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -87.8 40.57 3.08 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.434 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 164.03 -160.6 33.52 Favored Glycine 0 N--CA 1.437 -1.234 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' ASN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 272' ' ' LYS . 13.7 m120 -81.41 156.47 25.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.921 0.361 . . . . 0.0 110.425 177.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 15.4 p -138.92 121.14 15.84 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 176.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 270' ' ' GLU . 16.6 mt -136.16 164.1 32.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -174.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.413 HD21 ' H ' ' A' ' 249' ' ' GLU . 0.6 OUTLIER -134.61 132.12 38.65 Favored 'General case' 0 CA--C 1.496 -1.109 0 C-N-CA 117.789 -1.564 . . . . 0.0 114.36 -175.35 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.89 160.36 20.99 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.867 162.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.722 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 3.0 m -73.1 128.12 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 173.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.672 ' N ' ' HE2' ' A' ' 235' ' ' PHE . . . 112.45 -22.17 17.97 Favored Glycine 0 N--CA 1.419 -2.439 0 C-N-CA 119.977 -1.106 . . . . 0.0 112.147 -173.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.566 ' HB2' ' O ' ' A' ' 267' ' ' GLY . 8.5 t 166.77 165.04 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.342 0.592 . . . . 0.0 110.18 -177.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . 0.423 ' CZ ' HD11 ' A' ' 256' ' ' LEU . 36.3 p90 -101.15 155.45 18.0 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 119.864 -0.735 . . . . 0.0 109.965 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . 0.405 ' HB2' ' HB ' ' A' ' 263' ' ' ILE . 3.6 mt-10 -109.93 123.86 50.37 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -177.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 66.3 m -114.0 129.07 56.63 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.399 0.618 . . . . 0.0 110.156 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 261' ' ' ASN . 18.6 ttpp -102.61 114.49 28.76 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.838 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 70.0 m -91.6 148.09 36.59 Favored Pre-proline 0 C--N 1.296 -1.74 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.311 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 70.3 Cg_exo -52.81 152.67 16.68 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.006 1.804 . . . . 0.0 110.927 173.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -51.61 139.95 19.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.884 0.373 . . . . 0.0 111.115 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 86.92 -34.77 3.5 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.301 -0.952 . . . . 0.0 111.353 -176.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' HIS . . . . . 0.605 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 17.8 m-70 -80.24 163.33 24.08 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 120.968 0.413 . . . . 0.0 110.893 -176.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -146.29 133.71 20.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.561 -173.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.528 HD12 ' O ' ' A' ' 285' ' ' LYS . 46.8 tp -66.56 142.57 57.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.991 0.424 . . . . 0.0 111.063 -176.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -131.23 99.47 4.87 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -61.32 -17.15 52.37 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.861 0.725 . . . . 0.0 112.624 -176.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.502 ' HA ' ' NH1' ' A' ' 215' ' ' ARG . 77.0 t -58.01 -39.48 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.183 0.516 . . . . 0.0 110.597 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 57.7 p -140.89 36.9 1.78 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.951 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . 0.443 ' OE1' ' HA ' ' A' ' 256' ' ' LEU . 0.0 OUTLIER 28.25 50.92 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.326 1.051 . . . . 0.0 112.897 -174.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . 0.528 ' O ' HD12 ' A' ' 279' ' ' LEU . 68.9 tttt -104.44 169.59 8.38 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.699 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 53.7 m -141.65 100.21 3.72 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.605 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 57.8 mm-40 . . . . . 0 C--O 1.24 0.563 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -173.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 147' ' ' GLN . 67.7 m-85 . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.575 HG12 HE21 ' A' ' 147' ' ' GLN . 32.6 pt -138.4 -176.33 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.865 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.03 167.61 43.17 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.302 -174.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 34.4 p -77.99 -10.98 59.86 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.778 -0.248 . . . . 0.0 111.516 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 30.7 m80 -109.28 -3.76 16.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.047 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 140' ' ' TYR . 9.5 t 66.1 26.26 10.71 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.35 0.595 . . . . 0.0 109.623 -177.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -96.09 4.14 64.96 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.615 -0.721 . . . . 0.0 113.076 -173.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.575 HE21 HG12 ' A' ' 141' ' ' ILE . 0.1 OUTLIER -110.91 108.08 57.74 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.027 -178.297 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -74.06 140.72 28.66 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.119 2.546 . . . . 0.0 112.983 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 149' ' ' VAL . 13.6 p -78.38 103.59 5.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.34 1.067 . . . . 0.0 111.363 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -81.95 82.89 7.42 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.646 174.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -56.33 -69.09 0.16 Allowed 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -173.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 64.9 m -83.05 10.5 7.92 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.78 0.8 . . . . 0.0 110.659 -163.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 71.72 132.31 0.12 Allowed Glycine 0 N--CA 1.424 -2.13 0 CA-C-N 114.374 -1.285 . . . . 0.0 111.491 -170.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 160' ' ' CYS . 62.4 m -68.06 151.5 46.95 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.23 -0.985 . . . . 0.0 109.503 175.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 38.6 mt -132.36 175.39 9.32 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -172.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.774 ' HB2' ' CZ ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 66.88 11.52 8.36 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 123.791 0.682 . . . . 0.0 112.124 170.615 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.61 32.07 80.06 Favored Glycine 0 CA--C 1.507 -0.458 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -172.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.443 ' HA2' ' OG1' ' A' ' 169' ' ' THR . . . -77.76 -145.55 2.44 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.276 -0.462 . . . . 0.0 114.1 -175.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -149.76 114.13 5.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.63 0.252 . . . . 0.0 110.491 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . 0.467 ' HB2' ' SG ' ' A' ' 154' ' ' CYS . 35.1 t -58.78 113.77 2.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.891 0.377 . . . . 0.0 110.634 174.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 165' ' ' ARG . 13.0 m -106.96 -46.13 8.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.921 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.577 ' HB1' ' HD2' ' A' ' 163' ' ' PRO . . . -134.11 178.06 1.95 Allowed Pre-proline 0 CA--C 1.541 0.622 0 CA-C-O 118.72 -0.657 . . . . 0.0 109.981 175.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.577 ' HD2' ' HB1' ' A' ' 162' ' ' ALA . 96.2 Cg_exo -49.05 103.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 122.661 2.241 . . . . 0.0 113.589 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 66.31 8.94 6.01 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.238 1.015 . . . . 0.0 109.958 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.597 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -93.08 81.24 4.54 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.613 174.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 63.7 m -85.74 138.75 31.88 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.277 172.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.96 139.16 30.8 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.498 ' HA ' HD21 ' A' ' 156' ' ' ASN . 61.0 m -92.65 110.44 21.87 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 124.182 0.926 . . . . 0.0 111.601 -169.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.443 ' OG1' ' HA2' ' A' ' 158' ' ' GLY . 24.1 m -65.84 -55.28 17.88 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.44 ' CD2' ' N ' ' A' ' 171' ' ' GLY . 38.0 t80 -121.36 -116.41 0.31 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 118.89 -1.124 . . . . 0.0 112.532 -168.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.44 ' N ' ' CD2' ' A' ' 170' ' ' TYR . . . -91.77 52.13 2.95 Favored Glycine 0 CA--C 1.485 -1.799 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.163 -166.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.774 ' CZ ' ' HB2' ' A' ' 156' ' ' ASN . 6.9 m-85 -119.06 127.8 53.74 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 119.302 -0.959 . . . . 0.0 112.598 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.478 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 3.6 t -91.0 162.71 14.6 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 163.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 90.96 131.25 4.92 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.36 -13.2 30.48 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.312 1.341 . . . . 0.0 113.322 -166.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -106.83 14.41 26.71 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.246 0.546 . . . . 0.0 109.601 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.531 ' HB3' ' HB2' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 31.33 60.22 0.27 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.735 1.214 . . . . 0.0 113.958 177.385 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -115.94 -13.92 11.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.925 175.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -56.44 -61.91 2.09 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.907 -1.497 . . . . 0.0 107.967 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 32.8 t70 74.45 69.83 0.1 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.78 0.8 . . . . 0.0 109.524 160.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.478 ' HE2' ' N ' ' A' ' 173' ' ' THR . 45.3 p90 -94.75 66.22 3.13 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 174.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -57.19 123.74 16.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.136 171.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.578 ' HB ' HG13 ' A' ' 203' ' ' VAL . 41.3 p -73.22 138.02 45.34 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -163.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -140.51 141.61 11.58 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.79 -162.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -72.12 128.66 14.15 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.964 1.776 . . . . 0.0 111.382 172.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 6.4 t -84.53 113.6 21.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.131 0.491 . . . . 0.0 110.09 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . 0.561 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 14.6 m-85 -94.6 147.05 23.68 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.766 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.548 ' HA ' ' CB ' ' A' ' 215' ' ' ARG . 12.9 p -113.5 -2.92 13.77 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.5 t -130.35 159.23 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.799 HD11 ' HB2' ' A' ' 216' ' ' ALA . 40.5 mm -134.55 119.34 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.562 0.696 . . . . 0.0 111.336 174.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.418 ' HB3' ' H ' ' A' ' 194' ' ' MET . 48.2 t -143.17 169.18 18.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.308 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -79.37 -7.5 58.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 122.369 1.081 . . . . 0.0 108.106 167.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -92.44 -71.45 0.64 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.476 -1.693 . . . . 0.0 109.655 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.418 ' H ' ' HB3' ' A' ' 191' ' ' SER . 63.2 mtt -143.83 136.55 27.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.927 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 196' ' ' GLN . 34.3 m -85.17 -38.79 18.6 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 168.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 1.8 mm-40 157.11 -149.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 113.423 -1.717 . . . . 0.0 106.969 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 94.13 17.21 41.12 Favored Glycine 0 CA--C 1.509 -0.338 0 C-N-CA 119.743 -1.218 . . . . 0.0 112.747 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -90.58 -1.99 57.88 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.227 0.536 . . . . 0.0 110.204 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.464 ' N ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -160.53 8.97 0.09 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.755 -177.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 12.6 m -87.97 86.07 7.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.313 0.578 . . . . 0.0 112.248 -169.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -100.25 4.19 57.01 Favored Glycine 0 CA--C 1.506 -0.509 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 170.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.467 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -60.14 114.33 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 114.435 -0.882 . . . . 0.0 109.576 173.145 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.578 HG13 ' HB ' ' A' ' 183' ' ' THR . 23.0 t -104.68 101.1 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 CA-C-O 122.974 1.369 . . . . 0.0 110.728 176.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.434 ' HB2' HD11 ' A' ' 202' ' ' ILE . 9.6 t -129.27 -176.8 3.99 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 112.529 -2.123 . . . . 0.0 106.204 174.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 26.7 p -107.9 165.6 11.34 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.143 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.862 ' HB3' ' CE3' ' A' ' 217' ' ' TRP . 21.7 ptmt -69.58 -22.02 63.56 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.526 174.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 8.4 m -57.59 -53.07 62.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 172.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.491 ' CD1' HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -57.69 -56.43 22.06 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.737 175.001 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 68.7 m -67.99 -24.15 65.1 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.253 -172.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 78.2 m -101.9 -11.08 19.27 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -82.47 -50.74 8.51 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 164.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 214' ' ' GLY . 40.0 p -78.15 -156.76 0.09 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.886 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.7 t -19.82 -33.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 212' ' ' THR . . . 81.41 -165.33 46.44 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 119.796 -1.192 . . . . 0.0 114.429 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.548 ' CB ' ' HA ' ' A' ' 188' ' ' THR . 72.6 mmt-85 102.72 -80.29 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.837 1.655 . . . . 0.0 109.932 174.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.799 ' HB2' HD11 ' A' ' 190' ' ' ILE . . . -173.53 168.25 4.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 119.101 0.864 . . . . 0.0 110.347 175.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . 0.862 ' CE3' ' HB3' ' A' ' 206' ' ' LYS . 20.7 t90 -164.28 144.44 7.94 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 76.99 -174.27 54.52 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.0 -0.619 . . . . 0.0 113.014 175.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.52 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 31.1 p80 -135.64 131.71 19.36 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 31.6 Cg_exo -59.94 165.2 26.71 Favored 'Cis proline' 0 N--CA 1.477 0.505 0 C-N-CA 123.733 -1.361 . . . . 0.0 111.821 -5.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 55.9 m -62.63 81.32 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -173.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 216' ' ' ALA . 5.7 mm-40 -50.29 97.93 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.31 0.576 . . . . 0.0 110.438 167.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 19.8 ptt? -99.42 131.89 45.12 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.162 -173.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 18.5 m -142.11 144.17 30.74 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.386 -173.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -59.87 168.17 6.08 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.897 2.398 . . . . 0.0 110.046 160.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.01 -96.3 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.876 0.37 . . . . 0.0 111.213 -176.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' GLN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -83.28 113.34 45.67 Favored Pre-proline 0 C--N 1.32 -0.689 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.725 178.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -83.48 -41.24 0.1 OUTLIER 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.621 2.214 . . . . 0.0 113.698 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.445 ' HB3' ' HD2' ' A' ' 230' ' ' PRO . 41.7 m80 -103.89 173.57 3.32 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -174.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 229' ' ' HIS . 45.5 Cg_exo -60.19 -18.35 51.28 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.026 1.817 . . . . 0.0 112.011 174.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 14.8 t -64.07 124.69 22.26 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 172.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.587 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 45.3 mtt180 -63.45 135.23 56.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.386 -172.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.525 ' HB3' ' HB3' ' A' ' 227' ' ' GLN . 30.4 ptt180 -30.43 -44.54 0.05 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 246' ' ' ASP . . . -79.78 12.02 31.08 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.895 -1.145 . . . . 0.0 113.952 -173.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . 0.587 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 44.2 m-85 -125.05 158.55 33.47 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 117.994 0.897 . . . . 0.0 112.769 -175.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.496 HD13 ' O ' ' A' ' 235' ' ' PHE . 0.2 OUTLIER -132.28 130.53 21.97 Favored Pre-proline 0 N--CA 1.445 -0.695 0 CA-C-N 113.388 -1.733 . . . . 0.0 107.443 170.537 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.09 113.03 1.86 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.059 1.839 . . . . 0.0 111.509 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -47.13 130.0 12.52 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.665 0.745 . . . . 0.0 110.959 177.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 29.6 mt -74.49 -3.83 5.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.145 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -104.63 -60.09 1.65 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.913 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 34.9 p -86.41 -44.03 12.35 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.56 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 104.01 6.97 42.05 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.608 -177.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -96.55 130.37 43.75 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 122.039 0.923 . . . . 0.0 110.134 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 93.9 m -49.48 120.76 4.39 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 113.066 -1.879 . . . . 0.0 110.465 171.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.4 ' OE1' ' HA ' ' A' ' 245' ' ' GLN . 5.3 tp60 -120.61 136.07 54.92 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . 0.614 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 19.0 t70 -74.09 141.36 45.67 Favored 'General case' 0 CA--C 1.492 -1.256 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.502 -174.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.647 HG23 ' HG3' ' A' ' 249' ' ' GLU . 4.2 m -93.34 143.94 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.441 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -74.2 76.4 1.8 Allowed 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 166.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.647 ' HG3' HG23 ' A' ' 247' ' ' VAL . 29.7 mp0 -49.04 -38.4 23.78 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.896 0.748 . . . . 0.0 111.18 -171.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 15.5 m -53.19 -32.07 46.05 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.639 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -105.53 -50.29 3.24 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.499 0.72 . . . . 0.0 110.776 -175.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -59.88 -26.93 66.27 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.141 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.753 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.5 mp -118.14 79.88 14.83 Favored Pre-proline 0 N--CA 1.447 -0.575 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 169.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -38.0 103.14 0.04 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.564 0 C-N-CA 124.451 3.434 . . . . 0.0 115.509 -169.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 59.96 38.24 93.87 Favored Glycine 0 C--N 1.312 -0.787 0 CA-C-N 113.667 -1.606 . . . . 0.0 113.77 172.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.753 ' HB3' HG22 ' A' ' 253' ' ' ILE . 1.7 pt? -66.46 -31.31 71.98 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.004 177.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . 0.437 ' H ' HD23 ' A' ' 256' ' ' LEU . 51.7 t -119.74 81.19 1.69 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.281 0.562 . . . . 0.0 109.669 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -117.41 26.05 10.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.142 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -70.83 -27.32 72.51 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 172.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -149.49 -116.29 0.81 Allowed Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 175.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' ASN . . . . . 0.57 HD22 ' N ' ' A' ' 262' ' ' CYS . 0.2 OUTLIER -112.61 131.17 55.75 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.639 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . 0.57 ' N ' HD22 ' A' ' 261' ' ' ASN . 49.1 t -102.5 140.45 36.76 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 172.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 22.5 mt -130.97 163.31 37.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.493 ' ND2' ' HB3' ' A' ' 269' ' ' PHE . 0.7 OUTLIER -130.7 127.36 38.68 Favored 'General case' 0 CA--C 1.496 -1.131 0 C-N-CA 117.615 -1.634 . . . . 0.0 113.895 -174.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.4 t -113.68 165.56 12.41 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.076 163.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.614 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 30.7 m -70.46 125.36 28.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.83 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.527 ' HA2' ' CE2' ' A' ' 235' ' ' PHE . . . 97.05 -13.07 65.29 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-O 118.962 -0.91 . . . . 0.0 113.935 -177.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.0 t 178.68 157.5 0.49 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.732 1.266 . . . . 0.0 109.874 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . 0.493 ' HB3' ' ND2' ' A' ' 264' ' ' ASN . 24.1 p90 -105.97 159.2 16.23 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.872 -0.518 . . . . 0.0 109.876 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -114.84 121.33 42.93 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . 0.585 ' HB2' HD22 ' A' ' 279' ' ' LEU . 68.1 m -111.71 150.75 29.77 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 122.037 0.922 . . . . 0.0 111.917 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.28 109.56 7.83 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 113.503 -1.68 . . . . 0.0 109.694 175.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 10.1 m -84.56 164.4 42.88 Favored Pre-proline 0 C--N 1.314 -0.978 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.578 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 51.6 Cg_exo -53.31 156.41 10.69 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 121.921 1.747 . . . . 0.0 111.696 175.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -53.92 140.59 30.34 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.162 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 87.08 -28.55 5.53 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.421 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' HIS . . . . . 0.578 ' HB2' ' O ' ' A' ' 274' ' ' PRO . 21.5 m-70 -81.97 165.82 20.38 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.0 0.429 . . . . 0.0 111.587 -176.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 34.4 mtmm -139.69 137.52 35.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.143 -172.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.585 HD22 ' HB2' ' A' ' 271' ' ' CYS . 14.9 tp -85.48 139.91 31.11 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.116 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.45 ' HB3' ' HB2' ' A' ' 285' ' ' LYS . 29.4 t30 -131.42 98.76 4.62 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.415 173.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.401 ' HA ' ' NE2' ' A' ' 284' ' ' GLN . 48.4 mt-10 -56.19 -30.53 62.39 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.214 -175.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.526 ' O ' ' HB ' ' A' ' 188' ' ' THR . 42.0 t -56.08 -29.78 27.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.189 -176.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 67.6 m -145.16 33.32 1.09 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.599 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . 0.412 ' OE1' ' HB2' ' A' ' 257' ' ' CYS . 35.6 mm-40 32.28 45.15 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.914 -1.039 . . . . 0.0 113.474 -174.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 51.1 mttp -88.13 154.84 20.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.006 0.431 . . . . 0.0 111.95 -176.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 5.4 m -139.42 80.81 1.8 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.089 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 33.7 tt0 . . . . . 0 N--CA 1.44 -0.964 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.691 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 55.7 m-85 . . . . . 0 CA--C 1.514 -0.413 0 CA-C-O 120.772 0.32 . . . . 0.0 110.412 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.512 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 36.0 pt -138.81 -177.81 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.718 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.805 177.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.38 164.05 22.73 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.363 -175.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 43.5 p -78.16 -39.93 39.39 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.931 0.396 . . . . 0.0 110.905 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -98.67 -10.57 23.07 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.472 176.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 71.4 m 78.99 154.63 0.14 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.054 -1.43 . . . . 0.0 113.476 174.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.453 ' O ' ' HD3' ' A' ' 148' ' ' PRO . . . 132.41 2.4 4.08 Favored Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 112.913 -1.949 . . . . 0.0 113.808 175.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.573 HE21 ' C ' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -93.31 104.72 13.04 Favored Pre-proline 0 C--N 1.317 -0.806 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.199 174.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 146' ' ' GLY . 68.8 Cg_endo -82.71 149.96 14.41 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.4 2.066 . . . . 0.0 112.325 -175.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 149' ' ' VAL . 10.6 p -78.89 105.93 8.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 122.439 1.114 . . . . 0.0 112.611 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.06 80.15 6.51 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.155 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -56.23 -67.84 0.26 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -172.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 37.6 m -89.18 7.02 37.38 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.166 0.508 . . . . 0.0 111.392 -167.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 73.6 128.06 0.13 Allowed Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.016 -172.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . 0.58 ' O ' HD23 ' A' ' 155' ' ' LEU . 57.1 m -71.22 164.09 26.34 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 113.944 -1.128 . . . . 0.0 109.309 176.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.731 HD12 ' O ' ' A' ' 176' ' ' GLN . 68.7 mt -139.96 162.74 34.46 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.697 -167.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.741 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 2.4 t-20 53.35 26.08 5.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.659 0.743 . . . . 0.0 110.475 -167.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.63 37.24 94.14 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.119 -1.038 . . . . 0.0 112.007 -174.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.46 -147.13 0.51 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.08 134.63 9.63 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 117.591 0.695 . . . . 0.0 110.477 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 166' ' ' CYS . 0.5 OUTLIER -75.43 110.41 9.78 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.246 0.546 . . . . 0.0 110.514 175.133 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 165' ' ' ARG . 2.9 m -95.43 -29.59 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.521 0.677 . . . . 0.0 110.349 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.681 ' HB3' ' CB ' ' A' ' 165' ' ' ARG . . . -139.12 173.71 4.9 Favored Pre-proline 0 N--CA 1.451 -0.417 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.691 ' HD3' ' CE1' ' A' ' 140' ' ' TYR . 78.2 Cg_exo -54.54 105.07 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.199 1.933 . . . . 0.0 112.051 176.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 26.0 t30 66.2 9.83 6.63 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.097 0.959 . . . . 0.0 110.629 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.681 ' CB ' ' HB3' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -98.92 82.69 2.8 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.43 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 160' ' ' CYS . 74.1 m -82.26 148.17 28.52 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.414 174.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -99.23 131.14 45.47 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 58.2 m -102.65 132.09 48.99 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 123.877 0.736 . . . . 0.0 111.302 -169.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.741 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 19.7 m -47.68 -54.47 11.95 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -168.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.514 ' HD2' ' N ' ' A' ' 171' ' ' GLY . 5.6 t80 -157.65 -83.53 0.05 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 118.716 -1.194 . . . . 0.0 112.51 -170.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.514 ' N ' ' HD2' ' A' ' 170' ' ' TYR . . . -97.69 49.96 1.42 Allowed Glycine 0 CA--C 1.496 -1.151 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.262 -166.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 156' ' ' ASN . 10.2 m-85 -116.79 129.43 56.1 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 118.529 -1.268 . . . . 0.0 113.461 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.627 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 3.3 t -97.29 143.78 27.72 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.438 173.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' A' ' 176' ' ' GLN . . . 93.3 130.75 5.64 Favored Glycine 0 C--N 1.297 -1.628 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 -175.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.21 17.95 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.611 1.54 . . . . 0.0 112.914 -169.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.731 ' O ' HD12 ' A' ' 155' ' ' LEU . 65.8 tt0 -128.15 12.14 6.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.211 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.508 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.8 OUTLIER 27.17 59.08 0.09 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 116.885 2.18 . . . . 0.0 116.885 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.469 ' C ' ' HD2' ' A' ' 179' ' ' ARG . 2.3 pt-20 -109.85 16.18 22.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.24 1.019 . . . . 0.0 109.352 169.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.469 ' HD2' ' C ' ' A' ' 178' ' ' GLU . 19.3 mmm180 -120.39 91.1 3.46 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.409 -178.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -89.11 86.69 6.95 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.164 0.983 . . . . 0.0 111.853 -170.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.627 ' HE2' ' N ' ' A' ' 173' ' ' THR . 32.4 p90 -116.89 96.2 5.36 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 175.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -74.04 130.73 40.41 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 119.49 -2.006 . . . . 0.0 108.222 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 67.6 p -79.99 168.06 19.68 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.06 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.517 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . 158.16 148.09 5.04 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.316 -164.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -76.25 132.8 14.14 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.15 1.9 . . . . 0.0 111.922 174.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . 0.426 ' CB ' HD12 ' A' ' 202' ' ' ILE . 13.6 t -88.4 116.67 26.79 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . 0.638 ' CD2' ' HB2' ' A' ' 195' ' ' CYS . 16.1 m-85 -102.93 152.56 21.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.362 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.67 ' HA ' ' HB3' ' A' ' 215' ' ' ARG . 20.0 p -103.28 -54.9 2.51 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.1 p -140.54 120.03 12.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 O-C-N 120.914 -1.116 . . . . 0.0 112.645 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.466 HG13 ' SG ' ' A' ' 195' ' ' CYS . 2.1 mp -97.84 116.07 39.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-O 121.907 0.861 . . . . 0.0 111.612 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.0 p -106.86 -167.93 1.34 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 158.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -72.08 -4.83 31.19 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.367 0.604 . . . . 0.0 109.759 172.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -88.89 -69.8 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.482 -173.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.556 ' HG3' ' H ' ' A' ' 196' ' ' GLN . 33.0 tpp -162.99 135.62 5.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.189 -176.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.638 ' HB2' ' CD2' ' A' ' 187' ' ' PHE . 3.2 m -68.31 -19.41 64.67 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.877 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.604 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 44.8 mm-40 93.08 113.85 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.954 1.302 . . . . 0.0 113.34 173.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.04 -9.58 9.63 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.262 174.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 54.18 48.68 20.36 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.762 0.315 . . . . 0.0 110.82 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 6.6 mp 55.57 70.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.815 -175.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 46.3 t -72.2 148.36 45.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.475 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.33 21.55 12.71 Favored Glycine 0 CA--C 1.508 -0.366 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.898 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 254' ' ' PRO . 0.0 OUTLIER -65.3 98.12 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 163.699 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.39 118.66 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.383 0 CA-C-N 113.819 -1.537 . . . . 0.0 109.072 -175.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 10.1 t -158.11 -178.16 7.09 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 -175.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.477 HG21 ' HA ' ' A' ' 181' ' ' TYR . 26.7 p -108.24 168.44 9.3 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 120.278 1.399 . . . . 0.0 111.33 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.614 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 47.1 tttp -57.71 -44.33 85.84 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.406 174.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.1 m -47.01 -56.04 7.13 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.004 176.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.434 ' HG ' ' HB1' ' A' ' 252' ' ' ALA . 0.2 OUTLIER -58.75 -55.33 36.47 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.206 178.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 84.7 m -67.36 -23.75 65.63 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -172.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 227' ' ' GLN . 16.3 m -104.75 -26.69 12.17 Favored 'General case' 0 N--CA 1.429 -1.524 0 O-C-N 121.149 -0.969 . . . . 0.0 111.686 -175.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . . . -71.8 -56.99 4.75 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 170.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.681 HG22 ' HA2' ' A' ' 234' ' ' GLY . 6.0 p -100.23 156.22 17.34 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.592 -1.64 . . . . 0.0 107.16 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.2 t 68.0 -39.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 118.841 -0.599 . . . . 0.0 111.713 -177.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 65.12 49.71 60.79 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 119.061 0.846 . . . . 0.0 113.499 166.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.67 ' HB3' ' HA ' ' A' ' 188' ' ' THR . 31.3 mmt180 -127.7 -90.37 0.52 Allowed 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 120.527 -0.469 . . . . 0.0 112.206 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.515 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -165.83 164.96 18.64 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -177.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . 0.834 ' O ' ' HB2' ' A' ' 222' ' ' GLU . 7.0 t90 -168.29 139.55 2.74 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 127.7 167.72 12.34 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 119.634 -1.27 . . . . 0.0 114.53 172.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 220' ' ' PRO . 11.7 p80 -132.8 132.18 22.42 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.219 -0.491 . . . . 0.0 109.992 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 219' ' ' HIS . 2.4 Cg_endo -82.46 117.09 4.83 Favored 'Cis proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.011 -1.662 . . . . 0.0 111.61 -3.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . 0.418 ' SG ' ' CG1' ' A' ' 190' ' ' ILE . 34.1 t 39.0 92.89 0.01 OUTLIER 'General case' 0 C--O 1.243 0.751 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 175.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.834 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 34.7 mt-10 -105.48 110.12 22.34 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' MET . . . . . 0.515 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 2.8 tpt -90.31 138.74 31.29 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -173.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 54.6 m -111.48 129.49 24.05 Favored Pre-proline 0 C--O 1.234 0.277 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -169.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -80.03 151.12 20.97 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.513 2.809 . . . . 0.0 111.641 166.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.423 ' HB1' ' NE2' ' A' ' 227' ' ' GLN . . . 37.21 -86.54 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.276 0 O-C-N 124.799 1.312 . . . . 0.0 114.281 174.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' GLN . . . . . 0.423 ' NE2' ' HB1' ' A' ' 226' ' ' ALA . 0.0 OUTLIER -172.66 166.63 3.26 Favored Pre-proline 0 N--CA 1.44 -0.932 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -168.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 211' ' ' ALA . 4.6 Cg_exo -80.08 -85.91 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 121.884 1.722 . . . . 0.0 112.424 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -75.48 154.38 85.77 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.083 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -81.7 52.81 4.37 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.821 1.681 . . . . 0.0 113.775 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 71.9 m -104.78 -179.69 4.02 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 171.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.616 ' HB3' ' CD2' ' A' ' 235' ' ' PHE . 73.0 ttt180 -67.53 140.95 57.02 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 170.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.405 ' O ' HG22 ' A' ' 212' ' ' THR . 98.8 mtt180 -38.67 -50.92 1.66 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -175.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.681 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -70.26 9.27 3.28 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.41 -0.9 . . . . 0.0 114.145 -174.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . 0.616 ' CD2' ' HB3' ' A' ' 232' ' ' ARG . 5.3 m-85 -123.99 153.68 40.93 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 122.31 1.052 . . . . 0.0 113.721 -171.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.538 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.0 OUTLIER -130.19 133.23 24.7 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 113.619 -1.628 . . . . 0.0 108.227 168.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.76 116.39 3.52 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.329 2.019 . . . . 0.0 112.382 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -49.14 132.36 19.38 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.6 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 37.6 pt -73.8 1.2 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.316 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -111.89 -55.49 2.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.422 0.63 . . . . 0.0 110.181 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 66.3 p -92.96 -38.67 11.55 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.417 -175.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 98.33 4.47 57.35 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.394 -175.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -83.75 124.95 31.42 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 121.673 0.749 . . . . 0.0 109.662 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 10.8 m -57.91 114.69 2.44 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 113.446 -1.707 . . . . 0.0 109.401 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -117.1 141.07 48.72 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . 0.623 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 16.3 t70 -76.32 146.27 38.97 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -175.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.668 ' CG2' HG21 ' A' ' 212' ' ' THR . 4.4 m -96.78 151.65 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.983 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.87 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.534 ' OD1' ' HB2' ' A' ' 250' ' ' CYS . 6.3 t0 -78.98 81.07 5.28 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 167.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.648 ' HG3' HG23 ' A' ' 247' ' ' VAL . 2.1 mp0 -52.57 -32.05 39.19 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 123.901 0.751 . . . . 0.0 110.467 -173.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.534 ' HB2' ' OD1' ' A' ' 248' ' ' ASP . 58.0 m -55.04 -42.79 73.09 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.676 172.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -89.96 -33.48 16.38 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 122.29 1.043 . . . . 0.0 109.581 -175.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.434 ' HB1' ' HG ' ' A' ' 208' ' ' LEU . . . -79.27 -23.3 43.71 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.087 -174.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.672 ' O ' ' HB3' ' A' ' 256' ' ' LEU . 5.3 mp -132.58 79.21 65.31 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 176.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.468 ' O ' HG13 ' A' ' 202' ' ' ILE . 75.8 Cg_exo -55.57 153.93 27.23 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 121.776 1.651 . . . . 0.0 112.289 177.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 78.55 -19.18 5.04 Favored Glycine 0 C--N 1.316 -0.579 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.833 -174.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.672 ' HB3' ' O ' ' A' ' 253' ' ' ILE . 2.1 tt -76.04 115.19 15.51 Favored 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 122.425 -0.456 . . . . 0.0 109.847 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 37.3 t 63.33 19.37 11.64 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.171 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -84.31 56.22 3.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.761 0.791 . . . . 0.0 110.259 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -120.81 7.52 10.99 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 173.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -179.14 -117.47 0.54 Allowed Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -117.4 116.35 27.0 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 17.7 p -108.36 157.86 18.01 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 170.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 21.1 mt -145.49 156.64 13.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -170.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.588 HD21 ' HB2' ' A' ' 249' ' ' GLU . 0.4 OUTLIER -127.2 124.81 39.85 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -173.431 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.6 t -114.54 170.95 7.94 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.191 165.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.623 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 34.6 m -67.59 127.41 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 CA-C-O 121.826 0.822 . . . . 0.0 110.723 -176.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 88.38 -14.75 58.7 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-O 119.007 -0.885 . . . . 0.0 113.554 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 75.3 m -169.9 148.64 3.54 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 118.051 0.925 . . . . 0.0 110.52 -172.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . 0.449 ' HD2' ' OE2' ' A' ' 249' ' ' GLU . 26.8 p90 -105.37 152.4 23.0 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.64 -0.662 . . . . 0.0 110.384 174.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.88 126.52 52.03 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 -177.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . 0.485 ' SG ' HD22 ' A' ' 279' ' ' LEU . 18.4 m -106.22 152.06 23.97 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.815 0.817 . . . . 0.0 113.162 -176.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -141.52 96.93 3.06 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.59 171.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 11.7 m -83.55 164.87 43.15 Favored Pre-proline 0 C--N 1.314 -0.952 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 33.8 Cg_exo -57.32 165.92 5.09 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.939 1.76 . . . . 0.0 111.385 176.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -53.7 137.22 38.07 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.356 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 82.87 -31.07 3.11 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.458 -178.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' HIS . . . . . 0.546 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 15.8 m-70 -74.2 163.18 28.15 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.604 0.24 . . . . 0.0 111.352 -177.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -148.01 148.22 30.47 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.551 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 16.3 tp -82.16 141.36 33.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.377 . . . . 0.0 110.817 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -133.14 98.98 4.41 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.001 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -61.45 -23.26 65.74 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.465 0.478 . . . . 0.0 112.164 -174.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.27 -18.06 17.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.327 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 44.4 m -152.4 31.39 0.53 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.791 175.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 25.1 46.3 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.04 1.336 . . . . 0.0 113.808 -173.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 68.3 tttt -98.35 167.53 10.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.361 -171.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 1.8 m -144.43 83.41 1.72 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.546 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 36.4 tt0 . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.779 -0.629 . . . . 0.0 110.092 -171.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.592 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 75.3 m-85 . . . . . 0 C--O 1.235 0.338 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.547 ' O ' ' HA ' ' A' ' 145' ' ' CYS . 23.2 pt -139.82 178.42 3.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 CA-C-O 121.311 0.577 . . . . 0.0 111.214 -173.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.53 165.95 40.39 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.805 -169.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.9 m -70.73 -31.81 68.77 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.015 0.407 . . . . 0.0 110.785 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -89.84 -8.71 51.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.187 0.518 . . . . 0.0 109.927 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 141' ' ' ILE . 73.3 m 57.22 41.52 26.78 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.909 -175.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.23 2.3 59.42 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.588 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.502 ' O ' HG12 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -109.51 104.39 55.17 Favored Pre-proline 0 C--N 1.329 -0.298 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.809 178.667 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.61 142.46 20.61 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.466 2.111 . . . . 0.0 111.661 177.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 149' ' ' VAL . 8.8 p -66.64 106.72 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 122.569 1.176 . . . . 0.0 112.137 -173.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 20.8 m -80.23 66.1 5.61 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.831 173.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -52.16 -53.26 45.2 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.593 0.961 . . . . 0.0 113.593 -171.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 36.6 m -93.87 8.92 39.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.435 0.636 . . . . 0.0 110.576 -170.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 77.28 134.29 0.66 Allowed Glycine 0 N--CA 1.427 -1.964 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.266 -172.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . 0.44 ' O ' HD23 ' A' ' 155' ' ' LEU . 0.1 OUTLIER -69.64 154.85 41.41 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.743 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.574 HD12 ' O ' ' A' ' 176' ' ' GLN . 42.7 mt -126.78 170.28 12.33 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -173.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.521 HD22 ' C ' ' A' ' 155' ' ' LEU . 0.1 OUTLIER 36.49 35.55 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.731 1.269 . . . . 0.0 113.598 -172.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.36 34.23 67.66 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.003 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -75.52 -151.54 3.17 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-O 121.466 0.481 . . . . 0.0 114.031 -172.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.553 ' HG2' ' HB3' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -145.7 122.41 11.18 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.102 0.477 . . . . 0.0 110.567 -179.146 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 166' ' ' CYS . 19.1 m -68.79 112.12 5.31 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.833 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 165' ' ' ARG . 3.8 m -92.39 -33.28 5.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.071 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.562 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -139.88 177.03 2.18 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.592 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 77.7 Cg_exo -53.55 111.64 0.74 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 121.73 1.62 . . . . 0.0 112.496 176.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 61.54 12.7 4.63 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.94 0.896 . . . . 0.0 110.879 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.562 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.4 OUTLIER -103.68 78.25 1.55 Allowed 'General case' 0 CA--C 1.499 -1.003 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.082 178.014 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 160' ' ' CYS . 59.6 m -71.68 152.93 42.41 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.744 0.783 . . . . 0.0 110.54 171.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.553 ' HB3' ' HG2' ' A' ' 159' ' ' ARG . . . -106.28 141.72 37.15 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.629 169.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.442 ' HA ' HD21 ' A' ' 156' ' ' ASN . 29.2 m -97.68 128.68 44.54 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 124.346 1.029 . . . . 0.0 112.072 -163.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 77.9 m -62.96 -55.72 23.38 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 171' ' ' GLY . 40.1 t80 -128.18 -119.73 0.24 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 118.746 -1.181 . . . . 0.0 112.373 -169.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.401 ' N ' ' CD1' ' A' ' 170' ' ' TYR . . . -87.7 54.7 4.39 Favored Glycine 0 N--CA 1.428 -1.853 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.321 -167.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.564 ' HB2' ' HB3' ' A' ' 177' ' ' CYS . 5.1 m-85 -119.14 122.24 41.59 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 119.247 -0.981 . . . . 0.0 112.331 173.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.572 ' N ' ' HE1' ' A' ' 181' ' ' TYR . 2.9 t -88.09 157.51 18.84 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 167.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.1 128.48 3.29 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -177.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.06 -0.07 7.4 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.498 1.465 . . . . 0.0 113.467 -166.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.574 ' O ' HD12 ' A' ' 155' ' ' LEU . 41.7 tt0 -109.71 8.35 24.71 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.564 ' HB3' ' HB2' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 32.87 57.09 0.44 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 177.222 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -114.06 -15.73 12.23 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.877 173.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 173' ' ' THR . 19.3 mmt180 -57.58 -68.92 0.19 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.157 -1.383 . . . . 0.0 108.645 -176.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.0 t70 78.38 92.64 0.06 Allowed 'General case' 0 CA--C 1.509 -0.626 0 O-C-N 124.132 0.895 . . . . 0.0 110.102 164.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.572 ' HE1' ' N ' ' A' ' 173' ' ' THR . 32.2 p90 -112.36 64.16 0.63 Allowed 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 173.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 25.7 tpt85 -42.42 121.15 1.85 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.408 171.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 38.9 p -82.28 136.63 35.01 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.347 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.509 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -159.92 155.47 26.59 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.048 -176.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -85.07 167.87 10.72 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.444 2.096 . . . . 0.0 111.847 172.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 69.6 m -116.92 121.06 40.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.155 0.502 . . . . 0.0 111.44 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . 0.761 ' O ' ' HB3' ' A' ' 215' ' ' ARG . 29.6 m-85 -93.36 131.71 38.27 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.555 ' HA ' ' CG ' ' A' ' 215' ' ' ARG . 19.0 m -89.32 -15.16 34.07 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 113.944 1.091 . . . . 0.0 113.944 -163.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.1 p -165.11 117.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.066 -174.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.548 HD11 ' HB3' ' A' ' 216' ' ' ALA . 6.7 mt -123.7 118.35 53.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -171.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 7.3 p -114.77 -167.11 1.18 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.419 160.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -68.07 -4.08 12.35 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.434 0.635 . . . . 0.0 110.275 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -75.55 -69.97 0.45 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.307 -177.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 22.4 ttt -169.7 152.68 4.68 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.542 ' HA ' HG12 ' A' ' 190' ' ' ILE . 21.8 m -77.24 -24.2 51.2 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 121.099 0.476 . . . . 0.0 111.475 -174.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 42.7 tt0 176.22 -92.1 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.845 173.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.418 ' H ' ' HB3' ' A' ' 196' ' ' GLN . . . 124.55 11.14 4.66 Favored Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.939 171.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -89.04 -12.7 40.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.204 0.526 . . . . 0.0 109.992 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 65.17 -85.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.996 -177.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 71.1 m 68.93 125.85 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.574 0.702 . . . . 0.0 112.48 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.07 30.25 4.01 Favored Glycine 0 CA--C 1.508 -0.358 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.127 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.432 HG12 ' HD2' ' A' ' 254' ' ' PRO . 0.0 OUTLIER -65.75 100.35 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.175 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 4.1 t -92.57 98.29 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-O 122.914 1.34 . . . . 0.0 109.751 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.573 ' OG ' HD23 ' A' ' 208' ' ' LEU . 8.4 t -117.69 179.94 3.92 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.659 -2.064 . . . . 0.0 105.976 169.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 19.0 p -107.63 161.93 14.42 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.399 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.515 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 46.3 tttm -61.91 -43.62 98.46 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.13 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 8.4 m -44.76 -55.13 5.59 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 122.22 1.009 . . . . 0.0 109.415 173.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.81 HD11 HG11 ' A' ' 247' ' ' VAL . 6.0 tp -63.7 -52.25 61.41 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.294 -1.775 . . . . 0.0 112.344 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 4.7 t -64.3 -37.29 86.97 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.441 0.638 . . . . 0.0 110.479 -175.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 52.2 m -85.07 -23.82 28.37 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.626 -177.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . 0.556 ' HA ' ' CD ' ' A' ' 228' ' ' PRO . . . -69.88 -52.75 22.12 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 173.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 214' ' ' GLY . 80.8 p -64.77 -156.43 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 113.101 -1.863 . . . . 0.0 111.85 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.61 HG11 HE21 ' A' ' 284' ' ' GLN . 1.6 t -44.25 -1.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.349 0 N-CA-C 116.276 1.954 . . . . 0.0 116.276 -176.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 212' ' ' THR . . . 85.72 -101.97 2.61 Favored Glycine 0 CA--C 1.507 -0.457 0 C-N-CA 119.086 -1.53 . . . . 0.0 113.549 175.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.761 ' HB3' ' O ' ' A' ' 187' ' ' PHE . 0.8 OUTLIER 50.78 -120.33 1.56 Allowed 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.143 0.497 . . . . 0.0 110.34 -169.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.548 ' HB3' HD11 ' A' ' 190' ' ' ILE . . . -158.44 159.88 36.19 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 172.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . 0.515 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 26.9 t90 -136.07 146.33 46.94 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -174.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 82.25 177.44 51.87 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.735 171.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.608 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 8.0 p80 -143.01 133.4 12.26 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.626 -0.287 . . . . 0.0 110.252 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.608 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 41.4 Cg_exo -57.8 154.03 34.38 Favored 'Cis proline' 0 C--N 1.345 0.366 0 C-N-CA 123.667 -1.389 . . . . 0.0 112.119 -3.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 9.5 m -49.54 123.01 6.97 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.193 -171.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 37.1 mt-10 -105.87 102.49 11.92 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' MET . . . . . 0.532 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 17.7 ptm -85.73 137.64 32.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.576 -169.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 99.3 m -135.3 143.17 44.39 Favored Pre-proline 0 C--O 1.235 0.294 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -171.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -64.45 169.17 11.53 Favored 'Trans proline' 0 CA--C 1.512 -0.579 0 C-N-CA 122.788 2.325 . . . . 0.0 110.346 155.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.0 -129.67 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.808 168.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' GLN . . . . . 0.405 ' H ' ' HG3' ' A' ' 227' ' ' GLN . 0.1 OUTLIER -46.95 102.61 0.32 Allowed Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -166.318 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.556 ' CD ' ' HA ' ' A' ' 211' ' ' ALA . 63.9 Cg_endo -82.39 -59.68 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.628 2.218 . . . . 0.0 112.389 176.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.416 ' HB3' ' HD2' ' A' ' 230' ' ' PRO . 90.1 m-70 -70.87 159.6 84.9 Favored Pre-proline 0 CA--C 1.515 -0.368 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 229' ' ' HIS . 73.3 Cg_endo -78.91 58.25 6.81 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 121.706 1.604 . . . . 0.0 113.381 -174.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 43.0 m -135.43 -173.83 3.46 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.683 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 25.7 mmt180 -73.19 144.74 46.7 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.315 174.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -39.29 -42.96 1.08 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.581 ' O ' ' HA ' ' A' ' 246' ' ' ASP . . . -77.72 7.72 39.74 Favored Glycine 0 C--O 1.222 -0.612 0 C-N-CA 120.342 -0.933 . . . . 0.0 113.187 -176.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . 0.683 ' CD1' ' HB2' ' A' ' 232' ' ' ARG . 3.3 m-85 -120.42 143.0 48.7 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.865 0.84 . . . . 0.0 112.706 -171.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.464 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.5 OUTLIER -122.59 131.5 24.37 Favored Pre-proline 0 N--CA 1.439 -0.987 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.082 175.762 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -65.66 113.76 2.65 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.051 1.834 . . . . 0.0 111.356 174.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -49.21 135.9 16.08 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 123.492 0.717 . . . . 0.0 111.581 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 29.5 pt -75.63 2.87 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.165 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 240' ' ' ARG . 49.8 mtm180 -113.29 -56.51 2.4 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.973 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 35.0 p -95.91 -40.56 9.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.749 -174.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 99.44 5.63 55.6 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -175.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -79.01 134.01 36.8 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.806 0.812 . . . . 0.0 110.128 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 4.6 m -68.96 113.99 6.85 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.022 -1.445 . . . . 0.0 109.299 173.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.543 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 89.3 mt-30 -116.33 141.26 48.39 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . 0.675 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 12.5 t70 -77.58 144.65 37.38 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.81 HG11 HD11 ' A' ' 208' ' ' LEU . 4.3 m -95.56 146.11 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.082 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -178.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.442 ' HA ' ' ND2' ' A' ' 264' ' ' ASN . 4.9 m-20 -73.88 75.98 1.64 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 169.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.69 ' HG3' HG23 ' A' ' 247' ' ' VAL . 14.4 mp0 -52.5 -37.12 56.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 123.931 0.77 . . . . 0.0 110.776 -168.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 52.7 m -49.24 -38.71 27.6 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.866 174.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -101.21 -35.78 9.16 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.879 0.847 . . . . 0.0 110.565 -176.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.651 ' HB1' HD21 ' A' ' 208' ' ' LEU . . . -70.38 -20.1 62.97 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.33 -1.305 . . . . 0.0 110.459 -177.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.752 HG22 ' HB3' ' A' ' 256' ' ' LEU . 5.0 mp -137.29 77.63 41.16 Favored Pre-proline 0 N--CA 1.445 -0.703 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 169.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.432 ' HD2' HG12 ' A' ' 202' ' ' ILE . 9.8 Cg_endo -48.06 113.53 0.83 Allowed 'Trans proline' 0 CA--C 1.514 -0.508 0 C-N-CA 124.018 3.146 . . . . 0.0 114.39 -167.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 61.22 35.97 91.69 Favored Glycine 0 C--N 1.311 -0.824 0 CA-C-N 113.457 -1.702 . . . . 0.0 113.391 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.752 ' HB3' HG22 ' A' ' 253' ' ' ILE . 1.8 pt? -66.96 -23.1 65.92 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 117.367 0.584 . . . . 0.0 110.905 176.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 39.1 t -82.02 121.73 26.91 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 285' ' ' LYS . 59.1 tp60 -90.26 111.51 22.72 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -171.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 71.49 66.1 2.23 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.749 171.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 174.14 -170.17 43.27 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 119.967 -1.111 . . . . 0.0 112.792 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' ASN . . . . . 0.483 ' HB3' ' HB2' ' A' ' 272' ' ' LYS . 2.5 t-20 -88.79 159.08 17.92 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 21.2 t -141.49 125.03 16.71 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.423 HD11 ' OD1' ' A' ' 261' ' ' ASN . 18.2 mt -136.54 109.21 7.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.104 -170.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.442 ' ND2' ' HA ' ' A' ' 248' ' ' ASP . 65.9 t30 -72.17 117.17 13.46 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.281 -174.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.3 t -105.38 160.61 14.99 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 157.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.675 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 3.9 m -77.43 128.56 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 C-N-CA 118.344 -1.342 . . . . 0.0 107.924 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.658 ' N ' ' HE1' ' A' ' 235' ' ' PHE . . . 110.5 -30.79 7.88 Favored Glycine 0 C--N 1.311 -0.838 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.669 -170.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 31.7 m -179.11 158.36 0.9 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.079 0.939 . . . . 0.0 109.93 -168.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -104.96 152.36 22.78 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.818 -1.176 . . . . 0.0 108.63 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -107.45 127.89 54.01 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -176.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 261' ' ' ASN . 92.7 m -106.88 152.43 23.92 Favored 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.342 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 261' ' ' ASN . 7.4 mtpm? -124.07 100.03 6.53 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.033 175.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 4.3 m -81.81 149.32 63.42 Favored Pre-proline 0 C--N 1.31 -1.109 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.869 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 32.3 Cg_exo -56.57 162.31 8.48 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.08 1.854 . . . . 0.0 111.25 175.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -53.1 143.08 18.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.519 0.2 . . . . 0.0 111.059 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.49 -31.27 3.57 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.828 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' HIS . . . . . 0.601 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 14.4 m-70 -78.83 169.79 17.67 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 122.708 -0.289 . . . . 0.0 111.372 -177.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 56.5 mtpt -149.5 148.95 30.01 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 39.6 tp -84.94 136.11 33.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.075 0.464 . . . . 0.0 110.534 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -125.71 100.29 6.36 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 174.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.27 -21.11 61.52 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.829 0.705 . . . . 0.0 112.185 -174.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 68.3 t -60.47 -34.07 56.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.177 0.513 . . . . 0.0 110.45 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.458 ' HA ' ' CG2' ' A' ' 188' ' ' THR . 20.3 p -132.97 23.49 4.21 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.55 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . 0.61 HE21 HG11 ' A' ' 213' ' ' VAL . 12.5 mp0 29.62 46.63 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.062 -171.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 85.9 tttt -101.63 165.09 11.41 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.973 -172.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 5.7 m -140.89 88.42 2.18 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -177.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.601 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 7.1 tp10 . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.667 -0.682 . . . . 0.0 109.341 -173.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.617 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 98.8 m-85 . . . . . 0 CA--C 1.517 -0.315 0 CA-C-O 120.905 0.383 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.446 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 30.0 pt -132.88 174.6 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.967 177.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.99 174.15 33.23 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.737 -175.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.5 p -75.89 -29.74 58.57 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -111.32 12.61 21.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.34 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 46.2 m 59.67 35.91 22.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.091 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.59 -12.2 72.91 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.613 -0.721 . . . . 0.0 113.347 -174.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.446 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 0.0 OUTLIER -111.28 110.42 56.05 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 117.336 0.568 . . . . 0.0 110.718 -176.552 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.37 147.85 18.3 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.931 2.421 . . . . 0.0 112.489 178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 149' ' ' VAL . 12.4 p -75.14 109.87 8.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.943 0.878 . . . . 0.0 111.035 -176.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.24 77.54 5.75 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.24 173.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.412 ' OE1' ' HB2' ' A' ' 164' ' ' ASN . 49.0 mt-10 -56.54 -59.04 5.57 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -170.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.1 m -90.28 10.77 23.49 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.442 0.639 . . . . 0.0 111.267 -170.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 82.43 126.58 0.98 Allowed Glycine 0 N--CA 1.43 -1.761 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.654 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . 0.521 ' O ' HD23 ' A' ' 155' ' ' LEU . 3.6 m -71.94 153.51 41.79 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 113.854 -1.173 . . . . 0.0 109.559 171.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.521 HD23 ' O ' ' A' ' 154' ' ' CYS . 83.2 mt -141.3 172.7 12.32 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -169.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.715 ' ND2' ' HB2' ' A' ' 177' ' ' CYS . 8.5 p30 43.39 24.62 0.05 Allowed 'General case' 0 N--CA 1.478 0.949 0 O-C-N 124.108 0.88 . . . . 0.0 113.248 -174.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.1 36.8 93.71 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.199 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -73.76 -146.27 0.95 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 121.466 -0.397 . . . . 0.0 113.219 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.8 ttt85 -156.57 123.14 5.08 Favored 'General case' 0 C--O 1.222 -0.35 0 O-C-N 122.204 -0.586 . . . . 0.0 111.345 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 2.4 m -61.38 116.0 4.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.897 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 165' ' ' ARG . 11.2 m -102.1 -50.1 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.803 178.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.492 ' HB1' ' HD2' ' A' ' 163' ' ' PRO . . . -127.7 172.9 6.06 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.802 171.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.617 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 74.0 Cg_exo -51.15 107.78 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.128 1.885 . . . . 0.0 112.531 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.412 ' HB2' ' OE1' ' A' ' 151' ' ' GLU . 8.6 t-20 76.53 -14.2 0.84 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.816 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.548 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.6 OUTLIER -80.73 85.55 6.07 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.251 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 13.5 t -83.06 143.64 30.45 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.756 173.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.42 ' HB2' ' CG1' ' A' ' 161' ' ' VAL . . . -89.19 121.51 31.57 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 176.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 55.8 m -94.38 123.69 37.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.115 -169.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 170' ' ' TYR . 85.1 m -53.74 -48.83 69.27 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 114.211 -1.359 . . . . 0.0 113.16 -170.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.429 ' HE2' ' H ' ' A' ' 183' ' ' THR . 10.0 t80 177.54 115.95 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.929 -175.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 78.76 43.44 11.61 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 120.356 -0.926 . . . . 0.0 113.522 169.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.662 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 25.2 m-85 -124.8 128.25 48.43 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 117.951 0.876 . . . . 0.0 112.39 168.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.886 HG23 ' CE2' ' A' ' 181' ' ' TYR . 43.5 p -88.48 137.33 32.42 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.279 177.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.45 141.66 10.78 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.43 6.27 1.97 Allowed 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.451 1.434 . . . . 0.0 112.473 -170.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.499 ' O ' HD12 ' A' ' 155' ' ' LEU . 11.8 pt20 -129.3 24.64 5.52 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.32 177.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.715 ' HB2' ' ND2' ' A' ' 156' ' ' ASN . 0.0 OUTLIER 32.97 73.83 0.06 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 175.755 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -120.18 16.14 12.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.109 0.481 . . . . 0.0 111.406 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.662 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 15.9 mmt85 -123.33 96.26 4.92 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.547 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -80.05 84.36 5.79 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 122.241 1.02 . . . . 0.0 109.891 -173.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.886 ' CE2' HG23 ' A' ' 173' ' ' THR . 28.4 p90 -114.3 84.15 2.0 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 175.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -77.52 127.17 32.06 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 118.766 -2.459 . . . . 0.0 107.825 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.429 ' H ' ' HE2' ' A' ' 170' ' ' TYR . 18.0 p -81.93 134.28 35.37 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.877 -178.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.462 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -152.88 155.1 25.93 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.872 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.73 136.24 29.97 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.68 2.254 . . . . 0.0 111.012 172.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . 0.405 ' H ' HG23 ' A' ' 202' ' ' ILE . 5.8 t -108.28 115.65 30.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.92 0.391 . . . . 0.0 111.163 -174.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . 0.472 ' CE1' ' HA ' ' A' ' 198' ' ' GLN . 7.0 m-85 -95.54 160.4 14.53 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.512 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.505 HG21 ' HA ' ' A' ' 283' ' ' SER . 24.7 p -111.68 -16.11 13.3 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 -167.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 7.5 p -163.75 123.63 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 119.628 1.104 . . . . 0.0 112.394 -173.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.609 HG12 ' HA ' ' A' ' 195' ' ' CYS . 51.7 mt -126.46 115.97 43.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-O 121.645 0.736 . . . . 0.0 112.833 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.422 ' C ' ' H ' ' A' ' 193' ' ' GLN . 25.0 p -115.8 -163.61 0.9 Allowed 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 158.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -61.47 -5.18 1.6 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.601 0.637 . . . . 0.0 110.553 172.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.422 ' H ' ' C ' ' A' ' 191' ' ' SER . 58.3 tp60 -69.56 -74.39 0.13 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.802 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.546 ' SD ' ' HA2' ' A' ' 197' ' ' GLY . 23.9 ttm -179.16 -171.66 0.21 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 176.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.609 ' HA ' HG12 ' A' ' 190' ' ' ILE . 14.0 m -88.08 -24.27 23.48 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 118.185 0.448 . . . . 0.0 111.928 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.504 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 12.9 tt0 165.65 -4.24 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 122.015 0.912 . . . . 0.0 109.444 -173.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.546 ' HA2' ' SD ' ' A' ' 194' ' ' MET . . . 103.61 5.13 45.65 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -172.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.472 ' HA ' ' CE1' ' A' ' 187' ' ' PHE . 93.4 mt-30 61.71 52.66 3.47 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-O 121.466 0.651 . . . . 0.0 109.668 -176.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 63.7 mt -126.13 -179.73 4.86 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.964 -173.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 14.8 t 73.67 120.1 0.04 OUTLIER 'General case' 0 C--O 1.233 0.202 0 O-C-N 124.422 1.076 . . . . 0.0 111.285 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -93.42 33.23 5.25 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.606 177.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.405 HG23 ' H ' ' A' ' 186' ' ' CYS . 0.0 OUTLIER -64.78 97.7 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-O 122.238 1.018 . . . . 0.0 108.921 171.505 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.426 ' N ' ' HG2' ' A' ' 254' ' ' PRO . 1.4 t -90.07 118.62 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.368 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 11.2 t -153.59 -178.63 7.15 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 103.129 -2.915 . . . . 0.0 103.129 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.434 HG21 ' HA ' ' A' ' 181' ' ' TYR . 10.5 p -106.33 163.7 12.62 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 120.538 1.517 . . . . 0.0 110.012 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.579 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 49.6 tttm -63.85 -38.48 91.26 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.486 0.66 . . . . 0.0 109.788 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.0 m -48.63 -56.38 8.62 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.045 171.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.544 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -56.98 -53.73 54.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.905 177.04 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 54.4 m -67.09 -23.0 65.8 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -175.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 56.3 m -106.56 -11.69 15.81 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 118.979 0.809 . . . . 0.0 113.168 -177.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -83.88 -51.21 7.37 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.961 0.886 . . . . 0.0 108.991 165.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.539 HG22 ' HA2' ' A' ' 234' ' ' GLY . 6.7 p -101.66 151.9 21.47 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.275 -178.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.447 HG11 HE21 ' A' ' 284' ' ' GLN . 31.5 m 53.01 -37.19 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.556 ' O ' ' HD3' ' A' ' 215' ' ' ARG . . . 78.63 -159.51 46.27 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 120.416 1.462 . . . . 0.0 112.236 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.556 ' HD3' ' O ' ' A' ' 214' ' ' GLY . 0.0 OUTLIER 104.07 -90.6 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.692 1.197 . . . . 0.0 109.497 163.124 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.45 ' HB2' HD12 ' A' ' 190' ' ' ILE . . . -169.17 160.82 9.96 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.875 0.761 . . . . 0.0 110.125 170.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . 0.579 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 18.8 t90 -152.48 147.83 26.7 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -177.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 78.98 173.18 43.34 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 115.389 0.916 . . . . 0.0 115.389 167.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.578 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 36.0 m-70 -127.79 133.11 24.75 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 114.838 -0.681 . . . . 0.0 109.445 171.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.578 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 19.7 Cg_endo -58.6 152.3 39.23 Favored 'Cis proline' 0 C--N 1.347 0.461 0 C-N-CA 123.705 -1.373 . . . . 0.0 111.772 -3.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 43.5 t -55.89 118.43 4.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.254 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -115.28 121.23 42.25 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' MET . . . . . 0.434 ' HB3' HD12 ' A' ' 190' ' ' ILE . 19.8 ptm -98.07 146.48 25.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.645 0.26 . . . . 0.0 111.304 -173.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 61.8 m -143.24 148.37 44.27 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.959 -178.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.7 167.65 23.75 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.615 2.21 . . . . 0.0 109.9 163.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.527 ' O ' ' HD3' ' A' ' 228' ' ' PRO . . . -58.62 -94.67 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 120.764 0.316 . . . . 0.0 110.814 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' GLN . . . . . 0.473 ' HB3' ' HB3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -89.55 106.75 14.95 Favored Pre-proline 0 C--N 1.315 -0.9 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.072 172.419 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 226' ' ' ALA . 60.2 Cg_endo -90.63 -43.68 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.491 2.128 . . . . 0.0 113.252 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.457 ' HB3' ' HD2' ' A' ' 230' ' ' PRO . 90.3 m-70 -100.53 175.55 2.32 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 229' ' ' HIS . 36.6 Cg_exo -60.53 177.53 0.6 Allowed 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 121.656 1.571 . . . . 0.0 112.182 171.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 61.4 m 75.7 146.41 0.09 Allowed 'General case' 0 N--CA 1.47 0.575 0 O-C-N 124.112 0.883 . . . . 0.0 108.844 -166.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.513 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 83.2 mtt180 -63.13 140.48 58.88 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 118.997 -0.525 . . . . 0.0 109.905 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.483 ' O ' HG22 ' A' ' 212' ' ' THR . 38.1 ptt180 -32.86 -44.59 0.11 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 175.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.539 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -75.7 7.95 23.73 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.631 -175.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . 0.724 ' HE1' ' N ' ' A' ' 267' ' ' GLY . 2.5 m-85 -122.49 159.86 26.78 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.947 0.88 . . . . 0.0 112.085 -172.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.446 HD13 ' O ' ' A' ' 235' ' ' PHE . 0.4 OUTLIER -130.63 132.29 23.87 Favored Pre-proline 0 C--N 1.313 -1.018 0 CA-C-N 113.913 -1.494 . . . . 0.0 108.048 172.006 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -64.2 112.24 1.83 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.51 1.473 . . . . 0.0 110.635 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.417 ' OD1' ' HB2' ' A' ' 240' ' ' ARG . 18.2 t-20 -51.81 134.44 30.9 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.781 0.8 . . . . 0.0 111.065 -178.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 33.7 pt -78.52 -1.04 3.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 114.656 -1.156 . . . . 0.0 112.026 -174.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.417 ' HB2' ' OD1' ' A' ' 238' ' ' ASN . 87.1 mtt180 -111.27 -56.83 2.33 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.372 0.606 . . . . 0.0 110.057 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 44.3 p -84.52 -46.52 11.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.199 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 104.23 7.81 39.77 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.359 -175.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -92.6 126.61 37.76 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 122.005 0.907 . . . . 0.0 109.919 -177.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 3.8 m -53.89 124.18 14.64 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 113.433 -1.712 . . . . 0.0 110.359 174.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 81.2 mm-40 -124.54 135.51 53.22 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . 0.71 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 15.2 t70 -77.49 146.0 36.7 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 121.165 0.507 . . . . 0.0 110.142 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.762 HG23 ' HG3' ' A' ' 249' ' ' GLU . 6.9 m -98.49 146.16 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -74.66 76.76 2.03 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 167.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.762 ' HG3' HG23 ' A' ' 247' ' ' VAL . 32.2 mp0 -52.51 -39.01 60.81 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.388 0.614 . . . . 0.0 110.489 -171.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 262' ' ' CYS . 53.1 t -55.45 -30.63 60.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.943 176.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -97.42 -40.98 8.43 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 122.064 0.935 . . . . 0.0 109.62 -177.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.76 -16.91 63.94 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.947 -1.478 . . . . 0.0 110.836 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 2.6 mp -120.37 104.97 42.4 Favored Pre-proline 0 N--CA 1.447 -0.611 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 174.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.426 ' HG2' ' N ' ' A' ' 203' ' ' VAL . 1.1 Cg_exo -28.69 -47.88 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.604 1 C-N-CA 126.204 4.603 . . . . 0.0 116.87 -172.147 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -140.23 43.27 1.14 Allowed Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -174.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.413 HD21 ' CE1' ' A' ' 269' ' ' PHE . 11.1 tp -54.34 125.84 20.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.761 -0.72 . . . . 0.0 110.486 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 284' ' ' GLN . 98.9 m 60.35 58.37 2.59 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.515 0.674 . . . . 0.0 109.888 -176.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -60.44 120.89 10.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.381 -177.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 101.21 40.57 2.79 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.532 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 172.8 -156.49 25.01 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.787 179.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' ASN . . . . . 0.429 ' HB2' ' HB2' ' A' ' 272' ' ' LYS . 4.9 m-20 -111.93 156.82 21.48 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 250' ' ' CYS . 0.9 OUTLIER -137.86 132.88 33.19 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 170.268 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 58.5 mt -130.18 115.18 31.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.527 -170.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -73.61 121.84 21.33 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -172.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 268' ' ' SER . 0.5 OUTLIER -110.01 156.14 20.89 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 153.452 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.71 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 4.1 m -74.97 126.64 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 C-N-CA 117.861 -1.536 . . . . 0.0 107.605 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.724 ' N ' ' HE1' ' A' ' 235' ' ' PHE . . . 113.25 -26.62 10.2 Favored Glycine 0 C--N 1.309 -0.94 0 C-N-CA 119.764 -1.208 . . . . 0.0 111.807 -171.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.468 ' O ' HG23 ' A' ' 265' ' ' THR . 26.5 t 173.67 157.5 0.13 Allowed 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 121.315 0.579 . . . . 0.0 109.502 -174.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . 0.413 ' CE1' HD21 ' A' ' 256' ' ' LEU . 35.3 p90 -101.81 153.05 20.17 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -109.41 114.05 27.38 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 55.4 m -99.96 160.97 13.91 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.856 -0.737 . . . . 0.0 111.779 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.429 ' HB2' ' HB2' ' A' ' 261' ' ' ASN . 28.5 mmmt -134.19 112.55 11.19 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.306 -178.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 79.8 m -91.93 158.95 38.94 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.129 177.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.511 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 32.0 Cg_exo -61.04 157.07 40.89 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.402 2.068 . . . . 0.0 111.052 171.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -54.8 139.63 39.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.835 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 82.99 -27.1 4.01 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.957 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' HIS . . . . . 0.517 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 13.6 m-70 -77.03 162.94 27.13 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 121.343 0.592 . . . . 0.0 111.286 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -131.9 143.13 49.92 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.379 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 57.0 tp -87.34 133.29 33.72 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.114 0.483 . . . . 0.0 110.532 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.569 ' HB3' ' HB3' ' A' ' 285' ' ' LYS . 16.5 t-20 -114.48 106.27 14.08 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 172.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -66.8 -19.69 65.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.653 -173.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.435 ' HB ' ' OD1' ' A' ' 280' ' ' ASN . 47.6 t -62.75 -47.7 91.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.615 176.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.505 ' HA ' HG21 ' A' ' 188' ' ' THR . 31.3 t -123.74 31.05 5.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.095 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . 0.447 HE21 HG11 ' A' ' 213' ' ' VAL . 23.2 mp0 29.8 46.59 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.93 -172.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 280' ' ' ASN . 81.1 tttt -92.08 120.41 32.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.3 -170.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 7.2 m -102.98 81.1 1.94 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.89 0.376 . . . . 0.0 110.092 173.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 29.9 mm-40 . . . . . 0 C--O 1.242 0.696 0 CA-C-O 118.203 -0.903 . . . . 0.0 109.051 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.557 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 37.7 m-85 . . . . . 0 N--CA 1.448 -0.563 0 CA-C-O 121.188 0.518 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.418 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 37.7 pt -140.1 -174.96 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.977 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.192 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.17 157.94 32.61 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.693 -175.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.1 p -61.66 -41.94 98.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.955 0.407 . . . . 0.0 111.685 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -108.15 18.89 20.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.378 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 64.6 28.92 13.23 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.281 173.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.4 9.27 71.14 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 119.77 -1.205 . . . . 0.0 114.548 -175.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.418 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 0.0 OUTLIER -127.32 120.45 22.21 Favored Pre-proline 0 C--O 1.217 -0.624 0 CA-C-N 118.741 1.27 . . . . 0.0 112.24 -177.663 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -89.65 153.97 5.2 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.13 2.554 . . . . 0.0 112.973 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 163' ' ' PRO . 10.1 p -97.23 102.89 14.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 122.508 1.147 . . . . 0.0 111.942 -177.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.458 ' HA ' ' H ' ' A' ' 164' ' ' ASN . 64.7 m -83.64 96.63 8.73 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 122.097 0.951 . . . . 0.0 110.224 170.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -54.12 -55.41 27.95 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.919 -1.491 . . . . 0.0 114.918 -168.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 47.4 m -94.3 17.05 13.51 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.205 0.526 . . . . 0.0 111.039 -165.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 73.07 131.55 0.16 Allowed Glycine 0 N--CA 1.432 -1.586 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.005 -175.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . 0.499 ' O ' HD23 ' A' ' 155' ' ' LEU . 69.7 m -69.07 150.95 47.04 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.099 -1.051 . . . . 0.0 110.614 175.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 154' ' ' CYS . 58.7 mt -133.96 172.96 12.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.566 -170.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.75 ' ND2' ' H ' ' A' ' 169' ' ' THR . 0.0 OUTLIER 67.08 10.33 7.62 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.389 0.614 . . . . 0.0 111.188 178.05 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.87 36.26 91.72 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.079 -167.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -76.0 -145.23 1.54 Allowed Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.203 -0.498 . . . . 0.0 113.318 -175.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -150.86 118.02 5.95 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.665 -0.315 . . . . 0.0 111.111 -175.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 13.6 t -60.94 125.24 23.0 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.746 0.308 . . . . 0.0 110.34 176.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 165' ' ' ARG . 13.2 m -117.04 -49.28 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.922 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 163' ' ' PRO . . . -133.79 173.68 5.56 Favored Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 176.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.606 ' HA ' ' O ' ' A' ' 149' ' ' VAL . 54.3 Cg_exo -53.91 107.32 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 121.987 1.791 . . . . 0.0 112.465 177.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.458 ' H ' ' HA ' ' A' ' 150' ' ' CYS . 5.3 t-20 73.83 14.58 4.06 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.996 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.546 ' O ' HG22 ' A' ' 161' ' ' VAL . 2.0 mtm180 -113.35 89.45 3.09 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.027 174.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 82.4 m -88.32 141.69 28.34 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.0 169.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -90.32 131.28 36.21 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 60.0 m -104.53 130.96 52.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.901 0.857 . . . . 0.0 112.197 -169.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.75 ' H ' ' ND2' ' A' ' 156' ' ' ASN . 82.2 m -71.02 -57.59 4.4 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 116.204 1.928 . . . . 0.0 116.204 -170.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -136.89 -100.31 0.2 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 118.329 -1.348 . . . . 0.0 113.205 -165.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -90.32 45.39 2.97 Favored Glycine 0 CA--C 1.492 -1.379 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.773 -165.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 156' ' ' ASN . 4.2 m-85 -120.23 127.22 52.22 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 119.502 -0.879 . . . . 0.0 112.186 173.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.532 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 6.5 t -92.15 154.27 18.8 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 166.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 87.97 124.18 2.05 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.31 24.31 0.36 Allowed 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.053 1.836 . . . . 0.0 114.257 -166.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.422 ' O ' HD12 ' A' ' 155' ' ' LEU . 45.9 tt0 -126.57 5.11 6.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.896 0.855 . . . . 0.0 109.854 176.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.551 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.1 OUTLIER 36.99 51.24 0.96 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 113.838 -1.528 . . . . 0.0 114.46 -177.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -109.72 -15.46 14.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.073 0.463 . . . . 0.0 110.656 174.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 173' ' ' THR . 14.4 mmm180 -59.88 -58.49 8.32 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.442 -1.253 . . . . 0.0 107.697 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.472 ' HA ' ' CD2' ' A' ' 172' ' ' PHE . 34.9 t70 72.71 62.24 0.11 Allowed 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 160.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.532 ' HE2' ' N ' ' A' ' 173' ' ' THR . 50.5 p90 -91.46 65.47 5.26 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 122.74 1.257 . . . . 0.0 108.478 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.461 ' O ' ' HH2' ' A' ' 217' ' ' TRP . 61.2 mtt180 -53.76 125.86 19.98 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 168.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.409 ' HB ' HG13 ' A' ' 203' ' ' VAL . 82.1 p -72.25 143.75 48.68 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.345 -160.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -149.69 147.37 17.6 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -167.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -82.27 143.6 12.64 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.177 1.918 . . . . 0.0 111.241 173.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . 0.423 ' H ' HG23 ' A' ' 202' ' ' ILE . 1.8 m -76.34 116.64 17.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.21 0.529 . . . . 0.0 111.105 176.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . 0.749 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 21.9 m-30 -84.54 145.18 28.21 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.079 177.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.491 HG22 ' NH2' ' A' ' 215' ' ' ARG . 40.2 p -122.23 -18.35 6.86 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.489 -174.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 66.5 t -139.47 115.05 8.51 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -176.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.688 HD11 ' HB2' ' A' ' 216' ' ' ALA . 20.7 mm -83.71 119.44 32.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -168.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.499 ' HB3' ' O ' ' A' ' 194' ' ' MET . 35.0 t -143.55 138.43 29.12 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.537 -1.665 . . . . 0.0 107.344 170.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -62.73 -33.45 75.15 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 172.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -55.66 -63.02 1.3 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 113.358 -1.746 . . . . 0.0 110.02 171.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.499 ' O ' ' HB3' ' A' ' 191' ' ' SER . 61.3 mtt -154.78 119.26 4.78 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.037 176.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.547 ' HB2' ' CD1' ' A' ' 187' ' ' PHE . 62.9 m -80.65 1.24 30.77 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 110.588 -0.153 . . . . 0.0 110.588 176.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.525 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 31.6 mm-40 96.62 -138.49 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.578 1.551 . . . . 0.0 109.452 -172.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.425 ' HA3' ' CE2' ' A' ' 187' ' ' PHE . . . 73.56 -37.1 0.84 Allowed Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.131 -0.557 . . . . 0.0 114.468 177.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -63.71 -14.36 51.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.527 0.664 . . . . 0.0 111.129 -177.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.496 ' N ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -107.43 27.0 9.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.645 -179.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.402 ' OG ' HG22 ' A' ' 202' ' ' ILE . 27.0 t -156.6 155.35 31.69 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.214 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -125.88 23.19 5.95 Favored Glycine 0 CA--C 1.504 -0.596 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 175.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.604 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -60.9 112.18 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 175.245 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.409 HG13 ' HB ' ' A' ' 183' ' ' THR . 46.4 t -104.88 100.02 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-O 122.632 1.206 . . . . 0.0 110.441 175.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.443 ' HB2' HD11 ' A' ' 202' ' ' ILE . 15.6 t -125.17 -175.23 3.25 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 112.575 -2.102 . . . . 0.0 105.862 173.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.401 HG22 ' HB2' ' A' ' 181' ' ' TYR . 12.0 p -101.42 163.17 12.41 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.664 173.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.953 ' HB3' ' CE3' ' A' ' 217' ' ' TRP . 41.4 pttt -68.98 -22.76 64.08 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.337 176.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 9.2 m -59.94 -51.42 69.74 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.429 ' CD1' HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -58.13 -48.11 81.25 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.553 175.006 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.0 -21.98 61.49 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.168 -174.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 86.6 m -101.48 -17.67 16.33 Favored 'General case' 0 C--O 1.212 -0.892 0 O-C-N 121.549 -0.719 . . . . 0.0 112.064 -176.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -81.91 -48.9 10.93 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.915 0.865 . . . . 0.0 109.797 166.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 233' ' ' ARG . 6.4 p -102.4 141.63 34.91 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.675 -176.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.468 HG13 HE22 ' A' ' 284' ' ' GLN . 1.3 t 58.51 -38.08 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -178.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.555 ' O ' ' HD3' ' A' ' 215' ' ' ARG . . . 81.58 -161.11 42.27 Favored Glycine 0 CA--C 1.505 -0.566 0 CA-C-N 119.812 1.187 . . . . 0.0 112.915 -177.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.555 ' HD3' ' O ' ' A' ' 214' ' ' GLY . 0.0 OUTLIER 102.72 -93.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.487 1.115 . . . . 0.0 108.978 166.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.749 ' HB3' ' HB2' ' A' ' 187' ' ' PHE . . . -172.25 172.71 4.44 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 118.99 0.814 . . . . 0.0 109.24 173.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . 0.953 ' CE3' ' HB3' ' A' ' 206' ' ' LYS . 12.8 t90 -163.12 150.66 13.2 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -177.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 70.7 173.06 12.87 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 114.714 0.646 . . . . 0.0 114.714 170.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.484 ' CD2' ' HZ ' ' A' ' 187' ' ' PHE . 48.4 m80 -123.97 131.73 24.25 Favored Pre-proline 0 C--N 1.334 -0.105 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 37.2 Cg_endo -63.74 167.37 39.57 Favored 'Cis proline' 0 C--N 1.349 0.555 0 C-N-CA 123.806 -1.331 . . . . 0.0 112.616 -1.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 16.2 t -59.4 111.25 1.31 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.653 -176.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -106.12 102.07 11.51 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.02 141.9 35.01 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.381 -169.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 14.8 m -144.05 159.22 53.68 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.429 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.95 167.22 23.97 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.982 2.454 . . . . 0.0 109.769 164.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.571 ' O ' ' HD3' ' A' ' 228' ' ' PRO . . . -56.02 -92.23 0.0 OUTLIER 'General case' 0 C--O 1.211 -0.969 0 CA-C-N 117.957 0.344 . . . . 0.0 110.511 176.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' GLN . . . . . 0.447 ' HB3' ' HB3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -89.02 102.59 4.31 Favored Pre-proline 0 C--N 1.316 -0.861 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.057 169.555 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.571 ' HD3' ' O ' ' A' ' 226' ' ' ALA . 24.5 Cg_endo -93.52 -44.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.794 2.329 . . . . 0.0 113.858 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.483 ' HB3' ' HD2' ' A' ' 230' ' ' PRO . 72.0 m-70 -103.15 -179.85 0.85 Allowed Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -173.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 229' ' ' HIS . 51.6 Cg_exo -59.06 174.24 0.99 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 121.849 1.699 . . . . 0.0 112.251 172.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 73.9 m 70.12 128.63 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -168.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.503 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 65.0 mtt180 -58.96 148.85 29.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -176.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.506 ' O ' HG22 ' A' ' 212' ' ' THR . 17.3 ptp180 -31.71 -47.03 0.12 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.57 ' O ' ' HA ' ' A' ' 246' ' ' ASP . . . -79.52 11.79 30.45 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.475 -0.869 . . . . 0.0 114.168 -174.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . 0.55 ' O ' HD13 ' A' ' 236' ' ' ILE . 78.5 m-85 -123.08 155.9 35.99 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.867 0.842 . . . . 0.0 113.061 -173.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.55 HD13 ' O ' ' A' ' 235' ' ' PHE . 0.3 OUTLIER -135.41 134.48 21.21 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 114.011 -1.45 . . . . 0.0 107.866 173.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.89 112.47 1.29 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 121.86 1.707 . . . . 0.0 110.932 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -53.48 135.3 40.0 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.832 0.825 . . . . 0.0 110.364 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 30.9 mt -69.69 -13.23 16.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.752 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -103.67 -60.8 1.51 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.388 0.613 . . . . 0.0 110.057 -176.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 44.7 p -84.38 -40.41 17.89 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.873 -175.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 97.6 5.0 57.95 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -83.79 133.3 34.77 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.706 0.765 . . . . 0.0 110.942 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 22.3 m -56.16 108.14 0.44 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.905 170.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 60.3 mm-40 -115.19 134.87 54.76 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . 0.655 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 12.8 t70 -75.62 140.43 42.6 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -176.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.769 HG23 ' HG3' ' A' ' 249' ' ' GLU . 3.7 m -94.38 145.14 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -75.44 77.38 2.5 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 166.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.769 ' HG3' HG23 ' A' ' 247' ' ' VAL . 47.9 mp0 -50.04 -35.32 24.56 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.4 0.619 . . . . 0.0 110.716 -171.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 77.2 m -50.94 -34.83 30.35 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.069 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -103.94 -47.35 4.22 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.428 0.691 . . . . 0.0 110.466 -175.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -63.38 -26.52 68.79 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.935 -177.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.802 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.7 mp -121.38 78.43 35.83 Favored Pre-proline 0 N--CA 1.446 -0.635 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -57.31 112.75 1.22 Allowed 'Trans proline' 0 CA--C 1.514 -0.493 0 C-N-CA 123.358 2.705 . . . . 0.0 114.608 -164.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 74.46 24.51 72.72 Favored Glycine 0 C--N 1.308 -0.976 0 CA-C-N 113.561 -1.654 . . . . 0.0 113.665 175.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.802 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.6 OUTLIER -67.92 -32.94 73.75 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 117.615 0.707 . . . . 0.0 110.537 177.487 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . 0.625 ' HA ' ' HB3' ' A' ' 284' ' ' GLN . 35.3 t -104.05 83.28 2.08 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.488 0.661 . . . . 0.0 109.443 177.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -98.52 -2.79 37.97 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.927 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -60.21 -41.58 98.3 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.46 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -165.31 -109.85 0.23 Allowed Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.953 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' ASN . . . . . 0.598 ' HB2' ' HB3' ' A' ' 272' ' ' LYS . 10.0 m120 -86.68 162.08 18.1 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.162 0.506 . . . . 0.0 111.276 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 4.3 t -148.08 120.46 8.44 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.177 174.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.477 ' HB ' ' HB2' ' A' ' 270' ' ' GLU . 21.7 mt -128.29 165.2 28.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 -176.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.58 125.86 33.35 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 117.95 -1.5 . . . . 0.0 113.559 -177.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.2 t -114.25 162.6 16.36 Favored 'General case' 0 C--O 1.259 1.558 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.131 163.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.655 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 27.2 m -72.55 124.84 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 C-N-CA 119.717 -0.793 . . . . 0.0 108.953 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.474 ' HA2' ' CE2' ' A' ' 235' ' ' PHE . . . 105.43 -17.61 43.05 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 119.997 -1.097 . . . . 0.0 112.784 -175.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 41.3 t 175.58 155.2 0.18 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.77 0.785 . . . . 0.0 110.302 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -102.33 155.96 17.9 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . 0.477 ' HB2' ' HB ' ' A' ' 263' ' ' ILE . 9.5 mt-10 -113.18 116.96 30.64 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.057 -173.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 99.2 m -105.07 148.25 27.01 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.598 ' HB3' ' HB2' ' A' ' 261' ' ' ASN . 21.2 ttpp -127.95 132.46 49.24 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -177.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 286' ' ' CYS . 23.4 m -112.63 157.14 41.19 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.373 -175.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.502 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 51.1 Cg_exo -55.41 156.84 16.19 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.189 1.926 . . . . 0.0 110.944 168.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -56.32 144.15 31.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.676 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.38 -34.31 2.89 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.283 -0.961 . . . . 0.0 112.036 -176.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' HIS . . . . . 0.623 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 16.0 m-70 -75.8 164.16 26.52 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.592 0.234 . . . . 0.0 110.56 -175.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -139.82 142.6 36.63 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -176.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 285' ' ' LYS . 57.5 tp -73.07 125.01 26.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.112 0.482 . . . . 0.0 111.315 -178.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.484 ' HB3' ' HB2' ' A' ' 285' ' ' LYS . 17.6 t-20 -102.48 95.6 6.36 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -68.0 -16.05 63.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.085 -172.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 84.7 t -56.33 -49.36 77.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.512 173.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 2.4 p -134.87 40.21 2.94 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.229 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . 0.625 ' HB3' ' HA ' ' A' ' 257' ' ' CYS . 13.5 mp0 25.46 56.54 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.201 -1.363 . . . . 0.0 113.457 -173.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 280' ' ' ASN . 98.5 mttt -101.29 176.16 5.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.77 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 273' ' ' CYS . 38.8 m -147.61 97.64 2.86 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.486 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.623 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 65.7 mm-40 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.358 -0.829 . . . . 0.0 109.54 -174.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.682 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 98.0 m-85 . . . . . 0 C--O 1.227 -0.093 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.444 HG12 HE21 ' A' ' 147' ' ' GLN . 30.7 pt -126.9 171.8 14.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 176.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.55 157.71 20.31 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.7 p -65.06 -34.71 79.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.248 0.524 . . . . 0.0 111.174 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -100.22 2.26 42.66 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.051 0.453 . . . . 0.0 110.427 174.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 60.2 m 61.9 43.64 9.1 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.496 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -104.27 3.53 43.89 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 119.953 -1.118 . . . . 0.0 113.646 -176.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.444 HE21 HG12 ' A' ' 141' ' ' ILE . 0.3 OUTLIER -106.58 110.92 64.09 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 117.54 0.67 . . . . 0.0 109.422 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -80.81 140.3 12.82 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.846 2.364 . . . . 0.0 112.747 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 149' ' ' VAL . 13.9 p -67.08 111.36 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.291 1.043 . . . . 0.0 112.364 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.508 ' HB3' ' SG ' ' A' ' 154' ' ' CYS . 0.8 OUTLIER -80.21 73.53 7.05 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.541 171.343 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -50.65 -67.13 0.28 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.699 -1.591 . . . . 0.0 114.239 -171.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 19.4 m -98.22 13.78 30.08 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.394 0.616 . . . . 0.0 111.624 -166.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 79.2 123.35 0.37 Allowed Glycine 0 CA--C 1.5 -0.87 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.668 -175.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . 0.508 ' SG ' ' HB3' ' A' ' 150' ' ' CYS . 86.4 m -77.0 -17.29 58.96 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -175.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.643 HD13 ' HB3' ' A' ' 178' ' ' GLU . 2.2 mp 46.19 -172.37 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -172.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.418 ' ND2' ' SG ' ' A' ' 177' ' ' CYS . 0.8 OUTLIER 51.92 11.06 0.13 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.297 1.439 . . . . 0.0 113.902 171.586 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.31 36.7 84.55 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.799 -174.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -79.24 -145.65 3.31 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.446 -176.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -153.77 118.4 4.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.368 0.584 . . . . 0.0 110.823 -175.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.9 m -62.01 119.75 9.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.746 0.308 . . . . 0.0 111.554 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 165' ' ' ARG . 4.3 m -107.13 -35.85 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 121.134 0.493 . . . . 0.0 110.417 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.638 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -140.13 172.21 6.66 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.682 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 79.4 Cg_exo -52.73 106.06 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.175 1.916 . . . . 0.0 112.246 176.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 69.1 -0.04 2.62 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.483 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.638 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -90.41 83.99 5.96 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 172.405 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 40.5 m -84.12 145.33 28.48 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.2 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -92.67 124.66 36.84 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 37.1 m -104.07 135.62 45.23 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 124.142 0.901 . . . . 0.0 112.114 -168.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.4 m -48.73 -53.66 18.04 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -172.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -167.78 -88.16 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.366 -0.934 . . . . 0.0 112.55 -174.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -85.16 57.24 4.98 Favored Glycine 0 N--CA 1.435 -1.385 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.898 -167.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.588 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 8.1 m-85 -122.91 128.49 50.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.223 1.012 . . . . 0.0 111.669 172.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.84 HG23 ' CE1' ' A' ' 181' ' ' TYR . 14.9 p -86.72 119.88 27.42 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.181 177.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 107.4 133.3 7.15 Favored Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -174.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.43 -0.45 8.19 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 120.956 1.104 . . . . 0.0 112.429 -173.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -107.96 19.23 20.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.496 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.572 ' O ' ' HB2' ' A' ' 155' ' ' LEU . 0.5 OUTLIER 17.66 79.67 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 118.301 2.704 . . . . 0.0 118.301 176.222 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.643 ' HB3' HD13 ' A' ' 155' ' ' LEU . 14.5 pt-20 -126.22 34.53 4.83 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.132 0.968 . . . . 0.0 109.517 167.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.588 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 23.0 mmt180 -132.63 88.22 2.5 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.724 -1.58 . . . . 0.0 107.248 176.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.425 ' HA ' ' CE1' ' A' ' 172' ' ' PHE . 9.2 p-10 -81.0 49.83 1.29 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.808 0.813 . . . . 0.0 111.352 -169.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.84 ' CE1' HG23 ' A' ' 173' ' ' THR . 10.5 p90 -76.59 93.86 3.66 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 176.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -79.15 173.76 12.25 Favored 'General case' 0 N--CA 1.436 -1.15 0 O-C-N 119.733 -1.854 . . . . 0.0 106.162 174.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 81.6 p -98.76 138.87 35.3 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 118.851 -1.14 . . . . 0.0 108.889 169.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.458 ' HA3' ' HA2' ' A' ' 218' ' ' GLY . . . -159.75 149.78 19.66 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.727 -173.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.416 ' HB3' ' O ' ' A' ' 200' ' ' SER . 59.4 Cg_endo -75.44 132.51 14.94 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.365 2.044 . . . . 0.0 111.041 171.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . 0.712 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 71.5 m -75.2 122.09 23.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.4 0.619 . . . . 0.0 110.236 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -107.55 153.47 22.81 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.793 -175.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.62 ' O ' ' HB3' ' A' ' 215' ' ' ARG . 29.1 p -100.94 -56.99 2.19 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.002 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 36.9 t -134.06 118.45 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 119.686 -0.805 . . . . 0.0 111.767 -172.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.637 HG13 ' SG ' ' A' ' 195' ' ' CYS . 2.1 mp -102.32 117.21 47.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.465 0.65 . . . . 0.0 111.736 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.3 p -110.98 -168.67 1.33 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 159.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -68.87 -4.84 17.9 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.383 0.611 . . . . 0.0 110.066 171.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -90.81 -76.43 0.44 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.394 -174.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 98.6 mmm -141.68 160.28 40.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.275 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.637 ' SG ' HG13 ' A' ' 190' ' ' ILE . 38.8 m -91.09 -8.15 49.69 Favored 'General case' 0 C--O 1.248 0.99 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.953 175.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.435 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 79.9 mm-40 78.22 -140.49 0.02 OUTLIER 'General case' 0 C--N 1.347 0.464 0 CA-C-N 114.2 -1.364 . . . . 0.0 109.863 -175.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 82.56 -7.06 66.31 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.796 172.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 59.1 27.98 17.12 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 122.577 0.351 . . . . 0.0 111.2 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 51.9 44.74 29.17 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.687 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.416 ' O ' ' HB3' ' A' ' 185' ' ' PRO . 41.5 t -70.47 155.53 40.59 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.641 -174.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -109.33 20.01 28.58 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.332 177.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.45 HD11 ' HB2' ' A' ' 204' ' ' SER . 0.0 OUTLIER -63.11 113.57 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 173.198 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 48.9 t -102.46 99.11 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 122.346 1.069 . . . . 0.0 110.502 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.45 ' HB2' HD11 ' A' ' 202' ' ' ILE . 7.9 t -127.77 -175.4 3.46 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 112.479 -2.146 . . . . 0.0 105.436 170.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 30.6 p -101.72 165.29 11.29 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 119.648 1.113 . . . . 0.0 109.923 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.923 ' HB3' ' CE3' ' A' ' 217' ' ' TRP . 0.0 OUTLIER -66.64 -23.85 66.21 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 119.102 -1.039 . . . . 0.0 108.662 175.805 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.8 m -59.51 -55.93 28.4 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.507 ' CD1' HG11 ' A' ' 247' ' ' VAL . 0.3 OUTLIER -54.03 -54.96 31.97 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.74 176.553 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 52.9 m -77.41 -20.51 54.52 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -170.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 226' ' ' ALA . 97.5 m -83.93 -41.73 17.07 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 119.123 0.874 . . . . 0.0 109.914 173.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . 0.474 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . . . -64.6 -58.32 6.67 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.675 HG22 ' HA2' ' A' ' 234' ' ' GLY . 5.1 p -91.25 140.69 29.55 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.896 -1.502 . . . . 0.0 108.998 178.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.496 HG21 ' CD1' ' A' ' 256' ' ' LEU . 0.2 OUTLIER 58.62 -30.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -177.124 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.406 ' O ' ' HD2' ' A' ' 215' ' ' ARG . . . 75.82 -162.39 52.92 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 120.209 1.368 . . . . 0.0 114.449 177.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.62 ' HB3' ' O ' ' A' ' 188' ' ' THR . 2.1 mtt180 98.78 -83.3 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.546 1.138 . . . . 0.0 112.371 166.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' A' ' 223' ' ' MET . . . -174.57 172.02 3.18 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.117 0.417 . . . . 0.0 110.521 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . 0.923 ' CE3' ' HB3' ' A' ' 206' ' ' LYS . 9.6 t90 -165.33 151.38 9.75 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.306 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 221' ' ' CYS . . . 77.23 174.88 41.67 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 115.06 0.784 . . . . 0.0 115.06 171.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.525 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 17.6 m80 -133.3 131.72 21.74 Favored Pre-proline 0 N--CA 1.462 0.172 0 CA-C-N 114.692 -0.754 . . . . 0.0 109.315 174.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.525 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 23.0 Cg_endo -61.18 142.93 36.62 Favored 'Cis proline' 0 C--N 1.346 0.409 0 C-N-CA 123.132 -1.612 . . . . 0.0 111.175 -3.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 81.0 m -49.49 121.42 5.06 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.733 0.646 . . . . 0.0 111.784 -172.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -93.44 95.64 9.41 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' MET . . . . . 0.473 ' HA ' ' HB2' ' A' ' 216' ' ' ALA . 0.0 OUTLIER -90.22 122.7 33.39 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 -172.221 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 17.8 p -142.9 150.27 52.57 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.05 -165.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.34 167.11 13.47 Favored 'Trans proline' 0 CA--C 1.515 -0.437 0 C-N-CA 122.867 2.378 . . . . 0.0 110.672 162.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 210' ' ' CYS . . . -62.88 -119.74 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.853 0.835 . . . . 0.0 112.06 174.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 227' ' ' GLN . 6.8 pt20 -57.13 107.76 1.01 Allowed Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.13 -172.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 211' ' ' ALA . 1.9 Cg_endo -83.6 -55.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.146 2.564 . . . . 0.0 112.366 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -78.22 163.0 64.62 Favored Pre-proline 0 CA--C 1.511 -0.539 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.7 59.05 4.08 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 121.992 1.794 . . . . 0.0 112.031 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 59.3 m -131.23 162.58 29.67 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.466 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 20.8 mmt180 -66.02 139.8 58.23 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 175.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -36.22 -41.17 0.25 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.675 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -77.25 8.93 29.47 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.629 -175.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . 0.651 ' HE2' ' N ' ' A' ' 267' ' ' GLY . 2.3 m-85 -121.56 149.45 43.11 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.287 1.042 . . . . 0.0 113.067 -171.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.499 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.2 OUTLIER -125.37 124.2 25.14 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 113.736 -1.575 . . . . 0.0 108.818 172.204 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -63.58 122.1 10.09 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.295 1.997 . . . . 0.0 111.573 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -53.78 131.03 38.81 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.875 177.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 40.9 pt -76.5 7.07 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.555 176.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -113.48 -59.82 1.97 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.547 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 42.1 p -91.31 -44.01 9.44 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.913 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 105.6 7.84 36.05 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -92.77 125.16 37.25 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 121.907 0.861 . . . . 0.0 109.938 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 10.2 m -60.47 122.2 14.01 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 113.296 -1.775 . . . . 0.0 109.938 174.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.459 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 90.2 mt-30 -119.37 139.21 52.36 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . 0.787 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 17.4 t70 -74.46 143.68 44.54 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.845 HG23 ' HG3' ' A' ' 249' ' ' GLU . 10.0 m -94.52 145.98 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.252 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.89 77.04 1.64 Allowed 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 165.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.845 ' HG3' HG23 ' A' ' 247' ' ' VAL . 6.3 mp0 -52.73 -35.16 55.43 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.478 0.656 . . . . 0.0 109.56 -175.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 6.4 m -53.83 -29.51 41.15 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.211 174.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -103.72 -38.66 6.98 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.719 0.771 . . . . 0.0 109.906 -176.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -72.18 -19.8 61.69 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.869 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.684 HG22 ' HB3' ' A' ' 256' ' ' LEU . 46.7 mt -140.9 74.86 25.56 Favored Pre-proline 0 C--O 1.244 0.77 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -12.51 -80.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.947 1 C-N-CA 126.832 5.021 . . . . 0.0 116.174 -164.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -130.6 64.69 0.61 Allowed Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 119.464 -1.35 . . . . 0.0 111.472 176.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.684 ' HB3' HG22 ' A' ' 253' ' ' ILE . 1.4 pt? -68.63 8.19 0.53 Allowed 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -176.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 56.9 m -114.0 127.43 55.95 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 171.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . 0.518 ' O ' ' HB3' ' A' ' 286' ' ' CYS . 97.8 mt-30 -70.36 91.46 0.75 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.998 0.428 . . . . 0.0 111.962 -175.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 80.45 32.44 34.37 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.912 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -129.74 163.81 22.68 Favored Glycine 0 C--O 1.227 -0.308 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.06 -178.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -102.27 103.2 13.67 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 269' ' ' PHE . 50.8 t -68.21 123.05 19.63 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.079 0.466 . . . . 0.0 111.072 176.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 47.3 mt -125.56 103.75 12.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.707 ' ND2' ' HB3' ' A' ' 269' ' ' PHE . 1.0 OUTLIER -81.12 128.3 33.59 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -160.798 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 268' ' ' SER . 0.2 OUTLIER -109.21 157.5 18.74 Favored 'General case' 0 C--O 1.257 1.449 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.722 163.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.787 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 3.2 m -72.87 128.68 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 C-N-CA 118.839 -1.144 . . . . 0.0 108.531 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.651 ' N ' ' HE2' ' A' ' 235' ' ' PHE . . . 105.19 -26.81 20.83 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.073 -1.06 . . . . 0.0 110.887 -174.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.581 ' O ' HG23 ' A' ' 265' ' ' THR . 32.6 t 176.09 151.71 0.15 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.124 0.488 . . . . 0.0 110.358 -175.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . 0.707 ' HB3' ' ND2' ' A' ' 264' ' ' ASN . 26.7 p90 -99.4 162.44 13.04 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.968 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -115.32 106.49 14.08 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.808 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 54.4 m -94.6 112.18 23.94 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.346 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -79.19 132.21 36.45 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.106 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.425 ' HB3' ' CB ' ' A' ' 277' ' ' HIS . 36.2 m -116.26 143.73 31.63 Favored Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.115 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.563 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 36.6 Cg_exo -60.56 167.01 8.82 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.363 2.042 . . . . 0.0 110.89 173.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -59.44 144.35 47.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.711 0.291 . . . . 0.0 110.86 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.6 -27.69 4.66 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.625 -177.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' HIS . . . . . 0.638 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 18.0 m-70 -77.0 160.34 29.21 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.021 0.438 . . . . 0.0 111.317 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . 0.421 ' NZ ' ' HB2' ' A' ' 278' ' ' LYS . 9.8 mtmp? -145.97 121.34 10.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.396 -174.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 19.1 tp -77.32 141.47 39.89 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.77 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.421 ' HB3' ' HB2' ' A' ' 285' ' ' LYS . 37.4 t30 -133.16 100.09 4.75 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.178 175.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -60.56 -26.05 66.63 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.47 -175.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 58.0 t -58.06 -29.53 36.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.679 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' A' ' 285' ' ' LYS . 33.4 t -147.85 34.87 0.84 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.888 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 32.11 38.55 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.448 1.099 . . . . 0.0 113.664 -176.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 96.6 mttt -87.12 149.33 24.75 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.693 -175.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' CYS . . . . . 0.518 ' HB3' ' O ' ' A' ' 258' ' ' GLN . 42.2 t -140.08 83.04 1.9 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.342 0.591 . . . . 0.0 109.507 178.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.638 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 3.8 mm-40 . . . . . 0 C--O 1.248 0.988 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.904 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.584 ' CE2' ' HB3' ' A' ' 148' ' ' PRO . 78.9 m-85 . . . . . 0 CA--C 1.512 -0.491 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 147' ' ' GLN . 25.1 pt -135.57 -176.66 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.024 -177.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 96.19 172.98 35.64 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.749 -176.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.0 m -76.51 -29.57 56.84 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 122.759 -0.259 . . . . 0.0 111.12 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -110.61 11.07 22.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.873 0.368 . . . . 0.0 110.425 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 58.1 m 63.5 30.09 15.28 Favored 'General case' 0 C--O 1.228 -0.037 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.129 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -94.26 4.83 70.89 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.873 -174.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.516 ' O ' HG12 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -120.21 97.59 49.1 Favored Pre-proline 0 C--O 1.22 -0.496 0 CA-C-N 117.702 0.751 . . . . 0.0 110.755 -179.458 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.584 ' HB3' ' CE2' ' A' ' 140' ' ' TYR . 52.4 Cg_endo -73.01 148.14 44.53 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.49 2.127 . . . . 0.0 112.19 176.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 149' ' ' VAL . 9.8 p -71.17 108.89 3.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.237 -173.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.69 77.24 6.32 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.362 173.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -51.9 -65.97 0.46 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -173.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 60.7 m -86.98 12.43 11.25 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.074 0.464 . . . . 0.0 111.226 -168.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 81.6 127.47 0.91 Allowed Glycine 0 N--CA 1.429 -1.786 0 CA-C-O 122.19 0.883 . . . . 0.0 111.906 -173.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . 0.496 ' O ' HD23 ' A' ' 155' ' ' LEU . 1.7 m -73.56 152.93 40.45 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 113.989 -1.106 . . . . 0.0 109.307 171.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.748 HD12 ' O ' ' A' ' 176' ' ' GLN . 70.9 mt -135.34 162.89 31.31 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -168.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.743 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 2.6 t-20 48.76 24.88 0.88 Allowed 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.909 0.756 . . . . 0.0 111.605 -168.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 63.22 38.62 96.78 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.212 -176.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -76.28 -140.81 1.04 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.734 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 159' ' ' ARG . 0.1 OUTLIER -155.55 130.99 9.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.075 0.438 . . . . 0.0 111.081 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . 0.442 ' O ' ' HG2' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -71.26 110.12 5.71 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.265 0.555 . . . . 0.0 110.428 172.483 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 165' ' ' ARG . 2.3 m -98.51 -28.72 3.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.631 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.745 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -140.28 173.11 5.33 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 174.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.577 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 49.4 Cg_exo -56.83 104.57 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 121.973 1.782 . . . . 0.0 112.348 178.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 68.06 9.97 7.52 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.216 1.006 . . . . 0.0 110.904 -176.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.745 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.3 OUTLIER -99.69 84.1 2.87 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 8.9 t -86.52 147.72 25.84 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.672 176.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.412 ' HB3' ' HD3' ' A' ' 159' ' ' ARG . . . -103.3 131.07 50.65 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.074 175.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 52.1 m -107.5 136.65 46.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.563 -165.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.743 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 25.4 m -53.12 -56.58 15.21 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -168.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.479 ' HE1' ' H ' ' A' ' 183' ' ' THR . 35.7 t80 -154.53 -87.61 0.05 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 119.043 -1.063 . . . . 0.0 112.729 -170.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.45 ' N ' ' HD1' ' A' ' 170' ' ' TYR . . . -92.21 52.33 2.81 Favored Glycine 0 CA--C 1.493 -1.305 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.725 -166.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.616 ' HB3' ' HA ' ' A' ' 177' ' ' CYS . 3.3 m-85 -124.87 123.91 40.95 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.54 169.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.58 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 2.9 t -91.54 145.39 24.65 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 174.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 87.76 127.86 2.67 Favored Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -173.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.35 24.76 0.35 Allowed 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 121.534 1.489 . . . . 0.0 113.327 -168.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.748 ' O ' HD12 ' A' ' 155' ' ' LEU . 59.4 tt0 -122.31 7.14 9.62 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.616 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.7 OUTLIER 25.65 59.53 0.06 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 -179.393 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -112.42 15.54 20.2 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 122.169 0.985 . . . . 0.0 109.479 171.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.579 ' HG3' ' O ' ' A' ' 173' ' ' THR . 1.4 mmp_? -87.01 -73.33 0.47 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.556 -173.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 179' ' ' ARG . 21.3 t70 88.38 78.32 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.09 0.948 . . . . 0.0 108.657 167.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.58 ' HE2' ' N ' ' A' ' 173' ' ' THR . 13.4 p90 -149.46 108.78 3.95 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.678 -176.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -74.49 147.56 41.77 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 119.668 -1.895 . . . . 0.0 109.853 173.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.479 ' H ' ' HE1' ' A' ' 170' ' ' TYR . 71.9 p -87.76 137.37 32.4 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.023 0.439 . . . . 0.0 110.337 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -151.25 153.3 24.88 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.435 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.51 ' HG2' ' CE1' ' A' ' 219' ' ' HIS . 5.0 Cg_exo -78.58 132.91 11.3 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.748 2.299 . . . . 0.0 110.696 170.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . 0.514 ' SG ' ' NE ' ' A' ' 215' ' ' ARG . 12.7 t -100.74 117.0 33.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.04 0.447 . . . . 0.0 111.031 -174.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . 0.855 ' O ' ' HB2' ' A' ' 215' ' ' ARG . 20.4 m-85 -98.62 174.67 6.31 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.216 178.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.642 ' HA ' ' HB2' ' A' ' 215' ' ' ARG . 1.3 p -129.28 -59.52 1.1 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -177.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.2 p -113.88 117.66 56.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.077 0.465 . . . . 0.0 111.151 -170.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.599 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.0 mt -131.17 117.11 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-O 121.781 0.801 . . . . 0.0 113.129 -168.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.436 ' C ' ' H ' ' A' ' 193' ' ' GLN . 46.9 p -119.13 -164.69 1.07 Allowed 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.038 163.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -60.25 -4.97 0.94 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.878 0.37 . . . . 0.0 111.032 174.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.436 ' H ' ' C ' ' A' ' 191' ' ' SER . 27.4 mt-30 -87.53 -77.45 0.34 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.893 0.377 . . . . 0.0 110.99 -172.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.432 ' O ' ' HA ' ' A' ' 190' ' ' ILE . 72.0 mtp -147.38 167.9 23.19 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.599 ' HA ' HG12 ' A' ' 190' ' ' ILE . 35.7 m -90.88 -27.55 18.71 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 121.471 0.653 . . . . 0.0 112.191 -178.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -164.61 5.9 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.904 -0.497 . . . . 0.0 111.638 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 68.36 -52.78 0.45 Allowed Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.976 -0.631 . . . . 0.0 113.221 -172.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.403 HE21 ' N ' ' A' ' 199' ' ' LEU . 25.7 tp60 -115.83 122.42 45.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.188 0.518 . . . . 0.0 110.501 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.403 ' N ' HE21 ' A' ' 198' ' ' GLN . 10.3 tt -71.4 134.74 46.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.129 176.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 36.3 m -101.22 131.46 47.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.843 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -87.12 14.77 56.59 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.126 177.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.431 HG21 ' HD3' ' A' ' 254' ' ' PRO . 1.0 OUTLIER -61.05 121.5 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 167.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 6.8 t -99.03 96.95 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.031 0 CA-C-O 123.026 1.393 . . . . 0.0 109.227 173.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 12.7 p -129.06 -179.29 5.03 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 112.268 -2.242 . . . . 0.0 106.075 176.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 53.4 p -102.02 163.2 12.37 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 119.034 -1.067 . . . . 0.0 111.728 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.807 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 42.4 tttm -56.25 -38.72 71.52 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.689 170.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.4 m -45.86 -55.55 6.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.144 174.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.616 ' HG ' ' HB1' ' A' ' 252' ' ' ALA . 0.3 OUTLIER -56.44 -53.37 58.19 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 120.229 -0.589 . . . . 0.0 110.133 176.103 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . 0.868 ' HA ' ' CZ ' ' A' ' 215' ' ' ARG . 76.1 m -52.5 -37.29 57.07 Favored 'General case' 0 C--O 1.247 0.922 0 O-C-N 124.088 0.867 . . . . 0.0 113.266 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 61.3 m -94.15 -33.65 13.24 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.47 -45.45 72.36 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 120.721 -1.237 . . . . 0.0 108.93 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.539 HG22 ' HA2' ' A' ' 234' ' ' GLY . 73.6 p -105.65 149.57 26.22 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.34 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.475 HG21 HG12 ' A' ' 253' ' ' ILE . 2.1 t 57.48 -53.46 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 178.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.477 ' CA ' ' HA ' ' A' ' 226' ' ' ALA . . . 86.06 146.53 9.41 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 119.297 -1.43 . . . . 0.0 111.429 -169.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.868 ' CZ ' ' HA ' ' A' ' 209' ' ' CYS . 0.1 OUTLIER 153.16 -135.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.014 0.526 . . . . 0.0 111.451 -162.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.589 ' HB3' HD11 ' A' ' 190' ' ' ILE . . . -160.59 165.95 29.82 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . 0.807 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 17.2 t90 -161.79 145.52 12.44 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 121.891 -0.506 . . . . 0.0 110.26 -173.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 99.01 -175.21 28.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.374 -0.917 . . . . 0.0 114.363 171.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.51 ' CE1' ' HG2' ' A' ' 185' ' ' PRO . 11.2 m170 -132.2 130.84 22.13 Favored Pre-proline 0 C--N 1.327 -0.411 0 O-C-N 122.818 -0.224 . . . . 0.0 110.54 176.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.19 169.31 50.53 Favored 'Cis proline' 0 C--N 1.342 0.22 0 C-N-CA 123.014 -1.661 . . . . 0.0 110.976 -9.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 93.7 m -42.34 113.72 0.48 Allowed 'General case' 0 C--O 1.234 0.239 0 O-C-N 123.354 0.409 . . . . 0.0 111.655 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -102.07 106.26 17.12 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' MET . . . . . 0.528 ' HA ' ' HB2' ' A' ' 216' ' ' ALA . 0.6 OUTLIER -99.15 134.19 42.35 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.639 -164.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 32.1 p -141.12 152.25 64.27 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.981 0.42 . . . . 0.0 111.624 -176.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -55.69 171.28 0.72 Allowed 'Trans proline' 0 CA--C 1.514 -0.498 0 C-N-CA 123.154 2.569 . . . . 0.0 111.585 164.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.477 ' HA ' ' CA ' ' A' ' 214' ' ' GLY . . . -61.19 -126.69 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.763 0.792 . . . . 0.0 110.451 169.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.69 109.3 6.32 Favored Pre-proline 0 C--N 1.303 -1.433 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.358 -176.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -82.21 -92.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.254 1.969 . . . . 0.0 111.306 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -125.82 86.94 56.79 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.237 172.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -106.9 -168.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.693 0 C-N-CA 123.182 2.588 . . . . 0.0 111.631 171.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 8.9 p -86.77 -51.49 6.07 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 167.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.665 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 58.6 mtt180 -143.9 133.43 23.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 174.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.441 ' HG3' ' N ' ' A' ' 234' ' ' GLY . 22.3 ptt180 -45.49 -51.06 12.17 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -173.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.539 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -77.66 11.91 17.78 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.566 -0.826 . . . . 0.0 114.286 -175.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . 0.665 ' CD1' ' HB2' ' A' ' 232' ' ' ARG . 8.1 m-85 -123.32 152.5 41.38 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 122.109 0.957 . . . . 0.0 111.864 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.455 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.2 OUTLIER -125.22 122.92 25.25 Favored Pre-proline 0 N--CA 1.426 -1.641 0 CA-C-N 114.117 -1.401 . . . . 0.0 108.221 171.133 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -64.41 123.6 12.04 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.59 2.194 . . . . 0.0 112.094 178.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -57.69 126.01 25.5 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.667 174.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 29.1 pt -76.16 7.24 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.981 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 48.0 mtm180 -112.02 -60.92 1.79 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.734 177.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 37.6 p -86.89 -46.16 10.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.862 -176.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 108.71 6.52 30.56 Favored Glycine 0 N--CA 1.436 -1.314 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.487 -176.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -86.96 120.82 28.63 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-O 122.018 0.913 . . . . 0.0 110.505 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' CYS . . . . . 0.494 ' HB3' ' HB3' ' A' ' 235' ' ' PHE . 78.1 m -62.82 122.22 15.41 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.397 -1.729 . . . . 0.0 109.884 172.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 66.0 mt-30 -114.37 135.73 53.76 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . 0.581 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 4.2 t70 -73.97 147.94 42.56 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.655 HG23 ' HG3' ' A' ' 249' ' ' GLU . 5.3 m -100.19 147.38 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.084 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -177.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.489 ' HA ' ' ND2' ' A' ' 264' ' ' ASN . 27.4 m-20 -78.06 79.25 4.52 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 167.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.655 ' HG3' HG23 ' A' ' 247' ' ' VAL . 49.8 mp0 -53.2 -36.6 61.14 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.505 -172.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 36.5 m -42.32 -40.16 2.38 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.34 171.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -100.12 -29.05 12.72 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.623 0.725 . . . . 0.0 110.321 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.616 ' HB1' ' HG ' ' A' ' 208' ' ' LEU . . . -87.71 -5.88 58.47 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.2 -172.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.61 HG13 ' NH2' ' A' ' 215' ' ' ARG . 2.8 mp -124.82 125.77 25.4 Favored Pre-proline 0 C--O 1.24 0.573 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.441 ' HD2' HG23 ' A' ' 253' ' ' ILE . 1.1 Cg_endo -34.14 -81.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 125.277 3.984 . . . . 0.0 114.208 -165.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -116.12 52.28 0.68 Allowed Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 174.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.666 ' HA ' ' OE1' ' A' ' 284' ' ' GLN . 20.0 tp -43.76 -64.92 0.57 Allowed 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.97 0.453 . . . . 0.0 112.172 -175.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 71.7 m -134.05 89.02 2.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -83.06 -59.2 2.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.474 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -79.85 93.79 1.41 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.847 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 273' ' ' CYS . . . 124.89 -174.52 17.22 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.672 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' ASN . . . . . 0.548 ' HB3' ' HG3' ' A' ' 272' ' ' LYS . 3.0 t-20 -83.63 157.12 22.37 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.78 132.71 18.1 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 5.2 mt -137.71 156.07 31.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -172.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.489 ' ND2' ' HA ' ' A' ' 248' ' ' ASP . 50.9 t30 -121.61 117.33 26.45 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.335 -176.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 5.6 t -110.53 166.77 10.73 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.559 164.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.581 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 29.5 m -70.44 130.46 34.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.476 -177.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.451 ' CA ' ' HE1' ' A' ' 235' ' ' PHE . . . 83.2 -9.49 60.79 Favored Glycine 0 N--CA 1.433 -1.557 0 C-N-CA 120.263 -0.97 . . . . 0.0 114.315 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 75.1 m -165.42 154.61 12.3 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 118.442 1.121 . . . . 0.0 111.184 -173.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . 0.428 ' CZ ' HD11 ' A' ' 256' ' ' LEU . 28.2 p90 -114.09 149.73 35.11 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.144 -0.972 . . . . 0.0 109.611 171.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -105.46 113.41 26.96 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 59.0 m -121.15 154.93 35.56 Favored 'General case' 0 CA--C 1.5 -0.953 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.504 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.548 ' HG3' ' HB3' ' A' ' 261' ' ' ASN . 0.0 OUTLIER -155.05 106.27 2.61 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.663 -179.713 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.449 ' HA ' ' HA3' ' A' ' 260' ' ' GLY . 64.2 m -77.0 172.97 8.3 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.25 152.44 15.12 Favored 'Trans proline' 0 C--O 1.239 0.533 0 C-N-CA 121.243 1.296 . . . . 0.0 110.481 168.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -57.97 156.88 8.53 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.928 -173.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 86.6 -38.01 3.13 Favored Glycine 0 N--CA 1.435 -1.427 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.588 -176.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -81.38 168.51 18.3 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 122.588 -0.36 . . . . 0.0 110.366 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . 0.639 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 61.6 mttp -148.8 138.54 22.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.247 -175.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 46.7 tp -93.79 141.65 28.25 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.375 0.422 . . . . 0.0 110.267 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -122.84 106.7 11.12 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -65.15 -13.47 58.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -173.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 76.8 t -59.68 -38.31 75.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.109 0.48 . . . . 0.0 110.807 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.409 ' O ' ' HG2' ' A' ' 284' ' ' GLN . 45.1 m -144.63 38.34 1.23 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.955 177.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . 0.666 ' OE1' ' HA ' ' A' ' 256' ' ' LEU . 23.9 pt20 38.25 32.8 0.05 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.317 1.047 . . . . 0.0 112.81 -175.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -89.82 105.04 17.53 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 122.111 -0.368 . . . . 0.0 111.426 -172.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' CYS . . . . . 0.639 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 45.7 t -108.99 163.9 12.89 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 174.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 C--O 1.248 1.026 0 O-C-N 124.057 0.848 . . . . 0.0 110.249 175.253 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.518 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 88.1 m-85 . . . . . 0 N--CA 1.451 -0.414 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 28.5 pt -135.82 -171.63 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.962 0.41 . . . . 0.0 110.087 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.74 175.15 41.39 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.398 -172.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 37.5 p -71.38 -39.67 71.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.158 0.504 . . . . 0.0 110.738 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 25.9 p-80 -107.59 16.43 23.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.11 -176.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 56.3 m 62.34 28.79 17.1 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.921 174.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.04 -5.18 70.95 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.428 -0.892 . . . . 0.0 113.583 -174.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.561 HE21 ' C ' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -107.92 126.62 29.38 Favored Pre-proline 0 C--O 1.218 -0.565 0 CA-C-N 117.883 0.842 . . . . 0.0 110.562 -176.729 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -87.33 137.86 4.48 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 123.207 2.605 . . . . 0.0 113.078 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.5 p -69.48 122.51 21.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.876 0.846 . . . . 0.0 111.539 -176.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.734 ' HB3' ' SG ' ' A' ' 154' ' ' CYS . 1.4 m -80.08 120.03 23.68 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 168.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.437 ' OE2' ' HB2' ' A' ' 164' ' ' ASN . 7.1 mt-10 -95.33 -63.08 1.2 Allowed 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -172.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.44 ' C ' ' H ' ' A' ' 154' ' ' CYS . 5.4 p -76.75 27.04 0.13 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -172.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 80.27 -19.25 7.0 Favored Glycine 0 CA--C 1.494 -1.234 0 CA-C-O 121.807 0.67 . . . . 0.0 112.966 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . 0.734 ' SG ' ' HB3' ' A' ' 150' ' ' CYS . 68.4 m 62.94 133.81 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 113.201 -1.5 . . . . 0.0 112.208 -175.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.485 HD12 ' HB3' ' A' ' 178' ' ' GLU . 19.7 mt -128.19 167.82 16.3 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 113.484 -1.689 . . . . 0.0 108.69 -173.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.665 ' HB2' ' CZ ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 69.41 12.71 8.34 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.858 0.724 . . . . 0.0 111.526 174.669 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 72.1 33.9 61.91 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -168.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 167' ' ' ALA . . . -56.66 130.49 50.38 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 114.966 -0.617 . . . . 0.0 113.428 -175.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.474 ' O ' HG13 ' A' ' 161' ' ' VAL . 5.3 ttt180 -94.27 115.94 28.25 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.781 -0.709 . . . . 0.0 110.893 175.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 14.1 m -66.63 110.68 3.3 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.771 0.319 . . . . 0.0 110.725 -173.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.59 HG22 ' O ' ' A' ' 165' ' ' ARG . 5.7 m -104.27 -38.96 5.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.384 -177.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -140.39 171.9 7.06 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.518 ' HD3' ' CE1' ' A' ' 140' ' ' TYR . 88.5 Cg_exo -47.7 108.1 0.16 Allowed 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 122.137 1.892 . . . . 0.0 112.826 174.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.437 ' HB2' ' OE2' ' A' ' 151' ' ' GLU . 19.7 t-20 76.81 -18.33 0.49 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.736 1.215 . . . . 0.0 110.852 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.59 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.2 OUTLIER -78.12 81.68 4.49 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.355 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.35 142.77 29.94 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 169.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.438 ' O ' ' HA2' ' A' ' 158' ' ' GLY . . . -88.36 131.28 34.89 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -175.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.65 ' HA ' HD21 ' A' ' 156' ' ' ASN . 27.8 m -87.63 115.03 24.78 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 124.239 0.962 . . . . 0.0 111.307 -175.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 16.8 m -51.71 -54.4 28.68 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -174.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -148.88 -94.4 0.07 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.111 -1.035 . . . . 0.0 112.848 -168.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -89.54 47.81 3.29 Favored Glycine 0 N--CA 1.434 -1.487 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.909 -168.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.665 ' CZ ' ' HB2' ' A' ' 156' ' ' ASN . 16.3 m-85 -122.27 121.91 37.87 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.973 175.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.479 ' O ' ' HG2' ' A' ' 179' ' ' ARG . 4.9 t -90.8 164.56 14.04 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 161.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.37 132.35 5.45 Favored Glycine 0 N--CA 1.438 -1.182 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.27 -24.83 64.88 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.401 1.401 . . . . 0.0 113.501 -167.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -93.18 -0.12 56.99 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.518 0.675 . . . . 0.0 110.697 -178.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.55 ' HB3' ' CB ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 43.11 55.2 4.66 Favored 'General case' 0 N--CA 1.46 0.075 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.676 -174.115 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.485 ' HB3' HD12 ' A' ' 155' ' ' LEU . 13.7 pt-20 -106.12 -14.49 15.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.515 176.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 173' ' ' THR . 14.0 mmt180 -60.03 -64.2 1.03 Allowed 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.263 -177.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 31.1 t0 72.35 64.81 0.12 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.515 0.674 . . . . 0.0 109.853 163.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.433 ' CD1' ' O ' ' A' ' 181' ' ' TYR . 43.2 p90 -87.58 71.06 9.8 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 122.628 1.204 . . . . 0.0 108.026 177.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 -49.99 130.84 22.56 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.073 171.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 44.4 p -79.06 139.31 38.16 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.576 -0.45 . . . . 0.0 109.986 -176.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.423 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -157.02 154.8 25.84 Favored Glycine 0 C--N 1.321 -0.261 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -173.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -77.7 133.63 12.94 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.316 2.011 . . . . 0.0 111.889 175.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . 0.708 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 49.1 m -87.58 122.68 31.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.318 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . 0.508 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 36.5 m-85 -94.07 137.43 33.27 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.672 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.594 ' C ' ' HG2' ' A' ' 215' ' ' ARG . 23.9 m -111.64 -11.44 14.01 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.346 -160.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.7 p -169.72 116.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 O-C-N 121.925 -0.485 . . . . 0.0 110.48 174.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.591 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.4 mt -119.67 118.42 57.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -170.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.3 p -112.21 -171.32 1.83 Allowed 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 156.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -67.89 -4.03 11.6 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.591 0.71 . . . . 0.0 109.877 172.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -89.84 -67.65 0.83 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.631 -176.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.482 ' O ' ' HA ' ' A' ' 190' ' ' ILE . 62.7 mtm -136.86 145.47 44.43 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.179 -178.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.591 ' HA ' HG12 ' A' ' 190' ' ' ILE . 74.1 m -85.43 -21.1 28.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.731 0.777 . . . . 0.0 109.676 174.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.459 ' HB2' ' H ' ' A' ' 188' ' ' THR . 46.4 tt0 -162.78 -72.31 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 162.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 126.12 13.7 3.19 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.067 164.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -123.56 1.76 8.92 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 173.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 65.77 -75.03 0.05 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.552 0.741 . . . . 0.0 111.761 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 34.9 t 73.02 139.68 0.06 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.654 0.74 . . . . 0.0 112.362 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -98.93 25.28 28.81 Favored Glycine 0 CA--C 1.505 -0.57 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.593 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.524 HD11 HG23 ' A' ' 253' ' ' ILE . 1.7 tt -61.01 104.02 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-O 121.235 0.54 . . . . 0.0 109.849 173.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 10.7 t -96.28 97.43 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-O 122.603 1.192 . . . . 0.0 109.599 171.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.527 ' HB3' ' SG ' ' A' ' 209' ' ' CYS . 9.0 t -123.98 -179.51 4.43 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 172.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.431 HG22 ' HB2' ' A' ' 181' ' ' TYR . 10.4 p -103.17 161.39 13.84 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.659 -177.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.514 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 53.6 tttm -61.71 -44.29 97.21 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.177 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.6 m -46.87 -54.53 9.75 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.944 0.878 . . . . 0.0 110.133 174.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.668 HD21 ' HB1' ' A' ' 252' ' ' ALA . 4.3 tp -64.27 -52.91 56.32 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 113.423 -1.717 . . . . 0.0 112.774 -175.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' ' 204' ' ' SER . 53.2 m -74.32 -18.31 60.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.99 0.424 . . . . 0.0 111.827 -175.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 68.8 m -96.58 -25.69 15.51 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.672 176.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -73.73 -60.51 2.22 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 172.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.841 HG22 ' HA2' ' A' ' 234' ' ' GLY . 15.4 p -92.04 162.77 14.23 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 65.11 -54.04 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 95.05 -122.24 7.13 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 120.248 -0.977 . . . . 0.0 113.849 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.594 ' HG2' ' C ' ' A' ' 188' ' ' THR . 6.4 mpt_? 27.17 -86.84 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -174.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.518 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -167.6 167.46 13.44 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 119.52 1.055 . . . . 0.0 110.985 -171.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . 0.733 ' O ' ' HB2' ' A' ' 222' ' ' GLU . 10.0 t90 -155.02 144.91 21.6 Favored 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 102.3 177.2 27.58 Favored Glycine 0 CA--C 1.505 -0.586 0 C-N-CA 120.159 -1.02 . . . . 0.0 114.147 169.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 220' ' ' PRO . 13.8 p80 -129.61 133.97 25.68 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.251 -0.474 . . . . 0.0 110.804 -175.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 219' ' ' HIS . 9.7 Cg_endo -89.76 117.0 3.12 Favored 'Cis proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.17 -1.596 . . . . 0.0 111.815 -3.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 98.9 m 40.76 89.18 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 O-C-N 124.113 0.883 . . . . 0.0 112.928 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.733 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 23.8 mt-10 -102.68 111.48 23.82 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 177.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' MET . . . . . 0.518 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 18.9 ptt? -102.35 136.95 41.26 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.112 -166.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 59.4 m -119.24 147.58 43.3 Favored Pre-proline 0 C--O 1.233 0.212 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -167.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -60.27 153.67 57.86 Favored 'Trans proline' 0 CA--C 1.508 -0.812 0 C-N-CA 123.833 3.022 . . . . 0.0 113.495 167.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -42.23 113.27 0.42 Allowed 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.904 0.859 . . . . 0.0 110.508 160.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' GLN . . . . . 0.419 ' HB3' ' HA ' ' A' ' 233' ' ' ARG . 0.1 OUTLIER 23.95 99.66 0.02 OUTLIER Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 111.518 -2.583 . . . . 0.0 113.7 -177.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.65 -62.91 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.835 3.023 . . . . 0.0 113.627 -177.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -69.9 155.14 93.99 Favored Pre-proline 0 CA--C 1.514 -0.411 0 CA-C-O 120.691 0.282 . . . . 0.0 110.348 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.75 58.35 6.97 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 121.739 1.626 . . . . 0.0 113.799 -174.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 64.0 m -132.91 148.11 52.29 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 171.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.638 ' HG3' ' CD1' ' A' ' 235' ' ' PHE . 16.4 ptt180 -55.49 137.16 49.08 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.079 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.419 ' HA ' ' HB3' ' A' ' 227' ' ' GLN . 29.6 ptt180 -31.12 -47.15 0.1 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -166.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.841 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -68.58 5.87 3.93 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 114.981 0.753 . . . . 0.0 114.981 -174.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . 0.638 ' CD1' ' HG3' ' A' ' 232' ' ' ARG . 7.7 m-85 -122.77 150.29 42.99 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 122.089 0.947 . . . . 0.0 112.97 -169.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.524 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.1 OUTLIER -126.52 125.25 24.45 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 114.046 -1.433 . . . . 0.0 108.387 172.382 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -62.69 123.01 11.58 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.339 2.026 . . . . 0.0 111.679 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -54.08 127.25 25.86 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.354 0.597 . . . . 0.0 110.936 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 32.7 pt -65.8 -6.66 4.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.428 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 240' ' ' ARG . 63.8 mtt85 -106.51 -68.1 0.9 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.491 0.662 . . . . 0.0 110.199 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 24.4 p -79.62 -43.17 23.39 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.351 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 102.72 8.0 43.7 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -176.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -82.28 127.11 32.89 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 122.056 0.932 . . . . 0.0 109.714 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 33.3 m -63.76 114.78 4.24 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 113.458 -1.701 . . . . 0.0 109.829 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.474 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 79.3 mt-30 -112.94 134.44 54.45 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . 0.584 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 6.1 t70 -82.7 144.09 30.48 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.726 HG23 ' HG3' ' A' ' 249' ' ' GLU . 9.2 m -98.61 150.16 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.343 -174.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.67 76.39 2.04 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 169.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.726 ' HG3' HG23 ' A' ' 247' ' ' VAL . 9.7 mp0 -53.55 -39.9 65.1 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.191 0.596 . . . . 0.0 111.443 -167.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 49.2 t -51.54 -33.98 34.51 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.932 0.396 . . . . 0.0 111.284 175.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -98.67 -46.38 5.72 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.738 0.78 . . . . 0.0 110.05 -174.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.668 ' HB1' HD21 ' A' ' 208' ' ' LEU . . . -66.63 -21.55 66.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.813 -177.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.581 HG22 ' HB3' ' A' ' 256' ' ' LEU . 3.7 mp -120.39 79.56 28.64 Favored Pre-proline 0 N--CA 1.445 -0.716 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 175.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.446 ' CG ' HG13 ' A' ' 202' ' ' ILE . 0.1 OUTLIER -21.61 -29.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 1 C-N-CA 128.256 5.97 . . . . 0.0 120.032 -164.204 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 253' ' ' ILE . . . -172.06 39.03 0.16 Allowed Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 119.265 -1.445 . . . . 0.0 111.915 -175.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.581 ' HB3' HG22 ' A' ' 253' ' ' ILE . 2.2 pt? -70.57 -49.65 45.62 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 119.879 -0.728 . . . . 0.0 111.287 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . 0.557 ' H ' HD23 ' A' ' 256' ' ' LEU . 47.5 t -124.28 133.49 53.47 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 120.839 0.352 . . . . 0.0 110.086 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -134.77 -89.11 0.35 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.934 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 71.34 -71.49 0.81 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.838 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -152.81 -78.48 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' ASN . . . . . 0.548 ' HB3' ' HB2' ' A' ' 272' ' ' LYS . 3.9 t-20 -101.47 147.31 26.51 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 177.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 15.0 p -137.56 140.74 41.21 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 6.9 mt -144.62 166.16 12.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -170.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.61 ' ND2' ' HB3' ' A' ' 269' ' ' PHE . 0.8 OUTLIER -131.45 132.91 44.67 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 118.673 -1.211 . . . . 0.0 112.938 177.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 268' ' ' SER . 0.8 OUTLIER -114.85 161.05 18.75 Favored 'General case' 0 C--O 1.256 1.406 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.905 162.458 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.537 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 33.5 m -72.17 124.31 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.449 ' HA2' ' HE1' ' A' ' 235' ' ' PHE . . . 112.97 -29.5 8.03 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.057 -1.068 . . . . 0.0 112.895 -170.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.421 ' O ' HG23 ' A' ' 265' ' ' THR . 39.5 t 173.01 156.62 0.1 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 117.912 0.856 . . . . 0.0 109.465 -170.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . 0.61 ' HB3' ' ND2' ' A' ' 264' ' ' ASN . 40.2 p90 -98.43 161.4 13.7 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 121.832 -0.542 . . . . 0.0 110.029 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -114.93 141.18 48.31 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . 0.423 ' HB2' HD22 ' A' ' 279' ' ' LEU . 95.5 m -124.83 161.53 26.31 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.472 0.653 . . . . 0.0 111.493 175.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.548 ' HB2' ' HB3' ' A' ' 261' ' ' ASN . 61.1 mttp -140.39 109.52 6.13 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.592 173.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 286' ' ' CYS . 3.9 m -91.78 163.34 28.27 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.361 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 51.3 Cg_exo -53.91 158.61 8.47 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.564 2.176 . . . . 0.0 111.473 174.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -57.13 145.06 32.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 86.55 -30.89 4.36 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -173.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' HIS . . . . . 0.63 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 27.3 m-70 -89.08 173.64 8.33 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.001 0.429 . . . . 0.0 110.833 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . 0.667 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 95.6 mttt -162.38 153.19 17.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.903 -174.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.449 HD13 ' SG ' ' A' ' 257' ' ' CYS . 65.6 tp -87.57 136.82 32.79 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.45 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -126.6 101.23 6.56 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -63.4 -18.09 63.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.382 -174.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.509 ' HA ' ' NH2' ' A' ' 215' ' ' ARG . 93.9 t -57.08 -33.08 41.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.59 177.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 31.9 m -147.24 35.4 0.89 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.577 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 29.68 49.49 0.06 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.45 1.1 . . . . 0.0 113.368 -175.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 78.5 tttt -108.16 162.1 14.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.139 0.495 . . . . 0.0 111.768 -173.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' CYS . . . . . 0.667 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 40.4 m -129.63 102.79 6.51 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 18.1 tt0 . . . . . 0 C--O 1.243 0.756 0 CA-C-O 118.554 -0.736 . . . . 0.0 109.855 -173.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 147' ' ' GLN . 23.9 m-85 . . . . . 0 CA--C 1.509 -0.603 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.412 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 28.8 pt -133.44 -178.13 2.49 Favored 'Isoleucine or valine' 0 C--O 1.251 1.139 0 O-C-N 124.234 0.958 . . . . 0.0 109.588 172.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.19 163.74 34.77 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.711 -178.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.0 p -76.88 -22.42 53.48 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.883 0.373 . . . . 0.0 111.604 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -97.32 -6.74 33.63 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 13.1 t 67.9 14.48 9.4 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.817 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -89.64 4.78 83.85 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.924 -173.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.44 ' O ' ' HA ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -105.7 118.85 54.35 Favored Pre-proline 0 C--O 1.219 -0.533 0 CA-C-N 117.69 0.745 . . . . 0.0 111.126 -176.717 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -87.22 140.23 5.48 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.695 2.263 . . . . 0.0 112.537 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 149' ' ' VAL . 8.3 p -69.92 105.97 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 122.293 1.044 . . . . 0.0 111.934 -176.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.94 78.73 5.37 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.421 175.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -53.24 -70.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.606 -1.179 . . . . 0.0 113.924 -172.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.5 m -90.91 12.46 19.44 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.658 0.742 . . . . 0.0 111.17 -169.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 72.47 127.87 0.1 OUTLIER Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 114.161 -1.381 . . . . 0.0 111.713 -175.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . 0.579 ' O ' HD23 ' A' ' 155' ' ' LEU . 62.0 m -72.98 164.44 26.67 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.197 -1.002 . . . . 0.0 108.96 175.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.579 HD23 ' O ' ' A' ' 154' ' ' CYS . 62.6 mt -143.52 -178.49 5.91 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -166.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.554 ' HB2' ' CZ ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 44.44 24.48 0.09 Allowed 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 177.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 69.73 28.7 71.78 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.86 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -82.18 -138.7 2.88 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.306 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 166' ' ' CYS . 0.0 OUTLIER -166.25 140.68 4.37 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 117.396 0.598 . . . . 0.0 109.984 -179.192 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.97 110.98 13.37 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.319 0.581 . . . . 0.0 109.907 171.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 165' ' ' ARG . 2.5 m -99.67 -30.33 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.476 -176.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.582 ' HB3' ' CB ' ' A' ' 165' ' ' ARG . . . -140.36 171.73 7.33 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.462 ' HD2' ' HB1' ' A' ' 162' ' ' ALA . 96.6 Cg_exo -48.64 96.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.499 2.133 . . . . 0.0 113.229 177.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 42.0 t30 69.03 15.28 8.82 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.726 0.774 . . . . 0.0 109.997 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.582 ' CB ' ' HB3' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -100.74 86.5 3.12 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.793 172.224 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 60.0 m -82.75 138.37 34.06 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.016 171.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.72 131.81 34.35 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 171.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.435 ' HA ' HD21 ' A' ' 156' ' ' ASN . 72.8 m -115.28 138.27 51.13 Favored 'General case' 0 C--N 1.315 -0.916 0 O-C-N 123.876 0.735 . . . . 0.0 111.474 -170.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 39.6 m -50.37 -55.04 17.38 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.681 -168.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -162.74 -86.29 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 118.578 -1.249 . . . . 0.0 113.516 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -93.83 51.97 2.28 Favored Glycine 0 CA--C 1.489 -1.583 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.003 -164.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.692 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 1.7 m-85 -121.07 134.49 55.27 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 118.563 -1.255 . . . . 0.0 112.841 173.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.89 HG23 ' CE2' ' A' ' 181' ' ' TYR . 8.7 p -87.89 123.61 32.82 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.718 177.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' A' ' 176' ' ' GLN . . . 104.75 133.56 7.79 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 108.991 -1.643 . . . . 0.0 108.991 -175.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.49 12.81 0.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.747 1.631 . . . . 0.0 112.896 -170.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.51 ' O ' HD12 ' A' ' 155' ' ' LEU . 15.7 tt0 -121.95 16.81 10.91 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.246 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.657 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.5 OUTLIER 33.65 69.42 0.14 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 175.578 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -117.41 7.15 12.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.634 0.731 . . . . 0.0 110.509 172.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.692 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 21.4 mmt85 -117.49 89.62 3.16 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.2 -178.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -80.35 54.16 1.95 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.614 -170.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.89 ' CE2' HG23 ' A' ' 173' ' ' THR . 18.7 p90 -84.42 78.38 9.83 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -77.2 140.22 40.08 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 118.976 -2.327 . . . . 0.0 107.682 -178.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 67.0 p -83.73 136.25 34.25 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.168 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.45 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -156.16 160.83 30.39 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -80.51 129.52 7.46 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.592 2.195 . . . . 0.0 111.554 175.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . 0.775 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 83.2 m -85.8 118.44 25.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.193 0.52 . . . . 0.0 110.589 177.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . 0.595 ' O ' ' HB2' ' A' ' 215' ' ' ARG . 9.2 m-85 -94.72 150.07 20.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.972 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.444 ' HA ' ' CB ' ' A' ' 215' ' ' ARG . 21.7 p -108.5 -1.8 19.46 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 28.3 m -141.62 174.37 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.623 HD11 ' HB2' ' A' ' 216' ' ' ALA . 12.8 mm -122.15 114.21 41.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.867 0.842 . . . . 0.0 111.327 176.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.488 ' HB3' ' C ' ' A' ' 194' ' ' MET . 30.1 t -143.16 127.93 18.23 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.198 175.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -63.87 -20.75 66.06 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 171.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.46 ' HB3' ' OG ' ' A' ' 191' ' ' SER . 53.0 tt0 -71.23 -69.36 0.38 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.339 169.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.488 ' C ' ' HB3' ' A' ' 191' ' ' SER . 64.2 mtt -151.39 101.88 2.86 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 176.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 187' ' ' PHE . 39.7 m -64.83 -24.76 67.64 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 122.201 0.2 . . . . 0.0 110.737 172.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.503 ' HB2' ' HA ' ' A' ' 187' ' ' PHE . 7.7 mm-40 142.22 -139.52 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 126.959 2.104 . . . . 0.0 107.561 177.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.427 ' H ' ' HB3' ' A' ' 196' ' ' GLN . . . 84.02 -50.12 4.35 Favored Glycine 0 C--N 1.332 0.35 0 N-CA-C 115.146 0.818 . . . . 0.0 115.146 170.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -72.36 29.01 0.05 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -171.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.547 ' N ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -156.87 18.22 0.31 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.933 0.397 . . . . 0.0 110.272 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 32.2 t -153.38 135.23 14.59 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.27 0.557 . . . . 0.0 111.115 -175.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -102.37 29.73 11.88 Favored Glycine 0 CA--C 1.502 -0.778 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 173.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.626 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -64.32 104.05 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-O 122.008 0.909 . . . . 0.0 109.425 176.497 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.32 99.05 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-O 122.42 1.105 . . . . 0.0 110.283 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.3 t -123.19 -178.27 3.93 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 113.241 -1.799 . . . . 0.0 106.724 169.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.8 p -100.76 164.4 11.88 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.385 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.613 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 45.5 tttm -60.6 -46.16 91.29 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.44 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.1 m -43.95 -56.23 4.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.88 174.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.568 ' CD1' HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -55.68 -57.47 11.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.53 179.296 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 40.0 m -72.5 -17.4 61.75 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -170.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 66.3 m -92.39 -31.61 15.26 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.021 175.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -70.84 -61.67 1.68 Allowed 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.737 HG22 ' HA2' ' A' ' 234' ' ' GLY . 32.4 p -92.26 152.52 19.78 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.105 174.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.404 HG13 HE21 ' A' ' 284' ' ' GLN . 2.1 t 70.3 -43.8 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 177.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.618 ' O ' ' HD2' ' A' ' 215' ' ' ARG . . . 55.97 61.97 6.85 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 115.767 1.067 . . . . 0.0 115.767 170.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.618 ' HD2' ' O ' ' A' ' 214' ' ' GLY . 14.4 mmm180 -126.43 -82.25 0.62 Allowed 'General case' 0 C--O 1.237 0.44 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.888 176.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.623 ' HB2' HD11 ' A' ' 190' ' ' ILE . . . -169.11 166.74 10.8 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . 0.775 ' HD1' ' SG ' ' A' ' 186' ' ' CYS . 11.6 t90 -159.12 149.42 19.37 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 121.23 -0.919 . . . . 0.0 109.461 -175.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 221' ' ' CYS . . . 87.13 156.68 29.9 Favored Glycine 0 C--O 1.223 -0.542 0 C-N-CA 120.363 -0.922 . . . . 0.0 114.695 168.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.618 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 17.0 p80 -130.57 135.46 27.42 Favored Pre-proline 0 C--O 1.236 0.354 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.618 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 31.6 Cg_exo -59.31 143.37 29.79 Favored 'Cis proline' 0 N--CA 1.477 0.552 0 C-N-CA 124.16 -1.183 . . . . 0.0 111.71 -0.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 43.0 t -41.86 117.77 1.0 Allowed 'General case' 0 N--CA 1.464 0.257 0 O-C-N 124.222 0.951 . . . . 0.0 112.868 -170.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.45 ' HB3' ' HE3' ' A' ' 206' ' ' LYS . 22.9 mt-10 -109.41 120.25 41.95 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -80.29 148.28 30.8 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -176.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 5.8 m -85.4 123.34 73.09 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -172.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.2 167.56 19.89 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.394 2.73 . . . . 0.0 110.847 167.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -39.74 -60.06 1.05 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.12 -172.75 0.33 Allowed Pre-proline 0 N--CA 1.431 -1.418 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 -173.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -84.75 -98.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.801 1.667 . . . . 0.0 110.7 172.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.436 ' CG ' ' HG3' ' A' ' 237' ' ' PRO . 20.0 m-70 -84.24 166.77 31.33 Favored Pre-proline 0 CA--C 1.513 -0.473 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 169.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.12 65.52 4.25 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.852 1.702 . . . . 0.0 113.162 -176.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 64.2 m -106.2 -173.88 2.4 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 170.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.733 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 86.3 mtt180 -67.75 147.57 52.44 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 119.701 -0.799 . . . . 0.0 108.927 172.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -37.92 -49.98 1.27 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 178.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.737 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -79.33 12.44 26.2 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.605 -0.807 . . . . 0.0 114.833 -174.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . 0.733 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 2.3 m-85 -122.86 146.82 47.22 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 122.093 0.949 . . . . 0.0 113.21 -172.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.462 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.0 OUTLIER -124.87 132.74 24.36 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 114.098 -1.41 . . . . 0.0 107.967 170.543 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.436 ' HG3' ' CG ' ' A' ' 229' ' ' HIS . 18.1 Cg_endo -60.38 118.85 5.77 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.13 1.887 . . . . 0.0 111.721 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -52.29 136.85 30.01 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 121.727 0.775 . . . . 0.0 110.582 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 33.2 mt -70.93 -16.37 19.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.404 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 240' ' ' ARG . 42.0 mtm105 -102.52 -63.32 1.17 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.29 0.567 . . . . 0.0 110.248 -176.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 40.5 p -79.34 -38.46 35.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.75 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 94.89 5.41 61.11 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -176.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -86.67 124.36 32.85 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 121.935 0.874 . . . . 0.0 109.121 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 235' ' ' PHE . 13.0 m -57.92 123.13 14.77 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 113.403 -1.726 . . . . 0.0 110.479 178.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 80.7 mm-40 -119.39 142.85 47.82 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . 0.569 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 8.5 t70 -77.85 147.53 35.11 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.721 HG23 ' HG3' ' A' ' 249' ' ' GLU . 15.9 m -94.17 142.88 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.094 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.212 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -70.07 77.5 0.5 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 164.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.721 ' HG3' HG23 ' A' ' 247' ' ' VAL . 20.5 mp0 -52.7 -35.6 55.83 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 123.525 0.515 . . . . 0.0 110.498 -173.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 33.1 m -55.01 -29.33 57.12 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.176 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -103.93 -43.74 5.21 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.923 0.868 . . . . 0.0 109.7 -175.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.34 -22.1 64.71 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.024 -1.444 . . . . 0.0 111.286 -175.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.764 HG22 ' HB3' ' A' ' 256' ' ' LEU . 64.2 mt -131.34 75.61 77.17 Favored Pre-proline 0 N--CA 1.447 -0.603 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -13.04 -91.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.039 1 C-N-CA 126.106 4.537 . . . . 0.0 115.749 -162.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -119.69 59.41 0.53 Allowed Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 119.641 -1.266 . . . . 0.0 111.872 177.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.764 ' HB3' HG22 ' A' ' 253' ' ' ILE . 2.3 pt? -63.97 -38.91 92.79 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.139 177.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 45.8 t -104.86 107.36 18.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.492 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -116.68 35.69 4.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.903 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.678 ' HA3' ' SG ' ' A' ' 286' ' ' CYS . . . -87.96 -9.04 71.58 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.592 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 145.21 -100.11 0.22 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' ASN . . . . . 0.598 ' HB2' ' HB2' ' A' ' 272' ' ' LYS . 11.2 m120 -89.09 158.01 18.12 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.733 0.301 . . . . 0.0 110.778 177.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.71 132.73 14.29 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 10.7 mt -142.34 165.46 16.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -173.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.93 126.53 43.39 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 118.556 -1.258 . . . . 0.0 113.525 -175.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 4.6 t -115.55 167.78 10.59 Favored 'General case' 0 C--O 1.258 1.52 0 CA-C-O 122.243 1.021 . . . . 0.0 110.322 162.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.547 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 30.4 m -71.11 131.27 34.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.849 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.555 ' CA ' ' HE2' ' A' ' 235' ' ' PHE . . . 88.95 -9.79 75.28 Favored Glycine 0 N--CA 1.423 -2.201 0 CA-C-O 119.264 -0.742 . . . . 0.0 113.527 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 48.3 t -179.51 150.03 0.41 Allowed 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 117.838 0.819 . . . . 0.0 111.255 -172.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -107.31 156.53 18.78 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.89 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -108.27 128.88 55.12 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.961 -176.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . 0.421 ' HB2' HD22 ' A' ' 279' ' ' LEU . 54.9 m -120.56 160.38 23.32 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.313 0.578 . . . . 0.0 111.081 176.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.598 ' HB2' ' HB2' ' A' ' 261' ' ' ASN . 6.9 mtpm? -140.54 124.52 17.37 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.193 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 3.7 m -98.36 170.72 6.64 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 175.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 34.5 Cg_exo -58.31 156.18 31.7 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.567 1.511 . . . . 0.0 110.611 170.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -59.34 149.39 29.15 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.25 -33.26 3.19 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.113 -174.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' HIS . . . . . 0.473 ' HB2' ' O ' ' A' ' 274' ' ' PRO . 9.2 m170 -78.69 167.37 21.32 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 120.987 0.422 . . . . 0.0 110.69 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 67.1 mttm -140.22 139.15 35.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.227 -179.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.485 HD12 ' O ' ' A' ' 285' ' ' LYS . 21.4 tp -81.71 143.98 31.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.041 0.448 . . . . 0.0 110.75 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -124.55 98.46 5.74 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -68.04 -12.83 61.54 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -174.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 42.7 t -66.24 -25.42 35.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.252 0.548 . . . . 0.0 110.266 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 10.3 p -148.05 28.87 0.91 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.618 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . 0.404 HE21 HG13 ' A' ' 213' ' ' VAL . 77.8 mm-40 30.06 49.57 0.07 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.709 -1.132 . . . . 0.0 113.16 -171.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . 0.485 ' O ' HD12 ' A' ' 279' ' ' LEU . 97.9 mttt -102.65 175.65 5.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.754 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' CYS . . . . . 0.678 ' SG ' ' HA3' ' A' ' 259' ' ' GLY . 92.9 m -141.81 170.41 15.77 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 173.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.643 ' HB2' ' O ' ' A' ' 286' ' ' CYS . 2.4 mp0 . . . . . 0 C--O 1.25 1.099 0 C-N-CA 124.319 1.048 . . . . 0.0 109.408 170.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.667 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 97.9 m-85 . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 121.157 0.504 . . . . 0.0 110.376 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.484 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 40.6 pt -131.08 175.03 12.14 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.312 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 101.29 174.18 28.68 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.851 -177.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.3 p -73.54 -31.61 63.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.316 0.579 . . . . 0.0 111.45 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -110.87 7.05 21.7 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.411 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 34.1 m 63.91 37.49 9.48 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 124.204 0.94 . . . . 0.0 111.181 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -93.62 -7.09 61.92 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.906 -176.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.484 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 0.0 OUTLIER -103.27 112.72 65.9 Favored Pre-proline 0 C--N 1.327 -0.404 0 O-C-N 122.121 -0.635 . . . . 0.0 110.704 -177.554 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.67 142.45 14.34 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.342 2.695 . . . . 0.0 112.614 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 149' ' ' VAL . 8.9 p -73.15 107.73 3.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 122.504 1.145 . . . . 0.0 111.284 -178.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.86 88.03 5.29 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.298 175.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.34 -68.04 0.27 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -175.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 16.7 m -95.71 13.37 26.66 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.824 0.345 . . . . 0.0 111.628 -166.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.23 123.95 0.91 Allowed Glycine 0 N--CA 1.438 -1.221 0 CA-C-O 121.819 0.677 . . . . 0.0 113.066 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . 0.437 ' O ' HD23 ' A' ' 155' ' ' LEU . 80.4 m -81.14 162.23 23.75 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 172.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.621 HD12 ' O ' ' A' ' 176' ' ' GLN . 79.9 mt -148.22 167.27 25.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 118.04 0.382 . . . . 0.0 110.88 -162.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.605 ' HB2' ' CZ ' ' A' ' 172' ' ' PHE . 10.0 t30 48.31 23.72 0.6 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.327 -164.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 66.0 39.36 94.79 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.256 -0.974 . . . . 0.0 111.774 -177.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.62 -138.16 0.21 Allowed Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.772 -0.727 . . . . 0.0 111.313 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 13.1 ttt180 -159.47 128.99 5.41 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.08 -0.659 . . . . 0.0 111.221 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.4 m -62.91 119.99 10.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.59 0.233 . . . . 0.0 110.691 173.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 165' ' ' ARG . 16.7 m -105.68 -35.84 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.947 0.403 . . . . 0.0 110.546 178.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.75 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -139.93 170.55 9.56 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.667 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 76.6 Cg_exo -51.58 109.17 0.29 Allowed 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.208 1.939 . . . . 0.0 112.133 174.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 72.96 -3.07 2.52 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.36 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.75 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.9 OUTLIER -90.92 86.35 6.26 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.516 175.857 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 72.6 m -78.65 141.07 38.27 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.234 171.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.439 ' HB2' ' CG1' ' A' ' 161' ' ' VAL . . . -97.79 117.54 32.34 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 172.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 83.0 m -101.18 141.17 34.45 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.036 -170.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 7.0 m -51.11 -53.9 29.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -168.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -167.68 -84.72 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.36 -0.936 . . . . 0.0 113.227 -172.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -90.94 55.91 3.32 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.325 -167.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.674 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 7.0 m-85 -127.11 137.57 53.02 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.509 169.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.679 HG23 ' CE2' ' A' ' 181' ' ' TYR . 64.4 p -87.15 123.79 32.57 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.094 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 102.09 139.84 10.78 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.05 7.82 1.59 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 121.143 1.229 . . . . 0.0 112.449 -172.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.621 ' O ' HD12 ' A' ' 155' ' ' LEU . 18.9 tt0 -119.47 26.1 9.63 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.294 176.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.572 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.7 OUTLIER 23.89 72.72 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 118.693 2.849 . . . . 0.0 118.693 170.614 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.418 ' O ' ' HD3' ' A' ' 179' ' ' ARG . 9.9 pt-20 -124.96 29.8 6.05 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.103 -0.998 . . . . 0.0 110.929 169.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.674 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 23.9 mmt180 -130.2 93.0 3.38 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.168 175.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.427 ' HA ' ' CE1' ' A' ' 172' ' ' PHE . 3.7 m-20 -78.07 53.14 1.16 Allowed 'General case' 0 C--N 1.323 -0.55 0 O-C-N 123.402 0.439 . . . . 0.0 111.189 -169.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.75 ' HA ' HG21 ' A' ' 205' ' ' THR . 16.2 p90 -84.4 80.43 9.22 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -82.75 135.12 35.08 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 119.761 -1.837 . . . . 0.0 108.609 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 70.3 p -77.06 171.04 15.44 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.463 ' HA3' ' CE2' ' A' ' 217' ' ' TRP . . . 157.18 136.04 2.04 Favored Glycine 0 C--N 1.32 -0.322 0 C-N-CA 119.669 -1.253 . . . . 0.0 112.359 -163.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.489 ' HG2' ' CD2' ' A' ' 219' ' ' HIS . 16.6 Cg_exo -69.62 128.23 15.86 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.133 1.889 . . . . 0.0 111.531 172.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . 0.715 ' SG ' ' HD2' ' A' ' 215' ' ' ARG . 16.5 t -102.18 114.28 28.29 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.474 0.654 . . . . 0.0 110.68 -178.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . 0.658 ' O ' ' HB3' ' A' ' 215' ' ' ARG . 16.8 m-85 -93.62 143.43 26.31 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.262 -177.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.467 ' HA ' ' HB3' ' A' ' 215' ' ' ARG . 2.4 m -96.23 -27.73 14.87 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -162.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.1 p -163.2 118.79 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.628 -171.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.634 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.4 mt -125.51 118.8 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 122.182 0.992 . . . . 0.0 113.486 -168.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.418 ' C ' ' H ' ' A' ' 193' ' ' GLN . 36.2 t -116.15 -164.56 0.97 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 113.766 -1.561 . . . . 0.0 106.934 163.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -63.87 -5.71 4.81 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.718 0.77 . . . . 0.0 110.008 170.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.418 ' H ' ' C ' ' A' ' 191' ' ' SER . 96.3 mt-30 -69.84 -75.76 0.11 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.847 -178.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 46.0 ttm -171.2 151.37 3.15 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.957 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.634 ' HA ' HG12 ' A' ' 190' ' ' ILE . 72.8 m -57.43 -46.11 83.92 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 121.73 0.776 . . . . 0.0 110.91 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -151.54 -81.22 0.1 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 166.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.44 -24.33 6.91 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.569 172.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -131.14 45.3 2.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.393 0.616 . . . . 0.0 109.43 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 26.3 tp -169.82 132.76 1.17 Allowed 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.572 -173.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 34.7 t -149.04 -47.46 0.14 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.753 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.84 26.62 10.47 Favored Glycine 0 C--O 1.228 -0.225 0 C-N-CA 120.752 -0.737 . . . . 0.0 114.333 -171.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.487 ' O ' HD13 ' A' ' 202' ' ' ILE . 0.0 OUTLIER -79.29 91.58 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 165.424 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.49 112.47 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 CA-C-O 122.935 1.35 . . . . 0.0 110.171 -171.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 6.1 t -155.64 -178.74 7.5 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.75 HG21 ' HA ' ' A' ' 181' ' ' TYR . 17.8 p -106.35 171.5 7.32 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 120.883 1.674 . . . . 0.0 110.649 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.806 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 34.0 tttm -59.88 -47.43 85.77 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.777 175.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.9 m -45.21 -55.59 5.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.956 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.512 HD11 HG11 ' A' ' 247' ' ' VAL . 0.3 OUTLIER -58.73 -48.76 80.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.257 178.249 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 97.2 m -61.18 -38.81 87.83 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 227' ' ' GLN . 56.5 m -83.86 -37.19 22.77 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 121.65 -0.656 . . . . 0.0 111.249 -176.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . 0.5 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . . . -68.14 -57.69 5.66 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.695 HG22 ' HA2' ' A' ' 234' ' ' GLY . 30.5 p -104.05 144.16 31.92 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.152 -175.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.0 t 64.06 -22.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 63.55 51.86 50.85 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 120.435 1.47 . . . . 0.0 114.028 167.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.715 ' HD2' ' SG ' ' A' ' 186' ' ' CYS . 27.1 mtt85 -103.09 -123.03 0.19 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.797 0.808 . . . . 0.0 111.307 -178.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.574 ' HB3' HD11 ' A' ' 190' ' ' ILE . . . -156.8 168.52 27.21 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . 0.806 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 36.6 t90 -161.77 149.74 14.94 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 119.365 0.984 . . . . 0.0 111.188 -170.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 85.09 170.12 46.81 Favored Glycine 0 C--O 1.229 -0.186 0 N-CA-C 115.081 0.792 . . . . 0.0 115.081 170.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.584 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 85.8 m-70 -127.23 133.04 24.63 Favored Pre-proline 0 N--CA 1.457 -0.117 0 C-N-CA 122.949 0.5 . . . . 0.0 109.879 171.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.584 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 18.9 Cg_endo -58.73 157.67 36.99 Favored 'Cis proline' 0 C--O 1.236 0.393 0 C-N-CA 123.261 -1.558 . . . . 0.0 112.373 -4.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 33.2 t -53.41 115.56 1.99 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.586 -174.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 27.5 mt-10 -105.39 102.76 12.21 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' MET . . . . . 0.585 ' O ' ' HD3' ' A' ' 225' ' ' PRO . 1.3 tpt -79.09 132.42 36.59 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -175.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' CYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 215' ' ' ARG . 92.7 m -83.29 112.58 40.06 Favored Pre-proline 0 C--N 1.332 -0.154 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -172.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.585 ' HD3' ' O ' ' A' ' 223' ' ' MET . 6.1 Cg_exo -81.41 124.92 4.9 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.598 2.865 . . . . 0.0 111.054 169.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 48.25 -79.16 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.899 0.88 . . . . 0.0 113.228 -174.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 225' ' ' PRO . 0.0 OUTLIER -162.27 -171.54 0.28 Allowed Pre-proline 0 N--CA 1.441 -0.903 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -168.317 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 211' ' ' ALA . 6.9 Cg_endo -87.85 -90.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 121.835 1.69 . . . . 0.0 111.478 170.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -87.66 158.12 51.48 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 172.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.02 61.87 7.8 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.19 1.927 . . . . 0.0 114.593 -171.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 92.2 m -110.39 -177.94 3.37 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 169.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.643 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 31.1 mmt180 -62.72 140.63 58.74 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 173.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -37.33 -50.72 1.05 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.695 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -70.1 1.14 19.45 Favored Glycine 0 C--N 1.313 -0.728 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.72 -174.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . 0.643 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 11.3 m-85 -123.17 151.32 42.3 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.159 0.981 . . . . 0.0 113.324 -169.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.436 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.1 OUTLIER -127.32 128.7 24.02 Favored Pre-proline 0 N--CA 1.436 -1.143 0 CA-C-N 114.082 -1.417 . . . . 0.0 108.259 169.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.92 125.17 14.25 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.533 2.156 . . . . 0.0 111.802 178.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -62.61 136.64 57.98 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 35.5 pt -82.78 2.32 3.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.584 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -103.12 -57.37 2.05 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.853 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 52.3 p -89.06 -45.9 9.26 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.5 -178.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 103.06 11.02 35.35 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -96.17 125.23 40.55 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 121.95 0.881 . . . . 0.0 109.992 -177.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 4.3 m -59.06 122.56 14.06 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.832 172.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 75.5 mm-40 -123.37 137.9 54.72 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . 0.542 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 6.1 t70 -75.32 147.21 40.33 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-O 121.283 0.563 . . . . 0.0 110.001 -176.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.62 HG23 ' HG3' ' A' ' 249' ' ' GLU . 11.4 m -93.53 144.27 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.426 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.48 ' HA ' ' ND2' ' A' ' 264' ' ' ASN . 7.0 m-20 -75.03 77.28 2.22 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 168.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.62 ' HG3' HG23 ' A' ' 247' ' ' VAL . 36.2 mp0 -52.42 -35.73 52.7 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.651 0.739 . . . . 0.0 110.515 -171.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 9.5 m -53.39 -33.47 53.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.877 175.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -99.1 -37.42 9.34 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.78 0.8 . . . . 0.0 110.101 -177.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.23 -19.02 63.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.753 -175.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.403 HG12 HH22 ' A' ' 215' ' ' ARG . 3.2 mp -126.66 117.18 22.68 Favored Pre-proline 0 N--CA 1.446 -0.637 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 174.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -35.79 -91.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.483 0.911 1 C-N-CA 125.345 4.03 . . . . 0.0 114.39 -165.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -100.36 56.59 0.8 Allowed Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.406 171.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.409 ' O ' ' HG3' ' A' ' 284' ' ' GLN . 22.6 tp -40.3 -65.33 0.42 Allowed 'General case' 0 C--O 1.224 -0.273 0 O-C-N 124.465 0.744 . . . . 0.0 112.894 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 262' ' ' CYS . 11.3 t -87.62 62.72 7.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.104 0.478 . . . . 0.0 109.857 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -60.4 104.33 0.32 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.55 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 131.92 -17.35 4.92 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.764 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -150.78 -157.85 8.0 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.032 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -108.54 121.55 45.21 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 269' ' ' PHE . 52.6 t -92.14 133.55 35.68 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 176.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 39.3 mt -132.24 112.51 19.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.442 0.639 . . . . 0.0 110.075 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.48 ' ND2' ' HA ' ' A' ' 248' ' ' ASP . 66.1 t30 -74.13 126.44 30.57 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -170.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 6.2 t -113.35 164.91 12.98 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.021 154.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.542 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 30.7 m -69.97 132.2 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 118.705 -1.198 . . . . 0.0 108.899 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.502 ' CA ' ' HE2' ' A' ' 235' ' ' PHE . . . 88.53 -10.87 70.11 Favored Glycine 0 C--N 1.314 -0.678 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.571 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.4 p -174.43 143.14 0.82 Allowed 'General case' 0 C--O 1.212 -0.872 0 CA-C-N 118.112 0.956 . . . . 0.0 110.705 -174.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . 0.482 ' HB2' ' SG ' ' A' ' 262' ' ' CYS . 41.1 p90 -103.12 151.64 22.33 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -114.7 126.84 55.33 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -175.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . 0.433 ' HB2' HD22 ' A' ' 279' ' ' LEU . 11.1 m -97.05 158.17 15.56 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.867 0.841 . . . . 0.0 111.961 -178.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -134.71 106.26 6.86 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.278 172.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 4.6 m -96.52 156.03 37.21 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.502 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 52.2 Cg_exo -55.84 159.9 10.88 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.53 2.154 . . . . 0.0 111.425 172.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -56.17 146.02 24.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.551 0.215 . . . . 0.0 111.07 -177.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.26 -30.0 3.42 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.88 -176.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' HIS . . . . . 0.546 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 17.8 m-70 -78.84 165.01 24.01 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.135 0.493 . . . . 0.0 111.507 -177.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -146.4 135.0 22.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.605 -175.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.621 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 39.0 tp -71.34 140.85 50.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.223 0.535 . . . . 0.0 110.926 177.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -129.56 102.44 6.37 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 170.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -61.01 -24.38 66.12 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 123.521 0.513 . . . . 0.0 111.781 -173.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 16.4 t -62.66 -23.84 33.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.983 0.421 . . . . 0.0 110.826 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.4 ' C ' HE21 ' A' ' 284' ' ' GLN . 28.1 p -141.63 24.86 2.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.668 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 256' ' ' LEU . 0.0 OUTLIER 25.53 48.85 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.142 0.977 . . . . 0.0 112.178 -169.115 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . 0.621 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 81.8 tttt -97.87 159.14 15.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.16 -171.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 4.0 m -137.15 81.25 1.86 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.041 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.546 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 66.5 mm-40 . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.346 -0.835 . . . . 0.0 108.893 -174.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.657 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 94.8 m-85 . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 120.811 0.339 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 26.6 pt -128.31 176.65 7.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.669 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 96.64 167.94 33.77 Favored Glycine 0 C--N 1.318 -0.457 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.761 -176.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.9 p -74.62 -23.61 58.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.176 0.488 . . . . 0.0 111.669 -177.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -109.54 7.3 24.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.534 176.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 30.9 m 64.29 30.05 13.53 Favored 'General case' 0 N--CA 1.462 0.168 0 O-C-N 123.672 0.607 . . . . 0.0 111.013 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.3 -12.22 67.95 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.571 -173.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.77 109.67 63.24 Favored Pre-proline 0 C--O 1.224 -0.259 0 CA-C-N 117.912 0.856 . . . . 0.0 110.745 -174.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.01 139.4 24.2 Favored 'Trans proline' 0 CA--C 1.522 -0.092 0 C-N-CA 123.625 2.884 . . . . 0.0 112.578 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 149' ' ' VAL . 9.3 p -67.52 110.53 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.734 0.778 . . . . 0.0 111.479 -175.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.38 77.18 7.17 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.972 176.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -53.86 -68.89 0.14 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -174.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.4 m -88.01 13.55 10.82 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.137 0.494 . . . . 0.0 111.679 -165.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 87.99 122.1 1.75 Allowed Glycine 0 N--CA 1.428 -1.841 0 CA-C-O 122.237 0.909 . . . . 0.0 112.608 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . 0.414 ' C ' ' HG ' ' A' ' 155' ' ' LEU . 5.7 m -78.32 155.13 30.3 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 113.185 -1.507 . . . . 0.0 109.034 168.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.669 HD12 ' O ' ' A' ' 176' ' ' GLN . 56.3 mt -149.71 163.22 38.55 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.858 -166.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.577 HD22 ' HB ' ' A' ' 169' ' ' THR . 61.4 t30 47.69 24.13 0.51 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.66 -164.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 67.71 38.3 89.71 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.74 -177.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.22 -152.84 0.59 Allowed Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.723 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -149.07 121.57 8.52 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.223 -0.575 . . . . 0.0 111.808 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.5 m -63.19 114.69 3.92 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.668 177.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 165' ' ' ARG . 8.8 m -104.17 -34.92 3.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.81 0.338 . . . . 0.0 110.935 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.696 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -140.1 171.68 7.47 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.657 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 73.9 Cg_exo -53.3 108.55 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.988 1.792 . . . . 0.0 112.434 177.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 72.81 -7.88 1.37 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.362 1.065 . . . . 0.0 110.423 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.696 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.5 OUTLIER -83.49 82.54 8.25 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 176.295 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 7.1 t -80.88 145.8 31.15 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.463 ' HB2' ' CG1' ' A' ' 161' ' ' VAL . . . -96.5 118.68 33.51 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 173.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 84.0 m -90.45 126.97 36.08 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.791 -167.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.577 ' HB ' HD22 ' A' ' 156' ' ' ASN . 3.0 m -42.62 -51.44 5.19 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 124.633 1.208 . . . . 0.0 112.531 -172.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -165.76 -89.75 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 119.481 -0.888 . . . . 0.0 112.234 -176.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -90.98 54.89 3.32 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.636 -167.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.643 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 7.8 m-85 -129.63 136.5 49.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.608 0.704 . . . . 0.0 111.654 169.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.696 HG23 ' CE2' ' A' ' 181' ' ' TYR . 80.1 p -87.49 132.79 33.9 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.383 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 176' ' ' GLN . . . 92.06 146.75 19.14 Favored Glycine 0 N--CA 1.438 -1.167 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.799 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.32 22.89 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.616 1.544 . . . . 0.0 112.407 -174.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.669 ' O ' HD12 ' A' ' 155' ' ' LEU . 50.4 tt0 -120.85 3.28 10.57 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.512 176.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.596 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 32.15 57.59 0.36 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 176.639 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.454 ' HG3' ' HE ' ' A' ' 179' ' ' ARG . 15.7 pt-20 -115.84 17.21 16.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.501 0.667 . . . . 0.0 110.085 175.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.643 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 8.8 mmt180 -117.65 90.66 3.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.651 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -78.91 79.46 5.31 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.869 0.843 . . . . 0.0 110.97 -168.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.696 ' CE2' HG23 ' A' ' 173' ' ' THR . 17.4 p90 -112.13 79.97 1.28 Allowed 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 22.9 mtp85 -79.93 144.95 32.91 Favored 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 118.936 -2.352 . . . . 0.0 107.285 -176.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 82.3 p -78.65 138.22 38.21 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.083 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.488 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -151.91 149.78 21.55 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -70.62 128.44 15.25 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.76 1.64 . . . . 0.0 110.787 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . 0.507 ' H ' HG23 ' A' ' 202' ' ' ILE . 7.8 t -84.17 122.0 28.24 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.113 0.482 . . . . 0.0 109.824 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . 0.461 ' HB3' ' HB3' ' A' ' 195' ' ' CYS . 65.5 m-85 -107.07 149.03 28.03 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.758 -178.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.627 ' HA ' ' HB3' ' A' ' 215' ' ' ARG . 17.7 p -102.44 -59.0 1.78 Allowed 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -173.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 p -121.95 117.83 53.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.673 -173.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.522 HD13 ' HB3' ' A' ' 221' ' ' CYS . 4.2 mt -124.28 120.73 60.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -170.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 63.9 p -117.32 -166.29 1.17 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.562 -1.199 . . . . 0.0 107.849 161.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -68.31 -5.59 19.48 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.692 0.678 . . . . 0.0 110.22 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -92.19 -75.83 0.47 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.099 -173.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 72.7 mtm -141.13 143.03 34.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.662 0.268 . . . . 0.0 110.725 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.497 ' HA ' HG12 ' A' ' 190' ' ' ILE . 8.5 m -90.37 -45.61 8.9 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.982 176.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.405 ' HG3' ' H ' ' A' ' 188' ' ' THR . 20.0 mt-30 -152.13 3.99 0.39 Allowed 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.253 165.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 92.99 -3.81 74.01 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.132 -175.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 74.31 6.58 4.65 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.277 0.631 . . . . 0.0 112.333 174.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.795 ' H ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -85.9 19.88 2.41 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.269 0.557 . . . . 0.0 110.957 177.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.453 ' OG ' HG22 ' A' ' 202' ' ' ILE . 15.2 t -102.96 142.83 33.4 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.662 -175.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -126.84 19.61 6.13 Favored Glycine 0 CA--C 1.504 -0.606 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.611 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -67.72 99.27 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 122.093 0.949 . . . . 0.0 109.05 173.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.99 123.1 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.097 174.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 22.9 t -154.33 -178.35 7.08 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 181' ' ' TYR . 5.5 p -103.58 161.03 14.23 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 119.752 1.16 . . . . 0.0 108.811 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.527 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 45.4 tttm -59.82 -44.72 93.88 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.067 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.8 m -44.22 -56.2 4.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.931 172.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.573 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -53.77 -53.66 49.22 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.814 177.778 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 99.0 m -68.75 -22.92 64.28 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 45.0 m -96.1 -29.65 13.97 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.056 -178.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 227' ' ' GLN . . . -74.08 -60.06 2.44 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 173.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.775 HG22 ' HA2' ' A' ' 234' ' ' GLY . 10.8 p -96.78 160.64 14.26 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.283 178.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 1.4 t 66.32 -41.98 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 118.784 -0.626 . . . . 0.0 111.922 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 62.32 46.75 93.24 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-N 119.155 0.889 . . . . 0.0 113.584 168.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.627 ' HB3' ' HA ' ' A' ' 188' ' ' THR . 0.9 OUTLIER -119.87 -92.47 0.54 Allowed 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.746 -178.22 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.502 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -167.67 166.88 13.69 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . 0.527 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 21.8 t90 -155.18 148.42 24.88 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 122.213 -0.305 . . . . 0.0 110.276 -174.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 221' ' ' CYS . . . 86.09 160.98 34.68 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.756 172.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.657 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 26.2 t60 -135.62 131.88 19.45 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.657 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 51.6 Cg_exo -54.59 142.81 14.39 Favored 'Cis proline' 0 C--N 1.353 0.784 0 C-N-CA 123.896 -1.293 . . . . 0.0 112.282 -2.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . 0.66 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 72.2 m -50.64 128.28 20.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.714 -172.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -116.19 121.71 42.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.818 175.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' MET . . . . . 0.502 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 5.1 ppp? -106.62 153.87 21.74 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.287 -171.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 97.8 m -135.07 135.47 22.99 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -173.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -56.99 166.91 3.53 Favored 'Trans proline' 0 CA--C 1.515 -0.447 0 C-N-CA 123.98 3.12 . . . . 0.0 114.111 167.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -39.01 111.59 0.19 Allowed 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.081 162.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' GLN . . . . . 0.448 ' HB3' ' O ' ' A' ' 211' ' ' ALA . 0.3 OUTLIER 6.42 92.89 0.03 OUTLIER Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 110.137 -3.211 . . . . 0.0 114.162 177.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -58.07 -49.97 11.3 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.747 2.298 . . . . 0.0 113.256 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -49.72 134.58 19.9 Favored Pre-proline 0 CA--C 1.512 -0.488 0 C-N-CA 122.834 0.454 . . . . 0.0 110.521 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.49 45.29 1.93 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.006 1.804 . . . . 0.0 113.301 -172.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 48.8 m -127.7 -176.1 3.67 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.67 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 98.1 mtt180 -61.53 139.21 58.28 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 172.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.412 ' O ' HG22 ' A' ' 212' ' ' THR . 20.3 ptt180 -38.46 -42.74 0.77 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 177.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.775 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -77.48 9.28 29.18 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.033 -0.604 . . . . 0.0 114.018 -177.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . 0.717 ' HE2' ' N ' ' A' ' 267' ' ' GLY . 2.3 m-85 -121.53 147.5 45.71 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 122.044 0.926 . . . . 0.0 112.776 -172.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.41 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.5 OUTLIER -123.23 130.37 24.58 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 113.667 -1.606 . . . . 0.0 108.851 173.306 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -58.42 112.42 1.17 Allowed 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.333 2.022 . . . . 0.0 111.564 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -51.47 138.88 21.12 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.359 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 23.6 mt -81.91 -6.03 9.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.034 -173.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -109.18 -55.45 2.41 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.452 0.644 . . . . 0.0 110.221 -177.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 47.6 p -90.45 -38.24 13.39 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.907 -176.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 96.79 6.53 58.14 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -176.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -89.11 124.54 34.42 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 122.015 0.912 . . . . 0.0 109.943 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 12.1 m -54.87 121.44 8.64 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.454 176.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.451 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 84.5 mm-40 -119.81 137.66 53.84 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . 0.677 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 13.4 t70 -76.7 147.29 37.5 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.557 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.758 HG23 ' HG3' ' A' ' 249' ' ' GLU . 6.4 m -99.31 145.27 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.965 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.755 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -72.58 75.94 1.08 Allowed 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 167.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.758 ' HG3' HG23 ' A' ' 247' ' ' VAL . 21.3 mp0 -53.06 -34.62 57.31 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.746 0.784 . . . . 0.0 110.216 -170.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 11.9 m -48.39 -40.3 25.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.836 174.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -103.51 -41.5 5.97 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.856 0.836 . . . . 0.0 110.368 -175.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -66.76 -23.46 66.09 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.546 -1.207 . . . . 0.0 110.624 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.84 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.5 mp -127.54 78.57 74.59 Favored Pre-proline 0 N--CA 1.445 -0.679 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 172.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.465 ' HG2' HG12 ' A' ' 202' ' ' ILE . 9.7 Cg_endo -50.32 112.26 0.7 Allowed 'Trans proline' 0 CA--C 1.507 -0.869 0 C-N-CA 124.112 3.208 . . . . 0.0 114.64 -164.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 59.09 35.12 82.61 Favored Glycine 0 C--N 1.307 -1.03 0 CA-C-N 113.233 -1.803 . . . . 0.0 113.811 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.84 ' HB3' HG22 ' A' ' 253' ' ' ILE . 2.2 pt? -63.99 -22.54 66.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 118.06 0.93 . . . . 0.0 110.593 177.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 14.5 t -78.01 4.51 12.03 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.152 0.501 . . . . 0.0 110.688 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 67.34 -86.84 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.809 0.844 . . . . 0.0 113.013 171.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -126.62 11.1 7.11 Favored Glycine 0 CA--C 1.507 -0.417 0 C-N-CA 120.207 -0.997 . . . . 0.0 112.279 -174.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -98.94 -173.92 31.8 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.314 175.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' ASN . . . . . 0.582 ' HB3' ' CG ' ' A' ' 272' ' ' LYS . 2.7 t-20 -107.0 116.99 32.88 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 176.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' ' 269' ' ' PHE . 34.4 t -90.64 134.86 34.09 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 2.7 mp -127.48 112.13 27.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.609 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -74.56 123.52 24.95 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -172.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.4 t -110.74 160.04 17.08 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 155.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.677 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 4.1 m -76.42 128.4 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.886 0 C-N-CA 117.933 -1.507 . . . . 0.0 108.137 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.717 ' N ' ' HE2' ' A' ' 235' ' ' PHE . . . 112.57 -26.83 10.48 Favored Glycine 0 N--CA 1.432 -1.567 0 C-N-CA 119.904 -1.141 . . . . 0.0 111.338 -172.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 37.6 t 173.01 160.02 0.12 Allowed 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 121.112 0.482 . . . . 0.0 110.373 -172.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . 0.598 ' HB2' ' SG ' ' A' ' 262' ' ' CYS . 42.2 p90 -103.69 155.51 18.51 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 121.326 -0.859 . . . . 0.0 109.036 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -116.76 125.52 51.75 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 11.4 m -105.41 154.01 20.9 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.858 0.837 . . . . 0.0 112.203 -176.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.582 ' CG ' ' HB3' ' A' ' 261' ' ' ASN . 10.1 ptmm? -129.63 108.71 10.42 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.342 168.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 32.2 m -85.89 156.14 58.2 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.068 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.588 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 71.8 Cg_exo -50.51 160.64 1.54 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.479 2.12 . . . . 0.0 112.351 173.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -58.25 136.49 57.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.903 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.08 -26.15 5.66 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' HIS . . . . . 0.59 ' ND1' ' HA ' ' A' ' 287' ' ' GLU . 14.9 m-70 -79.43 176.78 9.38 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.18 0.514 . . . . 0.0 112.001 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -167.97 144.85 4.15 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.939 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 38.1 tp -91.66 137.99 31.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.033 0.444 . . . . 0.0 110.911 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -125.62 98.43 5.57 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.18 -19.38 61.51 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.629 0.581 . . . . 0.0 112.177 -172.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.477 ' HA ' ' NH1' ' A' ' 215' ' ' ARG . 79.7 t -58.07 -34.58 49.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.821 177.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.434 ' HA ' ' HB ' ' A' ' 188' ' ' THR . 32.2 m -139.49 31.01 2.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.08 177.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . 0.611 ' HB3' ' O ' ' A' ' 256' ' ' LEU . 82.0 mm-40 30.82 44.87 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.299 -0.864 . . . . 0.0 113.111 -173.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' A' ' 287' ' ' GLU . 62.0 tttp -91.43 110.15 21.45 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.49 -175.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 44.8 t -100.3 68.04 1.39 Allowed 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.59 ' HA ' ' ND1' ' A' ' 277' ' ' HIS . 42.3 mt-10 . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.423 -0.798 . . . . 0.0 109.491 -173.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.526 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 46.4 m-85 . . . . . 0 N--CA 1.445 -0.682 0 CA-C-O 120.976 0.417 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.514 HG13 ' HB3' ' A' ' 147' ' ' GLN . 25.7 pt -136.34 -166.01 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.748 -177.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.81 179.92 53.1 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.955 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 30.7 p -74.21 -37.36 63.89 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 122.827 0.451 . . . . 0.0 112.205 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -97.46 6.29 48.41 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 35.3 m 63.23 23.78 14.01 Favored 'General case' 0 C--O 1.22 -0.493 0 O-C-N 123.785 0.678 . . . . 0.0 109.497 -171.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -94.8 1.5 65.78 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.307 -0.473 . . . . 0.0 113.564 -171.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.514 ' HB3' HG13 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -104.87 105.7 52.17 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 117.409 0.604 . . . . 0.0 109.402 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.442 ' HD2' ' OE1' ' A' ' 147' ' ' GLN . 92.7 Cg_endo -79.69 151.34 22.02 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.756 2.304 . . . . 0.0 112.783 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 149' ' ' VAL . 13.3 p -87.95 104.23 14.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 122.325 1.06 . . . . 0.0 111.706 -173.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.53 90.84 5.71 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.548 170.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -52.83 -63.12 1.25 Allowed 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -173.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 4.2 m -84.19 7.34 19.32 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.568 0.699 . . . . 0.0 109.948 -168.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.47 131.71 0.08 OUTLIER Glycine 0 N--CA 1.432 -1.579 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.132 -168.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . 0.434 ' O ' HD23 ' A' ' 155' ' ' LEU . 72.4 m -66.54 154.6 39.95 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 114.447 -0.877 . . . . 0.0 110.364 176.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.434 HD23 ' O ' ' A' ' 154' ' ' CYS . 34.5 mt -123.23 162.97 21.55 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.647 -169.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.737 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 2.2 t-20 48.55 38.07 10.4 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.422 -167.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 55.94 38.48 74.98 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.743 -174.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.18 -155.06 0.88 Allowed Glycine 0 C--N 1.32 -0.322 0 CA-C-N 115.216 -0.492 . . . . 0.0 112.086 -176.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -144.95 122.36 11.65 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.746 -0.381 . . . . 0.0 111.232 -171.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.42 111.29 5.86 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.403 173.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 165' ' ' ARG . 14.8 m -101.08 -42.92 10.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 O-C-N 121.94 -0.475 . . . . 0.0 110.092 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.575 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -134.17 173.34 5.93 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.526 ' HD3' ' CE1' ' A' ' 140' ' ' TYR . 54.7 Cg_exo -54.29 113.01 1.16 Allowed 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 122.492 2.128 . . . . 0.0 112.033 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 75.2 -10.16 1.27 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.636 0.775 . . . . 0.0 109.642 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.575 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.9 OUTLIER -86.47 82.21 8.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.371 179.007 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 84.4 m -87.48 137.16 32.57 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.684 0.754 . . . . 0.0 110.288 172.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.51 134.74 33.64 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.309 174.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 86.3 m -102.2 124.07 47.15 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.288 0.992 . . . . 0.0 111.655 -169.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.737 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 65.2 m -56.34 -53.92 51.59 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -172.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -151.91 -87.75 0.06 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 118.482 -1.287 . . . . 0.0 114.135 -170.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -93.96 39.09 2.98 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.943 -166.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.607 ' CZ ' ' HB2' ' A' ' 156' ' ' ASN . 1.7 m-85 -123.72 125.28 44.46 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 118.188 0.994 . . . . 0.0 111.795 174.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.521 ' N ' ' HE1' ' A' ' 181' ' ' TYR . 5.5 t -87.04 163.73 16.87 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 166.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.91 127.84 2.06 Favored Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -175.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -75.22 15.94 0.74 Allowed 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 121.128 1.219 . . . . 0.0 113.274 -166.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -120.89 2.12 10.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.747 0.784 . . . . 0.0 110.325 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.45 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 42.65 48.0 4.66 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 114.299 -1.319 . . . . 0.0 113.854 -179.185 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -107.66 -18.13 13.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.286 0.565 . . . . 0.0 110.169 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' A' ' 180' ' ' ASP . 6.8 mmt180 -55.95 -73.66 0.06 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.582 -176.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.481 ' HB3' ' O ' ' A' ' 179' ' ' ARG . 27.1 t70 84.96 75.16 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.642 0 O-C-N 124.122 0.889 . . . . 0.0 110.176 168.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.521 ' HE1' ' N ' ' A' ' 173' ' ' THR . 44.6 p90 -94.72 61.56 2.64 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 169.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.458 ' HG3' ' CH2' ' A' ' 217' ' ' TRP . 22.1 ptt-85 -51.75 126.36 17.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.439 175.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 42.5 p -79.97 137.73 36.92 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 120.857 0.36 . . . . 0.0 110.188 -173.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.624 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -162.8 159.3 31.66 Favored Glycine 0 C--N 1.323 -0.154 0 CA-C-O 119.365 -0.686 . . . . 0.0 111.505 -175.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.11 141.6 11.79 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.421 2.081 . . . . 0.0 111.977 174.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . 0.759 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 74.7 m -91.03 123.25 34.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.445 0.641 . . . . 0.0 111.294 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . 0.556 ' O ' ' HB2' ' A' ' 215' ' ' ARG . 19.1 m-85 -86.47 144.68 27.16 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.989 176.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 5.0 m -108.39 -18.24 13.8 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -163.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 7.5 p -170.75 118.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 121.614 -0.678 . . . . 0.0 110.272 176.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.511 HG12 ' HA ' ' A' ' 195' ' ' CYS . 5.4 mt -114.72 120.92 65.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -171.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 11.4 m -110.09 173.57 6.26 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 105.194 -2.151 . . . . 0.0 105.194 152.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -67.45 -6.26 18.58 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.639 1.109 . . . . 0.0 109.902 177.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -77.01 -74.44 0.24 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.284 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 92.7 mmm -132.2 133.46 44.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.789 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.511 ' HA ' HG12 ' A' ' 190' ' ' ILE . 56.0 m -83.15 -31.52 27.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.724 174.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.467 ' O ' ' HD1' ' A' ' 187' ' ' PHE . 77.9 mt-30 68.42 117.49 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.425 174.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 118.96 21.25 3.87 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.162 -172.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -75.93 3.94 9.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.474 0.654 . . . . 0.0 110.425 -178.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.52 ' N ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -122.53 15.25 10.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.588 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 1.4 t -87.19 128.24 35.14 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.948 -173.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -105.13 14.37 48.3 Favored Glycine 0 CA--C 1.505 -0.534 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.011 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.56 ' CD1' ' HA ' ' A' ' 253' ' ' ILE . 2.1 tt -60.95 103.7 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 171.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.7 t -88.77 95.78 5.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 123.31 1.528 . . . . 0.0 108.09 171.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 19.3 m -137.64 177.33 7.95 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 111.458 -2.61 . . . . 0.0 106.875 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.428 ' OG1' ' HB ' ' A' ' 207' ' ' THR . 26.8 p -100.88 161.02 13.89 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.674 -174.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.673 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 44.5 tttm -58.84 -42.83 90.23 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.884 173.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.428 ' HB ' ' OG1' ' A' ' 205' ' ' THR . 56.8 m -44.4 -56.39 4.27 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 122.78 1.276 . . . . 0.0 109.594 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.787 HD11 HG11 ' A' ' 247' ' ' VAL . 10.8 tp -59.71 -49.68 76.79 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 112.379 -2.191 . . . . 0.0 112.043 -175.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 50.6 m -77.49 -17.62 57.84 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.224 0.535 . . . . 0.0 111.78 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 72.4 m -87.4 -27.21 22.9 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.985 -0.447 . . . . 0.0 110.022 172.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . 0.587 ' HB2' ' CE1' ' A' ' 229' ' ' HIS . . . -73.57 -56.57 4.85 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.816 0.817 . . . . 0.0 109.296 175.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.647 ' CG2' ' HA2' ' A' ' 234' ' ' GLY . 25.5 p -106.02 149.93 26.21 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.488 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.0 t 69.14 -42.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 O-C-N 123.948 0.78 . . . . 0.0 111.628 -174.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 56.75 64.29 4.54 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 119.401 1.0 . . . . 0.0 114.842 171.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.556 ' HB2' ' O ' ' A' ' 187' ' ' PHE . 21.4 mmt85 -130.41 -80.23 0.54 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 117.707 0.753 . . . . 0.0 110.532 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.43 ' HB3' ' HB2' ' A' ' 187' ' ' PHE . . . -169.35 169.73 8.87 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 176.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . 0.759 ' HD1' ' SG ' ' A' ' 186' ' ' CYS . 16.0 t90 -157.8 147.4 20.01 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 89.47 169.46 44.12 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 170.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.438 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 16.9 m-70 -128.04 131.38 23.76 Favored Pre-proline 0 C--N 1.341 0.237 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.456 175.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 23.4 Cg_exo -63.99 159.94 66.32 Favored 'Cis proline' 0 C--N 1.348 0.524 0 C-N-CA 123.569 -1.429 . . . . 0.0 111.149 -4.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 63.5 m -45.17 121.33 2.82 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 123.563 0.539 . . . . 0.0 111.982 -176.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.457 ' HB3' ' HE3' ' A' ' 206' ' ' LYS . 21.2 mt-10 -107.94 114.51 28.48 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 172.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 47.0 ttp -83.55 129.87 34.98 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.238 0.542 . . . . 0.0 110.244 -170.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 63.9 m -77.27 129.15 78.72 Favored Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -171.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.437 ' HB2' ' HD3' ' A' ' 228' ' ' PRO . 25.2 Cg_exo -64.75 173.41 5.69 Favored 'Trans proline' 0 C--N 1.329 -0.458 0 C-N-CA 123.806 3.004 . . . . 0.0 111.208 164.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.463 ' HB3' ' OE1' ' A' ' 227' ' ' GLN . . . -43.64 -54.15 5.22 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -169.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' GLN . . . . . 0.487 ' CB ' ' HD2' ' A' ' 233' ' ' ARG . 2.1 pm0 -164.22 28.67 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.809 0 CA-C-O 118.765 -0.636 . . . . 0.0 112.266 -176.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.437 ' HD3' ' HB2' ' A' ' 225' ' ' PRO . 63.3 Cg_exo -19.63 63.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.237 1 C-N-CA 125.664 4.243 . . . . 0.0 116.77 -155.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.587 ' CE1' ' HB2' ' A' ' 211' ' ' ALA . 28.3 m80 -135.76 155.44 78.05 Favored Pre-proline 0 C--N 1.324 -0.521 0 O-C-N 121.982 -0.449 . . . . 0.0 110.469 -178.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -92.47 35.48 0.24 Allowed 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.35 2.033 . . . . 0.0 110.587 165.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 9.9 t -162.77 -167.36 1.52 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.636 -176.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.622 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 88.9 mtt180 -67.12 149.53 50.41 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -174.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.487 ' HD2' ' CB ' ' A' ' 227' ' ' GLN . 34.9 mmm-85 -35.11 -64.1 0.29 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.868 0.867 . . . . 0.0 112.921 175.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.647 ' HA2' ' CG2' ' A' ' 212' ' ' THR . . . -82.96 16.04 29.47 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.424 -0.894 . . . . 0.0 114.35 -168.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . 0.622 ' CD1' ' HB2' ' A' ' 232' ' ' ARG . 7.0 m-85 -119.96 137.98 53.73 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 121.847 0.832 . . . . 0.0 112.063 -173.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.419 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.0 OUTLIER -121.79 141.74 34.54 Favored Pre-proline 0 C--N 1.311 -1.107 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 175.626 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.68 124.0 10.69 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.534 2.156 . . . . 0.0 112.473 -176.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -55.26 139.78 41.33 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.563 171.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 34.2 mt -77.29 -16.53 14.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.089 -173.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 240' ' ' ARG . 19.3 mtp180 -101.13 -61.26 1.39 Allowed 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.775 -175.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 40.7 p -82.09 -38.95 24.09 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.377 -176.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 94.11 5.89 62.05 Favored Glycine 0 N--CA 1.437 -1.296 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.062 -176.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -78.23 139.88 38.91 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 121.79 0.805 . . . . 0.0 110.919 -178.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' CYS . . . . . 0.402 ' HB3' ' HB3' ' A' ' 235' ' ' PHE . 63.7 m -62.64 122.41 15.76 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.743 -1.571 . . . . 0.0 110.146 174.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 81.0 mm-40 -122.7 133.16 54.51 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 176.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . 0.608 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 1.8 t70 -75.54 151.57 37.9 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.787 HG11 HD11 ' A' ' 208' ' ' LEU . 8.6 m -97.02 145.25 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.451 -177.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -75.75 76.46 2.71 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 169.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.711 ' HG3' HG23 ' A' ' 247' ' ' VAL . 34.1 mp0 -54.11 -33.36 57.54 Favored 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 123.98 0.8 . . . . 0.0 110.359 -169.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 35.1 m -51.1 -42.67 60.79 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.812 174.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -96.58 -34.81 11.3 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.768 0.794 . . . . 0.0 110.268 -177.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.532 ' HB1' HD21 ' A' ' 208' ' ' LEU . . . -73.13 -20.03 61.01 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.482 -176.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.714 ' O ' ' HG ' ' A' ' 256' ' ' LEU . 5.2 mp -140.54 81.46 17.32 Favored Pre-proline 0 N--CA 1.451 -0.376 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.464 ' HD2' HG13 ' A' ' 202' ' ' ILE . 16.5 Cg_exo -71.37 31.53 0.24 Allowed 'Trans proline' 0 CA--C 1.515 -0.474 0 C-N-CA 123.373 2.716 . . . . 0.0 113.025 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' GLY . . . . . 0.528 ' H ' ' C ' ' A' ' 253' ' ' ILE . . . -123.39 2.39 9.59 Favored Glycine 0 C--N 1.288 -2.119 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.484 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.714 ' HG ' ' O ' ' A' ' 253' ' ' ILE . 23.2 mt -65.75 -147.17 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 175.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 284' ' ' GLN . 76.1 m -38.55 128.16 1.46 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.394 0.677 . . . . 0.0 112.698 -174.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -79.73 68.77 5.89 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.998 -174.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 107.24 171.35 22.27 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.914 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 85.66 -154.73 28.56 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.203 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -109.64 138.68 45.65 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 50.2 t -122.48 138.57 54.51 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 173.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.489 HD11 ' HE2' ' A' ' 272' ' ' LYS . 20.9 mt -131.26 164.9 33.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 -174.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.454 ' ND2' ' HB3' ' A' ' 269' ' ' PHE . 0.8 OUTLIER -131.29 125.36 32.61 Favored 'General case' 0 CA--C 1.497 -1.062 0 C-N-CA 117.53 -1.668 . . . . 0.0 114.038 -175.375 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.0 t -109.26 163.87 12.98 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 122.333 1.063 . . . . 0.0 110.072 166.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.54 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 35.7 m -73.23 127.5 35.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 268' ' ' SER . . . 98.45 -12.63 63.19 Favored Glycine 0 C--N 1.311 -0.848 0 C-N-CA 119.523 -1.322 . . . . 0.0 111.999 -176.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 267' ' ' GLY . 10.5 t 176.44 162.51 0.39 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.112 1.456 . . . . 0.0 110.858 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . 0.534 ' CZ ' HD13 ' A' ' 256' ' ' LEU . 46.0 p90 -107.26 162.59 13.76 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.233 -0.917 . . . . 0.0 109.56 177.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -116.75 156.55 26.98 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.81 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 56.8 m -136.68 158.54 44.2 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.576 0.703 . . . . 0.0 112.338 172.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.489 ' HE2' HD11 ' A' ' 263' ' ' ILE . 50.0 mtmt -139.68 130.13 25.55 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.141 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.427 ' HB3' ' HD2' ' A' ' 274' ' ' PRO . 19.6 m -122.12 173.03 4.47 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.992 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.446 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 53.1 Cg_exo -56.21 155.07 25.77 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.862 1.708 . . . . 0.0 110.141 167.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -58.04 156.94 8.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.139 0.495 . . . . 0.0 111.376 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 86.51 -36.97 3.17 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.255 -176.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' HIS . . . . . 0.69 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 18.1 m-70 -69.63 153.41 43.47 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.08 0.466 . . . . 0.0 111.639 -177.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 54.7 mttp -144.96 139.44 27.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.487 -175.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 285' ' ' LYS . 45.9 tp -76.07 140.93 42.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.396 0.617 . . . . 0.0 111.85 -175.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -127.07 102.54 7.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.903 173.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -57.8 -27.98 63.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.292 -175.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 66.4 t -56.3 -33.4 37.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.133 0.492 . . . . 0.0 111.513 -175.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 8.3 p -137.83 28.21 2.66 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.015 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . 0.607 ' O ' ' HA ' ' A' ' 257' ' ' CYS . 0.9 OUTLIER 35.16 43.87 0.13 Allowed 'General case' 0 C--N 1.349 0.584 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.662 -169.602 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . 0.442 ' O ' HD12 ' A' ' 279' ' ' LEU . 66.6 tttt -94.64 166.15 12.16 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -172.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 12.4 t -156.93 106.06 2.21 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.596 -178.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.69 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 37.4 tt0 . . . . . 0 C--N 1.315 -0.901 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.411 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 74.4 m-85 . . . . . 0 CA--C 1.517 -0.315 0 CA-C-O 121.016 0.436 . . . . 0.0 111.545 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 34.0 pt -129.87 176.8 7.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.592 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.73 165.73 31.83 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.187 -176.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 40.3 p -64.98 -36.93 85.99 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -106.25 16.1 25.31 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.037 0.446 . . . . 0.0 110.264 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 60.3 m 55.98 36.82 28.04 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.131 173.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -94.25 -2.24 64.13 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.793 -175.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.88 113.67 60.87 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 117.752 0.776 . . . . 0.0 110.804 -176.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.89 143.87 23.72 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.96 2.44 . . . . 0.0 112.507 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 149' ' ' VAL . 9.3 p -78.07 110.47 13.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.867 0.842 . . . . 0.0 111.953 -175.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.64 76.73 7.51 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.37 172.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -58.36 -62.61 1.72 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -170.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.3 m -86.36 8.87 19.81 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.586 0.708 . . . . 0.0 109.815 -170.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 74.7 131.78 0.25 Allowed Glycine 0 N--CA 1.428 -1.881 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.149 -172.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . 0.442 ' O ' HD23 ' A' ' 155' ' ' LEU . 77.3 m -71.86 157.75 37.31 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 175.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 154' ' ' CYS . 55.6 mt -129.03 165.26 21.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.907 -170.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.807 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 2.3 t-20 49.53 30.97 3.76 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.837 0.711 . . . . 0.0 111.229 -168.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.68 37.25 82.56 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.219 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -73.65 -145.94 0.88 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.414 -0.422 . . . . 0.0 112.958 -175.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' A' ' 166' ' ' CYS . 21.5 tpt180 -148.37 121.97 9.19 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.881 -174.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 166' ' ' CYS . 0.8 OUTLIER -72.96 108.34 5.83 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.41 173.584 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 165' ' ' ARG . 4.4 m -94.46 -37.25 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.392 -177.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.546 ' HB1' ' HD2' ' A' ' 163' ' ' PRO . . . -133.58 177.85 2.05 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 168.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.546 ' HD2' ' HB1' ' A' ' 162' ' ' ALA . 88.0 Cg_exo -50.2 107.04 0.14 Allowed 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.383 2.055 . . . . 0.0 113.608 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 64.49 6.61 3.21 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.165 0.986 . . . . 0.0 110.517 -178.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.593 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -92.33 75.53 5.27 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.722 177.106 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 61.4 m -84.34 146.98 27.43 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.188 0.518 . . . . 0.0 110.334 176.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -98.07 144.5 27.5 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 57.7 m -102.96 122.88 45.5 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 124.449 1.093 . . . . 0.0 112.007 -166.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.807 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 93.7 m -61.24 -55.44 31.96 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.423 ' CG ' ' N ' ' A' ' 171' ' ' GLY . 79.6 t80 -132.2 -116.48 0.22 Allowed 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.269 -0.972 . . . . 0.0 112.277 -168.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.423 ' N ' ' CG ' ' A' ' 170' ' ' TYR . . . -87.63 55.51 4.43 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.742 -166.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.573 ' N ' ' CD1' ' A' ' 172' ' ' PHE . 2.1 m-85 -123.99 122.17 37.21 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.273 171.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.468 ' O ' ' HG2' ' A' ' 179' ' ' ARG . 3.1 t -86.36 163.65 17.52 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 166.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 84.75 125.19 1.33 Allowed Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 -176.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.56 19.86 0.53 Allowed 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 121.471 1.447 . . . . 0.0 114.033 -165.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -122.95 3.82 9.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.813 0.816 . . . . 0.0 109.682 175.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.481 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 39.06 51.79 1.97 Allowed 'General case' 0 C--N 1.346 0.444 0 CA-C-N 114.141 -1.391 . . . . 0.0 114.537 -179.44 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -106.82 -16.62 14.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.283 0.563 . . . . 0.0 109.854 174.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 173' ' ' THR . 19.7 mmm180 -56.62 -70.38 0.12 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.809 -174.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 41.1 t0 77.02 69.6 0.06 Allowed 'General case' 0 CA--C 1.502 -0.866 0 CA-C-O 121.907 0.86 . . . . 0.0 109.519 166.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.444 ' CD1' ' O ' ' A' ' 181' ' ' TYR . 38.6 p90 -86.13 65.85 9.29 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-O 122.741 1.258 . . . . 0.0 107.856 173.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.49 ' O ' ' HZ2' ' A' ' 217' ' ' TRP . 14.4 ptt180 -45.89 123.42 4.47 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.657 -1.61 . . . . 0.0 109.26 172.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 80.9 p -76.7 137.39 39.35 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.458 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -147.98 143.7 11.46 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -173.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.76 128.64 12.69 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.205 1.936 . . . . 0.0 111.337 174.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . 0.752 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 92.4 m -84.23 119.01 24.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.417 0.627 . . . . 0.0 110.947 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . 0.587 ' HB3' ' O ' ' A' ' 195' ' ' CYS . 69.1 m-85 -95.34 144.75 25.63 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.958 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.529 ' O ' ' HD2' ' A' ' 215' ' ' ARG . 20.2 p -108.98 -6.04 15.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -167.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.5 p -167.28 116.17 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.502 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.553 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.1 mt -133.86 127.07 51.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -170.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.9 m -128.33 -166.08 1.58 Allowed 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 160.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -63.04 -5.99 3.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 118.943 0.792 . . . . 0.0 110.453 173.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -76.95 -72.75 0.33 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.293 -177.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.517 ' SD ' ' HA2' ' A' ' 197' ' ' GLY . 13.6 ttt -149.96 160.09 43.88 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -173.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.587 ' O ' ' HB3' ' A' ' 187' ' ' PHE . 61.4 m -90.15 -32.17 16.76 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.167 0.508 . . . . 0.0 111.669 -176.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.469 ' HG3' ' OG1' ' A' ' 188' ' ' THR . 62.3 tt0 -148.09 -74.74 0.19 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.463 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.517 ' HA2' ' SD ' ' A' ' 194' ' ' MET . . . 125.78 -29.34 4.71 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -95.68 -24.2 16.65 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 119.845 -0.122 . . . . 0.0 111.206 173.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 58.57 79.81 0.2 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.266 0.555 . . . . 0.0 111.258 177.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 44.2 t -100.27 144.88 28.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.482 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -92.11 29.29 7.69 Favored Glycine 0 CA--C 1.499 -0.951 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 175.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.612 HG23 ' H ' ' A' ' 186' ' ' CYS . 0.0 OUTLIER -60.98 106.64 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 121.783 0.801 . . . . 0.0 108.843 173.107 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.0 t -94.69 123.9 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.816 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 16.7 t -155.24 -178.15 7.05 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.4 p -101.66 159.29 15.44 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 120.434 1.47 . . . . 0.0 109.311 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.54 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 42.2 tttm -56.11 -44.97 79.62 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 120.284 -0.567 . . . . 0.0 109.885 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.5 m -43.87 -56.81 3.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.371 173.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.526 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -55.58 -55.09 36.04 Favored 'General case' 0 CA--C 1.518 -0.261 0 O-C-N 123.755 0.659 . . . . 0.0 112.036 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 53.8 m -75.39 -18.7 59.88 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -171.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 79.9 m -89.67 -39.46 13.18 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 121.74 -0.6 . . . . 0.0 111.28 174.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . . . -67.8 -57.0 7.04 Favored 'General case' 0 C--N 1.345 0.383 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.689 HG22 ' HA2' ' A' ' 234' ' ' GLY . 18.8 p -94.08 157.45 16.08 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.346 174.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.1 t 68.42 -46.73 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 176.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 60.05 59.51 10.3 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 120.737 -0.744 . . . . 0.0 114.638 170.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.529 ' HD2' ' O ' ' A' ' 188' ' ' THR . 30.1 mmt180 -124.85 -84.95 0.64 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 117.525 0.663 . . . . 0.0 110.466 177.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.409 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -169.32 165.75 10.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . 0.752 ' HD1' ' SG ' ' A' ' 186' ' ' CYS . 18.5 t90 -153.39 148.4 26.66 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.552 0.215 . . . . 0.0 110.656 -175.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 221' ' ' CYS . . . 78.37 163.23 22.47 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 115.086 0.795 . . . . 0.0 115.086 167.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.513 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 6.6 m80 -116.09 132.22 23.36 Favored Pre-proline 0 N--CA 1.453 -0.294 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 168.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.513 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 25.4 Cg_exo -63.3 151.28 69.42 Favored 'Cis proline' 0 C--O 1.232 0.18 0 C-N-CA 123.593 -1.419 . . . . 0.0 111.516 -2.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 84.9 m -54.99 120.19 6.53 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 124.175 0.922 . . . . 0.0 111.15 -175.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -115.85 121.41 42.3 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' MET . . . . . 0.409 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 0.0 OUTLIER -100.89 150.23 23.05 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.604 -172.444 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 74.1 m -143.35 148.46 44.28 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 120.799 0.333 . . . . 0.0 111.687 -175.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -63.27 168.38 11.13 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.546 2.164 . . . . 0.0 109.94 155.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.8 -118.71 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.997 0.427 . . . . 0.0 110.971 171.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.07 108.52 1.26 Allowed Pre-proline 0 C--N 1.322 -0.623 0 CA-C-O 121.179 0.514 . . . . 0.0 111.91 -174.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 211' ' ' ALA . 55.8 Cg_endo -74.91 -49.53 0.15 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.214 1.943 . . . . 0.0 112.667 -175.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.442 ' HB3' ' CD ' ' A' ' 230' ' ' PRO . 41.2 m80 -94.36 178.99 1.32 Allowed Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.442 ' CD ' ' HB3' ' A' ' 229' ' ' HIS . 36.6 Cg_exo -63.49 -7.5 12.63 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.0 1.134 . . . . 0.0 112.108 173.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' CYS . . . . . 0.495 ' SG ' ' HD3' ' A' ' 237' ' ' PRO . 20.0 t -65.4 144.61 56.96 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.712 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 31.4 mmt180 -75.07 142.77 43.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.361 -174.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.47 ' HG3' ' N ' ' A' ' 234' ' ' GLY . 28.0 ptt-85 -37.78 -53.57 1.27 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.496 1.123 . . . . 0.0 113.06 -177.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.689 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -71.15 0.36 31.62 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.22 -0.514 . . . . 0.0 114.224 -172.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . 0.801 ' CE2' ' HA2' ' A' ' 267' ' ' GLY . 1.8 m-85 -123.1 166.67 14.78 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 118.352 1.076 . . . . 0.0 111.843 -175.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.51 HD13 ' O ' ' A' ' 235' ' ' PHE . 0.2 OUTLIER -130.54 128.0 22.47 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 113.623 -1.626 . . . . 0.0 107.59 169.326 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.495 ' HD3' ' SG ' ' A' ' 231' ' ' CYS . 14.2 Cg_endo -61.03 117.61 4.4 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.321 2.014 . . . . 0.0 112.075 178.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -55.96 134.69 52.41 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.114 177.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 39.0 mt -73.98 -11.21 14.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.607 175.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -98.04 -58.1 2.06 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.296 -175.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 31.3 p -93.05 -43.8 8.71 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.777 -177.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 102.01 7.36 47.24 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -178.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -94.14 128.73 40.73 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.959 0.885 . . . . 0.0 109.797 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' CYS . . . . . 0.409 ' HB3' ' CB ' ' A' ' 235' ' ' PHE . 86.6 m -51.32 117.92 2.93 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.167 -1.833 . . . . 0.0 109.867 169.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -121.24 131.24 54.11 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . 0.642 ' HB3' HG13 ' A' ' 266' ' ' VAL . 4.3 t70 -79.14 150.34 31.77 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 121.297 0.57 . . . . 0.0 110.384 -170.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.734 HG23 ' HG3' ' A' ' 249' ' ' GLU . 8.9 m -100.79 145.39 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.948 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.552 -178.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.455 ' HA ' ' CG ' ' A' ' 264' ' ' ASN . 2.2 m-20 -74.24 76.85 1.82 Allowed 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 167.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.734 ' HG3' HG23 ' A' ' 247' ' ' VAL . 55.4 mp0 -52.76 -35.07 55.67 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 123.722 0.639 . . . . 0.0 110.66 -170.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 32.3 m -53.88 -29.16 40.36 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.205 175.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -106.67 -47.44 3.75 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.633 0.73 . . . . 0.0 110.309 -175.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -63.15 -25.57 68.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.612 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.755 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.7 mp -122.65 79.96 47.97 Favored Pre-proline 0 C--O 1.243 0.726 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 173.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.525 ' HG2' HG12 ' A' ' 202' ' ' ILE . 10.2 Cg_endo -51.27 118.79 4.65 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.489 2.793 . . . . 0.0 114.649 -165.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 59.11 30.83 67.68 Favored Glycine 0 C--N 1.317 -0.518 0 CA-C-N 113.839 -1.528 . . . . 0.0 114.103 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.755 ' HB3' HG22 ' A' ' 253' ' ' ILE . 1.3 pt? -68.27 -25.79 65.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.565 0.683 . . . . 0.0 111.44 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 284' ' ' GLN . 48.2 t -102.66 82.39 2.13 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.581 0.705 . . . . 0.0 110.081 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -85.07 116.31 23.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.1 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 165.55 -41.25 0.28 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -170.63 -116.6 0.39 Allowed Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.502 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' ASN . . . . . 0.471 ' HB3' ' HB2' ' A' ' 272' ' ' LYS . 2.8 t-20 -98.78 157.56 16.21 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -175.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 32.6 t -140.45 133.61 29.55 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 28.4 mt -138.13 116.72 13.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.022 0.439 . . . . 0.0 110.54 -169.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.455 ' CG ' ' HA ' ' A' ' 248' ' ' ASP . 64.4 t30 -77.1 121.29 23.38 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.655 -174.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 8.4 t -106.3 160.9 15.02 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.661 157.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.768 HG12 ' CE1' ' A' ' 235' ' ' PHE . 1.7 t -72.39 119.52 19.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.801 ' HA2' ' CE2' ' A' ' 235' ' ' PHE . . . 113.71 -22.33 14.95 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.376 -174.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 267' ' ' GLY . 15.6 t 174.21 163.65 0.2 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.566 0.698 . . . . 0.0 111.103 -173.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . 0.402 ' CD1' ' HB2' ' A' ' 249' ' ' GLU . 13.1 p90 -111.48 153.53 26.03 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.231 -0.988 . . . . 0.0 108.759 177.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -111.64 135.85 51.67 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.444 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 64.7 m -109.48 160.33 16.3 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.656 -0.817 . . . . 0.0 111.142 178.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 261' ' ' ASN . 28.5 mmmt -135.35 95.38 3.27 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.47 176.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 13.7 m -76.05 161.29 75.98 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.161 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.433 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 27.7 Cg_exo -61.66 159.55 32.13 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 121.907 1.738 . . . . 0.0 109.968 170.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -57.76 145.73 33.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.515 0.197 . . . . 0.0 111.059 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.86 -28.9 3.89 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.13 -177.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' HIS . . . . . 0.707 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 17.1 m-70 -78.68 166.37 22.58 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 120.833 0.349 . . . . 0.0 111.228 -177.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -137.82 138.76 39.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.147 -176.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.625 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 51.4 tp -80.01 123.7 28.06 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.819 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.598 ' HB3' ' HB3' ' A' ' 285' ' ' LYS . 47.0 t30 -113.85 110.25 19.82 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.418 ' HA ' ' OE1' ' A' ' 284' ' ' GLN . 32.6 mt-10 -64.25 -14.96 58.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.717 -170.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.489 ' O ' ' HB ' ' A' ' 188' ' ' THR . 63.7 t -56.51 -38.84 58.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.908 0.385 . . . . 0.0 110.978 178.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 42.6 m -146.02 36.22 1.03 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.644 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 256' ' ' LEU . 8.3 mm100 34.49 48.32 0.28 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.41 0.684 . . . . 0.0 111.853 -170.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . 0.625 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 84.8 tttt -82.68 154.9 24.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.583 -172.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 23.2 m -141.02 85.75 2.0 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.707 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 19.0 mm-40 . . . . . 0 C--O 1.239 0.54 0 CA-C-O 118.392 -0.813 . . . . 0.0 108.904 -173.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -149.13 148.89 30.19 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.6 t -150.05 140.79 22.67 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.802 0.334 . . . . 0.0 110.487 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -92.38 -2.94 56.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.448 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.1 m -67.93 138.69 56.18 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.327 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.9 mm -82.32 114.75 23.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.975 0.417 . . . . 0.0 110.0 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -88.14 47.51 1.51 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.572 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.496 ' CG ' ' H ' ' A' ' 119' ' ' CYS . 5.6 t-80 -166.47 -153.78 0.17 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 -178.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.496 ' H ' ' CG ' ' A' ' 118' ' ' HIS . 28.2 p -76.46 -171.37 1.79 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 177.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -121.38 -39.64 2.65 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.924 0.392 . . . . 0.0 110.908 175.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.646 HD12 ' O ' ' A' ' 132' ' ' ASP . 0.3 OUTLIER -69.97 -169.89 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.051 -178.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.556 ' H ' ' HD2' ' A' ' 122' ' ' ARG . 0.5 OUTLIER -120.65 139.57 52.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.041 -176.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 10.2 m -117.17 134.83 54.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.38 0.609 . . . . 0.0 112.033 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 5.1 mpp? -138.41 166.22 24.81 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 173.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.532 ' O ' ' HB2' ' A' ' 137' ' ' GLN . 17.3 m120 64.41 54.93 1.45 Allowed 'General case' 0 N--CA 1.463 0.202 0 O-C-N 123.313 0.383 . . . . 0.0 111.493 173.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 65.81 21.33 69.26 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.341 174.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.441 ' HA3' ' SG ' ' A' ' 134' ' ' CYS . . . -89.41 136.0 13.3 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.076 -0.583 . . . . 0.0 113.633 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.51 ' HB2' ' HB2' ' A' ' 135' ' ' LEU . 1.9 m -90.25 126.55 35.87 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 173.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 10.6 t -90.67 91.0 8.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.896 -173.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 10.7 t -142.49 151.87 42.12 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.641 -0.662 . . . . 0.0 110.944 -175.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.486 ' O ' ' HB3' ' A' ' 132' ' ' ASP . 35.6 t0 77.66 -44.23 0.42 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 124.642 1.214 . . . . 0.0 112.879 170.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.646 ' O ' HD12 ' A' ' 121' ' ' ILE . 3.2 p30 156.53 -39.63 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 123.814 0.846 . . . . 0.0 110.228 -174.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.95 156.13 19.55 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.163 175.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.549 ' HB3' ' SG ' ' A' ' 145' ' ' CYS . 8.6 t -76.47 137.61 39.78 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.949 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 128' ' ' SER . 74.3 mt -89.48 96.61 10.78 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 176.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 61.4 m -62.62 145.91 53.34 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.29 -1.323 . . . . 0.0 113.22 -167.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.532 ' HB2' ' O ' ' A' ' 125' ' ' ASN . 32.7 tt0 -59.43 159.93 7.47 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.284 169.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -63.23 114.49 3.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.009 0.909 . . . . 0.0 111.695 -177.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 95.17 14.32 48.96 Favored Glycine 0 C--N 1.301 -1.381 0 CA-C-N 112.922 -1.945 . . . . 0.0 112.126 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.619 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 44.6 m-85 -115.55 146.97 41.25 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.572 174.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 145' ' ' CYS . 20.4 pt -134.96 177.46 6.8 Favored 'Isoleucine or valine' 0 C--O 1.246 0.876 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.498 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.13 174.03 30.22 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.936 -175.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.7 p -70.79 -48.22 55.41 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 120.753 0.311 . . . . 0.0 110.948 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -96.54 5.87 49.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.949 176.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.549 ' SG ' ' HB3' ' A' ' 134' ' ' CYS . 61.8 m 63.86 42.1 6.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.903 172.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.72 9.18 56.85 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.792 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.424 ' O ' HG12 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -115.13 113.63 43.71 Favored Pre-proline 0 C--O 1.222 -0.384 0 CA-C-N 117.645 0.723 . . . . 0.0 110.125 179.189 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.75 143.82 13.51 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.639 2.226 . . . . 0.0 112.612 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 12.7 p -71.08 112.84 6.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.655 -176.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.8 m -81.44 74.63 8.43 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.177 175.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -51.58 -64.33 0.85 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -173.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.6 m -91.9 13.33 18.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.47 0.652 . . . . 0.0 110.717 -169.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 74.13 131.96 0.23 Allowed Glycine 0 N--CA 1.436 -1.347 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.661 -177.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.687 ' O ' HD23 ' A' ' 155' ' ' LEU . 1.7 m -61.49 156.9 18.3 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 113.942 -1.129 . . . . 0.0 109.858 171.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 154' ' ' CYS . 41.2 mt -137.93 178.1 7.37 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -174.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.636 HD22 ' C ' ' A' ' 155' ' ' LEU . 0.1 OUTLIER 35.43 31.25 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.979 1.312 . . . . 0.0 114.446 -178.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 63.31 35.54 92.2 Favored Glycine 0 N--CA 1.454 -0.132 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.593 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -79.24 -147.66 4.1 Favored Glycine 0 C--N 1.328 0.104 0 C-N-CA 121.286 -0.483 . . . . 0.0 113.442 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -157.93 126.44 5.53 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.251 -0.558 . . . . 0.0 110.624 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 166' ' ' CYS . 4.9 m -64.18 124.56 21.98 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 122.241 0.216 . . . . 0.0 110.942 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.812 HG22 ' HG2' ' A' ' 165' ' ' ARG . 1.3 m -116.31 -35.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.913 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.66 ' HB3' ' HB3' ' A' ' 165' ' ' ARG . . . -139.28 169.62 11.93 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.619 ' HD3' ' CE1' ' A' ' 140' ' ' TYR . 78.4 Cg_exo -51.16 107.14 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.316 2.01 . . . . 0.0 112.604 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 75.28 -11.35 1.1 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.471 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.812 ' HG2' HG22 ' A' ' 161' ' ' VAL . 18.3 ttp180 -83.45 90.74 7.24 Favored 'General case' 0 CA--C 1.488 -1.425 0 CA-C-O 121.652 0.739 . . . . 0.0 109.312 175.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 160' ' ' CYS . 34.5 t -84.61 145.04 28.23 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.648 167.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.538 ' HB2' HG11 ' A' ' 161' ' ' VAL . . . -92.38 129.23 38.37 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 35.7 m -106.6 132.53 52.49 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.267 0.979 . . . . 0.0 111.925 -167.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 52.6 m -57.07 -55.5 33.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 113.331 -1.759 . . . . 0.0 114.501 -167.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 17.1 t80 177.75 125.89 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.692 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 79.98 28.95 48.45 Favored Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.42 169.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.597 ' CE2' ' HA ' ' A' ' 180' ' ' ASP . 1.4 m-85 -118.34 121.25 39.92 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 118.797 -1.161 . . . . 0.0 110.502 166.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.561 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 4.3 t -89.23 140.11 29.81 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 96.45 128.59 5.81 Favored Glycine 0 N--CA 1.425 -2.038 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -171.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.18 9.76 0.81 Allowed 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.413 1.409 . . . . 0.0 113.229 -168.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.605 ' O ' HD12 ' A' ' 155' ' ' LEU . 41.3 tt0 -117.79 19.79 13.64 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.378 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.585 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.6 OUTLIER 24.31 59.54 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 117.228 2.307 . . . . 0.0 117.228 178.077 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -115.47 21.0 14.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.395 1.093 . . . . 0.0 109.028 168.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 20.6 mmt180 -113.3 81.53 1.52 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.658 -1.61 . . . . 0.0 107.603 175.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.597 ' HA ' ' CE2' ' A' ' 172' ' ' PHE . 2.3 m-20 -80.5 49.6 1.18 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.52 -167.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.561 ' HE2' ' N ' ' A' ' 173' ' ' THR . 20.4 p90 -86.32 98.64 11.08 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -87.27 155.14 20.19 Favored 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 118.296 -2.753 . . . . 0.0 106.763 175.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 19.8 p -86.06 135.45 33.62 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.049 -1.06 . . . . 0.0 109.618 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -153.64 155.09 25.94 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -73.77 129.25 13.29 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.16 1.907 . . . . 0.0 110.809 173.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 10.6 t -82.43 114.21 20.72 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . 0.538 ' HE1' ' O ' ' A' ' 218' ' ' GLY . 59.3 m-85 -94.29 138.93 31.71 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.773 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.554 ' O ' ' HD2' ' A' ' 215' ' ' ARG . 89.2 m -107.8 -19.76 13.43 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -163.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 25.4 t -150.47 115.62 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 121.467 -0.771 . . . . 0.0 109.613 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.731 ' CG1' ' HA ' ' A' ' 195' ' ' CYS . 16.5 mt -130.88 120.16 46.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 10.7 p -117.08 -166.5 1.18 Allowed 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 155.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -66.75 -5.29 11.48 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.841 0.829 . . . . 0.0 109.764 172.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -83.76 -73.79 0.4 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.224 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.475 ' O ' ' HA ' ' A' ' 190' ' ' ILE . 60.7 mtt -128.38 161.18 30.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.443 0.163 . . . . 0.0 110.966 -175.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.731 ' HA ' ' CG1' ' A' ' 190' ' ' ILE . 84.5 m -92.03 -25.55 18.76 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.572 173.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -161.27 -58.7 0.05 Allowed 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 169.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 125.78 -26.05 5.46 Favored Glycine 0 C--N 1.317 -0.48 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.619 170.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -118.13 -0.11 11.66 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 117.159 0.48 . . . . 0.0 111.294 176.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.444 ' O ' ' HB2' ' A' ' 200' ' ' SER . 4.1 mm? 62.75 175.48 0.15 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.83 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 199' ' ' LEU . 22.8 t 176.14 130.3 0.04 OUTLIER 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.543 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -84.23 36.32 2.92 Favored Glycine 0 CA--C 1.509 -0.343 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 174.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.97 104.3 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 122.331 1.062 . . . . 0.0 109.412 175.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 37.9 t -93.05 124.1 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 CA-C-N 113.841 -1.527 . . . . 0.0 109.631 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 20.2 t -154.64 -177.3 6.39 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 104.292 -2.484 . . . . 0.0 104.292 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.426 ' OG1' HD22 ' A' ' 208' ' ' LEU . 14.3 p -99.36 157.28 16.52 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 120.317 1.417 . . . . 0.0 109.014 176.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.699 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 36.5 tttm -56.61 -44.37 81.06 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 120.201 -0.599 . . . . 0.0 109.788 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.2 m -43.58 -54.87 4.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.892 174.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.52 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -55.14 -53.07 60.62 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 124.05 0.844 . . . . 0.0 111.322 177.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 94.6 m -63.69 -26.62 68.75 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -176.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 226' ' ' ALA . 60.9 m -85.79 -47.49 9.68 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 118.481 0.582 . . . . 0.0 110.008 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . 0.554 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . . . -67.23 -54.44 21.0 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -173.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.77 HG22 ' HA2' ' A' ' 234' ' ' GLY . 16.2 p -102.8 152.86 20.76 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.851 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER 66.12 -40.5 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.336 0.654 . . . . 0.0 112.14 -176.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.413 ' O ' ' HD3' ' A' ' 215' ' ' ARG . . . 61.01 59.06 10.75 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 119.134 0.879 . . . . 0.0 114.785 169.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.554 ' HD2' ' O ' ' A' ' 188' ' ' THR . 8.6 mmt85 -128.64 -90.12 0.5 Allowed 'General case' 0 C--O 1.245 0.827 0 CA-C-N 117.845 0.822 . . . . 0.0 111.847 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.575 ' CB ' HD12 ' A' ' 190' ' ' ILE . . . -165.93 168.46 15.74 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . 0.699 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 11.2 t90 -164.96 150.15 9.53 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.538 ' O ' ' HE1' ' A' ' 187' ' ' PHE . . . 95.84 -174.06 31.29 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.305 -0.95 . . . . 0.0 114.245 168.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 220' ' ' PRO . 20.2 p80 -137.09 133.55 18.57 Favored Pre-proline 0 N--CA 1.444 -0.729 0 CA-C-O 121.248 0.547 . . . . 0.0 111.163 -175.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 219' ' ' HIS . 72.2 Cg_endo -86.11 117.05 4.09 Favored 'Cis proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.408 -1.913 . . . . 0.0 112.233 -5.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 70.3 m 33.23 94.57 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.768 1.227 . . . . 0.0 113.781 177.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 36.3 mt-10 -101.17 113.63 26.84 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.76 139.5 35.34 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.779 0.323 . . . . 0.0 111.253 -170.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 5.9 p -145.62 155.98 52.74 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.926 -175.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.64 166.89 14.53 Favored 'Trans proline' 0 CA--C 1.504 -1.025 0 C-N-CA 122.27 1.98 . . . . 0.0 111.339 167.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 210' ' ' CYS . . . -63.75 -122.98 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 O-C-N 123.969 0.793 . . . . 0.0 111.794 171.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.68 108.97 1.22 Allowed Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.533 -173.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.554 ' HD3' ' HA ' ' A' ' 211' ' ' ALA . 73.8 Cg_endo -80.58 -57.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.71 2.273 . . . . 0.0 113.168 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 230' ' ' PRO . 13.6 m-70 -84.15 153.56 63.01 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 229' ' ' HIS . 6.1 Cg_exo -78.12 64.75 8.39 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.415 2.077 . . . . 0.0 112.543 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 80.6 m -119.48 -103.85 0.4 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 172.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.646 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 59.5 mtt180 -145.45 134.43 22.57 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 172.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -39.85 -41.97 1.23 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.77 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -73.45 9.7 7.44 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.417 -0.897 . . . . 0.0 113.882 -176.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . 0.646 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 6.1 m-85 -124.05 146.97 48.22 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 122.099 0.952 . . . . 0.0 112.595 -171.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.442 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.5 OUTLIER -122.6 129.02 25.2 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 114.009 -1.451 . . . . 0.0 108.432 171.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -62.04 113.39 1.85 Allowed 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.097 1.865 . . . . 0.0 111.202 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -48.48 128.67 15.16 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.512 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 26.9 pt -75.75 4.18 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.587 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -110.97 -56.73 2.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.008 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 36.0 p -94.42 -37.53 11.39 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.01 -176.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 100.93 0.17 55.06 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.175 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -81.62 129.94 34.87 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.784 0.802 . . . . 0.0 110.578 -176.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' CYS . . . . . 0.425 ' C ' ' HD1' ' A' ' 235' ' ' PHE . 2.2 m -61.44 115.05 3.58 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 113.816 -1.538 . . . . 0.0 109.371 173.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.496 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 45.4 tt0 -119.57 139.74 51.66 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.187 -177.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.695 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 20.0 t70 -77.24 145.43 37.55 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -177.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.654 HG23 ' HG3' ' A' ' 249' ' ' GLU . 15.1 m -100.15 145.26 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.533 ' HB3' ' HG2' ' A' ' 251' ' ' GLN . 10.4 t70 -73.63 80.51 1.51 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 165.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.654 ' HG3' HG23 ' A' ' 247' ' ' VAL . 36.8 mp0 -51.63 -34.85 39.56 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.175 0.512 . . . . 0.0 110.334 -174.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.524 ' HB2' ' OD2' ' A' ' 248' ' ' ASP . 62.8 m -52.58 -44.22 65.78 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.501 173.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . 0.533 ' HG2' ' HB3' ' A' ' 248' ' ' ASP . 2.2 pt20 -90.16 -32.09 16.78 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.68 0.752 . . . . 0.0 110.401 -173.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.1 -17.43 31.04 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.942 -170.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.757 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.1 mp -125.55 79.93 66.71 Favored Pre-proline 0 C--O 1.239 0.551 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -39.41 114.23 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 124.446 3.431 . . . . 0.0 115.48 -172.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 57.74 34.37 70.43 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 113.637 -1.619 . . . . 0.0 114.174 174.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.757 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.9 OUTLIER -73.54 -24.51 60.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 118.16 0.98 . . . . 0.0 110.905 177.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . 0.505 ' HA ' ' HB3' ' A' ' 284' ' ' GLN . 50.5 t -90.49 114.69 26.93 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -103.77 83.36 2.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.267 0.556 . . . . 0.0 110.609 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -158.9 -105.49 0.21 Allowed Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.185 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -124.29 -88.33 0.8 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.525 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . 0.618 ' HB2' ' HB3' ' A' ' 272' ' ' LYS . 10.2 m120 -94.84 157.65 15.83 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 11.8 t -137.85 126.12 23.14 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 173.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 41.0 mt -132.13 169.78 21.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -171.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.525 ' ND2' ' HB3' ' A' ' 269' ' ' PHE . 0.9 OUTLIER -134.96 130.28 35.55 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 117.248 -1.781 . . . . 0.0 113.835 -174.249 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 1.7 t -113.61 163.96 14.29 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.532 163.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.695 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 4.1 m -73.12 130.0 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 C-N-CA 119.312 -0.955 . . . . 0.0 108.719 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.525 ' CA ' ' HE2' ' A' ' 235' ' ' PHE . . . 98.2 -17.52 58.49 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.959 -175.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 41.9 t -179.69 150.74 0.42 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.532 1.166 . . . . 0.0 110.524 -173.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . 0.525 ' HB3' ' ND2' ' A' ' 264' ' ' ASN . 30.2 p90 -96.43 160.28 14.49 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.61 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -116.77 117.59 30.19 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -177.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . 0.477 ' HB2' HD22 ' A' ' 279' ' ' LEU . 68.8 m -102.61 132.39 48.74 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.237 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.618 ' HB3' ' HB2' ' A' ' 261' ' ' ASN . 22.7 ttpp -101.18 122.52 43.78 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.131 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 56.6 m -107.1 145.1 30.46 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.114 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.532 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 38.9 Cg_exo -57.97 156.34 29.27 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.636 2.224 . . . . 0.0 110.842 169.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -54.41 146.37 16.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.073 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.15 -29.67 3.44 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.803 -177.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' HIS . . . . . 0.682 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 29.8 m-70 -81.25 162.66 23.44 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 120.986 0.422 . . . . 0.0 110.728 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -146.63 116.83 7.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.044 -171.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.477 HD22 ' HB2' ' A' ' 271' ' ' CYS . 45.2 tp -63.13 127.75 32.68 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.977 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -114.8 101.57 9.19 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -70.17 -8.02 46.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.724 0.297 . . . . 0.0 111.339 -173.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 51.5 t -67.68 -31.77 53.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.514 0.674 . . . . 0.0 110.18 172.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 30.7 p -139.68 28.93 2.15 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.015 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 0.505 ' HB3' ' HA ' ' A' ' 257' ' ' CYS . 0.9 OUTLIER 29.46 44.87 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.166 0.986 . . . . 0.0 113.292 -172.476 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -112.36 127.24 55.95 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.906 -172.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 98.0 m -88.03 107.62 18.83 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 171.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.682 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 8.9 tp10 . . . . . 0 C--O 1.244 0.792 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 10.3 p . . . . . 0 N--CA 1.475 0.775 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -131.34 85.66 2.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.953 0.406 . . . . 0.0 110.466 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 26.7 m -67.23 112.52 4.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.968 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -67.11 -44.95 78.64 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.565 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 32.6 t 56.64 86.26 0.07 Allowed 'General case' 0 C--O 1.234 0.26 0 O-C-N 123.703 0.627 . . . . 0.0 111.02 177.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 80.8 mt -61.45 -57.24 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-O 121.317 0.58 . . . . 0.0 109.483 175.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -99.42 92.73 5.54 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.095 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -61.07 131.97 52.29 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 123.646 0.591 . . . . 0.0 110.278 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 21.0 p -75.59 -175.96 3.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.871 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -98.79 -58.11 2.02 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-O 122.192 0.996 . . . . 0.0 110.368 -175.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.505 HD11 ' CA ' ' A' ' 133' ' ' HIS . 25.0 pt -72.13 -177.31 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 113.303 -1.771 . . . . 0.0 114.523 -169.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.558 ' H ' ' HD2' ' A' ' 122' ' ' ARG . 0.1 OUTLIER -130.27 130.65 44.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.72 -172.445 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' A' ' 129' ' ' CYS . 26.5 m -117.9 139.46 51.11 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -173.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.2 mtm -130.18 179.4 5.91 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 171.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.2 m120 66.26 52.93 1.07 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.022 0.439 . . . . 0.0 110.767 171.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.458 ' HA3' ' HG3' ' A' ' 137' ' ' GLN . . . 59.6 32.81 74.6 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 115.149 -0.932 . . . . 0.0 113.386 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 135' ' ' LEU . . . -113.12 129.89 9.16 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.015 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.3 m -94.29 146.32 24.11 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.521 ' HB2' ' SG ' ' A' ' 123' ' ' CYS . 50.1 t -96.59 123.1 40.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.9 0.381 . . . . 0.0 110.58 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.503 ' O ' ' HD2' ' A' ' 133' ' ' HIS . 22.6 t -141.65 138.4 32.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.467 177.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.609 ' O ' ' HB2' ' A' ' 132' ' ' ASP . 7.8 t70 63.1 -9.57 0.11 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 172.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.609 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 15.5 m-20 108.52 38.65 0.0 OUTLIER 'General case' 0 C--N 1.355 0.832 0 C-N-CA 125.4 1.48 . . . . 0.0 108.119 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.505 ' CA ' HD11 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -157.74 154.17 27.76 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.911 177.071 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 81.2 m -101.02 132.2 46.54 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.311 0.577 . . . . 0.0 112.01 -173.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.511 ' O ' ' HA2' ' A' ' 127' ' ' GLY . 94.0 mt -88.16 92.46 9.16 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.385 174.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 61.8 m -72.96 150.53 42.42 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.262 -171.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.458 ' HG3' ' HA3' ' A' ' 126' ' ' GLY . 78.4 mt-30 -62.01 142.04 57.72 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 167.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -62.45 113.4 2.92 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 122.554 1.169 . . . . 0.0 111.368 -176.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 116.29 5.88 16.37 Favored Glycine 0 N--CA 1.431 -1.644 0 CA-C-N 112.825 -1.989 . . . . 0.0 111.71 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.669 ' CE2' ' HD3' ' A' ' 163' ' ' PRO . 51.6 m-85 -120.46 146.54 46.14 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.932 0.396 . . . . 0.0 110.001 174.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.507 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 23.9 pt -137.21 -173.15 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.179 -177.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.75 176.5 46.84 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.649 -174.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.8 p -75.08 -32.75 61.54 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.596 -0.355 . . . . 0.0 111.726 -176.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -109.72 16.01 22.38 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.981 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 60.7 m 61.71 30.19 18.36 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.634 175.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.05 2.86 61.8 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.733 -1.223 . . . . 0.0 113.112 -174.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.507 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 0.0 OUTLIER -109.72 103.93 54.27 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 117.434 0.617 . . . . 0.0 110.192 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.89 149.82 26.39 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.468 2.112 . . . . 0.0 112.553 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 149' ' ' VAL . 8.2 p -80.07 105.14 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 122.118 0.961 . . . . 0.0 112.179 -174.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.8 m -80.69 82.41 6.7 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.958 173.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.496 ' HB2' HD22 ' A' ' 164' ' ' ASN . 2.9 mt-10 -51.04 -64.91 0.66 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -175.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 31.2 m -97.07 9.55 41.77 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.083 0.468 . . . . 0.0 110.862 -166.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 80.23 131.67 0.99 Allowed Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.333 -174.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.536 ' O ' HD23 ' A' ' 155' ' ' LEU . 85.7 m -72.21 159.43 34.11 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.323 -0.939 . . . . 0.0 108.881 172.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.651 HD12 ' O ' ' A' ' 176' ' ' GLN . 76.6 mt -141.79 164.35 30.43 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.719 0.295 . . . . 0.0 110.517 -167.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.451 ' HB2' ' CZ ' ' A' ' 172' ' ' PHE . 10.5 t30 52.0 24.43 2.63 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.413 1.07 . . . . 0.0 111.364 -166.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.05 38.41 95.96 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.39 -173.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.14 -151.6 0.45 Allowed Glycine 0 CA--C 1.524 0.596 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.42 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -151.51 119.29 6.14 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 122.0 -0.706 . . . . 0.0 111.894 -175.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.27 125.76 22.06 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 176.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 165' ' ' ARG . 20.0 m -118.06 -39.36 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 120.615 0.245 . . . . 0.0 110.966 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.627 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -140.63 171.19 8.05 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.669 ' HD3' ' CE2' ' A' ' 140' ' ' TYR . 87.3 Cg_exo -52.02 110.69 0.47 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 121.872 1.714 . . . . 0.0 111.988 175.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.496 HD22 ' HB2' ' A' ' 151' ' ' GLU . 17.6 t-20 77.11 -14.35 0.85 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.97 0.908 . . . . 0.0 110.793 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.627 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 1.7 mtm-85 -86.65 88.51 7.68 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 121.19 0.519 . . . . 0.0 110.151 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 73.8 m -82.31 145.98 29.67 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.965 166.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -89.75 119.32 30.05 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 175.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 73.6 m -98.12 130.1 44.91 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.97 0.794 . . . . 0.0 111.249 -171.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 16.4 m -53.8 -56.86 13.73 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -167.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.441 ' HD2' ' N ' ' A' ' 171' ' ' GLY . 21.2 t80 -158.19 -86.51 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.131 -1.027 . . . . 0.0 112.332 -169.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.441 ' N ' ' HD2' ' A' ' 170' ' ' TYR . . . -90.76 44.64 2.88 Favored Glycine 0 CA--C 1.498 -1.028 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.378 -166.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.608 ' HB3' ' HA ' ' A' ' 177' ' ' CYS . 3.1 m-85 -118.69 129.49 55.31 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.401 173.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.719 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 7.4 t -103.4 141.44 35.95 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 94.59 124.65 4.16 Favored Glycine 0 C--N 1.298 -1.542 0 N-CA-C 107.916 -2.074 . . . . 0.0 107.916 -168.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -72.21 19.55 0.3 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.934 1.756 . . . . 0.0 113.175 -166.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.651 ' O ' HD12 ' A' ' 155' ' ' LEU . 45.2 tt0 -122.58 15.21 10.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 176.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.608 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.6 OUTLIER 28.68 56.37 0.11 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 117.314 2.339 . . . . 0.0 117.314 177.549 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -111.46 22.05 15.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 122.34 1.066 . . . . 0.0 108.873 167.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.588 ' HD2' ' O ' ' A' ' 173' ' ' THR . 92.3 mtt180 -116.07 86.88 2.56 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.222 -1.353 . . . . 0.0 109.007 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.483 ' HA ' ' CE2' ' A' ' 172' ' ' PHE . 12.0 p-10 -85.63 48.63 1.62 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.547 -168.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.719 ' HE2' ' N ' ' A' ' 173' ' ' THR . 25.0 p90 -85.6 95.67 9.41 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -78.28 162.63 26.38 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 118.781 -2.449 . . . . 0.0 108.681 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 75.3 p -96.26 138.64 33.56 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.227 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -159.19 162.12 32.51 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.095 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -83.13 143.86 11.58 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.842 2.361 . . . . 0.0 111.889 173.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 4.9 t -96.71 115.82 28.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.959 0.409 . . . . 0.0 110.252 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . 0.425 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 19.5 m-85 -95.73 149.09 21.87 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.982 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.496 ' HA ' ' CB ' ' A' ' 215' ' ' ARG . 6.6 m -117.13 -15.08 10.53 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -167.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 26.2 t -145.66 114.35 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 O-C-N 121.176 -0.953 . . . . 0.0 110.709 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.594 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.5 mt -134.87 118.95 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -173.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.3 m -115.56 -166.84 1.17 Allowed 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 155.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -68.49 -5.06 17.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.761 0.791 . . . . 0.0 109.991 172.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -73.3 -74.01 0.19 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.353 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 62.3 mtt -149.67 160.68 43.32 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.594 ' HA ' HG12 ' A' ' 190' ' ' ILE . 55.5 m -89.52 -19.48 24.98 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.652 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.581 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 36.6 tt0 166.06 -85.9 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.204 171.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.436 ' H ' ' HB3' ' A' ' 196' ' ' GLN . . . 126.43 -27.24 5.04 Favored Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 171.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -82.25 69.16 8.93 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 167.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.424 ' H ' ' CD1' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -63.73 142.44 58.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.36 0.6 . . . . 0.0 111.023 -175.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 29.7 t -113.84 143.52 44.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.471 -175.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.95 22.28 8.38 Favored Glycine 0 CA--C 1.501 -0.783 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.179 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.758 HD12 ' HA ' ' A' ' 253' ' ' ILE . 1.5 tt -60.09 99.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 171.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 25.2 t -86.91 95.11 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.533 0 CA-C-O 123.918 1.818 . . . . 0.0 108.36 171.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.461 ' HB3' HD23 ' A' ' 208' ' ' LEU . 4.9 m -133.45 -179.03 5.26 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 111.123 -2.762 . . . . 0.0 106.072 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 27.5 p -103.29 166.74 10.25 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.131 -1.028 . . . . 0.0 112.323 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.655 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 21.9 tttp -61.13 -41.79 97.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.345 173.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 30.3 m -45.05 -52.04 9.4 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 114.515 -1.22 . . . . 0.0 109.409 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.633 HD11 HG11 ' A' ' 247' ' ' VAL . 8.6 tp -63.09 -49.27 75.15 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 112.53 -2.123 . . . . 0.0 110.606 -174.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . 0.442 ' CB ' ' HB2' ' A' ' 217' ' ' TRP . 88.0 m -68.51 -22.4 64.53 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.543 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 20.9 m -81.18 -45.2 16.72 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 123.681 0.613 . . . . 0.0 110.672 173.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.17 -52.35 35.55 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -172.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.619 HG22 ' HA2' ' A' ' 234' ' ' GLY . 17.7 p -105.56 152.78 22.65 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.198 177.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 1.4 t 67.55 -45.05 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 123.584 0.754 . . . . 0.0 112.218 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.671 ' O ' ' HD2' ' A' ' 215' ' ' ARG . . . 55.35 59.43 10.48 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 118.559 0.618 . . . . 0.0 114.499 173.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.671 ' HD2' ' O ' ' A' ' 214' ' ' GLY . 17.4 mmm180 -125.64 -75.98 0.59 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.226 0.513 . . . . 0.0 111.048 177.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.514 ' CB ' HD11 ' A' ' 190' ' ' ILE . . . -171.1 163.39 7.29 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 118.642 0.656 . . . . 0.0 109.88 174.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . 0.684 ' O ' ' HB2' ' A' ' 222' ' ' GLU . 19.1 t90 -158.81 142.77 15.37 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 106.15 179.03 23.41 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.144 -1.027 . . . . 0.0 113.954 170.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 220' ' ' PRO . 36.2 t-80 -135.52 133.44 20.33 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -177.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 219' ' ' HIS . 11.1 Cg_endo -89.6 118.36 3.64 Favored 'Cis proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.496 -1.46 . . . . 0.0 111.733 -4.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 68.7 m 45.17 88.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.684 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 12.3 mt-10 -107.27 107.23 18.06 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' MET . . . . . 0.46 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 0.6 OUTLIER -75.21 144.06 42.85 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.746 -166.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' CYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 216' ' ' ALA . 0.8 OUTLIER -123.53 120.95 26.85 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -174.144 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -62.14 167.04 11.47 Favored 'Trans proline' 0 CA--C 1.499 -1.239 0 C-N-CA 122.089 1.859 . . . . 0.0 110.563 159.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.35 -142.24 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 122.289 1.042 . . . . 0.0 110.397 163.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.37 106.37 0.65 Allowed Pre-proline 0 C--N 1.298 -1.668 0 CA-C-N 113.82 -1.536 . . . . 0.0 112.168 -169.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.1 -57.57 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.234 2.623 . . . . 0.0 112.87 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.403 ' HB3' ' HD2' ' A' ' 230' ' ' PRO . 48.0 m80 -95.99 162.8 22.73 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 229' ' ' HIS . 26.4 Cg_endo -64.31 83.27 0.15 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.135 1.89 . . . . 0.0 112.271 174.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' CYS . . . . . 0.429 ' SG ' ' HB2' ' A' ' 235' ' ' PHE . 34.1 t -157.91 152.67 25.12 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.196 -1.365 . . . . 0.0 107.504 177.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.583 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 24.0 mtt180 -64.04 131.68 48.29 Favored 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.101 -176.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -38.56 -45.95 1.13 Allowed 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -175.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.619 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -72.99 7.22 10.05 Favored Glycine 0 C--N 1.319 -0.385 0 C-N-CA 120.718 -0.753 . . . . 0.0 114.256 -173.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . 0.583 ' CD1' ' HB2' ' A' ' 232' ' ' ARG . 3.5 m-85 -122.28 150.66 42.02 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.942 0.877 . . . . 0.0 112.61 -171.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.464 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.1 OUTLIER -124.62 121.34 25.78 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 114.309 -1.314 . . . . 0.0 107.819 169.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.49 115.27 2.33 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.093 2.529 . . . . 0.0 112.26 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -50.62 137.9 18.89 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.853 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 41.8 mt -71.17 -16.34 19.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.207 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 -100.9 -62.46 1.24 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.617 0.722 . . . . 0.0 109.973 -174.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 32.2 p -80.18 -40.1 27.95 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.382 -176.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 98.05 8.26 55.52 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -90.81 127.03 36.2 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 121.852 0.834 . . . . 0.0 110.615 -177.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 235' ' ' PHE . 95.8 m -50.49 121.0 5.12 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 113.227 -1.806 . . . . 0.0 110.85 172.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -120.36 133.32 55.46 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.582 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 7.2 t70 -77.18 149.68 35.54 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -173.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.701 HG23 ' HG3' ' A' ' 249' ' ' GLU . 11.0 m -100.15 145.26 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -177.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -72.54 75.89 1.07 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 167.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.701 ' HG3' HG23 ' A' ' 247' ' ' VAL . 17.1 mp0 -53.24 -37.59 62.21 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.271 0.628 . . . . 0.0 110.654 -169.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 56.4 m -51.13 -35.83 37.56 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.096 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -100.43 -37.63 8.76 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.865 0.84 . . . . 0.0 110.246 -176.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.432 ' HB1' HD21 ' A' ' 208' ' ' LEU . . . -71.13 -17.72 62.55 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.374 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.8 HG22 ' HB3' ' A' ' 256' ' ' LEU . 5.3 mp -135.31 73.24 64.25 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 173.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.592 ' HD2' HG13 ' A' ' 202' ' ' ILE . 36.0 Cg_endo -62.65 124.28 13.85 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.509 2.139 . . . . 0.0 112.902 -170.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' A' ' 258' ' ' GLN . . . 95.18 -4.95 67.9 Favored Glycine 0 C--N 1.308 -0.995 0 CA-C-N 114.429 -1.259 . . . . 0.0 113.437 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.8 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.5 OUTLIER -68.03 -39.73 83.04 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 118.392 1.096 . . . . 0.0 110.0 -176.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 46.6 t -122.95 69.47 0.99 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.493 0.663 . . . . 0.0 109.281 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . 0.41 ' HB2' ' HA2' ' A' ' 255' ' ' GLY . 27.4 tp60 -107.46 16.04 24.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.964 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -87.55 -4.73 79.69 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.796 178.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -169.08 -137.61 2.29 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . 0.538 ' OD1' ' HE2' ' A' ' 272' ' ' LYS . 2.9 t-20 -88.66 156.82 18.8 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 9.1 t -145.79 125.12 13.04 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.427 ' HB ' ' HB2' ' A' ' 270' ' ' GLU . 7.6 mt -130.05 165.74 29.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 -174.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.562 ' ND2' ' HB3' ' A' ' 269' ' ' PHE . 0.8 OUTLIER -132.2 121.49 23.76 Favored 'General case' 0 CA--C 1.494 -1.177 0 C-N-CA 117.461 -1.695 . . . . 0.0 114.627 -177.051 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.1 t -105.83 159.83 15.71 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.777 167.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.558 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 35.7 m -72.28 121.4 22.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.451 ' HA2' ' HE1' ' A' ' 235' ' ' PHE . . . 114.42 -30.77 6.78 Favored Glycine 0 C--N 1.316 -0.547 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.423 -169.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.0 m -179.22 163.97 1.34 Allowed 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 118.383 1.091 . . . . 0.0 110.164 -169.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . 0.562 ' HB3' ' ND2' ' A' ' 264' ' ' ASN . 34.9 p90 -104.7 153.24 21.52 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.803 174.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . 0.427 ' HB2' ' HB ' ' A' ' 263' ' ' ILE . 13.9 mt-10 -108.27 118.2 36.13 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.454 -175.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 99.5 m -105.71 160.52 15.15 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.415 0.626 . . . . 0.0 110.372 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.538 ' HE2' ' OD1' ' A' ' 261' ' ' ASN . 46.2 mtmt -138.69 123.27 18.52 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.194 176.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 68.0 m -99.45 137.28 20.28 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.091 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.459 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 86.3 Cg_exo -48.94 152.71 4.41 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.913 2.409 . . . . 0.0 111.055 170.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -48.96 134.27 17.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.054 0.454 . . . . 0.0 111.811 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 88.63 -36.21 3.48 Favored Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.53 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' HIS . . . . . 0.546 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 24.4 m-70 -71.1 156.99 38.95 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.565 0.698 . . . . 0.0 111.329 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -140.94 129.26 22.37 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.924 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 42.4 tp -62.18 125.24 23.21 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.423 0.63 . . . . 0.0 111.016 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.593 ' OD1' ' HB ' ' A' ' 282' ' ' VAL . 22.0 t-20 -111.52 97.16 6.54 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -64.6 -15.73 61.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.455 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.593 ' HB ' ' OD1' ' A' ' 280' ' ' ASN . 48.1 t -57.58 -29.39 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 120.83 0.348 . . . . 0.0 110.416 173.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.604 ' O ' ' HG3' ' A' ' 285' ' ' LYS . 19.5 p -142.47 25.75 1.83 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.543 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 0.586 ' HB2' ' O ' ' A' ' 256' ' ' LEU . 79.0 mm-40 28.57 41.93 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -167.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . 0.604 ' HG3' ' O ' ' A' ' 283' ' ' SER . 90.7 mttt -115.65 135.72 53.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.306 0.575 . . . . 0.0 111.836 -173.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 94.1 m -87.61 112.45 22.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.825 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 10.8 tp10 . . . . . 0 N--CA 1.433 -1.289 0 CA-C-O 118.12 -0.943 . . . . 0.0 108.499 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.8 p . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 120.752 0.31 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.27 -34.81 78.2 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.154 0.502 . . . . 0.0 110.26 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 34.0 m -103.14 46.9 0.9 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.962 176.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -59.54 143.11 51.11 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.218 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.1 m -82.74 -22.89 34.23 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.542 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 79.8 mt -95.93 118.59 42.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.558 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -92.02 138.11 31.81 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.428 174.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -89.24 -3.2 58.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.751 -172.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 33.6 t -147.75 149.55 32.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.969 0.414 . . . . 0.0 110.637 176.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -107.08 -50.95 3.0 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.749 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.402 ' HB ' ' H ' ' A' ' 122' ' ' ARG . 37.7 pt -86.14 -161.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.409 -173.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.402 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -128.89 136.07 49.93 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.986 178.437 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.537 ' SG ' ' HA ' ' A' ' 129' ' ' CYS . 72.0 m -117.69 152.76 34.59 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.803 0.335 . . . . 0.0 111.817 -176.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 76.9 mtp -133.95 167.33 20.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.831 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 61.2 53.18 3.64 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 172.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.587 ' O ' ' HG3' ' A' ' 137' ' ' GLN . . . 64.0 30.0 76.48 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.304 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -99.09 125.86 8.72 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.009 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.559 ' HB2' ' HB2' ' A' ' 135' ' ' LEU . 18.7 m -74.16 125.58 28.67 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.819 0.342 . . . . 0.0 110.415 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.537 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 4.4 t -76.39 100.15 5.08 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.34 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.1 m -130.68 122.82 28.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -177.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.6 t70 49.75 -113.32 0.63 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -122.95 39.96 3.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.874 0.845 . . . . 0.0 109.455 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -166.11 167.28 16.48 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.527 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 78.7 m -115.78 124.05 49.77 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.985 -174.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 128' ' ' SER . 91.9 mt -86.49 97.3 10.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.09 0.948 . . . . 0.0 110.014 174.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 56.5 m -76.02 152.47 36.93 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 114.596 -1.184 . . . . 0.0 112.119 -170.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.587 ' HG3' ' O ' ' A' ' 126' ' ' GLY . 41.9 mt-30 -78.81 158.4 28.19 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 170.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -67.16 111.61 4.01 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 122.73 1.252 . . . . 0.0 112.105 -171.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 125.63 0.44 7.84 Favored Glycine 0 C--N 1.295 -1.745 0 CA-C-N 112.41 -2.177 . . . . 0.0 111.362 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.667 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 91.3 m-85 -118.81 138.88 52.39 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.14 0.495 . . . . 0.0 111.764 174.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.416 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 34.7 pt -132.71 -174.43 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.41 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.67 -170.81 34.04 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.904 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.1 p -77.83 -44.11 28.37 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.918 0.389 . . . . 0.0 111.7 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -111.35 21.12 16.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.084 -176.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 27.2 m 66.51 27.24 9.77 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 124.009 0.818 . . . . 0.0 110.551 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.2 -4.13 88.4 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.859 -172.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.416 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 0.0 OUTLIER -117.57 110.11 41.03 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 118.292 1.046 . . . . 0.0 110.976 179.089 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.437 ' HB3' ' CE1' ' A' ' 140' ' ' TYR . 94.2 Cg_endo -80.78 149.89 18.37 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.978 2.452 . . . . 0.0 112.385 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 149' ' ' VAL . 14.3 p -83.12 103.74 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-O 121.702 0.763 . . . . 0.0 111.089 -172.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.22 88.13 5.5 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.636 171.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -57.94 -53.85 53.62 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -169.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 34.7 m -95.82 16.87 16.41 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.199 0.524 . . . . 0.0 111.112 -169.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 77.26 129.5 0.41 Allowed Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.3 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.405 ' O ' HD23 ' A' ' 155' ' ' LEU . 35.5 m -76.1 150.85 37.18 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.421 -1.389 . . . . 0.0 110.129 172.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.672 HD12 ' O ' ' A' ' 176' ' ' GLN . 76.7 mt -147.72 167.34 24.89 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.019 -168.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.676 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 2.3 t-20 48.87 27.02 1.46 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.03 -164.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 66.39 37.22 92.57 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.756 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -68.66 -150.87 0.33 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.64 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -157.35 126.76 6.0 Favored 'General case' 0 C--N 1.318 -0.761 0 O-C-N 122.191 -0.594 . . . . 0.0 111.214 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -67.28 120.19 13.4 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 175.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.819 HG22 ' HG2' ' A' ' 165' ' ' ARG . 1.0 OUTLIER -109.16 -43.77 6.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.211 179.232 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.639 ' HB3' ' HB3' ' A' ' 165' ' ' ARG . . . -134.28 170.77 10.42 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 173.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.667 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 75.7 Cg_exo -54.34 111.36 0.69 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.282 1.988 . . . . 0.0 112.681 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 69.91 -1.82 2.23 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.928 0.891 . . . . 0.0 110.736 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.819 ' HG2' HG22 ' A' ' 161' ' ' VAL . 5.7 ttp180 -93.45 89.24 6.23 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 121.5 0.667 . . . . 0.0 109.216 169.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 49.3 t -92.41 139.83 30.2 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.375 171.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -90.52 106.91 18.82 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 80.3 m -84.68 134.79 34.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.617 -171.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.406 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 28.6 m -55.21 -55.53 30.23 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -168.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -175.7 117.89 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.016 0.436 . . . . 0.0 111.328 -178.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 76.94 42.41 20.24 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.433 -0.803 . . . . 0.0 114.28 165.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.676 ' CE2' ' HB2' ' A' ' 156' ' ' ASN . 62.3 m-85 -120.93 140.31 52.02 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 117.59 0.695 . . . . 0.0 112.146 163.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.822 HG23 ' CE2' ' A' ' 181' ' ' TYR . 39.6 p -87.1 119.24 27.12 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.724 0.774 . . . . 0.0 110.617 -177.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' A' ' 176' ' ' GLN . . . 101.84 144.69 15.2 Favored Glycine 0 N--CA 1.425 -2.048 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.18 20.62 0.4 Allowed 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.162 1.241 . . . . 0.0 112.306 -172.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.672 ' O ' HD12 ' A' ' 155' ' ' LEU . 35.7 tt0 -113.73 1.04 14.73 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.789 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.672 ' HA ' ' CB ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 36.32 62.3 0.72 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 118.018 2.599 . . . . 0.0 118.018 178.044 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -120.63 1.04 10.55 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 119.869 -0.732 . . . . 0.0 111.835 174.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 32.7 mmt180 -106.62 100.35 9.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.335 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.665 ' HA ' ' CE1' ' A' ' 172' ' ' PHE . 1.3 m-20 -74.63 100.63 4.0 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.291 -170.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.822 ' CE2' HG23 ' A' ' 173' ' ' THR . 19.7 p90 -140.05 77.97 1.64 Allowed 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 172.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 63.5 mtt85 -73.3 127.43 32.63 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 118.597 -2.564 . . . . 0.0 108.503 175.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.401 HG22 ' CG1' ' A' ' 203' ' ' VAL . 3.9 p -78.13 164.52 24.91 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.978 -176.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.629 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . 157.29 142.31 3.37 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.651 -162.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.53 132.47 6.8 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.821 2.347 . . . . 0.0 112.096 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.767 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 76.8 m -90.86 112.05 23.72 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.408 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . 0.47 ' HB3' ' O ' ' A' ' 195' ' ' CYS . 82.3 m-85 -89.0 154.81 19.91 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.17 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.451 ' OG1' ' HG3' ' A' ' 196' ' ' GLN . 35.1 p -105.27 -18.86 13.99 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -165.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 p -167.95 118.28 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-N 118.889 0.768 . . . . 0.0 110.474 -174.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.501 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.1 mt -130.35 123.11 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -169.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.402 ' C ' ' H ' ' A' ' 193' ' ' GLN . 15.1 m -126.44 -166.48 1.58 Allowed 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 162.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -61.08 -8.2 3.19 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.321 0.964 . . . . 0.0 110.251 174.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.402 ' H ' ' C ' ' A' ' 191' ' ' SER . 96.3 mt-30 -75.66 -76.05 0.16 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.114 -175.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.429 ' O ' ' HA ' ' A' ' 190' ' ' ILE . 70.7 mtm -144.42 168.58 19.76 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.501 ' HA ' HG12 ' A' ' 190' ' ' ILE . 67.6 m -86.67 -36.54 18.68 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 122.335 1.064 . . . . 0.0 109.292 175.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.451 ' HG3' ' OG1' ' A' ' 188' ' ' THR . 54.8 tt0 -148.14 -67.44 0.24 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.731 173.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 123.69 -0.26 9.28 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.508 171.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -119.0 -19.8 8.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.343 -0.428 . . . . 0.0 111.076 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 63.24 97.11 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.222 0.534 . . . . 0.0 111.077 -176.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 42.4 t -113.68 140.18 48.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.709 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -94.08 25.68 20.79 Favored Glycine 0 CA--C 1.505 -0.533 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.986 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.628 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -61.72 107.0 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 121.989 0.9 . . . . 0.0 109.388 174.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.401 ' CG1' HG22 ' A' ' 183' ' ' THR . 3.0 t -98.27 120.98 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 CA-C-O 122.734 1.254 . . . . 0.0 110.193 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 14.3 t -152.91 -178.76 7.11 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 103.137 -2.912 . . . . 0.0 103.137 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.707 HG21 ' HA ' ' A' ' 181' ' ' TYR . 8.0 p -102.38 161.44 13.7 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 121.197 1.817 . . . . 0.0 108.763 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.632 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 53.6 tttm -57.24 -43.22 82.73 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.997 177.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.5 m -47.9 -54.96 11.0 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.925 175.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.549 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -58.37 -55.07 39.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.716 179.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 65.8 m -74.45 -20.95 59.83 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -170.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 226' ' ' ALA . 80.0 m -90.22 -38.81 13.19 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 121.878 -0.514 . . . . 0.0 110.595 176.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . 0.533 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . . . -67.74 -57.73 5.84 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.716 HG22 ' HA2' ' A' ' 234' ' ' GLY . 3.4 p -92.53 160.81 14.87 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.385 -1.279 . . . . 0.0 107.765 175.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 27.3 m 58.01 -35.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 125.196 1.398 . . . . 0.0 114.668 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 58.11 60.45 8.93 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 119.548 1.067 . . . . 0.0 114.8 167.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.401 ' HE ' ' HA ' ' A' ' 188' ' ' THR . 0.0 OUTLIER -118.85 -95.02 0.49 Allowed 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.356 175.476 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.405 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -164.02 163.17 23.41 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 174.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . 0.767 ' HD1' ' SG ' ' A' ' 186' ' ' CYS . 17.7 t90 -151.45 146.33 25.85 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 121.56 -0.712 . . . . 0.0 109.794 -174.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 221' ' ' CYS . . . 86.75 -179.93 48.97 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.167 -0.539 . . . . 0.0 113.774 171.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.646 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 8.9 p80 -141.28 131.1 12.89 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 175.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.646 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 10.5 Cg_endo -53.63 149.51 16.15 Favored 'Cis proline' 0 C--N 1.352 0.763 0 C-N-CA 123.772 -1.345 . . . . 0.0 111.856 -5.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 22.2 m -63.43 83.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.775 0.672 . . . . 0.0 112.52 -170.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -58.55 123.0 14.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.63 0.252 . . . . 0.0 110.619 173.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' MET . . . . . 0.405 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 0.0 OUTLIER -107.36 147.32 30.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.259 -175.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 18.8 m -142.0 148.51 49.02 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -173.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -65.2 166.1 20.04 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.059 1.839 . . . . 0.0 109.151 156.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 210' ' ' CYS . . . -67.27 -107.32 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.314 0.578 . . . . 0.0 111.564 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' GLN . . . . . 0.482 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . 0.7 OUTLIER -58.07 113.05 5.69 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.325 -172.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.533 ' HD3' ' HA ' ' A' ' 211' ' ' ALA . 18.8 Cg_endo -89.9 -61.75 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.111 2.54 . . . . 0.0 112.526 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.5 ' HB3' ' HD2' ' A' ' 230' ' ' PRO . 78.6 m-70 -78.73 163.36 61.3 Favored Pre-proline 0 CA--C 1.514 -0.44 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 229' ' ' HIS . 59.1 Cg_endo -72.79 52.69 2.18 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.753 1.636 . . . . 0.0 112.865 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 50.9 m -123.67 -178.0 3.9 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 171.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.636 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 26.0 mmt180 -76.72 142.18 40.58 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.169 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.451 ' CA ' ' HB3' ' A' ' 227' ' ' GLN . 32.5 ptt-85 -38.5 -40.37 0.56 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.716 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -75.15 5.56 33.29 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.626 -176.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . 0.636 ' CD1' ' HB2' ' A' ' 232' ' ' ARG . 2.0 m-85 -120.88 154.85 35.29 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.971 0.891 . . . . 0.0 112.493 -171.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.454 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.1 OUTLIER -128.39 130.5 23.54 Favored Pre-proline 0 N--CA 1.441 -0.877 0 CA-C-N 113.982 -1.463 . . . . 0.0 108.152 170.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -61.15 112.86 1.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.001 1.8 . . . . 0.0 111.126 175.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -48.02 135.06 13.17 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.719 0.771 . . . . 0.0 110.678 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 23.6 mt -71.21 -12.52 16.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.496 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -107.96 -59.45 1.84 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.395 0.617 . . . . 0.0 110.677 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 33.7 p -81.68 -39.81 23.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.187 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 100.32 4.18 55.18 Favored Glycine 0 N--CA 1.435 -1.367 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -84.5 126.96 33.76 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 121.853 0.835 . . . . 0.0 110.634 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 7.4 m -55.61 120.16 6.81 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.716 172.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -126.85 132.89 50.85 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 7.3 t70 -77.8 147.42 35.25 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 121.447 0.641 . . . . 0.0 109.632 -175.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.756 HG23 ' HG3' ' A' ' 249' ' ' GLU . 10.4 m -97.83 145.09 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.281 -177.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -74.28 76.86 1.84 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 168.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.756 ' HG3' HG23 ' A' ' 247' ' ' VAL . 28.2 mp0 -52.11 -37.8 55.3 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 124.021 0.826 . . . . 0.0 109.946 -171.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 42.6 m -47.7 -36.4 11.2 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.824 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -102.4 -42.88 5.84 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.685 0.755 . . . . 0.0 110.319 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -63.84 -23.07 67.21 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.8 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.71 ' O ' ' HB2' ' A' ' 256' ' ' LEU . 3.9 mp -124.05 88.2 52.74 Favored Pre-proline 0 N--CA 1.45 -0.434 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 174.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.415 ' O ' HG12 ' A' ' 202' ' ' ILE . 8.3 Cg_exo -73.1 142.46 34.35 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 121.301 1.334 . . . . 0.0 112.35 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 77.43 5.7 85.96 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.506 -170.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.71 ' HB2' ' O ' ' A' ' 253' ' ' ILE . 10.4 tp -53.24 -92.31 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 122.827 0.451 . . . . 0.0 111.285 175.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 22.9 t -96.08 61.52 2.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.502 0.668 . . . . 0.0 109.51 -175.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -86.6 51.9 2.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.628 0.728 . . . . 0.0 109.643 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.535 ' O ' ' HD3' ' A' ' 274' ' ' PRO . . . -137.6 28.35 2.76 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 272' ' ' LYS . . . 148.43 -133.24 4.5 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -177.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . 0.514 ' HB2' ' HB2' ' A' ' 272' ' ' LYS . 4.9 m-20 -103.28 158.02 16.61 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 177.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 42.7 t -142.76 124.44 14.98 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 50.6 mt -130.21 116.33 36.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.918 -167.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -76.23 120.4 21.45 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.85 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.7 t -107.21 158.77 16.85 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 158.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.504 ' HB ' ' CZ ' ' A' ' 235' ' ' PHE . 31.3 m -75.11 123.15 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 C-N-CA 118.612 -1.235 . . . . 0.0 108.498 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.615 ' N ' ' HE1' ' A' ' 235' ' ' PHE . . . 113.04 -24.22 13.07 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.669 -171.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.7 t 174.01 162.08 0.18 Allowed 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 117.471 0.636 . . . . 0.0 109.852 -172.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . 0.419 ' CE1' HD21 ' A' ' 256' ' ' LEU . 45.5 p90 -102.8 158.45 16.25 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 121.002 -1.061 . . . . 0.0 109.178 174.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -115.51 127.96 55.65 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . 0.417 ' HB2' HD22 ' A' ' 279' ' ' LEU . 56.7 m -100.43 152.01 20.86 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.529 0.68 . . . . 0.0 111.751 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.514 ' HB2' ' HB2' ' A' ' 261' ' ' ASN . 13.0 mmmm -121.59 100.42 7.0 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.08 171.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 286' ' ' CYS . 18.2 m -88.8 156.99 49.59 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.395 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.55 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 43.6 Cg_exo -58.07 156.03 31.2 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 121.831 1.687 . . . . 0.0 110.359 171.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -56.55 144.53 31.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.655 0.264 . . . . 0.0 110.842 -177.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.13 -32.69 3.48 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.237 -0.983 . . . . 0.0 111.968 -176.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' HIS . . . . . 0.55 ' HB2' ' O ' ' A' ' 274' ' ' PRO . 14.6 m-70 -72.42 154.69 40.75 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.06 0.457 . . . . 0.0 111.283 -175.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -137.68 121.27 17.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.862 -174.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.417 HD22 ' HB2' ' A' ' 271' ' ' CYS . 35.2 tp -69.52 136.95 52.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.114 0.483 . . . . 0.0 111.672 -175.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -124.11 100.51 6.75 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 171.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -65.16 -14.19 59.98 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.951 0.782 . . . . 0.0 112.533 -172.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 73.5 t -58.43 -36.93 61.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.629 0.728 . . . . 0.0 109.874 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 31.3 m -134.08 30.49 3.63 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.398 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 23.51 50.52 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 114.135 -1.393 . . . . 0.0 113.164 -172.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -102.36 130.79 49.2 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.439 -174.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 273' ' ' CYS . 33.3 m -94.87 97.8 10.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.652 173.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.435 ' HA ' ' ND1' ' A' ' 277' ' ' HIS . 38.5 tt0 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.668 -0.682 . . . . 0.0 109.305 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.9 p . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.677 0.275 . . . . 0.0 111.526 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.55 105.97 5.8 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.816 0.341 . . . . 0.0 111.307 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.3 p -160.66 -57.58 0.05 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.207 176.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -172.46 156.4 3.71 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 52.1 m -73.45 71.89 1.33 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.459 0.647 . . . . 0.0 111.075 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.451 ' O ' HG12 ' A' ' 116' ' ' ILE . 14.6 tt -155.81 25.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.295 178.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -92.16 64.27 4.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.144 -174.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -135.03 85.93 2.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.307 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 23.8 p -151.89 -169.62 3.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.577 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -120.73 -56.56 1.94 Allowed 'General case' 0 CA--C 1.498 -1.023 0 CA-C-O 121.598 0.713 . . . . 0.0 109.992 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 33.7 pt -79.24 -168.68 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 114.415 -1.266 . . . . 0.0 113.352 -170.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.605 ' HD2' ' N ' ' A' ' 122' ' ' ARG . 2.0 mpt_? -118.95 122.79 43.05 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.91 -173.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.637 ' SG ' ' HA ' ' A' ' 129' ' ' CYS . 60.2 m -115.09 129.59 56.72 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.697 0.284 . . . . 0.0 110.973 -176.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.0 mtm -126.28 169.8 12.53 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.199 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 65.23 45.85 2.84 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.188 0.518 . . . . 0.0 111.121 174.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.666 ' HA3' ' OE1' ' A' ' 137' ' ' GLN . . . 70.1 27.15 73.34 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.114 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -96.21 126.87 8.96 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 119.608 -1.282 . . . . 0.0 111.1 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.436 ' HB3' ' HB2' ' A' ' 135' ' ' LEU . 4.9 t -77.89 130.64 36.85 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 117.222 0.511 . . . . 0.0 109.941 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.637 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 17.0 t -85.97 108.93 18.43 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -176.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.9 m -130.51 127.44 39.14 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.842 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.6 t70 53.98 -109.85 0.51 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.202 0.525 . . . . 0.0 111.359 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -126.15 36.13 4.56 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -157.29 171.18 20.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.525 -177.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 79.6 m -123.19 124.07 42.21 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.103 -174.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.436 ' HB2' ' HB3' ' A' ' 128' ' ' SER . 97.9 mt -85.01 99.42 11.0 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 172.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 56.1 m -80.76 160.48 24.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.152 -170.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.666 ' OE1' ' HA3' ' A' ' 126' ' ' GLY . 53.9 mt-30 -81.0 143.65 32.37 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 167.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.7 tptm -68.34 111.39 4.58 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 122.768 1.27 . . . . 0.0 110.866 -175.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.403 ' HA2' ' CG1' ' A' ' 149' ' ' VAL . . . 135.93 -10.58 4.22 Favored Glycine 0 C--N 1.3 -1.429 0 CA-C-N 112.459 -2.155 . . . . 0.0 110.218 -173.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.534 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 90.6 m-85 -125.95 145.92 50.08 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 171.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.431 HG13 ' HB3' ' A' ' 147' ' ' GLN . 33.3 pt -141.41 -171.21 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 123.531 0.519 . . . . 0.0 110.376 -173.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 86.97 -174.08 45.51 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.254 -0.884 . . . . 0.0 112.369 -174.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.5 p -75.82 -34.36 60.13 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -110.78 12.44 22.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.034 -176.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 33.6 m 62.66 29.46 16.86 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 123.668 0.605 . . . . 0.0 110.258 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.17 -17.92 60.13 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.618 -172.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.431 ' HB3' HG13 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -99.69 120.91 56.23 Favored Pre-proline 0 C--N 1.326 -0.428 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.315 -174.754 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 147' ' ' GLN . 78.7 Cg_endo -88.7 140.63 4.31 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.933 2.422 . . . . 0.0 112.605 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 149' ' ' VAL . 10.1 p -66.52 105.29 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 122.25 1.024 . . . . 0.0 111.731 -173.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 76.84 6.8 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.989 175.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -52.41 -65.82 0.49 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -176.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 37.7 m -85.6 23.37 1.39 Allowed 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 120.728 0.299 . . . . 0.0 111.63 -171.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 106.43 -101.6 1.79 Allowed Glycine 0 N--CA 1.436 -1.301 0 CA-C-O 122.21 0.895 . . . . 0.0 113.049 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 148.43 131.43 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 111.368 -2.416 . . . . 0.0 105.004 -175.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 176' ' ' GLN . 21.4 mt -117.49 171.58 7.9 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -168.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.663 ' HB3' ' CZ ' ' A' ' 172' ' ' PHE . 0.2 OUTLIER 42.43 30.11 0.19 Allowed 'General case' 0 N--CA 1.478 0.944 0 O-C-N 124.426 1.079 . . . . 0.0 113.157 -172.374 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.8 39.37 91.35 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 119.951 -1.118 . . . . 0.0 111.955 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -74.63 -144.54 0.98 Allowed Glycine 0 CA--C 1.511 -0.21 0 CA-C-N 115.426 -0.387 . . . . 0.0 113.685 -173.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.558 ' HG2' ' HB3' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -154.28 130.52 10.41 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.8 m -67.41 115.57 7.18 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 122.312 -0.242 . . . . 0.0 110.891 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 165' ' ' ARG . 3.7 m -101.43 -37.02 5.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.974 176.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.635 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -139.78 172.67 6.03 Favored Pre-proline 0 C--O 1.233 0.235 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.534 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 76.4 Cg_exo -54.09 107.1 0.19 Allowed 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.421 2.081 . . . . 0.0 112.869 176.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 70.52 8.68 6.69 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.044 0.938 . . . . 0.0 110.238 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.635 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 1.4 mmt180 -103.06 81.66 1.99 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.822 176.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 12.6 t -81.34 146.17 30.49 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 173.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.558 ' HB3' ' HG2' ' A' ' 159' ' ' ARG . . . -98.68 147.86 24.42 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.427 ' HA ' HD21 ' A' ' 156' ' ' ASN . 14.4 m -111.41 124.66 52.71 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 124.775 1.297 . . . . 0.0 112.66 -160.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.635 ' H ' ' ND2' ' A' ' 156' ' ' ASN . 64.5 m -51.99 -54.46 29.57 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -154.84 -86.37 0.05 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 118.516 -1.274 . . . . 0.0 113.746 -165.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -92.11 39.6 3.0 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 119.651 -1.262 . . . . 0.0 112.826 -167.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.663 ' CZ ' ' HB3' ' A' ' 156' ' ' ASN . 9.1 m-85 -120.7 126.23 49.67 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 119.522 -0.871 . . . . 0.0 113.036 176.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.62 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 4.7 t -93.37 164.81 13.07 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 164.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.28 132.63 5.51 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.54 2.9 4.69 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 121.198 1.265 . . . . 0.0 112.962 -167.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.468 ' O ' HD12 ' A' ' 155' ' ' LEU . 47.9 tt0 -118.68 4.34 11.63 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.325 0.584 . . . . 0.0 110.661 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 39.32 50.6 2.0 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -177.284 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -106.03 -12.37 15.81 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.476 0.655 . . . . 0.0 110.321 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -60.85 -67.41 0.4 Allowed 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.802 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.8 t70 79.59 81.96 0.06 Allowed 'General case' 0 CA--C 1.509 -0.603 0 O-C-N 123.775 0.672 . . . . 0.0 109.445 163.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.62 ' HE2' ' N ' ' A' ' 173' ' ' THR . 37.0 p90 -102.42 66.06 0.96 Allowed 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 172.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -46.97 119.52 2.58 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 113.479 -1.691 . . . . 0.0 109.869 172.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.487 ' HB ' HG22 ' A' ' 203' ' ' VAL . 64.6 p -84.39 136.91 33.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.809 -172.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.495 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -158.27 145.79 12.27 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.86 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.41 ' HB3' ' O ' ' A' ' 200' ' ' SER . 39.5 Cg_exo -59.92 139.87 90.17 Favored 'Trans proline' 0 CA--C 1.529 0.232 0 C-N-CA 122.268 1.979 . . . . 0.0 111.47 171.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 5.8 t -96.44 133.94 40.23 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.123 -174.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . 0.574 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 24.4 m-85 -110.32 130.81 55.48 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.481 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.567 ' O ' ' HG2' ' A' ' 215' ' ' ARG . 48.9 p -112.52 -4.34 14.2 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -168.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 p -168.58 116.85 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 118.991 0.814 . . . . 0.0 111.504 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.696 HD11 ' CB ' ' A' ' 216' ' ' ALA . 3.7 mt -117.07 119.32 61.61 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -169.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 45.7 t -104.54 156.45 17.95 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 145.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -50.43 -31.26 14.58 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 119.988 1.267 . . . . 0.0 109.702 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -56.17 -59.22 5.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 113.526 -1.67 . . . . 0.0 111.591 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 5.7 mmt -136.87 126.12 24.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.559 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.554 ' HA ' HG12 ' A' ' 190' ' ' ILE . 79.9 m -76.79 -19.24 57.81 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.87 0.843 . . . . 0.0 110.716 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -146.97 -68.6 0.25 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 171.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 125.06 -18.42 7.0 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -96.72 -41.87 8.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.705 -0.747 . . . . 0.0 110.068 177.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 67.62 84.85 0.15 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.477 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 185' ' ' PRO . 48.0 t -99.44 148.15 24.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.109 -177.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -92.59 22.29 34.05 Favored Glycine 0 CA--C 1.504 -0.626 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.771 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.594 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -60.61 110.99 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 167.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.487 HG22 ' HB ' ' A' ' 183' ' ' THR . 0.4 OUTLIER -107.02 97.22 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-O 124.081 1.896 . . . . 0.0 109.482 -173.344 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 13.7 t -119.38 -175.69 2.99 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 112.232 -2.258 . . . . 0.0 106.986 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 7.6 p -100.97 164.04 12.0 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 119.281 -0.968 . . . . 0.0 108.872 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.469 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 45.3 tttm -61.94 -45.95 91.47 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.994 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.9 m -45.24 -55.05 6.24 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.537 173.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.485 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -58.51 -54.5 46.28 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.988 179.262 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 19.1 m -68.95 -22.08 64.15 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 84.6 m -94.42 -33.83 12.98 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.1 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -73.69 -58.49 3.27 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.659 HG22 ' HA2' ' A' ' 234' ' ' GLY . 20.0 p -99.62 157.59 16.35 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.944 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.43 HG21 HG12 ' A' ' 253' ' ' ILE . 2.2 t 66.86 -46.69 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 122.855 0.462 . . . . 0.0 112.022 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 215' ' ' ARG . . . 80.6 178.96 52.56 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 114.68 0.632 . . . . 0.0 114.68 171.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.567 ' HG2' ' O ' ' A' ' 188' ' ' THR . 8.0 mpt_? 92.08 -73.94 0.01 OUTLIER 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.647 1.179 . . . . 0.0 112.844 170.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.696 ' CB ' HD11 ' A' ' 190' ' ' ILE . . . -172.8 165.86 5.27 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.069 1.304 . . . . 0.0 111.855 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . 0.495 ' CZ2' ' HA3' ' A' ' 184' ' ' GLY . 22.0 t90 -150.9 149.2 29.36 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.869 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 77.74 166.32 27.32 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 115.674 1.03 . . . . 0.0 115.674 167.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.492 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 77.7 m-70 -122.32 134.62 24.92 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 114.706 -0.747 . . . . 0.0 109.755 175.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 22.7 Cg_exo -65.37 155.85 77.79 Favored 'Cis proline' 0 C--N 1.347 0.46 0 C-N-CA 123.287 -1.547 . . . . 0.0 111.225 -2.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 33.7 t -52.14 115.61 1.8 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.322 -171.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -107.66 115.01 29.39 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 13.3 ttp -89.03 138.85 31.04 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.43 -172.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 84.0 m -128.08 122.8 22.34 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -54.03 166.26 1.63 Allowed 'Trans proline' 0 CA--C 1.515 -0.462 0 C-N-CA 123.609 2.873 . . . . 0.0 113.622 165.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -39.09 106.7 0.06 Allowed 'General case' 0 CA--C 1.504 -0.801 0 O-C-N 123.962 0.789 . . . . 0.0 111.214 163.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 31.4 85.75 0.14 Allowed Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 111.633 -2.531 . . . . 0.0 111.99 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -39.57 -58.61 0.81 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.874 3.049 . . . . 0.0 115.182 -170.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -78.58 156.09 78.25 Favored Pre-proline 0 CA--C 1.515 -0.385 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -68.61 91.57 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.773 1.648 . . . . 0.0 112.474 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' CYS . . . . . 0.461 ' HB2' ' HG3' ' A' ' 237' ' ' PRO . 42.7 t -163.85 179.21 7.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.787 -177.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.743 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 22.6 mmm-85 -92.75 140.22 29.74 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.433 ' O ' HG22 ' A' ' 212' ' ' THR . 22.1 ptt85 -41.31 -57.14 2.23 Favored 'General case' 0 C--O 1.218 -0.574 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -175.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.659 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -67.52 6.79 2.33 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 115.123 0.809 . . . . 0.0 115.123 -174.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . 0.743 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 2.1 m-85 -131.07 173.47 10.98 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 118.238 1.019 . . . . 0.0 111.828 -174.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.544 HD13 ' O ' ' A' ' 235' ' ' PHE . 0.2 OUTLIER -135.48 130.56 19.04 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 113.562 -1.654 . . . . 0.0 107.504 172.021 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.461 ' HG3' ' HB2' ' A' ' 231' ' ' CYS . 27.0 Cg_exo -61.01 113.82 1.9 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 121.95 1.766 . . . . 0.0 111.641 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -50.71 132.21 26.02 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.669 0.747 . . . . 0.0 110.964 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 19.6 mt -76.48 -2.01 3.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.024 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 240' ' ' ARG . 43.1 mtm180 -104.43 -57.59 2.01 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.301 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 31.5 p -95.2 -45.36 7.22 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.366 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 104.11 12.64 28.99 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -95.45 131.35 41.7 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 122.009 0.909 . . . . 0.0 110.352 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 77.8 m -49.08 112.25 0.6 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 113.261 -1.791 . . . . 0.0 110.495 167.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -116.84 134.49 54.71 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.624 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 10.9 t70 -75.84 145.36 40.66 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 121.635 0.731 . . . . 0.0 111.122 -170.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.716 HG23 ' HG3' ' A' ' 249' ' ' GLU . 4.5 m -98.23 145.19 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.87 177.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -75.85 78.13 2.76 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 169.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.716 ' HG3' HG23 ' A' ' 247' ' ' VAL . 22.7 mp0 -53.03 -36.06 60.14 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 123.747 0.654 . . . . 0.0 110.017 -172.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 24.6 m -48.36 -39.15 21.2 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.432 173.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -96.45 -39.73 9.43 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.83 0.824 . . . . 0.0 110.313 -177.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -73.68 -20.25 60.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.202 -1.363 . . . . 0.0 111.757 -172.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.594 HG23 HD11 ' A' ' 202' ' ' ILE . 4.1 mp -121.83 81.5 41.82 Favored Pre-proline 0 N--CA 1.446 -0.672 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 253' ' ' ILE . 50.6 Cg_exo -24.02 -49.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.889 1 C-N-CA 127.169 5.246 . . . . 0.0 117.764 -170.516 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -124.93 28.99 5.03 Favored Glycine 0 CA--C 1.502 -0.745 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.906 -165.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.439 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -93.6 143.07 26.65 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.673 -0.764 . . . . 0.0 110.385 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 7.5 t 72.29 -72.27 0.12 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -169.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 60.02 -75.01 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.056 0.942 . . . . 0.0 113.202 175.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -75.48 71.18 1.85 Allowed Glycine 0 CA--C 1.508 -0.38 0 N-CA-C 111.694 -0.562 . . . . 0.0 111.694 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 154.54 -175.86 32.53 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -106.15 113.19 26.57 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 117.476 0.638 . . . . 0.0 109.774 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 48.7 t -89.3 133.15 34.59 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 46.5 mt -132.87 106.77 10.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.335 -174.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.753 ' ND2' ' HB3' ' A' ' 269' ' ' PHE . 0.9 OUTLIER -83.83 129.39 34.94 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -167.255 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.8 t -111.13 163.86 13.45 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.908 163.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.624 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 2.4 p -70.07 120.39 17.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.415 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.658 ' HA2' ' CE2' ' A' ' 235' ' ' PHE . . . 114.42 -33.38 5.43 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.61 -172.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 7.5 p -179.81 161.51 0.98 Allowed 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 117.822 0.811 . . . . 0.0 109.765 -172.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . 0.753 ' HB3' ' ND2' ' A' ' 264' ' ' ASN . 43.1 p90 -101.38 157.94 16.43 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.823 175.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -120.67 122.0 39.52 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 52.8 m -101.21 143.18 31.6 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.725 0.774 . . . . 0.0 111.682 -176.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -103.04 104.71 14.91 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.436 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 56.8 m -86.3 138.42 34.3 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.552 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.518 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 52.5 Cg_exo -56.28 162.52 7.62 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.548 2.165 . . . . 0.0 111.308 172.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -54.35 136.83 43.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.179 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.15 -26.78 4.22 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.74 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' HIS . . . . . 0.602 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 16.1 m-70 -78.34 157.85 28.99 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.28 0.562 . . . . 0.0 111.613 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -145.99 140.87 27.18 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.417 -175.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 51.0 tp -74.78 126.53 31.11 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.19 0.519 . . . . 0.0 109.681 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 284' ' ' GLN . 52.7 t30 -120.29 112.13 18.64 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -78.99 -6.75 57.08 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.721 0.638 . . . . 0.0 112.263 -173.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 39.0 t -58.07 -21.21 16.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.116 0.484 . . . . 0.0 110.564 168.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 284' ' ' GLN . 24.8 t -146.93 -15.16 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.183 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 283' ' ' SER . 16.9 mp0 73.74 52.62 0.11 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.369 1.067 . . . . 0.0 109.481 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -130.99 149.9 52.39 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.289 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 86.8 m -101.35 94.71 6.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.294 176.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.602 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 76.4 mm-40 . . . . . 0 C--O 1.253 1.238 0 CA-C-O 118.755 -0.64 . . . . 0.0 109.483 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 54.5 m . . . . . 0 N--CA 1.478 0.95 0 CA-C-O 120.859 0.361 . . . . 0.0 111.279 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.74 -42.47 28.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.161 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.4 p -75.09 115.62 14.92 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.733 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -73.0 -34.14 66.22 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.5 m -78.61 72.23 5.12 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 172.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.1 mt -58.48 115.7 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.346 -173.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -77.52 -25.78 50.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.554 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -92.83 -173.7 3.39 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.427 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 43.3 m -85.03 165.49 17.49 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.866 0.365 . . . . 0.0 110.069 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -123.91 -44.48 2.06 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.859 0.838 . . . . 0.0 110.33 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.658 HG13 ' SG ' ' A' ' 134' ' ' CYS . 0.2 OUTLIER -74.28 178.65 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.716 -178.76 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.624 ' H ' ' HD2' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -107.36 104.54 14.16 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.795 -175.459 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 72.4 m -100.47 117.07 33.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.272 0.558 . . . . 0.0 110.615 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.451 ' HB2' ' O ' ' A' ' 144' ' ' HIS . 25.0 mmm -117.57 158.99 23.62 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.36 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.414 ' HB2' ' HB3' ' A' ' 145' ' ' CYS . 5.0 m-20 63.22 41.82 7.59 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.118 0.886 . . . . 0.0 110.232 174.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 78.38 7.15 87.99 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.196 -0.911 . . . . 0.0 113.067 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -49.36 124.71 14.83 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.172 -0.537 . . . . 0.0 113.262 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.0 m -79.84 149.26 31.06 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.688 0.28 . . . . 0.0 110.377 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 12.2 t -83.53 101.53 11.5 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.8 m -125.95 134.41 51.54 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.734 -174.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 33.95 -98.12 0.02 OUTLIER 'General case' 0 C--N 1.35 0.609 0 O-C-N 124.87 1.356 . . . . 0.0 112.36 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -134.72 20.25 3.56 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.947 -0.47 . . . . 0.0 110.722 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.454 ' HA ' HD12 ' A' ' 121' ' ' ILE . 0.8 OUTLIER -149.08 141.42 24.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.338 0.59 . . . . 0.0 110.449 174.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.658 ' SG ' HG13 ' A' ' 121' ' ' ILE . 30.1 m -69.04 160.55 30.77 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.329 0.585 . . . . 0.0 112.342 -173.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 26.9 mt -123.74 129.82 51.68 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 1.5 m -70.81 163.79 26.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 122.205 1.002 . . . . 0.0 113.337 -172.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -95.13 157.23 15.98 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.447 -1.706 . . . . 0.0 107.348 172.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -61.38 109.11 1.06 Allowed 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 123.051 1.405 . . . . 0.0 110.879 -174.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 131.91 -12.36 5.34 Favored Glycine 0 C--N 1.287 -2.186 0 CA-C-N 112.573 -2.103 . . . . 0.0 111.793 173.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.548 ' HB2' ' SG ' ' A' ' 145' ' ' CYS . 89.7 m-85 -123.71 157.54 33.69 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 118.173 0.987 . . . . 0.0 110.993 173.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.475 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 30.6 pt -129.29 169.11 21.13 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.86 172.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.97 169.61 20.75 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.651 -176.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 134' ' ' CYS . 14.2 p -77.62 -47.12 20.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.625 0.213 . . . . 0.0 110.528 177.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.451 ' O ' ' HB2' ' A' ' 124' ' ' MET . 25.8 p-80 -88.04 2.81 50.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.236 0.541 . . . . 0.0 109.937 175.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.548 ' SG ' ' HB2' ' A' ' 140' ' ' TYR . 0.6 OUTLIER 61.93 44.69 8.09 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.667 171.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.22 8.65 55.64 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 119.641 -1.266 . . . . 0.0 112.493 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.475 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 0.0 OUTLIER -112.62 118.75 44.65 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.222 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -89.09 131.92 2.23 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.959 2.44 . . . . 0.0 113.725 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 149' ' ' VAL . 9.5 p -66.47 116.03 5.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.954 -178.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.629 ' HB3' ' SG ' ' A' ' 154' ' ' CYS . 0.0 OUTLIER -81.87 75.87 8.79 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.275 0.56 . . . . 0.0 109.844 171.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.98 -64.79 0.79 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.306 -0.861 . . . . 0.0 113.133 -171.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 55.8 m -91.88 19.03 6.98 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.158 0.504 . . . . 0.0 111.941 -168.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 80.73 120.29 0.44 Allowed Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.898 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' ' 150' ' ' CYS . 89.1 m -74.29 157.75 35.24 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 113.443 -1.378 . . . . 0.0 108.33 172.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.656 HD12 ' O ' ' A' ' 176' ' ' GLN . 76.9 mt -147.15 174.52 11.51 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -165.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.548 HD22 ' C ' ' A' ' 156' ' ' ASN . 0.2 OUTLIER 49.25 19.13 0.29 Allowed 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.274 0.984 . . . . 0.0 112.624 -172.159 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.6 37.29 93.45 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.247 -0.977 . . . . 0.0 111.949 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -80.76 -141.56 2.95 Favored Glycine 0 C--O 1.236 0.25 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.658 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -157.78 126.54 5.66 Favored 'General case' 0 C--O 1.218 -0.597 0 O-C-N 122.317 -0.519 . . . . 0.0 111.526 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.99 124.46 19.98 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 123.139 0.274 . . . . 0.0 111.142 176.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 165' ' ' ARG . 4.0 m -116.28 -35.3 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.191 0.519 . . . . 0.0 111.419 -178.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.61 ' HB3' ' CB ' ' A' ' 165' ' ' ARG . . . -137.11 175.86 3.18 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 174.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.541 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 22.9 Cg_exo -60.58 109.24 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 121.316 1.344 . . . . 0.0 111.889 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 71.73 3.23 4.59 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.591 1.156 . . . . 0.0 111.119 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.61 ' CB ' ' HB3' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -96.11 86.74 4.35 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.527 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 70.1 m -79.63 150.64 30.93 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.368 172.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.494 ' HB2' HG11 ' A' ' 161' ' ' VAL . . . -93.08 121.41 34.39 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 172.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 61.6 m -106.08 132.12 52.54 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.418 -175.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 89.6 m -60.78 -52.03 66.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.963 -1.471 . . . . 0.0 114.114 -164.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -161.76 -93.6 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 118.852 -1.139 . . . . 0.0 113.111 -170.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -85.44 55.19 4.89 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.878 -164.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.658 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 4.5 m-85 -124.48 137.89 54.39 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.832 171.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.64 ' OG1' ' HG3' ' A' ' 179' ' ' ARG . 27.0 p -88.32 121.07 30.29 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.508 176.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 99.82 134.11 8.37 Favored Glycine 0 N--CA 1.426 -1.967 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.91 9.59 1.31 Allowed 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 120.903 1.068 . . . . 0.0 112.431 -172.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.656 ' O ' HD12 ' A' ' 155' ' ' LEU . 39.2 tt0 -110.37 25.01 12.25 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 171.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.549 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.8 OUTLIER 18.69 71.76 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 173.345 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.577 ' O ' ' HD3' ' A' ' 179' ' ' ARG . 8.6 pt-20 -124.13 31.64 5.75 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.93 0.871 . . . . 0.0 110.604 172.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.658 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 24.0 mmt180 -135.71 93.25 2.92 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 113.729 -1.578 . . . . 0.0 108.582 177.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -87.67 61.32 6.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 122.045 0.926 . . . . 0.0 109.935 -171.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.563 ' CE2' HG23 ' A' ' 173' ' ' THR . 26.0 p90 -83.12 91.39 7.21 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 171.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -89.33 136.5 32.99 Favored 'General case' 0 N--CA 1.437 -1.077 0 O-C-N 119.988 -1.695 . . . . 0.0 107.186 -176.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 77.1 p -86.57 134.69 33.63 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.72 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -158.73 155.29 26.34 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.434 ' O ' ' HA ' ' A' ' 217' ' ' TRP . 12.2 Cg_exo -71.73 160.23 48.63 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.41 2.073 . . . . 0.0 111.904 175.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.487 ' H ' HG23 ' A' ' 202' ' ' ILE . 3.6 t -117.73 105.83 12.4 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -177.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . 0.747 ' O ' ' HB3' ' A' ' 215' ' ' ARG . 37.4 m-85 -100.21 135.87 40.97 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.633 -172.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.6 m -97.45 -21.43 17.15 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -167.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.421 ' HB ' ' HG3' ' A' ' 196' ' ' GLN . 54.6 t -149.47 115.29 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -171.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.485 HD13 ' HB3' ' A' ' 221' ' ' CYS . 3.1 mt -134.73 119.67 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -164.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.4 p -116.56 -167.36 1.27 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.103 159.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -71.65 -5.61 34.95 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.024 0.916 . . . . 0.0 109.152 171.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -83.58 -67.26 0.8 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.551 -174.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.595 ' HG2' ' H ' ' A' ' 196' ' ' GLN . 43.0 ttp -146.53 139.28 25.3 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.666 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.759 ' O ' ' HB2' ' A' ' 196' ' ' GLN . 68.2 m -84.52 -15.43 45.88 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.586 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.759 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 3.9 mm-40 92.94 -158.8 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.568 1.147 . . . . 0.0 112.106 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.415 ' H ' ' HB3' ' A' ' 196' ' ' GLN . . . 64.71 8.24 32.51 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.274 -0.876 . . . . 0.0 113.693 176.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 55.59 25.94 8.6 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.865 0.332 . . . . 0.0 110.642 -175.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 61.68 27.93 17.2 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.312 -176.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 39.2 t -70.95 137.41 49.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.951 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.36 57.99 3.49 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.342 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.585 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -61.16 109.83 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 170.087 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 5.4 t -89.08 116.11 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 CA-C-O 122.527 1.156 . . . . 0.0 111.348 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 19.7 t -151.68 -179.7 7.65 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.442 ' OG1' HD22 ' A' ' 208' ' ' LEU . 18.5 p -105.66 161.58 14.26 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 120.64 1.564 . . . . 0.0 109.27 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.59 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 46.2 tttm -59.21 -41.51 88.77 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.609 0.718 . . . . 0.0 109.534 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.7 m -46.88 -54.91 8.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.826 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.49 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -57.93 -51.36 69.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.253 179.124 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 64.4 m -62.8 -39.53 94.55 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.497 ' HA ' ' HB3' ' A' ' 224' ' ' CYS . 60.2 m -79.95 -29.86 39.76 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.716 -175.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -71.1 -60.9 1.98 Allowed 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.79 HG22 ' HA2' ' A' ' 234' ' ' GLY . 24.6 p -97.29 144.4 27.11 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.89 -174.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.537 HG21 ' CD1' ' A' ' 256' ' ' LEU . 1.5 t 59.73 -36.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 96.15 -105.7 3.27 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 120.655 1.57 . . . . 0.0 112.498 -177.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.747 ' HB3' ' O ' ' A' ' 187' ' ' PHE . 78.1 mtt180 55.27 -131.84 1.83 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.648 0.737 . . . . 0.0 110.847 177.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.572 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -160.09 169.43 23.37 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 175.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . 0.59 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 24.9 t90 -149.69 145.4 26.68 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.606 -173.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 81.8 -178.33 53.71 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-O 121.527 0.515 . . . . 0.0 114.237 172.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.544 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 86.9 m-70 -131.62 130.29 22.35 Favored Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.544 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 18.8 Cg_endo -57.03 156.1 28.53 Favored 'Cis proline' 0 C--N 1.353 0.774 0 C-N-CA 124.002 -1.249 . . . . 0.0 111.044 -4.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . 0.485 ' HB3' HD13 ' A' ' 190' ' ' ILE . 58.3 m -67.51 78.46 0.17 Allowed 'General case' 0 C--N 1.32 -0.683 0 O-C-N 123.579 0.549 . . . . 0.0 111.923 -173.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.414 ' O ' ' HB1' ' A' ' 216' ' ' ALA . 12.4 mm-40 -53.94 115.15 1.87 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.034 0.445 . . . . 0.0 110.853 173.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' MET . . . . . 0.572 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 0.0 OUTLIER -91.1 132.66 35.91 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.032 -174.016 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' CYS . . . . . 0.497 ' HB3' ' HA ' ' A' ' 210' ' ' CYS . 70.8 m -97.94 124.04 49.18 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -167.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -62.26 152.63 75.26 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 123.968 3.112 . . . . 0.0 113.65 165.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -39.84 103.5 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.125 0 CA-C-O 122.284 1.04 . . . . 0.0 112.043 162.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 18.24 102.46 0.02 OUTLIER Pre-proline 0 C--N 1.311 -1.106 0 CA-C-N 111.335 -2.666 . . . . 0.0 114.42 -175.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -52.93 -49.88 16.04 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.893 2.395 . . . . 0.0 112.196 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -85.5 111.2 35.26 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.19 64.91 7.0 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.071 2.514 . . . . 0.0 114.265 -172.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 81.0 m -96.69 -84.52 0.36 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 168.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.522 ' HB3' ' CD2' ' A' ' 235' ' ' PHE . 14.4 ttm180 -145.98 135.72 23.34 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 168.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -39.16 -39.53 0.61 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -174.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.79 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -80.82 9.34 52.69 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 120.279 -0.963 . . . . 0.0 113.947 -176.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . 0.65 ' HE2' ' N ' ' A' ' 267' ' ' GLY . 1.9 m-85 -121.96 152.38 39.75 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -168.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.55 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.0 OUTLIER -129.89 131.82 23.75 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 114.047 -1.433 . . . . 0.0 107.778 169.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 244' ' ' CYS . 19.1 Cg_exo -63.41 111.59 1.51 Allowed 'Trans proline' 0 C--O 1.238 0.496 0 C-N-CA 122.173 1.915 . . . . 0.0 111.238 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -55.42 127.57 30.22 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.057 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 40.4 pt -80.9 12.35 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.14 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -110.46 -39.55 4.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.612 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 78.6 p -111.98 -39.51 4.49 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.95 0.881 . . . . 0.0 110.336 -177.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 102.03 6.07 49.27 Favored Glycine 0 N--CA 1.437 -1.253 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -175.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -97.39 119.7 36.4 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-O 122.079 0.942 . . . . 0.0 110.493 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 237' ' ' PRO . 3.7 m -55.62 123.54 14.39 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.266 176.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.42 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 41.3 tt0 -123.36 143.51 50.06 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.705 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 8.1 t70 -78.49 145.92 34.69 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.109 0.481 . . . . 0.0 110.32 -178.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.729 HG23 ' HG3' ' A' ' 249' ' ' GLU . 5.3 m -94.97 145.57 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.872 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.35 77.07 1.87 Allowed 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 168.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.729 ' HG3' HG23 ' A' ' 247' ' ' VAL . 35.9 mp0 -53.12 -33.94 54.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 124.375 1.047 . . . . 0.0 110.198 -172.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 7.7 m -46.91 -41.28 15.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.523 173.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -98.79 -42.17 7.32 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.648 0.737 . . . . 0.0 110.302 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.01 -28.62 69.63 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.463 -174.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.655 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.7 mp -123.72 83.13 54.25 Favored Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 173.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.43 ' HG2' HG12 ' A' ' 202' ' ' ILE . 19.3 Cg_endo -57.6 122.96 12.67 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.767 2.311 . . . . 0.0 113.919 -166.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 65.41 27.03 72.06 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 113.554 -1.657 . . . . 0.0 113.435 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.655 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.3 OUTLIER -74.46 -28.85 61.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 118.108 0.954 . . . . 0.0 110.407 177.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . 0.514 ' HA ' ' HB3' ' A' ' 284' ' ' GLN . 51.5 t -85.97 86.76 7.35 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.776 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -74.16 -19.49 60.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.448 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -54.02 -50.3 55.68 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.348 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 175.73 -93.45 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.069 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -110.25 135.76 50.5 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 269' ' ' PHE . 40.4 t -104.44 134.16 48.1 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 175.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 25.5 mt -131.01 105.78 11.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -70.08 125.4 26.66 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.534 -170.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.655 HG23 ' O ' ' A' ' 268' ' ' SER . 0.1 OUTLIER -110.83 156.23 21.42 Favored 'General case' 0 C--O 1.256 1.398 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.865 155.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.705 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 3.9 m -74.44 127.14 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 C-N-CA 118.155 -1.418 . . . . 0.0 107.876 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.65 ' N ' ' HE2' ' A' ' 235' ' ' PHE . . . 111.28 -25.13 14.37 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.521 -172.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.655 ' O ' HG23 ' A' ' 265' ' ' THR . 27.5 t 173.56 152.61 0.09 Allowed 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.476 0.655 . . . . 0.0 109.613 -174.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . 0.478 ' HB2' ' SG ' ' A' ' 262' ' ' CYS . 35.8 p90 -102.78 155.96 17.97 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -110.54 129.75 55.72 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 33.7 m -102.65 134.2 46.4 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.771 177.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -115.81 128.44 55.84 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.404 -177.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 19.3 m -129.57 168.52 16.08 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.724 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.62 155.35 21.87 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.212 1.941 . . . . 0.0 110.904 165.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.56 159.67 21.21 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.889 0.376 . . . . 0.0 110.779 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 89.41 -33.15 4.43 Favored Glycine 0 CA--C 1.504 -0.65 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.325 -174.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -72.15 156.22 39.41 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 120.806 0.336 . . . . 0.0 111.12 -176.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . 0.654 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 60.5 mttp -137.06 129.2 29.5 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -174.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.552 HD12 ' O ' ' A' ' 285' ' ' LYS . 32.7 tp -77.35 143.45 38.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 122.035 0.922 . . . . 0.0 112.622 -169.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.469 ' OD1' ' HB ' ' A' ' 282' ' ' VAL . 20.9 t-20 -124.12 100.45 6.72 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 114.366 -1.288 . . . . 0.0 107.833 175.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -69.94 -9.72 56.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.118 0.485 . . . . 0.0 111.691 -174.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.469 ' HB ' ' OD1' ' A' ' 280' ' ' ASN . 62.0 t -64.2 -59.02 4.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-O 121.193 0.521 . . . . 0.0 110.095 174.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 13.8 p -116.41 27.47 9.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.408 -176.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 0.514 ' HB3' ' HA ' ' A' ' 257' ' ' CYS . 12.7 mp0 31.14 51.67 0.14 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.805 -170.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . 0.552 ' O ' HD12 ' A' ' 279' ' ' LEU . 85.2 tttt -106.79 171.36 7.41 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' CYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 25.5 p -160.6 114.79 2.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 118.018 0.372 . . . . 0.0 110.318 177.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 N--CA 1.441 -0.916 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -175.584 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -92.59 11.37 26.78 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.756 0.312 . . . . 0.0 111.468 -177.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.3 m -101.32 26.03 7.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.245 0.545 . . . . 0.0 110.681 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -118.34 158.75 24.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.809 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.0 t -80.35 77.87 7.09 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 174.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.439 HG22 ' HG3' ' A' ' 117' ' ' GLN . 41.6 mt -85.18 142.79 12.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.157 -177.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.439 ' HG3' HG22 ' A' ' 116' ' ' ILE . 24.5 mt-30 64.71 44.93 3.61 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.42 0.629 . . . . 0.0 110.775 -176.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -78.9 -24.9 43.84 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.097 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 16.9 p -75.15 -179.33 4.33 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.352 176.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -115.86 -55.28 2.44 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 132' ' ' ASP . 0.2 OUTLIER -65.97 -176.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -178.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.6 ' HD2' ' N ' ' A' ' 122' ' ' ARG . 0.2 OUTLIER -119.03 156.61 29.34 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.426 -178.156 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 86.7 m -117.35 137.02 52.73 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.785 0.326 . . . . 0.0 111.621 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 63.6 mtm -141.83 140.45 32.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.828 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 70.12 55.91 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.088 0.47 . . . . 0.0 111.898 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.541 ' O ' ' HG3' ' A' ' 137' ' ' GLN . . . 79.12 39.01 20.94 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.787 171.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.405 ' HA3' ' SG ' ' A' ' 134' ' ' CYS . . . -112.4 151.98 17.96 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 119.609 -1.281 . . . . 0.0 113.853 176.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.0 m -111.28 126.76 55.23 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 175.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 9.6 t -75.35 122.07 23.19 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 -171.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 69.9 m -139.59 133.91 31.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.05 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.3 t70 44.06 -105.64 0.09 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.625 0.77 . . . . 0.0 112.468 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.474 ' HA ' HD12 ' A' ' 121' ' ' ILE . 25.7 t70 -130.25 27.96 5.03 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.952 0.882 . . . . 0.0 109.731 177.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -157.95 121.49 4.01 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.646 0.736 . . . . 0.0 109.621 -177.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.405 ' SG ' ' HA3' ' A' ' 127' ' ' GLY . 44.8 t -85.72 134.93 33.93 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.205 -170.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 49.4 mt -83.07 126.17 32.27 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 72.3 m -102.33 149.17 24.61 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.436 -171.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.541 ' HG3' ' O ' ' A' ' 126' ' ' GLY . 51.3 mt-30 -69.17 152.55 44.98 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 170.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -59.37 114.63 2.76 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 122.28 1.038 . . . . 0.0 111.353 -176.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.507 ' HA3' ' HB3' ' A' ' 163' ' ' PRO . . . 117.23 3.89 16.69 Favored Glycine 0 C--N 1.3 -1.462 0 CA-C-N 112.838 -1.983 . . . . 0.0 111.447 -178.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.535 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 88.5 m-85 -126.38 145.94 50.26 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.442 -0.446 . . . . 0.0 109.995 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.483 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 31.8 pt -139.28 -178.15 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.758 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.697 -173.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.51 153.88 28.51 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.636 -168.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.0 p -64.55 -33.31 75.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.819 0.343 . . . . 0.0 111.788 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -110.87 28.1 9.04 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 79.1 m 56.69 -124.99 1.89 Allowed 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.029 -169.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.65 -39.69 2.55 Favored Glycine 0 C--N 1.292 -1.913 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.402 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.483 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 0.0 OUTLIER -99.88 118.91 60.91 Favored Pre-proline 0 C--O 1.219 -0.539 0 CA-C-N 117.828 0.814 . . . . 0.0 111.073 -174.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 147' ' ' GLN . 8.5 Cg_endo -87.21 139.68 5.28 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.966 2.444 . . . . 0.0 112.411 175.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 149' ' ' VAL . 10.7 p -71.15 103.29 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 122.261 1.029 . . . . 0.0 111.291 -175.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.38 74.39 9.36 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 121.668 -0.645 . . . . 0.0 110.153 175.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.419 ' HB2' ' ND2' ' A' ' 164' ' ' ASN . 40.2 mt-10 -54.3 -48.07 71.71 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -169.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 69.8 m -90.81 18.65 6.27 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.499 0.666 . . . . 0.0 110.546 -168.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 74.97 128.85 0.2 Allowed Glycine 0 N--CA 1.427 -1.926 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.676 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.411 ' SG ' ' SG ' ' A' ' 160' ' ' CYS . 1.7 m -77.34 154.63 32.63 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.186 -1.007 . . . . 0.0 109.316 172.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 176' ' ' GLN . 50.1 mt -148.93 158.89 44.51 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.663 -166.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.609 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 2.8 t-20 52.58 27.88 5.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.899 -163.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.18 36.4 93.18 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.667 -172.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -64.88 151.77 51.08 Favored Glycine 0 N--CA 1.437 -1.279 0 CA-C-O 122.226 0.904 . . . . 0.0 114.257 -175.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.5 ttt85 -96.31 117.76 31.47 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 113.739 -1.23 . . . . 0.0 112.006 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.411 ' SG ' ' SG ' ' A' ' 154' ' ' CYS . 3.7 m -62.83 126.18 26.48 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 165' ' ' ARG . 19.7 m -114.77 -41.82 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -176.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -138.26 175.49 3.33 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.535 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 17.1 Cg_exo -63.06 108.11 0.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 121.044 1.163 . . . . 0.0 111.721 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.419 ' ND2' ' HB2' ' A' ' 151' ' ' GLU . 6.8 t-20 74.4 16.17 3.36 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.703 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.535 ' O ' HG22 ' A' ' 161' ' ' VAL . 1.8 mtm180 -112.83 95.31 5.34 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.545 169.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 9.1 t -87.82 151.98 22.45 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.753 171.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.47 ' HB2' HG11 ' A' ' 161' ' ' VAL . . . -105.33 120.03 40.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.457 0.646 . . . . 0.0 109.639 177.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 63.7 m -74.88 124.12 26.31 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.002 -170.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.609 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 77.0 m -60.0 -41.43 92.07 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.455 177.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.48 ' CG ' ' N ' ' A' ' 171' ' ' GLY . 52.5 t80 -140.23 -131.04 0.11 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.296 -176.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.48 ' N ' ' CG ' ' A' ' 170' ' ' TYR . . . -80.82 57.9 4.78 Favored Glycine 0 N--CA 1.435 -1.416 0 CA-C-N 116.157 -0.474 . . . . 0.0 113.148 -165.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.591 ' HB3' ' HA ' ' A' ' 177' ' ' CYS . 4.3 m-85 -121.3 125.57 47.38 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 119.714 -0.795 . . . . 0.0 111.527 170.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.517 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 3.4 t -90.41 158.57 17.02 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 168.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 87.23 130.84 3.14 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -177.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -75.17 21.29 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 121.498 1.466 . . . . 0.0 114.23 -165.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.494 ' O ' HD12 ' A' ' 155' ' ' LEU . 38.2 tt0 -120.36 -6.34 9.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.458 0.647 . . . . 0.0 110.029 176.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.591 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.3 OUTLIER 42.81 49.82 5.09 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -175.449 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.434 ' HB3' ' CD1' ' A' ' 155' ' ' LEU . 6.4 pt-20 -106.27 -15.33 14.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.281 0.562 . . . . 0.0 109.664 174.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.414 ' O ' ' HB3' ' A' ' 180' ' ' ASP . 11.1 mmt85 -57.85 -68.64 0.22 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.183 -1.371 . . . . 0.0 109.062 -175.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' A' ' 179' ' ' ARG . 36.5 t70 78.98 73.76 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.395 0.617 . . . . 0.0 110.159 165.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.517 ' HE2' ' N ' ' A' ' 173' ' ' THR . 28.9 p90 -91.38 67.54 5.7 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.8 1.286 . . . . 0.0 107.704 172.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 21.2 ttp85 -40.1 124.24 1.81 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 112.664 -2.062 . . . . 0.0 110.791 173.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 54.2 p -88.19 139.4 30.54 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.063 -171.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -160.01 146.72 13.09 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.47 129.29 12.7 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.202 1.935 . . . . 0.0 111.609 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.71 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 85.3 m -81.24 117.51 21.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.966 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . 0.678 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 43.8 m-85 -92.99 153.82 18.51 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.098 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.658 HG23 ' HE ' ' A' ' 215' ' ' ARG . 85.5 m -118.21 -18.79 9.22 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -162.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.2 p -164.9 116.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 O-C-N 121.417 -0.802 . . . . 0.0 110.043 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.494 HD13 ' SG ' ' A' ' 221' ' ' CYS . 2.7 mt -127.01 121.59 58.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -164.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.469 ' OG ' ' HB3' ' A' ' 193' ' ' GLN . 31.0 p -107.89 177.15 4.9 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 153.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -66.72 -12.4 58.41 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 122.477 1.132 . . . . 0.0 108.597 173.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.469 ' HB3' ' OG ' ' A' ' 191' ' ' SER . 60.2 tp60 -78.21 -38.8 42.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.235 -176.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.433 ' O ' ' HA ' ' A' ' 190' ' ' ILE . 41.9 ttm -162.31 140.63 8.86 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 -175.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.486 ' HA ' HG12 ' A' ' 190' ' ' ILE . 79.1 m -91.34 -23.91 19.95 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.257 0.551 . . . . 0.0 111.654 -176.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.467 ' HB2' ' H ' ' A' ' 188' ' ' THR . 55.0 tt0 -157.45 -73.69 0.09 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 170.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 127.78 -32.74 3.41 Favored Glycine 0 C--N 1.321 -0.262 0 C-N-CA 120.159 -1.02 . . . . 0.0 111.798 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 199' ' ' LEU . 92.1 mt-30 -74.61 -44.92 48.35 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 122.166 0.187 . . . . 0.0 110.701 171.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 198' ' ' GLN . 3.9 mm? 72.04 132.03 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.825 0.703 . . . . 0.0 110.735 -176.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 47.3 t -141.5 152.14 43.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.711 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -108.3 22.12 27.54 Favored Glycine 0 CA--C 1.502 -0.72 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.498 HG21 ' HB3' ' A' ' 254' ' ' PRO . 0.0 OUTLIER -60.74 114.22 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 172.418 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.3 t -102.99 99.73 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 CA-C-O 122.803 1.287 . . . . 0.0 111.093 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 7.4 t -133.3 -178.12 4.84 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 172.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 20.3 p -96.46 163.6 12.98 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.486 -174.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.508 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 72.2 tttt -59.31 -43.61 92.62 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.418 176.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.3 m -47.2 -54.47 10.67 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.391 174.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.589 ' CD1' HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -54.04 -62.29 1.75 Allowed 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.816 177.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 25.6 m -68.64 -22.17 64.42 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.351 -0.539 . . . . 0.0 112.361 -169.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 61.8 m -96.09 -27.8 14.91 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.376 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . 0.484 ' HA ' ' CD ' ' A' ' 228' ' ' PRO . . . -66.59 -55.74 13.99 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 172.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.548 HG21 HD11 ' A' ' 253' ' ' ILE . 46.3 p -61.77 -154.04 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 112.519 -2.128 . . . . 0.0 112.405 176.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.413 HG21 HG21 ' A' ' 253' ' ' ILE . 36.0 m -36.89 -5.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.498 ' O ' ' HD3' ' A' ' 215' ' ' ARG . . . 70.3 -153.77 52.06 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 120.565 1.53 . . . . 0.0 114.556 172.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.658 ' HE ' HG23 ' A' ' 188' ' ' THR . 1.7 mpp_? 99.41 -82.59 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.045 1.338 . . . . 0.0 110.131 169.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.678 ' HB3' ' HB2' ' A' ' 187' ' ' PHE . . . -174.29 168.11 3.99 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 118.026 0.375 . . . . 0.0 110.126 174.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . 0.71 ' HD1' ' SG ' ' A' ' 186' ' ' CYS . 13.9 t90 -156.68 146.77 21.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 81.22 156.94 16.26 Favored Glycine 0 C--N 1.333 0.377 0 N-CA-C 114.63 0.612 . . . . 0.0 114.63 170.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.703 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 2.4 p-80 -130.91 136.29 28.67 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 172.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.703 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 73.2 Cg_exo -50.94 143.13 8.05 Favored 'Cis proline' 0 C--N 1.352 0.745 0 C-N-CA 124.64 -0.983 . . . . 0.0 113.297 -0.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . 0.494 ' SG ' HD13 ' A' ' 190' ' ' ILE . 7.9 t -49.71 112.06 0.6 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.029 -171.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.705 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 49.8 mt-10 -103.09 103.71 13.81 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' MET . . . . . 0.415 ' HG2' HD12 ' A' ' 190' ' ' ILE . 34.4 mtm -87.81 131.14 34.63 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.846 -172.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 26.6 p -143.65 147.14 37.97 Favored Pre-proline 0 N--CA 1.466 0.354 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -173.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.04 169.33 6.16 Favored 'Trans proline' 0 CA--C 1.5 -1.191 0 C-N-CA 122.896 2.397 . . . . 0.0 112.293 165.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -78.9 -160.64 0.24 Allowed 'General case' 0 N--CA 1.414 -2.254 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 161.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -12.41 86.86 0.03 OUTLIER Pre-proline 0 C--N 1.299 -1.617 0 C-N-CA 126.413 1.885 . . . . 0.0 115.525 -170.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.484 ' CD ' ' HA ' ' A' ' 211' ' ' ALA . 8.6 Cg_exo -73.23 -53.49 0.13 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.98 2.454 . . . . 0.0 111.118 174.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 -72.49 141.69 83.19 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.815 177.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -83.08 27.45 0.61 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.26 1.974 . . . . 0.0 113.841 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' CYS . . . . . 0.463 ' C ' ' HD2' ' A' ' 232' ' ' ARG . 68.4 m -83.48 -91.66 0.08 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 173.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.781 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 3.8 mpt_? -146.04 147.57 31.76 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 168.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -41.47 -46.83 3.57 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.464 0.477 . . . . 0.0 111.657 170.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' A' ' 246' ' ' ASP . . . -77.44 7.0 41.65 Favored Glycine 0 C--O 1.224 -0.477 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.817 -176.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . 0.781 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 3.5 m-85 -119.36 142.19 48.38 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.075 0.941 . . . . 0.0 113.357 -170.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 237' ' ' PRO . 0.3 OUTLIER -124.1 125.76 25.72 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 113.918 -1.492 . . . . 0.0 108.975 174.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 236' ' ' ILE . 19.1 Cg_exo -67.14 123.3 10.74 Favored 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 122.498 2.132 . . . . 0.0 112.71 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -54.43 139.65 36.59 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.55 0.69 . . . . 0.0 111.033 175.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 31.0 mt -73.08 -16.81 17.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.36 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 47.2 mtm180 -101.34 -66.56 0.91 Allowed 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.682 0.753 . . . . 0.0 110.239 -176.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 28.9 p -76.17 -42.42 46.56 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.688 -175.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 99.26 7.87 53.99 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -85.3 127.27 34.27 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.896 0.855 . . . . 0.0 110.278 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' CYS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 235' ' ' PHE . 3.2 m -65.44 121.6 15.26 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.901 175.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.542 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 96.6 mt-30 -119.29 141.34 49.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.645 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.706 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 13.1 t70 -78.02 148.08 34.51 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.07 0.462 . . . . 0.0 110.321 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.638 HG23 ' HG3' ' A' ' 249' ' ' GLU . 5.4 m -100.05 151.28 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.848 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -73.24 77.43 1.31 Allowed 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 166.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.638 ' HG3' HG23 ' A' ' 247' ' ' VAL . 5.6 mp0 -51.26 -40.61 59.26 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.756 -175.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 32.0 m -35.83 -43.59 0.31 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 114.189 -1.369 . . . . 0.0 112.658 171.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -99.72 -31.77 11.38 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.188 0.518 . . . . 0.0 110.694 -174.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.422 ' HB1' ' HG ' ' A' ' 208' ' ' LEU . . . -88.01 -4.21 58.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.905 -170.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.658 ' HB ' ' CD2' ' A' ' 256' ' ' LEU . 54.8 mt -134.4 133.47 21.64 Favored Pre-proline 0 CA--C 1.557 1.243 0 CA-C-N 119.092 0.86 . . . . 0.0 113.193 -174.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.533 ' HG3' ' HB2' ' A' ' 186' ' ' CYS . 3.4 Cg_endo -41.14 -73.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.078 1 C-N-CA 125.415 4.076 . . . . 0.0 115.171 -169.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -90.11 31.14 5.5 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.499 -169.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.658 ' CD2' ' HB ' ' A' ' 253' ' ' ILE . 0.6 OUTLIER -66.43 137.96 57.22 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.556 -0.857 . . . . 0.0 109.437 177.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' ' 262' ' ' CYS . 7.9 p -55.82 99.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -167.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -92.07 -20.5 21.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.82 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -78.05 70.49 2.55 Favored Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 176.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 130.13 -148.48 18.55 Favored Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -174.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -109.08 146.12 34.53 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 117.033 0.417 . . . . 0.0 109.976 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . 0.521 ' HB3' ' SG ' ' A' ' 257' ' ' CYS . 17.8 p -127.91 147.38 50.46 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 172.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 53.3 mt -138.69 108.8 4.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.375 -167.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -73.36 114.45 11.59 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.747 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 268' ' ' SER . 0.2 OUTLIER -103.32 150.95 23.27 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 161.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.706 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 4.0 m -72.82 133.33 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 C-N-CA 117.553 -1.659 . . . . 0.0 107.503 177.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.684 ' N ' ' HE2' ' A' ' 235' ' ' PHE . . . 97.61 -19.54 54.25 Favored Glycine 0 N--CA 1.434 -1.494 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.607 -174.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.589 ' O ' HG23 ' A' ' 265' ' ' THR . 3.9 p 179.76 142.33 0.14 Allowed 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 117.399 0.599 . . . . 0.0 110.577 -175.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -97.98 156.74 16.49 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . 0.51 ' HG3' ' CG2' ' A' ' 265' ' ' THR . 8.8 mt-10 -117.83 155.69 29.67 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 58.4 m -123.21 154.89 38.13 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.948 0.88 . . . . 0.0 112.311 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.408 ' HB3' ' NZ ' ' A' ' 272' ' ' LYS . 9.2 mtpm? -135.5 100.5 4.52 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.763 -1.562 . . . . 0.0 109.386 170.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . 0.429 ' HB3' ' HD2' ' A' ' 274' ' ' PRO . 38.6 m -104.79 170.28 6.2 Favored Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.539 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 273' ' ' CYS . 51.2 Cg_exo -55.44 157.04 15.74 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 121.801 1.667 . . . . 0.0 111.019 171.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -58.27 154.24 13.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.185 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 87.46 -30.81 4.73 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.934 -176.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' HIS . . . . . 0.608 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 14.2 m-70 -70.66 155.4 40.8 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.176 0.512 . . . . 0.0 112.182 -176.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . 0.643 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 99.2 mttt -138.68 133.81 32.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.284 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 15.5 tp -91.28 141.2 29.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.753 0.787 . . . . 0.0 111.44 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.481 ' OD1' ' HB ' ' A' ' 282' ' ' VAL . 55.2 t-20 -126.76 101.59 6.68 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 174.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.66 -24.45 66.74 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 123.719 0.637 . . . . 0.0 111.387 -175.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.481 ' HB ' ' OD1' ' A' ' 280' ' ' ASN . 78.8 t -65.2 -43.97 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.488 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 47.3 t -118.92 20.56 12.74 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.276 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 36.13 43.48 0.22 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.737 -173.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 89.7 mttt -91.29 153.07 20.21 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' CYS . . . . . 0.643 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 7.7 t -152.07 86.36 1.3 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.608 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 34.5 tt0 . . . . . 0 C--N 1.312 -1.06 0 CA-C-O 118.259 -0.877 . . . . 0.0 109.822 -173.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 26.1 m . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 121.286 0.565 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.17 140.6 21.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.679 -177.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.8 t -87.15 61.0 6.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -83.78 133.74 34.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.874 -173.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.5 p -70.41 -30.59 67.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.945 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 57.5 mt -70.56 128.27 33.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.738 173.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 63.11 56.14 1.81 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.673 0.749 . . . . 0.0 109.464 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -67.07 142.12 57.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.896 -176.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 58.4 m -71.13 -177.96 1.86 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.583 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -115.89 -20.68 9.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.356 0.598 . . . . 0.0 109.634 -176.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.491 HD13 ' H ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -98.59 125.38 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 CA-C-O 121.444 0.64 . . . . 0.0 110.268 176.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.471 ' H ' ' NE ' ' A' ' 122' ' ' ARG . 0.1 OUTLIER -52.28 128.21 24.47 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.55 175.474 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.432 ' HB3' ' HA3' ' A' ' 127' ' ' GLY . 42.3 m -116.51 115.58 26.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.605 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 85.8 mtp -90.75 156.5 18.02 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.361 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 66.72 47.59 1.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.142 0.496 . . . . 0.0 111.579 172.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 70.25 18.78 75.31 Favored Glycine 0 CA--C 1.516 0.108 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.311 173.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.432 ' HA3' ' HB3' ' A' ' 123' ' ' CYS . . . -54.28 131.48 45.61 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.636 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.476 ' HB2' ' HB2' ' A' ' 135' ' ' LEU . 22.8 m -79.23 158.55 27.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.416 -0.392 . . . . 0.0 110.386 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 53.8 t -86.97 99.1 11.63 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.386 0.612 . . . . 0.0 110.673 -176.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.685 ' HB3' ' O ' ' A' ' 133' ' ' HIS . 29.0 t -112.32 139.99 47.41 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 175.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 132' ' ' ASP . 7.4 m-20 -43.14 72.85 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 116.172 1.916 . . . . 0.0 116.172 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.503 ' HB3' ' O ' ' A' ' 131' ' ' ASP . 27.3 t70 109.53 -25.08 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.715 1.606 . . . . 0.0 110.048 164.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.685 ' O ' ' HB3' ' A' ' 130' ' ' SER . 0.3 OUTLIER -119.92 147.59 44.54 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.257 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 69.2 m -81.32 158.95 24.56 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.921 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 128' ' ' SER . 40.0 mt -123.63 104.53 9.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 176.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 31.3 m -69.32 176.44 3.34 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.804 -168.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -92.69 141.82 28.05 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 173.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.44 ' HA ' ' HD2' ' A' ' 138' ' ' LYS . 43.7 tptt -63.46 110.04 1.82 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.521 1.153 . . . . 0.0 110.929 -167.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 142.62 -15.94 2.45 Favored Glycine 0 N--CA 1.433 -1.542 0 CA-C-N 112.584 -2.098 . . . . 0.0 109.948 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.535 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 95.7 m-85 -118.99 153.19 35.05 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.548 170.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.453 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 33.9 pt -132.2 172.49 16.28 Favored 'Isoleucine or valine' 0 C--O 1.245 0.838 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 174.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.75 158.62 24.6 Favored Glycine 0 N--CA 1.45 -0.368 0 O-C-N 124.014 0.821 . . . . 0.0 112.208 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.7 p -70.76 -25.82 63.08 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.507 -0.407 . . . . 0.0 111.48 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -100.5 -8.29 23.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.932 0.396 . . . . 0.0 109.992 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 86.1 m 69.03 40.52 1.58 Allowed 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.483 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.98 3.97 48.87 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.194 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.453 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 0.0 OUTLIER -108.31 111.54 61.59 Favored Pre-proline 0 N--CA 1.464 0.255 0 CA-C-N 117.502 0.651 . . . . 0.0 110.819 179.464 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -82.8 143.2 11.68 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.173 2.582 . . . . 0.0 112.998 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.3 p -71.75 115.87 12.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.641 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.641 ' HB3' ' O ' ' A' ' 153' ' ' GLY . 0.9 OUTLIER -80.73 78.25 7.51 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 172.343 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 164' ' ' ASN . 2.2 tt0 -52.27 -60.61 3.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.268 -173.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 17.8 m -94.84 14.52 21.18 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.057 0.456 . . . . 0.0 110.923 -175.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.641 ' O ' ' HB3' ' A' ' 150' ' ' CYS . . . 106.88 -117.32 5.29 Favored Glycine 0 N--CA 1.415 -2.701 0 CA-C-O 122.888 1.271 . . . . 0.0 111.601 -178.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.534 ' O ' HD23 ' A' ' 155' ' ' LEU . 0.6 OUTLIER 162.22 141.24 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 -172.349 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 176' ' ' GLN . 39.1 mt -132.58 170.7 14.81 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 -163.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.753 ' HB3' ' CZ ' ' A' ' 172' ' ' PHE . 9.6 p30 45.5 21.61 0.08 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -174.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 67.37 37.87 90.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.296 -174.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -75.4 -146.76 1.56 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.575 -0.345 . . . . 0.0 112.689 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -157.95 124.87 4.96 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 122.68 -0.306 . . . . 0.0 110.955 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.4 m -61.96 125.39 23.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.62 0.248 . . . . 0.0 111.31 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 165' ' ' ARG . 4.2 m -112.18 -46.91 5.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.859 -0.337 . . . . 0.0 110.453 177.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.502 ' HB1' ' HD2' ' A' ' 163' ' ' PRO . . . -128.97 176.1 3.05 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 118.45 -0.786 . . . . 0.0 109.859 170.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.535 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 82.0 Cg_exo -50.67 103.78 0.07 OUTLIER 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 122.524 2.149 . . . . 0.0 113.298 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.422 ' HB2' ' HB2' ' A' ' 151' ' ' GLU . 9.1 t30 67.09 5.31 4.05 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.377 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.542 ' O ' HG22 ' A' ' 161' ' ' VAL . 1.7 ttm180 -89.02 82.5 6.65 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 169.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 35.8 t -85.48 137.73 32.71 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -88.9 127.87 35.65 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 35.2 m -109.94 134.03 52.53 Favored 'General case' 0 C--O 1.239 0.502 0 O-C-N 124.231 0.957 . . . . 0.0 112.028 -168.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 91.4 m -56.16 -56.28 22.87 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -165.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -161.9 -87.98 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.06 -1.056 . . . . 0.0 112.901 -166.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -85.81 46.95 3.71 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.564 -165.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.753 ' CZ ' ' HB3' ' A' ' 156' ' ' ASN . 6.9 m-85 -121.28 130.83 53.86 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.922 170.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.688 ' N ' ' HE1' ' A' ' 181' ' ' TYR . 3.5 t -97.37 138.28 35.07 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 173.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 99.12 126.06 5.56 Favored Glycine 0 C--N 1.299 -1.502 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -169.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -67.86 -0.22 5.15 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.55 1.5 . . . . 0.0 113.301 -170.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.609 ' O ' HD12 ' A' ' 155' ' ' LEU . 45.7 tt0 -111.64 24.34 12.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.39 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.494 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 1.2 p 23.96 60.92 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 117.506 2.41 . . . . 0.0 117.506 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -113.84 26.17 10.57 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.508 1.147 . . . . 0.0 109.441 169.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.547 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 17.6 mmt85 -120.9 84.66 2.27 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.597 -1.638 . . . . 0.0 108.592 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -82.72 76.88 9.54 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.828 -172.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.688 ' HE1' ' N ' ' A' ' 173' ' ' THR . 20.4 p90 -111.94 83.29 1.77 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.757 173.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 61.1 mtt85 -84.45 145.7 28.01 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 119.542 -1.974 . . . . 0.0 107.157 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 73.2 p -91.47 135.22 34.0 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.401 -175.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -159.49 162.5 32.92 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.162 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.21 128.56 10.63 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.215 1.943 . . . . 0.0 111.796 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.537 ' H ' HG23 ' A' ' 202' ' ' ILE . 10.5 t -85.0 115.65 22.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.275 0.56 . . . . 0.0 110.452 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . 0.639 ' O ' ' HB2' ' A' ' 215' ' ' ARG . 42.6 m-85 -101.69 151.51 21.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.435 -175.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.624 ' HA ' ' CB ' ' A' ' 215' ' ' ARG . 15.4 p -114.42 -23.95 9.1 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -170.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.502 ' HB ' ' CG ' ' A' ' 196' ' ' GLN . 27.0 t -155.69 116.99 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -171.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.488 HG12 ' HA ' ' A' ' 195' ' ' CYS . 4.0 mt -130.14 118.42 43.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 119.012 -1.075 . . . . 0.0 113.892 -170.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.5 p -112.76 -166.81 1.11 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.566 161.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -67.51 -5.48 15.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.619 0.724 . . . . 0.0 110.388 172.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -92.47 -76.53 0.46 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.43 -173.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.598 ' HG2' ' H ' ' A' ' 196' ' ' GLN . 53.1 ttm -136.17 136.31 39.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.826 -172.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 196' ' ' GLN . 29.0 m -84.9 -15.47 44.43 Favored 'General case' 0 C--O 1.247 0.925 0 O-C-N 123.342 0.401 . . . . 0.0 110.823 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.598 ' H ' ' HG2' ' A' ' 194' ' ' MET . 72.3 mm-40 95.09 -165.06 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.211 1.405 . . . . 0.0 112.658 174.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.407 ' H ' ' HB3' ' A' ' 196' ' ' GLN . . . 69.17 -3.57 7.22 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 114.992 -1.003 . . . . 0.0 113.03 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 51.01 39.59 23.43 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.965 0.383 . . . . 0.0 110.263 -172.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 58.0 58.7 3.45 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.579 -177.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 33.5 t -72.85 147.83 45.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.692 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -91.01 26.46 11.13 Favored Glycine 0 CA--C 1.506 -0.511 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.537 HG23 ' H ' ' A' ' 186' ' ' CYS . 0.0 OUTLIER -63.08 106.47 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-O 121.95 0.881 . . . . 0.0 109.356 174.204 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 12.6 t -94.63 118.9 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.144 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 18.7 t -156.22 179.72 8.96 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.401 ' OG1' HD22 ' A' ' 208' ' ' LEU . 10.7 p -102.37 160.21 14.75 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 120.184 1.356 . . . . 0.0 109.736 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.588 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 37.8 tttm -59.01 -42.26 89.66 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.503 177.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.0 m -44.87 -56.62 4.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.332 174.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.499 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -54.09 -53.74 49.05 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.665 177.461 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 91.5 m -67.94 -23.48 65.07 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -174.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 61.4 m -93.84 -34.79 13.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.542 0.61 . . . . 0.0 111.649 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -72.67 -58.12 3.6 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.86 HG22 ' HA2' ' A' ' 234' ' ' GLY . 4.6 p -97.83 159.74 14.74 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.258 177.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.1 t 66.97 -48.42 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 122.565 0.346 . . . . 0.0 111.729 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 60.63 52.03 55.04 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 114.796 0.679 . . . . 0.0 114.796 171.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.639 ' HB2' ' O ' ' A' ' 187' ' ' PHE . 0.0 OUTLIER -123.41 -78.2 0.6 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.813 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.518 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -173.28 167.24 4.81 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . 0.605 ' O ' ' HB2' ' A' ' 222' ' ' GLU . 19.5 t90 -159.61 148.16 17.62 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 92.59 177.48 41.32 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 114.74 0.656 . . . . 0.0 114.74 168.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.59 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 12.2 p80 -143.01 132.14 11.67 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.132 -0.534 . . . . 0.0 109.707 177.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.59 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 52.1 Cg_exo -56.65 148.11 26.29 Favored 'Cis proline' 0 C--N 1.346 0.411 0 C-N-CA 123.694 -1.378 . . . . 0.0 111.444 -4.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . 0.467 ' HB3' HD13 ' A' ' 190' ' ' ILE . 80.0 m -47.22 122.81 4.84 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.795 0.685 . . . . 0.0 111.845 -173.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.605 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 33.6 mm-40 -108.35 112.5 24.98 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' MET . . . . . 0.518 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 10.4 ptm -94.38 133.79 37.58 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.269 0.557 . . . . 0.0 110.911 -172.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 74.2 m -94.12 125.16 53.71 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.198 -0.91 . . . . 0.0 113.397 -164.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -64.76 154.21 73.79 Favored 'Trans proline' 0 CA--C 1.512 -0.584 0 C-N-CA 123.092 2.528 . . . . 0.0 113.188 166.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -38.29 104.4 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 122.772 1.272 . . . . 0.0 111.93 163.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' GLN . . . . . 0.488 ' HA ' ' HD2' ' A' ' 228' ' ' PRO . 0.3 OUTLIER 18.52 88.24 0.05 OUTLIER Pre-proline 0 N--CA 1.483 1.189 0 CA-C-N 110.507 -3.042 . . . . 0.0 114.778 174.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.488 ' HD2' ' HA ' ' A' ' 227' ' ' GLN . 5.6 Cg_exo -38.04 -55.93 1.08 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 124.387 3.391 . . . . 0.0 113.246 173.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.441 ' CE1' ' HG3' ' A' ' 237' ' ' PRO . 90.6 m-70 -80.51 106.0 4.59 Favored Pre-proline 0 CA--C 1.518 -0.277 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 170.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.1 35.53 0.3 Allowed 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.112 1.875 . . . . 0.0 114.247 -171.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' CYS . . . . . 0.421 ' HB2' ' H ' ' A' ' 232' ' ' ARG . 33.8 m -69.22 -74.81 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 169.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.577 ' HB3' ' CD2' ' A' ' 235' ' ' PHE . 24.0 tpt180 -149.47 140.4 22.85 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 165.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -36.3 -45.46 0.47 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -177.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.86 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -78.8 9.97 34.55 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.93 -174.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . 0.672 ' HE2' ' N ' ' A' ' 267' ' ' GLY . 2.2 m-85 -116.53 138.39 51.44 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 122.009 0.909 . . . . 0.0 113.426 -169.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.523 HG22 ' HD2' ' A' ' 237' ' ' PRO . 0.0 OUTLIER -126.48 137.07 29.61 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.601 173.281 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.523 ' HD2' HG22 ' A' ' 236' ' ' ILE . 19.7 Cg_endo -57.61 124.41 16.01 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.658 2.239 . . . . 0.0 112.92 -177.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.418 ' O ' ' HA2' ' A' ' 242' ' ' GLY . 22.9 t-20 -58.27 141.66 50.23 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.652 173.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 26.3 mt -81.45 -13.82 12.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.079 -174.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 65.1 mtt180 -99.57 -59.01 1.8 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.335 0.588 . . . . 0.0 109.823 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 43.8 p -86.63 -33.96 19.97 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.879 -176.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 238' ' ' ASN . . . 90.3 5.77 69.5 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -177.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -83.46 134.02 34.88 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 121.591 0.71 . . . . 0.0 110.349 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 4.0 m -59.45 118.73 6.36 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.273 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.557 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 83.1 mm-40 -120.38 143.03 48.65 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.722 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 14.9 t70 -79.11 146.16 33.36 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -176.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.755 HG23 ' HG3' ' A' ' 249' ' ' GLU . 5.3 m -98.68 148.22 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.047 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.856 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -75.8 77.28 2.73 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 167.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.755 ' HG3' HG23 ' A' ' 247' ' ' VAL . 40.4 mp0 -53.57 -37.66 63.14 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 123.482 0.489 . . . . 0.0 111.689 -168.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 36.0 t -50.59 -40.47 52.64 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.121 0.486 . . . . 0.0 110.616 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -93.78 -40.32 10.26 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.591 0.71 . . . . 0.0 110.125 -172.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -67.49 -25.01 65.65 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.588 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.471 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.1 mp -121.3 83.76 40.11 Favored Pre-proline 0 N--CA 1.449 -0.525 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 173.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -65.34 8.81 0.21 Allowed 'Trans proline' 0 N--CA 1.482 0.813 0 C-N-CA 124.411 3.408 . . . . 0.0 116.379 -168.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -129.81 8.4 6.11 Favored Glycine 0 C--N 1.295 -1.708 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.755 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.471 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.1 OUTLIER -102.65 136.41 42.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.212 0.529 . . . . 0.0 112.189 -174.295 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 10.7 t 56.78 54.43 7.22 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.681 178.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -94.28 -17.63 22.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.257 177.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -87.8 40.57 3.08 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.434 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 164.03 -160.6 33.52 Favored Glycine 0 N--CA 1.437 -1.234 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 272' ' ' LYS . 13.7 m120 -81.41 156.47 25.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.921 0.361 . . . . 0.0 110.425 177.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 15.4 p -138.92 121.14 15.84 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 176.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 270' ' ' GLU . 16.6 mt -136.16 164.1 32.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -174.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.413 HD21 ' H ' ' A' ' 249' ' ' GLU . 0.6 OUTLIER -134.61 132.12 38.65 Favored 'General case' 0 CA--C 1.496 -1.109 0 C-N-CA 117.789 -1.564 . . . . 0.0 114.36 -175.35 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.89 160.36 20.99 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.867 162.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.722 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 3.0 m -73.1 128.12 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 173.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.672 ' N ' ' HE2' ' A' ' 235' ' ' PHE . . . 112.45 -22.17 17.97 Favored Glycine 0 N--CA 1.419 -2.439 0 C-N-CA 119.977 -1.106 . . . . 0.0 112.147 -173.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.566 ' HB2' ' O ' ' A' ' 267' ' ' GLY . 8.5 t 166.77 165.04 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.342 0.592 . . . . 0.0 110.18 -177.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . 0.423 ' CZ ' HD11 ' A' ' 256' ' ' LEU . 36.3 p90 -101.15 155.45 18.0 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 119.864 -0.735 . . . . 0.0 109.965 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . 0.405 ' HB2' ' HB ' ' A' ' 263' ' ' ILE . 3.6 mt-10 -109.93 123.86 50.37 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -177.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 66.3 m -114.0 129.07 56.63 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.399 0.618 . . . . 0.0 110.156 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 261' ' ' ASN . 18.6 ttpp -102.61 114.49 28.76 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.838 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 70.0 m -91.6 148.09 36.59 Favored Pre-proline 0 C--N 1.296 -1.74 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.311 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 70.3 Cg_exo -52.81 152.67 16.68 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.006 1.804 . . . . 0.0 110.927 173.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -51.61 139.95 19.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.884 0.373 . . . . 0.0 111.115 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 86.92 -34.77 3.5 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.301 -0.952 . . . . 0.0 111.353 -176.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' HIS . . . . . 0.605 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 17.8 m-70 -80.24 163.33 24.08 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 120.968 0.413 . . . . 0.0 110.893 -176.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -146.29 133.71 20.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.561 -173.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.528 HD12 ' O ' ' A' ' 285' ' ' LYS . 46.8 tp -66.56 142.57 57.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.991 0.424 . . . . 0.0 111.063 -176.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -131.23 99.47 4.87 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -61.32 -17.15 52.37 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.861 0.725 . . . . 0.0 112.624 -176.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.502 ' HA ' ' NH1' ' A' ' 215' ' ' ARG . 77.0 t -58.01 -39.48 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.183 0.516 . . . . 0.0 110.597 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 57.7 p -140.89 36.9 1.78 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.951 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 0.443 ' OE1' ' HA ' ' A' ' 256' ' ' LEU . 0.0 OUTLIER 28.25 50.92 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.326 1.051 . . . . 0.0 112.897 -174.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . 0.528 ' O ' HD12 ' A' ' 279' ' ' LEU . 68.9 tttt -104.44 169.59 8.38 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.699 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 53.7 m -141.65 100.21 3.72 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.605 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 57.8 mm-40 . . . . . 0 C--O 1.24 0.563 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -173.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.5 t . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.01 -47.05 48.46 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.869 0.366 . . . . 0.0 110.408 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.4 p -123.0 169.25 11.36 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.855 176.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -57.46 -54.9 41.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.143 0.497 . . . . 0.0 109.948 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 46.4 m -105.45 133.09 50.78 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.335 172.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.4 tt -57.77 -29.88 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.856 -177.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -78.03 126.88 31.48 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -68.04 111.52 4.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.76 0.314 . . . . 0.0 110.327 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 26.7 p -114.38 -174.71 2.53 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -119.52 -50.01 2.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.898 0.38 . . . . 0.0 110.372 -176.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.67 -178.31 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.583 ' H ' ' HD2' ' A' ' 122' ' ' ARG . 0.2 OUTLIER -124.22 142.08 51.54 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.308 -175.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 65.6 m -116.09 134.97 54.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.13 0.491 . . . . 0.0 111.914 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -125.81 162.65 24.65 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 170.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.497 ' HB3' ' CE1' ' A' ' 140' ' ' TYR . 90.5 m-20 66.17 43.57 2.81 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.003 0.43 . . . . 0.0 111.9 174.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.414 ' HA3' ' OE1' ' A' ' 137' ' ' GLN . . . 65.84 30.84 78.01 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 116.011 -0.54 . . . . 0.0 113.868 177.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -84.46 143.47 20.93 Favored Glycine 0 C--O 1.234 0.151 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.292 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.491 ' HB3' ' HB2' ' A' ' 135' ' ' LEU . 8.9 t -93.23 134.39 35.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.31 0.576 . . . . 0.0 109.463 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 11.3 t -99.76 113.2 25.53 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.728 -172.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.418 ' O ' ' HD2' ' A' ' 133' ' ' HIS . 40.3 t -130.06 125.26 34.79 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 43.86 -102.85 0.05 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.385 0.674 . . . . 0.0 112.406 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -123.38 34.13 5.18 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.711 -176.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.418 ' HD2' ' O ' ' A' ' 130' ' ' SER . 0.4 OUTLIER -155.83 141.76 18.12 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.986 0.422 . . . . 0.0 110.348 177.383 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.432 ' HB3' ' O ' ' A' ' 143' ' ' THR . 38.3 t -102.87 131.79 49.53 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.831 -178.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.491 ' HB2' ' HB3' ' A' ' 128' ' ' SER . 60.8 mt -90.86 97.42 11.17 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.627 0.727 . . . . 0.0 109.349 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . 0.954 ' SG ' ' HB2' ' A' ' 140' ' ' TYR . 42.4 t -74.92 157.0 35.75 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.976 -173.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.414 ' OE1' ' HA3' ' A' ' 126' ' ' GLY . 47.1 mt-30 -85.54 156.18 20.87 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.48 176.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -69.83 110.6 5.05 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 122.923 1.344 . . . . 0.0 110.839 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.46 ' HA2' ' CG1' ' A' ' 149' ' ' VAL . . . 136.79 -6.52 3.8 Favored Glycine 0 C--N 1.293 -1.812 0 CA-C-N 111.94 -2.391 . . . . 0.0 110.258 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.954 ' HB2' ' SG ' ' A' ' 136' ' ' CYS . 67.7 m-85 -130.63 162.16 29.99 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 168.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.575 HG12 HE21 ' A' ' 147' ' ' GLN . 32.6 pt -138.4 -176.33 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.865 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.03 167.61 43.17 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.302 -174.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.432 ' O ' ' HB3' ' A' ' 134' ' ' CYS . 34.4 p -77.99 -10.98 59.86 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.778 -0.248 . . . . 0.0 111.516 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 30.7 m80 -109.28 -3.76 16.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.047 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 140' ' ' TYR . 9.5 t 66.1 26.26 10.71 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.35 0.595 . . . . 0.0 109.623 -177.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -96.09 4.14 64.96 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.615 -0.721 . . . . 0.0 113.076 -173.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.575 HE21 HG12 ' A' ' 141' ' ' ILE . 0.1 OUTLIER -110.91 108.08 57.74 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.027 -178.297 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -74.06 140.72 28.66 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.119 2.546 . . . . 0.0 112.983 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 149' ' ' VAL . 13.6 p -78.38 103.59 5.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.34 1.067 . . . . 0.0 111.363 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -81.95 82.89 7.42 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.646 174.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -56.33 -69.09 0.16 Allowed 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -173.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 64.9 m -83.05 10.5 7.92 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.78 0.8 . . . . 0.0 110.659 -163.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 71.72 132.31 0.12 Allowed Glycine 0 N--CA 1.424 -2.13 0 CA-C-N 114.374 -1.285 . . . . 0.0 111.491 -170.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 160' ' ' CYS . 62.4 m -68.06 151.5 46.95 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.23 -0.985 . . . . 0.0 109.503 175.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 38.6 mt -132.36 175.39 9.32 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -172.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.774 ' HB2' ' CZ ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 66.88 11.52 8.36 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 123.791 0.682 . . . . 0.0 112.124 170.615 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.61 32.07 80.06 Favored Glycine 0 CA--C 1.507 -0.458 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -172.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.443 ' HA2' ' OG1' ' A' ' 169' ' ' THR . . . -77.76 -145.55 2.44 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.276 -0.462 . . . . 0.0 114.1 -175.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -149.76 114.13 5.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.63 0.252 . . . . 0.0 110.491 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.467 ' HB2' ' SG ' ' A' ' 154' ' ' CYS . 35.1 t -58.78 113.77 2.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.891 0.377 . . . . 0.0 110.634 174.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 165' ' ' ARG . 13.0 m -106.96 -46.13 8.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.921 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.577 ' HB1' ' HD2' ' A' ' 163' ' ' PRO . . . -134.11 178.06 1.95 Allowed Pre-proline 0 CA--C 1.541 0.622 0 CA-C-O 118.72 -0.657 . . . . 0.0 109.981 175.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.577 ' HD2' ' HB1' ' A' ' 162' ' ' ALA . 96.2 Cg_exo -49.05 103.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 122.661 2.241 . . . . 0.0 113.589 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 66.31 8.94 6.01 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.238 1.015 . . . . 0.0 109.958 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.597 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -93.08 81.24 4.54 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.613 174.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 63.7 m -85.74 138.75 31.88 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.277 172.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.96 139.16 30.8 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.498 ' HA ' HD21 ' A' ' 156' ' ' ASN . 61.0 m -92.65 110.44 21.87 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 124.182 0.926 . . . . 0.0 111.601 -169.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.443 ' OG1' ' HA2' ' A' ' 158' ' ' GLY . 24.1 m -65.84 -55.28 17.88 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.44 ' CD2' ' N ' ' A' ' 171' ' ' GLY . 38.0 t80 -121.36 -116.41 0.31 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 118.89 -1.124 . . . . 0.0 112.532 -168.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.44 ' N ' ' CD2' ' A' ' 170' ' ' TYR . . . -91.77 52.13 2.95 Favored Glycine 0 CA--C 1.485 -1.799 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.163 -166.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.774 ' CZ ' ' HB2' ' A' ' 156' ' ' ASN . 6.9 m-85 -119.06 127.8 53.74 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 119.302 -0.959 . . . . 0.0 112.598 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.478 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 3.6 t -91.0 162.71 14.6 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 163.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 90.96 131.25 4.92 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.36 -13.2 30.48 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.312 1.341 . . . . 0.0 113.322 -166.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -106.83 14.41 26.71 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.246 0.546 . . . . 0.0 109.601 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.531 ' HB3' ' HB2' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 31.33 60.22 0.27 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.735 1.214 . . . . 0.0 113.958 177.385 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -115.94 -13.92 11.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.925 175.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -56.44 -61.91 2.09 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.907 -1.497 . . . . 0.0 107.967 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 32.8 t70 74.45 69.83 0.1 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.78 0.8 . . . . 0.0 109.524 160.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.478 ' HE2' ' N ' ' A' ' 173' ' ' THR . 45.3 p90 -94.75 66.22 3.13 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 174.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -57.19 123.74 16.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.136 171.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.578 ' HB ' HG13 ' A' ' 203' ' ' VAL . 41.3 p -73.22 138.02 45.34 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -163.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -140.51 141.61 11.58 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.79 -162.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -72.12 128.66 14.15 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.964 1.776 . . . . 0.0 111.382 172.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 6.4 t -84.53 113.6 21.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.131 0.491 . . . . 0.0 110.09 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . 0.561 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 14.6 m-85 -94.6 147.05 23.68 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.766 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.548 ' HA ' ' CB ' ' A' ' 215' ' ' ARG . 12.9 p -113.5 -2.92 13.77 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.5 t -130.35 159.23 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.799 HD11 ' HB2' ' A' ' 216' ' ' ALA . 40.5 mm -134.55 119.34 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.562 0.696 . . . . 0.0 111.336 174.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.418 ' HB3' ' H ' ' A' ' 194' ' ' MET . 48.2 t -143.17 169.18 18.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.308 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -79.37 -7.5 58.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 122.369 1.081 . . . . 0.0 108.106 167.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -92.44 -71.45 0.64 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.476 -1.693 . . . . 0.0 109.655 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.418 ' H ' ' HB3' ' A' ' 191' ' ' SER . 63.2 mtt -143.83 136.55 27.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.927 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 196' ' ' GLN . 34.3 m -85.17 -38.79 18.6 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 168.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 1.8 mm-40 157.11 -149.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 113.423 -1.717 . . . . 0.0 106.969 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 94.13 17.21 41.12 Favored Glycine 0 CA--C 1.509 -0.338 0 C-N-CA 119.743 -1.218 . . . . 0.0 112.747 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -90.58 -1.99 57.88 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.227 0.536 . . . . 0.0 110.204 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.464 ' N ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -160.53 8.97 0.09 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.755 -177.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 12.6 m -87.97 86.07 7.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.313 0.578 . . . . 0.0 112.248 -169.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -100.25 4.19 57.01 Favored Glycine 0 CA--C 1.506 -0.509 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 170.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.467 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -60.14 114.33 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 114.435 -0.882 . . . . 0.0 109.576 173.145 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.578 HG13 ' HB ' ' A' ' 183' ' ' THR . 23.0 t -104.68 101.1 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 CA-C-O 122.974 1.369 . . . . 0.0 110.728 176.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.434 ' HB2' HD11 ' A' ' 202' ' ' ILE . 9.6 t -129.27 -176.8 3.99 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 112.529 -2.123 . . . . 0.0 106.204 174.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 26.7 p -107.9 165.6 11.34 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.143 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.862 ' HB3' ' CE3' ' A' ' 217' ' ' TRP . 21.7 ptmt -69.58 -22.02 63.56 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.526 174.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 8.4 m -57.59 -53.07 62.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 172.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.491 ' CD1' HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -57.69 -56.43 22.06 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.737 175.001 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 68.7 m -67.99 -24.15 65.1 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.253 -172.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 78.2 m -101.9 -11.08 19.27 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -82.47 -50.74 8.51 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 164.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 214' ' ' GLY . 40.0 p -78.15 -156.76 0.09 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.886 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.7 t -19.82 -33.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 212' ' ' THR . . . 81.41 -165.33 46.44 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 119.796 -1.192 . . . . 0.0 114.429 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.548 ' CB ' ' HA ' ' A' ' 188' ' ' THR . 72.6 mmt-85 102.72 -80.29 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.837 1.655 . . . . 0.0 109.932 174.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.799 ' HB2' HD11 ' A' ' 190' ' ' ILE . . . -173.53 168.25 4.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 119.101 0.864 . . . . 0.0 110.347 175.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . 0.862 ' CE3' ' HB3' ' A' ' 206' ' ' LYS . 20.7 t90 -164.28 144.44 7.94 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 76.99 -174.27 54.52 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.0 -0.619 . . . . 0.0 113.014 175.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.52 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 31.1 p80 -135.64 131.71 19.36 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 31.6 Cg_exo -59.94 165.2 26.71 Favored 'Cis proline' 0 N--CA 1.477 0.505 0 C-N-CA 123.733 -1.361 . . . . 0.0 111.821 -5.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 55.9 m -62.63 81.32 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -173.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 216' ' ' ALA . 5.7 mm-40 -50.29 97.93 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.31 0.576 . . . . 0.0 110.438 167.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 19.8 ptt? -99.42 131.89 45.12 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.162 -173.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 18.5 m -142.11 144.17 30.74 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.386 -173.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -59.87 168.17 6.08 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.897 2.398 . . . . 0.0 110.046 160.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.01 -96.3 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.876 0.37 . . . . 0.0 111.213 -176.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' GLN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -83.28 113.34 45.67 Favored Pre-proline 0 C--N 1.32 -0.689 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.725 178.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -83.48 -41.24 0.1 OUTLIER 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.621 2.214 . . . . 0.0 113.698 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.445 ' HB3' ' HD2' ' A' ' 230' ' ' PRO . 41.7 m80 -103.89 173.57 3.32 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -174.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 229' ' ' HIS . 45.5 Cg_exo -60.19 -18.35 51.28 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.026 1.817 . . . . 0.0 112.011 174.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 14.8 t -64.07 124.69 22.26 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 172.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.587 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 45.3 mtt180 -63.45 135.23 56.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.386 -172.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.525 ' HB3' ' HB3' ' A' ' 227' ' ' GLN . 30.4 ptt180 -30.43 -44.54 0.05 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 246' ' ' ASP . . . -79.78 12.02 31.08 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.895 -1.145 . . . . 0.0 113.952 -173.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . 0.587 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 44.2 m-85 -125.05 158.55 33.47 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 117.994 0.897 . . . . 0.0 112.769 -175.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.496 HD13 ' O ' ' A' ' 235' ' ' PHE . 0.2 OUTLIER -132.28 130.53 21.97 Favored Pre-proline 0 N--CA 1.445 -0.695 0 CA-C-N 113.388 -1.733 . . . . 0.0 107.443 170.537 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.09 113.03 1.86 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.059 1.839 . . . . 0.0 111.509 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -47.13 130.0 12.52 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.665 0.745 . . . . 0.0 110.959 177.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 29.6 mt -74.49 -3.83 5.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.145 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -104.63 -60.09 1.65 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.913 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 34.9 p -86.41 -44.03 12.35 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.56 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 104.01 6.97 42.05 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.608 -177.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -96.55 130.37 43.75 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 122.039 0.923 . . . . 0.0 110.134 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 93.9 m -49.48 120.76 4.39 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 113.066 -1.879 . . . . 0.0 110.465 171.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.4 ' OE1' ' HA ' ' A' ' 245' ' ' GLN . 5.3 tp60 -120.61 136.07 54.92 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.614 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 19.0 t70 -74.09 141.36 45.67 Favored 'General case' 0 CA--C 1.492 -1.256 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.502 -174.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.647 HG23 ' HG3' ' A' ' 249' ' ' GLU . 4.2 m -93.34 143.94 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.441 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -74.2 76.4 1.8 Allowed 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 166.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.647 ' HG3' HG23 ' A' ' 247' ' ' VAL . 29.7 mp0 -49.04 -38.4 23.78 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.896 0.748 . . . . 0.0 111.18 -171.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 15.5 m -53.19 -32.07 46.05 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.639 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -105.53 -50.29 3.24 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.499 0.72 . . . . 0.0 110.776 -175.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -59.88 -26.93 66.27 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.141 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.753 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.5 mp -118.14 79.88 14.83 Favored Pre-proline 0 N--CA 1.447 -0.575 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 169.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -38.0 103.14 0.04 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.564 0 C-N-CA 124.451 3.434 . . . . 0.0 115.509 -169.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 59.96 38.24 93.87 Favored Glycine 0 C--N 1.312 -0.787 0 CA-C-N 113.667 -1.606 . . . . 0.0 113.77 172.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.753 ' HB3' HG22 ' A' ' 253' ' ' ILE . 1.7 pt? -66.46 -31.31 71.98 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.004 177.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . 0.437 ' H ' HD23 ' A' ' 256' ' ' LEU . 51.7 t -119.74 81.19 1.69 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.281 0.562 . . . . 0.0 109.669 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -117.41 26.05 10.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.142 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -70.83 -27.32 72.51 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 172.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -149.49 -116.29 0.81 Allowed Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 175.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . 0.57 HD22 ' N ' ' A' ' 262' ' ' CYS . 0.2 OUTLIER -112.61 131.17 55.75 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.639 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . 0.57 ' N ' HD22 ' A' ' 261' ' ' ASN . 49.1 t -102.5 140.45 36.76 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 172.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 22.5 mt -130.97 163.31 37.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.493 ' ND2' ' HB3' ' A' ' 269' ' ' PHE . 0.7 OUTLIER -130.7 127.36 38.68 Favored 'General case' 0 CA--C 1.496 -1.131 0 C-N-CA 117.615 -1.634 . . . . 0.0 113.895 -174.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.4 t -113.68 165.56 12.41 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.076 163.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.614 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 30.7 m -70.46 125.36 28.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.83 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.527 ' HA2' ' CE2' ' A' ' 235' ' ' PHE . . . 97.05 -13.07 65.29 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-O 118.962 -0.91 . . . . 0.0 113.935 -177.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.0 t 178.68 157.5 0.49 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.732 1.266 . . . . 0.0 109.874 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . 0.493 ' HB3' ' ND2' ' A' ' 264' ' ' ASN . 24.1 p90 -105.97 159.2 16.23 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.872 -0.518 . . . . 0.0 109.876 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -114.84 121.33 42.93 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . 0.585 ' HB2' HD22 ' A' ' 279' ' ' LEU . 68.1 m -111.71 150.75 29.77 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 122.037 0.922 . . . . 0.0 111.917 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.28 109.56 7.83 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 113.503 -1.68 . . . . 0.0 109.694 175.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 10.1 m -84.56 164.4 42.88 Favored Pre-proline 0 C--N 1.314 -0.978 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.578 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 51.6 Cg_exo -53.31 156.41 10.69 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 121.921 1.747 . . . . 0.0 111.696 175.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -53.92 140.59 30.34 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.162 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 87.08 -28.55 5.53 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.421 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' HIS . . . . . 0.578 ' HB2' ' O ' ' A' ' 274' ' ' PRO . 21.5 m-70 -81.97 165.82 20.38 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.0 0.429 . . . . 0.0 111.587 -176.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 34.4 mtmm -139.69 137.52 35.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.143 -172.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.585 HD22 ' HB2' ' A' ' 271' ' ' CYS . 14.9 tp -85.48 139.91 31.11 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.116 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.45 ' HB3' ' HB2' ' A' ' 285' ' ' LYS . 29.4 t30 -131.42 98.76 4.62 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.415 173.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.401 ' HA ' ' NE2' ' A' ' 284' ' ' GLN . 48.4 mt-10 -56.19 -30.53 62.39 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.214 -175.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.526 ' O ' ' HB ' ' A' ' 188' ' ' THR . 42.0 t -56.08 -29.78 27.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.189 -176.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 67.6 m -145.16 33.32 1.09 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.599 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 0.412 ' OE1' ' HB2' ' A' ' 257' ' ' CYS . 35.6 mm-40 32.28 45.15 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.914 -1.039 . . . . 0.0 113.474 -174.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 51.1 mttp -88.13 154.84 20.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.006 0.431 . . . . 0.0 111.95 -176.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 5.4 m -139.42 80.81 1.8 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.089 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 33.7 tt0 . . . . . 0 N--CA 1.44 -0.964 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.473 0.719 0 CA-C-O 121.095 0.474 . . . . 0.0 110.017 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.493 ' HB1' ' SG ' ' A' ' 129' ' ' CYS . . . -119.08 -11.5 9.63 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.173 177.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' A' ' 119' ' ' CYS . 11.4 p -101.7 127.67 48.35 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.282 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -100.73 -177.13 3.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.061 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.9 t -64.67 -50.39 67.23 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.096 0.474 . . . . 0.0 110.475 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 65.9 mt -87.68 -49.89 14.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.991 0.424 . . . . 0.0 110.383 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -87.4 94.82 9.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.101 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -79.51 160.09 26.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.175 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 113' ' ' SER . 41.5 t -173.1 139.24 0.8 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -177.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -123.97 -27.71 3.87 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.336 0.589 . . . . 0.0 110.279 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.477 HD13 ' H ' ' A' ' 121' ' ' ILE . 0.3 OUTLIER -77.79 -168.27 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.772 -176.261 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.492 ' HD3' ' H ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -121.48 134.47 55.07 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.266 0.555 . . . . 0.0 110.67 -177.444 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 72.4 m -106.37 124.62 49.87 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.694 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -115.3 150.75 35.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.206 174.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 70.88 52.61 0.28 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.295 0.569 . . . . 0.0 111.344 176.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 64.51 30.38 77.73 Favored Glycine 0 C--O 1.224 -0.472 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.037 176.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -77.21 133.39 13.22 Favored Glycine 0 N--CA 1.428 -1.871 0 C-N-CA 120.017 -1.087 . . . . 0.0 111.93 -176.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.7 m -89.7 124.53 34.69 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 174.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.493 ' SG ' ' HB1' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -62.1 148.64 43.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.196 -171.385 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.617 ' HB2' ' O ' ' A' ' 133' ' ' HIS . 39.8 m -144.25 169.57 17.65 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.406 ' HB3' ' H ' ' A' ' 132' ' ' ASP . 9.9 t70 -41.24 -81.0 0.01 OUTLIER 'General case' 0 C--O 1.245 0.821 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.406 ' H ' ' HB3' ' A' ' 131' ' ' ASP . 3.9 p-10 -90.84 -40.3 11.85 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.964 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.617 ' O ' ' HB2' ' A' ' 130' ' ' SER . 0.3 OUTLIER -111.67 -170.55 1.67 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.886 -176.008 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 35.0 t -122.81 150.32 42.98 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.334 176.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.3 mt -100.31 95.05 6.51 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.932 0.872 . . . . 0.0 109.704 176.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 3.3 m -60.9 163.73 5.51 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.324 -175.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -64.79 155.45 33.82 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 170.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -66.39 114.4 5.39 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 122.571 1.177 . . . . 0.0 110.668 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 148' ' ' PRO . . . 114.92 4.61 20.97 Favored Glycine 0 C--N 1.294 -1.783 0 CA-C-N 112.831 -1.986 . . . . 0.0 111.234 -175.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.691 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 55.7 m-85 -125.0 154.46 41.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.772 0.32 . . . . 0.0 110.412 171.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.512 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 36.0 pt -138.81 -177.81 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.718 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.805 177.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.38 164.05 22.73 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.363 -175.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 43.5 p -78.16 -39.93 39.39 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.931 0.396 . . . . 0.0 110.905 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -98.67 -10.57 23.07 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.472 176.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 71.4 m 78.99 154.63 0.14 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.054 -1.43 . . . . 0.0 113.476 174.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.453 ' O ' ' HD3' ' A' ' 148' ' ' PRO . . . 132.41 2.4 4.08 Favored Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 112.913 -1.949 . . . . 0.0 113.808 175.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.573 HE21 ' C ' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -93.31 104.72 13.04 Favored Pre-proline 0 C--N 1.317 -0.806 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.199 174.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 146' ' ' GLY . 68.8 Cg_endo -82.71 149.96 14.41 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.4 2.066 . . . . 0.0 112.325 -175.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 149' ' ' VAL . 10.6 p -78.89 105.93 8.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 122.439 1.114 . . . . 0.0 112.611 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.06 80.15 6.51 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.155 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -56.23 -67.84 0.26 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -172.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 37.6 m -89.18 7.02 37.38 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.166 0.508 . . . . 0.0 111.392 -167.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 73.6 128.06 0.13 Allowed Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.016 -172.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.58 ' O ' HD23 ' A' ' 155' ' ' LEU . 57.1 m -71.22 164.09 26.34 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 113.944 -1.128 . . . . 0.0 109.309 176.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.731 HD12 ' O ' ' A' ' 176' ' ' GLN . 68.7 mt -139.96 162.74 34.46 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.697 -167.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.741 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 2.4 t-20 53.35 26.08 5.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.659 0.743 . . . . 0.0 110.475 -167.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.63 37.24 94.14 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.119 -1.038 . . . . 0.0 112.007 -174.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.46 -147.13 0.51 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.08 134.63 9.63 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 117.591 0.695 . . . . 0.0 110.477 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 166' ' ' CYS . 0.5 OUTLIER -75.43 110.41 9.78 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.246 0.546 . . . . 0.0 110.514 175.133 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 165' ' ' ARG . 2.9 m -95.43 -29.59 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.521 0.677 . . . . 0.0 110.349 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.681 ' HB3' ' CB ' ' A' ' 165' ' ' ARG . . . -139.12 173.71 4.9 Favored Pre-proline 0 N--CA 1.451 -0.417 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.691 ' HD3' ' CE1' ' A' ' 140' ' ' TYR . 78.2 Cg_exo -54.54 105.07 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.199 1.933 . . . . 0.0 112.051 176.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 26.0 t30 66.2 9.83 6.63 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.097 0.959 . . . . 0.0 110.629 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.681 ' CB ' ' HB3' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -98.92 82.69 2.8 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.43 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 160' ' ' CYS . 74.1 m -82.26 148.17 28.52 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.414 174.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -99.23 131.14 45.47 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 58.2 m -102.65 132.09 48.99 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 123.877 0.736 . . . . 0.0 111.302 -169.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.741 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 19.7 m -47.68 -54.47 11.95 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -168.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.514 ' HD2' ' N ' ' A' ' 171' ' ' GLY . 5.6 t80 -157.65 -83.53 0.05 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 118.716 -1.194 . . . . 0.0 112.51 -170.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.514 ' N ' ' HD2' ' A' ' 170' ' ' TYR . . . -97.69 49.96 1.42 Allowed Glycine 0 CA--C 1.496 -1.151 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.262 -166.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 156' ' ' ASN . 10.2 m-85 -116.79 129.43 56.1 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 118.529 -1.268 . . . . 0.0 113.461 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.627 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 3.3 t -97.29 143.78 27.72 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.438 173.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' A' ' 176' ' ' GLN . . . 93.3 130.75 5.64 Favored Glycine 0 C--N 1.297 -1.628 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 -175.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.21 17.95 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.611 1.54 . . . . 0.0 112.914 -169.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.731 ' O ' HD12 ' A' ' 155' ' ' LEU . 65.8 tt0 -128.15 12.14 6.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.211 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.508 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.8 OUTLIER 27.17 59.08 0.09 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 116.885 2.18 . . . . 0.0 116.885 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.469 ' C ' ' HD2' ' A' ' 179' ' ' ARG . 2.3 pt-20 -109.85 16.18 22.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.24 1.019 . . . . 0.0 109.352 169.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.469 ' HD2' ' C ' ' A' ' 178' ' ' GLU . 19.3 mmm180 -120.39 91.1 3.46 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.409 -178.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -89.11 86.69 6.95 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.164 0.983 . . . . 0.0 111.853 -170.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.627 ' HE2' ' N ' ' A' ' 173' ' ' THR . 32.4 p90 -116.89 96.2 5.36 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 175.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -74.04 130.73 40.41 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 119.49 -2.006 . . . . 0.0 108.222 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 67.6 p -79.99 168.06 19.68 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.06 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.517 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . 158.16 148.09 5.04 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.316 -164.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -76.25 132.8 14.14 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.15 1.9 . . . . 0.0 111.922 174.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.426 ' CB ' HD12 ' A' ' 202' ' ' ILE . 13.6 t -88.4 116.67 26.79 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . 0.638 ' CD2' ' HB2' ' A' ' 195' ' ' CYS . 16.1 m-85 -102.93 152.56 21.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.362 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.67 ' HA ' ' HB3' ' A' ' 215' ' ' ARG . 20.0 p -103.28 -54.9 2.51 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.1 p -140.54 120.03 12.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 O-C-N 120.914 -1.116 . . . . 0.0 112.645 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.466 HG13 ' SG ' ' A' ' 195' ' ' CYS . 2.1 mp -97.84 116.07 39.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-O 121.907 0.861 . . . . 0.0 111.612 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.0 p -106.86 -167.93 1.34 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 158.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -72.08 -4.83 31.19 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.367 0.604 . . . . 0.0 109.759 172.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -88.89 -69.8 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.482 -173.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.556 ' HG3' ' H ' ' A' ' 196' ' ' GLN . 33.0 tpp -162.99 135.62 5.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.189 -176.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.638 ' HB2' ' CD2' ' A' ' 187' ' ' PHE . 3.2 m -68.31 -19.41 64.67 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.877 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.604 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 44.8 mm-40 93.08 113.85 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.954 1.302 . . . . 0.0 113.34 173.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.04 -9.58 9.63 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.262 174.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 54.18 48.68 20.36 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.762 0.315 . . . . 0.0 110.82 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 6.6 mp 55.57 70.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.815 -175.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 46.3 t -72.2 148.36 45.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.475 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.33 21.55 12.71 Favored Glycine 0 CA--C 1.508 -0.366 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.898 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 254' ' ' PRO . 0.0 OUTLIER -65.3 98.12 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 163.699 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.39 118.66 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.383 0 CA-C-N 113.819 -1.537 . . . . 0.0 109.072 -175.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 10.1 t -158.11 -178.16 7.09 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 -175.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.477 HG21 ' HA ' ' A' ' 181' ' ' TYR . 26.7 p -108.24 168.44 9.3 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 120.278 1.399 . . . . 0.0 111.33 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.614 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 47.1 tttp -57.71 -44.33 85.84 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.406 174.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.1 m -47.01 -56.04 7.13 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.004 176.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.434 ' HG ' ' HB1' ' A' ' 252' ' ' ALA . 0.2 OUTLIER -58.75 -55.33 36.47 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.206 178.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 84.7 m -67.36 -23.75 65.63 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -172.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 227' ' ' GLN . 16.3 m -104.75 -26.69 12.17 Favored 'General case' 0 N--CA 1.429 -1.524 0 O-C-N 121.149 -0.969 . . . . 0.0 111.686 -175.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . . . -71.8 -56.99 4.75 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 170.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.681 HG22 ' HA2' ' A' ' 234' ' ' GLY . 6.0 p -100.23 156.22 17.34 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.592 -1.64 . . . . 0.0 107.16 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.2 t 68.0 -39.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 118.841 -0.599 . . . . 0.0 111.713 -177.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 65.12 49.71 60.79 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 119.061 0.846 . . . . 0.0 113.499 166.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.67 ' HB3' ' HA ' ' A' ' 188' ' ' THR . 31.3 mmt180 -127.7 -90.37 0.52 Allowed 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 120.527 -0.469 . . . . 0.0 112.206 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.515 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -165.83 164.96 18.64 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -177.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . 0.834 ' O ' ' HB2' ' A' ' 222' ' ' GLU . 7.0 t90 -168.29 139.55 2.74 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 127.7 167.72 12.34 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 119.634 -1.27 . . . . 0.0 114.53 172.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 220' ' ' PRO . 11.7 p80 -132.8 132.18 22.42 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.219 -0.491 . . . . 0.0 109.992 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 219' ' ' HIS . 2.4 Cg_endo -82.46 117.09 4.83 Favored 'Cis proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.011 -1.662 . . . . 0.0 111.61 -3.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . 0.418 ' SG ' ' CG1' ' A' ' 190' ' ' ILE . 34.1 t 39.0 92.89 0.01 OUTLIER 'General case' 0 C--O 1.243 0.751 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 175.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.834 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 34.7 mt-10 -105.48 110.12 22.34 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' MET . . . . . 0.515 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 2.8 tpt -90.31 138.74 31.29 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -173.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 54.6 m -111.48 129.49 24.05 Favored Pre-proline 0 C--O 1.234 0.277 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -169.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -80.03 151.12 20.97 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.513 2.809 . . . . 0.0 111.641 166.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.423 ' HB1' ' NE2' ' A' ' 227' ' ' GLN . . . 37.21 -86.54 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.276 0 O-C-N 124.799 1.312 . . . . 0.0 114.281 174.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' GLN . . . . . 0.423 ' NE2' ' HB1' ' A' ' 226' ' ' ALA . 0.0 OUTLIER -172.66 166.63 3.26 Favored Pre-proline 0 N--CA 1.44 -0.932 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -168.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 211' ' ' ALA . 4.6 Cg_exo -80.08 -85.91 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 121.884 1.722 . . . . 0.0 112.424 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -75.48 154.38 85.77 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.083 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -81.7 52.81 4.37 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.821 1.681 . . . . 0.0 113.775 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 71.9 m -104.78 -179.69 4.02 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 171.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.616 ' HB3' ' CD2' ' A' ' 235' ' ' PHE . 73.0 ttt180 -67.53 140.95 57.02 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 170.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.405 ' O ' HG22 ' A' ' 212' ' ' THR . 98.8 mtt180 -38.67 -50.92 1.66 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -175.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.681 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -70.26 9.27 3.28 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.41 -0.9 . . . . 0.0 114.145 -174.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . 0.616 ' CD2' ' HB3' ' A' ' 232' ' ' ARG . 5.3 m-85 -123.99 153.68 40.93 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 122.31 1.052 . . . . 0.0 113.721 -171.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.538 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.0 OUTLIER -130.19 133.23 24.7 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 113.619 -1.628 . . . . 0.0 108.227 168.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.76 116.39 3.52 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.329 2.019 . . . . 0.0 112.382 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -49.14 132.36 19.38 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.6 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 37.6 pt -73.8 1.2 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.316 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -111.89 -55.49 2.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.422 0.63 . . . . 0.0 110.181 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 66.3 p -92.96 -38.67 11.55 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.417 -175.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 98.33 4.47 57.35 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.394 -175.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -83.75 124.95 31.42 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 121.673 0.749 . . . . 0.0 109.662 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 10.8 m -57.91 114.69 2.44 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 113.446 -1.707 . . . . 0.0 109.401 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -117.1 141.07 48.72 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.623 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 16.3 t70 -76.32 146.27 38.97 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -175.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.668 ' CG2' HG21 ' A' ' 212' ' ' THR . 4.4 m -96.78 151.65 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.983 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.87 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.534 ' OD1' ' HB2' ' A' ' 250' ' ' CYS . 6.3 t0 -78.98 81.07 5.28 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 167.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.648 ' HG3' HG23 ' A' ' 247' ' ' VAL . 2.1 mp0 -52.57 -32.05 39.19 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 123.901 0.751 . . . . 0.0 110.467 -173.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.534 ' HB2' ' OD1' ' A' ' 248' ' ' ASP . 58.0 m -55.04 -42.79 73.09 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.676 172.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -89.96 -33.48 16.38 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 122.29 1.043 . . . . 0.0 109.581 -175.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.434 ' HB1' ' HG ' ' A' ' 208' ' ' LEU . . . -79.27 -23.3 43.71 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.087 -174.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.672 ' O ' ' HB3' ' A' ' 256' ' ' LEU . 5.3 mp -132.58 79.21 65.31 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 176.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.468 ' O ' HG13 ' A' ' 202' ' ' ILE . 75.8 Cg_exo -55.57 153.93 27.23 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 121.776 1.651 . . . . 0.0 112.289 177.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 78.55 -19.18 5.04 Favored Glycine 0 C--N 1.316 -0.579 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.833 -174.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.672 ' HB3' ' O ' ' A' ' 253' ' ' ILE . 2.1 tt -76.04 115.19 15.51 Favored 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 122.425 -0.456 . . . . 0.0 109.847 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 37.3 t 63.33 19.37 11.64 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.171 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -84.31 56.22 3.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.761 0.791 . . . . 0.0 110.259 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -120.81 7.52 10.99 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 173.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -179.14 -117.47 0.54 Allowed Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -117.4 116.35 27.0 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 17.7 p -108.36 157.86 18.01 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 170.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 21.1 mt -145.49 156.64 13.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -170.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.588 HD21 ' HB2' ' A' ' 249' ' ' GLU . 0.4 OUTLIER -127.2 124.81 39.85 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -173.431 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.6 t -114.54 170.95 7.94 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.191 165.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.623 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 34.6 m -67.59 127.41 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 CA-C-O 121.826 0.822 . . . . 0.0 110.723 -176.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 88.38 -14.75 58.7 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-O 119.007 -0.885 . . . . 0.0 113.554 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 75.3 m -169.9 148.64 3.54 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 118.051 0.925 . . . . 0.0 110.52 -172.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . 0.449 ' HD2' ' OE2' ' A' ' 249' ' ' GLU . 26.8 p90 -105.37 152.4 23.0 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.64 -0.662 . . . . 0.0 110.384 174.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.88 126.52 52.03 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 -177.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . 0.485 ' SG ' HD22 ' A' ' 279' ' ' LEU . 18.4 m -106.22 152.06 23.97 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.815 0.817 . . . . 0.0 113.162 -176.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -141.52 96.93 3.06 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.59 171.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 11.7 m -83.55 164.87 43.15 Favored Pre-proline 0 C--N 1.314 -0.952 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 33.8 Cg_exo -57.32 165.92 5.09 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.939 1.76 . . . . 0.0 111.385 176.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -53.7 137.22 38.07 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.356 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 82.87 -31.07 3.11 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.458 -178.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' HIS . . . . . 0.546 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 15.8 m-70 -74.2 163.18 28.15 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.604 0.24 . . . . 0.0 111.352 -177.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -148.01 148.22 30.47 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.551 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 16.3 tp -82.16 141.36 33.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.377 . . . . 0.0 110.817 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -133.14 98.98 4.41 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.001 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -61.45 -23.26 65.74 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.465 0.478 . . . . 0.0 112.164 -174.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.27 -18.06 17.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.327 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 44.4 m -152.4 31.39 0.53 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.791 175.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 25.1 46.3 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.04 1.336 . . . . 0.0 113.808 -173.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 68.3 tttt -98.35 167.53 10.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.361 -171.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 1.8 m -144.43 83.41 1.72 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.546 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 36.4 tt0 . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.779 -0.629 . . . . 0.0 110.092 -171.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 25.8 p . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.74 -19.25 55.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.127 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.8 t -75.1 -18.03 60.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.616 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -100.75 141.65 33.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.755 0.312 . . . . 0.0 110.791 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.9 m -77.13 80.77 3.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.336 0.589 . . . . 0.0 110.299 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 35.3 pt -69.21 145.95 12.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.759 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -121.07 174.77 6.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.005 -177.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -73.23 -33.65 65.44 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 23.2 p -99.95 -175.99 3.12 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.374 174.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -122.49 -47.78 2.09 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.796 0.331 . . . . 0.0 110.62 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.513 ' HA ' ' NH1' ' A' ' 122' ' ' ARG . 0.2 OUTLIER -59.82 174.72 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -175.15 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.712 ' HD2' ' N ' ' A' ' 122' ' ' ARG . 0.9 OUTLIER -111.75 140.93 45.98 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.979 -1.464 . . . . 0.0 110.346 -173.215 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 58.0 m -114.69 130.67 56.85 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 58.5 mtm -139.09 162.45 34.91 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 175.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 67.62 51.44 0.83 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.991 0.424 . . . . 0.0 111.521 174.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 72.34 32.57 62.34 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.078 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' A' ' 136' ' ' CYS . . . -91.62 146.2 18.14 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.521 -176.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.9 m -122.33 132.33 54.34 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 172.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 4.4 t -88.84 116.8 27.38 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.246 -171.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.447 ' O ' ' HD2' ' A' ' 133' ' ' HIS . 21.1 t -144.33 137.79 27.41 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.45 ' HB3' ' CD2' ' A' ' 133' ' ' HIS . 8.5 t70 52.64 32.91 12.63 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.891 0.853 . . . . 0.0 112.589 173.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.428 ' OD1' HG23 ' A' ' 121' ' ' ILE . 21.5 t0 52.35 46.66 26.25 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.693 -1.594 . . . . 0.0 111.088 -178.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.45 ' CD2' ' HB3' ' A' ' 131' ' ' ASP . 0.3 OUTLIER -166.69 117.89 0.95 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 114.429 -1.259 . . . . 0.0 108.383 170.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.462 ' SG ' ' SG ' ' A' ' 136' ' ' CYS . 5.9 t -69.72 130.87 43.52 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.13 -166.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 76.7 mt -106.35 105.12 15.0 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . 0.542 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 61.8 m -109.52 -96.49 0.4 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -161.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -152.08 145.83 25.07 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.082 -166.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.492 ' HD3' ' O ' ' A' ' 138' ' ' LYS . 1.1 tmtp? -67.43 113.71 5.52 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 122.483 1.135 . . . . 0.0 110.384 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 113.35 3.35 24.25 Favored Glycine 0 N--CA 1.43 -1.714 0 CA-C-N 113.113 -1.858 . . . . 0.0 112.296 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.592 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 75.3 m-85 -125.03 143.79 50.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.174 0.487 . . . . 0.0 109.901 172.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.547 ' O ' ' HA ' ' A' ' 145' ' ' CYS . 23.2 pt -139.82 178.42 3.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 CA-C-O 121.311 0.577 . . . . 0.0 111.214 -173.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.53 165.95 40.39 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.805 -169.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.9 m -70.73 -31.81 68.77 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.015 0.407 . . . . 0.0 110.785 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -89.84 -8.71 51.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.187 0.518 . . . . 0.0 109.927 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 141' ' ' ILE . 73.3 m 57.22 41.52 26.78 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.909 -175.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.23 2.3 59.42 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.588 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.502 ' O ' HG12 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -109.51 104.39 55.17 Favored Pre-proline 0 C--N 1.329 -0.298 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.809 178.667 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.61 142.46 20.61 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.466 2.111 . . . . 0.0 111.661 177.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 149' ' ' VAL . 8.8 p -66.64 106.72 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 122.569 1.176 . . . . 0.0 112.137 -173.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 20.8 m -80.23 66.1 5.61 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.831 173.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -52.16 -53.26 45.2 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.593 0.961 . . . . 0.0 113.593 -171.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 36.6 m -93.87 8.92 39.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.435 0.636 . . . . 0.0 110.576 -170.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 77.28 134.29 0.66 Allowed Glycine 0 N--CA 1.427 -1.964 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.266 -172.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.44 ' O ' HD23 ' A' ' 155' ' ' LEU . 0.1 OUTLIER -69.64 154.85 41.41 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.743 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.574 HD12 ' O ' ' A' ' 176' ' ' GLN . 42.7 mt -126.78 170.28 12.33 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -173.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.521 HD22 ' C ' ' A' ' 155' ' ' LEU . 0.1 OUTLIER 36.49 35.55 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.731 1.269 . . . . 0.0 113.598 -172.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.36 34.23 67.66 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.003 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -75.52 -151.54 3.17 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-O 121.466 0.481 . . . . 0.0 114.031 -172.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.553 ' HG2' ' HB3' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -145.7 122.41 11.18 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.102 0.477 . . . . 0.0 110.567 -179.146 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 166' ' ' CYS . 19.1 m -68.79 112.12 5.31 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.833 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 165' ' ' ARG . 3.8 m -92.39 -33.28 5.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.071 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.562 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -139.88 177.03 2.18 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.592 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 77.7 Cg_exo -53.55 111.64 0.74 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 121.73 1.62 . . . . 0.0 112.496 176.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 61.54 12.7 4.63 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.94 0.896 . . . . 0.0 110.879 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.562 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.4 OUTLIER -103.68 78.25 1.55 Allowed 'General case' 0 CA--C 1.499 -1.003 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.082 178.014 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 160' ' ' CYS . 59.6 m -71.68 152.93 42.41 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.744 0.783 . . . . 0.0 110.54 171.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.553 ' HB3' ' HG2' ' A' ' 159' ' ' ARG . . . -106.28 141.72 37.15 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.629 169.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.442 ' HA ' HD21 ' A' ' 156' ' ' ASN . 29.2 m -97.68 128.68 44.54 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 124.346 1.029 . . . . 0.0 112.072 -163.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 77.9 m -62.96 -55.72 23.38 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 171' ' ' GLY . 40.1 t80 -128.18 -119.73 0.24 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 118.746 -1.181 . . . . 0.0 112.373 -169.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.401 ' N ' ' CD1' ' A' ' 170' ' ' TYR . . . -87.7 54.7 4.39 Favored Glycine 0 N--CA 1.428 -1.853 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.321 -167.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.564 ' HB2' ' HB3' ' A' ' 177' ' ' CYS . 5.1 m-85 -119.14 122.24 41.59 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 119.247 -0.981 . . . . 0.0 112.331 173.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.572 ' N ' ' HE1' ' A' ' 181' ' ' TYR . 2.9 t -88.09 157.51 18.84 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 167.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.1 128.48 3.29 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -177.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.06 -0.07 7.4 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.498 1.465 . . . . 0.0 113.467 -166.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.574 ' O ' HD12 ' A' ' 155' ' ' LEU . 41.7 tt0 -109.71 8.35 24.71 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.564 ' HB3' ' HB2' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 32.87 57.09 0.44 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 177.222 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -114.06 -15.73 12.23 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.877 173.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 173' ' ' THR . 19.3 mmt180 -57.58 -68.92 0.19 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.157 -1.383 . . . . 0.0 108.645 -176.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.0 t70 78.38 92.64 0.06 Allowed 'General case' 0 CA--C 1.509 -0.626 0 O-C-N 124.132 0.895 . . . . 0.0 110.102 164.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.572 ' HE1' ' N ' ' A' ' 173' ' ' THR . 32.2 p90 -112.36 64.16 0.63 Allowed 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 173.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 25.7 tpt85 -42.42 121.15 1.85 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.408 171.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 38.9 p -82.28 136.63 35.01 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.347 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.509 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -159.92 155.47 26.59 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.048 -176.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -85.07 167.87 10.72 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.444 2.096 . . . . 0.0 111.847 172.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 69.6 m -116.92 121.06 40.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.155 0.502 . . . . 0.0 111.44 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . 0.761 ' O ' ' HB3' ' A' ' 215' ' ' ARG . 29.6 m-85 -93.36 131.71 38.27 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.555 ' HA ' ' CG ' ' A' ' 215' ' ' ARG . 19.0 m -89.32 -15.16 34.07 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 113.944 1.091 . . . . 0.0 113.944 -163.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.1 p -165.11 117.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.066 -174.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.548 HD11 ' HB3' ' A' ' 216' ' ' ALA . 6.7 mt -123.7 118.35 53.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -171.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 7.3 p -114.77 -167.11 1.18 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.419 160.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -68.07 -4.08 12.35 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.434 0.635 . . . . 0.0 110.275 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -75.55 -69.97 0.45 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.307 -177.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 22.4 ttt -169.7 152.68 4.68 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.542 ' HA ' HG12 ' A' ' 190' ' ' ILE . 21.8 m -77.24 -24.2 51.2 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 121.099 0.476 . . . . 0.0 111.475 -174.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 42.7 tt0 176.22 -92.1 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.845 173.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.418 ' H ' ' HB3' ' A' ' 196' ' ' GLN . . . 124.55 11.14 4.66 Favored Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.939 171.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -89.04 -12.7 40.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.204 0.526 . . . . 0.0 109.992 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 65.17 -85.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.996 -177.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 71.1 m 68.93 125.85 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.574 0.702 . . . . 0.0 112.48 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.07 30.25 4.01 Favored Glycine 0 CA--C 1.508 -0.358 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.127 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.432 HG12 ' HD2' ' A' ' 254' ' ' PRO . 0.0 OUTLIER -65.75 100.35 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.175 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 4.1 t -92.57 98.29 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-O 122.914 1.34 . . . . 0.0 109.751 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.573 ' OG ' HD23 ' A' ' 208' ' ' LEU . 8.4 t -117.69 179.94 3.92 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.659 -2.064 . . . . 0.0 105.976 169.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 19.0 p -107.63 161.93 14.42 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.399 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.515 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 46.3 tttm -61.91 -43.62 98.46 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.13 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 8.4 m -44.76 -55.13 5.59 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 122.22 1.009 . . . . 0.0 109.415 173.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.81 HD11 HG11 ' A' ' 247' ' ' VAL . 6.0 tp -63.7 -52.25 61.41 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.294 -1.775 . . . . 0.0 112.344 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 4.7 t -64.3 -37.29 86.97 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.441 0.638 . . . . 0.0 110.479 -175.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 52.2 m -85.07 -23.82 28.37 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.626 -177.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . 0.556 ' HA ' ' CD ' ' A' ' 228' ' ' PRO . . . -69.88 -52.75 22.12 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 173.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 214' ' ' GLY . 80.8 p -64.77 -156.43 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 113.101 -1.863 . . . . 0.0 111.85 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.61 HG11 HE21 ' A' ' 284' ' ' GLN . 1.6 t -44.25 -1.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.349 0 N-CA-C 116.276 1.954 . . . . 0.0 116.276 -176.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 212' ' ' THR . . . 85.72 -101.97 2.61 Favored Glycine 0 CA--C 1.507 -0.457 0 C-N-CA 119.086 -1.53 . . . . 0.0 113.549 175.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.761 ' HB3' ' O ' ' A' ' 187' ' ' PHE . 0.8 OUTLIER 50.78 -120.33 1.56 Allowed 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.143 0.497 . . . . 0.0 110.34 -169.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.548 ' HB3' HD11 ' A' ' 190' ' ' ILE . . . -158.44 159.88 36.19 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 172.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . 0.515 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 26.9 t90 -136.07 146.33 46.94 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -174.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 82.25 177.44 51.87 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.735 171.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.608 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 8.0 p80 -143.01 133.4 12.26 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.626 -0.287 . . . . 0.0 110.252 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.608 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 41.4 Cg_exo -57.8 154.03 34.38 Favored 'Cis proline' 0 C--N 1.345 0.366 0 C-N-CA 123.667 -1.389 . . . . 0.0 112.119 -3.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 9.5 m -49.54 123.01 6.97 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.193 -171.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 37.1 mt-10 -105.87 102.49 11.92 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' MET . . . . . 0.532 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 17.7 ptm -85.73 137.64 32.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.576 -169.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 99.3 m -135.3 143.17 44.39 Favored Pre-proline 0 C--O 1.235 0.294 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -171.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -64.45 169.17 11.53 Favored 'Trans proline' 0 CA--C 1.512 -0.579 0 C-N-CA 122.788 2.325 . . . . 0.0 110.346 155.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.0 -129.67 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.808 168.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' GLN . . . . . 0.405 ' H ' ' HG3' ' A' ' 227' ' ' GLN . 0.1 OUTLIER -46.95 102.61 0.32 Allowed Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -166.318 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.556 ' CD ' ' HA ' ' A' ' 211' ' ' ALA . 63.9 Cg_endo -82.39 -59.68 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.628 2.218 . . . . 0.0 112.389 176.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.416 ' HB3' ' HD2' ' A' ' 230' ' ' PRO . 90.1 m-70 -70.87 159.6 84.9 Favored Pre-proline 0 CA--C 1.515 -0.368 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 229' ' ' HIS . 73.3 Cg_endo -78.91 58.25 6.81 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 121.706 1.604 . . . . 0.0 113.381 -174.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 43.0 m -135.43 -173.83 3.46 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.683 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 25.7 mmt180 -73.19 144.74 46.7 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.315 174.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -39.29 -42.96 1.08 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.581 ' O ' ' HA ' ' A' ' 246' ' ' ASP . . . -77.72 7.72 39.74 Favored Glycine 0 C--O 1.222 -0.612 0 C-N-CA 120.342 -0.933 . . . . 0.0 113.187 -176.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . 0.683 ' CD1' ' HB2' ' A' ' 232' ' ' ARG . 3.3 m-85 -120.42 143.0 48.7 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.865 0.84 . . . . 0.0 112.706 -171.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.464 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.5 OUTLIER -122.59 131.5 24.37 Favored Pre-proline 0 N--CA 1.439 -0.987 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.082 175.762 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -65.66 113.76 2.65 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.051 1.834 . . . . 0.0 111.356 174.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -49.21 135.9 16.08 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 123.492 0.717 . . . . 0.0 111.581 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 29.5 pt -75.63 2.87 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.165 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 240' ' ' ARG . 49.8 mtm180 -113.29 -56.51 2.4 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.973 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 35.0 p -95.91 -40.56 9.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.749 -174.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 99.44 5.63 55.6 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -175.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -79.01 134.01 36.8 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.806 0.812 . . . . 0.0 110.128 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 4.6 m -68.96 113.99 6.85 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.022 -1.445 . . . . 0.0 109.299 173.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.543 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 89.3 mt-30 -116.33 141.26 48.39 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.675 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 12.5 t70 -77.58 144.65 37.38 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.81 HG11 HD11 ' A' ' 208' ' ' LEU . 4.3 m -95.56 146.11 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.082 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -178.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.442 ' HA ' ' ND2' ' A' ' 264' ' ' ASN . 4.9 m-20 -73.88 75.98 1.64 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 169.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.69 ' HG3' HG23 ' A' ' 247' ' ' VAL . 14.4 mp0 -52.5 -37.12 56.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 123.931 0.77 . . . . 0.0 110.776 -168.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 52.7 m -49.24 -38.71 27.6 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.866 174.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -101.21 -35.78 9.16 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.879 0.847 . . . . 0.0 110.565 -176.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.651 ' HB1' HD21 ' A' ' 208' ' ' LEU . . . -70.38 -20.1 62.97 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.33 -1.305 . . . . 0.0 110.459 -177.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.752 HG22 ' HB3' ' A' ' 256' ' ' LEU . 5.0 mp -137.29 77.63 41.16 Favored Pre-proline 0 N--CA 1.445 -0.703 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 169.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.432 ' HD2' HG12 ' A' ' 202' ' ' ILE . 9.8 Cg_endo -48.06 113.53 0.83 Allowed 'Trans proline' 0 CA--C 1.514 -0.508 0 C-N-CA 124.018 3.146 . . . . 0.0 114.39 -167.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 61.22 35.97 91.69 Favored Glycine 0 C--N 1.311 -0.824 0 CA-C-N 113.457 -1.702 . . . . 0.0 113.391 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.752 ' HB3' HG22 ' A' ' 253' ' ' ILE . 1.8 pt? -66.96 -23.1 65.92 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 117.367 0.584 . . . . 0.0 110.905 176.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 39.1 t -82.02 121.73 26.91 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 285' ' ' LYS . 59.1 tp60 -90.26 111.51 22.72 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -171.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 71.49 66.1 2.23 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.749 171.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 174.14 -170.17 43.27 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 119.967 -1.111 . . . . 0.0 112.792 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . 0.483 ' HB3' ' HB2' ' A' ' 272' ' ' LYS . 2.5 t-20 -88.79 159.08 17.92 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 21.2 t -141.49 125.03 16.71 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.423 HD11 ' OD1' ' A' ' 261' ' ' ASN . 18.2 mt -136.54 109.21 7.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.104 -170.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.442 ' ND2' ' HA ' ' A' ' 248' ' ' ASP . 65.9 t30 -72.17 117.17 13.46 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.281 -174.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.3 t -105.38 160.61 14.99 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 157.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.675 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 3.9 m -77.43 128.56 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 C-N-CA 118.344 -1.342 . . . . 0.0 107.924 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.658 ' N ' ' HE1' ' A' ' 235' ' ' PHE . . . 110.5 -30.79 7.88 Favored Glycine 0 C--N 1.311 -0.838 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.669 -170.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 31.7 m -179.11 158.36 0.9 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.079 0.939 . . . . 0.0 109.93 -168.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -104.96 152.36 22.78 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.818 -1.176 . . . . 0.0 108.63 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -107.45 127.89 54.01 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -176.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 261' ' ' ASN . 92.7 m -106.88 152.43 23.92 Favored 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.342 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 261' ' ' ASN . 7.4 mtpm? -124.07 100.03 6.53 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.033 175.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 4.3 m -81.81 149.32 63.42 Favored Pre-proline 0 C--N 1.31 -1.109 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.869 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 32.3 Cg_exo -56.57 162.31 8.48 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.08 1.854 . . . . 0.0 111.25 175.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -53.1 143.08 18.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.519 0.2 . . . . 0.0 111.059 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.49 -31.27 3.57 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.828 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' HIS . . . . . 0.601 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 14.4 m-70 -78.83 169.79 17.67 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 122.708 -0.289 . . . . 0.0 111.372 -177.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 56.5 mtpt -149.5 148.95 30.01 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 39.6 tp -84.94 136.11 33.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.075 0.464 . . . . 0.0 110.534 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -125.71 100.29 6.36 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 174.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.27 -21.11 61.52 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.829 0.705 . . . . 0.0 112.185 -174.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 68.3 t -60.47 -34.07 56.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.177 0.513 . . . . 0.0 110.45 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.458 ' HA ' ' CG2' ' A' ' 188' ' ' THR . 20.3 p -132.97 23.49 4.21 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.55 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 0.61 HE21 HG11 ' A' ' 213' ' ' VAL . 12.5 mp0 29.62 46.63 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.062 -171.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 85.9 tttt -101.63 165.09 11.41 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.973 -172.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 5.7 m -140.89 88.42 2.18 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -177.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.601 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 7.1 tp10 . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.667 -0.682 . . . . 0.0 109.341 -173.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 N--CA 1.476 0.835 0 CA-C-O 120.763 0.316 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.06 -39.62 65.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.007 0.432 . . . . 0.0 110.53 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.8 p -97.07 150.06 21.25 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.271 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -92.92 -22.31 19.31 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.247 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 12.7 p -81.69 9.33 7.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.4 tp -87.8 -3.45 9.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.401 0.62 . . . . 0.0 109.985 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -63.58 117.4 6.73 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.788 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.478 ' O ' ' HB3' ' A' ' 119' ' ' CYS . 44.1 t-80 -70.23 -24.22 63.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.816 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 118' ' ' HIS . 53.2 t 74.86 145.41 0.08 Allowed 'General case' 0 C--O 1.235 0.291 0 O-C-N 123.983 0.802 . . . . 0.0 110.345 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -115.29 -32.59 5.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.764 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.606 HD12 ' O ' ' A' ' 132' ' ' ASP . 0.3 OUTLIER -92.84 -169.34 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-O 121.304 0.573 . . . . 0.0 112.518 -174.306 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.501 ' H ' ' HD2' ' A' ' 122' ' ' ARG . 0.1 OUTLIER -123.0 128.27 49.96 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.46 -179.157 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.754 ' SG ' ' HA3' ' A' ' 127' ' ' GLY . 3.9 t -117.69 149.13 41.25 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.777 -177.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -127.66 166.44 18.09 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.402 ' HB3' ' CE2' ' A' ' 140' ' ' TYR . 93.8 m-20 66.52 45.14 2.15 Favored 'General case' 0 N--CA 1.462 0.165 0 O-C-N 123.598 0.561 . . . . 0.0 111.693 173.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.534 ' O ' ' HG3' ' A' ' 137' ' ' GLN . . . 75.27 21.32 78.04 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.245 176.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.754 ' HA3' ' SG ' ' A' ' 123' ' ' CYS . . . -79.11 114.38 3.88 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.949 -177.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 24.4 m -72.19 126.09 28.92 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 119' ' ' CYS . 0.0 OUTLIER -66.83 144.78 56.09 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.891 -173.798 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.762 ' HB2' ' O ' ' A' ' 133' ' ' HIS . 34.6 m -144.14 170.85 15.18 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -28.21 -94.51 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 O-C-N 125.036 1.46 . . . . 0.0 114.392 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.606 ' O ' HD12 ' A' ' 121' ' ' ILE . 35.9 m-20 -88.42 -38.6 14.92 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.663 176.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.762 ' O ' ' HB2' ' A' ' 130' ' ' SER . 0.3 OUTLIER -132.69 133.51 43.63 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.616 -176.34 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 24.7 p -75.12 160.24 30.69 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.118 -174.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 65.3 mt -96.57 138.06 34.72 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 71.3 m -91.3 156.17 17.99 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.548 -174.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 126' ' ' GLY . 44.6 mt-30 -80.48 145.12 32.04 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 167.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -62.9 113.54 3.12 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 122.658 1.218 . . . . 0.0 111.176 -172.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 128.68 -1.69 6.42 Favored Glycine 0 N--CA 1.433 -1.503 0 CA-C-N 112.625 -2.08 . . . . 0.0 111.314 -176.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.617 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 98.8 m-85 -121.1 149.47 42.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.343 0.572 . . . . 0.0 110.7 171.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.446 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 30.0 pt -132.88 174.6 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.967 177.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.99 174.15 33.23 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.737 -175.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.5 p -75.89 -29.74 58.57 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -111.32 12.61 21.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.34 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 46.2 m 59.67 35.91 22.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.091 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.59 -12.2 72.91 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.613 -0.721 . . . . 0.0 113.347 -174.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.446 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 0.0 OUTLIER -111.28 110.42 56.05 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 117.336 0.568 . . . . 0.0 110.718 -176.552 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.37 147.85 18.3 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.931 2.421 . . . . 0.0 112.489 178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 149' ' ' VAL . 12.4 p -75.14 109.87 8.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.943 0.878 . . . . 0.0 111.035 -176.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.24 77.54 5.75 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.24 173.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.412 ' OE1' ' HB2' ' A' ' 164' ' ' ASN . 49.0 mt-10 -56.54 -59.04 5.57 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -170.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.1 m -90.28 10.77 23.49 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.442 0.639 . . . . 0.0 111.267 -170.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 82.43 126.58 0.98 Allowed Glycine 0 N--CA 1.43 -1.761 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.654 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.521 ' O ' HD23 ' A' ' 155' ' ' LEU . 3.6 m -71.94 153.51 41.79 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 113.854 -1.173 . . . . 0.0 109.559 171.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.521 HD23 ' O ' ' A' ' 154' ' ' CYS . 83.2 mt -141.3 172.7 12.32 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -169.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.715 ' ND2' ' HB2' ' A' ' 177' ' ' CYS . 8.5 p30 43.39 24.62 0.05 Allowed 'General case' 0 N--CA 1.478 0.949 0 O-C-N 124.108 0.88 . . . . 0.0 113.248 -174.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.1 36.8 93.71 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.199 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -73.76 -146.27 0.95 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 121.466 -0.397 . . . . 0.0 113.219 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.8 ttt85 -156.57 123.14 5.08 Favored 'General case' 0 C--O 1.222 -0.35 0 O-C-N 122.204 -0.586 . . . . 0.0 111.345 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 2.4 m -61.38 116.0 4.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.897 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 165' ' ' ARG . 11.2 m -102.1 -50.1 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.803 178.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.492 ' HB1' ' HD2' ' A' ' 163' ' ' PRO . . . -127.7 172.9 6.06 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.802 171.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.617 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 74.0 Cg_exo -51.15 107.78 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.128 1.885 . . . . 0.0 112.531 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.412 ' HB2' ' OE1' ' A' ' 151' ' ' GLU . 8.6 t-20 76.53 -14.2 0.84 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.816 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.548 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.6 OUTLIER -80.73 85.55 6.07 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.251 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 13.5 t -83.06 143.64 30.45 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.756 173.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.42 ' HB2' ' CG1' ' A' ' 161' ' ' VAL . . . -89.19 121.51 31.57 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 176.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 55.8 m -94.38 123.69 37.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.115 -169.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 170' ' ' TYR . 85.1 m -53.74 -48.83 69.27 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 114.211 -1.359 . . . . 0.0 113.16 -170.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.429 ' HE2' ' H ' ' A' ' 183' ' ' THR . 10.0 t80 177.54 115.95 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.929 -175.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 78.76 43.44 11.61 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 120.356 -0.926 . . . . 0.0 113.522 169.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.662 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 25.2 m-85 -124.8 128.25 48.43 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 117.951 0.876 . . . . 0.0 112.39 168.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.886 HG23 ' CE2' ' A' ' 181' ' ' TYR . 43.5 p -88.48 137.33 32.42 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.279 177.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.45 141.66 10.78 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.43 6.27 1.97 Allowed 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.451 1.434 . . . . 0.0 112.473 -170.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.499 ' O ' HD12 ' A' ' 155' ' ' LEU . 11.8 pt20 -129.3 24.64 5.52 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.32 177.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.715 ' HB2' ' ND2' ' A' ' 156' ' ' ASN . 0.0 OUTLIER 32.97 73.83 0.06 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 175.755 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -120.18 16.14 12.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.109 0.481 . . . . 0.0 111.406 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.662 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 15.9 mmt85 -123.33 96.26 4.92 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.547 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -80.05 84.36 5.79 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 122.241 1.02 . . . . 0.0 109.891 -173.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.886 ' CE2' HG23 ' A' ' 173' ' ' THR . 28.4 p90 -114.3 84.15 2.0 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 175.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -77.52 127.17 32.06 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 118.766 -2.459 . . . . 0.0 107.825 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.429 ' H ' ' HE2' ' A' ' 170' ' ' TYR . 18.0 p -81.93 134.28 35.37 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.877 -178.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.462 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -152.88 155.1 25.93 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.872 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.73 136.24 29.97 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.68 2.254 . . . . 0.0 111.012 172.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.405 ' H ' HG23 ' A' ' 202' ' ' ILE . 5.8 t -108.28 115.65 30.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.92 0.391 . . . . 0.0 111.163 -174.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . 0.472 ' CE1' ' HA ' ' A' ' 198' ' ' GLN . 7.0 m-85 -95.54 160.4 14.53 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.512 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.505 HG21 ' HA ' ' A' ' 283' ' ' SER . 24.7 p -111.68 -16.11 13.3 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 -167.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 7.5 p -163.75 123.63 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 119.628 1.104 . . . . 0.0 112.394 -173.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.609 HG12 ' HA ' ' A' ' 195' ' ' CYS . 51.7 mt -126.46 115.97 43.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-O 121.645 0.736 . . . . 0.0 112.833 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.422 ' C ' ' H ' ' A' ' 193' ' ' GLN . 25.0 p -115.8 -163.61 0.9 Allowed 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 158.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -61.47 -5.18 1.6 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.601 0.637 . . . . 0.0 110.553 172.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.422 ' H ' ' C ' ' A' ' 191' ' ' SER . 58.3 tp60 -69.56 -74.39 0.13 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.802 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.546 ' SD ' ' HA2' ' A' ' 197' ' ' GLY . 23.9 ttm -179.16 -171.66 0.21 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 176.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.609 ' HA ' HG12 ' A' ' 190' ' ' ILE . 14.0 m -88.08 -24.27 23.48 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 118.185 0.448 . . . . 0.0 111.928 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.504 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 12.9 tt0 165.65 -4.24 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 122.015 0.912 . . . . 0.0 109.444 -173.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.546 ' HA2' ' SD ' ' A' ' 194' ' ' MET . . . 103.61 5.13 45.65 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -172.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.472 ' HA ' ' CE1' ' A' ' 187' ' ' PHE . 93.4 mt-30 61.71 52.66 3.47 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-O 121.466 0.651 . . . . 0.0 109.668 -176.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 63.7 mt -126.13 -179.73 4.86 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.964 -173.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 14.8 t 73.67 120.1 0.04 OUTLIER 'General case' 0 C--O 1.233 0.202 0 O-C-N 124.422 1.076 . . . . 0.0 111.285 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -93.42 33.23 5.25 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.606 177.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.405 HG23 ' H ' ' A' ' 186' ' ' CYS . 0.0 OUTLIER -64.78 97.7 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-O 122.238 1.018 . . . . 0.0 108.921 171.505 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.426 ' N ' ' HG2' ' A' ' 254' ' ' PRO . 1.4 t -90.07 118.62 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.368 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 11.2 t -153.59 -178.63 7.15 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 103.129 -2.915 . . . . 0.0 103.129 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.434 HG21 ' HA ' ' A' ' 181' ' ' TYR . 10.5 p -106.33 163.7 12.62 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 120.538 1.517 . . . . 0.0 110.012 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.579 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 49.6 tttm -63.85 -38.48 91.26 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.486 0.66 . . . . 0.0 109.788 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.0 m -48.63 -56.38 8.62 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.045 171.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.544 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -56.98 -53.73 54.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.905 177.04 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 54.4 m -67.09 -23.0 65.8 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -175.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 56.3 m -106.56 -11.69 15.81 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 118.979 0.809 . . . . 0.0 113.168 -177.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -83.88 -51.21 7.37 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.961 0.886 . . . . 0.0 108.991 165.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.539 HG22 ' HA2' ' A' ' 234' ' ' GLY . 6.7 p -101.66 151.9 21.47 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.275 -178.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.447 HG11 HE21 ' A' ' 284' ' ' GLN . 31.5 m 53.01 -37.19 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.556 ' O ' ' HD3' ' A' ' 215' ' ' ARG . . . 78.63 -159.51 46.27 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 120.416 1.462 . . . . 0.0 112.236 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.556 ' HD3' ' O ' ' A' ' 214' ' ' GLY . 0.0 OUTLIER 104.07 -90.6 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.692 1.197 . . . . 0.0 109.497 163.124 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.45 ' HB2' HD12 ' A' ' 190' ' ' ILE . . . -169.17 160.82 9.96 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.875 0.761 . . . . 0.0 110.125 170.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . 0.579 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 18.8 t90 -152.48 147.83 26.7 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -177.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 78.98 173.18 43.34 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 115.389 0.916 . . . . 0.0 115.389 167.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.578 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 36.0 m-70 -127.79 133.11 24.75 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 114.838 -0.681 . . . . 0.0 109.445 171.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.578 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 19.7 Cg_endo -58.6 152.3 39.23 Favored 'Cis proline' 0 C--N 1.347 0.461 0 C-N-CA 123.705 -1.373 . . . . 0.0 111.772 -3.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 43.5 t -55.89 118.43 4.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.254 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -115.28 121.23 42.25 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' MET . . . . . 0.434 ' HB3' HD12 ' A' ' 190' ' ' ILE . 19.8 ptm -98.07 146.48 25.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.645 0.26 . . . . 0.0 111.304 -173.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 61.8 m -143.24 148.37 44.27 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.959 -178.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.7 167.65 23.75 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.615 2.21 . . . . 0.0 109.9 163.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.527 ' O ' ' HD3' ' A' ' 228' ' ' PRO . . . -58.62 -94.67 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 120.764 0.316 . . . . 0.0 110.814 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' GLN . . . . . 0.473 ' HB3' ' HB3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -89.55 106.75 14.95 Favored Pre-proline 0 C--N 1.315 -0.9 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.072 172.419 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 226' ' ' ALA . 60.2 Cg_endo -90.63 -43.68 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.491 2.128 . . . . 0.0 113.252 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.457 ' HB3' ' HD2' ' A' ' 230' ' ' PRO . 90.3 m-70 -100.53 175.55 2.32 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 229' ' ' HIS . 36.6 Cg_exo -60.53 177.53 0.6 Allowed 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 121.656 1.571 . . . . 0.0 112.182 171.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 61.4 m 75.7 146.41 0.09 Allowed 'General case' 0 N--CA 1.47 0.575 0 O-C-N 124.112 0.883 . . . . 0.0 108.844 -166.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.513 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 83.2 mtt180 -63.13 140.48 58.88 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 118.997 -0.525 . . . . 0.0 109.905 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.483 ' O ' HG22 ' A' ' 212' ' ' THR . 38.1 ptt180 -32.86 -44.59 0.11 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 175.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.539 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -75.7 7.95 23.73 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.631 -175.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . 0.724 ' HE1' ' N ' ' A' ' 267' ' ' GLY . 2.5 m-85 -122.49 159.86 26.78 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.947 0.88 . . . . 0.0 112.085 -172.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.446 HD13 ' O ' ' A' ' 235' ' ' PHE . 0.4 OUTLIER -130.63 132.29 23.87 Favored Pre-proline 0 C--N 1.313 -1.018 0 CA-C-N 113.913 -1.494 . . . . 0.0 108.048 172.006 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -64.2 112.24 1.83 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.51 1.473 . . . . 0.0 110.635 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.417 ' OD1' ' HB2' ' A' ' 240' ' ' ARG . 18.2 t-20 -51.81 134.44 30.9 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.781 0.8 . . . . 0.0 111.065 -178.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 33.7 pt -78.52 -1.04 3.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 114.656 -1.156 . . . . 0.0 112.026 -174.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.417 ' HB2' ' OD1' ' A' ' 238' ' ' ASN . 87.1 mtt180 -111.27 -56.83 2.33 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.372 0.606 . . . . 0.0 110.057 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 44.3 p -84.52 -46.52 11.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.199 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 104.23 7.81 39.77 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.359 -175.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -92.6 126.61 37.76 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 122.005 0.907 . . . . 0.0 109.919 -177.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 3.8 m -53.89 124.18 14.64 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 113.433 -1.712 . . . . 0.0 110.359 174.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 81.2 mm-40 -124.54 135.51 53.22 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.71 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 15.2 t70 -77.49 146.0 36.7 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 121.165 0.507 . . . . 0.0 110.142 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.762 HG23 ' HG3' ' A' ' 249' ' ' GLU . 6.9 m -98.49 146.16 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -74.66 76.76 2.03 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 167.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.762 ' HG3' HG23 ' A' ' 247' ' ' VAL . 32.2 mp0 -52.51 -39.01 60.81 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.388 0.614 . . . . 0.0 110.489 -171.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 262' ' ' CYS . 53.1 t -55.45 -30.63 60.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.943 176.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -97.42 -40.98 8.43 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 122.064 0.935 . . . . 0.0 109.62 -177.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.76 -16.91 63.94 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.947 -1.478 . . . . 0.0 110.836 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 2.6 mp -120.37 104.97 42.4 Favored Pre-proline 0 N--CA 1.447 -0.611 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 174.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.426 ' HG2' ' N ' ' A' ' 203' ' ' VAL . 1.1 Cg_exo -28.69 -47.88 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.604 1 C-N-CA 126.204 4.603 . . . . 0.0 116.87 -172.147 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -140.23 43.27 1.14 Allowed Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -174.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.413 HD21 ' CE1' ' A' ' 269' ' ' PHE . 11.1 tp -54.34 125.84 20.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.761 -0.72 . . . . 0.0 110.486 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 284' ' ' GLN . 98.9 m 60.35 58.37 2.59 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.515 0.674 . . . . 0.0 109.888 -176.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -60.44 120.89 10.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.381 -177.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 101.21 40.57 2.79 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.532 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 172.8 -156.49 25.01 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.787 179.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . 0.429 ' HB2' ' HB2' ' A' ' 272' ' ' LYS . 4.9 m-20 -111.93 156.82 21.48 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 250' ' ' CYS . 0.9 OUTLIER -137.86 132.88 33.19 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 170.268 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 58.5 mt -130.18 115.18 31.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.527 -170.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -73.61 121.84 21.33 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -172.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 268' ' ' SER . 0.5 OUTLIER -110.01 156.14 20.89 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 153.452 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.71 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 4.1 m -74.97 126.64 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 C-N-CA 117.861 -1.536 . . . . 0.0 107.605 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.724 ' N ' ' HE1' ' A' ' 235' ' ' PHE . . . 113.25 -26.62 10.2 Favored Glycine 0 C--N 1.309 -0.94 0 C-N-CA 119.764 -1.208 . . . . 0.0 111.807 -171.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.468 ' O ' HG23 ' A' ' 265' ' ' THR . 26.5 t 173.67 157.5 0.13 Allowed 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 121.315 0.579 . . . . 0.0 109.502 -174.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . 0.413 ' CE1' HD21 ' A' ' 256' ' ' LEU . 35.3 p90 -101.81 153.05 20.17 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -109.41 114.05 27.38 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 55.4 m -99.96 160.97 13.91 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.856 -0.737 . . . . 0.0 111.779 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.429 ' HB2' ' HB2' ' A' ' 261' ' ' ASN . 28.5 mmmt -134.19 112.55 11.19 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.306 -178.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 79.8 m -91.93 158.95 38.94 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.129 177.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.511 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 32.0 Cg_exo -61.04 157.07 40.89 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.402 2.068 . . . . 0.0 111.052 171.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -54.8 139.63 39.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.835 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 82.99 -27.1 4.01 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.957 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' HIS . . . . . 0.517 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 13.6 m-70 -77.03 162.94 27.13 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 121.343 0.592 . . . . 0.0 111.286 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -131.9 143.13 49.92 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.379 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 57.0 tp -87.34 133.29 33.72 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.114 0.483 . . . . 0.0 110.532 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.569 ' HB3' ' HB3' ' A' ' 285' ' ' LYS . 16.5 t-20 -114.48 106.27 14.08 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 172.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -66.8 -19.69 65.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.653 -173.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.435 ' HB ' ' OD1' ' A' ' 280' ' ' ASN . 47.6 t -62.75 -47.7 91.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.615 176.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.505 ' HA ' HG21 ' A' ' 188' ' ' THR . 31.3 t -123.74 31.05 5.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.095 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 0.447 HE21 HG11 ' A' ' 213' ' ' VAL . 23.2 mp0 29.8 46.59 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.93 -172.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 280' ' ' ASN . 81.1 tttt -92.08 120.41 32.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.3 -170.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 7.2 m -102.98 81.1 1.94 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.89 0.376 . . . . 0.0 110.092 173.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 29.9 mm-40 . . . . . 0 C--O 1.242 0.696 0 CA-C-O 118.203 -0.903 . . . . 0.0 109.051 -178.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.475 0.811 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.45 119.78 21.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.943 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.7 p -93.55 -27.45 16.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.109 0.481 . . . . 0.0 110.927 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -65.15 -40.21 94.07 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.284 0.564 . . . . 0.0 110.154 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.2 m -80.01 123.45 27.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.4 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 72.5 mt -62.02 -42.76 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -98.33 122.18 41.18 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.243 -0.89 . . . . 0.0 108.993 171.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -59.62 122.64 14.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.981 0.42 . . . . 0.0 110.438 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 26.3 p -146.71 -163.87 1.85 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.329 -173.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -98.91 -55.19 2.78 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.182 0.515 . . . . 0.0 111.901 -175.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 14.7 pt -88.95 -166.72 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 CA-C-N 115.087 -0.96 . . . . 0.0 113.575 -162.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.588 ' HD3' ' H ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -127.9 147.88 50.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.469 -171.369 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 129' ' ' CYS . 96.4 m -117.96 154.75 31.43 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 67.0 mtm -140.95 165.81 26.52 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 170.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.427 ' HB3' ' CE2' ' A' ' 140' ' ' TYR . 78.4 m-20 68.35 49.83 0.78 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.264 0.484 . . . . 0.0 111.512 168.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 66.31 28.52 73.76 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.599 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -92.32 148.68 19.26 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.266 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.8 p -127.03 123.66 37.55 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 175.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 134' ' ' CYS . 43.0 t -86.57 126.75 34.69 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.96 0.41 . . . . 0.0 111.662 -172.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 29.0 t -142.51 140.96 32.01 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.876 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.596 ' O ' ' HB2' ' A' ' 132' ' ' ASP . 26.7 t70 76.63 -34.16 0.22 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 174.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 20.6 t70 151.43 -42.84 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -168.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -92.99 -175.63 3.94 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.186 0.517 . . . . 0.0 111.425 176.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 129' ' ' CYS . 41.2 t -110.8 134.94 52.08 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.614 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 88.9 mt -87.62 125.92 34.65 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 1.3 m -94.5 148.71 21.96 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -166.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -56.68 155.16 7.89 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.04 166.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -64.08 114.87 4.44 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.364 1.078 . . . . 0.0 111.479 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.48 ' CA ' HG12 ' A' ' 149' ' ' VAL . . . 99.27 18.37 24.25 Favored Glycine 0 C--N 1.3 -1.429 0 CA-C-N 112.891 -1.959 . . . . 0.0 111.473 -178.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.557 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 37.7 m-85 -123.43 150.67 43.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.188 0.518 . . . . 0.0 111.12 173.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.418 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 37.7 pt -140.1 -174.96 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.977 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.192 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.17 157.94 32.61 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.693 -175.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.1 p -61.66 -41.94 98.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.955 0.407 . . . . 0.0 111.685 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -108.15 18.89 20.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.378 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 64.6 28.92 13.23 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.281 173.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.4 9.27 71.14 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 119.77 -1.205 . . . . 0.0 114.548 -175.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.418 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 0.0 OUTLIER -127.32 120.45 22.21 Favored Pre-proline 0 C--O 1.217 -0.624 0 CA-C-N 118.741 1.27 . . . . 0.0 112.24 -177.663 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -89.65 153.97 5.2 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.13 2.554 . . . . 0.0 112.973 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 163' ' ' PRO . 10.1 p -97.23 102.89 14.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 122.508 1.147 . . . . 0.0 111.942 -177.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.458 ' HA ' ' H ' ' A' ' 164' ' ' ASN . 64.7 m -83.64 96.63 8.73 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 122.097 0.951 . . . . 0.0 110.224 170.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -54.12 -55.41 27.95 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.919 -1.491 . . . . 0.0 114.918 -168.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 47.4 m -94.3 17.05 13.51 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.205 0.526 . . . . 0.0 111.039 -165.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 73.07 131.55 0.16 Allowed Glycine 0 N--CA 1.432 -1.586 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.005 -175.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.499 ' O ' HD23 ' A' ' 155' ' ' LEU . 69.7 m -69.07 150.95 47.04 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.099 -1.051 . . . . 0.0 110.614 175.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 154' ' ' CYS . 58.7 mt -133.96 172.96 12.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.566 -170.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.75 ' ND2' ' H ' ' A' ' 169' ' ' THR . 0.0 OUTLIER 67.08 10.33 7.62 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.389 0.614 . . . . 0.0 111.188 178.05 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.87 36.26 91.72 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.079 -167.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -76.0 -145.23 1.54 Allowed Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.203 -0.498 . . . . 0.0 113.318 -175.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -150.86 118.02 5.95 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.665 -0.315 . . . . 0.0 111.111 -175.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 13.6 t -60.94 125.24 23.0 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.746 0.308 . . . . 0.0 110.34 176.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 165' ' ' ARG . 13.2 m -117.04 -49.28 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.922 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 163' ' ' PRO . . . -133.79 173.68 5.56 Favored Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 176.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.606 ' HA ' ' O ' ' A' ' 149' ' ' VAL . 54.3 Cg_exo -53.91 107.32 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 121.987 1.791 . . . . 0.0 112.465 177.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.458 ' H ' ' HA ' ' A' ' 150' ' ' CYS . 5.3 t-20 73.83 14.58 4.06 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.996 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.546 ' O ' HG22 ' A' ' 161' ' ' VAL . 2.0 mtm180 -113.35 89.45 3.09 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.027 174.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 82.4 m -88.32 141.69 28.34 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.0 169.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -90.32 131.28 36.21 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 60.0 m -104.53 130.96 52.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.901 0.857 . . . . 0.0 112.197 -169.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.75 ' H ' ' ND2' ' A' ' 156' ' ' ASN . 82.2 m -71.02 -57.59 4.4 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 116.204 1.928 . . . . 0.0 116.204 -170.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -136.89 -100.31 0.2 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 118.329 -1.348 . . . . 0.0 113.205 -165.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -90.32 45.39 2.97 Favored Glycine 0 CA--C 1.492 -1.379 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.773 -165.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 156' ' ' ASN . 4.2 m-85 -120.23 127.22 52.22 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 119.502 -0.879 . . . . 0.0 112.186 173.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.532 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 6.5 t -92.15 154.27 18.8 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 166.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 87.97 124.18 2.05 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.31 24.31 0.36 Allowed 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.053 1.836 . . . . 0.0 114.257 -166.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.422 ' O ' HD12 ' A' ' 155' ' ' LEU . 45.9 tt0 -126.57 5.11 6.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.896 0.855 . . . . 0.0 109.854 176.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.551 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.1 OUTLIER 36.99 51.24 0.96 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 113.838 -1.528 . . . . 0.0 114.46 -177.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -109.72 -15.46 14.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.073 0.463 . . . . 0.0 110.656 174.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 173' ' ' THR . 14.4 mmm180 -59.88 -58.49 8.32 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.442 -1.253 . . . . 0.0 107.697 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.472 ' HA ' ' CD2' ' A' ' 172' ' ' PHE . 34.9 t70 72.71 62.24 0.11 Allowed 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 160.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.532 ' HE2' ' N ' ' A' ' 173' ' ' THR . 50.5 p90 -91.46 65.47 5.26 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 122.74 1.257 . . . . 0.0 108.478 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.461 ' O ' ' HH2' ' A' ' 217' ' ' TRP . 61.2 mtt180 -53.76 125.86 19.98 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 168.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.409 ' HB ' HG13 ' A' ' 203' ' ' VAL . 82.1 p -72.25 143.75 48.68 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.345 -160.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -149.69 147.37 17.6 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -167.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -82.27 143.6 12.64 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.177 1.918 . . . . 0.0 111.241 173.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.423 ' H ' HG23 ' A' ' 202' ' ' ILE . 1.8 m -76.34 116.64 17.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.21 0.529 . . . . 0.0 111.105 176.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . 0.749 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 21.9 m-30 -84.54 145.18 28.21 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.079 177.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.491 HG22 ' NH2' ' A' ' 215' ' ' ARG . 40.2 p -122.23 -18.35 6.86 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.489 -174.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 66.5 t -139.47 115.05 8.51 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -176.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.688 HD11 ' HB2' ' A' ' 216' ' ' ALA . 20.7 mm -83.71 119.44 32.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -168.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.499 ' HB3' ' O ' ' A' ' 194' ' ' MET . 35.0 t -143.55 138.43 29.12 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.537 -1.665 . . . . 0.0 107.344 170.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -62.73 -33.45 75.15 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 172.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -55.66 -63.02 1.3 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 113.358 -1.746 . . . . 0.0 110.02 171.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.499 ' O ' ' HB3' ' A' ' 191' ' ' SER . 61.3 mtt -154.78 119.26 4.78 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.037 176.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.547 ' HB2' ' CD1' ' A' ' 187' ' ' PHE . 62.9 m -80.65 1.24 30.77 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 110.588 -0.153 . . . . 0.0 110.588 176.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.525 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 31.6 mm-40 96.62 -138.49 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.578 1.551 . . . . 0.0 109.452 -172.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.425 ' HA3' ' CE2' ' A' ' 187' ' ' PHE . . . 73.56 -37.1 0.84 Allowed Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.131 -0.557 . . . . 0.0 114.468 177.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -63.71 -14.36 51.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.527 0.664 . . . . 0.0 111.129 -177.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.496 ' N ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -107.43 27.0 9.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.645 -179.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.402 ' OG ' HG22 ' A' ' 202' ' ' ILE . 27.0 t -156.6 155.35 31.69 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.214 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -125.88 23.19 5.95 Favored Glycine 0 CA--C 1.504 -0.596 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 175.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.604 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -60.9 112.18 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 175.245 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.409 HG13 ' HB ' ' A' ' 183' ' ' THR . 46.4 t -104.88 100.02 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-O 122.632 1.206 . . . . 0.0 110.441 175.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.443 ' HB2' HD11 ' A' ' 202' ' ' ILE . 15.6 t -125.17 -175.23 3.25 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 112.575 -2.102 . . . . 0.0 105.862 173.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.401 HG22 ' HB2' ' A' ' 181' ' ' TYR . 12.0 p -101.42 163.17 12.41 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.664 173.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.953 ' HB3' ' CE3' ' A' ' 217' ' ' TRP . 41.4 pttt -68.98 -22.76 64.08 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.337 176.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 9.2 m -59.94 -51.42 69.74 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.429 ' CD1' HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -58.13 -48.11 81.25 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.553 175.006 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.0 -21.98 61.49 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.168 -174.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 86.6 m -101.48 -17.67 16.33 Favored 'General case' 0 C--O 1.212 -0.892 0 O-C-N 121.549 -0.719 . . . . 0.0 112.064 -176.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -81.91 -48.9 10.93 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.915 0.865 . . . . 0.0 109.797 166.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 233' ' ' ARG . 6.4 p -102.4 141.63 34.91 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.675 -176.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.468 HG13 HE22 ' A' ' 284' ' ' GLN . 1.3 t 58.51 -38.08 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -178.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.555 ' O ' ' HD3' ' A' ' 215' ' ' ARG . . . 81.58 -161.11 42.27 Favored Glycine 0 CA--C 1.505 -0.566 0 CA-C-N 119.812 1.187 . . . . 0.0 112.915 -177.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.555 ' HD3' ' O ' ' A' ' 214' ' ' GLY . 0.0 OUTLIER 102.72 -93.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.487 1.115 . . . . 0.0 108.978 166.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.749 ' HB3' ' HB2' ' A' ' 187' ' ' PHE . . . -172.25 172.71 4.44 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 118.99 0.814 . . . . 0.0 109.24 173.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . 0.953 ' CE3' ' HB3' ' A' ' 206' ' ' LYS . 12.8 t90 -163.12 150.66 13.2 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -177.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 70.7 173.06 12.87 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 114.714 0.646 . . . . 0.0 114.714 170.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.484 ' CD2' ' HZ ' ' A' ' 187' ' ' PHE . 48.4 m80 -123.97 131.73 24.25 Favored Pre-proline 0 C--N 1.334 -0.105 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 37.2 Cg_endo -63.74 167.37 39.57 Favored 'Cis proline' 0 C--N 1.349 0.555 0 C-N-CA 123.806 -1.331 . . . . 0.0 112.616 -1.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 16.2 t -59.4 111.25 1.31 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.653 -176.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -106.12 102.07 11.51 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.02 141.9 35.01 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.381 -169.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 14.8 m -144.05 159.22 53.68 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.429 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.95 167.22 23.97 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.982 2.454 . . . . 0.0 109.769 164.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.571 ' O ' ' HD3' ' A' ' 228' ' ' PRO . . . -56.02 -92.23 0.0 OUTLIER 'General case' 0 C--O 1.211 -0.969 0 CA-C-N 117.957 0.344 . . . . 0.0 110.511 176.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' GLN . . . . . 0.447 ' HB3' ' HB3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -89.02 102.59 4.31 Favored Pre-proline 0 C--N 1.316 -0.861 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.057 169.555 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.571 ' HD3' ' O ' ' A' ' 226' ' ' ALA . 24.5 Cg_endo -93.52 -44.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.794 2.329 . . . . 0.0 113.858 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.483 ' HB3' ' HD2' ' A' ' 230' ' ' PRO . 72.0 m-70 -103.15 -179.85 0.85 Allowed Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -173.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 229' ' ' HIS . 51.6 Cg_exo -59.06 174.24 0.99 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 121.849 1.699 . . . . 0.0 112.251 172.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 73.9 m 70.12 128.63 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -168.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.503 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 65.0 mtt180 -58.96 148.85 29.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -176.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.506 ' O ' HG22 ' A' ' 212' ' ' THR . 17.3 ptp180 -31.71 -47.03 0.12 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.57 ' O ' ' HA ' ' A' ' 246' ' ' ASP . . . -79.52 11.79 30.45 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.475 -0.869 . . . . 0.0 114.168 -174.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . 0.55 ' O ' HD13 ' A' ' 236' ' ' ILE . 78.5 m-85 -123.08 155.9 35.99 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.867 0.842 . . . . 0.0 113.061 -173.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.55 HD13 ' O ' ' A' ' 235' ' ' PHE . 0.3 OUTLIER -135.41 134.48 21.21 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 114.011 -1.45 . . . . 0.0 107.866 173.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.89 112.47 1.29 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 121.86 1.707 . . . . 0.0 110.932 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -53.48 135.3 40.0 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.832 0.825 . . . . 0.0 110.364 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 30.9 mt -69.69 -13.23 16.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.752 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -103.67 -60.8 1.51 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.388 0.613 . . . . 0.0 110.057 -176.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 44.7 p -84.38 -40.41 17.89 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.873 -175.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 97.6 5.0 57.95 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -83.79 133.3 34.77 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.706 0.765 . . . . 0.0 110.942 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 22.3 m -56.16 108.14 0.44 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.905 170.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 60.3 mm-40 -115.19 134.87 54.76 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.655 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 12.8 t70 -75.62 140.43 42.6 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -176.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.769 HG23 ' HG3' ' A' ' 249' ' ' GLU . 3.7 m -94.38 145.14 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -75.44 77.38 2.5 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 166.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.769 ' HG3' HG23 ' A' ' 247' ' ' VAL . 47.9 mp0 -50.04 -35.32 24.56 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.4 0.619 . . . . 0.0 110.716 -171.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 77.2 m -50.94 -34.83 30.35 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.069 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -103.94 -47.35 4.22 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.428 0.691 . . . . 0.0 110.466 -175.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -63.38 -26.52 68.79 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.935 -177.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.802 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.7 mp -121.38 78.43 35.83 Favored Pre-proline 0 N--CA 1.446 -0.635 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -57.31 112.75 1.22 Allowed 'Trans proline' 0 CA--C 1.514 -0.493 0 C-N-CA 123.358 2.705 . . . . 0.0 114.608 -164.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 74.46 24.51 72.72 Favored Glycine 0 C--N 1.308 -0.976 0 CA-C-N 113.561 -1.654 . . . . 0.0 113.665 175.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.802 ' HB3' HG22 ' A' ' 253' ' ' ILE . 0.6 OUTLIER -67.92 -32.94 73.75 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 117.615 0.707 . . . . 0.0 110.537 177.487 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . 0.625 ' HA ' ' HB3' ' A' ' 284' ' ' GLN . 35.3 t -104.05 83.28 2.08 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.488 0.661 . . . . 0.0 109.443 177.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -98.52 -2.79 37.97 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.927 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -60.21 -41.58 98.3 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.46 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -165.31 -109.85 0.23 Allowed Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.953 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . 0.598 ' HB2' ' HB3' ' A' ' 272' ' ' LYS . 10.0 m120 -86.68 162.08 18.1 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.162 0.506 . . . . 0.0 111.276 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 4.3 t -148.08 120.46 8.44 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.177 174.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.477 ' HB ' ' HB2' ' A' ' 270' ' ' GLU . 21.7 mt -128.29 165.2 28.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 -176.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.58 125.86 33.35 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 117.95 -1.5 . . . . 0.0 113.559 -177.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.2 t -114.25 162.6 16.36 Favored 'General case' 0 C--O 1.259 1.558 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.131 163.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.655 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 27.2 m -72.55 124.84 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 C-N-CA 119.717 -0.793 . . . . 0.0 108.953 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.474 ' HA2' ' CE2' ' A' ' 235' ' ' PHE . . . 105.43 -17.61 43.05 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 119.997 -1.097 . . . . 0.0 112.784 -175.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 41.3 t 175.58 155.2 0.18 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.77 0.785 . . . . 0.0 110.302 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -102.33 155.96 17.9 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . 0.477 ' HB2' ' HB ' ' A' ' 263' ' ' ILE . 9.5 mt-10 -113.18 116.96 30.64 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.057 -173.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 99.2 m -105.07 148.25 27.01 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.598 ' HB3' ' HB2' ' A' ' 261' ' ' ASN . 21.2 ttpp -127.95 132.46 49.24 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -177.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 286' ' ' CYS . 23.4 m -112.63 157.14 41.19 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.373 -175.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.502 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 51.1 Cg_exo -55.41 156.84 16.19 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.189 1.926 . . . . 0.0 110.944 168.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -56.32 144.15 31.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.676 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.38 -34.31 2.89 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.283 -0.961 . . . . 0.0 112.036 -176.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' HIS . . . . . 0.623 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 16.0 m-70 -75.8 164.16 26.52 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.592 0.234 . . . . 0.0 110.56 -175.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -139.82 142.6 36.63 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -176.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 285' ' ' LYS . 57.5 tp -73.07 125.01 26.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.112 0.482 . . . . 0.0 111.315 -178.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.484 ' HB3' ' HB2' ' A' ' 285' ' ' LYS . 17.6 t-20 -102.48 95.6 6.36 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -68.0 -16.05 63.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.085 -172.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 84.7 t -56.33 -49.36 77.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.512 173.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 2.4 p -134.87 40.21 2.94 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.229 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 0.625 ' HB3' ' HA ' ' A' ' 257' ' ' CYS . 13.5 mp0 25.46 56.54 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.201 -1.363 . . . . 0.0 113.457 -173.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 280' ' ' ASN . 98.5 mttt -101.29 176.16 5.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.77 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 273' ' ' CYS . 38.8 m -147.61 97.64 2.86 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.486 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.623 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 65.7 mm-40 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.358 -0.829 . . . . 0.0 109.54 -174.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.2 m . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 120.791 0.329 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -91.97 -14.82 28.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.803 0.335 . . . . 0.0 110.85 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.1 m -86.3 101.64 13.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.231 0.539 . . . . 0.0 109.824 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -120.95 149.38 42.73 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.738 -175.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 31.1 p -79.95 -20.56 45.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.153 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.4 pt -87.16 57.74 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.275 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -68.43 170.66 8.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.528 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -100.26 60.72 1.04 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.038 0.447 . . . . 0.0 110.65 -176.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 4.1 m -71.88 166.8 21.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.474 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -113.05 -11.56 13.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.394 0.616 . . . . 0.0 111.303 -174.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.612 HD13 ' H ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -91.71 -164.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.482 0.658 . . . . 0.0 112.548 -177.802 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.527 ' HD2' ' N ' ' A' ' 122' ' ' ARG . 3.0 mpt_? -117.33 119.53 35.4 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.136 -174.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 78.0 m -107.43 98.46 8.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.031 -177.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 5.0 mpp? -107.49 165.11 11.65 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.577 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.5 m120 70.38 37.27 1.58 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.55 0.69 . . . . 0.0 110.704 173.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 82.33 8.89 85.72 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.527 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.14 124.56 34.06 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.161 -176.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.525 ' HB3' ' HB2' ' A' ' 135' ' ' LEU . 30.8 t -90.29 168.64 11.75 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.25 124.07 33.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.199 0.523 . . . . 0.0 112.257 -173.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.477 ' HB2' ' HG ' ' A' ' 135' ' ' LEU . 31.4 t -138.91 146.22 40.83 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.58 172.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.9 t70 25.79 -94.69 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 O-C-N 125.042 1.464 . . . . 0.0 111.785 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -141.44 16.01 2.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.229 1.014 . . . . 0.0 108.605 167.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.446 ' O ' ' HB3' ' A' ' 130' ' ' SER . 0.3 OUTLIER -120.84 136.35 54.94 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.451 170.607 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 64.1 m -74.85 158.28 33.66 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -172.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 128' ' ' SER . 96.1 mt -103.86 107.67 18.64 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 39.8 m -67.07 160.44 26.64 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.613 -173.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -89.04 145.51 25.43 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 169.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -62.09 110.34 1.56 Allowed 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 122.939 1.352 . . . . 0.0 112.276 -170.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 132.47 -5.43 5.23 Favored Glycine 0 N--CA 1.432 -1.611 0 CA-C-N 111.808 -2.451 . . . . 0.0 111.53 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.682 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 98.0 m-85 -122.35 149.09 44.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.934 0.867 . . . . 0.0 110.207 171.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.444 HG12 HE21 ' A' ' 147' ' ' GLN . 30.7 pt -126.9 171.8 14.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 176.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.55 157.71 20.31 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.7 p -65.06 -34.71 79.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.248 0.524 . . . . 0.0 111.174 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -100.22 2.26 42.66 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.051 0.453 . . . . 0.0 110.427 174.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 60.2 m 61.9 43.64 9.1 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.496 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -104.27 3.53 43.89 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 119.953 -1.118 . . . . 0.0 113.646 -176.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.444 HE21 HG12 ' A' ' 141' ' ' ILE . 0.3 OUTLIER -106.58 110.92 64.09 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 117.54 0.67 . . . . 0.0 109.422 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -80.81 140.3 12.82 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.846 2.364 . . . . 0.0 112.747 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 149' ' ' VAL . 13.9 p -67.08 111.36 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.291 1.043 . . . . 0.0 112.364 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.508 ' HB3' ' SG ' ' A' ' 154' ' ' CYS . 0.8 OUTLIER -80.21 73.53 7.05 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.541 171.343 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -50.65 -67.13 0.28 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.699 -1.591 . . . . 0.0 114.239 -171.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 19.4 m -98.22 13.78 30.08 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.394 0.616 . . . . 0.0 111.624 -166.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 79.2 123.35 0.37 Allowed Glycine 0 CA--C 1.5 -0.87 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.668 -175.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.508 ' SG ' ' HB3' ' A' ' 150' ' ' CYS . 86.4 m -77.0 -17.29 58.96 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -175.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.643 HD13 ' HB3' ' A' ' 178' ' ' GLU . 2.2 mp 46.19 -172.37 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -172.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.418 ' ND2' ' SG ' ' A' ' 177' ' ' CYS . 0.8 OUTLIER 51.92 11.06 0.13 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.297 1.439 . . . . 0.0 113.902 171.586 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.31 36.7 84.55 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.799 -174.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -79.24 -145.65 3.31 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.446 -176.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -153.77 118.4 4.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.368 0.584 . . . . 0.0 110.823 -175.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.9 m -62.01 119.75 9.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.746 0.308 . . . . 0.0 111.554 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 165' ' ' ARG . 4.3 m -107.13 -35.85 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 121.134 0.493 . . . . 0.0 110.417 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.638 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -140.13 172.21 6.66 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.682 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 79.4 Cg_exo -52.73 106.06 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.175 1.916 . . . . 0.0 112.246 176.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 69.1 -0.04 2.62 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.483 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.638 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -90.41 83.99 5.96 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 172.405 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 40.5 m -84.12 145.33 28.48 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.2 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -92.67 124.66 36.84 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 37.1 m -104.07 135.62 45.23 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 124.142 0.901 . . . . 0.0 112.114 -168.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.4 m -48.73 -53.66 18.04 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -172.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -167.78 -88.16 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.366 -0.934 . . . . 0.0 112.55 -174.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -85.16 57.24 4.98 Favored Glycine 0 N--CA 1.435 -1.385 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.898 -167.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.588 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 8.1 m-85 -122.91 128.49 50.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.223 1.012 . . . . 0.0 111.669 172.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.84 HG23 ' CE1' ' A' ' 181' ' ' TYR . 14.9 p -86.72 119.88 27.42 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.181 177.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 107.4 133.3 7.15 Favored Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -174.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.43 -0.45 8.19 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 120.956 1.104 . . . . 0.0 112.429 -173.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -107.96 19.23 20.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.496 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.572 ' O ' ' HB2' ' A' ' 155' ' ' LEU . 0.5 OUTLIER 17.66 79.67 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 118.301 2.704 . . . . 0.0 118.301 176.222 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.643 ' HB3' HD13 ' A' ' 155' ' ' LEU . 14.5 pt-20 -126.22 34.53 4.83 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.132 0.968 . . . . 0.0 109.517 167.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.588 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 23.0 mmt180 -132.63 88.22 2.5 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.724 -1.58 . . . . 0.0 107.248 176.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.425 ' HA ' ' CE1' ' A' ' 172' ' ' PHE . 9.2 p-10 -81.0 49.83 1.29 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.808 0.813 . . . . 0.0 111.352 -169.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.84 ' CE1' HG23 ' A' ' 173' ' ' THR . 10.5 p90 -76.59 93.86 3.66 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 176.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -79.15 173.76 12.25 Favored 'General case' 0 N--CA 1.436 -1.15 0 O-C-N 119.733 -1.854 . . . . 0.0 106.162 174.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 81.6 p -98.76 138.87 35.3 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 118.851 -1.14 . . . . 0.0 108.889 169.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.458 ' HA3' ' HA2' ' A' ' 218' ' ' GLY . . . -159.75 149.78 19.66 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.727 -173.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.416 ' HB3' ' O ' ' A' ' 200' ' ' SER . 59.4 Cg_endo -75.44 132.51 14.94 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.365 2.044 . . . . 0.0 111.041 171.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.712 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 71.5 m -75.2 122.09 23.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.4 0.619 . . . . 0.0 110.236 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -107.55 153.47 22.81 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.793 -175.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.62 ' O ' ' HB3' ' A' ' 215' ' ' ARG . 29.1 p -100.94 -56.99 2.19 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.002 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 36.9 t -134.06 118.45 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 119.686 -0.805 . . . . 0.0 111.767 -172.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.637 HG13 ' SG ' ' A' ' 195' ' ' CYS . 2.1 mp -102.32 117.21 47.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.465 0.65 . . . . 0.0 111.736 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.3 p -110.98 -168.67 1.33 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 159.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -68.87 -4.84 17.9 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.383 0.611 . . . . 0.0 110.066 171.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -90.81 -76.43 0.44 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.394 -174.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 98.6 mmm -141.68 160.28 40.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.275 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.637 ' SG ' HG13 ' A' ' 190' ' ' ILE . 38.8 m -91.09 -8.15 49.69 Favored 'General case' 0 C--O 1.248 0.99 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.953 175.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.435 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 79.9 mm-40 78.22 -140.49 0.02 OUTLIER 'General case' 0 C--N 1.347 0.464 0 CA-C-N 114.2 -1.364 . . . . 0.0 109.863 -175.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 82.56 -7.06 66.31 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.796 172.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 59.1 27.98 17.12 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 122.577 0.351 . . . . 0.0 111.2 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 51.9 44.74 29.17 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.687 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.416 ' O ' ' HB3' ' A' ' 185' ' ' PRO . 41.5 t -70.47 155.53 40.59 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.641 -174.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -109.33 20.01 28.58 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.332 177.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.45 HD11 ' HB2' ' A' ' 204' ' ' SER . 0.0 OUTLIER -63.11 113.57 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 173.198 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 48.9 t -102.46 99.11 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 122.346 1.069 . . . . 0.0 110.502 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.45 ' HB2' HD11 ' A' ' 202' ' ' ILE . 7.9 t -127.77 -175.4 3.46 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 112.479 -2.146 . . . . 0.0 105.436 170.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 30.6 p -101.72 165.29 11.29 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 119.648 1.113 . . . . 0.0 109.923 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.923 ' HB3' ' CE3' ' A' ' 217' ' ' TRP . 0.0 OUTLIER -66.64 -23.85 66.21 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 119.102 -1.039 . . . . 0.0 108.662 175.805 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.8 m -59.51 -55.93 28.4 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.507 ' CD1' HG11 ' A' ' 247' ' ' VAL . 0.3 OUTLIER -54.03 -54.96 31.97 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.74 176.553 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 52.9 m -77.41 -20.51 54.52 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -170.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 226' ' ' ALA . 97.5 m -83.93 -41.73 17.07 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 119.123 0.874 . . . . 0.0 109.914 173.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . 0.474 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . . . -64.6 -58.32 6.67 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.675 HG22 ' HA2' ' A' ' 234' ' ' GLY . 5.1 p -91.25 140.69 29.55 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.896 -1.502 . . . . 0.0 108.998 178.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.496 HG21 ' CD1' ' A' ' 256' ' ' LEU . 0.2 OUTLIER 58.62 -30.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -177.124 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.406 ' O ' ' HD2' ' A' ' 215' ' ' ARG . . . 75.82 -162.39 52.92 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 120.209 1.368 . . . . 0.0 114.449 177.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.62 ' HB3' ' O ' ' A' ' 188' ' ' THR . 2.1 mtt180 98.78 -83.3 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.546 1.138 . . . . 0.0 112.371 166.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' A' ' 223' ' ' MET . . . -174.57 172.02 3.18 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.117 0.417 . . . . 0.0 110.521 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . 0.923 ' CE3' ' HB3' ' A' ' 206' ' ' LYS . 9.6 t90 -165.33 151.38 9.75 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.306 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 221' ' ' CYS . . . 77.23 174.88 41.67 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 115.06 0.784 . . . . 0.0 115.06 171.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.525 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 17.6 m80 -133.3 131.72 21.74 Favored Pre-proline 0 N--CA 1.462 0.172 0 CA-C-N 114.692 -0.754 . . . . 0.0 109.315 174.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.525 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 23.0 Cg_endo -61.18 142.93 36.62 Favored 'Cis proline' 0 C--N 1.346 0.409 0 C-N-CA 123.132 -1.612 . . . . 0.0 111.175 -3.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 81.0 m -49.49 121.42 5.06 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.733 0.646 . . . . 0.0 111.784 -172.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -93.44 95.64 9.41 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' MET . . . . . 0.473 ' HA ' ' HB2' ' A' ' 216' ' ' ALA . 0.0 OUTLIER -90.22 122.7 33.39 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 -172.221 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 17.8 p -142.9 150.27 52.57 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.05 -165.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.34 167.11 13.47 Favored 'Trans proline' 0 CA--C 1.515 -0.437 0 C-N-CA 122.867 2.378 . . . . 0.0 110.672 162.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 210' ' ' CYS . . . -62.88 -119.74 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.853 0.835 . . . . 0.0 112.06 174.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 227' ' ' GLN . 6.8 pt20 -57.13 107.76 1.01 Allowed Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.13 -172.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 211' ' ' ALA . 1.9 Cg_endo -83.6 -55.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.146 2.564 . . . . 0.0 112.366 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -78.22 163.0 64.62 Favored Pre-proline 0 CA--C 1.511 -0.539 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.7 59.05 4.08 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 121.992 1.794 . . . . 0.0 112.031 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 59.3 m -131.23 162.58 29.67 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.466 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 20.8 mmt180 -66.02 139.8 58.23 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 175.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -36.22 -41.17 0.25 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.675 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -77.25 8.93 29.47 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.629 -175.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . 0.651 ' HE2' ' N ' ' A' ' 267' ' ' GLY . 2.3 m-85 -121.56 149.45 43.11 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.287 1.042 . . . . 0.0 113.067 -171.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.499 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.2 OUTLIER -125.37 124.2 25.14 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 113.736 -1.575 . . . . 0.0 108.818 172.204 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -63.58 122.1 10.09 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.295 1.997 . . . . 0.0 111.573 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -53.78 131.03 38.81 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.875 177.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 40.9 pt -76.5 7.07 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.555 176.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -113.48 -59.82 1.97 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.547 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 42.1 p -91.31 -44.01 9.44 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.913 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 105.6 7.84 36.05 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -92.77 125.16 37.25 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 121.907 0.861 . . . . 0.0 109.938 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 10.2 m -60.47 122.2 14.01 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 113.296 -1.775 . . . . 0.0 109.938 174.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.459 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 90.2 mt-30 -119.37 139.21 52.36 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.787 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 17.4 t70 -74.46 143.68 44.54 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.845 HG23 ' HG3' ' A' ' 249' ' ' GLU . 10.0 m -94.52 145.98 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.252 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.89 77.04 1.64 Allowed 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 165.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.845 ' HG3' HG23 ' A' ' 247' ' ' VAL . 6.3 mp0 -52.73 -35.16 55.43 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.478 0.656 . . . . 0.0 109.56 -175.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 6.4 m -53.83 -29.51 41.15 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.211 174.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -103.72 -38.66 6.98 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.719 0.771 . . . . 0.0 109.906 -176.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -72.18 -19.8 61.69 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.869 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.684 HG22 ' HB3' ' A' ' 256' ' ' LEU . 46.7 mt -140.9 74.86 25.56 Favored Pre-proline 0 C--O 1.244 0.77 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -12.51 -80.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.947 1 C-N-CA 126.832 5.021 . . . . 0.0 116.174 -164.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -130.6 64.69 0.61 Allowed Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 119.464 -1.35 . . . . 0.0 111.472 176.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.684 ' HB3' HG22 ' A' ' 253' ' ' ILE . 1.4 pt? -68.63 8.19 0.53 Allowed 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -176.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 56.9 m -114.0 127.43 55.95 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 171.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . 0.518 ' O ' ' HB3' ' A' ' 286' ' ' CYS . 97.8 mt-30 -70.36 91.46 0.75 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.998 0.428 . . . . 0.0 111.962 -175.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 80.45 32.44 34.37 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.912 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -129.74 163.81 22.68 Favored Glycine 0 C--O 1.227 -0.308 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.06 -178.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -102.27 103.2 13.67 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 269' ' ' PHE . 50.8 t -68.21 123.05 19.63 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.079 0.466 . . . . 0.0 111.072 176.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 47.3 mt -125.56 103.75 12.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.707 ' ND2' ' HB3' ' A' ' 269' ' ' PHE . 1.0 OUTLIER -81.12 128.3 33.59 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -160.798 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 268' ' ' SER . 0.2 OUTLIER -109.21 157.5 18.74 Favored 'General case' 0 C--O 1.257 1.449 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.722 163.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.787 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 3.2 m -72.87 128.68 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 C-N-CA 118.839 -1.144 . . . . 0.0 108.531 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.651 ' N ' ' HE2' ' A' ' 235' ' ' PHE . . . 105.19 -26.81 20.83 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.073 -1.06 . . . . 0.0 110.887 -174.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.581 ' O ' HG23 ' A' ' 265' ' ' THR . 32.6 t 176.09 151.71 0.15 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.124 0.488 . . . . 0.0 110.358 -175.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . 0.707 ' HB3' ' ND2' ' A' ' 264' ' ' ASN . 26.7 p90 -99.4 162.44 13.04 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.968 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -115.32 106.49 14.08 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.808 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 54.4 m -94.6 112.18 23.94 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.346 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -79.19 132.21 36.45 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.106 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . 0.425 ' HB3' ' CB ' ' A' ' 277' ' ' HIS . 36.2 m -116.26 143.73 31.63 Favored Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.115 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.563 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 36.6 Cg_exo -60.56 167.01 8.82 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.363 2.042 . . . . 0.0 110.89 173.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -59.44 144.35 47.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.711 0.291 . . . . 0.0 110.86 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.6 -27.69 4.66 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.625 -177.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' HIS . . . . . 0.638 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 18.0 m-70 -77.0 160.34 29.21 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.021 0.438 . . . . 0.0 111.317 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . 0.421 ' NZ ' ' HB2' ' A' ' 278' ' ' LYS . 9.8 mtmp? -145.97 121.34 10.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.396 -174.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 19.1 tp -77.32 141.47 39.89 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.77 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.421 ' HB3' ' HB2' ' A' ' 285' ' ' LYS . 37.4 t30 -133.16 100.09 4.75 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.178 175.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -60.56 -26.05 66.63 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.47 -175.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 58.0 t -58.06 -29.53 36.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.679 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' A' ' 285' ' ' LYS . 33.4 t -147.85 34.87 0.84 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.888 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 32.11 38.55 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.448 1.099 . . . . 0.0 113.664 -176.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 96.6 mttt -87.12 149.33 24.75 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.693 -175.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' CYS . . . . . 0.518 ' HB3' ' O ' ' A' ' 258' ' ' GLN . 42.2 t -140.08 83.04 1.9 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.342 0.591 . . . . 0.0 109.507 178.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.638 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 3.8 mm-40 . . . . . 0 C--O 1.248 0.988 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.904 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.59 37.26 0.63 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.863 0.363 . . . . 0.0 111.913 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.9 p -86.64 0.3 54.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.451 0.643 . . . . 0.0 110.322 177.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -159.44 -172.65 3.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.295 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 32.6 m -81.35 -46.99 13.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.783 0.325 . . . . 0.0 110.179 178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.4 mt -67.44 114.02 3.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.148 0.499 . . . . 0.0 110.389 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -95.19 101.7 13.46 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.15 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -72.73 119.57 17.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.655 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.95 163.69 16.63 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.117 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -103.85 -62.94 1.24 Allowed 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.14 0.495 . . . . 0.0 109.879 -176.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.413 ' HA ' HH11 ' A' ' 122' ' ' ARG . 0.4 OUTLIER -89.12 -173.45 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-O 121.449 0.642 . . . . 0.0 112.567 179.001 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.595 ' HD2' ' N ' ' A' ' 122' ' ' ARG . 1.2 mpt_? -100.43 137.41 38.89 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.932 -167.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.741 ' SG ' ' HA ' ' A' ' 129' ' ' CYS . 94.1 m -118.83 125.84 50.48 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.721 176.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -129.84 161.56 30.5 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.479 ' HB3' ' CE2' ' A' ' 140' ' ' TYR . 16.3 m120 70.92 40.09 0.96 Allowed 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.457 0.473 . . . . 0.0 111.64 172.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.733 ' O ' ' HG2' ' A' ' 137' ' ' GLN . . . 82.37 24.63 53.69 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.214 -179.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -89.38 127.71 8.83 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.169 -1.015 . . . . 0.0 112.596 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 135' ' ' LEU . 23.7 m -86.4 124.02 32.28 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 176.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.741 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 27.6 p -82.81 116.31 22.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.725 0.774 . . . . 0.0 111.955 -170.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 133' ' ' HIS . 48.0 t -108.37 -176.79 3.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.445 176.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -94.21 104.39 16.4 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.865 -176.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.1 t70 93.95 -6.82 0.13 Allowed 'General case' 0 N--CA 1.469 0.486 0 O-C-N 124.485 1.116 . . . . 0.0 109.586 171.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.451 ' O ' ' HB3' ' A' ' 130' ' ' SER . 0.3 OUTLIER -160.21 171.47 19.14 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.607 173.606 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 34.9 t -122.58 132.99 54.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.276 -174.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 128' ' ' SER . 64.2 mt -82.98 120.65 25.98 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.487 0.66 . . . . 0.0 110.54 174.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 82.2 m -91.98 148.51 22.14 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.564 0.697 . . . . 0.0 112.39 -174.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.733 ' HG2' ' O ' ' A' ' 126' ' ' GLY . 24.8 mm-40 -66.37 152.07 45.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.314 166.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -66.14 113.41 4.49 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 122.045 0.926 . . . . 0.0 111.13 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 108.45 10.36 25.56 Favored Glycine 0 C--N 1.302 -1.337 0 CA-C-N 113.29 -1.777 . . . . 0.0 111.143 -175.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.584 ' CE2' ' HB3' ' A' ' 148' ' ' PRO . 78.9 m-85 -123.8 144.02 49.96 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 122.402 -0.469 . . . . 0.0 109.955 171.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 147' ' ' GLN . 25.1 pt -135.57 -176.66 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.024 -177.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 96.19 172.98 35.64 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.749 -176.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.0 m -76.51 -29.57 56.84 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 122.759 -0.259 . . . . 0.0 111.12 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -110.61 11.07 22.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.873 0.368 . . . . 0.0 110.425 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 58.1 m 63.5 30.09 15.28 Favored 'General case' 0 C--O 1.228 -0.037 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.129 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -94.26 4.83 70.89 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.873 -174.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.516 ' O ' HG12 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -120.21 97.59 49.1 Favored Pre-proline 0 C--O 1.22 -0.496 0 CA-C-N 117.702 0.751 . . . . 0.0 110.755 -179.458 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.584 ' HB3' ' CE2' ' A' ' 140' ' ' TYR . 52.4 Cg_endo -73.01 148.14 44.53 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.49 2.127 . . . . 0.0 112.19 176.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 149' ' ' VAL . 9.8 p -71.17 108.89 3.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.237 -173.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.69 77.24 6.32 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.362 173.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -51.9 -65.97 0.46 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -173.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 60.7 m -86.98 12.43 11.25 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.074 0.464 . . . . 0.0 111.226 -168.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 81.6 127.47 0.91 Allowed Glycine 0 N--CA 1.429 -1.786 0 CA-C-O 122.19 0.883 . . . . 0.0 111.906 -173.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.496 ' O ' HD23 ' A' ' 155' ' ' LEU . 1.7 m -73.56 152.93 40.45 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 113.989 -1.106 . . . . 0.0 109.307 171.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.748 HD12 ' O ' ' A' ' 176' ' ' GLN . 70.9 mt -135.34 162.89 31.31 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -168.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.743 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 2.6 t-20 48.76 24.88 0.88 Allowed 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.909 0.756 . . . . 0.0 111.605 -168.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 63.22 38.62 96.78 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.212 -176.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -76.28 -140.81 1.04 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.734 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 159' ' ' ARG . 0.1 OUTLIER -155.55 130.99 9.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.075 0.438 . . . . 0.0 111.081 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.442 ' O ' ' HG2' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -71.26 110.12 5.71 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.265 0.555 . . . . 0.0 110.428 172.483 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 165' ' ' ARG . 2.3 m -98.51 -28.72 3.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.631 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.745 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -140.28 173.11 5.33 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 174.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.577 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 49.4 Cg_exo -56.83 104.57 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 121.973 1.782 . . . . 0.0 112.348 178.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 68.06 9.97 7.52 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.216 1.006 . . . . 0.0 110.904 -176.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.745 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.3 OUTLIER -99.69 84.1 2.87 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 8.9 t -86.52 147.72 25.84 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.672 176.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.412 ' HB3' ' HD3' ' A' ' 159' ' ' ARG . . . -103.3 131.07 50.65 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.074 175.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 52.1 m -107.5 136.65 46.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.563 -165.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.743 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 25.4 m -53.12 -56.58 15.21 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -168.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.479 ' HE1' ' H ' ' A' ' 183' ' ' THR . 35.7 t80 -154.53 -87.61 0.05 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 119.043 -1.063 . . . . 0.0 112.729 -170.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.45 ' N ' ' HD1' ' A' ' 170' ' ' TYR . . . -92.21 52.33 2.81 Favored Glycine 0 CA--C 1.493 -1.305 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.725 -166.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.616 ' HB3' ' HA ' ' A' ' 177' ' ' CYS . 3.3 m-85 -124.87 123.91 40.95 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.54 169.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.58 ' N ' ' HE2' ' A' ' 181' ' ' TYR . 2.9 t -91.54 145.39 24.65 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 174.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 87.76 127.86 2.67 Favored Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -173.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.35 24.76 0.35 Allowed 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 121.534 1.489 . . . . 0.0 113.327 -168.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.748 ' O ' HD12 ' A' ' 155' ' ' LEU . 59.4 tt0 -122.31 7.14 9.62 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.616 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.7 OUTLIER 25.65 59.53 0.06 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 -179.393 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -112.42 15.54 20.2 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 122.169 0.985 . . . . 0.0 109.479 171.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.579 ' HG3' ' O ' ' A' ' 173' ' ' THR . 1.4 mmp_? -87.01 -73.33 0.47 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.556 -173.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 179' ' ' ARG . 21.3 t70 88.38 78.32 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.09 0.948 . . . . 0.0 108.657 167.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.58 ' HE2' ' N ' ' A' ' 173' ' ' THR . 13.4 p90 -149.46 108.78 3.95 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.678 -176.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -74.49 147.56 41.77 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 119.668 -1.895 . . . . 0.0 109.853 173.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.479 ' H ' ' HE1' ' A' ' 170' ' ' TYR . 71.9 p -87.76 137.37 32.4 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.023 0.439 . . . . 0.0 110.337 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -151.25 153.3 24.88 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.435 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.51 ' HG2' ' CE1' ' A' ' 219' ' ' HIS . 5.0 Cg_exo -78.58 132.91 11.3 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.748 2.299 . . . . 0.0 110.696 170.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.514 ' SG ' ' NE ' ' A' ' 215' ' ' ARG . 12.7 t -100.74 117.0 33.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.04 0.447 . . . . 0.0 111.031 -174.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . 0.855 ' O ' ' HB2' ' A' ' 215' ' ' ARG . 20.4 m-85 -98.62 174.67 6.31 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.216 178.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.642 ' HA ' ' HB2' ' A' ' 215' ' ' ARG . 1.3 p -129.28 -59.52 1.1 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -177.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.2 p -113.88 117.66 56.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.077 0.465 . . . . 0.0 111.151 -170.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.599 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.0 mt -131.17 117.11 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-O 121.781 0.801 . . . . 0.0 113.129 -168.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.436 ' C ' ' H ' ' A' ' 193' ' ' GLN . 46.9 p -119.13 -164.69 1.07 Allowed 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.038 163.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -60.25 -4.97 0.94 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.878 0.37 . . . . 0.0 111.032 174.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.436 ' H ' ' C ' ' A' ' 191' ' ' SER . 27.4 mt-30 -87.53 -77.45 0.34 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.893 0.377 . . . . 0.0 110.99 -172.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.432 ' O ' ' HA ' ' A' ' 190' ' ' ILE . 72.0 mtp -147.38 167.9 23.19 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.599 ' HA ' HG12 ' A' ' 190' ' ' ILE . 35.7 m -90.88 -27.55 18.71 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 121.471 0.653 . . . . 0.0 112.191 -178.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -164.61 5.9 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.904 -0.497 . . . . 0.0 111.638 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 68.36 -52.78 0.45 Allowed Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.976 -0.631 . . . . 0.0 113.221 -172.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.403 HE21 ' N ' ' A' ' 199' ' ' LEU . 25.7 tp60 -115.83 122.42 45.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.188 0.518 . . . . 0.0 110.501 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.403 ' N ' HE21 ' A' ' 198' ' ' GLN . 10.3 tt -71.4 134.74 46.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.129 176.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 36.3 m -101.22 131.46 47.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.843 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -87.12 14.77 56.59 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.126 177.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.431 HG21 ' HD3' ' A' ' 254' ' ' PRO . 1.0 OUTLIER -61.05 121.5 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 167.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 6.8 t -99.03 96.95 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.031 0 CA-C-O 123.026 1.393 . . . . 0.0 109.227 173.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 12.7 p -129.06 -179.29 5.03 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 112.268 -2.242 . . . . 0.0 106.075 176.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 53.4 p -102.02 163.2 12.37 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 119.034 -1.067 . . . . 0.0 111.728 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.807 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 42.4 tttm -56.25 -38.72 71.52 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.689 170.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.4 m -45.86 -55.55 6.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.144 174.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.616 ' HG ' ' HB1' ' A' ' 252' ' ' ALA . 0.3 OUTLIER -56.44 -53.37 58.19 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 120.229 -0.589 . . . . 0.0 110.133 176.103 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . 0.868 ' HA ' ' CZ ' ' A' ' 215' ' ' ARG . 76.1 m -52.5 -37.29 57.07 Favored 'General case' 0 C--O 1.247 0.922 0 O-C-N 124.088 0.867 . . . . 0.0 113.266 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 61.3 m -94.15 -33.65 13.24 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.47 -45.45 72.36 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 120.721 -1.237 . . . . 0.0 108.93 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.539 HG22 ' HA2' ' A' ' 234' ' ' GLY . 73.6 p -105.65 149.57 26.22 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.34 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.475 HG21 HG12 ' A' ' 253' ' ' ILE . 2.1 t 57.48 -53.46 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 178.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.477 ' CA ' ' HA ' ' A' ' 226' ' ' ALA . . . 86.06 146.53 9.41 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 119.297 -1.43 . . . . 0.0 111.429 -169.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.868 ' CZ ' ' HA ' ' A' ' 209' ' ' CYS . 0.1 OUTLIER 153.16 -135.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.014 0.526 . . . . 0.0 111.451 -162.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.589 ' HB3' HD11 ' A' ' 190' ' ' ILE . . . -160.59 165.95 29.82 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . 0.807 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 17.2 t90 -161.79 145.52 12.44 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 121.891 -0.506 . . . . 0.0 110.26 -173.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 99.01 -175.21 28.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.374 -0.917 . . . . 0.0 114.363 171.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.51 ' CE1' ' HG2' ' A' ' 185' ' ' PRO . 11.2 m170 -132.2 130.84 22.13 Favored Pre-proline 0 C--N 1.327 -0.411 0 O-C-N 122.818 -0.224 . . . . 0.0 110.54 176.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.19 169.31 50.53 Favored 'Cis proline' 0 C--N 1.342 0.22 0 C-N-CA 123.014 -1.661 . . . . 0.0 110.976 -9.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 93.7 m -42.34 113.72 0.48 Allowed 'General case' 0 C--O 1.234 0.239 0 O-C-N 123.354 0.409 . . . . 0.0 111.655 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -102.07 106.26 17.12 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' MET . . . . . 0.528 ' HA ' ' HB2' ' A' ' 216' ' ' ALA . 0.6 OUTLIER -99.15 134.19 42.35 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.639 -164.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 32.1 p -141.12 152.25 64.27 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.981 0.42 . . . . 0.0 111.624 -176.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -55.69 171.28 0.72 Allowed 'Trans proline' 0 CA--C 1.514 -0.498 0 C-N-CA 123.154 2.569 . . . . 0.0 111.585 164.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.477 ' HA ' ' CA ' ' A' ' 214' ' ' GLY . . . -61.19 -126.69 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.763 0.792 . . . . 0.0 110.451 169.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.69 109.3 6.32 Favored Pre-proline 0 C--N 1.303 -1.433 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.358 -176.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -82.21 -92.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.254 1.969 . . . . 0.0 111.306 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -125.82 86.94 56.79 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.237 172.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -106.9 -168.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.693 0 C-N-CA 123.182 2.588 . . . . 0.0 111.631 171.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 8.9 p -86.77 -51.49 6.07 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 167.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.665 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 58.6 mtt180 -143.9 133.43 23.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 174.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.441 ' HG3' ' N ' ' A' ' 234' ' ' GLY . 22.3 ptt180 -45.49 -51.06 12.17 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -173.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.539 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -77.66 11.91 17.78 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.566 -0.826 . . . . 0.0 114.286 -175.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . 0.665 ' CD1' ' HB2' ' A' ' 232' ' ' ARG . 8.1 m-85 -123.32 152.5 41.38 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 122.109 0.957 . . . . 0.0 111.864 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.455 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.2 OUTLIER -125.22 122.92 25.25 Favored Pre-proline 0 N--CA 1.426 -1.641 0 CA-C-N 114.117 -1.401 . . . . 0.0 108.221 171.133 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -64.41 123.6 12.04 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.59 2.194 . . . . 0.0 112.094 178.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -57.69 126.01 25.5 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.667 174.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 29.1 pt -76.16 7.24 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.981 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 48.0 mtm180 -112.02 -60.92 1.79 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.734 177.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 37.6 p -86.89 -46.16 10.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.862 -176.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 108.71 6.52 30.56 Favored Glycine 0 N--CA 1.436 -1.314 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.487 -176.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -86.96 120.82 28.63 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-O 122.018 0.913 . . . . 0.0 110.505 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' CYS . . . . . 0.494 ' HB3' ' HB3' ' A' ' 235' ' ' PHE . 78.1 m -62.82 122.22 15.41 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.397 -1.729 . . . . 0.0 109.884 172.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 66.0 mt-30 -114.37 135.73 53.76 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.581 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 4.2 t70 -73.97 147.94 42.56 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.655 HG23 ' HG3' ' A' ' 249' ' ' GLU . 5.3 m -100.19 147.38 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.084 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -177.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.489 ' HA ' ' ND2' ' A' ' 264' ' ' ASN . 27.4 m-20 -78.06 79.25 4.52 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 167.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.655 ' HG3' HG23 ' A' ' 247' ' ' VAL . 49.8 mp0 -53.2 -36.6 61.14 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.505 -172.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 36.5 m -42.32 -40.16 2.38 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.34 171.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -100.12 -29.05 12.72 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.623 0.725 . . . . 0.0 110.321 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.616 ' HB1' ' HG ' ' A' ' 208' ' ' LEU . . . -87.71 -5.88 58.47 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.2 -172.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.61 HG13 ' NH2' ' A' ' 215' ' ' ARG . 2.8 mp -124.82 125.77 25.4 Favored Pre-proline 0 C--O 1.24 0.573 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.441 ' HD2' HG23 ' A' ' 253' ' ' ILE . 1.1 Cg_endo -34.14 -81.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 125.277 3.984 . . . . 0.0 114.208 -165.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -116.12 52.28 0.68 Allowed Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 174.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.666 ' HA ' ' OE1' ' A' ' 284' ' ' GLN . 20.0 tp -43.76 -64.92 0.57 Allowed 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.97 0.453 . . . . 0.0 112.172 -175.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 71.7 m -134.05 89.02 2.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -83.06 -59.2 2.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.474 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -79.85 93.79 1.41 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.847 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 273' ' ' CYS . . . 124.89 -174.52 17.22 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.672 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . 0.548 ' HB3' ' HG3' ' A' ' 272' ' ' LYS . 3.0 t-20 -83.63 157.12 22.37 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.78 132.71 18.1 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 5.2 mt -137.71 156.07 31.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -172.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.489 ' ND2' ' HA ' ' A' ' 248' ' ' ASP . 50.9 t30 -121.61 117.33 26.45 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.335 -176.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 5.6 t -110.53 166.77 10.73 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.559 164.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.581 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 29.5 m -70.44 130.46 34.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.476 -177.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.451 ' CA ' ' HE1' ' A' ' 235' ' ' PHE . . . 83.2 -9.49 60.79 Favored Glycine 0 N--CA 1.433 -1.557 0 C-N-CA 120.263 -0.97 . . . . 0.0 114.315 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 75.1 m -165.42 154.61 12.3 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 118.442 1.121 . . . . 0.0 111.184 -173.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . 0.428 ' CZ ' HD11 ' A' ' 256' ' ' LEU . 28.2 p90 -114.09 149.73 35.11 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.144 -0.972 . . . . 0.0 109.611 171.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -105.46 113.41 26.96 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 59.0 m -121.15 154.93 35.56 Favored 'General case' 0 CA--C 1.5 -0.953 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.504 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.548 ' HG3' ' HB3' ' A' ' 261' ' ' ASN . 0.0 OUTLIER -155.05 106.27 2.61 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.663 -179.713 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . 0.449 ' HA ' ' HA3' ' A' ' 260' ' ' GLY . 64.2 m -77.0 172.97 8.3 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.25 152.44 15.12 Favored 'Trans proline' 0 C--O 1.239 0.533 0 C-N-CA 121.243 1.296 . . . . 0.0 110.481 168.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -57.97 156.88 8.53 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.928 -173.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 86.6 -38.01 3.13 Favored Glycine 0 N--CA 1.435 -1.427 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.588 -176.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -81.38 168.51 18.3 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 122.588 -0.36 . . . . 0.0 110.366 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . 0.639 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 61.6 mttp -148.8 138.54 22.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.247 -175.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 46.7 tp -93.79 141.65 28.25 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.375 0.422 . . . . 0.0 110.267 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -122.84 106.7 11.12 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -65.15 -13.47 58.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -173.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 76.8 t -59.68 -38.31 75.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.109 0.48 . . . . 0.0 110.807 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.409 ' O ' ' HG2' ' A' ' 284' ' ' GLN . 45.1 m -144.63 38.34 1.23 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.955 177.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 0.666 ' OE1' ' HA ' ' A' ' 256' ' ' LEU . 23.9 pt20 38.25 32.8 0.05 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.317 1.047 . . . . 0.0 112.81 -175.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -89.82 105.04 17.53 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 122.111 -0.368 . . . . 0.0 111.426 -172.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' CYS . . . . . 0.639 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 45.7 t -108.99 163.9 12.89 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 174.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 C--O 1.248 1.026 0 O-C-N 124.057 0.848 . . . . 0.0 110.249 175.253 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 45.2 t . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -88.59 81.41 7.11 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 120.952 0.406 . . . . 0.0 110.216 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.3 t -67.7 109.46 3.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.72 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -83.92 64.21 7.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.435 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.9 m -75.18 123.22 24.87 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.608 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.525 HG23 ' SG ' ' A' ' 119' ' ' CYS . 69.1 mt -68.7 103.24 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.12 0.486 . . . . 0.0 109.781 174.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -80.59 61.07 4.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.983 -176.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 46.4 t60 41.65 62.14 1.65 Allowed 'General case' 0 N--CA 1.465 0.308 0 O-C-N 124.047 0.842 . . . . 0.0 110.529 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.525 ' SG ' HG23 ' A' ' 116' ' ' ILE . 24.2 p -88.21 162.05 16.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.271 -175.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -114.85 -38.08 4.03 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.453 HD13 ' HB2' ' A' ' 119' ' ' CYS . 0.2 OUTLIER -65.98 178.22 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.331 176.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.641 ' H ' ' HD2' ' A' ' 122' ' ' ARG . 0.2 OUTLIER -127.55 134.39 49.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.522 -174.525 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.655 ' SG ' ' HB3' ' A' ' 129' ' ' CYS . 23.1 m -118.62 145.61 45.29 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -172.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.6 mtm -138.33 173.22 11.84 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 62.88 53.12 2.49 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.175 0.297 . . . . 0.0 111.471 175.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.458 ' HA3' ' OE1' ' A' ' 137' ' ' GLN . . . 61.86 25.24 65.59 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.891 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 135' ' ' LEU . . . -98.61 129.47 9.91 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 119.944 -1.122 . . . . 0.0 111.677 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.2 m -107.85 133.12 52.67 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.655 ' HB3' ' SG ' ' A' ' 123' ' ' CYS . 14.0 p -72.98 134.84 44.86 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.983 0.421 . . . . 0.0 111.006 -173.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.4 t -137.73 104.92 5.44 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.2 t70 50.48 -110.08 0.44 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.985 -168.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.422 ' O ' HG21 ' A' ' 121' ' ' ILE . 6.4 p-10 -80.99 -41.95 21.95 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.15 -172.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -107.58 179.35 4.26 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.285 -176.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 129' ' ' CYS . 80.9 m -104.15 146.33 28.91 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.658 176.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.405 ' O ' ' HA2' ' A' ' 127' ' ' GLY . 90.0 mt -90.04 95.65 10.31 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 58.0 m -72.44 158.41 35.8 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.469 -174.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.458 ' OE1' ' HA3' ' A' ' 126' ' ' GLY . 42.4 mt-30 -80.37 144.66 32.53 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 168.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -63.57 110.83 2.12 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 122.832 1.301 . . . . 0.0 111.553 -174.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.403 ' HA2' ' CG1' ' A' ' 149' ' ' VAL . . . 132.82 -4.51 5.05 Favored Glycine 0 C--N 1.294 -1.774 0 CA-C-N 112.093 -2.321 . . . . 0.0 110.87 -177.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.518 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 88.1 m-85 -127.32 149.24 50.13 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 172.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 28.5 pt -135.82 -171.63 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.962 0.41 . . . . 0.0 110.087 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.74 175.15 41.39 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.398 -172.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 37.5 p -71.38 -39.67 71.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.158 0.504 . . . . 0.0 110.738 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 25.9 p-80 -107.59 16.43 23.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.11 -176.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 56.3 m 62.34 28.79 17.1 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.921 174.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.04 -5.18 70.95 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.428 -0.892 . . . . 0.0 113.583 -174.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.561 HE21 ' C ' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -107.92 126.62 29.38 Favored Pre-proline 0 C--O 1.218 -0.565 0 CA-C-N 117.883 0.842 . . . . 0.0 110.562 -176.729 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -87.33 137.86 4.48 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 123.207 2.605 . . . . 0.0 113.078 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.403 ' CG1' ' HA2' ' A' ' 139' ' ' GLY . 11.5 p -69.48 122.51 21.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.876 0.846 . . . . 0.0 111.539 -176.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.734 ' HB3' ' SG ' ' A' ' 154' ' ' CYS . 1.4 m -80.08 120.03 23.68 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 168.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.437 ' OE2' ' HB2' ' A' ' 164' ' ' ASN . 7.1 mt-10 -95.33 -63.08 1.2 Allowed 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -172.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.44 ' C ' ' H ' ' A' ' 154' ' ' CYS . 5.4 p -76.75 27.04 0.13 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -172.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 80.27 -19.25 7.0 Favored Glycine 0 CA--C 1.494 -1.234 0 CA-C-O 121.807 0.67 . . . . 0.0 112.966 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.734 ' SG ' ' HB3' ' A' ' 150' ' ' CYS . 68.4 m 62.94 133.81 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 113.201 -1.5 . . . . 0.0 112.208 -175.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.485 HD12 ' HB3' ' A' ' 178' ' ' GLU . 19.7 mt -128.19 167.82 16.3 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 113.484 -1.689 . . . . 0.0 108.69 -173.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.665 ' HB2' ' CZ ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 69.41 12.71 8.34 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.858 0.724 . . . . 0.0 111.526 174.669 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 72.1 33.9 61.91 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -168.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 167' ' ' ALA . . . -56.66 130.49 50.38 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 114.966 -0.617 . . . . 0.0 113.428 -175.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.474 ' O ' HG13 ' A' ' 161' ' ' VAL . 5.3 ttt180 -94.27 115.94 28.25 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.781 -0.709 . . . . 0.0 110.893 175.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 14.1 m -66.63 110.68 3.3 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.771 0.319 . . . . 0.0 110.725 -173.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.59 HG22 ' O ' ' A' ' 165' ' ' ARG . 5.7 m -104.27 -38.96 5.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.384 -177.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -140.39 171.9 7.06 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.518 ' HD3' ' CE1' ' A' ' 140' ' ' TYR . 88.5 Cg_exo -47.7 108.1 0.16 Allowed 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 122.137 1.892 . . . . 0.0 112.826 174.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.437 ' HB2' ' OE2' ' A' ' 151' ' ' GLU . 19.7 t-20 76.81 -18.33 0.49 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.736 1.215 . . . . 0.0 110.852 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.59 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.2 OUTLIER -78.12 81.68 4.49 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.355 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.35 142.77 29.94 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 169.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.438 ' O ' ' HA2' ' A' ' 158' ' ' GLY . . . -88.36 131.28 34.89 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -175.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.65 ' HA ' HD21 ' A' ' 156' ' ' ASN . 27.8 m -87.63 115.03 24.78 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 124.239 0.962 . . . . 0.0 111.307 -175.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 16.8 m -51.71 -54.4 28.68 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -174.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -148.88 -94.4 0.07 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.111 -1.035 . . . . 0.0 112.848 -168.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -89.54 47.81 3.29 Favored Glycine 0 N--CA 1.434 -1.487 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.909 -168.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.665 ' CZ ' ' HB2' ' A' ' 156' ' ' ASN . 16.3 m-85 -122.27 121.91 37.87 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.973 175.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.479 ' O ' ' HG2' ' A' ' 179' ' ' ARG . 4.9 t -90.8 164.56 14.04 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 161.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.37 132.35 5.45 Favored Glycine 0 N--CA 1.438 -1.182 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.27 -24.83 64.88 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.401 1.401 . . . . 0.0 113.501 -167.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -93.18 -0.12 56.99 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.518 0.675 . . . . 0.0 110.697 -178.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.55 ' HB3' ' CB ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 43.11 55.2 4.66 Favored 'General case' 0 N--CA 1.46 0.075 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.676 -174.115 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.485 ' HB3' HD12 ' A' ' 155' ' ' LEU . 13.7 pt-20 -106.12 -14.49 15.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.515 176.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 173' ' ' THR . 14.0 mmt180 -60.03 -64.2 1.03 Allowed 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.263 -177.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 31.1 t0 72.35 64.81 0.12 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.515 0.674 . . . . 0.0 109.853 163.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.433 ' CD1' ' O ' ' A' ' 181' ' ' TYR . 43.2 p90 -87.58 71.06 9.8 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 122.628 1.204 . . . . 0.0 108.026 177.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 -49.99 130.84 22.56 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.073 171.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 44.4 p -79.06 139.31 38.16 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.576 -0.45 . . . . 0.0 109.986 -176.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.423 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -157.02 154.8 25.84 Favored Glycine 0 C--N 1.321 -0.261 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -173.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -77.7 133.63 12.94 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.316 2.011 . . . . 0.0 111.889 175.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.708 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 49.1 m -87.58 122.68 31.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.318 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . 0.508 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 36.5 m-85 -94.07 137.43 33.27 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.672 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.594 ' C ' ' HG2' ' A' ' 215' ' ' ARG . 23.9 m -111.64 -11.44 14.01 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.346 -160.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.7 p -169.72 116.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 O-C-N 121.925 -0.485 . . . . 0.0 110.48 174.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.591 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.4 mt -119.67 118.42 57.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -170.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.3 p -112.21 -171.32 1.83 Allowed 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 156.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -67.89 -4.03 11.6 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.591 0.71 . . . . 0.0 109.877 172.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -89.84 -67.65 0.83 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.631 -176.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.482 ' O ' ' HA ' ' A' ' 190' ' ' ILE . 62.7 mtm -136.86 145.47 44.43 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.179 -178.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.591 ' HA ' HG12 ' A' ' 190' ' ' ILE . 74.1 m -85.43 -21.1 28.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.731 0.777 . . . . 0.0 109.676 174.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.459 ' HB2' ' H ' ' A' ' 188' ' ' THR . 46.4 tt0 -162.78 -72.31 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 162.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 126.12 13.7 3.19 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.067 164.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -123.56 1.76 8.92 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 173.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 65.77 -75.03 0.05 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.552 0.741 . . . . 0.0 111.761 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 34.9 t 73.02 139.68 0.06 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.654 0.74 . . . . 0.0 112.362 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -98.93 25.28 28.81 Favored Glycine 0 CA--C 1.505 -0.57 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.593 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.524 HD11 HG23 ' A' ' 253' ' ' ILE . 1.7 tt -61.01 104.02 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-O 121.235 0.54 . . . . 0.0 109.849 173.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 10.7 t -96.28 97.43 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-O 122.603 1.192 . . . . 0.0 109.599 171.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.527 ' HB3' ' SG ' ' A' ' 209' ' ' CYS . 9.0 t -123.98 -179.51 4.43 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 172.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.431 HG22 ' HB2' ' A' ' 181' ' ' TYR . 10.4 p -103.17 161.39 13.84 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.659 -177.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.514 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 53.6 tttm -61.71 -44.29 97.21 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.177 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.6 m -46.87 -54.53 9.75 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.944 0.878 . . . . 0.0 110.133 174.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.668 HD21 ' HB1' ' A' ' 252' ' ' ALA . 4.3 tp -64.27 -52.91 56.32 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 113.423 -1.717 . . . . 0.0 112.774 -175.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' ' 204' ' ' SER . 53.2 m -74.32 -18.31 60.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.99 0.424 . . . . 0.0 111.827 -175.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 68.8 m -96.58 -25.69 15.51 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.672 176.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -73.73 -60.51 2.22 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 172.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.841 HG22 ' HA2' ' A' ' 234' ' ' GLY . 15.4 p -92.04 162.77 14.23 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 65.11 -54.04 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 95.05 -122.24 7.13 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 120.248 -0.977 . . . . 0.0 113.849 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.594 ' HG2' ' C ' ' A' ' 188' ' ' THR . 6.4 mpt_? 27.17 -86.84 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -174.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.518 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -167.6 167.46 13.44 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 119.52 1.055 . . . . 0.0 110.985 -171.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . 0.733 ' O ' ' HB2' ' A' ' 222' ' ' GLU . 10.0 t90 -155.02 144.91 21.6 Favored 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 102.3 177.2 27.58 Favored Glycine 0 CA--C 1.505 -0.586 0 C-N-CA 120.159 -1.02 . . . . 0.0 114.147 169.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 220' ' ' PRO . 13.8 p80 -129.61 133.97 25.68 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.251 -0.474 . . . . 0.0 110.804 -175.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 219' ' ' HIS . 9.7 Cg_endo -89.76 117.0 3.12 Favored 'Cis proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.17 -1.596 . . . . 0.0 111.815 -3.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 98.9 m 40.76 89.18 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 O-C-N 124.113 0.883 . . . . 0.0 112.928 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.733 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 23.8 mt-10 -102.68 111.48 23.82 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 177.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' MET . . . . . 0.518 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 18.9 ptt? -102.35 136.95 41.26 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.112 -166.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 59.4 m -119.24 147.58 43.3 Favored Pre-proline 0 C--O 1.233 0.212 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -167.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -60.27 153.67 57.86 Favored 'Trans proline' 0 CA--C 1.508 -0.812 0 C-N-CA 123.833 3.022 . . . . 0.0 113.495 167.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -42.23 113.27 0.42 Allowed 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.904 0.859 . . . . 0.0 110.508 160.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' GLN . . . . . 0.419 ' HB3' ' HA ' ' A' ' 233' ' ' ARG . 0.1 OUTLIER 23.95 99.66 0.02 OUTLIER Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 111.518 -2.583 . . . . 0.0 113.7 -177.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.65 -62.91 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.835 3.023 . . . . 0.0 113.627 -177.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -69.9 155.14 93.99 Favored Pre-proline 0 CA--C 1.514 -0.411 0 CA-C-O 120.691 0.282 . . . . 0.0 110.348 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.75 58.35 6.97 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 121.739 1.626 . . . . 0.0 113.799 -174.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 64.0 m -132.91 148.11 52.29 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 171.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.638 ' HG3' ' CD1' ' A' ' 235' ' ' PHE . 16.4 ptt180 -55.49 137.16 49.08 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.079 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.419 ' HA ' ' HB3' ' A' ' 227' ' ' GLN . 29.6 ptt180 -31.12 -47.15 0.1 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -166.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.841 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -68.58 5.87 3.93 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 114.981 0.753 . . . . 0.0 114.981 -174.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . 0.638 ' CD1' ' HG3' ' A' ' 232' ' ' ARG . 7.7 m-85 -122.77 150.29 42.99 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 122.089 0.947 . . . . 0.0 112.97 -169.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.524 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.1 OUTLIER -126.52 125.25 24.45 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 114.046 -1.433 . . . . 0.0 108.387 172.382 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -62.69 123.01 11.58 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.339 2.026 . . . . 0.0 111.679 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -54.08 127.25 25.86 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.354 0.597 . . . . 0.0 110.936 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 32.7 pt -65.8 -6.66 4.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.428 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 240' ' ' ARG . 63.8 mtt85 -106.51 -68.1 0.9 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.491 0.662 . . . . 0.0 110.199 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 24.4 p -79.62 -43.17 23.39 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.351 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 102.72 8.0 43.7 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -176.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -82.28 127.11 32.89 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 122.056 0.932 . . . . 0.0 109.714 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 33.3 m -63.76 114.78 4.24 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 113.458 -1.701 . . . . 0.0 109.829 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.474 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 79.3 mt-30 -112.94 134.44 54.45 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.584 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 6.1 t70 -82.7 144.09 30.48 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.726 HG23 ' HG3' ' A' ' 249' ' ' GLU . 9.2 m -98.61 150.16 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.343 -174.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.67 76.39 2.04 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 169.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.726 ' HG3' HG23 ' A' ' 247' ' ' VAL . 9.7 mp0 -53.55 -39.9 65.1 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.191 0.596 . . . . 0.0 111.443 -167.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 49.2 t -51.54 -33.98 34.51 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.932 0.396 . . . . 0.0 111.284 175.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -98.67 -46.38 5.72 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.738 0.78 . . . . 0.0 110.05 -174.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.668 ' HB1' HD21 ' A' ' 208' ' ' LEU . . . -66.63 -21.55 66.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.813 -177.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.581 HG22 ' HB3' ' A' ' 256' ' ' LEU . 3.7 mp -120.39 79.56 28.64 Favored Pre-proline 0 N--CA 1.445 -0.716 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 175.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.446 ' CG ' HG13 ' A' ' 202' ' ' ILE . 0.1 OUTLIER -21.61 -29.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 1 C-N-CA 128.256 5.97 . . . . 0.0 120.032 -164.204 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 253' ' ' ILE . . . -172.06 39.03 0.16 Allowed Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 119.265 -1.445 . . . . 0.0 111.915 -175.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.581 ' HB3' HG22 ' A' ' 253' ' ' ILE . 2.2 pt? -70.57 -49.65 45.62 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 119.879 -0.728 . . . . 0.0 111.287 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . 0.557 ' H ' HD23 ' A' ' 256' ' ' LEU . 47.5 t -124.28 133.49 53.47 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 120.839 0.352 . . . . 0.0 110.086 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -134.77 -89.11 0.35 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.934 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 71.34 -71.49 0.81 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.838 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -152.81 -78.48 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . 0.548 ' HB3' ' HB2' ' A' ' 272' ' ' LYS . 3.9 t-20 -101.47 147.31 26.51 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 177.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 15.0 p -137.56 140.74 41.21 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 6.9 mt -144.62 166.16 12.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -170.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.61 ' ND2' ' HB3' ' A' ' 269' ' ' PHE . 0.8 OUTLIER -131.45 132.91 44.67 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 118.673 -1.211 . . . . 0.0 112.938 177.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 268' ' ' SER . 0.8 OUTLIER -114.85 161.05 18.75 Favored 'General case' 0 C--O 1.256 1.406 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.905 162.458 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.537 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 33.5 m -72.17 124.31 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.449 ' HA2' ' HE1' ' A' ' 235' ' ' PHE . . . 112.97 -29.5 8.03 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.057 -1.068 . . . . 0.0 112.895 -170.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.421 ' O ' HG23 ' A' ' 265' ' ' THR . 39.5 t 173.01 156.62 0.1 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 117.912 0.856 . . . . 0.0 109.465 -170.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . 0.61 ' HB3' ' ND2' ' A' ' 264' ' ' ASN . 40.2 p90 -98.43 161.4 13.7 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 121.832 -0.542 . . . . 0.0 110.029 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -114.93 141.18 48.31 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . 0.423 ' HB2' HD22 ' A' ' 279' ' ' LEU . 95.5 m -124.83 161.53 26.31 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.472 0.653 . . . . 0.0 111.493 175.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.548 ' HB2' ' HB3' ' A' ' 261' ' ' ASN . 61.1 mttp -140.39 109.52 6.13 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.592 173.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 286' ' ' CYS . 3.9 m -91.78 163.34 28.27 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.361 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 51.3 Cg_exo -53.91 158.61 8.47 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.564 2.176 . . . . 0.0 111.473 174.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -57.13 145.06 32.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 86.55 -30.89 4.36 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -173.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' HIS . . . . . 0.63 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 27.3 m-70 -89.08 173.64 8.33 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.001 0.429 . . . . 0.0 110.833 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . 0.667 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 95.6 mttt -162.38 153.19 17.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.903 -174.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.449 HD13 ' SG ' ' A' ' 257' ' ' CYS . 65.6 tp -87.57 136.82 32.79 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.45 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -126.6 101.23 6.56 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -63.4 -18.09 63.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.382 -174.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.509 ' HA ' ' NH2' ' A' ' 215' ' ' ARG . 93.9 t -57.08 -33.08 41.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.59 177.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 31.9 m -147.24 35.4 0.89 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.577 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 29.68 49.49 0.06 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.45 1.1 . . . . 0.0 113.368 -175.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 78.5 tttt -108.16 162.1 14.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.139 0.495 . . . . 0.0 111.768 -173.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' CYS . . . . . 0.667 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 40.4 m -129.63 102.79 6.51 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 18.1 tt0 . . . . . 0 C--O 1.243 0.756 0 CA-C-O 118.554 -0.736 . . . . 0.0 109.855 -173.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 120.958 0.409 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.36 -17.85 16.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.142 0.496 . . . . 0.0 110.96 178.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.0 t -94.31 93.53 7.77 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.102 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 74.0 mtm180 -86.76 79.96 8.67 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 177.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.5 p -85.11 -65.88 0.96 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.761 0.315 . . . . 0.0 111.569 -176.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 66.0 mt -108.73 -44.9 6.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.197 -176.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -64.75 97.96 0.25 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.955 -176.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -138.12 36.39 2.33 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 172.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 129' ' ' CYS . 5.7 p -159.02 -179.88 8.44 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.559 -164.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -110.47 -40.24 4.69 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.11 173.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.538 HD12 ' O ' ' A' ' 132' ' ' ASP . 0.2 OUTLIER -68.1 -172.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.341 -1.299 . . . . 0.0 113.143 -178.278 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.532 ' H ' ' HD2' ' A' ' 122' ' ' ARG . 0.3 OUTLIER -128.98 144.87 51.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.762 -174.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 20.4 m -116.19 161.61 18.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.855 0.836 . . . . 0.0 112.118 -175.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 12.1 mmm -161.66 161.7 29.61 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 64.62 50.29 2.16 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.365 0.603 . . . . 0.0 111.632 171.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.639 ' HA3' ' OE1' ' A' ' 137' ' ' GLN . . . 62.44 34.24 88.78 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.613 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.649 ' HA3' ' SG ' ' A' ' 134' ' ' CYS . . . -87.53 148.31 21.12 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.104 -1.046 . . . . 0.0 113.151 -176.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.1 m -115.3 150.21 36.62 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 172.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 119' ' ' CYS . 6.4 m -78.36 77.6 4.85 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -174.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.87 178.93 0.3 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.712 171.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -50.59 -6.95 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 -167.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.538 ' O ' HD12 ' A' ' 121' ' ' ILE . 13.9 t70 173.66 -31.79 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -172.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -105.32 -168.51 1.47 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.816 174.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.649 ' SG ' ' HA3' ' A' ' 127' ' ' GLY . 22.4 t -116.39 152.53 33.76 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.633 176.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.608 ' O ' ' HA2' ' A' ' 127' ' ' GLY . 69.4 mt -88.9 112.4 23.25 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . 0.727 ' SG ' ' HB2' ' A' ' 140' ' ' TYR . 9.3 t -91.95 145.59 24.42 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.275 -169.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.639 ' OE1' ' HA3' ' A' ' 126' ' ' GLY . 33.3 mt-30 -97.49 -164.61 1.16 Allowed 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.628 0.728 . . . . 0.0 112.156 -177.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -50.19 134.42 22.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.386 -1.279 . . . . 0.0 113.917 -171.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 54.31 16.86 7.17 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 112.746 -2.025 . . . . 0.0 114.791 177.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.727 ' HB2' ' SG ' ' A' ' 136' ' ' CYS . 23.9 m-85 -116.43 150.07 38.42 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 118.249 1.024 . . . . 0.0 111.664 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.412 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 28.8 pt -133.44 -178.13 2.49 Favored 'Isoleucine or valine' 0 C--O 1.251 1.139 0 O-C-N 124.234 0.958 . . . . 0.0 109.588 172.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.19 163.74 34.77 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.711 -178.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.0 p -76.88 -22.42 53.48 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.883 0.373 . . . . 0.0 111.604 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -97.32 -6.74 33.63 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 13.1 t 67.9 14.48 9.4 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.817 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -89.64 4.78 83.85 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.924 -173.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.44 ' O ' ' HA ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -105.7 118.85 54.35 Favored Pre-proline 0 C--O 1.219 -0.533 0 CA-C-N 117.69 0.745 . . . . 0.0 111.126 -176.717 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -87.22 140.23 5.48 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.695 2.263 . . . . 0.0 112.537 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 149' ' ' VAL . 8.3 p -69.92 105.97 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 122.293 1.044 . . . . 0.0 111.934 -176.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.94 78.73 5.37 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.421 175.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -53.24 -70.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.606 -1.179 . . . . 0.0 113.924 -172.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.5 m -90.91 12.46 19.44 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.658 0.742 . . . . 0.0 111.17 -169.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 72.47 127.87 0.1 OUTLIER Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 114.161 -1.381 . . . . 0.0 111.713 -175.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.579 ' O ' HD23 ' A' ' 155' ' ' LEU . 62.0 m -72.98 164.44 26.67 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.197 -1.002 . . . . 0.0 108.96 175.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.579 HD23 ' O ' ' A' ' 154' ' ' CYS . 62.6 mt -143.52 -178.49 5.91 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -166.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.554 ' HB2' ' CZ ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 44.44 24.48 0.09 Allowed 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 177.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 69.73 28.7 71.78 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.86 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -82.18 -138.7 2.88 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.306 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 166' ' ' CYS . 0.0 OUTLIER -166.25 140.68 4.37 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 117.396 0.598 . . . . 0.0 109.984 -179.192 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.97 110.98 13.37 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.319 0.581 . . . . 0.0 109.907 171.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 165' ' ' ARG . 2.5 m -99.67 -30.33 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.476 -176.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.582 ' HB3' ' CB ' ' A' ' 165' ' ' ARG . . . -140.36 171.73 7.33 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.462 ' HD2' ' HB1' ' A' ' 162' ' ' ALA . 96.6 Cg_exo -48.64 96.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.499 2.133 . . . . 0.0 113.229 177.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 42.0 t30 69.03 15.28 8.82 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.726 0.774 . . . . 0.0 109.997 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.582 ' CB ' ' HB3' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -100.74 86.5 3.12 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.793 172.224 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 60.0 m -82.75 138.37 34.06 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.016 171.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.72 131.81 34.35 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 171.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.435 ' HA ' HD21 ' A' ' 156' ' ' ASN . 72.8 m -115.28 138.27 51.13 Favored 'General case' 0 C--N 1.315 -0.916 0 O-C-N 123.876 0.735 . . . . 0.0 111.474 -170.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 39.6 m -50.37 -55.04 17.38 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.681 -168.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -162.74 -86.29 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 118.578 -1.249 . . . . 0.0 113.516 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -93.83 51.97 2.28 Favored Glycine 0 CA--C 1.489 -1.583 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.003 -164.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.692 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 1.7 m-85 -121.07 134.49 55.27 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 118.563 -1.255 . . . . 0.0 112.841 173.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.89 HG23 ' CE2' ' A' ' 181' ' ' TYR . 8.7 p -87.89 123.61 32.82 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.718 177.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' A' ' 176' ' ' GLN . . . 104.75 133.56 7.79 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 108.991 -1.643 . . . . 0.0 108.991 -175.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.49 12.81 0.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.747 1.631 . . . . 0.0 112.896 -170.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.51 ' O ' HD12 ' A' ' 155' ' ' LEU . 15.7 tt0 -121.95 16.81 10.91 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.246 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.657 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.5 OUTLIER 33.65 69.42 0.14 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 175.578 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -117.41 7.15 12.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.634 0.731 . . . . 0.0 110.509 172.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.692 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 21.4 mmt85 -117.49 89.62 3.16 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.2 -178.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -80.35 54.16 1.95 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.614 -170.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.89 ' CE2' HG23 ' A' ' 173' ' ' THR . 18.7 p90 -84.42 78.38 9.83 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -77.2 140.22 40.08 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 118.976 -2.327 . . . . 0.0 107.682 -178.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 67.0 p -83.73 136.25 34.25 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.168 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.45 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -156.16 160.83 30.39 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -80.51 129.52 7.46 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.592 2.195 . . . . 0.0 111.554 175.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.775 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 83.2 m -85.8 118.44 25.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.193 0.52 . . . . 0.0 110.589 177.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . 0.595 ' O ' ' HB2' ' A' ' 215' ' ' ARG . 9.2 m-85 -94.72 150.07 20.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.972 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.444 ' HA ' ' CB ' ' A' ' 215' ' ' ARG . 21.7 p -108.5 -1.8 19.46 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 28.3 m -141.62 174.37 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.623 HD11 ' HB2' ' A' ' 216' ' ' ALA . 12.8 mm -122.15 114.21 41.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.867 0.842 . . . . 0.0 111.327 176.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.488 ' HB3' ' C ' ' A' ' 194' ' ' MET . 30.1 t -143.16 127.93 18.23 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.198 175.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -63.87 -20.75 66.06 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 171.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.46 ' HB3' ' OG ' ' A' ' 191' ' ' SER . 53.0 tt0 -71.23 -69.36 0.38 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.339 169.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.488 ' C ' ' HB3' ' A' ' 191' ' ' SER . 64.2 mtt -151.39 101.88 2.86 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 176.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 187' ' ' PHE . 39.7 m -64.83 -24.76 67.64 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 122.201 0.2 . . . . 0.0 110.737 172.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.503 ' HB2' ' HA ' ' A' ' 187' ' ' PHE . 7.7 mm-40 142.22 -139.52 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 126.959 2.104 . . . . 0.0 107.561 177.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.427 ' H ' ' HB3' ' A' ' 196' ' ' GLN . . . 84.02 -50.12 4.35 Favored Glycine 0 C--N 1.332 0.35 0 N-CA-C 115.146 0.818 . . . . 0.0 115.146 170.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -72.36 29.01 0.05 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -171.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.547 ' N ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -156.87 18.22 0.31 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.933 0.397 . . . . 0.0 110.272 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 32.2 t -153.38 135.23 14.59 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.27 0.557 . . . . 0.0 111.115 -175.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -102.37 29.73 11.88 Favored Glycine 0 CA--C 1.502 -0.778 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 173.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.626 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -64.32 104.05 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-O 122.008 0.909 . . . . 0.0 109.425 176.497 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.32 99.05 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-O 122.42 1.105 . . . . 0.0 110.283 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.3 t -123.19 -178.27 3.93 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 113.241 -1.799 . . . . 0.0 106.724 169.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.8 p -100.76 164.4 11.88 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.385 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.613 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 45.5 tttm -60.6 -46.16 91.29 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.44 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.1 m -43.95 -56.23 4.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.88 174.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.568 ' CD1' HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -55.68 -57.47 11.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.53 179.296 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 40.0 m -72.5 -17.4 61.75 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -170.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 66.3 m -92.39 -31.61 15.26 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.021 175.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -70.84 -61.67 1.68 Allowed 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.737 HG22 ' HA2' ' A' ' 234' ' ' GLY . 32.4 p -92.26 152.52 19.78 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.105 174.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.404 HG13 HE21 ' A' ' 284' ' ' GLN . 2.1 t 70.3 -43.8 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 177.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.618 ' O ' ' HD2' ' A' ' 215' ' ' ARG . . . 55.97 61.97 6.85 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 115.767 1.067 . . . . 0.0 115.767 170.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.618 ' HD2' ' O ' ' A' ' 214' ' ' GLY . 14.4 mmm180 -126.43 -82.25 0.62 Allowed 'General case' 0 C--O 1.237 0.44 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.888 176.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.623 ' HB2' HD11 ' A' ' 190' ' ' ILE . . . -169.11 166.74 10.8 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . 0.775 ' HD1' ' SG ' ' A' ' 186' ' ' CYS . 11.6 t90 -159.12 149.42 19.37 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 121.23 -0.919 . . . . 0.0 109.461 -175.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 221' ' ' CYS . . . 87.13 156.68 29.9 Favored Glycine 0 C--O 1.223 -0.542 0 C-N-CA 120.363 -0.922 . . . . 0.0 114.695 168.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.618 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 17.0 p80 -130.57 135.46 27.42 Favored Pre-proline 0 C--O 1.236 0.354 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.618 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 31.6 Cg_exo -59.31 143.37 29.79 Favored 'Cis proline' 0 N--CA 1.477 0.552 0 C-N-CA 124.16 -1.183 . . . . 0.0 111.71 -0.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 43.0 t -41.86 117.77 1.0 Allowed 'General case' 0 N--CA 1.464 0.257 0 O-C-N 124.222 0.951 . . . . 0.0 112.868 -170.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.45 ' HB3' ' HE3' ' A' ' 206' ' ' LYS . 22.9 mt-10 -109.41 120.25 41.95 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -80.29 148.28 30.8 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -176.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 5.8 m -85.4 123.34 73.09 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -172.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.2 167.56 19.89 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.394 2.73 . . . . 0.0 110.847 167.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -39.74 -60.06 1.05 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.12 -172.75 0.33 Allowed Pre-proline 0 N--CA 1.431 -1.418 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 -173.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -84.75 -98.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.801 1.667 . . . . 0.0 110.7 172.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.436 ' CG ' ' HG3' ' A' ' 237' ' ' PRO . 20.0 m-70 -84.24 166.77 31.33 Favored Pre-proline 0 CA--C 1.513 -0.473 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 169.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.12 65.52 4.25 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.852 1.702 . . . . 0.0 113.162 -176.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 64.2 m -106.2 -173.88 2.4 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 170.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.733 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 86.3 mtt180 -67.75 147.57 52.44 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 119.701 -0.799 . . . . 0.0 108.927 172.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -37.92 -49.98 1.27 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 178.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.737 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -79.33 12.44 26.2 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.605 -0.807 . . . . 0.0 114.833 -174.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . 0.733 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 2.3 m-85 -122.86 146.82 47.22 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 122.093 0.949 . . . . 0.0 113.21 -172.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.462 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.0 OUTLIER -124.87 132.74 24.36 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 114.098 -1.41 . . . . 0.0 107.967 170.543 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.436 ' HG3' ' CG ' ' A' ' 229' ' ' HIS . 18.1 Cg_endo -60.38 118.85 5.77 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.13 1.887 . . . . 0.0 111.721 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -52.29 136.85 30.01 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 121.727 0.775 . . . . 0.0 110.582 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 33.2 mt -70.93 -16.37 19.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.404 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 240' ' ' ARG . 42.0 mtm105 -102.52 -63.32 1.17 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.29 0.567 . . . . 0.0 110.248 -176.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 40.5 p -79.34 -38.46 35.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.75 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 94.89 5.41 61.11 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -176.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -86.67 124.36 32.85 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 121.935 0.874 . . . . 0.0 109.121 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 235' ' ' PHE . 13.0 m -57.92 123.13 14.77 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 113.403 -1.726 . . . . 0.0 110.479 178.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 80.7 mm-40 -119.39 142.85 47.82 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.569 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 8.5 t70 -77.85 147.53 35.11 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.721 HG23 ' HG3' ' A' ' 249' ' ' GLU . 15.9 m -94.17 142.88 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.094 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.212 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -70.07 77.5 0.5 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 164.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.721 ' HG3' HG23 ' A' ' 247' ' ' VAL . 20.5 mp0 -52.7 -35.6 55.83 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 123.525 0.515 . . . . 0.0 110.498 -173.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 33.1 m -55.01 -29.33 57.12 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.176 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -103.93 -43.74 5.21 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.923 0.868 . . . . 0.0 109.7 -175.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.34 -22.1 64.71 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.024 -1.444 . . . . 0.0 111.286 -175.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.764 HG22 ' HB3' ' A' ' 256' ' ' LEU . 64.2 mt -131.34 75.61 77.17 Favored Pre-proline 0 N--CA 1.447 -0.603 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -13.04 -91.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.039 1 C-N-CA 126.106 4.537 . . . . 0.0 115.749 -162.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -119.69 59.41 0.53 Allowed Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 119.641 -1.266 . . . . 0.0 111.872 177.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.764 ' HB3' HG22 ' A' ' 253' ' ' ILE . 2.3 pt? -63.97 -38.91 92.79 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.139 177.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 45.8 t -104.86 107.36 18.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.492 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -116.68 35.69 4.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.903 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.678 ' HA3' ' SG ' ' A' ' 286' ' ' CYS . . . -87.96 -9.04 71.58 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.592 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 145.21 -100.11 0.22 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . 0.598 ' HB2' ' HB2' ' A' ' 272' ' ' LYS . 11.2 m120 -89.09 158.01 18.12 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.733 0.301 . . . . 0.0 110.778 177.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.71 132.73 14.29 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 10.7 mt -142.34 165.46 16.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -173.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.93 126.53 43.39 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 118.556 -1.258 . . . . 0.0 113.525 -175.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 4.6 t -115.55 167.78 10.59 Favored 'General case' 0 C--O 1.258 1.52 0 CA-C-O 122.243 1.021 . . . . 0.0 110.322 162.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.547 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 30.4 m -71.11 131.27 34.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.849 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.555 ' CA ' ' HE2' ' A' ' 235' ' ' PHE . . . 88.95 -9.79 75.28 Favored Glycine 0 N--CA 1.423 -2.201 0 CA-C-O 119.264 -0.742 . . . . 0.0 113.527 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 48.3 t -179.51 150.03 0.41 Allowed 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 117.838 0.819 . . . . 0.0 111.255 -172.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -107.31 156.53 18.78 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.89 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -108.27 128.88 55.12 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.961 -176.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . 0.421 ' HB2' HD22 ' A' ' 279' ' ' LEU . 54.9 m -120.56 160.38 23.32 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.313 0.578 . . . . 0.0 111.081 176.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.598 ' HB2' ' HB2' ' A' ' 261' ' ' ASN . 6.9 mtpm? -140.54 124.52 17.37 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.193 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 3.7 m -98.36 170.72 6.64 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 175.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 34.5 Cg_exo -58.31 156.18 31.7 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.567 1.511 . . . . 0.0 110.611 170.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -59.34 149.39 29.15 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.25 -33.26 3.19 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.113 -174.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' HIS . . . . . 0.473 ' HB2' ' O ' ' A' ' 274' ' ' PRO . 9.2 m170 -78.69 167.37 21.32 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 120.987 0.422 . . . . 0.0 110.69 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 67.1 mttm -140.22 139.15 35.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.227 -179.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.485 HD12 ' O ' ' A' ' 285' ' ' LYS . 21.4 tp -81.71 143.98 31.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.041 0.448 . . . . 0.0 110.75 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -124.55 98.46 5.74 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -68.04 -12.83 61.54 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -174.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 42.7 t -66.24 -25.42 35.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.252 0.548 . . . . 0.0 110.266 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 10.3 p -148.05 28.87 0.91 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.618 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 0.404 HE21 HG13 ' A' ' 213' ' ' VAL . 77.8 mm-40 30.06 49.57 0.07 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.709 -1.132 . . . . 0.0 113.16 -171.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . 0.485 ' O ' HD12 ' A' ' 279' ' ' LEU . 97.9 mttt -102.65 175.65 5.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.754 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' CYS . . . . . 0.678 ' SG ' ' HA3' ' A' ' 259' ' ' GLY . 92.9 m -141.81 170.41 15.77 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 173.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.643 ' HB2' ' O ' ' A' ' 286' ' ' CYS . 2.4 mp0 . . . . . 0 C--O 1.25 1.099 0 C-N-CA 124.319 1.048 . . . . 0.0 109.408 170.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 39.8 t . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 121.102 0.477 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.9 30.28 7.42 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -176.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.1 m -82.83 15.27 2.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.545 0.688 . . . . 0.0 109.907 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.1 mtm180 -128.96 138.25 51.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.644 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 43.1 t -78.05 132.18 37.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.752 0.311 . . . . 0.0 110.722 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.8 pt -73.67 -11.33 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.246 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -72.98 -11.67 60.66 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.597 0.713 . . . . 0.0 109.691 174.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -97.6 35.84 1.6 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.743 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 39.0 t -159.24 140.51 12.95 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.872 -176.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.569 ' OD1' HG23 ' A' ' 121' ' ' ILE . 29.0 p-10 -122.55 -31.16 3.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.824 0.821 . . . . 0.0 110.322 175.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.569 HG23 ' OD1' ' A' ' 120' ' ' ASN . 0.2 OUTLIER -91.77 -164.18 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 122.075 0.94 . . . . 0.0 113.246 -176.673 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.536 ' HD2' ' N ' ' A' ' 122' ' ' ARG . 4.3 mpt_? -114.7 126.06 54.44 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.013 -178.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.494 ' SG ' ' HA ' ' A' ' 129' ' ' CYS . 65.2 m -116.55 117.05 28.8 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -114.53 165.74 12.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.268 -176.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 66.96 42.77 2.37 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.076 0.465 . . . . 0.0 110.889 173.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.451 ' O ' ' HG2' ' A' ' 137' ' ' GLN . . . 75.66 22.17 75.53 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.467 -178.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -73.36 124.1 8.7 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 -176.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.474 ' HB2' ' HB2' ' A' ' 135' ' ' LEU . 19.1 m -91.99 126.31 37.02 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.494 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 9.1 m -58.76 147.99 31.24 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 122.366 1.079 . . . . 0.0 113.668 -173.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.59 ' HB2' ' O ' ' A' ' 133' ' ' HIS . 50.8 m -142.73 169.86 16.78 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 173.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.408 ' HB3' ' H ' ' A' ' 132' ' ' ASP . 15.1 t70 -38.61 -89.51 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 O-C-N 124.397 1.061 . . . . 0.0 112.206 176.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.408 ' H ' ' HB3' ' A' ' 131' ' ' ASP . 33.1 t70 -82.98 -42.43 17.58 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.983 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.59 ' O ' ' HB2' ' A' ' 130' ' ' SER . 0.3 OUTLIER -108.98 -167.81 1.26 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -176.397 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 59.9 m -122.99 153.03 40.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.004 177.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.474 ' HB2' ' HB2' ' A' ' 128' ' ' SER . 97.2 mt -92.51 120.47 33.01 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 74.5 m -84.93 153.95 22.51 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.403 -169.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 126' ' ' GLY . 26.7 mm-40 -81.86 148.16 28.95 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 169.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -63.16 111.44 2.22 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 123.1 1.428 . . . . 0.0 111.929 -174.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 125.65 -4.34 8.08 Favored Glycine 0 N--CA 1.431 -1.683 0 CA-C-N 112.327 -2.215 . . . . 0.0 111.441 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.667 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 97.9 m-85 -119.58 145.81 46.06 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.157 0.504 . . . . 0.0 110.376 173.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.484 ' CG1' ' HB3' ' A' ' 147' ' ' GLN . 40.6 pt -131.08 175.03 12.14 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.312 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 101.29 174.18 28.68 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.851 -177.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.3 p -73.54 -31.61 63.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.316 0.579 . . . . 0.0 111.45 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -110.87 7.05 21.7 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.411 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 34.1 m 63.91 37.49 9.48 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 124.204 0.94 . . . . 0.0 111.181 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -93.62 -7.09 61.92 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.906 -176.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.484 ' HB3' ' CG1' ' A' ' 141' ' ' ILE . 0.0 OUTLIER -103.27 112.72 65.9 Favored Pre-proline 0 C--N 1.327 -0.404 0 O-C-N 122.121 -0.635 . . . . 0.0 110.704 -177.554 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.67 142.45 14.34 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.342 2.695 . . . . 0.0 112.614 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 149' ' ' VAL . 8.9 p -73.15 107.73 3.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 122.504 1.145 . . . . 0.0 111.284 -178.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.86 88.03 5.29 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.298 175.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.34 -68.04 0.27 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -175.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 16.7 m -95.71 13.37 26.66 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.824 0.345 . . . . 0.0 111.628 -166.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.23 123.95 0.91 Allowed Glycine 0 N--CA 1.438 -1.221 0 CA-C-O 121.819 0.677 . . . . 0.0 113.066 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.437 ' O ' HD23 ' A' ' 155' ' ' LEU . 80.4 m -81.14 162.23 23.75 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 172.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.621 HD12 ' O ' ' A' ' 176' ' ' GLN . 79.9 mt -148.22 167.27 25.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 118.04 0.382 . . . . 0.0 110.88 -162.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.605 ' HB2' ' CZ ' ' A' ' 172' ' ' PHE . 10.0 t30 48.31 23.72 0.6 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.327 -164.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 66.0 39.36 94.79 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.256 -0.974 . . . . 0.0 111.774 -177.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.62 -138.16 0.21 Allowed Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.772 -0.727 . . . . 0.0 111.313 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 13.1 ttt180 -159.47 128.99 5.41 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.08 -0.659 . . . . 0.0 111.221 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.4 m -62.91 119.99 10.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.59 0.233 . . . . 0.0 110.691 173.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 165' ' ' ARG . 16.7 m -105.68 -35.84 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.947 0.403 . . . . 0.0 110.546 178.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.75 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -139.93 170.55 9.56 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.667 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 76.6 Cg_exo -51.58 109.17 0.29 Allowed 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.208 1.939 . . . . 0.0 112.133 174.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 72.96 -3.07 2.52 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.36 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.75 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.9 OUTLIER -90.92 86.35 6.26 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.516 175.857 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 72.6 m -78.65 141.07 38.27 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.234 171.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.439 ' HB2' ' CG1' ' A' ' 161' ' ' VAL . . . -97.79 117.54 32.34 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 172.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 83.0 m -101.18 141.17 34.45 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.036 -170.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 7.0 m -51.11 -53.9 29.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -168.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -167.68 -84.72 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.36 -0.936 . . . . 0.0 113.227 -172.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -90.94 55.91 3.32 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.325 -167.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.674 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 7.0 m-85 -127.11 137.57 53.02 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.509 169.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.679 HG23 ' CE2' ' A' ' 181' ' ' TYR . 64.4 p -87.15 123.79 32.57 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.094 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 102.09 139.84 10.78 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.05 7.82 1.59 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 121.143 1.229 . . . . 0.0 112.449 -172.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.621 ' O ' HD12 ' A' ' 155' ' ' LEU . 18.9 tt0 -119.47 26.1 9.63 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.294 176.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.572 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.7 OUTLIER 23.89 72.72 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 118.693 2.849 . . . . 0.0 118.693 170.614 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.418 ' O ' ' HD3' ' A' ' 179' ' ' ARG . 9.9 pt-20 -124.96 29.8 6.05 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.103 -0.998 . . . . 0.0 110.929 169.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.674 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 23.9 mmt180 -130.2 93.0 3.38 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.168 175.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.427 ' HA ' ' CE1' ' A' ' 172' ' ' PHE . 3.7 m-20 -78.07 53.14 1.16 Allowed 'General case' 0 C--N 1.323 -0.55 0 O-C-N 123.402 0.439 . . . . 0.0 111.189 -169.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.75 ' HA ' HG21 ' A' ' 205' ' ' THR . 16.2 p90 -84.4 80.43 9.22 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -82.75 135.12 35.08 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 119.761 -1.837 . . . . 0.0 108.609 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 70.3 p -77.06 171.04 15.44 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.463 ' HA3' ' CE2' ' A' ' 217' ' ' TRP . . . 157.18 136.04 2.04 Favored Glycine 0 C--N 1.32 -0.322 0 C-N-CA 119.669 -1.253 . . . . 0.0 112.359 -163.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.489 ' HG2' ' CD2' ' A' ' 219' ' ' HIS . 16.6 Cg_exo -69.62 128.23 15.86 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.133 1.889 . . . . 0.0 111.531 172.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.715 ' SG ' ' HD2' ' A' ' 215' ' ' ARG . 16.5 t -102.18 114.28 28.29 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.474 0.654 . . . . 0.0 110.68 -178.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . 0.658 ' O ' ' HB3' ' A' ' 215' ' ' ARG . 16.8 m-85 -93.62 143.43 26.31 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.262 -177.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.467 ' HA ' ' HB3' ' A' ' 215' ' ' ARG . 2.4 m -96.23 -27.73 14.87 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -162.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.1 p -163.2 118.79 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.628 -171.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.634 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.4 mt -125.51 118.8 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 122.182 0.992 . . . . 0.0 113.486 -168.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.418 ' C ' ' H ' ' A' ' 193' ' ' GLN . 36.2 t -116.15 -164.56 0.97 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 113.766 -1.561 . . . . 0.0 106.934 163.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -63.87 -5.71 4.81 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.718 0.77 . . . . 0.0 110.008 170.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.418 ' H ' ' C ' ' A' ' 191' ' ' SER . 96.3 mt-30 -69.84 -75.76 0.11 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.847 -178.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 46.0 ttm -171.2 151.37 3.15 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.957 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.634 ' HA ' HG12 ' A' ' 190' ' ' ILE . 72.8 m -57.43 -46.11 83.92 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 121.73 0.776 . . . . 0.0 110.91 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -151.54 -81.22 0.1 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 166.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.44 -24.33 6.91 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.569 172.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -131.14 45.3 2.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.393 0.616 . . . . 0.0 109.43 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 26.3 tp -169.82 132.76 1.17 Allowed 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.572 -173.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 34.7 t -149.04 -47.46 0.14 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.753 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.84 26.62 10.47 Favored Glycine 0 C--O 1.228 -0.225 0 C-N-CA 120.752 -0.737 . . . . 0.0 114.333 -171.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.487 ' O ' HD13 ' A' ' 202' ' ' ILE . 0.0 OUTLIER -79.29 91.58 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 165.424 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.49 112.47 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 CA-C-O 122.935 1.35 . . . . 0.0 110.171 -171.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 6.1 t -155.64 -178.74 7.5 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.75 HG21 ' HA ' ' A' ' 181' ' ' TYR . 17.8 p -106.35 171.5 7.32 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 120.883 1.674 . . . . 0.0 110.649 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.806 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 34.0 tttm -59.88 -47.43 85.77 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.777 175.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.9 m -45.21 -55.59 5.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.956 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.512 HD11 HG11 ' A' ' 247' ' ' VAL . 0.3 OUTLIER -58.73 -48.76 80.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.257 178.249 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 97.2 m -61.18 -38.81 87.83 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 227' ' ' GLN . 56.5 m -83.86 -37.19 22.77 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 121.65 -0.656 . . . . 0.0 111.249 -176.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . 0.5 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . . . -68.14 -57.69 5.66 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.695 HG22 ' HA2' ' A' ' 234' ' ' GLY . 30.5 p -104.05 144.16 31.92 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.152 -175.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.0 t 64.06 -22.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 63.55 51.86 50.85 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 120.435 1.47 . . . . 0.0 114.028 167.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.715 ' HD2' ' SG ' ' A' ' 186' ' ' CYS . 27.1 mtt85 -103.09 -123.03 0.19 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.797 0.808 . . . . 0.0 111.307 -178.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.574 ' HB3' HD11 ' A' ' 190' ' ' ILE . . . -156.8 168.52 27.21 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . 0.806 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 36.6 t90 -161.77 149.74 14.94 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 119.365 0.984 . . . . 0.0 111.188 -170.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 85.09 170.12 46.81 Favored Glycine 0 C--O 1.229 -0.186 0 N-CA-C 115.081 0.792 . . . . 0.0 115.081 170.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.584 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 85.8 m-70 -127.23 133.04 24.63 Favored Pre-proline 0 N--CA 1.457 -0.117 0 C-N-CA 122.949 0.5 . . . . 0.0 109.879 171.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.584 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 18.9 Cg_endo -58.73 157.67 36.99 Favored 'Cis proline' 0 C--O 1.236 0.393 0 C-N-CA 123.261 -1.558 . . . . 0.0 112.373 -4.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 33.2 t -53.41 115.56 1.99 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.586 -174.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 27.5 mt-10 -105.39 102.76 12.21 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' MET . . . . . 0.585 ' O ' ' HD3' ' A' ' 225' ' ' PRO . 1.3 tpt -79.09 132.42 36.59 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -175.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' CYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 215' ' ' ARG . 92.7 m -83.29 112.58 40.06 Favored Pre-proline 0 C--N 1.332 -0.154 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -172.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.585 ' HD3' ' O ' ' A' ' 223' ' ' MET . 6.1 Cg_exo -81.41 124.92 4.9 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.598 2.865 . . . . 0.0 111.054 169.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 48.25 -79.16 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.899 0.88 . . . . 0.0 113.228 -174.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 225' ' ' PRO . 0.0 OUTLIER -162.27 -171.54 0.28 Allowed Pre-proline 0 N--CA 1.441 -0.903 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -168.317 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 211' ' ' ALA . 6.9 Cg_endo -87.85 -90.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 121.835 1.69 . . . . 0.0 111.478 170.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -87.66 158.12 51.48 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 172.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.02 61.87 7.8 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.19 1.927 . . . . 0.0 114.593 -171.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 92.2 m -110.39 -177.94 3.37 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 169.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.643 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 31.1 mmt180 -62.72 140.63 58.74 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 173.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -37.33 -50.72 1.05 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.695 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -70.1 1.14 19.45 Favored Glycine 0 C--N 1.313 -0.728 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.72 -174.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . 0.643 ' CD2' ' HB2' ' A' ' 232' ' ' ARG . 11.3 m-85 -123.17 151.32 42.3 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.159 0.981 . . . . 0.0 113.324 -169.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.436 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.1 OUTLIER -127.32 128.7 24.02 Favored Pre-proline 0 N--CA 1.436 -1.143 0 CA-C-N 114.082 -1.417 . . . . 0.0 108.259 169.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.92 125.17 14.25 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.533 2.156 . . . . 0.0 111.802 178.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -62.61 136.64 57.98 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 35.5 pt -82.78 2.32 3.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.584 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -103.12 -57.37 2.05 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.853 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 52.3 p -89.06 -45.9 9.26 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.5 -178.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 103.06 11.02 35.35 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -96.17 125.23 40.55 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 121.95 0.881 . . . . 0.0 109.992 -177.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 4.3 m -59.06 122.56 14.06 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.832 172.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 75.5 mm-40 -123.37 137.9 54.72 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.542 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 6.1 t70 -75.32 147.21 40.33 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-O 121.283 0.563 . . . . 0.0 110.001 -176.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.62 HG23 ' HG3' ' A' ' 249' ' ' GLU . 11.4 m -93.53 144.27 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.426 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.48 ' HA ' ' ND2' ' A' ' 264' ' ' ASN . 7.0 m-20 -75.03 77.28 2.22 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 168.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.62 ' HG3' HG23 ' A' ' 247' ' ' VAL . 36.2 mp0 -52.42 -35.73 52.7 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.651 0.739 . . . . 0.0 110.515 -171.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 9.5 m -53.39 -33.47 53.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.877 175.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -99.1 -37.42 9.34 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.78 0.8 . . . . 0.0 110.101 -177.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.23 -19.02 63.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.753 -175.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.403 HG12 HH22 ' A' ' 215' ' ' ARG . 3.2 mp -126.66 117.18 22.68 Favored Pre-proline 0 N--CA 1.446 -0.637 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 174.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -35.79 -91.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.483 0.911 1 C-N-CA 125.345 4.03 . . . . 0.0 114.39 -165.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -100.36 56.59 0.8 Allowed Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.406 171.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.409 ' O ' ' HG3' ' A' ' 284' ' ' GLN . 22.6 tp -40.3 -65.33 0.42 Allowed 'General case' 0 C--O 1.224 -0.273 0 O-C-N 124.465 0.744 . . . . 0.0 112.894 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 262' ' ' CYS . 11.3 t -87.62 62.72 7.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.104 0.478 . . . . 0.0 109.857 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -60.4 104.33 0.32 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.55 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 131.92 -17.35 4.92 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.764 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -150.78 -157.85 8.0 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.032 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -108.54 121.55 45.21 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 269' ' ' PHE . 52.6 t -92.14 133.55 35.68 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 176.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 39.3 mt -132.24 112.51 19.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.442 0.639 . . . . 0.0 110.075 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.48 ' ND2' ' HA ' ' A' ' 248' ' ' ASP . 66.1 t30 -74.13 126.44 30.57 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -170.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 6.2 t -113.35 164.91 12.98 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.021 154.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.542 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 30.7 m -69.97 132.2 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 118.705 -1.198 . . . . 0.0 108.899 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.502 ' CA ' ' HE2' ' A' ' 235' ' ' PHE . . . 88.53 -10.87 70.11 Favored Glycine 0 C--N 1.314 -0.678 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.571 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.4 p -174.43 143.14 0.82 Allowed 'General case' 0 C--O 1.212 -0.872 0 CA-C-N 118.112 0.956 . . . . 0.0 110.705 -174.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . 0.482 ' HB2' ' SG ' ' A' ' 262' ' ' CYS . 41.1 p90 -103.12 151.64 22.33 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -114.7 126.84 55.33 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -175.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . 0.433 ' HB2' HD22 ' A' ' 279' ' ' LEU . 11.1 m -97.05 158.17 15.56 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.867 0.841 . . . . 0.0 111.961 -178.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -134.71 106.26 6.86 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.278 172.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 4.6 m -96.52 156.03 37.21 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.502 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 52.2 Cg_exo -55.84 159.9 10.88 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.53 2.154 . . . . 0.0 111.425 172.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -56.17 146.02 24.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.551 0.215 . . . . 0.0 111.07 -177.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.26 -30.0 3.42 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.88 -176.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' HIS . . . . . 0.546 ' HA ' ' OXT' ' A' ' 287' ' ' GLU . 17.8 m-70 -78.84 165.01 24.01 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.135 0.493 . . . . 0.0 111.507 -177.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -146.4 135.0 22.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.605 -175.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.621 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 39.0 tp -71.34 140.85 50.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.223 0.535 . . . . 0.0 110.926 177.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -129.56 102.44 6.37 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 170.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -61.01 -24.38 66.12 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 123.521 0.513 . . . . 0.0 111.781 -173.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 16.4 t -62.66 -23.84 33.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.983 0.421 . . . . 0.0 110.826 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.4 ' C ' HE21 ' A' ' 284' ' ' GLN . 28.1 p -141.63 24.86 2.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.668 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 256' ' ' LEU . 0.0 OUTLIER 25.53 48.85 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.142 0.977 . . . . 0.0 112.178 -169.115 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . 0.621 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 81.8 tttt -97.87 159.14 15.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.16 -171.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 4.0 m -137.15 81.25 1.86 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.041 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.546 ' OXT' ' HA ' ' A' ' 277' ' ' HIS . 66.5 mm-40 . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.346 -0.835 . . . . 0.0 108.893 -174.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -94.81 144.97 25.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.115 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 41.0 m -81.66 71.54 8.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.89 0.376 . . . . 0.0 110.295 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -75.29 114.45 13.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.559 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.8 m -70.27 137.89 51.14 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.203 177.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.0 mt -98.61 108.96 23.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -74.82 140.52 44.0 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.459 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -60.34 121.73 12.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.16 0.505 . . . . 0.0 109.95 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.447 ' HB3' ' O ' ' A' ' 130' ' ' SER . 33.4 m -86.74 -177.18 6.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.321 -174.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 44.0 m-20 -96.14 -50.35 4.87 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 121.786 0.803 . . . . 0.0 109.907 -176.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 133' ' ' HIS . 36.3 pt -98.5 -168.21 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-N 114.354 -1.293 . . . . 0.0 112.254 -167.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.472 ' HD3' ' H ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -127.88 142.79 51.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.341 -173.397 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 71.5 m -117.05 167.99 10.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.455 0.645 . . . . 0.0 112.554 -173.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 85.0 mtp -144.8 158.16 43.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.823 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 65.57 45.7 2.65 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.993 0.425 . . . . 0.0 111.528 169.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.644 ' O ' ' HG2' ' A' ' 137' ' ' GLN . . . 75.2 16.85 80.38 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.527 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.83 119.03 10.34 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.021 -177.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.6 t -84.21 126.64 33.33 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 19.1 p -76.88 160.7 29.01 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.189 0.518 . . . . 0.0 110.775 -170.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.55 ' HB3' ' O ' ' A' ' 133' ' ' HIS . 11.3 t -143.05 168.09 20.55 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 120' ' ' ASN . 13.0 t70 -30.76 -91.56 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 O-C-N 124.582 1.176 . . . . 0.0 113.024 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -83.53 -43.94 15.2 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.142 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.55 ' O ' ' HB3' ' A' ' 130' ' ' SER . 0.6 OUTLIER -110.63 -174.98 2.6 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.095 -1.042 . . . . 0.0 112.958 -178.209 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 44.9 t -122.71 149.43 44.08 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.697 -175.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 86.1 mt -107.55 114.62 28.74 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.3 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 59.8 m -74.38 162.49 28.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.133 -173.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.644 ' HG2' ' O ' ' A' ' 126' ' ' GLY . 14.8 mm-40 -78.44 150.87 32.96 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.515 168.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' A' ' 138' ' ' LYS . 13.5 tmtt? -65.98 112.5 3.86 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 122.59 1.186 . . . . 0.0 110.748 -176.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 123.04 -1.59 9.85 Favored Glycine 0 C--N 1.302 -1.325 0 CA-C-N 112.752 -2.022 . . . . 0.0 111.567 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.657 ' CZ ' ' HD3' ' A' ' 163' ' ' PRO . 94.8 m-85 -122.03 142.75 50.02 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 122.43 -0.453 . . . . 0.0 110.133 172.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 26.6 pt -128.31 176.65 7.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.669 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 96.64 167.94 33.77 Favored Glycine 0 C--N 1.318 -0.457 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.761 -176.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.9 p -74.62 -23.61 58.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.176 0.488 . . . . 0.0 111.669 -177.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -109.54 7.3 24.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.534 176.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 30.9 m 64.29 30.05 13.53 Favored 'General case' 0 N--CA 1.462 0.168 0 O-C-N 123.672 0.607 . . . . 0.0 111.013 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.3 -12.22 67.95 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.571 -173.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.77 109.67 63.24 Favored Pre-proline 0 C--O 1.224 -0.259 0 CA-C-N 117.912 0.856 . . . . 0.0 110.745 -174.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.01 139.4 24.2 Favored 'Trans proline' 0 CA--C 1.522 -0.092 0 C-N-CA 123.625 2.884 . . . . 0.0 112.578 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 149' ' ' VAL . 9.3 p -67.52 110.53 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.734 0.778 . . . . 0.0 111.479 -175.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.38 77.18 7.17 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.972 176.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -53.86 -68.89 0.14 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -174.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.4 m -88.01 13.55 10.82 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.137 0.494 . . . . 0.0 111.679 -165.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 87.99 122.1 1.75 Allowed Glycine 0 N--CA 1.428 -1.841 0 CA-C-O 122.237 0.909 . . . . 0.0 112.608 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.414 ' C ' ' HG ' ' A' ' 155' ' ' LEU . 5.7 m -78.32 155.13 30.3 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 113.185 -1.507 . . . . 0.0 109.034 168.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.669 HD12 ' O ' ' A' ' 176' ' ' GLN . 56.3 mt -149.71 163.22 38.55 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.858 -166.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.577 HD22 ' HB ' ' A' ' 169' ' ' THR . 61.4 t30 47.69 24.13 0.51 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.66 -164.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 67.71 38.3 89.71 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.74 -177.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.22 -152.84 0.59 Allowed Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.723 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -149.07 121.57 8.52 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.223 -0.575 . . . . 0.0 111.808 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.5 m -63.19 114.69 3.92 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.668 177.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 165' ' ' ARG . 8.8 m -104.17 -34.92 3.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.81 0.338 . . . . 0.0 110.935 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.696 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -140.1 171.68 7.47 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.657 ' HD3' ' CZ ' ' A' ' 140' ' ' TYR . 73.9 Cg_exo -53.3 108.55 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.988 1.792 . . . . 0.0 112.434 177.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 72.81 -7.88 1.37 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.362 1.065 . . . . 0.0 110.423 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.696 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.5 OUTLIER -83.49 82.54 8.25 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 176.295 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 7.1 t -80.88 145.8 31.15 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.463 ' HB2' ' CG1' ' A' ' 161' ' ' VAL . . . -96.5 118.68 33.51 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 173.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 84.0 m -90.45 126.97 36.08 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.791 -167.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.577 ' HB ' HD22 ' A' ' 156' ' ' ASN . 3.0 m -42.62 -51.44 5.19 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 124.633 1.208 . . . . 0.0 112.531 -172.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -165.76 -89.75 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 119.481 -0.888 . . . . 0.0 112.234 -176.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -90.98 54.89 3.32 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.636 -167.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.643 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 7.8 m-85 -129.63 136.5 49.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.608 0.704 . . . . 0.0 111.654 169.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.696 HG23 ' CE2' ' A' ' 181' ' ' TYR . 80.1 p -87.49 132.79 33.9 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.383 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 176' ' ' GLN . . . 92.06 146.75 19.14 Favored Glycine 0 N--CA 1.438 -1.167 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.799 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.32 22.89 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.616 1.544 . . . . 0.0 112.407 -174.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.669 ' O ' HD12 ' A' ' 155' ' ' LEU . 50.4 tt0 -120.85 3.28 10.57 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.512 176.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.596 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 32.15 57.59 0.36 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 176.639 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.454 ' HG3' ' HE ' ' A' ' 179' ' ' ARG . 15.7 pt-20 -115.84 17.21 16.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.501 0.667 . . . . 0.0 110.085 175.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.643 ' O ' ' HA ' ' A' ' 172' ' ' PHE . 8.8 mmt180 -117.65 90.66 3.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.651 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -78.91 79.46 5.31 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.869 0.843 . . . . 0.0 110.97 -168.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.696 ' CE2' HG23 ' A' ' 173' ' ' THR . 17.4 p90 -112.13 79.97 1.28 Allowed 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 22.9 mtp85 -79.93 144.95 32.91 Favored 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 118.936 -2.352 . . . . 0.0 107.285 -176.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 82.3 p -78.65 138.22 38.21 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.083 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.488 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -151.91 149.78 21.55 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -70.62 128.44 15.25 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.76 1.64 . . . . 0.0 110.787 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.507 ' H ' HG23 ' A' ' 202' ' ' ILE . 7.8 t -84.17 122.0 28.24 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.113 0.482 . . . . 0.0 109.824 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . 0.461 ' HB3' ' HB3' ' A' ' 195' ' ' CYS . 65.5 m-85 -107.07 149.03 28.03 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.758 -178.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.627 ' HA ' ' HB3' ' A' ' 215' ' ' ARG . 17.7 p -102.44 -59.0 1.78 Allowed 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -173.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 p -121.95 117.83 53.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.673 -173.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.522 HD13 ' HB3' ' A' ' 221' ' ' CYS . 4.2 mt -124.28 120.73 60.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -170.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 63.9 p -117.32 -166.29 1.17 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.562 -1.199 . . . . 0.0 107.849 161.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -68.31 -5.59 19.48 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.692 0.678 . . . . 0.0 110.22 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -92.19 -75.83 0.47 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.099 -173.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 72.7 mtm -141.13 143.03 34.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.662 0.268 . . . . 0.0 110.725 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.497 ' HA ' HG12 ' A' ' 190' ' ' ILE . 8.5 m -90.37 -45.61 8.9 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.982 176.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.405 ' HG3' ' H ' ' A' ' 188' ' ' THR . 20.0 mt-30 -152.13 3.99 0.39 Allowed 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.253 165.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 92.99 -3.81 74.01 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.132 -175.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 74.31 6.58 4.65 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.277 0.631 . . . . 0.0 112.333 174.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.795 ' H ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -85.9 19.88 2.41 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.269 0.557 . . . . 0.0 110.957 177.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.453 ' OG ' HG22 ' A' ' 202' ' ' ILE . 15.2 t -102.96 142.83 33.4 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.662 -175.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -126.84 19.61 6.13 Favored Glycine 0 CA--C 1.504 -0.606 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.611 HD11 HG23 ' A' ' 253' ' ' ILE . 0.0 OUTLIER -67.72 99.27 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 122.093 0.949 . . . . 0.0 109.05 173.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.99 123.1 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.097 174.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 22.9 t -154.33 -178.35 7.08 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 181' ' ' TYR . 5.5 p -103.58 161.03 14.23 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 119.752 1.16 . . . . 0.0 108.811 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.527 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 45.4 tttm -59.82 -44.72 93.88 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.067 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.8 m -44.22 -56.2 4.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.931 172.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.573 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -53.77 -53.66 49.22 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.814 177.778 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 99.0 m -68.75 -22.92 64.28 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 45.0 m -96.1 -29.65 13.97 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.056 -178.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 227' ' ' GLN . . . -74.08 -60.06 2.44 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 173.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.775 HG22 ' HA2' ' A' ' 234' ' ' GLY . 10.8 p -96.78 160.64 14.26 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.283 178.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 1.4 t 66.32 -41.98 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 118.784 -0.626 . . . . 0.0 111.922 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 62.32 46.75 93.24 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-N 119.155 0.889 . . . . 0.0 113.584 168.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.627 ' HB3' ' HA ' ' A' ' 188' ' ' THR . 0.9 OUTLIER -119.87 -92.47 0.54 Allowed 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.746 -178.22 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.502 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -167.67 166.88 13.69 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . 0.527 ' CE3' ' HB2' ' A' ' 206' ' ' LYS . 21.8 t90 -155.18 148.42 24.88 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 122.213 -0.305 . . . . 0.0 110.276 -174.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 221' ' ' CYS . . . 86.09 160.98 34.68 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.756 172.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.657 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 26.2 t60 -135.62 131.88 19.45 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.657 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 51.6 Cg_exo -54.59 142.81 14.39 Favored 'Cis proline' 0 C--N 1.353 0.784 0 C-N-CA 123.896 -1.293 . . . . 0.0 112.282 -2.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . 0.66 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 72.2 m -50.64 128.28 20.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.714 -172.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -116.19 121.71 42.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.818 175.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' MET . . . . . 0.502 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 5.1 ppp? -106.62 153.87 21.74 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.287 -171.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 97.8 m -135.07 135.47 22.99 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -173.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -56.99 166.91 3.53 Favored 'Trans proline' 0 CA--C 1.515 -0.447 0 C-N-CA 123.98 3.12 . . . . 0.0 114.111 167.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -39.01 111.59 0.19 Allowed 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.081 162.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' GLN . . . . . 0.448 ' HB3' ' O ' ' A' ' 211' ' ' ALA . 0.3 OUTLIER 6.42 92.89 0.03 OUTLIER Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 110.137 -3.211 . . . . 0.0 114.162 177.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -58.07 -49.97 11.3 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.747 2.298 . . . . 0.0 113.256 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -49.72 134.58 19.9 Favored Pre-proline 0 CA--C 1.512 -0.488 0 C-N-CA 122.834 0.454 . . . . 0.0 110.521 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.49 45.29 1.93 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.006 1.804 . . . . 0.0 113.301 -172.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 48.8 m -127.7 -176.1 3.67 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.67 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 98.1 mtt180 -61.53 139.21 58.28 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 172.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.412 ' O ' HG22 ' A' ' 212' ' ' THR . 20.3 ptt180 -38.46 -42.74 0.77 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 177.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.775 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -77.48 9.28 29.18 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.033 -0.604 . . . . 0.0 114.018 -177.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . 0.717 ' HE2' ' N ' ' A' ' 267' ' ' GLY . 2.3 m-85 -121.53 147.5 45.71 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 122.044 0.926 . . . . 0.0 112.776 -172.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.41 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.5 OUTLIER -123.23 130.37 24.58 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 113.667 -1.606 . . . . 0.0 108.851 173.306 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -58.42 112.42 1.17 Allowed 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.333 2.022 . . . . 0.0 111.564 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -51.47 138.88 21.12 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.359 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 23.6 mt -81.91 -6.03 9.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.034 -173.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -109.18 -55.45 2.41 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.452 0.644 . . . . 0.0 110.221 -177.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 47.6 p -90.45 -38.24 13.39 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.907 -176.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 96.79 6.53 58.14 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -176.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -89.11 124.54 34.42 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 122.015 0.912 . . . . 0.0 109.943 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' CYS . . . . . . . . . . . . . 12.1 m -54.87 121.44 8.64 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.454 176.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.451 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 84.5 mm-40 -119.81 137.66 53.84 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.677 ' CG ' ' HA ' ' A' ' 266' ' ' VAL . 13.4 t70 -76.7 147.29 37.5 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.557 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.758 HG23 ' HG3' ' A' ' 249' ' ' GLU . 6.4 m -99.31 145.27 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.965 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.755 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -72.58 75.94 1.08 Allowed 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 167.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.758 ' HG3' HG23 ' A' ' 247' ' ' VAL . 21.3 mp0 -53.06 -34.62 57.31 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.746 0.784 . . . . 0.0 110.216 -170.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 11.9 m -48.39 -40.3 25.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.836 174.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -103.51 -41.5 5.97 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.856 0.836 . . . . 0.0 110.368 -175.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -66.76 -23.46 66.09 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.546 -1.207 . . . . 0.0 110.624 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.84 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.5 mp -127.54 78.57 74.59 Favored Pre-proline 0 N--CA 1.445 -0.679 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 172.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.465 ' HG2' HG12 ' A' ' 202' ' ' ILE . 9.7 Cg_endo -50.32 112.26 0.7 Allowed 'Trans proline' 0 CA--C 1.507 -0.869 0 C-N-CA 124.112 3.208 . . . . 0.0 114.64 -164.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 59.09 35.12 82.61 Favored Glycine 0 C--N 1.307 -1.03 0 CA-C-N 113.233 -1.803 . . . . 0.0 113.811 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.84 ' HB3' HG22 ' A' ' 253' ' ' ILE . 2.2 pt? -63.99 -22.54 66.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 118.06 0.93 . . . . 0.0 110.593 177.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 14.5 t -78.01 4.51 12.03 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.152 0.501 . . . . 0.0 110.688 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 67.34 -86.84 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.809 0.844 . . . . 0.0 113.013 171.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -126.62 11.1 7.11 Favored Glycine 0 CA--C 1.507 -0.417 0 C-N-CA 120.207 -0.997 . . . . 0.0 112.279 -174.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -98.94 -173.92 31.8 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.314 175.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . 0.582 ' HB3' ' CG ' ' A' ' 272' ' ' LYS . 2.7 t-20 -107.0 116.99 32.88 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 176.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' ' 269' ' ' PHE . 34.4 t -90.64 134.86 34.09 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 2.7 mp -127.48 112.13 27.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.609 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -74.56 123.52 24.95 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -172.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.4 t -110.74 160.04 17.08 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 155.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.677 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 4.1 m -76.42 128.4 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.886 0 C-N-CA 117.933 -1.507 . . . . 0.0 108.137 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.717 ' N ' ' HE2' ' A' ' 235' ' ' PHE . . . 112.57 -26.83 10.48 Favored Glycine 0 N--CA 1.432 -1.567 0 C-N-CA 119.904 -1.141 . . . . 0.0 111.338 -172.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 37.6 t 173.01 160.02 0.12 Allowed 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 121.112 0.482 . . . . 0.0 110.373 -172.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . 0.598 ' HB2' ' SG ' ' A' ' 262' ' ' CYS . 42.2 p90 -103.69 155.51 18.51 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 121.326 -0.859 . . . . 0.0 109.036 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -116.76 125.52 51.75 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 11.4 m -105.41 154.01 20.9 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.858 0.837 . . . . 0.0 112.203 -176.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.582 ' CG ' ' HB3' ' A' ' 261' ' ' ASN . 10.1 ptmm? -129.63 108.71 10.42 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.342 168.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 32.2 m -85.89 156.14 58.2 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.068 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.588 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 71.8 Cg_exo -50.51 160.64 1.54 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.479 2.12 . . . . 0.0 112.351 173.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -58.25 136.49 57.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.903 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.08 -26.15 5.66 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' HIS . . . . . 0.59 ' ND1' ' HA ' ' A' ' 287' ' ' GLU . 14.9 m-70 -79.43 176.78 9.38 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.18 0.514 . . . . 0.0 112.001 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -167.97 144.85 4.15 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.939 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 38.1 tp -91.66 137.99 31.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.033 0.444 . . . . 0.0 110.911 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -125.62 98.43 5.57 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.18 -19.38 61.51 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.629 0.581 . . . . 0.0 112.177 -172.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.477 ' HA ' ' NH1' ' A' ' 215' ' ' ARG . 79.7 t -58.07 -34.58 49.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.821 177.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.434 ' HA ' ' HB ' ' A' ' 188' ' ' THR . 32.2 m -139.49 31.01 2.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.08 177.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 0.611 ' HB3' ' O ' ' A' ' 256' ' ' LEU . 82.0 mm-40 30.82 44.87 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.299 -0.864 . . . . 0.0 113.111 -173.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' A' ' 287' ' ' GLU . 62.0 tttp -91.43 110.15 21.45 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.49 -175.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 44.8 t -100.3 68.04 1.39 Allowed 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.59 ' HA ' ' ND1' ' A' ' 277' ' ' HIS . 42.3 mt-10 . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.423 -0.798 . . . . 0.0 109.491 -173.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 N--CA 1.474 0.729 0 CA-C-O 121.001 0.429 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.44 -32.0 71.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.63 0.729 . . . . 0.0 110.012 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.1 p -98.35 170.65 8.71 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.044 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -123.06 49.67 1.63 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.853 0.358 . . . . 0.0 110.905 -177.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.9 m 65.81 -177.39 0.19 Allowed 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.195 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 69.0 mt -115.71 108.95 26.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.102 176.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 117' ' ' GLN . 20.9 tt0 65.14 23.01 12.33 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.505 0.669 . . . . 0.0 110.202 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -146.48 54.87 1.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.388 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 8.4 p -101.65 -103.36 0.26 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.204 0.526 . . . . 0.0 111.395 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.519 ' HB3' ' H ' ' A' ' 132' ' ' ASP . 75.6 m-20 -90.81 -48.58 6.94 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.535 HD11 ' N ' ' A' ' 134' ' ' CYS . 0.2 OUTLIER -164.38 144.75 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-N 113.102 -1.863 . . . . 0.0 108.625 160.513 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.405 ' CD ' ' H ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -61.62 121.09 11.92 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.478 0.656 . . . . 0.0 111.138 177.126 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 92.1 m -117.13 152.63 34.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.646 0.736 . . . . 0.0 112.942 -175.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 69.7 mmm -150.37 175.24 12.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.407 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 60.65 55.67 3.26 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.708 0.29 . . . . 0.0 111.715 170.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.504 ' O ' ' HG3' ' A' ' 137' ' ' GLN . . . 63.98 32.99 86.04 Favored Glycine 0 C--O 1.218 -0.885 0 C-N-CA 120.424 -0.894 . . . . 0.0 112.431 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 135' ' ' LEU . . . -115.26 131.37 9.68 Favored Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.7 m -104.65 130.0 52.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.267 0.556 . . . . 0.0 111.032 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.408 ' SG ' ' HB2' ' A' ' 120' ' ' ASN . 18.2 t -60.75 103.3 0.25 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.322 178.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.0 m -126.22 135.3 51.43 Favored 'General case' 0 C--O 1.213 -0.832 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.412 ' HA ' ' HB3' ' A' ' 120' ' ' ASN . 8.9 m-20 -31.7 99.61 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -175.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.519 ' H ' ' HB3' ' A' ' 120' ' ' ASN . 11.0 m-20 80.5 -6.66 1.67 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.413 166.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.75 130.02 9.68 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 121.419 -0.801 . . . . 0.0 110.429 174.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.535 ' N ' HD11 ' A' ' 121' ' ' ILE . 25.3 t -86.49 136.48 33.07 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.655 -173.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.552 ' O ' ' HA2' ' A' ' 127' ' ' GLY . 79.2 mt -81.32 90.64 6.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.371 0.605 . . . . 0.0 110.034 176.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 56.0 m -76.23 138.13 40.41 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.844 -178.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 126' ' ' GLY . 38.5 mt-30 -51.62 152.48 2.75 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.145 171.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.504 ' HD3' ' O ' ' A' ' 138' ' ' LYS . 9.6 tmtt? -63.03 116.45 5.35 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.917 0.865 . . . . 0.0 111.207 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 100.1 14.12 34.53 Favored Glycine 0 C--N 1.304 -1.234 0 CA-C-N 113.29 -1.777 . . . . 0.0 111.894 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.526 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 46.4 m-85 -119.99 139.18 52.87 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.976 0.417 . . . . 0.0 111.191 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.514 HG13 ' HB3' ' A' ' 147' ' ' GLN . 25.7 pt -136.34 -166.01 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.748 -177.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.81 179.92 53.1 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.955 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 30.7 p -74.21 -37.36 63.89 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 122.827 0.451 . . . . 0.0 112.205 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -97.46 6.29 48.41 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 35.3 m 63.23 23.78 14.01 Favored 'General case' 0 C--O 1.22 -0.493 0 O-C-N 123.785 0.678 . . . . 0.0 109.497 -171.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -94.8 1.5 65.78 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.307 -0.473 . . . . 0.0 113.564 -171.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.514 ' HB3' HG13 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -104.87 105.7 52.17 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 117.409 0.604 . . . . 0.0 109.402 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.442 ' HD2' ' OE1' ' A' ' 147' ' ' GLN . 92.7 Cg_endo -79.69 151.34 22.02 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.756 2.304 . . . . 0.0 112.783 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 149' ' ' VAL . 13.3 p -87.95 104.23 14.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 122.325 1.06 . . . . 0.0 111.706 -173.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.53 90.84 5.71 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.548 170.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -52.83 -63.12 1.25 Allowed 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -173.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 4.2 m -84.19 7.34 19.32 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.568 0.699 . . . . 0.0 109.948 -168.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.47 131.71 0.08 OUTLIER Glycine 0 N--CA 1.432 -1.579 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.132 -168.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.434 ' O ' HD23 ' A' ' 155' ' ' LEU . 72.4 m -66.54 154.6 39.95 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 114.447 -0.877 . . . . 0.0 110.364 176.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.434 HD23 ' O ' ' A' ' 154' ' ' CYS . 34.5 mt -123.23 162.97 21.55 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.647 -169.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.737 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 2.2 t-20 48.55 38.07 10.4 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.422 -167.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 55.94 38.48 74.98 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.743 -174.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.18 -155.06 0.88 Allowed Glycine 0 C--N 1.32 -0.322 0 CA-C-N 115.216 -0.492 . . . . 0.0 112.086 -176.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -144.95 122.36 11.65 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.746 -0.381 . . . . 0.0 111.232 -171.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.42 111.29 5.86 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.403 173.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 165' ' ' ARG . 14.8 m -101.08 -42.92 10.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 O-C-N 121.94 -0.475 . . . . 0.0 110.092 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.575 ' HB3' ' HB2' ' A' ' 165' ' ' ARG . . . -134.17 173.34 5.93 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.526 ' HD3' ' CE1' ' A' ' 140' ' ' TYR . 54.7 Cg_exo -54.29 113.01 1.16 Allowed 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 122.492 2.128 . . . . 0.0 112.033 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 75.2 -10.16 1.27 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.636 0.775 . . . . 0.0 109.642 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.575 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 0.9 OUTLIER -86.47 82.21 8.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.371 179.007 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 84.4 m -87.48 137.16 32.57 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.684 0.754 . . . . 0.0 110.288 172.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.51 134.74 33.64 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.309 174.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 86.3 m -102.2 124.07 47.15 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.288 0.992 . . . . 0.0 111.655 -169.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.737 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 65.2 m -56.34 -53.92 51.59 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -172.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -151.91 -87.75 0.06 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 118.482 -1.287 . . . . 0.0 114.135 -170.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -93.96 39.09 2.98 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.943 -166.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.607 ' CZ ' ' HB2' ' A' ' 156' ' ' ASN . 1.7 m-85 -123.72 125.28 44.46 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 118.188 0.994 . . . . 0.0 111.795 174.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.521 ' N ' ' HE1' ' A' ' 181' ' ' TYR . 5.5 t -87.04 163.73 16.87 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 166.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.91 127.84 2.06 Favored Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -175.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -75.22 15.94 0.74 Allowed 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 121.128 1.219 . . . . 0.0 113.274 -166.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -120.89 2.12 10.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.747 0.784 . . . . 0.0 110.325 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.45 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 42.65 48.0 4.66 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 114.299 -1.319 . . . . 0.0 113.854 -179.185 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -107.66 -18.13 13.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.286 0.565 . . . . 0.0 110.169 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' A' ' 180' ' ' ASP . 6.8 mmt180 -55.95 -73.66 0.06 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.582 -176.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.481 ' HB3' ' O ' ' A' ' 179' ' ' ARG . 27.1 t70 84.96 75.16 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.642 0 O-C-N 124.122 0.889 . . . . 0.0 110.176 168.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.521 ' HE1' ' N ' ' A' ' 173' ' ' THR . 44.6 p90 -94.72 61.56 2.64 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 169.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.458 ' HG3' ' CH2' ' A' ' 217' ' ' TRP . 22.1 ptt-85 -51.75 126.36 17.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.439 175.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 42.5 p -79.97 137.73 36.92 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 120.857 0.36 . . . . 0.0 110.188 -173.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.624 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -162.8 159.3 31.66 Favored Glycine 0 C--N 1.323 -0.154 0 CA-C-O 119.365 -0.686 . . . . 0.0 111.505 -175.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.11 141.6 11.79 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.421 2.081 . . . . 0.0 111.977 174.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.759 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 74.7 m -91.03 123.25 34.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.445 0.641 . . . . 0.0 111.294 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . 0.556 ' O ' ' HB2' ' A' ' 215' ' ' ARG . 19.1 m-85 -86.47 144.68 27.16 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.989 176.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 5.0 m -108.39 -18.24 13.8 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -163.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 7.5 p -170.75 118.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 121.614 -0.678 . . . . 0.0 110.272 176.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.511 HG12 ' HA ' ' A' ' 195' ' ' CYS . 5.4 mt -114.72 120.92 65.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -171.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 11.4 m -110.09 173.57 6.26 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 105.194 -2.151 . . . . 0.0 105.194 152.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -67.45 -6.26 18.58 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.639 1.109 . . . . 0.0 109.902 177.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -77.01 -74.44 0.24 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.284 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 92.7 mmm -132.2 133.46 44.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.789 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.511 ' HA ' HG12 ' A' ' 190' ' ' ILE . 56.0 m -83.15 -31.52 27.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.724 174.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.467 ' O ' ' HD1' ' A' ' 187' ' ' PHE . 77.9 mt-30 68.42 117.49 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.425 174.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 118.96 21.25 3.87 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.162 -172.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -75.93 3.94 9.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.474 0.654 . . . . 0.0 110.425 -178.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.52 ' N ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -122.53 15.25 10.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.588 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 1.4 t -87.19 128.24 35.14 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.948 -173.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -105.13 14.37 48.3 Favored Glycine 0 CA--C 1.505 -0.534 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.011 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.56 ' CD1' ' HA ' ' A' ' 253' ' ' ILE . 2.1 tt -60.95 103.7 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 171.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.7 t -88.77 95.78 5.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 123.31 1.528 . . . . 0.0 108.09 171.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 19.3 m -137.64 177.33 7.95 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 111.458 -2.61 . . . . 0.0 106.875 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.428 ' OG1' ' HB ' ' A' ' 207' ' ' THR . 26.8 p -100.88 161.02 13.89 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.674 -174.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.673 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 44.5 tttm -58.84 -42.83 90.23 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.884 173.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.428 ' HB ' ' OG1' ' A' ' 205' ' ' THR . 56.8 m -44.4 -56.39 4.27 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 122.78 1.276 . . . . 0.0 109.594 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.787 HD11 HG11 ' A' ' 247' ' ' VAL . 10.8 tp -59.71 -49.68 76.79 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 112.379 -2.191 . . . . 0.0 112.043 -175.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 50.6 m -77.49 -17.62 57.84 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.224 0.535 . . . . 0.0 111.78 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 72.4 m -87.4 -27.21 22.9 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.985 -0.447 . . . . 0.0 110.022 172.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . 0.587 ' HB2' ' CE1' ' A' ' 229' ' ' HIS . . . -73.57 -56.57 4.85 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.816 0.817 . . . . 0.0 109.296 175.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.647 ' CG2' ' HA2' ' A' ' 234' ' ' GLY . 25.5 p -106.02 149.93 26.21 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.488 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.0 t 69.14 -42.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 O-C-N 123.948 0.78 . . . . 0.0 111.628 -174.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 56.75 64.29 4.54 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 119.401 1.0 . . . . 0.0 114.842 171.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.556 ' HB2' ' O ' ' A' ' 187' ' ' PHE . 21.4 mmt85 -130.41 -80.23 0.54 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 117.707 0.753 . . . . 0.0 110.532 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.43 ' HB3' ' HB2' ' A' ' 187' ' ' PHE . . . -169.35 169.73 8.87 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 176.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . 0.759 ' HD1' ' SG ' ' A' ' 186' ' ' CYS . 16.0 t90 -157.8 147.4 20.01 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 89.47 169.46 44.12 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 170.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.438 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 16.9 m-70 -128.04 131.38 23.76 Favored Pre-proline 0 C--N 1.341 0.237 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.456 175.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 23.4 Cg_exo -63.99 159.94 66.32 Favored 'Cis proline' 0 C--N 1.348 0.524 0 C-N-CA 123.569 -1.429 . . . . 0.0 111.149 -4.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 63.5 m -45.17 121.33 2.82 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 123.563 0.539 . . . . 0.0 111.982 -176.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.457 ' HB3' ' HE3' ' A' ' 206' ' ' LYS . 21.2 mt-10 -107.94 114.51 28.48 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 172.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' MET . . . . . . . . . . . . . 47.0 ttp -83.55 129.87 34.98 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.238 0.542 . . . . 0.0 110.244 -170.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 63.9 m -77.27 129.15 78.72 Favored Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -171.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.437 ' HB2' ' HD3' ' A' ' 228' ' ' PRO . 25.2 Cg_exo -64.75 173.41 5.69 Favored 'Trans proline' 0 C--N 1.329 -0.458 0 C-N-CA 123.806 3.004 . . . . 0.0 111.208 164.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.463 ' HB3' ' OE1' ' A' ' 227' ' ' GLN . . . -43.64 -54.15 5.22 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -169.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' GLN . . . . . 0.487 ' CB ' ' HD2' ' A' ' 233' ' ' ARG . 2.1 pm0 -164.22 28.67 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.809 0 CA-C-O 118.765 -0.636 . . . . 0.0 112.266 -176.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.437 ' HD3' ' HB2' ' A' ' 225' ' ' PRO . 63.3 Cg_exo -19.63 63.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.237 1 C-N-CA 125.664 4.243 . . . . 0.0 116.77 -155.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.587 ' CE1' ' HB2' ' A' ' 211' ' ' ALA . 28.3 m80 -135.76 155.44 78.05 Favored Pre-proline 0 C--N 1.324 -0.521 0 O-C-N 121.982 -0.449 . . . . 0.0 110.469 -178.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -92.47 35.48 0.24 Allowed 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.35 2.033 . . . . 0.0 110.587 165.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' CYS . . . . . . . . . . . . . 9.9 t -162.77 -167.36 1.52 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.636 -176.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.622 ' HB2' ' CD1' ' A' ' 235' ' ' PHE . 88.9 mtt180 -67.12 149.53 50.41 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -174.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.487 ' HD2' ' CB ' ' A' ' 227' ' ' GLN . 34.9 mmm-85 -35.11 -64.1 0.29 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.868 0.867 . . . . 0.0 112.921 175.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.647 ' HA2' ' CG2' ' A' ' 212' ' ' THR . . . -82.96 16.04 29.47 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.424 -0.894 . . . . 0.0 114.35 -168.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . 0.622 ' CD1' ' HB2' ' A' ' 232' ' ' ARG . 7.0 m-85 -119.96 137.98 53.73 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 121.847 0.832 . . . . 0.0 112.063 -173.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.419 HD13 ' C ' ' A' ' 235' ' ' PHE . 0.0 OUTLIER -121.79 141.74 34.54 Favored Pre-proline 0 C--N 1.311 -1.107 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 175.626 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.68 124.0 10.69 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.534 2.156 . . . . 0.0 112.473 -176.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -55.26 139.78 41.33 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.563 171.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 34.2 mt -77.29 -16.53 14.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.089 -173.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 240' ' ' ARG . 19.3 mtp180 -101.13 -61.26 1.39 Allowed 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.775 -175.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 40.7 p -82.09 -38.95 24.09 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.377 -176.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 94.11 5.89 62.05 Favored Glycine 0 N--CA 1.437 -1.296 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.062 -176.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -78.23 139.88 38.91 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 121.79 0.805 . . . . 0.0 110.919 -178.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' CYS . . . . . 0.402 ' HB3' ' HB3' ' A' ' 235' ' ' PHE . 63.7 m -62.64 122.41 15.76 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.743 -1.571 . . . . 0.0 110.146 174.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 235' ' ' PHE . 81.0 mm-40 -122.7 133.16 54.51 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 176.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.608 ' HA ' ' O ' ' A' ' 234' ' ' GLY . 1.8 t70 -75.54 151.57 37.9 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.787 HG11 HD11 ' A' ' 208' ' ' LEU . 8.6 m -97.02 145.25 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.451 -177.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -75.75 76.46 2.71 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 169.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.711 ' HG3' HG23 ' A' ' 247' ' ' VAL . 34.1 mp0 -54.11 -33.36 57.54 Favored 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 123.98 0.8 . . . . 0.0 110.359 -169.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 35.1 m -51.1 -42.67 60.79 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.812 174.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -96.58 -34.81 11.3 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.768 0.794 . . . . 0.0 110.268 -177.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.532 ' HB1' HD21 ' A' ' 208' ' ' LEU . . . -73.13 -20.03 61.01 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.482 -176.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.714 ' O ' ' HG ' ' A' ' 256' ' ' LEU . 5.2 mp -140.54 81.46 17.32 Favored Pre-proline 0 N--CA 1.451 -0.376 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.464 ' HD2' HG13 ' A' ' 202' ' ' ILE . 16.5 Cg_exo -71.37 31.53 0.24 Allowed 'Trans proline' 0 CA--C 1.515 -0.474 0 C-N-CA 123.373 2.716 . . . . 0.0 113.025 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . 0.528 ' H ' ' C ' ' A' ' 253' ' ' ILE . . . -123.39 2.39 9.59 Favored Glycine 0 C--N 1.288 -2.119 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.484 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.714 ' HG ' ' O ' ' A' ' 253' ' ' ILE . 23.2 mt -65.75 -147.17 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 175.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 284' ' ' GLN . 76.1 m -38.55 128.16 1.46 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.394 0.677 . . . . 0.0 112.698 -174.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -79.73 68.77 5.89 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.998 -174.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 107.24 171.35 22.27 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.914 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 85.66 -154.73 28.56 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.203 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -109.64 138.68 45.65 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 50.2 t -122.48 138.57 54.51 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 173.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.489 HD11 ' HE2' ' A' ' 272' ' ' LYS . 20.9 mt -131.26 164.9 33.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 -174.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.454 ' ND2' ' HB3' ' A' ' 269' ' ' PHE . 0.8 OUTLIER -131.29 125.36 32.61 Favored 'General case' 0 CA--C 1.497 -1.062 0 C-N-CA 117.53 -1.668 . . . . 0.0 114.038 -175.375 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.0 t -109.26 163.87 12.98 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 122.333 1.063 . . . . 0.0 110.072 166.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.54 ' HA ' ' CG ' ' A' ' 246' ' ' ASP . 35.7 m -73.23 127.5 35.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 268' ' ' SER . . . 98.45 -12.63 63.19 Favored Glycine 0 C--N 1.311 -0.848 0 C-N-CA 119.523 -1.322 . . . . 0.0 111.999 -176.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 267' ' ' GLY . 10.5 t 176.44 162.51 0.39 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.112 1.456 . . . . 0.0 110.858 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . 0.534 ' CZ ' HD13 ' A' ' 256' ' ' LEU . 46.0 p90 -107.26 162.59 13.76 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.233 -0.917 . . . . 0.0 109.56 177.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -116.75 156.55 26.98 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.81 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 56.8 m -136.68 158.54 44.2 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.576 0.703 . . . . 0.0 112.338 172.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.489 ' HE2' HD11 ' A' ' 263' ' ' ILE . 50.0 mtmt -139.68 130.13 25.55 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.141 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . 0.427 ' HB3' ' HD2' ' A' ' 274' ' ' PRO . 19.6 m -122.12 173.03 4.47 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.992 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.446 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 53.1 Cg_exo -56.21 155.07 25.77 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.862 1.708 . . . . 0.0 110.141 167.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -58.04 156.94 8.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.139 0.495 . . . . 0.0 111.376 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 86.51 -36.97 3.17 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.255 -176.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' HIS . . . . . 0.69 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 18.1 m-70 -69.63 153.41 43.47 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.08 0.466 . . . . 0.0 111.639 -177.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 286' ' ' CYS . 54.7 mttp -144.96 139.44 27.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.487 -175.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 285' ' ' LYS . 45.9 tp -76.07 140.93 42.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.396 0.617 . . . . 0.0 111.85 -175.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -127.07 102.54 7.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.903 173.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -57.8 -27.98 63.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.292 -175.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 66.4 t -56.3 -33.4 37.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.133 0.492 . . . . 0.0 111.513 -175.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 8.3 p -137.83 28.21 2.66 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.015 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 0.607 ' O ' ' HA ' ' A' ' 257' ' ' CYS . 0.9 OUTLIER 35.16 43.87 0.13 Allowed 'General case' 0 C--N 1.349 0.584 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.662 -169.602 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . 0.442 ' O ' HD12 ' A' ' 279' ' ' LEU . 66.6 tttt -94.64 166.15 12.16 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -172.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 278' ' ' LYS . 12.4 t -156.93 106.06 2.21 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.596 -178.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.69 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 37.4 tt0 . . . . . 0 C--N 1.315 -0.901 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.86 -2.91 57.39 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.849 0.357 . . . . 0.0 110.846 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.5 t 63.23 30.91 15.79 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.536 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -127.71 117.24 21.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.29 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.7 p -79.8 118.75 21.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.438 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 74.5 mt -77.35 121.0 28.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.143 -175.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -82.58 178.51 8.17 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.191 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -61.67 -39.58 91.9 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.197 -0.201 . . . . 0.0 110.947 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 37.4 t -173.36 -97.15 0.01 OUTLIER 'General case' 0 C--O 1.231 0.101 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 173.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -128.91 -58.22 1.16 Allowed 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 119.826 -0.749 . . . . 0.0 112.599 -175.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.564 HD11 ' C ' ' A' ' 133' ' ' HIS . 0.2 OUTLIER -169.88 -165.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.646 -170.106 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.652 ' HD3' ' H ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -100.96 123.58 45.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.035 171.438 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 39.1 m -118.93 144.1 46.64 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 54.0 mtm -135.24 165.9 24.35 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 172.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.406 ' ND2' ' HA2' ' A' ' 146' ' ' GLY . 90.1 m-20 63.87 49.65 2.8 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.23 0.538 . . . . 0.0 110.841 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.472 ' HA3' ' CD ' ' A' ' 137' ' ' GLN . . . 67.1 25.39 73.4 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.077 -0.965 . . . . 0.0 113.256 176.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 135' ' ' LEU . . . -72.09 125.29 10.8 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.089 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 135' ' ' LEU . 36.0 m -91.88 150.16 21.19 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -69.73 118.73 12.96 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.083 0.468 . . . . 0.0 110.012 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.432 ' OG ' ' HG ' ' A' ' 135' ' ' LEU . 5.9 p -142.33 162.94 34.2 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.308 -176.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -47.75 82.6 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -166.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 59.54 35.26 22.65 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.205 -1.361 . . . . 0.0 109.796 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.564 ' C ' HD11 ' A' ' 121' ' ' ILE . 2.5 p-80 -166.52 174.6 8.74 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.108 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 9.8 t -120.34 139.69 52.4 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.073 0.463 . . . . 0.0 111.403 -171.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.445 ' O ' ' HA2' ' A' ' 127' ' ' GLY . 94.1 mt -95.78 103.82 15.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.454 176.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 60.5 m -72.12 147.83 46.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.743 -174.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.472 ' CD ' ' HA3' ' A' ' 126' ' ' GLY . 24.6 mt-30 -80.29 -177.94 6.37 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.047 174.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -52.77 113.23 1.01 Allowed 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.198 0.999 . . . . 0.0 111.64 -174.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.46 21.17 58.85 Favored Glycine 0 C--N 1.296 -1.684 0 CA-C-N 112.698 -2.046 . . . . 0.0 114.51 170.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.411 ' CE1' ' HD3' ' A' ' 163' ' ' PRO . 74.4 m-85 -119.52 145.17 46.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 119.736 1.768 . . . . 0.0 111.545 177.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 34.0 pt -129.87 176.8 7.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.592 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.73 165.73 31.83 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.187 -176.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 40.3 p -64.98 -36.93 85.99 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -106.25 16.1 25.31 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.037 0.446 . . . . 0.0 110.264 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 60.3 m 55.98 36.82 28.04 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.131 173.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.406 ' HA2' ' ND2' ' A' ' 125' ' ' ASN . . . -94.25 -2.24 64.13 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.793 -175.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.88 113.67 60.87 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 117.752 0.776 . . . . 0.0 110.804 -176.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.89 143.87 23.72 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.96 2.44 . . . . 0.0 112.507 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 149' ' ' VAL . 9.3 p -78.07 110.47 13.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.867 0.842 . . . . 0.0 111.953 -175.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.64 76.73 7.51 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.37 172.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -58.36 -62.61 1.72 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -170.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.3 m -86.36 8.87 19.81 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.586 0.708 . . . . 0.0 109.815 -170.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 74.7 131.78 0.25 Allowed Glycine 0 N--CA 1.428 -1.881 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.149 -172.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.442 ' O ' HD23 ' A' ' 155' ' ' LEU . 77.3 m -71.86 157.75 37.31 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 175.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 154' ' ' CYS . 55.6 mt -129.03 165.26 21.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.907 -170.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.807 ' OD1' ' HB ' ' A' ' 169' ' ' THR . 2.3 t-20 49.53 30.97 3.76 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.837 0.711 . . . . 0.0 111.229 -168.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.68 37.25 82.56 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.219 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -73.65 -145.94 0.88 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.414 -0.422 . . . . 0.0 112.958 -175.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' A' ' 166' ' ' CYS . 21.5 tpt180 -148.37 121.97 9.19 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.881 -174.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 166' ' ' CYS . 0.8 OUTLIER -72.96 108.34 5.83 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.41 173.584 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 165' ' ' ARG . 4.4 m -94.46 -37.25 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.392 -177.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.546 ' HB1' ' HD2' ' A' ' 163' ' ' PRO . . . -133.58 177.85 2.05 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 168.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.546 ' HD2' ' HB1' ' A' ' 162' ' ' ALA . 88.0 Cg_exo -50.2 107.04 0.14 Allowed 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.383 2.055 . . . . 0.0 113.608 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 64.49 6.61 3.21 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.165 0.986 . . . . 0.0 110.517 -178.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.593 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -92.33 75.53 5.27 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.722 177.106 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 61.4 m -84.34 146.98 27.43 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.188 0.518 . . . . 0.0 110.334 176.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -98.07 144.5 27.5 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 57.7 m -102.96 122.88 45.5 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 124.449 1.093 . . . . 0.0 112.007 -166.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.807 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 93.7 m -61.24 -55.44 31.96 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.423 ' CG ' ' N ' ' A' ' 171' ' ' GLY . 79.6 t80 -132.2 -116.48 0.22 Allowed 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.269 -0.972 . . . . 0.0 112.277 -168.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.423 ' N ' ' CG ' ' A' ' 170' ' ' TYR . . . -87.63 55.51 4.43 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.742 -166.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.573 ' N ' ' CD1' ' A' ' 172' ' ' PHE . 2.1 m-85 -123.99 122.17 37.21 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.273 171.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.468 ' O ' ' HG2' ' A' ' 179' ' ' ARG . 3.1 t -86.36 163.65 17.52 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 166.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 84.75 125.19 1.33 Allowed Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 -176.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.56 19.86 0.53 Allowed 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 121.471 1.447 . . . . 0.0 114.033 -165.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -122.95 3.82 9.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.813 0.816 . . . . 0.0 109.682 175.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.481 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 0.0 OUTLIER 39.06 51.79 1.97 Allowed 'General case' 0 C--N 1.346 0.444 0 CA-C-N 114.141 -1.391 . . . . 0.0 114.537 -179.44 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -106.82 -16.62 14.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.283 0.563 . . . . 0.0 109.854 174.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 173' ' ' THR . 19.7 mmm180 -56.62 -70.38 0.12 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.809 -174.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 41.1 t0 77.02 69.6 0.06 Allowed 'General case' 0 CA--C 1.502 -0.866 0 CA-C-O 121.907 0.86 . . . . 0.0 109.519 166.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.444 ' CD1' ' O ' ' A' ' 181' ' ' TYR . 38.6 p90 -86.13 65.85 9.29 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-O 122.741 1.258 . . . . 0.0 107.856 173.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.49 ' O ' ' HZ2' ' A' ' 217' ' ' TRP . 14.4 ptt180 -45.89 123.42 4.47 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.657 -1.61 . . . . 0.0 109.26 172.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 80.9 p -76.7 137.39 39.35 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.458 ' HA3' ' CZ2' ' A' ' 217' ' ' TRP . . . -147.98 143.7 11.46 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -173.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.76 128.64 12.69 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.205 1.936 . . . . 0.0 111.337 174.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.752 ' SG ' ' HD1' ' A' ' 217' ' ' TRP . 92.4 m -84.23 119.01 24.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.417 0.627 . . . . 0.0 110.947 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . 0.587 ' HB3' ' O ' ' A' ' 195' ' ' CYS . 69.1 m-85 -95.34 144.75 25.63 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.958 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.529 ' O ' ' HD2' ' A' ' 215' ' ' ARG . 20.2 p -108.98 -6.04 15.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -167.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.5 p -167.28 116.17 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.502 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.553 HG12 ' HA ' ' A' ' 195' ' ' CYS . 3.1 mt -133.86 127.07 51.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -170.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.9 m -128.33 -166.08 1.58 Allowed 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 160.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -63.04 -5.99 3.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 118.943 0.792 . . . . 0.0 110.453 173.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -76.95 -72.75 0.33 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.293 -177.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.517 ' SD ' ' HA2' ' A' ' 197' ' ' GLY . 13.6 ttt -149.96 160.09 43.88 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -173.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.587 ' O ' ' HB3' ' A' ' 187' ' ' PHE . 61.4 m -90.15 -32.17 16.76 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.167 0.508 . . . . 0.0 111.669 -176.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.469 ' HG3' ' OG1' ' A' ' 188' ' ' THR . 62.3 tt0 -148.09 -74.74 0.19 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.463 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.517 ' HA2' ' SD ' ' A' ' 194' ' ' MET . . . 125.78 -29.34 4.71 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -95.68 -24.2 16.65 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 119.845 -0.122 . . . . 0.0 111.206 173.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 58.57 79.81 0.2 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.266 0.555 . . . . 0.0 111.258 177.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 44.2 t -100.27 144.88 28.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.482 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -92.11 29.29 7.69 Favored Glycine 0 CA--C 1.499 -0.951 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 175.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.612 HG23 ' H ' ' A' ' 186' ' ' CYS . 0.0 OUTLIER -60.98 106.64 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 121.783 0.801 . . . . 0.0 108.843 173.107 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.0 t -94.69 123.9 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.816 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 16.7 t -155.24 -178.15 7.05 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.4 p -101.66 159.29 15.44 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 120.434 1.47 . . . . 0.0 109.311 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.54 ' HB2' ' CE3' ' A' ' 217' ' ' TRP . 42.2 tttm -56.11 -44.97 79.62 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 120.284 -0.567 . . . . 0.0 109.885 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.5 m -43.87 -56.81 3.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.371 173.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.526 HD11 HG11 ' A' ' 247' ' ' VAL . 0.2 OUTLIER -55.58 -55.09 36.04 Favored 'General case' 0 CA--C 1.518 -0.261 0 O-C-N 123.755 0.659 . . . . 0.0 112.036 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . . . . . . . . . 53.8 m -75.39 -18.7 59.88 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -171.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 79.9 m -89.67 -39.46 13.18 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 121.74 -0.6 . . . . 0.0 111.28 174.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . . . -67.8 -57.0 7.04 Favored 'General case' 0 C--N 1.345 0.383 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.689 HG22 ' HA2' ' A' ' 234' ' ' GLY . 18.8 p -94.08 157.45 16.08 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.346 174.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.1 t 68.42 -46.73 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 176.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 60.05 59.51 10.3 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 120.737 -0.744 . . . . 0.0 114.638 170.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.529 ' HD2' ' O ' ' A' ' 188' ' ' THR . 30.1 mmt180 -124.85 -84.95 0.64 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 117.525 0.663 . . . . 0.0 110.466 177.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.409 ' CB ' ' HA ' ' A' ' 223' ' ' MET . . . -169.32 165.75 10.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . 0.752 ' HD1' ' SG ' ' A' ' 186' ' ' CYS . 18.5 t90 -153.39 148.4 26.66 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.552 0.215 . . . . 0.0 110.656 -175.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 221' ' ' CYS . . . 78.37 163.23 22.47 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 115.086 0.795 . . . . 0.0 115.086 167.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.513 ' HA ' ' C ' ' A' ' 220' ' ' PRO . 6.6 m80 -116.09 132.22 23.36 Favored Pre-proline 0 N--CA 1.453 -0.294 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 168.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.513 ' C ' ' HA ' ' A' ' 219' ' ' HIS . 25.4 Cg_exo -63.3 151.28 69.42 Favored 'Cis proline' 0 C--O 1.232 0.18 0 C-N-CA 123.593 -1.419 . . . . 0.0 111.516 -2.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 84.9 m -54.99 120.19 6.53 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 124.175 0.922 . . . . 0.0 111.15 -175.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -115.85 121.41 42.3 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' MET . . . . . 0.409 ' HA ' ' CB ' ' A' ' 216' ' ' ALA . 0.0 OUTLIER -100.89 150.23 23.05 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.604 -172.444 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' CYS . . . . . . . . . . . . . 74.1 m -143.35 148.46 44.28 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 120.799 0.333 . . . . 0.0 111.687 -175.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -63.27 168.38 11.13 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.546 2.164 . . . . 0.0 109.94 155.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.8 -118.71 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.997 0.427 . . . . 0.0 110.971 171.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.07 108.52 1.26 Allowed Pre-proline 0 C--N 1.322 -0.623 0 CA-C-O 121.179 0.514 . . . . 0.0 111.91 -174.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 211' ' ' ALA . 55.8 Cg_endo -74.91 -49.53 0.15 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.214 1.943 . . . . 0.0 112.667 -175.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.442 ' HB3' ' CD ' ' A' ' 230' ' ' PRO . 41.2 m80 -94.36 178.99 1.32 Allowed Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.442 ' CD ' ' HB3' ' A' ' 229' ' ' HIS . 36.6 Cg_exo -63.49 -7.5 12.63 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.0 1.134 . . . . 0.0 112.108 173.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' CYS . . . . . 0.495 ' SG ' ' HD3' ' A' ' 237' ' ' PRO . 20.0 t -65.4 144.61 56.96 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.712 ' HB2' ' CD2' ' A' ' 235' ' ' PHE . 31.4 mmt180 -75.07 142.77 43.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.361 -174.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.47 ' HG3' ' N ' ' A' ' 234' ' ' GLY . 28.0 ptt-85 -37.78 -53.57 1.27 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.496 1.123 . . . . 0.0 113.06 -177.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.689 ' HA2' HG22 ' A' ' 212' ' ' THR . . . -71.15 0.36 31.62 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.22 -0.514 . . . . 0.0 114.224 -172.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . 0.801 ' CE2' ' HA2' ' A' ' 267' ' ' GLY . 1.8 m-85 -123.1 166.67 14.78 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 118.352 1.076 . . . . 0.0 111.843 -175.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.51 HD13 ' O ' ' A' ' 235' ' ' PHE . 0.2 OUTLIER -130.54 128.0 22.47 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 113.623 -1.626 . . . . 0.0 107.59 169.326 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.495 ' HD3' ' SG ' ' A' ' 231' ' ' CYS . 14.2 Cg_endo -61.03 117.61 4.4 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.321 2.014 . . . . 0.0 112.075 178.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -55.96 134.69 52.41 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.114 177.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 39.0 mt -73.98 -11.21 14.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.607 175.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -98.04 -58.1 2.06 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.296 -175.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 31.3 p -93.05 -43.8 8.71 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.777 -177.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 102.01 7.36 47.24 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -178.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -94.14 128.73 40.73 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.959 0.885 . . . . 0.0 109.797 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' CYS . . . . . 0.409 ' HB3' ' CB ' ' A' ' 235' ' ' PHE . 86.6 m -51.32 117.92 2.93 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.167 -1.833 . . . . 0.0 109.867 169.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -121.24 131.24 54.11 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.642 ' HB3' HG13 ' A' ' 266' ' ' VAL . 4.3 t70 -79.14 150.34 31.77 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 121.297 0.57 . . . . 0.0 110.384 -170.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.734 HG23 ' HG3' ' A' ' 249' ' ' GLU . 8.9 m -100.79 145.39 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.948 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.552 -178.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.455 ' HA ' ' CG ' ' A' ' 264' ' ' ASN . 2.2 m-20 -74.24 76.85 1.82 Allowed 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 167.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.734 ' HG3' HG23 ' A' ' 247' ' ' VAL . 55.4 mp0 -52.76 -35.07 55.67 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 123.722 0.639 . . . . 0.0 110.66 -170.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 32.3 m -53.88 -29.16 40.36 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.205 175.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -106.67 -47.44 3.75 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.633 0.73 . . . . 0.0 110.309 -175.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -63.15 -25.57 68.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.612 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.755 HG22 ' HB3' ' A' ' 256' ' ' LEU . 4.7 mp -122.65 79.96 47.97 Favored Pre-proline 0 C--O 1.243 0.726 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 173.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.525 ' HG2' HG12 ' A' ' 202' ' ' ILE . 10.2 Cg_endo -51.27 118.79 4.65 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.489 2.793 . . . . 0.0 114.649 -165.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 59.11 30.83 67.68 Favored Glycine 0 C--N 1.317 -0.518 0 CA-C-N 113.839 -1.528 . . . . 0.0 114.103 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.755 ' HB3' HG22 ' A' ' 253' ' ' ILE . 1.3 pt? -68.27 -25.79 65.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.565 0.683 . . . . 0.0 111.44 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 284' ' ' GLN . 48.2 t -102.66 82.39 2.13 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.581 0.705 . . . . 0.0 110.081 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -85.07 116.31 23.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.1 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 165.55 -41.25 0.28 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -170.63 -116.6 0.39 Allowed Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.502 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . 0.471 ' HB3' ' HB2' ' A' ' 272' ' ' LYS . 2.8 t-20 -98.78 157.56 16.21 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -175.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 32.6 t -140.45 133.61 29.55 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 28.4 mt -138.13 116.72 13.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.022 0.439 . . . . 0.0 110.54 -169.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.455 ' CG ' ' HA ' ' A' ' 248' ' ' ASP . 64.4 t30 -77.1 121.29 23.38 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.655 -174.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 8.4 t -106.3 160.9 15.02 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.661 157.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.768 HG12 ' CE1' ' A' ' 235' ' ' PHE . 1.7 t -72.39 119.52 19.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.801 ' HA2' ' CE2' ' A' ' 235' ' ' PHE . . . 113.71 -22.33 14.95 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.376 -174.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 267' ' ' GLY . 15.6 t 174.21 163.65 0.2 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.566 0.698 . . . . 0.0 111.103 -173.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . 0.402 ' CD1' ' HB2' ' A' ' 249' ' ' GLU . 13.1 p90 -111.48 153.53 26.03 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.231 -0.988 . . . . 0.0 108.759 177.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -111.64 135.85 51.67 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.444 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . . . . . . . . . 64.7 m -109.48 160.33 16.3 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.656 -0.817 . . . . 0.0 111.142 178.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 261' ' ' ASN . 28.5 mmmt -135.35 95.38 3.27 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.47 176.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 13.7 m -76.05 161.29 75.98 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.161 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.433 ' O ' ' HB2' ' A' ' 277' ' ' HIS . 27.7 Cg_exo -61.66 159.55 32.13 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 121.907 1.738 . . . . 0.0 109.968 170.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -57.76 145.73 33.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.515 0.197 . . . . 0.0 111.059 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.86 -28.9 3.89 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.13 -177.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' HIS . . . . . 0.707 ' HA ' ' O ' ' A' ' 287' ' ' GLU . 17.1 m-70 -78.68 166.37 22.58 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 120.833 0.349 . . . . 0.0 111.228 -177.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -137.82 138.76 39.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.147 -176.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.625 ' HA ' ' O ' ' A' ' 285' ' ' LYS . 51.4 tp -80.01 123.7 28.06 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.819 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.598 ' HB3' ' HB3' ' A' ' 285' ' ' LYS . 47.0 t30 -113.85 110.25 19.82 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.418 ' HA ' ' OE1' ' A' ' 284' ' ' GLN . 32.6 mt-10 -64.25 -14.96 58.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.717 -170.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.489 ' O ' ' HB ' ' A' ' 188' ' ' THR . 63.7 t -56.51 -38.84 58.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.908 0.385 . . . . 0.0 110.978 178.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 42.6 m -146.02 36.22 1.03 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.644 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 256' ' ' LEU . 8.3 mm100 34.49 48.32 0.28 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.41 0.684 . . . . 0.0 111.853 -170.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . 0.625 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 84.8 tttt -82.68 154.9 24.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.583 -172.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' CYS . . . . . . . . . . . . . 23.2 m -141.02 85.75 2.0 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.707 ' O ' ' HA ' ' A' ' 277' ' ' HIS . 19.0 mm-40 . . . . . 0 C--O 1.239 0.54 0 CA-C-O 118.392 -0.813 . . . . 0.0 108.904 -173.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_